Labeling Type,Dosage Form(s),Route(s) of Administration,Marketing Category,Application Number(s),Trade Name,Generic/Proper Name(s),SPL Effective Date (Month/Day/Year),Established Pharmacologic Class(es),Initial U.S. Approval,Company,Marketing Date(s) (YYYY/MM/DD),NDC(s),Active Ingredient UNII(s),Active Ingredient(s),Active Moiety Name(s),Active Moiety UNII(s),FDALabel Link,DailyMed SPL Link,DailyMed PDF Link,SET ID,Query Link for Entire Search Output,Result Link for Entire Search Output,Export Date (YYYY/MM/DD) and Time for Entire Search Output
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION,ORAL,NDA,212690,XYWAV,"(CALCIUM, MAGNESIUM, POTASSIUM, AND SODIUM OXYBATES)",2023/04/25,Central Nervous System Depressant,2002,JAZZ PHARMACEUTICALS INC,2020/11/02-,68727-150,7G33012534; 8W24SYD6ZI; G983HLV265; S8NKF3H3KT,Calcium Oxybate; Magnesium Oxybate; Potassium Oxybate; SODIUM OXYBATE,OXYBATE,30IW36W5B2,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/1e0ae43a-037f-42af-8e23-a0e51d75abe8/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1e0ae43a-037f-42af-8e23-a0e51d75abe8,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=1e0ae43a-037f-42af-8e23-a0e51d75abe8,1e0ae43a-037f-42af-8e23-a0e51d75abe8,https://fdalabel.fda.gov:8443/fdalabel/ui/search/spl-summaries/criteria/109276,https://fdalabel.fda.gov:8443/fdalabel/ui/spl-summaries/criteria/109276,2024/05/27 20:02:18 (US/Eastern)
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION,AURICULAR (OTIC),NDA,208251,OTOVEL,(CIPROFLOXACIN AND FLUOCINOLONE ACETONIDE),2019/09/12,Corticosteroid; Fluoroquinolone Antibacterial,2016,ARBOR PHARMACEUTICALS,2016/04/29-,24338-080,0CD5FD6S2M; 5E8K9I0O4U,CIPROFLOXACIN; FLUOCINOLONE ACETONIDE,CIPROFLOXACIN; FLUOCINOLONE ACETONIDE,0CD5FD6S2M; 5E8K9I0O4U,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/1a7e4806-3138-4b7a-b798-a99e163ee846/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1a7e4806-3138-4b7a-b798-a99e163ee846,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=1a7e4806-3138-4b7a-b798-a99e163ee846,1a7e4806-3138-4b7a-b798-a99e163ee846,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION",INTRAVENOUS,NDA,209401,VYXEOS,(DAUNORUBICIN AND CYTARABINE) LIPOSOME,2022/09/27,Anthracycline Topoisomerase Inhibitor; Nucleoside Metabolic Inhibitor,2017,JAZZ PHARMACEUTICALS INC,2017/08/03-,68727-745,04079A1RDZ; ZS7284E0ZP,CYTARABINE; DAUNORUBICIN,CYTARABINE; DAUNORUBICIN,04079A1RDZ; ZS7284E0ZP,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/7ea701ce-e7d3-4349-a9c2-642a501d45c8/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7ea701ce-e7d3-4349-a9c2-642a501d45c8,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=7ea701ce-e7d3-4349-a9c2-642a501d45c8,7ea701ce-e7d3-4349-a9c2-642a501d45c8,,,
HUMAN PRESCRIPTION DRUG LABEL,KIT,INTRAVENOUS,NDA,208547,NETSPOT,68GA-DOTATATE,2024/05/13,Radioactive Diagnostic Agent,2016,ADVANCED ACCELERATOR APPLICATIONS USA INC,2016/06/01-,69488-001,MRL3739G66,DOTATATE,DOTATATE GALLIUM GA-68,9L17Y0H71P,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/b2b3be70-17d8-4093-896c-f1c54a2cf242/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b2b3be70-17d8-4093-896c-f1c54a2cf242,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=b2b3be70-17d8-4093-896c-f1c54a2cf242,b2b3be70-17d8-4093-896c-f1c54a2cf242,,,
HUMAN PRESCRIPTION DRUG LABEL,"SOLUTION; TABLET, FILM COATED",ORAL,NDA,020977;020978,ZIAGEN,ABACAVIR SULFATE,2023/09/29,Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor,1998,VIIV HEALTHCARE COMPANY,1998/12/29-; 1999/01/28-,49702-221; 49702-222,J220T4J9Q2,ABACAVIR SULFATE,ABACAVIR,WR2TIP26VS,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/ca73b519-015a-436d-aa3c-af53492825a1/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ca73b519-015a-436d-aa3c-af53492825a1,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=ca73b519-015a-436d-aa3c-af53492825a1,ca73b519-015a-436d-aa3c-af53492825a1,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,021652,EPZICOM,ABACAVIR SULFATE AND LAMIVUDINE,2022/12/14,Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor,2004,VIIV HEALTHCARE COMPANY,2010/10/12-,49702-206,2T8Q726O95; J220T4J9Q2,ABACAVIR SULFATE; LAMIVUDINE,ABACAVIR; LAMIVUDINE,2T8Q726O95; WR2TIP26VS,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/f1139e7f-2db9-4961-9da3-9b7f2088736f/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f1139e7f-2db9-4961-9da3-9b7f2088736f,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=f1139e7f-2db9-4961-9da3-9b7f2088736f,f1139e7f-2db9-4961-9da3-9b7f2088736f,,,
HUMAN PRESCRIPTION DRUG LABEL,"KIT; TABLET, FILM COATED",ORAL,NDA,205551;215413,Triumeq; Triumeq PD,"ABACAVIR SULFATE, DOLUTEGRAVIR SODIUM, LAMIVUDINE",2024/04/18,Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor; Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor,2014,VIIV HEALTHCARE COMPANY,2014/08/22-; 2022/03/30-,49702-231; 49702-258,1Q1V9V5WYQ; 2T8Q726O95; J220T4J9Q2,ABACAVIR SULFATE; DOLUTEGRAVIR SODIUM; LAMIVUDINE,ABACAVIR; DOLUTEGRAVIR; LAMIVUDINE,2T8Q726O95; DKO1W9H7M1; WR2TIP26VS,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/2997739a-aa91-42aa-a206-a70e2db7b84f/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2997739a-aa91-42aa-a206-a70e2db7b84f,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=2997739a-aa91-42aa-a206-a70e2db7b84f,2997739a-aa91-42aa-a206-a70e2db7b84f,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,021205,TRIZIVIR,"ABACAVIR SULFATE, LAMIVUDINE, AND ZIDOVUDINE",2021/02/17,Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor,2000,VIIV HEALTHCARE COMPANY,2010/11/02-,49702-217,2T8Q726O95; 4B9XT59T7S; J220T4J9Q2,ABACAVIR SULFATE; LAMIVUDINE; ZIDOVUDINE,ABACAVIR; LAMIVUDINE; ZIDOVUDINE,2T8Q726O95; 4B9XT59T7S; WR2TIP26VS,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/9b32f5a4-d0f7-486b-b699-8dc9202b6869/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9b32f5a4-d0f7-486b-b699-8dc9202b6869,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=9b32f5a4-d0f7-486b-b699-8dc9202b6869,9b32f5a4-d0f7-486b-b699-8dc9202b6869,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",SUBCUTANEOUS,NDA,208743,Tymlos,ABALOPARATIDE,2024/02/08,Parathyroid Hormone-Related Peptide Analog,2017,RADIUS HEALTH INC,2017/05/01-,70539-001,AVK0I6HY2U,ABALOPARATIDE,ABALOPARATIDE,AVK0I6HY2U,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/712143d9-e21e-4013-bb3b-3426a21060a8/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=712143d9-e21e-4013-bb3b-3426a21060a8,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=712143d9-e21e-4013-bb3b-3426a21060a8,712143d9-e21e-4013-bb3b-3426a21060a8,,,
HUMAN PRESCRIPTION DRUG LABEL,LOTION,TOPICAL,NDA,206966,Xeglyze,ABAMETAPIR,2023/12/29,,2020,DR REDDY S LABORATORIES INC,2021/01/29-,43598-921,6UO390AMFB,Abametapir,Abametapir,6UO390AMFB,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/4fe38e95-8738-a28f-4079-43eff7318cb9/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4fe38e95-8738-a28f-4079-43eff7318cb9,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=4fe38e95-8738-a28f-4079-43eff7318cb9,4fe38e95-8738-a28f-4079-43eff7318cb9,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,208716,Verzenio,ABEMACICLIB,2024/01/03,Kinase Inhibitor,2017,ELI LILLY AND COMPANY,2017/09/28-,0002-4483; 0002-4815; 0002-5337; 0002-6216,60UAB198HK,abemaciclib,abemaciclib,60UAB198HK,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/be4bc0de-0fdc-4d46-8d25-be43c79e6a06/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=be4bc0de-0fdc-4d46-8d25-be43c79e6a06,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=be4bc0de-0fdc-4d46-8d25-be43c79e6a06,be4bc0de-0fdc-4d46-8d25-be43c79e6a06,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,210308,YONSA,ABIRATERONE ACETATE,2023/01/16,Cytochrome P450 17A1 Inhibitor,2011,SUN PHARMACEUTICAL INDUSTRIES INC,2018/05/22-,47335-401,EM5OCB9YJ6,ABIRATERONE ACETATE,ABIRATERONE,G819A456D0,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/b8967e10-f768-47ce-ac9e-2324c8390132/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b8967e10-f768-47ce-ac9e-2324c8390132,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=b8967e10-f768-47ce-ac9e-2324c8390132,b8967e10-f768-47ce-ac9e-2324c8390132,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET; TABLET, FILM COATED",ORAL,NDA,202379,Zytiga,ABIRATERONE ACETATE,2021/10/14,Cytochrome P450 17A1 Inhibitor,2011,JANSSEN BIOTECH INC,2011/04/28-; 2017/04/17-,57894-150; 57894-195,EM5OCB9YJ6,Abiraterone acetate; abiraterone acetate,Abiraterone; abiraterone,G819A456D0,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/4e338e89-3cf2-48eb-b6e2-a06c608c6513/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4e338e89-3cf2-48eb-b6e2-a06c608c6513,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=4e338e89-3cf2-48eb-b6e2-a06c608c6513,4e338e89-3cf2-48eb-b6e2-a06c608c6513,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,213871,CIBINQO,ABROCITINIB,2024/01/08,Janus Kinase Inhibitor,2022,U S PHARMACEUTICALS,2022/02/24-,63539-236; 63539-336; 63539-436,73SM5SF3OR,ABROCITINIB,ABROCITINIB,73SM5SF3OR,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/16c12a56-4550-414b-ac9d-b785b41fea6b/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=16c12a56-4550-414b-ac9d-b785b41fea6b,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=16c12a56-4550-414b-ac9d-b785b41fea6b,16c12a56-4550-414b-ac9d-b785b41fea6b,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,213871,Cibinqo,ABROCITINIB,2023/12/21,Janus Kinase Inhibitor,2022,PFIZER LABORATORIES DIV PFIZER INC,2022/02/24-,0069-0235; 0069-0335; 0069-0435,73SM5SF3OR,ABROCITINIB,ABROCITINIB,73SM5SF3OR,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/3f6d6fcd-e9f9-42c8-bfa2-bb2cfc9ed258/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3f6d6fcd-e9f9-42c8-bfa2-bb2cfc9ed258,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=3f6d6fcd-e9f9-42c8-bfa2-bb2cfc9ed258,3f6d6fcd-e9f9-42c8-bfa2-bb2cfc9ed258,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,216387,CALQUENCE,ACALABRUTINIB,2022/08/04,Kinase Inhibitor,2017,ASTRAZENECA PHARMACEUTICALS LP,2022/08/04-,0310-3512,I42748ELQW,ACALABRUTINIB,ACALABRUTINIB,I42748ELQW,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/b1409184-3267-4d8c-8f17-4e01f69828b1/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b1409184-3267-4d8c-8f17-4e01f69828b1,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=b1409184-3267-4d8c-8f17-4e01f69828b1,b1409184-3267-4d8c-8f17-4e01f69828b1,,,
HUMAN PRESCRIPTION DRUG LABEL,"CAPSULE, GELATIN COATED",ORAL,NDA,210259,CALQUENCE,ACALABRUTINIB,2022/03/23,Kinase Inhibitor,2017,ASTRAZENECA PHARMACEUTICALS LP,2017/10/31-,0310-0512,I42748ELQW,ACALABRUTINIB,ACALABRUTINIB,I42748ELQW,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/dd4835ef-e1bc-4997-a399-1ffa2556fbfe/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=dd4835ef-e1bc-4997-a399-1ffa2556fbfe,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=dd4835ef-e1bc-4997-a399-1ffa2556fbfe,dd4835ef-e1bc-4997-a399-1ffa2556fbfe,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,NDA,018917,SECTRAL,ACEBUTOLOL HYDROCHLORIDE,2012/01/12,beta-Adrenergic Blocker,,PROMIUS PHARMA LLC,1984/12/28-,67857-700; 67857-701,B025Y34C54,ACEBUTOLOL HYDROCHLORIDE,ACEBUTOLOL,67P356D8GH,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/7eee95bf-0452-4d6e-9712-33403768695a/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7eee95bf-0452-4d6e-9712-33403768695a,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=7eee95bf-0452-4d6e-9712-33403768695a,7eee95bf-0452-4d6e-9712-33403768695a,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRAVENOUS,NDA,206968,Acetaminophen,ACETAMINOPHEN,2024/04/11,,1951,HIKMA PHARMACEUTICALS USA INC,2022/06/03-,0143-9386,362O9ITL9D,ACETAMINOPHEN,ACETAMINOPHEN,362O9ITL9D,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/88c29438-3648-4b09-bd43-70ad7a35bcb5/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=88c29438-3648-4b09-bd43-70ad7a35bcb5,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=88c29438-3648-4b09-bd43-70ad7a35bcb5,88c29438-3648-4b09-bd43-70ad7a35bcb5,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRAVENOUS,NDA,204957,Acetaminophen,ACETAMINOPHEN,2023/05/18,,1951,B BRAUN MEDICAL INC,2021/02/18-,0264-4050; 0264-4100,362O9ITL9D,ACETAMINOPHEN,ACETAMINOPHEN,362O9ITL9D,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/6d763554-913d-4bed-9efd-b9c9b936a2f4/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6d763554-913d-4bed-9efd-b9c9b936a2f4,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=6d763554-913d-4bed-9efd-b9c9b936a2f4,6d763554-913d-4bed-9efd-b9c9b936a2f4,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRAVENOUS,NDA,204957,Acetaminophen,ACETAMINOPHEN,2022/01/31,,1951,B BRAUN MEDICAL INC,2023/10/10-,0264-4050,362O9ITL9D,ACETAMINOPHEN,ACETAMINOPHEN,362O9ITL9D,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/9744d804-2857-47ef-a27a-bca27db9394c/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9744d804-2857-47ef-a27a-bca27db9394c,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=9744d804-2857-47ef-a27a-bca27db9394c,9744d804-2857-47ef-a27a-bca27db9394c,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,209471,Combogesic,ACETAMINOPHEN AND IBUPROFEN,2023/03/09,Nonsteroidal Anti-inflammatory Drug,2023,AFT PHARMACEUTICALS LTD,2024/03/01-,72260-129,362O9ITL9D; WK2XYI10QM,ACETAMINOPHEN; IBUPROFEN,ACETAMINOPHEN; IBUPROFEN,362O9ITL9D; WK2XYI10QM,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/f863558f-2a44-41f8-a6b7-271851d4c2ff/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f863558f-2a44-41f8-a6b7-271851d4c2ff,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=f863558f-2a44-41f8-a6b7-271851d4c2ff,f863558f-2a44-41f8-a6b7-271851d4c2ff,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRAVENOUS,NDA,215320,COMBOGESIC IV,ACETAMINOPHEN AND IBUPROFEN INJECTION,2024/04/29,Nonsteroidal Anti-inflammatory Drug,2023,HIKMA PHARMACEUTICALS USA INC,2024/02/05-,0143-9150,362O9ITL9D; WK2XYI10QM,ACETAMINOPHEN; IBUPROFEN,ACETAMINOPHEN; IBUPROFEN,362O9ITL9D; WK2XYI10QM,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/be408a5a-48e4-43c0-9cb1-bbf830b54f5b/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=be408a5a-48e4-43c0-9cb1-bbf830b54f5b,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=be408a5a-48e4-43c0-9cb1-bbf830b54f5b,be408a5a-48e4-43c0-9cb1-bbf830b54f5b,,,
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION,AURICULAR (OTIC),NDA,012179,Acetic Acid,ACETIC ACID,2022/09/19,,,AKORN,2010/01/22-,50383-889,Q40Q9N063P,ACETIC ACID,ACETIC ACID,Q40Q9N063P,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/c53fc11e-b177-446e-839d-391e1b2eacff/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c53fc11e-b177-446e-839d-391e1b2eacff,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=c53fc11e-b177-446e-839d-391e1b2eacff,c53fc11e-b177-446e-839d-391e1b2eacff,,,
HUMAN PRESCRIPTION DRUG LABEL,IRRIGANT,IRRIGATION,NDA,017656,Acetic Acid,ACETIC ACID,2020/06/17,,,ICU MEDICAL INC,2019/11/25-,0990-6143,Q40Q9N063P,ACETIC ACID,ACETIC ACID,Q40Q9N063P,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/bc5b936e-eaf4-4814-a087-ee4446fb667a/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=bc5b936e-eaf4-4814-a087-ee4446fb667a,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=bc5b936e-eaf4-4814-a087-ee4446fb667a,bc5b936e-eaf4-4814-a087-ee4446fb667a,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,018749,Lithostat,ACETOHYDROXAMIC ACID,2024/01/08,Urease Inhibitor,,MISSION PHARMACAL COMPANY,1983/05/31-,0178-0500,4RZ82L2GY5,ACETOHYDROXAMIC ACID,ACETOHYDROXAMIC ACID,4RZ82L2GY5,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/6660b616-a82d-9109-19ce-2bdf9747acea/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6660b616-a82d-9109-19ce-2bdf9747acea,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=6660b616-a82d-9109-19ce-2bdf9747acea,6660b616-a82d-9109-19ce-2bdf9747acea,,,
HUMAN PRESCRIPTION DRUG LABEL,KIT,INTRAOCULAR,NDA,020213,Miochol E,ACETYLCHOLINE CHLORIDE,2023/03/17,Cholinergic Receptor Agonist,,BAUSCH AND LOMB INCORPORATED,1993/09/22-,24208-539,AF73293C2R,ACETYLCHOLINE CHLORIDE,ACETYLCHOLINE,N9YNS0M02X,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/e701ef07-9499-4b56-931f-f4eb3eedbe24/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e701ef07-9499-4b56-931f-f4eb3eedbe24,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=e701ef07-9499-4b56-931f-f4eb3eedbe24,e701ef07-9499-4b56-931f-f4eb3eedbe24,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,021539,ACETADOTE,ACETYLCYSTEINE,2023/01/27,Antidote; Antidote for Acetaminophen Overdose; Mucolytic,2004,CUMBERLAND PHARMACEUTICALS INC,2004/01/23-,66220-207,WYQ7N0BPYC,Acetylcysteine,Acetylcysteine,WYQ7N0BPYC,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/472f158a-5ab9-4308-8e49-1116e6ea3d39/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=472f158a-5ab9-4308-8e49-1116e6ea3d39,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=472f158a-5ab9-4308-8e49-1116e6ea3d39,472f158a-5ab9-4308-8e49-1116e6ea3d39,,,
HUMAN PRESCRIPTION DRUG LABEL,"CAPSULE, EXTENDED RELEASE",ORAL,NDA,200671,DURLAZA,ACETYLSALICYLIC ACID,2015/09/25,Nonsteroidal Anti-inflammatory Drug; Platelet Aggregation Inhibitor,2015,NEW HAVEN PHARMACEUTICALS INC,2015/09/25-,58487-001,R16CO5Y76E,Aspirin,Aspirin,R16CO5Y76E,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/4c2a1403-3862-1efd-0a91-444989222b37/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4c2a1403-3862-1efd-0a91-444989222b37,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=4c2a1403-3862-1efd-0a91-444989222b37,4c2a1403-3862-1efd-0a91-444989222b37,,,
HUMAN PRESCRIPTION DRUG LABEL,"POWDER, METERED",INHALATION,NDA,202450,Tudorza Pressair,ACLIDINIUM BROMIDE,2022/08/01,Anticholinergic,2012,COVIS PHARMA US INC,2015/07/01-,70515-002,UQW7UF9N91,ACLIDINIUM BROMIDE,ACLIDINIUM,K17VY42F6C,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/6f92cceb-a63f-4470-99b6-56179d98f10f/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6f92cceb-a63f-4470-99b6-56179d98f10f,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=6f92cceb-a63f-4470-99b6-56179d98f10f,6f92cceb-a63f-4470-99b6-56179d98f10f,,,
HUMAN PRESCRIPTION DRUG LABEL,"POWDER, METERED",INHALATION,NDA,202450,Tudorza Pressair,ACLIDINIUM BROMIDE,2021/02/23,Anticholinergic,2012,ASTRAZENECA PHARMACEUTICALS LP,completed:2015/07/01-2024/07/31,0310-0800,UQW7UF9N91,ACLIDINIUM BROMIDE,ACLIDINIUM,K17VY42F6C,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/acdd5932-375b-4966-8a06-3806ab74c36d/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=acdd5932-375b-4966-8a06-3806ab74c36d,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=acdd5932-375b-4966-8a06-3806ab74c36d,acdd5932-375b-4966-8a06-3806ab74c36d,,,
HUMAN PRESCRIPTION DRUG LABEL,"POWDER, METERED",INHALATION,NDA,210595,DUAKLIR PRESSAIR,ACLIDINIUM BROMIDE AND FORMOTEROL FUMARATE,2022/08/01,Anticholinergic; beta2-Adrenergic Agonist,2019,COVIS PHARMA US INC,2019/03/29-,70515-001,UQW7UF9N91; W34SHF8J2K,ACLIDINIUM BROMIDE; FORMOTEROL FUMARATE,ACLIDINIUM; FORMOTEROL,5ZZ84GCW8B; K17VY42F6C,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/2eba3089-28b4-4190-9fba-2511246cfd16/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2eba3089-28b4-4190-9fba-2511246cfd16,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=2eba3089-28b4-4190-9fba-2511246cfd16,2eba3089-28b4-4190-9fba-2511246cfd16,,,
HUMAN PRESCRIPTION DRUG LABEL,"POWDER, METERED",INHALATION,NDA,210595,DUAKLIR PRESSAIR,ACLIDINIUM BROMIDE AND FORMOTEROL FUMARATE,2022/01/25,Anticholinergic; beta2-Adrenergic Agonist,2019,ASTRAZENECA PHARMACEUTICALS LP,completed:2022/08/17-2025/04/30,0310-0900,UQW7UF9N91; W34SHF8J2K,ACLIDINIUM BROMIDE; FORMOTEROL FUMARATE,ACLIDINIUM; FORMOTEROL,5ZZ84GCW8B; K17VY42F6C,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/8fdb44a3-4fe3-451c-b18f-d458c04fe7eb/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8fdb44a3-4fe3-451c-b18f-d458c04fe7eb,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=8fdb44a3-4fe3-451c-b18f-d458c04fe7eb,8fdb44a3-4fe3-451c-b18f-d458c04fe7eb,,,
HUMAN PRESCRIPTION DRUG LABEL,CREAM,TOPICAL,NDA,021478,Zovirax,ACYCLOVIR,2021/02/01,Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor; Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor; Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor,2002,BAUSCH HEALTH US LLC,2002/12/30-,0187-0994,X4HES1O11F,acyclovir,acyclovir,X4HES1O11F,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/125dbe4e-94ba-45bd-a714-f9c4b8e8b5c2/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=125dbe4e-94ba-45bd-a714-f9c4b8e8b5c2,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=125dbe4e-94ba-45bd-a714-f9c4b8e8b5c2,125dbe4e-94ba-45bd-a714-f9c4b8e8b5c2,,,
HUMAN PRESCRIPTION DRUG LABEL,OINTMENT,TOPICAL,NDA,018604,Zovirax,ACYCLOVIR,2020/10/31,Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor; Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor; Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor,,BAUSCH HEALTH US LLC,1982/03/29-,0187-0993,X4HES1O11F,acyclovir,acyclovir,X4HES1O11F,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/50278e0e-da1e-45ee-9fcb-672b2a219911/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=50278e0e-da1e-45ee-9fcb-672b2a219911,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=50278e0e-da1e-45ee-9fcb-672b2a219911,50278e0e-da1e-45ee-9fcb-672b2a219911,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, DELAYED RELEASE",BUCCAL,NDA,203791,Sitavig,ACYCLOVIR,2020/06/11,Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor; Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor; Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor,1982,EPI HEALTH INC,2014/03/20-,71403-049,X4HES1O11F,ACYCLOVIR,ACYCLOVIR,X4HES1O11F,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/cd6e902d-5753-49ec-bec8-b27176ed978e/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=cd6e902d-5753-49ec-bec8-b27176ed978e,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=cd6e902d-5753-49ec-bec8-b27176ed978e,cd6e902d-5753-49ec-bec8-b27176ed978e,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, DELAYED RELEASE",BUCCAL,NDA,203791,Sitavig,ACYCLOVIR,2017/04/18,Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor; Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor; Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor,,CIPHER PHARMACEUTICALS US LLC,2014/03/20-,68712-049,X4HES1O11F,ACYCLOVIR,ACYCLOVIR,X4HES1O11F,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/00f7425a-6236-47ff-a087-f28f8cdb1aec/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=00f7425a-6236-47ff-a087-f28f8cdb1aec,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=00f7425a-6236-47ff-a087-f28f8cdb1aec,00f7425a-6236-47ff-a087-f28f8cdb1aec,,,
HUMAN PRESCRIPTION DRUG LABEL,CREAM,TOPICAL,NDA,022436,Xerese,ACYCLOVIR AND HYDROCORTISONE,2020/08/03,Corticosteroid; Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor; Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor; Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor,2009,BAUSCH HEALTH US LLC,2009/07/31-,0187-5104,WI4X0X7BPJ; X4HES1O11F,ACYCLOVIR; HYDROCORTISONE,ACYCLOVIR; HYDROCORTISONE,WI4X0X7BPJ; X4HES1O11F,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/3b6ac164-0f1e-4f36-94a1-1fdb07d710f5/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3b6ac164-0f1e-4f36-94a1-1fdb07d710f5,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=3b6ac164-0f1e-4f36-94a1-1fdb07d710f5,3b6ac164-0f1e-4f36-94a1-1fdb07d710f5,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, COATED",ORAL,NDA,216340,KRAZATI,ADAGRASIB,2021/12/10,,2022,MIRATI THERAPEUTICS INC,2022/12/12-,80739-812,8EOO6HQF8Y,ADAGRASIB,ADAGRASIB,8EOO6HQF8Y,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/0b8bf078-34c2-4f45-9012-38a8ac082b01/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0b8bf078-34c2-4f45-9012-38a8ac082b01,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=0b8bf078-34c2-4f45-9012-38a8ac082b01,0b8bf078-34c2-4f45-9012-38a8ac082b01,,,
HUMAN PRESCRIPTION DRUG LABEL,GEL,TOPICAL,NDA,021753,DIFFERIN,ADAPALENE,2023/12/27,Retinoid,1996,GALDERMA LABORATORIES L P,completed:2009/09/15-2027/02/01,0299-5918,1L4806J2QF,Adapalene,ADAPALENE,1L4806J2QF,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/a0031324-92a6-4c11-90e2-c2818f7278ec/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a0031324-92a6-4c11-90e2-c2818f7278ec,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=a0031324-92a6-4c11-90e2-c2818f7278ec,a0031324-92a6-4c11-90e2-c2818f7278ec,,,
HUMAN PRESCRIPTION DRUG LABEL,LOTION,TOPICAL,NDA,022502,Differin,ADAPALENE,2023/04/19,Retinoid,1996,GALDERMA LABORATORIES L P,completed:2010/03/31-2025/12/31,0299-5912,1L4806J2QF,Adapalene,Adapalene,1L4806J2QF,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/78b3c1f9-0fc2-4075-6cf0-454a492e6ae3/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=78b3c1f9-0fc2-4075-6cf0-454a492e6ae3,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=78b3c1f9-0fc2-4075-6cf0-454a492e6ae3,78b3c1f9-0fc2-4075-6cf0-454a492e6ae3,,,
HUMAN PRESCRIPTION DRUG LABEL,CREAM,TOPICAL,NDA,020748,Differin,ADAPALENE,2022/10/31,Retinoid,,GALDERMA LABORATORIES L P,2009/11/24-,0299-5915,1L4806J2QF,ADAPALENE,ADAPALENE,1L4806J2QF,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/ab4b2120-57fc-6c61-b239-37c21789c065/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ab4b2120-57fc-6c61-b239-37c21789c065,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=ab4b2120-57fc-6c61-b239-37c21789c065,ab4b2120-57fc-6c61-b239-37c21789c065,,,
HUMAN PRESCRIPTION DRUG LABEL,GEL,TOPICAL,NDA,207917,epiduo forte,ADAPALENE AND BENZOYL PEROXIDE,2022/04/27,Retinoid,2015,GALDERMA LABORATORIES L P,2015/07/01-,0299-5906,1L4806J2QF; W9WZN9A0GM,ADAPALENE; BENZOYL PEROXIDE,ADAPALENE; BENZOYL PEROXIDE,1L4806J2QF; W9WZN9A0GM,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/f4e5d381-098a-4c93-9ff0-002cae46daac/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f4e5d381-098a-4c93-9ff0-002cae46daac,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=f4e5d381-098a-4c93-9ff0-002cae46daac,f4e5d381-098a-4c93-9ff0-002cae46daac,,,
HUMAN PRESCRIPTION DRUG LABEL,GEL,TOPICAL,NDA,022320,EPIDUO,ADAPALENE AND BENZOYL PEROXIDE,2018/02/21,Retinoid,2008,GALDERMA LABORATORIES L P,2008/12/08-,0299-5908,1L4806J2QF; W9WZN9A0GM,ADAPALENE; BENZOYL PEROXIDE,ADAPALENE; BENZOYL PEROXIDE,1L4806J2QF; W9WZN9A0GM,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/a0610f87-3b39-458a-afa3-66be1fefd1de/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a0610f87-3b39-458a-afa3-66be1fefd1de,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=a0610f87-3b39-458a-afa3-66be1fefd1de,a0610f87-3b39-458a-afa3-66be1fefd1de,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,021449,Hepsera,ADEFOVIR DIPIVOXIL,2009/10/27,Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor,2002,EXCELLA GMBH,2002/09/20-,46014-0501,U6Q8Z01514,Adefovir Dipivoxil,adefovir,6GQP90I798,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/80595d45-2224-47d1-bd5c-4b11a824e5bd/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=80595d45-2224-47d1-bd5c-4b11a824e5bd,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=80595d45-2224-47d1-bd5c-4b11a824e5bd,80595d45-2224-47d1-bd5c-4b11a824e5bd,,,
HUMAN PRESCRIPTION DRUG LABEL,IMPLANT,SUBCUTANEOUS,NDA,210797,SCENESSE,AFAMELANOTIDE,2023/10/16,,2019,CLINUVEL INC,2019/12/31-,73372-0116,QW68W3J66U,AFAMELANOTIDE,AFAMELANOTIDE,QW68W3J66U,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/94f53286-11dd-7fbb-e053-2a95a90a7c48/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=94f53286-11dd-7fbb-e053-2a95a90a7c48,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=94f53286-11dd-7fbb-e053-2a95a90a7c48,94f53286-11dd-7fbb-e053-2a95a90a7c48,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,201292,Gilotrif,AFATINIB,2022/07/11,Kinase Inhibitor,2013,BOEHRINGER INGELHEIM PHARMACEUTICALS INC,2013/07/12-,0597-0137; 0597-0138; 0597-0141,41UD74L59M,AFATINIB,AFATINIB,41UD74L59M,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/fd638e5e-8032-e7ca-0179-95e96ab5d387/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=fd638e5e-8032-e7ca-0179-95e96ab5d387,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=fd638e5e-8032-e7ca-0179-95e96ab5d387,fd638e5e-8032-e7ca-0179-95e96ab5d387,,,
HUMAN PRESCRIPTION DRUG LABEL,KIT,INTRAUTERINE,NDA,212279,ExEm Foam,AIR POLYMER-TYPE A INTRAUTERINE FOAM,2023/11/08,Non-Standardized Chemical Allergen,2019,GISKIT PHARMA B V,2020/10/16-,73254-310,059QF0KO0R; M825OX60H9; PDC6A3C0OX,GLYCERIN; HYDROXYETHYL CELLULOSE (5500 MPA.S AT 2%); WATER,GLYCERIN; HYDROXYETHYL CELLULOSE (5500 MPA.S AT 2%); WATER,059QF0KO0R; M825OX60H9; PDC6A3C0OX,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/b8cb3e4d-ed22-4e88-abca-508c794b4b91/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b8cb3e4d-ed22-4e88-abca-508c794b4b91,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=b8cb3e4d-ed22-4e88-abca-508c794b4b91,b8cb3e4d-ed22-4e88-abca-508c794b4b91,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,020666,Albendazole,ALBENDAZOLE,2019/09/30,Anthelmintic,1996,AMNEAL PHARMACEUTICALS OF NEW YORK LLC,1996/06/11-,0115-1701,F4216019LN,ALBENDAZOLE,ALBENDAZOLE,F4216019LN,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/06b5eefc-0b95-4862-b9b6-770063f2adf0/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=06b5eefc-0b95-4862-b9b6-770063f2adf0,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=06b5eefc-0b95-4862-b9b6-770063f2adf0,06b5eefc-0b95-4862-b9b6-770063f2adf0,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,020666,ALBENZA,ALBENDAZOLE,2019/09/16,Anthelmintic,1996,AMNEAL PHARMACEUTICALS LLC,1996/06/11-,64896-693,F4216019LN,ALBENDAZOLE,ALBENDAZOLE,F4216019LN,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/1977a867-0ee1-44c0-8da3-fe59c48699f5/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1977a867-0ee1-44c0-8da3-fe59c48699f5,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=1977a867-0ee1-44c0-8da3-fe59c48699f5,1977a867-0ee1-44c0-8da3-fe59c48699f5,,,
HUMAN PRESCRIPTION DRUG LABEL,"AEROSOL, METERED",INHALATION,NDA,020983,VENTOLIN HFA,ALBUTEROL SULFATE,2024/04/26,beta2-Adrenergic Agonist,1981,GLAXOSMITHKLINE LLC,2006/06/09-,0173-0682,021SEF3731,ALBUTEROL SULFATE,ALBUTEROL,QF8SVZ843E,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/d92c5d6b-ff10-4087-36a2-1cfc464cb967/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d92c5d6b-ff10-4087-36a2-1cfc464cb967,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=d92c5d6b-ff10-4087-36a2-1cfc464cb967,d92c5d6b-ff10-4087-36a2-1cfc464cb967,,,
HUMAN PRESCRIPTION DRUG LABEL,"AEROSOL, METERED",INHALATION,NDA,020503,Proventil HFA,ALBUTEROL SULFATE,2023/06/14,beta2-Adrenergic Agonist,,SANDOZ,completed:2021/05/04-2024/09/30,66758-959,021SEF3731,ALBUTEROL SULFATE,ALBUTEROL,QF8SVZ843E,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/917b6148-61f2-4e4d-9560-d261bac97060/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=917b6148-61f2-4e4d-9560-d261bac97060,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=917b6148-61f2-4e4d-9560-d261bac97060,917b6148-61f2-4e4d-9560-d261bac97060,,,
HUMAN PRESCRIPTION DRUG LABEL,"AEROSOL, METERED",INHALATION,NDA,021457,PROAIR HFA,ALBUTEROL SULFATE,2022/09/28,beta2-Adrenergic Agonist,1981,TEVA RESPIRATORY LLC,completed:2012/12/03-2024/06/21,59310-579,021SEF3731,ALBUTEROL SULFATE,ALBUTEROL,QF8SVZ843E,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/8e701d71-1dcb-4b84-bada-84e4f04f5e62/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8e701d71-1dcb-4b84-bada-84e4f04f5e62,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=8e701d71-1dcb-4b84-bada-84e4f04f5e62,8e701d71-1dcb-4b84-bada-84e4f04f5e62,,,
HUMAN PRESCRIPTION DRUG LABEL,"POWDER, METERED",INHALATION,NDA,205636,ProAir RespiClick,ALBUTEROL SULFATE,2022/09/27,beta2-Adrenergic Agonist,1981,TEVA RESPIRATORY LLC,2015/04/23-,59310-580,021SEF3731,ALBUTEROL SULFATE,ALBUTEROL,QF8SVZ843E,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/9324e2eb-26fd-4f14-9f10-e5aa467306f4/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9324e2eb-26fd-4f14-9f10-e5aa467306f4,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=9324e2eb-26fd-4f14-9f10-e5aa467306f4,9324e2eb-26fd-4f14-9f10-e5aa467306f4,,,
HUMAN PRESCRIPTION DRUG LABEL,"INHALANT; POWDER, METERED",INHALATION,NDA,205636,ProAir Digihaler,ALBUTEROL SULFATE,2022/06/01,beta2-Adrenergic Agonist,1981,TEVA RESPIRATORY LLC,2019/10/04-; completed:2019/10/04-2026/02/28,59310-117; 59310-540,021SEF3731,ALBUTEROL SULFATE,ALBUTEROL,QF8SVZ843E,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/667ce3ec-5217-4b10-b712-f3e54fbbf087/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=667ce3ec-5217-4b10-b712-f3e54fbbf087,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=667ce3ec-5217-4b10-b712-f3e54fbbf087,667ce3ec-5217-4b10-b712-f3e54fbbf087,,,
HUMAN PRESCRIPTION DRUG LABEL,"AEROSOL, METERED",INHALATION,NDA,020503,Proventil HFA,ALBUTEROL SULFATE,2019/10/07,beta2-Adrenergic Agonist,,MERCK SHARP AND DOHME CORP,2001/10/01-,0085-1132,021SEF3731,Albuterol Sulfate,Albuterol,QF8SVZ843E,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/f454947c-6055-474b-bf35-29a379e01aa3/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f454947c-6055-474b-bf35-29a379e01aa3,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=f454947c-6055-474b-bf35-29a379e01aa3,f454947c-6055-474b-bf35-29a379e01aa3,,,
HUMAN PRESCRIPTION DRUG LABEL,"AEROSOL, METERED",INHALATION,NDA,021457,ALBUTEROL SULFATE HFA,ALBUTEROL SULFATE,2019/04/24,beta2-Adrenergic Agonist,,H J HARKINS COMPANY INC,2019/03/25-,76519-1171,021SEF3731,ALBUTEROL SULFATE,ALBUTEROL,QF8SVZ843E,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/874bcb9b-3b51-1375-e053-2a95a90ad559/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=874bcb9b-3b51-1375-e053-2a95a90ad559,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=874bcb9b-3b51-1375-e053-2a95a90ad559,874bcb9b-3b51-1375-e053-2a95a90ad559,,,
HUMAN PRESCRIPTION DRUG LABEL,"AEROSOL, METERED",INHALATION,NDA,214070,AIRSUPRA,ALBUTEROL SULFATE AND BUDESONIDE,2024/03/07,Corticosteroid; beta2-Adrenergic Agonist,2023,ASTRAZENECA PHARMACEUTICALS LP,2023/10/02-,0310-9080,021SEF3731; Q3OKS62Q6X,ALBUTEROL SULFATE; BUDESONIDE,ALBUTEROL; BUDESONIDE,Q3OKS62Q6X; QF8SVZ843E,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/e60aa9f9-5139-44df-b886-ebddc3c7eb13/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e60aa9f9-5139-44df-b886-ebddc3c7eb13,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=e60aa9f9-5139-44df-b886-ebddc3c7eb13,e60aa9f9-5139-44df-b886-ebddc3c7eb13,,,
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION/ DROPS,OPHTHALMIC,NDA,022134,LASTACAFT,ALCAFTADINE,2020/06/09,Histamine-1 Receptor Antagonist,2010,ALLERGAN INC,2010/11/01-,0023-4290,7Z8O94ECSX,alcaftadine,alcaftadine,7Z8O94ECSX,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/17d37e8d-7825-424b-b6ca-0a85d0bf4694/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=17d37e8d-7825-424b-b6ca-0a85d0bf4694,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=17d37e8d-7825-424b-b6ca-0a85d0bf4694,17d37e8d-7825-424b-b6ca-0a85d0bf4694,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",PERCUTANEOUS,NDA,207987,Dehydrated Alcohol,ALCOHOL,2023/10/05,,1946,BPI LABS LLC,2018/10/24-,54288-105,3K9958V90M,ALCOHOL,ALCOHOL,3K9958V90M,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/314b1dab-8f4f-49ae-a105-f974842818b8/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=314b1dab-8f4f-49ae-a105-f974842818b8,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=314b1dab-8f4f-49ae-a105-f974842818b8,314b1dab-8f4f-49ae-a105-f974842818b8,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",PERCUTANEOUS,NDA,207987,Dehydrated Alcohol,ALCOHOL,2021/12/10,,1946,BELCHER PHARMACEUTICALS LLC,2018/07/02-,62250-105,3K9958V90M,ALCOHOL,ALCOHOL,3K9958V90M,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/379e7c93-14a7-42d0-920f-a6b5eca34b99/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=379e7c93-14a7-42d0-920f-a6b5eca34b99,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=379e7c93-14a7-42d0-920f-a6b5eca34b99,379e7c93-14a7-42d0-920f-a6b5eca34b99,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,NDA,208434,ALECENSA,ALECTINIB HYDROCHLORIDE,2024/04/30,Kinase Inhibitor,2015,GENENTECH INC,2015/12/11-,50242-130,P9YY73LO6J,ALECTINIB HYDROCHLORIDE,ALECTINIB,LIJ4CT1Z3Y,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/42c49deb-713b-427a-9670-08af08adcffb/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=42c49deb-713b-427a-9670-08af08adcffb,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=42c49deb-713b-427a-9670-08af08adcffb,42c49deb-713b-427a-9670-08af08adcffb,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,020560,FOSAMAX,ALENDRONATE SODIUM,2024/04/16,Bisphosphonate,1995,ORGANON LLC,2021/06/01-,78206-135,2UY4M2U3RA,ALENDRONATE SODIUM,ALENDRONIC ACID,X1J18R4W8P,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/14e931fd-2c5f-4d90-b7db-5980706f4a56/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=14e931fd-2c5f-4d90-b7db-5980706f4a56,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=14e931fd-2c5f-4d90-b7db-5980706f4a56,14e931fd-2c5f-4d90-b7db-5980706f4a56,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, EFFERVESCENT",ORAL,NDA,202344,Binosto,ALENDRONATE SODIUM,2023/12/20,Bisphosphonate,1995,ASCEND THERAPEUTICS,2012/09/03-,17139-400,2UY4M2U3RA,ALENDRONATE SODIUM,ALENDRONIC ACID,X1J18R4W8P,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/b278a11a-b8d7-49f3-9b38-29b67c4c417e/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b278a11a-b8d7-49f3-9b38-29b67c4c417e,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=b278a11a-b8d7-49f3-9b38-29b67c4c417e,b278a11a-b8d7-49f3-9b38-29b67c4c417e,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, EFFERVESCENT",ORAL,NDA,202344,Binosto,ALENDRONATE SODIUM,2023/11/16,Bisphosphonate,1995,RADIUS HEALTH INC,2012/03/12-,70539-400,2UY4M2U3RA,ALENDRONATE SODIUM,ALENDRONIC ACID,X1J18R4W8P,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/09765234-01bc-40f7-b9bb-c167056f3909/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=09765234-01bc-40f7-b9bb-c167056f3909,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=09765234-01bc-40f7-b9bb-c167056f3909,09765234-01bc-40f7-b9bb-c167056f3909,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, EFFERVESCENT",ORAL,NDA,202344,Binosto,ALENDRONATE SODIUM,2018/10/22,Bisphosphonate,1995,MISSION PHARMACAL COMPANY,2012/09/03-,0178-0101,2UY4M2U3RA,ALENDRONATE SODIUM,ALENDRONIC ACID,X1J18R4W8P,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/ad670460-141b-e481-f713-7aed9485de8d/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ad670460-141b-e481-f713-7aed9485de8d,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=ad670460-141b-e481-f713-7aed9485de8d,ad670460-141b-e481-f713-7aed9485de8d,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,021762,FOSAMAX PLUS D,ALENDRONATE SODIUM AND CHOLECALCIFEROL,2024/04/17,Bisphosphonate; Vitamin D,2005,ORGANON LLC,2021/06/01-,78206-136; 78206-137,1C6V77QF41; 2UY4M2U3RA,ALENDRONATE SODIUM; CHOLECALCIFEROL,ALENDRONIC ACID; CHOLECALCIFEROL,1C6V77QF41; X1J18R4W8P,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/10307e7e-9a84-4aa1-8c5c-4b209cffe4d1/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=10307e7e-9a84-4aa1-8c5c-4b209cffe4d1,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=10307e7e-9a84-4aa1-8c5c-4b209cffe4d1,10307e7e-9a84-4aa1-8c5c-4b209cffe4d1,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRAVENOUS,NDA,019353,Alfentanil Hydrochloride,ALFENTANIL HYDROCHLORIDE,2024/01/25,Opioid Agonist,1986,AKORN,completed:2010/02/01-2025/04/30,17478-067,11S92G0TIW,Alfentanil Hydrochloride,Alfentanil,1N74HM2BS7,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/098af6c6-7400-4b2b-bae6-03d5913ad712/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=098af6c6-7400-4b2b-bae6-03d5913ad712,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=098af6c6-7400-4b2b-bae6-03d5913ad712,098af6c6-7400-4b2b-bae6-03d5913ad712,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, EXTENDED RELEASE",ORAL,NDA,021287,Uroxatral,ALFUZOSIN HCL,2021/08/18,alpha-Adrenergic Blocker,2003,CONCORDIA PHARMACEUTICALS INC,2013/06/03-,59212-200,75046A1XTN,alfuzosin hydrochloride,alfuzosin,90347YTW5F,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/9fc7f119-f36b-44cf-945d-940160f3afe3/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9fc7f119-f36b-44cf-945d-940160f3afe3,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=9fc7f119-f36b-44cf-945d-940160f3afe3,9fc7f119-f36b-44cf-945d-940160f3afe3,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,021985,Tekturna,ALISKIREN HEMIFUMARATE,2024/03/07,Renin Inhibitor,2007,LXO US INC,2007/03/05-,70839-150; 70839-300,C8A0P8G029,ALISKIREN HEMIFUMARATE,ALISKIREN,502FWN4Q32,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/3dd61fa5-1620-4ebf-bbdb-ede29b92fce2/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3dd61fa5-1620-4ebf-bbdb-ede29b92fce2,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=3dd61fa5-1620-4ebf-bbdb-ede29b92fce2,3dd61fa5-1620-4ebf-bbdb-ede29b92fce2,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,022107,Tekturna HCT,ALISKIREN HEMIFUMARATE AND HYDROCHLOROTHIAZIDE,2022/11/16,Renin Inhibitor; Thiazide Diuretic,2008,NODEN PHARMA USA INC,2008/08/01-,70839-112; 70839-125; 70839-312; 70839-325,0J48LPH2TH; C8A0P8G029,ALISKIREN HEMIFUMARATE; HYDROCHLOROTHIAZIDE,ALISKIREN; HYDROCHLOROTHIAZIDE,0J48LPH2TH; 502FWN4Q32,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/8df0ca6a-58cf-41fc-b890-5c7fa5a3792c/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8df0ca6a-58cf-41fc-b890-5c7fa5a3792c,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=8df0ca6a-58cf-41fc-b890-5c7fa5a3792c,8df0ca6a-58cf-41fc-b890-5c7fa5a3792c,,,
HUMAN PRESCRIPTION DRUG LABEL,GEL,TOPICAL,NDA,020886,PANRETIN,ALITRETINOIN,2021/08/18,Retinoid,,CONCORDIA PHARMACEUTICALS INC,2019/09/10-,59212-601,1UA8E65KDZ,ALITRETINOIN,ALITRETINOIN,1UA8E65KDZ,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/49c16717-7d86-4257-80c9-baa1417e5555/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=49c16717-7d86-4257-80c9-baa1417e5555,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=49c16717-7d86-4257-80c9-baa1417e5555,49c16717-7d86-4257-80c9-baa1417e5555,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,016084,Zyloprim,ALLOPURINOL,2023/09/25,Xanthine Oxidase Inhibitor,1966,CASPER PHARMA LLC,2023/09/21-,70199-031; 70199-032; 70199-033,63CZ7GJN5I,ALLOPURINOL,ALLOPURINOL,63CZ7GJN5I,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/07d71f52-bafb-4307-a7cc-b52724151d42/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=07d71f52-bafb-4307-a7cc-b52724151d42,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=07d71f52-bafb-4307-a7cc-b52724151d42,07d71f52-bafb-4307-a7cc-b52724151d42,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAVENOUS,NDA,020298,Aloprim,ALLOPURINOL,2022/02/18,Xanthine Oxidase Inhibitor,1966,MYLAN INSTITUTIONAL LLC,2007/05/15-,67457-187,428673RC2Z,ALLOPURINOL SODIUM,Allopurinol,63CZ7GJN5I,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/10cc918f-aa44-415b-932d-2404695ac449/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=10cc918f-aa44-415b-932d-2404695ac449,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=10cc918f-aa44-415b-932d-2404695ac449,10cc918f-aa44-415b-932d-2404695ac449,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAVENOUS,NDA,020298,Aloprim,ALLOPURINOL,2022/02/07,Xanthine Oxidase Inhibitor,1966,MYLAN INSTITUTIONAL LLC,2020/11/18-,67457-978,428673RC2Z,ALLOPURINOL SODIUM,Allopurinol,63CZ7GJN5I,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/018525b1-e37d-4ff2-9dc3-36b3d90ac3e0/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=018525b1-e37d-4ff2-9dc3-36b3d90ac3e0,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=018525b1-e37d-4ff2-9dc3-36b3d90ac3e0,018525b1-e37d-4ff2-9dc3-36b3d90ac3e0,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,016084,ZYLOPRIM,ALLOPURINOL,2009/11/30,Xanthine Oxidase Inhibitor,,PROMETHEUS LABORATORIES INC,1966/08/19-,65483-991; 65483-993,63CZ7GJN5I,allopurinol,allopurinol,63CZ7GJN5I,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/342832b5-1a32-4bea-bc49-ab0fd152154e/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=342832b5-1a32-4bea-bc49-ab0fd152154e,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=342832b5-1a32-4bea-bc49-ab0fd152154e,342832b5-1a32-4bea-bc49-ab0fd152154e,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,022271,Nesina,ALOGLIPTIN,2023/08/07,Dipeptidyl Peptidase 4 Inhibitor,2013,TAKEDA PHARMACEUTICALS AMERICA INC,2013/01/25-,64764-125; 64764-250; 64764-625,EEN99869SC,ALOGLIPTIN BENZOATE,ALOGLIPTIN,JHC049LO86,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/a3768c7e-aa4c-44d3-bc53-43bb7346c0b0/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a3768c7e-aa4c-44d3-bc53-43bb7346c0b0,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=a3768c7e-aa4c-44d3-bc53-43bb7346c0b0,a3768c7e-aa4c-44d3-bc53-43bb7346c0b0,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,203414,KAZANO,ALOGLIPTIN AND METFORMIN HYDROCHLORIDE,2023/08/07,Biguanide; Dipeptidyl Peptidase 4 Inhibitor,2013,TAKEDA PHARMACEUTICALS AMERICA INC,2013/01/25-,64764-335; 64764-337,786Z46389E; EEN99869SC,ALOGLIPTIN BENZOATE; Metformin hydrochloride,Alogliptin; Metformin,9100L32L2N; JHC049LO86,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/83cb7914-a683-47bb-a713-f2bc6a596bd2/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=83cb7914-a683-47bb-a713-f2bc6a596bd2,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=83cb7914-a683-47bb-a713-f2bc6a596bd2,83cb7914-a683-47bb-a713-f2bc6a596bd2,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,022426,OSENI,ALOGLIPTIN AND PIOGLITAZONE,2023/12/04,Dipeptidyl Peptidase 4 Inhibitor; Peroxisome Proliferator Receptor alpha Agonist; Peroxisome Proliferator Receptor gamma Agonist; Thiazolidinedione,2013,TAKEDA PHARMACEUTICALS AMERICA INC,2013/01/25-,64764-123; 64764-251; 64764-253; 64764-254,EEN99869SC; JQT35NPK6C,ALOGLIPTIN BENZOATE; PIOGLITAZONE HYDROCHLORIDE,ALOGLIPTIN; PIOGLITAZONE,JHC049LO86; X4OV71U42S,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/4c619ed9-fe3e-4158-9938-80c6c3493d55/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4c619ed9-fe3e-4158-9938-80c6c3493d55,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=4c619ed9-fe3e-4158-9938-80c6c3493d55,4c619ed9-fe3e-4158-9938-80c6c3493d55,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,021107,LOTRONEX,ALOSETRON HYDROCHLORIDE,2019/05/03,Serotonin-3 Receptor Antagonist,2000,SEBELA PHARMACEUTICALS INC,2016/07/11-,54766-894; 54766-895,2F5R1A46YW,ALOSETRON HYDROCHLORIDE,ALOSETRON,13Z9HTH115,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/35cbb9d5-639b-207a-e054-00144ff88e88/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=35cbb9d5-639b-207a-e054-00144ff88e88,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=35cbb9d5-639b-207a-e054-00144ff88e88,35cbb9d5-639b-207a-e054-00144ff88e88,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,021107,LOTRONEX,ALOSETRON HYDROCHLORIDE,2016/01/19,Serotonin-3 Receptor Antagonist,2000,PROMETHEUS LABORATORIES INC,2009/02/09-,65483-894; 65483-895,2F5R1A46YW,alosetron hydrochloride,alosetron,13Z9HTH115,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/526ba44c-a476-4675-a63c-4d0a72b723f5/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=526ba44c-a476-4675-a63c-4d0a72b723f5,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=526ba44c-a476-4675-a63c-4d0a72b723f5,526ba44c-a476-4675-a63c-4d0a72b723f5,,,
HUMAN PRESCRIPTION DRUG LABEL,GRANULE; KIT; TABLET,ORAL,NDA,215039;218466,VIJOICE,ALPELISIB,2024/04/24,,2019,NOVARTIS PHARMACEUTICALS CORPORATION,2022/04/05-; 2024/04/24-,0078-1021; 0078-1028; 0078-1035; 0078-1175,08W5N2C97Q,ALPELISIB,ALPELISIB,08W5N2C97Q,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/638069a4-aee0-46c9-9e21-54ad449c163c/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=638069a4-aee0-46c9-9e21-54ad449c163c,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=638069a4-aee0-46c9-9e21-54ad449c163c,638069a4-aee0-46c9-9e21-54ad449c163c,,,
HUMAN PRESCRIPTION DRUG LABEL,KIT; TABLET,ORAL,NDA,212526,PIQRAY,ALPELISIB,2024/01/18,,2019,NOVARTIS PHARMACEUTICALS CORPORATION,2019/05/24-,0078-0701; 0078-0708; 0078-0715,08W5N2C97Q,ALPELISIB,ALPELISIB,08W5N2C97Q,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/b20b4e18-7a4b-4500-a08f-06c6dab0ee5b/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b20b4e18-7a4b-4500-a08f-06c6dab0ee5b,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=b20b4e18-7a4b-4500-a08f-06c6dab0ee5b,b20b4e18-7a4b-4500-a08f-06c6dab0ee5b,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, EXTENDED RELEASE",ORAL,NDA,021434,Xanax XR,ALPRAZOLAM,2023/01/18,Benzodiazepine,1981,PHARMACIA AND UPJOHN COMPANY LLC,2003/01/17-; completed:2003/01/17-2025/02/28,0009-0057; 0009-0059; 0009-0066; 0009-0068,YU55MQ3IZY,ALPRAZOLAM,ALPRAZOLAM,YU55MQ3IZY,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/aa58fff3-c297-49be-838b-599c32ad9835/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=aa58fff3-c297-49be-838b-599c32ad9835,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=aa58fff3-c297-49be-838b-599c32ad9835,aa58fff3-c297-49be-838b-599c32ad9835,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,018276,Xanax,ALPRAZOLAM,2023/01/18,Benzodiazepine,1981,PHARMACIA AND UPJOHN COMPANY LLC,1981/10/16-,0009-0029; 0009-0055; 0009-0090; 0009-0094,YU55MQ3IZY,ALPRAZOLAM,ALPRAZOLAM,YU55MQ3IZY,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/388e249d-b9b6-44c3-9f8f-880eced0239f/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=388e249d-b9b6-44c3-9f8f-880eced0239f,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=388e249d-b9b6-44c3-9f8f-880eced0239f,388e249d-b9b6-44c3-9f8f-880eced0239f,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRACAVERNOUS,NDA,020379,Caverject,ALPROSTADIL,2024/05/13,Prostaglandin Analog; Prostaglandin E1 Agonist,1981,PHARMACIA AND UPJOHN COMPANY LLC,1995/07/06-,0009-3701; 0009-7686,F5TD010360,ALPROSTADIL,ALPROSTADIL,F5TD010360,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/a295fc1e-d82c-4f44-bc2d-a552bf594c98/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a295fc1e-d82c-4f44-bc2d-a552bf594c98,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=a295fc1e-d82c-4f44-bc2d-a552bf594c98,a295fc1e-d82c-4f44-bc2d-a552bf594c98,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRACAVERNOUS,NDA,020649,Edex,ALPROSTADIL,2024/03/27,Prostaglandin Analog; Prostaglandin E1 Agonist,,ENDO USA INC,2012/01/15-; 2012/03/15-; 2012/04/15-,52244-010; 52244-020; 52244-040,F5TD010360,ALPROSTADIL,ALPROSTADIL,F5TD010360,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/e8b8ec8d-1318-43e4-a182-446e9f9579de/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e8b8ec8d-1318-43e4-a182-446e9f9579de,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=e8b8ec8d-1318-43e4-a182-446e9f9579de,e8b8ec8d-1318-43e4-a182-446e9f9579de,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVASCULAR; INTRAVENOUS,NDA,018484,PROSTIN VR PEDIATRIC,ALPROSTADIL,2022/10/03,Prostaglandin Analog; Prostaglandin E1 Agonist,,PHARMACIA AND UPJOHN COMPANY LLC,2022/10/03-,0009-0215,F5TD010360,ALPROSTADIL,ALPROSTADIL,F5TD010360,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/930f8c02-46a8-4cff-a484-660468ab23c3/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=930f8c02-46a8-4cff-a484-660468ab23c3,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=930f8c02-46a8-4cff-a484-660468ab23c3,930f8c02-46a8-4cff-a484-660468ab23c3,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVASCULAR; INTRAVENOUS,NDA,018484,PROSTIN VR PEDIATRIC,ALPROSTADIL,2020/05/08,Prostaglandin Analog; Prostaglandin E1 Agonist,,PHARMACIA AND UPJOHN COMPANY LLC,1981/10/16-,0009-3169,F5TD010360,ALPROSTADIL,ALPROSTADIL,F5TD010360,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/dea460fa-d05e-4191-8461-f185a711ad89/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=dea460fa-d05e-4191-8461-f185a711ad89,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=dea460fa-d05e-4191-8461-f185a711ad89,dea460fa-d05e-4191-8461-f185a711ad89,,,
HUMAN PRESCRIPTION DRUG LABEL,SUPPOSITORY,URETHRAL,NDA,020700,MUSE,ALPROSTADIL,2018/04/25,Prostaglandin Analog; Prostaglandin E1 Agonist,,MEDA PHARMACEUTICALS INC,2011/07/22-; completed:2011/07/22-2022/04/30,0037-8110; 0037-8120; 0037-8130; 0037-8140,F5TD010360,Alprostadil,Alprostadil,F5TD010360,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/4c55f3f9-c4cf-11df-851a-0800200c9a66/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4c55f3f9-c4cf-11df-851a-0800200c9a66,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=4c55f3f9-c4cf-11df-851a-0800200c9a66,4c55f3f9-c4cf-11df-851a-0800200c9a66,,,
HUMAN PRESCRIPTION DRUG LABEL,"CAPSULE, COATED PELLETS",ORAL,NDA,208944,GOCOVRI,AMANTADINE,2024/02/08,Influenza A M2 Protein Inhibitor,1968,ADAMAS PHARMA LLC,2017/08/24-,70482-085; 70482-170,BF4C9Z1J53,AMANTADINE,AMANTADINE,BF4C9Z1J53,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/82ff865f-78f3-4c94-b6a9-727a54944b28/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=82ff865f-78f3-4c94-b6a9-727a54944b28,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=82ff865f-78f3-4c94-b6a9-727a54944b28,82ff865f-78f3-4c94-b6a9-727a54944b28,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, EXTENDED RELEASE",ORAL,NDA,209410,OSMOLEX ER,AMANTADINE,2024/02/08,Influenza A M2 Protein Inhibitor,1966,ADAMAS PHARMA LLC,2018/06/01-,70482-075; 70482-076,M6Q1EO9TD0,AMANTADINE HYDROCHLORIDE,AMANTADINE,BF4C9Z1J53,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/6fbddb66-8b9d-4d37-a348-abcc31276e89/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6fbddb66-8b9d-4d37-a348-abcc31276e89,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=6fbddb66-8b9d-4d37-a348-abcc31276e89,6fbddb66-8b9d-4d37-a348-abcc31276e89,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,022081,Letairis,AMBRISENTAN,2020/12/17,Endothelin Receptor Antagonist,2007,GILEAD SCIENCES INC,2007/06/15-,61958-0801; 61958-0802,HW6NV07QEC,AMBRISENTAN,AMBRISENTAN,HW6NV07QEC,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/725d4e73-6c83-477a-adc6-0ae4a133a844/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=725d4e73-6c83-477a-adc6-0ae4a133a844,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=725d4e73-6c83-477a-adc6-0ae4a133a844,725d4e73-6c83-477a-adc6-0ae4a133a844,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,208078,Firdapse,AMIFAMPRIDINE PHOSPHATE,2023/09/08,Potassium Channel Blocker,2018,CATALYST PHARMACEUTICALS INC,2019/01/07-,69616-211,8HF8FIN815,amifampridine phosphate,amifampridine,RU4S6E2G0J,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/f015fe60-3128-4a43-8c31-19fc6b5def3f/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f015fe60-3128-4a43-8c31-19fc6b5def3f,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=f015fe60-3128-4a43-8c31-19fc6b5def3f,f015fe60-3128-4a43-8c31-19fc6b5def3f,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAVENOUS,NDA,020221,Ethyol,AMIFOSTINE,2024/02/09,Cytoprotective Agent,1995,CLINIGEN LIMITED,2020/01/01-,76310-017,M487QF2F4V,AMIFOSTINE,AMIFOSTINE ANHYDROUS,ILA426L95O,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/973ed458-f46b-4f61-a329-816c4db79a2c/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=973ed458-f46b-4f61-a329-816c4db79a2c,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=973ed458-f46b-4f61-a329-816c4db79a2c,973ed458-f46b-4f61-a329-816c4db79a2c,,,
HUMAN PRESCRIPTION DRUG LABEL,SUSPENSION,INHALATION,NDA,207356,ARIKAYCE,AMIKACIN,2023/02/08,Aminoglycoside Antibacterial,2018,INSMED INCORPORATED,2018/10/12-,71558-590,84319SGC3C,Amikacin,Amikacin,84319SGC3C,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/499ab990-2b21-474f-aaba-d86388965f40/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=499ab990-2b21-474f-aaba-d86388965f40,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=499ab990-2b21-474f-aaba-d86388965f40,499ab990-2b21-474f-aaba-d86388965f40,,,
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION; TABLET,ORAL,NDA,015197;015230,AMICAR,AMINOCAPROIC ACID,2022/06/28,Antifibrinolytic Agent,,AKORN OPERATING COMPANY LLC,2015/06/01-,49411-050; 49411-051; 49411-052,U6F3787206,AMINOCAPROIC ACID,AMINOCAPROIC ACID,U6F3787206,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/2238c70f-b0b5-4755-896b-45b28777b217/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2238c70f-b0b5-4755-896b-45b28777b217,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=2238c70f-b0b5-4755-896b-45b28777b217,2238c70f-b0b5-4755-896b-45b28777b217,,,
HUMAN PRESCRIPTION DRUG LABEL,GEL,TOPICAL,NDA,208081,AMELUZ,AMINOLEVULINIC ACID HYDROCHLORIDE,2024/05/14,Optical Imaging Agent; Porphyrin Precursor,1999,BIOFRONTERA INC,2016/08/26-,70621-101,V35KBM8JGR,AMINOLEVULINIC ACID HYDROCHLORIDE,AMINOLEVULINIC ACID,88755TAZ87,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/650daa9f-aeec-49ce-95b9-5fa20b988afd/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=650daa9f-aeec-49ce-95b9-5fa20b988afd,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=650daa9f-aeec-49ce-95b9-5fa20b988afd,650daa9f-aeec-49ce-95b9-5fa20b988afd,,,
HUMAN PRESCRIPTION DRUG LABEL,"POWDER, FOR SOLUTION",ORAL,NDA,208630,GLEOLAN,AMINOLEVULINIC ACID HYDROCHLORIDE,2024/05/03,Optical Imaging Agent; Porphyrin Precursor,1999,MEDEXUS PHARMA INC,2018/04/14-,59137-231,V35KBM8JGR,AMINOLEVULINIC ACID HYDROCHLORIDE,AMINOLEVULINIC ACID,88755TAZ87,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/4873911e-a5d7-47e3-9679-fa5c95999323/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4873911e-a5d7-47e3-9679-fa5c95999323,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=4873911e-a5d7-47e3-9679-fa5c95999323,4873911e-a5d7-47e3-9679-fa5c95999323,,,
HUMAN PRESCRIPTION DRUG LABEL,"POWDER, FOR SOLUTION",ORAL,NDA,208630,GLEOLAN,AMINOLEVULINIC ACID HYDROCHLORIDE,2021/03/04,Optical Imaging Agent; Porphyrin Precursor,1999,NX DEVELOPMENT CORP,2018/03/14-,71469-231,V35KBM8JGR,AMINOLEVULINIC ACID HYDROCHLORIDE,AMINOLEVULINIC ACID,88755TAZ87,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/cdeded66-0017-42cf-9471-13f231014323/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=cdeded66-0017-42cf-9471-13f231014323,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=cdeded66-0017-42cf-9471-13f231014323,cdeded66-0017-42cf-9471-13f231014323,,,
HUMAN PRESCRIPTION DRUG LABEL,KIT,TOPICAL,NDA,020965,LEVULAN KERASTICK,AMINOLEVULINIC ACID HYDROCHLORIDE,2020/02/20,Optical Imaging Agent; Porphyrin Precursor,1999,DUSA PHARMACEUTICALS INC,2000/09/04-,67308-101,V35KBM8JGR,Aminolevulinic Acid Hydrochloride,Aminolevulinic Acid,88755TAZ87,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/e45cc371-9ebc-4904-12bc-65cb4e2817ad/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e45cc371-9ebc-4904-12bc-65cb4e2817ad,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=e45cc371-9ebc-4904-12bc-65cb4e2817ad,e45cc371-9ebc-4904-12bc-65cb4e2817ad,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,022325,Nexterone,AMIODARONE HYDROCHLORIDE,2021/09/07,Antiarrhythmic,1985,BAXTER HEALTHCARE CORPORATION,2010/11/16-,43066-150; 43066-360,976728SY6Z,AMIODARONE HYDROCHLORIDE,AMIODARONE,N3RQ532IUT,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/e9108958-b8d7-4fba-87c3-9a32990de551/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e9108958-b8d7-4fba-87c3-9a32990de551,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=e9108958-b8d7-4fba-87c3-9a32990de551,e9108958-b8d7-4fba-87c3-9a32990de551,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,209510,Barhemsys,AMISULPRIDE,2022/09/26,Dopamine-2 Receptor Antagonist,2020,ACACIA PHARMA LTD,2020/02/27-,71390-125,8110R61I4U,Amisulpride,Amisulpride,8110R61I4U,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/ab23bc6e-b6a8-165f-e053-2a95a90ab144/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ab23bc6e-b6a8-165f-e053-2a95a90ab144,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=ab23bc6e-b6a8-165f-e053-2a95a90ab144,ab23bc6e-b6a8-165f-e053-2a95a90ab144,,,
HUMAN PRESCRIPTION DRUG LABEL,SUSPENSION,ORAL,NDA,211340,Katerzia,AMLODIPINE,2023/04/28,Calcium Channel Blocker; Dihydropyridine Calcium Channel Blocker,1992,AZURITY PHARMACEUTICALS INC,2019/08/15-,52652-5001,XD75TQ8A2P,Amlodipine Benzoate,AMLODIPINE,1J444QC288,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/df673a4d-acb8-444c-a472-c87ab8cbd366/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=df673a4d-acb8-444c-a472-c87ab8cbd366,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=df673a4d-acb8-444c-a472-c87ab8cbd366,df673a4d-acb8-444c-a472-c87ab8cbd366,,,
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION,ORAL,NDA,214439,NORLIQVA,AMLODIPINE,2022/02/28,Calcium Channel Blocker; Dihydropyridine Calcium Channel Blocker,1992,CMP PHARMA INC,2022/04/15-,46287-035,1J444QC288,amlodipine,amlodipine,1J444QC288,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/c1730a51-4383-4c61-a9a1-7e1326bd0abe/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c1730a51-4383-4c61-a9a1-7e1326bd0abe,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=c1730a51-4383-4c61-a9a1-7e1326bd0abe,c1730a51-4383-4c61-a9a1-7e1326bd0abe,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,021540,Caduet,AMLODIPINE AND ATORVASTATIN; AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM,2024/04/05,Calcium Channel Blocker; Dihydropyridine Calcium Channel Blocker; HMG-CoA Reductase Inhibitor,2004,PFIZER LABORATORIES DIV PFIZER INC,2004/01/30-; 2022/06/06-; 2022/08/31-; completed:2004/01/30-2022/12/31; completed:2004/01/30-2023/04/30,0069-2150; 0069-2160; 0069-2170; 0069-2180; 0069-2190; 0069-2250; 0069-2260; 0069-2270; 0069-6180; 0069-6323; 0069-6565; 0069-6747; 0069-7232; 0069-7476; 0069-7654; 0069-7810,48A5M73Z4Q; 864V2Q084H,AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM TRIHYDRATE,AMLODIPINE; ATORVASTATIN,1J444QC288; A0JWA85V8F,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/6f1a9bd8-ee30-4c7d-932f-3fa8c4e087b6/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6f1a9bd8-ee30-4c7d-932f-3fa8c4e087b6,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=6f1a9bd8-ee30-4c7d-932f-3fa8c4e087b6,6f1a9bd8-ee30-4c7d-932f-3fa8c4e087b6,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,019787,Norvasc,AMLODIPINE BESYLATE,2023/02/15,Calcium Channel Blocker; Dihydropyridine Calcium Channel Blocker,1992,VIATRIS SPECIALTY LLC,2024/02/09-,58151-353; 58151-354; 58151-355,864V2Q084H,AMLODIPINE BESYLATE,AMLODIPINE,1J444QC288,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/7367289c-b0b0-466a-83e2-558e2985c29f/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7367289c-b0b0-466a-83e2-558e2985c29f,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=7367289c-b0b0-466a-83e2-558e2985c29f,7367289c-b0b0-466a-83e2-558e2985c29f,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,019787,Norvasc,AMLODIPINE BESYLATE,2019/01/15,Calcium Channel Blocker; Dihydropyridine Calcium Channel Blocker,1992,PFIZER LABORATORIES DIV PFIZER INC,1992/07/31-,0069-1520; 0069-1530; 0069-1540,864V2Q084H,AMLODIPINE BESYLATE,AMLODIPINE,1J444QC288,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/abd6a2ca-40c2-485c-bc53-db1c652505ed/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=abd6a2ca-40c2-485c-bc53-db1c652505ed,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=abd6a2ca-40c2-485c-bc53-db1c652505ed,abd6a2ca-40c2-485c-bc53-db1c652505ed,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,NDA,020364,Lotrel,AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE,2023/08/01,Angiotensin Converting Enzyme Inhibitor; Calcium Channel Blocker; Dihydropyridine Calcium Channel Blocker,1995,NOVARTIS PHARMACEUTICALS CORPORATION,completed:1995/03/03-2026/09/30,0078-0364; 0078-0379; 0078-0405; 0078-0406,864V2Q084H; N1SN99T69T,AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE,AMLODIPINE; BENAZEPRILAT,1J444QC288; JRM708L703,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/94ae6054-b7ae-4212-a567-4f803af8f2c7/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=94ae6054-b7ae-4212-a567-4f803af8f2c7,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=94ae6054-b7ae-4212-a567-4f803af8f2c7,94ae6054-b7ae-4212-a567-4f803af8f2c7,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,022100,Azor,AMLODIPINE BESYLATE AND OLMESARTAN MEDOXOMIL,2023/07/12,Angiotensin 2 Receptor Blocker; Calcium Channel Blocker; Dihydropyridine Calcium Channel Blocker,2007,COSETTE PHARMACEUTICALS INC,2022/09/01-,0713-0870; 0713-0871; 0713-0872; 0713-0873,6M97XTV3HD; 864V2Q084H,AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL,AMLODIPINE; OLMESARTAN,1J444QC288; 8W1IQP3U10,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/c5535406-b63b-49aa-88b9-169aaf0ed08e/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c5535406-b63b-49aa-88b9-169aaf0ed08e,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=c5535406-b63b-49aa-88b9-169aaf0ed08e,c5535406-b63b-49aa-88b9-169aaf0ed08e,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,022100,Azor,AMLODIPINE BESYLATE AND OLMESARTAN MEDOXOMIL,2022/06/07,Angiotensin 2 Receptor Blocker; Calcium Channel Blocker; Dihydropyridine Calcium Channel Blocker,2007,DAIICHI SANKYO INC,completed:2007/09/26-2023/05/31; completed:2007/09/26-2023/10/31; completed:2007/09/26-2024/08/31; completed:2007/09/26-2025/02/28,65597-110; 65597-111; 65597-112; 65597-113,6M97XTV3HD; 864V2Q084H,AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL,AMLODIPINE; OLMESARTAN,1J444QC288; 8W1IQP3U10,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/f48911e0-705f-11dc-afc9-0002a5d5c51b/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f48911e0-705f-11dc-afc9-0002a5d5c51b,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=f48911e0-705f-11dc-afc9-0002a5d5c51b,f48911e0-705f-11dc-afc9-0002a5d5c51b,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,021990,Exforge,AMLODIPINE BESYLATE AND VALSARTAN,2023/07/13,Angiotensin 2 Receptor Blocker; Calcium Channel Blocker; Dihydropyridine Calcium Channel Blocker,2007,NOVARTIS PHARMACEUTICALS CORPORATION,2007/06/20-,0078-0488; 0078-0489; 0078-0490; 0078-0491,80M03YXJ7I; 864V2Q084H,AMLODIPINE BESYLATE; VALSARTAN,AMLODIPINE; VALSARTAN,1J444QC288; 80M03YXJ7I,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/d0caec89-96ec-411d-a933-63eda74a6da7/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d0caec89-96ec-411d-a933-63eda74a6da7,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=d0caec89-96ec-411d-a933-63eda74a6da7,d0caec89-96ec-411d-a933-63eda74a6da7,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,022314,Exforge HCT,AMLODIPINE VALSARTAN AND HYDROCHLOROTHIAZIDE,2023/07/13,Angiotensin 2 Receptor Blocker; Calcium Channel Blocker; Dihydropyridine Calcium Channel Blocker; Thiazide Diuretic,2009,NOVARTIS PHARMACEUTICALS CORPORATION,2009/04/04-,0078-0559; 0078-0560; 0078-0561; 0078-0562; 0078-0563,0J48LPH2TH; 80M03YXJ7I; 864V2Q084H,AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; VALSARTAN,AMLODIPINE; HYDROCHLOROTHIAZIDE; VALSARTAN,0J48LPH2TH; 1J444QC288; 80M03YXJ7I,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/18d7820d-471f-4ee2-9ec6-25d8d27c77de/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=18d7820d-471f-4ee2-9ec6-25d8d27c77de,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=18d7820d-471f-4ee2-9ec6-25d8d27c77de,18d7820d-471f-4ee2-9ec6-25d8d27c77de,,,
HUMAN PRESCRIPTION DRUG LABEL,FOR SUSPENSION,ORAL,NDA,050760,Amoxicillin,AMOXICILLIN,2024/05/20,Penicillin-class Antibacterial,1974,USANTIBIOTICS LLC,2024/04/01-,81964-207,804826J2HU,AMOXICILLIN,AMOXICILLIN ANHYDROUS,9EM05410Q9,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/06e5c07d-d95c-4955-8d35-a4703ca2359e/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=06e5c07d-d95c-4955-8d35-a4703ca2359e,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=06e5c07d-d95c-4955-8d35-a4703ca2359e,06e5c07d-d95c-4955-8d35-a4703ca2359e,,,
HUMAN PRESCRIPTION DRUG LABEL,FOR SUSPENSION,ORAL,NDA,050575,Augmentin,AMOXICILLIN AND CLAVULANATE POTASSIUM,2024/05/16,Penicillin-class Antibacterial; beta Lactamase Inhibitor,1984,ALLEGIS HOLDINGS LLC,2023/09/01-,71297-240,804826J2HU; Q42OMW3AT8,AMOXICILLIN; CLAVULANATE POTASSIUM,AMOXICILLIN ANHYDROUS; CLAVULANIC ACID,23521W1S24; 9EM05410Q9,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/04a31a42-d79e-bbb4-e063-6394a90a63ee/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=04a31a42-d79e-bbb4-e063-6394a90a63ee,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=04a31a42-d79e-bbb4-e063-6394a90a63ee,04a31a42-d79e-bbb4-e063-6394a90a63ee,,,
HUMAN PRESCRIPTION DRUG LABEL,FOR SUSPENSION,ORAL,NDA,050575,Augmentin,AMOXICILLIN AND CLAVULANATE POTASSIUM,2023/03/21,Penicillin-class Antibacterial; beta Lactamase Inhibitor,1984,ALLEGIS PHARMACEUTICALS LLC,2023/02/23-,28595-240,804826J2HU; Q42OMW3AT8,AMOXICILLIN; CLAVULANATE POTASSIUM,AMOXICILLIN ANHYDROUS; CLAVULANIC ACID,23521W1S24; 9EM05410Q9,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/f55f61af-10f1-0e17-e053-2995a90adc43/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f55f61af-10f1-0e17-e053-2995a90adc43,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=f55f61af-10f1-0e17-e053-2995a90adc43,f55f61af-10f1-0e17-e053-2995a90adc43,,,
HUMAN PRESCRIPTION DRUG LABEL,FOR SUSPENSION,ORAL,NDA,050755,AUGMENTIN ES-600,AMOXICILLIN AND CLAVULANATE POTASSIUM,2022/10/28,Penicillin-class Antibacterial; beta Lactamase Inhibitor,2001,USANTIBIOTICS LLC,2022/07/15-,81964-003,804826J2HU; Q42OMW3AT8,AMOXICILLIN; CLAVULANATE POTASSIUM,AMOXICILLIN ANHYDROUS; CLAVULANIC ACID,23521W1S24; 9EM05410Q9,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/59979859-8c9b-4173-a5e3-2e6312fd9d79/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=59979859-8c9b-4173-a5e3-2e6312fd9d79,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=59979859-8c9b-4173-a5e3-2e6312fd9d79,59979859-8c9b-4173-a5e3-2e6312fd9d79,,,
HUMAN PRESCRIPTION DRUG LABEL,"POWDER, FOR SUSPENSION; TABLET, FILM COATED",ORAL,NDA,050564;050575;050720;050725,amoxicillin and clavulanate potassium,AMOXICILLIN AND CLAVULANATE POTASSIUM,2016/09/01,Penicillin-class Antibacterial; beta Lactamase Inhibitor,1984,DR REDDY S LABORATORIES INC,1990/10/22-; 1996/10/02-,43598-204; 43598-206; 43598-208; 43598-213; 43598-218; 43598-221,804826J2HU; Q42OMW3AT8,AMOXICILLIN; CLAVULANATE POTASSIUM,AMOXICILLIN ANHYDROUS; CLAVULANIC ACID,23521W1S24; 9EM05410Q9,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/58a20183-4eb6-438e-bd1e-a74f4645bb0d/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=58a20183-4eb6-438e-bd1e-a74f4645bb0d,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=58a20183-4eb6-438e-bd1e-a74f4645bb0d,58a20183-4eb6-438e-bd1e-a74f4645bb0d,,,
HUMAN PRESCRIPTION DRUG LABEL,"POWDER, FOR SUSPENSION; TABLET, FILM COATED",ORAL,NDA,050564;050575;050720,AUGMENTIN,AMOXICILLIN AND CLAVULANATE POTASSIUM,2016/09/01,Penicillin-class Antibacterial; beta Lactamase Inhibitor,1984,DR REDDY S LABORATORIES INC,1990/10/22-; 1996/10/02-,43598-004; 43598-006; 43598-012; 43598-018; 43598-021,804826J2HU; Q42OMW3AT8,AMOXICILLIN; CLAVULANATE POTASSIUM,AMOXICILLIN ANHYDROUS; CLAVULANIC ACID,23521W1S24; 9EM05410Q9,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/174cc098-fe49-4f1a-87e2-601c7573f0db/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=174cc098-fe49-4f1a-87e2-601c7573f0db,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=174cc098-fe49-4f1a-87e2-601c7573f0db,174cc098-fe49-4f1a-87e2-601c7573f0db,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,NDA,050785,Amoxicillin and Clavulanate Potassium Extended Release,AMOXICILLIN AND CLAVULANATE POTASSIUM,2014/01/17,Penicillin-class Antibacterial; beta Lactamase Inhibitor,2002,DR REDDY S LABORATORIES INC,2003/09/11-,43598-220,544Y3D6MYH; 804826J2HU; Q42OMW3AT8,AMOXICILLIN; AMOXICILLIN SODIUM; CLAVULANATE POTASSIUM,AMOXICILLIN ANHYDROUS; CLAVULANIC ACID,23521W1S24; 9EM05410Q9,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/fc4bb4b0-9330-4701-a600-199c42fb3255/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=fc4bb4b0-9330-4701-a600-199c42fb3255,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=fc4bb4b0-9330-4701-a600-199c42fb3255,fc4bb4b0-9330-4701-a600-199c42fb3255,,,
HUMAN PRESCRIPTION DRUG LABEL,"POWDER, FOR SUSPENSION",ORAL,NDA,050755,AUGMENTIN ES-600,AMOXICILLIN AND CLAVULANATE POTASSIUM,2012/12/03,Penicillin-class Antibacterial; beta Lactamase Inhibitor,,DR REDDYS LABORATORIES INC,2012/10/31-,43598-003,804826J2HU; Q42OMW3AT8,AMOXICILLIN; CLAVULANATE POTASSIUM,AMOXICILLIN ANHYDROUS; CLAVULANIC ACID,23521W1S24; 9EM05410Q9,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/55aefa88-46fc-2b73-0819-0c2f88274852/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=55aefa88-46fc-2b73-0819-0c2f88274852,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=55aefa88-46fc-2b73-0819-0c2f88274852,55aefa88-46fc-2b73-0819-0c2f88274852,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, ORALLY DISINTEGRATING",ORAL,NDA,204326,Adzenys XR-ODT,AMPHETAMINE,2024/03/27,Central Nervous System Stimulant,1960,NEOS THERAPEUTICS BRANDS LLC,2016/02/16-,70165-005; 70165-010; 70165-015; 70165-020; 70165-025; 70165-030,CK833KGX7E,AMPHETAMINE,AMPHETAMINE,CK833KGX7E,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/c1179269-00b5-48ea-972d-31e614e99b7e/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c1179269-00b5-48ea-972d-31e614e99b7e,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=c1179269-00b5-48ea-972d-31e614e99b7e,c1179269-00b5-48ea-972d-31e614e99b7e,,,
HUMAN PRESCRIPTION DRUG LABEL,"SUSPENSION, EXTENDED RELEASE; TABLET, EXTENDED RELEASE",ORAL,NDA,208147;210526,DYANAVEL XR; Dyanavel XR,AMPHETAMINE,2023/10/26,Central Nervous System Stimulant,1960,NEXTWAVE PHARMACEUTICALS INC,2015/10/01-; 2021/11/04-,24478-102; 24478-106; 24478-108; 24478-109; 24478-110,CK833KGX7E,AMPHETAMINE,AMPHETAMINE,CK833KGX7E,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/ae304b29-0b40-40ec-ad0d-76b742d4a9b9/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ae304b29-0b40-40ec-ad0d-76b742d4a9b9,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=ae304b29-0b40-40ec-ad0d-76b742d4a9b9,ae304b29-0b40-40ec-ad0d-76b742d4a9b9,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAVENOUS,NDA,050740,AmBisome,AMPHOTERICIN B,2020/07/28,Lipid-based Polyene Antifungal; Polyene Antifungal,,ASTELLAS PHARMA US INC,1997/08/11-,0469-3051,7XU7A7DROE,AMPHOTERICIN B,AMPHOTERICIN B,7XU7A7DROE,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/f7be6506-4d20-401e-a0ff-02ad7c33158a/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f7be6506-4d20-401e-a0ff-02ad7c33158a,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=f7be6506-4d20-401e-a0ff-02ad7c33158a,f7be6506-4d20-401e-a0ff-02ad7c33158a,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRAVENOUS,NDA,050724,ABELCET,"AMPHOTERICIN B, DIMYRISTOYLPHOSPHATIDYLCHOLINE, DL- AND DIMYRISTOYLPHOSPHATIDYLGLYCEROL, DL-",2023/11/21,Lipid-based Polyene Antifungal; Polyene Antifungal,,LEADIANT BIOSCIENCES INC,2010/10/18-,57665-101,7XU7A7DROE; BI71WT9P3R; U86ZGC74V5,"AMPHOTERICIN B; DIMYRISTOYLPHOSPHATIDYLCHOLINE, DL-; DIMYRISTOYLPHOSPHATIDYLGLYCEROL, DL-","AMPHOTERICIN B; DIMYRISTOYLPHOSPHATIDYLCHOLINE, DL-; DIMYRISTOYLPHOSPHATIDYLGLYCEROL, DL-",7XU7A7DROE; BI71WT9P3R; U86ZGC74V5,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/5587db37-f21a-4a39-a319-e1077032ced9/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5587db37-f21a-4a39-a319-e1077032ced9,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=5587db37-f21a-4a39-a319-e1077032ced9,5587db37-f21a-4a39-a319-e1077032ced9,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, POWDER, FOR SOLUTION",INTRAMUSCULAR; INTRAVENOUS,NDA,050608,UNASYN,AMPICILLIN SODIUM AND SULBACTAM SODIUM,2024/05/09,Penicillin-class Antibacterial; beta Lactamase Inhibitor,,ROERIG,1991/11/22-,0049-0024,DKQ4T82YE6; JFN36L5S8K,AMPICILLIN SODIUM; SULBACTAM SODIUM,AMPICILLIN; SULBACTAM,7C782967RD; S4TF6I2330,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/12eeb72a-403d-41be-bae4-4cb930862884/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=12eeb72a-403d-41be-bae4-4cb930862884,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=12eeb72a-403d-41be-bae4-4cb930862884,12eeb72a-403d-41be-bae4-4cb930862884,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, POWDER, FOR SOLUTION",INTRAMUSCULAR; INTRAVENOUS,ANDA; NDA,050608;062901,UNASYN,AMPICILLIN SODIUM AND SULBACTAM SODIUM,2024/05/09,Penicillin-class Antibacterial; beta Lactamase Inhibitor,,ROERIG,1991/11/22-; completed:2019/03/25-2019/03/25,0049-0013; 0049-0014; 0049-0031; 0049-0032,DKQ4T82YE6; JFN36L5S8K,AMPICILLIN SODIUM; SULBACTAM SODIUM,AMPICILLIN; SULBACTAM,7C782967RD; S4TF6I2330,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/155c7ec0-5862-404f-b1d0-f278f8a8bbda/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=155c7ec0-5862-404f-b1d0-f278f8a8bbda,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=155c7ec0-5862-404f-b1d0-f278f8a8bbda,155c7ec0-5862-404f-b1d0-f278f8a8bbda,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,NDA,020333,Agrylin,ANAGRELIDE HYDROCHLORIDE,2023/12/29,Platelet-reducing Agent,1997,TAKEDA PHARMACEUTICALS AMERICA INC,1997/03/14-,54092-063,VNS4435G39,ANAGRELIDE HYDROCHLORIDE ANHYDROUS,ANAGRELIDE,K9X45X0051,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/cb960074-99c1-4a73-941f-f0644a7ec219/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=cb960074-99c1-4a73-941f-f0644a7ec219,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=cb960074-99c1-4a73-941f-f0644a7ec219,cb960074-99c1-4a73-941f-f0644a7ec219,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,020541,ARIMIDEX,ANASTROZOLE,2022/12/16,Aromatase Inhibitor,1995,ANI PHARMACEUTICALS INC,2018/06/26-,62559-670,2Z07MYW1AZ,ANASTROZOLE,ANASTROZOLE,2Z07MYW1AZ,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/acbfaaa9-503c-4691-9828-76a7146ed6de/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=acbfaaa9-503c-4691-9828-76a7146ed6de,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=acbfaaa9-503c-4691-9828-76a7146ed6de,acbfaaa9-503c-4691-9828-76a7146ed6de,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRAVENOUS,NDA,209360,Giapreza,ANGIOTENSIN II,2023/01/04,Vasoconstrictor,2017,LA JOLLA PHARMACEUTICAL COMPANY,2018/02/05-; 2022/09/15-,68547-005; 68547-501,M089EFU921,ANGIOTENSIN II,ANGIOTENSIN II,M089EFU921,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/c265d69a-3efe-4107-9a9e-e6fd3d531c48/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c265d69a-3efe-4107-9a9e-e6fd3d531c48,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=c265d69a-3efe-4107-9a9e-e6fd3d531c48,c265d69a-3efe-4107-9a9e-e6fd3d531c48,,,
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION,EXTRACORPOREAL,NDA,020037,Anticoagulant Citrate Dextrose A,"ANHYDROUS CITRIC ACID, DEXTROSE MONOHYDRATE, AND TRISODIUM CITRATE DIHYDRATE",2023/02/14,Anti-coagulant; Calculi Dissolution Agent,,CITRA LABS LLC,2003/08/26-,23731-6051,B22547B95K; LX22YL083G; XF417D3PSL,ANHYDROUS CITRIC ACID; DEXTROSE MONOHYDRATE; TRISODIUM CITRATE DIHYDRATE,ANHYDROUS CITRIC ACID; ANHYDROUS DEXTROSE,5SL0G7R0OK; XF417D3PSL,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/5bcd261e-ebba-4ecb-af22-e5aaeb04499b/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5bcd261e-ebba-4ecb-af22-e5aaeb04499b,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=5bcd261e-ebba-4ecb-af22-e5aaeb04499b,5bcd261e-ebba-4ecb-af22-e5aaeb04499b,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION; TABLET, COATED",INTRAVENOUS; ORAL,NDA,211672;211673,Citric Buffered Normal Saline; Xenleta,ANHYDROUS CITRIC ACID; LEFAMULIN ACETATE,2022/12/28,Anti-coagulant; Calculi Dissolution Agent; Pleuromutilin Antibacterial,2019,NABRIVA THERAPEUTICS US INC,2019/09/09-,72000-030; 72000-110; 72000-120,HDN0B924X4; XF417D3PSL,ANHYDROUS CITRIC ACID; LEFAMULIN ACETATE,ANHYDROUS CITRIC ACID; LEFAMULIN,21904A5386; XF417D3PSL,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/101db63d-2fe2-48df-8506-1382d6dcd4a3/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=101db63d-2fe2-48df-8506-1382d6dcd4a3,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=101db63d-2fe2-48df-8506-1382d6dcd4a3,101db63d-2fe2-48df-8506-1382d6dcd4a3,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAVENOUS,NDA,021632,ERAXIS,ANIDULAFUNGIN,2024/03/01,Echinocandin Antifungal,2006,ROERIG,2006/02/17-,0049-0114; 0049-0116,9HLM53094I,ANIDULAFUNGIN,ANIDULAFUNGIN,9HLM53094I,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/a88d9010-55fb-4a02-baff-042cd27688ea/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a88d9010-55fb-4a02-baff-042cd27688ea,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=a88d9010-55fb-4a02-baff-042cd27688ea,a88d9010-55fb-4a02-baff-042cd27688ea,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAVENOUS,NDA,021632,ERAXIS,ANIDULAFUNGIN,2024/02/19,Echinocandin Antifungal,2006,ROERIG,2024/02/20-,0049-2242,9HLM53094I,ANIDULAFUNGIN,ANIDULAFUNGIN,9HLM53094I,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/d138ab10-1ed9-44be-8d81-49dda1e434ac/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d138ab10-1ed9-44be-8d81-49dda1e434ac,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=d138ab10-1ed9-44be-8d81-49dda1e434ac,d138ab10-1ed9-44be-8d81-49dda1e434ac,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,210951,ERLEADA,APALUTAMIDE,2024/01/17,,2018,JANSSEN PRODUCTS LP,2018/02/14-,59676-600; 59676-604,4T36H88UA7,APALUTAMIDE,APALUTAMIDE,4T36H88UA7,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/d1cda4f7-cb33-46ea-b9ac-431f6452b1a5/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d1cda4f7-cb33-46ea-b9ac-431f6452b1a5,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=d1cda4f7-cb33-46ea-b9ac-431f6452b1a5,d1cda4f7-cb33-46ea-b9ac-431f6452b1a5,,,
HUMAN PRESCRIPTION DRUG LABEL,"KIT; TABLET, FILM COATED",ORAL,NDA,202155,ELIQUIS; ELIQUIS 30-Day Starter Pack,APIXABAN,2021/09/30,Factor Xa Inhibitor,2012,E R SQUIBB AND SONS L L C,2012/12/28-; 2017/11/29-,0003-0893; 0003-0894; 0003-3764,3Z9Y7UWC1J,APIXABAN; apixaban,APIXABAN; apixaban,3Z9Y7UWC1J,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/e9481622-7cc6-418a-acb6-c5450daae9b0/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e9481622-7cc6-418a-acb6-c5450daae9b0,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=e9481622-7cc6-418a-acb6-c5450daae9b0,e9481622-7cc6-418a-acb6-c5450daae9b0,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,SUBCUTANEOUS,NDA,021264,APOKYN,APOMORPHINE HYDROCHLORIDE,2023/12/20,Dopaminergic Agonist,2004,MDD US OPERATIONS LLC,2004/07/02-,27505-004,F39049Y068,APOMORPHINE HYDROCHLORIDE,APOMORPHINE,N21FAR7B4S,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/3235535d-9ef9-4657-8b2a-176a807d091c/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3235535d-9ef9-4657-8b2a-176a807d091c,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=3235535d-9ef9-4657-8b2a-176a807d091c,3235535d-9ef9-4657-8b2a-176a807d091c,,,
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION/ DROPS,OPHTHALMIC,NDA,019779,IOPIDINE,APRACLONIDINE HYDROCHLORIDE,2021/10/07,alpha-Adrenergic Agonist,,ALCON LABORATORIES INC,1988/05/15-,0065-0660,D2VW67N38H,APRACLONIDINE HYDROCHLORIDE,APRACLONIDINE,843CEN85DI,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/2a6c44a6-e415-467f-bf3b-3e7f2c7dc714/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2a6c44a6-e415-467f-bf3b-3e7f2c7dc714,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=2a6c44a6-e415-467f-bf3b-3e7f2c7dc714,2a6c44a6-e415-467f-bf3b-3e7f2c7dc714,,,
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION/ DROPS,OPHTHALMIC,NDA,019779,IOPIDINE 1%,APRACLONIDINE HYDROCHLORIDE OPHTHALMIC SOLUTION,2023/07/31,alpha-Adrenergic Agonist,,HARROW EYE LLC,2023/08/01-,82667-200,D2VW67N38H,APRACLONIDINE HYDROCHLORIDE,APRACLONIDINE,843CEN85DI,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/00f18845-ccde-8678-e063-6294a90a3374/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=00f18845-ccde-8678-e063-6294a90a3374,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=00f18845-ccde-8678-e063-6294a90a3374,00f18845-ccde-8678-e063-6294a90a3374,,,
HUMAN PRESCRIPTION DRUG LABEL,"KIT; TABLET, FILM COATED",ORAL,NDA,205437,Otezla,APREMILAST,2024/05/01,Phosphodiesterase 4 Inhibitor,2014,AMGEN INC,2020/02/26-; 2024/04/27-,55513-137; 55513-369; 55513-485; 55513-497; 55513-508; 55513-996,UP7QBP99PN,APREMILAST,APREMILAST,UP7QBP99PN,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/f6b1f516-4972-4d82-bced-113e47b41cc5/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f6b1f516-4972-4d82-bced-113e47b41cc5,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=f6b1f516-4972-4d82-bced-113e47b41cc5,f6b1f516-4972-4d82-bced-113e47b41cc5,,,
HUMAN PRESCRIPTION DRUG LABEL,"KIT; TABLET, FILM COATED",ORAL,NDA,205437,OTEZLA,APREMILAST,2021/02/05,Phosphodiesterase 4 Inhibitor,2014,CELGENE CORPORATION,2014/03/25-; 2014/04/03-; 2015/02/01-,59572-630; 59572-631; 59572-632,UP7QBP99PN,APREMILAST,APREMILAST,UP7QBP99PN,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/3acf6751-827d-11e2-9e96-0800200c9a66/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3acf6751-827d-11e2-9e96-0800200c9a66,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=3acf6751-827d-11e2-9e96-0800200c9a66,3acf6751-827d-11e2-9e96-0800200c9a66,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, EMULSION",INTRAVENOUS,NDA,209296,CINVANTI,APREPITANT,2024/03/13,Substance P/Neurokinin-1 Receptor Antagonist,2003,HERON THERAPEUTICS INC,2018/01/03-,47426-201,1NF15YR6UY,APREPITANT,APREPITANT,1NF15YR6UY,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/4c218d3a-a508-4abc-9ed8-a6e8e191d1b4/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4c218d3a-a508-4abc-9ed8-a6e8e191d1b4,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=4c218d3a-a508-4abc-9ed8-a6e8e191d1b4,4c218d3a-a508-4abc-9ed8-a6e8e191d1b4,,,
HUMAN PRESCRIPTION DRUG LABEL,EMULSION,INTRAVENOUS,NDA,216457,APONVIE,APREPITANT,2024/03/13,Substance P/Neurokinin-1 Receptor Antagonist,2003,HERON THERAPEUTICS INC,2023/03/06-,47426-401,1NF15YR6UY,APREPITANT,APREPITANT,1NF15YR6UY,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/d1b111eb-659a-496b-a86a-8f0fa370f147/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d1b111eb-659a-496b-a86a-8f0fa370f147,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=d1b111eb-659a-496b-a86a-8f0fa370f147,d1b111eb-659a-496b-a86a-8f0fa370f147,,,
HUMAN PRESCRIPTION DRUG LABEL,"CAPSULE; KIT; POWDER, FOR SUSPENSION",ORAL,NDA,021549;207865,EMEND,APREPITANT,2023/12/01,Substance P/Neurokinin-1 Receptor Antagonist,2003,MERCK SHARP AND DOHME LLC,2003/03/26-; 2015/12/17-,0006-0461; 0006-0462; 0006-0464; 0006-3066; 0006-3862,1NF15YR6UY,aprepitant,aprepitant,1NF15YR6UY,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/696f9e80-9cae-403b-de9e-078343ce4713/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=696f9e80-9cae-403b-de9e-078343ce4713,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=696f9e80-9cae-403b-de9e-078343ce4713,696f9e80-9cae-403b-de9e-078343ce4713,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,217686,TRYVIO,APROCITENTAN,2024/03/29,,2024,IDORSIA PHARMACEUTICALS LTD,2024/03/20-,80491-0812,MZI81HV01P,APROCITENTAN,APROCITENTAN,MZI81HV01P,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/dfe7a2ee-612c-4aba-834a-d68e6b59a0a6/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=dfe7a2ee-612c-4aba-834a-d68e6b59a0a6,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=dfe7a2ee-612c-4aba-834a-d68e6b59a0a6,dfe7a2ee-612c-4aba-834a-d68e6b59a0a6,,,
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION,INHALATION,NDA,021912,BROVANA,ARFORMOTEROL TARTRATE,2024/04/15,beta2-Adrenergic Agonist,2006,LUPIN PHARMACEUTICALS INC,2024/04/15-,27437-060,5P8VJ2I235,ARFORMOTEROL TARTRATE,ARFORMOTEROL,F91H02EBWT,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/e2ae9b8c-7529-44c2-8e71-ba0aaddff0e2/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e2ae9b8c-7529-44c2-8e71-ba0aaddff0e2,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=e2ae9b8c-7529-44c2-8e71-ba0aaddff0e2,e2ae9b8c-7529-44c2-8e71-ba0aaddff0e2,,,
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION,INHALATION,NDA,021912,BROVANA,ARFORMOTEROL TARTRATE,2023/10/04,beta2-Adrenergic Agonist,2006,LUPIN PHARMACEUTICALS INC,2023/10/01-,27437-055,5P8VJ2I235,ARFORMOTEROL TARTRATE,ARFORMOTEROL,F91H02EBWT,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/f9633c92-99e5-4b5e-ab51-fa77453e5761/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f9633c92-99e5-4b5e-ab51-fa77453e5761,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=f9633c92-99e5-4b5e-ab51-fa77453e5761,f9633c92-99e5-4b5e-ab51-fa77453e5761,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRAVENOUS,NDA,203049,Argatroban,ARGATROBAN,2024/04/11,Anti-coagulant; Direct Thrombin Inhibitor,2000,HIKMA PHARMACEUTICALS USA INC,2012/01/05-,0143-9288,IY90U61Z3S,ARGATROBAN,ARGATROBAN ANHYDROUS,OCY3U280Y3,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/79eec27d-ac63-4996-8b1a-c2cd52ad2b2c/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=79eec27d-ac63-4996-8b1a-c2cd52ad2b2c,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=79eec27d-ac63-4996-8b1a-c2cd52ad2b2c,79eec27d-ac63-4996-8b1a-c2cd52ad2b2c,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRAVENOUS,NDA,203049,Argatroban,ARGATROBAN,2024/04/11,Anti-coagulant; Direct Thrombin Inhibitor,2000,HIKMA PHARMACEUTICALS USA INC,2020/03/25-,0143-9377,IY90U61Z3S,ARGATROBAN,ARGATROBAN ANHYDROUS,OCY3U280Y3,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/41f56fe7-4824-4032-aa73-cfb4f8db2252/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=41f56fe7-4824-4032-aa73-cfb4f8db2252,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=41f56fe7-4824-4032-aa73-cfb4f8db2252,41f56fe7-4824-4032-aa73-cfb4f8db2252,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRAVENOUS,NDA,203049,Argatroban,ARGATROBAN,2024/04/11,Anti-coagulant; Direct Thrombin Inhibitor,2000,HIKMA PHARMACEUTICALS USA INC,2012/01/05-; 2016/11/01-,0143-9559; 0143-9674,IY90U61Z3S,ARGATROBAN,ARGATROBAN ANHYDROUS,OCY3U280Y3,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/0cdf3f67-5bf3-4d58-b330-03febdc652bf/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0cdf3f67-5bf3-4d58-b330-03febdc652bf,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=0cdf3f67-5bf3-4d58-b330-03febdc652bf,0cdf3f67-5bf3-4d58-b330-03febdc652bf,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRAVENOUS,NDA,212035,ARGATROBAN,ARGATROBAN,2022/11/07,Anti-coagulant; Direct Thrombin Inhibitor,2000,ACCORD HEALTHCARE INC,2021/10/07-,16729-430,IY90U61Z3S,ARGATROBAN,ARGATROBAN ANHYDROUS,OCY3U280Y3,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/46cdf9e6-839c-49c8-9ee1-c30cfdd9368d/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=46cdf9e6-839c-49c8-9ee1-c30cfdd9368d,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=46cdf9e6-839c-49c8-9ee1-c30cfdd9368d,46cdf9e6-839c-49c8-9ee1-c30cfdd9368d,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,016931,R-Gene,ARGININE HYDROCHLORIDE,2024/04/02,,,PHARMACIA AND UPJOHN COMPANY LLC,1976/06/15-,0009-0436,F7LTH1E20Y,ARGININE HYDROCHLORIDE,ARGININE,94ZLA3W45F,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/6accf33f-9841-4327-8923-93c42020ef12/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6accf33f-9841-4327-8923-93c42020ef12,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=6accf33f-9841-4327-8923-93c42020ef12,6accf33f-9841-4327-8923-93c42020ef12,,,
HUMAN PRESCRIPTION DRUG LABEL,KIT,INTRAMUSCULAR,NDA,202971,ABILIFY MAINTENA,ARIPIPRAZOLE,2024/02/13,Atypical Antipsychotic,2002,OTSUKA AMERICA PHARMACEUTICAL INC,2013/02/28-; 2014/10/08-,59148-018; 59148-019; 59148-045; 59148-072,82VFR53I78,ARIPIPRAZOLE,ARIPIPRAZOLE,82VFR53I78,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/ee49f3b1-1650-47ff-9fb1-ea53fe0b92b6/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ee49f3b1-1650-47ff-9fb1-ea53fe0b92b6,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=ee49f3b1-1650-47ff-9fb1-ea53fe0b92b6,ee49f3b1-1650-47ff-9fb1-ea53fe0b92b6,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SUSPENSION, EXTENDED RELEASE",INTRAMUSCULAR,NDA,217006,Abilify Asimtufii,ARIPIPRAZOLE,2024/01/30,Atypical Antipsychotic,2002,OTSUKA AMERICA PHARMACEUTICAL INC,2023/04/27-,59148-102; 59148-114,82VFR53I78,Aripiprazole,Aripiprazole,82VFR53I78,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/da4c07fd-1130-4341-bb44-63acfa4162be/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=da4c07fd-1130-4341-bb44-63acfa4162be,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=da4c07fd-1130-4341-bb44-63acfa4162be,da4c07fd-1130-4341-bb44-63acfa4162be,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION; SOLUTION; TABLET; TABLET, ORALLY DISINTEGRATING",INTRAMUSCULAR; ORAL,NDA,021436;021713;021729;021866,ABILIFY,ARIPIPRAZOLE,2022/11/30,Atypical Antipsychotic,2002,OTSUKA AMERICA PHARMACEUTICAL INC,2002/11/15-; completed:2004/12/10-2021/04/15; completed:2006/06/07-2021/04/15; completed:2006/09/20-2021/04/15,59148-006; 59148-007; 59148-008; 59148-009; 59148-010; 59148-011; 59148-013; 59148-016; 59148-640; 59148-641,82VFR53I78,ARIPIPRAZOLE,ARIPIPRAZOLE,82VFR53I78,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/c040bd1d-45b7-49f2-93ea-aed7220b30ac/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c040bd1d-45b7-49f2-93ea-aed7220b30ac,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=c040bd1d-45b7-49f2-93ea-aed7220b30ac,c040bd1d-45b7-49f2-93ea-aed7220b30ac,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SUSPENSION, EXTENDED RELEASE",INTRAMUSCULAR,NDA,207533,ARISTADA,ARIPIPRAZOLE LAUROXIL,2023/12/01,,2015,ALKERMES INC,2015/10/05-; 2017/06/05-,65757-401; 65757-402; 65757-403; 65757-404,B786J7A343,aripiprazole lauroxil,aripiprazole lauroxil,B786J7A343,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/17a8d11b-73b0-4833-a0b4-cf1ef85edefb/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=17a8d11b-73b0-4833-a0b4-cf1ef85edefb,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=17a8d11b-73b0-4833-a0b4-cf1ef85edefb,17a8d11b-73b0-4833-a0b4-cf1ef85edefb,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SUSPENSION, EXTENDED RELEASE",INTRAMUSCULAR,NDA,209830,ARISTADA INITIO,ARIPIPRAZOLE LAUROXIL,2023/12/01,,2015,ALKERMES INC,2018/06/29-,65757-500,B786J7A343,aripiprazole lauroxil,aripiprazole lauroxil,B786J7A343,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/b18fdfd9-31cd-4a2f-9f1c-ebc70d7a9403/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b18fdfd9-31cd-4a2f-9f1c-ebc70d7a9403,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=b18fdfd9-31cd-4a2f-9f1c-ebc70d7a9403,b18fdfd9-31cd-4a2f-9f1c-ebc70d7a9403,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,021875,Nuvigil,ARMODAFINIL,2022/12/31,,2007,CEPHALON LLC,2009/05/26-; 2014/02/20-,63459-205; 63459-215; 63459-220; 63459-225,V63XWA605I,ARMODAFINIL,ARMODAFINIL,V63XWA605I,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/d878aed0-ddbf-8fa1-abf7-d3e480260845/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d878aed0-ddbf-8fa1-abf7-d3e480260845,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=d878aed0-ddbf-8fa1-abf7-d3e480260845,d878aed0-ddbf-8fa1-abf7-d3e480260845,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,021248,Trisenox,ARSENIC TRIOXIDE,2022/06/30,,2000,CEPHALON LLC,2017/12/22-,63459-601,S7V92P67HO,ARSENIC TRIOXIDE,ARSENIC CATION (3+),C96613F5AV,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/101fc347-d0ad-4aee-8b06-9feb187fd741/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=101fc347-d0ad-4aee-8b06-9feb187fd741,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=101fc347-d0ad-4aee-8b06-9feb187fd741,101fc347-d0ad-4aee-8b06-9feb187fd741,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,022268,COARTEM,ARTEMETHER AND LUMEFANTRINE,2023/08/02,Antimalarial,2009,NOVARTIS PHARMACEUTICALS CORPORATION,2009/04/07-,0078-0568,C7D6T3H22J; F38R0JR742,ARTEMETHER; LUMEFANTRINE,ARTEMETHER; LUMEFANTRINE,C7D6T3H22J; F38R0JR742,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/7866ec19-dfac-47d4-a53f-511a12643cbf/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7866ec19-dfac-47d4-a53f-511a12643cbf,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=7866ec19-dfac-47d4-a53f-511a12643cbf,7866ec19-dfac-47d4-a53f-511a12643cbf,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",SUBMUCOSAL,NDA,020971,Septocaine and Epinephrine,ARTICAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE,2024/03/04,Amide Local Anesthetic; Catecholamine; alpha-Adrenergic Agonist; beta-Adrenergic Agonist,2000,SEPTODONT INC,2011/01/12-,0362-9048; 0362-9049,30Q7KI53AK; QS9014Q792,Articaine Hydrochloride; Epinephrine Bitartrate,Articaine; Epinephrine,D3SQ406G9X; YKH834O4BH,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/0eba0bd2-ccb6-4f7e-8d0c-e4b4e6cdce03/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0eba0bd2-ccb6-4f7e-8d0c-e4b4e6cdce03,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=0eba0bd2-ccb6-4f7e-8d0c-e4b4e6cdce03,0eba0bd2-ccb6-4f7e-8d0c-e4b4e6cdce03,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,SUBMUCOSAL,NDA,022466,Orabloc,ARTICAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE,2018/11/22,Amide Local Anesthetic; Catecholamine; alpha-Adrenergic Agonist; beta-Adrenergic Agonist,2000,PIERREL S P A,2011/03/01-,45146-110; 45146-120,30Q7KI53AK; QS9014Q792,ARTICAINE HYDROCHLORIDE; EPINEPHRINE BITARTRATE,ARTICAINE; EPINEPHRINE,D3SQ406G9X; YKH834O4BH,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/d18424f0-a691-11dd-ad8b-0800200c9a66/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d18424f0-a691-11dd-ad8b-0800200c9a66,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=d18424f0-a691-11dd-ad8b-0800200c9a66,d18424f0-a691-11dd-ad8b-0800200c9a66,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",SUBMUCOSAL,NDA,022466,Articaine Hydrochloride and Epinephrine,"ARTICAINE HYDROCHLORIDE, EPINEPHRINE BITARTRATE; ARTICAINE HYDROCHLORIDE,EPINEPHRINE BITARTRATE",2022/12/12,Amide Local Anesthetic; Catecholamine; alpha-Adrenergic Agonist; beta-Adrenergic Agonist,2000,MIDWAY DENTAL SUPPLY LLC,completed:2021/04/26-2024/06/01,72304-015; 72304-016,30Q7KI53AK; QS9014Q792,ARTICAINE HYDROCHLORIDE; EPINEPHRINE BITARTRATE,ARTICAINE; EPINEPHRINE,D3SQ406G9X; YKH834O4BH,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/be742506-8c6e-6ff2-e053-2995a90a6b21/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=be742506-8c6e-6ff2-e053-2995a90a6b21,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=be742506-8c6e-6ff2-e053-2995a90a6b21,be742506-8c6e-6ff2-e053-2995a90a6b21,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,215358,SCEMBLIX,ASCIMINIB,2024/04/18,,2021,NOVARTIS PHARMACEUTICALS CORPORATION,2021/10/29-,0078-1091; 0078-1098; 0078-1196,C5U34S9XFV,ASCIMINIB HYDROCHLORIDE,ASCIMINIB,L1F3R18W77,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/e33001e7-3650-42b1-ae56-cddb5c43aa2b/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e33001e7-3650-42b1-ae56-cddb5c43aa2b,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=e33001e7-3650-42b1-ae56-cddb5c43aa2b,e33001e7-3650-42b1-ae56-cddb5c43aa2b,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRAVENOUS,NDA,209112,Ascor,ASCORBIC ACID,2024/01/25,Vitamin C,1947,MCGUFF PHARMACEUTICALS INC,2018/01/15-,67157-101,PQ6CK8PD0R,ASCORBIC ACID,ASCORBIC ACID,PQ6CK8PD0R,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/388aad52-fc01-4784-9791-1dbc80c69306/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=388aad52-fc01-4784-9791-1dbc80c69306,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=388aad52-fc01-4784-9791-1dbc80c69306,388aad52-fc01-4784-9791-1dbc80c69306,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,021265,PEDIATRIC INFUVITE MULTIPLE VITAMINS FOR INFUSION,"ASCORBIC ACID, VITAMIN A PALMITATE, CHOLECALCIFEROL, THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5-PHOSPHATE SODIUM, PYRIDOXINE HYDROCHLORIDE, NIACINAMIDE, DEXPANTHENOL, ALPHA-TOCOPHEROL ACETATE, VITAMIN K1, F",2016/03/28,Photoenhancer; Vitamin A; Vitamin B12; Vitamin B6 Analog; Vitamin C; Vitamin D; Vitamin K; Warfarin Reversal Agent,2001,SANDOZ INC,2001/02/21-,54643-5646,1C6V77QF41; 1D1K0N0VVC; 1O6C93RI7Z; 20RD1DZH99; 25X51I8RD4; 68Y4CF58BV; 6SO6U10H04; 935E97BOY8; 9E8X80D2L0; A034SE7857; M572600E5P; P6YC3EG204; PQ6CK8PD0R,.ALPHA.-TOCOPHEROL ACETATE; ASCORBIC ACID; BIOTIN; CHOLECALCIFEROL; CYANOCOBALAMIN; DEXPANTHENOL; FOLIC ACID; NIACINAMIDE; PHYTONADIONE; PYRIDOXINE HYDROCHLORIDE,.ALPHA.-TOCOPHEROL; ASCORBIC ACID; BIOTIN; CHOLECALCIFEROL; CYANOCOBALAMIN; DEXPANTHENOL; FLAVIN MONONUCLEOTIDE; FOLIC ACID; NIACINAMIDE; PHYTONADIONE,1C6V77QF41; 1O6C93RI7Z; 25X51I8RD4; 4ABT0J945J; 6SO6U10H04; 7N464URE7E; 81G40H8B0T; 935E97BOY8; A034SE7857; H4N855PNZ1; KV2JZ1BI6Z; P6YC3EG204; PQ6CK8PD0R,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/2e3c2e71-a3b8-48bf-8e95-96299424cad5/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2e3c2e71-a3b8-48bf-8e95-96299424cad5,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=2e3c2e71-a3b8-48bf-8e95-96299424cad5,2e3c2e71-a3b8-48bf-8e95-96299424cad5,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,021163;021559,Adult Infuvite Multiple Vitamins,"ASCORBIC ACID, VITAMIN A PALMITATE, CHOLECALCIFEROL, THIAMINE HYDROCHLORIDE, RIBOFLAVIN-5 PHOSPHATE SODIUM, PYRIDOXINE HYDROCHLORIDE, NIACINAMIDE, DEXPANTHENOL, ALPHA-TOCOPHEROL ACETATE, VITAMIN K1, F",2016/10/28,Photoenhancer; Vitamin A; Vitamin B12; Vitamin B6 Analog; Vitamin C; Vitamin D; Vitamin K; Warfarin Reversal Agent,2003,SANDOZ INC,2003/06/16-; 2005/05/18-,54643-7862; 54643-7874,1C6V77QF41; 1D1K0N0VVC; 1O6C93RI7Z; 20RD1DZH99; 25X51I8RD4; 68Y4CF58BV; 6SO6U10H04; 935E97BOY8; 9E8X80D2L0; A034SE7857; M572600E5P; P6YC3EG204; PQ6CK8PD0R,.ALPHA.-TOCOPHEROL ACETATE; ASCORBIC ACID; BIOTIN; CHOLECALCIFEROL; CYANOCOBALAMIN; DEXPANTHENOL; FOLIC ACID; NIACINAMIDE; PHYTONADIONE; PYRIDOXINE HYDROCHLORIDE,.ALPHA.-TOCOPHEROL; ASCORBIC ACID; BIOTIN; CHOLECALCIFEROL; CYANOCOBALAMIN; DEXPANTHENOL; FLAVIN MONONUCLEOTIDE; FOLIC ACID; NIACINAMIDE; PHYTONADIONE,1C6V77QF41; 1O6C93RI7Z; 25X51I8RD4; 4ABT0J945J; 6SO6U10H04; 7N464URE7E; 81G40H8B0T; 935E97BOY8; A034SE7857; H4N855PNZ1; KV2JZ1BI6Z; P6YC3EG204; PQ6CK8PD0R,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/f10e7c39-b9ce-4d3b-98e0-891ccb8d0b1a/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f10e7c39-b9ce-4d3b-98e0-891ccb8d0b1a,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=f10e7c39-b9ce-4d3b-98e0-891ccb8d0b1a,f10e7c39-b9ce-4d3b-98e0-891ccb8d0b1a,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION; KIT",INTRAVENOUS,NDA,021265;021646,Pediatric Infuvite Multiple Vitamins,"ASCORBIC ACID, VITAMIN A PALMITATE, CHOLECALCIFEROL, THIAMINE HYDROCHLORIDE, RIBOFLAVIN-5 PHOSPHATE SODIUM, PYRIDOXINE HYDROCHLORIDE, NIACINAMIDE, DEXPANTHENOL, ALPHA-TOCOPHEROL ACETATE, VITAMIN K1, F",2016/10/28,Photoenhancer; Vitamin A; Vitamin B12; Vitamin B6 Analog; Vitamin C; Vitamin D; Vitamin K; Warfarin Reversal Agent,2001,SANDOZ INC,2016/12/23-,54643-9023; 54643-9031,1C6V77QF41; 1D1K0N0VVC; 1O6C93RI7Z; 20RD1DZH99; 25X51I8RD4; 68Y4CF58BV; 6SO6U10H04; 935E97BOY8; 9E8X80D2L0; A034SE7857; M572600E5P; P6YC3EG204; PQ6CK8PD0R,.ALPHA.-TOCOPHEROL ACETATE; ASCORBIC ACID; BIOTIN; CHOLECALCIFEROL; CYANOCOBALAMIN; DEXPANTHENOL; FOLIC ACID; NIACINAMIDE; PHYTONADIONE; PYRIDOXINE HYDROCHLORIDE,.ALPHA.-TOCOPHEROL; ASCORBIC ACID; BIOTIN; CHOLECALCIFEROL; CYANOCOBALAMIN; DEXPANTHENOL; FLAVIN MONONUCLEOTIDE; FOLIC ACID; NIACINAMIDE; PHYTONADIONE,1C6V77QF41; 1O6C93RI7Z; 25X51I8RD4; 4ABT0J945J; 6SO6U10H04; 7N464URE7E; 81G40H8B0T; 935E97BOY8; A034SE7857; H4N855PNZ1; KV2JZ1BI6Z; P6YC3EG204; PQ6CK8PD0R,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/4ff223f7-e076-4e81-8151-5c06724fabd9/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4ff223f7-e076-4e81-8151-5c06724fabd9,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=4ff223f7-e076-4e81-8151-5c06724fabd9,4ff223f7-e076-4e81-8151-5c06724fabd9,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,021163;021559,Adult Infuvite Multiple Vitamins,"ASCORBIC ACID, VITAMIN A PALMITATE, CHOLECALCIFEROL, THIAMINE HYDROCHLORIDE, RIBOFLAVIN-5 PHOSPHATE SODIUM, PYRIDOXINE HYDROCHLORIDE, NIACINAMIDE, DEXPANTHENOL, ALPHA-TOCOPHEROL ACETATE, VITAMIN K1, F",2016/10/28,Photoenhancer; Vitamin A; Vitamin B12; Vitamin B6 Analog; Vitamin C; Vitamin D; Vitamin K; Warfarin Reversal Agent,2003,SANDOZ INC,2003/06/16-; 2005/05/18-,54643-9007; 54643-9015,1C6V77QF41; 1D1K0N0VVC; 1O6C93RI7Z; 20RD1DZH99; 25X51I8RD4; 68Y4CF58BV; 6SO6U10H04; 935E97BOY8; 9E8X80D2L0; A034SE7857; M572600E5P; P6YC3EG204; PQ6CK8PD0R,.ALPHA.-TOCOPHEROL ACETATE; ASCORBIC ACID; BIOTIN; CHOLECALCIFEROL; CYANOCOBALAMIN; DEXPANTHENOL; FOLIC ACID; NIACINAMIDE; PHYTONADIONE; PYRIDOXINE HYDROCHLORIDE,.ALPHA.-TOCOPHEROL; ASCORBIC ACID; BIOTIN; CHOLECALCIFEROL; CYANOCOBALAMIN; DEXPANTHENOL; FLAVIN MONONUCLEOTIDE; FOLIC ACID; NIACINAMIDE; PHYTONADIONE,1C6V77QF41; 1O6C93RI7Z; 25X51I8RD4; 4ABT0J945J; 6SO6U10H04; 7N464URE7E; 81G40H8B0T; 935E97BOY8; A034SE7857; H4N855PNZ1; KV2JZ1BI6Z; P6YC3EG204; PQ6CK8PD0R,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/4c8d32a4-3334-434b-a828-979d087a6ed9/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4c8d32a4-3334-434b-a828-979d087a6ed9,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=4c8d32a4-3334-434b-a828-979d087a6ed9,4c8d32a4-3334-434b-a828-979d087a6ed9,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION; KIT",INTRAVENOUS,NDA,021265;021646,Pediatric Infuvite Multiple Vitamins,"ASCORBIC ACID, VITAMIN A PALMITATE, CHOLECALCIFEROL, THIAMINE HYDROCHLORIDE, RIBOFLAVIN-5 PHOSPHATE SODIUM, PYRIDOXINE HYDROCHLORIDE, NIACINAMIDE, DEXPANTHENOL, ALPHA-TOCOPHEROL ACETATE, VITAMIN K1, F",2016/10/28,Photoenhancer; Vitamin A; Vitamin B12; Vitamin B6 Analog; Vitamin C; Vitamin D; Vitamin K; Warfarin Reversal Agent,2001,SANDOZ INC,2001/02/21-; 2004/01/29-,54643-7886; 54643-7898,1C6V77QF41; 1D1K0N0VVC; 1O6C93RI7Z; 20RD1DZH99; 25X51I8RD4; 68Y4CF58BV; 6SO6U10H04; 935E97BOY8; 9E8X80D2L0; A034SE7857; M572600E5P; P6YC3EG204; PQ6CK8PD0R,.ALPHA.-TOCOPHEROL ACETATE; ASCORBIC ACID; BIOTIN; CHOLECALCIFEROL; CYANOCOBALAMIN; DEXPANTHENOL; FOLIC ACID; NIACINAMIDE; PHYTONADIONE; PYRIDOXINE HYDROCHLORIDE,.ALPHA.-TOCOPHEROL; ASCORBIC ACID; BIOTIN; CHOLECALCIFEROL; CYANOCOBALAMIN; DEXPANTHENOL; FLAVIN MONONUCLEOTIDE; FOLIC ACID; NIACINAMIDE; PHYTONADIONE,1C6V77QF41; 1O6C93RI7Z; 25X51I8RD4; 4ABT0J945J; 6SO6U10H04; 7N464URE7E; 81G40H8B0T; 935E97BOY8; A034SE7857; H4N855PNZ1; KV2JZ1BI6Z; P6YC3EG204; PQ6CK8PD0R,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/02064c66-3f2d-4502-a96d-800a4d128593/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=02064c66-3f2d-4502-a96d-800a4d128593,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=02064c66-3f2d-4502-a96d-800a4d128593,02064c66-3f2d-4502-a96d-800a4d128593,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,021163;021559,Infuvite Adult Multiple Vitamins,"ASCORBIC ACID, VITAMIN A PALMITATE, CHOLECALCIFEROL, THIAMINE HYDROCHLORIDE, RIBOFLAVIN-5 PHOSPHATE SODIUM, PYRIDOXINE HYDROCHLORIDE, NIACINAMIDE, DEXPANTHENOL, ALPHA-TOCOPHEROL ACETATE, VITAMIN K1, F",2016/03/17,Photoenhancer; Vitamin A; Vitamin B12; Vitamin B6 Analog; Vitamin C; Vitamin D; Vitamin K; Warfarin Reversal Agent,2003,SANDOZ INC,2003/06/16-; 2005/05/18-,54643-5649; 54643-5650,1C6V77QF41; 1D1K0N0VVC; 1O6C93RI7Z; 20RD1DZH99; 25X51I8RD4; 68Y4CF58BV; 6SO6U10H04; 935E97BOY8; 9E8X80D2L0; A034SE7857; M572600E5P; P6YC3EG204; PQ6CK8PD0R,.ALPHA.-TOCOPHEROL ACETATE; ASCORBIC ACID; BIOTIN; CHOLECALCIFEROL; CYANOCOBALAMIN; DEXPANTHENOL; FOLIC ACID; NIACINAMIDE; PHYTONADIONE; PYRIDOXINE HYDROCHLORIDE,.ALPHA.-TOCOPHEROL; ASCORBIC ACID; BIOTIN; CHOLECALCIFEROL; CYANOCOBALAMIN; DEXPANTHENOL; FLAVIN MONONUCLEOTIDE; FOLIC ACID; NIACINAMIDE; PHYTONADIONE,1C6V77QF41; 1O6C93RI7Z; 25X51I8RD4; 4ABT0J945J; 6SO6U10H04; 7N464URE7E; 81G40H8B0T; 935E97BOY8; A034SE7857; H4N855PNZ1; KV2JZ1BI6Z; P6YC3EG204; PQ6CK8PD0R,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/14c7bfc5-07e8-400f-b8ff-5e4794dd2805/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=14c7bfc5-07e8-400f-b8ff-5e4794dd2805,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=14c7bfc5-07e8-400f-b8ff-5e4794dd2805,14c7bfc5-07e8-400f-b8ff-5e4794dd2805,,,
HUMAN PRESCRIPTION DRUG LABEL,"FILM, EXTENDED RELEASE",TRANSDERMAL,NDA,212268,SECUADO,ASENAPINE,2023/11/28,Atypical Antipsychotic,2009,NOVEN THERAPEUTICS LLC,2020/02/12-,68968-0172; 68968-0173; 68968-0174,JKZ19V908O,ASENAPINE,ASENAPINE,JKZ19V908O,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/685eaf44-5944-4f38-afba-0a4fc0b3462b/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=685eaf44-5944-4f38-afba-0a4fc0b3462b,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=685eaf44-5944-4f38-afba-0a4fc0b3462b,685eaf44-5944-4f38-afba-0a4fc0b3462b,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,SUBLINGUAL,NDA,022117,SAPHRIS,ASENAPINE MALEATE,2021/10/01,Atypical Antipsychotic,2009,ALLERGAN INC,2013/09/30-; 2014/12/30-,0456-2402; 0456-2405; 0456-2410,CU9463U2E2,ASENAPINE MALEATE,Asenapine,JKZ19V908O,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/5429f134-839f-4ffc-9944-55f51238def8/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5429f134-839f-4ffc-9944-55f51238def8,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=5429f134-839f-4ffc-9944-55f51238def8,5429f134-839f-4ffc-9944-55f51238def8,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,205103,Yosprala,ASPIRIN AND OMEPRAZOLE,2020/01/30,Nonsteroidal Anti-inflammatory Drug; Platelet Aggregation Inhibitor; Proton Pump Inhibitor,2016,PHARMACEUTIKA LTD,2020/01/30-,73568-004; 73568-005,KG60484QX9; R16CO5Y76E,aspirin; omeprazole,aspirin; omeprazole,KG60484QX9; R16CO5Y76E,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/bce0eb08-7eac-4437-ba88-fafac350a8f6/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=bce0eb08-7eac-4437-ba88-fafac350a8f6,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=bce0eb08-7eac-4437-ba88-fafac350a8f6,bce0eb08-7eac-4437-ba88-fafac350a8f6,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,205103,aspirin and omeprazole delayed-release tab,ASPIRIN AND OMEPRAZOLE,2019/11/20,Nonsteroidal Anti-inflammatory Drug; Platelet Aggregation Inhibitor; Proton Pump Inhibitor,2016,INNOVIDA THERAPEUTIQUE CORPORATION,2019/11/13-,73457-415,KG60484QX9; R16CO5Y76E,aspirin; omeprazole,aspirin; omeprazole,KG60484QX9; R16CO5Y76E,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/ae8f4eb4-b1eb-432e-b5ab-598c29996d6a/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ae8f4eb4-b1eb-432e-b5ab-598c29996d6a,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=ae8f4eb4-b1eb-432e-b5ab-598c29996d6a,ae8f4eb4-b1eb-432e-b5ab-598c29996d6a,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,205103,YOSPRALA,ASPIRIN AND OMEPRAZOLE,2018/06/19,Nonsteroidal Anti-inflammatory Drug; Platelet Aggregation Inhibitor; Proton Pump Inhibitor,2016,ARALEZ PHARMACEUTICALS US INC,2016/09/14-,70347-081; 70347-325,KG60484QX9; R16CO5Y76E,ASPIRIN; OMEPRAZOLE,ASPIRIN; OMEPRAZOLE,KG60484QX9; R16CO5Y76E,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/73f74f6d-e624-4551-8924-1c747ffb2140/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=73f74f6d-e624-4551-8924-1c747ffb2140,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=73f74f6d-e624-4551-8924-1c747ffb2140,73f74f6d-e624-4551-8924-1c747ffb2140,,,
HUMAN PRESCRIPTION DRUG LABEL,"CAPSULE, GELATIN COATED; POWDER",ORAL,NDA,021567;206352,REYATAZ,ATAZANAVIR,2023/11/07,Protease Inhibitor,2003,E R SQUIBB AND SONS L L C,2003/06/24-; 2014/12/19-; completed:2003/06/24-2023/04/30,0003-3622; 0003-3624; 0003-3631; 0003-3638,4MT4VIE29P,ATAZANAVIR SULFATE,ATAZANAVIR,QZU4H47A3S,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/165cff62-b284-4a27-a65d-9ec8a5bfcdd8/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=165cff62-b284-4a27-a65d-9ec8a5bfcdd8,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=165cff62-b284-4a27-a65d-9ec8a5bfcdd8,165cff62-b284-4a27-a65d-9ec8a5bfcdd8,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,206353,EVOTAZ,ATAZANAVIR AND COBICISTAT,2023/05/12,Cytochrome P450 3A Inhibitor; Protease Inhibitor,2015,E R SQUIBB AND SONS L L C,2015/01/29-,0003-3641,4MT4VIE29P; LW2E03M5PG,ATAZANAVIR SULFATE; COBICISTAT,ATAZANAVIR; COBICISTAT,LW2E03M5PG; QZU4H47A3S,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/83db29d7-5d85-49d6-8cb6-740473365cf8/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=83db29d7-5d85-49d6-8cb6-740473365cf8,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=83db29d7-5d85-49d6-8cb6-740473365cf8,83db29d7-5d85-49d6-8cb6-740473365cf8,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,018240,TENORMIN,ATENOLOL,2023/08/31,beta-Adrenergic Blocker,,ALMATICA PHARMA LLC,2015/04/15-,52427-429; 52427-430; 52427-431,50VV3VW0TI,ATENOLOL,ATENOLOL,50VV3VW0TI,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/746db603-a6e1-4dc3-c2d8-92314419098c/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=746db603-a6e1-4dc3-c2d8-92314419098c,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=746db603-a6e1-4dc3-c2d8-92314419098c,746db603-a6e1-4dc3-c2d8-92314419098c,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,018760,TENORETIC,ATENOLOL AND CHLORTHALIDONE,2023/11/14,Thiazide-like Diuretic; beta-Adrenergic Blocker,,TWI PHARMACEUTICALS INC,2024/04/25-,24979-256; 24979-257,50VV3VW0TI; Q0MQD1073Q,ATENOLOL; CHLORTHALIDONE,ATENOLOL; CHLORTHALIDONE,50VV3VW0TI; Q0MQD1073Q,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/992e66b7-525a-4bf8-bce7-6b29cb120378/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=992e66b7-525a-4bf8-bce7-6b29cb120378,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=992e66b7-525a-4bf8-bce7-6b29cb120378,992e66b7-525a-4bf8-bce7-6b29cb120378,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,018760,TENORETIC,ATENOLOL AND CHLORTHALIDONE,2023/08/31,Thiazide-like Diuretic; beta-Adrenergic Blocker,,ALMATICA PHARMA LLC,2015/04/21-,52427-382; 52427-383,50VV3VW0TI; Q0MQD1073Q,ATENOLOL; CHLORTHALIDONE,ATENOLOL; CHLORTHALIDONE,50VV3VW0TI; Q0MQD1073Q,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/4c7b43e9-d6f1-45e6-5699-5f5f2d075449/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4c7b43e9-d6f1-45e6-5699-5f5f2d075449,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=4c7b43e9-d6f1-45e6-5699-5f5f2d075449,4c7b43e9-d6f1-45e6-5699-5f5f2d075449,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,215206,Qulipta,ATOGEPANT,2023/06/01,Calcitonin Gene-related Peptide Receptor Antagonist,2021,ABBVIE INC,2021/09/30-,0074-7094; 0074-7095; 0074-7096,7CRV8RR151,ATOGEPANT,ATOGEPANT,7CRV8RR151,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/8c8ab8f4-32bd-497a-befa-70c8a51d8d52/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8c8ab8f4-32bd-497a-befa-70c8a51d8d52,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=8c8ab8f4-32bd-497a-befa-70c8a51d8d52,8c8ab8f4-32bd-497a-befa-70c8a51d8d52,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,NDA,021411,Strattera,ATOMOXETINE HYDROCHLORIDE,2022/01/06,Norepinephrine Reuptake Inhibitor,2002,ELI LILLY AND COMPANY,2002/11/26-; 2005/02/14-,0002-3227; 0002-3228; 0002-3229; 0002-3238; 0002-3239; 0002-3250; 0002-3251,57WVB6I2W0,Atomoxetine hydrochloride,Atomoxetine,ASW034S0B8,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/309de576-c318-404a-bc15-660c2b1876fb/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=309de576-c318-404a-bc15-660c2b1876fb,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=309de576-c318-404a-bc15-660c2b1876fb,309de576-c318-404a-bc15-660c2b1876fb,,,
HUMAN PRESCRIPTION DRUG LABEL,SUSPENSION,ORAL,NDA,213260,ATORVALIQ,ATORVALIQ,2023/02/16,HMG-CoA Reductase Inhibitor,1996,CMP PHARMA INC,2023/03/01-,46287-030,48A5M73Z4Q,ATORVASTATIN CALCIUM TRIHYDRATE,ATORVASTATIN,A0JWA85V8F,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/41fca2d8-7f3f-45b9-8974-81b89accc211/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=41fca2d8-7f3f-45b9-8974-81b89accc211,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=41fca2d8-7f3f-45b9-8974-81b89accc211,41fca2d8-7f3f-45b9-8974-81b89accc211,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,020702,Lipitor,ATORVASTATIN CALCIUM,2024/04/15,HMG-CoA Reductase Inhibitor,1996,VIATRIS SPECIALTY LLC,2024/01/03-; 2024/02/20-; 2024/02/29-; 2024/05/01-,58151-155; 58151-156; 58151-157; 58151-158,48A5M73Z4Q,ATORVASTATIN CALCIUM TRIHYDRATE,ATORVASTATIN,A0JWA85V8F,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/a60cc18b-0631-4cf0-b021-9f52224ece65/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a60cc18b-0631-4cf0-b021-9f52224ece65,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=a60cc18b-0631-4cf0-b021-9f52224ece65,a60cc18b-0631-4cf0-b021-9f52224ece65,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,020702,Lipitor,ATORVASTATIN CALCIUM,2022/12/01,HMG-CoA Reductase Inhibitor,1996,PARKE DAVIS DIV OF PFIZER INC,completed:1996/12/17-2025/04/30; completed:1996/12/17-2025/09/30; completed:1996/12/17-2026/03/31; completed:2000/04/07-2025/09/30,0071-0155; 0071-0156; 0071-0157; 0071-0158,48A5M73Z4Q,ATORVASTATIN CALCIUM TRIHYDRATE,ATORVASTATIN,A0JWA85V8F,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/c6e131fe-e7df-4876-83f7-9156fc4e8228/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c6e131fe-e7df-4876-83f7-9156fc4e8228,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=c6e131fe-e7df-4876-83f7-9156fc4e8228,c6e131fe-e7df-4876-83f7-9156fc4e8228,,,
HUMAN PRESCRIPTION DRUG LABEL,SUSPENSION,ORAL,NDA,020500,MEPRON,ATOVAQUONE,2023/07/20,Antimalarial; Antiprotozoal,1992,GLAXOSMITHKLINE LLC,1995/02/28-; 1998/09/18-,0173-0547; 0173-0665,Y883P1Z2LT,ATOVAQUONE,ATOVAQUONE,Y883P1Z2LT,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/b426b6bf-f07e-4580-97ae-dfca1ddf5b8f/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b426b6bf-f07e-4580-97ae-dfca1ddf5b8f,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=b426b6bf-f07e-4580-97ae-dfca1ddf5b8f,b426b6bf-f07e-4580-97ae-dfca1ddf5b8f,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,021078,MALARONE,ATOVAQUONE AND PROGUANIL HYDROCHLORIDE,2023/11/14,Antimalarial; Antiprotozoal,2000,GLAXOSMITHKLINE LLC,2000/07/26-,0173-0675; 0173-0676,R71Y86M0WT; Y883P1Z2LT,ATOVAQUONE; PROGUANIL HYDROCHLORIDE,ATOVAQUONE; PROGUANIL,S61K3P7B2V; Y883P1Z2LT,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/fc22e8d8-3bfb-4f70-a599-dd81262a4887/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=fc22e8d8-3bfb-4f70-a599-dd81262a4887,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=fc22e8d8-3bfb-4f70-a599-dd81262a4887,fc22e8d8-3bfb-4f70-a599-dd81262a4887,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRAMUSCULAR,NDA,017106,ATROPEN Auto-Injector,ATROPINE,2022/09/15,Anticholinergic; Cholinergic Muscarinic Antagonist,1960,MERIDIAN MEDICAL TECHNOLOGIES LLC,1973/05/15-; 2003/06/19-; 2004/09/17-,11704-101; 11704-104; 11704-105; 11704-106; 11704-107,7C0697DR9I,atropine,atropine,7C0697DR9I,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/e2d4307d-da8f-49f5-aac0-02355dd9ffb7/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e2d4307d-da8f-49f5-aac0-02355dd9ffb7,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=e2d4307d-da8f-49f5-aac0-02355dd9ffb7,e2d4307d-da8f-49f5-aac0-02355dd9ffb7,,,
HUMAN PRESCRIPTION DRUG LABEL,KIT,INTRAMUSCULAR,NDA,021983,DuoDote,ATROPINE AND PRALIDOXIME CHLORIDE,2022/04/04,Anticholinergic; Cholinergic Muscarinic Antagonist; Cholinesterase Reactivator,2006,MERIDIAN MEDICAL TECHNOLOGIES LLC,2006/09/28-,11704-620,38X7XS076H; 7C0697DR9I,atropine; pralidoxime chloride,atropine; pralidoxime,7C0697DR9I; P7MU9UTP52,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/241f42a0-1a33-40e8-8221-201767d999e5/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=241f42a0-1a33-40e8-8221-201767d999e5,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=241f42a0-1a33-40e8-8221-201767d999e5,241f42a0-1a33-40e8-8221-201767d999e5,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,214652,ATROPINE SULFATE,ATROPINE SULFATE,2023/03/16,Anticholinergic; Cholinergic Muscarinic Antagonist,1960,ACCORD HEALTHCARE INC,2021/01/11-,16729-525; 16729-526,03J5ZE7KA5,ATROPINE SULFATE,ATROPINE,7C0697DR9I,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/d5e07279-48ca-4f83-9633-299e65a7f821/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d5e07279-48ca-4f83-9633-299e65a7f821,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=d5e07279-48ca-4f83-9633-299e65a7f821,d5e07279-48ca-4f83-9633-299e65a7f821,,,
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION,OPHTHALMIC,NDA,208151,Isopto Atropine,ATROPINE SULFATE,2022/10/07,Anticholinergic; Cholinergic Muscarinic Antagonist,1960,ALCON LABORATORIES INC,2018/08/01-,0065-0303,03J5ZE7KA5,Atropine Sulfate,Atropine,7C0697DR9I,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/20491566-e6eb-8d4a-3083-77ea429f7bc4/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=20491566-e6eb-8d4a-3083-77ea429f7bc4,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=20491566-e6eb-8d4a-3083-77ea429f7bc4,20491566-e6eb-8d4a-3083-77ea429f7bc4,,,
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION,OPHTHALMIC,NDA,208151,atropine sulfate,ATROPINE SULFATE,2022/08/30,Anticholinergic; Cholinergic Muscarinic Antagonist,1960,ALCON LABORATORIES INC,2022/11/01-,0065-0817,03J5ZE7KA5,Atropine Sulfate,Atropine,7C0697DR9I,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/c8093125-ed1a-4eb6-9c81-52c5c7376481/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c8093125-ed1a-4eb6-9c81-52c5c7376481,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=c8093125-ed1a-4eb6-9c81-52c5c7376481,c8093125-ed1a-4eb6-9c81-52c5c7376481,,,
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION/ DROPS,OPHTHALMIC,NDA,206289,Atropine,ATROPINE SULFATE,2022/07/01,Anticholinergic; Cholinergic Muscarinic Antagonist,1960,AKORN,2014/07/18-,17478-215,03J5ZE7KA5,Atropine Sulfate,Atropine,7C0697DR9I,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/f7b40bf1-3063-4849-a5a0-0ac5d0d1e72a/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f7b40bf1-3063-4849-a5a0-0ac5d0d1e72a,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=f7b40bf1-3063-4849-a5a0-0ac5d0d1e72a,f7b40bf1-3063-4849-a5a0-0ac5d0d1e72a,,,
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION/ DROPS,OPHTHALMIC,NDA,206289,Atropine,ATROPINE SULFATE,2022/04/30,Anticholinergic; Cholinergic Muscarinic Antagonist,1960,MWI,2015/03/23-,13985-606,03J5ZE7KA5,Atropine Sulfate,Atropine,7C0697DR9I,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/590a4e7b-565f-415f-a8e4-499a382c9a3b/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=590a4e7b-565f-415f-a8e4-499a382c9a3b,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=590a4e7b-565f-415f-a8e4-499a382c9a3b,590a4e7b-565f-415f-a8e4-499a382c9a3b,,,
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION,OPHTHALMIC,NDA,213581,Atropine Sulfate,ATROPINE SULFATE,2022/03/03,Anticholinergic; Cholinergic Muscarinic Antagonist,1960,BAUSCH AND LOMB INCORPORATED,2022/07/13-,24208-965,03J5ZE7KA5,ATROPINE SULFATE,ATROPINE,7C0697DR9I,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/aeab333c-3cdb-45c0-9e22-949624d69fbc/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=aeab333c-3cdb-45c0-9e22-949624d69fbc,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=aeab333c-3cdb-45c0-9e22-949624d69fbc,aeab333c-3cdb-45c0-9e22-949624d69fbc,,,
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION,OPHTHALMIC,NDA,213581,Atropine Sulfate,ATROPINE SULFATE,2022/03/03,Anticholinergic; Cholinergic Muscarinic Antagonist,1960,BAUSCH AND LOMB AMERICAS INC,2023/04/21-,82260-001,03J5ZE7KA5,ATROPINE SULFATE,ATROPINE,7C0697DR9I,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/e294ce2b-6bb5-4f84-8a6d-ce2402ed926d/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e294ce2b-6bb5-4f84-8a6d-ce2402ed926d,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=e294ce2b-6bb5-4f84-8a6d-ce2402ed926d,e294ce2b-6bb5-4f84-8a6d-ce2402ed926d,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,021146,Atropine Sulfate,ATROPINE SULFATE,2021/08/05,Anticholinergic; Cholinergic Muscarinic Antagonist,1960,HOSPIRA INC,2004/12/31-; 2005/08/25-; 2005/10/25-; 2006/01/19-,0409-1630; 0409-4910; 0409-4911; 0409-9630,03J5ZE7KA5,ATROPINE SULFATE,ATROPINE,7C0697DR9I,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/ad8916e7-206e-409e-2582-30d072845dd4/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ad8916e7-206e-409e-2582-30d072845dd4,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=ad8916e7-206e-409e-2582-30d072845dd4,ad8916e7-206e-409e-2582-30d072845dd4,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",ENDOTRACHEAL; INTRAMEDULLARY; INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS,NDA,209260,Atropine Sulfate,ATROPINE SULFATE,2020/01/21,Anticholinergic; Cholinergic Muscarinic Antagonist,1960,FRESENIUS KABI USA LLC,2017/01/23-,63323-580,03J5ZE7KA5,ATROPINE SULFATE,ATROPINE,7C0697DR9I,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/310c8a74-ea24-4357-8099-81e394b1634e/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=310c8a74-ea24-4357-8099-81e394b1634e,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=310c8a74-ea24-4357-8099-81e394b1634e,310c8a74-ea24-4357-8099-81e394b1634e,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,NDA,018689,RIDAURA,AURANOFIN,2018/12/14,,,SEBELA PHARMACEUTICALS INC,2016/12/15-,54766-093,3H04W2810V,AURANOFIN,AURANOFIN,3H04W2810V,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/43ba3de1-ab2e-06f6-e054-00144ff8d46c/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=43ba3de1-ab2e-06f6-e054-00144ff8d46c,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=43ba3de1-ab2e-06f6-e054-00144ff8d46c,43ba3de1-ab2e-06f6-e054-00144ff8d46c,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,NDA,018689,RIDAURA,AURANOFIN,2011/12/15,,,PROMETHEUS LABORATORIES INC,1985/04/24-,65483-093,3H04W2810V,auranofin,auranofin,3H04W2810V,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/05c34ddf-a0f7-4267-83f5-d02be3defc37/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=05c34ddf-a0f7-4267-83f5-d02be3defc37,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=05c34ddf-a0f7-4267-83f5-d02be3defc37,05c34ddf-a0f7-4267-83f5-d02be3defc37,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRAVITREAL,NDA,217225,IZERVAY,AVACINCAPTAD PEGOL,2024/02/01,Complement Inhibitor,2023,ASTELLAS PHARMA US INC,2023/08/19-,82829-002,K86ENL12I5,AVACINCAPTAD PEGOL SODIUM,AVACINCAPTAD PEGOL,TT0V5JLG5B,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/1642fe6a-dc26-4d20-ae6e-654af744e3bd/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1642fe6a-dc26-4d20-ae6e-654af744e3bd,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=1642fe6a-dc26-4d20-ae6e-654af744e3bd,1642fe6a-dc26-4d20-ae6e-654af744e3bd,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,NDA,214487,TAVNEOS,AVACOPAN,2022/02/15,Complement 5a Receptor Antagonist,2021,CHEMOCENTRYX INC,2021/10/18-,73556-168,O880NM097T,AVACOPAN,AVACOPAN,O880NM097T,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/c93cbc0b-29a3-46a5-9c85-41815ea5cf4a/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c93cbc0b-29a3-46a5-9c85-41815ea5cf4a,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=c93cbc0b-29a3-46a5-9c85-41815ea5cf4a,c93cbc0b-29a3-46a5-9c85-41815ea5cf4a,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,202276,Stendra,AVANAFIL,2023/08/07,Phosphodiesterase 5 Inhibitor,2012,METUCHEN PHARMACEUTICALS LLC,2013/12/27-,72384-751; 72384-752; 72384-753,DR5S136IVO,AVANAFIL,AVANAFIL,DR5S136IVO,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/fa7d93e3-b69b-4e02-8146-89760cd8e9d6/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=fa7d93e3-b69b-4e02-8146-89760cd8e9d6,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=fa7d93e3-b69b-4e02-8146-89760cd8e9d6,fa7d93e3-b69b-4e02-8146-89760cd8e9d6,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,212608,Ayvakit,AVAPRITINIB,2024/05/15,Kinase Inhibitor,2020,BLUEPRINT MEDICINES CORPORATION,2020/01/09-; 2021/06/16-,72064-110; 72064-120; 72064-125; 72064-130; 72064-150,513P80B4YJ,avapritinib,avapritinib,513P80B4YJ,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/645c887c-8cd4-4623-8da9-ac223d71a8b9/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=645c887c-8cd4-4623-8da9-ac223d71a8b9,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=645c887c-8cd4-4623-8da9-ac223d71a8b9,645c887c-8cd4-4623-8da9-ac223d71a8b9,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,210238,DOPTELET,AVATROMBOPAG MALEATE,2021/07/01,,2018,AKARX INC,2018/05/23-,71369-020,GDW7M2P1IS,AVATROMBOPAG MALEATE,AVATROMBOPAG,3H8GSZ4SQL,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/e2d5960d-6c18-46cc-86bd-089222b09852/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e2d5960d-6c18-46cc-86bd-089222b09852,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=e2d5960d-6c18-46cc-86bd-089222b09852,e2d5960d-6c18-46cc-86bd-089222b09852,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,202324,INLYTA,AXITINIB,2024/03/11,Kinase Inhibitor,2012,U S PHARMACEUTICALS,2012/01/27-,63539-026; 63539-044,C9LVQ0YUXG,AXITINIB,AXITINIB,C9LVQ0YUXG,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/8a903e31-936e-4ed7-8a59-59f32374f338/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8a903e31-936e-4ed7-8a59-59f32374f338,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=8a903e31-936e-4ed7-8a59-59f32374f338,8a903e31-936e-4ed7-8a59-59f32374f338,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,202324,INLYTA,AXITINIB,2024/03/11,Kinase Inhibitor,2012,PFIZER LABORATORIES DIV PFIZER INC,2012/01/27-,0069-0145; 0069-0151,C9LVQ0YUXG,AXITINIB,AXITINIB,C9LVQ0YUXG,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/84137882-e000-47da-bd5b-fa76ab3c76f9/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=84137882-e000-47da-bd5b-fa76ab3c76f9,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=84137882-e000-47da-bd5b-fa76ab3c76f9,84137882-e000-47da-bd5b-fa76ab3c76f9,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAVENOUS; SUBCUTANEOUS,NDA,050794,VIDAZA,AZACITIDINE,2024/01/29,Nucleoside Metabolic Inhibitor,2004,CELGENE CORPORATION,2004/07/05-,59572-102,M801H13NRU,AZACITIDINE,AZACITIDINE,M801H13NRU,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/3495a71a-cc04-4776-851f-f185956f32af/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3495a71a-cc04-4776-851f-f185956f32af,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=3495a71a-cc04-4776-851f-f185956f32af,3495a71a-cc04-4776-851f-f185956f32af,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,214120,ONUREG,AZACITIDINE,2022/10/26,Nucleoside Metabolic Inhibitor,2004,CELGENE CORPORATION,2020/09/01-,59572-730; 59572-740,M801H13NRU,AZACITIDINE,AZACITIDINE,M801H13NRU,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/0e95e33f-8aba-4f19-b332-2416580d358b/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0e95e33f-8aba-4f19-b332-2416580d358b,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=0e95e33f-8aba-4f19-b332-2416580d358b,0e95e33f-8aba-4f19-b332-2416580d358b,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,016324,IMURAN,AZATHIOPRINE,2019/03/20,Purine Antimetabolite,,SEBELA PHARMACEUTICALS INC,2017/12/01-,54766-590,MRK240IY2L,AZATHIOPRINE,AZATHIOPRINE,MRK240IY2L,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/606101a0-6244-7eff-e053-2a91aa0acadd/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=606101a0-6244-7eff-e053-2a91aa0acadd,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=606101a0-6244-7eff-e053-2a91aa0acadd,606101a0-6244-7eff-e053-2a91aa0acadd,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,016324,IMURAN,AZATHIOPRINE,2014/01/01,Purine Antimetabolite,,PROMETHEUS LABORATORIES INC,1968/03/20-,65483-590,MRK240IY2L,azathioprine,azathioprine,MRK240IY2L,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/aaa6c540-4c84-48a0-939c-cd423134fa2a/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=aaa6c540-4c84-48a0-939c-cd423134fa2a,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=aaa6c540-4c84-48a0-939c-cd423134fa2a,aaa6c540-4c84-48a0-939c-cd423134fa2a,,,
HUMAN PRESCRIPTION DRUG LABEL,CREAM,CUTANEOUS,NDA,020428,AZELEX,AZELAIC ACID,2024/03/04,,,ALMIRALL LLC,2018/09/24-,16110-869,F2VW3D43YT,AZELAIC ACID,AZELAIC ACID,F2VW3D43YT,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/ebdfcaf7-b5d6-47e1-be87-ccaba4b97e75/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ebdfcaf7-b5d6-47e1-be87-ccaba4b97e75,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=ebdfcaf7-b5d6-47e1-be87-ccaba4b97e75,ebdfcaf7-b5d6-47e1-be87-ccaba4b97e75,,,
HUMAN PRESCRIPTION DRUG LABEL,"AEROSOL, FOAM",TOPICAL,NDA,207071,FINACEA FOAM,AZELAIC ACID,2020/12/08,,1995,LEO PHARMA INC,2018/10/01-,50222-303,F2VW3D43YT,AZELAIC ACID,AZELAIC ACID,F2VW3D43YT,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/9fabd24e-4c3b-49a0-aa5f-c8d75ae67572/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9fabd24e-4c3b-49a0-aa5f-c8d75ae67572,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=9fabd24e-4c3b-49a0-aa5f-c8d75ae67572,9fabd24e-4c3b-49a0-aa5f-c8d75ae67572,,,
HUMAN PRESCRIPTION DRUG LABEL,GEL,TOPICAL,NDA,021470,Finacea,AZELAIC ACID,2019/07/10,,1995,LEO PHARMA INC,completed:2002/12/24-2026/01/31,50222-505,F2VW3D43YT,AZELAIC ACID,AZELAIC ACID,F2VW3D43YT,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/bea1957c-55ca-48cd-8cbc-ed44d546a857/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=bea1957c-55ca-48cd-8cbc-ed44d546a857,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=bea1957c-55ca-48cd-8cbc-ed44d546a857,bea1957c-55ca-48cd-8cbc-ed44d546a857,,,
HUMAN PRESCRIPTION DRUG LABEL,GEL; KIT,TOPICAL,NDA,021470,Finacea,AZELAIC ACID,2011/04/12,,,INTENDIS INC,2004/12/24-; 2011/04/12-,10922-825; 10922-826,F2VW3D43YT,AZELAIC ACID,AZELAIC ACID,F2VW3D43YT,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/63773349-0295-4d56-a72e-0d7cade88ddb/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=63773349-0295-4d56-a72e-0d7cade88ddb,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=63773349-0295-4d56-a72e-0d7cade88ddb,63773349-0295-4d56-a72e-0d7cade88ddb,,,
HUMAN PRESCRIPTION DRUG LABEL,"SPRAY, METERED",NASAL,NDA,202236,DYMISTA,AZELASTINE HYDROCHLORIDE AND FLUTICASONE PROPIONATE,2022/08/08,Corticosteroid; Histamine-1 Receptor Antagonist,2012,MEDA PHARMACEUTICALS INC,2012/05/01-,0037-0245,0L591QR10I; O2GMZ0LF5W,AZELASTINE HYDROCHLORIDE; FLUTICASONE PROPIONATE,AZELASTINE; FLUTICASONE,CUT2W21N7U; ZQI909440X,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/4c557ec4-c4cf-11df-851a-0800200c9a66/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4c557ec4-c4cf-11df-851a-0800200c9a66,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=4c557ec4-c4cf-11df-851a-0800200c9a66,4c557ec4-c4cf-11df-851a-0800200c9a66,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,200796,Edarbi,AZILSARTAN KAMEDOXOMIL,2024/01/23,Angiotensin 2 Receptor Blocker,2011,AZURITY PHARMACEUTICALS INC,2013/02/01-,60631-040; 60631-080,WEC6I2K1FC,Azilsartan kamedoxomil,Azilsartan,F9NUX55P23,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/52b27c75-9f5a-4816-bafd-dace9d7d2063/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=52b27c75-9f5a-4816-bafd-dace9d7d2063,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=52b27c75-9f5a-4816-bafd-dace9d7d2063,52b27c75-9f5a-4816-bafd-dace9d7d2063,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,202331,Edarbyclor,AZILSARTAN KAMEDOXOMIL AND CHLORTHALIDONE,2024/02/01,Angiotensin 2 Receptor Blocker; Thiazide-like Diuretic,2011,PHARMA PACKAGING SOLUTIONS LLC DBA TJOAPACK LLC,2013/02/01-,75929-230,Q0MQD1073Q; WEC6I2K1FC,AZILSARTAN KAMEDOXOMIL; CHLORTHALIDONE,AZILSARTAN; CHLORTHALIDONE,F9NUX55P23; Q0MQD1073Q,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/10566939-c8b1-18a1-e063-6294a90a7601/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=10566939-c8b1-18a1-e063-6294a90a7601,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=10566939-c8b1-18a1-e063-6294a90a7601,10566939-c8b1-18a1-e063-6294a90a7601,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,202331,Edarbyclor,AZILSARTAN KAMEDOXOMIL AND CHLORTHALIDONE,2023/03/29,Angiotensin 2 Receptor Blocker; Thiazide-like Diuretic,2011,AZURITY PHARMACEUTICALS INC FORMERLY ARBOR PHARMACEUTICALS,2013/02/01-,60631-412; 60631-425,Q0MQD1073Q; WEC6I2K1FC,Azilsartan kamedoxomil; chlorthalidone,AZILSARTAN; chlorthalidone,F9NUX55P23; Q0MQD1073Q,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/e60f795b-fce3-4361-aa03-f143451689d1/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e60f795b-fce3-4361-aa03-f143451689d1,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=e60f795b-fce3-4361-aa03-f143451689d1,e60f795b-fce3-4361-aa03-f143451689d1,,,
HUMAN PRESCRIPTION DRUG LABEL,"POWDER, FOR SUSPENSION; TABLET, FILM COATED",ORAL,NDA,050710;050711;050784,Zithromax,AZITHROMYCIN DIHYDRATE,2024/04/15,Macrolide Antimicrobial,1991,PFIZER LABORATORIES DIV PFIZER INC,1995/10/19-; 1996/07/18-; 2002/05/24-; 2019/05/17-,0069-3060; 0069-3070; 0069-3110; 0069-3120; 0069-3130; 0069-3140; 0069-4061,5FD1131I7S,AZITHROMYCIN DIHYDRATE,AZITHROMYCIN ANHYDROUS,J2KLZ20U1M,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/db52b91e-79f7-4cc1-9564-f2eee8e31c45/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=db52b91e-79f7-4cc1-9564-f2eee8e31c45,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=db52b91e-79f7-4cc1-9564-f2eee8e31c45,db52b91e-79f7-4cc1-9564-f2eee8e31c45,,,
HUMAN PRESCRIPTION DRUG LABEL,"POWDER, FOR SUSPENSION; TABLET, FILM COATED",ORAL,NDA,050693;050730,ZITHROMAX,AZITHROMYCIN DIHYDRATE,2023/09/29,Macrolide Antimicrobial,1991,PFIZER LABORATORIES DIV PFIZER INC,1994/09/28-; completed:1996/06/12-2018/09/30,0069-3051; 0069-3080,5FD1131I7S,AZITHROMYCIN DIHYDRATE,AZITHROMYCIN ANHYDROUS,J2KLZ20U1M,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/b749df83-49b0-433e-8a62-589a048dd716/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b749df83-49b0-433e-8a62-589a048dd716,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=b749df83-49b0-433e-8a62-589a048dd716,b749df83-49b0-433e-8a62-589a048dd716,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAVENOUS,NDA,050733,Zithromax,AZITHROMYCIN DIHYDRATE,2022/03/22,Macrolide Antimicrobial,1991,PFIZER LABORATORIES DIV PFIZER INC,1997/01/30-,0069-3150,5FD1131I7S,AZITHROMYCIN DIHYDRATE,AZITHROMYCIN ANHYDROUS,J2KLZ20U1M,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/3b631aa1-2d46-40bc-a614-d698301ea4f9/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3b631aa1-2d46-40bc-a614-d698301ea4f9,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=3b631aa1-2d46-40bc-a614-d698301ea4f9,3b631aa1-2d46-40bc-a614-d698301ea4f9,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAVENOUS,NDA,050733,Zithromax,AZITHROMYCIN DIHYDRATE,2022/03/22,Macrolide Antimicrobial,1991,PFIZER LABORATORIES DIV PFIZER INC,2014/03/07-,0069-0400,5FD1131I7S,AZITHROMYCIN DIHYDRATE,AZITHROMYCIN ANHYDROUS,J2KLZ20U1M,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/8d24bacb-feff-4c6a-b8df-625e1435387a/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8d24bacb-feff-4c6a-b8df-625e1435387a,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=8d24bacb-feff-4c6a-b8df-625e1435387a,8d24bacb-feff-4c6a-b8df-625e1435387a,,,
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION/ DROPS,OPHTHALMIC,NDA,050810,AZASITE,AZITHROMYCIN MONOHYDRATE,2023/01/06,Macrolide Antimicrobial,2007,THEA PHARMA INC,2022/11/01-,82584-307,JTE4MNN1MD,AZITHROMYCIN MONOHYDRATE,AZITHROMYCIN ANHYDROUS,J2KLZ20U1M,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/0c5d6f5e-18ea-436f-8c62-bbaf66effe3d/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0c5d6f5e-18ea-436f-8c62-bbaf66effe3d,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=0c5d6f5e-18ea-436f-8c62-bbaf66effe3d,0c5d6f5e-18ea-436f-8c62-bbaf66effe3d,,,
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION/ DROPS,OPHTHALMIC,NDA,050810,AzaSITE,AZITHROMYCIN MONOHYDRATE,2020/10/08,Macrolide Antimicrobial,2007,AKORN,2014/05/14-,17478-307,JTE4MNN1MD,Azithromycin Monohydrate,Azithromycin Anhydrous,J2KLZ20U1M,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/14ae4c07-b042-452a-b069-2b41bc646e04/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=14ae4c07-b042-452a-b069-2b41bc646e04,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=14ae4c07-b042-452a-b069-2b41bc646e04,14ae4c07-b042-452a-b069-2b41bc646e04,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, POWDER, FOR SOLUTION",INTRAMUSCULAR; INTRAVENOUS,NDA,050580,AZACTAM,AZTREONAM,2023/03/17,Monobactam Antibacterial,,E R SQUIBB AND SONS L L C,2010/04/01-,0003-2560; 0003-2570,G2B4VE5GH8,aztreonam,aztreonam,G2B4VE5GH8,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/9a105eaf-ee77-4016-beeb-d425a5565db2/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9a105eaf-ee77-4016-beeb-d425a5565db2,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=9a105eaf-ee77-4016-beeb-d425a5565db2,9a105eaf-ee77-4016-beeb-d425a5565db2,,,
HUMAN PRESCRIPTION DRUG LABEL,KIT,INHALATION,NDA,050814,Cayston,AZTREONAM,2021/12/15,Monobactam Antibacterial,1986,GILEAD SCIENCES INC,2010/02/22-,61958-0901,G2B4VE5GH8,aztreonam,aztreonam,G2B4VE5GH8,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/67300ca3-8c53-4ce4-8e86-2c03be1f9b8a/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=67300ca3-8c53-4ce4-8e86-2c03be1f9b8a,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=67300ca3-8c53-4ce4-8e86-2c03be1f9b8a,67300ca3-8c53-4ce4-8e86-2c03be1f9b8a,,,
HUMAN PRESCRIPTION DRUG LABEL,SUSPENSION,ORAL,NDA,215602,FLEQSUVY,BACLOFEN,2024/05/16,gamma-Aminobutyric Acid-ergic Agonist,1977,AZURITY PHARMACEUTICALS INC,2022/02/07-,52652-6001,H789N3FKE8,BACLOFEN,BACLOFEN,H789N3FKE8,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/9076d6ce-bbc2-4a9f-9cb9-2de1b675b9aa/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9076d6ce-bbc2-4a9f-9cb9-2de1b675b9aa,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=9076d6ce-bbc2-4a9f-9cb9-2de1b675b9aa,9076d6ce-bbc2-4a9f-9cb9-2de1b675b9aa,,,
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION,ORAL,NDA,208193,OZOBAX DS,BACLOFEN,2023/10/17,gamma-Aminobutyric Acid-ergic Agonist,1977,METACEL PHARMACEUTICALS LLC,2023/10/12-,69528-302,H789N3FKE8,BACLOFEN,BACLOFEN,H789N3FKE8,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/d8ddcec5-debe-42b4-a803-e65917cc6a54/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d8ddcec5-debe-42b4-a803-e65917cc6a54,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=d8ddcec5-debe-42b4-a803-e65917cc6a54,d8ddcec5-debe-42b4-a803-e65917cc6a54,,,
HUMAN PRESCRIPTION DRUG LABEL,GRANULE,ORAL,NDA,215422,LYVISPAH,BACLOFEN,2023/04/20,gamma-Aminobutyric Acid-ergic Agonist,1977,AMNEAL PHARMACEUTICALS LLC,2023/06/01-,64896-076; 64896-077; 64896-078,H789N3FKE8,BACLOFEN,BACLOFEN,H789N3FKE8,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/f8992a56-9010-4c4b-84d5-ddcc3e2c3317/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f8992a56-9010-4c4b-84d5-ddcc3e2c3317,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=f8992a56-9010-4c4b-84d5-ddcc3e2c3317,f8992a56-9010-4c4b-84d5-ddcc3e2c3317,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION; KIT,INTRATHECAL,NDA,020075,Lioresal (baclofen),BACLOFEN,2022/12/14,gamma-Aminobutyric Acid-ergic Agonist,,AMNEAL PHARMACEUTICALS LLC,completed:2022/06/12-2024/11/30,70121-2496; 70121-2501; 70121-2502; 70121-2503; 70121-2504; 70121-2505,H789N3FKE8,BACLOFEN,BACLOFEN,H789N3FKE8,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/6f3bdcc0-ffc8-4911-8c35-958c8103a2c5/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6f3bdcc0-ffc8-4911-8c35-958c8103a2c5,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=6f3bdcc0-ffc8-4911-8c35-958c8103a2c5,6f3bdcc0-ffc8-4911-8c35-958c8103a2c5,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRATHECAL,NDA,020075,Lioresal (baclofen),BACLOFEN,2022/07/28,gamma-Aminobutyric Acid-ergic Agonist,,SAOL THERAPEUTICS INC,completed:2022/06/12-2024/11/30,70257-560; 70257-561; 70257-562; 70257-563,H789N3FKE8,baclofen,baclofen,H789N3FKE8,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/4e478edb-e340-4976-ac24-4bb32c5e12e3/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4e478edb-e340-4976-ac24-4bb32c5e12e3,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=4e478edb-e340-4976-ac24-4bb32c5e12e3,4e478edb-e340-4976-ac24-4bb32c5e12e3,,,
HUMAN PRESCRIPTION DRUG LABEL,GRANULE,ORAL,NDA,215422,Lyvispah,BACLOFEN,2021/11/26,gamma-Aminobutyric Acid-ergic Agonist,1977,SAOL THERAPEUTICS INC,2021/11/22-,70257-412; 70257-414; 70257-416,H789N3FKE8,BACLOFEN,BACLOFEN,H789N3FKE8,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/a7d2dc58-e167-4ebc-ac1d-932f000fb412/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a7d2dc58-e167-4ebc-ac1d-932f000fb412,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=a7d2dc58-e167-4ebc-ac1d-932f000fb412,a7d2dc58-e167-4ebc-ac1d-932f000fb412,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRATHECAL,NDA,020075,Lioresal,BACLOFEN,2016/10/07,gamma-Aminobutyric Acid-ergic Agonist,,MEDTRONIC NEUROMODULATION,1992/06/17-; 1996/11/07-; 2003/05/08-,58281-560; 58281-561; 58281-562; 58281-563,H789N3FKE8,baclofen,baclofen,H789N3FKE8,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/351cde63-00fa-404a-92df-cb055e991840/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=351cde63-00fa-404a-92df-cb055e991840,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=351cde63-00fa-404a-92df-cb055e991840,351cde63-00fa-404a-92df-cb055e991840,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRATHECAL,NDA,022462,Gablofen,BACLOFEN INJECTION,2022/12/24,gamma-Aminobutyric Acid-ergic Agonist,1992,PIRAMAL CRITICAL CARE INC,2017/04/01-,66794-151; 66794-155; 66794-156; 66794-157,H789N3FKE8,BACLOFEN,BACLOFEN,H789N3FKE8,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/00d3e846-dd92-448d-9ab8-6a07be823cc1/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=00d3e846-dd92-448d-9ab8-6a07be823cc1,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=00d3e846-dd92-448d-9ab8-6a07be823cc1,00d3e846-dd92-448d-9ab8-6a07be823cc1,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS,NDA,018802,Bacteriostatic Water,BACTERIOSTATIC WATER,2020/10/26,,,HOSPIRA INC,2005/04/30-; completed:2005/04/30-2005/04/30,0409-1093; 0409-3977,059QF0KO0R,WATER,WATER,059QF0KO0R,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/87d6e9dc-fe3b-4593-ac9a-d7493d1959c7/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=87d6e9dc-fe3b-4593-ac9a-d7493d1959c7,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=87d6e9dc-fe3b-4593-ac9a-d7493d1959c7,87d6e9dc-fe3b-4593-ac9a-d7493d1959c7,,,
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION,OPHTHALMIC,NDA,020742,BSS,BALANCED SALT SOLUTION,2024/01/25,Blood Coagulation Factor; Calculi Dissolution Agent; Osmotic Laxative; Phosphate Binder; Potassium Salt,,ALCON LABORATORIES INC,1969/03/28-,0065-0795,02F3473H9O; 1Q73Q2JULR; 451W47IQ8X; 4550K0SC9B; 660YQ98I10; M4I0D6VV5M,CALCIUM CHLORIDE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE; SODIUM CITRATE,CALCIUM CATION; MAGNESIUM CATION; POTASSIUM CATION; SODIUM CATION,295O53K152; 2M83C4R6ZB; LYR4M0NH37; T6V3LHY838,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/4bd4d59c-eb3b-4a5e-9eb7-ae95b0a92bea/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4bd4d59c-eb3b-4a5e-9eb7-ae95b0a92bea,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=4bd4d59c-eb3b-4a5e-9eb7-ae95b0a92bea,4bd4d59c-eb3b-4a5e-9eb7-ae95b0a92bea,,,
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION,OPHTHALMIC,NDA,020742,BSS,BALANCED SALT SOLUTION,2023/12/14,Blood Coagulation Factor; Calculi Dissolution Agent; Osmotic Laxative; Phosphate Binder; Potassium Salt,,ALCON LABORATORIES INC,1969/03/28-,0065-1795,02F3473H9O; 1Q73Q2JULR; 451W47IQ8X; 4550K0SC9B; 660YQ98I10; M4I0D6VV5M,CALCIUM CHLORIDE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE; SODIUM CITRATE,CALCIUM CATION; MAGNESIUM CATION; POTASSIUM CATION; SODIUM CATION; Sodium Cation,295O53K152; 2M83C4R6ZB; LYR4M0NH37; T6V3LHY838,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/28488c7b-cf6a-4a03-916f-cc66b3afdc57/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=28488c7b-cf6a-4a03-916f-cc66b3afdc57,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=28488c7b-cf6a-4a03-916f-cc66b3afdc57,28488c7b-cf6a-4a03-916f-cc66b3afdc57,,,
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION,OPHTHALMIC,NDA,020742,BSS,BALANCED SALT SOLUTION,2016/01/28,Blood Coagulation Factor; Calculi Dissolution Agent; Osmotic Laxative; Phosphate Binder; Potassium Salt,,ALCON LABORATORIES INC,1969/03/28-,0065-0795,02F3473H9O; 1Q73Q2JULR; 451W47IQ8X; 4550K0SC9B; 660YQ98I10; M4I0D6VV5M,CALCIUM CHLORIDE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE; SODIUM CITRATE,CALCIUM CATION; MAGNESIUM CATION; POTASSIUM CATION; SODIUM CATION,295O53K152; 2M83C4R6ZB; LYR4M0NH37; T6V3LHY838,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/d2f55b3f-0873-4536-aedb-2829a91927c7/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d2f55b3f-0873-4536-aedb-2829a91927c7,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=d2f55b3f-0873-4536-aedb-2829a91927c7,d2f55b3f-0873-4536-aedb-2829a91927c7,,,
HUMAN PRESCRIPTION DRUG LABEL,KIT,OPHTHALMIC,NDA,018469,BSS PLUS,"BALANCED SALT SOLUTION ENRICHED WITH BICARBONATE, DEXTROSE, AND GLUTATHIONE",2024/01/25,,,ALCON LABORATORIES INC,2013/06/20-,0065-0800,02F3473H9O; 451W47IQ8X; 660YQ98I10; 8MDF5V39QO; GR686LBA74; IY9XDZ35W2; M4I0D6VV5M; ULW86O013H,"Calcium Chloride; Dextrose, Unspecified Form; Magnesium Chloride; Oxiglutatione; Potassium Chloride; Sodium Bicarbonate; Sodium Chloride; Sodium Phosphate, Dibasic",Anhydrous Dextrose; Bicarbonate Ion; Calcium Cation; Chloride Ion; Magnesium Cation; Oxiglutatione; Phosphate Ion; Potassium Cation; Sodium Cation,295O53K152; 2M83C4R6ZB; 5SL0G7R0OK; HN1ZRA3Q20; LYR4M0NH37; NK08V8K8HR; Q32ZN48698; T6V3LHY838; ULW86O013H,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/9b6d7322-4a90-b31e-9fbb-f1fba1343608/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9b6d7322-4a90-b31e-9fbb-f1fba1343608,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=9b6d7322-4a90-b31e-9fbb-f1fba1343608,9b6d7322-4a90-b31e-9fbb-f1fba1343608,,,
HUMAN PRESCRIPTION DRUG LABEL,KIT,OPHTHALMIC,NDA,018469,BSS PLUS,"BALANCED SALT SOLUTION ENRICHED WITH BICARBONATE, DEXTROSE, AND GLUTATHIONE",2024/01/25,Blood Coagulation Factor; Calculi Dissolution Agent; Osmotic Laxative; Phosphate Binder; Potassium Salt,,ALCON LABORATORIES INC,1982/06/28-,0065-0800,02F3473H9O; 451W47IQ8X; 660YQ98I10; 8MDF5V39QO; GR686LBA74; IY9XDZ35W2; M4I0D6VV5M; ULW86O013H,"Calcium Chloride; Dextrose, Unspecified Form; Magnesium Chloride; Oxiglutatione; Potassium Chloride; Sodium Bicarbonate; Sodium Chloride; Sodium Phosphate, Dibasic, Unspecified Form",Anhydrous Dextrose; Calcium Cation; Magnesium Cation; Oxiglutatione; Potassium Cation; Sodium Cation,295O53K152; 2M83C4R6ZB; 5SL0G7R0OK; LYR4M0NH37; T6V3LHY838; ULW86O013H,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/f69655c5-cf32-6461-e00e-3a5c4a761344/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f69655c5-cf32-6461-e00e-3a5c4a761344,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=f69655c5-cf32-6461-e00e-3a5c4a761344,f69655c5-cf32-6461-e00e-3a5c4a761344,,,
HUMAN PRESCRIPTION DRUG LABEL,"GRANULE, FOR SOLUTION; TABLET, FILM COATED",ORAL,NDA,210854;214410,Xofluza,BALOXAVIR MARBOXIL,2024/03/11,Polymerase Acidic Endonuclease Inhibitor,2018,GENENTECH INC,2018/10/24-,50242-583; 50242-860; 50242-877,505CXM6OHG,BALOXAVIR MARBOXIL,BALOXAVIR,4G86Y4JT3F,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/e49e1a61-1b7c-4be5-ac84-af6240b511e7/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e49e1a61-1b7c-4be5-ac84-af6240b511e7,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=e49e1a61-1b7c-4be5-ac84-af6240b511e7,e49e1a61-1b7c-4be5-ac84-af6240b511e7,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,NDA,020610,Colazal,BALSALAZIDE DISODIUM,2023/11/02,Aminosalicylate,2000,SALIX PHARMACEUTICALS INC,2000/07/18-,65649-101,1XL6BJI034,BALSALAZIDE DISODIUM,BALSALAZIDE,P80AL8J7ZP,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/22f41e83-b9fb-4c9e-8cc3-f457034191a8/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=22f41e83-b9fb-4c9e-8cc3-f457034191a8,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=22f41e83-b9fb-4c9e-8cc3-f457034191a8,22f41e83-b9fb-4c9e-8cc3-f457034191a8,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,207924,Olumiant,BARICITINIB,2023/03/20,Janus Kinase Inhibitor,2018,ELI LILLY AND COMPANY,2018/05/31-; 2019/10/08-; 2022/05/10-,0002-4182; 0002-4479; 0002-4732,ISP4442I3Y,baricitinib,baricitinib,ISP4442I3Y,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/866e9f35-9035-4581-a4b1-75a621ab55cf/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=866e9f35-9035-4581-a4b1-75a621ab55cf,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=866e9f35-9035-4581-a4b1-75a621ab55cf,866e9f35-9035-4581-a4b1-75a621ab55cf,,,
HUMAN PRESCRIPTION DRUG LABEL,SUSPENSION,ORAL,NDA,208143,Varibar Thin Honey,BARIUM SULFATE,2023/10/25,Radiographic Contrast Agent,2016,E Z EM CANADA INC,2018/01/03-,32909-121,25BB7EKE2E,Barium Sulfate,Barium Sulfate,25BB7EKE2E,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/37bf7f08-5486-e570-7f80-0e0ee5cd33e8/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=37bf7f08-5486-e570-7f80-0e0ee5cd33e8,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=37bf7f08-5486-e570-7f80-0e0ee5cd33e8,37bf7f08-5486-e570-7f80-0e0ee5cd33e8,,,
HUMAN PRESCRIPTION DRUG LABEL,SUSPENSION,ORAL,NDA,208143,Varibar Honey,BARIUM SULFATE,2023/10/24,Radiographic Contrast Agent,2016,E Z EM CANADA INC,2018/03/01-,32909-122,25BB7EKE2E,Barium Sulfate,Barium Sulfate,25BB7EKE2E,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/d404b381-a180-4a85-6863-0a0d2bcabc52/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d404b381-a180-4a85-6863-0a0d2bcabc52,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=d404b381-a180-4a85-6863-0a0d2bcabc52,d404b381-a180-4a85-6863-0a0d2bcabc52,,,
HUMAN PRESCRIPTION DRUG LABEL,"POWDER, FOR SUSPENSION",ORAL,NDA,208036,Varibar Thin Liquid,BARIUM SULFATE,2023/07/20,Radiographic Contrast Agent,2016,E Z EM CANADA INC,2019/04/30-,32909-105,25BB7EKE2E,Barium Sulfate,Barium Sulfate,25BB7EKE2E,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/59493c83-3941-cc84-cc37-a8696ae42873/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=59493c83-3941-cc84-cc37-a8696ae42873,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=59493c83-3941-cc84-cc37-a8696ae42873,59493c83-3941-cc84-cc37-a8696ae42873,,,
HUMAN PRESCRIPTION DRUG LABEL,"POWDER, FOR SUSPENSION",ORAL,NDA,208036,E-Z-Paque,BARIUM SULFATE,2022/11/07,Radiographic Contrast Agent,2016,E Z EM CANADA INC,2017/06/01-,32909-750,25BB7EKE2E,Barium Sulfate,Barium Sulfate,25BB7EKE2E,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/7225868a-4037-c96a-44e3-3326d36cbedc/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7225868a-4037-c96a-44e3-3326d36cbedc,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=7225868a-4037-c96a-44e3-3326d36cbedc,7225868a-4037-c96a-44e3-3326d36cbedc,,,
HUMAN PRESCRIPTION DRUG LABEL,"POWDER, FOR SUSPENSION",ORAL,NDA,208036,E-Z-HD,BARIUM SULFATE,2022/11/04,Radiographic Contrast Agent,2016,E Z EM CANADA INC,2016/01/11-,32909-764,25BB7EKE2E,Barium Sulfate,Barium Sulfate,25BB7EKE2E,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/a4330804-7179-472a-91cb-84bbd5079bb8/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a4330804-7179-472a-91cb-84bbd5079bb8,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=a4330804-7179-472a-91cb-84bbd5079bb8,a4330804-7179-472a-91cb-84bbd5079bb8,,,
HUMAN PRESCRIPTION DRUG LABEL,SUSPENSION,ORAL,NDA,208143,Tagitol V,BARIUM SULFATE,2022/10/26,Radiographic Contrast Agent,2016,E Z EM CANADA INC,2017/08/04-,32909-814,25BB7EKE2E,Barium Sulfate,Barium Sulfate,25BB7EKE2E,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/30c68756-c7db-bf50-9cd5-ef4b0c7ab1d0/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=30c68756-c7db-bf50-9cd5-ef4b0c7ab1d0,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=30c68756-c7db-bf50-9cd5-ef4b0c7ab1d0,30c68756-c7db-bf50-9cd5-ef4b0c7ab1d0,,,
HUMAN PRESCRIPTION DRUG LABEL,SUSPENSION,ORAL,NDA,208143,ENTERO Vu 24%,BARIUM SULFATE,2022/01/17,Radiographic Contrast Agent,2016,E Z EM CANADA INC,2020/10/01-; completed:2020/05/01-2021/10/31,32909-145; 32909-146,25BB7EKE2E,BARIUM SULFATE,BARIUM SULFATE,25BB7EKE2E,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/83a06a8e-93db-a59b-933c-5882127bce7c/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=83a06a8e-93db-a59b-933c-5882127bce7c,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=83a06a8e-93db-a59b-933c-5882127bce7c,83a06a8e-93db-a59b-933c-5882127bce7c,,,
HUMAN PRESCRIPTION DRUG LABEL,SUSPENSION,ORAL,NDA,208143,Readi-Cat 2; Readi-Cat 2 Banana Smoothie; Readi-Cat 2 Berry Smoothie; Readi-Cat 2 Creamy Vanilla Smoothie; Readi-Cat 2 Mochaccino Smoothie,BARIUM SULFATE,2020/10/09,Radiographic Contrast Agent,2016,E Z EM CANADA INC,2020/11/01-; completed:2017/03/27-2022/03/31; completed:2017/03/27-2022/04/30; completed:2017/03/27-2022/05/31,32909-711; 32909-722; 32909-724; 32909-741; 32909-742; 32909-744; 32909-746; 32909-747; 32909-756; 32909-777,25BB7EKE2E,Barium Sulfate,Barium Sulfate,25BB7EKE2E,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/d2d293d5-dcc9-0d3f-58ed-686ef0132d7c/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d2d293d5-dcc9-0d3f-58ed-686ef0132d7c,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=d2d293d5-dcc9-0d3f-58ed-686ef0132d7c,d2d293d5-dcc9-0d3f-58ed-686ef0132d7c,,,
HUMAN PRESCRIPTION DRUG LABEL,SUSPENSION,ORAL,NDA,208143,Varibar Nectar,BARIUM SULFATE,2020/10/09,Radiographic Contrast Agent,2016,E Z EM CANADA INC,2020/11/01-; completed:2017/07/17-2022/05/31,32909-115; 32909-116,25BB7EKE2E,Barium Sulfate,Barium Sulfate,25BB7EKE2E,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/5e7045f7-b771-d8af-ce30-be95b2597c10/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5e7045f7-b771-d8af-ce30-be95b2597c10,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=5e7045f7-b771-d8af-ce30-be95b2597c10,5e7045f7-b771-d8af-ce30-be95b2597c10,,,
HUMAN PRESCRIPTION DRUG LABEL,SUSPENSION,ORAL,NDA,208143,E-Z-Paque,BARIUM SULFATE,2020/10/09,Radiographic Contrast Agent,2016,E Z EM CANADA INC,2020/11/01-; completed:2017/03/01-2021/10/31,32909-186; 32909-187,25BB7EKE2E,Barium Sulfate,Barium Sulfate,25BB7EKE2E,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/2ecea1ab-66c8-4eb0-8503-6d6b41b51328/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2ecea1ab-66c8-4eb0-8503-6d6b41b51328,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=2ecea1ab-66c8-4eb0-8503-6d6b41b51328,2ecea1ab-66c8-4eb0-8503-6d6b41b51328,,,
HUMAN PRESCRIPTION DRUG LABEL,"AEROSOL, METERED",NASAL,NDA,202813,QNASL,BECLOMETHASONE DIPROPIONATE,2022/09/27,Corticosteroid,1976,TEVA RESPIRATORY LLC,2019/01/02-,59310-406; 59310-410,5B307S63B2,BECLOMETHASONE DIPROPIONATE,BECLOMETHASONE,KGZ1SLC28Z,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/4b8d8e84-b5d2-4e56-97ec-4f72971465c5/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4b8d8e84-b5d2-4e56-97ec-4f72971465c5,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=4b8d8e84-b5d2-4e56-97ec-4f72971465c5,4b8d8e84-b5d2-4e56-97ec-4f72971465c5,,,
HUMAN PRESCRIPTION DRUG LABEL,"AEROSOL, METERED",INHALATION,NDA,207921,QVAR REDIHALER,BECLOMETHASONE DIPROPIONATE HFA,2022/09/27,Corticosteroid,1976,TEVA RESPIRATORY LLC,2018/02/15-,59310-302; 59310-304,5B307S63B2,BECLOMETHASONE DIPROPIONATE,BECLOMETHASONE,KGZ1SLC28Z,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/cada897a-264e-450d-ae00-36e7fe747080/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=cada897a-264e-450d-ae00-36e7fe747080,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=cada897a-264e-450d-ae00-36e7fe747080,cada897a-264e-450d-ae00-36e7fe747080,,,
HUMAN PRESCRIPTION DRUG LABEL,"SPRAY, SUSPENSION",NASAL,NDA,019389,BECONASE AQ,BECLOMETHASONE DIPROPIONATE MONOHYDRATE,2021/02/09,Corticosteroid,,GLAXOSMITHKLINE LLC,1989/10/01-,0173-0388,4H7L9AI22I,BECLOMETHASONE DIPROPIONATE MONOHYDRATE,BECLOMETHASONE,KGZ1SLC28Z,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/a44782cf-4ab5-4c8a-79b7-221f21e40a34/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a44782cf-4ab5-4c8a-79b7-221f21e40a34,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=a44782cf-4ab5-4c8a-79b7-221f21e40a34,a44782cf-4ab5-4c8a-79b7-221f21e40a34,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,204384,SIRTURO,BEDAQUILINE FUMARATE,2023/10/17,Diarylquinoline Antimycobacterial,2012,JANSSEN PRODUCTS LP,2012/12/28-; 2020/05/27-,59676-701; 59676-702,P04QX2C1A5,BEDAQUILINE FUMARATE,BEDAQUILINE,78846I289Y,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/1534c9ae-4948-4cf4-9f66-222a99db6d0e/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1534c9ae-4948-4cf4-9f66-222a99db6d0e,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=1534c9ae-4948-4cf4-9f66-222a99db6d0e,1534c9ae-4948-4cf4-9f66-222a99db6d0e,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAVENOUS,NDA,206256,Beleodaq,BELINOSTAT,2023/05/15,Histone Deacetylase Inhibitor,2014,ACROTECH BIOPHARMA INC,2014/07/21-,72893-002,F4H96P17NZ,BELINOSTAT,BELINOSTAT,F4H96P17NZ,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/2e8ef36b-71fa-4492-a16f-577d5f7d111d/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2e8ef36b-71fa-4492-a16f-577d5f7d111d,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=2e8ef36b-71fa-4492-a16f-577d5f7d111d,2e8ef36b-71fa-4492-a16f-577d5f7d111d,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,214783,Rezurock,BELUMOSUDIL,2024/04/16,,2021,KADMON PHARMACEUTICALS LLC,2021/07/16-,79802-200,834YJF89WO,BELUMOSUDIL,BELUMOSUDIL,834YJF89WO,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/102e4ef4-7f84-4e34-8df1-479c24d1575d/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=102e4ef4-7f84-4e34-8df1-479c24d1575d,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=102e4ef4-7f84-4e34-8df1-479c24d1575d,102e4ef4-7f84-4e34-8df1-479c24d1575d,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,215383,WELIREG,BELZUTIFAN,2024/01/18,Hypoxia-inducible Factor Inhibitor,2021,MERCK SHARP AND DOHME LLC,2021/08/13-,0006-5331,7K28NB895L,BELZUTIFAN,BELZUTIFAN,7K28NB895L,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/13e15ee0-d679-4fa9-9430-e2e2170474da/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=13e15ee0-d679-4fa9-9430-e2e2170474da,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=13e15ee0-d679-4fa9-9430-e2e2170474da,13e15ee0-d679-4fa9-9430-e2e2170474da,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,211616,Nexletol,BEMPEDOIC ACID,2024/03/28,Adenosine Triphosphate-Citrate Lyase Inhibitor,2020,ESPERION THERAPEUTICS INC,2020/03/06-,72426-118,1EJ6Z6Q368,BEMPEDOIC ACID,BEMPEDOIC ACID,1EJ6Z6Q368,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/88d06d89-a3da-40b4-b273-8f4f7d56c4c9/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=88d06d89-a3da-40b4-b273-8f4f7d56c4c9,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=88d06d89-a3da-40b4-b273-8f4f7d56c4c9,88d06d89-a3da-40b4-b273-8f4f7d56c4c9,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,211617,Nexlizet,BEMPEDOIC ACID AND EZETIMIBE,2024/03/28,Adenosine Triphosphate-Citrate Lyase Inhibitor; Dietary Cholesterol Absorption Inhibitor,2020,ESPERION THERAPEUTICS INC,2020/03/09-,72426-818,1EJ6Z6Q368; EOR26LQQ24,BEMPEDOIC ACID; EZETIMIBE,BEMPEDOIC ACID; EZETIMIBE,1EJ6Z6Q368; EOR26LQQ24,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/3fa2108c-0300-47b8-9d34-f762af7c93c6/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3fa2108c-0300-47b8-9d34-f762af7c93c6,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=3fa2108c-0300-47b8-9d34-f762af7c93c6,3fa2108c-0300-47b8-9d34-f762af7c93c6,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,019851,Lotensin,BENAZEPRIL HYDROCHLORIDE,2019/01/21,Angiotensin Converting Enzyme Inhibitor,1991,VALIDUS PHARMACEUTICALS LLC,1991/06/21-,30698-448; 30698-449; 30698-450,N1SN99T69T,BENAZEPRIL HYDROCHLORIDE,BENAZEPRILAT,JRM708L703,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/2abb091b-a53e-46b0-9b84-e5ee8f2bdd8e/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2abb091b-a53e-46b0-9b84-e5ee8f2bdd8e,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=2abb091b-a53e-46b0-9b84-e5ee8f2bdd8e,2abb091b-a53e-46b0-9b84-e5ee8f2bdd8e,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,020033,Lotensin HCT,BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE,2023/11/09,Angiotensin Converting Enzyme Inhibitor; Thiazide Diuretic,,VALIDUS PHARMACEUTICALS LLC,1992/05/30-,30698-452; 30698-453; 30698-454,0J48LPH2TH; N1SN99T69T,BENAZEPRIL HYDROCHLORIDE; HYDROCHLOROTHIAZIDE,BENAZEPRILAT; HYDROCHLOROTHIAZIDE,0J48LPH2TH; JRM708L703,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/94c4536f-e28e-48b1-8336-b3939917e99d/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=94c4536f-e28e-48b1-8336-b3939917e99d,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=94c4536f-e28e-48b1-8336-b3939917e99d,94c4536f-e28e-48b1-8336-b3939917e99d,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,215033,Bendamustine Hydrochloride,BENDAMUSTINE HYDROCHLORIDE,2024/04/11,Alkylating Drug,2008,APOTEX CORP,2023/04/26-,60505-6228,981Y8SX18M,BENDAMUSTINE HYDROCHLORIDE,Bendamustine,9266D9P3PQ,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/085dd54c-4212-d879-afef-ee52732a48c0/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=085dd54c-4212-d879-afef-ee52732a48c0,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=085dd54c-4212-d879-afef-ee52732a48c0,085dd54c-4212-d879-afef-ee52732a48c0,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRAVENOUS,NDA,216078,BENDAMUSTINE HYDROCHLORIDE,BENDAMUSTINE HYDROCHLORIDE,2024/02/19,Alkylating Drug,2008,BAXTER HEALTHCARE CORPORATION,2022/12/15-,10019-079,981Y8SX18M,BENDAMUSTINE HYDROCHLORIDE,BENDAMUSTINE,9266D9P3PQ,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/766b73e2-49bb-47f9-bbb1-44cfa1a3197e/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=766b73e2-49bb-47f9-bbb1-44cfa1a3197e,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=766b73e2-49bb-47f9-bbb1-44cfa1a3197e,766b73e2-49bb-47f9-bbb1-44cfa1a3197e,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRAVENOUS,NDA,205580,BELRAPZO,BENDAMUSTINE HYDROCHLORIDE,2024/01/19,Alkylating Drug,2008,EAGLE PHARMACEUTICALS INC,2019/06/03-,42367-521,981Y8SX18M,BENDAMUSTINE HYDROCHLORIDE,BENDAMUSTINE,9266D9P3PQ,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/9759a4ae-82ca-40cf-9c02-e1cadb21cbdc/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9759a4ae-82ca-40cf-9c02-e1cadb21cbdc,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=9759a4ae-82ca-40cf-9c02-e1cadb21cbdc,9759a4ae-82ca-40cf-9c02-e1cadb21cbdc,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,208194,Bendeka,BENDAMUSTINE HYDROCHLORIDE,2024/01/19,Alkylating Drug,2008,TEVA PHARMACEUTICALS USA INC,2015/12/08-,63459-348,981Y8SX18M,BENDAMUSTINE HYDROCHLORIDE,BENDAMUSTINE,9266D9P3PQ,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/ace9a43b-f9bd-4896-abfe-0ef4fec67ddf/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ace9a43b-f9bd-4896-abfe-0ef4fec67ddf,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=ace9a43b-f9bd-4896-abfe-0ef4fec67ddf,ace9a43b-f9bd-4896-abfe-0ef4fec67ddf,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRAVENOUS,NDA,212209,VIVIMUSTA,BENDAMUSTINE HYDROCHLORIDE,2022/12/07,Alkylating Drug,2008,SLAYBACK PHARMA LLC,2022/12/07-,71225-120,981Y8SX18M,BENDAMUSTINE HYDROCHLORIDE,BENDAMUSTINE,9266D9P3PQ,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/cbcc6eb7-aa62-4599-af49-05203fedb4bb/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=cbcc6eb7-aa62-4599-af49-05203fedb4bb,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=cbcc6eb7-aa62-4599-af49-05203fedb4bb,cbcc6eb7-aa62-4599-af49-05203fedb4bb,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION; INJECTION, SOLUTION, CONCENTRATE",INTRAVENOUS,NDA,022249,TREANDA,BENDAMUSTINE HYDROCHLORIDE,2022/10/27,Alkylating Drug,2008,CEPHALON LLC,2008/03/31-; 2010/01/05-; completed:2014/11/05-2017/04/30; completed:2014/11/05-2017/05/31,63459-390; 63459-391; 63459-395; 63459-396,981Y8SX18M,BENDAMUSTINE HYDROCHLORIDE,BENDAMUSTINE,9266D9P3PQ,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/39d53698-57fa-7c99-fc5b-f52a55684826/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=39d53698-57fa-7c99-fc5b-f52a55684826,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=39d53698-57fa-7c99-fc5b-f52a55684826,39d53698-57fa-7c99-fc5b-f52a55684826,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,208653,APADAZ,BENZHYDROCODONE AND ACETAMINOPHEN,2021/03/12,,1982,KVK TECH INC,2019/06/28-,10702-340; 10702-341; 10702-342,362O9ITL9D; I894QAU7FJ,ACETAMINOPHEN; BENZHYDROCODONE HYDROCHLORIDE,ACETAMINOPHEN; BENZHYDROCODONE,362O9ITL9D; 75MS0AAZ9I,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/3a790a49-df42-4577-914c-6ee07a40b60f/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3a790a49-df42-4577-914c-6ee07a40b60f,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=3a790a49-df42-4577-914c-6ee07a40b60f,3a790a49-df42-4577-914c-6ee07a40b60f,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,209570,Benznidazole,BENZNIDAZOLE,2023/11/10,,2017,EXELTIS USA INC,2018/03/30-,0642-7463; 0642-7464,YC42NRJ1ZD,BENZNIDAZOLE,BENZNIDAZOLE,YC42NRJ1ZD,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/8983d6a0-f63f-4f8e-bba4-38223f39e29b/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8983d6a0-f63f-4f8e-bba4-38223f39e29b,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=8983d6a0-f63f-4f8e-bba4-38223f39e29b,8983d6a0-f63f-4f8e-bba4-38223f39e29b,,,
HUMAN PRESCRIPTION DRUG LABEL,CREAM,TOPICAL,NDA,214510,EPSOLAY,BENZOYL PEROXIDE,2023/04/12,,1984,GALDERMA LABORATORIES L P,2022/05/09-,0299-5890,W9WZN9A0GM,Benzoyl Peroxide,Benzoyl Peroxide,W9WZN9A0GM,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/507e2cd7-6bcf-4606-bc62-694d64537701/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=507e2cd7-6bcf-4606-bc62-694d64537701,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=507e2cd7-6bcf-4606-bc62-694d64537701,507e2cd7-6bcf-4606-bc62-694d64537701,,,
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION/ DROPS,OPHTHALMIC,NDA,022288,Bepreve,BEPOTASTINE BESILATE,2022/08/31,Histamine-1 Receptor Antagonist,2009,BAUSCH AND LOMB INCORPORATED,2009/09/08-,24208-629,6W18MO1QR3,BEPOTASTINE BESYLATE,BEPOTASTINE,HYD2U48IAS,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/68bbf6a0-c4b5-47c1-8a1c-08220fbdbce6/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=68bbf6a0-c4b5-47c1-8a1c-08220fbdbce6,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=68bbf6a0-c4b5-47c1-8a1c-08220fbdbce6,68bbf6a0-c4b5-47c1-8a1c-08220fbdbce6,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,NDA,214094,Orladeyo,BEROTRALSTAT HYDROCHLORIDE,2023/11/29,Plasma Kallikrein Inhibitor,2020,BIOCRYST PHARMACEUTICALS INC,2020/12/04-,72769-101; 72769-102,88SH1NBL2B,Berotralstat hydrochloride,Berotralstat,XZA0KB1BDQ,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/3527ece1-e7e0-40b1-b0c5-6baeb0deabeb/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3527ece1-e7e0-40b1-b0c5-6baeb0deabeb,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=3527ece1-e7e0-40b1-b0c5-6baeb0deabeb,3527ece1-e7e0-40b1-b0c5-6baeb0deabeb,,,
HUMAN PRESCRIPTION DRUG LABEL,SUSPENSION,OPHTHALMIC,NDA,022308,Besivance,BESIFLOXACIN,2022/02/02,Quinolone Antimicrobial,2009,BAUSCH AND LOMB INCORPORATED,2009/05/28-,24208-446,BFE2NBZ7NX,BESIFLOXACIN,BESIFLOXACIN,BFE2NBZ7NX,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/a3e6d688-7e5e-4ca3-b27e-79756c322a32/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a3e6d688-7e5e-4ca3-b27e-79756c322a32,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=a3e6d688-7e5e-4ca3-b27e-79756c322a32,a3e6d688-7e5e-4ca3-b27e-79756c322a32,,,
HUMAN PRESCRIPTION DRUG LABEL,"POWDER, FOR SOLUTION",ORAL,NDA,020576,Cystadane,BETAINE,2023/01/11,Methylating Agent,1996,RECORDATI RARE DISEASES,1996/10/25-,52276-400,3SCV180C9W,BETAINE,BETAINE,3SCV180C9W,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/31a684d0-cd98-4e46-b43a-ccbd17c41559/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=31a684d0-cd98-4e46-b43a-ccbd17c41559,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=31a684d0-cd98-4e46-b43a-ccbd17c41559,31a684d0-cd98-4e46-b43a-ccbd17c41559,,,
HUMAN PRESCRIPTION DRUG LABEL,"POWDER, FOR SOLUTION",ORAL,NDA,020576,Cystadane,BETAINE,2015/01/09,Methylating Agent,1996,RARE DISEASE THERAPEUTICS INC,1996/10/25-,66621-4000,3SCV180C9W,BETAINE,BETAINE,3SCV180C9W,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/84f7c21f-d0af-4ae6-9cd5-d5af96ade329/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=84f7c21f-d0af-4ae6-9cd5-d5af96ade329,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=84f7c21f-d0af-4ae6-9cd5-d5af96ade329,84f7c21f-d0af-4ae6-9cd5-d5af96ade329,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SUSPENSION",INTRA-ARTICULAR; INTRALESIONAL; INTRAMUSCULAR; SOFT TISSUE,NDA,014602,CELESTONE SOLUSPAN,BETAMETHASONE ACETATE AND BETAMETHASONE SODIUM PHOSPHATE,2024/03/12,Corticosteroid,,ORGANON LLC,2021/06/01-,78206-118,7BK02SCL3W; TI05AO53L7,BETAMETHASONE ACETATE; BETAMETHASONE SODIUM PHOSPHATE,BETAMETHASONE,9842X06Q6M,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/bf78d1be-42d7-4837-92a5-49113a79278f/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=bf78d1be-42d7-4837-92a5-49113a79278f,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=bf78d1be-42d7-4837-92a5-49113a79278f,bf78d1be-42d7-4837-92a5-49113a79278f,,,
HUMAN PRESCRIPTION DRUG LABEL,SPRAY,TOPICAL,NDA,208079,Sernivo,BETAMETHASONE DIPROPIONATE,2024/01/30,Corticosteroid,1975,PRIMUS PHARMACEUTICALS INC,2021/06/28-,68040-714,826Y60901U,BETAMETHASONE DIPROPIONATE,BETAMETHASONE,9842X06Q6M,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/b1b3d1b0-da9b-11eb-ad76-0800200c9a66/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b1b3d1b0-da9b-11eb-ad76-0800200c9a66,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=b1b3d1b0-da9b-11eb-ad76-0800200c9a66,b1b3d1b0-da9b-11eb-ad76-0800200c9a66,,,
HUMAN PRESCRIPTION DRUG LABEL,OINTMENT,TOPICAL,NDA,018741,DIPROLENE,BETAMETHASONE DIPROPIONATE,2022/02/23,Corticosteroid,1983,ORGANON LLC,2021/06/01-,78206-124,826Y60901U,BETAMETHASONE DIPROPIONATE,BETAMETHASONE,9842X06Q6M,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/0b9543ad-2ca7-430d-aef9-81c376dc2e6c/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0b9543ad-2ca7-430d-aef9-81c376dc2e6c,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=0b9543ad-2ca7-430d-aef9-81c376dc2e6c,0b9543ad-2ca7-430d-aef9-81c376dc2e6c,,,
HUMAN PRESCRIPTION DRUG LABEL,CREAM; LOTION; OINTMENT,TOPICAL,ANDA; NDA,019137;019141;070275,Betamethasone Dipropionate,BETAMETHASONE DIPROPIONATE,2022/02/01,Corticosteroid,,E FOUGERA AND CO A DIVISION OF FOUGERA PHARMACEUTICALS INC,1984/06/26-; 1984/09/04-; 1985/08/12-,0168-0055; 0168-0056; 0168-0057,826Y60901U,betamethasone dipropionate,betamethasone,9842X06Q6M,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/97dde5f5-a865-4af2-b562-8da72c8475f3/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=97dde5f5-a865-4af2-b562-8da72c8475f3,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=97dde5f5-a865-4af2-b562-8da72c8475f3,97dde5f5-a865-4af2-b562-8da72c8475f3,,,
HUMAN PRESCRIPTION DRUG LABEL,SPRAY,TOPICAL,NDA,208079,Sernivo,BETAMETHASONE DIPROPIONATE,2020/07/27,Corticosteroid,1975,ENCORE DERMATOLOGY INC,2020/01/01-,69482-800,826Y60901U,BETAMETHASONE DIPROPIONATE,BETAMETHASONE,9842X06Q6M,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/21ca2c66-4ad1-4b6a-9c81-77d89eeb9edd/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=21ca2c66-4ad1-4b6a-9c81-77d89eeb9edd,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=21ca2c66-4ad1-4b6a-9c81-77d89eeb9edd,21ca2c66-4ad1-4b6a-9c81-77d89eeb9edd,,,
HUMAN PRESCRIPTION DRUG LABEL,SPRAY,TOPICAL,NDA,208079,Sernivo,BETAMETHASONE DIPROPIONATE,2018/11/30,Corticosteroid,1975,PROMIUS PHARMA LLC,2016/02/22-,67857-808,826Y60901U,BETAMETHASONE DIPROPIONATE,BETAMETHASONE,9842X06Q6M,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/590cee5b-2712-4da6-99fe-5e14b44f2597/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=590cee5b-2712-4da6-99fe-5e14b44f2597,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=590cee5b-2712-4da6-99fe-5e14b44f2597,590cee5b-2712-4da6-99fe-5e14b44f2597,,,
HUMAN PRESCRIPTION DRUG LABEL,CREAM; LOTION; OINTMENT,TOPICAL,NDA,018861;018865;018866,Betamethasone Valerate,BETAMETHASONE VALERATE,2021/12/03,Corticosteroid,,E FOUGERA AND CO A DIVISION OF FOUGERA PHARMACEUTICALS INC,1983/08/31-,0168-0033; 0168-0040; 0168-0041,9IFA5XM7R2,BETAMETHASONE VALERATE,BETAMETHASONE,9842X06Q6M,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/0b386ccc-a2d4-4d18-a2d7-e46ff894c674/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0b386ccc-a2d4-4d18-a2d7-e46ff894c674,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=0b386ccc-a2d4-4d18-a2d7-e46ff894c674,0b386ccc-a2d4-4d18-a2d7-e46ff894c674,,,
HUMAN PRESCRIPTION DRUG LABEL,SUSPENSION/ DROPS,OPHTHALMIC,NDA,019845,Betoptic S,BETAXOLOL HYDROCHLORIDE,2023/08/02,beta-Adrenergic Blocker,1985,NOVARTIS PHARMACEUTICALS CORPORATION,1996/01/15-,0078-0729,6X97D2XT0O,Betaxolol Hydrochloride,Betaxolol,O0ZR1R6RZ2,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/905ba189-456c-4aa4-8231-39a971374ad8/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=905ba189-456c-4aa4-8231-39a971374ad8,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=905ba189-456c-4aa4-8231-39a971374ad8,905ba189-456c-4aa4-8231-39a971374ad8,,,
HUMAN PRESCRIPTION DRUG LABEL,SUSPENSION/ DROPS,OPHTHALMIC,NDA,019845,Betoptic S,BETAXOLOL HYDROCHLORIDE,2023/02/02,beta-Adrenergic Blocker,1985,ALCON LABORATORIES INC,completed:1996/01/15-2024/08/31,0065-0246,6X97D2XT0O,Betaxolol Hydrochloride,Betaxolol,O0ZR1R6RZ2,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/71659a34-efad-4147-81c7-da10985e9224/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=71659a34-efad-4147-81c7-da10985e9224,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=71659a34-efad-4147-81c7-da10985e9224,71659a34-efad-4147-81c7-da10985e9224,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,214373,BRENZAVVY,BEXAGLIFLOZIN,2024/02/08,Sodium-Glucose Cotransporter 2 Inhibitor,2023,THERACOSBIO LLC,2023/07/13-,82381-2174,EY00JF42FV,BEXAGLIFLOZIN,BEXAGLIFLOZIN,EY00JF42FV,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/3cdf28fc-4194-4ad6-aa03-c9eaa68da83e/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3cdf28fc-4194-4ad6-aa03-c9eaa68da83e,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=3cdf28fc-4194-4ad6-aa03-c9eaa68da83e,3cdf28fc-4194-4ad6-aa03-c9eaa68da83e,,,
HUMAN PRESCRIPTION DRUG LABEL,"CAPSULE, LIQUID FILLED",ORAL,NDA,021055,Targretin,BEXAROTENE,2020/04/30,Retinoid,1999,BAUSCH HEALTH US LLC,1999/12/29-,0187-5526,A61RXM4375,BEXAROTENE,BEXAROTENE,A61RXM4375,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/1d056725-0576-4338-8089-6336e768ccdc/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1d056725-0576-4338-8089-6336e768ccdc,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=1d056725-0576-4338-8089-6336e768ccdc,1d056725-0576-4338-8089-6336e768ccdc,,,
HUMAN PRESCRIPTION DRUG LABEL,GEL,TOPICAL,NDA,021056,Targretin,BEXAROTENE,2020/02/03,Retinoid,,BAUSCH HEALTH US LLC,2000/06/28-,0187-5525,A61RXM4375,BEXAROTENE,BEXAROTENE,A61RXM4375,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/d35b4697-3f3b-4aa1-b5d9-153993e83811/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d35b4697-3f3b-4aa1-b5d9-153993e83811,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=d35b4697-3f3b-4aa1-b5d9-153993e83811,d35b4697-3f3b-4aa1-b5d9-153993e83811,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,020498,Bicalutamide,BICALUTAMIDE,2023/12/18,Androgen Receptor Inhibitor,1995,ANI PHARMACEUTICALS INC,2020/10/26-,62559-890,A0Z3NAU9DP,BICALUTAMIDE,BICALUTAMIDE,A0Z3NAU9DP,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/7a08d88b-051a-4c16-9560-12685c500c58/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7a08d88b-051a-4c16-9560-12685c500c58,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=7a08d88b-051a-4c16-9560-12685c500c58,7a08d88b-051a-4c16-9560-12685c500c58,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,020498,CASODEX,BICALUTAMIDE,2023/12/18,Androgen Receptor Inhibitor,1995,ANI PHARMACEUTICALS INC,2018/06/26-,62559-680,A0Z3NAU9DP,BICALUTAMIDE,BICALUTAMIDE,A0Z3NAU9DP,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/dfee4fe7-8478-4a3e-925d-00be3cd0ab67/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=dfee4fe7-8478-4a3e-925d-00be3cd0ab67,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=dfee4fe7-8478-4a3e-925d-00be3cd0ab67,dfee4fe7-8478-4a3e-925d-00be3cd0ab67,,,
HUMAN PRESCRIPTION DRUG LABEL,KIT,INTRAVENOUS,NDA,020256,NEUROLITE,BICISATE DIHYDROCHLORIDE,2022/11/18,,,LANTHEUS MEDICAL IMAGING INC,1994/11/23-,11994-006,B005P07V07,BICISATE DIHYDROCHLORIDE,BICISATE,3JXF0Z0XOI,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/f9adbcd5-1ac1-42d8-b18a-a76c9204014c/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f9adbcd5-1ac1-42d8-b18a-a76c9204014c,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=f9adbcd5-1ac1-42d8-b18a-a76c9204014c,f9adbcd5-1ac1-42d8-b18a-a76c9204014c,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,210251,Biktarvy,"BICTEGRAVIR SODIUM, EMTRICITABINE, AND TENOFOVIR ALAFENAMIDE FUMARATE",2024/04/30,Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor,2018,GILEAD SCIENCES INC,2018/02/07-; 2021/10/07-,61958-2501; 61958-2505,4L5MP1Y7W7; FWF6Q91TZO; G70B4ETF4S,BICTEGRAVIR SODIUM; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE,BICTEGRAVIR; EMTRICITABINE; TENOFOVIR ANHYDROUS,8GB79LOJ07; G70B4ETF4S; W4HFE001U5,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/664cb8f0-1f65-441b-b0d9-ba3d798be309/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=664cb8f0-1f65-441b-b0d9-ba3d798be309,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=664cb8f0-1f65-441b-b0d9-ba3d798be309,664cb8f0-1f65-441b-b0d9-ba3d798be309,,,
HUMAN PRESCRIPTION DRUG LABEL,IMPLANT,INTRACAMERAL,NDA,211911,DURYSTA,BIMATOPROST,2023/11/16,Prostaglandin Analog,2001,ALLERGAN INC,2020/03/04-,0023-9652,QXS94885MZ,BIMATOPROST,BIMATOPROST,QXS94885MZ,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/3f59da84-0bcc-4c84-b3e2-e215681ef341/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3f59da84-0bcc-4c84-b3e2-e215681ef341,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=3f59da84-0bcc-4c84-b3e2-e215681ef341,3f59da84-0bcc-4c84-b3e2-e215681ef341,,,
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION/ DROPS,OPHTHALMIC,NDA,022184,LUMIGAN,BIMATOPROST,2022/03/08,Prostaglandin Analog,2001,ALLERGAN INC,2010/09/10-,0023-3205,QXS94885MZ,BIMATOPROST,BIMATOPROST,QXS94885MZ,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/a5e67c75-db88-4372-bb07-c8dd15c97631/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a5e67c75-db88-4372-bb07-c8dd15c97631,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=a5e67c75-db88-4372-bb07-c8dd15c97631,a5e67c75-db88-4372-bb07-c8dd15c97631,,,
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION/ DROPS,OPHTHALMIC,NDA,022369,LATISSE,BIMATOPROST,2021/08/01,Prostaglandin Analog,2001,ALLERGAN INC,2009/01/26-,0023-3616,QXS94885MZ,BIMATOPROST,BIMATOPROST,QXS94885MZ,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/34f83d9d-2c64-463e-8a90-9a460fedfead/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=34f83d9d-2c64-463e-8a90-9a460fedfead,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=34f83d9d-2c64-463e-8a90-9a460fedfead,34f83d9d-2c64-463e-8a90-9a460fedfead,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,210498,MEKTOVI,BINIMETINIB,2023/10/18,,2018,ARRAY BIOPHARMA INC,2018/06/27-,70255-010,181R97MR71,BINIMETINIB,BINIMETINIB,181R97MR71,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/6c3408ac-d401-4925-8a03-26591afbc240/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6c3408ac-d401-4925-8a03-26591afbc240,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=6c3408ac-d401-4925-8a03-26591afbc240,6c3408ac-d401-4925-8a03-26591afbc240,,,
HUMAN PRESCRIPTION DRUG LABEL,GEL,TOPICAL,NDA,215064,FILSUVEZ,BIRCH TRITERPENES,2024/05/16,,2023,CHIESI USA INC,2024/02/22-,10122-310,BX09B0RQR0,birch triterpenes,birch triterpenes,BX09B0RQR0,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/32ba9194-734c-47d4-84e1-b21e28a85ec5/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=32ba9194-734c-47d4-84e1-b21e28a85ec5,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=32ba9194-734c-47d4-84e1-b21e28a85ec5,32ba9194-734c-47d4-84e1-b21e28a85ec5,,,
HUMAN PRESCRIPTION DRUG LABEL,GEL,TOPICAL,NDA,215064,FILSUVEZ,BIRCH TRITERPENES,2024/02/14,,2023,AMRYT PHARMACEUTICALS DAC,2024/02/22-,76431-310,BX09B0RQR0,birch triterpenes,birch triterpenes,BX09B0RQR0,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/da793f2d-0a3d-4792-8c22-982f9f8cdd97/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=da793f2d-0a3d-4792-8c22-982f9f8cdd97,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=da793f2d-0a3d-4792-8c22-982f9f8cdd97,da793f2d-0a3d-4792-8c22-982f9f8cdd97,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,NDA,050786,PYLERA,"BISMUTH SUBCITRATE POTASSIUM, METRONIDAZOLE, AND TETRACYCLINE HYDROCHLORIDE",2023/10/19,Bismuth; Nitroimidazole Antimicrobial; Tetracycline-class Antimicrobial,2006,H PHARMA LLC,2023/10/01-,61269-380,140QMO216E; P6R62377KV; R3O80H60KX,BISMUTH SUBCITRATE POTASSIUM; METRONIDAZOLE; TETRACYCLINE HYDROCHLORIDE,BISMUTH CATION; METRONIDAZOLE; TETRACYCLINE,140QMO216E; F8VB5M810T; ZS9CD1I8YE,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/5cdacbf5-67be-42eb-bd54-8acc32ea1abc/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5cdacbf5-67be-42eb-bd54-8acc32ea1abc,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=5cdacbf5-67be-42eb-bd54-8acc32ea1abc,5cdacbf5-67be-42eb-bd54-8acc32ea1abc,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,NDA,050786,"BISMUTH SUBCITRATE POTASSIUM, METRONIDAZOLE, AND TETRACYCLINE HYDROCHLORIDE","BISMUTH SUBCITRATE POTASSIUM, METRONIDAZOLE, AND TETRACYCLINE HYDROCHLORIDE",2023/08/07,Bismuth; Nitroimidazole Antimicrobial; Tetracycline-class Antimicrobial,2006,H PHARMA LLC,2023/07/31-,61269-385,140QMO216E; P6R62377KV; R3O80H60KX,BISMUTH SUBCITRATE POTASSIUM; METRONIDAZOLE; TETRACYCLINE HYDROCHLORIDE,BISMUTH CATION; METRONIDAZOLE; TETRACYCLINE,140QMO216E; F8VB5M810T; ZS9CD1I8YE,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/c07e32ee-cd99-405d-b5e2-927d9cb204ee/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c07e32ee-cd99-405d-b5e2-927d9cb204ee,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=c07e32ee-cd99-405d-b5e2-927d9cb204ee,c07e32ee-cd99-405d-b5e2-927d9cb204ee,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,NDA,050786,Pylera,"BISMUTH SUBCITRATE POTASSIUM, METRONIDAZOLE, TETRACYCLINE HYDROCHLORIDE",2021/12/15,Bismuth; Nitroimidazole Antimicrobial; Tetracycline-class Antimicrobial,2006,ALLERGAN INC,2013/08/01-,58914-601,140QMO216E; P6R62377KV; R3O80H60KX,BISMUTH SUBCITRATE POTASSIUM; METRONIDAZOLE; TETRACYCLINE HYDROCHLORIDE,BISMUTH CATION; METRONIDAZOLE; TETRACYCLINE,140QMO216E; F8VB5M810T; ZS9CD1I8YE,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/a762e164-b390-4e8c-bd46-bf6c31eeb486/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a762e164-b390-4e8c-bd46-bf6c31eeb486,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=a762e164-b390-4e8c-bd46-bf6c31eeb486,a762e164-b390-4e8c-bd46-bf6c31eeb486,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,020186,Ziac,BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE,2024/01/04,Thiazide Diuretic; beta-Adrenergic Blocker,,TEVA WOMEN S HEALTH LLC,completed:1993/10/26-2025/05/31; completed:1993/10/26-2025/06/30,51285-040; 51285-047; 51285-050,0J48LPH2TH; UR59KN573L,BISOPROLOL FUMARATE; HYDROCHLOROTHIAZIDE,BISOPROLOL; HYDROCHLOROTHIAZIDE,0J48LPH2TH; Y41JS2NL6U,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/238176e5-df10-457b-a5cf-c950a583e748/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=238176e5-df10-457b-a5cf-c950a583e748,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=238176e5-df10-457b-a5cf-c950a583e748,238176e5-df10-457b-a5cf-c950a583e748,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,211215,Bivalirudin RTU,BIVALIRUDIN,2024/03/02,Anti-coagulant; Direct Thrombin Inhibitor,2000,ATHENEX PHARMACEUTICAL DIVISION LLC,completed:2020/03/01-2024/06/26,70860-403,TN9BEX005G,BIVALIRUDIN,BIVALIRUDIN,TN9BEX005G,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/1ed8c822-6fe1-49c1-a59f-31a4c72818c8/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1ed8c822-6fe1-49c1-a59f-31a4c72818c8,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=1ed8c822-6fe1-49c1-a59f-31a4c72818c8,1ed8c822-6fe1-49c1-a59f-31a4c72818c8,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,211215,Bivalirudin,BIVALIRUDIN,2023/04/30,Anti-coagulant; Direct Thrombin Inhibitor,2000,PAR PHARMACEUTICAL INC,2023/06/19-,42023-622,TN9BEX005G,BIVALIRUDIN,BIVALIRUDIN,TN9BEX005G,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/91cf9d00-29e0-4357-a184-f70026c47edb/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=91cf9d00-29e0-4357-a184-f70026c47edb,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=91cf9d00-29e0-4357-a184-f70026c47edb,91cf9d00-29e0-4357-a184-f70026c47edb,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,211215,Angiomax RTU,BIVALIRUDIN,2019/11/05,Anti-coagulant; Direct Thrombin Inhibitor,2000,MAIA PHARMACEUTICALS INC,2019/08/08-,70511-141,TN9BEX005G,BIVALIRUDIN,BIVALIRUDIN,TN9BEX005G,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/72c5413f-882a-4784-9be6-312c0a0a2a97/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=72c5413f-882a-4784-9be6-312c0a0a2a97,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=72c5413f-882a-4784-9be6-312c0a0a2a97,72c5413f-882a-4784-9be6-312c0a0a2a97,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRAVENOUS,NDA,020873,Angiomax,BIVALIRUDIN,2019/06/30,Anti-coagulant; Direct Thrombin Inhibitor,2000,SANDOZ INC,2019/08/01-,0781-3447,TN9BEX005G,BIVALIRUDIN,BIVALIRUDIN,TN9BEX005G,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/5f133813-f74e-4508-bc64-debbf104ff1e/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5f133813-f74e-4508-bc64-debbf104ff1e,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=5f133813-f74e-4508-bc64-debbf104ff1e,5f133813-f74e-4508-bc64-debbf104ff1e,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRAVENOUS,NDA,215331,Bortezomib,BORTEZOMIB,2024/05/08,Proteasome Inhibitor,2003,FOSUN PHARMA USA INC,completed:2022/08/23-2024/06/30,72266-243; 72266-244,69G8BD63PP,BORTEZOMIB,BORTEZOMIB,69G8BD63PP,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/e6718f64-b39e-fcc3-e053-2995a90ab69e/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e6718f64-b39e-fcc3-e053-2995a90ab69e,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=e6718f64-b39e-fcc3-e053-2995a90ab69e,e6718f64-b39e-fcc3-e053-2995a90ab69e,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAVENOUS; SUBCUTANEOUS,NDA,209191,BORTEZOMIB,BORTEZOMIB,2023/02/27,Proteasome Inhibitor,2003,HOSPIRA INC,2022/05/16-,0409-1703; 0409-1704,69G8BD63PP,BORTEZOMIB,BORTEZOMIB,69G8BD63PP,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/9fdf6169-699f-40eb-bda1-760253062b3c/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9fdf6169-699f-40eb-bda1-760253062b3c,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=9fdf6169-699f-40eb-bda1-760253062b3c,9fdf6169-699f-40eb-bda1-760253062b3c,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAVENOUS; SUBCUTANEOUS,NDA,021602,VELCADE,BORTEZOMIB,2022/10/25,Proteasome Inhibitor,2003,TAKEDA PHARMACEUTICALS AMERICA INC,2003/05/13-,63020-049,69G8BD63PP,bortezomib,bortezomib,69G8BD63PP,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/1521d321-e724-4ffc-adad-34bf4f44fac7/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1521d321-e724-4ffc-adad-34bf4f44fac7,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=1521d321-e724-4ffc-adad-34bf4f44fac7,1521d321-e724-4ffc-adad-34bf4f44fac7,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRAVENOUS,NDA,215331,Bortezomib,BORTEZOMIB,2021/09/22,Proteasome Inhibitor,2003,MAIA PHARMACEUTICALS INC,2022/08/10-; 2022/08/11-,70511-161; 70511-162,69G8BD63PP,BORTEZOMIB,BORTEZOMIB,69G8BD63PP,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/c40e6a28-d577-43d4-bca6-bef28da1d580/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c40e6a28-d577-43d4-bca6-bef28da1d580,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=c40e6a28-d577-43d4-bca6-bef28da1d580,c40e6a28-d577-43d4-bca6-bef28da1d580,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED; TABLET, FOR SUSPENSION",ORAL,NDA,021290;209279,Tracleer,BOSENTAN,2024/02/21,Endothelin Receptor Antagonist,2001,ACTELION PHARMACEUTICALS US INC,2001/11/20-; 2017/11/13-; 2021/07/29-,66215-101; 66215-102; 66215-103; 66215-232,Q326023R30,BOSENTAN,BOSENTAN ANHYDROUS,XUL93R30K2,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/749e42fb-2fe0-45dd-9268-b43bb3f4081c/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=749e42fb-2fe0-45dd-9268-b43bb3f4081c,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=749e42fb-2fe0-45dd-9268-b43bb3f4081c,749e42fb-2fe0-45dd-9268-b43bb3f4081c,,,
HUMAN PRESCRIPTION DRUG LABEL,"CAPSULE; TABLET, FILM COATED",ORAL,NDA,203341;217729,BOSULIF,BOSUTINIB,2023/09/29,Kinase Inhibitor,2012,PFIZER LABORATORIES DIV PFIZER INC,2012/09/04-; 2017/12/18-; 2024/01/02-,0069-0135; 0069-0136; 0069-0193; 0069-0504; 0069-1014,844ZJE6I55,BOSUTINIB MONOHYDRATE,BOSUTINIB,5018V4AEZ0,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/adc84ad5-a04d-4fee-9ba8-91f7abd928e3/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=adc84ad5-a04d-4fee-9ba8-91f7abd928e3,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=adc84ad5-a04d-4fee-9ba8-91f7abd928e3,adc84ad5-a04d-4fee-9ba8-91f7abd928e3,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,203341,BOSULIF,BOSUTINIB,2021/10/28,Kinase Inhibitor,2012,U S PHARMACEUTICALS,2012/09/04-,63539-117; 63539-193,844ZJE6I55,BOSUTINIB MONOHYDRATE,BOSUTINIB,5018V4AEZ0,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/d5929f91-6496-4c0e-97e8-0bd524e15763/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d5929f91-6496-4c0e-97e8-0bd524e15763,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=d5929f91-6496-4c0e-97e8-0bd524e15763,d5929f91-6496-4c0e-97e8-0bd524e15763,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,SUBCUTANEOUS,NDA,210557,Vyleesi,BREMELANOTIDE,2023/10/09,Melanocortin Receptor Agonist,2019,PALATIN TECHNOLOGIES,2019/06/21-,80064-141,PV2WI7495P,bremelanotide acetate,bremelanotide,6Y24O4F92S,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/8c9607a2-5b57-4a59-b159-cf196deebdd9/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8c9607a2-5b57-4a59-b159-cf196deebdd9,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=8c9607a2-5b57-4a59-b159-cf196deebdd9,8c9607a2-5b57-4a59-b159-cf196deebdd9,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,SUBCUTANEOUS,NDA,210557,Vyleesi,BREMELANOTIDE,2021/01/12,Melanocortin Receptor Agonist,2019,AMAG PHARMACEUTICALS INC,2019/06/21-,64011-701,PV2WI7495P,BREMELANOTIDE ACETATE,BREMELANOTIDE,6Y24O4F92S,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/9146ae05-918b-483e-b86d-933485ce36eb/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9146ae05-918b-483e-b86d-933485ce36eb,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=9146ae05-918b-483e-b86d-933485ce36eb,9146ae05-918b-483e-b86d-933485ce36eb,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,211371,Zulresso,BREXANOLONE,2022/06/20,Neuroactive Steroid Gamma-Aminobutyric Acid A Receptor Positive Modulator,2019,SAGE THERAPEUTICS INC,2019/06/17-,72152-547,S39XZ5QV8Y,BREXANOLONE,BREXANOLONE,S39XZ5QV8Y,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/b40f3b2a-1859-4ed6-8551-444300806d13/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b40f3b2a-1859-4ed6-8551-444300806d13,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=b40f3b2a-1859-4ed6-8551-444300806d13,b40f3b2a-1859-4ed6-8551-444300806d13,,,
HUMAN PRESCRIPTION DRUG LABEL,KIT; TABLET,ORAL,NDA,205422,Rexulti,BREXPIPRAZOLE,2024/05/14,Atypical Antipsychotic,2015,OTSUKA AMERICA PHARMACEUTICAL INC,2015/07/10-,59148-035; 59148-036; 59148-037; 59148-038; 59148-039; 59148-040; 59148-042; 59148-044,2J3YBM1K8C,brexpiprazole,brexpiprazole,2J3YBM1K8C,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/2d301358-6291-4ec1-bd87-37b4ad9bd850/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2d301358-6291-4ec1-bd87-37b4ad9bd850,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=2d301358-6291-4ec1-bd87-37b4ad9bd850,2d301358-6291-4ec1-bd87-37b4ad9bd850,,,
HUMAN PRESCRIPTION DRUG LABEL,"KIT; TABLET, FILM COATED",ORAL,NDA,208772,Alunbrig,BRIGATINIB,2023/08/21,Kinase Inhibitor,2017,TAKEDA PHARMACEUTICALS AMERICA INC,2017/04/28-,63020-090; 63020-113; 63020-180; 63020-198,HYW8DB273J,brigatinib,brigatinib,HYW8DB273J,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/0fe9ff20-d402-41f3-bc1e-7002ea7007db/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0fe9ff20-d402-41f3-bc1e-7002ea7007db,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=0fe9ff20-d402-41f3-bc1e-7002ea7007db,0fe9ff20-d402-41f3-bc1e-7002ea7007db,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAOCULAR; OPHTHALMIC,NDA,209569,TISSUEBLUE,BRILLIANT BLUE G,2023/10/05,Disclosing Agent,2019,D O R C DUTCH OPHTHALMIC RESEARCH CENTER INTERNATIONAL B V,2019/12/31-,68803-722,M1ZRX790SI,BRILLIANT BLUE G,BRILLIANT BLUE G,M1ZRX790SI,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/9d4b28b4-c582-4e2c-abd9-f7e203378e2d/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9d4b28b4-c582-4e2c-abd9-f7e203378e2d,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=9d4b28b4-c582-4e2c-abd9-f7e203378e2d,9d4b28b4-c582-4e2c-abd9-f7e203378e2d,,,
HUMAN PRESCRIPTION DRUG LABEL,GEL,TOPICAL,NDA,204708,Mirvaso,BRIMONIDINE TARTRATE,2022/12/05,alpha-Adrenergic Agonist,1996,GALDERMA LABORATORIES L P,2013/08/23-,0299-5980,4S9CL2DY2H,BRIMONIDINE TARTRATE,BRIMONIDINE,E6GNX3HHTE,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/f6a4353f-ae69-4214-901f-e5d42a6fbde7/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f6a4353f-ae69-4214-901f-e5d42a6fbde7,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=f6a4353f-ae69-4214-901f-e5d42a6fbde7,f6a4353f-ae69-4214-901f-e5d42a6fbde7,,,
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION,OPHTHALMIC,NDA,021764,Brimonidine Tartrate,BRIMONIDINE TARTRATE,2021/05/31,alpha-Adrenergic Agonist,1996,SANDOZ INC,2010/10/02-,61314-144,4S9CL2DY2H,BRIMONIDINE TARTRATE,BRIMONIDINE,E6GNX3HHTE,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/b1e7ebd4-d0d2-40a5-aa11-5f68bc5972bd/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b1e7ebd4-d0d2-40a5-aa11-5f68bc5972bd,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=b1e7ebd4-d0d2-40a5-aa11-5f68bc5972bd,b1e7ebd4-d0d2-40a5-aa11-5f68bc5972bd,,,
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION/ DROPS,OPHTHALMIC,NDA,021262;021770,ALPHAGAN P,BRIMONIDINE TARTRATE,2013/09/01,alpha-Adrenergic Agonist,1996,ALLERGAN INC,2001/07/10-; 2006/01/25-,0023-9177; 0023-9321,4S9CL2DY2H,BRIMONIDINE TARTRATE,BRIMONIDINE,E6GNX3HHTE,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/264c4494-c225-486f-888a-caaf36be46b3/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=264c4494-c225-486f-888a-caaf36be46b3,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=264c4494-c225-486f-888a-caaf36be46b3,264c4494-c225-486f-888a-caaf36be46b3,,,
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION/ DROPS,OPHTHALMIC,NDA,021398,COMBIGAN,"BRIMONIDINE TARTRATE, TIMOLOL MALEATE",2015/10/01,alpha-Adrenergic Agonist; beta-Adrenergic Blocker,2007,ALLERGAN INC,2007/11/14-,0023-9211,4S9CL2DY2H; P8Y54F701R,brimonidine tartrate; timolol maleate,brimonidine; timolol anhydrous,5JKY92S7BR; E6GNX3HHTE,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/feaf1480-a4b8-4486-992a-96be3a596243/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=feaf1480-a4b8-4486-992a-96be3a596243,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=feaf1480-a4b8-4486-992a-96be3a596243,feaf1480-a4b8-4486-992a-96be3a596243,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,214461,Tembexa,BRINCIDOFOVIR,2023/02/24,,1996,EMERGENT BIODEFENSE OPERATIONS LANSING LLC,2022/04/20-,64678-010,6794O900AX,BRINCIDOFOVIR,BRINCIDOFOVIR,6794O900AX,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/209aa94b-c613-4880-ad89-41be83d12c0a/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=209aa94b-c613-4880-ad89-41be83d12c0a,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=209aa94b-c613-4880-ad89-41be83d12c0a,209aa94b-c613-4880-ad89-41be83d12c0a,,,
HUMAN PRESCRIPTION DRUG LABEL,SUSPENSION,ORAL,NDA,214460,Tembexa,BRINCIDOFOVIR,2023/02/24,,1996,EMERGENT BIODEFENSE OPERATIONS LANSING LLC,2022/04/20-,64678-012,6794O900AX,BRINCIDOFOVIR,BRINCIDOFOVIR,6794O900AX,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/0784838e-00bd-4b14-9b7e-653b7fbb7eea/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0784838e-00bd-4b14-9b7e-653b7fbb7eea,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=0784838e-00bd-4b14-9b7e-653b7fbb7eea,0784838e-00bd-4b14-9b7e-653b7fbb7eea,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,214461,Tembexa,BRINCIDOFOVIR,2022/04/18,,1996,CHIMERIX INC,2022/04/20-,79622-010,6794O900AX,BRINCIDOFOVIR,BRINCIDOFOVIR,6794O900AX,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/31d6fa29-791e-4988-8758-e7e4d5b6a352/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=31d6fa29-791e-4988-8758-e7e4d5b6a352,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=31d6fa29-791e-4988-8758-e7e4d5b6a352,31d6fa29-791e-4988-8758-e7e4d5b6a352,,,
HUMAN PRESCRIPTION DRUG LABEL,SUSPENSION,ORAL,NDA,214460,Tembexa,BRINCIDOFOVIR,2022/04/18,,1996,CHIMERIX INC,2022/04/20-,79622-012,6794O900AX,BRINCIDOFOVIR,BRINCIDOFOVIR,6794O900AX,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/12569e7c-9c2a-4b8b-94e2-f05607b4a866/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=12569e7c-9c2a-4b8b-94e2-f05607b4a866,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=12569e7c-9c2a-4b8b-94e2-f05607b4a866,12569e7c-9c2a-4b8b-94e2-f05607b4a866,,,
HUMAN PRESCRIPTION DRUG LABEL,SUSPENSION/ DROPS,OPHTHALMIC,NDA,020816,Azopt,BRINZOLAMIDE,2023/06/28,Carbonic Anhydrase Inhibitor,1998,NOVARTIS PHARMACEUTICALS CORPORATION,1998/04/30-,0078-0722,9451Z89515,BRINZOLAMIDE,BRINZOLAMIDE,9451Z89515,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/acc89925-3ee3-4632-98ae-38a546848346/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=acc89925-3ee3-4632-98ae-38a546848346,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=acc89925-3ee3-4632-98ae-38a546848346,acc89925-3ee3-4632-98ae-38a546848346,,,
HUMAN PRESCRIPTION DRUG LABEL,SUSPENSION/ DROPS,OPHTHALMIC,NDA,204251,SIMBRINZA,BRINZOLAMIDE/BRIMONIDINE TARTRATE,2023/05/16,Carbonic Anhydrase Inhibitor; alpha-Adrenergic Agonist,2013,ALCON LABORATORIES INC,2013/05/06-,0065-4147,4S9CL2DY2H; 9451Z89515,Brimonidine Tartrate; Brinzolamide,Brimonidine; Brinzolamide,9451Z89515; E6GNX3HHTE,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/a49c157e-6310-0011-7b7f-e26fc1820d59/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a49c157e-6310-0011-7b7f-e26fc1820d59,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=a49c157e-6310-0011-7b7f-e26fc1820d59,a49c157e-6310-0011-7b7f-e26fc1820d59,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SUSPENSION; SOLUTION; TABLET, FILM COATED",INTRAVENOUS; ORAL,NDA,205836;205837;205838,Briviact,BRIVARACETAM,2023/05/24,,2016,UCB INC,2016/05/12-,50474-370; 50474-470; 50474-570; 50474-670; 50474-770; 50474-870; 50474-970,U863JGG2IA,brivaracetam,brivaracetam,U863JGG2IA,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/3cf2f439-0e97-443e-8e33-25ecef616f6c/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3cf2f439-0e97-443e-8e33-25ecef616f6c,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=3cf2f439-0e97-443e-8e33-25ecef616f6c,3cf2f439-0e97-443e-8e33-25ecef616f6c,,,
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION/ DROPS,OPHTHALMIC,NDA,206911,BROMSITE 0.075%,BROMFENAC,2023/04/14,Nonsteroidal Anti-inflammatory Drug,1997,SUN PHARMACEUTICAL INDUSTRIES INC,2016/05/01-,49708-754,8ECV571Y37,BROMFENAC SODIUM,BROMFENAC,864P0921DW,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/144a5072-341b-4591-8705-773b63044bcc/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=144a5072-341b-4591-8705-773b63044bcc,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=144a5072-341b-4591-8705-773b63044bcc,144a5072-341b-4591-8705-773b63044bcc,,,
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION/ DROPS,OPHTHALMIC,NDA,203168,Prolensa,BROMFENAC SODIUM,2023/01/31,Nonsteroidal Anti-inflammatory Drug,1997,BAUSCH AND LOMB INCORPORATED,2013/04/05-,24208-602,8ECV571Y37,BROMFENAC SODIUM,BROMFENAC,864P0921DW,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/4e072537-f73c-4a96-a65f-e2805ce112d8/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4e072537-f73c-4a96-a65f-e2805ce112d8,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=4e072537-f73c-4a96-a65f-e2805ce112d8,4e072537-f73c-4a96-a65f-e2805ce112d8,,,
HUMAN PRESCRIPTION DRUG LABEL,"CAPSULE, GELATIN COATED; TABLET",ORAL,NDA,017962,Parlodel,BROMOCRIPTINE MESYLATE,2023/12/15,Ergot Derivative,,VALIDUS PHARMACEUTICALS LLC,2014/04/28-,30698-201; 30698-202,FFP983J3OD,BROMOCRIPTINE MESYLATE,BROMOCRIPTINE,3A64E3G5ZO,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/fc2a08dd-4fb6-4ac4-9082-f99552fae25c/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=fc2a08dd-4fb6-4ac4-9082-f99552fae25c,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=fc2a08dd-4fb6-4ac4-9082-f99552fae25c,fc2a08dd-4fb6-4ac4-9082-f99552fae25c,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,020866,CYCLOSET,BROMOCRIPTINE MESYLATE,2020/11/30,Ergot Derivative,1978,SANTARUS INC,2010/11/15-,68012-258,FFP983J3OD,bromocriptine mesylate,bromocriptine,3A64E3G5ZO,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/3e719d6a-342e-428b-93d3-377d31cb15c7/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3e719d6a-342e-428b-93d3-377d31cb15c7,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=3e719d6a-342e-428b-93d3-377d31cb15c7,3e719d6a-342e-428b-93d3-377d31cb15c7,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE; TABLET,ORAL,NDA,017962,BROMOCRIPTINE MESYLATE,BROMOCRIPTINE MESYLATE,2020/02/06,Ergot Derivative,,SUN PHARMACEUTICAL INDUSTRIES INC,2016/12/22-,63304-158; 63304-962,FFP983J3OD,BROMOCRIPTINE MESYLATE,BROMOCRIPTINE,3A64E3G5ZO,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/44cc1e5f-c509-40e6-ac51-eba6d0440b16/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=44cc1e5f-c509-40e6-ac51-eba6d0440b16,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=44cc1e5f-c509-40e6-ac51-eba6d0440b16,44cc1e5f-c509-40e6-ac51-eba6d0440b16,,,
HUMAN PRESCRIPTION DRUG LABEL,SUSPENSION,ORAL,NDA,213976,Eohilia,BUDESONIDE,2024/05/22,Corticosteroid,1997,TAKEDA PHARMACEUTICALS AMERICA INC,2024/02/09-,64764-105,Q3OKS62Q6X,Budesonide,Budesonide,Q3OKS62Q6X,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/56f2023a-69b2-4470-b4ad-af7ec1be527a/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=56f2023a-69b2-4470-b4ad-af7ec1be527a,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=56f2023a-69b2-4470-b4ad-af7ec1be527a,56f2023a-69b2-4470-b4ad-af7ec1be527a,,,
HUMAN PRESCRIPTION DRUG LABEL,"CAPSULE, DELAYED RELEASE",ORAL,NDA,215935,Tarpeyo,BUDESONIDE,2023/12/31,Corticosteroid,1997,CALLIDITAS THERAPEUTICS AB,2021/12/15-,81749-004,Q3OKS62Q6X,budesonide,budesonide,Q3OKS62Q6X,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/938cada4-d6bf-4252-836f-dd40f9eadb4d/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=938cada4-d6bf-4252-836f-dd40f9eadb4d,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=938cada4-d6bf-4252-836f-dd40f9eadb4d,938cada4-d6bf-4252-836f-dd40f9eadb4d,,,
HUMAN PRESCRIPTION DRUG LABEL,"AEROSOL, POWDER",INHALATION,NDA,021949,PULMICORT FLEXHALER,BUDESONIDE,2023/09/04,Corticosteroid,2006,H PHARMA LLC,2007/03/19-,61269-509; 61269-518,Q3OKS62Q6X,BUDESONIDE,BUDESONIDE,Q3OKS62Q6X,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/10f2ae5b-a6fb-4804-9111-0cd067c2b1b2/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=10f2ae5b-a6fb-4804-9111-0cd067c2b1b2,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=10f2ae5b-a6fb-4804-9111-0cd067c2b1b2,10f2ae5b-a6fb-4804-9111-0cd067c2b1b2,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,NDA,021324,budesonide,BUDESONIDE,2023/06/30,Corticosteroid,1997,PADAGIS US LLC,2018/06/29-,0574-9855,Q3OKS62Q6X,BUDESONIDE,BUDESONIDE,Q3OKS62Q6X,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/3a18d5a7-04c5-4137-8155-70a8adc0a48b/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3a18d5a7-04c5-4137-8155-70a8adc0a48b,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=3a18d5a7-04c5-4137-8155-70a8adc0a48b,3a18d5a7-04c5-4137-8155-70a8adc0a48b,,,
HUMAN PRESCRIPTION DRUG LABEL,"AEROSOL, FOAM",RECTAL,NDA,205613,budesonide,BUDESONIDE,2021/10/01,Corticosteroid,1997,OCEANSIDE PHARMACEUTICALS,2022/07/15-,68682-658,Q3OKS62Q6X,BUDESONIDE,BUDESONIDE,Q3OKS62Q6X,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/b2cf85c5-3ae0-4f91-9f3a-1d6771e14a73/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b2cf85c5-3ae0-4f91-9f3a-1d6771e14a73,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=b2cf85c5-3ae0-4f91-9f3a-1d6771e14a73,b2cf85c5-3ae0-4f91-9f3a-1d6771e14a73,,,
HUMAN PRESCRIPTION DRUG LABEL,"AEROSOL, FOAM",RECTAL,NDA,205613,Uceris,BUDESONIDE,2020/04/23,Corticosteroid,1997,SALIX PHARMACEUTICALS INC,2014/12/01-,65649-651,Q3OKS62Q6X,BUDESONIDE,BUDESONIDE,Q3OKS62Q6X,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/230e4596-2a9b-4d55-b0a0-0cabbcff5289/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=230e4596-2a9b-4d55-b0a0-0cabbcff5289,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=230e4596-2a9b-4d55-b0a0-0cabbcff5289,230e4596-2a9b-4d55-b0a0-0cabbcff5289,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, EXTENDED RELEASE",ORAL,NDA,203634,Uceris,BUDESONIDE,2020/04/23,Corticosteroid,1997,SANTARUS INC,2013/01/14-,68012-309,Q3OKS62Q6X,BUDESONIDE,BUDESONIDE,Q3OKS62Q6X,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/92cbb190-8851-46ed-bfe0-166ca62ef2e9/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=92cbb190-8851-46ed-bfe0-166ca62ef2e9,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=92cbb190-8851-46ed-bfe0-166ca62ef2e9,92cbb190-8851-46ed-bfe0-166ca62ef2e9,,,
HUMAN PRESCRIPTION DRUG LABEL,"AEROSOL, POWDER",INHALATION,NDA,021949,PULMICORT FLEXHALER,BUDESONIDE,2019/10/11,Corticosteroid,2006,ASTRAZENECA PHARMACEUTICALS LP,completed:2007/03/19-2025/10/31,0186-0916; 0186-0917,Q3OKS62Q6X,BUDESONIDE,BUDESONIDE,Q3OKS62Q6X,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/54234b7d-3bcc-4809-1881-1d21484856a0/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=54234b7d-3bcc-4809-1881-1d21484856a0,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=54234b7d-3bcc-4809-1881-1d21484856a0,54234b7d-3bcc-4809-1881-1d21484856a0,,,
HUMAN PRESCRIPTION DRUG LABEL,SUSPENSION,INHALATION,NDA,020929,PULMICORT RESPULES,BUDESONIDE,2019/10/11,Corticosteroid,2000,ASTRAZENECA PHARMACEUTICALS LP,2000/09/08-; 2007/09/17-,0186-1988; 0186-1989; 0186-1990,Q3OKS62Q6X,BUDESONIDE,BUDESONIDE,Q3OKS62Q6X,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/33cd9834-76df-4f26-3fa2-aab6b9eee8f2/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=33cd9834-76df-4f26-3fa2-aab6b9eee8f2,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=33cd9834-76df-4f26-3fa2-aab6b9eee8f2,33cd9834-76df-4f26-3fa2-aab6b9eee8f2,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,NDA,021324,ENTOCORT EC,BUDESONIDE,2009/06/24,Corticosteroid,,PROMETHEUS LABORATORIES INC,2001/10/29-,65483-702,Q3OKS62Q6X,BUDESONIDE,BUDESONIDE,Q3OKS62Q6X,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/fe6530ef-1b23-451f-1290-0e3ef02ec1b5/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=fe6530ef-1b23-451f-1290-0e3ef02ec1b5,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=fe6530ef-1b23-451f-1290-0e3ef02ec1b5,fe6530ef-1b23-451f-1290-0e3ef02ec1b5,,,
HUMAN PRESCRIPTION DRUG LABEL,AEROSOL,INHALATION,NDA,021929,SYMBICORT,BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE,2019/07/24,Corticosteroid; beta2-Adrenergic Agonist,2006,ASTRAZENECA PHARMACEUTICALS LP,2007/05/29-,0186-0370; 0186-0372,Q3OKS62Q6X; W34SHF8J2K,BUDESONIDE; FORMOTEROL FUMARATE,BUDESONIDE; FORMOTEROL,5ZZ84GCW8B; Q3OKS62Q6X,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/fafa4cf1-99c2-43d5-73ad-51f256de3be0/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=fafa4cf1-99c2-43d5-73ad-51f256de3be0,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=fafa4cf1-99c2-43d5-73ad-51f256de3be0,fafa4cf1-99c2-43d5-73ad-51f256de3be0,,,
HUMAN PRESCRIPTION DRUG LABEL,"AEROSOL, METERED",INHALATION,NDA,212122,BREZTRI,"BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE",2022/01/26,Anticholinergic; Cholinergic Muscarinic Antagonist; Corticosteroid; beta2-Adrenergic Agonist,2020,ASTRAZENECA PHARMACEUTICALS LP,2020/07/23-,0310-4616,5ZZ84GCW8B; Q3OKS62Q6X; V92SO9WP2I,BUDESONIDE; FORMOTEROL; GLYCOPYRROLATE,BUDESONIDE; FORMOTEROL; GLYCOPYRRONIUM,5ZZ84GCW8B; A14FB57V1D; Q3OKS62Q6X,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/715433dc-cb2b-43ea-b6df-c5b4177adc6c/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=715433dc-cb2b-43ea-b6df-c5b4177adc6c,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=715433dc-cb2b-43ea-b6df-c5b4177adc6c,715433dc-cb2b-43ea-b6df-c5b4177adc6c,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,018225,Bumex,BUMETANIDE,2023/12/12,Loop Diuretic,,VALIDUS PHARMACEUTICALS LLC,1983/02/28-,30698-630; 30698-631; 30698-632,0Y2S3XUQ5H,BUMETANIDE,BUMETANIDE,0Y2S3XUQ5H,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/32dfbea3-eb2b-4070-8605-57ce3e6d5a2f/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=32dfbea3-eb2b-4070-8605-57ce3e6d5a2f,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=32dfbea3-eb2b-4070-8605-57ce3e6d5a2f,32dfbea3-eb2b-4070-8605-57ce3e6d5a2f,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SUSPENSION, LIPOSOMAL",INFILTRATION,NDA,022496,EXPAREL,BUPIVACAINE,2023/11/30,Amide Local Anesthetic,1972,PACIRA PHARMACEUTICALS INC,2012/01/01-; 2016/01/01-,65250-133; 65250-266,Y8335394RO,BUPIVACAINE,BUPIVACAINE,Y8335394RO,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/bb5a9e59-0f51-11df-8a39-0800200c9a66/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=bb5a9e59-0f51-11df-8a39-0800200c9a66,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=bb5a9e59-0f51-11df-8a39-0800200c9a66,bb5a9e59-0f51-11df-8a39-0800200c9a66,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INFILTRATION,NDA,204803,POSIMIR,BUPIVACAINE,2022/12/13,Amide Local Anesthetic,,RENAISSANCE LAKEWOOD LLC,2022/05/31-,49396-6601,Y8335394RO,BUPIVACAINE,BUPIVACAINE,Y8335394RO,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/efb90d91-f984-294d-e053-2a95a90ad3c4/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=efb90d91-f984-294d-e053-2a95a90ad3c4,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=efb90d91-f984-294d-e053-2a95a90ad3c4,efb90d91-f984-294d-e053-2a95a90ad3c4,,,
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION,INFILTRATION,NDA,204803,POSIMIR,BUPIVACAINE,2022/12/12,Amide Local Anesthetic,1972,INNOCOLL PHARMACEUTICALS,2022/05/31-,51715-660,Y8335394RO,BUPIVACAINE,BUPIVACAINE,Y8335394RO,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/dbc4df8d-62ba-4893-9c0c-90cbc4c4ca39/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=dbc4df8d-62ba-4893-9c0c-90cbc4c4ca39,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=dbc4df8d-62ba-4893-9c0c-90cbc4c4ca39,dbc4df8d-62ba-4893-9c0c-90cbc4c4ca39,,,
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION,INFILTRATION,NDA,211988,ZYNRELEF,BUPIVACAINE AND MELOXICAM,2024/02/01,Amide Local Anesthetic; Nonsteroidal Anti-inflammatory Drug,2021,HERON THERAPEUTICS INC,2021/07/01-,47426-301; 47426-302; 47426-303; 47426-304,VG2QF83CGL; Y8335394RO,BUPIVACAINE; MELOXICAM,BUPIVACAINE; MELOXICAM,VG2QF83CGL; Y8335394RO,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/dab484a7-9353-43ba-9e74-7fab910c712b/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=dab484a7-9353-43ba-9e74-7fab910c712b,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=dab484a7-9353-43ba-9e74-7fab910c712b,dab484a7-9353-43ba-9e74-7fab910c712b,,,
HUMAN PRESCRIPTION DRUG LABEL,IMPLANT,PARENTERAL,NDA,209511,XARACOLL,BUPIVACAINE HCL COLLAGEN-MATRIX,2020/09/08,Amide Local Anesthetic,1972,INNOCOLL PHARMACEUTICALS,2020/08/28-,51715-100,Y8335394RO,BUPIVACAINE,BUPIVACAINE,Y8335394RO,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/46da5733-c892-43a5-b826-1898a753f1c3/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=46da5733-c892-43a5-b826-1898a753f1c3,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=46da5733-c892-43a5-b826-1898a753f1c3,46da5733-c892-43a5-b826-1898a753f1c3,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",EPIDURAL; RETROBULBAR,NDA,016964,Durapren 0.75%,BUPIVACAINE HYDROCHLORIDE,2022/02/22,Amide Local Anesthetic,,IT MEDICAL LLC,2017/03/01-,70529-007,7TQO7W3VT8,BUPIVACAINE HYDROCHLORIDE,BUPIVACAINE,Y8335394RO,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/290b9588-05a0-457e-bc65-7684eaff4057/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=290b9588-05a0-457e-bc65-7684eaff4057,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=290b9588-05a0-457e-bc65-7684eaff4057,290b9588-05a0-457e-bc65-7684eaff4057,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",EPIDURAL; INTRACAUDAL; PERINEURAL,NDA,016964,Durapren 0.5%,BUPIVACAINE HYDROCHLORIDE,2022/02/22,Amide Local Anesthetic,,IT MEDICAL LLC,2017/03/01-,70529-005,7TQO7W3VT8,BUPIVACAINE HYDROCHLORIDE,BUPIVACAINE,Y8335394RO,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/ed820739-b9f4-454b-b8b7-a9df81f24c4e/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ed820739-b9f4-454b-b8b7-a9df81f24c4e,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=ed820739-b9f4-454b-b8b7-a9df81f24c4e,ed820739-b9f4-454b-b8b7-a9df81f24c4e,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",EPIDURAL; INFILTRATION; INTRACAUDAL; PERINEURAL,NDA,016964,Marcaine with Epinephrine,BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE,2024/02/02,Amide Local Anesthetic; Catecholamine; alpha-Adrenergic Agonist; beta-Adrenergic Agonist,1972,HOSPIRA INC,2022/09/06-; 2022/09/26-,0409-1541; 0409-3812; 0409-4208; 0409-5738; 0409-6581; 0409-8126,30Q7KI53AK; 7TQO7W3VT8,BUPIVACAINE HYDROCHLORIDE; EPINEPHRINE BITARTRATE,BUPIVACAINE; EPINEPHRINE,Y8335394RO; YKH834O4BH,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/93cf0914-de08-4ec6-8f8c-d663243b9958/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=93cf0914-de08-4ec6-8f8c-d663243b9958,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=93cf0914-de08-4ec6-8f8c-d663243b9958,93cf0914-de08-4ec6-8f8c-d663243b9958,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",SUBARACHNOID,NDA,018692,Marcaine Spinal,BUPIVACAINE HYDROCHLORIDE IN DEXTROSE,2024/05/23,Amide Local Anesthetic,1984,HOSPIRA INC,2005/05/19-,0409-1761,7TQO7W3VT8,BUPIVACAINE HYDROCHLORIDE,BUPIVACAINE,Y8335394RO,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/9679cc05-2f8a-4e88-53b5-6e9122c8b8c0/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9679cc05-2f8a-4e88-53b5-6e9122c8b8c0,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=9679cc05-2f8a-4e88-53b5-6e9122c8b8c0,9679cc05-2f8a-4e88-53b5-6e9122c8b8c0,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",EPIDURAL; INFILTRATION; INTRACAUDAL; PERINEURAL; RETROBULBAR,NDA,016964,Marcaine; Marcaine with Epinephrine,BUPIVACAINE HYDROCHLORIDE; BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE,2024/02/02,Amide Local Anesthetic; Catecholamine; alpha-Adrenergic Agonist; beta-Adrenergic Agonist,1972,HOSPIRA INC,2005/07/27-; 2005/08/16-; 2005/08/23-; 2005/09/12-; 2005/11/30-,0409-1559; 0409-1560; 0409-1582; 0409-1587; 0409-1610; 0409-1746; 0409-1749; 0409-1752; 0409-1755,30Q7KI53AK; 7TQO7W3VT8,BUPIVACAINE HYDROCHLORIDE; EPINEPHRINE BITARTRATE,BUPIVACAINE; EPINEPHRINE,Y8335394RO; YKH834O4BH,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/67578b56-7540-487e-1fba-481255620e78/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=67578b56-7540-487e-1fba-481255620e78,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=67578b56-7540-487e-1fba-481255620e78,67578b56-7540-487e-1fba-481255620e78,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",EPIDURAL; INFILTRATION; INTRACAUDAL; PERINEURAL; RETROBULBAR,NDA,018304,SENSORCAINE; SENSORCAINE MPF,BUPIVACAINE HYDROCHLORIDE; BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE,2019/07/12,Amide Local Anesthetic; Catecholamine; alpha-Adrenergic Agonist; beta-Adrenergic Agonist,,FRESENIUS KABI USA LLC,2010/11/19-,63323-460; 63323-462; 63323-464; 63323-465; 63323-466; 63323-467,30Q7KI53AK; 7TQO7W3VT8,BUPIVACAINE HYDROCHLORIDE; EPINEPHRINE BITARTRATE,BUPIVACAINE; EPINEPHRINE,Y8335394RO; YKH834O4BH,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/eb6d8fee-def4-4c96-9972-695e8cea8ea8/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=eb6d8fee-def4-4c96-9972-695e8cea8ea8,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=eb6d8fee-def4-4c96-9972-695e8cea8ea8,eb6d8fee-def4-4c96-9972-695e8cea8ea8,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,SUBCUTANEOUS,NDA,210136,BRIXADI,BUPRENORPHINE,2023/12/28,Partial Opioid Agonist,2002,BRAEBURN INC,2023/06/06-,58284-208; 58284-216; 58284-224; 58284-228; 58284-232; 58284-264; 58284-296,40D3SCR4GZ,BUPRENORPHINE,BUPRENORPHINE,40D3SCR4GZ,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/5d8a8fd0-8619-422a-a664-d1d2e8970f48/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5d8a8fd0-8619-422a-a664-d1d2e8970f48,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=5d8a8fd0-8619-422a-a664-d1d2e8970f48,5d8a8fd0-8619-422a-a664-d1d2e8970f48,,,
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION,SUBCUTANEOUS,NDA,209819,SUBLOCADE,BUPRENORPHINE,2023/12/18,Partial Opioid Agonist,2002,INDIVIOR INC,2018/02/26-,12496-0100; 12496-0300,40D3SCR4GZ,buprenorphine,buprenorphine,40D3SCR4GZ,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/6189fb21-9432-45f8-8481-0bfaf3ccde95/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6189fb21-9432-45f8-8481-0bfaf3ccde95,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=6189fb21-9432-45f8-8481-0bfaf3ccde95,6189fb21-9432-45f8-8481-0bfaf3ccde95,,,
HUMAN PRESCRIPTION DRUG LABEL,"PATCH, EXTENDED RELEASE",TRANSDERMAL,NDA,021306,Butrans,BUPRENORPHINE,2023/12/18,Partial Opioid Agonist,1981,PURDUE PHARMA LP,2011/02/14-,59011-750; 59011-751; 59011-752; 59011-757; 59011-758,40D3SCR4GZ,buprenorphine,buprenorphine,40D3SCR4GZ,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/794aa355-66de-41b8-aedf-f2c40f6bc664/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=794aa355-66de-41b8-aedf-f2c40f6bc664,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=794aa355-66de-41b8-aedf-f2c40f6bc664,794aa355-66de-41b8-aedf-f2c40f6bc664,,,
HUMAN PRESCRIPTION DRUG LABEL,"FILM, SOLUBLE",BUCCAL,NDA,207932,BELBUCA,BUPRENORPHINE HYDROCHLORIDE,2023/12/21,Partial Opioid Agonist,1981,BIODELIVERY SCIENCES INTERNATIONAL INC,2017/08/11-; 2017/08/21-; 2017/08/24-; 2017/09/01-; 2017/10/01-,59385-021; 59385-022; 59385-023; 59385-024; 59385-025; 59385-026; 59385-027,56W8MW3EN1,buprenorphine hydrochloride,buprenorphine,40D3SCR4GZ,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/bc2b7a3d-72cf-497c-95b0-ba2b71f63c64/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=bc2b7a3d-72cf-497c-95b0-ba2b71f63c64,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=bc2b7a3d-72cf-497c-95b0-ba2b71f63c64,bc2b7a3d-72cf-497c-95b0-ba2b71f63c64,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, ORALLY DISINTEGRATING",SUBLINGUAL,NDA,204242,Zubsolv,BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE,2023/12/17,Opioid Antagonist; Partial Opioid Agonist,2002,OREXO US INC,2013/07/04-; 2014/12/11-,54123-114; 54123-907; 54123-914; 54123-929; 54123-957; 54123-986,56W8MW3EN1; F850569PQR,BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE,BUPRENORPHINE; NALOXONE,36B82AMQ7N; 40D3SCR4GZ,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/5f5cfcfe-d52b-49e6-8fe4-550477332dd2/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5f5cfcfe-d52b-49e6-8fe4-550477332dd2,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=5f5cfcfe-d52b-49e6-8fe4-550477332dd2,5f5cfcfe-d52b-49e6-8fe4-550477332dd2,,,
HUMAN PRESCRIPTION DRUG LABEL,"FILM, SOLUBLE",BUCCAL; SUBLINGUAL,NDA,022410,Suboxone,"BUPRENORPHINE HYDROCHLORIDE, NALOXONE HYDROCHLORIDE",2023/12/18,Opioid Antagonist; Partial Opioid Agonist,2002,INDIVIOR INC,2010/09/13-; 2012/08/24-,12496-1202; 12496-1204; 12496-1208; 12496-1212,56W8MW3EN1; F850569PQR,buprenorphine hydrochloride; naloxone hydrochloride,buprenorphine; naloxone,36B82AMQ7N; 40D3SCR4GZ,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/8a5edcf9-828c-4f97-b671-268ab13a8ecd/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8a5edcf9-828c-4f97-b671-268ab13a8ecd,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=8a5edcf9-828c-4f97-b671-268ab13a8ecd,8a5edcf9-828c-4f97-b671-268ab13a8ecd,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, EXTENDED RELEASE",ORAL,NDA,022108,Aplenzin,BUPROPION HYDROBROMIDE,2024/03/01,Aminoketone,1985,BAUSCH HEALTH US LLC,2008/04/23-,0187-5810; 0187-5811; 0187-5812,E70G3G5863,BUPROPION HYDROBROMIDE,BUPROPION,01ZG3TPX31,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/6494d2d9-0ce4-4126-b1c7-49684395942b/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6494d2d9-0ce4-4126-b1c7-49684395942b,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=6494d2d9-0ce4-4126-b1c7-49684395942b,6494d2d9-0ce4-4126-b1c7-49684395942b,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, EXTENDED RELEASE",ORAL,NDA,021515,WELLBUTRIN XL,BUPROPION HYDROCHLORIDE,2024/05/13,Aminoketone,1985,BAUSCH HEALTH US LLC,2003/08/29-,0187-0730; 0187-0731,ZG7E5POY8O,BUPROPION HYDROCHLORIDE,BUPROPION,01ZG3TPX31,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/a435da9d-f6e8-4ddc-897d-8cd2bf777b21/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a435da9d-f6e8-4ddc-897d-8cd2bf777b21,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=a435da9d-f6e8-4ddc-897d-8cd2bf777b21,a435da9d-f6e8-4ddc-897d-8cd2bf777b21,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,NDA,022497,Forfivo XL,BUPROPION HYDROCHLORIDE,2024/05/13,Aminoketone,1985,TWI PHARMACEUTICALS INC,2023/12/15-,24979-247,ZG7E5POY8O,BUPROPION HYDROCHLORIDE,BUPROPION,01ZG3TPX31,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/80b01182-dc94-4990-8ebb-55c306d7e536/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=80b01182-dc94-4990-8ebb-55c306d7e536,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=80b01182-dc94-4990-8ebb-55c306d7e536,80b01182-dc94-4990-8ebb-55c306d7e536,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,NDA,022497,Forfivo XL,BUPROPION HYDROCHLORIDE,2024/04/29,Aminoketone,1985,ALMATICA PHARMA INC,completed:2017/05/15-2025/01/01,52427-575,ZG7E5POY8O,BUPROPION HYDROCHLORIDE,BUPROPION,01ZG3TPX31,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/6917be04-3eff-be1f-99cc-1a20093a6ef0/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6917be04-3eff-be1f-99cc-1a20093a6ef0,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=6917be04-3eff-be1f-99cc-1a20093a6ef0,6917be04-3eff-be1f-99cc-1a20093a6ef0,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,020358,WELLBUTRIN SR,BUPROPION HYDROCHLORIDE,2024/04/22,Aminoketone,1985,GLAXOSMITHKLINE LLC,1996/11/15-; 2002/06/25-,0173-0135; 0173-0722; 0173-0947,ZG7E5POY8O,BUPROPION HYDROCHLORIDE; bupropion hydrochloride,BUPROPION; bupropion,01ZG3TPX31,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/cbc8c074-f080-4489-a5ae-207b5fadeba3/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=cbc8c074-f080-4489-a5ae-207b5fadeba3,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=cbc8c074-f080-4489-a5ae-207b5fadeba3,cbc8c074-f080-4489-a5ae-207b5fadeba3,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRAVENOUS,NDA,020954,BUSULFEX,BUSULFAN,2023/12/14,Alkylating Drug,1999,OTSUKA AMERICA PHARMACEUTICAL INC,1999/02/04-,59148-070,G1LN9045DK,Busulfan,Busulfan,G1LN9045DK,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/5cb9d285-1803-4a99-946a-d0b239b32df6/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5cb9d285-1803-4a99-946a-d0b239b32df6,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=5cb9d285-1803-4a99-946a-d0b239b32df6,5cb9d285-1803-4a99-946a-d0b239b32df6,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,009386,MYLERAN,BUSULFAN,2023/05/15,Alkylating Drug,,WAYLIS THERAPEUTICS LLC,2023/05/15-,80725-620,G1LN9045DK,BUSULFAN,BUSULFAN,G1LN9045DK,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/2da33e5b-dcfb-4cdf-b163-50398e42f41c/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2da33e5b-dcfb-4cdf-b163-50398e42f41c,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=2da33e5b-dcfb-4cdf-b163-50398e42f41c,2da33e5b-dcfb-4cdf-b163-50398e42f41c,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,009386,MYLERAN,BUSULFAN,2022/12/29,Alkylating Drug,,WOODWARD PHARMA SERVICES LLC,2022/06/30-,69784-620,G1LN9045DK,BUSULFAN,BUSULFAN,G1LN9045DK,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/00ca5f69-8944-47f8-8ebf-98b0b8062c20/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=00ca5f69-8944-47f8-8ebf-98b0b8062c20,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=00ca5f69-8944-47f8-8ebf-98b0b8062c20,00ca5f69-8944-47f8-8ebf-98b0b8062c20,,,
HUMAN PRESCRIPTION DRUG LABEL,KIT,INTRAVENOUS,NDA,201023,Jevtana,CABAZITAXEL,2023/07/14,Microtubule Inhibitor,2010,SANOFI AVENTIS U S LLC,2010/06/17-,0024-5824,51F690397J,cabazitaxel,cabazitaxel,51F690397J,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/de3d9c26-572b-4ea4-9b2d-dd58a2b3e8fa/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=de3d9c26-572b-4ea4-9b2d-dd58a2b3e8fa,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=de3d9c26-572b-4ea4-9b2d-dd58a2b3e8fa,de3d9c26-572b-4ea4-9b2d-dd58a2b3e8fa,,,
HUMAN PRESCRIPTION DRUG LABEL,KIT,INTRAMUSCULAR,NDA,215499,Apretude,CABOTEGRAVIR,2023/12/13,Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor,2021,VIIV HEALTHCARE COMPANY,2021/12/20-; 2024/03/31-,49702-264; 49702-280,HMH0132Z1Q,CABOTEGRAVIR,CABOTEGRAVIR,HMH0132Z1Q,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/4338428e-43d4-4e02-ac9d-bd98e738a7da/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4338428e-43d4-4e02-ac9d-bd98e738a7da,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=4338428e-43d4-4e02-ac9d-bd98e738a7da,4338428e-43d4-4e02-ac9d-bd98e738a7da,,,
HUMAN PRESCRIPTION DRUG LABEL,KIT,INTRAMUSCULAR,NDA,212888,Cabenuva,CABOTEGRAVIR AND RILPIVIRINE,2023/12/13,Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor; Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor,2021,VIIV HEALTHCARE COMPANY,2021/01/21-,49702-240; 49702-253,FI96A8X663; HMH0132Z1Q,CABOTEGRAVIR; RILPIVIRINE,CABOTEGRAVIR; RILPIVIRINE,FI96A8X663; HMH0132Z1Q,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/1698baf3-f895-4c42-a1b1-e9ee3f20da36/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1698baf3-f895-4c42-a1b1-e9ee3f20da36,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=1698baf3-f895-4c42-a1b1-e9ee3f20da36,1698baf3-f895-4c42-a1b1-e9ee3f20da36,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,212887,Vocabria,CABOTEGRAVIR SODIUM,2023/12/13,Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor,2021,VIIV HEALTHCARE COMPANY,2021/01/21-,49702-248,3L12PT535M,CABOTEGRAVIR SODIUM,CABOTEGRAVIR,HMH0132Z1Q,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/66d450fb-cca4-476c-b0c7-c0730e3e4cf3/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=66d450fb-cca4-476c-b0c7-c0730e3e4cf3,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=66d450fb-cca4-476c-b0c7-c0730e3e4cf3,66d450fb-cca4-476c-b0c7-c0730e3e4cf3,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,208692,CABOMETYX,CABOZANTINIB,2023/09/29,Kinase Inhibitor,2012,EXELIXIS INC,2016/04/25-,42388-023; 42388-024; 42388-025,DR7ST46X58,cabozantinib s-malate,CABOZANTINIB,1C39JW444G,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/3850cce2-6137-42e5-a792-d318c4a4b3b5/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3850cce2-6137-42e5-a792-d318c4a4b3b5,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=3850cce2-6137-42e5-a792-d318c4a4b3b5,3850cce2-6137-42e5-a792-d318c4a4b3b5,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE; KIT,ORAL,NDA,203756,COMETRIQ,CABOZANTINIB,2023/08/23,Kinase Inhibitor,2012,EXELIXIS INC,2012/11/29-,42388-011; 42388-012; 42388-013,DR7ST46X58,cabozantinib s-malate,cabozantinib,1C39JW444G,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/1a0c3bea-c87b-4d25-bb44-5f0174da6b34/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1a0c3bea-c87b-4d25-bb44-5f0174da6b34,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=1a0c3bea-c87b-4d25-bb44-5f0174da6b34,1a0c3bea-c87b-4d25-bb44-5f0174da6b34,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRAVENOUS,NDA,020793,Caffeine Citrate,CAFFEINE CITRATE,2024/04/08,Central Nervous System Stimulant; Methylxanthine,,HIKMA PHARMACEUTICALS USA INC,2024/01/11-,0641-6267,U26EO4675Q,CAFFEINE CITRATE,CAFFEINE,3G6A5W338E,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/21489401-f2a7-47d3-897a-4b7efa04dd7a/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=21489401-f2a7-47d3-897a-4b7efa04dd7a,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=21489401-f2a7-47d3-897a-4b7efa04dd7a,21489401-f2a7-47d3-897a-4b7efa04dd7a,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRAVENOUS,NDA,020793,Caffeine Citrate,CAFFEINE CITRATE,2024/02/07,Central Nervous System Stimulant; Methylxanthine,,HIKMA PHARMACEUTICALS USA INC,2008/11/04-,0641-6164,U26EO4675Q,CAFFEINE CITRATE,CAFFEINE,3G6A5W338E,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/f9feb925-e1b8-41bc-b9c5-89198f07c0e9/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f9feb925-e1b8-41bc-b9c5-89198f07c0e9,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=f9feb925-e1b8-41bc-b9c5-89198f07c0e9,f9feb925-e1b8-41bc-b9c5-89198f07c0e9,,,
HUMAN PRESCRIPTION DRUG LABEL,"CAPSULE, EXTENDED RELEASE",ORAL,NDA,208010,Rayaldee,CALCIFEDIOL,2024/01/19,Vitamin D3 Analog,2016,OPKO PHARMACEUTICALS LLC,2016/10/25-; 2024/03/11-,70301-1001; 70301-1002,P6YZ13C99Q,CALCIFEDIOL,CALCIFEDIOL ANHYDROUS,T0WXW8F54E,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/6a95effd-32a5-46b6-a30e-7f4f9bf8cc77/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6a95effd-32a5-46b6-a30e-7f4f9bf8cc77,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=6a95effd-32a5-46b6-a30e-7f4f9bf8cc77,6a95effd-32a5-46b6-a30e-7f4f9bf8cc77,,,
HUMAN PRESCRIPTION DRUG LABEL,"AEROSOL, FOAM",TOPICAL,NDA,022563,calcipotriene,CALCIPOTRIENE,2024/05/09,Vitamin D Analog,1993,MAYNE PHARMA,2021/02/15-,51862-512,143NQ3779B,calcipotriene,calcipotriene,143NQ3779B,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/26756ac7-a80c-49db-97bb-351f76ad8a71/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=26756ac7-a80c-49db-97bb-351f76ad8a71,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=26756ac7-a80c-49db-97bb-351f76ad8a71,26756ac7-a80c-49db-97bb-351f76ad8a71,,,
HUMAN PRESCRIPTION DRUG LABEL,"AEROSOL, FOAM",TOPICAL,NDA,022563,SORILUX,CALCIPOTRIENE,2024/05/09,Vitamin D Analog,1993,MAYNE PHARMA,2017/04/11-,51862-376,143NQ3779B,calcipotriene,calcipotriene,143NQ3779B,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/51f208d0-7b3f-44cc-8bed-92fa3d2e7bbe/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=51f208d0-7b3f-44cc-8bed-92fa3d2e7bbe,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=51f208d0-7b3f-44cc-8bed-92fa3d2e7bbe,51f208d0-7b3f-44cc-8bed-92fa3d2e7bbe,,,
HUMAN PRESCRIPTION DRUG LABEL,CREAM,TOPICAL,NDA,213422,Wynzora,CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE,2023/11/29,Corticosteroid; Vitamin D Analog,2020,MC THERAPEUTICS LTD,2021/06/30-,73499-001,143NQ3779B; 826Y60901U,Betamethasone dipropionate; Calcipotriene,Betamethasone; Calcipotriene,143NQ3779B; 9842X06Q6M,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/36c5c818-0d40-445e-a3c0-0f46723a25e2/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=36c5c818-0d40-445e-a3c0-0f46723a25e2,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=36c5c818-0d40-445e-a3c0-0f46723a25e2,36c5c818-0d40-445e-a3c0-0f46723a25e2,,,
HUMAN PRESCRIPTION DRUG LABEL,OINTMENT,TOPICAL,NDA,021852,Taclonex,CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE,2022/05/24,Corticosteroid; Vitamin D Analog,2006,LEO PHARMA INC,completed:2008/06/01-2024/10/31,50222-227,826Y60901U; S7499TYY6G,BETAMETHASONE DIPROPIONATE; CALCIPOTRIENE MONOHYDRATE,BETAMETHASONE; CALCIPOTRIENE,143NQ3779B; 9842X06Q6M,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/ef43ba2d-20ce-4415-b5c2-e486b836812e/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ef43ba2d-20ce-4415-b5c2-e486b836812e,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=ef43ba2d-20ce-4415-b5c2-e486b836812e,ef43ba2d-20ce-4415-b5c2-e486b836812e,,,
HUMAN PRESCRIPTION DRUG LABEL,"AEROSOL, FOAM",TOPICAL,NDA,207589,ENSTILAR,CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE,2021/10/18,Corticosteroid; Vitamin D Analog,2006,LEO PHARMA INC,2015/10/16-,50222-302,826Y60901U; S7499TYY6G,BETAMETHASONE DIPROPIONATE; CALCIPOTRIENE MONOHYDRATE,BETAMETHASONE; CALCIPOTRIENE,143NQ3779B; 9842X06Q6M,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/d1193df2-d53f-4342-bd9d-d9cba7c89709/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d1193df2-d53f-4342-bd9d-d9cba7c89709,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=d1193df2-d53f-4342-bd9d-d9cba7c89709,d1193df2-d53f-4342-bd9d-d9cba7c89709,,,
HUMAN PRESCRIPTION DRUG LABEL,SUSPENSION,TOPICAL,NDA,022185,TACLONEX,CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE,2017/11/30,Corticosteroid; Vitamin D Analog,2006,LEO PHARMA INC,2008/06/01-,50222-501,826Y60901U; S7499TYY6G,BETAMETHASONE DIPROPIONATE; CALCIPOTRIENE HYDRATE,BETAMETHASONE; CALCIPOTRIENE,143NQ3779B; 9842X06Q6M,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/757c914f-dd8d-43cc-a973-212d591af4af/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=757c914f-dd8d-43cc-a973-212d591af4af,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=757c914f-dd8d-43cc-a973-212d591af4af,757c914f-dd8d-43cc-a973-212d591af4af,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAMUSCULAR; SUBCUTANEOUS,NDA,017808,Miacalcin,CALCITONIN SALMON,2021/08/15,Calcitonin,1975,MYLAN INSTITUTIONAL LLC,2022/06/16-,72078-038,7SFC6U2VI5,CALCITONIN SALMON,CALCITONIN SALMON,7SFC6U2VI5,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/753ecc6a-07be-4fc6-9032-cc6ad116a662/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=753ecc6a-07be-4fc6-9032-cc6ad116a662,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=753ecc6a-07be-4fc6-9032-cc6ad116a662,753ecc6a-07be-4fc6-9032-cc6ad116a662,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAMUSCULAR; SUBCUTANEOUS,NDA,017808,Miacalcin,CALCITONIN SALMON,2021/08/15,Calcitonin,1975,MYLAN INSTITUTIONAL LLC,2022/07/18-,72078-039,7SFC6U2VI5,CALCITONIN SALMON,CALCITONIN SALMON,7SFC6U2VI5,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/26caf31f-7f7c-48a8-a1ac-35d2ceefda2b/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=26caf31f-7f7c-48a8-a1ac-35d2ceefda2b,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=26caf31f-7f7c-48a8-a1ac-35d2ceefda2b,26caf31f-7f7c-48a8-a1ac-35d2ceefda2b,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAMUSCULAR; SUBCUTANEOUS,NDA,017808,Miacalcin,CALCITONIN SALMON,2021/08/15,Calcitonin,1975,MYLAN INSTITUTIONAL LLC,2016/09/16-,67457-675,7SFC6U2VI5,CALCITONIN SALMON,CALCITONIN SALMON,7SFC6U2VI5,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/89cd4f46-b88a-4c10-b25c-47352280dc4e/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=89cd4f46-b88a-4c10-b25c-47352280dc4e,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=89cd4f46-b88a-4c10-b25c-47352280dc4e,89cd4f46-b88a-4c10-b25c-47352280dc4e,,,
HUMAN PRESCRIPTION DRUG LABEL,"CAPSULE, GELATIN COATED; SOLUTION",ORAL,NDA,018044;021068,Rocaltrol,CALCITRIOL,2023/12/15,Vitamin D3 Analog,,VALIDUS PHARMACEUTICALS LLC,2009/07/23-; 2009/08/20-,30698-143; 30698-144; 30698-911,FXC9231JVH,CALCITRIOL,CALCITRIOL,FXC9231JVH,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/d1013494-bf62-4e68-9f0c-e6571137f20f/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d1013494-bf62-4e68-9f0c-e6571137f20f,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=d1013494-bf62-4e68-9f0c-e6571137f20f,d1013494-bf62-4e68-9f0c-e6571137f20f,,,
HUMAN PRESCRIPTION DRUG LABEL,OINTMENT,TOPICAL,NDA,022087,Vectical,CALCITRIOL,2022/10/31,Vitamin D3 Analog,1978,GALDERMA LABORATORIES L P,2009/02/01-,0299-2012,FXC9231JVH,CALCITRIOL,CALCITRIOL,FXC9231JVH,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/a1567da9-af74-4afd-9ac5-8b53ec5d7cbf/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a1567da9-af74-4afd-9ac5-8b53ec5d7cbf,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=a1567da9-af74-4afd-9ac5-8b53ec5d7cbf,a1567da9-af74-4afd-9ac5-8b53ec5d7cbf,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS; INTRAVENTRICULAR,NDA; Unapproved drug other,021117,Calcium Chloride,CALCIUM CHLORIDE,2023/05/31,,1938,HOSPIRA INC,2005/09/14-; 2006/01/24-,0409-1631; 0409-4928,M4I0D6VV5M,CALCIUM CHLORIDE,CALCIUM CATION; CHLORIDE ION,2M83C4R6ZB; Q32ZN48698,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/c4c65e48-85f8-4dcf-6281-06e40959cc79/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c4c65e48-85f8-4dcf-6281-06e40959cc79,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=c4c65e48-85f8-4dcf-6281-06e40959cc79,c4c65e48-85f8-4dcf-6281-06e40959cc79,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRAVENOUS,NDA,021703;207026,PHOXILLUM B22K4/0; PHOXILLUM BK4/2.5; PRISMASOL B22GK4/0; PRISMASOL BGK0/2.5; PRISMASOL BGK2/0; PRISMASOL BGK2/3.5; PRISMASOL BGK4/0/1.2; PRISMASOL BGK4/2.5; PRISMASOL BK0/0/1.2,"CALCIUM CHLORIDE, MAGNESIUM CHLORIDE, DEXTROSE MONOHYDRATE, LACTIC ACID, SODIUM CHLORIDE AND SODIUM BICARBONATE; CALCIUM CHLORIDE, MAGNESIUM CHLORIDE, DEXTROSE MONOHYDRATE, LACTIC ACID, SODIUM CHLORIDE, SODIUM BICARBONATE AND POTASSIUM CHLORIDE; CALCIUM CHLORIDE, MAGNESIUM CHLORIDE, SODIUM CHLORIDE, SODIUM BICARBONATE, POTASSIUM CHLORIDE AND SODIUM PHOSPHATE DIBASIC DIHYDRATE; MAGNESIUM CHLORIDE, DEXTROSE MONOHYDRATE, LACTIC ACID, SODIUM CHLORIDE, SODIUM BICARBONATE AND POTASSIUM CHLORIDE; MAGNESIUM CHLORIDE, LACTIC ACID, SODIUM CHLORIDE AND SODIUM BICARBONATE; MAGNESIUM CHLORIDE, SODIUM CHLORIDE, SODIUM BICARBONATE, POTASSIUM CHLORIDE AND SODIUM PHOSPHATE DIBASIC DIHYDRATE",2023/05/02,,2006,BAXTER HEALTHCARE CORPORATION,2006/10/25-; 2015/01/13-,24571-102; 24571-103; 24571-105; 24571-108; 24571-111; 24571-113; 24571-114; 24571-116; 24571-117,02F3473H9O; 33X04XA5AT; 451W47IQ8X; 660YQ98I10; 8MDF5V39QO; 94255I6E2T; LX22YL083G; M4I0D6VV5M,"CALCIUM CHLORIDE; DEXTROSE MONOHYDRATE; LACTIC ACID, UNSPECIFIED FORM; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE; SODIUM PHOSPHATE, DIBASIC, DIHYDRATE","ANHYDROUS DEXTROSE; BICARBONATE ION; CALCIUM CATION; CHLORIDE ION; LACTIC ACID, UNSPECIFIED FORM; MAGNESIUM CATION; PHOSPHATE ION; POTASSIUM CATION; SODIUM CATION",295O53K152; 2M83C4R6ZB; 33X04XA5AT; 5SL0G7R0OK; HN1ZRA3Q20; LYR4M0NH37; NK08V8K8HR; Q32ZN48698; T6V3LHY838,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/7f675fee-8940-4ece-bb0c-75ac79d8708c/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7f675fee-8940-4ece-bb0c-75ac79d8708c,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=7f675fee-8940-4ece-bb0c-75ac79d8708c,7f675fee-8940-4ece-bb0c-75ac79d8708c,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,208418,Calcium Gluconate,CALCIUM GLUCONATE,2024/05/06,Blood Coagulation Factor; Phosphate Binder,1941,FRESENIUS KABI USA LLC,2021/06/17-,65219-162; 65219-164,CZN0MI5R31,CALCIUM GLUCONATE MONOHYDRATE,CALCIUM CATION,2M83C4R6ZB,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/7f5101e0-abf9-4fcf-8986-c799e3333434/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7f5101e0-abf9-4fcf-8986-c799e3333434,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=7f5101e0-abf9-4fcf-8986-c799e3333434,7f5101e0-abf9-4fcf-8986-c799e3333434,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,210906,Calcium Gluconate in Sodium Chloride,CALCIUM GLUCONATE,2024/02/12,Blood Coagulation Factor; Phosphate Binder,1941,WG CRITICAL CARE LLC,2018/10/26-,44567-620; 44567-621,CZN0MI5R31,CALCIUM GLUCONATE MONOHYDRATE,CALCIUM CATION,2M83C4R6ZB,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/0deed071-d89d-420e-b4b4-797dce0ad8f0/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0deed071-d89d-420e-b4b4-797dce0ad8f0,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=0deed071-d89d-420e-b4b4-797dce0ad8f0,0deed071-d89d-420e-b4b4-797dce0ad8f0,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,210906,Calcium Gluconate in Sodium Chloride,CALCIUM GLUCONATE,2023/09/18,Blood Coagulation Factor; Phosphate Binder,1941,WG CRITICAL CARE LLC,2018/10/26-; 2021/07/13-,44567-620; 44567-621; 44567-622,CZN0MI5R31,CALCIUM GLUCONATE MONOHYDRATE,CALCIUM CATION,2M83C4R6ZB,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/e6d531ec-fcdc-49f6-b0c4-878d3952827f/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e6d531ec-fcdc-49f6-b0c4-878d3952827f,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=e6d531ec-fcdc-49f6-b0c4-878d3952827f,e6d531ec-fcdc-49f6-b0c4-878d3952827f,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,208418,Calcium Gluconate,CALCIUM GLUCONATE,2023/06/28,Blood Coagulation Factor; Phosphate Binder,1941,FRESENIUS KABI USA LLC,2017/06/15-,63323-360,CZN0MI5R31,CALCIUM GLUCONATE MONOHYDRATE,CALCIUM CATION,2M83C4R6ZB,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/8b77c3d2-992d-4261-8421-9cfd07328fbf/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8b77c3d2-992d-4261-8421-9cfd07328fbf,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=8b77c3d2-992d-4261-8421-9cfd07328fbf,8b77c3d2-992d-4261-8421-9cfd07328fbf,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,204042,INVOKANA,CANAGLIFLOZIN,2023/07/12,Sodium-Glucose Cotransporter 2 Inhibitor,2013,JANSSEN PHARMACEUTICALS INC,2013/03/29-,50458-140; 50458-141,0SAC974Z85,CANAGLIFLOZIN,CANAGLIFLOZIN ANHYDROUS,6S49DGR869,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/b9057d3b-b104-4f09-8a61-c61ef9d4a3f3/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b9057d3b-b104-4f09-8a61-c61ef9d4a3f3,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=b9057d3b-b104-4f09-8a61-c61ef9d4a3f3,b9057d3b-b104-4f09-8a61-c61ef9d4a3f3,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED; TABLET, FILM COATED, EXTENDED RELEASE",ORAL,NDA,204353;205879,INVOKAMET; INVOKAMET XR,CANAGLIFLOZIN AND METFORMIN HYDROCHLORIDE,2024/01/30,Biguanide; Sodium-Glucose Cotransporter 2 Inhibitor,2014,JANSSEN PHARMACEUTICALS INC,2014/08/08-; 2016/09/20-,50458-540; 50458-541; 50458-542; 50458-543; 50458-940; 50458-941; 50458-942; 50458-943,0SAC974Z85; 786Z46389E,CANAGLIFLOZIN; METFORMIN HYDROCHLORIDE,CANAGLIFLOZIN ANHYDROUS; METFORMIN,6S49DGR869; 9100L32L2N,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/6868666b-c25e-40d1-9d1f-306bbe9390c1/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6868666b-c25e-40d1-9d1f-306bbe9390c1,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=6868666b-c25e-40d1-9d1f-306bbe9390c1,6868666b-c25e-40d1-9d1f-306bbe9390c1,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,020838,ATACAND,CANDESARTAN CILEXETIL,2020/06/19,Angiotensin 2 Receptor Blocker,1998,ANI PHARMACEUTICALS INC,2018/10/01-,62559-640; 62559-641; 62559-642; 62559-643,R85M2X0D68,CANDESARTAN CILEXETIL,CANDESARTAN,S8Q36MD2XX,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/94a59260-d2b6-464a-b5b9-bbc599e57e10/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=94a59260-d2b6-464a-b5b9-bbc599e57e10,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=94a59260-d2b6-464a-b5b9-bbc599e57e10,94a59260-d2b6-464a-b5b9-bbc599e57e10,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,021093,ATACAND HCT,CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE,2020/05/07,Angiotensin 2 Receptor Blocker; Thiazide Diuretic,,ANI PHARMACEUTICALS INC,2018/10/01-,62559-650; 62559-651; 62559-652,0J48LPH2TH; R85M2X0D68,CANDESARTAN CILEXETIL; HYDROCHLOROTHIAZIDE,CANDESARTAN; HYDROCHLOROTHIAZIDE,0J48LPH2TH; S8Q36MD2XX,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/d91152c4-66ba-466f-b4f9-0da628d42b1d/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d91152c4-66ba-466f-b4f9-0da628d42b1d,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=d91152c4-66ba-466f-b4f9-0da628d42b1d,d91152c4-66ba-466f-b4f9-0da628d42b1d,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAVENOUS,NDA,204958,KENGREAL,CANGRELOR,2022/09/06,P2Y12 Platelet Inhibitor,2015,CHIESI USA INC,2015/07/08-,10122-620,6AQ1Y404U7,CANGRELOR,CANGRELOR,6AQ1Y404U7,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/88b434fa-8891-4fd5-9d86-7ea64667c08f/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=88b434fa-8891-4fd5-9d86-7ea64667c08f,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=88b434fa-8891-4fd5-9d86-7ea64667c08f,88b434fa-8891-4fd5-9d86-7ea64667c08f,,,
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION,ORAL,NDA,210365,Epidiolex,CANNABIDIOL,2024/03/13,,2018,JAZZ PHARMACEUTICALS INC,2018/10/05-,70127-100,19GBJ60SN5,CANNABIDIOL,CANNABIDIOL,19GBJ60SN5,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/8bf27097-4870-43fb-94f0-f3d0871d1eec/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8bf27097-4870-43fb-94f0-f3d0871d1eec,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=8bf27097-4870-43fb-94f0-f3d0871d1eec,8bf27097-4870-43fb-94f0-f3d0871d1eec,,,
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION,TOPICAL,NDA,212905,YCANTH,CANTHARIDIN,2024/03/18,,2023,VERRICA PHARMACEUTICALS INC,2023/07/21-,71349-070; 71349-999,IGL471WQ8P,Cantharidin,cantharidin,IGL471WQ8P,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/7c9bdeaa-9822-4c69-a719-ea4a8643f59c/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7c9bdeaa-9822-4c69-a719-ea4a8643f59c,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=7c9bdeaa-9822-4c69-a719-ea4a8643f59c,7c9bdeaa-9822-4c69-a719-ea4a8643f59c,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,020896,Xeloda,CAPECITABINE,2023/12/08,Nucleoside Metabolic Inhibitor,1998,H PHARMA LLC,1998/04/30-,61269-470; 61269-475,6804DJ8Z9U,CAPECITABINE,CAPECITABINE,6804DJ8Z9U,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/e702d84d-7162-4751-bf37-d724cc7e45a5/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e702d84d-7162-4751-bf37-d724cc7e45a5,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=e702d84d-7162-4751-bf37-d724cc7e45a5,e702d84d-7162-4751-bf37-d724cc7e45a5,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,020896,Xeloda,CAPECITABINE,2023/11/28,Nucleoside Metabolic Inhibitor,1998,GENENTECH INC,1998/04/30-,0004-1100; 0004-1101,6804DJ8Z9U,CAPECITABINE,CAPECITABINE,6804DJ8Z9U,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/a1de8bba-3b1d-4c9d-ab8a-32d2c05e67c8/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a1de8bba-3b1d-4c9d-ab8a-32d2c05e67c8,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=a1de8bba-3b1d-4c9d-ab8a-32d2c05e67c8,a1de8bba-3b1d-4c9d-ab8a-32d2c05e67c8,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,218197,TRUQAP,CAPIVASERTIB,2023/11/16,,2023,ASTRAZENECA PHARMACEUTICALS LP,2023/11/16-,0310-9500; 0310-9501,WFR23M21IE,CAPIVASERTIB,CAPIVASERTIB,WFR23M21IE,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/d698c106-2322-401e-b738-cbd83c843ecf/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d698c106-2322-401e-b738-cbd83c843ecf,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=d698c106-2322-401e-b738-cbd83c843ecf,d698c106-2322-401e-b738-cbd83c843ecf,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,213591,TABRECTA,CAPMATINIB,2024/03/14,Kinase Inhibitor,2020,NOVARTIS PHARMACEUTICALS CORPORATION,2020/05/06-,0078-0709; 0078-0716,C2A374O70X,CAPMATINIB HYDROCHLORIDE,CAPMATINIB,TY34L4F9OZ,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/455892c3-d144-4ba8-9ab4-79cabff9876d/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=455892c3-d144-4ba8-9ab4-79cabff9876d,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=455892c3-d144-4ba8-9ab4-79cabff9876d,455892c3-d144-4ba8-9ab4-79cabff9876d,,,
HUMAN PRESCRIPTION DRUG LABEL,KIT,CUTANEOUS; TOPICAL,NDA,022395,Qutenza,CAPSAICIN,2023/03/28,,2009,AVERITAS PHARMA INC,2018/10/30-; 2021/03/25-,72512-928; 72512-929; 72512-930,S07O44R1ZM,CAPSAICIN,CAPSAICIN,S07O44R1ZM,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/3ffbbcb0-ad93-4f15-bb38-5da76a71c735/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3ffbbcb0-ad93-4f15-bb38-5da76a71c735,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=3ffbbcb0-ad93-4f15-bb38-5da76a71c735,3ffbbcb0-ad93-4f15-bb38-5da76a71c735,,,
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION,OPHTHALMIC,NDA,016968,MIOSTAT,CARBACHOL,2023/02/10,Cholinergic Receptor Agonist,,ALCON LABORATORIES INC,1974/04/15-,0065-0023,8Y164V895Y,CARBACHOL,Carbamoylcholine,54Z8M50D6Q,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/f28d7a56-e079-4a8b-ad81-9a97c780de67/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f28d7a56-e079-4a8b-ad81-9a97c780de67,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=f28d7a56-e079-4a8b-ad81-9a97c780de67,f28d7a56-e079-4a8b-ad81-9a97c780de67,,,
HUMAN PRESCRIPTION DRUG LABEL,"SUSPENSION; TABLET; TABLET, EXTENDED RELEASE",ORAL,NDA,016608;018927;020234,Tegretol; Tegretol XR,CARBAMAZEPINE,2023/09/13,Mood Stabilizer,,NOVARTIS PHARMACEUTICALS CORPORATION,1968/03/11-; 1987/12/18-; 1996/03/25-,0078-0508; 0078-0509; 0078-0510; 0078-0511; 0078-0512,33CM23913M,CARBAMAZEPINE,CARBAMAZEPINE,33CM23913M,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/8d409411-aa9f-4f3a-a52c-fbcb0c3ec053/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8d409411-aa9f-4f3a-a52c-fbcb0c3ec053,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=8d409411-aa9f-4f3a-a52c-fbcb0c3ec053,8d409411-aa9f-4f3a-a52c-fbcb0c3ec053,,,
HUMAN PRESCRIPTION DRUG LABEL,"CAPSULE, EXTENDED RELEASE",ORAL,NDA,020712,Carbatrol,CARBAMAZEPINE,2023/04/17,Mood Stabilizer,,TAKEDA PHARMACEUTICALS AMERICA INC,1997/09/30-; 1999/12/22-,54092-171; 54092-172; 54092-173,33CM23913M,CARBAMAZEPINE,CARBAMAZEPINE,33CM23913M,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/bc03e499-5bac-4293-bff4-6864153a624d/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=bc03e499-5bac-4293-bff4-6864153a624d,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=bc03e499-5bac-4293-bff4-6864153a624d,bc03e499-5bac-4293-bff4-6864153a624d,,,
HUMAN PRESCRIPTION DRUG LABEL,"CAPSULE, EXTENDED RELEASE",ORAL,NDA,021710,EQUETRO,CARBAMAZEPINE,2022/10/13,Mood Stabilizer,1968,VALIDUS PHARMACEUTICALS LLC,2004/12/10-,30698-419; 30698-421; 30698-423,33CM23913M,CARBAMAZEPINE,CARBAMAZEPINE,33CM23913M,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/be478f3c-40f6-47cc-8ab9-f420a9372b1c/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=be478f3c-40f6-47cc-8ab9-f420a9372b1c,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=be478f3c-40f6-47cc-8ab9-f420a9372b1c,be478f3c-40f6-47cc-8ab9-f420a9372b1c,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, POWDER, FOR SOLUTION",INTRAVENOUS,NDA,206030,CARNEXIV,CARBAMAZEPINE,2021/12/01,Mood Stabilizer,1968,LUNDBECK PHARMACEUTICALS LLC,2014/10/21-,67386-621,33CM23913M,CARBAMAZEPINE,CARBAMAZEPINE,33CM23913M,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/fd22916c-ee35-4b57-9b1b-68d106422f5d/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=fd22916c-ee35-4b57-9b1b-68d106422f5d,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=fd22916c-ee35-4b57-9b1b-68d106422f5d,fd22916c-ee35-4b57-9b1b-68d106422f5d,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,017830,Lodosyn,CARBIDOPA,2020/07/01,,,BAUSCH HEALTH US LLC,2010/04/13-,25010-711,MNX7R8C5VO,carbidopa,carbidopa anhydrous,KR87B45RGH,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/ff8e105b-7415-42d4-bbb2-b36cfb8945a5/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ff8e105b-7415-42d4-bbb2-b36cfb8945a5,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=ff8e105b-7415-42d4-bbb2-b36cfb8945a5,ff8e105b-7415-42d4-bbb2-b36cfb8945a5,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,017555,SINEMET,CARBIDOPA AND LEVODOPA,2022/06/01,Aromatic Amino Acid,,ORGANON LLC,2021/06/01-,78206-166; 78206-167; 78206-168,46627O600J; MNX7R8C5VO,CARBIDOPA; LEVODOPA,CARBIDOPA ANHYDROUS; LEVODOPA,46627O600J; KR87B45RGH,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/9b17b028-964a-473c-823d-81423535bd66/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9b17b028-964a-473c-823d-81423535bd66,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=9b17b028-964a-473c-823d-81423535bd66,9b17b028-964a-473c-823d-81423535bd66,,,
HUMAN PRESCRIPTION DRUG LABEL,SUSPENSION,ENTERAL,NDA,203952,Duopa,CARBIDOPA AND LEVODOPA,2022/03/04,Aromatic Amino Acid,1975,ABBVIE INC,2015/01/15-,0074-3012,46627O600J; MNX7R8C5VO,Carbidopa; Levodopa,Carbidopa Anhydrous; Levodopa,46627O600J; KR87B45RGH,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/7066d371-dc6a-0d6f-7bed-e5dd4ee912da/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7066d371-dc6a-0d6f-7bed-e5dd4ee912da,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=7066d371-dc6a-0d6f-7bed-e5dd4ee912da,7066d371-dc6a-0d6f-7bed-e5dd4ee912da,,,
HUMAN PRESCRIPTION DRUG LABEL,"CAPSULE, EXTENDED RELEASE",ORAL,NDA,203312,RYTARY,CARBIDOPA AND LEVODOPA,2019/12/07,Aromatic Amino Acid,1975,AMNEAL PHARMACEUTICALS LLC,2015/01/12-,64896-661; 64896-662; 64896-663; 64896-664,46627O600J; MNX7R8C5VO,CARBIDOPA; LEVODOPA,CARBIDOPA ANHYDROUS; LEVODOPA,46627O600J; KR87B45RGH,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/6c1f7cd4-de56-45c1-a734-5e77b4aeb6f7/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6c1f7cd4-de56-45c1-a734-5e77b4aeb6f7,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=6c1f7cd4-de56-45c1-a734-5e77b4aeb6f7,6c1f7cd4-de56-45c1-a734-5e77b4aeb6f7,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,214869,Dhivy,CARBIDOPA LEVODOPA,2024/01/31,Aromatic Amino Acid,1975,AVION PHARMACEUTICALS LLC,2022/02/10-,75854-701,46627O600J; MNX7R8C5VO,CARBIDOPA; LEVODOPA,CARBIDOPA ANHYDROUS; LEVODOPA,46627O600J; KR87B45RGH,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/39d79ade-8ee0-40ba-9fdd-13045b8ddbdf/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=39d79ade-8ee0-40ba-9fdd-13045b8ddbdf,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=39d79ade-8ee0-40ba-9fdd-13045b8ddbdf,39d79ade-8ee0-40ba-9fdd-13045b8ddbdf,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,021485,Stalevo,"CARBIDOPA, LEVODOPA, AND ENTACAPONE",2021/07/30,Aromatic Amino Acid; Catechol-O-Methyltransferase Inhibitor,2003,ALMATICA PHARMA LLC,2020/10/05-,52427-805; 52427-809; 52427-816; 52427-827; 52427-834; 52427-842,46627O600J; 4975G9NM6T; MNX7R8C5VO,carbidopa; entacapone; levodopa,carbidopa anhydrous; entacapone; levodopa,46627O600J; 4975G9NM6T; KR87B45RGH,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/53c488d8-4146-7563-8021-d90c931d1a95/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=53c488d8-4146-7563-8021-d90c931d1a95,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=53c488d8-4146-7563-8021-d90c931d1a95,53c488d8-4146-7563-8021-d90c931d1a95,,,
HUMAN PRESCRIPTION DRUG LABEL,"SUSPENSION, EXTENDED RELEASE",ORAL,NDA,022556,Karbinal ER,CARBINOXAMINE MALEATE,2023/01/05,Histamine-1 Receptor Antagonist,1953,AYTU THERAPEUTICS LLC,2014/01/03-,23594-101,02O55696WH,CARBINOXAMINE MALEATE,CARBINOXAMINE,982A7M02H5,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/c40b3f4e-2d71-41a1-a1fc-f64f38724879/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c40b3f4e-2d71-41a1-a1fc-f64f38724879,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=c40b3f4e-2d71-41a1-a1fc-f64f38724879,c40b3f4e-2d71-41a1-a1fc-f64f38724879,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAMUSCULAR,NDA,017989,Hemabate,CARBOPROST TROMETHAMINE,2022/01/10,Prostaglandin Analog,,PHARMACIA AND UPJOHN COMPANY LLC,1979/01/09-,0009-0856,U4526F86FJ,CARBOPROST TROMETHAMINE,CARBOPROST,7B5032XT6O,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/3d282998-ff0c-480a-bd80-155606ef0a65/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3d282998-ff0c-480a-bd80-155606ef0a65,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=3d282998-ff0c-480a-bd80-155606ef0a65,3d282998-ff0c-480a-bd80-155606ef0a65,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAVENOUS,NDA,202714,KYPROLIS,CARFILZOMIB,2022/06/30,Proteasome Inhibitor,2012,ONYX PHARMACEUTICALS INC,2012/07/20-; 2016/07/15-; 2018/05/23-,76075-101; 76075-102; 76075-103,72X6E3J5AR,CARFILZOMIB,CARFILZOMIB,72X6E3J5AR,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/ea66eb30-e665-4693-99a1-a9d3b4bbe2d6/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ea66eb30-e665-4693-99a1-a9d3b4bbe2d6,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=ea66eb30-e665-4693-99a1-a9d3b4bbe2d6,ea66eb30-e665-4693-99a1-a9d3b4bbe2d6,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FOR SUSPENSION",ORAL,NDA,022562,Carbaglu,CARGLUMIC ACID,2024/01/25,Carbamoyl Phosphate Synthetase 1 Activator,2010,RECORDATI RARE DISEASES,2010/03/18-,52276-312,5L0HB4V1EW,CARGLUMIC ACID,CARGLUMIC ACID,5L0HB4V1EW,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/10175e73-5172-4dde-a508-8a88b7afc0a1/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=10175e73-5172-4dde-a508-8a88b7afc0a1,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=10175e73-5172-4dde-a508-8a88b7afc0a1,10175e73-5172-4dde-a508-8a88b7afc0a1,,,
HUMAN PRESCRIPTION DRUG LABEL,"CAPSULE, GELATIN COATED; KIT",ORAL,NDA,204370,Vraylar,CARIPRAZINE,2024/02/06,Atypical Antipsychotic,2015,ALLERGAN INC,2015/09/17-; completed:2015/09/17-2024/05/31,61874-115; 61874-130; 61874-145; 61874-160; 61874-170,F6RJL8B278,CARIPRAZINE,CARIPRAZINE,F6RJL8B278,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/4b5f7c65-aa2d-452a-b3db-bc85c06ff12f/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4b5f7c65-aa2d-452a-b3db-bc85c06ff12f,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=4b5f7c65-aa2d-452a-b3db-bc85c06ff12f,4b5f7c65-aa2d-452a-b3db-bc85c06ff12f,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,011792,Soma,CARISOPRODOL,2023/05/15,Muscle Relaxant,1959,MEDA PHARMACEUTICALS INC,1995/11/01-; 2007/09/08-,0037-2001; 0037-2250,21925K482H,CARISOPRODOL,CARISOPRODOL,21925K482H,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/6297cf20-830a-11dc-94c8-0002a5d5c51b/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6297cf20-830a-11dc-94c8-0002a5d5c51b,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=6297cf20-830a-11dc-94c8-0002a5d5c51b,6297cf20-830a-11dc-94c8-0002a5d5c51b,,,
HUMAN PRESCRIPTION DRUG LABEL,WAFER,INTRACAVITARY,NDA,020637,Gliadel,CARMUSTINE,2018/12/13,Alkylating Drug,1996,ARBOR PHARMACEUTICALS,2012/12/13-,24338-050,U68WG3173Y,carmustine,carmustine,U68WG3173Y,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/38962a55-a514-4c48-bea5-f99a8da4beec/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=38962a55-a514-4c48-bea5-f99a8da4beec,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=38962a55-a514-4c48-bea5-f99a8da4beec,38962a55-a514-4c48-bea5-f99a8da4beec,,,
HUMAN PRESCRIPTION DRUG LABEL,SUSPENSION,ORAL,NDA,209478,CaroSpir,CAROSPIR,2023/08/15,Aldosterone Antagonist,1960,CMP PHARMA INC,2017/08/04-,46287-020,27O7W4T232,spironolactone,spironolactone,27O7W4T232,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/c4f70a04-7d89-4b73-8b02-17d43471bf08/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c4f70a04-7d89-4b73-8b02-17d43471bf08,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=c4f70a04-7d89-4b73-8b02-17d43471bf08,c4f70a04-7d89-4b73-8b02-17d43471bf08,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,020297,Coreg,CARVEDILOL,2023/11/21,alpha-Adrenergic Blocker; beta-Adrenergic Blocker,1995,WAYLIS THERAPEUTICS LLC,2023/03/15-,80725-139; 80725-140; 80725-141; 80725-142,0K47UL67F2,Carvedilol,Carvedilol,0K47UL67F2,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/07c619c6-4a0c-445e-94fa-664a54f68a39/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=07c619c6-4a0c-445e-94fa-664a54f68a39,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=07c619c6-4a0c-445e-94fa-664a54f68a39,07c619c6-4a0c-445e-94fa-664a54f68a39,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,020297,Coreg,CARVEDILOL,2023/04/25,alpha-Adrenergic Blocker; beta-Adrenergic Blocker,1995,WOODWARD PHARMA SERVICES LLC,2023/03/15-,69784-139; 69784-140; 69784-141; 69784-142,0K47UL67F2,Carvedilol,Carvedilol,0K47UL67F2,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/0e36a0e5-3ed2-47d4-890e-38000791b678/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0e36a0e5-3ed2-47d4-890e-38000791b678,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=0e36a0e5-3ed2-47d4-890e-38000791b678,0e36a0e5-3ed2-47d4-890e-38000791b678,,,
HUMAN PRESCRIPTION DRUG LABEL,"CAPSULE, EXTENDED RELEASE",ORAL,NDA,022012,Coreg CR,CARVEDILOL PHOSPHATE,2023/12/19,alpha-Adrenergic Blocker; beta-Adrenergic Blocker,1995,WAYLIS THERAPEUTICS LLC,2022/11/07-,80725-383; 80725-385; 80725-387; 80725-388,EQT531S367,carvedilol phosphate,CARVEDILOL,0K47UL67F2,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/d3625d78-6eb6-41fe-8f6f-664965c104c4/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d3625d78-6eb6-41fe-8f6f-664965c104c4,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=d3625d78-6eb6-41fe-8f6f-664965c104c4,d3625d78-6eb6-41fe-8f6f-664965c104c4,,,
HUMAN PRESCRIPTION DRUG LABEL,"CAPSULE, EXTENDED RELEASE",ORAL,NDA,022012,Coreg CR,CARVEDILOL PHOSPHATE,2022/10/31,alpha-Adrenergic Blocker; beta-Adrenergic Blocker,1995,WOODWARD PHARMA SERVICES LLC,2022/11/07-,69784-383; 69784-385; 69784-387; 69784-388,EQT531S367,carvedilol phosphate,CARVEDILOL,0K47UL67F2,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/9008ede8-3e53-4061-ae4c-c51cbbb56ef2/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9008ede8-3e53-4061-ae4c-c51cbbb56ef2,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=9008ede8-3e53-4061-ae4c-c51cbbb56ef2,9008ede8-3e53-4061-ae4c-c51cbbb56ef2,,,
HUMAN PRESCRIPTION DRUG LABEL,"CAPSULE, EXTENDED RELEASE",ORAL,NDA,022012,COREG CR,CARVEDILOL PHOSPHATE,2020/11/02,alpha-Adrenergic Blocker; beta-Adrenergic Blocker,1995,GLAXOSMITHKLINE LLC,completed:2007/02/06-2023/09/30; completed:2007/02/09-2023/04/30; completed:2007/02/14-2023/05/31; completed:2007/02/20-2023/09/30; completed:2019/11/01-2019/11/01,0007-3370; 0007-3371; 0007-3372; 0007-3373; 0007-3383; 0007-3385; 0007-3387; 0007-3388,EQT531S367,CARVEDILOL PHOSPHATE,CARVEDILOL,0K47UL67F2,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/06400a4c-42b4-440a-92b4-1f47f98ac7ba/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=06400a4c-42b4-440a-92b4-1f47f98ac7ba,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=06400a4c-42b4-440a-92b4-1f47f98ac7ba,06400a4c-42b4-440a-92b4-1f47f98ac7ba,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRAVENOUS,NDA,213026,AMONDYS 45,CASIMERSEN,2023/03/23,Antisense Oligonucleotide,2021,SAREPTA THERAPEUTICS INC,2021/02/25-,60923-227,X8UHF7SX0R,casimersen,casimersen,X8UHF7SX0R,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/e9e5fd44-eeda-4580-bba1-a734828bbcc3/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e9e5fd44-eeda-4580-bba1-a734828bbcc3,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=e9e5fd44-eeda-4580-bba1-a734828bbcc3,e9e5fd44-eeda-4580-bba1-a734828bbcc3,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAVENOUS,NDA,021227,CANCIDAS,CASPOFUNGIN ACETATE,2023/11/20,Echinocandin Antifungal,2001,MERCK SHARP AND DOHME LLC,2001/01/26-,0006-3822; 0006-3823,VUW370O5QE,CASPOFUNGIN ACETATE,CASPOFUNGIN,F0XDI6ZL63,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/3bad23a6-09a6-4194-9182-093ed61bc71c/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3bad23a6-09a6-4194-9182-093ed61bc71c,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=3bad23a6-09a6-4194-9182-093ed61bc71c,3bad23a6-09a6-4194-9182-093ed61bc71c,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,212576,INQOVI,CEDAZURIDINE AND DECITABINE,2022/05/05,Nucleoside Metabolic Inhibitor,2020,TAIHO PHARMACEUTICAL CO LTD,2020/07/07-,64842-0727,39IS23Q1EW; 776B62CQ27,CEDAZURIDINE; DECITABINE,CEDAZURIDINE; DECITABINE,39IS23Q1EW; 776B62CQ27,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/91a0f80b-f865-4d06-a40d-4d148d99ee71/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=91a0f80b-f865-4d06-a40d-4d148d99ee71,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=91a0f80b-f865-4d06-a40d-4d148d99ee71,91a0f80b-f865-4d06-a40d-4d148d99ee71,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, POWDER, FOR SOLUTION",INTRAVENOUS,NDA,216109,Cefazolin,CEFAZOLIN,2024/04/11,Cephalosporin Antibacterial,1973,HIKMA PHARMACEUTICALS USA INC,2023/03/01-,0143-9139; 0143-9140,P380M0454Z,CEFAZOLIN SODIUM,CEFAZOLIN,IHS69L0Y4T,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/6c7761d3-c154-4802-9876-627cd42913f0/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6c7761d3-c154-4802-9876-627cd42913f0,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=6c7761d3-c154-4802-9876-627cd42913f0,6c7761d3-c154-4802-9876-627cd42913f0,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, POWDER, FOR SOLUTION",INTRAVENOUS,NDA,211413,Cefazolin,CEFAZOLIN,2024/03/29,Cephalosporin Antibacterial,1973,WG CRITICAL CARE LLC,2023/05/18-; 2024/05/10-,44567-840; 44567-845,P380M0454Z,CEFAZOLIN SODIUM,CEFAZOLIN,IHS69L0Y4T,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/4f3a9248-a354-4c77-bf5b-9eed38f00219/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4f3a9248-a354-4c77-bf5b-9eed38f00219,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=4f3a9248-a354-4c77-bf5b-9eed38f00219,4f3a9248-a354-4c77-bf5b-9eed38f00219,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,207131,Cefazolin,CEFAZOLIN SODIUM,2024/02/01,Cephalosporin Antibacterial,1973,BAXTER HEALTHCARE CORPORATION,2015/08/07-,0338-3503; 0338-3508,P380M0454Z,CEFAZOLIN SODIUM,CEFAZOLIN,IHS69L0Y4T,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/d91a8d13-99a0-4d87-88dc-71cbd37922b4/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d91a8d13-99a0-4d87-88dc-71cbd37922b4,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=d91a8d13-99a0-4d87-88dc-71cbd37922b4,d91a8d13-99a0-4d87-88dc-71cbd37922b4,,,
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION,INTRAVENOUS,NDA,050779,Cefazolin Sodium,CEFAZOLIN SODIUM,2021/07/13,Cephalosporin Antibacterial,1973,B BRAUN MEDICAL INC,2000/07/27-; 2012/01/13-,0264-3103; 0264-3105,P380M0454Z,CEFAZOLIN SODIUM,CEFAZOLIN,IHS69L0Y4T,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/17f8f038-c204-4dab-80d7-6f7ac41ddbec/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=17f8f038-c204-4dab-80d7-6f7ac41ddbec,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=17f8f038-c204-4dab-80d7-6f7ac41ddbec,17f8f038-c204-4dab-80d7-6f7ac41ddbec,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,050817,Cefepime,CEFEPIME,2023/10/24,Cephalosporin Antibacterial,1996,BAXTER HEALTHCARE CORPORATION,2008/08/05-,0338-1301,I8X1O0607P,CEFEPIME HYDROCHLORIDE,CEFEPIME,807PW4VQE3,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/be5f8ca6-7232-423a-a2d5-cccb7abe7921/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=be5f8ca6-7232-423a-a2d5-cccb7abe7921,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=be5f8ca6-7232-423a-a2d5-cccb7abe7921,be5f8ca6-7232-423a-a2d5-cccb7abe7921,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, POWDER, FOR SOLUTION",INTRAVENOUS,NDA,209445,Fetroja,CEFIDEROCOL SULFATE TOSYLATE,2024/02/21,Cephalosporin Antibacterial,2019,SHIONOGI INC,2020/01/31-,59630-266,TTP8LBP45D,Cefiderocol sulfate tosylate,Cefiderocol,SZ34OMG6E8,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/75c0c785-38e0-4049-a6fb-b77581f5b35c/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=75c0c785-38e0-4049-a6fb-b77581f5b35c,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=75c0c785-38e0-4049-a6fb-b77581f5b35c,75c0c785-38e0-4049-a6fb-b77581f5b35c,,,
HUMAN PRESCRIPTION DRUG LABEL,"CAPSULE; POWDER, FOR SUSPENSION; TABLET; TABLET, CHEWABLE",ORAL,ANDA; NDA,065130;065355;065380;202091;203195,SUPRAX,CEFIXIME,2023/12/15,Cephalosporin Antibacterial,1986,LUPIN PHARMACEUTICALS INC,2007/06/01-; 2008/04/01-; 2012/12/05-; completed:2013/03/15-2019/07/31; completed:2013/03/15-2021/05/31,27437-201; 27437-203; 27437-205; 27437-206; 27437-207; 27437-208,97I1C92E55,CEFIXIME,CEFIXIME ANHYDROUS,XZ7BG04GJX,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/d0fd45bd-7d52-4fa6-a5f7-f46d5651ffa2/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d0fd45bd-7d52-4fa6-a5f7-f46d5651ffa2,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=d0fd45bd-7d52-4fa6-a5f7-f46d5651ffa2,d0fd45bd-7d52-4fa6-a5f7-f46d5651ffa2,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, POWDER, FOR SOLUTION",INTRAMUSCULAR; INTRAVENOUS,NDA,050588,Cefotan,CEFOTETAN,2024/04/08,Cephalosporin Antibacterial,,PAI HOLDINGS LLC DBA PAI PHARMA,2024/04/08-,0121-0976; 0121-0977,0GXP746VXB,CEFOTETAN DISODIUM,Cefotetan,48SPP0PA9Q,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/f1510f5e-d001-44e0-accb-27cf79fd4f9a/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f1510f5e-d001-44e0-accb-27cf79fd4f9a,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=f1510f5e-d001-44e0-accb-27cf79fd4f9a,f1510f5e-d001-44e0-accb-27cf79fd4f9a,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, POWDER, FOR SOLUTION",INTRAMUSCULAR; INTRAVENOUS,NDA,050588,CEFOTAN; Cefotan,CEFOTETAN DISODIUM,2018/11/30,Cephalosporin Antibacterial,,TELIGENT PHARMA INC,2015/10/01-,52565-052; 52565-053,0GXP746VXB,Cefotetan Disodium,Cefotetan,48SPP0PA9Q,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/0860bfe0-da3e-4460-da57-2411db14c426/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0860bfe0-da3e-4460-da57-2411db14c426,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=0860bfe0-da3e-4460-da57-2411db14c426,0860bfe0-da3e-4460-da57-2411db14c426,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,065214,Cefoxitin and Dextrose,CEFOXITIN SODIUM,2019/07/29,Cephalosporin Antibacterial,1978,B BRAUN MEDICAL INC,2006/03/10-,0264-3123; 0264-3125,Q68050H03T,CEFOXITIN SODIUM,CEFOXITIN,6OEV9DX57Y,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/6c7e9485-1ede-411c-8c46-911439332864/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6c7e9485-1ede-411c-8c46-911439332864,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=6c7e9485-1ede-411c-8c46-911439332864,6c7e9485-1ede-411c-8c46-911439332864,,,
HUMAN PRESCRIPTION DRUG LABEL,"POWDER, FOR SOLUTION",INTRAVENOUS,NDA,200327,Teflaro,CEFTAROLINE FOSAMIL,2021/12/01,Cephalosporin Antibacterial,2010,ALLERGAN INC,2010/10/29-,0456-0400; 0456-0600,7P6FQA5D21,CEFTAROLINE FOSAMIL,CEFTAROLINE,H36Z0FHR8K,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/3ecde48b-75a2-4beb-9999-369f3f61bb8a/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3ecde48b-75a2-4beb-9999-369f3f61bb8a,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=3ecde48b-75a2-4beb-9999-369f3f61bb8a,3ecde48b-75a2-4beb-9999-369f3f61bb8a,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, POWDER, FOR SOLUTION",INTRAMUSCULAR; INTRAVENOUS,NDA,050578,FORTAZ,CEFTAZIDIME,2017/07/28,Cephalosporin Antibacterial,,TELIGENT PHARMA INC,2012/12/14-,52565-105; 52565-106; 52565-107,9M416Z9QNR,CEFTAZIDIME,CEFTAZIDIME ANHYDROUS,DZR1ENT301,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/78982c98-7866-49f1-989f-a289c4242358/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=78982c98-7866-49f1-989f-a289c4242358,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=78982c98-7866-49f1-989f-a289c4242358,78982c98-7866-49f1-989f-a289c4242358,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, POWDER, FOR SOLUTION",INTRAMUSCULAR; INTRAVENOUS,NDA,050578,FORTAZ,CEFTAZIDIME,2017/06/20,Cephalosporin Antibacterial,,TELIGENT PHARMA INC,2017/06/20-,52565-109,9M416Z9QNR,CEFTAZIDIME,CEFTAZIDIME ANHYDROUS,DZR1ENT301,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/8b55504e-38c5-fa0c-7766-ee68d38c041b/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8b55504e-38c5-fa0c-7766-ee68d38c041b,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=8b55504e-38c5-fa0c-7766-ee68d38c041b,8b55504e-38c5-fa0c-7766-ee68d38c041b,,,
HUMAN PRESCRIPTION DRUG LABEL,"POWDER, FOR SOLUTION",INTRAVENOUS,NDA,206494,AVYCAZ,"CEFTAZIDIME, AVIBACTAM",2024/01/26,Cephalosporin Antibacterial; beta Lactamase Inhibitor,2015,ALLERGAN INC,2014/12/26-,0456-2700,9M416Z9QNR; 9V824P8TAI,AVIBACTAM SODIUM; CEFTAZIDIME,AVIBACTAM; CEFTAZIDIME ANHYDROUS,7352665165; DZR1ENT301,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/d9c2803f-dc9c-4b19-b4a3-8303bc8c15fd/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d9c2803f-dc9c-4b19-b4a3-8303bc8c15fd,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=d9c2803f-dc9c-4b19-b4a3-8303bc8c15fd,d9c2803f-dc9c-4b19-b4a3-8303bc8c15fd,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE; SUSPENSION,ORAL,NDA,050685;050686,Cedax,CEFTIBUTEN DIHYDRATE,2010/01/12,Cephalosporin Antibacterial,,SCIELE PHARMA INC,1995/12/20-,59630-820; 59630-821,62F4443RWP,Ceftibuten dihydrate,Ceftibuten,IW71N46B4Y,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/2dd58c88-142f-41ad-bc31-0a4fff074970/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2dd58c88-142f-41ad-bc31-0a4fff074970,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=2dd58c88-142f-41ad-bc31-0a4fff074970,2dd58c88-142f-41ad-bc31-0a4fff074970,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAVENOUS,NDA,206829,ZERBAXA,CEFTOLOZANE AND TAZOBACTAM,2023/11/21,Cephalosporin Antibacterial; beta Lactamase Inhibitor,2014,MERCK SHARP AND DOHME LLC,2014/12/19-,67919-030,7R247U84HY; UXA545ABTT,ceftolozane sulfate; tazobactam sodium,ceftolozane; tazobactam,37A4IES95Q; SE10G96M8W,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/70ac1d90-eff3-4f0b-9f46-5846c571b32f/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=70ac1d90-eff3-4f0b-9f46-5846c571b32f,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=70ac1d90-eff3-4f0b-9f46-5846c571b32f,70ac1d90-eff3-4f0b-9f46-5846c571b32f,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,050796,CEFTRIAXONE AND DEXTROSE,CEFTRIAXONE,2022/01/13,Cephalosporin Antibacterial,2005,B BRAUN MEDICAL INC,2005/04/20-,0264-3153; 0264-3155,023Z5BR09K,CEFTRIAXONE SODIUM,CEFTRIAXONE,75J73V1629,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/67153914-16bc-490d-82d7-638061618467/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=67153914-16bc-490d-82d7-638061618467,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=67153914-16bc-490d-82d7-638061618467,67153914-16bc-490d-82d7-638061618467,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,050780,Cefuroxime and Dextrose,CEFUROXIME AND DEXTROSE,2020/12/05,Cephalosporin Antibacterial,,B BRAUN MEDICAL INC,2001/02/21-,0264-3112; 0264-3114,R8A7M9MY61,CEFUROXIME SODIUM,CEFUROXIME,O1R9FJ93ED,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/07170ee3-1a24-424f-a2a2-00bc92e98f85/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=07170ee3-1a24-424f-a2a2-00bc92e98f85,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=07170ee3-1a24-424f-a2a2-00bc92e98f85,07170ee3-1a24-424f-a2a2-00bc92e98f85,,,
HUMAN PRESCRIPTION DRUG LABEL,LIQUID,ORAL,NDA,212157,ELYXYB - celecoxib,CELECOXIB,2023/11/20,Nonsteroidal Anti-inflammatory Drug,1998,SCILEX PHARMACEUTICALS INC,2023/11/27-,69557-333,JCX84Q7J1L,CELECOXIB,CELECOXIB,JCX84Q7J1L,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/c8a5de07-9f27-4a54-a885-8089f0307bd7/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c8a5de07-9f27-4a54-a885-8089f0307bd7,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=c8a5de07-9f27-4a54-a885-8089f0307bd7,c8a5de07-9f27-4a54-a885-8089f0307bd7,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,NDA,020998,CELEBREX,CELECOXIB,2023/02/15,Nonsteroidal Anti-inflammatory Drug,1998,VIATRIS SPECIALTY LLC,2023/09/12-; 2023/10/11-; 2024/01/10-,58151-082; 58151-083; 58151-084; 58151-085,JCX84Q7J1L,CELECOXIB,CELECOXIB,JCX84Q7J1L,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/2d6675e4-5859-4be2-8037-a20ce9f707aa/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2d6675e4-5859-4be2-8037-a20ce9f707aa,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=2d6675e4-5859-4be2-8037-a20ce9f707aa,2d6675e4-5859-4be2-8037-a20ce9f707aa,,,
HUMAN PRESCRIPTION DRUG LABEL,LIQUID,ORAL,NDA,212157,ELYXYB - celecoxib,CELECOXIB,2021/10/01,Nonsteroidal Anti-inflammatory Drug,1998,BIODELIVERY SCIENCES INTERNATIONAL INC,2022/01/01-,59385-055,JCX84Q7J1L,celecoxib,celecoxib,JCX84Q7J1L,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/a0bfcba9-0af6-4b45-80e3-c4c94065b777/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a0bfcba9-0af6-4b45-80e3-c4c94065b777,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=a0bfcba9-0af6-4b45-80e3-c4c94065b777,a0bfcba9-0af6-4b45-80e3-c4c94065b777,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,NDA,020998,CELEBREX,CELECOXIB,2021/04/15,Nonsteroidal Anti-inflammatory Drug,1998,PFIZER LABORATORIES DIV PFIZER INC,1998/10/02-; completed:1998/10/02-2024/08/31,0025-1515; 0025-1520; 0025-1525; 0025-1530,JCX84Q7J1L,CELECOXIB,CELECOXIB,JCX84Q7J1L,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/8d52185d-421f-4e34-8db7-f7676db2a226/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8d52185d-421f-4e34-8db7-f7676db2a226,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=8d52185d-421f-4e34-8db7-f7676db2a226,8d52185d-421f-4e34-8db7-f7676db2a226,,,
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION,ORAL,NDA,212157,ELYXYB,CELECOXIB,2020/05/13,Nonsteroidal Anti-inflammatory Drug,1998,DR REDDY S LABORATORIES INC,2020/10/05-,43598-866,JCX84Q7J1L,CELECOXIB,CELECOXIB,JCX84Q7J1L,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/34454fef-e029-513c-f843-21f5cd3362ab/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=34454fef-e029-513c-f843-21f5cd3362ab,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=34454fef-e029-513c-f843-21f5cd3362ab,34454fef-e029-513c-f843-21f5cd3362ab,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,213426,SEGLENTIS,CELECOXIB AND TRAMADOL HYDROCHLORIDE,2024/03/05,Nonsteroidal Anti-inflammatory Drug; Opioid Agonist,2021,KOWA PHARMACEUTICALS AMERICA INC,2022/01/01-,66869-564,9N7R477WCK; JCX84Q7J1L,CELECOXIB; TRAMADOL HYDROCHLORIDE,CELECOXIB; TRAMADOL,39J1LGJ30J; JCX84Q7J1L,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/cf2c8436-a9f3-473c-e053-2a95a90a1123/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=cf2c8436-a9f3-473c-e053-2a95a90a1123,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=cf2c8436-a9f3-473c-e053-2a95a90a1123,cf2c8436-a9f3-473c-e053-2a95a90a1123,,,
HUMAN PRESCRIPTION DRUG LABEL,"KIT; TABLET, FILM COATED",ORAL,NDA,212839,Xcopri; Xcopri Maintenance Pack; Xcopri Titration Pack,CENOBAMATE,2024/05/08,,2020,SK LIFE SCIENCE INC,2020/03/12-; 2021/04/30-; 2024/04/06-,71699-025; 71699-050; 71699-100; 71699-103; 71699-104; 71699-150; 71699-200; 71699-201; 71699-202; 71699-203; 71699-999,P85X70RZWS,CENOBAMATE,CENOBAMATE,P85X70RZWS,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/565c2126-57ae-4e29-b443-723bbe7e2072/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=565c2126-57ae-4e29-b443-723bbe7e2072,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=565c2126-57ae-4e29-b443-723bbe7e2072,565c2126-57ae-4e29-b443-723bbe7e2072,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,212839,"XCOPRI MAINTENANCE PACK 100 mg, 150 mg; XCOPRI MAINTENANCE PACK 150 mg, 200 mg; XCOPRI TITRATION PACK 12.5 mg, 25 mg; XCOPRI TITRATION PACK 150 mg, 200 mg; XCOPRI TITRATION PACK 50 mg, 100 mg",CENOBAMATE,2024/05/06,,,PCI PHARMA SERVICES CANADA INC,2020/03/12-,83114-101; 83114-102; 83114-103; 83114-104; 83114-201; 83114-202; 83114-203; 83114-204; 83114-205; 83114-206,P85X70RZWS,CENOBAMATE,CENOBAMATE,P85X70RZWS,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/0f2c0e91-f75a-5b29-e063-6294a90abf1a/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0f2c0e91-f75a-5b29-e063-6294a90abf1a,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=0f2c0e91-f75a-5b29-e063-6294a90abf1a,0f2c0e91-f75a-5b29-e063-6294a90abf1a,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,211225,ZYKADIA,CERITINIB,2024/01/11,Kinase Inhibitor,2014,NOVARTIS PHARMACEUTICALS CORPORATION,2019/03/18-,0078-0694,K418KG2GET,CERITINIB,CERITINIB,K418KG2GET,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/fff5d805-4ffd-4e8e-8e63-6f129697563e/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=fff5d805-4ffd-4e8e-8e63-6f129697563e,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=fff5d805-4ffd-4e8e-8e63-6f129697563e,fff5d805-4ffd-4e8e-8e63-6f129697563e,,,
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION/ DROPS,OPHTHALMIC,NDA,208694,Zerviate,CETIRIZINE,2023/10/09,Histamine-1 Receptor Antagonist,1995,EYEVANCE PHARMACEUTICALS,2019/02/19-,71776-024,YO7261ME24,CETIRIZINE,CETIRIZINE,YO7261ME24,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/3e6fecc1-df71-4c01-a654-f55635617a7f/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3e6fecc1-df71-4c01-a654-f55635617a7f,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=3e6fecc1-df71-4c01-a654-f55635617a7f,3e6fecc1-df71-4c01-a654-f55635617a7f,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRAVENOUS,NDA,211415,QUZYTTIR,CETIRIZINE HYDROCHLORIDE,2022/10/25,Histamine-1 Receptor Antagonist,1995,TERSERA THERAPEUTICS LLC,2019/11/13-,70720-100,64O047KTOA,cetirizine hydrochloride,cetirizine,YO7261ME24,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/f33e859d-ebc9-4d4f-a57d-204c48760d20/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f33e859d-ebc9-4d4f-a57d-204c48760d20,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=f33e859d-ebc9-4d4f-a57d-204c48760d20,f33e859d-ebc9-4d4f-a57d-204c48760d20,,,
HUMAN PRESCRIPTION DRUG LABEL,KIT,SUBCUTANEOUS,NDA,021197,Cetrotide,CETRORELIX ACETATE,2023/12/22,Gonadotropin Releasing Hormone Receptor Antagonist,,EMD SERONO INC,2000/08/11-,44087-1225,W9Y8L7GP4C,CETRORELIX ACETATE,CETRORELIX,OON1HFZ4BA,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/aca7768e-28a7-4027-b1d8-e66247665f79/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=aca7768e-28a7-4027-b1d8-e66247665f79,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=aca7768e-28a7-4027-b1d8-e66247665f79,aca7768e-28a7-4027-b1d8-e66247665f79,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,NDA,020989,Cevimeline,CEVIMELINE,2022/07/15,Cholinergic Receptor Agonist,,SUN PHARMACEUTICAL INDUSTRIES INC,completed:2016/03/10-2027/04/30,63304-479,P81Q6V85NP,CEVIMELINE HYDROCHLORIDE,CEVIMELINE,K9V0CDQ56E,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/773a19e8-4c3e-4414-99a6-aea98c9790ee/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=773a19e8-4c3e-4414-99a6-aea98c9790ee,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=773a19e8-4c3e-4414-99a6-aea98c9790ee,773a19e8-4c3e-4414-99a6-aea98c9790ee,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,NDA,020989,cevimeline hydrochloride,CEVIMELINE HYDROCHLORIDE,2023/01/05,Cholinergic Receptor Agonist,,COSETTE PHARMACEUTICALS INC,2023/01/03-,0713-0937,P81Q6V85NP,CEVIMELINE HYDROCHLORIDE,CEVIMELINE,K9V0CDQ56E,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/efc2bb24-4dda-4781-bef5-fcd9abf082dd/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=efc2bb24-4dda-4781-bef5-fcd9abf082dd,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=efc2bb24-4dda-4781-bef5-fcd9abf082dd,efc2bb24-4dda-4781-bef5-fcd9abf082dd,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,NDA,020989,Evoxac,CEVIMELINE HYDROCHLORIDE,2022/09/07,Cholinergic Receptor Agonist,,COSETTE PHARMACEUTICALS INC,2022/09/01-,0713-0883,P81Q6V85NP,CEVIMELINE HYDROCHLORIDE,CEVIMELINE,K9V0CDQ56E,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/dac32a9b-05b8-42c2-9a29-d885a9279456/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=dac32a9b-05b8-42c2-9a29-d885a9279456,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=dac32a9b-05b8-42c2-9a29-d885a9279456,dac32a9b-05b8-42c2-9a29-d885a9279456,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,NDA,020989,Evoxac,CEVIMELINE HYDROCHLORIDE,2022/06/03,Cholinergic Receptor Agonist,,DAIICHI SANKYO INC,completed:2000/01/12-2025/08/31,63395-201,P81Q6V85NP,CEVIMELINE HYDROCHLORIDE,CEVIMELINE,K9V0CDQ56E,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/0679dd4c-fece-4c6d-b273-2c62237e8973/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0679dd4c-fece-4c6d-b273-2c62237e8973,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=0679dd4c-fece-4c6d-b273-2c62237e8973,0679dd4c-fece-4c6d-b273-2c62237e8973,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,010669,LEUKERAN,CHLORAMBUCIL,2023/05/15,Alkylating Drug,,WAYLIS THERAPEUTICS LLC,2023/05/15-,80725-610,18D0SL7309,CHLORAMBUCIL,CHLORAMBUCIL,18D0SL7309,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/58a3c995-5ad6-465d-8437-5970c9088213/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=58a3c995-5ad6-465d-8437-5970c9088213,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=58a3c995-5ad6-465d-8437-5970c9088213,58a3c995-5ad6-465d-8437-5970c9088213,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,010669,LEUKERAN,CHLORAMBUCIL,2022/12/29,Alkylating Drug,,WOODWARD PHARMA SERVICES LLC,2022/06/30-,69784-610,18D0SL7309,CHLORAMBUCIL,CHLORAMBUCIL,18D0SL7309,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/e3d7a0f9-d704-4676-b16e-622ff6d22aa2/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e3d7a0f9-d704-4676-b16e-622ff6d22aa2,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=e3d7a0f9-d704-4676-b16e-622ff6d22aa2,e3d7a0f9-d704-4676-b16e-622ff6d22aa2,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,NDA,012750,Librax,CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE,2023/01/13,Anticholinergic; Benzodiazepine,,BAUSCH HEALTH US LLC,1966/09/01-,0187-4100,91ZQW5JF1Z; MFM6K1XWDK,Chlordiazepoxide Hydrochloride; Clidinium Bromide,CLIDINIUM; Chlordiazepoxide,6RZ6XEZ3CR; BO76JF850N,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/f99ebf66-f207-4a97-9666-4da1d72b061c/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f99ebf66-f207-4a97-9666-4da1d72b061c,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=f99ebf66-f207-4a97-9666-4da1d72b061c,f99ebf66-f207-4a97-9666-4da1d72b061c,,,
HUMAN PRESCRIPTION DRUG LABEL,RINSE,ORAL,NDA,019028,Peridex,CHLORHEXIDINE GLUCONATE,2024/04/01,,,SOLVENTUM US OPCO LLC,1986/08/13-,48878-0620,MOR84MUD8E,Chlorhexidine Gluconate,chlorhexidine,R4KO0DY52L,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/3fcd41c4-875a-4e54-b533-261f198011af/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3fcd41c4-875a-4e54-b533-261f198011af,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=3fcd41c4-875a-4e54-b533-261f198011af,3fcd41c4-875a-4e54-b533-261f198011af,,,
HUMAN PRESCRIPTION DRUG LABEL,RINSE,ORAL,NDA,019028,Peridex,CHLORHEXIDINE GLUCONATE,2022/12/22,,,XTTRIUM LABORATORIES INC,1986/08/13-,0116-0620,MOR84MUD8E,CHLORHEXIDINE GLUCONATE,CHLORHEXIDINE,R4KO0DY52L,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/4703eff7-b30b-5a7d-e054-00144ff88e88/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4703eff7-b30b-5a7d-e054-00144ff88e88,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=4703eff7-b30b-5a7d-e054-00144ff88e88,4703eff7-b30b-5a7d-e054-00144ff88e88,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",EPIDURAL; INFILTRATION; INTRACAUDAL; PERINEURAL,NDA,009435,Nesacaine; Nesacaine MPF,CHLOROPROCAINE HYDROCHLORIDE,2022/09/01,Ester Local Anesthetic,,FRESENIUS KABI USA LLC,2010/10/14-,63323-475; 63323-476; 63323-477; 63323-478,LT7Z1YW11H,CHLOROPROCAINE HYDROCHLORIDE,CHLOROPROCAINE,5YVB0POT2H,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/a844e68a-1462-40e4-be5e-f56214906eb9/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a844e68a-1462-40e4-be5e-f56214906eb9,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=a844e68a-1462-40e4-be5e-f56214906eb9,a844e68a-1462-40e4-be5e-f56214906eb9,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRATHECAL,NDA,208791,Clorotekal,CHLOROPROCAINE HYDROCHLORIDE,2020/12/04,Ester Local Anesthetic,1955,B BRAUN MEDICAL INC,2018/05/01-,0264-7055,LT7Z1YW11H,CHLOROPROCAINE HYDROCHLORIDE,CHLOROPROCAINE,5YVB0POT2H,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/90f7a095-f6db-456b-951f-9aee54c5dbc0/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=90f7a095-f6db-456b-951f-9aee54c5dbc0,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=90f7a095-f6db-456b-951f-9aee54c5dbc0,90f7a095-f6db-456b-951f-9aee54c5dbc0,,,
HUMAN PRESCRIPTION DRUG LABEL,GEL,OPHTHALMIC,NDA,216227,IHEEZO,CHLOROPROCAINE HYDROCHLORIDE OPHTHALMIC GEL,2023/02/21,Ester Local Anesthetic,1955,HARROW EYE LLC,2022/09/27-,82667-300,LT7Z1YW11H,CHLOROPROCAINE HYDROCHLORIDE,CHLOROPROCAINE,5YVB0POT2H,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/ea3b2d2c-8b33-d199-e053-2995a90a699c/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ea3b2d2c-8b33-d199-e053-2995a90a699c,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=ea3b2d2c-8b33-d199-e053-2995a90a699c,ea3b2d2c-8b33-d199-e053-2995a90a699c,,,
HUMAN PRESCRIPTION DRUG LABEL,SUSPENSION,ORAL,NDA,011870,DIURIL,CHLOROTHIAZIDE,2021/11/01,Thiazide Diuretic,,SALIX PHARMACEUTICALS INC,1962/02/15-,65649-311,77W477J15H,CHLOROTHIAZIDE,CHLOROTHIAZIDE,77W477J15H,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/bd936e35-1af8-42da-bcc0-f22489d68574/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=bd936e35-1af8-42da-bcc0-f22489d68574,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=bd936e35-1af8-42da-bcc0-f22489d68574,bd936e35-1af8-42da-bcc0-f22489d68574,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRAVENOUS,NDA,011145,Sodium Diuril,CHLOROTHIAZIDE SODIUM,2022/07/01,Thiazide Diuretic,,AKORN,1958/10/03-,76478-711,SN86FG7N2K,chlorothiazide sodium,chlorothiazide,77W477J15H,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/1d9fa4e6-6516-45cd-a316-292c6a529ecc/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1d9fa4e6-6516-45cd-a316-292c6a529ecc,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=1d9fa4e6-6516-45cd-a316-292c6a529ecc,1d9fa4e6-6516-45cd-a316-292c6a529ecc,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,019574,Thalitone,CHLORTHALIDONE,2019/12/30,Thiazide-like Diuretic,1988,CASPER PHARMA LLC,2019/11/27-,70199-001; 70199-017,Q0MQD1073Q,CHLORTHALIDONE,CHLORTHALIDONE,Q0MQD1073Q,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/bc5a0299-115b-4e60-bb3f-c75a95c51c15/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=bc5a0299-115b-4e60-bb3f-c75a95c51c15,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=bc5a0299-115b-4e60-bb3f-c75a95c51c15,bc5a0299-115b-4e60-bb3f-c75a95c51c15,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,NDA,205750,Cholbam,CHOLIC ACID,2023/03/13,Bile Acid,2015,MANCHESTER PHARMACEUTICALS LLC,2015/03/31-,45043-001; 45043-002,G1JO7801AE,CHOLIC ACID,CHOLIC ACID,G1JO7801AE,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/e5b67402-8550-4604-97a0-c7b149fbf753/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e5b67402-8550-4604-97a0-c7b149fbf753,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=e5b67402-8550-4604-97a0-c7b149fbf753,e5b67402-8550-4604-97a0-c7b149fbf753,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRAVENOUS,NDA,203155,Choline C 11,CHOLINE C-11,2024/01/10,Radioactive Diagnostic Agent,2012,MAYO CLINIC,2012/09/12-,52670-556,M4AS4XGD4Q,CHOLINE C-11,CHOLINE C-11,M4AS4XGD4Q,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/8e046642-5038-4094-b1bb-a1915558fb1c/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8e046642-5038-4094-b1bb-a1915558fb1c,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=8e046642-5038-4094-b1bb-a1915558fb1c,8e046642-5038-4094-b1bb-a1915558fb1c,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,018961,CHROMIUM,CHROMIC CHLORIDE,2021/06/28,,,HOSPIRA INC,2005/06/30-,0409-4093,KB1PCR9DMW,CHROMIC CHLORIDE,CHROMIC CATION,X1N4508KF1,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/b4d01ebb-a36e-44b7-028c-43c0ab2d13b4/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b4d01ebb-a36e-44b7-028c-43c0ab2d13b4,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=b4d01ebb-a36e-44b7-028c-43c0ab2d13b4,b4d01ebb-a36e-44b7-028c-43c0ab2d13b4,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,018961,Chromium,CHROMIC CHLORIDE,2021/06/28,,,HOSPIRA INC,2016/04/27-,0409-4093,KB1PCR9DMW,CHROMIC CHLORIDE,CHROMIC CATION,X1N4508KF1,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/da207ca8-7836-4c66-92fe-36cc89baf773/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=da207ca8-7836-4c66-92fe-36cc89baf773,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=da207ca8-7836-4c66-92fe-36cc89baf773,da207ca8-7836-4c66-92fe-36cc89baf773,,,
HUMAN PRESCRIPTION DRUG LABEL,"AEROSOL, METERED",NASAL,NDA,202129,Zetonna,CICLESONIDE,2023/02/16,,2006,COVIS PHARMA US INC,2018/04/30-,70515-737,S59502J185,CICLESONIDE,CICLESONIDE,S59502J185,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/f0316d1b-9ba8-4ef3-9802-4cfed5d91d55/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f0316d1b-9ba8-4ef3-9802-4cfed5d91d55,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=f0316d1b-9ba8-4ef3-9802-4cfed5d91d55,f0316d1b-9ba8-4ef3-9802-4cfed5d91d55,,,
HUMAN PRESCRIPTION DRUG LABEL,"AEROSOL, METERED",INHALATION,NDA,021658,Alvesco,CICLESONIDE,2023/02/16,,2006,COVIS PHARMA US INC,2018/03/26-,70515-711; 70515-712,S59502J185,CICLESONIDE,CICLESONIDE,S59502J185,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/9f6112fb-78ef-43cf-8ae3-36370eb45468/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9f6112fb-78ef-43cf-8ae3-36370eb45468,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=9f6112fb-78ef-43cf-8ae3-36370eb45468,9f6112fb-78ef-43cf-8ae3-36370eb45468,,,
HUMAN PRESCRIPTION DRUG LABEL,SPRAY,NASAL,NDA,022004,Omnaris,CICLESONIDE,2022/11/08,,2006,COVIS PHARMA US INC,2018/04/23-,70515-701,S59502J185,CICLESONIDE,CICLESONIDE,S59502J185,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/15fefd46-ac7e-40d0-b635-e6c3d653c666/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=15fefd46-ac7e-40d0-b635-e6c3d653c666,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=15fefd46-ac7e-40d0-b635-e6c3d653c666,15fefd46-ac7e-40d0-b635-e6c3d653c666,,,
HUMAN PRESCRIPTION DRUG LABEL,SHAMPOO,TOPICAL,NDA,021159,Loprox,CICLOPIROX,2019/05/01,,1982,BAUSCH HEALTH US LLC,2003/03/20-,99207-010,19W019ZDRJ,ciclopirox,ciclopirox,19W019ZDRJ,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/464a1be3-b72b-424d-b11b-a8f26126cce7/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=464a1be3-b72b-424d-b11b-a8f26126cce7,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=464a1be3-b72b-424d-b11b-a8f26126cce7,464a1be3-b72b-424d-b11b-a8f26126cce7,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRAVENOUS,NDA,020638,Vistide,CIDOFOVIR,2013/09/24,Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor,,GILEAD SCIENCES INC,1996/06/26-,61958-0101,JIL713Q00N,CIDOFOVIR,CIDOFOVIR ANHYDROUS,768M1V522C,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/90639fc6-0295-4115-98f0-054b783850ce/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=90639fc6-0295-4115-98f0-054b783850ce,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=90639fc6-0295-4115-98f0-054b783850ce,90639fc6-0295-4115-98f0-054b783850ce,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, COATED",ORAL,NDA,021688,Sensipar,CINACALCET HYDROCHLORIDE,2022/10/18,Calcium-sensing Receptor Agonist,2004,AMGEN INC,2004/04/04-,55513-073; 55513-074; 55513-075,1K860WSG25,CINACALCET HYDROCHLORIDE,CINACALCET,UAZ6V7728S,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/45028573-13c4-4c8b-ae62-6c75bba97c81/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=45028573-13c4-4c8b-ae62-6c75bba97c81,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=45028573-13c4-4c8b-ae62-6c75bba97c81,45028573-13c4-4c8b-ae62-6c75bba97c81,,,
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION/ DROPS,AURICULAR (OTIC),NDA,021918,CETRAXAL,CIPROFLOXACIN,2024/04/20,Fluoroquinolone Antibacterial,1987,WRASER LLC,2009/05/14-,66992-450,4BA73M5E37,CIPROFLOXACIN HYDROCHLORIDE,CIPROFLOXACIN,5E8K9I0O4U,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/213b339a-75e0-4b1d-9052-8ee82a65d713/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=213b339a-75e0-4b1d-9052-8ee82a65d713,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=213b339a-75e0-4b1d-9052-8ee82a65d713,213b339a-75e0-4b1d-9052-8ee82a65d713,,,
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION/ DROPS,AURICULAR (OTIC),NDA,021918,Ciprofloxacin Otic,CIPROFLOXACIN,2024/04/20,Fluoroquinolone Antibacterial,1987,XSPIRE PHARMA LLC,2012/08/27-,42195-550,4BA73M5E37,CIPROFLOXACIN HYDROCHLORIDE,CIPROFLOXACIN,5E8K9I0O4U,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/d0125acf-1879-452d-ba29-c0f753653789/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d0125acf-1879-452d-ba29-c0f753653789,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=d0125acf-1879-452d-ba29-c0f753653789,d0125acf-1879-452d-ba29-c0f753653789,,,
HUMAN PRESCRIPTION DRUG LABEL,SUSPENSION/ DROPS,AURICULAR (OTIC),NDA,021537,CIPRODEX,CIPROFLOXACIN AND DEXAMETHASONE,2023/06/26,Corticosteroid; Fluoroquinolone Antibacterial,2003,NOVARTIS PHARMACEUTICALS CORPORATION,2003/08/04-,0078-0799,4BA73M5E37; 7S5I7G3JQL,Ciprofloxacin Hydrochloride; Dexamethasone,Ciprofloxacin; Dexamethasone,5E8K9I0O4U; 7S5I7G3JQL,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/3e2cf3ea-a8f2-42e3-8424-9a6d6f0a4cb3/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3e2cf3ea-a8f2-42e3-8424-9a6d6f0a4cb3,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=3e2cf3ea-a8f2-42e3-8424-9a6d6f0a4cb3,3e2cf3ea-a8f2-42e3-8424-9a6d6f0a4cb3,,,
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION,AURICULAR (OTIC),NDA,208251,OTOVEL,CIPROFLOXACIN AND FLUOCINOLONE ACETONIDE,2024/04/20,Corticosteroid; Fluoroquinolone Antibacterial,2016,WRASER LLC,2021/10/04-,66992-128,0CD5FD6S2M; 5E8K9I0O4U,CIPROFLOXACIN; FLUOCINOLONE ACETONIDE,CIPROFLOXACIN; FLUOCINOLONE ACETONIDE,0CD5FD6S2M; 5E8K9I0O4U,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/dc17b816-b97f-4c44-9f05-b41f76ab3a52/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=dc17b816-b97f-4c44-9f05-b41f76ab3a52,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=dc17b816-b97f-4c44-9f05-b41f76ab3a52,dc17b816-b97f-4c44-9f05-b41f76ab3a52,,,
HUMAN PRESCRIPTION DRUG LABEL,OINTMENT,OPHTHALMIC,NDA,020369,CILOXAN,CIPROFLOXACIN HYDROCHLORIDE,2023/06/27,Fluoroquinolone Antibacterial,,NOVARTIS PHARMACEUTICALS CORPORATION,1998/06/02-,0078-0841,4BA73M5E37,CIPROFLOXACIN HYDROCHLORIDE,CIPROFLOXACIN,5E8K9I0O4U,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/7b557d15-bd97-42d2-adcb-d172b4216cb6/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7b557d15-bd97-42d2-adcb-d172b4216cb6,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=7b557d15-bd97-42d2-adcb-d172b4216cb6,7b557d15-bd97-42d2-adcb-d172b4216cb6,,,
HUMAN PRESCRIPTION DRUG LABEL,SUSPENSION/ DROPS,AURICULAR (OTIC),NDA,020805,CIPRO HC,CIPROFLOXACIN HYDROCHLORIDE AND HYDROCORTISONE,2023/06/27,Corticosteroid; Fluoroquinolone Antibacterial,,NOVARTIS PHARMACEUTICALS CORPORATION,1999/03/15-,0078-0855,4BA73M5E37; WI4X0X7BPJ,CIPROFLOXACIN HYDROCHLORIDE; HYDROCORTISONE,CIPROFLOXACIN; HYDROCORTISONE,5E8K9I0O4U; WI4X0X7BPJ,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/eff6ee40-6e52-4f61-b54d-edc612543f71/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=eff6ee40-6e52-4f61-b54d-edc612543f71,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=eff6ee40-6e52-4f61-b54d-edc612543f71,eff6ee40-6e52-4f61-b54d-edc612543f71,,,
HUMAN PRESCRIPTION DRUG LABEL,"KIT; TABLET, FILM COATED",ORAL,NDA,019537;020780,Cipro,CIPROFLOXACIN; CIPROFLOXACIN HYDROCHLORIDE,2023/01/31,Fluoroquinolone Antibacterial,1987,BAYER HEALTHCARE PHARMACEUTICALS INC,1987/10/22-; 1997/09/26-,50419-754; 50419-758; 50419-773; 50419-777,4BA73M5E37,CIPROFLOXACIN HYDROCHLORIDE,CIPROFLOXACIN,5E8K9I0O4U,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/888dc7f9-ad9c-4c00-8d50-8ddfd9bd27c0/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=888dc7f9-ad9c-4c00-8d50-8ddfd9bd27c0,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=888dc7f9-ad9c-4c00-8d50-8ddfd9bd27c0,888dc7f9-ad9c-4c00-8d50-8ddfd9bd27c0,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAVENOUS,NDA,018057,Cisplatin,CISPLATIN,2021/09/27,Platinum-based Drug,1978,WG CRITICAL CARE LLC,2019/04/05-,44567-530,Q20Q21Q62J,cisplatin,cisplatin,Q20Q21Q62J,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/508496cb-3441-46b3-a4fe-e0d440e6adc6/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=508496cb-3441-46b3-a4fe-e0d440e6adc6,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=508496cb-3441-46b3-a4fe-e0d440e6adc6,508496cb-3441-46b3-a4fe-e0d440e6adc6,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,018057,CISplatin,CISPLATIN,2021/09/16,Platinum-based Drug,,WG CRITICAL CARE LLC,2012/01/13-; 2015/04/15-,44567-509; 44567-510; 44567-511,Q20Q21Q62J,cisplatin,cisplatin,Q20Q21Q62J,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/2bf8d2fb-80c8-401d-8e9b-d58463f5e954/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2bf8d2fb-80c8-401d-8e9b-d58463f5e954,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=2bf8d2fb-80c8-401d-8e9b-d58463f5e954,2bf8d2fb-80c8-401d-8e9b-d58463f5e954,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,020822,Celexa,CITALOPRAM,2023/10/09,Serotonin Reuptake Inhibitor,1998,ALLERGAN INC,1998/07/17-,0456-4010; 0456-4020; 0456-4040,I1E9D14F36,CITALOPRAM HYDROBROMIDE,citalopram,0DHU5B8D6V,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/4259d9b1-de34-43a4-85a8-41dd214e9177/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4259d9b1-de34-43a4-85a8-41dd214e9177,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=4259d9b1-de34-43a4-85a8-41dd214e9177,4259d9b1-de34-43a4-85a8-41dd214e9177,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,NDA,215428,citalopram,CITALOPRAM,2023/08/24,Serotonin Reuptake Inhibitor,1998,ALMATICA PHARMA LLC,2022/01/31-,52427-691,I1E9D14F36,CITALOPRAM HYDROBROMIDE,CITALOPRAM,0DHU5B8D6V,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/2f815b0c-6da7-cb61-e89c-7de628092d0d/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2f815b0c-6da7-cb61-e89c-7de628092d0d,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=2f815b0c-6da7-cb61-e89c-7de628092d0d,2f815b0c-6da7-cb61-e89c-7de628092d0d,,,
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION,ORAL,NDA,021314,IDkit HP ONE,CITRIC ACID ANHYDROUS AND 13C UREA,2023/09/14,Anti-coagulant; Calculi Dissolution Agent; Helicobacter pylori Diagnostic,,MERIDIAN BIOSCIENCE ISRAEL LTD,2009/12/28-,50402-100,2968PHW8QP; W6KX9E6D8X,CITRIC ACID MONOHYDRATE; UREA C-13,ANHYDROUS CITRIC ACID; UREA C-13,W6KX9E6D8X; XF417D3PSL,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/8baab7a7-5d20-46ad-9c4a-762992ef6b51/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8baab7a7-5d20-46ad-9c4a-762992ef6b51,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=8baab7a7-5d20-46ad-9c4a-762992ef6b51,8baab7a7-5d20-46ad-9c4a-762992ef6b51,,,
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION,IRRIGATION,NDA,019481,Renacidin,"CITRIC ACID, GLUCONOLACTONE AND MAGNESIUM CARBONATE",2019/12/17,Anti-coagulant; Calculi Dissolution Agent,,UNITED GUARDIAN INC,2016/02/01-,0327-0012,0E53J927NA; WQ29KQ9POT; XF417D3PSL,ANHYDROUS CITRIC ACID; GLUCONOLACTONE; MAGNESIUM CARBONATE,ANHYDROUS CITRIC ACID; CARBONATE ION; GLUCONOLACTONE,7UJQ5OPE7D; WQ29KQ9POT; XF417D3PSL,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/13a9bbba-db21-4cba-991c-5d8afaf2ed74/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=13a9bbba-db21-4cba-991c-5d8afaf2ed74,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=13a9bbba-db21-4cba-991c-5d8afaf2ed74,13a9bbba-db21-4cba-991c-5d8afaf2ed74,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,022561,Mavenclad,CLADRIBINE,2024/05/21,Purine Antimetabolite,1993,EMD SERONO INC,2019/04/01-,44087-4000,47M74X9YT5,Cladribine,Cladribine,47M74X9YT5,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/9c75e30a-a410-40f1-b653-04d532bd9144/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9c75e30a-a410-40f1-b653-04d532bd9144,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=9c75e30a-a410-40f1-b653-04d532bd9144,9c75e30a-a410-40f1-b653-04d532bd9144,,,
HUMAN PRESCRIPTION DRUG LABEL,CREAM,TOPICAL,NDA,213433,Winlevi,CLASCOTERONE,2022/07/15,Androgen Receptor Inhibitor,2020,SUN PHARMACEUTICAL INDUSTRIES INC,2021/10/04-,47335-994,XN7MM8XG2M,CLASCOTERONE,CLASCOTERONE,XN7MM8XG2M,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/1673a84b-7f5c-47ab-a99c-1e3db21a6a09/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1673a84b-7f5c-47ab-a99c-1e3db21a6a09,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=1673a84b-7f5c-47ab-a99c-1e3db21a6a09,1673a84b-7f5c-47ab-a99c-1e3db21a6a09,,,
HUMAN PRESCRIPTION DRUG LABEL,EMULSION,INTRAVENOUS,NDA,022156,Cleviprex,CLEVIDIPINE,2022/11/09,Dihydropyridine Calcium Channel Blocker,2008,FRESENIUS KABI AUSTRIA GMBH,2008/09/15-,18124-011,19O2GP3B7Q,CLEVIDIPINE,CLEVIDIPINE,19O2GP3B7Q,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/a6826aa3-fabb-4ff1-a7a3-cd4c34e3a330/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a6826aa3-fabb-4ff1-a7a3-cd4c34e3a330,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=a6826aa3-fabb-4ff1-a7a3-cd4c34e3a330,a6826aa3-fabb-4ff1-a7a3-cd4c34e3a330,,,
HUMAN PRESCRIPTION DRUG LABEL,EMULSION,INTRAVENOUS,NDA,022156,Cleviprex,CLEVIPIDINE,2022/09/06,Dihydropyridine Calcium Channel Blocker,2008,CHIESI USA INC,2008/09/15-,10122-610; 10122-611,19O2GP3B7Q,CLEVIDIPINE,CLEVIDIPINE,19O2GP3B7Q,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/f9290625-b723-4eda-bab8-a97bef6041f6/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f9290625-b723-4eda-bab8-a97bef6041f6,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=f9290625-b723-4eda-bab8-a97bef6041f6,f9290625-b723-4eda-bab8-a97bef6041f6,,,
HUMAN PRESCRIPTION DRUG LABEL,GEL,TOPICAL,NDA,050782,Clindagel,CLINDAMYCIN,2020/01/01,Lincosamide Antibacterial,,BAUSCH HEALTH US LLC,2013/11/25-,16781-462,EH6D7113I8,CLINDAMYCIN PHOSPHATE,CLINDAMYCIN,3U02EL437C,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/f7b4e985-719a-4547-b624-94612d520991/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f7b4e985-719a-4547-b624-94612d520991,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=f7b4e985-719a-4547-b624-94612d520991,f7b4e985-719a-4547-b624-94612d520991,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,NDA,050162,Cleocin Hydrochloride,CLINDAMYCIN HYDROCHLORIDE,2022/11/09,Lincosamide Antibacterial,,PHARMACIA AND UPJOHN COMPANY LLC,1970/05/22-,0009-0225; 0009-0331; 0009-0395,T20OQ1YN1W,CLINDAMYCIN HYDROCHLORIDE,CLINDAMYCIN,3U02EL437C,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/df9a2a41-b132-4f43-8940-b2d773b1369a/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=df9a2a41-b132-4f43-8940-b2d773b1369a,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=df9a2a41-b132-4f43-8940-b2d773b1369a,df9a2a41-b132-4f43-8940-b2d773b1369a,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,208083,clindamycin phosphate,CLINDAMYCIN PHOSPHATE,2024/03/22,Lincosamide Antibacterial,1989,BAXTER HEALTHCARE CORPORATION,2017/04/20-,0338-9545; 0338-9549; 0338-9553,EH6D7113I8,CLINDAMYCIN PHOSPHATE,CLINDAMYCIN,3U02EL437C,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/44fa506b-90ac-42de-831b-5f3f1a500fc0/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=44fa506b-90ac-42de-831b-5f3f1a500fc0,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=44fa506b-90ac-42de-831b-5f3f1a500fc0,44fa506b-90ac-42de-831b-5f3f1a500fc0,,,
HUMAN PRESCRIPTION DRUG LABEL,GEL,VAGINAL,NDA,215650,XACIATO,CLINDAMYCIN PHOSPHATE,2024/02/16,Lincosamide Antibacterial,2021,ORGANON LLC,2023/10/13-,78206-189,EH6D7113I8,Clindamycin phosphate,CLINDAMYCIN,3U02EL437C,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/0423007f-28fa-4159-bf58-9174626d2347/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0423007f-28fa-4159-bf58-9174626d2347,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=0423007f-28fa-4159-bf58-9174626d2347,0423007f-28fa-4159-bf58-9174626d2347,,,
HUMAN PRESCRIPTION DRUG LABEL,SUPPOSITORY,VAGINAL,NDA,050767,Cleocin,CLINDAMYCIN PHOSPHATE,2024/02/06,Lincosamide Antibacterial,,PHARMACIA AND UPJOHN COMPANY LLC,1999/08/13-,0009-7667,EH6D7113I8,CLINDAMYCIN PHOSPHATE,CLINDAMYCIN,3U02EL437C,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/3db26227-208d-4fdd-8426-1d9be5cda9b4/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3db26227-208d-4fdd-8426-1d9be5cda9b4,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=3db26227-208d-4fdd-8426-1d9be5cda9b4,3db26227-208d-4fdd-8426-1d9be5cda9b4,,,
HUMAN PRESCRIPTION DRUG LABEL,CREAM,VAGINAL,NDA,050793,Clindesse,CLINDAMYCIN PHOSPHATE,2023/11/03,Lincosamide Antibacterial,1972,PADAGIS ISRAEL PHARMACEUTICALS LTD,2015/07/03-,45802-042,EH6D7113I8,CLINDAMYCIN PHOSPHATE,CLINDAMYCIN,3U02EL437C,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/fe8bb204-f173-44fe-803b-b08f2ec5aa31/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=fe8bb204-f173-44fe-803b-b08f2ec5aa31,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=fe8bb204-f173-44fe-803b-b08f2ec5aa31,fe8bb204-f173-44fe-803b-b08f2ec5aa31,,,
HUMAN PRESCRIPTION DRUG LABEL,GEL; LOTION; SOLUTION,TOPICAL,NDA,050537;050600;050615,Cleocin T,CLINDAMYCIN PHOSPHATE,2023/01/26,Lincosamide Antibacterial,,PHARMACIA AND UPJOHN COMPANY LLC,1989/05/31-; completed:1980/06/20-2019/03/31; completed:1987/01/07-2021/10/31,0009-3116; 0009-3329; 0009-3331,EH6D7113I8,CLINDAMYCIN PHOSPHATE,CLINDAMYCIN,3U02EL437C,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/4a3901a4-194f-4a15-9c85-3d0982afcf31/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4a3901a4-194f-4a15-9c85-3d0982afcf31,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=4a3901a4-194f-4a15-9c85-3d0982afcf31,4a3901a4-194f-4a15-9c85-3d0982afcf31,,,
HUMAN PRESCRIPTION DRUG LABEL,CREAM,VAGINAL,NDA,050680,Cleocin,CLINDAMYCIN PHOSPHATE,2022/11/11,Lincosamide Antibacterial,,PHARMACIA AND UPJOHN COMPANY LLC,1992/08/11-,0009-3448,EH6D7113I8,CLINDAMYCIN PHOSPHATE,CLINDAMYCIN,3U02EL437C,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/f9be442d-0782-4b93-828f-9ebbf67dbced/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f9be442d-0782-4b93-828f-9ebbf67dbced,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=f9be442d-0782-4b93-828f-9ebbf67dbced,f9be442d-0782-4b93-828f-9ebbf67dbced,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAMUSCULAR; INTRAVENOUS,NDA,050441,Cleocin Phosphate,CLINDAMYCIN PHOSPHATE,2022/11/10,Lincosamide Antibacterial,,PHARMACIA AND UPJOHN COMPANY LLC,2019/11/18-,0009-3051; 0009-4073; 0009-5095,EH6D7113I8,CLINDAMYCIN PHOSPHATE,CLINDAMYCIN,3U02EL437C,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/a0a2eff7-b7de-42fe-8e5a-0cfbed38bb4b/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a0a2eff7-b7de-42fe-8e5a-0cfbed38bb4b,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=a0a2eff7-b7de-42fe-8e5a-0cfbed38bb4b,a0a2eff7-b7de-42fe-8e5a-0cfbed38bb4b,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAMUSCULAR; INTRAVENOUS,ANDA; NDA,050441;050639;062803,CLEOCIN PHOSPHATE (0009-6582) (STANDALONE); Cleocin Phosphate,CLINDAMYCIN PHOSPHATE,2022/11/10,Lincosamide Antibacterial,,PHARMACIA AND UPJOHN COMPANY LLC,1972/10/02-; completed:1987/10/16-2019/04/30; completed:1987/10/16-2019/09/30; completed:1990/08/30-2019/04/30; completed:1990/08/30-2019/06/30,0009-0728; 0009-0775; 0009-0870; 0009-0902; 0009-3124; 0009-3375; 0009-3381; 0009-3382; 0009-3447; 0009-6582,EH6D7113I8,CLINDAMYCIN PHOSPHATE,CLINDAMYCIN,3U02EL437C,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/05a75685-0af5-407c-ac57-e380c882b49d/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=05a75685-0af5-407c-ac57-e380c882b49d,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=05a75685-0af5-407c-ac57-e380c882b49d,05a75685-0af5-407c-ac57-e380c882b49d,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,050441,Clindamycin Phosphate,CLINDAMYCIN PHOSPHATE,2022/07/18,Lincosamide Antibacterial,,ALMAJECT INC,1972/10/02-,72611-634; 72611-639; 72611-642; 72611-645,EH6D7113I8,CLINDAMYCIN PHOSPHATE,CLINDAMYCIN,3U02EL437C,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/dad811c8-6471-4b42-a3ae-045047dd6cb8/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=dad811c8-6471-4b42-a3ae-045047dd6cb8,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=dad811c8-6471-4b42-a3ae-045047dd6cb8,dad811c8-6471-4b42-a3ae-045047dd6cb8,,,
HUMAN PRESCRIPTION DRUG LABEL,GEL,TOPICAL,NDA,050819,Acanya,CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE,2020/09/30,Lincosamide Antibacterial,2000,BAUSCH HEALTH US LLC,2010/07/26-,13548-132,EH6D7113I8; W9WZN9A0GM,Benzoyl Peroxide; Clindamycin Phosphate,Benzoyl Peroxide; Clindamycin,3U02EL437C; W9WZN9A0GM,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/3dcd2c96-72b1-4a9f-b65c-08198d63b7df/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3dcd2c96-72b1-4a9f-b65c-08198d63b7df,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=3dcd2c96-72b1-4a9f-b65c-08198d63b7df,3dcd2c96-72b1-4a9f-b65c-08198d63b7df,,,
HUMAN PRESCRIPTION DRUG LABEL,GEL,TOPICAL,NDA,050819,ONEXTON,CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE,2020/04/06,Lincosamide Antibacterial,2000,BAUSCH HEALTH US LLC,2014/11/24-,0187-3050,EH6D7113I8; W9WZN9A0GM,Benzoyl Peroxide; Clindamycin Phosphate,Benzoyl Peroxide; Clindamycin,3U02EL437C; W9WZN9A0GM,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/697e760a-c206-4565-8f4e-a8085e215827/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=697e760a-c206-4565-8f4e-a8085e215827,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=697e760a-c206-4565-8f4e-a8085e215827,697e760a-c206-4565-8f4e-a8085e215827,,,
HUMAN PRESCRIPTION DRUG LABEL,GEL,TOPICAL,NDA,050756,Benzaclin,CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE,2017/02/16,Lincosamide Antibacterial,,BAUSCH HEALTH US LLC,2000/12/21-,0187-5190,EH6D7113I8; W9WZN9A0GM,BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE,BENZOYL PEROXIDE; CLINDAMYCIN,3U02EL437C; W9WZN9A0GM,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/4c6b2aca-d940-42af-a068-418f015d277a/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4c6b2aca-d940-42af-a068-418f015d277a,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=4c6b2aca-d940-42af-a068-418f015d277a,4c6b2aca-d940-42af-a068-418f015d277a,,,
HUMAN PRESCRIPTION DRUG LABEL,GEL,TOPICAL,NDA,050803,VELTIN,CLINDAMYCIN PHOSPHATE AND TRETINOIN,2021/08/01,Lincosamide Antibacterial; Retinoid,2006,ALMIRALL LLC,2010/07/29-,16110-071,5688UTC01R; EH6D7113I8,CLINDAMYCIN PHOSPHATE; TRETINOIN,CLINDAMYCIN; TRETINOIN,3U02EL437C; 5688UTC01R,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/0dad9bef-cfcc-4216-86c8-9ccd6b8613d8/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0dad9bef-cfcc-4216-86c8-9ccd6b8613d8,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=0dad9bef-cfcc-4216-86c8-9ccd6b8613d8,0dad9bef-cfcc-4216-86c8-9ccd6b8613d8,,,
HUMAN PRESCRIPTION DRUG LABEL,GEL,TOPICAL,NDA,050802,ZIANA,CLINDAMYCIN PHOSPHATE AND TRETINOIN,2017/03/01,Lincosamide Antibacterial; Retinoid,2006,BAUSCH HEALTH US LLC,2006/12/01-,99207-300,5688UTC01R; EH6D7113I8,clindamycin phosphate; tretinoin,clindamycin; tretinoin,3U02EL437C; 5688UTC01R,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/78c329f9-f0c9-486d-9e54-0123699fb9e1/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=78c329f9-f0c9-486d-9e54-0123699fb9e1,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=78c329f9-f0c9-486d-9e54-0123699fb9e1,78c329f9-f0c9-486d-9e54-0123699fb9e1,,,
HUMAN PRESCRIPTION DRUG LABEL,GEL,TOPICAL,NDA,216632,Cabtreo,CLINDAMYCIN PHOSPHATE/BENZOYL PEROXIDE/ADAPALENE,2023/11/07,Lincosamide Antibacterial; Retinoid,2023,BAUSCH HEALTH US LLC,2023/10/20-,0187-0006,1L4806J2QF; EH6D7113I8; W9WZN9A0GM,ADAPALENE; BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE,ADAPALENE; BENZOYL PEROXIDE; CLINDAMYCIN,1L4806J2QF; 3U02EL437C; W9WZN9A0GM,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/9468da0f-9978-4c58-8135-0274c3415084/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9468da0f-9978-4c58-8135-0274c3415084,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=9468da0f-9978-4c58-8135-0274c3415084,9468da0f-9978-4c58-8135-0274c3415084,,,
HUMAN PRESCRIPTION DRUG LABEL,FILM,ORAL,NDA,210833,SYMPAZAN,CLOBAZAM,2024/03/12,Benzodiazepine,2011,AQUESTIVE THERAPEUTICS,2018/11/01-,10094-205; 10094-210; 10094-220,2MRO291B4U,CLOBAZAM,CLOBAZAM,2MRO291B4U,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/5e3d8fcb-aa7d-4822-88fc-4f06264c3242/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5e3d8fcb-aa7d-4822-88fc-4f06264c3242,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=5e3d8fcb-aa7d-4822-88fc-4f06264c3242,5e3d8fcb-aa7d-4822-88fc-4f06264c3242,,,
HUMAN PRESCRIPTION DRUG LABEL,SUSPENSION; TABLET,ORAL,NDA,202067;203993,Onfi,CLOBAZAM,2024/03/12,Benzodiazepine,2011,LUNDBECK PHARMACEUTICALS LLC,2012/12/14-; 2013/12/10-,67386-313; 67386-314; 67386-315,2MRO291B4U,CLOBAZAM,CLOBAZAM,2MRO291B4U,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/de03bd69-2dca-459c-93b4-541fd3e9571c/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=de03bd69-2dca-459c-93b4-541fd3e9571c,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=de03bd69-2dca-459c-93b4-541fd3e9571c,de03bd69-2dca-459c-93b4-541fd3e9571c,,,
HUMAN PRESCRIPTION DRUG LABEL,SUSPENSION/ DROPS,OPHTHALMIC,NDA,218158,CLOBETASOL PROPIONATE,CLOBETASOL PROPIONATE,2024/03/22,Corticosteroid,1985,EYENOVIA INC,2024/03/25-,81046-0319,779619577M,CLOBETASOL PROPIONATE,CLOBETASOL,ADN79D536H,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/7687c980-7006-4222-80b9-c32773772d3e/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7687c980-7006-4222-80b9-c32773772d3e,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=7687c980-7006-4222-80b9-c32773772d3e,7687c980-7006-4222-80b9-c32773772d3e,,,
HUMAN PRESCRIPTION DRUG LABEL,CREAM,TOPICAL,NDA,209483,Impoyz,CLOBETASOL PROPIONATE,2024/01/30,Corticosteroid,1985,PRIMUS PHARMACEUTICALS INC,2021/12/01-,68040-713,779619577M,CLOBETASOL PROPIONATE,CLOBETASOL,ADN79D536H,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/40173654-334e-4618-847b-6a1e030cd2fd/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=40173654-334e-4618-847b-6a1e030cd2fd,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=40173654-334e-4618-847b-6a1e030cd2fd,40173654-334e-4618-847b-6a1e030cd2fd,,,
HUMAN PRESCRIPTION DRUG LABEL,SPRAY,TOPICAL,NDA,021835,CLOBEX,CLOBETASOL PROPIONATE,2023/02/02,Corticosteroid,1985,GALDERMA LABORATORIES L P,2005/10/27-,0299-3849,779619577M,CLOBETASOL PROPIONATE,CLOBETASOL,ADN79D536H,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/aaba92a9-65fb-4150-aec0-9d9f721ca5a5/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=aaba92a9-65fb-4150-aec0-9d9f721ca5a5,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=aaba92a9-65fb-4150-aec0-9d9f721ca5a5,aaba92a9-65fb-4150-aec0-9d9f721ca5a5,,,
HUMAN PRESCRIPTION DRUG LABEL,SHAMPOO,TOPICAL,NDA,021644,Clobex,CLOBETASOL PROPIONATE,2023/01/31,Corticosteroid,1985,GALDERMA LABORATORIES L P,2004/03/01-,0299-3847,779619577M,Clobetasol propionate,Clobetasol,ADN79D536H,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/acb3a25e-5746-4df6-89fd-cf3023e755cc/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=acb3a25e-5746-4df6-89fd-cf3023e755cc,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=acb3a25e-5746-4df6-89fd-cf3023e755cc,acb3a25e-5746-4df6-89fd-cf3023e755cc,,,
HUMAN PRESCRIPTION DRUG LABEL,CREAM,TOPICAL,NDA,209483,Impoyz,CLOBETASOL PROPIONATE,2021/03/24,Corticosteroid,1985,ENCORE DERMATOLOGY INC,2018/01/12-,69482-700,779619577M,CLOBETASOL PROPIONATE,CLOBETASOL,ADN79D536H,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/a1cdc7ca-898e-412b-b814-7492e1afe1ee/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a1cdc7ca-898e-412b-b814-7492e1afe1ee,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=a1cdc7ca-898e-412b-b814-7492e1afe1ee,a1cdc7ca-898e-412b-b814-7492e1afe1ee,,,
HUMAN PRESCRIPTION DRUG LABEL,LOTION,TOPICAL,NDA,021535,Clobex,CLOBETASOL PROPIONATE,2018/02/07,Corticosteroid,1985,GALDERMA LABORATORIES L P,2003/08/01-,0299-3848,779619577M,Clobetasol Propionate,Clobetasol,ADN79D536H,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/54eca64c-af43-48ba-bf86-bab9d8e46bb6/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=54eca64c-af43-48ba-bf86-bab9d8e46bb6,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=54eca64c-af43-48ba-bf86-bab9d8e46bb6,54eca64c-af43-48ba-bf86-bab9d8e46bb6,,,
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION,TOPICAL,NDA,019966,Temovate Scalp Application,CLOBETASOL PROPIONATE,2012/07/06,Corticosteroid,,PHARMADERM A DIVISION OF FOUGERA PHARMACEUTICALS INC,1990/02/22-,0462-0269,779619577M,clobetasol propionate,clobetasol,ADN79D536H,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/b269d3ad-fbae-4ef9-8b3e-e0477ab4615a/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b269d3ad-fbae-4ef9-8b3e-e0477ab4615a,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=b269d3ad-fbae-4ef9-8b3e-e0477ab4615a,b269d3ad-fbae-4ef9-8b3e-e0477ab4615a,,,
HUMAN PRESCRIPTION DRUG LABEL,GEL,TOPICAL,NDA,020337,Temovate,CLOBETASOL PROPIONATE,2012/04/15,Corticosteroid,,PHARMADERM A DIVISION OF FOUGERA PHARMACEUTICALS INC,1994/04/29-,0462-0293,779619577M,clobetasol propionate,clobetasol,ADN79D536H,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/ecc6049d-2c2a-40e0-8780-158b166af406/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ecc6049d-2c2a-40e0-8780-158b166af406,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=ecc6049d-2c2a-40e0-8780-158b166af406,ecc6049d-2c2a-40e0-8780-158b166af406,,,
HUMAN PRESCRIPTION DRUG LABEL,CREAM,TOPICAL,NDA,017765,Cloderm,CLOCORTOLONE PIVALATE,2022/11/02,Corticosteroid,,EPI HEALTH INC,2018/10/30-,71403-804,QBL8IZH14X,clocortolone pivalate,CLOCORTOLONE,N8ZUB7XE0H,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/a8f6ef34-471c-4f30-961b-08cb777a7cd8/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a8f6ef34-471c-4f30-961b-08cb777a7cd8,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=a8f6ef34-471c-4f30-961b-08cb777a7cd8,a8f6ef34-471c-4f30-961b-08cb777a7cd8,,,
HUMAN PRESCRIPTION DRUG LABEL,CREAM,TOPICAL,NDA,017765,Cloderm,CLOCORTOLONE PIVALATE,2019/04/22,Corticosteroid,,PROMIUS PHARMA LLC,1977/08/22-,67857-804,QBL8IZH14X,clocortolone pivalate,clocortolone,N8ZUB7XE0H,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/4abc01f2-03d4-43d5-a085-f452443cfca2/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4abc01f2-03d4-43d5-a085-f452443cfca2,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=4abc01f2-03d4-43d5-a085-f452443cfca2,4abc01f2-03d4-43d5-a085-f452443cfca2,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRAVENOUS,NDA,021673,Clolar,CLOFARABINE,2023/11/15,Nucleoside Metabolic Inhibitor,2004,SANOFI AVENTIS U S LLC,2013/04/01-,0024-5860,762RDY0Y2H,CLOFARABINE,CLOFARABINE,762RDY0Y2H,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/55d3c78b-dca5-436b-97b5-73d166217415/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=55d3c78b-dca5-436b-97b5-73d166217415,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=55d3c78b-dca5-436b-97b5-73d166217415,55d3c78b-dca5-436b-97b5-73d166217415,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,NDA,019906,CLOMIPRAMINE HYDROCHLORIDE,CLOMIPRAMINE HYDROCHLORIDE,2023/12/07,Tricyclic Antidepressant,,SPECGX LLC,2015/06/01-,0406-8806; 0406-8807; 0406-8808,2LXW0L6GWJ,CLOMIPRAMINE HYDROCHLORIDE,CLOMIPRAMINE,NUV44L116D,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/d7cee3fa-d05c-4702-8f75-f446627bdb49/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d7cee3fa-d05c-4702-8f75-f446627bdb49,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=d7cee3fa-d05c-4702-8f75-f446627bdb49,d7cee3fa-d05c-4702-8f75-f446627bdb49,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,NDA,019906,ANAFRANIL,CLOMIPRAMINE HYDROCHLORIDE,2023/11/29,Tricyclic Antidepressant,,SPECGX LLC,1989/12/29-,0406-9906; 0406-9907; 0406-9908,2LXW0L6GWJ,CLOMIPRAMINE HYDROCHLORIDE,CLOMIPRAMINE,NUV44L116D,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/4074b555-7635-41a9-809d-fae3b3610059/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4074b555-7635-41a9-809d-fae3b3610059,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=4074b555-7635-41a9-809d-fae3b3610059,4074b555-7635-41a9-809d-fae3b3610059,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,017533,Klonopin,CLONAZEPAM,2023/12/07,Benzodiazepine,,H PHARMA LLC,1975/06/02-,61269-605; 61269-610; 61269-620,5PE9FDE8GB,CLONAZEPAM,CLONAZEPAM,5PE9FDE8GB,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/cfa0d79a-843c-4b88-95a1-e9511d649ca1/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=cfa0d79a-843c-4b88-95a1-e9511d649ca1,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=cfa0d79a-843c-4b88-95a1-e9511d649ca1,cfa0d79a-843c-4b88-95a1-e9511d649ca1,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",EPIDURAL,NDA,020615,Duraclon,CLONIDINE HYDROCHLORIDE,2021/03/17,Central alpha-2 Adrenergic Agonist,,MYLAN INSTITUTIONAL LLC,1997/01/26-,67457-218,W76I6XXF06,CLONIDINE HYDROCHLORIDE,CLONIDINE,MN3L5RMN02,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/8c126bb8-732a-4949-8754-2f50b5543638/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8c126bb8-732a-4949-8754-2f50b5543638,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=8c126bb8-732a-4949-8754-2f50b5543638,8c126bb8-732a-4949-8754-2f50b5543638,,,
HUMAN PRESCRIPTION DRUG LABEL,PATCH,TRANSDERMAL,NDA,018891,"Clonidine Transdermal System USP, 0.1 mg/day; Clonidine Transdermal System USP, 0.2 mg/day; Clonidine Transdermal System USP, 0.3 mg/day",CLONIDINE TRANSDERMAL SYSTEM,2023/06/30,Central alpha-2 Adrenergic Agonist,,TRUPHARMA LLC,2023/06/30-,52817-610; 52817-611; 52817-612,MN3L5RMN02,CLONIDINE,CLONIDINE,MN3L5RMN02,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/05d520bf-3ab7-4337-9f38-4418e5e7e1e9/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=05d520bf-3ab7-4337-9f38-4418e5e7e1e9,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=05d520bf-3ab7-4337-9f38-4418e5e7e1e9,05d520bf-3ab7-4337-9f38-4418e5e7e1e9,,,
HUMAN PRESCRIPTION DRUG LABEL,PATCH,TRANSDERMAL,NDA,018891,Catapres-TTS-1; Catapres-TTS-2; Catapres-TTS-3,CLONIDINE TRANSDERMAL SYSTEM,2023/03/25,Central alpha-2 Adrenergic Agonist,,TECHNOMED INC,completed:2022/03/01-2026/10/30,82089-101; 82089-102; 82089-103,MN3L5RMN02,CLONIDINE,CLONIDINE,MN3L5RMN02,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/d4a55825-7041-42f4-b3b2-dd7a25dbe793/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d4a55825-7041-42f4-b3b2-dd7a25dbe793,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=d4a55825-7041-42f4-b3b2-dd7a25dbe793,d4a55825-7041-42f4-b3b2-dd7a25dbe793,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,020839,Plavix,CLOPIDOGREL,2022/09/22,P2Y12 Platelet Inhibitor,1997,SANOFI AVENTIS U S LLC,1997/11/17-; 2009/05/09-,0024-1171; 0024-1332,08I79HTP27,CLOPIDOGREL BISULFATE,CLOPIDOGREL,A74586SNO7,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/de8b0b67-eb25-4684-83b5-7ad785314227/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=de8b0b67-eb25-4684-83b5-7ad785314227,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=de8b0b67-eb25-4684-83b5-7ad785314227,de8b0b67-eb25-4684-83b5-7ad785314227,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,019758,Clozaril,CLOZAPINE,2023/05/23,Atypical Antipsychotic,1989,HLS THERAPEUTICS USA INC,2016/05/06-; 2019/12/17-,69809-0126; 69809-0127; 69809-0130; 69809-0135,J60AR2IKIC,CLOZAPINE,CLOZAPINE,J60AR2IKIC,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/90876802-0e3a-44c9-9ff7-1754dfbe736a/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=90876802-0e3a-44c9-9ff7-1754dfbe736a,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=90876802-0e3a-44c9-9ff7-1754dfbe736a,90876802-0e3a-44c9-9ff7-1754dfbe736a,,,
HUMAN PRESCRIPTION DRUG LABEL,SUSPENSION,ORAL,NDA,203479,VERSACLOZ,CLOZAPINE,2023/03/24,Atypical Antipsychotic,1989,TRUPHARMA LLC,2018/06/15-,52817-601,J60AR2IKIC,CLOZAPINE,CLOZAPINE,J60AR2IKIC,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/2592c9a8-fd74-4e0d-a895-b07b014cf355/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2592c9a8-fd74-4e0d-a895-b07b014cf355,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=2592c9a8-fd74-4e0d-a895-b07b014cf355,2592c9a8-fd74-4e0d-a895-b07b014cf355,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,203094,Tybost,COBICISTAT,2021/09/15,Cytochrome P450 3A Inhibitor,2012,GILEAD SCIENCES INC,2014/09/24-,61958-1401,LW2E03M5PG,COBICISTAT,COBICISTAT,LW2E03M5PG,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/3784c35c-e87f-410c-900b-8fd6313c6010/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3784c35c-e87f-410c-900b-8fd6313c6010,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=3784c35c-e87f-410c-900b-8fd6313c6010,3784c35c-e87f-410c-900b-8fd6313c6010,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,206192,Cotellic,COBIMETINIB,2023/06/09,Kinase Inhibitor,2015,GENENTECH INC,2015/11/10-,50242-717,6EXI96H8SV,COBIMETINIB FUMARATE,COBIMETINIB,ER29L26N1X,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/c387579e-cee0-4334-bd1e-73f93ac1bde6/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c387579e-cee0-4334-bd1e-73f93ac1bde6,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=c387579e-cee0-4334-bd1e-73f93ac1bde6,c387579e-cee0-4334-bd1e-73f93ac1bde6,,,
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION,NASAL,NDA,209963,GOPRELTO,COCAINE HYDROCHLORIDE,2023/08/08,,2017,GENUS LIFESCIENCES INC,2018/01/08-,64950-359,XH8T8T6WZH,cocaine hydrochloride,cocaine,I5Y540LHVR,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/689750b7-8e51-47d9-a428-078f3f6c9dec/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=689750b7-8e51-47d9-a428-078f3f6c9dec,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=689750b7-8e51-47d9-a428-078f3f6c9dec,689750b7-8e51-47d9-a428-078f3f6c9dec,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,022402,Codeine sulfate,CODEINE SULFATE,2023/12/15,Opioid Agonist,1950,HIKMA PHARMACEUTICALS USA INC,2009/07/16-,0054-0243; 0054-0244; 0054-0245,11QV9BS0CB,CODEINE SULFATE,CODEINE ANHYDROUS,UX6OWY2V7J,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/010905f9-3bcb-4b50-9fe8-a3ad0010f14c/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=010905f9-3bcb-4b50-9fe8-a3ad0010f14c,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=010905f9-3bcb-4b50-9fe8-a3ad0010f14c,010905f9-3bcb-4b50-9fe8-a3ad0010f14c,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,NDA,204820,Colchicine,COLCHICINE,2024/05/22,Alkaloid,1961,HIKMA PHARMACEUTICALS USA INC,2014/10/01-,0143-3018,SML2Y3J35T,COLCHICINE,COLCHICINE,SML2Y3J35T,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/ee1583ac-c308-4beb-b602-9ecac4977026/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ee1583ac-c308-4beb-b602-9ecac4977026,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=ee1583ac-c308-4beb-b602-9ecac4977026,ee1583ac-c308-4beb-b602-9ecac4977026,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,NDA,204820,MITIGARE,COLCHICINE,2024/05/16,Alkaloid,1961,HIKMA SPECIALTY USA INC,2014/10/01-,59467-318,SML2Y3J35T,COLCHICINE,COLCHICINE,SML2Y3J35T,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/cb5f9d85-6b81-49f8-bcd6-17b7bfbc10f2/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=cb5f9d85-6b81-49f8-bcd6-17b7bfbc10f2,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=cb5f9d85-6b81-49f8-bcd6-17b7bfbc10f2,cb5f9d85-6b81-49f8-bcd6-17b7bfbc10f2,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,022352,Colcrys,COLCHICINE,2023/12/29,Alkaloid,1961,TAKEDA PHARMACEUTICALS AMERICA INC,2009/09/01-,64764-119,SML2Y3J35T,Colchicine,Colchicine,SML2Y3J35T,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/56c130d1-7581-4152-99a2-0014ee9366c0/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=56c130d1-7581-4152-99a2-0014ee9366c0,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=56c130d1-7581-4152-99a2-0014ee9366c0,56c130d1-7581-4152-99a2-0014ee9366c0,,,
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION,ORAL,NDA,210942,Gloperba,COLCHICINE,2023/12/28,Alkaloid,1961,SCILEX PHARMACEUTICALS INC,2024/01/31-,69557-222,SML2Y3J35T,Colchicine,Colchicine,SML2Y3J35T,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/467cd83f-d695-4040-9434-10e80b4271da/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=467cd83f-d695-4040-9434-10e80b4271da,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=467cd83f-d695-4040-9434-10e80b4271da,467cd83f-d695-4040-9434-10e80b4271da,,,
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION,ORAL,NDA,210942,Gloperba,COLCHICINE,2019/02/05,Alkaloid,1961,ROMEG THERAPEUTICS LLC,2019/08/01-,72690-010,SML2Y3J35T,COLCHICINE,COLCHICINE,SML2Y3J35T,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/6971137c-deef-4309-909e-552f1930999d/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6971137c-deef-4309-909e-552f1930999d,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=6971137c-deef-4309-909e-552f1930999d,6971137c-deef-4309-909e-552f1930999d,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,022352,Colcrys,COLCHICINE,2012/03/15,Alkaloid,1961,AR SCIENTIFIC INC,2009/09/01-,13310-119,SML2Y3J35T,Colchicine,Colchicine,SML2Y3J35T,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/5ecaa34e-1bed-49a5-b97c-a8f8c0d885a7/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5ecaa34e-1bed-49a5-b97c-a8f8c0d885a7,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=5ecaa34e-1bed-49a5-b97c-a8f8c0d885a7,5ecaa34e-1bed-49a5-b97c-a8f8c0d885a7,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,215727,LODOCO,COLCHICINE TABLETS 0.5 MG,2023/08/24,Alkaloid,,AGEPHA PHARMA USA LLC,2023/06/16-,82867-001,SML2Y3J35T,COLCHICINE,COLCHICINE,SML2Y3J35T,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/ff06d68f-d65f-d097-e053-6294a90a7e5f/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ff06d68f-d65f-d097-e053-6294a90a7e5f,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=ff06d68f-d65f-d097-e053-6294a90a7e5f,ff06d68f-d65f-d097-e053-6294a90a7e5f,,,
HUMAN PRESCRIPTION DRUG LABEL,"FOR SUSPENSION; TABLET, FILM COATED",ORAL,NDA,021176;022362,COLESEVELAM HYDROCHLORIDE,COLESEVELAM HYDROCHLORIDE,2022/09/12,Bile Acid Sequestrant,2000,COSETTE PHARMACEUTICALS INC,2022/08/01-,0713-0935; 0713-0936,P4SG24WI5Q,COLESEVELAM HYDROCHLORIDE,COLESEVELAM,1XU104G55N,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/15ceb7db-ef59-4182-99b6-09b6c3c5430a/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=15ceb7db-ef59-4182-99b6-09b6c3c5430a,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=15ceb7db-ef59-4182-99b6-09b6c3c5430a,15ceb7db-ef59-4182-99b6-09b6c3c5430a,,,
HUMAN PRESCRIPTION DRUG LABEL,"FOR SUSPENSION; TABLET, FILM COATED",ORAL,NDA,021176;022362,Welchol,COLESEVELAM HYDROCHLORIDE,2022/09/07,Bile Acid Sequestrant,2000,COSETTE PHARMACEUTICALS INC,2022/09/01-,0713-0879; 0713-0880,P4SG24WI5Q,COLESEVELAM HYDROCHLORIDE,COLESEVELAM,1XU104G55N,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/89cbd0a3-2d1b-41db-8c97-35ec67b7b09f/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=89cbd0a3-2d1b-41db-8c97-35ec67b7b09f,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=89cbd0a3-2d1b-41db-8c97-35ec67b7b09f,89cbd0a3-2d1b-41db-8c97-35ec67b7b09f,,,
HUMAN PRESCRIPTION DRUG LABEL,"BAR, CHEWABLE; FOR SUSPENSION; TABLET, FILM COATED",ORAL,NDA,021176;022362;210895,Welchol,COLESEVELAM HYDROCHLORIDE,2022/06/10,Bile Acid Sequestrant,2000,DAIICHI SANKYO INC,completed:2000/09/01-2025/09/30; completed:2010/01/01-2019/01/16; completed:2010/01/01-2026/02/28; completed:2019/04/04-2019/04/04,65597-208; 65597-209; 65597-210; 65597-701; 65597-902; 65597-903,P4SG24WI5Q,COLESEVELAM HYDROCHLORIDE,COLESEVELAM,1XU104G55N,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/4a06d3b2-7229-4398-baba-5d0a72f63821/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4a06d3b2-7229-4398-baba-5d0a72f63821,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=4a06d3b2-7229-4398-baba-5d0a72f63821,4a06d3b2-7229-4398-baba-5d0a72f63821,,,
HUMAN PRESCRIPTION DRUG LABEL,"GRANULE, FOR SUSPENSION",ORAL,NDA,017563,Colestid; Flavored Colestid,COLESTIPOL HYDROCHLORIDE,2023/11/29,Bile Acid Sequestrant,,PHARMACIA AND UPJOHN COMPANY LLC,1977/06/01-; completed:1977/06/01-2024/04/30,0009-0260; 0009-0370,X7D10K905G,COLESTIPOL HYDROCHLORIDE,COLESTIPOL,K50N755924,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/21b37725-fc0c-4365-a7dc-1a473d42502d/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=21b37725-fc0c-4365-a7dc-1a473d42502d,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=21b37725-fc0c-4365-a7dc-1a473d42502d,21b37725-fc0c-4365-a7dc-1a473d42502d,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,020222,Colestid,COLESTIPOL HYDROCHLORIDE,2023/08/30,Bile Acid Sequestrant,,PHARMACIA AND UPJOHN COMPANY LLC,1994/07/19-,0009-0450,X7D10K905G,COLESTIPOL HYDROCHLORIDE,COLESTIPOL,K50N755924,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/3e270911-f27b-44d4-b0a2-33506418cc1d/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3e270911-f27b-44d4-b0a2-33506418cc1d,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=3e270911-f27b-44d4-b0a2-33506418cc1d,3e270911-f27b-44d4-b0a2-33506418cc1d,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRAMUSCULAR; INTRAVENOUS,NDA,050108,Coly-Mycin M,COLISTIMETHATE,2018/12/03,Polymyxin-class Antibacterial,,PAR PHARMACEUTICAL INC,2007/11/01-,42023-107,XW0E5YS77G,COLISTIMETHATE SODIUM,COLISTIMETHATE,DL2R53P963,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/6d6e13e2-dc33-4b7b-84d0-66146a57c552/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6d6e13e2-dc33-4b7b-84d0-66146a57c552,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=6d6e13e2-dc33-4b7b-84d0-66146a57c552,6d6e13e2-dc33-4b7b-84d0-66146a57c552,,,
HUMAN PRESCRIPTION DRUG LABEL,SUSPENSION,AURICULAR (OTIC),NDA,050356,Cortisporin TC,"COLISTIN SULFATE, NEOMYCIN SULFATE, THONZONIUM BROMIDE AND HYDROCORTISONE ACETATE",2019/01/15,Aminoglycoside Antibacterial; Corticosteroid,,ENDO PHARMACEUTICALS INC,2019/06/03-,63481-529,057Y626693; 3X7931PO74; JI2B19CR0R; WP15DXU577,COLISTIN SULFATE; HYDROCORTISONE ACETATE; NEOMYCIN SULFATE; THONZONIUM BROMIDE,COLISTIN; HYDROCORTISONE; NEOMYCIN; THONZONIUM,I16QD7X297; WI4X0X7BPJ; Z05ZE98FV8; Z67X93HJG1,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/9c6fc1c7-3350-42ae-b999-aca48e704bb1/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9c6fc1c7-3350-42ae-b999-aca48e704bb1,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=9c6fc1c7-3350-42ae-b999-aca48e704bb1,9c6fc1c7-3350-42ae-b999-aca48e704bb1,,,
HUMAN PRESCRIPTION DRUG LABEL,CREAM,VAGINAL,NDA,020216,Premarin Vaginal,CONJUGATED ESTROGENS,2024/02/28,Estrogen,1946,WYETH PHARMACEUTICALS LLC A SUBSIDIARY OF PFIZER INC,1978/11/01-,0046-0872,IU5QR144QX,"ESTROGENS, CONJUGATED","ESTROGENS, CONJUGATED",IU5QR144QX,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/96609623-528e-4aba-cabe-7254aed816d5/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=96609623-528e-4aba-cabe-7254aed816d5,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=96609623-528e-4aba-cabe-7254aed816d5,96609623-528e-4aba-cabe-7254aed816d5,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAMUSCULAR; INTRAVENOUS,NDA,010402,Premarin,CONJUGATED ESTROGENS,2024/02/28,Estrogen,,WYETH PHARMACEUTICALS LLC A SUBSIDIARY OF PFIZER INC,1956/12/01-,0046-0749,IU5QR144QX,"ESTROGENS, CONJUGATED","ESTROGENS, CONJUGATED",IU5QR144QX,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/87e2da8d-432c-4ed5-67a1-dc26294b2295/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=87e2da8d-432c-4ed5-67a1-dc26294b2295,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=87e2da8d-432c-4ed5-67a1-dc26294b2295,87e2da8d-432c-4ed5-67a1-dc26294b2295,,,
HUMAN PRESCRIPTION DRUG LABEL,"KIT; TABLET, SUGAR COATED",ORAL,NDA,020527,Premphase; Prempro,CONJUGATED ESTROGENS AND MEDROXYPROGESTERONE ACETATE,2024/02/20,Estrogen; Progestin,1995,WYETH PHARMACEUTICALS LLC A SUBSIDIARY OF PFIZER INC,2009/09/21-; 2012/03/01-; 2012/12/03-,0046-1105; 0046-1106; 0046-1107; 0046-1108; 0046-2575,C2QI4IOI2G; IU5QR144QX,"ESTROGENS, CONJUGATED; MEDROXYPROGESTERONE ACETATE","ESTROGENS, CONJUGATED; MEDROXYPROGESTERONE",HSU1C9YRES; IU5QR144QX,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/fd0c0836-5d23-2183-da81-9dc7f4287052/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=fd0c0836-5d23-2183-da81-9dc7f4287052,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=fd0c0836-5d23-2183-da81-9dc7f4287052,fd0c0836-5d23-2183-da81-9dc7f4287052,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,022247,Duavee,CONJUGATED ESTROGENS/BAZEDOXIFENE,2024/03/13,Estrogen; Estrogen Agonist/Antagonist,2013,WYETH PHARMACEUTICALS LLC A SUBSIDIARY OF PFIZER INC,2013/10/03-,0008-1123,IU5QR144QX; J70472UD3D,"BAZEDOXIFENE ACETATE; ESTROGENS, CONJUGATED","BAZEDOXIFENE; ESTROGENS, CONJUGATED",IU5QR144QX; Q16TT9C5BK,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/e1b75458-2e5b-46b9-92c6-fa6daba3770f/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e1b75458-2e5b-46b9-92c6-fa6daba3770f,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=e1b75458-2e5b-46b9-92c6-fa6daba3770f,e1b75458-2e5b-46b9-92c6-fa6daba3770f,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,022247,Duavee,CONJUGATED ESTROGENS/BAZEDOXIFENE,2023/11/01,Estrogen; Estrogen Agonist/Antagonist,2013,U S PHARMACEUTICALS,2013/11/15-,63539-122,IU5QR144QX; J70472UD3D,"BAZEDOXIFENE ACETATE; ESTROGENS, CONJUGATED","BAZEDOXIFENE; ESTROGENS, CONJUGATED",IU5QR144QX; Q16TT9C5BK,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/e16705d8-4472-4f83-96ac-69fa2be066cb/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e16705d8-4472-4f83-96ac-69fa2be066cb,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=e16705d8-4472-4f83-96ac-69fa2be066cb,e16705d8-4472-4f83-96ac-69fa2be066cb,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAVENOUS,NDA,209936,ALIQOPA,COPANLISIB,2023/09/07,Kinase Inhibitor,2017,BAYER HEALTHCARE PHARMACEUTICALS INC,2017/09/14-,50419-385,WI6V529FZ9,COPANLISIB,COPANLISIB,WI6V529FZ9,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/ade50241-2c10-4038-b4e9-72f6bf905f03/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ade50241-2c10-4038-b4e9-72f6bf905f03,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=ade50241-2c10-4038-b4e9-72f6bf905f03,ade50241-2c10-4038-b4e9-72f6bf905f03,,,
HUMAN PRESCRIPTION DRUG LABEL,INTRAUTERINE DEVICE,INTRAUTERINE,NDA,018680,ParaGard T 380A,COPPER,2019/09/01,Copper-containing Intrauterine Device,1984,COOPERSURGICAL INC,2017/11/02-,59365-5128,789U1901C5,COPPER,COPPER,789U1901C5,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/5ea7ce51-b87a-485e-b841-99466a07a4b2/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5ea7ce51-b87a-485e-b841-99466a07a4b2,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=5ea7ce51-b87a-485e-b841-99466a07a4b2,5ea7ce51-b87a-485e-b841-99466a07a4b2,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,213227,Detectnet,COPPER CU 64 DOTATATE,2021/12/22,Radioactive Diagnostic Agent,2020,CURIUM US LLC,2020/09/14-,69945-064,N3858377KC,COPPER OXODOTREOTIDE CU-64,COPPER OXODOTREOTIDE CU-64,N3858377KC,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/f898c8a7-beb7-4318-a8ea-6f058d69342b/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f898c8a7-beb7-4318-a8ea-6f058d69342b,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=f898c8a7-beb7-4318-a8ea-6f058d69342b,f898c8a7-beb7-4318-a8ea-6f058d69342b,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAMUSCULAR; INTRAVENOUS,NDA,016750,Cortrosyn,COSYNTROPIN,2024/02/28,Adrenocorticotropic Hormone,,AMPHASTAR PHARMACEUTICALS INC,2003/08/01-,0548-5900,72YY86EA29,Cosyntropin,Cosyntropin,72YY86EA29,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/746856e9-3930-4f6a-b8e6-a03845d6dd0b/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=746856e9-3930-4f6a-b8e6-a03845d6dd0b,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=746856e9-3930-4f6a-b8e6-a03845d6dd0b,746856e9-3930-4f6a-b8e6-a03845d6dd0b,,,
HUMAN PRESCRIPTION DRUG LABEL,OINTMENT,TOPICAL,NDA,207695,Eucrisa,CRISABOROLE,2024/01/16,Phosphodiesterase 4 Inhibitor,2016,PFIZER LABORATORIES DIV PFIZER INC,2017/01/30-,55724-211,Q2R47HGR7P,CRISABOROLE,CRISABOROLE,Q2R47HGR7P,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/609b77de-1ca3-4783-b8f5-01a9c0f1d77d/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=609b77de-1ca3-4783-b8f5-01a9c0f1d77d,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=609b77de-1ca3-4783-b8f5-01a9c0f1d77d,609b77de-1ca3-4783-b8f5-01a9c0f1d77d,,,
HUMAN PRESCRIPTION DRUG LABEL,"CAPSULE; CAPSULE, COATED PELLETS",ORAL,NDA,202570;217581,Xalkori,CRIZOTINIB,2023/11/20,Kinase Inhibitor,2011,PFIZER LABORATORIES DIV PFIZER INC,2011/08/26-; 2023/11/20-,0069-0251; 0069-0507; 0069-1500; 0069-8140; 0069-8141,53AH36668S,CRIZOTINIB,CRIZOTINIB,53AH36668S,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/2a51b0de-47d6-455e-a94c-d2c737b04ff7/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2a51b0de-47d6-455e-a94c-d2c737b04ff7,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=2a51b0de-47d6-455e-a94c-d2c737b04ff7,2a51b0de-47d6-455e-a94c-d2c737b04ff7,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, COATED",ORAL,NDA,202292,MYTESI,CROFELEMER,2024/02/08,Antidiarrheal,2012,NAPO PHARMACEUTICALS INC,2016/08/01-,70564-802,PY79D6C8RX,CROFELEMER,CROFELEMER,PY79D6C8RX,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/45584fba-8081-4cd1-a21e-3ea8237f62ff/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=45584fba-8081-4cd1-a21e-3ea8237f62ff,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=45584fba-8081-4cd1-a21e-3ea8237f62ff,45584fba-8081-4cd1-a21e-3ea8237f62ff,,,
HUMAN PRESCRIPTION DRUG LABEL,LIQUID,ORAL,NDA,020479,Gastrocrom,CROMOLYN SODIUM,2018/10/10,Mast Cell Stabilizer,,MEDA PHARMACEUTICALS,2015/05/01-,0037-0678,Q2WXR1I0PK,CROMOLYN SODIUM,CROMOLYN,Y0TK0FS77W,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/00623958-a8fe-47d1-a0d2-0aa4e2f7966e/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=00623958-a8fe-47d1-a0d2-0aa4e2f7966e,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=00623958-a8fe-47d1-a0d2-0aa4e2f7966e,00623958-a8fe-47d1-a0d2-0aa4e2f7966e,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,018960,COPPER,CUPRIC CHLORIDE,2022/06/30,,,HOSPIRA INC,2005/02/28-,0409-4092,S2QG84156O,CUPRIC CHLORIDE,CUPRIC CATION,8CBV67279L,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/a84d61a4-8e7f-4be1-aba6-f633b334aafc/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a84d61a4-8e7f-4be1-aba6-f633b334aafc,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=a84d61a4-8e7f-4be1-aba6-f633b334aafc,a84d61a4-8e7f-4be1-aba6-f633b334aafc,,,
HUMAN PRESCRIPTION DRUG LABEL,SPRAY,NASAL,NDA,021642,Nascobal,CYANOCOBALAMIN,2018/11/30,Vitamin B12,1942,PAR PHARMACEUTICAL INC,2009/08/13-,49884-270,P6YC3EG204,CYANOCOBALAMIN,CYANOCOBALAMIN,P6YC3EG204,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/697e0e52-c01b-4b53-9994-f79c46eb6b4f/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=697e0e52-c01b-4b53-9994-f79c46eb6b4f,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=697e0e52-c01b-4b53-9994-f79c46eb6b4f,697e0e52-c01b-4b53-9994-f79c46eb6b4f,,,
HUMAN PRESCRIPTION DRUG LABEL,SPRAY,NASAL,NDA,021642,Nascobal,CYANOCOBALAMIN,2015/02/20,Vitamin B12,,PAR PHARMACEUTICAL INC,2009/08/13-,49884-270,P6YC3EG204,CYANOCOBALAMIN,CYANOCOBALAMIN,P6YC3EG204,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/0a6178f6-48af-4a1d-9b35-c3c2663d0b10/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0a6178f6-48af-4a1d-9b35-c3c2663d0b10,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=0a6178f6-48af-4a1d-9b35-c3c2663d0b10,0a6178f6-48af-4a1d-9b35-c3c2663d0b10,,,
HUMAN PRESCRIPTION DRUG LABEL,"CAPSULE, EXTENDED RELEASE",ORAL,NDA,021777,AMRIX,CYCLOBENZAPRINE HYDROCHLORIDE,2024/04/29,Muscle Relaxant,1977,CEPHALON LLC,2007/10/01-; 2007/10/02-,63459-700; 63459-701,0VE05JYS2P,CYCLOBENZAPRINE HYDROCHLORIDE,CYCLOBENZAPRINE,69O5WQQ5TI,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/3902123b-1365-ac3c-0934-afff9eeeb1bd/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3902123b-1365-ac3c-0934-afff9eeeb1bd,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=3902123b-1365-ac3c-0934-afff9eeeb1bd,3902123b-1365-ac3c-0934-afff9eeeb1bd,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,212501,Cyclophosphamide,CYCLOPHOSPHAMIDE,2024/03/03,,1959,ATHENEX PHARMACEUTICAL DIVISION LLC,completed:2020/12/11-2024/10/31,70860-218,6UXW23996M,CYCLOPHOSPHAMIDE ANHYDROUS,4-HYDROXYCYCLOPHOSPHAMIDE,1XBF4E50HS,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/a0e99679-f939-4fb3-9d38-dfdb824f89bc/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a0e99679-f939-4fb3-9d38-dfdb824f89bc,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=a0e99679-f939-4fb3-9d38-dfdb824f89bc,a0e99679-f939-4fb3-9d38-dfdb824f89bc,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRAVENOUS,NDA,210735,Cyclophosphamide,CYCLOPHOSPHAMIDE,2024/01/05,Alkylating Drug,1959,EUGIA US LLC,2023/11/20-,55150-270; 55150-271; 55150-272,8N3DW7272P,CYCLOPHOSPHAMIDE,CYCLOPHOSPHAMIDE ANHYDROUS,6UXW23996M,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/7b2418f8-8581-4f47-8861-b9dee79fa6bb/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7b2418f8-8581-4f47-8861-b9dee79fa6bb,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=7b2418f8-8581-4f47-8861-b9dee79fa6bb,7b2418f8-8581-4f47-8861-b9dee79fa6bb,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,212501,CYCLOPHOSPHAMIDE,CYCLOPHOSPHAMIDE,2023/11/01,Alkylating Drug,1959,GOLDEN STATE MEDICAL SUPPLY INC,2020/07/30-; 2021/11/19-,51407-748; 51407-749; 51407-750,6UXW23996M,CYCLOPHOSPHAMIDE ANHYDROUS,CYCLOPHOSPHAMIDE ANHYDROUS,6UXW23996M,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/f75a4037-38e8-c59d-e053-6294a90a3927/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f75a4037-38e8-c59d-e053-6294a90a3927,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=f75a4037-38e8-c59d-e053-6294a90a3927,f75a4037-38e8-c59d-e053-6294a90a3927,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,212501,CYCLOPHOSPHAMIDE,CYCLOPHOSPHAMIDE,2023/09/27,Alkylating Drug,1959,INGENUS PHARMACEUTICALS LLC,2020/07/30-; 2021/11/19-,50742-519; 50742-520; 50742-521,6UXW23996M,CYCLOPHOSPHAMIDE ANHYDROUS,CYCLOPHOSPHAMIDE ANHYDROUS,6UXW23996M,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/783d7523-8505-4b3e-837c-cefbcec61da6/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=783d7523-8505-4b3e-837c-cefbcec61da6,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=783d7523-8505-4b3e-837c-cefbcec61da6,783d7523-8505-4b3e-837c-cefbcec61da6,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION, CONCENTRATE",INTRAVENOUS,NDA,217150,Cyclophosphamide,CYCLOPHOSPHAMIDE,2023/09/08,,1959,SANDOZ INC,2024/04/08-,0781-3528; 0781-3529; 0781-3530,8N3DW7272P,CYCLOPHOSPHAMIDE,4-HYDROXYCYCLOPHOSPHAMIDE,1XBF4E50HS,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/cf2f4b95-0327-499a-a5a3-51b1bdef68c5/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=cf2f4b95-0327-499a-a5a3-51b1bdef68c5,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=cf2f4b95-0327-499a-a5a3-51b1bdef68c5,cf2f4b95-0327-499a-a5a3-51b1bdef68c5,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,NDA,203856,Cyclophosphamide,CYCLOPHOSPHAMIDE,2023/07/13,Alkylating Drug,1959,HIKMA PHARMACEUTICALS USA INC,2013/09/16-,0054-0382; 0054-0383,8N3DW7272P,CYCLOPHOSPHAMIDE,CYCLOPHOSPHAMIDE ANHYDROUS,6UXW23996M,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/8135b917-882f-4b4c-99b7-fa8ea54af4bf/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8135b917-882f-4b4c-99b7-fa8ea54af4bf,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=8135b917-882f-4b4c-99b7-fa8ea54af4bf,8135b917-882f-4b4c-99b7-fa8ea54af4bf,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,217651,CYCLOPHOSPHAMIDE,CYCLOPHOSPHAMIDE,2023/07/11,Alkylating Drug,1959,NEVAKAR INJECTABLES INC,2024/01/01-,82943-100; 82943-101,8N3DW7272P,CYCLOPHOSPHAMIDE,CYCLOPHOSPHAMIDE ANHYDROUS,6UXW23996M,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/9895cdbd-79cc-4bce-8e16-1c2e045e2592/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9895cdbd-79cc-4bce-8e16-1c2e045e2592,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=9895cdbd-79cc-4bce-8e16-1c2e045e2592,9895cdbd-79cc-4bce-8e16-1c2e045e2592,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRAVENOUS,NDA,210852,Cyclophosphamide,CYCLOPHOSPHAMIDE,2023/06/01,Alkylating Drug,1959,DR REDDY S LABORATORIES INC,2023/07/24-,43598-660; 43598-661; 43598-662,8N3DW7272P,Cyclophosphamide,Cyclophosphamide Anhydrous,6UXW23996M,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/d3f5c4e9-1c96-c816-7aad-57a2cc1080f8/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d3f5c4e9-1c96-c816-7aad-57a2cc1080f8,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=d3f5c4e9-1c96-c816-7aad-57a2cc1080f8,d3f5c4e9-1c96-c816-7aad-57a2cc1080f8,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,212501,CYCLOPHOSPHAMIDE,CYCLOPHOSPHAMIDE,2023/05/05,Alkylating Drug,1959,BLUEPOINT LABORATORIES,2023/02/20-,68001-563; 68001-564; 68001-565,6UXW23996M,CYCLOPHOSPHAMIDE ANHYDROUS,CYCLOPHOSPHAMIDE ANHYDROUS,6UXW23996M,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/0afd2cc7-09e6-481a-afea-9d2e3742da46/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0afd2cc7-09e6-481a-afea-9d2e3742da46,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=0afd2cc7-09e6-481a-afea-9d2e3742da46,0afd2cc7-09e6-481a-afea-9d2e3742da46,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRAVENOUS,NDA,210735,Cyclophosphamide,CYCLOPHOSPHAMIDE,2021/09/08,Alkylating Drug,1959,AUROMEDICS PHARMA LLC,2021/08/25-,55150-270; 55150-271,8N3DW7272P,CYCLOPHOSPHAMIDE,CYCLOPHOSPHAMIDE ANHYDROUS,6UXW23996M,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/3c1eb470-0bba-457d-94e3-b9508f0d398a/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3c1eb470-0bba-457d-94e3-b9508f0d398a,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=3c1eb470-0bba-457d-94e3-b9508f0d398a,3c1eb470-0bba-457d-94e3-b9508f0d398a,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA; NDA Authorized Generic,012141;012141,Cyclophosphamide,CYCLOPHOSPHAMIDE,2020/08/07,,1959,BAXTER HEALTHCARE CORPORATION,2020/08/07-,10019-982; 10019-984,8N3DW7272P,CYCLOPHOSPHAMIDE,4-HYDROXYCYCLOPHOSPHAMIDE,1XBF4E50HS,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/769ded74-6186-40a8-8e44-ceff67287451/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=769ded74-6186-40a8-8e44-ceff67287451,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=769ded74-6186-40a8-8e44-ceff67287451,769ded74-6186-40a8-8e44-ceff67287451,,,
HUMAN PRESCRIPTION DRUG LABEL,"CAPSULE, LIQUID FILLED; SOLUTION",ORAL,NDA,050715;050716,Neoral,CYCLOSPORINE,2024/01/09,Calcineurin Inhibitor Immunosuppressant,,NOVARTIS PHARMACEUTICALS CORPORATION,1995/07/14-,0078-0246; 0078-0248; 0078-0274,83HN0GTJ6D,CYCLOSPORINE,CYCLOSPORINE,83HN0GTJ6D,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/94461af3-11f1-4670-95d4-2965b9538ae3/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=94461af3-11f1-4670-95d4-2965b9538ae3,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=94461af3-11f1-4670-95d4-2965b9538ae3,94461af3-11f1-4670-95d4-2965b9538ae3,,,
HUMAN PRESCRIPTION DRUG LABEL,"CAPSULE, LIQUID FILLED; INJECTION; SOLUTION",INTRAVENOUS; ORAL,NDA,050573;050574;050625,Sandimmune,CYCLOSPORINE,2024/01/09,Calcineurin Inhibitor Immunosuppressant,,NOVARTIS PHARMACEUTICALS CORPORATION,1983/11/14-; 1990/03/02-,0078-0109; 0078-0110; 0078-0240; 0078-0241,83HN0GTJ6D,CYCLOSPORINE,CYCLOSPORINE,83HN0GTJ6D,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/5e5926a7-1de0-4b54-a5c0-286b6200ff82/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5e5926a7-1de0-4b54-a5c0-286b6200ff82,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=5e5926a7-1de0-4b54-a5c0-286b6200ff82,5e5926a7-1de0-4b54-a5c0-286b6200ff82,,,
HUMAN PRESCRIPTION DRUG LABEL,EMULSION,OPHTHALMIC; TOPICAL,NDA,214965,Verkazia,CYCLOSPORINE,2023/10/12,Calcineurin Inhibitor Immunosuppressant,1983,SANTEN INCORPORATED,2022/02/01-,65086-001,83HN0GTJ6D,CYCLOSPORINE,CYCLOSPORINE,83HN0GTJ6D,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/c795cd2f-89da-78e3-e053-2a95a90a9422/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c795cd2f-89da-78e3-e053-2a95a90a9422,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=c795cd2f-89da-78e3-e053-2a95a90a9422,c795cd2f-89da-78e3-e053-2a95a90a9422,,,
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION/ DROPS,OPHTHALMIC; TOPICAL,NDA,210913,CEQUA,CYCLOSPORINE,2023/04/26,Calcineurin Inhibitor Immunosuppressant,1983,SUN PHARMACEUTICAL INDUSTRIES INC,2018/08/15-,47335-506; 47335-507,83HN0GTJ6D,CYCLOSPORINE,CYCLOSPORINE,83HN0GTJ6D,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/48c3d8a3-4289-4b52-9189-58b48596095c/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=48c3d8a3-4289-4b52-9189-58b48596095c,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=48c3d8a3-4289-4b52-9189-58b48596095c,48c3d8a3-4289-4b52-9189-58b48596095c,,,
HUMAN PRESCRIPTION DRUG LABEL,EMULSION,OPHTHALMIC,NDA,050790,RESTASIS,CYCLOSPORINE,2017/07/01,Calcineurin Inhibitor Immunosuppressant,1983,ALLERGAN INC,2003/04/01-,0023-9163,83HN0GTJ6D,CYCLOSPORINE,CYCLOSPORINE,83HN0GTJ6D,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/8e24af2b-bc1c-4849-94f2-6df950cdca89/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8e24af2b-bc1c-4849-94f2-6df950cdca89,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=8e24af2b-bc1c-4849-94f2-6df950cdca89,8e24af2b-bc1c-4849-94f2-6df950cdca89,,,
HUMAN PRESCRIPTION DRUG LABEL,EMULSION,OPHTHALMIC,NDA,050790,Restasis MultiDose,CYCLOSPORINE,2016/10/01,Calcineurin Inhibitor Immunosuppressant,1983,ALLERGAN INC,2016/11/10-,0023-5301,83HN0GTJ6D,CYCLOSPORINE,CYCLOSPORINE,83HN0GTJ6D,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/7224d810-bb96-4682-a942-3355e6e8061a/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7224d810-bb96-4682-a942-3355e6e8061a,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=7224d810-bb96-4682-a942-3355e6e8061a,7224d810-bb96-4682-a942-3355e6e8061a,,,
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION/ DROPS,OPHTHALMIC,NDA,217469,VEVYE,CYCLOSPORINE OPHTHALMIC SOLUTION,2023/11/21,Calcineurin Inhibitor Immunosuppressant,1983,HARROW EYE LLC,2023/05/30-,82667-900,83HN0GTJ6D,CYCLOSPORINE,CYCLOSPORINE,83HN0GTJ6D,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/0a60fccf-7e1b-44fe-e063-6394a90aadd5/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0a60fccf-7e1b-44fe-e063-6394a90aadd5,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=0a60fccf-7e1b-44fe-e063-6394a90aadd5,0a60fccf-7e1b-44fe-e063-6394a90aadd5,,,
HUMAN PRESCRIPTION DRUG LABEL,"CAPSULE, DELAYED RELEASE PELLETS; GRANULE, DELAYED RELEASE",ORAL,NDA,203389;213491,PROCYSBI,CYSTEAMINE BITARTRATE,2022/02/22,Cystine Depleting Agent,1994,HORIZON THERAPEUTICS USA INC,2013/04/30-; 2020/02/14-,75987-100; 75987-101; 75987-140; 75987-145,QO84GZ3TST,CYSTEAMINE BITARTRATE,CYSTEAMINE,5UX2SD1KE2,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/d3a3ec28-f746-463a-bb92-3bc8826db09e/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d3a3ec28-f746-463a-bb92-3bc8826db09e,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=d3a3ec28-f746-463a-bb92-3bc8826db09e,d3a3ec28-f746-463a-bb92-3bc8826db09e,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,NDA,020392,Cystagon,CYSTEAMINE BITARTRATE,2021/08/16,Cystine Depleting Agent,,MYLAN PHARMACEUTICALS INC,2005/04/11-,0378-9040; 0378-9045,QO84GZ3TST,CYSTEAMINE BITARTRATE,CYSTEAMINE,5UX2SD1KE2,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/f495b76d-96c6-48e5-8fa3-30a4336628eb/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f495b76d-96c6-48e5-8fa3-30a4336628eb,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=f495b76d-96c6-48e5-8fa3-30a4336628eb,f495b76d-96c6-48e5-8fa3-30a4336628eb,,,
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION,OPHTHALMIC,NDA,200740,CYSTARAN,CYSTEAMINE HYDROCHLORIDE,2024/05/16,Cystine Depleting Agent,1994,LEADIANT BIOSCIENCES INC,2012/12/30-,54482-020,IF1B771SVB,CYSTEAMINE HYDROCHLORIDE,CYSTEAMINE,5UX2SD1KE2,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/b98ee838-ed23-42a9-93b5-72579e490fba/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b98ee838-ed23-42a9-93b5-72579e490fba,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=b98ee838-ed23-42a9-93b5-72579e490fba,b98ee838-ed23-42a9-93b5-72579e490fba,,,
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION,OPHTHALMIC,NDA,211302,CYSTADROPS,CYSTEAMINE HYDROCHLORIDE,2024/02/01,Cystine Depleting Agent,1994,RECORDATI RARE DISEASES INC,2020/08/19-,55292-410,IF1B771SVB,Cysteamine Hydrochloride,Cysteamine,5UX2SD1KE2,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/5d2bcce3-9b89-4141-aeb7-db00449047f5/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5d2bcce3-9b89-4141-aeb7-db00449047f5,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=5d2bcce3-9b89-4141-aeb7-db00449047f5,5d2bcce3-9b89-4141-aeb7-db00449047f5,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,210660,ELCYS,CYSTEINE HYDROCHLORIDE,2024/02/01,,1971,EXELA PHARMA SCIENCES LLC,2019/05/28-,51754-1007,ZT934N0X4W,CYSTEINE HYDROCHLORIDE,CYSTEINE,K848JZ4886,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/e7652275-1c53-490c-82ad-e63867df5788/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e7652275-1c53-490c-82ad-e63867df5788,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=e7652275-1c53-490c-82ad-e63867df5788,e7652275-1c53-490c-82ad-e63867df5788,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,210660,ELCYS,CYSTEINE HYDROCHLORIDE,2024/02/01,,1971,EXELA PHARMA SCIENCES LLC,2023/12/12-,51754-1008,ZT934N0X4W,CYSTEINE HYDROCHLORIDE,CYSTEINE,K848JZ4886,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/9a52ae2f-1cea-4ad5-a074-66bbf06578d3/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9a52ae2f-1cea-4ad5-a074-66bbf06578d3,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=9a52ae2f-1cea-4ad5-a074-66bbf06578d3,9a52ae2f-1cea-4ad5-a074-66bbf06578d3,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRAVENOUS,NDA,212535,CYSTEINE HYDROCHLORIDE,CYSTEINE HYDROCHLORIDE,2022/04/29,,1971,BAXTER HEALTHCARE CORPORATION,2022/04/29-,0338-9645,ZT934N0X4W,CYSTEINE HYDROCHLORIDE,CYSTEINE,K848JZ4886,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/cbf70fc3-14b3-4c17-8de8-acba1e12ac95/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=cbf70fc3-14b3-4c17-8de8-acba1e12ac95,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=cbf70fc3-14b3-4c17-8de8-acba1e12ac95,cbf70fc3-14b3-4c17-8de8-acba1e12ac95,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRAVENOUS,NDA,212535,Nouress,CYSTEINE HYDROCHLORIDE,2020/01/30,,1971,AVADEL LEGACY PHARMACEUTICALS LLC,2020/04/01-,76014-006,ZT934N0X4W,CYSTEINE HYDROCHLORIDE,CYSTEINE,K848JZ4886,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/627cc059-4124-49b3-a3d3-2eb3ed918bc7/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=627cc059-4124-49b3-a3d3-2eb3ed918bc7,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=627cc059-4124-49b3-a3d3-2eb3ed918bc7,627cc059-4124-49b3-a3d3-2eb3ed918bc7,,,
HUMAN PRESCRIPTION DRUG LABEL,PELLET,ORAL,NDA,214358,Pradaxa,DABIGATRAN ETEXILATE,2023/11/27,Direct Thrombin Inhibitor,2010,BOEHRINGER INGELHEIM PHARMACEUTICALS INC,2022/03/16-,0597-0425; 0597-0430; 0597-0435; 0597-0440; 0597-0445; 0597-0450,SC7NUW5IIT,DABIGATRAN ETEXILATE MESYLATE,DABIGATRAN,I0VM4M70GC,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/9ac0a64a-8666-45f7-9d4f-40fd894f7e6d/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9ac0a64a-8666-45f7-9d4f-40fd894f7e6d,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=9ac0a64a-8666-45f7-9d4f-40fd894f7e6d,9ac0a64a-8666-45f7-9d4f-40fd894f7e6d,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,NDA,022512,Pradaxa,DABIGATRAN ETEXILATE MESYLATE,2023/11/28,Direct Thrombin Inhibitor,2010,BOEHRINGER INGELHEIM PHARMACEUTICALS INC,2011/08/08-; 2015/11/23-; 2017/07/28-,0597-0108; 0597-0355; 0597-0360,SC7NUW5IIT,DABIGATRAN ETEXILATE MESYLATE,DABIGATRAN,I0VM4M70GC,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/ba74e3cd-b06f-4145-b284-5fd6b84ff3c9/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ba74e3cd-b06f-4145-b284-5fd6b84ff3c9,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=ba74e3cd-b06f-4145-b284-5fd6b84ff3c9,ba74e3cd-b06f-4145-b284-5fd6b84ff3c9,,,
HUMAN PRESCRIPTION DRUG LABEL,"CAPSULE; TABLET, FOR SUSPENSION",ORAL,NDA,202806;217514,Tafinlar,DABRAFENIB,2024/03/29,Kinase Inhibitor,2013,NOVARTIS PHARMACEUTICALS CORPORATION,2016/04/01-; 2016/04/12-; 2023/03/16-,0078-0681; 0078-0682; 0078-1154,B6DC89I63E,DABRAFENIB MESYLATE,DABRAFENIB,QGP4HA4G1B,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/fee1e6b1-e1a5-4254-9f2e-a70e0f8dbdea/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=fee1e6b1-e1a5-4254-9f2e-a70e0f8dbdea,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=fee1e6b1-e1a5-4254-9f2e-a70e0f8dbdea,fee1e6b1-e1a5-4254-9f2e-a70e0f8dbdea,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,211288,Vizimpro,DACOMITINIB,2023/10/13,,2018,U S PHARMACEUTICALS,2019/02/01-,63539-197,5092U85G58,DACOMITINIB,DACOMITINIB ANHYDROUS,2XJX250C20,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/90da33c1-5689-4b4d-a2b5-377e1057a843/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=90da33c1-5689-4b4d-a2b5-377e1057a843,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=90da33c1-5689-4b4d-a2b5-377e1057a843,90da33c1-5689-4b4d-a2b5-377e1057a843,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,211288,Vizimpro,DACOMITINIB,2023/10/13,,2018,PFIZER LABORATORIES DIV PFIZER INC,2018/10/04-,0069-0197; 0069-1198; 0069-2299,5092U85G58,DACOMITINIB,DACOMITINIB ANHYDROUS,2XJX250C20,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/4ab27d2f-e385-4e9c-b324-fa69c10b855a/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4ab27d2f-e385-4e9c-b324-fa69c10b855a,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=4ab27d2f-e385-4e9c-b324-fa69c10b855a,4ab27d2f-e385-4e9c-b324-fa69c10b855a,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAVENOUS,NDA,050682,Cosmegen,DACTINOMYCIN,2024/01/18,Actinomycin,1964,RECORDATI RARE DISEASES INC,completed:1964/12/10-2024/11/30,55292-811,1CC1JFE158,DACTINOMYCIN,DACTINOMYCIN,1CC1JFE158,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/9914e793-a49c-eb00-1ab7-f606c786fe25/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9914e793-a49c-eb00-1ab7-f606c786fe25,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=9914e793-a49c-eb00-1ab7-f606c786fe25,9914e793-a49c-eb00-1ab7-f606c786fe25,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, POWDER, FOR SOLUTION",INTRAVENOUS,NDA,021883,DALVANCE,DALBAVANCIN,2024/04/29,Lipoglycopeptide Antibacterial,2014,ALLERGAN INC,2014/05/23-,57970-100,33WDQ7T81E,DALBAVANCIN HYDROCHLORIDE,DALBAVANCIN,808UI9MS5K,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/4b4674d8-4d1e-4728-8465-d42ada33fa5c/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4b4674d8-4d1e-4728-8465-d42ada33fa5c,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=4b4674d8-4d1e-4728-8465-d42ada33fa5c,4b4674d8-4d1e-4728-8465-d42ada33fa5c,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,NDA,022250,AMPYRA,DALFAMPRIDINE,2024/03/12,Potassium Channel Blocker,2010,ACORDA THERAPEUTICS INC,2010/03/01-,10144-427,BH3B64OKL9,DALFAMPRIDINE,DALFAMPRIDINE,BH3B64OKL9,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/550eb76a-e4a6-4fa1-ad65-c0fd8b0ce783/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=550eb76a-e4a6-4fa1-ad65-c0fd8b0ce783,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=550eb76a-e4a6-4fa1-ad65-c0fd8b0ce783,550eb76a-e4a6-4fa1-ad65-c0fd8b0ce783,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,SUBCUTANEOUS,NDA,020287,Fragmin,DALTEPARIN SODIUM,2023/09/16,Anti-coagulant; Low Molecular Weight Heparin,1994,PFIZER LABORATORIES DIV PFIZER INC,2015/04/01-; 2022/10/17-,0069-0195; 0069-0196; 0069-0206; 0069-0217; 0069-0220; 0069-0223; 0069-0228; 0069-0232; 0069-0253,12M44VTJ7B,DALTEPARIN SODIUM,DALTEPARIN,S79O08V79F,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/23527b8b-9b28-4e6d-9751-33b143975ac7/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=23527b8b-9b28-4e6d-9751-33b143975ac7,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=23527b8b-9b28-4e6d-9751-33b143975ac7,23527b8b-9b28-4e6d-9751-33b143975ac7,,,
HUMAN PRESCRIPTION DRUG LABEL,"KIT; TABLET, FILM COATED",ORAL,NDA,218037,Voydeya,DANICOPAN,2024/04/03,,2024,ALEXION PHARMACEUTICALS INC,2024/03/29-,25682-043; 25682-046; 25682-049,JM8C1SFX0U,Danicopan,Danicopan,JM8C1SFX0U,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/ab8d1cbd-a28b-4d49-82ab-5c7460719ac7/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ab8d1cbd-a28b-4d49-82ab-5c7460719ac7,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=ab8d1cbd-a28b-4d49-82ab-5c7460719ac7,ab8d1cbd-a28b-4d49-82ab-5c7460719ac7,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRAVENOUS,NDA,018264,Dantrium,DANTROLENE SODIUM,2024/04/10,Skeletal Muscle Relaxant,,PAR PHARMACEUTICAL INC,2009/04/20-,42023-123,287M0347EV,DANTROLENE SODIUM,DANTROLENE,F64QU97QCR,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/4df35098-8702-46be-ac67-30cfdf1aa570/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4df35098-8702-46be-ac67-30cfdf1aa570,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=4df35098-8702-46be-ac67-30cfdf1aa570,4df35098-8702-46be-ac67-30cfdf1aa570,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SUSPENSION",INTRAVENOUS,NDA,205579,RYANODEX dantrolene sodium,DANTROLENE SODIUM,2024/04/08,Skeletal Muscle Relaxant,1974,EAGLE PHARMACEUTICALS INC,2014/07/23-,42367-540,287M0347EV,DANTROLENE SODIUM,DANTROLENE,F64QU97QCR,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/8f7b3ac0-604d-4c78-b545-5e0f8ea3d698/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8f7b3ac0-604d-4c78-b545-5e0f8ea3d698,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=8f7b3ac0-604d-4c78-b545-5e0f8ea3d698,8f7b3ac0-604d-4c78-b545-5e0f8ea3d698,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,NDA,017443,Dantrium,DANTROLENE SODIUM,2018/03/01,Skeletal Muscle Relaxant,,PAR PHARMACEUTICAL INC,2008/08/01-; completed:2008/08/01-2015/07/31; completed:2008/08/01-2022/02/28,42023-124; 42023-125; 42023-126,287M0347EV,DANTROLENE SODIUM,DANTROLENE,F64QU97QCR,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/57b4eec1-49e1-432c-95ae-0fe36e32d64b/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=57b4eec1-49e1-432c-95ae-0fe36e32d64b,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=57b4eec1-49e1-432c-95ae-0fe36e32d64b,57b4eec1-49e1-432c-95ae-0fe36e32d64b,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,202293,FARXIGA,DAPAGLIFLOZIN,2024/01/15,Sodium-Glucose Cotransporter 2 Inhibitor,2014,ASTRAZENECA PHARMACEUTICALS LP,2008/01/14-,0310-6205; 0310-6210,887K2391VH,DAPAGLIFLOZIN PROPANEDIOL,dapagliflozin,1ULL0QJ8UC,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/72ad22ae-efe6-4cd6-a302-98aaee423d69/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=72ad22ae-efe6-4cd6-a302-98aaee423d69,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=72ad22ae-efe6-4cd6-a302-98aaee423d69,72ad22ae-efe6-4cd6-a302-98aaee423d69,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,NDA,205649,XIGDUO XR,DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE,2023/09/12,Biguanide; Sodium-Glucose Cotransporter 2 Inhibitor,2014,ASTRAZENECA PHARMACEUTICALS LP,2014/10/29-,0310-6225; 0310-6250; 0310-6260; 0310-6270; 0310-6280,786Z46389E; 887K2391VH,DAPAGLIFLOZIN PROPANEDIOL; METFORMIN HYDROCHLORIDE,dapagliflozin; metformin,1ULL0QJ8UC; 9100L32L2N,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/ac8a0f7b-9f69-4495-abbc-3a47cd75a859/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ac8a0f7b-9f69-4495-abbc-3a47cd75a859,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=ac8a0f7b-9f69-4495-abbc-3a47cd75a859,ac8a0f7b-9f69-4495-abbc-3a47cd75a859,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,209091,QTERN,DAPAGLIFLOZIN AND SAXAGLIPTIN,2023/09/29,Dipeptidyl Peptidase 4 Inhibitor; Sodium-Glucose Cotransporter 2 Inhibitor,2017,ASTRAZENECA PHARMACEUTICALS LP,2017/12/04-,0310-6770; 0310-6780,1ULL0QJ8UC; Z8J84YIX6L,DAPAGLIFLOZIN; SAXAGLIPTIN HYDROCHLORIDE,DAPAGLIFLOZIN; SAXAGLIPTIN ANHYDROUS,1ULL0QJ8UC; 8I7IO46IVQ,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/423c489c-085b-4320-b892-7868ebd6dc6b/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=423c489c-085b-4320-b892-7868ebd6dc6b,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=423c489c-085b-4320-b892-7868ebd6dc6b,423c489c-085b-4320-b892-7868ebd6dc6b,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,216951,Jesduvroq,DAPRODUSTAT,2023/08/30,Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitor,2023,GLAXOSMITHKLINE LLC,2023/02/01-,0173-0897; 0173-0903; 0173-0906; 0173-0911; 0173-0914,JVR38ZM64B,DAPRODUSTAT,DAPRODUSTAT,JVR38ZM64B,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/d82aa06e-5a33-4844-99b7-4701313455a4/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d82aa06e-5a33-4844-99b7-4701313455a4,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=d82aa06e-5a33-4844-99b7-4701313455a4,d82aa06e-5a33-4844-99b7-4701313455a4,,,
HUMAN PRESCRIPTION DRUG LABEL,GEL,TOPICAL,NDA,207154,Aczone,DAPSONE,2024/03/25,Sulfone,1955,ALMIRALL LLC,2019/09/10-,16110-526,8W5C518302,DAPSONE,DAPSONE,8W5C518302,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/22058b7d-a578-4eaa-a476-ac982337f02a/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=22058b7d-a578-4eaa-a476-ac982337f02a,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=22058b7d-a578-4eaa-a476-ac982337f02a,22058b7d-a578-4eaa-a476-ac982337f02a,,,
HUMAN PRESCRIPTION DRUG LABEL,GEL,TOPICAL,NDA,021794,Aczone,DAPSONE,2023/06/12,Sulfone,1955,ALMIRALL LLC,2021/02/12-,16110-367,8W5C518302,DAPSONE,DAPSONE,8W5C518302,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/fc4ac90b-8962-4b9b-8c69-b1ea59d00009/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=fc4ac90b-8962-4b9b-8c69-b1ea59d00009,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=fc4ac90b-8962-4b9b-8c69-b1ea59d00009,fc4ac90b-8962-4b9b-8c69-b1ea59d00009,,,
HUMAN PRESCRIPTION DRUG LABEL,GEL,TOPICAL,NDA,021794,ACZONE,DAPSONE,2018/05/28,Sulfone,1955,ALLERGAN INC,2009/06/24-,0023-3670,8W5C518302,DAPSONE,DAPSONE,8W5C518302,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/b7d605cf-bf84-461b-939b-1f773a4cba65/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b7d605cf-bf84-461b-939b-1f773a4cba65,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=b7d605cf-bf84-461b-939b-1f773a4cba65,b7d605cf-bf84-461b-939b-1f773a4cba65,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAVENOUS,NDA,213645,DAPZURA RT,DAPTOMYCIN,2024/05/06,Lipopeptide Antibacterial,2003,BAMBOO US BIDCO LLC,2022/01/25-,83703-035,NWQ5N31VKK,DAPTOMYCIN,DAPTOMYCIN,NWQ5N31VKK,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/17405aa0-70a5-53b0-e063-6394a90a8b51/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=17405aa0-70a5-53b0-e063-6394a90a8b51,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=17405aa0-70a5-53b0-e063-6394a90a8b51,17405aa0-70a5-53b0-e063-6394a90a8b51,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAVENOUS,NDA,209949,Daptomycin,DAPTOMYCIN,2024/04/08,Lipopeptide Antibacterial,2003,XELLIA PHARMACEUTICALS USA LLC,2019/03/15-,70594-053,NWQ5N31VKK,DAPTOMYCIN,DAPTOMYCIN,NWQ5N31VKK,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/97c47c18-985d-4373-88f7-a86ec591ea44/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=97c47c18-985d-4373-88f7-a86ec591ea44,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=97c47c18-985d-4373-88f7-a86ec591ea44,97c47c18-985d-4373-88f7-a86ec591ea44,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAVENOUS,NDA,209949,Daptomycin,DAPTOMYCIN,2024/04/05,Lipopeptide Antibacterial,2003,CIVICA INC,2019/09/03-,72572-100,NWQ5N31VKK,DAPTOMYCIN,DAPTOMYCIN,NWQ5N31VKK,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/bcacf746-a3ee-48b5-bfbe-6a2b548ad24c/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=bcacf746-a3ee-48b5-bfbe-6a2b548ad24c,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=bcacf746-a3ee-48b5-bfbe-6a2b548ad24c,bcacf746-a3ee-48b5-bfbe-6a2b548ad24c,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAVENOUS,NDA,217415,Daptomycin,DAPTOMYCIN,2023/11/07,Lipopeptide Antibacterial,2003,XELLIA PHARMACEUTICALS USA LLC,2023/11/03-,70594-060; 70594-066,NWQ5N31VKK,DAPTOMYCIN,DAPTOMYCIN,NWQ5N31VKK,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/5e1f739a-eb81-43d8-9a14-89f32b7e1ba1/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5e1f739a-eb81-43d8-9a14-89f32b7e1ba1,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=5e1f739a-eb81-43d8-9a14-89f32b7e1ba1,5e1f739a-eb81-43d8-9a14-89f32b7e1ba1,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAVENOUS,NDA,021572,Cubicin,DAPTOMYCIN,2023/08/24,Lipopeptide Antibacterial,2003,MERCK SHARP AND DOHME LLC,2003/09/12-,67919-011,NWQ5N31VKK,Daptomycin,Daptomycin,NWQ5N31VKK,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/a7975871-46a6-4e9b-a8b5-38bfcb465f0e/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a7975871-46a6-4e9b-a8b5-38bfcb465f0e,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=a7975871-46a6-4e9b-a8b5-38bfcb465f0e,a7975871-46a6-4e9b-a8b5-38bfcb465f0e,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAVENOUS,NDA,021572,CUBICIN RF,DAPTOMYCIN,2023/08/14,Lipopeptide Antibacterial,2003,MERCK SHARP AND DOHME LLC,2016/07/06-,67919-012,NWQ5N31VKK,Daptomycin,Daptomycin,NWQ5N31VKK,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/0b1a8885-2198-4a0e-8105-0c76c1cba6c2/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0b1a8885-2198-4a0e-8105-0c76c1cba6c2,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=0b1a8885-2198-4a0e-8105-0c76c1cba6c2,0b1a8885-2198-4a0e-8105-0c76c1cba6c2,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAVENOUS,NDA,210282,Daptomycin,DAPTOMYCIN,2022/08/18,Lipopeptide Antibacterial,2003,HOSPIRA INC,2021/08/02-,0409-0120; 0409-0122,NWQ5N31VKK,DAPTOMYCIN,DAPTOMYCIN,NWQ5N31VKK,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/1957b6ce-7382-4a7b-bf02-3595948d09c6/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1957b6ce-7382-4a7b-bf02-3595948d09c6,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=1957b6ce-7382-4a7b-bf02-3595948d09c6,1957b6ce-7382-4a7b-bf02-3595948d09c6,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAVENOUS,NDA,208385,Daptomycin,DAPTOMYCIN,2022/06/17,Lipopeptide Antibacterial,2003,SAGENT PHARMACEUTICALS,2020/02/01-,25021-179,NWQ5N31VKK,Daptomycin,Daptomycin,NWQ5N31VKK,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/4a0ad110-e55e-4d3b-84f8-dd0b924fe2f6/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4a0ad110-e55e-4d3b-84f8-dd0b924fe2f6,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=4a0ad110-e55e-4d3b-84f8-dd0b924fe2f6,4a0ad110-e55e-4d3b-84f8-dd0b924fe2f6,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAVENOUS,NDA,213645,DAPZURA RT,DAPTOMYCIN,2022/01/25,Lipopeptide Antibacterial,2003,BAXTER HEALTHCARE CORPORATION,2022/01/25-,60977-145,NWQ5N31VKK,DAPTOMYCIN,DAPTOMYCIN,NWQ5N31VKK,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/cb1283e1-35b8-425c-b338-d9ac0c7161f8/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=cb1283e1-35b8-425c-b338-d9ac0c7161f8,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=cb1283e1-35b8-425c-b338-d9ac0c7161f8,cb1283e1-35b8-425c-b338-d9ac0c7161f8,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAVENOUS,NDA,208385,Daptomycin,DAPTOMYCIN,2021/12/31,Lipopeptide Antibacterial,2003,SAGENT PHARMACEUTICALS,2018/01/15-,25021-179,NWQ5N31VKK,Daptomycin,Daptomycin,NWQ5N31VKK,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/548f3559-0531-4c95-9e1d-81f81a3801f1/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=548f3559-0531-4c95-9e1d-81f81a3801f1,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=548f3559-0531-4c95-9e1d-81f81a3801f1,548f3559-0531-4c95-9e1d-81f81a3801f1,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAVENOUS,NDA,209949,Daptomycin,DAPTOMYCIN,2019/10/07,Lipopeptide Antibacterial,2003,XELLIA PHARMACEUTICALS USA LLC,2018/07/19-,45932-0039,NWQ5N31VKK,DAPTOMYCIN,DAPTOMYCIN,NWQ5N31VKK,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/e3e6b91e-c673-46da-a654-2bb1312cb02b/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e3e6b91e-c673-46da-a654-2bb1312cb02b,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=e3e6b91e-c673-46da-a654-2bb1312cb02b,e3e6b91e-c673-46da-a654-2bb1312cb02b,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,213645,Daptomycin in Sodium Chloride,DAPTOMYCIN IN SODIUM CHLORIDE,2023/02/27,Lipopeptide Antibacterial,2003,BAXTER HEALTHCARE CORPORATION,2022/01/25-,0338-0712; 0338-0714; 0338-0716; 0338-0718,NWQ5N31VKK,DAPTOMYCIN,DAPTOMYCIN,NWQ5N31VKK,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/7ed4d986-2aa9-43cd-9a8a-fbd11cb5ecef/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7ed4d986-2aa9-43cd-9a8a-fbd11cb5ecef,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=7ed4d986-2aa9-43cd-9a8a-fbd11cb5ecef,7ed4d986-2aa9-43cd-9a8a-fbd11cb5ecef,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,214985,QUVIVIQ,DARIDOREXANT,2023/11/02,Orexin Receptor Antagonist,2022,IDORSIA PHARMACEUTICALS LTD,2022/04/07-,80491-7825; 80491-7850,LMQ24G57E9,daridorexant,daridorexant,LMQ24G57E9,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/3a2d1503-b816-40c9-9fac-7e03c5a3bcef/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3a2d1503-b816-40c9-9fac-7e03c5a3bcef,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=3a2d1503-b816-40c9-9fac-7e03c5a3bcef,3a2d1503-b816-40c9-9fac-7e03c5a3bcef,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,212099,NUBEQA,DAROLUTAMIDE,2023/10/13,,2019,BAYER HEALTHCARE PHARMACEUTICALS INC,2019/07/31-,50419-395,X05U0N2RCO,DAROLUTAMIDE,DAROLUTAMIDE,X05U0N2RCO,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/1a7cb212-56e4-4b9d-a73d-bfee7fe4735e/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1a7cb212-56e4-4b9d-a73d-bfee7fe4735e,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=1a7cb212-56e4-4b9d-a73d-bfee7fe4735e,1a7cb212-56e4-4b9d-a73d-bfee7fe4735e,,,
HUMAN PRESCRIPTION DRUG LABEL,"SUSPENSION; TABLET, FILM COATED",ORAL,NDA,021976;202895,PREZISTA,DARUNAVIR,2023/08/15,Protease Inhibitor,2006,JANSSEN PRODUCTS LP,2008/03/08-; 2009/01/14-; 2009/04/27-; 2011/12/16-; 2012/11/09-,59676-562; 59676-563; 59676-564; 59676-565; 59676-566,33O78XF0BW,DARUNAVIR ETHANOLATE,DARUNAVIR,YO603Y8113,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/814301f9-c990-46a5-b481-2879a521a16f/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=814301f9-c990-46a5-b481-2879a521a16f,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=814301f9-c990-46a5-b481-2879a521a16f,814301f9-c990-46a5-b481-2879a521a16f,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,205395,PREZCOBIX,DARUNAVIR ETHANOLATE AND COBICISTAT,2023/08/15,Cytochrome P450 3A Inhibitor; Protease Inhibitor,2015,JANSSEN PRODUCTS LP,2015/01/31-,59676-575,33O78XF0BW; LW2E03M5PG,COBICISTAT; DARUNAVIR ETHANOLATE,COBICISTAT; DARUNAVIR,LW2E03M5PG; YO603Y8113,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/9c38fdb6-d0ba-4f16-a0e3-85d9ec334d9f/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9c38fdb6-d0ba-4f16-a0e3-85d9ec334d9f,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=9c38fdb6-d0ba-4f16-a0e3-85d9ec334d9f,9c38fdb6-d0ba-4f16-a0e3-85d9ec334d9f,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,210455,Symtuza,"DARUNAVIR, COBICISTAT, EMTRICITABINE, AND TENOFOVIR ALAFENAMIDE",2023/08/18,Cytochrome P450 3A Inhibitor; Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor; Protease Inhibitor,2018,JANSSEN PRODUCTS LP,2018/07/17-,59676-800,EL9943AG5J; G70B4ETF4S; LW2E03M5PG; YO603Y8113,COBICISTAT; DARUNAVIR; EMTRICITABINE; TENOFOVIR ALAFENAMIDE,COBICISTAT; DARUNAVIR; EMTRICITABINE; TENOFOVIR ANHYDROUS,G70B4ETF4S; LW2E03M5PG; W4HFE001U5; YO603Y8113,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/85a17d00-6b7c-41ea-a6b3-5ad924820dab/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=85a17d00-6b7c-41ea-a6b3-5ad924820dab,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=85a17d00-6b7c-41ea-a6b3-5ad924820dab,85a17d00-6b7c-41ea-a6b3-5ad924820dab,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,021986,SPRYCEL,DASATINIB,2023/02/08,Kinase Inhibitor,2006,E R SQUIBB AND SONS L L C,2006/06/27-; 2008/05/30-; 2010/10/28-,0003-0524; 0003-0527; 0003-0528; 0003-0852; 0003-0855; 0003-0857,RBZ1571X5H,dasatinib,dasatinib anhydrous,X78UG0A0RN,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/4764f37b-c9e6-4ede-bcc2-8a03b7c521df/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4764f37b-c9e6-4ede-bcc2-8a03b7c521df,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=4764f37b-c9e6-4ede-bcc2-8a03b7c521df,4764f37b-c9e6-4ede-bcc2-8a03b7c521df,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",SUBCUTANEOUS,NDA,214231,Zegalogue,DASIGLUCAGON,2023/10/04,Antihypoglycemic Agent,2021,ZEALAND PHARMA US INC,2021/04/05-,80644-0012; 80644-0013,AD4J2O47FQ,DASIGLUCAGON,DASIGLUCAGON,AD4J2O47FQ,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/c6c32b47-c47c-4a7f-8d4d-23578f663217/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c6c32b47-c47c-4a7f-8d4d-23578f663217,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=c6c32b47-c47c-4a7f-8d4d-23578f663217,c6c32b47-c47c-4a7f-8d4d-23578f663217,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",SUBCUTANEOUS,NDA,214231,Zegalogue,DASIGLUCAGON,2023/01/01,Antihypoglycemic Agent,2021,NOVO NORDISK,2023/06/26-,0169-1912; 0169-1913,AD4J2O47FQ,DASIGLUCAGON,DASIGLUCAGON,AD4J2O47FQ,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/14704879-872c-4967-8779-04a3bbdfb4e6/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=14704879-872c-4967-8779-04a3bbdfb4e6,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=14704879-872c-4967-8779-04a3bbdfb4e6,14704879-872c-4967-8779-04a3bbdfb4e6,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRAVENOUS,NDA,050731,Daunorubicin Hydrochloride,DAUNORUBICIN HYDROCHLORIDE,2024/02/15,Anthracycline Topoisomerase Inhibitor,,HIKMA PHARMACEUTICALS USA INC,2018/01/02-,0143-9550; 0143-9551,UD984I04LZ,DAUNORUBICIN HYDROCHLORIDE,DAUNORUBICIN,ZS7284E0ZP,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/227784a8-ce68-4dd4-8ac5-a65265969677/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=227784a8-ce68-4dd4-8ac5-a65265969677,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=227784a8-ce68-4dd4-8ac5-a65265969677,227784a8-ce68-4dd4-8ac5-a65265969677,,,
HUMAN PRESCRIPTION DRUG LABEL,KIT,INTRAVENOUS,NDA,205582,decitabine,DECITABINE,2020/07/23,Nucleoside Metabolic Inhibitor,2006,SUN PHARMACEUTICAL INDUSTRIES INC,2014/01/24-,47335-361,776B62CQ27,DECITABINE,DECITABINE,776B62CQ27,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/c155d6ba-9a16-406c-919e-65a149689ab9/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c155d6ba-9a16-406c-919e-65a149689ab9,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=c155d6ba-9a16-406c-919e-65a149689ab9,c155d6ba-9a16-406c-919e-65a149689ab9,,,
HUMAN PRESCRIPTION DRUG LABEL,"GRANULE; TABLET, FILM COATED",ORAL,NDA,206910;207968,Jadenu,DEFERASIROX,2024/01/22,Iron Chelator,2005,NOVARTIS PHARMACEUTICALS CORPORATION,2015/03/30-; 2017/05/18-,0078-0654; 0078-0655; 0078-0656; 0078-0713; 0078-0720; 0078-0727,V8G4MOF2V9,DEFERASIROX,DEFERASIROX,V8G4MOF2V9,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/fee89140-fff1-4443-9f42-24ac004fcda1/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=fee89140-fff1-4443-9f42-24ac004fcda1,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=fee89140-fff1-4443-9f42-24ac004fcda1,fee89140-fff1-4443-9f42-24ac004fcda1,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FOR SUSPENSION",ORAL,NDA,021882,Exjade,DEFERASIROX,2023/08/08,Iron Chelator,2005,NOVARTIS PHARMACEUTICALS CORPORATION,2005/11/30-,0078-0468; 0078-0469; 0078-0470,V8G4MOF2V9,DEFERASIROX,DEFERASIROX,V8G4MOF2V9,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/3495a70c-870c-4968-940e-8baea152cf85/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3495a70c-870c-4968-940e-8baea152cf85,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=3495a70c-870c-4968-940e-8baea152cf85,3495a70c-870c-4968-940e-8baea152cf85,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET; TABLET, FILM COATED",ORAL,NDA,021825;212269,FERRIPROX,DEFERIPRONE,2023/07/01,Iron Chelator,2011,CHIESI USA INC,2011/11/25-; 2019/08/01-; 2020/05/19-,10122-100; 10122-103; 10122-104,2BTY8KH53L,DEFERIPRONE,DEFERIPRONE,2BTY8KH53L,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/946718ff-df43-1baa-74d1-e5bcfbe8ad86/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=946718ff-df43-1baa-74d1-e5bcfbe8ad86,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=946718ff-df43-1baa-74d1-e5bcfbe8ad86,946718ff-df43-1baa-74d1-e5bcfbe8ad86,,,
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION,ORAL,NDA,208030,FERRIPROX,DEFERIPRONE,2021/11/30,Iron Chelator,2011,CHIESI USA INC,2015/09/09-,10122-101,2BTY8KH53L,DEFERIPRONE,DEFERIPRONE,2BTY8KH53L,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/f057cf4d-b06f-4fbd-aa2e-68c5e4d8a846/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f057cf4d-b06f-4fbd-aa2e-68c5e4d8a846,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=f057cf4d-b06f-4fbd-aa2e-68c5e4d8a846,f057cf4d-b06f-4fbd-aa2e-68c5e4d8a846,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,021825,FERRIPROX,DEFERIPRONE,2021/08/19,Iron Chelator,2011,CHIESI USA INC,2011/11/25-,10122-100,2BTY8KH53L,DEFERIPRONE,DEFERIPRONE,2BTY8KH53L,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/dcd67c2c-63e6-4189-87cc-d453706fa092/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=dcd67c2c-63e6-4189-87cc-d453706fa092,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=dcd67c2c-63e6-4189-87cc-d453706fa092,dcd67c2c-63e6-4189-87cc-d453706fa092,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,021825,FERRIPROX,DEFERIPRONE,2020/03/04,Iron Chelator,2011,APOPHARMA USA INC,2019/08/01-,52609-0007,2BTY8KH53L,DEFERIPRONE,DEFERIPRONE,2BTY8KH53L,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/57bd50e6-c948-0037-4a4b-c8951f70d04a/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=57bd50e6-c948-0037-4a4b-c8951f70d04a,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=57bd50e6-c948-0037-4a4b-c8951f70d04a,57bd50e6-c948-0037-4a4b-c8951f70d04a,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,021825,FERRIPROX,DEFERIPRONE,2020/02/20,Iron Chelator,2011,APOPHARMA USA INC,2011/11/25-,52609-0006,2BTY8KH53L,DEFERIPRONE,DEFERIPRONE,2BTY8KH53L,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/dc8cbc3d-026c-0db5-42e8-8e93d374dd23/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=dc8cbc3d-026c-0db5-42e8-8e93d374dd23,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=dc8cbc3d-026c-0db5-42e8-8e93d374dd23,dc8cbc3d-026c-0db5-42e8-8e93d374dd23,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS,NDA,016267,Desferal,DEFEROXAMINE MESYLATE,2023/08/02,Iron Chelator,1968,NOVARTIS PHARMACEUTICALS CORPORATION,1968/04/02-,0078-0467,V9TKO7EO6K,DEFEROXAMINE MESYLATE,DEFEROXAMINE,J06Y7MXW4D,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/a7174843-5965-49fc-b842-f7eff7b48bbc/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a7174843-5965-49fc-b842-f7eff7b48bbc,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=a7174843-5965-49fc-b842-f7eff7b48bbc,a7174843-5965-49fc-b842-f7eff7b48bbc,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,208114,DEFITELIO,DEFIBROTIDE SODIUM,2022/12/07,,2016,JAZZ PHARMACEUTICALS INC,2016/03/30-,68727-800,L7CHH2B2J0,DEFIBROTIDE SODIUM,DEFIBROTIDE FREE ACID,568FY5I1YI,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/2c3db989-d7ad-41ed-9ebf-698dcf6c24ec/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2c3db989-d7ad-41ed-9ebf-698dcf6c24ec,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=2c3db989-d7ad-41ed-9ebf-698dcf6c24ec,2c3db989-d7ad-41ed-9ebf-698dcf6c24ec,,,
HUMAN PRESCRIPTION DRUG LABEL,SUSPENSION; TABLET,ORAL,NDA,208684;208685,EMFLAZA,DEFLAZACORT,2023/02/21,Corticosteroid,2017,PTC THERAPEUTICS INC,2018/09/10-,52856-501; 52856-502; 52856-503; 52856-504; 52856-505,KR5YZ6AE4B,DEFLAZACORT,DEFLAZACORT,KR5YZ6AE4B,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/31b347d2-f156-4055-9d8f-7cf0df420296/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=31b347d2-f156-4055-9d8f-7cf0df420296,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=31b347d2-f156-4055-9d8f-7cf0df420296,31b347d2-f156-4055-9d8f-7cf0df420296,,,
HUMAN PRESCRIPTION DRUG LABEL,KIT,SUBCUTANEOUS,NDA,022201,FIRMAGON,DEGARELIX,2024/01/30,Gonadotropin Releasing Hormone Receptor Antagonist,2008,FERRING PHARMACEUTICALS INC,2009/03/02-,55566-8303; 55566-8403,SX0XJI3A11,DEGARELIX,DEGARELIX,SX0XJI3A11,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/ab11dd8a-0fd9-4013-89ab-e114557c7e4b/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ab11dd8a-0fd9-4013-89ab-e114557c7e4b,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=ab11dd8a-0fd9-4013-89ab-e114557c7e4b,ab11dd8a-0fd9-4013-89ab-e114557c7e4b,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION; TABLET",INTRAVENOUS; ORAL,NDA,208610;208611,Baxdela,DELAFLOXACIN MEGLUMINE,2021/07/02,Fluoroquinolone Antibacterial,2017,MELINTA THERAPEUTICS LLC,2017/06/19-,70842-101; 70842-102,N7V53U4U4T,DELAFLOXACIN MEGLUMINE,DELAFLOXACIN,6315412YVF,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/fb77637a-88d9-4aea-958f-e270030ce30d/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=fb77637a-88d9-4aea-958f-e270030ce30d,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=fb77637a-88d9-4aea-958f-e270030ce30d,fb77637a-88d9-4aea-958f-e270030ce30d,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",SUBCUTANEOUS,NDA,206333,KYBELLA,DEOXYCHOLIC ACID,2023/03/01,Cytolytic Agent,2015,KYTHERA BIOPHARMACEUTICALS INC,2015/06/08-,61168-101,005990WHZZ,DEOXYCHOLIC ACID,DEOXYCHOLIC ACID,005990WHZZ,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/fe431ed4-ea6f-4e99-b4bc-ec25ae7b8553/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=fe431ed4-ea6f-4e99-b4bc-ec25ae7b8553,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=fe431ed4-ea6f-4e99-b4bc-ec25ae7b8553,fe431ed4-ea6f-4e99-b4bc-ec25ae7b8553,,,
HUMAN PRESCRIPTION DRUG LABEL,KIT,INFILTRATION; INTRA-ARTICULAR; INTRALESIONAL; INTRAMUSCULAR; SOFT TISSUE; TOPICAL,NDA,011757,Point Of Care L2,"DEPO-MEDROL, LIDOCAINE HCI, ISOPROPYL ALCOHOL",2021/05/04,Amide Local Anesthetic; Antiarrhythmic; Corticosteroid,,NUCARE PHARMACEUTICALS INC,1959/05/28-,70859-037,43502P7F0P; ND2M416302; V13007Z41A,ISOPROPYL ALCOHOL; LIDOCAINE HYDROCHLORIDE; METHYLPREDNISOLONE ACETATE,ISOPROPYL ALCOHOL; LIDOCAINE; METHYLPREDNISOLONE,98PI200987; ND2M416302; X4W7ZR7023,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/6ce4acc6-3a08-31f5-e053-2991aa0a6ec7/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6ce4acc6-3a08-31f5-e053-2991aa0a6ec7,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=6ce4acc6-3a08-31f5-e053-2991aa0a6ec7,6ce4acc6-3a08-31f5-e053-2991aa0a6ec7,,,
HUMAN PRESCRIPTION DRUG LABEL,KIT,INFILTRATION; INTRA-ARTICULAR; INTRALESIONAL; INTRAMUSCULAR; SOFT TISSUE; TOPICAL,NDA,011757,Point Of Care L5,"DEPO-MEDROL, LIDOCAINE HCI, ISOPROPYL ALCOHOL",2021/05/04,Amide Local Anesthetic; Antiarrhythmic; Corticosteroid,,NUCARE PHARMACEUTICALS INC,1959/05/28-,70859-038,43502P7F0P; ND2M416302; V13007Z41A,ISOPROPYL ALCOHOL; LIDOCAINE HYDROCHLORIDE; METHYLPREDNISOLONE ACETATE,ISOPROPYL ALCOHOL; LIDOCAINE; METHYLPREDNISOLONE,98PI200987; ND2M416302; X4W7ZR7023,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/72dcd99f-59e3-a11f-e053-2a91aa0a4bd3/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=72dcd99f-59e3-a11f-e053-2a91aa0a4bd3,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=72dcd99f-59e3-a11f-e053-2a91aa0a4bd3,72dcd99f-59e3-a11f-e053-2a91aa0a4bd3,,,
HUMAN PRESCRIPTION DRUG LABEL,LIQUID,INHALATION,NDA,020118,Suprane,DESFLURANE,2023/02/23,General Anesthetic,1992,BAXTER HEALTHCARE CORPORATION,1992/09/18-,10019-644,CRS35BZ94Q,DESFLURANE,DESFLURANE,CRS35BZ94Q,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/efbb228b-7b38-4176-8bae-826103178c35/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=efbb228b-7b38-4176-8bae-826103178c35,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=efbb228b-7b38-4176-8bae-826103178c35,efbb228b-7b38-4176-8bae-826103178c35,,,
HUMAN PRESCRIPTION DRUG LABEL,LIQUID,INHALATION,NDA,020118,SUPRANE,DESFLURANE,2023/02/23,General Anesthetic,1992,BAXTER HEALTHCARE CORPORATION,1992/09/18-,10019-646,CRS35BZ94Q,DESFLURANE,DESFLURANE,CRS35BZ94Q,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/7f977eb6-c7c4-4dc5-ab3b-07414dbe5da5/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7f977eb6-c7c4-4dc5-ab3b-07414dbe5da5,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=7f977eb6-c7c4-4dc5-ab3b-07414dbe5da5,7f977eb6-c7c4-4dc5-ab3b-07414dbe5da5,,,
HUMAN PRESCRIPTION DRUG LABEL,LIQUID,INHALATION,NDA,020118,SUPRANE,DESFLURANE,2023/02/22,General Anesthetic,1992,BAXTER HEALTHCARE CORPORATION,1992/09/18-,10019-641,CRS35BZ94Q,DESFLURANE,DESFLURANE,CRS35BZ94Q,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/3fe3d468-d283-4dd0-a1a7-29291a9b2d0b/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3fe3d468-d283-4dd0-a1a7-29291a9b2d0b,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=3fe3d468-d283-4dd0-a1a7-29291a9b2d0b,3fe3d468-d283-4dd0-a1a7-29291a9b2d0b,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, SUGAR COATED",ORAL,NDA,014399,Norpramin,DESIPRAMINE HYDROCHLORIDE,2023/12/12,Tricyclic Antidepressant,,VALIDUS PHARMACEUTICALS LLC,1964/11/20-,30698-007; 30698-011; 30698-015; 30698-019; 30698-020; 30698-021,1Y58DO4MY1,DESIPRAMINE HYDROCHLORIDE,DESIPRAMINE,TG537D343B,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/70b562ea-9f21-4e4a-b3ed-0590b2892f6a/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=70b562ea-9f21-4e4a-b3ed-0590b2892f6a,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=70b562ea-9f21-4e4a-b3ed-0590b2892f6a,70b562ea-9f21-4e4a-b3ed-0590b2892f6a,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,021165,Clarinex,DESLORATADINE,2022/11/14,Histamine-1 Receptor Antagonist,2001,ORGANON LLC,2021/06/01-; 2022/08/23-,78206-119; 78206-188,FVF865388R,DESLORATADINE,DESLORATADINE,FVF865388R,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/c671342e-69a2-4ca5-abc2-8166ed4240d4/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c671342e-69a2-4ca5-abc2-8166ed4240d4,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=c671342e-69a2-4ca5-abc2-8166ed4240d4,c671342e-69a2-4ca5-abc2-8166ed4240d4,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, EXTENDED RELEASE",ORAL,NDA,021313,CLARINEX-D 12 HOUR,DESLORATADINE AND PSEUDOEPHEDRINE SULFATE,2022/11/14,Histamine-1 Receptor Antagonist; alpha-Adrenergic Agonist,2005,ORGANON LLC,2021/06/01-,78206-120,FVF865388R; Y9DL7QPE6B,desloratadine; pseudoephedrine sulfate,desloratadine; pseudoephedrine,7CUC9DDI9F; FVF865388R,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/1af66b7a-4ab8-40d8-abdd-22d3310228a8/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1af66b7a-4ab8-40d8-abdd-22d3310228a8,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=1af66b7a-4ab8-40d8-abdd-22d3310228a8,1af66b7a-4ab8-40d8-abdd-22d3310228a8,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,SUBLINGUAL,NDA,022517,NOCDURNA,DESMOPRESSIN ACETATE,2023/10/19,Factor VIII Activator; Vasopressin Analog,1978,ANTARES PHARMA INC,completed:2021/08/06-2025/05/31,54436-325; 54436-350,XB13HYU18U,DESMOPRESSIN ACETATE,DESMOPRESSIN,ENR1LLB0FP,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/cf51914a-55df-4b4a-8ea8-c7af257c1d59/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=cf51914a-55df-4b4a-8ea8-c7af257c1d59,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=cf51914a-55df-4b4a-8ea8-c7af257c1d59,cf51914a-55df-4b4a-8ea8-c7af257c1d59,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRAVENOUS,NDA,018938,DDAVP,DESMOPRESSIN ACETATE,2022/09/28,Factor VIII Activator; Vasopressin Analog,1978,FERRING PHARMACEUTICALS INC,1984/05/01-,55566-2200; 55566-2300,XB13HYU18U,DESMOPRESSIN ACETATE,DESMOPRESSIN,ENR1LLB0FP,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/651f6fee-a2c7-431b-8d5d-58b156c72244/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=651f6fee-a2c7-431b-8d5d-58b156c72244,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=651f6fee-a2c7-431b-8d5d-58b156c72244,651f6fee-a2c7-431b-8d5d-58b156c72244,,,
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION,INTRAVENOUS,NDA,018938,Desmopressin Acetate,DESMOPRESSIN ACETATE,2022/08/10,Factor VIII Activator; Vasopressin Analog,1978,AMRING PHARMACEUTICALS INC,2016/01/20-,69918-899; 69918-901,XB13HYU18U,Desmopressin Acetate,desmopressin,ENR1LLB0FP,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/29df0492-f7ef-47bb-aa67-4ef9e5c2846f/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=29df0492-f7ef-47bb-aa67-4ef9e5c2846f,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=29df0492-f7ef-47bb-aa67-4ef9e5c2846f,29df0492-f7ef-47bb-aa67-4ef9e5c2846f,,,
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION,INTRAVENOUS,NDA,018938,Desmopressin Acetate,DESMOPRESSIN ACETATE,2022/08/10,Factor VIII Activator; Vasopressin Analog,1978,AMRING PHARMACEUTICALS INC,2022/05/09-,69918-901,XB13HYU18U,DESMOPRESSIN ACETATE,DESMOPRESSIN,ENR1LLB0FP,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/131fd4d8-48ca-4c1f-8165-848dc0a4d511/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=131fd4d8-48ca-4c1f-8165-848dc0a4d511,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=131fd4d8-48ca-4c1f-8165-848dc0a4d511,131fd4d8-48ca-4c1f-8165-848dc0a4d511,,,
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION,INTRAVENOUS,NDA,018938,Desmopressin Acetate,DESMOPRESSIN ACETATE,2022/08/10,Factor VIII Activator; Vasopressin Analog,1978,AMRING PHARMACEUTICALS INC,2022/01/07-,69918-899; 69918-901,XB13HYU18U,Desmopressin Acetate,desmopressin,ENR1LLB0FP,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/10b29aa2-274e-4c29-bccd-424bd3761758/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=10b29aa2-274e-4c29-bccd-424bd3761758,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=10b29aa2-274e-4c29-bccd-424bd3761758,10b29aa2-274e-4c29-bccd-424bd3761758,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,019955,Desmopressin Acetate,DESMOPRESSIN ACETATE,2021/05/21,Factor VIII Activator; Vasopressin Analog,,AMRING PHARMACEUTICALS INC,2015/12/10-,69918-101; 69918-201,XB13HYU18U,DESMOPRESSIN ACETATE,DESMOPRESSIN,ENR1LLB0FP,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/c01048e8-d28f-4085-9c37-3d5d48395a77/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c01048e8-d28f-4085-9c37-3d5d48395a77,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=c01048e8-d28f-4085-9c37-3d5d48395a77,c01048e8-d28f-4085-9c37-3d5d48395a77,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,019955,DDAVP,DESMOPRESSIN ACETATE,2021/02/03,Factor VIII Activator; Vasopressin Analog,,FERRING PHARMACEUTICALS INC,1995/09/06-,55566-2600; 55566-2700,XB13HYU18U,DESMOPRESSIN ACETATE,DESMOPRESSIN,ENR1LLB0FP,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/6d55baa9-2b62-469c-93ae-3909ab249332/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6d55baa9-2b62-469c-93ae-3909ab249332,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=6d55baa9-2b62-469c-93ae-3909ab249332,6d55baa9-2b62-469c-93ae-3909ab249332,,,
HUMAN PRESCRIPTION DRUG LABEL,OINTMENT,TOPICAL,NDA,017426,Desonide,DESONIDE,2022/12/01,Corticosteroid,,PADAGIS ISRAEL PHARMACEUTICALS LTD,2006/08/22-,45802-423,J280872D1O,DESONIDE,DESONIDE,J280872D1O,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/525c035d-d54b-41c0-90c5-bcd284b1abe3/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=525c035d-d54b-41c0-90c5-bcd284b1abe3,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=525c035d-d54b-41c0-90c5-bcd284b1abe3,525c035d-d54b-41c0-90c5-bcd284b1abe3,,,
HUMAN PRESCRIPTION DRUG LABEL,"AEROSOL, FOAM",TOPICAL,NDA,021978,Verdeso,DESONIDE,2021/08/01,Corticosteroid,1972,ALMIRALL LLC,2006/10/06-,16110-111,J280872D1O,DESONIDE,DESONIDE,J280872D1O,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/64c10d60-1af5-11e3-a19b-0800200c9a66/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=64c10d60-1af5-11e3-a19b-0800200c9a66,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=64c10d60-1af5-11e3-a19b-0800200c9a66,64c10d60-1af5-11e3-a19b-0800200c9a66,,,
HUMAN PRESCRIPTION DRUG LABEL,GEL,TOPICAL,NDA,021844,DESONATE,DESONIDE,2010/11/08,Corticosteroid,1972,INTENDIS INC,2010/01/28-,10922-828,J280872D1O,DESONIDE,DESONIDE,J280872D1O,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/4ae18cfa-0451-466d-80cd-73f6748405b6/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4ae18cfa-0451-466d-80cd-73f6748405b6,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=4ae18cfa-0451-466d-80cd-73f6748405b6,4ae18cfa-0451-466d-80cd-73f6748405b6,,,
HUMAN PRESCRIPTION DRUG LABEL,CREAM,TOPICAL,NDA,017010,Tridesilon Cream,DESONIDE 0.05%,2016/04/21,Corticosteroid,,ENCORE DERMATOLOGY INC,2016/10/01-,69482-600,J280872D1O,DESONIDE,DESONIDE,J280872D1O,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/30d60cbc-fba8-7209-e054-00144ff8d46c/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=30d60cbc-fba8-7209-e054-00144ff8d46c,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=30d60cbc-fba8-7209-e054-00144ff8d46c,30d60cbc-fba8-7209-e054-00144ff8d46c,,,
HUMAN PRESCRIPTION DRUG LABEL,SPRAY,TOPICAL,NDA,204141,Topicort,DESOXIMETASONE,2021/09/14,Corticosteroid,1977,TARO PHARMACEUTICALS U S A INC,2013/04/11-,51672-5281,4E07GXB7AU,Desoximetasone,Desoximetasone,4E07GXB7AU,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/e417856a-b760-4626-bc34-8e4bc62c026c/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e417856a-b760-4626-bc34-8e4bc62c026c,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=e417856a-b760-4626-bc34-8e4bc62c026c,e417856a-b760-4626-bc34-8e4bc62c026c,,,
HUMAN PRESCRIPTION DRUG LABEL,OINTMENT,TOPICAL,NDA,018594,Topicort,DESOXIMETASONE,2019/12/06,Corticosteroid,,TARO PHARMACEUTICALS U S A INC,1985/01/17-,51672-5263,4E07GXB7AU,Desoximetasone,Desoximetasone,4E07GXB7AU,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/96dfac6f-540f-4b7d-bcee-7e62088ebc93/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=96dfac6f-540f-4b7d-bcee-7e62088ebc93,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=96dfac6f-540f-4b7d-bcee-7e62088ebc93,96dfac6f-540f-4b7d-bcee-7e62088ebc93,,,
HUMAN PRESCRIPTION DRUG LABEL,OINTMENT,TOPICAL,NDA,018594,Desoximetasone,DESOXIMETASONE,2017/05/03,Corticosteroid,,TARO PHARMACEUTICALS U S A INC,1985/01/17-,51672-1352,4E07GXB7AU,Desoximetasone,Desoximetasone,4E07GXB7AU,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/96898d55-aa50-4281-8c23-ec4738ede394/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=96898d55-aa50-4281-8c23-ec4738ede394,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=96898d55-aa50-4281-8c23-ec4738ede394,96898d55-aa50-4281-8c23-ec4738ede394,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, EXTENDED RELEASE",ORAL,NDA,204150,Desvenlafaxine,DESVENLAFAXINE,2023/08/07,Serotonin and Norepinephrine Reuptake Inhibitor,2008,SUN PHARMACEUTICAL INDUSTRIES INC,2013/03/05-,63304-191; 63304-192,NG99554ANW,DESVENLAFAXINE,DESVENLAFAXINE,NG99554ANW,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/91cf39c9-4d26-480a-a3a3-a3d8d4c4d222/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=91cf39c9-4d26-480a-a3a3-a3d8d4c4d222,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=91cf39c9-4d26-480a-a3a3-a3d8d4c4d222,91cf39c9-4d26-480a-a3a3-a3d8d4c4d222,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, EXTENDED RELEASE",ORAL,NDA,204150,Desvenlafaxine,DESVENLAFAXINE,2023/01/27,Serotonin and Norepinephrine Reuptake Inhibitor,2008,ALEMBIC PHARMACEUTICALS LIMITED,2013/03/05-,46708-152; 46708-153,NG99554ANW,DESVENLAFAXINE,DESVENLAFAXINE,NG99554ANW,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/9f74708c-6f6a-46cf-8c79-87a25c2bb6f8/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9f74708c-6f6a-46cf-8c79-87a25c2bb6f8,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=9f74708c-6f6a-46cf-8c79-87a25c2bb6f8,9f74708c-6f6a-46cf-8c79-87a25c2bb6f8,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, EXTENDED RELEASE",ORAL,NDA,021992,Pristiq Extended-Release,DESVENLAFAXINE SUCCINATE,2023/08/30,Serotonin and Norepinephrine Reuptake Inhibitor,2008,WYETH PHARMACEUTICALS LLC A SUBSIDIARY OF PFIZER INC,2008/05/01-; 2015/04/01-,0008-1210; 0008-1211; 0008-1222,ZB22ENF0XR,DESVENLAFAXINE SUCCINATE,DESVENLAFAXINE,NG99554ANW,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/0f43610c-f290-46ea-d186-4f998ed99fce/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0f43610c-f290-46ea-d186-4f998ed99fce,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=0f43610c-f290-46ea-d186-4f998ed99fce,0f43610c-f290-46ea-d186-4f998ed99fce,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,214958,SOTYKTU,DEUCRAVACITINIB,2022/09/09,Tyrosine Kinase 2 Inhibitor,2022,E R SQUIBB AND SONS L L C,2022/09/09-,0003-0895,N0A21N6RAU,DEUCRAVACITINIB,DEUCRAVACITINIB,N0A21N6RAU,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/ff4d7258-5068-4cdf-9692-8cae04c3198e/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ff4d7258-5068-4cdf-9692-8cae04c3198e,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=ff4d7258-5068-4cdf-9692-8cae04c3198e,ff4d7258-5068-4cdf-9692-8cae04c3198e,,,
HUMAN PRESCRIPTION DRUG LABEL,"KIT; TABLET, COATED; TABLET, FILM COATED, EXTENDED RELEASE",ORAL,NDA,208082;216354,AUSTEDO; AUSTEDO XR; Austedo,DEUTETRABENAZINE,2023/09/30,,2017,TEVA NEUROSCIENCE INC,2017/04/12-; 2020/02/01-; 2023/02/21-; completed:2020/02/01-2023/02/28; completed:2021/05/06-2023/02/28,68546-170; 68546-171; 68546-172; 68546-176; 68546-177; 68546-181; 68546-182; 68546-470; 68546-471; 68546-472; 68546-490,P341G6W9NB,DEUTETRABENAZINE,DEUTETRABENAZINE,P341G6W9NB,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/7ea3c60a-45c7-44cc-afc2-d87fa53993c0/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7ea3c60a-45c7-44cc-afc2-d87fa53993c0,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=7ea3c60a-45c7-44cc-afc2-d87fa53993c0,7ea3c60a-45c7-44cc-afc2-d87fa53993c0,,,
HUMAN PRESCRIPTION DRUG LABEL,IMPLANT,INTRAVITREAL,NDA,022315,OZURDEX,DEXAMETHASONE,2024/05/16,Corticosteroid,1958,ALLERGAN INC,2009/09/01-,0023-3348,7S5I7G3JQL,DEXAMETHASONE,DEXAMETHASONE,7S5I7G3JQL,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/4b204f44-6e8a-4d17-803c-268f0b04679f/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4b204f44-6e8a-4d17-803c-268f0b04679f,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=4b204f44-6e8a-4d17-803c-268f0b04679f,4b204f44-6e8a-4d17-803c-268f0b04679f,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,211379,Hemady,DEXAMETHASONE,2024/02/20,Corticosteroid,1958,EDENBRIDGE PHARMACEUTICALS LLC,2019/10/03-,82111-955,7S5I7G3JQL,DEXAMETHASONE,DEXAMETHASONE,7S5I7G3JQL,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/6b9cf32c-6d60-4853-bbfd-2304ffc2c129/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6b9cf32c-6d60-4853-bbfd-2304ffc2c129,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=6b9cf32c-6d60-4853-bbfd-2304ffc2c129,6b9cf32c-6d60-4853-bbfd-2304ffc2c129,,,
HUMAN PRESCRIPTION DRUG LABEL,SUSPENSION/ DROPS,OPHTHALMIC,NDA,013422,Maxidex,DEXAMETHASONE,2023/04/20,Corticosteroid,,NOVARTIS PHARMACEUTICALS CORPORATION,1966/05/15-,0078-0925,7S5I7G3JQL,DEXAMETHASONE,DEXAMETHASONE,7S5I7G3JQL,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/603f0bac-16b8-42f5-985e-fb0d73ee284d/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=603f0bac-16b8-42f5-985e-fb0d73ee284d,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=603f0bac-16b8-42f5-985e-fb0d73ee284d,603f0bac-16b8-42f5-985e-fb0d73ee284d,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SUSPENSION",INTRAOCULAR,NDA,208912,Dexycu,DEXAMETHASONE,2023/04/14,Corticosteroid,1958,EYEPOINT PHARMACEUTICALS US INC,2018/05/22-,71879-001,7S5I7G3JQL,DEXAMETHASONE,DEXAMETHASONE,7S5I7G3JQL,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/583d70ed-bc42-465b-983d-c770db58406f/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=583d70ed-bc42-465b-983d-c770db58406f,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=583d70ed-bc42-465b-983d-c770db58406f,583d70ed-bc42-465b-983d-c770db58406f,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,211379,Hemady,DEXAMETHASONE,2022/07/28,Corticosteroid,1958,ACROTECH BIOPHARMA LLC,2020/06/11-,72893-015,7S5I7G3JQL,DEXAMETHASONE,DEXAMETHASONE,7S5I7G3JQL,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/aec60743-f925-4d91-a865-064696a9f9e6/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=aec60743-f925-4d91-a865-064696a9f9e6,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=aec60743-f925-4d91-a865-064696a9f9e6,aec60743-f925-4d91-a865-064696a9f9e6,,,
HUMAN PRESCRIPTION DRUG LABEL,"CAPSULE, DELAYED RELEASE",ORAL,NDA,022287,Dexilant,DEXLANSOPRAZOLE,2023/07/25,Proton Pump Inhibitor,1995,TAKEDA PHARMACEUTICALS AMERICA INC,2010/04/12-,64764-171; 64764-175,UYE4T5I70X,dexlansoprazole,dexlansoprazole,UYE4T5I70X,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/9819f033-3bbe-442e-8e92-45fec77b237d/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9819f033-3bbe-442e-8e92-45fec77b237d,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=9819f033-3bbe-442e-8e92-45fec77b237d,9819f033-3bbe-442e-8e92-45fec77b237d,,,
HUMAN PRESCRIPTION DRUG LABEL,FILM,SUBLINGUAL,NDA,215390,IGALMI,DEXMEDETOMIDINE,2022/12/14,Central alpha-2 Adrenergic Agonist,1999,BIOXCEL THERAPEUTICS INC,2022/07/01-,81092-1120; 81092-1180,67VB76HONO,DEXMEDETOMIDINE,DEXMEDETOMIDINE,67VB76HONO,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/99476e8c-2527-4cb0-9d67-9f9cd91343c6/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=99476e8c-2527-4cb0-9d67-9f9cd91343c6,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=99476e8c-2527-4cb0-9d67-9f9cd91343c6,99476e8c-2527-4cb0-9d67-9f9cd91343c6,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION; INJECTION, SOLUTION, CONCENTRATE",INTRAVENOUS,NDA,021038,Precedex,DEXMEDETOMIDINE HYDROCHLORIDE,2024/05/10,Central alpha-2 Adrenergic Agonist,1999,HOSPIRA INC,2004/11/30-; 2013/04/08-; 2020/09/28-; 2023/11/13-,0409-1434; 0409-1596; 0409-1638; 0409-1660,1018WH7F9I,DEXMEDETOMIDINE HYDROCHLORIDE,DEXMEDETOMIDINE,67VB76HONO,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/548a88c0-afda-427e-75ac-5af0cfa2224c/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=548a88c0-afda-427e-75ac-5af0cfa2224c,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=548a88c0-afda-427e-75ac-5af0cfa2224c,548a88c0-afda-427e-75ac-5af0cfa2224c,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,021038,Precedex,DEXMEDETOMIDINE HYDROCHLORIDE,2023/12/22,Central alpha-2 Adrenergic Agonist,1999,HOSPIRA INC,2022/03/07-; 2023/01/17-,0409-1174; 0409-1454; 0409-2815; 0409-3301,1018WH7F9I,DEXMEDETOMIDINE HYDROCHLORIDE,DEXMEDETOMIDINE,67VB76HONO,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/4419162d-81d4-49bd-96de-1729440bdb74/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4419162d-81d4-49bd-96de-1729440bdb74,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=4419162d-81d4-49bd-96de-1729440bdb74,4419162d-81d4-49bd-96de-1729440bdb74,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,021038,Precedex,DEXMEDETOMIDINE HYDROCHLORIDE,2023/02/07,Central alpha-2 Adrenergic Agonist,1999,HOSPIRA INC,2023/01/03-,0409-0155; 0409-4596,1018WH7F9I,DEXMEDETOMIDINE HYDROCHLORIDE,DEXMEDETOMIDINE,67VB76HONO,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/92b7ddaa-e45a-4b64-a802-bb5df8771dd6/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=92b7ddaa-e45a-4b64-a802-bb5df8771dd6,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=92b7ddaa-e45a-4b64-a802-bb5df8771dd6,92b7ddaa-e45a-4b64-a802-bb5df8771dd6,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION; INJECTION, SOLUTION, CONCENTRATE",INTRAVENOUS,NDA,206628,Dexmedetomidine Hydrochloride; Dexmedetomidine Hydrochloride in Dextrose,DEXMEDETOMIDINE HYDROCHLORIDE,2021/12/31,Central alpha-2 Adrenergic Agonist,1999,WG CRITICAL CARE LLC,2016/04/19-,44567-600; 44567-601; 44567-602; 44567-603,1018WH7F9I,DEXMEDETOMIDINE HYDROCHLORIDE,DEXMEDETOMIDINE,67VB76HONO,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/0d2710f2-ee47-4114-ab5c-8dca74cdcb8d/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0d2710f2-ee47-4114-ab5c-8dca74cdcb8d,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=0d2710f2-ee47-4114-ab5c-8dca74cdcb8d,0d2710f2-ee47-4114-ab5c-8dca74cdcb8d,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,021278,Focalin,DEXMETHYLPHENIDATE HYDROCHLORIDE,2023/10/13,Central Nervous System Stimulant,2001,NOVARTIS PHARMACEUTICALS CORPORATION,2001/11/30-,0078-0380; 0078-0381; 0078-0382,1678OK0E08,DEXMETHYLPHENIDATE HYDROCHLORIDE,DEXMETHYLPHENIDATE,M32RH9MFGP,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/7c552f11-e24a-4d9b-bb8d-be10c928eca8/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7c552f11-e24a-4d9b-bb8d-be10c928eca8,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=7c552f11-e24a-4d9b-bb8d-be10c928eca8,7c552f11-e24a-4d9b-bb8d-be10c928eca8,,,
HUMAN PRESCRIPTION DRUG LABEL,"CAPSULE, EXTENDED RELEASE",ORAL,NDA,021802,Focalin XR,DEXMETHYLPHENIDATE HYDROCHLORIDE,2023/10/13,Central Nervous System Stimulant,2005,NOVARTIS PHARMACEUTICALS CORPORATION,2005/05/31-,0078-0430; 0078-0431; 0078-0432; 0078-0433; 0078-0434; 0078-0493; 0078-0608; 0078-0609,1678OK0E08,DEXMETHYLPHENIDATE HYDROCHLORIDE,DEXMETHYLPHENIDATE,M32RH9MFGP,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/1a1da905-42a0-4748-9c39-67eca45deccc/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1a1da905-42a0-4748-9c39-67eca45deccc,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=1a1da905-42a0-4748-9c39-67eca45deccc,1a1da905-42a0-4748-9c39-67eca45deccc,,,
HUMAN PRESCRIPTION DRUG LABEL,"PATCH, EXTENDED RELEASE",TRANSDERMAL,NDA,215401,XELSTRYM,DEXTROAMPHETAMINE,2023/10/27,Central Nervous System Stimulant,1975,NOVEN THERAPEUTICS LLC,2023/05/15-,68968-0205; 68968-0210; 68968-0215; 68968-0220,TZ47U051FI,DEXTROAMPHETAMINE,DEXTROAMPHETAMINE,TZ47U051FI,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/0862f02a-72a8-41cc-8845-57cf4974bb6f/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0862f02a-72a8-41cc-8845-57cf4974bb6f,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=0862f02a-72a8-41cc-8845-57cf4974bb6f,0862f02a-72a8-41cc-8845-57cf4974bb6f,,,
HUMAN PRESCRIPTION DRUG LABEL,"CAPSULE, EXTENDED RELEASE",ORAL,NDA,017078,DEXEDRINE SPANSULE,DEXTROAMPHETAMINE SULFATE,2023/10/23,Central Nervous System Stimulant,,AMNEAL PHARMACEUTICALS LLC,1976/08/02-,64896-673; 64896-674; 64896-675,JJ768O327N,DEXTROAMPHETAMINE SULFATE,DEXTROAMPHETAMINE,TZ47U051FI,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/cc717b9b-22ea-4c60-a1d4-ee38a40bce78/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=cc717b9b-22ea-4c60-a1d4-ee38a40bce78,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=cc717b9b-22ea-4c60-a1d4-ee38a40bce78,cc717b9b-22ea-4c60-a1d4-ee38a40bce78,,,
HUMAN PRESCRIPTION DRUG LABEL,"CAPSULE, EXTENDED RELEASE",ORAL,NDA,022063,MYDAYIS,"DEXTROAMPHETAMINE SULFATE, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, AND AMPHETAMINE SULFATE",2023/10/25,Central Nervous System Stimulant,2001,TAKEDA PHARMACEUTICALS AMERICA INC,2017/06/20-,54092-468; 54092-471; 54092-474; 54092-477,6DPV8NK46S; G83415V073; JJ768O327N; O1ZPV620O4,AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE,AMPHETAMINE; DEXTROAMPHETAMINE,CK833KGX7E; TZ47U051FI,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/141a7970-3f06-44ea-9ab7-aeece2c085fc/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=141a7970-3f06-44ea-9ab7-aeece2c085fc,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=141a7970-3f06-44ea-9ab7-aeece2c085fc,141a7970-3f06-44ea-9ab7-aeece2c085fc,,,
HUMAN PRESCRIPTION DRUG LABEL,"CAPSULE, EXTENDED RELEASE",ORAL,NDA,021303,Adderall XR,"DEXTROAMPHETAMINE SULFATE, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE SULFATE AND AMPHETAMINE ASPARTATE",2023/10/25,Central Nervous System Stimulant,2001,TAKEDA PHARMACEUTICALS AMERICA INC,2001/10/11-; 2002/05/22-,54092-381; 54092-383; 54092-385; 54092-387; 54092-389; 54092-391,6DPV8NK46S; G83415V073; JJ768O327N; O1ZPV620O4,AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE,AMPHETAMINE; DEXTROAMPHETAMINE,CK833KGX7E; TZ47U051FI,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/aff45863-ffe1-4d4f-8acf-c7081512a6c0/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=aff45863-ffe1-4d4f-8acf-c7081512a6c0,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=aff45863-ffe1-4d4f-8acf-c7081512a6c0,aff45863-ffe1-4d4f-8acf-c7081512a6c0,,,
HUMAN PRESCRIPTION DRUG LABEL,"CAPSULE, GELATIN COATED",ORAL,NDA,021879,NUEDEXTA,DEXTROMETHORPHAN HYDROBROMIDE AND QUINIDINE SULFATE,2023/12/01,Antiarrhythmic; Cytochrome P450 2D6 Inhibitor; Sigma-1 Agonist; Uncompetitive N-methyl-D-aspartate Receptor Antagonist,2010,AVANIR PHARMACEUTICALS INC,2010/12/01-,64597-301,9D2RTI9KYH; J13S2394HE,DEXTROMETHORPHAN HYDROBROMIDE; QUINIDINE SULFATE,DEXTROMETHORPHAN; QUINIDINE,7355X3ROTS; ITX08688JL,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/484e0918-3442-49dc-8ccf-177f1f3ee9f3/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=484e0918-3442-49dc-8ccf-177f1f3ee9f3,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=484e0918-3442-49dc-8ccf-177f1f3ee9f3,484e0918-3442-49dc-8ccf-177f1f3ee9f3,,,
HUMAN PRESCRIPTION DRUG LABEL,"CAPSULE, GELATIN COATED",ORAL,NDA,021879,Nuedexta,DEXTROMETHORPHAN HYDROBROMIDE AND QUINIDINE SULFATE,2023/10/13,Antiarrhythmic; Cytochrome P450 2D6 Inhibitor; Sigma-1 Agonist; Uncompetitive N-methyl-D-aspartate Receptor Antagonist,2010,OTSUKA AMERICA PHARMACEUTICAL INC,2023/01/03-,59148-053,9D2RTI9KYH; J13S2394HE,QUINIDINE SULFATE; dextromethorphan hydrobromide,dextromethorphan; quinidine,7355X3ROTS; ITX08688JL,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/c8cce784-8c5f-415b-8068-76e5d481d159/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c8cce784-8c5f-415b-8068-76e5d481d159,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=c8cce784-8c5f-415b-8068-76e5d481d159,c8cce784-8c5f-415b-8068-76e5d481d159,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, MULTILAYER, EXTENDED RELEASE",ORAL,NDA,215430,AUVELITY,"DEXTROMETHORPHAN HYDROBROMIDE, BUPROPION HYDROCHLORIDE",2024/05/13,Aminoketone; Sigma-1 Agonist; Uncompetitive N-methyl-D-aspartate Receptor Antagonist,2022,AXSOME THERAPEUTICS INC,2022/08/18-,81968-045,9D2RTI9KYH; ZG7E5POY8O,BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE,BUPROPION; DEXTROMETHORPHAN,01ZG3TPX31; 7355X3ROTS,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/dcefda7c-9a68-278e-e053-2995a90aec79/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=dcefda7c-9a68-278e-e053-2995a90aec79,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=dcefda7c-9a68-278e-e053-2995a90aec79,dcefda7c-9a68-278e-e053-2995a90aec79,,,
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION,INTRAVENOUS,NDA,019626,DEXTROSE,DEXTROSE,2024/03/12,,,B BRAUN MEDICAL INC,1988/02/02-,0264-7510; 0264-7520,IY9XDZ35W2,"DEXTROSE, UNSPECIFIED FORM",ANHYDROUS DEXTROSE,5SL0G7R0OK,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/085614c7-ada4-4e2c-87c0-c9bc2f18365a/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=085614c7-ada4-4e2c-87c0-c9bc2f18365a,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=085614c7-ada4-4e2c-87c0-c9bc2f18365a,085614c7-ada4-4e2c-87c0-c9bc2f18365a,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,016730,Dextrose,DEXTROSE,2024/01/05,,,B BRAUN MEDICAL INC,1973/12/21-,0264-1510,LX22YL083G,DEXTROSE MONOHYDRATE,ANHYDROUS DEXTROSE,5SL0G7R0OK,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/60b6d7c3-0164-46c9-aa38-b5aa1c31a5d5/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=60b6d7c3-0164-46c9-aa38-b5aa1c31a5d5,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=60b6d7c3-0164-46c9-aa38-b5aa1c31a5d5,60b6d7c3-0164-46c9-aa38-b5aa1c31a5d5,,,
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION,INTRAVENOUS,NDA,019626,Dextrose,DEXTROSE,2021/08/10,,,B BRAUN MEDICAL INC,2015/02/19-,0264-7387,IY9XDZ35W2,DEXTROSE,DEXTROSE,IY9XDZ35W2,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/8ccb10fe-75a5-440b-8cd4-b11f4e98f7b0/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8ccb10fe-75a5-440b-8cd4-b11f4e98f7b0,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=8ccb10fe-75a5-440b-8cd4-b11f4e98f7b0,8ccb10fe-75a5-440b-8cd4-b11f4e98f7b0,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,018561;018562;018563;018564;019345,Dextrose,DEXTROSE,2020/06/17,,1940,ICU MEDICAL INC,2019/10/01-,0990-7918; 0990-7935; 0990-7936; 0990-7937; 0990-8004,LX22YL083G,DEXTROSE MONOHYDRATE,ANHYDROUS DEXTROSE,5SL0G7R0OK,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/b5cb7a5a-bbe8-4217-a82e-da818f7771c9/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b5cb7a5a-bbe8-4217-a82e-da818f7771c9,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=b5cb7a5a-bbe8-4217-a82e-da818f7771c9,b5cb7a5a-bbe8-4217-a82e-da818f7771c9,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,016678;016683;016687;016689;016697,Dextrose and Sodium Chloride,DEXTROSE AND SODIUM CHLORIDE,2019/08/22,,1970,BAXTER HEALTHCARE CORPORATION,1970/12/08-; 1970/12/09-; 1971/03/22-,0338-0073; 0338-0077; 0338-0081; 0338-0085; 0338-0089,451W47IQ8X; LX22YL083G,DEXTROSE MONOHYDRATE; SODIUM CHLORIDE,ANHYDROUS DEXTROSE; CHLORIDE ION; SODIUM CATION,5SL0G7R0OK; LYR4M0NH37; Q32ZN48698,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/dcbf1907-1841-4afc-ab5d-a9893a2d7256/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=dcbf1907-1841-4afc-ab5d-a9893a2d7256,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=dcbf1907-1841-4afc-ab5d-a9893a2d7256,dcbf1907-1841-4afc-ab5d-a9893a2d7256,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,019445,Dextrose,DEXTROSE MONOHYDRATE,2024/01/11,,,HOSPIRA INC,2006/02/22-,0409-1775,LX22YL083G,DEXTROSE MONOHYDRATE,ANHYDROUS DEXTROSE,5SL0G7R0OK,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/672264e3-9709-4bba-2a9d-12bf70c7396a/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=672264e3-9709-4bba-2a9d-12bf70c7396a,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=672264e3-9709-4bba-2a9d-12bf70c7396a,672264e3-9709-4bba-2a9d-12bf70c7396a,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,019445,Dextrose,DEXTROSE MONOHYDRATE,2023/11/16,,,HOSPIRA INC,2005/03/31-; 2005/12/02-; 2005/12/07-; completed:2024/04/15-2024/04/15,0409-0505; 0409-4902; 0409-6648; 0409-7517,LX22YL083G,DEXTROSE MONOHYDRATE,ANHYDROUS DEXTROSE,5SL0G7R0OK,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/4ed365da-4e62-4329-c1b9-c197ab4fb6e1/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4ed365da-4e62-4329-c1b9-c197ab4fb6e1,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=4ed365da-4e62-4329-c1b9-c197ab4fb6e1,4ed365da-4e62-4329-c1b9-c197ab4fb6e1,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRAVENOUS,NDA,020179,Dextrose,DEXTROSE MONOHYDRATE,2022/12/07,,1940,BAXTER HEALTHCARE CORPORATION,1992/12/07-,0338-0170; 0338-0172; 0338-0174; 0338-0176,LX22YL083G,DEXTROSE MONOHYDRATE,ANHYDROUS DEXTROSE,5SL0G7R0OK,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/9c80dfee-8923-4d1f-85b0-98bd68b94212/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9c80dfee-8923-4d1f-85b0-98bd68b94212,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=9c80dfee-8923-4d1f-85b0-98bd68b94212,9c80dfee-8923-4d1f-85b0-98bd68b94212,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRAVENOUS,NDA,020179,Dextrose,DEXTROSE MONOHYDRATE,2022/12/07,,1940,BAXTER HEALTHCARE CORPORATION,1992/12/07-,0338-0204; 0338-0208; 0338-0211; 0338-0216,LX22YL083G,DEXTROSE MONOHYDRATE,ANHYDROUS DEXTROSE,5SL0G7R0OK,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/50603082-bce5-49eb-9737-e04239cfb695/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=50603082-bce5-49eb-9737-e04239cfb695,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=50603082-bce5-49eb-9737-e04239cfb695,50603082-bce5-49eb-9737-e04239cfb695,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,016367;018080,Dextrose,DEXTROSE MONOHYDRATE,2021/10/18,,1940,ICU MEDICAL INC,2019/07/15-,0990-7922; 0990-7923; 0990-7930,LX22YL083G,DEXTROSE MONOHYDRATE,ANHYDROUS DEXTROSE,5SL0G7R0OK,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/8b25b7e0-703e-4b43-a4eb-52863511602d/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8b25b7e0-703e-4b43-a4eb-52863511602d,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=8b25b7e0-703e-4b43-a4eb-52863511602d,8b25b7e0-703e-4b43-a4eb-52863511602d,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,019466,Dextrose,DEXTROSE MONOHYDRATE,2021/10/11,,,HOSPIRA INC,2005/06/27-,0409-7100,LX22YL083G,DEXTROSE MONOHYDRATE,ANHYDROUS DEXTROSE,5SL0G7R0OK,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/10e98cb0-31a5-4ad1-3eaa-aa4af387a42d/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=10e98cb0-31a5-4ad1-3eaa-aa4af387a42d,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=10e98cb0-31a5-4ad1-3eaa-aa4af387a42d,10e98cb0-31a5-4ad1-3eaa-aa4af387a42d,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRAVENOUS,NDA,020179,Dextrose,DEXTROSE MONOHYDRATE,2021/02/19,,1940,BAXTER HEALTHCARE CORPORATION,1992/12/07-,0338-9143; 0338-9147,LX22YL083G,DEXTROSE MONOHYDRATE,ANHYDROUS DEXTROSE,5SL0G7R0OK,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/0bfb32b2-d034-4219-a055-3448f0c424f7/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0bfb32b2-d034-4219-a055-3448f0c424f7,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=0bfb32b2-d034-4219-a055-3448f0c424f7,0bfb32b2-d034-4219-a055-3448f0c424f7,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,016673,DEXTROSE,DEXTROSE MONOHYDRATE,2020/08/12,,1940,BAXTER HEALTHCARE CORPORATION,1971/03/04-,0338-0062; 0338-0066; 0338-0070; 0338-0074; 0338-0078; 0338-0082,LX22YL083G,DEXTROSE MONOHYDRATE,ANHYDROUS DEXTROSE,5SL0G7R0OK,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/36e9478c-5df0-4b47-b97d-de3626d7cb29/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=36e9478c-5df0-4b47-b97d-de3626d7cb29,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=36e9478c-5df0-4b47-b97d-de3626d7cb29,36e9478c-5df0-4b47-b97d-de3626d7cb29,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,016673;016694,DEXTROSE,DEXTROSE MONOHYDRATE,2020/08/12,,1940,BAXTER HEALTHCARE CORPORATION,1971/01/25-; 1971/03/04-,0338-0017; 0338-0023,LX22YL083G,DEXTROSE MONOHYDRATE,ANHYDROUS DEXTROSE,5SL0G7R0OK,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/3bb406a9-f5cb-403a-b1bb-5c4facbea3d5/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3bb406a9-f5cb-403a-b1bb-5c4facbea3d5,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=3bb406a9-f5cb-403a-b1bb-5c4facbea3d5,3bb406a9-f5cb-403a-b1bb-5c4facbea3d5,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,019893,Dextrose,DEXTROSE MONOHYDRATE,2020/06/18,,,ICU MEDICAL INC,2019/07/01-,0990-7120,LX22YL083G,DEXTROSE MONOHYDRATE,ANHYDROUS DEXTROSE,5SL0G7R0OK,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/cdf35d11-fbc8-4f8e-85a8-33220312c0b4/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=cdf35d11-fbc8-4f8e-85a8-33220312c0b4,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=cdf35d11-fbc8-4f8e-85a8-33220312c0b4,cdf35d11-fbc8-4f8e-85a8-33220312c0b4,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRAVENOUS,NDA,020179,Dextrose,DEXTROSE MONOHYDRATE,2020/02/27,,1940,BAXTER HEALTHCARE CORPORATION,1992/12/07-,0338-0551,LX22YL083G,DEXTROSE MONOHYDRATE,ANHYDROUS DEXTROSE,5SL0G7R0OK,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/7de48bdb-9a05-4f2a-bbff-dcfeb284ca6e/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7de48bdb-9a05-4f2a-bbff-dcfeb284ca6e,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=7de48bdb-9a05-4f2a-bbff-dcfeb284ca6e,7de48bdb-9a05-4f2a-bbff-dcfeb284ca6e,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION, CONCENTRATE",INTRAVENOUS,NDA,018080,Dextrose,DEXTROSE MONOHYDRATE,2019/11/11,,1940,ICU MEDICAL INC,2019/11/20-,0990-7938,LX22YL083G,DEXTROSE MONOHYDRATE,ANHYDROUS DEXTROSE,5SL0G7R0OK,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/cb578dba-094c-4787-951d-763d12fd06e1/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=cb578dba-094c-4787-951d-763d12fd06e1,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=cb578dba-094c-4787-951d-763d12fd06e1,cb578dba-094c-4787-951d-763d12fd06e1,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,020047,DEXTROSE,DEXTROSE MONOHYDRATE,2019/08/05,,1940,BAXTER HEALTHCARE CORPORATION,1991/07/02-,0338-0719,LX22YL083G,DEXTROSE MONOHYDRATE,ANHYDROUS DEXTROSE,5SL0G7R0OK,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/0332f34a-7038-47cc-ba59-d55cad6b73ca/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0332f34a-7038-47cc-ba59-d55cad6b73ca,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=0332f34a-7038-47cc-ba59-d55cad6b73ca,0332f34a-7038-47cc-ba59-d55cad6b73ca,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,017585;017606;017607;017799,Dextrose and Sodium Chloride,DEXTROSE MONOHYDRATE AND SODIUM CHLORIDE,2021/10/18,,,ICU MEDICAL INC,2019/09/01-,0990-7924; 0990-7925; 0990-7926; 0990-7941,451W47IQ8X; LX22YL083G,DEXTROSE MONOHYDRATE; SODIUM CHLORIDE,ANHYDROUS DEXTROSE; CHLORIDE ION; SODIUM CATION,5SL0G7R0OK; LYR4M0NH37; Q32ZN48698,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/4555b1bf-6d97-4798-a63d-6d34291c85ce/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4555b1bf-6d97-4798-a63d-6d34291c85ce,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=4555b1bf-6d97-4798-a63d-6d34291c85ce,4555b1bf-6d97-4798-a63d-6d34291c85ce,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,018362;018365;019691,Potassium Chloride in Dextrose and Sodium Chloride,"DEXTROSE MONOHYDRATE, SODIUM CHLORIDE, AND POTASSIUM CHLORIDE",2021/10/18,,,ICU MEDICAL INC,2020/01/25-; 2020/02/01-,0990-7107; 0990-7109; 0990-7901; 0990-7902; 0990-7903; 0990-7904; 0990-7993,451W47IQ8X; 660YQ98I10; LX22YL083G,DEXTROSE MONOHYDRATE; POTASSIUM CHLORIDE; SODIUM CHLORIDE,ANHYDROUS DEXTROSE; CHLORIDE ION; POTASSIUM CATION; SODIUM CATION,295O53K152; 5SL0G7R0OK; LYR4M0NH37; Q32ZN48698,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/d8ee14e9-6733-4813-9f21-2b043a5f7188/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d8ee14e9-6733-4813-9f21-2b043a5f7188,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=d8ee14e9-6733-4813-9f21-2b043a5f7188,d8ee14e9-6733-4813-9f21-2b043a5f7188,,,
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION,INTRAPERITONEAL,NDA,018883,DELFLEX,"DEXTROSE MONOHYDRATE, SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE",2023/10/19,,1984,FRESENIUS MEDICAL CARE NORTH AMERICA,1984/11/30-,49230-188; 49230-191,02F3473H9O; 451W47IQ8X; LX22YL083G; M4I0D6VV5M; TU7HW0W0QT,CALCIUM CHLORIDE; DEXTROSE MONOHYDRATE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE,ANHYDROUS DEXTROSE; CALCIUM CATION; CHLORIDE ION; LACTIC ACID; MAGNESIUM CATION; SODIUM CATION,2M83C4R6ZB; 33X04XA5AT; 5SL0G7R0OK; LYR4M0NH37; Q32ZN48698; T6V3LHY838,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/515dcee0-3e34-11e2-a25f-0800200c9a66/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=515dcee0-3e34-11e2-a25f-0800200c9a66,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=515dcee0-3e34-11e2-a25f-0800200c9a66,515dcee0-3e34-11e2-a25f-0800200c9a66,,,
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION,INTRAPERITONEAL,NDA,020171,DELFLEX,"DEXTROSE MONOHYDRATE, SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE",2023/10/19,,1984,FRESENIUS MEDICAL CARE NORTH AMERICA,1992/08/19-,49230-206; 49230-209; 49230-212,02F3473H9O; 451W47IQ8X; LX22YL083G; M4I0D6VV5M; TU7HW0W0QT,CALCIUM CHLORIDE; DEXTROSE MONOHYDRATE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE,ANHYDROUS DEXTROSE; CALCIUM CATION; CHLORIDE ION; LACTIC ACID; MAGNESIUM CATION; SODIUM CATION,2M83C4R6ZB; 33X04XA5AT; 5SL0G7R0OK; LYR4M0NH37; Q32ZN48698; T6V3LHY838,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/bbc5b820-4973-11e2-a192-0002a5d5c51b/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=bbc5b820-4973-11e2-a192-0002a5d5c51b,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=bbc5b820-4973-11e2-a192-0002a5d5c51b,bbc5b820-4973-11e2-a192-0002a5d5c51b,,,
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION,INTRAPERITONEAL,NDA,020171,DELFLEX,"DEXTROSE MONOHYDRATE, SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE",2023/10/19,,1992,FRESENIUS MEDICAL CARE NORTH AMERICA,1992/08/19-,49230-206; 49230-209; 49230-212,02F3473H9O; 451W47IQ8X; LX22YL083G; M4I0D6VV5M; TU7HW0W0QT,CALCIUM CHLORIDE; DEXTROSE MONOHYDRATE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE,ANHYDROUS DEXTROSE; CALCIUM CATION; CHLORIDE ION; LACTIC ACID; MAGNESIUM CATION; SODIUM CATION,2M83C4R6ZB; 33X04XA5AT; 5SL0G7R0OK; LYR4M0NH37; Q32ZN48698; T6V3LHY838,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/c29bdfa0-4976-11e2-939b-0002a5d5c51b/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c29bdfa0-4976-11e2-939b-0002a5d5c51b,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=c29bdfa0-4976-11e2-939b-0002a5d5c51b,c29bdfa0-4976-11e2-939b-0002a5d5c51b,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, EMULSION",INTRAVENOUS,NDA,200656,Perikabiven,"DEXTROSE, SOYBEAN OIL, ELECTROLYTES, LYSINE, PHENYLALANINE, LEUCINE, VALINE, THREONINE, METHIONINE, ISOLEUCINE, TRYPTOPHAN, ALANINE, ARGININE, GLYCINE, PROLINE, HISTIDINE, GLUTAMIC ACID, SERINE, ASPAR",2023/08/07,Amino Acid; Calculi Dissolution Agent; Lipid Emulsion; Osmotic Laxative,2014,FRESENIUS KABI USA LLC,2014/08/25-,63323-714,04Y7590D77; 241ATL177A; 2ZD004190S; 30KYC7MIAI; 3KX376GY7L; 42HK56048U; 452VLY9402; 4550K0SC9B; 47E5O17Y3R; 4QD397987E; 660YQ98I10; 8DUH1N11BX; 94ZLA3W45F; 9DLQ4CIU6V; AE28F7PNPL; GMW67QNF9C; HG18B9YRS7; JNJ23Q2COM; LX22YL083G; M4I0D6VV5M,ALANINE; ARGININE; ASPARTIC ACID; CALCIUM CHLORIDE; DEXTROSE MONOHYDRATE; GLUTAMIC ACID; GLYCINE; HISTIDINE; ISOLEUCINE; LEUCINE,ACETATE ION; ALANINE; ANHYDROUS DEXTROSE; ARGININE; ASPARTIC ACID; CALCIUM CATION; CHLORIDE ION; GLUTAMIC ACID; GLYCINE; HISTIDINE,04Y7590D77; 241ATL177A; 295O53K152; 2M83C4R6ZB; 2ZD004190S; 30KYC7MIAI; 3KX376GY7L; 42HK56048U; 452VLY9402; 47E5O17Y3R; 4QD397987E; 569DQM74SC; 5SL0G7R0OK; 8DUH1N11BX; 94ZLA3W45F; 9DLQ4CIU6V; AE28F7PNPL; GMW67QNF9C; HG18B9YRS7; K3Z4F929H6,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/c2eb5522-8572-45f4-869d-42f9fd251bb6/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c2eb5522-8572-45f4-869d-42f9fd251bb6,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=c2eb5522-8572-45f4-869d-42f9fd251bb6,c2eb5522-8572-45f4-869d-42f9fd251bb6,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, EMULSION",INTRAVENOUS,NDA,200656,Kabiven,"DEXTROSE, SOYBEAN OIL, ELECTROLYTES, LYSINE, PHENYLALANINE, LEUCINE, VALINE, THREONINE, METHIONINE, ISOLEUCINE, TRYPTOPHAN, ALANINE, ARGININE, GLYCINE, PROLINE, HISTIDINE, GLUTAMIC ACID, SERINE, ASPAR",2023/08/02,Amino Acid; Calculi Dissolution Agent; Lipid Emulsion; Osmotic Laxative,2014,FRESENIUS KABI USA LLC,2014/08/25-,63323-712,04Y7590D77; 241ATL177A; 2ZD004190S; 30KYC7MIAI; 3KX376GY7L; 42HK56048U; 452VLY9402; 4550K0SC9B; 47E5O17Y3R; 4QD397987E; 660YQ98I10; 8DUH1N11BX; 94ZLA3W45F; 9DLQ4CIU6V; AE28F7PNPL; GMW67QNF9C; HG18B9YRS7; JNJ23Q2COM; LX22YL083G; M4I0D6VV5M,ALANINE; ARGININE; ASPARTIC ACID; CALCIUM CHLORIDE; DEXTROSE MONOHYDRATE; GLUTAMIC ACID; GLYCINE; HISTIDINE; ISOLEUCINE; LEUCINE,ACETATE ION; ALANINE; ANHYDROUS DEXTROSE; ARGININE; ASPARTIC ACID; CALCIUM CATION; CHLORIDE ION; GLUTAMIC ACID; GLYCINE; HISTIDINE,04Y7590D77; 241ATL177A; 295O53K152; 2M83C4R6ZB; 2ZD004190S; 30KYC7MIAI; 3KX376GY7L; 42HK56048U; 452VLY9402; 47E5O17Y3R; 4QD397987E; 569DQM74SC; 5SL0G7R0OK; 8DUH1N11BX; 94ZLA3W45F; 9DLQ4CIU6V; AE28F7PNPL; GMW67QNF9C; HG18B9YRS7; K3Z4F929H6,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/afeb4837-a759-4484-a76e-e04611c459e7/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=afeb4837-a759-4484-a76e-e04611c459e7,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=afeb4837-a759-4484-a76e-e04611c459e7,afeb4837-a759-4484-a76e-e04611c459e7,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVESICAL,NDA,010040,Cystografin Dilute,DIATRIZOATE MEGLUMINE,2018/10/02,Radiographic Contrast Agent,,BRACCO DIAGNOSTICS INC,1982/11/09-,0270-1410,3X9MR4N98U,diatrizoate meglumine,diatrizoic acid,5UVC90J1LK,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/e56882fa-4a30-43b1-bb6b-f7d4a4101c4e/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e56882fa-4a30-43b1-bb6b-f7d4a4101c4e,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=e56882fa-4a30-43b1-bb6b-f7d4a4101c4e,e56882fa-4a30-43b1-bb6b-f7d4a4101c4e,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,010040,Cystografin,DIATRIZOATE MEGLUMINE,2018/04/15,Radiographic Contrast Agent,,BRACCO DIAGNOSTICS INC,1970/11/03-,0270-0149,3X9MR4N98U,diatrizoate meglumine,diatrizoic acid,5UVC90J1LK,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/7496d736-9f7d-4136-ad5d-b24c7803c21b/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7496d736-9f7d-4136-ad5d-b24c7803c21b,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=7496d736-9f7d-4136-ad5d-b24c7803c21b,7496d736-9f7d-4136-ad5d-b24c7803c21b,,,
HUMAN PRESCRIPTION DRUG LABEL,LIQUID,ORAL; RECTAL,NDA,011245,Gastrografin,DIATRIZOATE MEGLUMINE AND DIATRIZOATE SODIUM,2021/10/04,Radiographic Contrast Agent,,BRACCO DIAGNOSTICS INC,1958/02/26-,0270-0445,3X9MR4N98U; V5403H8VG7,diatrizoate meglumine; diatrizoate sodium,DIATRIZOIC ACID,5UVC90J1LK,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/8c2340e4-2b42-45dc-8fac-9960e8172547/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8c2340e4-2b42-45dc-8fac-9960e8172547,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=8c2340e4-2b42-45dc-8fac-9960e8172547,8c2340e4-2b42-45dc-8fac-9960e8172547,,,
HUMAN PRESCRIPTION DRUG LABEL,FILM,BUCCAL,NDA,218623,LIBERVANT,DIAZEPAM,2024/04/27,Benzodiazepine,1963,AQUESTIVE THERAPEUTICS,2024/04/29-,10094-305; 10094-307; 10094-310; 10094-312; 10094-315,Q3JTX2Q7TU,DIAZEPAM,DIAZEPAM,Q3JTX2Q7TU,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/12527569-8eb3-4624-b3c0-5c0e0c5f88c9/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=12527569-8eb3-4624-b3c0-5c0e0c5f88c9,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=12527569-8eb3-4624-b3c0-5c0e0c5f88c9,12527569-8eb3-4624-b3c0-5c0e0c5f88c9,,,
HUMAN PRESCRIPTION DRUG LABEL,GEL,RECTAL,NDA,020648,Diastat,DIAZEPAM,2024/01/02,Benzodiazepine,,BAUSCH HEALTH US LLC,completed:1997/07/29-2023/12/31; completed:1997/07/29-2024/08/31,0187-0658; 0187-0659,Q3JTX2Q7TU,DIAZEPAM,DIAZEPAM,Q3JTX2Q7TU,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/a84a73a7-8e3a-4985-8be0-04b3028f5e49/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a84a73a7-8e3a-4985-8be0-04b3028f5e49,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=a84a73a7-8e3a-4985-8be0-04b3028f5e49,a84a73a7-8e3a-4985-8be0-04b3028f5e49,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,013263,Valium,DIAZEPAM,2023/11/28,Benzodiazepine,,ROCHE LABORATORIES INC,completed:1963/11/15-2021/08/10; completed:1963/11/15-2023/07/22; completed:1963/11/15-2027/12/09,0140-0004; 0140-0005; 0140-0006,Q3JTX2Q7TU,DIAZEPAM,DIAZEPAM,Q3JTX2Q7TU,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/554baee5-b171-4452-a50a-41a0946f956c/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=554baee5-b171-4452-a50a-41a0946f956c,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=554baee5-b171-4452-a50a-41a0946f956c,554baee5-b171-4452-a50a-41a0946f956c,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,013263,Valium,DIAZEPAM,2023/10/31,Benzodiazepine,,WAYLIS THERAPUETICS LLC,2022/04/04-,80725-004; 80725-005; 80725-006,Q3JTX2Q7TU,DIAZEPAM,DIAZEPAM,Q3JTX2Q7TU,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/260e2041-2bb3-482f-850e-b5d47a7bdbe6/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=260e2041-2bb3-482f-850e-b5d47a7bdbe6,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=260e2041-2bb3-482f-850e-b5d47a7bdbe6,260e2041-2bb3-482f-850e-b5d47a7bdbe6,,,
HUMAN PRESCRIPTION DRUG LABEL,SPRAY,NASAL,NDA,211635,Valtoco,DIAZEPAM,2023/08/15,Benzodiazepine,1963,NEURELIS INC,2020/01/10-,72252-505; 72252-510; 72252-515; 72252-520,Q3JTX2Q7TU,diazepam,diazepam,Q3JTX2Q7TU,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/1a8bcc90-68fa-474d-832c-0df01e825f39/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1a8bcc90-68fa-474d-832c-0df01e825f39,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=1a8bcc90-68fa-474d-832c-0df01e825f39,1a8bcc90-68fa-474d-832c-0df01e825f39,,,
HUMAN PRESCRIPTION DRUG LABEL,SUSPENSION,ORAL,NDA,017453,Proglycem,DIAZOXIDE,2023/03/29,,,TEVA PHARMACEUTICALS USA INC,1990/09/30-,0575-6200,O5CB12L4FN,DIAZOXIDE,DIAZOXIDE,O5CB12L4FN,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/b16c7832-2fd9-49af-b923-1dc0d91fd6e2/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b16c7832-2fd9-49af-b923-1dc0d91fd6e2,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=b16c7832-2fd9-49af-b923-1dc0d91fd6e2,b16c7832-2fd9-49af-b923-1dc0d91fd6e2,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,011366,Keveyis,DICHLORPHENAMIDE,2024/01/02,Carbonic Anhydrase Inhibitor,1958,XERIS PHARMACEUTICALS INC,2021/12/13-,72065-001,VVJ6673MHY,DICHLORPHENAMIDE,DICHLORPHENAMIDE,VVJ6673MHY,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/d30a87b9-90fb-35b2-e053-2995a90aea2c/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d30a87b9-90fb-35b2-e053-2995a90aea2c,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=d30a87b9-90fb-35b2-e053-2995a90aea2c,d30a87b9-90fb-35b2-e053-2995a90aea2c,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,011366,Keveyis,DICHLORPHENAMIDE,2021/12/13,Carbonic Anhydrase Inhibitor,1958,STRONGBRIDGE US INC,completed:2015/08/07-2025/10/23,71090-001,VVJ6673MHY,DICHLORPHENAMIDE,DICHLORPHENAMIDE,VVJ6673MHY,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/2d4d6a8e-3122-4b91-b46a-5708e60ea5c1/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2d4d6a8e-3122-4b91-b46a-5708e60ea5c1,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=2d4d6a8e-3122-4b91-b46a-5708e60ea5c1,2d4d6a8e-3122-4b91-b46a-5708e60ea5c1,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,NDA,204592,Zorvolex,DICLOFENAC,2019/04/08,Nonsteroidal Anti-inflammatory Drug,1988,IROKO PHARMACEUTICALS LLC,2013/10/31-,42211-203; 42211-204,144O8QL0L1,DICLOFENAC,DICLOFENAC,144O8QL0L1,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/dff10e66-a577-451d-ba75-1889458ca833/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=dff10e66-a577-451d-ba75-1889458ca833,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=dff10e66-a577-451d-ba75-1889458ca833,dff10e66-a577-451d-ba75-1889458ca833,,,
HUMAN PRESCRIPTION DRUG LABEL,DRUG DELIVERY SYSTEM,TOPICAL,NDA,206976,LICART,DICLOFENAC EPOLAMINE,2023/12/01,Nonsteroidal Anti-inflammatory Drug,1988,IBSA PHARMA INC,2020/09/01-,71858-0305,X5F8EKL9ZG,DICLOFENAC EPOLAMINE,DICLOFENAC,144O8QL0L1,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/851c8b39-6056-4bbc-812e-b9b13977c1ac/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=851c8b39-6056-4bbc-812e-b9b13977c1ac,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=851c8b39-6056-4bbc-812e-b9b13977c1ac,851c8b39-6056-4bbc-812e-b9b13977c1ac,,,
HUMAN PRESCRIPTION DRUG LABEL,DRUG DELIVERY SYSTEM,TOPICAL,NDA,021234,FLECTOR,DICLOFENAC EPOLAMINE,2022/09/20,Nonsteroidal Anti-inflammatory Drug,1988,IBSA PHARMA INC,2020/11/01-,71858-0405,X5F8EKL9ZG,DICLOFENAC EPOLAMINE,DICLOFENAC,144O8QL0L1,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/1f19a016-c4fc-43c5-9990-e5f2e2776a82/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1f19a016-c4fc-43c5-9990-e5f2e2776a82,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=1f19a016-c4fc-43c5-9990-e5f2e2776a82,1f19a016-c4fc-43c5-9990-e5f2e2776a82,,,
HUMAN PRESCRIPTION DRUG LABEL,"POWDER, FOR SOLUTION",ORAL,NDA,022165,Cambia,DICLOFENAC POTASSIUM,2024/04/25,Nonsteroidal Anti-inflammatory Drug,1988,ASSERTIO THERAPEUTICS INC,2016/03/10-,13913-012,L4D5UA6CB4,DICLOFENAC POTASSIUM,DICLOFENAC,144O8QL0L1,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/d249ced1-4ca0-4f57-adcb-23440f58f659/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d249ced1-4ca0-4f57-adcb-23440f58f659,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=d249ced1-4ca0-4f57-adcb-23440f58f659,d249ced1-4ca0-4f57-adcb-23440f58f659,,,
HUMAN PRESCRIPTION DRUG LABEL,"CAPSULE, LIQUID FILLED",ORAL,NDA,022202,ZIPSOR,DICLOFENAC POTASSIUM,2021/04/30,Nonsteroidal Anti-inflammatory Drug,1988,ASSERTIO THERAPEUTICS INC,2009/06/16-,13913-008,L4D5UA6CB4,DICLOFENAC POTASSIUM,DICLOFENAC,144O8QL0L1,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/c982eca0-fc41-11e1-a9c8-0002a5d5c51b/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c982eca0-fc41-11e1-a9c8-0002a5d5c51b,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=c982eca0-fc41-11e1-a9c8-0002a5d5c51b,c982eca0-fc41-11e1-a9c8-0002a5d5c51b,,,
HUMAN PRESCRIPTION DRUG LABEL,"POWDER, FOR SOLUTION",ORAL,NDA,022165,Cambia,DICLOFENAC POTASSIUM,2019/10/09,Nonsteroidal Anti-inflammatory Drug,1988,ASSERTIO THERAPEUTICS INC,2010/04/20-,13913-011,L4D5UA6CB4,DICLOFENAC POTASSIUM,DICLOFENAC,144O8QL0L1,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/c5856c21-f322-11e3-ac10-0800200c9a66/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c5856c21-f322-11e3-ac10-0800200c9a66,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=c5856c21-f322-11e3-ac10-0800200c9a66,c5856c21-f322-11e3-ac10-0800200c9a66,,,
HUMAN PRESCRIPTION DRUG LABEL,"POWDER, FOR SOLUTION",ORAL,NDA,022165,CAMBIA,DICLOFENAC POTASSIUM,2012/03/29,Nonsteroidal Anti-inflammatory Drug,1988,NAUTILUS NEUROSCIENCES INC,2010/04/20-,50192-113,L4D5UA6CB4,DICLOFENAC POTASSIUM,DICLOFENAC,144O8QL0L1,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/d7335594-50c9-4ae2-a3e3-b9a375187b62/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d7335594-50c9-4ae2-a3e3-b9a375187b62,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=d7335594-50c9-4ae2-a3e3-b9a375187b62,d7335594-50c9-4ae2-a3e3-b9a375187b62,,,
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION,TOPICAL,NDA,204623,Pennsaid,DICLOFENAC SODIUM,2022/02/08,Nonsteroidal Anti-inflammatory Drug,1988,HORIZON THERAPEUTICS USA INC,completed:2014/02/03-2026/07/31,75987-040,QTG126297Q,DICLOFENAC SODIUM,DICLOFENAC,144O8QL0L1,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/802cd382-443d-48e3-9c9d-fd946c73c79f/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=802cd382-443d-48e3-9c9d-fd946c73c79f,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=802cd382-443d-48e3-9c9d-fd946c73c79f,802cd382-443d-48e3-9c9d-fd946c73c79f,,,
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION,OPHTHALMIC,NDA,020037,VOLTAREN,DICLOFENAC SODIUM,2012/10/01,Nonsteroidal Anti-inflammatory Drug,,NOVARTIS PHARMACEUTICAL CORPORATION,1991/03/28-,0078-0478,QTG126297Q,Diclofenac Sodium,Diclofenac,144O8QL0L1,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/65037222-146c-493d-aa1c-e6df89bf5b8d/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=65037222-146c-493d-aa1c-e6df89bf5b8d,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=65037222-146c-493d-aa1c-e6df89bf5b8d,65037222-146c-493d-aa1c-e6df89bf5b8d,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,020607,ARTHROTEC,DICLOFENAC SODIUM AND MISOPROSTOL,2023/08/16,Nonsteroidal Anti-inflammatory Drug; Prostaglandin E1 Analog,1997,PFIZER LABORATORIES DIV PFIZER INC,1997/12/24-,0025-1411; 0025-1421,0E43V0BB57; QTG126297Q,DICLOFENAC SODIUM; MISOPROSTOL,DICLOFENAC; MISOPROSTOL,0E43V0BB57; 144O8QL0L1,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/600fe842-45d9-4d68-9ef2-456dbbebaa11/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=600fe842-45d9-4d68-9ef2-456dbbebaa11,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=600fe842-45d9-4d68-9ef2-456dbbebaa11,600fe842-45d9-4d68-9ef2-456dbbebaa11,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAMUSCULAR,NDA,008370,Bentyl,DICYCLOMINE HYDROCHLORIDE,2024/04/03,Anticholinergic,1950,ALLERGAN INC,completed:1952/08/13-2025/04/30,58914-080,CQ903KQA31,DICYCLOMINE HYDROCHLORIDE,Dicyclomine,4KV4X8IF6V,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/c56598d5-9cd1-4cce-b172-ac338775aec7/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c56598d5-9cd1-4cce-b172-ac338775aec7,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=c56598d5-9cd1-4cce-b172-ac338775aec7,c56598d5-9cd1-4cce-b172-ac338775aec7,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,214916,Korsuva,DIFELIKEFALIN,2024/01/30,Kappa Opioid Receptor Agonist,2021,VIFOR INTERNATIONAL INC,2021/01/11-,59353-065,0P70AR5BYB,DIFELIKEFALIN ACETATE,DIFELIKEFALIN,NA1U919MRO,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/0c7b81f2-0fd3-47cb-8b0f-185e07f19c87/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0c7b81f2-0fd3-47cb-8b0f-185e07f19c87,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=0c7b81f2-0fd3-47cb-8b0f-185e07f19c87,0c7b81f2-0fd3-47cb-8b0f-185e07f19c87,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,017744,Motofen,DIFENOXIN AND ATROPINE SULFATE,2018/12/14,Anticholinergic; Antidiarrheal; Cholinergic Muscarinic Antagonist,,SEBELA PHARMACEUTICALS INC,2017/04/11-,54766-200,03J5ZE7KA5; VQZ63K01IW,ATROPINE SULFATE; DIFENOXIN HYDROCHLORIDE,ATROPINE; DIFENOXIN,3ZZ5BJ9F2Q; 7C0697DR9I,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/4cd3f029-a5e3-5812-e054-00144ff8d46c/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4cd3f029-a5e3-5812-e054-00144ff8d46c,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=4cd3f029-a5e3-5812-e054-00144ff8d46c,4cd3f029-a5e3-5812-e054-00144ff8d46c,,,
HUMAN PRESCRIPTION DRUG LABEL,EMULSION,OPHTHALMIC,NDA,022212,DUREZOL,DIFLUPREDNATE,2023/06/27,,2008,NOVARTIS PHARMACEUTICALS CORPORATION,2011/01/25-,0078-0862,S8A06QG2QE,DIFLUPREDNATE,DIFLUPREDNATE,S8A06QG2QE,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/830dd64e-8b1a-4bc4-86bd-e0a0915b59e7/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=830dd64e-8b1a-4bc4-86bd-e0a0915b59e7,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=830dd64e-8b1a-4bc4-86bd-e0a0915b59e7,830dd64e-8b1a-4bc4-86bd-e0a0915b59e7,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,020405,LANOXIN,DIGOXIN,2024/05/10,Cardiac Glycoside,1954,CONCORDIA PHARMACEUTICALS INC,2012/09/30-; completed:2012/09/30-2019/09/30,59212-240; 59212-242; 59212-245; 59212-249,73K4184T59,DIGOXIN,DIGOXIN,73K4184T59,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/d91e3646-4c63-4512-ab22-db39c085c4dc/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d91e3646-4c63-4512-ab22-db39c085c4dc,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=d91e3646-4c63-4512-ab22-db39c085c4dc,d91e3646-4c63-4512-ab22-db39c085c4dc,,,
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION,ORAL,NDA,021648,Digoxin,DIGOXIN,2024/04/26,Cardiac Glycoside,1982,HIKMA PHARMACEUTICALS USA INC,2004/08/26-,0054-0057,73K4184T59,DIGOXIN,DIGOXIN,73K4184T59,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/1b7e5c6e-e052-41b0-a4ce-05dfe62faaaf/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1b7e5c6e-e052-41b0-a4ce-05dfe62faaaf,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=1b7e5c6e-e052-41b0-a4ce-05dfe62faaaf,1b7e5c6e-e052-41b0-a4ce-05dfe62faaaf,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAMUSCULAR; INTRAVENOUS,NDA,009330,LANOXIN,DIGOXIN,2022/11/02,Cardiac Glycoside,1954,COVIS PHARMA US INC,2017/09/15-; 2019/10/29-,70515-260; 70515-261; 70515-262; 70515-263,73K4184T59,DIGOXIN,DIGOXIN,73K4184T59,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/9ec84cac-6ecc-43dc-8006-6ccc029e2707/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9ec84cac-6ecc-43dc-8006-6ccc029e2707,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=9ec84cac-6ecc-43dc-8006-6ccc029e2707,9ec84cac-6ecc-43dc-8006-6ccc029e2707,,,
HUMAN PRESCRIPTION DRUG LABEL,"SPRAY, METERED",NASAL,NDA,213436,Trudhesa,DIHYDROERGOTAMINE MESYLATE,2023/08/01,Ergotamine Derivative,1946,IMPEL PHARMACEUTICALS INC,2021/09/24-,77530-725,81AXN7R2QT,Dihydroergotamine mesylate,DIHYDROERGOTAMINE,436O5HM03C,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/b81397b0-910d-4eb4-8fee-a9a3c9d94d63/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b81397b0-910d-4eb4-8fee-a9a3c9d94d63,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=b81397b0-910d-4eb4-8fee-a9a3c9d94d63,b81397b0-910d-4eb4-8fee-a9a3c9d94d63,,,
HUMAN PRESCRIPTION DRUG LABEL,SPRAY,NASAL,NDA,020148,Migranal,DIHYDROERGOTAMINE MESYLATE,2022/09/01,Ergotamine Derivative,,BAUSCH HEALTH US LLC,1997/12/08-,0187-0245,81AXN7R2QT,dihydroergotamine mesylate,dihydroergotamine,436O5HM03C,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/a24befa8-b952-48ac-942a-379585250782/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a24befa8-b952-48ac-942a-379585250782,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=a24befa8-b952-48ac-942a-379585250782,a24befa8-b952-48ac-942a-379585250782,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,215252,DILTIAZEM HYDROCHLORIDE,DILTIAZEM HYDROCHLORIDE,2021/11/30,Calcium Channel Blocker,1982,EXELA PHARMA SCIENCES LLC,2021/11/30-,51754-3000; 51754-3500,OLH94387TE,DILTIAZEM HYDROCHLORIDE,DILTIAZEM,EE92BBP03H,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/51ddc49b-f2b5-4e79-93f5-e236fb546a66/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=51ddc49b-f2b5-4e79-93f5-e236fb546a66,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=51ddc49b-f2b5-4e79-93f5-e236fb546a66,51ddc49b-f2b5-4e79-93f5-e236fb546a66,,,
HUMAN PRESCRIPTION DRUG LABEL,"CAPSULE, EXTENDED RELEASE",ORAL,NDA,020401,TIAZAC EXTENDED RELEASE,DILTIAZEM HYDROCHLORIDE,2020/10/01,Calcium Channel Blocker,,BAUSCH HEALTH US LLC,2014/08/20-,0187-2612; 0187-2613; 0187-2614; 0187-2615; 0187-2616; 0187-2617,OLH94387TE,diltiazem hydrochloride,Diltiazem,EE92BBP03H,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/c567fe7e-887e-4291-a0d1-2dd3f25cbf25/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c567fe7e-887e-4291-a0d1-2dd3f25cbf25,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=c567fe7e-887e-4291-a0d1-2dd3f25cbf25,c567fe7e-887e-4291-a0d1-2dd3f25cbf25,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, COATED",ORAL,NDA,018602,Cardizem,DILTIAZEM HYDROCHLORIDE,2020/06/02,Calcium Channel Blocker,,BAUSCH HEALTH US LLC,2010/12/25-; completed:2010/12/25-2017/11/14,0187-0771; 0187-0772; 0187-0791; 0187-0792,OLH94387TE,Diltiazem Hydrochloride,Diltiazem,EE92BBP03H,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/f3e7ecef-f360-4987-a4f5-933214130ab2/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f3e7ecef-f360-4987-a4f5-933214130ab2,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=f3e7ecef-f360-4987-a4f5-933214130ab2,f3e7ecef-f360-4987-a4f5-933214130ab2,,,
HUMAN PRESCRIPTION DRUG LABEL,"CAPSULE, COATED, EXTENDED RELEASE",ORAL,NDA,020062,Cardizem CD,DILTIAZEM HYDROCHLORIDE,2020/04/30,Calcium Channel Blocker,,BAUSCH HEALTH US LLC,2001/04/11-,0187-0795; 0187-0796; 0187-0797; 0187-0798; 0187-0799,OLH94387TE,Diltiazem Hydrochloride,Diltiazem,EE92BBP03H,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/1042fa13-e6af-46b9-8008-6c941f0978b1/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1042fa13-e6af-46b9-8008-6c941f0978b1,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=1042fa13-e6af-46b9-8008-6c941f0978b1,1042fa13-e6af-46b9-8008-6c941f0978b1,,,
HUMAN PRESCRIPTION DRUG LABEL,"CAPSULE, COATED, EXTENDED RELEASE",ORAL,NDA,020062,Diltiazem HCl CD,DILTIAZEM HYDROCHLORIDE,2020/04/01,Calcium Channel Blocker,,OCEANSIDE PHARMACEUTICALS,2001/04/11-,68682-521,OLH94387TE,Diltiazem Hydrochloride,Diltiazem,EE92BBP03H,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/5e39be50-ea17-4077-a2dc-668267049f6a/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5e39be50-ea17-4077-a2dc-668267049f6a,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=5e39be50-ea17-4077-a2dc-668267049f6a,5e39be50-ea17-4077-a2dc-668267049f6a,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, EXTENDED RELEASE",ORAL,NDA,021392,Cardizem LA,DILTIAZEM HYDROCHLORIDE,2019/05/02,Calcium Channel Blocker,1982,BAUSCH HEALTH US LLC,2010/12/25-,0187-2045; 0187-2046; 0187-2047; 0187-2048; 0187-2049; 0187-2050,OLH94387TE,Diltiazem Hydrochloride,Diltiazem,EE92BBP03H,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/3e180dc7-c871-4efc-8755-cae882976c8d/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3e180dc7-c871-4efc-8755-cae882976c8d,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=3e180dc7-c871-4efc-8755-cae882976c8d,3e180dc7-c871-4efc-8755-cae882976c8d,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRAMUSCULAR,NDA,005939,BAL,DIMERCAPROL,2022/06/20,Metal Chelator,,AKORN,2012/05/01-,17478-526,0CPP32S55X,Dimercaprol,Dimercaprol,0CPP32S55X,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/bee9a137-160f-47e8-a551-ca461ae4f51e/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=bee9a137-160f-47e8-a551-ca461ae4f51e,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=bee9a137-160f-47e8-a551-ca461ae4f51e,bee9a137-160f-47e8-a551-ca461ae4f51e,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE; KIT,ORAL,NDA,204063,TECFIDERA; Tecfidera,DIMETHYL FUMARATE,2024/03/14,,2013,BIOGEN INC,2013/03/27-,64406-005; 64406-006; 64406-007,FO2303MNI2,dimethyl fumarate,monomethyl fumarate,45IUB1PX8R,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/665d7e74-036c-5f68-5b67-ab84b9b49151/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=665d7e74-036c-5f68-5b67-ab84b9b49151,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=665d7e74-036c-5f68-5b67-ab84b9b49151,665d7e74-036c-5f68-5b67-ab84b9b49151,,,
HUMAN PRESCRIPTION DRUG LABEL,IRRIGANT,INTRAVESICAL,NDA,017788,RIMSO-50,DIMETHYL SULFOXIDE,2021/03/17,,,MYLAN INSTITUTIONAL LLC,1978/04/04-,67457-177,YOW8V9698H,Dimethyl Sulfoxide,Dimethyl Sulfoxide,YOW8V9698H,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/58b25d79-78f2-4953-b0c6-61658dc4ef0d/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=58b25d79-78f2-4953-b0c6-61658dc4ef0d,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=58b25d79-78f2-4953-b0c6-61658dc4ef0d,58b25d79-78f2-4953-b0c6-61658dc4ef0d,,,
HUMAN PRESCRIPTION DRUG LABEL,INSERT,VAGINAL,NDA,020411,CERVIDIL,DINOPROSTONE,2023/06/02,Prostaglandin Analog,1977,FERRING PHARMACEUTICALS INC,1995/03/30-,55566-2800,K7Q1JQR04M,DINOPROSTONE,DINOPROSTONE,K7Q1JQR04M,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/f3bc9031-0620-4a50-b440-f661cadfeb1d/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f3bc9031-0620-4a50-b440-f661cadfeb1d,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=f3bc9031-0620-4a50-b440-f661cadfeb1d,f3bc9031-0620-4a50-b440-f661cadfeb1d,,,
HUMAN PRESCRIPTION DRUG LABEL,GEL,VAGINAL,NDA,019617,Prepidil,DINOPROSTONE,2019/12/11,Prostaglandin Analog,,PHARMACIA AND UPJOHN COMPANY LLC,1992/12/09-,0009-3359,K7Q1JQR04M,DINOPROSTONE,DINOPROSTONE,K7Q1JQR04M,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/ab03de5b-782c-4f81-a8dc-7ef9969dd0cf/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ab03de5b-782c-4f81-a8dc-7ef9969dd0cf,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=ab03de5b-782c-4f81-a8dc-7ef9969dd0cf,ab03de5b-782c-4f81-a8dc-7ef9969dd0cf,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,012462,Lomotil,DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE,2023/09/12,Anticholinergic; Antidiarrheal; Cholinergic Muscarinic Antagonist,,PFIZER LABORATORIES DIV PFIZER INC,1960/09/15-,0025-0061,03J5ZE7KA5; W24OD7YW48,ATROPINE SULFATE; DIPHENOXYLATE HYDROCHLORIDE,ATROPINE; DIPHENOXYLATE,73312P173G; 7C0697DR9I,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/f170584a-1072-4fd7-b1dc-6756703483b9/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f170584a-1072-4fd7-b1dc-6756703483b9,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=f170584a-1072-4fd7-b1dc-6756703483b9,f170584a-1072-4fd7-b1dc-6756703483b9,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,NDA,211855,Vumerity,DIROXIMEL FUMARATE,2024/03/25,,2013,BIOGEN INC,2019/10/29-,64406-020,K0N0Z40J3W,diroximel fumarate,monomethyl fumarate,45IUB1PX8R,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/2d74414f-6b83-4ea2-9a95-3cecabbce774/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2d74414f-6b83-4ea2-9a95-3cecabbce774,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=2d74414f-6b83-4ea2-9a95-3cecabbce774,2d74414f-6b83-4ea2-9a95-3cecabbce774,,,
HUMAN PRESCRIPTION DRUG LABEL,"CAPSULE, EXTENDED RELEASE; CAPSULE, GELATIN COATED",ORAL,NDA,017447;018655,Norpace; Norpace CR,DISOPYRAMIDE PHOSPHATE,2023/08/30,Antiarrhythmic,,PFIZER LABORATORIES DIV PFIZER INC,1977/09/01-; 1982/07/20-,0025-2732; 0025-2742; 0025-2752; 0025-2762,N6BOM1935W,DISOPYRAMIDE PHOSPHATE,DISOPYRAMIDE,GFO928U8MQ,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/e2aa1642-d262-4520-bc6a-9fd3ad795677/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e2aa1642-d262-4520-bc6a-9fd3ad795677,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=e2aa1642-d262-4520-bc6a-9fd3ad795677,e2aa1642-d262-4520-bc6a-9fd3ad795677,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, EXTENDED RELEASE",ORAL,NDA,021168,Depakote ER,DIVALPROEX SODIUM,2024/03/18,Anti-epileptic Agent; Mood Stabilizer,2000,ABBVIE INC,2000/08/04-; completed:2000/08/04-2024/03/26; completed:2000/08/04-2024/06/21,0074-3826; 0074-7126; 0074-7401; 0074-7402,644VL95AO6,DIVALPROEX SODIUM,VALPROIC ACID,614OI1Z5WI,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/0dc024ce-efc8-4690-7cb5-639c728fccac/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0dc024ce-efc8-4690-7cb5-639c728fccac,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=0dc024ce-efc8-4690-7cb5-639c728fccac,0dc024ce-efc8-4690-7cb5-639c728fccac,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,NDA,019680,Depakote Sprinkles,DIVALPROEX SODIUM,2024/03/18,Anti-epileptic Agent; Mood Stabilizer,1989,ABBVIE INC,1989/09/12-,0074-6114,644VL95AO6,DIVALPROEX SODIUM,VALPROIC ACID,614OI1Z5WI,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/4619aff4-0f80-444f-858d-42e4137aa809/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4619aff4-0f80-444f-858d-42e4137aa809,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=4619aff4-0f80-444f-858d-42e4137aa809,4619aff4-0f80-444f-858d-42e4137aa809,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, DELAYED RELEASE",ORAL,NDA,018723,Depakote,DIVALPROEX SODIUM,2024/03/18,Anti-epileptic Agent; Mood Stabilizer,1983,ABBVIE INC,1983/03/10-; 2023/06/30-; completed:1983/03/10-2022/10/05; completed:1983/03/10-2024/02/25; completed:1983/03/10-2024/03/01,0074-6212; 0074-6214; 0074-6215; 0074-7325; 0074-7326; 0074-7327,644VL95AO6,DIVALPROEX SODIUM,VALPROIC ACID,614OI1Z5WI,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/08a65cf4-7749-4ceb-6895-8f4805e2b01f/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=08a65cf4-7749-4ceb-6895-8f4805e2b01f,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=08a65cf4-7749-4ceb-6895-8f4805e2b01f,08a65cf4-7749-4ceb-6895-8f4805e2b01f,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRAVENOUS,NDA,020255,Dobutamine Hydrochloride in Dextrose,DOBUTAMINE HYDROCHLORIDE,2023/09/08,beta-Adrenergic Agonist,,BAXTER HEALTHCARE CORPORATION,1993/09/23-; 1993/09/27-,0338-1073; 0338-1075; 0338-1077,0WR771DJXV,DOBUTAMINE HYDROCHLORIDE,DOBUTAMINE,3S12J47372,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/6b17b98b-e06d-42ed-925f-69aa2699dead/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6b17b98b-e06d-42ed-925f-69aa2699dead,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=6b17b98b-e06d-42ed-925f-69aa2699dead,6b17b98b-e06d-42ed-925f-69aa2699dead,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,020201,Dobutamine in Dextrose,DOBUTAMINE IN DEXTROSE,2021/11/03,beta-Adrenergic Agonist,,HOSPIRA INC,2005/08/12-; 2005/10/12-; 2006/01/20-,0409-2346; 0409-2347; 0409-3724,0WR771DJXV,DOBUTAMINE HYDROCHLORIDE,DOBUTAMINE,3S12J47372,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/9943a961-3b50-4847-8a84-d8414ce38daa/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9943a961-3b50-4847-8a84-d8414ce38daa,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=9943a961-3b50-4847-8a84-d8414ce38daa,9943a961-3b50-4847-8a84-d8414ce38daa,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,215813,DOCIVYX,DOCETAXEL,2024/04/18,Microtubule Inhibitor,1996,AVYXA PHARMA LLC,2024/04/18-,83831-101; 83831-102; 83831-103,15H5577CQD,DOCETAXEL,DOCETAXEL ANHYDROUS,699121PHCA,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/4763744e-360e-4d37-be05-cce4114548cd/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4763744e-360e-4d37-be05-cce4114548cd,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=4763744e-360e-4d37-be05-cce4114548cd,4763744e-360e-4d37-be05-cce4114548cd,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,022234,Docetaxel,DOCETAXEL,2024/03/08,Microtubule Inhibitor,1996,HOSPIRA INC,2016/08/24-; 2018/01/09-,0409-0366; 0409-0367; 0409-0368,15H5577CQD,DOCETAXEL,DOCETAXEL ANHYDROUS,699121PHCA,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/3104aab1-cd6e-4ad2-8e0a-286a0c5d1940/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3104aab1-cd6e-4ad2-8e0a-286a0c5d1940,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=3104aab1-cd6e-4ad2-8e0a-286a0c5d1940,3104aab1-cd6e-4ad2-8e0a-286a0c5d1940,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,022234,Docetaxel,DOCETAXEL,2024/03/07,Microtubule Inhibitor,1996,HOSPIRA INC,2021/06/28-,0409-0365; 0409-4235; 0409-5068,15H5577CQD,DOCETAXEL,DOCETAXEL ANHYDROUS,699121PHCA,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/6b9999bb-869e-4d25-838c-23c3ab280044/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6b9999bb-869e-4d25-838c-23c3ab280044,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=6b9999bb-869e-4d25-838c-23c3ab280044,6b9999bb-869e-4d25-838c-23c3ab280044,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION, CONCENTRATE",INTRAVENOUS,NDA,201195,DOCETAXEL,DOCETAXEL,2023/09/21,Microtubule Inhibitor,1996,ACCORD HEALTHCARE INC,2013/05/30-; completed:2012/07/01-2019/06/21,16729-231; 16729-267,699121PHCA,DOCETAXEL ANHYDROUS,DOCETAXEL ANHYDROUS,699121PHCA,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/f59f7811-70b7-4c44-99f7-4f4fdce3ed22/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f59f7811-70b7-4c44-99f7-4f4fdce3ed22,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=f59f7811-70b7-4c44-99f7-4f4fdce3ed22,f59f7811-70b7-4c44-99f7-4f4fdce3ed22,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,022534,Docetaxel,DOCETAXEL,2021/02/04,Microtubule Inhibitor,1996,SUN PHARMACEUTICAL INDUSTRIES INC,2020/11/26-,47335-323; 47335-895; 47335-939,699121PHCA,DOCETAXEL ANHYDROUS,DOCETAXEL ANHYDROUS,699121PHCA,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/c85b2c62-3c33-4cbc-8b79-d5e17851a1b4/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c85b2c62-3c33-4cbc-8b79-d5e17851a1b4,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=c85b2c62-3c33-4cbc-8b79-d5e17851a1b4,c85b2c62-3c33-4cbc-8b79-d5e17851a1b4,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,022234,Docetaxel,DOCETAXEL ANHYDROUS,2024/04/01,Microtubule Inhibitor,1996,HOSPIRA INC,2011/03/17-,0409-0201,699121PHCA,DOCETAXEL ANHYDROUS,DOCETAXEL ANHYDROUS,699121PHCA,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/a0ec4bcc-93ea-4c41-a4b6-95ec19491807/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a0ec4bcc-93ea-4c41-a4b6-95ec19491807,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=a0ec4bcc-93ea-4c41-a4b6-95ec19491807,a0ec4bcc-93ea-4c41-a4b6-95ec19491807,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,022234,Docetaxel,DOCETAXEL ANHYDROUS,2024/03/08,Microtubule Inhibitor,1996,HOSPIRA INC,2021/06/28-,0409-1732; 0409-7870,699121PHCA,DOCETAXEL ANHYDROUS,DOCETAXEL ANHYDROUS,699121PHCA,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/644c5035-20d2-4686-beaa-bef08e99051c/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=644c5035-20d2-4686-beaa-bef08e99051c,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=644c5035-20d2-4686-beaa-bef08e99051c,644c5035-20d2-4686-beaa-bef08e99051c,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,022234,Docetaxel,DOCETAXEL ANHYDROUS,2024/03/07,Microtubule Inhibitor,1996,HOSPIRA INC,2022/01/10-,0409-0016; 0409-2026,699121PHCA,DOCETAXEL ANHYDROUS,DOCETAXEL ANHYDROUS,699121PHCA,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/00c61d11-d6b7-4618-b6f6-2592dbcc8af7/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=00c61d11-d6b7-4618-b6f6-2592dbcc8af7,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=00c61d11-d6b7-4618-b6f6-2592dbcc8af7,00c61d11-d6b7-4618-b6f6-2592dbcc8af7,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,NDA,020931,Tikosyn,DOFETILIDE,2024/05/06,Antiarrhythmic,,PFIZER LABORATORIES DIV PFIZER INC,1999/10/01-,0069-5800; 0069-5810; 0069-5820,R4Z9X1N2ND,DOFETILIDE,DOFETILIDE,R4Z9X1N2ND,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/02438044-d6a3-49e9-a1ac-3aad21ef2c8c/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=02438044-d6a3-49e9-a1ac-3aad21ef2c8c,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=02438044-d6a3-49e9-a1ac-3aad21ef2c8c,02438044-d6a3-49e9-a1ac-3aad21ef2c8c,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,020623,ANZEMET,DOLASETRON MESYLATE,2023/12/12,Serotonin-3 Receptor Antagonist,,VALIDUS PHARMACEUTICALS LLC,1997/09/11-,30698-220,U3C8E5BWKR,DOLASETRON MESYLATE,DOLASETRON,82WI2L7Q6E,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/201b0eb8-4a1e-4e22-ab4b-addb642710d6/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=201b0eb8-4a1e-4e22-ab4b-addb642710d6,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=201b0eb8-4a1e-4e22-ab4b-addb642710d6,201b0eb8-4a1e-4e22-ab4b-addb642710d6,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED; TABLET, FOR SUSPENSION",ORAL,NDA,204790;213983,Tivicay; Tivicay PD,DOLUTEGRAVIR SODIUM,2024/04/18,Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor,2013,VIIV HEALTHCARE COMPANY,2013/08/13-; 2020/06/12-; completed:2016/06/09-2027/05/31; completed:2016/06/09-2027/08/31,49702-226; 49702-227; 49702-228; 49702-255,1Q1V9V5WYQ,DOLUTEGRAVIR SODIUM,DOLUTEGRAVIR,DKO1W9H7M1,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/63df5af3-b8ac-4e76-9830-2dbb340af922/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=63df5af3-b8ac-4e76-9830-2dbb340af922,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=63df5af3-b8ac-4e76-9830-2dbb340af922,63df5af3-b8ac-4e76-9830-2dbb340af922,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,211994,Dovato,DOLUTEGRAVIR SODIUM AND LAMIVUDINE,2024/04/18,Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor; Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor,2019,VIIV HEALTHCARE COMPANY,2019/04/08-,49702-246,1Q1V9V5WYQ; 2T8Q726O95,DOLUTEGRAVIR SODIUM; LAMIVUDINE,DOLUTEGRAVIR; LAMIVUDINE,2T8Q726O95; DKO1W9H7M1,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/68e45422-43ed-4cfb-9356-fae88d14a53a/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=68e45422-43ed-4cfb-9356-fae88d14a53a,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=68e45422-43ed-4cfb-9356-fae88d14a53a,68e45422-43ed-4cfb-9356-fae88d14a53a,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,210192,Juluca,DOLUTEGRAVIR SODIUM AND RILPIVIRINE HYDROCHLORIDE,2024/04/18,Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor; Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor,2017,VIIV HEALTHCARE COMPANY,2017/11/21-,49702-242,1Q1V9V5WYQ; 212WAX8KDD,DOLUTEGRAVIR SODIUM; RILPIVIRINE HYDROCHLORIDE,DOLUTEGRAVIR; RILPIVIRINE,DKO1W9H7M1; FI96A8X663,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/806653d1-bf35-4924-b999-ad5d21821cc1/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=806653d1-bf35-4924-b999-ad5d21821cc1,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=806653d1-bf35-4924-b999-ad5d21821cc1,806653d1-bf35-4924-b999-ad5d21821cc1,,,
HUMAN PRESCRIPTION DRUG LABEL,PATCH,TRANSDERMAL,NDA,212304,Adlarity,DONEPEZIL HYDROCHLORIDE,2023/02/17,Cholinesterase Inhibitor,1996,CORIUM LLC,2022/03/11-,65038-055; 65038-056,3O2T2PJ89D,Donepezil hydrochloride,DONEPEZIL,8SSC91326P,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/1cb44c65-00e8-4b5c-99c2-ad15173115a0/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1cb44c65-00e8-4b5c-99c2-ad15173115a0,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=1cb44c65-00e8-4b5c-99c2-ad15173115a0,1cb44c65-00e8-4b5c-99c2-ad15173115a0,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED; TABLET, ORALLY DISINTEGRATING",ORAL,NDA,020690;021720;022568,Aricept; Aricept ODT,DONEPEZIL HYDROCHLORIDE,2021/12/01,Cholinesterase Inhibitor,1996,EISAI INC,1996/11/25-; 2010/07/23-; completed:2004/10/18-2015/04/30; completed:2004/10/18-2017/02/28,62856-245; 62856-246; 62856-247; 62856-831; 62856-832,3O2T2PJ89D,DONEPEZIL HYDROCHLORIDE,DONEPEZIL,8SSC91326P,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/98e451e1-e4d7-4439-a675-c5457ba20975/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=98e451e1-e4d7-4439-a675-c5457ba20975,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=98e451e1-e4d7-4439-a675-c5457ba20975,98e451e1-e4d7-4439-a675-c5457ba20975,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION, CONCENTRATE",INTRAVENOUS,NDA,018132,DOPamine Hydrochloride,DOPAMINE HYDROCHLORIDE,2023/09/21,Catecholamine,1974,HOSPIRA INC,2005/06/30-; 2005/08/25-,0409-5820; 0409-9104,7L3E358N9L,DOPAMINE HYDROCHLORIDE,DOPAMINE,VTD58H1Z2X,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/1f306ad2-3606-4525-5a8a-ce78f426c1a2/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1f306ad2-3606-4525-5a8a-ce78f426c1a2,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=1f306ad2-3606-4525-5a8a-ce78f426c1a2,1f306ad2-3606-4525-5a8a-ce78f426c1a2,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,019615,Dopamine Hydrochloride and Dextrose,DOPAMINE HYDROCHLORIDE,2020/11/11,Catecholamine,,BAXTER HEALTHCARE CORPORATION,1987/03/27-,0338-1005; 0338-1007; 0338-1009,7L3E358N9L,DOPAMINE HYDROCHLORIDE,DOPAMINE,VTD58H1Z2X,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/cb97d4a0-89ed-407c-a763-209386b6f75c/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=cb97d4a0-89ed-407c-a763-209386b6f75c,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=cb97d4a0-89ed-407c-a763-209386b6f75c,cb97d4a0-89ed-407c-a763-209386b6f75c,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,018826,Dopamine Hydrochloride in Dextrose,DOPAMINE HYDROCHLORIDE IN DEXTROSE,2021/09/20,Catecholamine,1974,HOSPIRA INC,2005/04/30-; 2005/08/08-,0409-7809; 0409-7810,7L3E358N9L,DOPAMINE HYDROCHLORIDE,DOPAMINE,VTD58H1Z2X,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/08f23f6e-150d-45ea-098e-f2edf64c21a1/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=08f23f6e-150d-45ea-098e-f2edf64c21a1,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=08f23f6e-150d-45ea-098e-f2edf64c21a1,08f23f6e-150d-45ea-098e-f2edf64c21a1,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,210806,PIFELTRO,DORAVIRINE,2023/11/14,Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor,2018,MERCK SHARP AND DOHME LLC,2018/07/20-,0006-3069,913P6LK81M,doravirine,doravirine,913P6LK81M,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/76ce1f00-28c0-4314-bd2c-d473fe3d0970/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=76ce1f00-28c0-4314-bd2c-d473fe3d0970,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=76ce1f00-28c0-4314-bd2c-d473fe3d0970,76ce1f00-28c0-4314-bd2c-d473fe3d0970,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,210807,DELSTRIGO,"DORAVIRINE, LAMIVUDINE, AND TENOFOVIR DISOPROXIL FUMARATE",2023/11/14,Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor; Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor,2018,MERCK SHARP AND DOHME LLC,2018/07/20-,0006-5007,2T8Q726O95; 913P6LK81M; OTT9J7900I,doravirine; lamivudine; tenofovir disoproxil fumarate,doravirine; lamivudine; tenofovir anhydrous,2T8Q726O95; 913P6LK81M; W4HFE001U5,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/cd1e9f84-607a-46d3-b01e-2736018d67b6/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=cd1e9f84-607a-46d3-b01e-2736018d67b6,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=cd1e9f84-607a-46d3-b01e-2736018d67b6,cd1e9f84-607a-46d3-b01e-2736018d67b6,,,
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION/ DROPS,OPHTHALMIC,NDA,020869,COSOPT,DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE,2024/04/17,Carbonic Anhydrase Inhibitor; beta-Adrenergic Blocker,1998,THEA PHARMA INC,2022/11/10-,82584-605,P8Y54F701R; QZO5366EW7,DORZOLAMIDE HYDROCHLORIDE; TIMOLOL MALEATE,DORZOLAMIDE; TIMOLOL ANHYDROUS,5JKY92S7BR; 9JDX055TW1,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/23bdf1c1-3134-4ad1-8e7c-bc655156bdc6/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=23bdf1c1-3134-4ad1-8e7c-bc655156bdc6,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=23bdf1c1-3134-4ad1-8e7c-bc655156bdc6,23bdf1c1-3134-4ad1-8e7c-bc655156bdc6,,,
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION/ DROPS,OPHTHALMIC,NDA,202667,COSOPT PF,DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE,2024/01/08,Carbonic Anhydrase Inhibitor; beta-Adrenergic Blocker,1998,THEA PHARMA INC,2022/12/10-,82584-604,P8Y54F701R; QZO5366EW7,DORZOLAMIDE HYDROCHLORIDE; TIMOLOL MALEATE,DORZOLAMIDE; TIMOLOL ANHYDROUS,5JKY92S7BR; 9JDX055TW1,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/535fc801-8c3f-4974-a120-3eff1d5a5062/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=535fc801-8c3f-4974-a120-3eff1d5a5062,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=535fc801-8c3f-4974-a120-3eff1d5a5062,535fc801-8c3f-4974-a120-3eff1d5a5062,,,
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION/ DROPS,OPHTHALMIC,NDA,020869,COSOPT,DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE,2022/12/02,Carbonic Anhydrase Inhibitor; beta-Adrenergic Blocker,1998,AKORN,2014/04/30-,17478-605,P8Y54F701R; QZO5366EW7,Dorzolamide Hydrochloride; Timolol Maleate,Dorzolamide; Timolol Anhydrous,5JKY92S7BR; 9JDX055TW1,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/b7aa1986-1c24-4733-96b3-e6d8e1d44558/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b7aa1986-1c24-4733-96b3-e6d8e1d44558,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=b7aa1986-1c24-4733-96b3-e6d8e1d44558,b7aa1986-1c24-4733-96b3-e6d8e1d44558,,,
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION/ DROPS,OPHTHALMIC,NDA,202667,Dorzolamide Hydrochloride and Timolol Maleate,DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE,2022/05/27,Carbonic Anhydrase Inhibitor; beta-Adrenergic Blocker,1998,AKORN,2019/02/01-,50383-261,P8Y54F701R; QZO5366EW7,DORZOLAMIDE HYDROCHLORIDE; TIMOLOL MALEATE,DORZOLAMIDE; TIMOLOL ANHYDROUS,5JKY92S7BR; 9JDX055TW1,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/4e90c721-21e8-46ea-ab49-19f535bf7202/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4e90c721-21e8-46ea-ab49-19f535bf7202,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=4e90c721-21e8-46ea-ab49-19f535bf7202,4e90c721-21e8-46ea-ab49-19f535bf7202,,,
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION/ DROPS,OPHTHALMIC,NDA,202667,COSOPT PF,DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE,2020/10/08,Carbonic Anhydrase Inhibitor; beta-Adrenergic Blocker,1998,AKORN,2014/05/14-,17478-604,P8Y54F701R; QZO5366EW7,Dorzolamide Hydrochloride; Timolol Maleate,Dorzolamide; Timolol Anhydrous,5JKY92S7BR; 9JDX055TW1,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/a8d4e2b5-c7bb-48fc-9314-7095cd77617e/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a8d4e2b5-c7bb-48fc-9314-7095cd77617e,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=a8d4e2b5-c7bb-48fc-9314-7095cd77617e,a8d4e2b5-c7bb-48fc-9314-7095cd77617e,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRAVENOUS,NDA,014879,Dopram,DOXAPRAM HYDROCHLORIDE,2024/04/09,Respiratory Stimulant,,HIKMA PHARMACEUTICALS USA INC,1965/06/23-,0641-6018,P5RU6UOQ5Y,DOXAPRAM HYDROCHLORIDE,DOXAPRAM,94F3830Q73,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/b8eb330a-a75b-46cb-b694-5be9327ed2eb/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b8eb330a-a75b-46cb-b694-5be9327ed2eb,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=b8eb330a-a75b-46cb-b694-5be9327ed2eb,b8eb330a-a75b-46cb-b694-5be9327ed2eb,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,NDA,021269,Cardura XL,DOXAZOSIN MESYLATE,2023/05/15,alpha-Adrenergic Blocker,1990,VIATRIS SPECIALTY LLC,2024/01/04-; 2024/04/23-,58151-078; 58151-079,86P6PQK0MU,DOXAZOSIN MESYLATE,DOXAZOSIN,NW1291F1W8,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/355bcdce-0481-48ba-8ebd-2009106aaf77/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=355bcdce-0481-48ba-8ebd-2009106aaf77,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=355bcdce-0481-48ba-8ebd-2009106aaf77,355bcdce-0481-48ba-8ebd-2009106aaf77,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, MULTILAYER, EXTENDED RELEASE",ORAL,NDA,021269,Cardura XL,DOXAZOSIN; DOXAZOSIN MESYLATE,2022/04/26,alpha-Adrenergic Blocker,1990,ROERIG,completed:2005/02/22-2022/08/31; completed:2021/01/21-2025/03/31; completed:2022/04/26-2025/03/31,0049-2040; 0049-2080; 0049-2710; 0049-2720,86P6PQK0MU,DOXAZOSIN MESYLATE,DOXAZOSIN,NW1291F1W8,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/cfbb4ddc-00e9-403e-8529-41eb96b81618/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=cfbb4ddc-00e9-403e-8529-41eb96b81618,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=cfbb4ddc-00e9-403e-8529-41eb96b81618,cfbb4ddc-00e9-403e-8529-41eb96b81618,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,019668,Cardura,DOXAZOSIN; DOXAZOSIN MESYLATE,2022/01/20,alpha-Adrenergic Blocker,1990,ROERIG,2021/10/19-; 2023/02/15-; completed:1991/01/01-2022/01/31; completed:1991/01/01-2022/04/30; completed:1991/01/01-2023/09/30,0049-2410; 0049-2512; 0049-2614; 0049-2716; 0049-2750; 0049-2760; 0049-2770; 0049-2780,86P6PQK0MU,DOXAZOSIN MESYLATE,DOXAZOSIN,NW1291F1W8,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/eefc47bc-c10f-49bb-8ef7-5999f798ab39/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=eefc47bc-c10f-49bb-8ef7-5999f798ab39,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=eefc47bc-c10f-49bb-8ef7-5999f798ab39,eefc47bc-c10f-49bb-8ef7-5999f798ab39,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,022036,Silenor,DOXEPIN HYDROCHLORIDE,2023/05/08,Tricyclic Antidepressant,1969,CURRAX PHARMACEUTICALS LLC,2010/08/01-,42847-103; 42847-106,3U9A0FE9N5,doxepin hydrochloride,doxepin,5ASJ6HUZ7D,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/1bec1223-5239-4eb6-a9e8-62444106d2c0/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1bec1223-5239-4eb6-a9e8-62444106d2c0,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=1bec1223-5239-4eb6-a9e8-62444106d2c0,1bec1223-5239-4eb6-a9e8-62444106d2c0,,,
HUMAN PRESCRIPTION DRUG LABEL,CREAM,TOPICAL,NDA,020126,PRUDOXIN,DOXEPIN HYDROCHLORIDE,2017/06/29,Tricyclic Antidepressant,,MYLAN PHARMACEUTICALS INC,2018/08/01-,0378-8130,3U9A0FE9N5,DOXEPIN HYDROCHLORIDE,DOXEPIN,5ASJ6HUZ7D,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/ca53346b-8ab3-4722-98f6-cf272706d3fa/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ca53346b-8ab3-4722-98f6-cf272706d3fa,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=ca53346b-8ab3-4722-98f6-cf272706d3fa,ca53346b-8ab3-4722-98f6-cf272706d3fa,,,
HUMAN PRESCRIPTION DRUG LABEL,CREAM,TOPICAL,NDA,020126,Zonalon,DOXEPIN HYDROCHLORIDE,2017/06/14,Tricyclic Antidepressant,,MYLAN PHARMACEUTICALS INC,2018/11/14-,0378-8123,3U9A0FE9N5,DOXEPIN HYDROCHLORIDE,DOXEPIN,5ASJ6HUZ7D,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/5f302247-525e-4acc-852b-00eb1d79af4b/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5f302247-525e-4acc-852b-00eb1d79af4b,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=5f302247-525e-4acc-852b-00eb1d79af4b,5f302247-525e-4acc-852b-00eb1d79af4b,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,021027,Hectorol,DOXERCALCIFEROL,2023/04/27,Vitamin D2 Analog,1999,GENZYME CORPORATION,2008/12/08-; completed:2008/12/08-2021/04/30,58468-0123; 58468-0126; 58468-0127,3DIZ9LF5Y9,DOXERCALCIFEROL,DOXERCALCIFEROL,3DIZ9LF5Y9,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/7efc3d9c-12f5-43f6-9a22-88d66cbe6f62/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7efc3d9c-12f5-43f6-9a22-88d66cbe6f62,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=7efc3d9c-12f5-43f6-9a22-88d66cbe6f62,7efc3d9c-12f5-43f6-9a22-88d66cbe6f62,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,050629,Doxorubicin Hydrochloride,DOXORUBICIN HYDROCHLORIDE,2024/01/23,Anthracycline Topoisomerase Inhibitor,1974,PFIZER LABORATORIES DIV PFIZER INC,1987/12/23-,0069-3030; 0069-3031; 0069-3032; 0069-3033; 0069-3034,82F2G7BL4E,DOXORUBICIN HYDROCHLORIDE,DOXORUBICIN,80168379AG,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/1fd148fb-0fbc-4b6f-b790-23546fb46a71/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1fd148fb-0fbc-4b6f-b790-23546fb46a71,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=1fd148fb-0fbc-4b6f-b790-23546fb46a71,1fd148fb-0fbc-4b6f-b790-23546fb46a71,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,050629,Doxorubicin Hydrochloride,DOXORUBICIN HYDROCHLORIDE,2023/05/04,Anthracycline Topoisomerase Inhibitor,1974,PFIZER LABORATORIES DIV PFIZER INC,2013/03/17-; 2014/03/17-,0069-4004; 0069-4015; 0069-4026; 0069-4037,82F2G7BL4E,DOXORUBICIN HYDROCHLORIDE,DOXORUBICIN,80168379AG,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/00634b2b-4e48-4178-8877-28582af894ad/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=00634b2b-4e48-4178-8877-28582af894ad,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=00634b2b-4e48-4178-8877-28582af894ad,00634b2b-4e48-4178-8877-28582af894ad,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SUSPENSION, LIPOSOMAL",INTRAVENOUS; INTRAVITREAL,NDA,050718,DOXIL,DOXORUBICIN HYDROCHLORIDE,2022/05/31,Anthracycline Topoisomerase Inhibitor,1995,BAXTER HEALTHCARE CORPORATION,2019/08/13-,0338-0063; 0338-0067,82F2G7BL4E,doxorubicin hydrochloride,doxorubicin,80168379AG,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/1c153e9e-4cf2-4ac7-9cf9-16f9b48d7dce/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1c153e9e-4cf2-4ac7-9cf9-16f9b48d7dce,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=1c153e9e-4cf2-4ac7-9cf9-16f9b48d7dce,1c153e9e-4cf2-4ac7-9cf9-16f9b48d7dce,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,NDA,050805,ORACEA,DOXYCYCLINE,2022/03/16,Tetracycline-class Drug,1967,GALDERMA LABORATORIES L P,2010/05/14-,0299-3822,N12000U13O,DOXYCYCLINE,DOXYCYCLINE ANHYDROUS,334895S862,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/aa15c93a-ff4c-447a-8a21-96da506d8997/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=aa15c93a-ff4c-447a-8a21-96da506d8997,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=aa15c93a-ff4c-447a-8a21-96da506d8997,aa15c93a-ff4c-447a-8a21-96da506d8997,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,NDA,050641,Monodox,DOXYCYCLINE,2017/04/26,Tetracycline-class Drug,,AQUA PHARMACEUTICALS LLC,1989/12/29-; 1992/02/10-; 2007/01/31-,16110-075; 16110-259; 16110-260,N12000U13O,DOXYCYCLINE,DOXYCYCLINE ANHYDROUS,334895S862,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/a65325a7-ae0a-4704-99c4-a3a2e4e1dcf2/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a65325a7-ae0a-4704-99c4-a3a2e4e1dcf2,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=a65325a7-ae0a-4704-99c4-a3a2e4e1dcf2,a65325a7-ae0a-4704-99c4-a3a2e4e1dcf2,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, DELAYED RELEASE",ORAL,NDA,050795,DORYX MPC,DOXYCYCLINE HYCLATE,2024/04/26,Tetracycline-class Drug,1967,MAYNE PHARMA COMMERCIAL LLC,2023/01/02-; completed:2016/07/01-2024/06/30,51862-559; 51862-560,19XTS3T51U,Doxycycline Hyclate,Doxycycline Anhydrous,334895S862,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/f9277bb8-982d-444d-9325-35d5c53a2d35/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f9277bb8-982d-444d-9325-35d5c53a2d35,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=f9277bb8-982d-444d-9325-35d5c53a2d35,f9277bb8-982d-444d-9325-35d5c53a2d35,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, DELAYED RELEASE",ORAL,NDA,050795,Doryx,DOXYCYCLINE HYCLATE,2023/05/30,Tetracycline-class Drug,1967,MAYNE PHARMA COMMERCIAL LLC,completed:2015/04/13-2025/04/30; completed:2015/05/26-2024/01/31; completed:2020/10/02-2023/01/31,51862-557; 51862-558; 51862-562,19XTS3T51U,DOXYCYCLINE HYCLATE,DOXYCYCLINE ANHYDROUS,334895S862,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/99cf2de6-e0a3-42f2-9929-d33e107af948/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=99cf2de6-e0a3-42f2-9929-d33e107af948,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=99cf2de6-e0a3-42f2-9929-d33e107af948,99cf2de6-e0a3-42f2-9929-d33e107af948,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,209844,LymePak,DOXYCYCLINE HYCLATE,2022/12/20,Tetracycline-class Drug,1967,CHARTWELL RX LLC,2020/04/01-,62135-596,19XTS3T51U,DOXYCYCLINE HYCLATE,DOXYCYCLINE ANHYDROUS,334895S862,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/4021d8aa-6802-403a-a569-65d99bdaa658/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4021d8aa-6802-403a-a569-65d99bdaa658,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=4021d8aa-6802-403a-a569-65d99bdaa658,4021d8aa-6802-403a-a569-65d99bdaa658,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,NDA,208253,Acticlate CAP,DOXYCYCLINE HYCLATE,2017/11/28,Tetracycline-class Drug,1967,AQUA PHARMACEUTICALS,2018/05/31-,16110-601,19XTS3T51U,DOXYCYCLINE HYCLATE,DOXYCYCLINE ANHYDROUS,334895S862,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/5e96d473-63dd-4446-88cf-eef2cd3339f0/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5e96d473-63dd-4446-88cf-eef2cd3339f0,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=5e96d473-63dd-4446-88cf-eef2cd3339f0,5e96d473-63dd-4446-88cf-eef2cd3339f0,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,NDA,050641,Doxycycline Monohydrate,DOXYCYCLINE MONOHYDRATE,2023/10/10,Tetracycline-class Drug,,CHARTWELL RX LLC,1989/12/29-,62135-260; 62135-261; 62135-262; 62135-263,N12000U13O,DOXYCYCLINE,DOXYCYCLINE ANHYDROUS,334895S862,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/02aa8731-d40f-43d8-8b63-a79a0503f8db/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=02aa8731-d40f-43d8-8b63-a79a0503f8db,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=02aa8731-d40f-43d8-8b63-a79a0503f8db,02aa8731-d40f-43d8-8b63-a79a0503f8db,,,
HUMAN PRESCRIPTION DRUG LABEL,"CAPSULE; POWDER, FOR SUSPENSION; SYRUP; TABLET, FILM COATED",ORAL,NDA,050006;050007;050480;050533,Vibra-Tabs; Vibramycin Calcium; Vibramycin Hyclate; Vibramycin Monohydrate,DOXYCYCLINE; DOXYCYCLINE CALCIUM; DOXYCYCLINE HYCLATE,2024/01/22,Tetracycline-class Drug,,PFIZER LABORATORIES DIV PFIZER INC,1967/12/05-; 1967/12/06-; 1974/09/23-; completed:1980/01/15-2010/10/01,0069-0950; 0069-0970; 0069-0971; 0069-0990,19XTS3T51U; 8ZL07I20SB; N12000U13O,DOXYCYCLINE; DOXYCYCLINE CALCIUM; DOXYCYCLINE HYCLATE,DOXYCYCLINE ANHYDROUS,334895S862,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/d6f98d3c-5a20-4cbf-9a9c-abef10b9e465/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d6f98d3c-5a20-4cbf-9a9c-abef10b9e465,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=d6f98d3c-5a20-4cbf-9a9c-abef10b9e465,d6f98d3c-5a20-4cbf-9a9c-abef10b9e465,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, EXTENDED RELEASE",ORAL,NDA,209661,BONJESTA,DOXYLAMINE SUCCINATE AND PYRIDOXINE HYDROCHLORIDE,2023/07/07,Antihistamine; Vitamin B6 Analog,1976,DUCHESNAY USA INC,2018/02/19-,55494-120,68Y4CF58BV; V9BI9B5YI2,DOXYLAMINE SUCCINATE; PYRIDOXINE HYDROCHLORIDE,DOXYLAMINE; PYRIDOXINE,95QB77JKPL; KV2JZ1BI6Z,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/dba60bb4-54ff-4e06-b8d2-acbbd3717666/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=dba60bb4-54ff-4e06-b8d2-acbbd3717666,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=dba60bb4-54ff-4e06-b8d2-acbbd3717666,dba60bb4-54ff-4e06-b8d2-acbbd3717666,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, DELAYED RELEASE",ORAL,NDA,021876,DICLEGIS,DOXYLAMINE SUCCINATE AND PYRIDOXINE HYDROCHLORIDE,2023/06/15,Antihistamine; Vitamin B6 Analog,1976,DUCHESNAY USA INC,2013/05/15-,55494-100,68Y4CF58BV; V9BI9B5YI2,DOXYLAMINE SUCCINATE; PYRIDOXINE HYDROCHLORIDE,DOXYLAMINE; PYRIDOXINE,95QB77JKPL; KV2JZ1BI6Z,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/8bde08f6-e8bd-4e90-baa7-82e01876a86a/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8bde08f6-e8bd-4e90-baa7-82e01876a86a,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=8bde08f6-e8bd-4e90-baa7-82e01876a86a,8bde08f6-e8bd-4e90-baa7-82e01876a86a,,,
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION,ORAL,NDA,205525,SYNDROS,DRONABINOL,2024/01/11,Cannabinoid,1985,BENUVIA OPERATIONS LLC,2017/07/01-,78613-201,7J8897W37S,DRONABINOL,DRONABINOL,7J8897W37S,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/a7801c70-995d-46a2-91ee-141ef427c6b5/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a7801c70-995d-46a2-91ee-141ef427c6b5,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=a7801c70-995d-46a2-91ee-141ef427c6b5,a7801c70-995d-46a2-91ee-141ef427c6b5,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,NDA,018651,MARINOL,DRONABINOL,2023/02/14,Cannabinoid,1985,THEPHARMANETWORK LLC,2021/03/03-,53097-571; 53097-572; 53097-573,7J8897W37S,DRONABINOL,DRONABINOL,7J8897W37S,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/d0efeeec-640d-43c3-8f0a-d31324a11c68/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d0efeeec-640d-43c3-8f0a-d31324a11c68,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=d0efeeec-640d-43c3-8f0a-d31324a11c68,d0efeeec-640d-43c3-8f0a-d31324a11c68,,,
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION,ORAL,NDA,205525,SYNDROS,DRONABINOL,2019/12/11,Cannabinoid,1985,INSYS THERAPEUTICS INC,2017/07/27-,20482-335,7J8897W37S,DRONABINOL,DRONABINOL,7J8897W37S,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/c2bc83c1-f9fe-11e2-b778-0800200c9a66/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c2bc83c1-f9fe-11e2-b778-0800200c9a66,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=c2bc83c1-f9fe-11e2-b778-0800200c9a66,c2bc83c1-f9fe-11e2-b778-0800200c9a66,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,NDA,018651,Marinol,DRONABINOL,2019/04/08,Cannabinoid,1985,THEPHARMANETWORK LLC,2017/05/10-,53097-568; 53097-569; 53097-570,7J8897W37S,DRONABINOL,DRONABINOL,7J8897W37S,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/628f9609-6583-49be-be77-b64cfbc46fd7/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=628f9609-6583-49be-be77-b64cfbc46fd7,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=628f9609-6583-49be-be77-b64cfbc46fd7,628f9609-6583-49be-be77-b64cfbc46fd7,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,022425,Multaq,DRONEDARONE,2023/11/03,Antiarrhythmic,2009,SANOFI AVENTIS U S LLC,2009/07/01-,0024-4142,JQZ1L091Y2,Dronedarone,Dronedarone,JQZ1L091Y2,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/7fa41601-7fb5-4155-8e50-2ae903f0d2d6/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7fa41601-7fb5-4155-8e50-2ae903f0d2d6,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=7fa41601-7fb5-4155-8e50-2ae903f0d2d6,7fa41601-7fb5-4155-8e50-2ae903f0d2d6,,,
HUMAN PRESCRIPTION DRUG LABEL,KIT,ORAL,NDA,211367,SLYND,DROSPIRENONE,2022/11/22,Progestin,2001,EXELTIS USA INC,2019/06/06-,0642-7470,N295J34A25,DROSPIRENONE,DROSPIRENONE,N295J34A25,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/db32bc55-f295-4d87-9dbb-0a2f45573dcf/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=db32bc55-f295-4d87-9dbb-0a2f45573dcf,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=db32bc55-f295-4d87-9dbb-0a2f45573dcf,db32bc55-f295-4d87-9dbb-0a2f45573dcf,,,
HUMAN PRESCRIPTION DRUG LABEL,KIT,ORAL,NDA,214154,Nextstellis,DROSPIRENONE AND ESTETROL,2023/05/11,Estrogen; Progestin,2021,MAYNE PHARMA,2021/04/16-,51862-258,KC3GI9UM9V; N295J34A25,drospirenone; estetrol monohydrate,drospirenone; estetrol,ENB39R14VF; N295J34A25,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/c5270073-d083-4109-ae4b-156986175e0a/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c5270073-d083-4109-ae4b-156986175e0a,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=c5270073-d083-4109-ae4b-156986175e0a,c5270073-d083-4109-ae4b-156986175e0a,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,021355,Angeliq,DROSPIRENONE AND ESTRADIOL,2023/12/08,Estrogen; Progestin,2005,BAYER HEALTHCARE PHARMACEUTICALS INC,2005/11/28-; 2012/02/29-,50419-482; 50419-483,4TI98Z838E; N295J34A25,DROSPIRENONE; ESTRADIOL,DROSPIRENONE; ESTRADIOL,4TI98Z838E; N295J34A25,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/761834c2-6b61-4583-84c2-f1ca4a97c4f2/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=761834c2-6b61-4583-84c2-f1ca4a97c4f2,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=761834c2-6b61-4583-84c2-f1ca4a97c4f2,761834c2-6b61-4583-84c2-f1ca4a97c4f2,,,
HUMAN PRESCRIPTION DRUG LABEL,KIT,ORAL,NDA,021098,Yasmin,DROSPIRENONE AND ETHINYL ESTRADIOL,2023/05/19,Estrogen; Progestin,2001,BAYER HEALTHCARE PHARMACEUTICALS INC,2001/05/11-,50419-402,423D2T571U; N295J34A25,DROSPIRENONE; ETHINYL ESTRADIOL,DROSPIRENONE; ETHINYL ESTRADIOL,423D2T571U; N295J34A25,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/d7ea6a60-5a56-4f81-b206-9b27b7e58875/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d7ea6a60-5a56-4f81-b206-9b27b7e58875,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=d7ea6a60-5a56-4f81-b206-9b27b7e58875,d7ea6a60-5a56-4f81-b206-9b27b7e58875,,,
HUMAN PRESCRIPTION DRUG LABEL,KIT,ORAL,NDA,021676,Yaz,DROSPIRENONE AND ETHINYL ESTRADIOL,2023/05/19,Estrogen; Progestin,2001,BAYER HEALTHCARE PHARMACEUTICALS INC,2006/03/16-,50419-405,423D2T571U; N295J34A25,DROSPIRENONE; ETHINYL ESTRADIOL,DROSPIRENONE; ETHINYL ESTRADIOL,423D2T571U; N295J34A25,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/065f33e4-b587-4e66-b896-ca9ab7b7c876/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=065f33e4-b587-4e66-b896-ca9ab7b7c876,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=065f33e4-b587-4e66-b896-ca9ab7b7c876,065f33e4-b587-4e66-b896-ca9ab7b7c876,,,
HUMAN PRESCRIPTION DRUG LABEL,KIT,ORAL,NDA,022532,Beyaz,DROSPIRENONE/ETHINYL ESTRADIOL/LEVOMEFOLATE CALCIUM AND LEVOMEFOLATE CALCIUM,2023/05/19,Estrogen; Folate Analog; Progestin,2010,BAYER HEALTHCARE PHARMACEUTICALS INC,2010/10/07-,50419-407,423D2T571U; A9R10K3F2F; N295J34A25,DROSPIRENONE; ETHINYL ESTRADIOL; LEVOMEFOLATE CALCIUM,DROSPIRENONE; ETHINYL ESTRADIOL; LEVOMEFOLIC ACID,423D2T571U; 8S95DH25XC; N295J34A25,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/8132454a-6135-4bac-b206-83a55eb8dbc6/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8132454a-6135-4bac-b206-83a55eb8dbc6,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=8132454a-6135-4bac-b206-83a55eb8dbc6,8132454a-6135-4bac-b206-83a55eb8dbc6,,,
HUMAN PRESCRIPTION DRUG LABEL,KIT,ORAL,NDA,022574,Drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium,DROSPIRENONE/ETHINYL ESTRADIOL/LEVOMEFOLATE CALCIUM AND LEVOMEFOLATE CALCIUM,2023/05/19,Estrogen; Folate Analog; Progestin,2010,SANDOZ INC,2015/08/01-,0781-4103,423D2T571U; A9R10K3F2F; N295J34A25,DROSPIRENONE; ETHINYL ESTRADIOL; LEVOMEFOLATE CALCIUM,DROSPIRENONE; ETHINYL ESTRADIOL; LEVOMEFOLIC ACID,423D2T571U; 8S95DH25XC; N295J34A25,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/6928f186-190d-4c40-beab-81cf80cd45cb/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6928f186-190d-4c40-beab-81cf80cd45cb,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=6928f186-190d-4c40-beab-81cf80cd45cb,6928f186-190d-4c40-beab-81cf80cd45cb,,,
HUMAN PRESCRIPTION DRUG LABEL,KIT,ORAL,NDA,022574,Safyral,DROSPIRENONE/ETHINYL ESTRADIOL/LEVOMEFOLATE CALCIUM AND LEVOMEFOLATE CALCIUM,2023/05/19,Estrogen; Folate Analog; Progestin,2010,BAYER HEALTHCARE PHARMACEUTICALS INC,2012/02/13-,50419-403,423D2T571U; A9R10K3F2F; N295J34A25,DROSPIRENONE; ETHINYL ESTRADIOL; LEVOMEFOLATE CALCIUM,DROSPIRENONE; ETHINYL ESTRADIOL; LEVOMEFOLIC ACID,423D2T571U; 8S95DH25XC; N295J34A25,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/97563516-306a-4e17-9690-edbda49ecd83/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=97563516-306a-4e17-9690-edbda49ecd83,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=97563516-306a-4e17-9690-edbda49ecd83,97563516-306a-4e17-9690-edbda49ecd83,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,NDA,203202,Northera,DROXIDOPA,2019/07/01,,2014,LUNDBECK PHARMACEUTICALS LLC,2014/09/01-,67386-820; 67386-821; 67386-822,J7A92W69L7,DROXIDOPA,DROXIDOPA,J7A92W69L7,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/2179f02c-48d7-48eb-8007-5ae43d8d16bc/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2179f02c-48d7-48eb-8007-5ae43d8d16bc,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=2179f02c-48d7-48eb-8007-5ae43d8d16bc,2179f02c-48d7-48eb-8007-5ae43d8d16bc,,,
HUMAN PRESCRIPTION DRUG LABEL,"CAPSULE, DELAYED RELEASE",ORAL,NDA,212516,DRIZALMA SPRINKLE,DULOXETINE,2021/07/28,Serotonin and Norepinephrine Reuptake Inhibitor,2004,SUN PHARMACEUTICAL INDUSTRIES INC,2019/08/01-,47335-616; 47335-617; 47335-618; 47335-619,9044SC542W,DULOXETINE HYDROCHLORIDE,DULOXETINE,O5TNM5N07U,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/b41423b8-dfec-4d79-ba3c-e43a87803d85/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b41423b8-dfec-4d79-ba3c-e43a87803d85,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=b41423b8-dfec-4d79-ba3c-e43a87803d85,b41423b8-dfec-4d79-ba3c-e43a87803d85,,,
HUMAN PRESCRIPTION DRUG LABEL,"CAPSULE, DELAYED RELEASE",ORAL,NDA,021427,Cymbalta,DULOXETINE HYDROCHLORIDE,2023/08/18,Serotonin and Norepinephrine Reuptake Inhibitor,2004,ELI LILLY AND COMPANY,2004/08/24-; 2010/01/15-,0002-3235; 0002-3240; 0002-3270,9044SC542W,Duloxetine hydrochloride,Duloxetine,O5TNM5N07U,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/2f7d4d67-10c1-4bf4-a7f2-c185fbad64ba/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2f7d4d67-10c1-4bf4-a7f2-c185fbad64ba,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=2f7d4d67-10c1-4bf4-a7f2-c185fbad64ba,2f7d4d67-10c1-4bf4-a7f2-c185fbad64ba,,,
HUMAN PRESCRIPTION DRUG LABEL,"CAPSULE, LIQUID FILLED",ORAL,NDA,021319,AVODART,DUTASTERIDE,2023/11/28,5-alpha Reductase Inhibitor,2001,WAYLIS THERAPEUTICS LLC,2022/12/15-,80725-712,O0J6XJN02I,DUTASTERIDE,DUTASTERIDE,O0J6XJN02I,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/960797b3-09b1-4d6a-8ece-8b5d918e93e4/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=960797b3-09b1-4d6a-8ece-8b5d918e93e4,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=960797b3-09b1-4d6a-8ece-8b5d918e93e4,960797b3-09b1-4d6a-8ece-8b5d918e93e4,,,
HUMAN PRESCRIPTION DRUG LABEL,"CAPSULE, LIQUID FILLED",ORAL,NDA,021319,AVODART,DUTASTERIDE,2022/12/15,5-alpha Reductase Inhibitor,2001,WOODWARD PHARMA SERVICES LLC,2022/12/15-,69784-712,O0J6XJN02I,DUTASTERIDE,DUTASTERIDE,O0J6XJN02I,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/4cad5edd-1f9b-4537-8506-24d93fe935ae/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4cad5edd-1f9b-4537-8506-24d93fe935ae,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=4cad5edd-1f9b-4537-8506-24d93fe935ae,4cad5edd-1f9b-4537-8506-24d93fe935ae,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,NDA,211155,Copiktra,DUVELISIB,2022/02/11,,2018,VERASTEM INC,2018/09/25-,71779-115; 71779-125,610V23S0JI,DUVELISIB,DUVELISIB,610V23S0JI,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/47547f93-489c-4298-aeea-d6a37ca6cb1d/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=47547f93-489c-4298-aeea-d6a37ca6cb1d,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=47547f93-489c-4298-aeea-d6a37ca6cb1d,47547f93-489c-4298-aeea-d6a37ca6cb1d,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,NDA,211155,COPIKTRA,DUVELISIB,2021/12/28,,2018,SECURA BIO INC,2018/09/25-,73116-215; 73116-225,610V23S0JI,DUVELISIB,DUVELISIB,610V23S0JI,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/e3c5ac56-e1f6-473a-bc73-687836534780/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e3c5ac56-e1f6-473a-bc73-687836534780,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=e3c5ac56-e1f6-473a-bc73-687836534780,e3c5ac56-e1f6-473a-bc73-687836534780,,,
HUMAN PRESCRIPTION DRUG LABEL,KIT,OPHTHALMIC,NDA,011963,Phospholine Iodide,ECHOTHIOPHATE IODIDE FOR OPHTHALMIC SOLUTION,2023/10/10,Cholinesterase Inhibitor,,FERA PHARMACEUTICALS LLC,2021/11/17-,48102-053,BA9QH3P00T,echothiophate iodide,echothiophate,0F350BVT6S,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/8afc8951-db76-4f27-8752-7c0d6aa47244/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8afc8951-db76-4f27-8752-7c0d6aa47244,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=8afc8951-db76-4f27-8752-7c0d6aa47244,8afc8951-db76-4f27-8752-7c0d6aa47244,,,
HUMAN PRESCRIPTION DRUG LABEL,"AEROSOL, FOAM",TOPICAL,NDA,205175,Ecoza,ECONAZOLE NITRATE,2023/12/04,Azole Antifungal,1982,RESILIA PHARMACEUTICALS INC,2023/12/04-,81811-100,H438WYN10E,ECONAZOLE NITRATE,ECONAZOLE,6Z1Y2V4A7M,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/0bb5fa27-32ed-ed13-e063-6394a90a1577/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0bb5fa27-32ed-ed13-e063-6394a90a1577,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=0bb5fa27-32ed-ed13-e063-6394a90a1577,0bb5fa27-32ed-ed13-e063-6394a90a1577,,,
HUMAN PRESCRIPTION DRUG LABEL,"AEROSOL, FOAM",TOPICAL,NDA,205175,ECOZA,ECONAZOLE NITRATE,2022/01/01,Azole Antifungal,1982,EXELTIS USA DERMATOLOGY LLC,2020/10/02-,23710-100,H438WYN10E,ECONAZOLE NITRATE,ECONAZOLE,6Z1Y2V4A7M,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/998798bc-5c64-4e4c-a0d6-925278ff76a4/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=998798bc-5c64-4e4c-a0d6-925278ff76a4,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=998798bc-5c64-4e4c-a0d6-925278ff76a4,998798bc-5c64-4e4c-a0d6-925278ff76a4,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION; KIT,INTRAVENOUS; ORAL,NDA,209176;215446,RADICAVA; RADICAVA ORS,EDARAVONE,2023/12/07,,2017,MITSUBISHI TANABE PHARMA AMERICA INC,2017/05/05-; 2022/05/12-,70510-2171; 70510-2321; 70510-2322,S798V6YJRP,EDARAVONE,EDARAVONE,S798V6YJRP,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/0ce2c1c4-2a40-485c-b7cb-96a9b85d9d11/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0ce2c1c4-2a40-485c-b7cb-96a9b85d9d11,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=0ce2c1c4-2a40-485c-b7cb-96a9b85d9d11,0ce2c1c4-2a40-485c-b7cb-96a9b85d9d11,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,210828,Ga-68-DOTATOC,EDOTREOTIDE GALLIUM GA-68,2021/12/08,,2019,UIHC P E T IMAGING CENTER,2019/09/01-,24417-681,Y68179SY2L,EDOTREOTIDE GALLIUM GA-68,EDOTREOTIDE GALLIUM GA-68,Y68179SY2L,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/c4d185c3-d520-462d-ba50-4f4ee485ace3/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c4d185c3-d520-462d-ba50-4f4ee485ace3,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=c4d185c3-d520-462d-ba50-4f4ee485ace3,c4d185c3-d520-462d-ba50-4f4ee485ace3,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,206316,SAVAYSA,EDOXABAN TOSYLATE,2024/02/06,Factor Xa Inhibitor,2015,DAIICHI SANKYO INC,2015/01/12-,65597-201; 65597-202; 65597-203,32W99UE810,EDOXABAN TOSYLATE,EDOXABAN,NDU3J18APO,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/e77d3400-56ad-11e3-949a-0800200c9a66/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e77d3400-56ad-11e3-949a-0800200c9a66,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=e77d3400-56ad-11e3-949a-0800200c9a66,e77d3400-56ad-11e3-949a-0800200c9a66,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,021937,Atripla,"EFAVIRENZ, EMTRICITABINE, AND TENOFOVIR DISOPROXIL FUMARATE",2021/12/14,Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor; Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor,2006,GILEAD SCIENCES LLC,2006/07/20-,15584-0101,G70B4ETF4S; JE6H2O27P8; OTT9J7900I,EFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE,EFAVIRENZ; EMTRICITABINE; TENOFOVIR ANHYDROUS,G70B4ETF4S; JE6H2O27P8; W4HFE001U5,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/2e97aa6d-09f7-46df-9499-63db7e9bac35/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2e97aa6d-09f7-46df-9499-63db7e9bac35,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=2e97aa6d-09f7-46df-9499-63db7e9bac35,2e97aa6d-09f7-46df-9499-63db7e9bac35,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,208255,SYMFI LO,"EFAVIRENZ, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE",2019/10/15,Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor; Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor,2018,MYLAN SPECIALTY L P,2018/03/13-,49502-425,2T8Q726O95; JE6H2O27P8; OTT9J7900I,EFAVIRENZ; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE,EFAVIRENZ; LAMIVUDINE; TENOFOVIR ANHYDROUS,2T8Q726O95; JE6H2O27P8; W4HFE001U5,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/86aad85d-5460-4c38-9761-a225e6bce190/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=86aad85d-5460-4c38-9761-a225e6bce190,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=86aad85d-5460-4c38-9761-a225e6bce190,86aad85d-5460-4c38-9761-a225e6bce190,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,022142,SYMFI,"EFAVIRENZ, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE",2019/10/15,Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor; Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor,2018,MYLAN SPECIALTY L P,2018/04/25-,49502-475,2T8Q726O95; JE6H2O27P8; OTT9J7900I,EFAVIRENZ; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE,EFAVIRENZ; LAMIVUDINE; TENOFOVIR ANHYDROUS,2T8Q726O95; JE6H2O27P8; W4HFE001U5,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/81a55dd9-78a8-49c3-88ab-8f5bffafa359/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=81a55dd9-78a8-49c3-88ab-8f5bffafa359,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=81a55dd9-78a8-49c3-88ab-8f5bffafa359,81a55dd9-78a8-49c3-88ab-8f5bffafa359,,,
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION,TOPICAL,NDA,203567,JUBLIA,EFINACONAZOLE,2022/03/31,Azole Antifungal,2014,BAUSCH HEALTH US LLC,2014/06/06-,0187-5400,J82SB7FXWB,EFINACONAZOLE,EFINACONAZOLE,J82SB7FXWB,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/922d4d25-c530-11e1-9b21-0800200c9a66/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=922d4d25-c530-11e1-9b21-0800200c9a66,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=922d4d25-c530-11e1-9b21-0800200c9a66,922d4d25-c530-11e1-9b21-0800200c9a66,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,215500,iwilfin,EFLORNITHINE HYDROCHLORIDE,2023/12/21,Antiprotozoal; Decarboxylase Inhibitor,2023,USWM LLC,2024/01/15-,78670-150,4NH22NDW9H,EFLORNITHINE HYDROCHLORIDE,EFLORNITHINE,ZQN1G5V6SR,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/6716d8cc-66e6-4cee-935c-ccb85ed984f5/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6716d8cc-66e6-4cee-935c-ccb85ed984f5,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=6716d8cc-66e6-4cee-935c-ccb85ed984f5,6716d8cc-66e6-4cee-935c-ccb85ed984f5,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,217639,ORSERDU,ELACESTRANT,2023/11/21,Estrogen Receptor Antagonist,2023,STEMLINE THERAPEUTICS INC,2023/01/27-,72187-0101; 72187-0102,FM6A2627A8,ELACESTRANT,ELACESTRANT,FM6A2627A8,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/aa66ae5c-2bd2-4444-8178-b55651e054ef/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=aa66ae5c-2bd2-4444-8178-b55651e054ef,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=aa66ae5c-2bd2-4444-8178-b55651e054ef,aa66ae5c-2bd2-4444-8178-b55651e054ef,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,210450,Orilissa,ELAGOLIX,2023/06/05,Gonadotropin Releasing Hormone Receptor Antagonist,2018,ABBVIE INC,2018/07/23-,0074-0038; 0074-0039,5948VUI423,ELAGOLIX SODIUM,ELAGOLIX,5B2546MB5Z,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/a86757b3-09c5-fd3b-1223-244e94f50a66/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a86757b3-09c5-fd3b-1223-244e94f50a66,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=a86757b3-09c5-fd3b-1223-244e94f50a66,a86757b3-09c5-fd3b-1223-244e94f50a66,,,
HUMAN PRESCRIPTION DRUG LABEL,KIT,ORAL,NDA,213388,Oriahnn,ELAGOLIX AND ESTRADIOL AND NORETHISTERONE,2023/06/05,Estrogen; Gonadotropin Releasing Hormone Receptor Antagonist; Progestin,2020,ABBVIE INC,2020/05/29-,0074-1017,4TI98Z838E; 5948VUI423; T18F433X4S,ELAGOLIX SODIUM; ESTRADIOL; NORETHINDRONE,ELAGOLIX; ESTRADIOL; NORETHINDRONE,4TI98Z838E; 5B2546MB5Z; T18F433X4S,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/99f6eee7-7e52-6999-7eb8-488d06dd1710/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=99f6eee7-7e52-6999-7eb8-488d06dd1710,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=99f6eee7-7e52-6999-7eb8-488d06dd1710,99f6eee7-7e52-6999-7eb8-488d06dd1710,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,208261,ZEPATIER,ELBASVIR AND GRAZOPREVIR,2023/11/21,Hepatitis C Virus NS3/4A Protease Inhibitor; Hepatitis C Virus NS5A Inhibitor,2016,MERCK SHARP AND DOHME LLC,2016/01/28-,0006-3074,632L571YDK; 8YE81R1X1J,ELBASVIR; GRAZOPREVIR ANHYDROUS,ELBASVIR; GRAZOPREVIR ANHYDROUS,632L571YDK; 8YE81R1X1J,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/164dc02a-9180-426a-b8b5-04ab39d2bbd4/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=164dc02a-9180-426a-b8b5-04ab39d2bbd4,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=164dc02a-9180-426a-b8b5-04ab39d2bbd4,164dc02a-9180-426a-b8b5-04ab39d2bbd4,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,021016,Relpax,ELETRIPTAN HYDROBROMIDE,2020/03/11,Serotonin-1b and Serotonin-1d Receptor Agonist,2002,ROERIG,2002/12/26-,0049-2330; 0049-2340,M41W832TA3,ELETRIPTAN HYDROBROMIDE,ELETRIPTAN,22QOO9B8KI,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/85745375-fcb6-4edc-b6db-a77b4a5f3e8c/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=85745375-fcb6-4edc-b6db-a77b4a5f3e8c,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=85745375-fcb6-4edc-b6db-a77b4a5f3e8c,85745375-fcb6-4edc-b6db-a77b4a5f3e8c,,,
HUMAN PRESCRIPTION DRUG LABEL,KIT,ORAL,NDA,212273;217660,Trikafta,"ELEXACAFTOR, TEZACAFTOR, AND IVACAFTOR",2023/10/16,Cystic Fibrosis Transmembrane Conductance Regulator Potentiator,2019,VERTEX PHARMACEUTICALS INCORPORATED,2019/10/21-; 2021/06/08-; 2023/04/26-,51167-106; 51167-331; 51167-445; 51167-446,1Y740ILL1Z; 8RW88Y506K; RRN67GMB0V,Elexacaftor; Ivacaftor; Tezacaftor,Elexacaftor; Ivacaftor; Tezacaftor,1Y740ILL1Z; 8RW88Y506K; RRN67GMB0V,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/f354423a-85c2-41c3-a9db-0f3aee135d8d/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f354423a-85c2-41c3-a9db-0f3aee135d8d,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=f354423a-85c2-41c3-a9db-0f3aee135d8d,f354423a-85c2-41c3-a9db-0f3aee135d8d,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,NDA,205494,Cerdelga,ELIGLUSTAT,2024/03/03,Glucosylceramide Synthase Inhibitor,2014,GENZYME CORPORATION,2014/09/03-,58468-0220,DR40J4WA67,ELIGLUSTAT,ELIGLUSTAT,DR40J4WA67,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/819f828a-b888-4e46-83fc-94d774a28a83/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=819f828a-b888-4e46-83fc-94d774a28a83,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=819f828a-b888-4e46-83fc-94d774a28a83,819f828a-b888-4e46-83fc-94d774a28a83,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,216774,ALVAIZ,ELTROMBOPAG,2024/02/13,Thrombopoietin Receptor Agonist,2008,TEVA PHARMACEUTICALS INC,2024/02/13-,0480-3273; 0480-3274; 0480-3275; 0480-3276,F9G8XE24IB,ELTROMBOPAG CHOLINE,ELTROMBOPAG,S56D65XJ9G,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/ed51e463-7a03-4858-bbd2-882ce4753d5a/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ed51e463-7a03-4858-bbd2-882ce4753d5a,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=ed51e463-7a03-4858-bbd2-882ce4753d5a,ed51e463-7a03-4858-bbd2-882ce4753d5a,,,
HUMAN PRESCRIPTION DRUG LABEL,"POWDER, FOR SUSPENSION; TABLET, FILM COATED",ORAL,NDA,022291;207027,PROMACTA,ELTROMBOPAG OLAMINE,2024/03/26,Thrombopoietin Receptor Agonist,2008,NOVARTIS PHARMACEUTICALS CORPORATION,2016/04/01-; 2016/04/07-; 2016/05/24-; 2016/08/22-; 2018/09/27-,0078-0684; 0078-0685; 0078-0686; 0078-0687; 0078-0697; 0078-0972,4U07F515LG,ELTROMBOPAG OLAMINE,ELTROMBOPAG,S56D65XJ9G,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/7714a0ed-34bb-46e6-a0a5-b363908b22c2/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7714a0ed-34bb-46e6-a0a5-b363908b22c2,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=7714a0ed-34bb-46e6-a0a5-b363908b22c2,7714a0ed-34bb-46e6-a0a5-b363908b22c2,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,206940,Viberzi,ELUXADOLINE,2020/06/01,mu-Opioid Receptor Agonist,2015,ALLERGAN INC,2015/10/01-,61874-075; 61874-100,45TPJ4MBQ1,ELUXADOLINE,ELUXADOLINE,45TPJ4MBQ1,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/7821bd40-4c84-4984-951b-6436ae20421a/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7821bd40-4c84-4984-951b-6436ae20421a,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=7821bd40-4c84-4984-951b-6436ae20421a,7821bd40-4c84-4984-951b-6436ae20421a,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,207561,Genvoya,"ELVITEGRAVIR, COBICISTAT, EMTRICITABINE, AND TENOFOVIR ALAFENAMIDE",2022/01/13,Cytochrome P450 3A Inhibitor; Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor; Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor,2015,GILEAD SCIENCES INC,2015/11/05-,61958-1901,4GDQ854U53; FWF6Q91TZO; G70B4ETF4S; LW2E03M5PG,cobicistat; elvitegravir; emtricitabine; tenofovir alafenamide fumarate,cobicistat; elvitegravir; emtricitabine; tenofovir anhydrous,4GDQ854U53; G70B4ETF4S; LW2E03M5PG; W4HFE001U5,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/34784acf-15ed-4715-b504-eb30430518e9/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=34784acf-15ed-4715-b504-eb30430518e9,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=34784acf-15ed-4715-b504-eb30430518e9,34784acf-15ed-4715-b504-eb30430518e9,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,203100,Stribild,"ELVITEGRAVIR, COBICISTAT, EMTRICITABINE, AND TENOFOVIR DISOPROXIL FUMARATE",2021/09/16,Cytochrome P450 3A Inhibitor; Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor; Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor,2012,GILEAD SCIENCES INC,2012/08/27-,61958-1201,4GDQ854U53; G70B4ETF4S; LW2E03M5PG; OTT9J7900I,cobicistat; elvitegravir; emtricitabine; tenofovir disoproxil fumarate,TENOFOVIR ANHYDROUS; cobicistat; elvitegravir; emtricitabine,4GDQ854U53; G70B4ETF4S; LW2E03M5PG; W4HFE001U5,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/74ae2a93-b267-444c-8f0f-a2a6522260ee/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=74ae2a93-b267-444c-8f0f-a2a6522260ee,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=74ae2a93-b267-444c-8f0f-a2a6522260ee,74ae2a93-b267-444c-8f0f-a2a6522260ee,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,204629,Jardiance,EMPAGLIFLOZIN,2023/11/21,Sodium-Glucose Cotransporter 2 Inhibitor,2014,BOEHRINGER INGELHEIM PHARMACEUTICALS INC,2014/08/01-,0597-0152; 0597-0153,HDC1R2M35U,EMPAGLIFLOZIN,EMPAGLIFLOZIN,HDC1R2M35U,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/faf3dd6a-9cd0-39c2-0d2e-232cb3f67565/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=faf3dd6a-9cd0-39c2-0d2e-232cb3f67565,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=faf3dd6a-9cd0-39c2-0d2e-232cb3f67565,faf3dd6a-9cd0-39c2-0d2e-232cb3f67565,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,206073,Glyxambi,EMPAGLIFLOZIN AND LINAGLIPTIN,2023/11/02,Dipeptidyl Peptidase 4 Inhibitor; Sodium-Glucose Cotransporter 2 Inhibitor,2015,BOEHRINGER INGELHEIM PHARMACEUTICALS INC,2015/01/30-,0597-0164; 0597-0182,3X29ZEJ4R2; HDC1R2M35U,EMPAGLIFLOZIN; LINAGLIPTIN,EMPAGLIFLOZIN; LINAGLIPTIN,3X29ZEJ4R2; HDC1R2M35U,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/ddbab689-f76c-488c-9613-4168d41dd730/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ddbab689-f76c-488c-9613-4168d41dd730,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=ddbab689-f76c-488c-9613-4168d41dd730,ddbab689-f76c-488c-9613-4168d41dd730,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,206111,Synjardy,EMPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE,2024/05/02,Biguanide; Sodium-Glucose Cotransporter 2 Inhibitor,2015,BOEHRINGER INGELHEIM PHARMACEUTICALS INC,2015/08/26-,0597-0159; 0597-0168; 0597-0175; 0597-0180,786Z46389E; HDC1R2M35U,EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE,EMPAGLIFLOZIN; METFORMIN,9100L32L2N; HDC1R2M35U,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/0fdd0255-0055-65f3-b2c0-db8fbb87beae/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0fdd0255-0055-65f3-b2c0-db8fbb87beae,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=0fdd0255-0055-65f3-b2c0-db8fbb87beae,0fdd0255-0055-65f3-b2c0-db8fbb87beae,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, EXTENDED RELEASE",ORAL,NDA,212614,Trijardy XR,"EMPAGLIFLOZIN, LINAGLIPTIN, METFORMIN HYDROCHLORIDE",2023/11/07,Biguanide; Dipeptidyl Peptidase 4 Inhibitor; Sodium-Glucose Cotransporter 2 Inhibitor,2020,BOEHRINGER INGELHEIM PHARMACEUTICALS INC,2020/04/23-,0597-0380; 0597-0385; 0597-0390; 0597-0395,3X29ZEJ4R2; 786Z46389E; HDC1R2M35U,EMPAGLIFLOZIN; LINAGLIPTIN; METFORMIN HYDROCHLORIDE,EMPAGLIFLOZIN; LINAGLIPTIN; METFORMIN,3X29ZEJ4R2; 9100L32L2N; HDC1R2M35U,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/71873567-9594-452a-bb92-34a129adecac/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=71873567-9594-452a-bb92-34a129adecac,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=71873567-9594-452a-bb92-34a129adecac,71873567-9594-452a-bb92-34a129adecac,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, EXTENDED RELEASE",ORAL,NDA,208658,Synjardy XR,"EMPAGLIFLOZIN, METFORMIN HYDROCHLORIDE",2023/10/31,Biguanide; Sodium-Glucose Cotransporter 2 Inhibitor,2015,BOEHRINGER INGELHEIM PHARMACEUTICALS INC,2016/12/10-,0597-0280; 0597-0290; 0597-0295; 0597-0300,786Z46389E; HDC1R2M35U,EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE,EMPAGLIFLOZIN; METFORMIN,9100L32L2N; HDC1R2M35U,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/8006ba29-ee3a-f852-a9bb-c8ec9b41cf66/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8006ba29-ee3a-f852-a9bb-c8ec9b41cf66,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=8006ba29-ee3a-f852-a9bb-c8ec9b41cf66,8006ba29-ee3a-f852-a9bb-c8ec9b41cf66,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE; SOLUTION,ORAL,NDA,021500;021896,Emtriva,EMTRICITABINE,2021/06/29,Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor,2003,GILEAD SCIENCES INC,2003/07/02-; 2005/09/28-,61958-0601; 61958-0602,G70B4ETF4S,EMTRICITABINE,EMTRICITABINE,G70B4ETF4S,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/d6599395-3944-44f9-97f2-e0424c6b6a1f/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d6599395-3944-44f9-97f2-e0424c6b6a1f,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=d6599395-3944-44f9-97f2-e0424c6b6a1f,d6599395-3944-44f9-97f2-e0424c6b6a1f,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,NDA,021500,Emtriva,EMTRICITABINE,2009/07/01,Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor,2003,EXCELLA GMBH,2003/07/02-,46014-0601,G70B4ETF4S,emtricitabine,emtricitabine,G70B4ETF4S,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/946b680e-34e2-4789-8a9f-c00f851ad033/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=946b680e-34e2-4789-8a9f-c00f851ad033,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=946b680e-34e2-4789-8a9f-c00f851ad033,946b680e-34e2-4789-8a9f-c00f851ad033,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,208215,DESCOVY,EMTRICITABINE AND TENOFOVIR ALAFENAMIDE,2022/01/13,Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor,2015,GILEAD SCIENCES INC,2016/04/04-; 2022/01/07-,61958-2002; 61958-2005,FWF6Q91TZO; G70B4ETF4S,EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE,EMTRICITABINE; TENOFOVIR ANHYDROUS,G70B4ETF4S; W4HFE001U5,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/06f66e98-e6ee-4538-9506-6c1282cc14c1/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=06f66e98-e6ee-4538-9506-6c1282cc14c1,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=06f66e98-e6ee-4538-9506-6c1282cc14c1,06f66e98-e6ee-4538-9506-6c1282cc14c1,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,021752,Truvada,EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE,2024/05/09,Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor,2004,GILEAD SCIENCES INC,2004/08/02-; 2016/03/10-,61958-0701; 61958-0703; 61958-0704; 61958-0705,G70B4ETF4S; OTT9J7900I,emtricitabine; tenofovir disoproxil fumarate,emtricitabine; tenofovir anhydrous,G70B4ETF4S; W4HFE001U5,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/54e82b13-a037-49ed-b4b3-030b37c0ecdd/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=54e82b13-a037-49ed-b4b3-030b37c0ecdd,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=54e82b13-a037-49ed-b4b3-030b37c0ecdd,54e82b13-a037-49ed-b4b3-030b37c0ecdd,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,208351,ODEFSEY,"EMTRICITABINE, RILPIVIRINE HYDROCHLORIDE, AND TENOFOVIR ALAFENAMIDE",2023/02/06,Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor; Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor,2016,GILEAD SCIENCES INC,2016/03/01-,61958-2101,212WAX8KDD; FWF6Q91TZO; G70B4ETF4S,EMTRICITABINE; RILPIVIRINE HYDROCHLORIDE; TENOFOVIR ALAFENAMIDE FUMARATE,EMTRICITABINE; RILPIVIRINE; TENOFOVIR ANHYDROUS,FI96A8X663; G70B4ETF4S; W4HFE001U5,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/ea3b9ec8-e04a-412c-8b3f-e5cbc7e641d5/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ea3b9ec8-e04a-412c-8b3f-e5cbc7e641d5,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=ea3b9ec8-e04a-412c-8b3f-e5cbc7e641d5,ea3b9ec8-e04a-412c-8b3f-e5cbc7e641d5,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,202123,COMPLERA,"EMTRICITABINE, RILPIVIRINE HYDROCHLORIDE, AND TENOFOVIR DISOPROXIL FUMARATE",2021/03/26,Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor; Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor,2011,GILEAD SCIENCES INC,2011/08/10-,61958-1101,212WAX8KDD; G70B4ETF4S; OTT9J7900I,emtricitabine; rilpivirine hydrochloride; tenofovir disoproxil fumarate,emtricitabine; rilpivirine; tenofovir anhydrous,FI96A8X663; G70B4ETF4S; W4HFE001U5,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/d637cfab-f1e8-4eb3-a1b3-f85ca3bec612/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d637cfab-f1e8-4eb3-a1b3-f85ca3bec612,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=d637cfab-f1e8-4eb3-a1b3-f85ca3bec612,d637cfab-f1e8-4eb3-a1b3-f85ca3bec612,,,
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION,ORAL,NDA,208686,Enalapril maleate,ENALAPRIL MALEATE,2024/04/11,Angiotensin Converting Enzyme Inhibitor,1985,WILSHIRE PHARMACEUTICALS INC,2024/04/08-,52536-401,9O25354EPJ,ENALAPRIL MALEATE,ENALAPRILAT ANHYDROUS,Q508Q118JM,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/c7934b45-eb6b-44c1-bd2c-ef0fa10850c1/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c7934b45-eb6b-44c1-bd2c-ef0fa10850c1,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=c7934b45-eb6b-44c1-bd2c-ef0fa10850c1,c7934b45-eb6b-44c1-bd2c-ef0fa10850c1,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,018998,Vasotec,ENALAPRIL MALEATE,2020/12/01,Angiotensin Converting Enzyme Inhibitor,,BAUSCH HEALTH US LLC,1985/12/24-; 1988/07/26-,0187-0140; 0187-0141; 0187-0142; 0187-0143,9O25354EPJ,Enalapril Maleate,Enalaprilat Anhydrous,Q508Q118JM,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/39631f1f-5d19-43c1-b504-bf56d991ed97/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=39631f1f-5d19-43c1-b504-bf56d991ed97,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=39631f1f-5d19-43c1-b504-bf56d991ed97,39631f1f-5d19-43c1-b504-bf56d991ed97,,,
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION,ORAL,NDA,208686,Epaned,ENALAPRIL MALEATE,2020/07/27,Angiotensin Converting Enzyme Inhibitor,1985,AZURITY PHARMACEUTICALS INC,2016/10/03-,52652-4001,9O25354EPJ,ENALAPRIL MALEATE,ENALAPRILAT ANHYDROUS,Q508Q118JM,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/e6dbda02-779e-420c-893d-d0fea09432be/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e6dbda02-779e-420c-893d-d0fea09432be,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=e6dbda02-779e-420c-893d-d0fea09432be,e6dbda02-779e-420c-893d-d0fea09432be,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,019221,Vaseretic,ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE,2020/08/31,Angiotensin Converting Enzyme Inhibitor; Thiazide Diuretic,,BAUSCH HEALTH US LLC,1986/10/31-,0187-0146,0J48LPH2TH; 9O25354EPJ,Enalapril Maleate; Hydrochlorothiazide,Hydrochlorothiazide; enalaprilat anhydrous,0J48LPH2TH; Q508Q118JM,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/bf3007e2-8fcc-48de-8fd5-55e95033d62f/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=bf3007e2-8fcc-48de-8fd5-55e95033d62f,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=bf3007e2-8fcc-48de-8fd5-55e95033d62f,bf3007e2-8fcc-48de-8fd5-55e95033d62f,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,209606,Idhifa,ENASIDENIB MESYLATE,2023/12/21,Isocitrate Dehydrogenase 2 Inhibitor,2017,CELGENE CORPORATION,2017/08/01-,59572-705; 59572-710,UF6PC17XAV,ENASIDENIB MESYLATE,ENASIDENIB,3T1SS4E7AG,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/a5b4cdf0-3fa8-4c6c-80f6-8d8a00e3a5b6/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a5b4cdf0-3fa8-4c6c-80f6-8d8a00e3a5b6,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=a5b4cdf0-3fa8-4c6c-80f6-8d8a00e3a5b6,a5b4cdf0-3fa8-4c6c-80f6-8d8a00e3a5b6,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,NDA,210496,BRAFTOVI,ENCORAFENIB,2023/10/18,,2018,ARRAY BIOPHARMA INC,2018/06/27-,70255-025,8L7891MRB6,ENCORAFENIB,ENCORAFENIB,8L7891MRB6,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/235dfc38-0f0b-4037-b501-7a9f4294740c/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=235dfc38-0f0b-4037-b501-7a9f4294740c,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=235dfc38-0f0b-4037-b501-7a9f4294740c,235dfc38-0f0b-4037-b501-7a9f4294740c,,,
HUMAN PRESCRIPTION DRUG LABEL,KIT,SUBCUTANEOUS,NDA,021481,FUZEON,ENFUVIRTIDE,2019/12/01,Human Immunodeficiency Virus 1 Fusion Inhibitor,2003,GENENTECH INC,2012/04/10-,0004-0381,19OWO1T3ZE,ENFUVIRTIDE,ENFUVIRTIDE,19OWO1T3ZE,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/6935e846-d5a1-49e5-89a2-f8ebe4d5590d/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6935e846-d5a1-49e5-89a2-f8ebe4d5590d,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=6935e846-d5a1-49e5-89a2-f8ebe4d5590d,6935e846-d5a1-49e5-89a2-f8ebe4d5590d,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRAVENOUS; SUBCUTANEOUS,NDA,020164,Lovenox,ENOXAPARIN SODIUM,2022/04/08,Low Molecular Weight Heparin,1993,SANOFI AVENTIS U S LLC,1993/03/29-,0075-8013; 0075-8014; 0075-8016; 0075-8018; 0075-8020; 0075-8022; 0075-8025; 0075-8030,8NZ41MIK1O,ENOXAPARIN SODIUM,ENOXAPARIN,E47C0NF7LV,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/de6fb917-a94a-41ea-9d7d-937d4080ffcd/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=de6fb917-a94a-41ea-9d7d-937d4080ffcd,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=de6fb917-a94a-41ea-9d7d-937d4080ffcd,de6fb917-a94a-41ea-9d7d-937d4080ffcd,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRAVENOUS; SUBCUTANEOUS,NDA,020164,Lovenox,ENOXAPARIN SODIUM,2022/01/11,Low Molecular Weight Heparin,1993,SANOFI AVENTIS U S LLC,1993/03/29-,0075-0620; 0075-0621; 0075-0622; 0075-0623; 0075-0624; 0075-0626; 0075-2912; 0075-2915,8NZ41MIK1O,ENOXAPARIN SODIUM,ENOXAPARIN,E47C0NF7LV,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/5017a927-2a24-4f27-89f9-27c805bf7d59/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5017a927-2a24-4f27-89f9-27c805bf7d59,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=5017a927-2a24-4f27-89f9-27c805bf7d59,5017a927-2a24-4f27-89f9-27c805bf7d59,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,020796,Comtan,ENTACAPONE,2021/07/30,Catechol-O-Methyltransferase Inhibitor,,ALMATICA PHARMA LLC,2020/10/05-,52427-800,4975G9NM6T,ENTACAPONE,ENTACAPONE,4975G9NM6T,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/3b45ebd7-ca36-b691-fea2-652858a5c590/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3b45ebd7-ca36-b691-fea2-652858a5c590,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=3b45ebd7-ca36-b691-fea2-652858a5c590,3b45ebd7-ca36-b691-fea2-652858a5c590,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,020796,Entacapone,ENTACAPONE,2020/12/24,Catechol-O-Methyltransferase Inhibitor,,WOCKHARDT USA LLC,2012/09/30-,64679-781,4975G9NM6T,ENTACAPONE,ENTACAPONE,4975G9NM6T,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/3b19e8e3-336c-4aef-8721-ed121e216155/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3b19e8e3-336c-4aef-8721-ed121e216155,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=3b19e8e3-336c-4aef-8721-ed121e216155,3b19e8e3-336c-4aef-8721-ed121e216155,,,
HUMAN PRESCRIPTION DRUG LABEL,"SOLUTION; TABLET, FILM COATED",ORAL,NDA,021797;021798,BARACLUDE,ENTECAVIR,2024/05/09,Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor,2005,E R SQUIBB AND SONS L L C,2005/03/29-,0003-1611; 0003-1612; 0003-1614,5968Y6H45M,ENTECAVIR,entecavir anhydrous,NNU2O4609D,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/046e61c9-9298-4b2e-b76e-b26b81fecd20/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=046e61c9-9298-4b2e-b76e-b26b81fecd20,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=046e61c9-9298-4b2e-b76e-b26b81fecd20,046e61c9-9298-4b2e-b76e-b26b81fecd20,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE; PELLET,ORAL,NDA,212725;218550,Rozlytrek,ENTRECTINIB,2024/02/06,,2019,GENENTECH INC,2019/08/15-; 2023/10/20-,50242-091; 50242-094; 50242-623,L5ORF0AN1I,ENTRECTINIB,ENTRECTINIB,L5ORF0AN1I,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/c7c71b0c-2549-4495-86b6-c2807fa54908/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c7c71b0c-2549-4495-86b6-c2807fa54908,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=c7c71b0c-2549-4495-86b6-c2807fa54908,c7c71b0c-2549-4495-86b6-c2807fa54908,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE; TABLET,ORAL,NDA,203415;213674,Xtandi,ENZALUTAMIDE,2023/11/20,Androgen Receptor Inhibitor,2012,ASTELLAS PHARMA US INC,2012/08/31-; 2020/08/04-,0469-0125; 0469-0625; 0469-0725; 0469-1125; 0469-1725,93T0T9GKNU,ENZALUTAMIDE,ENZALUTAMIDE,93T0T9GKNU,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/b129fdc9-1d8e-425c-a5a9-8a2ed36dfbdf/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b129fdc9-1d8e-425c-a5a9-8a2ed36dfbdf,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=b129fdc9-1d8e-425c-a5a9-8a2ed36dfbdf,b129fdc9-1d8e-425c-a5a9-8a2ed36dfbdf,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,213536,REZIPRES,EPHEDRINE HYDROCHLORIDE,2023/12/04,Norepinephrine Releasing Agent; alpha-Adrenergic Agonist; beta-Adrenergic Agonist,2016,DR REDDY S LABORATORIES INC,2023/12/21-,43598-181,NLJ6390P1Z,EPHEDRINE HYDROCHLORIDE,EPHEDRINE,GN83C131XS,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/8e506ea1-8df0-4425-c1b9-6c89a293f52e/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8e506ea1-8df0-4425-c1b9-6c89a293f52e,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=8e506ea1-8df0-4425-c1b9-6c89a293f52e,8e506ea1-8df0-4425-c1b9-6c89a293f52e,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRAVENOUS,NDA,213994,EPHEDRINE SULFATE,EPHEDRINE SULFATE,2024/04/10,Norepinephrine Releasing Agent; alpha-Adrenergic Agonist; beta-Adrenergic Agonist,2016,ENDO USA INC,2021/01/31-; completed:2022/05/31-2022/05/31,42023-243; 42023-253,U6X61U5ZEG,EPHEDRINE SULFATE,EPHEDRINE,GN83C131XS,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/2c203482-8a04-40fc-93d2-74b30dec7742/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2c203482-8a04-40fc-93d2-74b30dec7742,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=2c203482-8a04-40fc-93d2-74b30dec7742,2c203482-8a04-40fc-93d2-74b30dec7742,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRAVENOUS,NDA,213407,Emerphed,EPHEDRINE SULFATE,2024/02/14,Norepinephrine Releasing Agent; alpha-Adrenergic Agonist; beta-Adrenergic Agonist,2016,NEXUS PHARMACEUTICALS LLC,2023/03/01-,14789-251; 14789-252,U6X61U5ZEG,Ephedrine Sulfate,EPHEDRINE,GN83C131XS,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/14601778-93ac-43ec-b66b-5a942317133f/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=14601778-93ac-43ec-b66b-5a942317133f,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=14601778-93ac-43ec-b66b-5a942317133f,14601778-93ac-43ec-b66b-5a942317133f,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRAVENOUS,NDA,213994,EPHEDRINE SULFATE,EPHEDRINE SULFATE,2023/05/24,Norepinephrine Releasing Agent; alpha-Adrenergic Agonist; beta-Adrenergic Agonist,2016,PAR PHARMACEUTICAL INC,2024/01/31-,42023-243,U6X61U5ZEG,EPHEDRINE SULFATE,EPHEDRINE,GN83C131XS,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/a247857e-ba7b-4a37-b132-4ba9b0d1c4d1/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a247857e-ba7b-4a37-b132-4ba9b0d1c4d1,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=a247857e-ba7b-4a37-b132-4ba9b0d1c4d1,a247857e-ba7b-4a37-b132-4ba9b0d1c4d1,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRAVENOUS,NDA,213407,Emerphed,EPHEDRINE SULFATE,2022/09/30,Norepinephrine Releasing Agent; alpha-Adrenergic Agonist; beta-Adrenergic Agonist,2016,NEXUS PHARAMACEUTICALS INC,2020/05/15-,14789-250,U6X61U5ZEG,Ephedrine Sulfate,EPHEDRINE,GN83C131XS,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/e1323592-dc57-4c9d-b84d-442648a7b114/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e1323592-dc57-4c9d-b84d-442648a7b114,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=e1323592-dc57-4c9d-b84d-442648a7b114,e1323592-dc57-4c9d-b84d-442648a7b114,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRAVENOUS,NDA,208289,Akovaz,EPHEDRINE SULFATE,2020/11/27,Norepinephrine Releasing Agent; alpha-Adrenergic Agonist; beta-Adrenergic Agonist,2016,EXELA PHARMA SCIENCES LLC,2021/04/15-; 2021/05/10-,51754-4200; 51754-4250,U6X61U5ZEG,EPHEDRINE SULFATE,EPHEDRINE,GN83C131XS,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/e92f3eda-33eb-4b34-9e8b-db8d32a5dbd9/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e92f3eda-33eb-4b34-9e8b-db8d32a5dbd9,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=e92f3eda-33eb-4b34-9e8b-db8d32a5dbd9,e92f3eda-33eb-4b34-9e8b-db8d32a5dbd9,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS,NDA,205029,EPINEPHRINE,EPINEPHRINE,2024/03/21,Catecholamine; alpha-Adrenergic Agonist; beta-Adrenergic Agonist,1939,BPI LABS LLC,2022/03/16-; 2024/03/07-; 2024/03/21-,54288-119; 54288-120; 54288-152,YKH834O4BH,EPINEPHRINE,EPINEPHRINE,YKH834O4BH,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/db18519b-82a9-435b-85c7-a040d644f057/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=db18519b-82a9-435b-85c7-a040d644f057,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=db18519b-82a9-435b-85c7-a040d644f057,db18519b-82a9-435b-85c7-a040d644f057,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAMUSCULAR,NDA,201739,Auvi-Q,EPINEPHRINE,2024/03/13,Catecholamine; alpha-Adrenergic Agonist; beta-Adrenergic Agonist,1939,KALEO INC,2012/11/15-; 2017/11/17-,60842-021; 60842-022; 60842-023,YKH834O4BH,EPINEPHRINE,EPINEPHRINE,YKH834O4BH,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/6180fb40-7fca-4602-b3da-ce62b8cd2470/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6180fb40-7fca-4602-b3da-ce62b8cd2470,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=6180fb40-7fca-4602-b3da-ce62b8cd2470,6180fb40-7fca-4602-b3da-ce62b8cd2470,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS,NDA,205029,EPINEPHRINE,EPINEPHRINE,2023/10/09,Catecholamine; alpha-Adrenergic Agonist; beta-Adrenergic Agonist,1939,BPI LABS LLC,2023/01/16-,54288-600,YKH834O4BH,EPINEPHRINE,EPINEPHRINE,YKH834O4BH,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/3fd8dd51-0aeb-43dd-9de0-c11b0330b15e/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3fd8dd51-0aeb-43dd-9de0-c11b0330b15e,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=3fd8dd51-0aeb-43dd-9de0-c11b0330b15e,3fd8dd51-0aeb-43dd-9de0-c11b0330b15e,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRAVENOUS,NDA,205029,EPINEPHRINE,EPINEPHRINE,2023/10/05,Catecholamine; alpha-Adrenergic Agonist; beta-Adrenergic Agonist,1939,BPI LABS LLC,2023/05/24-,54288-117,YKH834O4BH,EPINEPHRINE,EPINEPHRINE,YKH834O4BH,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/7499cbca-b8fe-4fc3-a318-13859ab989a7/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7499cbca-b8fe-4fc3-a318-13859ab989a7,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=7499cbca-b8fe-4fc3-a318-13859ab989a7,7499cbca-b8fe-4fc3-a318-13859ab989a7,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION, CONCENTRATE",INTRAVENOUS,NDA,205029,Epinephrine,EPINEPHRINE,2023/10/05,Catecholamine; alpha-Adrenergic Agonist; beta-Adrenergic Agonist,1939,BPI LABS LLC,2014/08/08-,54288-103,YKH834O4BH,EPINEPHRINE,EPINEPHRINE,YKH834O4BH,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/5b5282a9-b149-4f0a-978e-5adbf48ec8aa/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5b5282a9-b149-4f0a-978e-5adbf48ec8aa,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=5b5282a9-b149-4f0a-978e-5adbf48ec8aa,5b5282a9-b149-4f0a-978e-5adbf48ec8aa,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS,NDA,204640,Adrenalin,EPINEPHRINE,2023/04/28,Catecholamine; alpha-Adrenergic Agonist; beta-Adrenergic Agonist,1939,PAR PHARMACEUTICAL INC,2020/12/04-,42023-168,YKH834O4BH,EPINEPHRINE,EPINEPHRINE,YKH834O4BH,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/a5ce0c01-dd47-4997-ab09-490de65d3835/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a5ce0c01-dd47-4997-ab09-490de65d3835,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=a5ce0c01-dd47-4997-ab09-490de65d3835,a5ce0c01-dd47-4997-ab09-490de65d3835,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS,NDA,204640,Adrenalin,EPINEPHRINE,2023/04/28,Catecholamine; alpha-Adrenergic Agonist; beta-Adrenergic Agonist,1939,PAR PHARMACEUTICAL INC,2020/12/04-,42023-168,YKH834O4BH,EPINEPHRINE,EPINEPHRINE,YKH834O4BH,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/b27e06aa-5b40-44bc-8de7-80b027580a3b/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b27e06aa-5b40-44bc-8de7-80b027580a3b,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=b27e06aa-5b40-44bc-8de7-80b027580a3b,b27e06aa-5b40-44bc-8de7-80b027580a3b,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRAMUSCULAR,NDA,019430,EPIPEN; EPIPEN JR,EPINEPHRINE,2023/02/15,Catecholamine; alpha-Adrenergic Agonist; beta-Adrenergic Agonist,1939,MYLAN SPECIALTY L P,1987/12/22-,49502-500; 49502-501,YKH834O4BH,EPINEPHRINE,EPINEPHRINE,YKH834O4BH,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/7560c201-9246-487c-a13b-6295db04274a/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7560c201-9246-487c-a13b-6295db04274a,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=7560c201-9246-487c-a13b-6295db04274a,7560c201-9246-487c-a13b-6295db04274a,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRAVENOUS,NDA,211363,Epinephrine,EPINEPHRINE,2023/01/31,Catecholamine; alpha-Adrenergic Agonist; beta-Adrenergic Agonist,1939,INTERNATIONAL MEDICATION SYSTEMS LIMITED,2023/01/30-,76329-3318,YKH834O4BH,EPINEPHRINE,EPINEPHRINE,YKH834O4BH,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/f2b5f15b-8541-466a-a27a-ee57bc4aac67/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f2b5f15b-8541-466a-a27a-ee57bc4aac67,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=f2b5f15b-8541-466a-a27a-ee57bc4aac67,f2b5f15b-8541-466a-a27a-ee57bc4aac67,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,209359,EPINEPHRINE,EPINEPHRINE,2022/12/09,Catecholamine; alpha-Adrenergic Agonist; beta-Adrenergic Agonist,1939,HOSPIRA INC,2021/03/10-,0409-4933,YKH834O4BH,EPINEPHRINE,EPINEPHRINE,YKH834O4BH,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/ef18a92f-ba83-4bb0-808b-d09d736f6a81/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ef18a92f-ba83-4bb0-808b-d09d736f6a81,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=ef18a92f-ba83-4bb0-808b-d09d736f6a81,ef18a92f-ba83-4bb0-808b-d09d736f6a81,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS,NDA,204200;204640,Adrenalin,EPINEPHRINE,2022/06/02,Catecholamine; alpha-Adrenergic Agonist; beta-Adrenergic Agonist,1939,ENDO USA INC,2013/07/01-; 2014/03/01-,42023-159; 42023-168,YKH834O4BH,EPINEPHRINE,EPINEPHRINE,YKH834O4BH,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/3b7a4364-668d-4eb2-a20c-04adc35aabe4/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3b7a4364-668d-4eb2-a20c-04adc35aabe4,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=3b7a4364-668d-4eb2-a20c-04adc35aabe4,3b7a4364-668d-4eb2-a20c-04adc35aabe4,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS,NDA,205029,EPINEPHRINE,EPINEPHRINE,2022/02/14,Catecholamine; alpha-Adrenergic Agonist; beta-Adrenergic Agonist,1939,BELCHER PHARMACEUTICALS LLC,2022/02/28-,62250-102,YKH834O4BH,EPINEPHRINE,EPINEPHRINE,YKH834O4BH,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/6a8d8eb1-66aa-4195-9f98-8ebcc2e166d1/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6a8d8eb1-66aa-4195-9f98-8ebcc2e166d1,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=6a8d8eb1-66aa-4195-9f98-8ebcc2e166d1,6a8d8eb1-66aa-4195-9f98-8ebcc2e166d1,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION, CONCENTRATE",INTRAVENOUS,NDA,205029,EPINEPHRINE,EPINEPHRINE,2021/09/14,Catecholamine; alpha-Adrenergic Agonist; beta-Adrenergic Agonist,1939,BELCHER PHARMACEUTICALS LLC,2014/08/08-,62250-103,YKH834O4BH,EPINEPHRINE,EPINEPHRINE,YKH834O4BH,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/e51c9ca2-6057-4830-9dcc-e8c7491f861b/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e51c9ca2-6057-4830-9dcc-e8c7491f861b,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=e51c9ca2-6057-4830-9dcc-e8c7491f861b,e51c9ca2-6057-4830-9dcc-e8c7491f861b,,,
HUMAN PRESCRIPTION DRUG LABEL,KIT,INTRAMUSCULAR; SUBCUTANEOUS,NDA,204200,Epinephrine Convenience Kit,EPINEPHRINE,2020/03/06,Catecholamine; alpha-Adrenergic Agonist; beta-Adrenergic Agonist,,HF ACQUISITION CO LLC DBA HEALTHFIRST,2020/02/08-,51662-1507,YKH834O4BH,EPINEPHRINE,EDETIC ACID; EPINEPHRINE,9G34HU7RV0; YKH834O4BH,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/9df23744-3b5b-5815-e053-2a95a90acc47/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9df23744-3b5b-5815-e053-2a95a90acc47,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=9df23744-3b5b-5815-e053-2a95a90acc47,9df23744-3b5b-5815-e053-2a95a90acc47,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRAMUSCULAR; SUBCUTANEOUS,NDA,207534,SYMJEPI,EPINEPHRINE,2019/02/06,Catecholamine; alpha-Adrenergic Agonist; beta-Adrenergic Agonist,1939,ADAMIS PHARMACEUTICALS CORPORATION,2017/11/15-,38739-200,YKH834O4BH,epinephrine,epinephrine,YKH834O4BH,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/4b414a33-7371-4801-ae16-59db8c7b1aab/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4b414a33-7371-4801-ae16-59db8c7b1aab,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=4b414a33-7371-4801-ae16-59db8c7b1aab,4b414a33-7371-4801-ae16-59db8c7b1aab,,,
HUMAN PRESCRIPTION DRUG LABEL,KIT,INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS; TOPICAL,NDA,204200,Epinephrine Professional,EPINEPHRINE AND ISOPROPYL ALCOHOL,2022/10/19,Catecholamine; alpha-Adrenergic Agonist; beta-Adrenergic Agonist,,FOCUS HEALTH GROUP,2019/07/01-,24357-011,ND2M416302; YKH834O4BH,EPINEPHRINE; ISOPROPYL ALCOHOL,BISULFITE ION; EDETIC ACID; EPINEPHRINE; ISOPROPYL ALCOHOL,9G34HU7RV0; ND2M416302; OJ9787WBLU; YKH834O4BH,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/8c502fcc-1b61-7d1f-e053-2a95a90adc46/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8c502fcc-1b61-7d1f-e053-2a95a90adc46,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=8c502fcc-1b61-7d1f-e053-2a95a90adc46,8c502fcc-1b61-7d1f-e053-2a95a90adc46,,,
HUMAN PRESCRIPTION DRUG LABEL,KIT,INTRAMUSCULAR; SUBCUTANEOUS,NDA,204200,Certa Dose Epinephrine Convenience Kit,EPINEPHRINE CONVENIENCE KIT,2023/12/31,Catecholamine; alpha-Adrenergic Agonist; beta-Adrenergic Agonist,2012,CD ACQUISITIONS LLC,2018/11/26-,71754-001,YKH834O4BH,EPINEPHRINE,EPINEPHRINE,YKH834O4BH,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/780ca016-d85c-6fac-e053-2a91aa0abd0b/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=780ca016-d85c-6fac-e053-2a91aa0abd0b,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=780ca016-d85c-6fac-e053-2a91aa0abd0b,780ca016-d85c-6fac-e053-2a91aa0abd0b,,,
HUMAN PRESCRIPTION DRUG LABEL,KIT,INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS; TOPICAL,NDA,204200,Epinephrine Professional EMS,EPINEPHRINE CONVENIENCE KIT,2023/04/10,Catecholamine; alpha-Adrenergic Agonist; beta-Adrenergic Agonist,,FOCUS HEALTH GROUP,2019/07/01-,24357-012,ND2M416302; YKH834O4BH,EPINEPHRINE; ISOPROPYL ALCOHOL,EPINEPHRINE; ISOPROPYL ALCOHOL,ND2M416302; YKH834O4BH,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/8d4491fa-aaf8-37b6-e053-2a95a90a3f9e/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8d4491fa-aaf8-37b6-e053-2a95a90a3f9e,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=8d4491fa-aaf8-37b6-e053-2a95a90a3f9e,8d4491fa-aaf8-37b6-e053-2a95a90a3f9e,,,
HUMAN PRESCRIPTION DRUG LABEL,KIT,INTRAMUSCULAR; SUBCUTANEOUS; TOPICAL,NDA,204200,EpinephrineSnap-V,EPINEPHRINE CONVENIENCE KIT,2022/01/13,Catecholamine; alpha-Adrenergic Agonist; beta-Adrenergic Agonist,1939,SNAP MEDICAL INDUSTRIES,2018/12/01-,71923-200,ND2M416302; YKH834O4BH,EPINEPHRINE; ISOPROPYL ALCOHOL,BISULFITE ION; EDETIC ACID; EPINEPHRINE; ISOPROPYL ALCOHOL,9G34HU7RV0; ND2M416302; OJ9787WBLU; YKH834O4BH,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/791025c6-5425-c68d-e053-2a91aa0a2bc5/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=791025c6-5425-c68d-e053-2a91aa0a2bc5,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=791025c6-5425-c68d-e053-2a91aa0a2bc5,791025c6-5425-c68d-e053-2a91aa0a2bc5,,,
HUMAN PRESCRIPTION DRUG LABEL,KIT,INTRAMUSCULAR; SUBCUTANEOUS; TOPICAL,NDA,204200,EpinephrineSnap-EMS,EPINEPHRINE CONVENIENCE KIT,2022/01/13,Catecholamine; alpha-Adrenergic Agonist; beta-Adrenergic Agonist,1939,SNAP MEDICAL INDUSTRIES,2018/12/01-,71923-100,ND2M416302; YKH834O4BH,EPINEPHRINE; ISOPROPYL ALCOHOL,BISULFITE ION; EDETIC ACID; EPINEPHRINE; ISOPROPYL ALCOHOL,9G34HU7RV0; ND2M416302; OJ9787WBLU; YKH834O4BH,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/77b974f7-e3be-0d6b-e053-2991aa0a65fd/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=77b974f7-e3be-0d6b-e053-2991aa0a65fd,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=77b974f7-e3be-0d6b-e053-2991aa0a65fd,77b974f7-e3be-0d6b-e053-2991aa0a65fd,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,050778,Ellence,EPIRUBICIN HYDROCHLORIDE,2024/04/25,Anthracycline Topoisomerase Inhibitor,1999,PHARMACIA AND UPJOHN COMPANY LLC,1999/09/15-,0009-5091; 0009-5093,22966TX7J5,EPIRUBICIN HYDROCHLORIDE,EPIRUBICIN,3Z8479ZZ5X,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/0a03c798-a652-4895-b29c-3b521a89ba42/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0a03c798-a652-4895-b29c-3b521a89ba42,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=0a03c798-a652-4895-b29c-3b521a89ba42,0a03c798-a652-4895-b29c-3b521a89ba42,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,021437,Inspra,EPLERENONE,2023/07/18,Aldosterone Antagonist,2002,VIATRIS SPECIALTY LLC,2024/04/19-,58151-142; 58151-143,6995V82D0B,EPLERENONE,EPLERENONE,6995V82D0B,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/1a52bedc-8e2c-4116-a296-a87770676b4a/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1a52bedc-8e2c-4116-a296-a87770676b4a,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=1a52bedc-8e2c-4116-a296-a87770676b4a,1a52bedc-8e2c-4116-a296-a87770676b4a,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,021437,Inspra,EPLERENONE,2021/10/01,Aldosterone Antagonist,2002,PFIZER LABORATORIES DIV PFIZER INC,2002/09/27-; completed:2002/09/27-2025/09/30,0025-1710; 0025-1720,6995V82D0B,EPLERENONE,EPLERENONE,6995V82D0B,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/a55a39ff-1bd5-428b-a64f-c44262e2f3ed/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a55a39ff-1bd5-428b-a64f-c44262e2f3ed,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=a55a39ff-1bd5-428b-a64f-c44262e2f3ed,a55a39ff-1bd5-428b-a64f-c44262e2f3ed,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",SUBCUTANEOUS,NDA,217388,WAINUA,EPLONTERSEN,2023/12/21,,2023,ASTRAZENECA PHARMACEUTICALS LP,2023/12/21-,0310-9400,0GRZ0F5XJ6,EPLONTERSEN,EPLONTERSEN,0GRZ0F5XJ6,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/d7dcb847-71dd-4fff-82d0-d43a465fc096/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d7dcb847-71dd-4fff-82d0-d43a465fc096,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=d7dcb847-71dd-4fff-82d0-d43a465fc096,d7dcb847-71dd-4fff-82d0-d43a465fc096,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAVENOUS,NDA,022260,Veletri,EPOPROSTENOL,2022/11/28,Prostacycline Vasodilator,1995,ACTELION PHARMACEUTICALS US INC,2010/04/22-,66215-402; 66215-403,DCR9Z582X0,epoprostenol,epoprostenol,DCR9Z582X0,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/df502787-46ec-4dd1-a2c0-be90f6d95a5d/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=df502787-46ec-4dd1-a2c0-be90f6d95a5d,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=df502787-46ec-4dd1-a2c0-be90f6d95a5d,df502787-46ec-4dd1-a2c0-be90f6d95a5d,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION; SOLUTION",INTRAVENOUS,NDA,020444,Diluent; FLOLAN,EPOPROSTENOL SODIUM; WATER,2023/10/26,Prostacycline Vasodilator,1995,GLAXOSMITHKLINE LLC,1995/12/08-; 2016/04/01-,0173-0517; 0173-0519; 0173-0857,059QF0KO0R; 4K04IQ1OF4,EPOPROSTENOL SODIUM; WATER,EPOPROSTENOL; WATER,059QF0KO0R; DCR9Z582X0,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/8e4b636e-ee9c-4111-779d-28c8369d283b/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8e4b636e-ee9c-4111-779d-28c8369d283b,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=8e4b636e-ee9c-4111-779d-28c8369d283b,8e4b636e-ee9c-4111-779d-28c8369d283b,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAVENOUS,NDA,211109,Xerava,ERAVACYCLINE,2024/02/12,Tetracycline-class Antibacterial,2018,TETRAPHASE PHARMACEUTICALS INC,2018/09/10-,71773-050; 71773-100,WK1NMH89VJ,ERAVACYCLINE DIHYDROCHLORIDE,ERAVACYCLINE,07896928ZC,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/a4b188d4-f467-470c-ad7b-25ffbdd8862a/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a4b188d4-f467-470c-ad7b-25ffbdd8862a,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=a4b188d4-f467-470c-ad7b-25ffbdd8862a,a4b188d4-f467-470c-ad7b-25ffbdd8862a,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,212018,BALVERSA,ERDAFITINIB,2024/02/01,Kinase Inhibitor,2019,JANSSEN PRODUCTS LP,2019/04/12-,59676-030; 59676-040; 59676-050,890E37NHMV,ERDAFITINIB,ERDAFITINIB,890E37NHMV,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/2a8aa5c0-6c92-4566-8c45-e8f4d1fc20ee/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2a8aa5c0-6c92-4566-8c45-e8f4d1fc20ee,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=2a8aa5c0-6c92-4566-8c45-e8f4d1fc20ee,2a8aa5c0-6c92-4566-8c45-e8f4d1fc20ee,,,
HUMAN PRESCRIPTION DRUG LABEL,"CAPSULE, LIQUID FILLED",ORAL,NDA,003444,DRISDOL,ERGOCALCIFEROL,2023/03/14,Provitamin D2 Compound,,VALIDUS PHARMACEUTICALS LLC,2018/04/01-,30698-493,VS041H42XC,ERGOCALCIFEROL,ERGOCALCIFEROL,VS041H42XC,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/acb61678-d23d-405d-8c14-1a16cfd3a776/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=acb61678-d23d-405d-8c14-1a16cfd3a776,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=acb61678-d23d-405d-8c14-1a16cfd3a776,acb61678-d23d-405d-8c14-1a16cfd3a776,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRAVENOUS,NDA,201532,Halaven,ERIBULIN MESYLATE,2023/11/22,Microtubule Inhibitor,,BSP PHARMACEUTICALS SPA,2017/04/21-,43624-002,AV9U0660CW,ERIBULIN MESYLATE,ERIBULIN,LR24G6354G,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/8fc8fe1d-59fe-4e43-a95c-e7aa13422cd6/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8fc8fe1d-59fe-4e43-a95c-e7aa13422cd6,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=8fc8fe1d-59fe-4e43-a95c-e7aa13422cd6,8fc8fe1d-59fe-4e43-a95c-e7aa13422cd6,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRAVENOUS,NDA,201532,Halaven,ERIBULIN MESYLATE,2022/09/17,Microtubule Inhibitor,2010,EISAI INC,2010/11/15-,62856-389,AV9U0660CW,ERIBULIN MESYLATE,ERIBULIN,LR24G6354G,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/31ce4750-ded5-4a0b-95e9-f229fa6bc822/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=31ce4750-ded5-4a0b-95e9-f229fa6bc822,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=31ce4750-ded5-4a0b-95e9-f229fa6bc822,31ce4750-ded5-4a0b-95e9-f229fa6bc822,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,021743,TARCEVA,ERLOTINIB HYDROCHLORIDE,2018/12/12,Kinase Inhibitor,2004,GENENTECH INC,2005/04/30-,50242-062; 50242-063; 50242-064,DA87705X9K,ERLOTINIB HYDROCHLORIDE; erlotinib hydrochloride,ERLOTINIB,J4T82NDH7E,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/57bccb29-1c47-4c64-ab6a-77960a91cc20/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=57bccb29-1c47-4c64-ab6a-77960a91cc20,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=57bccb29-1c47-4c64-ab6a-77960a91cc20,57bccb29-1c47-4c64-ab6a-77960a91cc20,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAMUSCULAR; INTRAVENOUS,NDA,021337,INVANZ,ERTAPENEM SODIUM,2024/02/15,Penem Antibacterial,2001,MERCK SHARP AND DOHME LLC,2001/11/21-; completed:2001/11/21-2018/07/31,0006-3843; 0006-3845,2T90KE67L0,ERTAPENEM SODIUM,ertapenem,G32F6EID2H,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/33f3b99b-fa82-42e0-26bf-f49891ae3d22/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=33f3b99b-fa82-42e0-26bf-f49891ae3d22,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=33f3b99b-fa82-42e0-26bf-f49891ae3d22,33f3b99b-fa82-42e0-26bf-f49891ae3d22,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAMUSCULAR; INTRAVENOUS,NDA,021337,ERTAPENEM,ERTAPENEM SODIUM,2022/11/07,Penem Antibacterial,2001,PAR PHARMACEUTICAL INC,2018/07/26-,42023-221,2T90KE67L0,ERTAPENEM SODIUM,ERTAPENEM,G32F6EID2H,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/657855f2-7c92-4aa8-9c3d-51d08e56a09a/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=657855f2-7c92-4aa8-9c3d-51d08e56a09a,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=657855f2-7c92-4aa8-9c3d-51d08e56a09a,657855f2-7c92-4aa8-9c3d-51d08e56a09a,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAMUSCULAR; INTRAVENOUS,NDA,021337,ERTAPENEM,ERTAPENEM SODIUM,2022/11/07,Penem Antibacterial,2001,PAR PHARMACEUTICAL INC,2018/11/01-,42023-221,2T90KE67L0,ERTAPENEM SODIUM,ERTAPENEM,G32F6EID2H,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/41304b1d-7db4-468a-ab1d-04e56fb50de4/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=41304b1d-7db4-468a-ab1d-04e56fb50de4,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=41304b1d-7db4-468a-ab1d-04e56fb50de4,41304b1d-7db4-468a-ab1d-04e56fb50de4,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,209803,STEGLATRO,ERTUGLIFLOZIN,2023/09/12,,2017,MERCK SHARP AND DOHME LLC,2017/12/19-,0006-5363; 0006-5364,MLU731K321,ERTUGLIFLOZIN PIDOLATE,ERTUGLIFLOZIN,6C282481IP,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/e6f3e718-bb99-48f1-ab94-b9f0af05fed6/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e6f3e718-bb99-48f1-ab94-b9f0af05fed6,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=e6f3e718-bb99-48f1-ab94-b9f0af05fed6,e6f3e718-bb99-48f1-ab94-b9f0af05fed6,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,209806,SEGLUROMET,ERTUGLIFLOZIN AND METFORMIN HYDROCHLORIDE,2023/09/12,Biguanide,2017,MERCK SHARP AND DOHME LLC,2017/12/19-,0006-5369; 0006-5370; 0006-5373; 0006-5374,786Z46389E; MLU731K321,ERTUGLIFLOZIN PIDOLATE; METFORMIN HYDROCHLORIDE,ERTUGLIFLOZIN; METFORMIN,6C282481IP; 9100L32L2N,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/a6aeb99a-ce49-4125-90ce-642df3f1ebad/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a6aeb99a-ce49-4125-90ce-642df3f1ebad,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=a6aeb99a-ce49-4125-90ce-642df3f1ebad,a6aeb99a-ce49-4125-90ce-642df3f1ebad,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,209805,STEGLUJAN,ERTUGLIFLOZIN AND SITAGLIPTIN,2023/10/20,Dipeptidyl Peptidase 4 Inhibitor,2017,MERCK SHARP AND DOHME LLC,2017/12/19-,0006-5367; 0006-5368,MLU731K321; TS63EW8X6F,ERTUGLIFLOZIN PIDOLATE; SITAGLIPTIN PHOSPHATE,ERTUGLIFLOZIN; SITAGLIPTIN,6C282481IP; QFP0P1DV7Z,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/c2c553d8-5a9d-4366-bf53-8bdb5a876d19/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c2c553d8-5a9d-4366-bf53-8bdb5a876d19,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=c2c553d8-5a9d-4366-bf53-8bdb5a876d19,c2c553d8-5a9d-4366-bf53-8bdb5a876d19,,,
HUMAN PRESCRIPTION DRUG LABEL,GEL,TOPICAL,NDA,050617,ERYGEL,ERYTHROMYCIN,2018/06/21,Macrolide; Macrolide Antimicrobial,,MYLAN PHARMACEUTICALS INC,2019/03/07-,0378-8075,63937KV33D,ERYTHROMYCIN,ERYTHROMYCIN,63937KV33D,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/f1c6885e-4136-4542-a8a2-7fa8fcd77a03/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f1c6885e-4136-4542-a8a2-7fa8fcd77a03,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=f1c6885e-4136-4542-a8a2-7fa8fcd77a03,f1c6885e-4136-4542-a8a2-7fa8fcd77a03,,,
HUMAN PRESCRIPTION DRUG LABEL,KIT,TOPICAL,NDA,050557,Benzamycin,ERYTHROMYCIN AND BENZOYL PEROXIDE,2020/11/30,Macrolide; Macrolide Antimicrobial,,BAUSCH HEALTH US LLC,1984/10/26-,0187-5205,63937KV33D; W9WZN9A0GM,benzoyl peroxide; erythromycin,benzoyl peroxide; erythromycin,63937KV33D; W9WZN9A0GM,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/c8c05e98-ec28-4636-8e5c-9a2557483e3c/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c8c05e98-ec28-4636-8e5c-9a2557483e3c,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=c8c05e98-ec28-4636-8e5c-9a2557483e3c,c8c05e98-ec28-4636-8e5c-9a2557483e3c,,,
HUMAN PRESCRIPTION DRUG LABEL,SUSPENSION,ORAL,NDA,050207,Ery-Ped,ERYTHROMYCIN ETHYLSUCCINATE,2023/12/16,Macrolide; Macrolide Antimicrobial,,AZURITY PHARMACEUTICALS INC FORMERLY ARBOR PHARMACEUTICALS,2011/07/05-; 2012/06/14-,24338-130; 24338-132,1014KSJ86F,ERYTHROMYCIN ETHYLSUCCINATE,ERYTHROMYCIN,63937KV33D,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/04775721-ab87-4b66-808c-d67a21032385/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=04775721-ab87-4b66-808c-d67a21032385,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=04775721-ab87-4b66-808c-d67a21032385,04775721-ab87-4b66-808c-d67a21032385,,,
HUMAN PRESCRIPTION DRUG LABEL,"GRANULE, FOR SUSPENSION; TABLET",ORAL,ANDA; NDA,050207;061905,E.E.S; E.E.S 400,ERYTHROMYCIN ETHYLSUCCINATE,2023/12/16,Macrolide; Macrolide Antimicrobial,,AZURITY PHARMACEUTICALS INC FORMERLY ARBOR PHARMACEUTICALS,2011/04/18-; 2011/05/03-,24338-100; 24338-134; 24338-136,1014KSJ86F,ERYTHROMYCIN ETHYLSUCCINATE,ERYTHROMYCIN,63937KV33D,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/b455bbdb-a3f1-470f-aa5f-ed83ac2e228d/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b455bbdb-a3f1-470f-aa5f-ed83ac2e228d,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=b455bbdb-a3f1-470f-aa5f-ed83ac2e228d,b455bbdb-a3f1-470f-aa5f-ed83ac2e228d,,,
HUMAN PRESCRIPTION DRUG LABEL,SUSPENSION,ORAL,NDA,050207,ERYTHROMYCIN ETHYLSUCCINATE,ERYTHROMYCIN ETHYLSUCCINATE,2020/09/24,Macrolide; Macrolide Antimicrobial,,WILSHIRE PHARMACEUTICALS,2019/03/25-; 2020/08/24-,52536-130; 52536-132,1014KSJ86F,Erythromycin Ethylsuccinate,Erythromycin,63937KV33D,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/86d6353c-2b58-4219-b31d-fb5b97789094/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=86d6353c-2b58-4219-b31d-fb5b97789094,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=86d6353c-2b58-4219-b31d-fb5b97789094,86d6353c-2b58-4219-b31d-fb5b97789094,,,
HUMAN PRESCRIPTION DRUG LABEL,"GRANULE, FOR SUSPENSION",ORAL,NDA,050207,Erythromycin Ethylsuccinate,ERYTHROMYCIN ETHYLSUCCINATE,2019/01/29,Macrolide; Macrolide Antimicrobial,,WILSHIRE PHARMACEUTICALS INC,2016/09/28-,52536-134; 52536-136,1014KSJ86F,Erythromycin Ethylsuccinate,Erythromycin,63937KV33D,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/f4a3fffd-ce02-450f-bbcc-d425374e3e32/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f4a3fffd-ce02-450f-bbcc-d425374e3e32,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=f4a3fffd-ce02-450f-bbcc-d425374e3e32,f4a3fffd-ce02-450f-bbcc-d425374e3e32,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAVENOUS,NDA,050609,Erythrocin Lactobionate,ERYTHROMYCIN LACTOBIONATE,2023/09/26,Macrolide; Macrolide Antimicrobial,,HOSPIRA INC,2005/05/25-,0409-6482,33H58I7GLQ,ERYTHROMYCIN LACTOBIONATE,ERYTHROMYCIN,63937KV33D,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/a96c405f-bd70-4bb4-719e-ac6a79dcc213/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a96c405f-bd70-4bb4-719e-ac6a79dcc213,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=a96c405f-bd70-4bb4-719e-ac6a79dcc213,a96c405f-bd70-4bb4-719e-ac6a79dcc213,,,
HUMAN PRESCRIPTION DRUG LABEL,"SOLUTION; TABLET, FILM COATED",ORAL,NDA,021323;021365,Lexapro,ESCITALOPRAM,2023/10/01,Serotonin Reuptake Inhibitor,2002,ALLERGAN INC,2002/08/14-; completed:2002/11/26-2017/11/30,0456-2005; 0456-2010; 0456-2020; 0456-2101,5U85DBW7LO,ESCITALOPRAM OXALATE,ESCITALOPRAM,4O4S742ANY,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/13bb8267-1cab-43e5-acae-55a4d957630a/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=13bb8267-1cab-43e5-acae-55a4d957630a,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=13bb8267-1cab-43e5-acae-55a4d957630a,13bb8267-1cab-43e5-acae-55a4d957630a,,,
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION,NASAL,NDA,211243,Spravato,ESKETAMINE HYDROCHLORIDE,2023/10/25,,1970,JANSSEN PHARMACEUTICALS INC,2019/03/05-,50458-028,L8P1H35P2Z,ESKETAMINE HYDROCHLORIDE,ESKETAMINE,50LFG02TXD,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/d81a6a79-a74a-44b7-822c-0dfa3036eaed/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d81a6a79-a74a-44b7-822c-0dfa3036eaed,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=d81a6a79-a74a-44b7-822c-0dfa3036eaed,d81a6a79-a74a-44b7-822c-0dfa3036eaed,,,
HUMAN PRESCRIPTION DRUG LABEL,KIT; TABLET,ORAL,NDA,022416,Aptiom,ESLICARBAZEPINE ACETATE,2023/11/10,,2013,SUMITOMO PHARMA AMERICA INC,2014/04/07-,63402-202; 63402-204; 63402-206; 63402-208; 63402-248,BEA68ZVB2K,ESLICARBAZEPINE ACETATE,ESLICARBAZEPINE,S5VXA428R4,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/3d0c9554-eaeb-4694-8089-00133fcadce3/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3d0c9554-eaeb-4694-8089-00133fcadce3,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=3d0c9554-eaeb-4694-8089-00133fcadce3,3d0c9554-eaeb-4694-8089-00133fcadce3,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRAVENOUS,NDA,019386,BREVIBLOC,ESMOLOL HYDROCHLORIDE,2023/06/15,beta-Adrenergic Blocker,1986,BAXTER HEALTHCARE CORPORATION,1986/12/31-,10019-668; 10019-672,V05260LC8D,ESMOLOL HYDROCHLORIDE,ESMOLOL,MDY902UXSR,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/220a07b8-5c68-41a3-8705-fd91f14c50b4/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=220a07b8-5c68-41a3-8705-fd91f14c50b4,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=220a07b8-5c68-41a3-8705-fd91f14c50b4,220a07b8-5c68-41a3-8705-fd91f14c50b4,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRAVENOUS,NDA,019386,BREVIBLOC,ESMOLOL HYDROCHLORIDE,2023/06/15,beta-Adrenergic Blocker,1986,BAXTER HEALTHCARE CORPORATION,1986/12/31-,10019-666; 10019-670,V05260LC8D,ESMOLOL HYDROCHLORIDE,ESMOLOL,MDY902UXSR,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/9c593cdb-cdfe-4492-8862-9b05116aa25e/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9c593cdb-cdfe-4492-8862-9b05116aa25e,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=9c593cdb-cdfe-4492-8862-9b05116aa25e,9c593cdb-cdfe-4492-8862-9b05116aa25e,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRAVENOUS,NDA,019386,Brevibloc,ESMOLOL HYDROCHLORIDE,2023/06/15,beta-Adrenergic Blocker,1986,BAXTER HEALTHCARE CORPORATION,1986/12/31-,10019-055; 10019-075; 10019-115,V05260LC8D,ESMOLOL HYDROCHLORIDE,ESMOLOL,MDY902UXSR,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/595cc3d5-1306-4828-aefa-5595219ffd62/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=595cc3d5-1306-4828-aefa-5595219ffd62,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=595cc3d5-1306-4828-aefa-5595219ffd62,595cc3d5-1306-4828-aefa-5595219ffd62,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRAVENOUS,NDA,019386,Esmolol Hydrochloride,ESMOLOL HYDROCHLORIDE,2023/06/15,beta-Adrenergic Blocker,1986,BAXTER HEALTHCARE CORPORATION,1986/12/31-,10019-120,V05260LC8D,ESMOLOL HYDROCHLORIDE,ESMOLOL,MDY902UXSR,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/f0a56c07-8f0f-4499-8d00-f13a966bf988/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f0a56c07-8f0f-4499-8d00-f13a966bf988,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=f0a56c07-8f0f-4499-8d00-f13a966bf988,f0a56c07-8f0f-4499-8d00-f13a966bf988,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRAVENOUS,NDA,205703,Esmolol Hydrochloride in Water,ESMOLOL HYDROCHLORIDE,2021/12/31,beta-Adrenergic Blocker,1986,WG CRITICAL CARE LLC,2017/12/04-,44567-811; 44567-812,V05260LC8D,ESMOLOL HYDROCHLORIDE,ESMOLOL,MDY902UXSR,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/60b10020-f802-4fef-a487-0f11eca246c5/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=60b10020-f802-4fef-a487-0f11eca246c5,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=60b10020-f802-4fef-a487-0f11eca246c5,60b10020-f802-4fef-a487-0f11eca246c5,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRAVENOUS,NDA,019386,Esmolol Hydrochloride,ESMOLOL HYDROCHLORIDE,2007/11/06,beta-Adrenergic Blocker,,WEST WARD PHARMACEUTICAL CORPORATION,1986/12/31-,0641-2965,V05260LC8D,ESMOLOL HYDROCHLORIDE,ESMOLOL,MDY902UXSR,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/a70baf53-e38a-4b23-8905-ee284170236d/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a70baf53-e38a-4b23-8905-ee284170236d,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=a70baf53-e38a-4b23-8905-ee284170236d,a70baf53-e38a-4b23-8905-ee284170236d,,,
HUMAN PRESCRIPTION DRUG LABEL,"CAPSULE, DELAYED RELEASE; GRANULE, DELAYED RELEASE",ORAL,NDA,021153;021957;022101,NEXIUM,ESOMEPRAZOLE MAGNESIUM,2023/07/18,Proton Pump Inhibitor,1989,ASTRAZENECA PHARMACEUTICALS LP,2001/03/19-; 2007/03/19-; 2008/07/07-; 2012/06/01-,0186-4010; 0186-4020; 0186-4025; 0186-4040; 0186-4050; 0186-5020; 0186-5040,R6DXU4WAY9,ESOMEPRAZOLE MAGNESIUM,ESOMEPRAZOLE,N3PA6559FT,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/f4853677-1622-4037-688b-fdf533a11d96/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f4853677-1622-4037-688b-fdf533a11d96,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=f4853677-1622-4037-688b-fdf533a11d96,f4853677-1622-4037-688b-fdf533a11d96,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRAVENOUS,NDA,021689,NEXIUM I.V.,ESOMEPRAZOLE SODIUM,2023/07/18,Proton Pump Inhibitor,2005,ASTRAZENECA PHARMACEUTICALS LP,completed:2005/05/03-2024/12/31,0186-6040,L2C9GWQ43H,ESOMEPRAZOLE SODIUM,ESOMEPRAZOLE,N3PA6559FT,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/c325bbfc-46f3-471e-7bbc-ed0d6965d13b/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c325bbfc-46f3-471e-7bbc-ed0d6965d13b,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=c325bbfc-46f3-471e-7bbc-ed0d6965d13b,c325bbfc-46f3-471e-7bbc-ed0d6965d13b,,,
HUMAN PRESCRIPTION DRUG LABEL,"CAPSULE, DELAYED RELEASE",ORAL,NDA,202342,Esomeprazole strontium,ESOMEPRAZOLE STRONTIUM,2022/11/18,Proton Pump Inhibitor,1989,AMNEAL PHARMACEUTICALS OF NEW YORK LLC,2013/08/12-,53746-955; 53746-957,C5N25H3803,ESOMEPRAZOLE STRONTIUM,ESOMEPRAZOLE,N3PA6559FT,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/e2e18e10-6f02-4ccc-842d-1962a3838b74/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e2e18e10-6f02-4ccc-842d-1962a3838b74,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=e2e18e10-6f02-4ccc-842d-1962a3838b74,e2e18e10-6f02-4ccc-842d-1962a3838b74,,,
HUMAN PRESCRIPTION DRUG LABEL,"CAPSULE, DELAYED RELEASE",ORAL,NDA,202342,ESOMEPRAZOLE STRONTIUM,ESOMEPRAZOLE STRONTIUM,2016/09/22,Proton Pump Inhibitor,1989,R PHARMA LLC,2016/09/15-,70849-200; 70849-400,C5N25H3803,ESOMEPRAZOLE STRONTIUM,ESOMEPRAZOLE,N3PA6559FT,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/3c916d32-f9e9-1d15-e054-00144ff88e88/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3c916d32-f9e9-1d15-e054-00144ff88e88,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=3c916d32-f9e9-1d15-e054-00144ff88e88,3c916d32-f9e9-1d15-e054-00144ff88e88,,,
HUMAN PRESCRIPTION DRUG LABEL,INSERT,VAGINAL,NDA,208564,Imvexxy,ESTRADIOL,2024/04/24,Estrogen,1975,MAYNE PHARMA,2024/05/03-,68308-747,4TI98Z838E,estradiol,estradiol,4TI98Z838E,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/6ce645c0-a550-4ae9-8dbd-3853ee8b7d26/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6ce645c0-a550-4ae9-8dbd-3853ee8b7d26,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=6ce645c0-a550-4ae9-8dbd-3853ee8b7d26,6ce645c0-a550-4ae9-8dbd-3853ee8b7d26,,,
HUMAN PRESCRIPTION DRUG LABEL,"GEL, METERED",TOPICAL,NDA,021166,EstroGel,ESTRADIOL,2024/03/25,Estrogen,1975,ASCEND THERAPEUTICS US LLC,2004/02/09-,17139-617,4TI98Z838E,ESTRADIOL,ESTRADIOL,4TI98Z838E,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/762ac371-bb8b-47e7-b48f-e80d452c9dd4/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=762ac371-bb8b-47e7-b48f-e80d452c9dd4,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=762ac371-bb8b-47e7-b48f-e80d452c9dd4,762ac371-bb8b-47e7-b48f-e80d452c9dd4,,,
HUMAN PRESCRIPTION DRUG LABEL,DRUG DELIVERY SYSTEM,VAGINAL,NDA,020472,Estring,ESTRADIOL,2024/02/27,Estrogen,,PFIZER LABORATORIES DIV PFIZER INC,2023/06/05-,0013-1042,4TI98Z838E,ESTRADIOL,ESTRADIOL,4TI98Z838E,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/110b9865-5a07-4d45-b560-e89947f12600/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=110b9865-5a07-4d45-b560-e89947f12600,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=110b9865-5a07-4d45-b560-e89947f12600,110b9865-5a07-4d45-b560-e89947f12600,,,
HUMAN PRESCRIPTION DRUG LABEL,"FILM, EXTENDED RELEASE",TRANSDERMAL,NDA,203752,Minivelle,ESTRADIOL,2024/02/22,Estrogen,1975,NOVEN THERAPEUTICS LLC,2012/12/20-,68968-6610; 68968-6625; 68968-6637; 68968-6650; 68968-6675,4TI98Z838E,ESTRADIOL,ESTRADIOL,4TI98Z838E,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/6c5c47ab-28ee-11e1-bfc2-0800200c9a66/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6c5c47ab-28ee-11e1-bfc2-0800200c9a66,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=6c5c47ab-28ee-11e1-bfc2-0800200c9a66,6c5c47ab-28ee-11e1-bfc2-0800200c9a66,,,
HUMAN PRESCRIPTION DRUG LABEL,INSERT,VAGINAL,NDA,208564,IMVEXXY,ESTRADIOL,2024/02/15,Estrogen,1975,MAYNE PHARMA LLC,2018/07/03-; 2018/07/05-,50261-104; 50261-110,4TI98Z838E,estradiol,estradiol,4TI98Z838E,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/104be9f2-a8f6-430e-9e01-2ee7cc1861f1/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=104be9f2-a8f6-430e-9e01-2ee7cc1861f1,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=104be9f2-a8f6-430e-9e01-2ee7cc1861f1,104be9f2-a8f6-430e-9e01-2ee7cc1861f1,,,
HUMAN PRESCRIPTION DRUG LABEL,"GEL, METERED",TOPICAL,NDA,021813,ELESTRIN,ESTRADIOL,2023/12/15,Estrogen,1975,MEDA PHARMACEUTICALS INC,2014/06/02-,0037-4801,4TI98Z838E,ESTRADIOL,ESTRADIOL,4TI98Z838E,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/eff2dea1-f117-11e3-ac10-0800200c9a66/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=eff2dea1-f117-11e3-ac10-0800200c9a66,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=eff2dea1-f117-11e3-ac10-0800200c9a66,eff2dea1-f117-11e3-ac10-0800200c9a66,,,
HUMAN PRESCRIPTION DRUG LABEL,PATCH,TRANSDERMAL,NDA,020375,Menostar,ESTRADIOL,2023/12/08,Estrogen,1975,BAYER HEALTHCARE PHARMACEUTICALS INC,2004/06/08-,50419-455,4TI98Z838E,ESTRADIOL,ESTRADIOL,4TI98Z838E,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/a78708cd-04d4-4221-a4e4-53680bbe2912/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a78708cd-04d4-4221-a4e4-53680bbe2912,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=a78708cd-04d4-4221-a4e4-53680bbe2912,a78708cd-04d4-4221-a4e4-53680bbe2912,,,
HUMAN PRESCRIPTION DRUG LABEL,PATCH,TRANSDERMAL,NDA,020375,Climara,ESTRADIOL,2023/12/06,Estrogen,1975,BAYER HEALTHCARE PHARMACEUTICALS INC,1994/12/22-; 1998/03/23-; 1999/03/05-; 2003/05/27-; 2008/01/03-,50419-451; 50419-452; 50419-453; 50419-454; 50419-456; 50419-459,4TI98Z838E,ESTRADIOL,ESTRADIOL,4TI98Z838E,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/1e9702c4-f2d7-4ea8-b6e8-7dca31671864/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1e9702c4-f2d7-4ea8-b6e8-7dca31671864,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=1e9702c4-f2d7-4ea8-b6e8-7dca31671864,1e9702c4-f2d7-4ea8-b6e8-7dca31671864,,,
HUMAN PRESCRIPTION DRUG LABEL,SPRAY,TRANSDERMAL,NDA,022014,Evamist,ESTRADIOL,2023/12/06,Estrogen,1975,PADAGIS US LLC,2015/04/11-,0574-2067,4TI98Z838E,ESTRADIOL,ESTRADIOL,4TI98Z838E,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/9a0aa631-133d-406b-9d32-8a1a99af4e50/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9a0aa631-133d-406b-9d32-8a1a99af4e50,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=9a0aa631-133d-406b-9d32-8a1a99af4e50,9a0aa631-133d-406b-9d32-8a1a99af4e50,,,
HUMAN PRESCRIPTION DRUG LABEL,INSERT,VAGINAL,NDA,020908,Vagifem,ESTRADIOL,2023/12/04,Estrogen,1999,NOVO NORDISK,2010/01/11-,0169-5176,4TI98Z838E,ESTRADIOL,ESTRADIOL,4TI98Z838E,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/e5ad3cf6-dd96-4e64-af21-c1eee38d0b88/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e5ad3cf6-dd96-4e64-af21-c1eee38d0b88,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=e5ad3cf6-dd96-4e64-af21-c1eee38d0b88,e5ad3cf6-dd96-4e64-af21-c1eee38d0b88,,,
HUMAN PRESCRIPTION DRUG LABEL,"PATCH, EXTENDED RELEASE",TRANSDERMAL,NDA,020538,Vivelle-Dot,ESTRADIOL,2023/11/17,Estrogen,1996,SANDOZ INC,1999/01/08-,66758-145; 66758-146; 66758-147; 66758-148; 66758-149,4TI98Z838E,ESTRADIOL,ESTRADIOL,4TI98Z838E,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/5ccb77f9-d47b-4381-ad5c-5b92524e1c4a/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5ccb77f9-d47b-4381-ad5c-5b92524e1c4a,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=5ccb77f9-d47b-4381-ad5c-5b92524e1c4a,5ccb77f9-d47b-4381-ad5c-5b92524e1c4a,,,
HUMAN PRESCRIPTION DRUG LABEL,RING,VAGINAL,NDA,020472,Estring,ESTRADIOL,2023/09/18,Estrogen,,PFIZER LABORATORIES DIV PFIZER INC,completed:1996/04/26-2024/12/31,0013-2150,4TI98Z838E,ESTRADIOL,ESTRADIOL,4TI98Z838E,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/aa530dfd-3a48-46b9-9678-a7bc48316e41/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=aa530dfd-3a48-46b9-9678-a7bc48316e41,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=aa530dfd-3a48-46b9-9678-a7bc48316e41,aa530dfd-3a48-46b9-9678-a7bc48316e41,,,
HUMAN PRESCRIPTION DRUG LABEL,GEL,TOPICAL,NDA,022038,DIVIGEL,ESTRADIOL,2023/05/30,Estrogen,1975,VERTICAL PHARMACEUTICALS LLC,2014/10/27-; 2019/01/18-; 2019/12/17-,68025-065; 68025-066; 68025-067; 68025-083; 68025-086,4TI98Z838E,ESTRADIOL,ESTRADIOL,4TI98Z838E,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/59e610dc-883e-4f07-9ec6-a5841b0bf9fb/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=59e610dc-883e-4f07-9ec6-a5841b0bf9fb,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=59e610dc-883e-4f07-9ec6-a5841b0bf9fb,59e610dc-883e-4f07-9ec6-a5841b0bf9fb,,,
HUMAN PRESCRIPTION DRUG LABEL,GEL,TOPICAL,NDA,022038,Estradiol,ESTRADIOL,2023/01/30,Estrogen,1975,TRIGEN LABORATORIES LLC,2022/10/10-,13811-090; 13811-091; 13811-092; 13811-093; 13811-094,4TI98Z838E,ESTRADIOL; Estradiol,ESTRADIOL,4TI98Z838E,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/e84ad638-6768-41aa-b2b8-e2514ef63881/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e84ad638-6768-41aa-b2b8-e2514ef63881,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=e84ad638-6768-41aa-b2b8-e2514ef63881,e84ad638-6768-41aa-b2b8-e2514ef63881,,,
HUMAN PRESCRIPTION DRUG LABEL,"PATCH, EXTENDED RELEASE",TRANSDERMAL,NDA,020538,Vivelle-Dot,ESTRADIOL,2022/07/11,Estrogen,1996,NOVARTIS PHARMACEUTICALS CORPORATION,1999/01/08-,0078-0343; 0078-0344; 0078-0345; 0078-0346; 0078-0365,4TI98Z838E,ESTRADIOL,ESTRADIOL,4TI98Z838E,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/e6f2e7ed-41a9-4a53-ac80-0cb1fa2edcbf/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e6f2e7ed-41a9-4a53-ac80-0cb1fa2edcbf,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=e6f2e7ed-41a9-4a53-ac80-0cb1fa2edcbf,e6f2e7ed-41a9-4a53-ac80-0cb1fa2edcbf,,,
HUMAN PRESCRIPTION DRUG LABEL,RING,VAGINAL,NDA,021367,Femring,ESTRADIOL ACETATE,2024/03/18,Estrogen,1975,MILLICENT US INC,2018/12/10-,72495-201; 72495-202,5R97F5H93P,ESTRADIOL ACETATE,ESTRADIOL,4TI98Z838E,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/7aaa97f9-a9d1-c815-e053-2991aa0afb9e/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7aaa97f9-a9d1-c815-e053-2991aa0afb9e,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=7aaa97f9-a9d1-c815-e053-2991aa0afb9e,7aaa97f9-a9d1-c815-e053-2991aa0afb9e,,,
HUMAN PRESCRIPTION DRUG LABEL,PATCH,TRANSDERMAL,NDA,021258,Climara Pro,ESTRADIOL AND LEVONORGESTREL,2023/12/06,Estrogen; Progestin; Progestin-containing Intrauterine System,1975,BAYER HEALTHCARE PHARMACEUTICALS INC,2003/11/21-,50419-491,4TI98Z838E; 5W7SIA7YZW,ESTRADIOL; LEVONORGESTREL,ESTRADIOL; LEVONORGESTREL,4TI98Z838E; 5W7SIA7YZW,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/184d3092-7fc6-4375-816b-1ab06bb99cfd/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=184d3092-7fc6-4375-816b-1ab06bb99cfd,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=184d3092-7fc6-4375-816b-1ab06bb99cfd,184d3092-7fc6-4375-816b-1ab06bb99cfd,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,NDA,210132,Bijuva,ESTRADIOL AND PROGESTERONE,2023/12/07,Estrogen; Progesterone,2018,MAYNE PHARMA,2023/12/01-; 2023/12/18-,68308-750; 68308-751,4G7DS2Q64Y; 4TI98Z838E,estradiol; progesterone,estradiol; progesterone,4G7DS2Q64Y; 4TI98Z838E,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/59eadb88-c9f3-4871-b176-7ddd98faf9bc/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=59eadb88-c9f3-4871-b176-7ddd98faf9bc,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=59eadb88-c9f3-4871-b176-7ddd98faf9bc,59eadb88-c9f3-4871-b176-7ddd98faf9bc,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,NDA,210132,Bijuva,ESTRADIOL AND PROGESTERONE,2023/12/01,Estrogen; Progesterone,2018,MAYNE PHARMA LLC,2019/04/03-; 2023/03/31-,50261-211; 50261-251,4G7DS2Q64Y; 4TI98Z838E,estradiol; progesterone,estradiol; progesterone,4G7DS2Q64Y; 4TI98Z838E,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/bc52489a-5149-411d-9665-2c75405ad15d/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=bc52489a-5149-411d-9665-2c75405ad15d,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=bc52489a-5149-411d-9665-2c75405ad15d,bc52489a-5149-411d-9665-2c75405ad15d,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRAMUSCULAR,NDA,009402,Delestrogen,ESTRADIOL VALERATE,2024/02/23,Estrogen,,PAR PHARMACEUTICAL INC,2007/11/01-,42023-110; 42023-111; 42023-112,OKG364O896,ESTRADIOL VALERATE,ESTRADIOL,4TI98Z838E,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/e8f94df9-0692-4462-a7f0-fe019a0a3f07/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e8f94df9-0692-4462-a7f0-fe019a0a3f07,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=e8f94df9-0692-4462-a7f0-fe019a0a3f07,e8f94df9-0692-4462-a7f0-fe019a0a3f07,,,
HUMAN PRESCRIPTION DRUG LABEL,KIT,ORAL,NDA,022252,Natazia,ESTRADIOL VALERATE AND ESTRADIOL VALERATE/DIENOGEST,2023/04/29,Estrogen; Progestin,2010,BAYER HEALTHCARE PHARMACEUTICALS INC,2010/05/06-,50419-409,46M3EV8HHE; OKG364O896,DIENOGEST; ESTRADIOL VALERATE,DIENOGEST; ESTRADIOL,46M3EV8HHE; 4TI98Z838E,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/02c91fba-9c47-43ef-ac78-e82369798834/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=02c91fba-9c47-43ef-ac78-e82369798834,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=02c91fba-9c47-43ef-ac78-e82369798834,02c91fba-9c47-43ef-ac78-e82369798834,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,020907,Activella,ESTRADIOL/NORETHINDRONE ACETATE,2021/08/18,Estrogen; Progestin,1998,AMNEAL PHARMACEUTICALS LLC,2019/05/01-,60846-231; 60846-232,4TI98Z838E; 9S44LIC7OJ,ESTRADIOL; NORETHINDRONE ACETATE,ESTRADIOL; NORETHINDRONE,4TI98Z838E; T18F433X4S,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/d4b0c1dd-aae9-4ca2-958c-71dbe5d0fab0/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d4b0c1dd-aae9-4ca2-958c-71dbe5d0fab0,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=d4b0c1dd-aae9-4ca2-958c-71dbe5d0fab0,d4b0c1dd-aae9-4ca2-958c-71dbe5d0fab0,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,020907,LOPREEZA,ESTRADIOL/NORETHINDRONE ACETATE,2018/07/25,Estrogen; Progestin,1998,AMNEAL PHARMACEUTICALS NY LLC,2019/01/07-,69238-1610,4TI98Z838E; 9S44LIC7OJ,ESTRADIOL; NORETHINDRONE ACETATE,ESTRADIOL; NORETHINDRONE,4TI98Z838E; T18F433X4S,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/966ac064-9eb7-4d15-b271-a7880ed1e79a/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=966ac064-9eb7-4d15-b271-a7880ed1e79a,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=966ac064-9eb7-4d15-b271-a7880ed1e79a,966ac064-9eb7-4d15-b271-a7880ed1e79a,,,
HUMAN PRESCRIPTION DRUG LABEL,"PATCH, EXTENDED RELEASE",TRANSDERMAL,NDA,020870,CombiPatch (estradiol/norethindrone acetate transdermal system),ESTRADIOL/NORETHINDRONE ACETATE TRANSDERMAL SYSTEM,2024/02/21,Estrogen; Progestin,,NOVEN THERAPEUTICS LLC,1998/08/07-,68968-0514; 68968-0525,4TI98Z838E; 9S44LIC7OJ,ESTRADIOL; NORETHINDRONE ACETATE,ESTRADIOL; NORETHINDRONE,4TI98Z838E; T18F433X4S,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/83198ef1-11c4-11e4-9191-0800200c9a66/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=83198ef1-11c4-11e4-9191-0800200c9a66,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=83198ef1-11c4-11e4-9191-0800200c9a66,83198ef1-11c4-11e4-9191-0800200c9a66,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,NDA,018045,Emcyt,ESTRAMUSTINE PHOSPHATE SODIUM,2024/02/22,Alkylating Drug,,PFIZER LABORATORIES DIV PFIZER INC,completed:1992/01/01-2024/09/30,0013-0132,75F375MT2N,ESTRAMUSTINE PHOSPHATE SODIUM,ESTRAMUSTINE,35LT29625A,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/a9b01bc6-95ac-46f9-befa-d845a74d53c1/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a9b01bc6-95ac-46f9-befa-d845a74d53c1,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=a9b01bc6-95ac-46f9-befa-d845a74d53c1,a9b01bc6-95ac-46f9-befa-d845a74d53c1,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,004782,Premarin,"ESTROGENS, CONJUGATED",2024/02/22,Estrogen,1942,WYETH PHARMACEUTICALS LLC A SUBSIDIARY OF PFIZER INC,2004/09/01-; 2006/01/01-,0046-1100; 0046-1101; 0046-1102; 0046-1103; 0046-1104,IU5QR144QX,"ESTROGENS, CONJUGATED","ESTROGENS, CONJUGATED",IU5QR144QX,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/258e1602-a3cf-4ccc-ca80-73dbbfb812ff/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=258e1602-a3cf-4ccc-ca80-73dbbfb812ff,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=258e1602-a3cf-4ccc-ca80-73dbbfb812ff,258e1602-a3cf-4ccc-ca80-73dbbfb812ff,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, COATED",ORAL,NDA,021476,Lunesta,ESZOPICLONE,2023/12/07,,2004,SUMITOMO PHARMA AMERICA INC,completed:2005/04/04-2025/01/31; completed:2005/04/04-2025/07/31,63402-190; 63402-191; 63402-193,UZX80K71OE,ESZOPICLONE,ESZOPICLONE,UZX80K71OE,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/fd047b2b-05a6-4d99-95cb-955f14bf329f/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=fd047b2b-05a6-4d99-95cb-955f14bf329f,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=fd047b2b-05a6-4d99-95cb-955f14bf329f,fd047b2b-05a6-4d99-95cb-955f14bf329f,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, COATED",ORAL,NDA,021476,Lunesta,ESZOPICLONE,2023/08/10,,2004,WAYLIS THERAPEUTICS LLC,2023/08/15-,80725-010; 80725-011; 80725-012,UZX80K71OE,ESZOPICLONE,ESZOPICLONE,UZX80K71OE,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/3821f4b7-a3c8-4920-ba80-18aa96532c09/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3821f4b7-a3c8-4920-ba80-18aa96532c09,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=3821f4b7-a3c8-4920-ba80-18aa96532c09,3821f4b7-a3c8-4920-ba80-18aa96532c09,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,208325,PARSABIV,ETELCALCETIDE,2021/02/17,Calcium-sensing Receptor Agonist,2017,AMGEN INC,2017/04/03-,55513-740; 55513-741; 55513-742,72PT5993DU,ETELCALCETIDE HYDROCHLORIDE,ETELCALCETIDE,60ME133FJB,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/cd270093-c6a8-4596-a4ab-e6aa0a2c8a0c/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=cd270093-c6a8-4596-a4ab-e6aa0a2c8a0c,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=cd270093-c6a8-4596-a4ab-e6aa0a2c8a0c,cd270093-c6a8-4596-a4ab-e6aa0a2c8a0c,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRAVENOUS,NDA,206488,Exondys 51,ETEPLIRSEN,2022/03/14,Antisense Oligonucleotide,2016,SAREPTA THERAPEUTICS INC,2016/09/19-,60923-284; 60923-363,AIW6036FAS,eteplirsen,eteplirsen,AIW6036FAS,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/33bff678-7829-479e-9110-b8e33a0bc0aa/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=33bff678-7829-479e-9110-b8e33a0bc0aa,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=33bff678-7829-479e-9110-b8e33a0bc0aa,33bff678-7829-479e-9110-b8e33a0bc0aa,,,
HUMAN PRESCRIPTION DRUG LABEL,"POWDER, FOR SOLUTION; TABLET",INTRAVENOUS; ORAL,NDA,016092;016093,EDECRIN; SODIUM EDECRIN,ETHACRYNATE SODIUM; ETHACRYNIC ACID,2020/08/31,Loop Diuretic,,BAUSCH HEALTH US LLC,1967/01/10-,25010-210; 25010-215,K41MYV7MPM; M5DP350VZV,ETHACRYNATE SODIUM; ethacrynic acid,ethacrynic acid,M5DP350VZV,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/1efe378e-fee1-4ae9-8ea5-0fe2265fe2d8/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1efe378e-fee1-4ae9-8ea5-0fe2265fe2d8,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=1efe378e-fee1-4ae9-8ea5-0fe2265fe2d8,1efe378e-fee1-4ae9-8ea5-0fe2265fe2d8,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,016320,Myambutol,ETHAMBUTOL HYDROCHLORIDE,2022/02/15,Antimycobacterial,,STI PHARMA LLC,2007/08/10-,68850-010; 68850-012,QE4VW5FO07,ETHAMBUTOL HYDROCHLORIDE,ETHAMBUTOL,8G167061QZ,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/b362b3cd-2c26-4af5-baa4-084217729fa5/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b362b3cd-2c26-4af5-baa4-084217729fa5,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=b362b3cd-2c26-4af5-baa4-084217729fa5,b362b3cd-2c26-4af5-baa4-084217729fa5,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,019357,Ethamolin,ETHANOLAMINE OLEATE,2023/12/15,Sclerosing Agent,,QOL MEDICAL LLC,1998/12/22-,67871-479,U4RY8MRX7C,ETHANOLAMINE OLEATE,MONOETHANOLAMINE,5KV86114PT,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/a9c1d8c5-443e-400e-a42c-16a25fb47231/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a9c1d8c5-443e-400e-a42c-16a25fb47231,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=a9c1d8c5-443e-400e-a42c-16a25fb47231,a9c1d8c5-443e-400e-a42c-16a25fb47231,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRA-ARTERIAL; INTRALYMPHATIC; INTRAUTERINE,NDA,009190,LIPIODOL,ETHIODIZED OIL,2023/04/17,,1954,GUERBET LLC,2014/03/21-,67684-1901,KZW0R0686Q,ETHIODIZED OIL,IODINE,9679TC07X4,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/511d1f64-5cb9-4baa-a123-96205467e59a/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=511d1f64-5cb9-4baa-a123-96205467e59a,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=511d1f64-5cb9-4baa-a123-96205467e59a,511d1f64-5cb9-4baa-a123-96205467e59a,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,013026,Trecator,ETHIONAMIDE,2024/05/21,Antimycobacterial,,WYETH PHARMACEUTICALS LLC A SUBSIDIARY OF PFIZER INC,2004/11/08-,0008-4117,OAY8ORS3CQ,ETHIONAMIDE,ETHIONAMIDE,OAY8ORS3CQ,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/04a413fe-95f4-47a7-42ac-283a9e78297d/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=04a413fe-95f4-47a7-42ac-283a9e78297d,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=04a413fe-95f4-47a7-42ac-283a9e78297d,04a413fe-95f4-47a7-42ac-283a9e78297d,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,NDA,012380,Zarontin,ETHOSUXIMIDE,2023/06/08,Anti-epileptic Agent,,PARKE DAVIS DIV OF PFIZER INC,2000/09/22-,0071-0237,5SEH9X1D1D,ETHOSUXIMIDE,ETHOSUXIMIDE,5SEH9X1D1D,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/0e008f33-70a1-4bc6-b3a0-d45214418ab6/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0e008f33-70a1-4bc6-b3a0-d45214418ab6,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=0e008f33-70a1-4bc6-b3a0-d45214418ab6,0e008f33-70a1-4bc6-b3a0-d45214418ab6,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,018227,Amidate,ETOMIDATE,2023/10/19,General Anesthetic,,HOSPIRA INC,2005/07/26-,0409-6695,Z22628B598,ETOMIDATE,ETOMIDATE,Z22628B598,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/b7ed5bf8-ba75-44dc-8f81-96b4ad5766be/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b7ed5bf8-ba75-44dc-8f81-96b4ad5766be,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=b7ed5bf8-ba75-44dc-8f81-96b4ad5766be,b7ed5bf8-ba75-44dc-8f81-96b4ad5766be,,,
HUMAN PRESCRIPTION DRUG LABEL,IMPLANT,SUBCUTANEOUS,NDA,021529,Nexplanon,ETONOGESTREL,2023/09/29,Progestin,2001,ORGANON LLC,2021/06/01-,78206-145,304GTH6RNH,ETONOGESTREL,ETONOGESTREL,304GTH6RNH,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/487f8a62-e142-457c-97cc-2e398fde7594/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=487f8a62-e142-457c-97cc-2e398fde7594,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=487f8a62-e142-457c-97cc-2e398fde7594,487f8a62-e142-457c-97cc-2e398fde7594,,,
HUMAN PRESCRIPTION DRUG LABEL,"INSERT, EXTENDED RELEASE",VAGINAL,NDA,021187,NuvaRing,ETONOGESTREL AND ETHINYL ESTRADIOL,2023/01/09,Estrogen; Progestin,2001,ORGANON LLC,2021/06/01-,78206-146,304GTH6RNH; 423D2T571U,ETHINYL ESTRADIOL; ETONOGESTREL,ETHINYL ESTRADIOL; ETONOGESTREL,304GTH6RNH; 423D2T571U,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/55eb60e3-6f4d-40a3-8ee6-e7fd2d0c7d97/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=55eb60e3-6f4d-40a3-8ee6-e7fd2d0c7d97,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=55eb60e3-6f4d-40a3-8ee6-e7fd2d0c7d97,55eb60e3-6f4d-40a3-8ee6-e7fd2d0c7d97,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAVENOUS,NDA,020457,ETOPOPHOS,ETOPOSIDE PHOSPHATE,2023/11/13,Topoisomerase Inhibitor,1983,H PHARMA LLC,2009/06/01-,61269-410,528XYJ8L1N,etoposide phosphate,etoposide,6PLQ3CP4P3,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/7499fc35-fae8-44ad-bbab-9a1a589bf3ee/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7499fc35-fae8-44ad-bbab-9a1a589bf3ee,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=7499fc35-fae8-44ad-bbab-9a1a589bf3ee,7499fc35-fae8-44ad-bbab-9a1a589bf3ee,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,216956,Velsipity,ETRASIMOD,2023/11/17,,2023,U S PHARMACEUTICALS,2023/11/09-,63539-274,MXE5EMA09L,ETRASIMOD ARGININE,ETRASIMOD,6WH8495MMH,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/d5b2a717-1b5c-4aed-a69c-64a0c4561c40/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d5b2a717-1b5c-4aed-a69c-64a0c4561c40,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=d5b2a717-1b5c-4aed-a69c-64a0c4561c40,d5b2a717-1b5c-4aed-a69c-64a0c4561c40,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,216956,Velsipity,ETRASIMOD,2023/11/16,,2023,PFIZER LABORATORIES DIV PFIZER INC,2023/10/19-,0069-0274,MXE5EMA09L,ETRASIMOD ARGININE,ETRASIMOD,6WH8495MMH,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/65171e4a-d136-4abc-b08c-c40c1b486ff6/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=65171e4a-d136-4abc-b08c-c40c1b486ff6,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=65171e4a-d136-4abc-b08c-c40c1b486ff6,65171e4a-d136-4abc-b08c-c40c1b486ff6,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,022187,Intelence,ETRAVIRINE,2023/08/15,Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor,2008,JANSSEN PRODUCTS LP,2008/01/18-; 2010/12/22-; 2012/03/26-,59676-570; 59676-571; 59676-572,0C50HW4FO1,ETRAVIRINE,ETRAVIRINE,0C50HW4FO1,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/6a9cbc29-9f15-4b24-8d86-206b82887f3d/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6a9cbc29-9f15-4b24-8d86-206b82887f3d,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=6a9cbc29-9f15-4b24-8d86-206b82887f3d,6a9cbc29-9f15-4b24-8d86-206b82887f3d,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET; TABLET, FOR SUSPENSION",ORAL,NDA,022334;203985,Afinitor; Afinitor Disperz,EVEROLIMUS,2024/03/25,Kinase Inhibitor; mTOR Inhibitor Immunosuppressant,2009,NOVARTIS PHARMACEUTICALS CORPORATION,2009/03/31-; 2010/07/09-; 2011/07/29-; 2012/08/29-,0078-0566; 0078-0567; 0078-0594; 0078-0620; 0078-0626; 0078-0627; 0078-0628,9HW64Q8G6G,EVEROLIMUS,EVEROLIMUS,9HW64Q8G6G,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/2150f73a-179b-4afc-b8ce-67c85cc72f04/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2150f73a-179b-4afc-b8ce-67c85cc72f04,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=2150f73a-179b-4afc-b8ce-67c85cc72f04,2150f73a-179b-4afc-b8ce-67c85cc72f04,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,021560,Zortress,EVEROLIMUS,2024/02/28,Kinase Inhibitor; mTOR Inhibitor Immunosuppressant,2010,NOVARTIS PHARMACEUTICALS CORPORATION,2010/04/22-,0078-0414; 0078-0415; 0078-0417; 0078-0422,9HW64Q8G6G,EVEROLIMUS,EVEROLIMUS,9HW64Q8G6G,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/e082a024-7850-400b-a5c2-2a140612562a/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e082a024-7850-400b-a5c2-2a140612562a,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=e082a024-7850-400b-a5c2-2a140612562a,e082a024-7850-400b-a5c2-2a140612562a,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,020753,Aromasin,EXEMESTANE,2023/09/08,Aromatase Inhibitor,1999,PHARMACIA AND UPJOHN COMPANY LLC,1999/10/21-,0009-7663,NY22HMQ4BX,EXEMESTANE,EXEMESTANE,NY22HMQ4BX,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/cf066b7a-032a-416c-8d40-15ba581423e3/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=cf066b7a-032a-416c-8d40-15ba581423e3,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=cf066b7a-032a-416c-8d40-15ba581423e3,cf066b7a-032a-416c-8d40-15ba581423e3,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SUSPENSION, EXTENDED RELEASE",SUBCUTANEOUS,NDA,209210,BYDUREON BCise,EXENATIDE,2023/05/04,GLP-1 Receptor Agonist,2005,ASTRAZENECA PHARMACEUTICALS LP,2017/12/01-,0310-6540,9P1872D4OL,EXENATIDE,EXENATIDE,9P1872D4OL,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/2d18cfc4-e0de-4814-a712-c1b7c504bff5/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2d18cfc4-e0de-4814-a712-c1b7c504bff5,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=2d18cfc4-e0de-4814-a712-c1b7c504bff5,2d18cfc4-e0de-4814-a712-c1b7c504bff5,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,SUBCUTANEOUS,NDA,021773,Byetta,EXENATIDE,2022/12/21,GLP-1 Receptor Agonist,2005,ASTRAZENECA PHARMACEUTICALS LP,2014/12/10-; 2014/12/12-,0310-6512; 0310-6524,9P1872D4OL,exenatide,exenatide,9P1872D4OL,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/53d03c03-ebf7-418d-88a8-533eabd2ee4f/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=53d03c03-ebf7-418d-88a8-533eabd2ee4f,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=53d03c03-ebf7-418d-88a8-533eabd2ee4f,53d03c03-ebf7-418d-88a8-533eabd2ee4f,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,021445,Zetia,EZETIMIBE,2024/02/21,Dietary Cholesterol Absorption Inhibitor,2002,ORGANON LLC,2021/06/01-,78206-178,EOR26LQQ24,EZETIMIBE,EZETIMIBE,EOR26LQQ24,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/174e45e0-45bb-48b7-9e60-8f6cfc1d22bb/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=174e45e0-45bb-48b7-9e60-8f6cfc1d22bb,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=174e45e0-45bb-48b7-9e60-8f6cfc1d22bb,174e45e0-45bb-48b7-9e60-8f6cfc1d22bb,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,021687,VYTORIN,EZETIMIBE AND SIMVASTATIN,2024/03/28,Dietary Cholesterol Absorption Inhibitor; HMG-CoA Reductase Inhibitor,2004,ORGANON LLC,2021/06/01-,78206-174; 78206-175; 78206-176; 78206-177,AGG2FN16EV; EOR26LQQ24,EZETIMIBE; SIMVASTATIN,EZETIMIBE; SIMVASTATIN,AGG2FN16EV; EOR26LQQ24,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/89b860d2-de83-468e-b7e8-76aeec2edca2/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=89b860d2-de83-468e-b7e8-76aeec2edca2,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=89b860d2-de83-468e-b7e8-76aeec2edca2,89b860d2-de83-468e-b7e8-76aeec2edca2,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,021856,ULORIC,FEBUXOSTAT,2023/04/27,Xanthine Oxidase Inhibitor,2009,TAKEDA PHARMACEUTICALS AMERICA INC,2009/02/13-,64764-677; 64764-918,101V0R1N2E,febuxostat,febuxostat,101V0R1N2E,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/54de10ef-fe5f-4930-b91d-6bbb04c664bd/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=54de10ef-fe5f-4930-b91d-6bbb04c664bd,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=54de10ef-fe5f-4930-b91d-6bbb04c664bd,54de10ef-fe5f-4930-b91d-6bbb04c664bd,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,NDA,212327,Inrebic,FEDRATINIB HYDROCHLORIDE,2023/05/15,,2019,CELGENE CORPORATION,2019/08/16-,59572-720,UH9J2HBQWJ,FEDRATINIB HYDROCHLORIDE,FEDRATINIB,6L1XP550I6,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/f0f55a2a-4e0c-4cba-8571-03e1424486d7/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f0f55a2a-4e0c-4cba-8571-03e1424486d7,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=f0f55a2a-4e0c-4cba-8571-03e1424486d7,f0f55a2a-4e0c-4cba-8571-03e1424486d7,,,
HUMAN PRESCRIPTION DRUG LABEL,SUSPENSION; TABLET,ORAL,NDA,020189,Felbatol,FELBAMATE,2011/11/14,Anti-epileptic Agent,,MEDA PHARMACEUTICALS INC,1993/07/29-; completed:1993/07/29-2026/03/31,0037-0430; 0037-0431; 0037-0442,X72RBB02N8,FELBAMATE,FELBAMATE,X72RBB02N8,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/2f522701-397a-11de-8a39-0800200c9a66/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2f522701-397a-11de-8a39-0800200c9a66,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=2f522701-397a-11de-8a39-0800200c9a66,2f522701-397a-11de-8a39-0800200c9a66,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, EXTENDED RELEASE",ORAL,NDA,019834,FELODIPINEEXTENDED-RELEASE TABLETS,FELODIPINE,2009/09/09,Dihydropyridine Calcium Channel Blocker,,RANBAXY PHARMACEUTICALS INC,2008/09/10-,63304-435; 63304-436; 63304-437,OL961R6O2C,FELODIPINE,FELODIPINE,OL961R6O2C,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/b951455c-c235-4e23-9e21-08672d108726/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b951455c-c235-4e23-9e21-08672d108726,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=b951455c-c235-4e23-9e21-08672d108726,b951455c-c235-4e23-9e21-08672d108726,,,
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION,ORAL,NDA,212102,Fintepla,FENFLURAMINE,2023/12/14,,1973,UCB INC,2020/07/15-,43376-322,2DS058H2CF,fenfluramine,fenfluramine,2DS058H2CF,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/e88f360e-33ad-4cd6-b2de-5ef885857c5d/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e88f360e-33ad-4cd6-b2de-5ef885857c5d,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=e88f360e-33ad-4cd6-b2de-5ef885857c5d,e88f360e-33ad-4cd6-b2de-5ef885857c5d,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,NDA,021695,ANTARA,FENOFIBRATE,2023/12/12,Peroxisome Proliferator Receptor alpha Agonist,1993,LUPIN PHARMACEUTICALS INC,2009/09/25-,27437-109; 27437-110,U202363UOS,FENOFIBRATE,FENOFIBRIC ACID,BGF9MN2HU1,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/24790a18-0291-4b88-a724-acac43b616ce/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=24790a18-0291-4b88-a724-acac43b616ce,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=24790a18-0291-4b88-a724-acac43b616ce,24790a18-0291-4b88-a724-acac43b616ce,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,NDA,021695,Antara,FENOFIBRATE,2023/11/06,Peroxisome Proliferator Receptor alpha Agonist,1993,LUPIN PHARMACEUTICALS INC,2013/11/01-,27437-107; 27437-108,U202363UOS,FENOFIBRATE,FENOFIBRIC ACID,BGF9MN2HU1,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/12ebf783-64df-4ffa-9e84-f8fdf4d245d4/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=12ebf783-64df-4ffa-9e84-f8fdf4d245d4,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=12ebf783-64df-4ffa-9e84-f8fdf4d245d4,12ebf783-64df-4ffa-9e84-f8fdf4d245d4,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,NDA,021612,Lipofen,FENOFIBRATE,2021/09/21,Peroxisome Proliferator Receptor alpha Agonist,1993,ANI PHARMACEUTICALS INC,2021/09/24-,62559-305; 62559-306,U202363UOS,FENOFIBRATE,FENOFIBRIC ACID,BGF9MN2HU1,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/78b789b9-854f-46b9-97f3-a48759a6ff89/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=78b789b9-854f-46b9-97f3-a48759a6ff89,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=78b789b9-854f-46b9-97f3-a48759a6ff89,78b789b9-854f-46b9-97f3-a48759a6ff89,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,022118,Fenoglide,FENOFIBRATE,2021/06/01,Peroxisome Proliferator Receptor alpha Agonist,1993,SANTARUS INC,2010/11/18-,68012-490; 68012-495,U202363UOS,fenofibrate,FENOFIBRIC ACID,BGF9MN2HU1,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/35e89d4e-45cf-4374-bf93-fca8d40d783b/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=35e89d4e-45cf-4374-bf93-fca8d40d783b,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=35e89d4e-45cf-4374-bf93-fca8d40d783b,35e89d4e-45cf-4374-bf93-fca8d40d783b,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA; NDA Authorized Generic,022118;022118,Fenofibrate,FENOFIBRATE,2021/06/01,Peroxisome Proliferator Receptor alpha Agonist,1993,OCEANSIDE PHARMACEUTICALS,2021/03/16-,68682-490; 68682-495,U202363UOS,fenofibrate,FENOFIBRIC ACID,BGF9MN2HU1,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/3532d895-faf8-4e72-ace8-156c29d4bd47/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3532d895-faf8-4e72-ace8-156c29d4bd47,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=3532d895-faf8-4e72-ace8-156c29d4bd47,3532d895-faf8-4e72-ace8-156c29d4bd47,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,021656,Tricor,FENOFIBRATE,2021/06/01,Peroxisome Proliferator Receptor alpha Agonist,1993,ABBVIE INC,2016/02/05-; completed:2004/11/05-2017/06/10; completed:2004/11/05-2019/01/24,0074-3173; 0074-3189; 0074-6122; 0074-6123,U202363UOS,FENOFIBRATE,FENOFIBRIC ACID,BGF9MN2HU1,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/b693e68d-f812-4993-54b6-852e3517c344/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b693e68d-f812-4993-54b6-852e3517c344,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=b693e68d-f812-4993-54b6-852e3517c344,b693e68d-f812-4993-54b6-852e3517c344,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,022118,Fenoglide,FENOFIBRATE,2011/05/13,Peroxisome Proliferator Receptor alpha Agonist,1993,SHORE THERAPEUTICS INC,2010/11/18-,52725-490; 52725-495,U202363UOS,fenofibrate,fenofibrate,U202363UOS,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/b38489c0-ee7b-11df-b958-0002a5d5c51b/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b38489c0-ee7b-11df-b958-0002a5d5c51b,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=b38489c0-ee7b-11df-b958-0002a5d5c51b,b38489c0-ee7b-11df-b958-0002a5d5c51b,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,022418,FIBRICOR,FENOFIBRIC ACID,2021/12/30,Peroxisome Proliferator Receptor alpha Agonist,1993,ATHENA BIOSCIENCE LLC,2017/08/05-,71511-501; 71511-502,BGF9MN2HU1,Fenofibric Acid,Fenofibric Acid,BGF9MN2HU1,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/454af7e2-8734-4a56-b659-02e83d2024fb/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=454af7e2-8734-4a56-b659-02e83d2024fb,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=454af7e2-8734-4a56-b659-02e83d2024fb,454af7e2-8734-4a56-b659-02e83d2024fb,,,
HUMAN PRESCRIPTION DRUG LABEL,"CAPSULE, DELAYED RELEASE",ORAL,NDA,022224,Trilipix,FENOFIBRIC ACID,2021/06/01,Peroxisome Proliferator Receptor alpha Agonist,2008,ABBVIE INC,2016/09/12-; completed:2008/12/15-2018/08/27; completed:2008/12/15-2018/11/13,0074-3161; 0074-3162; 0074-9189; 0074-9642,BGF9MN2HU1,FENOFIBRIC ACID,FENOFIBRIC ACID,BGF9MN2HU1,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/bbf3e782-d163-49c8-0e81-4eeabef48190/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=bbf3e782-d163-49c8-0e81-4eeabef48190,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=bbf3e782-d163-49c8-0e81-4eeabef48190,bbf3e782-d163-49c8-0e81-4eeabef48190,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,022418,Fenofibric Acid,FENOFIBRIC ACID,2018/10/10,Peroxisome Proliferator Receptor alpha Agonist,1993,HALTON LABORATORIES,2015/07/30-,69973-035; 69973-105,BGF9MN2HU1,Fenofibric Acid,Fenofibric Acid,BGF9MN2HU1,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/be471aad-d936-48be-8c79-351b56ae9cc7/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=be471aad-d936-48be-8c79-351b56ae9cc7,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=be471aad-d936-48be-8c79-351b56ae9cc7,be471aad-d936-48be-8c79-351b56ae9cc7,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,022418,FIBRICOR,FENOFIBRIC ACID,2018/10/10,Peroxisome Proliferator Receptor alpha Agonist,1993,ARALEZ PHARMACEUTICALS US INC,2017/08/05-,70347-035; 70347-105,BGF9MN2HU1,Fenofibric Acid,Fenofibric Acid,BGF9MN2HU1,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/31c80f84-0169-4659-b9cf-8f897ed319eb/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=31c80f84-0169-4659-b9cf-8f897ed319eb,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=31c80f84-0169-4659-b9cf-8f897ed319eb,31c80f84-0169-4659-b9cf-8f897ed319eb,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,022418,FIBRICOR,FENOFIBRIC ACID,2016/01/08,Peroxisome Proliferator Receptor alpha Agonist,1993,TRIBUTE PHARMACEUTICALS US INC,2015/07/30-,69916-035; 69916-105,BGF9MN2HU1,Fenofibric Acid,Fenofibric Acid,BGF9MN2HU1,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/777b0c6b-cd25-454d-a35b-d2df9b44497f/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=777b0c6b-cd25-454d-a35b-d2df9b44497f,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=777b0c6b-cd25-454d-a35b-d2df9b44497f,777b0c6b-cd25-454d-a35b-d2df9b44497f,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,022418,FIBRICOR,FENOFIBRIC ACID,2013/03/19,Peroxisome Proliferator Receptor alpha Agonist,1993,AR SCIENTIFIC INC,2009/08/14-,13310-101; 13310-102,BGF9MN2HU1,Fenofibric Acid,Fenofibric Acid,BGF9MN2HU1,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/86c49aff-0a4a-46b5-ac6e-26789bf17c9b/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=86c49aff-0a4a-46b5-ac6e-26789bf17c9b,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=86c49aff-0a4a-46b5-ac6e-26789bf17c9b,86c49aff-0a4a-46b5-ac6e-26789bf17c9b,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,NDA,017604,Nalfon,FENOPROFEN CALCIUM,2023/10/13,Nonsteroidal Anti-inflammatory Drug,1982,XSPIRE PHARMA,2012/08/27-,42195-308; 42195-600,0X2CW1QABJ,FENOPROFEN CALCIUM,FENOPROFEN,RA33EAC7KY,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/dfc2ab1e-0d75-4eff-9489-2afb51b02702/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=dfc2ab1e-0d75-4eff-9489-2afb51b02702,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=dfc2ab1e-0d75-4eff-9489-2afb51b02702,dfc2ab1e-0d75-4eff-9489-2afb51b02702,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,NDA,017604,Fenoprofen Calcium,FENOPROFEN CALCIUM,2022/02/22,Nonsteroidal Anti-inflammatory Drug,1982,MISEMER PHARMACEUTICALS INC,2021/11/01-; completed:2021/11/01-2022/02/20,0276-0501; 0276-0502; 0276-0503,0X2CW1QABJ,FENOPROFEN CALCIUM,FENOPROFEN,RA33EAC7KY,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/d33ad329-1ca6-ac2e-e053-2995a90a15c5/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d33ad329-1ca6-ac2e-e053-2995a90a15c5,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=d33ad329-1ca6-ac2e-e053-2995a90a15c5,d33ad329-1ca6-ac2e-e053-2995a90a15c5,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,NDA,017604,FENOPROFEN CALCIUM,FENOPROFEN CALCIUM,2020/01/24,Nonsteroidal Anti-inflammatory Drug,1982,STERLING KNIGHT PHARMACEUTICALS,2016/07/06-,69336-124,0X2CW1QABJ,FENOPROFEN CALCIUM,FENOPROFEN,RA33EAC7KY,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/f85ed255-fc1a-4202-a61c-857936c4c868/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f85ed255-fc1a-4202-a61c-857936c4c868,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=f85ed255-fc1a-4202-a61c-857936c4c868,f85ed255-fc1a-4202-a61c-857936c4c868,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,NDA,017604,FENOPROFEN,FENOPROFEN CALCIUM,2017/04/21,Nonsteroidal Anti-inflammatory Drug,1982,BELCHER PHARMACEUTICALS LLC,2017/04/19-,62250-691,0X2CW1QABJ,FENOPROFEN CALCIUM,FENOPROFEN,RA33EAC7KY,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/fccf649d-ff26-4813-920f-cf3d20ee1546/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=fccf649d-ff26-4813-920f-cf3d20ee1546,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=fccf649d-ff26-4813-920f-cf3d20ee1546,fccf649d-ff26-4813-920f-cf3d20ee1546,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,NDA,017604,FENOPROFEN CALCIUM,FENOPROFEN CALCIUM,2016/06/08,Nonsteroidal Anti-inflammatory Drug,1982,BPI LABS LLC,2016/07/06-,54288-131; 54288-132,0X2CW1QABJ,FENOPROFEN CALCIUM,FENOPROFEN,RA33EAC7KY,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/3028652a-56ee-497d-8f77-edba86ddf8cb/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3028652a-56ee-497d-8f77-edba86ddf8cb,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=3028652a-56ee-497d-8f77-edba86ddf8cb,3028652a-56ee-497d-8f77-edba86ddf8cb,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,BUCCAL; SUBLINGUAL,NDA,021947,FENTORA,FENTANYL,2023/12/17,Opioid Agonist,1968,CEPHALON LLC,2006/10/02-,63459-541; 63459-542; 63459-544; 63459-546; 63459-548,MUN5LYG46H,FENTANYL CITRATE,FENTANYL,UF599785JZ,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/8f549d95-985b-f783-1ebb-ef57bd2ecb05/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8f549d95-985b-f783-1ebb-ef57bd2ecb05,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=8f549d95-985b-f783-1ebb-ef57bd2ecb05,8f549d95-985b-f783-1ebb-ef57bd2ecb05,,,
HUMAN PRESCRIPTION DRUG LABEL,SPRAY,SUBLINGUAL,NDA,202788,SUBSYS,FENTANYL,2021/05/04,Opioid Agonist,1968,INSYS THERAPEUTICS INC,2012/03/13-; 2012/08/30-,20482-001; 20482-002; 20482-004; 20482-006; 20482-008; 20482-012; 20482-016,UF599785JZ,FENTANYL,FENTANYL,UF599785JZ,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/18a413e9-11e0-4a8f-86c0-d33b37b7b771/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=18a413e9-11e0-4a8f-86c0-d33b37b7b771,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=18a413e9-11e0-4a8f-86c0-d33b37b7b771,18a413e9-11e0-4a8f-86c0-d33b37b7b771,,,
HUMAN PRESCRIPTION DRUG LABEL,SPRAY,SUBLINGUAL,NDA,202788,SUBSYS,FENTANYL,2021/04/28,Opioid Agonist,1968,WEST THERAPEUTICS DEVELOPMENT LLC,2021/03/10-,71500-001; 71500-002; 71500-004; 71500-006; 71500-008; 71500-012; 71500-016,UF599785JZ,FENTANYL,FENTANYL,UF599785JZ,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/be7670d5-b88a-13bd-e053-2995a90a2f78/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=be7670d5-b88a-13bd-e053-2995a90a2f78,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=be7670d5-b88a-13bd-e053-2995a90a2f78,be7670d5-b88a-13bd-e053-2995a90a2f78,,,
HUMAN PRESCRIPTION DRUG LABEL,SPRAY,NASAL,NDA,022569,LAZANDA,FENTANYL,2021/03/31,Opioid Agonist,,WEST THERAPEUTIC DEVELOPMENT LLC,2018/08/25-,71500-110; 71500-130; 71500-140,MUN5LYG46H,FENTANYL CITRATE,FENTANYL,UF599785JZ,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/73f38bde-2132-2b5a-e053-2a91aa0a6efb/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=73f38bde-2132-2b5a-e053-2a91aa0a6efb,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=73f38bde-2132-2b5a-e053-2a91aa0a6efb,73f38bde-2132-2b5a-e053-2a91aa0a6efb,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,SUBLINGUAL,NDA,022510,Abstral,FENTANYL,2012/02/29,Opioid Agonist,1968,PROSTRAKAN INC,2011/01/07-,42747-221; 42747-222; 42747-223; 42747-224; 42747-226; 42747-228,MUN5LYG46H,FENTANYL CITRATE,FENTANYL,UF599785JZ,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/4906457e-30ad-4da7-b3ac-bb9e6651a670/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4906457e-30ad-4da7-b3ac-bb9e6651a670,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=4906457e-30ad-4da7-b3ac-bb9e6651a670,4906457e-30ad-4da7-b3ac-bb9e6651a670,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRAMUSCULAR; INTRAVENOUS,NDA,019101,Fentanyl Citrate,FENTANYL CITRATE,2024/04/09,Opioid Agonist,1968,HIKMA PHARMACEUTICALS USA INC,1984/07/11-; 2021/03/18-; 2023/02/01-,0641-6024; 0641-6025; 0641-6026; 0641-6027; 0641-6028; 0641-6029; 0641-6030; 0641-6247; 0641-6248; 0641-6249,MUN5LYG46H,FENTANYL CITRATE,FENTANYL,UF599785JZ,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/ce5db1c2-feb1-4ad2-847a-d02e865bd47e/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ce5db1c2-feb1-4ad2-847a-d02e865bd47e,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=ce5db1c2-feb1-4ad2-847a-d02e865bd47e,ce5db1c2-feb1-4ad2-847a-d02e865bd47e,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRAMUSCULAR; INTRAVENOUS,NDA,019101,Fentanyl Citrate,FENTANYL CITRATE,2024/04/02,Opioid Agonist,1968,CIVICA INC,2019/12/10-; 2020/10/07-,72572-170; 72572-171; 72572-172,MUN5LYG46H,FENTANYL CITRATE,FENTANYL,UF599785JZ,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/aacf276b-e133-4199-ad3f-67b894744c04/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=aacf276b-e133-4199-ad3f-67b894744c04,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=aacf276b-e133-4199-ad3f-67b894744c04,aacf276b-e133-4199-ad3f-67b894744c04,,,
HUMAN PRESCRIPTION DRUG LABEL,LOZENGE,ORAL; TRANSMUCOSAL,NDA,020747,ACTIQ,FENTANYL CITRATE,2023/12/18,Opioid Agonist,1968,CEPHALON LLC,completed:1999/01/20-2022/05/31; completed:1999/01/20-2024/05/31; completed:1999/01/20-2024/06/30; completed:1999/01/20-2025/05/31,63459-502; 63459-504; 63459-506; 63459-508; 63459-512; 63459-516,MUN5LYG46H,FENTANYL CITRATE,FENTANYL,UF599785JZ,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/90b94524-f913-48b3-3771-7b2fcffd888a/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=90b94524-f913-48b3-3771-7b2fcffd888a,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=90b94524-f913-48b3-3771-7b2fcffd888a,90b94524-f913-48b3-3771-7b2fcffd888a,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRAVENOUS,NDA,215870,Fentanyl Citrate,FENTANYL CITRATE,2023/12/18,Opioid Agonist,1968,EXELA PHARMA SCIENCES LLC,2023/05/01-,51754-2150; 51754-2160,MUN5LYG46H,FENTANYL CITRATE,FENTANYL,UF599785JZ,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/c94b4a5e-4224-4d0b-a0f8-371fba043ebe/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c94b4a5e-4224-4d0b-a0f8-371fba043ebe,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=c94b4a5e-4224-4d0b-a0f8-371fba043ebe,c94b4a5e-4224-4d0b-a0f8-371fba043ebe,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRAMUSCULAR; INTRAVENOUS,NDA,019101,Fentanyl Citrate,FENTANYL CITRATE,2023/01/18,Opioid Agonist,1968,PHLOW CORP,2023/01/11-,81565-205,MUN5LYG46H,FENTANYL CITRATE,FENTANYL,UF599785JZ,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/58dcd3f7-e3d8-4929-a186-8f680a51ff11/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=58dcd3f7-e3d8-4929-a186-8f680a51ff11,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=58dcd3f7-e3d8-4929-a186-8f680a51ff11,58dcd3f7-e3d8-4929-a186-8f680a51ff11,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAMUSCULAR; INTRAVENOUS,NDA,016619,FENTANYL CITRATE,FENTANYL CITRATE,2022/09/09,Opioid Agonist,1968,AKORN,2012/03/22-,17478-030,MUN5LYG46H,FENTANYL CITRATE,FENTANYL,UF599785JZ,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/c5d40297-b769-48cc-9f84-f98b7a333507/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c5d40297-b769-48cc-9f84-f98b7a333507,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=c5d40297-b769-48cc-9f84-f98b7a333507,c5d40297-b769-48cc-9f84-f98b7a333507,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,SUBLINGUAL,NDA,022510,Abstral,FENTANYL CITRATE,2014/11/30,Opioid Agonist,1968,GALENA BIOPHARMA INC,2013/08/08-,57881-331; 57881-332; 57881-333; 57881-334; 57881-336; 57881-338,MUN5LYG46H,fentanyl citrate,fentanyl,UF599785JZ,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/f969e2bc-6297-4e29-89d3-a3685a2c7c6b/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f969e2bc-6297-4e29-89d3-a3685a2c7c6b,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=f969e2bc-6297-4e29-89d3-a3685a2c7c6b,f969e2bc-6297-4e29-89d3-a3685a2c7c6b,,,
HUMAN PRESCRIPTION DRUG LABEL,SPRAY,NASAL,NDA,022569,LAZANDA,FENTANYL CITRATE,2012/07/30,Opioid Agonist,1968,ARCHIMEDES PHARMA US INC,2011/10/17-,51772-311; 51772-314,MUN5LYG46H,Fentanyl Citrate,Fentanyl,UF599785JZ,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/39531d0c-db12-4627-81c9-6563076b637b/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=39531d0c-db12-4627-81c9-6563076b637b,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=39531d0c-db12-4627-81c9-6563076b637b,39531d0c-db12-4627-81c9-6563076b637b,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,203565,Injectafer,FERRIC CARBOXYMALTOSE; FERRIC CARBOXYMALTOSE INJECTION,2023/05/01,Parenteral Iron Replacement; Phosphate Binder,2013,AMERICAN REGENT INC,2013/08/12-; 2021/06/01-; 2022/06/01-,0517-0602; 0517-0620; 0517-0650,6897GXD6OE,FERRIC CARBOXYMALTOSE,FERRIC CATION,91O4LML611,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/517b4a19-45b3-4286-9f6a-ced4e10447de/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=517b4a19-45b3-4286-9f6a-ced4e10447de,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=517b4a19-45b3-4286-9f6a-ced4e10447de,517b4a19-45b3-4286-9f6a-ced4e10447de,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,205874,Auryxia,FERRIC CITRATE,2024/01/22,Parenteral Iron Replacement; Phosphate Binder,2014,AKEBIA THERAPEUTICS INC,2014/09/17-,59922-631,Q91187K011,TETRAFERRIC TRICITRATE DECAHYDRATE,FERRIC CATION,91O4LML611,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/aadd18e0-3752-11e4-8510-0800200c9a66/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=aadd18e0-3752-11e4-8510-0800200c9a66,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=aadd18e0-3752-11e4-8510-0800200c9a66,aadd18e0-3752-11e4-8510-0800200c9a66,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,208171,Monoferric,FERRIC DERISOMALTOSE,2024/01/16,,2020,PHARMACOSMOS THERAPEUTICS INC,2020/01/16-,73594-9301; 73594-9305; 73594-9310,AHU547PI9H,FERRIC DERISOMALTOSE,FERRIC DERISOMALTOSE,AHU547PI9H,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/55859d2d-0456-4fa9-b41f-f535accc97db/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=55859d2d-0456-4fa9-b41f-f535accc97db,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=55859d2d-0456-4fa9-b41f-f535accc97db,55859d2d-0456-4fa9-b41f-f535accc97db,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,NDA,212320,ACCRUFER,FERRIC MALTOL,2023/12/06,Parenteral Iron Replacement; Phosphate Binder,2019,SHIELD TX UK LTD,2021/07/01-,73059-001,MA10QYF1Z0,FERRIC MALTOL,FERRIC CATION,91O4LML611,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/367ac157-2d25-4f34-99ce-b126e0f03851/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=367ac157-2d25-4f34-99ce-b126e0f03851,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=367ac157-2d25-4f34-99ce-b126e0f03851,367ac157-2d25-4f34-99ce-b126e0f03851,,,
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION,INTRAVENOUS,NDA,212860,Triferic AVNU,FERRIC PYROPHOSPHATE CITRATE,2020/09/15,Parenteral Iron Replacement; Phosphate Binder,2015,ROCKWELL MEDICAL INC,2020/03/30-,57278-318,UBY79OCO9G,FERRIC PYROPHOSPHATE CITRATE,FERRIC CATION,91O4LML611,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/51197a48-6078-42cd-b5ed-5ea22b6757b4/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=51197a48-6078-42cd-b5ed-5ea22b6757b4,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=51197a48-6078-42cd-b5ed-5ea22b6757b4,51197a48-6078-42cd-b5ed-5ea22b6757b4,,,
HUMAN PRESCRIPTION DRUG LABEL,POWDER; SOLUTION,HEMODIALYSIS; INTRAVENOUS,NDA,206317;208551,Triferic,FERRIC PYROPHOSPHATE; FERRIC PYROPHOSPHATE CITRATE,2020/09/15,Parenteral Iron Replacement; Phosphate Binder,2015,ROCKWELL MEDICAL INC,2015/02/06-; 2016/04/25-,57278-314; 57278-315,UBY79OCO9G,FERRIC PYROPHOSPHATE CITRATE,FERRIC CATION,91O4LML611,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/46ec9233-4063-4c48-e054-00144ff8d46c/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=46ec9233-4063-4c48-e054-00144ff8d46c,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=46ec9233-4063-4c48-e054-00144ff8d46c,46ec9233-4063-4c48-e054-00144ff8d46c,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRAVENOUS,NDA,022180,Feraheme,FERUMOXYTOL,2022/06/13,Parenteral Iron Replacement,2009,AMAG PHARMACEUTICALS INC,2009/07/13-,59338-775,CLH5FT6412,FERUMOXYTOL NON-STOICHIOMETRIC MAGNETITE,FERUMOXYTOL NON-STOICHIOMETRIC MAGNETITE,CLH5FT6412,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/32b0e320-a739-11dc-a704-0002a5d5c51b/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=32b0e320-a739-11dc-a704-0002a5d5c51b,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=32b0e320-a739-11dc-a704-0002a5d5c51b,32b0e320-a739-11dc-a704-0002a5d5c51b,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,NDA,022030,Toviaz,FESOTERODINE FUMARATE,2024/03/04,,2008,PFIZER LABORATORIES DIV PFIZER INC,2008/10/31-,0069-0242; 0069-0244,EOS72165S7,FESOTERODINE FUMARATE,FESOTERODINE,621G617227,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/5be745f0-8ae7-4c3c-9962-37d6263326f1/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5be745f0-8ae7-4c3c-9962-37d6263326f1,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=5be745f0-8ae7-4c3c-9962-37d6263326f1,5be745f0-8ae7-4c3c-9962-37d6263326f1,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,NDA,022030,Toviaz,FESOTERODINE FUMARATE,2024/03/04,,2008,U S PHARMACEUTICALS,2008/10/31-,63539-183; 63539-242,EOS72165S7,FESOTERODINE FUMARATE,FESOTERODINE,621G617227,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/4f01dced-195a-4712-a614-d68012bc29df/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4f01dced-195a-4712-a614-d68012bc29df,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=4f01dced-195a-4712-a614-d68012bc29df,4f01dced-195a-4712-a614-d68012bc29df,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,214429,Fexinidazole,FEXINIDAZOLE,2023/01/04,Nitroimidazole Antimicrobial,2021,SANOFI AVENTIS U S LLC,2021/07/16-,0024-4512,306ERL82IR,FEXINIDAZOLE,FEXINIDAZOLE,306ERL82IR,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/74a611bc-9977-46bb-b626-0370b3031628/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=74a611bc-9977-46bb-b626-0370b3031628,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=74a611bc-9977-46bb-b626-0370b3031628,74a611bc-9977-46bb-b626-0370b3031628,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,216578,VEOZAH,FEZOLINETANT,2023/10/18,Neurokinin 3 Receptor Antagonist,2023,ASTELLAS PHARMA US INC,2023/05/12-; 2023/05/16-,0469-2460; 0469-2660; 0469-2760,83VNE45KXX,FEZOLINETANT,FEZOLINETANT,83VNE45KXX,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/cae9f798-24f9-4580-a4fc-e6c710cbda3c/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=cae9f798-24f9-4580-a4fc-e6c710cbda3c,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=cae9f798-24f9-4580-a4fc-e6c710cbda3c,cae9f798-24f9-4580-a4fc-e6c710cbda3c,,,
HUMAN PRESCRIPTION DRUG LABEL,"GRANULE, FOR SUSPENSION; TABLET, FILM COATED",ORAL,NDA,201699;213138,DIFICID; Dificid,FIDAXOMICIN,2023/11/20,Macrolide Antibacterial,2011,MERCK SHARP AND DOHME LLC,2011/05/27-; 2020/02/18-,52015-080; 52015-700,Z5N076G8YQ,FIDAXOMICIN,FIDAXOMICIN,Z5N076G8YQ,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/dd966338-c820-4270-b704-09ef75fa3ceb/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=dd966338-c820-4270-b704-09ef75fa3ceb,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=dd966338-c820-4270-b704-09ef75fa3ceb,dd966338-c820-4270-b704-09ef75fa3ceb,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,020788,PROPECIA,FINASTERIDE,2023/11/22,5-alpha Reductase Inhibitor,1992,ORGANON LLC,2021/06/01-,78206-152,57GNO57U7G,FINASTERIDE,FINASTERIDE,57GNO57U7G,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/6f904709-65aa-44ce-b144-b4c8a0416e36/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6f904709-65aa-44ce-b144-b4c8a0416e36,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=6f904709-65aa-44ce-b144-b4c8a0416e36,6f904709-65aa-44ce-b144-b4c8a0416e36,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,020180,PROSCAR,FINASTERIDE,2023/11/22,5-alpha Reductase Inhibitor,1992,ORGANON LLC,2021/06/01-,78206-153,57GNO57U7G,FINASTERIDE,FINASTERIDE,57GNO57U7G,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/6f988153-fc74-4ca4-b29a-111f750c4a4b/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6f988153-fc74-4ca4-b29a-111f750c4a4b,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=6f988153-fc74-4ca4-b29a-111f750c4a4b,6f988153-fc74-4ca4-b29a-111f750c4a4b,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,NDA,215423,ENTADFI,FINASTERIDE AND TADALAFIL,2023/01/12,5-alpha Reductase Inhibitor; Phosphodiesterase 5 Inhibitor,2021,VERU INC,2021/12/12-,69681-125,57GNO57U7G; 742SXX0ICT,finasteride; tadalafil,finasteride; tadalafil,57GNO57U7G; 742SXX0ICT,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/112bf653-8322-4444-8d4d-03234b11c38c/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=112bf653-8322-4444-8d4d-03234b11c38c,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=112bf653-8322-4444-8d4d-03234b11c38c,112bf653-8322-4444-8d4d-03234b11c38c,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,215341,Kerendia,FINERENONE,2022/09/01,Nonsteroidal Mineralocorticoid-Receptor Antagonist,2021,BAYER HEALTHCARE PHARMACEUTICALS INC,2021/07/09-,50419-540; 50419-541,DE2O63YV8R,FINERENONE,FINERENONE,DE2O63YV8R,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/fc726765-5d5a-4d6e-b037-b847bda9fb7c/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=fc726765-5d5a-4d6e-b037-b847bda9fb7c,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=fc726765-5d5a-4d6e-b037-b847bda9fb7c,fc726765-5d5a-4d6e-b037-b847bda9fb7c,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,NDA,022527,Gilenya,FINGOLIMOD HCL,2024/01/31,Sphingosine 1-phosphate Receptor Modulator,2010,NOVARTIS PHARMACEUTICALS CORPORATION,2010/09/21-,0078-0607; 0078-0965,G926EC510T,FINGOLIMOD HYDROCHLORIDE,FINGOLIMOD,3QN8BYN5QF,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/cc9e1c8c-0e2b-44e2-878b-27057f786be9/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=cc9e1c8c-0e2b-44e2-878b-27057f786be9,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=cc9e1c8c-0e2b-44e2-878b-27057f786be9,cc9e1c8c-0e2b-44e2-878b-27057f786be9,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, ORALLY DISINTEGRATING",ORAL,NDA,214962,TASCENSO ODT,FINGOLIMOD LAURYL SULFATE,2023/08/17,Sphingosine 1-phosphate Receptor Modulator,2010,CYCLE PHARMACEUTICALS LTD,2023/02/01-,70709-062; 70709-065,J3HZQ9BE2S,Fingolimod Lauryl Sulfate,Fingolimod,3QN8BYN5QF,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/bf8e7f89-ea09-43c7-a7eb-e44724350721/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=bf8e7f89-ea09-43c7-a7eb-e44724350721,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=bf8e7f89-ea09-43c7-a7eb-e44724350721,bf8e7f89-ea09-43c7-a7eb-e44724350721,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, EMULSION",INTRAVENOUS,NDA,210589,Omegaven,FISH OIL,2023/07/19,,2018,FRESENIUS KABI USA LLC,2018/07/27-,63323-205,XGF7L72M0F,Fish oil,Fish oil,XGF7L72M0F,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/5d9d0b24-e139-48bf-ab2d-536fb59cf8e0/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5d9d0b24-e139-48bf-ab2d-536fb59cf8e0,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=5d9d0b24-e139-48bf-ab2d-536fb59cf8e0,5d9d0b24-e139-48bf-ab2d-536fb59cf8e0,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,022526,ADDYI,FLIBANSERIN,2021/09/01,,2015,SPROUT PHARMACEUTICALS INC,2015/08/18-,58604-214,37JK4STR6Z,Flibanserin,Flibanserin,37JK4STR6Z,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/3819daf3-e935-2c53-c527-e1d57922f394/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3819daf3-e935-2c53-c527-e1d57922f394,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=3819daf3-e935-2c53-c527-e1d57922f394,3819daf3-e935-2c53-c527-e1d57922f394,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,204677,Neuraceq,FLORBETABEN F 18,2024/04/30,Radioactive Diagnostic Agent,2014,LIFE MOLECULAR IMAGING LTD,2014/03/20-,54828-001,TLA7312TOI,FLORBETABEN F-18,FLORBETABEN F-18,TLA7312TOI,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/b0915068-cfd4-4d72-b9f8-7e31fe83cd1e/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b0915068-cfd4-4d72-b9f8-7e31fe83cd1e,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=b0915068-cfd4-4d72-b9f8-7e31fe83cd1e,b0915068-cfd4-4d72-b9f8-7e31fe83cd1e,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,202008,Amyvid,FLORBETAPIR F 18,2023/10/13,Radioactive Diagnostic Agent,2012,ELI LILLY AND COMPANY,2012/06/01-,0002-1200,6W15Z5R0RU,FLORBETAPIR F-18,FLORBETAPIR F-18,6W15Z5R0RU,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/bb5a5043-0f51-11df-8a39-0800200c9a66/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=bb5a5043-0f51-11df-8a39-0800200c9a66,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=bb5a5043-0f51-11df-8a39-0800200c9a66,bb5a5043-0f51-11df-8a39-0800200c9a66,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,212123,TAUVID,FLORTAUCIPIR F-18,2024/02/05,,2020,ELI LILLY AND COMPANY,2022/07/01-,0002-1220,T1JP1KYU9O,Flortaucipir F-18,Flortaucipir F-18,T1JP1KYU9O,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/b483abad-5230-462a-adfb-1a65160f01d0/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b483abad-5230-462a-adfb-1a65160f01d0,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=b483abad-5230-462a-adfb-1a65160f01d0,b483abad-5230-462a-adfb-1a65160f01d0,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRAVENOUS,NDA,216023,POSLUMA,FLOTUFOLASTAT F-18,2023/12/13,Radioactive Diagnostic Agent,2023,BLUE EARTH DIAGNOSTICS,2023/05/25-,69932-002,811W19E3OL,FLOTUFOLASTAT F-18,FLOTUFOLASTAT F-18,811W19E3OL,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/907ac4a4-a088-4826-ab50-cfc31985c9d4/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=907ac4a4-a088-4826-ab50-cfc31985c9d4,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=907ac4a4-a088-4826-ab50-cfc31985c9d4,907ac4a4-a088-4826-ab50-cfc31985c9d4,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,208054,Axumin,FLUCICLOVINE F-18,2023/12/08,Radioactive Diagnostic Agent,2016,BLUE EARTH DIAGNOSTICS,2016/05/27-,69932-001,38R1Q0L1ZE,FLUCICLOVINE F-18,FLUCICLOVINE F-18,38R1Q0L1ZE,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/389a502e-a7d5-43dd-b6bf-f022ff23f3b9/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=389a502e-a7d5-43dd-b6bf-f022ff23f3b9,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=389a502e-a7d5-43dd-b6bf-f022ff23f3b9,389a502e-a7d5-43dd-b6bf-f022ff23f3b9,,,
HUMAN PRESCRIPTION DRUG LABEL,"POWDER, FOR SUSPENSION; TABLET",ORAL,NDA,019949;020090,Diflucan,FLUCONAZOLE,2024/05/07,Azole Antifungal,,ROERIG,1990/01/29-; 1993/12/23-; completed:1990/01/29-2023/06/30; completed:1993/12/23-2024/07/31; completed:1994/06/30-2023/09/30,0049-3410; 0049-3420; 0049-3430; 0049-3440; 0049-3450; 0049-3500,8VZV102JFY,FLUCONAZOLE,FLUCONAZOLE,8VZV102JFY,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/f694c617-3383-416c-91b6-b94fda371204/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f694c617-3383-416c-91b6-b94fda371204,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=f694c617-3383-416c-91b6-b94fda371204,f694c617-3383-416c-91b6-b94fda371204,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,NDA,017001,ANCOBON,FLUCYTOSINE,2022/02/02,Nucleoside Analog Antifungal,,BAUSCH HEALTH US LLC,1971/11/26-,0187-3554; 0187-3555,D83282DT06,Flucytosine,Flucytosine,D83282DT06,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/aea0df00-a88c-4a16-abcf-750f3ff2004e/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=aea0df00-a88c-4a16-abcf-750f3ff2004e,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=aea0df00-a88c-4a16-abcf-750f3ff2004e,aea0df00-a88c-4a16-abcf-750f3ff2004e,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRAVENOUS,NDA,021870,Fludeoxyglucose F18,FLUDEOXYGLUCOSE F18,2019/07/11,Radioactive Diagnostic Agent,2005,THE FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH,2005/08/19-,13267-234,0Z5B2CJX4D,FLUDEOXYGLUCOSE F-18,FLUDEOXYGLUCOSE F-18,0Z5B2CJX4D,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/dfd91498-4bfc-4d45-a9a3-cee6153ae573/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=dfd91498-4bfc-4d45-a9a3-cee6153ae573,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=dfd91498-4bfc-4d45-a9a3-cee6153ae573,dfd91498-4bfc-4d45-a9a3-cee6153ae573,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRAVENOUS,NDA,021870,Fludeoxyglucose F18,FLUDEOXYGLUCOSE F18,2012/01/18,Radioactive Diagnostic Agent,2005,THE FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH,2005/08/19-,13267-123,0Z5B2CJX4D,FLUDEOXYGLUCOSE F-18,FLUDEOXYGLUCOSE F-18,0Z5B2CJX4D,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/96398ed5-ffb9-4ed4-92c1-6a9535864475/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=96398ed5-ffb9-4ed4-92c1-6a9535864475,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=96398ed5-ffb9-4ed4-92c1-6a9535864475,96398ed5-ffb9-4ed4-92c1-6a9535864475,,,
HUMAN PRESCRIPTION DRUG LABEL,OIL,TOPICAL,NDA,019452,Derma-Smoothe/FS,FLUOCINOLONE ACETONIDE,2024/05/02,Corticosteroid,,ROYAL PHARMACEUTICALS,1995/02/16-,68791-102,0CD5FD6S2M,fluocinolone acetonide,fluocinolone acetonide,0CD5FD6S2M,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/113e167a-a9fe-440e-9446-d6d87963ef46/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=113e167a-a9fe-440e-9446-d6d87963ef46,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=113e167a-a9fe-440e-9446-d6d87963ef46,113e167a-a9fe-440e-9446-d6d87963ef46,,,
HUMAN PRESCRIPTION DRUG LABEL,OIL,AURICULAR (OTIC),NDA,019452,DermOtic,FLUOCINOLONE ACETONIDE,2024/02/12,Corticosteroid,,ROYAL PHARMACEUTICALS,2005/11/09-,68791-103,0CD5FD6S2M,fluocinolone acetonide,fluocinolone acetonide,0CD5FD6S2M,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/eb00f222-8105-4e05-90e8-bbd129784364/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=eb00f222-8105-4e05-90e8-bbd129784364,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=eb00f222-8105-4e05-90e8-bbd129784364,eb00f222-8105-4e05-90e8-bbd129784364,,,
HUMAN PRESCRIPTION DRUG LABEL,OIL,TOPICAL,NDA,019452,Derma-Smoothe/FS,FLUOCINOLONE ACETONIDE,2024/02/12,Corticosteroid,1988,ROYAL PHARMACEUTICALS,1995/02/16-,68791-101,0CD5FD6S2M,fluocinolone acetonide,fluocinolone acetonide,0CD5FD6S2M,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/bc61c619-a71c-46f5-80f1-9e9ee71134aa/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=bc61c619-a71c-46f5-80f1-9e9ee71134aa,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=bc61c619-a71c-46f5-80f1-9e9ee71134aa,bc61c619-a71c-46f5-80f1-9e9ee71134aa,,,
HUMAN PRESCRIPTION DRUG LABEL,IMPLANT,INTRAVITREAL,NDA,021737,Retisert,FLUOCINOLONE ACETONIDE,2024/01/18,Corticosteroid,1963,BAUSCH AND LOMB INCORPORATED,2005/04/08-,24208-416,0CD5FD6S2M,FLUOCINOLONE ACETONIDE,FLUOCINOLONE ACETONIDE,0CD5FD6S2M,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/1ab0f849-2a0d-47ce-ad05-768094da8cc9/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1ab0f849-2a0d-47ce-ad05-768094da8cc9,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=1ab0f849-2a0d-47ce-ad05-768094da8cc9,1ab0f849-2a0d-47ce-ad05-768094da8cc9,,,
HUMAN PRESCRIPTION DRUG LABEL,IMPLANT,INTRAOCULAR,NDA,210331,YUTIQ,FLUOCINOLONE ACETONIDE,2023/12/13,Corticosteroid,1963,EYEPOINT PHARMACEUTICALS INC,2018/10/12-,71879-136,0CD5FD6S2M,FLUOCINOLONE ACETONIDE,FLUOCINOLONE ACETONIDE,0CD5FD6S2M,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/43ba66d9-653d-48b9-9914-b0a50b68b79a/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=43ba66d9-653d-48b9-9914-b0a50b68b79a,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=43ba66d9-653d-48b9-9914-b0a50b68b79a,43ba66d9-653d-48b9-9914-b0a50b68b79a,,,
HUMAN PRESCRIPTION DRUG LABEL,CREAM; KIT,TOPICAL,NDA,012787,Synalar,FLUOCINOLONE ACETONIDE,2023/12/08,Corticosteroid,,MEDIMETRIKS PHARMACEUTICALS INC,2012/09/27-; completed:2012/12/15-2023/11/01,43538-900; 43538-901,0CD5FD6S2M,fluocinolone acetonide,fluocinolone acetonide,0CD5FD6S2M,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/5af2e4c1-082b-48a0-aae7-72d4a68cbb2d/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5af2e4c1-082b-48a0-aae7-72d4a68cbb2d,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=5af2e4c1-082b-48a0-aae7-72d4a68cbb2d,5af2e4c1-082b-48a0-aae7-72d4a68cbb2d,,,
HUMAN PRESCRIPTION DRUG LABEL,OINTMENT,TOPICAL,NDA,013960,Synalar,FLUOCINOLONE ACETONIDE,2023/11/29,Corticosteroid,,MEDIMETRIKS PHARMACEUTICALS INC,2012/09/27-,43538-910,0CD5FD6S2M,fluocinolone acetonide,fluocinolone acetonide,0CD5FD6S2M,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/d2d155cf-a635-4ab7-87de-34e90b9a74cd/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d2d155cf-a635-4ab7-87de-34e90b9a74cd,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=d2d155cf-a635-4ab7-87de-34e90b9a74cd,d2d155cf-a635-4ab7-87de-34e90b9a74cd,,,
HUMAN PRESCRIPTION DRUG LABEL,IMPLANT,INTRAVITREAL,NDA,201923,Iluvien,FLUOCINOLONE ACETONIDE,2023/11/06,Corticosteroid,1963,ALIMERA SCIENCES INC,2014/10/15-,68611-190,0CD5FD6S2M,FLUOCINOLONE ACETONIDE,FLUOCINOLONE ACETONIDE,0CD5FD6S2M,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/4400e471-7402-11df-93f2-0800200c9a66/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4400e471-7402-11df-93f2-0800200c9a66,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=4400e471-7402-11df-93f2-0800200c9a66,4400e471-7402-11df-93f2-0800200c9a66,,,
HUMAN PRESCRIPTION DRUG LABEL,IMPLANT,INTRAVITREAL,NDA,210331,YUTIQ,FLUOCINOLONE ACETONIDE,2023/10/16,Corticosteroid,1963,ALIMERA SCIENCES INC,2023/05/17-,68611-180,0CD5FD6S2M,FLUOCINOLONE ACETONIDE,FLUOCINOLONE ACETONIDE,0CD5FD6S2M,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/f270cad8-ed82-4969-b785-831a1910bfa6/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f270cad8-ed82-4969-b785-831a1910bfa6,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=f270cad8-ed82-4969-b785-831a1910bfa6,f270cad8-ed82-4969-b785-831a1910bfa6,,,
HUMAN PRESCRIPTION DRUG LABEL,CREAM,TOPICAL,NDA,021112,TRI-LUMA,"FLUOCINOLONE ACETONIDE, HYDROQUINONE, AND TRETINOIN",2023/08/22,Corticosteroid; Melanin Synthesis Inhibitor; Retinoid,2002,GALDERMA LABORATORIES L P,2002/01/18-,0299-5950,0CD5FD6S2M; 5688UTC01R; XV74C1N1AE,FLUOCINOLONE ACETONIDE; HYDROQUINONE; TRETINOIN,FLUOCINOLONE ACETONIDE; HYDROQUINONE; TRETINOIN,0CD5FD6S2M; 5688UTC01R; XV74C1N1AE,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/a35fa709-5eb5-4429-b38f-f1e0019bf0ee/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a35fa709-5eb5-4429-b38f-f1e0019bf0ee,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=a35fa709-5eb5-4429-b38f-f1e0019bf0ee,a35fa709-5eb5-4429-b38f-f1e0019bf0ee,,,
HUMAN PRESCRIPTION DRUG LABEL,CREAM,TOPICAL,NDA,021758,Vanos,FLUOCINONIDE,2024/02/27,Corticosteroid,1971,BAUSCH HEALTH US LLC,2006/03/13-,99207-525,2W4A77YPAN,FLUOCINONIDE,FLUOCINONIDE,2W4A77YPAN,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/95cb19a0-4b71-4c66-92bd-901cfd223301/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=95cb19a0-4b71-4c66-92bd-901cfd223301,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=95cb19a0-4b71-4c66-92bd-901cfd223301,95cb19a0-4b71-4c66-92bd-901cfd223301,,,
HUMAN PRESCRIPTION DRUG LABEL,OINTMENT,TOPICAL,NDA,016909,Fluocinonide,FLUOCINONIDE,2023/07/18,Corticosteroid,,ALVOGEN INC,completed:2017/10/02-2024/11/01,47781-569,2W4A77YPAN,Fluocinonide,Fluocinonide,2W4A77YPAN,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/bccf8840-3919-9f2d-0c91-496f224f76a5/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=bccf8840-3919-9f2d-0c91-496f224f76a5,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=bccf8840-3919-9f2d-0c91-496f224f76a5,bccf8840-3919-9f2d-0c91-496f224f76a5,,,
HUMAN PRESCRIPTION DRUG LABEL,CREAM; GEL; OINTMENT,TOPICAL,ANDA; NDA,019117;072494;074935;075008,Fluocinonide,FLUOCINONIDE,2018/02/07,Corticosteroid,,TARO PHARMACEUTICALS U S A INC,1984/06/26-; 1989/01/19-; 1997/07/29-; 1999/06/30-,51672-1253; 51672-1254; 51672-1264; 51672-1279,2W4A77YPAN,Fluocinonide,Fluocinonide,2W4A77YPAN,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/b0bc89a9-c9d5-4adb-9785-2d4487c4c656/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b0bc89a9-c9d5-4adb-9785-2d4487c4c656,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=b0bc89a9-c9d5-4adb-9785-2d4487c4c656,b0bc89a9-c9d5-4adb-9785-2d4487c4c656,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",OPHTHALMIC,NDA,021980,FLUORESCITE,FLUORESCEIN SODIUM,2023/12/14,Diagnostic Dye,1976,ALCON INC,1972/09/15-,0065-0092,93X55PE38X,FLUORESCEIN SODIUM,FLUORESCEIN,TPY09G7XIR,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/ebb3883c-71f6-4fd0-a7e6-0ba8e1136dd9/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ebb3883c-71f6-4fd0-a7e6-0ba8e1136dd9,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=ebb3883c-71f6-4fd0-a7e6-0ba8e1136dd9,ebb3883c-71f6-4fd0-a7e6-0ba8e1136dd9,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRAVENOUS,NDA,022186,AK-FLUOR,FLUORESCEIN SODIUM,2022/09/09,Diagnostic Dye,1976,AKORN,2008/10/01-,17478-250; 17478-253,93X55PE38X,fluorescein sodium,fluorescein,TPY09G7XIR,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/a1823be3-a739-48bc-a3ea-ceb7cc5105ce/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a1823be3-a739-48bc-a3ea-ceb7cc5105ce,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=a1823be3-a739-48bc-a3ea-ceb7cc5105ce,a1823be3-a739-48bc-a3ea-ceb7cc5105ce,,,
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION/ DROPS,OPHTHALMIC,NDA,211039,Fluorescein Sodium and Benoxinate Hydrochloride,FLUORESCEIN SODIUM AND BENOXINATE HYDROCHLORIDE,2022/08/31,Diagnostic Dye,2017,BAUSCH AND LOMB INCORPORATED,2020/03/20-,24208-734,0VE4U49K15; 93X55PE38X,BENOXINATE HYDROCHLORIDE; FLUORESCEIN SODIUM,BENOXINATE; FLUORESCEIN,AXQ0JYM303; TPY09G7XIR,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/1797c5ef-66c4-4cf8-b62d-b484242be2ee/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1797c5ef-66c4-4cf8-b62d-b484242be2ee,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=1797c5ef-66c4-4cf8-b62d-b484242be2ee,1797c5ef-66c4-4cf8-b62d-b484242be2ee,,,
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION,OPHTHALMIC,NDA,208582,ALTAFLUOR,FLUORESCEIN SODIUM AND BENOXINATE HYDROCHLORIDE,2017/12/06,Diagnostic Dye,2017,ALTAIRE PHARMACEUTICALS INC,2018/03/01-,59390-218,0VE4U49K15; 93X55PE38X,BENOXINATE HYDROCHLORIDE; FLUORESCEIN SODIUM,BENOXINATE; FLUORESCEIN,AXQ0JYM303; TPY09G7XIR,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/54017304-e680-4129-b52a-69cb9810af76/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=54017304-e680-4129-b52a-69cb9810af76,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=54017304-e680-4129-b52a-69cb9810af76,54017304-e680-4129-b52a-69cb9810af76,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRAVENOUS,NDA,200655,Fluorodopa F18,FLUORODOPA F18,2021/01/15,,2019,THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH,2019/10/10-,13267-346,2C598205QX,FLUORODOPA F-18,FLUORODOPA F-18,2C598205QX,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/37f8c405-ccb6-4fcd-8513-108956bb1674/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=37f8c405-ccb6-4fcd-8513-108956bb1674,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=37f8c405-ccb6-4fcd-8513-108956bb1674,37f8c405-ccb6-4fcd-8513-108956bb1674,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRAVENOUS,NDA,200655,Fluorodopa F18,FLUORODOPA F18,2019/10/12,,2019,THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH,2019/10/10-,13267-345,2C598205QX,FLUORODOPA F-18,FLUORODOPA F-18,2C598205QX,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/262503e7-de09-4b42-9963-ec00cbc7c35c/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=262503e7-de09-4b42-9963-ec00cbc7c35c,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=262503e7-de09-4b42-9963-ec00cbc7c35c,262503e7-de09-4b42-9963-ec00cbc7c35c,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRAVENOUS,NDA,212155,CERIANNA,FLUOROESTRADIOL F 18,2024/05/10,Radioactive Diagnostic Agent,2020,GE HEALTHCARE INC,2020/05/20-,72874-001,T32277KB09,FLUOROESTRADIOL F-18,FLUOROESTRADIOL F-18,T32277KB09,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/b2c2a2df-cf3e-4a29-a033-231ed5a94b58/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b2c2a2df-cf3e-4a29-a033-231ed5a94b58,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=b2c2a2df-cf3e-4a29-a033-231ed5a94b58,b2c2a2df-cf3e-4a29-a033-231ed5a94b58,,,
HUMAN PRESCRIPTION DRUG LABEL,SUSPENSION/ DROPS,OPHTHALMIC,NDA,019216,FML FORTE,FLUOROMETHOLONE,2023/12/15,Corticosteroid,,ALLERGAN INC,1986/05/01-,11980-228,SV0CSG527L,FLUOROMETHOLONE,FLUOROMETHOLONE,SV0CSG527L,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/b810b4c3-ac7a-4ba5-85bf-ebfaf3b1dabf/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b810b4c3-ac7a-4ba5-85bf-ebfaf3b1dabf,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=b810b4c3-ac7a-4ba5-85bf-ebfaf3b1dabf,b810b4c3-ac7a-4ba5-85bf-ebfaf3b1dabf,,,
HUMAN PRESCRIPTION DRUG LABEL,SUSPENSION/ DROPS,OPHTHALMIC,NDA,016851,FML,FLUOROMETHOLONE,2023/12/15,Corticosteroid,,ALLERGAN INC,1972/02/01-,11980-211,SV0CSG527L,FLUOROMETHOLONE,FLUOROMETHOLONE,SV0CSG527L,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/c374d65a-35b5-4c9e-9069-5148875dc4df/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c374d65a-35b5-4c9e-9069-5148875dc4df,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=c374d65a-35b5-4c9e-9069-5148875dc4df,c374d65a-35b5-4c9e-9069-5148875dc4df,,,
HUMAN PRESCRIPTION DRUG LABEL,SUSPENSION/ DROPS,OPHTHALMIC,NDA,019079,Flarex,FLUOROMETHOLONE ACETATE,2023/10/10,Corticosteroid,,EYEVANCE PHARMACEUTICALS,2019/03/05-,71776-100,9I50C3I3OK,FLUOROMETHOLONE ACETATE,FLUOROMETHOLONE,SV0CSG527L,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/19918ea5-8568-44d6-b8ee-7b2197cee85c/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=19918ea5-8568-44d6-b8ee-7b2197cee85c,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=19918ea5-8568-44d6-b8ee-7b2197cee85c,19918ea5-8568-44d6-b8ee-7b2197cee85c,,,
HUMAN PRESCRIPTION DRUG LABEL,SUSPENSION/ DROPS,OPHTHALMIC,NDA,019079,Flarex,FLUOROMETHOLONE ACETATE,2016/10/10,Corticosteroid,,ALCON LABORATORIES INC,1992/02/06-,0065-0096,9I50C3I3OK,FLUOROMETHOLONE ACETATE,FLUOROMETHOLONE,SV0CSG527L,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/6ae122c0-eb4f-4124-96d7-ba5e9a350d35/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6ae122c0-eb4f-4124-96d7-ba5e9a350d35,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=6ae122c0-eb4f-4124-96d7-ba5e9a350d35,6ae122c0-eb4f-4124-96d7-ba5e9a350d35,,,
HUMAN PRESCRIPTION DRUG LABEL,CREAM; SOLUTION,TOPICAL,NDA,016831,Efudex,FLUOROURACIL,2024/03/01,Nucleoside Metabolic Inhibitor,,BAUSCH HEALTH US LLC,1970/07/29-; completed:1970/07/29-2008/02/28; completed:1970/07/29-2010/01/31,0187-3202; 0187-3203; 0187-3204,U3P01618RT,Fluorouracil,Fluorouracil,U3P01618RT,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/35de1c1c-bef5-46c5-b6f8-ea032147411c/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=35de1c1c-bef5-46c5-b6f8-ea032147411c,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=35de1c1c-bef5-46c5-b6f8-ea032147411c,35de1c1c-bef5-46c5-b6f8-ea032147411c,,,
HUMAN PRESCRIPTION DRUG LABEL,CREAM,TOPICAL,NDA,022259,TOLAK,FLUOROURACIL,2022/09/06,Nucleoside Metabolic Inhibitor,1962,HILL DERMACEUTICALS INC,2015/09/18-,28105-421,U3P01618RT,FLUOROURACIL,FLUOROURACIL,U3P01618RT,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/59de2709-00b8-4f0a-867c-f0dfeb947192/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=59de2709-00b8-4f0a-867c-f0dfeb947192,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=59de2709-00b8-4f0a-867c-f0dfeb947192,59de2709-00b8-4f0a-867c-f0dfeb947192,,,
HUMAN PRESCRIPTION DRUG LABEL,CREAM,TOPICAL,NDA,016988,Fluoroplex,FLUOROURACIL,2022/03/14,Nucleoside Metabolic Inhibitor,,ALMIRALL LLC,1993/12/03-,16110-812,U3P01618RT,FLUOROURACIL,FLUOROURACIL,U3P01618RT,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/258bb79a-56b3-4f46-ade6-7331ec031074/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=258bb79a-56b3-4f46-ade6-7331ec031074,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=258bb79a-56b3-4f46-ade6-7331ec031074,258bb79a-56b3-4f46-ade6-7331ec031074,,,
HUMAN PRESCRIPTION DRUG LABEL,CREAM,TOPICAL,NDA,020985,Carac,FLUOROURACIL,2021/05/17,Nucleoside Metabolic Inhibitor,,BAUSCH HEALTH US LLC,2013/06/28-,0187-5200,U3P01618RT,fluorouracil,fluorouracil,U3P01618RT,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/6795f2b1-1381-4a4f-ad34-2c28ebd1cfaf/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6795f2b1-1381-4a4f-ad34-2c28ebd1cfaf,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=6795f2b1-1381-4a4f-ad34-2c28ebd1cfaf,6795f2b1-1381-4a4f-ad34-2c28ebd1cfaf,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,202133,Fluoxetine HCl,FLUOXETINE HCL,2024/05/01,Serotonin Reuptake Inhibitor,1987,ALMATICA PHARMA INC,completed:2017/09/01-2026/04/01,52427-576,I9W7N6B1KJ,FLUOXETINE HYDROCHLORIDE,FLUOXETINE,01K63SUP8D,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/b47b291f-3340-0c2a-3585-0926b9c1a71f/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b47b291f-3340-0c2a-3585-0926b9c1a71f,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=b47b291f-3340-0c2a-3585-0926b9c1a71f,b47b291f-3340-0c2a-3585-0926b9c1a71f,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,202133,Fluoxetine HCl,FLUOXETINE HCL,2023/12/29,Serotonin Reuptake Inhibitor,1987,TWI PHARMACEUTICALS INC,2024/01/15-,24979-255,I9W7N6B1KJ,FLUOXETINE HYDROCHLORIDE,FLUOXETINE,01K63SUP8D,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/02591302-fe4b-47e8-8dfc-bd1fd1b3764a/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=02591302-fe4b-47e8-8dfc-bd1fd1b3764a,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=02591302-fe4b-47e8-8dfc-bd1fd1b3764a,02591302-fe4b-47e8-8dfc-bd1fd1b3764a,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,NDA,018936,Prozac,FLUOXETINE HYDROCHLORIDE,2023/08/18,Serotonin Reuptake Inhibitor,1987,DISTA PRODUCTS COMPANY,1988/02/01-; 1993/01/13-; 1999/06/15-,0777-3104; 0777-3105; 0777-3107,I9W7N6B1KJ,Fluoxetine hydrochloride,Fluoxetine,01K63SUP8D,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/c88f33ed-6dfb-4c5e-bc01-d8e36dd97299/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c88f33ed-6dfb-4c5e-bc01-d8e36dd97299,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=c88f33ed-6dfb-4c5e-bc01-d8e36dd97299,c88f33ed-6dfb-4c5e-bc01-d8e36dd97299,,,
HUMAN PRESCRIPTION DRUG LABEL,TAPE,TOPICAL,NDA,016455,CORDRAN,FLURANDRENOLIDE,2023/11/10,Corticosteroid,,ALMIRALL LLC,2018/09/24-,16110-587,8EUL29XUQT,Flurandrenolide,Flurandrenolide,8EUL29XUQT,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/837a7b23-ab14-4f23-873d-bdee95177691/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=837a7b23-ab14-4f23-873d-bdee95177691,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=837a7b23-ab14-4f23-873d-bdee95177691,837a7b23-ab14-4f23-873d-bdee95177691,,,
HUMAN PRESCRIPTION DRUG LABEL,CREAM; OINTMENT,TOPICAL,NDA,012806,Cordran,FLURANDRENOLIDE,2023/01/13,Corticosteroid,,ALMIRALL LLC,1965/10/18-; completed:1965/10/18-2021/01/30; completed:2018/10/12-2021/07/30,16110-026; 16110-034; 16110-035,8EUL29XUQT,FLURANDRENOLIDE,FLURANDRENOLIDE,8EUL29XUQT,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/a0949773-c75f-4ef0-a69c-1abd978340d0/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a0949773-c75f-4ef0-a69c-1abd978340d0,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=a0949773-c75f-4ef0-a69c-1abd978340d0,a0949773-c75f-4ef0-a69c-1abd978340d0,,,
HUMAN PRESCRIPTION DRUG LABEL,LOTION,TOPICAL,NDA,013790,Cordran,FLURANDRENOLIDE,2021/08/01,Corticosteroid,,ALMIRALL LLC,1963/03/19-,16110-052,8EUL29XUQT,FLURANDRENOLIDE,FLURANDRENOLIDE,8EUL29XUQT,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/a2fd87ce-cfb2-4118-9274-37974897292a/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a2fd87ce-cfb2-4118-9274-37974897292a,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=a2fd87ce-cfb2-4118-9274-37974897292a,a2fd87ce-cfb2-4118-9274-37974897292a,,,
HUMAN PRESCRIPTION DRUG LABEL,TAPE,TOPICAL,NDA,016455,Cordran,FLURANDRENOLIDE,2019/12/13,Corticosteroid,,ALLERGAN INC,2016/08/15-,0023-5870,8EUL29XUQT,FLURANDRENOLIDE,FLURANDRENOLIDE,8EUL29XUQT,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/a9377de5-a07f-4c9f-bdfe-ba7f13809f14/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a9377de5-a07f-4c9f-bdfe-ba7f13809f14,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=a9377de5-a07f-4c9f-bdfe-ba7f13809f14,a9377de5-a07f-4c9f-bdfe-ba7f13809f14,,,
HUMAN PRESCRIPTION DRUG LABEL,CREAM,TOPICAL,NDA,012806,Flurandrenolide,FLURANDRENOLIDE,2016/04/28,Corticosteroid,,TARO PHARMACEUTICALS U S A INC,2016/04/25-,51672-5301,8EUL29XUQT,Flurandrenolide,Flurandrenolide,8EUL29XUQT,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/89ff5067-af91-4d28-8ce7-8a86f8a080ab/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=89ff5067-af91-4d28-8ce7-8a86f8a080ab,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=89ff5067-af91-4d28-8ce7-8a86f8a080ab,89ff5067-af91-4d28-8ce7-8a86f8a080ab,,,
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION,INTRAVENOUS,NDA,203137,Vizamyl,FLUTEMETAMOL F-18,2023/04/03,Radioactive Diagnostic Agent,2013,MEDI PHYSICS INC DBA GE HEALTHCARE,2014/01/01-,17156-067,L49M066S0O,Flutemetamol F-18,Flutemetamol F-18,L49M066S0O,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/b3558f16-8f9a-4e55-8d9c-836427ebaa57/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b3558f16-8f9a-4e55-8d9c-836427ebaa57,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=b3558f16-8f9a-4e55-8d9c-836427ebaa57,b3558f16-8f9a-4e55-8d9c-836427ebaa57,,,
HUMAN PRESCRIPTION DRUG LABEL,POWDER,INHALATION,NDA,205625,Arnuity Ellipta,FLUTICASONE FUROATE,2023/10/18,Corticosteroid,2014,GLAXOSMITHKLINE LLC,2014/08/20-; 2018/05/17-,0173-0874; 0173-0876; 0173-0888,JS86977WNV,FLUTICASONE FUROATE,FLUTICASONE,CUT2W21N7U,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/50f193ee-1691-486d-9370-a664df63695c/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=50f193ee-1691-486d-9370-a664df63695c,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=50f193ee-1691-486d-9370-a664df63695c,50f193ee-1691-486d-9370-a664df63695c,,,
HUMAN PRESCRIPTION DRUG LABEL,POWDER,INHALATION,NDA,204275,Breo Ellipta,FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE,2023/05/12,Corticosteroid; beta2-Adrenergic Agonist,2013,GLAXOSMITHKLINE LLC,2013/08/26-; 2015/04/30-; 2023/05/12-,0173-0859; 0173-0882; 0173-0916,40AHO2C6DG; JS86977WNV,FLUTICASONE FUROATE; VILANTEROL TRIFENATATE,FLUTICASONE; VILANTEROL,028LZY775B; CUT2W21N7U,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/96428df1-ea05-431a-98d3-1ec2c4b63878/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=96428df1-ea05-431a-98d3-1ec2c4b63878,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=96428df1-ea05-431a-98d3-1ec2c4b63878,96428df1-ea05-431a-98d3-1ec2c4b63878,,,
HUMAN PRESCRIPTION DRUG LABEL,POWDER,INHALATION,NDA,209482,Trelegy Ellipta,"FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE",2023/06/02,Anticholinergic; Corticosteroid; beta2-Adrenergic Agonist,2017,GLAXOSMITHKLINE LLC,2017/09/18-; 2020/09/09-,0173-0887; 0173-0893,40AHO2C6DG; 7AN603V4JV; JS86977WNV,FLUTICASONE FUROATE; UMECLIDINIUM BROMIDE; VILANTEROL TRIFENATATE,FLUTICASONE; UMECLIDINIUM; VILANTEROL,028LZY775B; CUT2W21N7U; GE2T1418SV,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/b5a81d5a-4648-4c7a-951d-33c014a63c7e/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b5a81d5a-4648-4c7a-951d-33c014a63c7e,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=b5a81d5a-4648-4c7a-951d-33c014a63c7e,b5a81d5a-4648-4c7a-951d-33c014a63c7e,,,
HUMAN PRESCRIPTION DRUG LABEL,"SPRAY, METERED",NASAL,NDA,209022,XHANCE,FLUTICASONE PROPIONATE,2024/03/15,Corticosteroid,1994,OPTINOSE US INC,2017/10/03-,71143-375,O2GMZ0LF5W,FLUTICASONE PROPIONATE,FLUTICASONE,CUT2W21N7U,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/c79bbb9f-e483-4093-8c92-ea978e7bf278/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c79bbb9f-e483-4093-8c92-ea978e7bf278,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=c79bbb9f-e483-4093-8c92-ea978e7bf278,c79bbb9f-e483-4093-8c92-ea978e7bf278,,,
HUMAN PRESCRIPTION DRUG LABEL,"AEROSOL, METERED",INHALATION,NDA,021433,FLOVENT HFA,FLUTICASONE PROPIONATE,2023/09/19,Corticosteroid,1994,GLAXOSMITHKLINE LLC,2007/01/25-; 2007/01/29-; 2007/04/06-,0173-0718; 0173-0719; 0173-0720,O2GMZ0LF5W,FLUTICASONE PROPIONATE,FLUTICASONE,CUT2W21N7U,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/b49ed7c1-123e-4b1d-fea6-0c6839fd9d6a/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b49ed7c1-123e-4b1d-fea6-0c6839fd9d6a,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=b49ed7c1-123e-4b1d-fea6-0c6839fd9d6a,b49ed7c1-123e-4b1d-fea6-0c6839fd9d6a,,,
HUMAN PRESCRIPTION DRUG LABEL,"POWDER, METERED",INHALATION,NDA,020833,FLOVENT DISKUS,FLUTICASONE PROPIONATE,2023/08/11,Corticosteroid,1994,GLAXOSMITHKLINE LLC,2007/05/08-; 2008/10/13-,0173-0600; 0173-0601; 0173-0602,O2GMZ0LF5W,FLUTICASONE PROPIONATE,FLUTICASONE,CUT2W21N7U,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/001f22f8-a83d-495f-9196-d0264ef4d76e/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=001f22f8-a83d-495f-9196-d0264ef4d76e,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=001f22f8-a83d-495f-9196-d0264ef4d76e,001f22f8-a83d-495f-9196-d0264ef4d76e,,,
HUMAN PRESCRIPTION DRUG LABEL,"POWDER, METERED",INHALATION,NDA,208798,ArmonAir Digihaler,FLUTICASONE PROPIONATE,2022/04/01,Corticosteroid,1994,TEVA RESPIRATORY LLC,completed:2020/09/15-2024/09/30; completed:2020/09/15-2025/09/30; completed:2020/09/15-2026/01/31,59310-114; 59310-200; 59310-311; 59310-505; 59310-515; 59310-525,O2GMZ0LF5W,FLUTICASONE PROPIONATE,FLUTICASONE,CUT2W21N7U,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/5cea205f-e6d4-45e8-bfcc-a12a6907d5bb/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5cea205f-e6d4-45e8-bfcc-a12a6907d5bb,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=5cea205f-e6d4-45e8-bfcc-a12a6907d5bb,5cea205f-e6d4-45e8-bfcc-a12a6907d5bb,,,
HUMAN PRESCRIPTION DRUG LABEL,"POWDER, METERED",INHALATION,NDA,020833,FLOVENT DISKUS,FLUTICASONE PROPIONATE,2019/04/30,Corticosteroid,,H J HARKINS COMPANY INC,2019/04/23-,76519-1177,O2GMZ0LF5W,FLUTICASONE PROPIONATE,FLUTICASONE,CUT2W21N7U,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/87c7febc-6d0e-874c-e053-2995a90a9656/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=87c7febc-6d0e-874c-e053-2995a90a9656,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=87c7febc-6d0e-874c-e053-2995a90a9656,87c7febc-6d0e-874c-e053-2995a90a9656,,,
HUMAN PRESCRIPTION DRUG LABEL,CREAM,TOPICAL,NDA,019958,Cutivate,FLUTICASONE PROPIONATE,2013/06/25,Corticosteroid,,PHARMADERM A DIVISION OF FOUGERA PHARMACEUTICALS INC,1990/12/18-,10337-332,O2GMZ0LF5W,fluticasone propionate,fluticasone,CUT2W21N7U,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/657aee47-558f-4634-a566-fc81dab2fabc/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=657aee47-558f-4634-a566-fc81dab2fabc,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=657aee47-558f-4634-a566-fc81dab2fabc,657aee47-558f-4634-a566-fc81dab2fabc,,,
HUMAN PRESCRIPTION DRUG LABEL,"POWDER, METERED",INHALATION,NDA,208799,AirDuo Digihaler,FLUTICASONE PROPIONATE AND SALMETEROL,2024/04/29,Corticosteroid; beta2-Adrenergic Agonist,2000,TEVA RESPIRATORY LLC,completed:2020/09/15-2024/08/31; completed:2020/09/15-2025/07/31,59310-111; 59310-129; 59310-136; 59310-510; 59310-520; 59310-530,6EW8Q962A5; O2GMZ0LF5W,FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE,FLUTICASONE; SALMETEROL,2I4BC502BT; CUT2W21N7U,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/ac79cc13-4241-427c-a69b-6b00dafcef00/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ac79cc13-4241-427c-a69b-6b00dafcef00,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=ac79cc13-4241-427c-a69b-6b00dafcef00,ac79cc13-4241-427c-a69b-6b00dafcef00,,,
HUMAN PRESCRIPTION DRUG LABEL,"POWDER, METERED",INHALATION,NDA,208799,AirDuo RespiClick,FLUTICASONE PROPIONATE AND SALMETEROL,2024/02/06,Corticosteroid; beta2-Adrenergic Agonist,2000,TEVA RESPIRATORY LLC,2017/04/12-; 2017/04/20-,59310-805; 59310-812; 59310-822,6EW8Q962A5; O2GMZ0LF5W,FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE,FLUTICASONE; SALMETEROL,2I4BC502BT; CUT2W21N7U,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/9c122b91-a11f-49ca-80bb-3eec5112db87/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9c122b91-a11f-49ca-80bb-3eec5112db87,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=9c122b91-a11f-49ca-80bb-3eec5112db87,9c122b91-a11f-49ca-80bb-3eec5112db87,,,
HUMAN PRESCRIPTION DRUG LABEL,POWDER,INHALATION,NDA,021077,ADVAIR DISKUS,FLUTICASONE PROPIONATE AND SALMETEROL,2023/06/30,Corticosteroid; beta2-Adrenergic Agonist,2000,GLAXOSMITHKLINE LLC,2001/02/05-; 2001/02/28-; 2001/03/05-,0173-0695; 0173-0696; 0173-0697,6EW8Q962A5; O2GMZ0LF5W,FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE,FLUTICASONE; SALMETEROL,2I4BC502BT; CUT2W21N7U,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/4eeb5f6a-593f-4a9e-9692-adefa2caf8fc/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4eeb5f6a-593f-4a9e-9692-adefa2caf8fc,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=4eeb5f6a-593f-4a9e-9692-adefa2caf8fc,4eeb5f6a-593f-4a9e-9692-adefa2caf8fc,,,
HUMAN PRESCRIPTION DRUG LABEL,"AEROSOL, METERED",INHALATION,NDA,021254,ADVAIR HFA,FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE,2023/07/26,Corticosteroid; beta2-Adrenergic Agonist,2000,GLAXOSMITHKLINE LLC,2008/09/29-; 2009/03/06-,0173-0715; 0173-0716; 0173-0717,6EW8Q962A5; O2GMZ0LF5W,FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE,FLUTICASONE; SALMETEROL,2I4BC502BT; CUT2W21N7U,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/dfaca6f9-3277-47b2-319d-1377917cb54c/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=dfaca6f9-3277-47b2-319d-1377917cb54c,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=dfaca6f9-3277-47b2-319d-1377917cb54c,dfaca6f9-3277-47b2-319d-1377917cb54c,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, EXTENDED RELEASE",ORAL,NDA,021192,Lescol XL,FLUVASTATIN SODIUM,2023/11/07,HMG-CoA Reductase Inhibitor,1993,NOVARTIS PHARMACEUTICALS CORPORATION,2000/10/06-,0078-0354,PYF7O1FV7F,FLUVASTATIN SODIUM,FLUVASTATIN,4L066368AS,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/8a1823e7-26fb-4858-bac7-9e152e5ea16a/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8a1823e7-26fb-4858-bac7-9e152e5ea16a,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=8a1823e7-26fb-4858-bac7-9e152e5ea16a,8a1823e7-26fb-4858-bac7-9e152e5ea16a,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRAVENOUS,NDA,020696,Antizol,FOMEPIZOLE,2009/07/27,Antidote,,PALADIN LABORATORIES USA INC,2009/07/31-,46129-200,83LCM6L2BY,FOMEPIZOLE,FOMEPIZOLE,83LCM6L2BY,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/c045b5a8-b220-4f0a-a831-155b29c19454/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c045b5a8-b220-4f0a-a831-155b29c19454,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=c045b5a8-b220-4f0a-a831-155b29c19454,c045b5a8-b220-4f0a-a831-155b29c19454,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",SUBCUTANEOUS,NDA,021345,Arixtra,FONDAPARINUX SODIUM,2020/08/20,Factor Xa Inhibitor,2001,MYLAN INSTITUTIONAL LLC,2015/05/06-; 2015/08/07-; 2015/11/13-; 2016/02/11-,67457-592; 67457-593; 67457-594; 67457-595,X0Q6N9USOZ,FONDAPARINUX SODIUM,FONDAPARINUX,J177FOW5JL,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/d3b30c68-cf45-4b46-8ba6-72090f7ba01a/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d3b30c68-cf45-4b46-8ba6-72090f7ba01a,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=d3b30c68-cf45-4b46-8ba6-72090f7ba01a,d3b30c68-cf45-4b46-8ba6-72090f7ba01a,,,
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION,INHALATION,NDA,022007,Perforomist,FORMOTEROL FUMARATE DIHYDRATE,2019/05/01,beta2-Adrenergic Agonist,2001,MYLAN SPECIALTY L P,2007/10/01-,49502-605,W34SHF8J2K,FORMOTEROL FUMARATE,FORMOTEROL,5ZZ84GCW8B,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/fb2fe258-fe2e-47f6-8adf-ca75bf6f90af/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=fb2fe258-fe2e-47f6-8adf-ca75bf6f90af,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=fb2fe258-fe2e-47f6-8adf-ca75bf6f90af,fb2fe258-fe2e-47f6-8adf-ca75bf6f90af,,,
HUMAN PRESCRIPTION DRUG LABEL,"SUSPENSION; TABLET, FILM COATED",ORAL,NDA,021548;022116,LEXIVA,FOSAMPRENAVIR CALCIUM,2020/10/01,Protease Inhibitor,2003,VIIV HEALTHCARE COMPANY,2010/10/04-,49702-207; 49702-208,ID1GU2627N,FOSAMPRENAVIR CALCIUM,AMPRENAVIR,5S0W860XNR,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/24feb9be-32a6-45fd-a896-f3e202edd8a9/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=24feb9be-32a6-45fd-a896-f3e202edd8a9,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=24feb9be-32a6-45fd-a896-f3e202edd8a9,24feb9be-32a6-45fd-a896-f3e202edd8a9,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRAVENOUS,NDA,216686,FOCINVEZ,FOSAPREPITANT,2023/08/31,Substance P/Neurokinin-1 Receptor Antagonist,2008,SPES PHARMACEUTICALS INC,2023/08/30-,82243-1001,D35FM8T64X,FOSAPREPITANT DIMEGLUMINE,APREPITANT,1NF15YR6UY,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/eb2ec6c7-5f10-49e7-82b3-a4d1ddcc3b14/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=eb2ec6c7-5f10-49e7-82b3-a4d1ddcc3b14,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=eb2ec6c7-5f10-49e7-82b3-a4d1ddcc3b14,eb2ec6c7-5f10-49e7-82b3-a4d1ddcc3b14,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAVENOUS,NDA,022023,EMEND,FOSAPREPITANT DIMEGLUMINE,2022/05/02,Substance P/Neurokinin-1 Receptor Antagonist,2008,MERCK SHARP AND DOHME LLC,2017/02/03-,0006-3061,D35FM8T64X,FOSAPREPITANT DIMEGLUMINE,APREPITANT,1NF15YR6UY,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/8d66803a-6811-4c29-9c57-e16acfa87f21/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8d66803a-6811-4c29-9c57-e16acfa87f21,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=8d66803a-6811-4c29-9c57-e16acfa87f21,8d66803a-6811-4c29-9c57-e16acfa87f21,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAVENOUS,NDA,022023,EMEND,FOSAPREPITANT DIMEGLUMINE,2018/03/26,Substance P/Neurokinin-1 Receptor Antagonist,2008,MERCK SHARP AND DOHME CORP,2010/11/12-; completed:2008/01/25-2012/07/31,0006-3884; 0006-3941,D35FM8T64X,FOSAPREPITANT DIMEGLUMINE,APREPITANT,1NF15YR6UY,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/44f634f4-b794-4d55-8ab7-037fdef8ff0f/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=44f634f4-b794-4d55-8ab7-037fdef8ff0f,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=44f634f4-b794-4d55-8ab7-037fdef8ff0f,44f634f4-b794-4d55-8ab7-037fdef8ff0f,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,020068,Foscavir,FOSCARNET SODIUM,2023/11/02,Pyrophosphate Analog DNA Polymerase Inhibitor,,CLINIGEN LIMITED,2012/07/09-,76310-024,964YS0OOG1,foscarnet sodium,foscarnet,364P9RVW4X,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/a09299d5-9c55-4cef-aed0-3a6a45532289/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a09299d5-9c55-4cef-aed0-3a6a45532289,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=a09299d5-9c55-4cef-aed0-3a6a45532289,a09299d5-9c55-4cef-aed0-3a6a45532289,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,020068,Foscavir,FOSCARNET SODIUM,2023/11/02,Pyrophosphate Analog DNA Polymerase Inhibitor,,CLINIGEN LIMITED,2014/04/01-,76310-024,964YS0OOG1,foscarnet sodium,foscarnet,364P9RVW4X,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/90e3da4e-3b1f-428b-99ca-e4bed1c80028/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=90e3da4e-3b1f-428b-99ca-e4bed1c80028,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=90e3da4e-3b1f-428b-99ca-e4bed1c80028,90e3da4e-3b1f-428b-99ca-e4bed1c80028,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAVENOUS,NDA,214018,Nulibry,FOSDENOPTERIN HYDROBROMIDE,2022/10/28,Cyclic Pyranopterin Monophosphate,2021,SENTYNL THERAPEUTICS INC,2021/03/30-,42358-295,X41B5W735T,fosdenopterin hydrobromide,fosdenopterin,4X7K2681Y7,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/736aeea3-f206-454d-95d0-fd30964e8aab/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=736aeea3-f206-454d-95d0-fd30964e8aab,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=736aeea3-f206-454d-95d0-fd30964e8aab,736aeea3-f206-454d-95d0-fd30964e8aab,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE; INJECTION,INTRAVENOUS; ORAL,NDA,205718;210493,AKYNZEO,FOSNETUPITANT AND PALONOSETRON; NETUPITANT AND PALONOSETRON,2023/12/10,Serotonin-3 Receptor Antagonist; Substance P/Neurokinin-1 Receptor Antagonist,2014,HELSINN THERAPEUTICS U S INC,2014/10/13-; 2018/04/20-; 2020/06/15-; 2023/08/01-,69639-101; 69639-102; 69639-105; 69639-106,23310D4I19; 5D06587D6R; 7732P08TIR; T672P80L2S,FOSNETUPITANT; NETUPITANT; PALONOSETRON; PALONOSETRON HYDROCHLORIDE,FOSNETUPITANT; NETUPITANT; PALONOSETRON,5D06587D6R; 7732P08TIR; T672P80L2S,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/8e47618e-af46-4d82-94e8-1507c042252d/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8e47618e-af46-4d82-94e8-1507c042252d,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=8e47618e-af46-4d82-94e8-1507c042252d,8e47618e-af46-4d82-94e8-1507c042252d,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAMUSCULAR; INTRAVENOUS,NDA,020450,CEREBYX,FOSPHENYTOIN SODIUM,2022/05/10,Anti-epileptic Agent,1996,PFIZER LABORATORIES DIV PFIZER INC,2013/10/28-,0069-5471; 0069-5474,7VLR55452Z,FOSPHENYTOIN SODIUM,PHENYTOIN,6158TKW0C5,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/de5a6711-4abb-4c3d-a18b-266b094ace11/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=de5a6711-4abb-4c3d-a18b-266b094ace11,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=de5a6711-4abb-4c3d-a18b-266b094ace11,de5a6711-4abb-4c3d-a18b-266b094ace11,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAMUSCULAR; INTRAVENOUS,NDA,020450,CEREBYX,FOSPHENYTOIN SODIUM,2022/05/04,Anti-epileptic Agent,1996,PFIZER LABORATORIES DIV PFIZER INC,2013/10/28-,0069-6001,7VLR55452Z,FOSPHENYTOIN SODIUM,PHENYTOIN,6158TKW0C5,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/d4c36fad-0ba2-4cd4-9c5e-dcf843f38a5a/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d4c36fad-0ba2-4cd4-9c5e-dcf843f38a5a,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=d4c36fad-0ba2-4cd4-9c5e-dcf843f38a5a,d4c36fad-0ba2-4cd4-9c5e-dcf843f38a5a,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,209299,TAVALISSE,FOSTAMATINIB,2024/01/02,,2018,RIGEL PHARMACEUTICALS INC,2018/05/09-,71332-001; 71332-002,SQ8A3S5101,FOSTAMATINIB,FOSTAMATINIB,SQ8A3S5101,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/21149cc3-049b-43e2-b141-c9499160556c/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=21149cc3-049b-43e2-b141-c9499160556c,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=21149cc3-049b-43e2-b141-c9499160556c,21149cc3-049b-43e2-b141-c9499160556c,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,NDA,212950,Rukobia,FOSTEMSAVIR TROMETHAMINE,2024/02/13,,2020,VIIV HEALTHCARE COMPANY,2020/07/02-,49702-250,2X513P36U0,FOSTEMSAVIR TROMETHAMINE,TEMSAVIR,4B6J53W8N3,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/a21006b7-6d6f-4f06-81b4-17978756452b/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a21006b7-6d6f-4f06-81b4-17978756452b,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=a21006b7-6d6f-4f06-81b4-17978756452b,a21006b7-6d6f-4f06-81b4-17978756452b,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,021006,Frovatriptan Succinate,FROVATRIPTAN SUCCINATE,2019/01/23,Serotonin-1b and Serotonin-1d Receptor Agonist,2001,PAR PHARMACEUTICAL,2015/10/05-,0603-3718,D28J6W18HY,FROVATRIPTAN SUCCINATE,FROVATRIPTAN,H82Q2D5WA7,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/c21300d7-891f-4e13-9070-d73de1aa1333/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c21300d7-891f-4e13-9070-d73de1aa1333,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=c21300d7-891f-4e13-9070-d73de1aa1333,c21300d7-891f-4e13-9070-d73de1aa1333,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,021006,FROVA,FROVATRIPTAN SUCCINATE,2018/08/27,Serotonin-1b and Serotonin-1d Receptor Agonist,2001,ENDO PHARMACEUTICALS INC,2001/11/08-,63481-025,D28J6W18HY,FROVATRIPTAN SUCCINATE,FROVATRIPTAN,H82Q2D5WA7,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/c0703630-9ce8-4259-841e-71fd2019fa66/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c0703630-9ce8-4259-841e-71fd2019fa66,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=c0703630-9ce8-4259-841e-71fd2019fa66,c0703630-9ce8-4259-841e-71fd2019fa66,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,NDA,217564,Fruzaqla,FRUQUINTINIB,2023/12/21,,2023,TAKEDA PHARMACEUTICALS AMERICA INC,2023/11/08-,63020-210; 63020-225,49DXG3M5ZW,FRUQUINTINIB,FRUQUINTINIB,49DXG3M5ZW,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/186d786e-dc8a-45f2-b5e1-01ac0201879f/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=186d786e-dc8a-45f2-b5e1-01ac0201879f,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=186d786e-dc8a-45f2-b5e1-01ac0201879f,186d786e-dc8a-45f2-b5e1-01ac0201879f,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRAMUSCULAR,NDA,021344,FASLODEX,FULVESTRANT,2020/09/25,Estrogen Receptor Antagonist,2002,ASTRAZENECA PHARMACEUTICALS LP,2010/11/01-,0310-0720,22X328QOC4,FULVESTRANT,FULVESTRANT,22X328QOC4,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/83d7a440-e904-4e36-afb5-cb02b1c919f7/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=83d7a440-e904-4e36-afb5-cb02b1c919f7,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=83d7a440-e904-4e36-afb5-cb02b1c919f7,83d7a440-e904-4e36-afb5-cb02b1c919f7,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,016273,Lasix,FUROSEMIDE,2023/02/13,Loop Diuretic,,VALIDUS PHARMACEUTICALS LLC,1978/04/24-,30698-060; 30698-066; 30698-067,7LXU5N7ZO5,FUROSEMIDE,FUROSEMIDE,7LXU5N7ZO5,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/2c9b4d8f-0770-482d-a9e6-9c616a440b1a/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2c9b4d8f-0770-482d-a9e6-9c616a440b1a,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=2c9b4d8f-0770-482d-a9e6-9c616a440b1a,2c9b4d8f-0770-482d-a9e6-9c616a440b1a,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,SUBCUTANEOUS,NDA,209988,FUROSCIX,FUROSEMIDE INJECTION 80 MG/ 10 ML,2023/11/30,Loop Diuretic,1968,SCPHARMACEUTICALS INC,2022/11/14-,71767-100,7LXU5N7ZO5,FUROSEMIDE,FUROSEMIDE,7LXU5N7ZO5,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/eac958dd-8d43-e44e-e053-2995a90a4d5e/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=eac958dd-8d43-e44e-e053-2995a90a4d5e,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=eac958dd-8d43-e44e-e053-2995a90a4d5e,eac958dd-8d43-e44e-e053-2995a90a4d5e,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,214801,LYTGOBI,FUTIBATINIB,2024/04/23,Kinase Inhibitor,2022,TAIHO PHARMACEUTICAL CO LTD,2023/02/03-,64842-0120,4B93MGE4AL,FUTIBATINIB,FUTIBATINIB,4B93MGE4AL,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/0b1332a1-0581-4707-9bf6-1eccfa39bef4/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0b1332a1-0581-4707-9bf6-1eccfa39bef4,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=0b1332a1-0581-4707-9bf6-1eccfa39bef4,0b1332a1-0581-4707-9bf6-1eccfa39bef4,,,
HUMAN PRESCRIPTION DRUG LABEL,"KIT; TABLET, FILM COATED",ORAL,NDA,022544,Gralise,GABAPENTIN,2023/03/01,,1993,ALMATICA PHARMA LLC,2020/10/01-; 2023/04/20-; completed:2020/10/01-2024/08/01,52427-803; 52427-804; 52427-806; 52427-815; 52427-850; 52427-890,6CW7F3G59X,GABAPENTIN,GABAPENTIN,6CW7F3G59X,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/466273b1-c9fc-3930-c94b-aa11394d5140/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=466273b1-c9fc-3930-c94b-aa11394d5140,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=466273b1-c9fc-3930-c94b-aa11394d5140,466273b1-c9fc-3930-c94b-aa11394d5140,,,
HUMAN PRESCRIPTION DRUG LABEL,"CAPSULE; SOLUTION; TABLET, FILM COATED",ORAL,NDA,020235;020882;021129,Neurontin,GABAPENTIN,2022/07/12,,1993,PARKE DAVIS DIV OF PFIZER INC,1993/12/30-; 1998/10/09-; 2000/03/02-,0071-0401; 0071-0513; 0071-0803; 0071-0805; 0071-0806; 0071-2012,6CW7F3G59X,GABAPENTIN,GABAPENTIN,6CW7F3G59X,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/ee9ad9ed-6d9f-4ee1-9d7f-cfad438df388/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ee9ad9ed-6d9f-4ee1-9d7f-cfad438df388,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=ee9ad9ed-6d9f-4ee1-9d7f-cfad438df388,ee9ad9ed-6d9f-4ee1-9d7f-cfad438df388,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, EXTENDED RELEASE",ORAL,NDA,022399,Horizant,GABAPENTIN ENACARBIL,2023/08/29,,2011,AZURITY PHARMACEUTICALS INC FORMERLY ARBOR PHARMACEUTICALS,2013/05/01-,53451-0101; 53451-0103,75OCL1SPBQ,gabapentin enacarbil,gabapentin,6CW7F3G59X,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/4c486fc7-c8c4-4c6c-b30c-366dabaeaadd/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4c486fc7-c8c4-4c6c-b30c-366dabaeaadd,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=4c486fc7-c8c4-4c6c-b30c-366dabaeaadd,4c486fc7-c8c4-4c6c-b30c-366dabaeaadd,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,021358,MultiHance,GADOBENATE DIMEGLUMINE,2024/01/24,Gadolinium-based Contrast Agent,2004,BRACCO DIAGNOSTICS INC,2004/11/23-,0270-5264,3Q6PPC19PO,gadobenate dimeglumine,GADOLINIUM CATION (3+),AZV954TZ9N,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/f63abe56-46d9-4e32-afb1-f4e22370717d/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f63abe56-46d9-4e32-afb1-f4e22370717d,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=f63abe56-46d9-4e32-afb1-f4e22370717d,f63abe56-46d9-4e32-afb1-f4e22370717d,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,021357,MultiHance,GADOBENATE DIMEGLUMINE,2024/01/23,Gadolinium-based Contrast Agent,2004,BRACCO DIAGNOSTICS INC,2004/11/23-,0270-5164,3Q6PPC19PO,gadobenate dimeglumine,GADOLINIUM CATION (3+),AZV954TZ9N,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/59077a3e-5f03-4342-ae24-856267545631/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=59077a3e-5f03-4342-ae24-856267545631,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=59077a3e-5f03-4342-ae24-856267545631,59077a3e-5f03-4342-ae24-856267545631,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRAVENOUS,NDA,201277,Gadavist,GADOBUTROL,2024/01/30,Gadolinium-based Contrast Agent,2011,BAYER HEALTHCARE PHARMACEUTICALS INC,2011/03/14-,50419-325,1BJ477IO2L,GADOBUTROL,GADOLINIUM CATION (3+),AZV954TZ9N,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/bd28560f-de4d-4140-874e-31df823f4dbb/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=bd28560f-de4d-4140-874e-31df823f4dbb,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=bd28560f-de4d-4140-874e-31df823f4dbb,bd28560f-de4d-4140-874e-31df823f4dbb,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRAVENOUS,NDA,201277,Gadavist,GADOBUTROL,2024/01/30,Gadolinium-based Contrast Agent,2011,BAYER HEALTHCARE PHARMACEUTICALS INC,2011/03/14-,50419-325,1BJ477IO2L,GADOBUTROL,GADOLINIUM CATION (3+),AZV954TZ9N,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/b7afe34d-b70f-41a5-b89c-561bdf29f046/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b7afe34d-b70f-41a5-b89c-561bdf29f046,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=b7afe34d-b70f-41a5-b89c-561bdf29f046,b7afe34d-b70f-41a5-b89c-561bdf29f046,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRAVENOUS,NDA,201277,Gadavist,GADOBUTROL,2024/01/30,Gadolinium-based Contrast Agent,2011,BAYER HEALTHCARE PHARMACEUTICALS INC,2011/03/14-,50419-325,1BJ477IO2L,GADOBUTROL,GADOLINIUM CATION (3+),AZV954TZ9N,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/3c5101a0-0c7e-4078-8dc3-a57beb9a0e92/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3c5101a0-0c7e-4078-8dc3-a57beb9a0e92,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=3c5101a0-0c7e-4078-8dc3-a57beb9a0e92,3c5101a0-0c7e-4078-8dc3-a57beb9a0e92,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRAVENOUS,NDA,020123,OMNISCAN,GADODIAMIDE,2024/02/06,Paramagnetic Contrast Agent,1993,GE HEALTHCARE INC,2002/04/19-; completed:2006/09/21-2019/11/30,0407-0690; 0407-0691,84F6U3J2R6,GADODIAMIDE,GADODIAMIDE,84F6U3J2R6,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/1e9a37e2-f28a-4373-bf0f-3e9b60f42d8a/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1e9a37e2-f28a-4373-bf0f-3e9b60f42d8a,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=1e9a37e2-f28a-4373-bf0f-3e9b60f42d8a,1e9a37e2-f28a-4373-bf0f-3e9b60f42d8a,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRAVENOUS,NDA,020123,OMNISCAN,GADODIAMIDE,2024/01/10,Paramagnetic Contrast Agent,1993,GE HEALTHCARE INC,2010/06/01-,0407-0690,84F6U3J2R6,gadodiamide,gadodiamide,84F6U3J2R6,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/d539c8b2-13fe-4ba2-994e-b4d0ee1ef490/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d539c8b2-13fe-4ba2-994e-b4d0ee1ef490,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=d539c8b2-13fe-4ba2-994e-b4d0ee1ef490,d539c8b2-13fe-4ba2-994e-b4d0ee1ef490,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRAVENOUS,NDA,216986,Vueway,GADOPICLENOL,2024/01/25,,2022,BRACCO DIAGNOSTICS INC,2022/09/21-,0270-7015; 0270-7020; 0270-7025; 0270-7030; 0270-7035,S276568KOY,GADOPICLENOL,Gadopiclenol,S276568KOY,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/192725e9-e83e-1a36-33f2-abee55792ab3/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=192725e9-e83e-1a36-33f2-abee55792ab3,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=192725e9-e83e-1a36-33f2-abee55792ab3,192725e9-e83e-1a36-33f2-abee55792ab3,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRAVENOUS,NDA,216986,ELUCIREM,GADOPICLENOL,2024/01/05,,2022,GUERBET LLC,2022/09/21-,67684-4230; 67684-4231; 67684-4232; 67684-4233; 67684-4240; 67684-4241; 67684-4242; 67684-4250,S276568KOY,Gadopiclenol,Gadopiclenol,S276568KOY,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/ca582f31-1042-487f-82e4-533f1b541902/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ca582f31-1042-487f-82e4-533f1b541902,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=ca582f31-1042-487f-82e4-533f1b541902,ca582f31-1042-487f-82e4-533f1b541902,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRAVENOUS,NDA,204781,DOTAREM,GADOTERATE MEGLUMINE,2024/01/08,Gadolinium-based Contrast Agent,2013,GUERBET LLC,2013/03/20-; 2019/09/18-,67684-2000; 67684-2001; 67684-3001,L0ND3981AG,GADOTERATE MEGLUMINE,GADOLINIUM CATION (3+),AZV954TZ9N,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/e2c4a5ac-2df2-4cf4-a2d3-6fbe2d898ebc/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e2c4a5ac-2df2-4cf4-a2d3-6fbe2d898ebc,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=e2c4a5ac-2df2-4cf4-a2d3-6fbe2d898ebc,e2c4a5ac-2df2-4cf4-a2d3-6fbe2d898ebc,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRAVENOUS,NDA,204781,DOTAREM,GADOTERATE MEGLUMINE,2024/01/07,Gadolinium-based Contrast Agent,2013,GUERBET LLC,2013/04/26-,67684-2000; 67684-2001,L0ND3981AG,gadoterate meglumine,GADOLINIUM CATION (3+),AZV954TZ9N,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/82b83e61-6af8-4225-aa39-8cbf206f65b0/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=82b83e61-6af8-4225-aa39-8cbf206f65b0,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=82b83e61-6af8-4225-aa39-8cbf206f65b0,82b83e61-6af8-4225-aa39-8cbf206f65b0,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,020131,ProHance,GADOTERIDOL,2024/01/24,Paramagnetic Contrast Agent,1992,BRACCO DIAGNOSTICS INC,1992/11/16-,0270-1111,0199MV609F,gadoteridol,gadoteridol,0199MV609F,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/778aee03-7d4c-481a-be8a-a75db0702f5a/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=778aee03-7d4c-481a-be8a-a75db0702f5a,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=778aee03-7d4c-481a-be8a-a75db0702f5a,778aee03-7d4c-481a-be8a-a75db0702f5a,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,021489,ProHance,GADOTERIDOL,2024/01/24,Paramagnetic Contrast Agent,2003,BRACCO DIAGNOSTICS INC,2003/10/09-,0270-1111,0199MV609F,gadoteridol,gadoteridol,0199MV609F,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/e8b76200-c0aa-491b-aad7-e22d2f68496f/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e8b76200-c0aa-491b-aad7-e22d2f68496f,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=e8b76200-c0aa-491b-aad7-e22d2f68496f,e8b76200-c0aa-491b-aad7-e22d2f68496f,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,022090,EOVIST,GADOXETATE DISODIUM,2024/01/30,Gadolinium-based Contrast Agent,2008,BAYER HEALTHCARE PHARMACEUTICALS INC,2008/07/03-,50419-320,HOY74VZE0M,GADOXETATE DISODIUM,GADOLINIUM CATION (3+),AZV954TZ9N,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/6218b1e1-cbc3-4c14-bec7-528ac163a561/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6218b1e1-cbc3-4c14-bec7-528ac163a561,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=6218b1e1-cbc3-4c14-bec7-528ac163a561,6218b1e1-cbc3-4c14-bec7-528ac163a561,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,021169,Galantamine Hydrobromide,GALANTAMINE HYDROBROMIDE,2015/05/15,Cholinesterase Inhibitor,2001,YABAO PHARMACEUTICAL CO LTD BEIJING,2001/03/01-,51990-111; 51990-112; 51990-113,MJ4PTD2VVW,galantamine hydrobromide,galantamine,0D3Q044KCA,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/7dc963dd-84d6-45f3-857f-46a44fe9edc8/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7dc963dd-84d6-45f3-857f-46a44fe9edc8,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=7dc963dd-84d6-45f3-857f-46a44fe9edc8,7dc963dd-84d6-45f3-857f-46a44fe9edc8,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,212643,Gallium Ga-68 PSMA-11,GALLIUM GA-68 GOZETOTIDE,2023/11/08,Radioactive Diagnostic Agent,2020,UCSF RADIOPHARMACEUTICAL FACILITY,2020/12/14-,24275-0525,ZJ0EKR6M10,GALLIUM GA-68 GOZETOTIDE,GALLIUM GA-68 GOZETOTIDE,ZJ0EKR6M10,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/b6253a7b-0f73-36be-e053-2a95a90a9015/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b6253a7b-0f73-36be-e053-2a95a90a9015,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=b6253a7b-0f73-36be-e053-2a95a90a9015,b6253a7b-0f73-36be-e053-2a95a90a9015,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,212642,Gallium Ga-68 PSMA-11,GALLIUM GA-68 GOZETOTIDE,2022/12/01,Radioactive Diagnostic Agent,2020,UCLA BIOMEDICAL CYCLOTRON,2020/12/09-,76394-2642,ZJ0EKR6M10,GALLIUM GA-68 GOZETOTIDE,GALLIUM GA-68 GOZETOTIDE,ZJ0EKR6M10,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/7744bafb-755e-29a2-e053-2991aa0a86a9/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7744bafb-755e-29a2-e053-2991aa0a86a9,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=7744bafb-755e-29a2-e053-2991aa0a86a9,7744bafb-755e-29a2-e053-2991aa0a86a9,,,
HUMAN PRESCRIPTION DRUG LABEL,SUSPENSION,ORAL,NDA,215904,ZTALMY,GANAXOLONE,2024/04/30,Neuroactive Steroid Gamma-Aminobutyric Acid A Receptor Positive Modulator,2022,MARINUS PHARMACEUTICALS INC,2022/06/06-,81583-100,98WI44OHIQ,ganaxolone,ganaxolone,98WI44OHIQ,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/d91612c4-b03a-4be4-a1ee-6a13e3b83d4e/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d91612c4-b03a-4be4-a1ee-6a13e3b83d4e,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=d91612c4-b03a-4be4-a1ee-6a13e3b83d4e,d91612c4-b03a-4be4-a1ee-6a13e3b83d4e,,,
HUMAN PRESCRIPTION DRUG LABEL,GEL,OPHTHALMIC,NDA,022211,ZIRGAN,GANCICLOVIR,2024/02/27,Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor; Nucleoside Analog Antiviral,1989,BAUSCH AND LOMB INCORPORATED,2010/04/30-,24208-535,P9G3CKZ4P5,GANCICLOVIR,GANCICLOVIR,P9G3CKZ4P5,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/ea25e7ac-7a93-4ec8-975b-2cec197e1c27/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ea25e7ac-7a93-4ec8-975b-2cec197e1c27,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=ea25e7ac-7a93-4ec8-975b-2cec197e1c27,ea25e7ac-7a93-4ec8-975b-2cec197e1c27,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,209347,GANCICLOVIR,GANCICLOVIR,2017/10/06,Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor; Nucleoside Analog Antiviral,1989,EXELA PHARMA SCIENCES LLC,2017/02/28-,51754-2500,P9G3CKZ4P5,GANCICLOVIR,GANCICLOVIR,P9G3CKZ4P5,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/26361de8-39b5-4266-90f6-2b307940135d/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=26361de8-39b5-4266-90f6-2b307940135d,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=26361de8-39b5-4266-90f6-2b307940135d,26361de8-39b5-4266-90f6-2b307940135d,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",SUBCUTANEOUS,NDA,021057,Ganirelix Acetate,GANIRELIX ACETATE,2024/02/16,Gonadotropin Releasing Hormone Receptor Antagonist,,ORGANON LLC,2021/06/01-,78206-138,56U7906FQW,Ganirelix Acetate,ganirelix,IX503L9WN0,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/32fb74ff-993a-49fe-8943-e029372b863e/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=32fb74ff-993a-49fe-8943-e029372b863e,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=32fb74ff-993a-49fe-8943-e029372b863e,32fb74ff-993a-49fe-8943-e029372b863e,,,
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION/ DROPS,OPHTHALMIC,NDA,022548,ZYMAXID,GATIFLOXACIN,2016/09/01,Quinolone Antimicrobial,1999,ALLERGAN INC,2010/05/19-,0023-3615,L4618BD7KJ,GATIFLOXACIN,GATIFLOXACIN ANHYDROUS,81485Y3A9A,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/1160b16c-929a-4e85-9c0b-1d8c96a7678b/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1160b16c-929a-4e85-9c0b-1d8c96a7678b,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=1160b16c-929a-4e85-9c0b-1d8c96a7678b,1160b16c-929a-4e85-9c0b-1d8c96a7678b,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, COATED",ORAL,NDA,206995,IRESSA,GEFITINIB,2023/02/28,Kinase Inhibitor,2015,ASTRAZENECA PHARMACEUTICALS LP,2015/07/13-,0310-0482,S65743JHBS,GEFITINIB,GEFITINIB,S65743JHBS,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/827d60e8-7e07-41b7-c28b-49ef1c4a5a41/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=827d60e8-7e07-41b7-c28b-49ef1c4a5a41,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=827d60e8-7e07-41b7-c28b-49ef1c4a5a41,827d60e8-7e07-41b7-c28b-49ef1c4a5a41,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,209604,GEMCITABINE,GEMCITABINE,2023/09/11,Nucleoside Metabolic Inhibitor,1996,BLUEPOINT LABORATORIES,2018/05/25-; completed:2018/05/25-2018/05/26,68001-342; 68001-348; 68001-350; 68001-359,U347PV74IL,GEMCITABINE HYDROCHLORIDE,GEMCITABINE,B76N6SBZ8R,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/4031017d-d768-46de-8081-476bcb883f5e/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4031017d-d768-46de-8081-476bcb883f5e,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=4031017d-d768-46de-8081-476bcb883f5e,4031017d-d768-46de-8081-476bcb883f5e,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,200795,Gemcitabine,GEMCITABINE,2023/08/15,Nucleoside Metabolic Inhibitor,1996,HOSPIRA INC,2011/08/22-; 2011/08/24-; 2011/08/26-,0409-0181; 0409-0182; 0409-0183,U347PV74IL,GEMCITABINE HYDROCHLORIDE,GEMCITABINE,B76N6SBZ8R,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/dc02a23b-3ff9-4441-aa91-8e9e629a7315/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=dc02a23b-3ff9-4441-aa91-8e9e629a7315,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=dc02a23b-3ff9-4441-aa91-8e9e629a7315,dc02a23b-3ff9-4441-aa91-8e9e629a7315,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,209604,GEMCITABINE,GEMCITABINE,2022/11/05,Nucleoside Metabolic Inhibitor,1996,ACCORD HEALTHCARE INC,2018/01/24-; 2018/01/25-; 2018/08/06-,16729-391; 16729-419; 16729-423; 16729-426,U347PV74IL,GEMCITABINE HYDROCHLORIDE,GEMCITABINE,B76N6SBZ8R,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/5a335d36-408b-478f-9563-4bc140b69bb6/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5a335d36-408b-478f-9563-4bc140b69bb6,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=5a335d36-408b-478f-9563-4bc140b69bb6,5a335d36-408b-478f-9563-4bc140b69bb6,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,200795,Gemcitabine,GEMCITABINE,2020/03/09,Nucleoside Metabolic Inhibitor,1996,HOSPIRA INC,2013/07/09-; 2013/07/29-,0409-0181; 0409-0182; 0409-0183,U347PV74IL,GEMCITABINE HYDROCHLORIDE,GEMCITABINE,B76N6SBZ8R,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/e18ed1cb-7dd0-4001-bfda-17d1f4587fb8/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e18ed1cb-7dd0-4001-bfda-17d1f4587fb8,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=e18ed1cb-7dd0-4001-bfda-17d1f4587fb8,e18ed1cb-7dd0-4001-bfda-17d1f4587fb8,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,018422,Lopid,GEMFIBROZIL,2023/08/31,Peroxisome Proliferator Receptor alpha Agonist,,PARKE DAVIS DIV OF PFIZER INC,2004/03/30-,0071-0737,Q8X02027X3,GEMFIBROZIL,GEMFIBROZIL,Q8X02027X3,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/c48855b7-215e-453b-b3b1-a0f9dee7221f/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c48855b7-215e-453b-b3b1-a0f9dee7221f,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=c48855b7-215e-453b-b3b1-a0f9dee7221f,c48855b7-215e-453b-b3b1-a0f9dee7221f,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,021158,FACTIVE,GEMIFLOXACIN MESYLATE,2016/08/01,Quinolone Antimicrobial,,MERUS LABS INTERNATIONAL INC,2003/04/04-,44001-321,X4S9F8RL01,GEMIFLOXACIN MESYLATE,GEMIFLOXACIN,OKR68Y0E4T,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/63f60426-e27f-4258-9bfc-b4a15ebdca83/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=63f60426-e27f-4258-9bfc-b4a15ebdca83,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=63f60426-e27f-4258-9bfc-b4a15ebdca83,63f60426-e27f-4258-9bfc-b4a15ebdca83,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,021158,FACTIVE,GEMIFLOXACIN MESYLATE,2013/10/28,Quinolone Antimicrobial,,VANSEN PHARMA INC,2003/04/04-,44004-321,X4S9F8RL01,GEMIFLOXACIN MESYLATE,GEMIFLOXACIN,OKR68Y0E4T,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/4502217c-3424-4453-a3ab-4bb2c35d2f0a/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4502217c-3424-4453-a3ab-4bb2c35d2f0a,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=4502217c-3424-4453-a3ab-4bb2c35d2f0a,4502217c-3424-4453-a3ab-4bb2c35d2f0a,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, EXTENDED RELEASE",ORAL,NDA,021164,EXXUA,GEPIRONE,2024/02/12,,2023,FABRE KRAMER PHARMACEUTICALS INC,2024/01/01-,83504-150; 83504-151; 83504-152; 83504-153,80C9L8EP6V,GEPIRONE HYDROCHLORIDE,GEPIRONE,JW5Y7B8Z18,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/28b360dc-6337-4cae-a5bb-79f974b5a3b2/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=28b360dc-6337-4cae-a5bb-79f974b5a3b2,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=28b360dc-6337-4cae-a5bb-79f974b5a3b2,28b360dc-6337-4cae-a5bb-79f974b5a3b2,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,211349,Xospata,GILTERITINIB,2022/01/01,,2018,ASTELLAS PHARMA US INC,2018/11/29-,0469-1425,5RZZ0Z1GJT,GILTERITINIB FUMARATE,GILTERITINIB,66D92MGC8M,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/b5ff59aa-9c0d-49a8-9053-1f179b482383/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b5ff59aa-9c0d-49a8-9053-1f179b482383,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=b5ff59aa-9c0d-49a8-9053-1f179b482383,b5ff59aa-9c0d-49a8-9053-1f179b482383,,,
HUMAN PRESCRIPTION DRUG LABEL,SUSPENSION,ORAL,NDA,217865,DUVYZAT,GIVINOSTAT,2024/03/29,,2024,ITALFARMACO SPA,2024/03/21-,11797-110,5P60F84FBH,GIVINOSTAT,GIVINOSTAT,5P60F84FBH,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/1a28a3db-7880-4ac2-a2f2-2b4e362aafb6/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1a28a3db-7880-4ac2-a2f2-2b4e362aafb6,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=1a28a3db-7880-4ac2-a2f2-2b4e362aafb6,1a28a3db-7880-4ac2-a2f2-2b4e362aafb6,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",SUBCUTANEOUS,NDA,212194,GIVLAARI,GIVOSIRAN SODIUM,2024/04/30,Aminolevulinate Synthase 1-directed RNA Interaction; Small Interfering RNA,2019,ALNYLAM PHARMACEUTICALS INC,2019/12/12-,71336-1001,5XE21E41RT,givosiran sodium,givosiran,ROV204583W,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/167e663c-11e1-497b-a3fc-951d65d58eaa/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=167e663c-11e1-497b-a3fc-951d65d58eaa,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=167e663c-11e1-497b-a3fc-951d65d58eaa,167e663c-11e1-497b-a3fc-951d65d58eaa,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,210656,Daurismo,GLASDEGIB,2023/11/02,Hedgehog Pathway Inhibitor,2018,PFIZER LABORATORIES DIV PFIZER INC,2018/12/10-,0069-0298; 0069-1531,K673DMO5H9,GLASDEGIB,GLASDEGIB,K673DMO5H9,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/204a6f7e-c9a4-472b-abd2-9527bda64d17/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=204a6f7e-c9a4-472b-abd2-9527bda64d17,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=204a6f7e-c9a4-472b-abd2-9527bda64d17,204a6f7e-c9a4-472b-abd2-9527bda64d17,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",SUBCUTANEOUS,NDA,020622,Copaxone,GLATIRAMER ACETATE,2023/11/20,,1996,TEVA NEUROSCIENCE INC,2008/04/28-; 2014/01/29-,68546-317; 68546-325,5M691HL4BO,GLATIRAMER ACETATE,GLATIRAMER,U782C039QP,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/aa88f583-4f5f-433b-80b4-1f4c9fb28357/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=aa88f583-4f5f-433b-80b4-1f4c9fb28357,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=aa88f583-4f5f-433b-80b4-1f4c9fb28357,aa88f583-4f5f-433b-80b4-1f4c9fb28357,,,
HUMAN PRESCRIPTION DRUG LABEL,"PELLET; TABLET, FILM COATED",ORAL,NDA,209394;215110,Mavyret,GLECAPREVIR AND PIBRENTASVIR,2023/10/10,Hepatitis C Virus NS3/4A Protease Inhibitor; Hepatitis C Virus NS5A Inhibitor,2017,ABBVIE INC,2017/08/03-; 2021/06/10-,0074-2600; 0074-2625,2WU922TK3L; K6BUU8J72P,GLECAPREVIR; PIBRENTASVIR,GLECAPREVIR; PIBRENTASVIR,2WU922TK3L; K6BUU8J72P,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/7bf99777-0401-9095-8645-16c6e907fcc0/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7bf99777-0401-9095-8645-16c6e907fcc0,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=7bf99777-0401-9095-8645-16c6e907fcc0,7bf99777-0401-9095-8645-16c6e907fcc0,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, EXTENDED RELEASE",ORAL,NDA,020329,Glucotrol XL,GLIPIZIDE,2024/05/15,Sulfonylurea,1994,ROERIG,2013/05/09-; completed:2013/07/15-2023/12/31,0049-0170; 0049-0174; 0049-0178,X7WDT95N5C,GLIPIZIDE,GLIPIZIDE,X7WDT95N5C,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/eed99b60-d043-4249-9b2a-f05e46fb588d/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=eed99b60-d043-4249-9b2a-f05e46fb588d,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=eed99b60-d043-4249-9b2a-f05e46fb588d,eed99b60-d043-4249-9b2a-f05e46fb588d,,,
HUMAN PRESCRIPTION DRUG LABEL,POWDER,NASAL,NDA,210134,Baqsimi,GLUCAGON,2024/03/15,Antihypoglycemic Agent; Gastrointestinal Motility Inhibitor,1960,AMPHASTAR PHARMACEUTICALS INC,2019/07/24-,0548-8351; 0548-8352,76LA80IG2G,glucagon,glucagon,76LA80IG2G,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/f1f5df9b-872f-44e5-a18f-f0b68e7e9254/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f1f5df9b-872f-44e5-a18f-f0b68e7e9254,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=f1f5df9b-872f-44e5-a18f-f0b68e7e9254,f1f5df9b-872f-44e5-a18f-f0b68e7e9254,,,
HUMAN PRESCRIPTION DRUG LABEL,KIT,INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS,NDA,020928,Glucagon,GLUCAGON,2023/05/15,Antihypoglycemic Agent; Gastrointestinal Motility Inhibitor,1960,ELI LILLY AND COMPANY,1999/03/01-,0002-8031,76LA80IG2G,glucagon,glucagon,76LA80IG2G,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/f143db10-e889-41c3-84ed-603a0ab02f61/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f143db10-e889-41c3-84ed-603a0ab02f61,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=f143db10-e889-41c3-84ed-603a0ab02f61,f143db10-e889-41c3-84ed-603a0ab02f61,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION; KIT",INTRAMUSCULAR; INTRAVENOUS,NDA,201849,Glucagon,GLUCAGON,2022/04/01,Antihypoglycemic Agent; Gastrointestinal Motility Inhibitor,1998,FRESENIUS KABI USA LLC,2015/05/08-; 2015/12/01-,63323-594; 63323-596,059QF0KO0R; 1H87NVF4DB,GLUCAGON HYDROCHLORIDE; WATER,GLUCAGON; WATER,059QF0KO0R; 76LA80IG2G,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/8c8acad6-44cc-43aa-966b-027e053be8f5/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8c8acad6-44cc-43aa-966b-027e053be8f5,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=8c8acad6-44cc-43aa-966b-027e053be8f5,8c8acad6-44cc-43aa-966b-027e053be8f5,,,
HUMAN PRESCRIPTION DRUG LABEL,KIT,INTRAMUSCULAR; INTRAVENOUS,NDA,201849,Glucagon,GLUCAGON,2021/11/10,Antihypoglycemic Agent; Gastrointestinal Motility Inhibitor,1960,FRESENIUS KABI USA LLC,2019/09/09-,63323-582,059QF0KO0R; 1H87NVF4DB,GLUCAGON HYDROCHLORIDE; WATER,GLUCAGON; WATER,059QF0KO0R; 76LA80IG2G,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/c5c431b4-5618-4ff4-954e-4c0fbfed67b6/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c5c431b4-5618-4ff4-954e-4c0fbfed67b6,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=c5c431b4-5618-4ff4-954e-4c0fbfed67b6,c5c431b4-5618-4ff4-954e-4c0fbfed67b6,,,
HUMAN PRESCRIPTION DRUG LABEL,POWDER,NASAL,NDA,210134,Baqsimi,GLUCAGON,2021/08/16,Antihypoglycemic Agent; Gastrointestinal Motility Inhibitor,1960,ELI LILLY AND COMPANY,2019/07/24-,0002-6145,76LA80IG2G,glucagon,glucagon,76LA80IG2G,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/3fdb4e92-2e19-487d-9f14-99871e9fd15a/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3fdb4e92-2e19-487d-9f14-99871e9fd15a,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=3fdb4e92-2e19-487d-9f14-99871e9fd15a,3fdb4e92-2e19-487d-9f14-99871e9fd15a,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION; KIT",INTRAMUSCULAR; INTRAVENOUS,NDA,201849,Glucagon,GLUCAGON,2020/09/16,Antihypoglycemic Agent; Gastrointestinal Motility Inhibitor,1960,FRESENIUS KABI USA LLC,2015/05/08-,63323-593; 63323-596,059QF0KO0R; 1H87NVF4DB,GLUCAGON HYDROCHLORIDE; WATER,GLUCAGON; WATER,059QF0KO0R; 76LA80IG2G,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/e4be1c0e-0fe6-45a0-9229-5cde98434b84/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e4be1c0e-0fe6-45a0-9229-5cde98434b84,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=e4be1c0e-0fe6-45a0-9229-5cde98434b84,e4be1c0e-0fe6-45a0-9229-5cde98434b84,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, POWDER, FOR SOLUTION; KIT",INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS,NDA,020918,GlucaGen,GLUCAGON HYDROCHLORIDE,2021/07/20,Antihypoglycemic Agent; Gastrointestinal Motility Inhibitor,1960,BOEHRINGER INGELHEIM PHARMACEUTICALS INC,2005/06/22-,0597-0053; 0597-0260,1H87NVF4DB,GLUCAGON HYDROCHLORIDE,GLUCAGON; glucagon,76LA80IG2G,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/ff16e4b1-3668-4cb4-91a4-77ee509cd6f6/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ff16e4b1-3668-4cb4-91a4-77ee509cd6f6,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=ff16e4b1-3668-4cb4-91a4-77ee509cd6f6,ff16e4b1-3668-4cb4-91a4-77ee509cd6f6,,,
HUMAN PRESCRIPTION DRUG LABEL,KIT,INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS,NDA,020918,GlucaGen HypoKit,GLUCAGON HYDROCHLORIDE,2021/03/19,Antihypoglycemic Agent; Gastrointestinal Motility Inhibitor,1960,NOVO NORDISK,2005/06/22-,0169-7065,1H87NVF4DB,GLUCAGON HYDROCHLORIDE,GLUCAGON,76LA80IG2G,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/f09feb8e-6651-4708-a811-bb5264712059/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f09feb8e-6651-4708-a811-bb5264712059,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=f09feb8e-6651-4708-a811-bb5264712059,f09feb8e-6651-4708-a811-bb5264712059,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",SUBCUTANEOUS,NDA,212097,Gvoke HypoPen 0.5 mg Auto-Injector; Gvoke HypoPen 1 mg Auto-Injector; Gvoke Kit; Gvoke Kit Vial; Gvoke PFS 0.5 mg Pre-filled Syringe; Gvoke PFS 1 mg Pre-filled Syringe,"GLUCAGON INJECTION, SOLUTION",2023/12/29,Antihypoglycemic Agent; Gastrointestinal Motility Inhibitor,1960,XERIS PHARMACEUTICALS INC,2019/09/10-; 2021/10/11-; completed:2019/09/10-2023/01/30,72065-120; 72065-121; 72065-130; 72065-131; 72065-140; 72065-141,76LA80IG2G,GLUCAGON,GLUCAGON,76LA80IG2G,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/92385737-dbad-98c5-e053-2995a90a2805/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=92385737-dbad-98c5-e053-2995a90a2805,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=92385737-dbad-98c5-e053-2995a90a2805,92385737-dbad-98c5-e053-2995a90a2805,,,
HUMAN PRESCRIPTION DRUG LABEL,"POWDER, FOR SOLUTION",ORAL,NDA,208587,Endari,GLUTAMINE,2022/08/19,Amino Acid,2017,EMMAUS MEDICAL INC,2017/07/07-,42457-420,0RH81L854J,Glutamine,Glutamine,0RH81L854J,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/d5a783f4-12ef-4326-8faa-40018e45ba3b/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d5a783f4-12ef-4326-8faa-40018e45ba3b,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=d5a783f4-12ef-4326-8faa-40018e45ba3b,d5a783f4-12ef-4326-8faa-40018e45ba3b,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,020051,Glynase,GLYBURIDE,2023/12/06,Sulfonylurea,,PHARMACIA AND UPJOHN COMPANY LLC,1992/03/04-; completed:1992/03/04-2023/09/30,0009-0341; 0009-0352; 0009-3449,SX6K58TVWC,GLYBURIDE,GLYBURIDE,SX6K58TVWC,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/a7fce80a-2f13-43cc-8e1c-561f7d3ec3d5/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a7fce80a-2f13-43cc-8e1c-561f7d3ec3d5,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=a7fce80a-2f13-43cc-8e1c-561f7d3ec3d5,a7fce80a-2f13-43cc-8e1c-561f7d3ec3d5,,,
HUMAN PRESCRIPTION DRUG LABEL,LIQUID,ORAL,NDA,203284,Ravicti,GLYCEROL PHENYLBUTYRATE,2021/09/13,Nitrogen Binding Agent,1996,HORIZON THERAPEUTICS USA INC,2013/02/28-,75987-050,ZH6F1VCV7B,GLYCEROL PHENYLBUTYRATE,PHENYLBUTYRIC ACID,7WY7YBI87E,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/900e7dc0-9afe-4f50-80de-90567bb78519/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=900e7dc0-9afe-4f50-80de-90567bb78519,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=900e7dc0-9afe-4f50-80de-90567bb78519,900e7dc0-9afe-4f50-80de-90567bb78519,,,
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION,IRRIGATION,NDA,017865,Glycine,GLYCINE,2018/01/02,,,BAXTER HEALTHCARE CORPORATION,1980/05/30-,0338-0289,TE7660XO1C,GLYCINE,GLYCINE,TE7660XO1C,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/d4665408-04d8-4ad7-8589-708d4defb869/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d4665408-04d8-4ad7-8589-708d4defb869,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=d4665408-04d8-4ad7-8589-708d4defb869,d4665408-04d8-4ad7-8589-708d4defb869,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRAMUSCULAR; INTRAVENOUS,NDA,214919,Glycopyrrolate,GLYCOPYRROLATE,2024/02/08,Anticholinergic; Cholinergic Muscarinic Antagonist,1961,FRESENIUS KABI USA LLC,2022/04/21-,76045-023,V92SO9WP2I,GLYCOPYRROLATE,GLYCOPYRRONIUM,A14FB57V1D,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/685aaf64-1a64-42f9-a96f-4764d650c26f/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=685aaf64-1a64-42f9-a96f-4764d650c26f,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=685aaf64-1a64-42f9-a96f-4764d650c26f,685aaf64-1a64-42f9-a96f-4764d650c26f,,,
HUMAN PRESCRIPTION DRUG LABEL,LIQUID,ORAL,NDA,022571,Cuvposa,GLYCOPYRROLATE,2023/09/13,Anticholinergic; Cholinergic Muscarinic Antagonist,1961,MERZ PHARMACEUTICALS LLC,2013/01/01-,0259-0501,V92SO9WP2I,glycopyrrolate,GLYCOPYRRONIUM,A14FB57V1D,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/d200bd44-9856-4104-a29e-a4cca3db6737/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d200bd44-9856-4104-a29e-a4cca3db6737,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=d200bd44-9856-4104-a29e-a4cca3db6737,d200bd44-9856-4104-a29e-a4cca3db6737,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,012827,Robinul; Robinul Forte,GLYCOPYRROLATE,2022/09/22,Anticholinergic; Cholinergic Muscarinic Antagonist,1961,CASPER PHARMA LLC,2020/10/06-,70199-007; 70199-008,V92SO9WP2I,GLYCOPYRROLATE,GLYCOPYRRONIUM,A14FB57V1D,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/94fb029a-6371-4b1c-89de-35e8209c7cab/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=94fb029a-6371-4b1c-89de-35e8209c7cab,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=94fb029a-6371-4b1c-89de-35e8209c7cab,94fb029a-6371-4b1c-89de-35e8209c7cab,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAMUSCULAR; INTRAVENOUS,NDA,210997,GLYRX-PF,GLYCOPYRROLATE,2018/08/01,Anticholinergic; Cholinergic Muscarinic Antagonist,1975,EXELA PHARMA SCIENCES LLC,2018/08/01-; 2020/06/01-,51754-6000; 51754-6001; 51754-6013; 51754-6015,V92SO9WP2I,GLYCOPYRROLATE,GLYCOPYRRONIUM,A14FB57V1D,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/2189f3f5-39dc-4e85-b7c6-9515ded59686/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2189f3f5-39dc-4e85-b7c6-9515ded59686,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=2189f3f5-39dc-4e85-b7c6-9515ded59686,2189f3f5-39dc-4e85-b7c6-9515ded59686,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRAMUSCULAR; INTRAVENOUS,NDA,017558,Glycopyrrolate,GLYCOPYRROLATE,2012/02/09,,,WEST WARD PHARMACEUTICAL CORP,1975/02/06-,0641-6033; 0641-6034; 0641-6035; 0641-6036,V92SO9WP2I,GLYCOPYRROLATE,GLYCOPYRROLATE,V92SO9WP2I,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/61767a0d-c94c-44d8-b35c-316a5731a275/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=61767a0d-c94c-44d8-b35c-316a5731a275,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=61767a0d-c94c-44d8-b35c-316a5731a275,61767a0d-c94c-44d8-b35c-316a5731a275,,,
HUMAN PRESCRIPTION DRUG LABEL,"AEROSOL, METERED",INHALATION,NDA,208294,BEVESPI AEROSPHERE,GLYCOPYRROLATE AND FORMOTEROL FUMARATE,2023/03/24,Anticholinergic; Cholinergic Muscarinic Antagonist; beta2-Adrenergic Agonist,2016,ASTRAZENECA PHARMACEUTICALS LP,2016/10/03-,0310-4600,V92SO9WP2I; W34SHF8J2K,FORMOTEROL FUMARATE; GLYCOPYRROLATE,FORMOTEROL; GLYCOPYRRONIUM,5ZZ84GCW8B; A14FB57V1D,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/ae02436e-9528-490e-a844-0c0f6f2843f9/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ae02436e-9528-490e-a844-0c0f6f2843f9,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=ae02436e-9528-490e-a844-0c0f6f2843f9,ae02436e-9528-490e-a844-0c0f6f2843f9,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, ORALLY DISINTEGRATING",ORAL,NDA,215019,DARTISLA ODT,GLYCOPYRROLATE ORALLY DISINTEGRATING TABLETS,2023/10/19,Anticholinergic; Cholinergic Muscarinic Antagonist,1961,EDENBRIDGE PHARMACEUTICALS LLC,2023/10/11-; completed:2022/02/01-2023/10/11,82111-517; 82111-518,V92SO9WP2I,GLYCOPYRROLATE,Glycopyrronium,A14FB57V1D,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/52daf47e-7ba3-4105-be7f-27001a87e16e/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=52daf47e-7ba3-4105-be7f-27001a87e16e,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=52daf47e-7ba3-4105-be7f-27001a87e16e,52daf47e-7ba3-4105-be7f-27001a87e16e,,,
HUMAN PRESCRIPTION DRUG LABEL,CLOTH,TOPICAL,NDA,210361,Qbrexza,GLYCOPYRRONIUM,2023/12/19,Anticholinergic; Cholinergic Muscarinic Antagonist,2018,JOURNEY MEDICAL CORPORATION,2018/06/28-,69489-411,1PVF6JLU7B,GLYCOPYRRONIUM TOSYLATE,GLYCOPYRRONIUM,A14FB57V1D,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/5b372650-e56e-47a5-93e2-c0c292017059/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5b372650-e56e-47a5-93e2-c0c292017059,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=5b372650-e56e-47a5-93e2-c0c292017059,5b372650-e56e-47a5-93e2-c0c292017059,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRAVENOUS,NDA,211970,Vyondys 53,GOLODIRSEN,2022/03/14,Antisense Oligonucleotide,2019,SAREPTA THERAPEUTICS INC,2019/12/12-,60923-465,033072U4MZ,golodirsen,golodirsen,033072U4MZ,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/35c227d1-5b24-44b0-b5d3-f0f6b1c46bd5/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=35c227d1-5b24-44b0-b5d3-f0f6b1c46bd5,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=35c227d1-5b24-44b0-b5d3-f0f6b1c46bd5,35c227d1-5b24-44b0-b5d3-f0f6b1c46bd5,,,
HUMAN PRESCRIPTION DRUG LABEL,IMPLANT,SUBCUTANEOUS,NDA,019726,ZOLADEX,GOSERELIN,2023/03/24,Gonadotropin Releasing Hormone Receptor Agonist,1989,TERSERA THERAPEUTICS LLC,2018/03/31-,70720-950,6YUU2PV0U8,goserelin acetate,goserelin,0F65R8P09N,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/294b168b-6e5f-4db9-bf70-d599271458b3/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=294b168b-6e5f-4db9-bf70-d599271458b3,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=294b168b-6e5f-4db9-bf70-d599271458b3,294b168b-6e5f-4db9-bf70-d599271458b3,,,
HUMAN PRESCRIPTION DRUG LABEL,IMPLANT,SUBCUTANEOUS,NDA,020578,ZOLADEX,GOSERELIN,2022/10/25,Gonadotropin Releasing Hormone Receptor Agonist,1996,TERSERA THERAPEUTICS LLC,2018/01/26-,70720-951,6YUU2PV0U8,goserelin acetate,goserelin,0F65R8P09N,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/e4cb3c20-2738-400a-b522-3f36f71fe6c5/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e4cb3c20-2738-400a-b522-3f36f71fe6c5,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=e4cb3c20-2738-400a-b522-3f36f71fe6c5,e4cb3c20-2738-400a-b522-3f36f71fe6c5,,,
HUMAN PRESCRIPTION DRUG LABEL,PATCH,TRANSDERMAL,NDA,022198,SANCUSO,GRANISETRON,2023/08/24,Serotonin-3 Receptor Antagonist,2008,KYOWA KIRIN INC,2008/09/12-,42747-726,WZG3J2MCOL,granisetron,granisetron,WZG3J2MCOL,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/ba44e7d8-0c71-4eb9-a951-3d91038293c5/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ba44e7d8-0c71-4eb9-a951-3d91038293c5,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=ba44e7d8-0c71-4eb9-a951-3d91038293c5,ba44e7d8-0c71-4eb9-a951-3d91038293c5,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,SUBCUTANEOUS,NDA,022445,SUSTOL,GRANISETRON,2023/06/07,Serotonin-3 Receptor Antagonist,1993,HERON THERAPEUTICS INC,2016/08/09-,47426-101,WZG3J2MCOL,GRANISETRON,GRANISETRON,WZG3J2MCOL,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/f7c7ffdd-8270-4030-bc1e-a1cb28a6de56/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f7c7ffdd-8270-4030-bc1e-a1cb28a6de56,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=f7c7ffdd-8270-4030-bc1e-a1cb28a6de56,f7c7ffdd-8270-4030-bc1e-a1cb28a6de56,,,
HUMAN PRESCRIPTION DRUG LABEL,"KIT; TABLET, EXTENDED RELEASE",ORAL,NDA,022037,Intuniv,GUANFACINE,2022/12/23,Central alpha-2 Adrenergic Agonist,1986,TAKEDA PHARMACEUTICALS AMERICA INC,2009/09/02-; completed:2009/09/02-2015/10/29,54092-513; 54092-515; 54092-517; 54092-519; 54092-520,PML56A160O,GUANFACINE HYDROCHLORIDE,GUANFACINE,30OMY4G3MK,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/b972af81-3a37-40be-9fe1-3ddf59852528/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b972af81-3a37-40be-9fe1-3ddf59852528,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=b972af81-3a37-40be-9fe1-3ddf59852528,b972af81-3a37-40be-9fe1-3ddf59852528,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,019032,TENEX,GUANFACINE HYDROCHLORIDE,2013/05/08,Central alpha-2 Adrenergic Agonist,,PROMIUS PHARMA LLC,1986/10/27-,67857-705; 67857-706,PML56A160O,GUANFACINE HYDROCHLORIDE,GUANFACINE,30OMY4G3MK,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/886e050c-dd22-4f35-ac3b-243f091125c3/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=886e050c-dd22-4f35-ac3b-243f091125c3,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=886e050c-dd22-4f35-ac3b-243f091125c3,886e050c-dd22-4f35-ac3b-243f091125c3,,,
HUMAN PRESCRIPTION DRUG LABEL,OINTMENT,TOPICAL,NDA,017824,HALOG,HALCINONIDE,2019/07/29,Corticosteroid,,SUN PHARMACEUTICAL INDUSTRIES INC,2009/05/19-,10631-096,SI86V6QNEG,HALCINONIDE,HALCINONIDE,SI86V6QNEG,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/4f6ffa29-577b-4377-a068-0846df221771/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4f6ffa29-577b-4377-a068-0846df221771,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=4f6ffa29-577b-4377-a068-0846df221771,4f6ffa29-577b-4377-a068-0846df221771,,,
HUMAN PRESCRIPTION DRUG LABEL,CREAM,TOPICAL,NDA,017556,Halog,HALCINONIDE CREAM,2019/01/07,Corticosteroid,,SUN PHARMACEUTICAL INDUSTRIES INC,2009/02/10-,10631-094,SI86V6QNEG,HALCINONIDE,HALCINONIDE,SI86V6QNEG,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/e60d0691-0628-4c98-9a17-f4a89822baf2/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e60d0691-0628-4c98-9a17-f4a89822baf2,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=e60d0691-0628-4c98-9a17-f4a89822baf2,e60d0691-0628-4c98-9a17-f4a89822baf2,,,
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION,TOPICAL,NDA,017823,HALOG,HALCINONIDE TOPICAL,2021/05/18,Corticosteroid,,SUN PHARMACEUTICAL INDUSTRIES INC,2020/03/18-,10631-095,SI86V6QNEG,HALCINONIDE,HALCINONIDE,SI86V6QNEG,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/550b8c9f-e5a8-48c4-a3ff-1a56a3caac33/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=550b8c9f-e5a8-48c4-a3ff-1a56a3caac33,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=550b8c9f-e5a8-48c4-a3ff-1a56a3caac33,550b8c9f-e5a8-48c4-a3ff-1a56a3caac33,,,
HUMAN PRESCRIPTION DRUG LABEL,"AEROSOL, FOAM",TOPICAL,NDA,210566,Halobetasol propionate,HALOBETASOL PROPIONATE,2023/08/10,Corticosteroid,1990,MAYNE PHARMA,2019/02/04-,51862-606,91A0K1TY3Z,Halobetasol propionate,Halobetasol,9P6159HM7T,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/d6994177-be9f-4c59-8330-e841c8239a0e/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d6994177-be9f-4c59-8330-e841c8239a0e,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=d6994177-be9f-4c59-8330-e841c8239a0e,d6994177-be9f-4c59-8330-e841c8239a0e,,,
HUMAN PRESCRIPTION DRUG LABEL,"AEROSOL, FOAM",TOPICAL,NDA,210566,LEXETTE,HALOBETASOL PROPIONATE,2023/08/10,Corticosteroid,1990,MAYNE PHARMA,2019/04/23-,51862-604,91A0K1TY3Z,Halobetasol propionate,Halobetasol,9P6159HM7T,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/d5d0d307-37ad-4714-ba3f-5343672bc0e7/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d5d0d307-37ad-4714-ba3f-5343672bc0e7,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=d5d0d307-37ad-4714-ba3f-5343672bc0e7,d5d0d307-37ad-4714-ba3f-5343672bc0e7,,,
HUMAN PRESCRIPTION DRUG LABEL,LOTION,TOPICAL,NDA,208183,Ultravate,HALOBETASOL PROPIONATE,2020/09/02,Corticosteroid,1990,SUN PHARMACEUTICAL INDUSTRIES INC,2016/03/01-,10631-122,91A0K1TY3Z,HALOBETASOL PROPIONATE,HALOBETASOL,9P6159HM7T,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/0d563d44-17fd-4976-9f2c-f1d509f29587/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0d563d44-17fd-4976-9f2c-f1d509f29587,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=0d563d44-17fd-4976-9f2c-f1d509f29587,0d563d44-17fd-4976-9f2c-f1d509f29587,,,
HUMAN PRESCRIPTION DRUG LABEL,LOTION,TOPICAL,NDA,209355,Bryhali,HALOBETASOL PROPIONATE,2020/06/01,Corticosteroid,1990,BAUSCH HEALTH US LLC,2018/11/06-,0187-0002,91A0K1TY3Z,HALOBETASOL PROPIONATE,HALOBETASOL,9P6159HM7T,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/d4bbb66a-3f9d-4091-b1b0-1cbc908432d3/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d4bbb66a-3f9d-4091-b1b0-1cbc908432d3,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=d4bbb66a-3f9d-4091-b1b0-1cbc908432d3,d4bbb66a-3f9d-4091-b1b0-1cbc908432d3,,,
HUMAN PRESCRIPTION DRUG LABEL,KIT,TOPICAL,NDA,019968,Ultravate X,HALOBETASOL PROPIONATE,2012/11/08,Corticosteroid,,RANBAXY LABORATORIES INC,2012/07/01-,10631-119,67M901L9NQ; 91A0K1TY3Z,AMMONIUM LACTATE; HALOBETASOL PROPIONATE,AMMONIUM CATION; HALOBETASOL,54S68520I4; 9P6159HM7T,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/21e4e0c0-18c7-480a-af4e-7b553fe8b68c/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=21e4e0c0-18c7-480a-af4e-7b553fe8b68c,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=21e4e0c0-18c7-480a-af4e-7b553fe8b68c,21e4e0c0-18c7-480a-af4e-7b553fe8b68c,,,
HUMAN PRESCRIPTION DRUG LABEL,LOTION,TOPICAL,NDA,209354,Duobrii,HALOBETASOL PROPIONATE AND TAZAROTENE,2020/01/01,Corticosteroid; Retinoid,2019,BAUSCH HEALTH US LLC,2019/04/25-,0187-0653,81BDR9Y8PS; 91A0K1TY3Z,HALOBETASOL PROPIONATE; TAZAROTENE,HALOBETASOL; TAZAROTENE,81BDR9Y8PS; 9P6159HM7T,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/b3f0cdc0-69fd-43d1-baf2-d776a3a20715/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b3f0cdc0-69fd-43d1-baf2-d776a3a20715,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=b3f0cdc0-69fd-43d1-baf2-d776a3a20715,b3f0cdc0-69fd-43d1-baf2-d776a3a20715,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRAMUSCULAR,NDA,018701,Haldol Decanoate,HALOPERIDOL DECANOATE,2024/02/09,Typical Antipsychotic,,JANSSEN PHARMACEUTICALS INC,1986/01/14-,50458-253; 50458-254,AC20PJ4101,HALOPERIDOL DECANOATE,HALOPERIDOL,J6292F8L3D,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/af0159a8-dff5-449a-aa2b-a0c430081e21/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=af0159a8-dff5-449a-aa2b-a0c430081e21,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=af0159a8-dff5-449a-aa2b-a0c430081e21,af0159a8-dff5-449a-aa2b-a0c430081e21,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS; SUBCUTANEOUS,NDA,017029,Heparin Sodium,HEPARIN SODIUM,2024/05/16,Anti-coagulant; Unfractionated Heparin,1939,PHLOW CORPORATION,2022/03/07-,81565-203,ZZ45AB24CA,HEPARIN SODIUM,HEPARIN,T2410KM04A,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/cece935c-1c0a-4949-b023-d6df3d53fbfa/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=cece935c-1c0a-4949-b023-d6df3d53fbfa,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=cece935c-1c0a-4949-b023-d6df3d53fbfa,cece935c-1c0a-4949-b023-d6df3d53fbfa,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,017029,Heparin Sodium,HEPARIN SODIUM,2024/04/30,Anti-coagulant; Unfractionated Heparin,1939,FRESENIUS KABI USA LLC,2017/08/24-,63323-517; 63323-518; 63323-522; 63323-523,ZZ45AB24CA,HEPARIN SODIUM,HEPARIN,T2410KM04A,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/cb1c1e7a-c9ca-4a07-8833-e45ce436d287/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=cb1c1e7a-c9ca-4a07-8833-e45ce436d287,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=cb1c1e7a-c9ca-4a07-8833-e45ce436d287,cb1c1e7a-c9ca-4a07-8833-e45ce436d287,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRAVENOUS; SUBCUTANEOUS,NDA,017037,Heparin Sodium,HEPARIN SODIUM,2024/04/10,Anti-coagulant; Unfractionated Heparin,1939,HIKMA PHARMACEUTICALS USA INC,1972/03/22-; 2019/05/18-; 2020/01/14-,0641-0391; 0641-0400; 0641-0410; 0641-2450; 0641-2460; 0641-6199; 0641-6204,ZZ45AB24CA,HEPARIN SODIUM,HEPARIN,T2410KM04A,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/7014808d-cec9-4b2c-8eb5-940493e356ab/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7014808d-cec9-4b2c-8eb5-940493e356ab,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=7014808d-cec9-4b2c-8eb5-940493e356ab,7014808d-cec9-4b2c-8eb5-940493e356ab,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,018916,Heparin Sodium,HEPARIN SODIUM,2024/01/29,Anti-coagulant; Unfractionated Heparin,1939,HOSPIRA INC,2005/03/31-; 2023/02/27-,0409-1005; 0409-2222; 0409-7620,ZZ45AB24CA,HEPARIN SODIUM,HEPARIN,T2410KM04A,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/32e34077-aff1-4ec7-f9b0-b8e240768fb8/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=32e34077-aff1-4ec7-f9b0-b8e240768fb8,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=32e34077-aff1-4ec7-f9b0-b8e240768fb8,32e34077-aff1-4ec7-f9b0-b8e240768fb8,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,018916,Heparin Sodium,HEPARIN SODIUM,2024/01/29,Anti-coagulant; Unfractionated Heparin,1939,HOSPIRA INC,2005/06/30-; 2023/01/03-; 2023/02/27-; completed:2005/06/21-2023/06/01,0409-0012; 0409-3150; 0409-7650; 0409-7651,ZZ45AB24CA,HEPARIN SODIUM,HEPARIN,T2410KM04A,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/0413f511-6b34-4c15-e48b-3fad08baacbe/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0413f511-6b34-4c15-e48b-3fad08baacbe,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=0413f511-6b34-4c15-e48b-3fad08baacbe,0413f511-6b34-4c15-e48b-3fad08baacbe,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS; SUBCUTANEOUS,NDA,017029,Heparin Sodium,HEPARIN SODIUM,2024/01/05,Anti-coagulant; Unfractionated Heparin,1939,FRESENIUS KABI USA LLC,2022/03/22-,65219-066,ZZ45AB24CA,HEPARIN SODIUM,HEPARIN,T2410KM04A,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/a120bdfd-21e1-4024-82a7-13cfeed290c1/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a120bdfd-21e1-4024-82a7-13cfeed290c1,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=a120bdfd-21e1-4024-82a7-13cfeed290c1,a120bdfd-21e1-4024-82a7-13cfeed290c1,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS; SUBCUTANEOUS,NDA,017029,Heparin Sodium,HEPARIN SODIUM,2021/12/03,Anti-coagulant; Unfractionated Heparin,1939,FRESENIUS KABI USA LLC,2019/11/04-; 2020/03/25-,63323-262; 63323-459; 63323-540; 63323-542; 63323-543; 63323-915,ZZ45AB24CA,HEPARIN SODIUM,HEPARIN,T2410KM04A,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/2a173253-dfdc-4d9d-8dee-b9c13e6fa9f5/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2a173253-dfdc-4d9d-8dee-b9c13e6fa9f5,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=2a173253-dfdc-4d9d-8dee-b9c13e6fa9f5,2a173253-dfdc-4d9d-8dee-b9c13e6fa9f5,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS; SUBCUTANEOUS,NDA,017029,Heparin Sodium,HEPARIN SODIUM,2021/09/01,Anti-coagulant; Unfractionated Heparin,,FRESENIUS KABI USA LLC,1972/02/22-,63323-262; 63323-540,ZZ45AB24CA,HEPARIN SODIUM,HEPARIN,T2410KM04A,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/ed937dd2-8fab-4875-a1e8-627b71ccb7fb/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ed937dd2-8fab-4875-a1e8-627b71ccb7fb,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=ed937dd2-8fab-4875-a1e8-627b71ccb7fb,ed937dd2-8fab-4875-a1e8-627b71ccb7fb,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS; SUBCUTANEOUS,NDA,017029,Heparin Sodium,HEPARIN SODIUM,2021/09/01,Anti-coagulant; Unfractionated Heparin,,FRESENIUS KABI USA LLC,2020/03/02-,63323-262,ZZ45AB24CA,HEPARIN SODIUM,HEPARIN,T2410KM04A,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/3facd525-b9ad-46d0-b63e-f13a5f6d591d/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3facd525-b9ad-46d0-b63e-f13a5f6d591d,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=3facd525-b9ad-46d0-b63e-f13a5f6d591d,3facd525-b9ad-46d0-b63e-f13a5f6d591d,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS; SUBCUTANEOUS,NDA,017029,Heparin Sodium,HEPARIN SODIUM,2021/08/18,Anti-coagulant; Unfractionated Heparin,1939,FRESENIUS KABI USA LLC,2018/11/16-,63323-118,ZZ45AB24CA,Heparin Sodium,Heparin,T2410KM04A,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/9207cef5-4cec-41e7-a351-29ba726feb44/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9207cef5-4cec-41e7-a351-29ba726feb44,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=9207cef5-4cec-41e7-a351-29ba726feb44,9207cef5-4cec-41e7-a351-29ba726feb44,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRAVENOUS; SUBCUTANEOUS,NDA,201370,Heparin Sodium,HEPARIN SODIUM,2020/05/27,Anti-coagulant; Unfractionated Heparin,1939,PFIZER LABORATORIES DIV PFIZER INC,2011/07/21-; 2013/03/11-; completed:2011/07/21-2018/12/31,0069-0043; 0069-0058; 0069-0059; 0069-0062; 0069-0137,ZZ45AB24CA,HEPARIN SODIUM,HEPARIN,T2410KM04A,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/56dc3074-f1c5-45a3-b923-f1d14858e06d/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=56dc3074-f1c5-45a3-b923-f1d14858e06d,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=56dc3074-f1c5-45a3-b923-f1d14858e06d,56dc3074-f1c5-45a3-b923-f1d14858e06d,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS; SUBCUTANEOUS,NDA,017029;017651,Heparin Sodium,HEPARIN SODIUM,2020/02/18,Anti-coagulant; Unfractionated Heparin,,FRESENIUS KABI USA LLC,1972/02/22-; 1978/02/10-,63323-047; 63323-262; 63323-276; 63323-459; 63323-540; 63323-542; 63323-543; 63323-915,ZZ45AB24CA,HEPARIN SODIUM,HEPARIN,T2410KM04A,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/d55b4a63-0c04-4874-b74f-9e9b9e8b008c/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d55b4a63-0c04-4874-b74f-9e9b9e8b008c,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=d55b4a63-0c04-4874-b74f-9e9b9e8b008c,d55b4a63-0c04-4874-b74f-9e9b9e8b008c,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRAVENOUS; SUBCUTANEOUS,NDA,017037,Heparin Sodium,HEPARIN SODIUM,2019/08/11,Anti-coagulant; Unfractionated Heparin,1939,CIVICA INC,2019/11/15-,72572-250; 72572-255,ZZ45AB24CA,HEPARIN SODIUM,HEPARIN,T2410KM04A,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/1e362730-5a56-4948-a90f-2cb75fed9e91/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1e362730-5a56-4948-a90f-2cb75fed9e91,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=1e362730-5a56-4948-a90f-2cb75fed9e91,1e362730-5a56-4948-a90f-2cb75fed9e91,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRAVENOUS,NDA,019952,Heparin Sodium in Dextrose,HEPARIN SODIUM AND DEXTROSE,2023/07/27,Anti-coagulant; Unfractionated Heparin,1939,B BRAUN MEDICAL INC,1992/07/20-,0264-9567; 0264-9577; 0264-9587,LX22YL083G; ZZ45AB24CA,DEXTROSE MONOHYDRATE; HEPARIN SODIUM,ANHYDROUS DEXTROSE; HEPARIN,5SL0G7R0OK; T2410KM04A,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/92a6f533-1a3d-4734-b413-d245592454e3/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=92a6f533-1a3d-4734-b413-d245592454e3,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=92a6f533-1a3d-4734-b413-d245592454e3,92a6f533-1a3d-4734-b413-d245592454e3,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRAVENOUS,NDA,019953,Heparin Sodium in Sodium Chloride,HEPARIN SODIUM IN SODIUM CHLORIDE,2023/12/15,Anti-coagulant; Unfractionated Heparin,1939,B BRAUN MEDICAL INC,1992/07/20-,0264-9872,ZZ45AB24CA,HEPARIN SODIUM,HEPARIN,T2410KM04A,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/a3041c04-0ea8-4d36-81ce-c5091c906316/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a3041c04-0ea8-4d36-81ce-c5091c906316,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=a3041c04-0ea8-4d36-81ce-c5091c906316,a3041c04-0ea8-4d36-81ce-c5091c906316,,,
HUMAN PRESCRIPTION DRUG LABEL,KIT,INTRAVESICAL,NDA,022555,Cysview,HEXAMINOLEVULINATE HYDROCHLORIDE,2023/11/07,,2010,PHOTOCURE INC,2018/05/01-,10511-3001,D4F329SL1O,HEXAMINOLEVULINATE HYDROCHLORIDE,HEXAMINOLEVULINATE,G7H20TKI67,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/5aeed40d-6841-4adf-8940-f51d439fdfa3/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5aeed40d-6841-4adf-8940-f51d439fdfa3,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=5aeed40d-6841-4adf-8940-f51d439fdfa3,5aeed40d-6841-4adf-8940-f51d439fdfa3,,,
HUMAN PRESCRIPTION DRUG LABEL,IMPLANT,SUBCUTANEOUS,NDA,022058,SUPPRELIN LA,HISTRELIN ACETATE,2022/04/30,Gonadotropin Releasing Hormone Receptor Agonist,1991,ENDO USA INC,2007/05/31-,67979-002,QMG7HLD1ZE,HISTRELIN ACETATE,HISTRELIN,H50H3S3W74,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/d8fb000e-3cc9-4803-b71d-2cc597661977/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d8fb000e-3cc9-4803-b71d-2cc597661977,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=d8fb000e-3cc9-4803-b71d-2cc597661977,d8fb000e-3cc9-4803-b71d-2cc597661977,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,020899,Optison Perflutren Protein-Type A Microspheres,HUMAN ALBUMIN MICROSPHERES AND PERFLUTREN,2024/01/11,Contrast Agent for Ultrasound Imaging,1997,GE HEALTHCARE INC,2002/01/02-,0407-2707,CK0N3WH0SR; T8C6W1N6NW,HUMAN ALBUMIN MICROSPHERES; PERFLUTREN,HUMAN ALBUMIN MICROSPHERES; PERFLUTREN,CK0N3WH0SR; T8C6W1N6NW,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/46bcf276-d423-408a-a410-f11383406a94/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=46bcf276-d423-408a-a410-f11383406a94,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=46bcf276-d423-408a-a410-f11383406a94,46bcf276-d423-408a-a410-f11383406a94,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAVENOUS,NDA,021256,ChiRhoStim; ChiRhoStim 40,HUMAN SECRETIN,2024/04/02,,2004,CHIRHOCLIN INC,2004/08/01-; 2007/06/01-,67066-005; 67066-007,A0426J905J,SECRETIN HUMAN,SECRETIN HUMAN,A0426J905J,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/b4dfe70f-0a86-4488-9ba1-dcd8f86cbfcd/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b4dfe70f-0a86-4488-9ba1-dcd8f86cbfcd,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=b4dfe70f-0a86-4488-9ba1-dcd8f86cbfcd,b4dfe70f-0a86-4488-9ba1-dcd8f86cbfcd,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,020727,BiDil,HYDRALAZINE HYDROCHLORIDE AND ISOSORBIDE DINITRATE,2022/07/19,Arteriolar Vasodilator; Nitrate Vasodilator,2005,AZURITY,2012/12/05-,24338-010,FD171B778Y; IA7306519N,Hydralazine hydrochloride; Isosorbide dinitrate,Hydralazine; Isosorbide dinitrate,26NAK24LS8; IA7306519N,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/e1e63cd5-d1e4-4af5-bad5-1ad41ea46b00/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e1e63cd5-d1e4-4af5-bad5-1ad41ea46b00,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=e1e63cd5-d1e4-4af5-bad5-1ad41ea46b00,e1e63cd5-d1e4-4af5-bad5-1ad41ea46b00,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, EXTENDED RELEASE",ORAL,NDA,206627,Hysingla ER,HYDROCODONE BITARTRATE,2023/12/18,Opioid Agonist,1943,PURDUE PHARMA LP,2015/01/15-,59011-271; 59011-272; 59011-273; 59011-274; 59011-275; 59011-276; 59011-277,NO70W886KK,HYDROCODONE BITARTRATE,HYDROCODONE,6YKS4Y3WQ7,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/b7d23ac2-e776-9f62-3290-c64c2d6eb353/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b7d23ac2-e776-9f62-3290-c64c2d6eb353,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=b7d23ac2-e776-9f62-3290-c64c2d6eb353,b7d23ac2-e776-9f62-3290-c64c2d6eb353,,,
HUMAN PRESCRIPTION DRUG LABEL,"CAPSULE, EXTENDED RELEASE",ORAL,NDA,202880,Zohydro,HYDROCODONE BITARTRATE,2015/02/25,Opioid Agonist,1943,ZOGENIX INC,2013/10/25-,43376-310; 43376-315; 43376-320; 43376-330; 43376-340; 43376-350,NO70W886KK,HYDROCODONE BITARTRATE,HYDROCODONE,6YKS4Y3WQ7,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/6ccfbd98-7750-4955-a654-ec104fb666f9/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6ccfbd98-7750-4955-a654-ec104fb666f9,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=6ccfbd98-7750-4955-a654-ec104fb666f9,6ccfbd98-7750-4955-a654-ec104fb666f9,,,
HUMAN PRESCRIPTION DRUG LABEL,"CAPSULE, EXTENDED RELEASE",ORAL,NDA,202880,Zohydro,HYDROCODONE BITARTRATE,2014/08/26,Opioid Agonist,1943,ZOGENIX INC,2013/10/25-,43376-210; 43376-215; 43376-220; 43376-230; 43376-240; 43376-250,NO70W886KK,HYDROCODONE BITARTRATE,HYDROCODONE,6YKS4Y3WQ7,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/cf68f7fe-30a9-4f1a-a3a4-6352dc436bbe/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=cf68f7fe-30a9-4f1a-a3a4-6352dc436bbe,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=cf68f7fe-30a9-4f1a-a3a4-6352dc436bbe,cf68f7fe-30a9-4f1a-a3a4-6352dc436bbe,,,
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION,ORAL,NDA,205474,OBREDON,HYDROCODONE BITARTRATE AND GUAIFENESIN,2023/12/15,Expectorant; Opioid Agonist,2014,SOVEREIGN PHARMACEUTICALS LLC,2014/12/30-,58716-433,495W7451VQ; NO70W886KK,GUAIFENESIN; HYDROCODONE BITARTRATE,GUAIFENESIN; HYDROCODONE,495W7451VQ; 6YKS4Y3WQ7,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/f73fdec5-d330-4d8c-894b-d0bcf5490624/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f73fdec5-d330-4d8c-894b-d0bcf5490624,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=f73fdec5-d330-4d8c-894b-d0bcf5490624,f73fdec5-d330-4d8c-894b-d0bcf5490624,,,
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION; TABLET,ORAL,NDA,005213,Hycodan,HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE,2021/12/29,Opioid Agonist,1943,GENUS LIFESCIENCES INC,2019/06/10-; 2021/11/01-,64950-205; 64950-342,68JRS2HC1C; NO70W886KK,homatropine methylbromide; hydrocodone bitartrate,hydrocodone; methylhomatropine,6YKS4Y3WQ7; P97OGJ7L1L,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/901d4115-f71a-4681-bd0e-c9b691151b78/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=901d4115-f71a-4681-bd0e-c9b691151b78,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=901d4115-f71a-4681-bd0e-c9b691151b78,901d4115-f71a-4681-bd0e-c9b691151b78,,,
HUMAN PRESCRIPTION DRUG LABEL,"SUSPENSION, EXTENDED RELEASE",ORAL,NDA,019111,Tussionex Pennkinetic,HYDROCODONE POLISTIREX AND CHLORPHENIRAMINE POLISTIREX,2017/01/20,Histamine-1 Receptor Antagonist; Opioid Agonist,,UNITHER MANUFACTURING LLC,1987/12/31-,53014-548,3U6IO1965U; 6YKS4Y3WQ7,chlorpheniramine; hydrocodone,chlorpheniramine; hydrocodone,3U6IO1965U; 6YKS4Y3WQ7,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/af2caf33-e587-4d80-9523-44e1b565aae2/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=af2caf33-e587-4d80-9523-44e1b565aae2,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=af2caf33-e587-4d80-9523-44e1b565aae2,af2caf33-e587-4d80-9523-44e1b565aae2,,,
HUMAN PRESCRIPTION DRUG LABEL,GRANULE,ORAL,NDA,213876,ALKINDI SPRINKLE; Alkindi Sprinkle,HYDROCORTISONE,2024/04/15,Corticosteroid,1952,ETON PHARMACEUTICALS INC,2020/09/29-; 2023/11/06-,71863-109; 71863-110; 71863-111; 71863-112; 71863-117; 71863-118,WI4X0X7BPJ,HYDROCORTISONE,HYDROCORTISONE,WI4X0X7BPJ,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/26c13a5f-7119-4c6a-bf10-fda4e07d7682/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=26c13a5f-7119-4c6a-bf10-fda4e07d7682,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=26c13a5f-7119-4c6a-bf10-fda4e07d7682,26c13a5f-7119-4c6a-bf10-fda4e07d7682,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,008697,CORTEF,HYDROCORTISONE,2024/01/30,Corticosteroid,,PHARMACIA AND UPJOHN COMPANY LLC,1952/12/15-,0009-0012; 0009-0031; 0009-0044,WI4X0X7BPJ,HYDROCORTISONE,HYDROCORTISONE,WI4X0X7BPJ,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/9ce19944-dd88-4a7b-84ca-b07f4ec23bad/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9ce19944-dd88-4a7b-84ca-b07f4ec23bad,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=9ce19944-dd88-4a7b-84ca-b07f4ec23bad,9ce19944-dd88-4a7b-84ca-b07f4ec23bad,,,
HUMAN PRESCRIPTION DRUG LABEL,ENEMA,RECTAL,NDA,016199,Cortenema,HYDROCORTISONE,2022/04/27,Corticosteroid,,ANI PHARMACEUTICALS INC,2012/08/10-,62559-111,WI4X0X7BPJ,HYDROCORTISONE,HYDROCORTISONE,WI4X0X7BPJ,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/a307448a-ccc4-41a8-977a-11f28f0bded9/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a307448a-ccc4-41a8-977a-11f28f0bded9,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=a307448a-ccc4-41a8-977a-11f28f0bded9,a307448a-ccc4-41a8-977a-11f28f0bded9,,,
HUMAN PRESCRIPTION DRUG LABEL,"AEROSOL, FOAM",TOPICAL,NDA,017351,Cortifoam,HYDROCORTISONE ACETATE,2024/05/15,Corticosteroid,,MEDA PHARMACEUTICALS INC,2015/06/15-,0037-6830,3X7931PO74,HYDROCORTISONE ACETATE,HYDROCORTISONE,WI4X0X7BPJ,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/0093b694-9fcb-46ae-b1ab-7d0fa204c6c8/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0093b694-9fcb-46ae-b1ab-7d0fa204c6c8,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=0093b694-9fcb-46ae-b1ab-7d0fa204c6c8,0093b694-9fcb-46ae-b1ab-7d0fa204c6c8,,,
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION,AURICULAR (OTIC),NDA,012770,hydrocortisone and acetic acid,HYDROCORTISONE AND ACETIC ACID,2022/10/13,Corticosteroid,,AKORN OPERATING COMPANY LLC,2009/06/04-,50383-901,Q40Q9N063P; WI4X0X7BPJ,ACETIC ACID; HYDROCORTISONE,ACETIC ACID; HYDROCORTISONE,Q40Q9N063P; WI4X0X7BPJ,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/ffd1edc1-2f40-4b0a-a53a-9fb53b8d3184/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ffd1edc1-2f40-4b0a-a53a-9fb53b8d3184,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=ffd1edc1-2f40-4b0a-a53a-9fb53b8d3184,ffd1edc1-2f40-4b0a-a53a-9fb53b8d3184,,,
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION,AURICULAR (OTIC),NDA,012770,hydrocortisone and acetic acid,HYDROCORTISONE AND ACETIC ACID OTIC,2024/01/16,Corticosteroid,,SAPTALIS PHARMACEUTICALS LLC,2024/01/16-,71656-064,Q40Q9N063P; WI4X0X7BPJ,ACETIC ACID; HYDROCORTISONE,ACETIC ACID; HYDROCORTISONE,Q40Q9N063P; WI4X0X7BPJ,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/d9a3597c-2c9d-46cc-818b-8bb3aa5c4f32/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d9a3597c-2c9d-46cc-818b-8bb3aa5c4f32,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=d9a3597c-2c9d-46cc-818b-8bb3aa5c4f32,d9a3597c-2c9d-46cc-818b-8bb3aa5c4f32,,,
HUMAN PRESCRIPTION DRUG LABEL,LOTION,TOPICAL,NDA,022076,Locoid,HYDROCORTISONE BUTYRATE,2023/10/30,Corticosteroid,1982,BAUSCH HEALTH US LLC,2013/07/03-,16781-392,05RMF7YPWN,HYDROCORTISONE BUTYRATE,HYDROCORTISONE,WI4X0X7BPJ,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/a147236d-be90-47cf-9d88-7ea14d3a8158/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a147236d-be90-47cf-9d88-7ea14d3a8158,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=a147236d-be90-47cf-9d88-7ea14d3a8158,a147236d-be90-47cf-9d88-7ea14d3a8158,,,
HUMAN PRESCRIPTION DRUG LABEL,CREAM,TOPICAL,NDA,020769,Locoid Lipocream,HYDROCORTISONE BUTYRATE,2021/03/31,Corticosteroid,1982,BAUSCH HEALTH US LLC,2013/07/03-,16781-384,05RMF7YPWN,HYDROCORTISONE BUTYRATE,HYDROCORTISONE,WI4X0X7BPJ,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/f950988c-0bcc-4d07-bdc2-2426959a85a4/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f950988c-0bcc-4d07-bdc2-2426959a85a4,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=f950988c-0bcc-4d07-bdc2-2426959a85a4,f950988c-0bcc-4d07-bdc2-2426959a85a4,,,
HUMAN PRESCRIPTION DRUG LABEL,OINTMENT,TOPICAL,NDA,018652,Hydrocortisone Butyrate,HYDROCORTISONE BUTYRATE,2020/12/31,Corticosteroid,,OCEANSIDE PHARMACEUTICALS,2009/09/01-,68682-271,05RMF7YPWN,HYDROCORTISONE BUTYRATE,HYDROCORTISONE,WI4X0X7BPJ,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/7c3f8417-7861-41e3-876f-9b82aff7d1a0/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7c3f8417-7861-41e3-876f-9b82aff7d1a0,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=7c3f8417-7861-41e3-876f-9b82aff7d1a0,7c3f8417-7861-41e3-876f-9b82aff7d1a0,,,
HUMAN PRESCRIPTION DRUG LABEL,CREAM,TOPICAL,NDA,020453,PANDEL,HYDROCORTISONE PROBUTATE,2022/09/30,Corticosteroid,1997,ANI PHARMACEUTICALS INC,2022/09/30-,62559-325,O6550D6K3A,HYDROCORTISONE PROBUTATE,HYDROCORTISONE,WI4X0X7BPJ,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/ed5acba1-3634-45d6-ac15-44f500e84885/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ed5acba1-3634-45d6-ac15-44f500e84885,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=ed5acba1-3634-45d6-ac15-44f500e84885,ed5acba1-3634-45d6-ac15-44f500e84885,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, POWDER, FOR SOLUTION",INTRAMUSCULAR; INTRAVENOUS,NDA,009866,Solu-Cortef,HYDROCORTISONE SODIUM SUCCINATE,2024/01/30,Corticosteroid,,PHARMACIA AND UPJOHN COMPANY LLC,1955/04/27-,0009-0005; 0009-0011; 0009-0013; 0009-0016; 0009-0825,50LQB69S1Z,HYDROCORTISONE SODIUM SUCCINATE,HYDROCORTISONE,WI4X0X7BPJ,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/65eefd58-b166-4d71-ade6-45c8fdf86922/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=65eefd58-b166-4d71-ade6-45c8fdf86922,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=65eefd58-b166-4d71-ade6-45c8fdf86922,65eefd58-b166-4d71-ade6-45c8fdf86922,,,
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION,TOPICAL,NDA,209305,Eskata,HYDROGEN PEROXIDE,2019/03/27,,2017,ACLARIS THERAPEUTICS INC,2017/12/14-,71180-001; 71180-002,BBX060AN9V,HYDROGEN PEROXIDE,HYDROGEN PEROXIDE,BBX060AN9V,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/52f4cc49-6553-426f-9778-0bd34e31b942/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=52f4cc49-6553-426f-9778-0bd34e31b942,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=52f4cc49-6553-426f-9778-0bd34e31b942,52f4cc49-6553-426f-9778-0bd34e31b942,,,
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION; TABLET,ORAL,NDA,019891;019892,Dilaudid,HYDROMORPHONE HYDROCHLORIDE,2024/01/08,Opioid Agonist,1984,RHODES PHARMACEUTICALS L P,2017/05/15-,42858-122; 42858-234; 42858-338; 42858-416,L960UP2KRW,hydromorphone hydrochloride,hydromorphone,Q812464R06,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/d6b40e39-a57e-402c-b4f6-7041e832f837/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d6b40e39-a57e-402c-b4f6-7041e832f837,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=d6b40e39-a57e-402c-b4f6-7041e832f837,d6b40e39-a57e-402c-b4f6-7041e832f837,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS,NDA,019034,Dilaudid,HYDROMORPHONE HYDROCHLORIDE,2024/01/01,Opioid Agonist,1984,FRESENIUS KABI USA LLC,2016/12/16-; 2018/12/04-,76045-009; 76045-010; 76045-121,L960UP2KRW,HYDROMORPHONE HYDROCHLORIDE,HYDROMORPHONE,Q812464R06,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/9eebd88a-5632-460f-b7b6-26c8a180540d/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9eebd88a-5632-460f-b7b6-26c8a180540d,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=9eebd88a-5632-460f-b7b6-26c8a180540d,9eebd88a-5632-460f-b7b6-26c8a180540d,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS,NDA,019034,Hydromorphone Hydrochloride,HYDROMORPHONE HYDROCHLORIDE,2020/01/08,Opioid Agonist,1984,FRESENIUS KABI USA LLC,2017/12/15-,63323-851; 63323-852; 63323-853; 63323-854,L960UP2KRW,HYDROMORPHONE HYDROCHLORIDE,HYDROMORPHONE,Q812464R06,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/e034eb96-03e0-46e1-8b92-5e1f94555e7b/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e034eb96-03e0-46e1-8b92-5e1f94555e7b,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=e034eb96-03e0-46e1-8b92-5e1f94555e7b,e034eb96-03e0-46e1-8b92-5e1f94555e7b,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAVENOUS,NDA,022041,Cyanokit,HYDROXOCOBALAMIN,2023/04/27,Antidote,1975,BTG INTERNATIONAL INC,2021/12/15-,50633-310,Q40X8H422O,Hydroxocobalamin,Hydroxocobalamin,Q40X8H422O,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/d56fcc8d-bd64-46ab-b0c0-2124bd745a6b/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d56fcc8d-bd64-46ab-b0c0-2124bd745a6b,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=d56fcc8d-bd64-46ab-b0c0-2124bd745a6b,d56fcc8d-bd64-46ab-b0c0-2124bd745a6b,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAVENOUS,NDA,022041,Cyanokit,HYDROXOCOBALAMIN,2021/10/15,Antidote,1975,MERIDIAN MEDICAL TECHNOLOGIES INC,completed:2011/10/01-2024/05/24,11704-370,Q40X8H422O,Hydroxocobalamin,Hydroxocobalamin,Q40X8H422O,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/4368656c-6c2b-474c-6144-4f532d424646/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4368656c-6c2b-474c-6144-4f532d424646,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=4368656c-6c2b-474c-6144-4f532d424646,4368656c-6c2b-474c-6144-4f532d424646,,,
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION,OPHTHALMIC,NDA,019261,Paremyd,"HYDROXYAMPHETAMINE HYDROBROMIDE, TROPICAMIDE",2022/09/14,Adrenergic Receptor Agonist; Anticholinergic,,AKORN,1992/01/30-,17478-704,59IG47SZ0E; N0A3Z5XTC6,Hydroxyamphetamine hydrobromide; Tropicamide,Hydroxyamphetamine; Tropicamide,FQR280JW2N; N0A3Z5XTC6,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/da8a8a19-ac1b-4160-aac4-c4c57598eb5d/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=da8a8a19-ac1b-4160-aac4-c4c57598eb5d,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=da8a8a19-ac1b-4160-aac4-c4c57598eb5d,da8a8a19-ac1b-4160-aac4-c4c57598eb5d,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,214581,SOVUNA,HYDROXYCHLOROQUINE SULFATE,2024/04/12,Antimalarial; Antirheumatic Agent,1955,ANI PHARMACEUTICALS INC,2023/09/15-,70954-804; 70954-805,8Q2869CNVH,HYDROXYCHLOROQUINE SULFATE,HYDROXYCHLOROQUINE,4QWG6N8QKH,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/dd441154-b196-4d4c-bc56-2e37f345ef8d/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=dd441154-b196-4d4c-bc56-2e37f345ef8d,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=dd441154-b196-4d4c-bc56-2e37f345ef8d,dd441154-b196-4d4c-bc56-2e37f345ef8d,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,009768,Plaquenil,HYDROXYCHLOROQUINE SULFATE,2023/12/20,Antimalarial; Antirheumatic Agent,1955,CONCORDIA PHARMACEUTICALS INC,2013/06/28-,59212-562,8Q2869CNVH,hydroxychloroquine sulfate,hydroxychloroquine,4QWG6N8QKH,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/34496b43-05a2-45fb-a769-52b12e099341/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=34496b43-05a2-45fb-a769-52b12e099341,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=34496b43-05a2-45fb-a769-52b12e099341,34496b43-05a2-45fb-a769-52b12e099341,,,
HUMAN PRESCRIPTION DRUG LABEL,INSERT,OPHTHALMIC,NDA,018771,Lacrisert,HYDROXYPROPYL CELLULOSE,2019/10/01,Demulcent,,BAUSCH AND LOMB INCORPORATED,1981/06/01-,24208-800,RFW2ET671P,HYDROXYPROPYL CELLULOSE (1600000 WAMW),HYDROXYPROPYL CELLULOSE (1600000 WAMW),RFW2ET671P,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/cc7a6a52-0b77-4df7-8403-dd21c1334f6c/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=cc7a6a52-0b77-4df7-8403-dd21c1334f6c,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=cc7a6a52-0b77-4df7-8403-dd21c1334f6c,cc7a6a52-0b77-4df7-8403-dd21c1334f6c,,,
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION,ORAL,NDA,216593,XROMI,HYDROXYUREA,2024/04/08,Antimetabolite,1967,NOVA LABORATORIES LTD,2024/04/04-,62484-0015,X6Q56QN5QC,Hydroxyurea,Hydroxyurea,X6Q56QN5QC,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/4b37d336-86da-4363-aef1-34a7d3ba973b/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4b37d336-86da-4363-aef1-34a7d3ba973b,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=4b37d336-86da-4363-aef1-34a7d3ba973b,4b37d336-86da-4363-aef1-34a7d3ba973b,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,208843,Siklos,HYDROXYUREA,2024/01/04,Antimetabolite,1967,MEDUNIK,2018/04/15-; 2020/10/15-,71770-105; 71770-120,X6Q56QN5QC,hydroxyurea,hydroxyurea,X6Q56QN5QC,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/76957c0d-0f98-4376-bb06-eee651adc09d/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=76957c0d-0f98-4376-bb06-eee651adc09d,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=76957c0d-0f98-4376-bb06-eee651adc09d,76957c0d-0f98-4376-bb06-eee651adc09d,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,NDA,016295,HYDREA,HYDROXYUREA,2023/12/13,Antimetabolite,1967,H PHARMA LLC,2009/06/01-,61269-835,X6Q56QN5QC,hydroxyurea,hydroxyurea,X6Q56QN5QC,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/6053c775-68de-45e4-9af9-33b18fd0e140/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6053c775-68de-45e4-9af9-33b18fd0e140,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=6053c775-68de-45e4-9af9-33b18fd0e140,6053c775-68de-45e4-9af9-33b18fd0e140,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,NDA,016295,DROXIA,HYDROXYUREA,2023/12/13,Antimetabolite,1967,H PHARMA LLC,2009/06/01-,61269-402; 61269-403; 61269-404,X6Q56QN5QC,hydroxyurea,hydroxyurea,X6Q56QN5QC,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/a9494409-3571-4a81-9ad3-15ef7cb636a2/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a9494409-3571-4a81-9ad3-15ef7cb636a2,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=a9494409-3571-4a81-9ad3-15ef7cb636a2,a9494409-3571-4a81-9ad3-15ef7cb636a2,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,NDA,016295,HYDREA,HYDROXYUREA,2022/11/15,Antimetabolite,1967,E R SQUIBB AND SONS L L C,completed:2009/06/01-2025/03/31,0003-0830,X6Q56QN5QC,hydroxyurea,hydroxyurea,X6Q56QN5QC,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/050bd2a2-a125-721a-e366-255c5466f018/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=050bd2a2-a125-721a-e366-255c5466f018,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=050bd2a2-a125-721a-e366-255c5466f018,050bd2a2-a125-721a-e366-255c5466f018,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,NDA,016295,DROXIA,HYDROXYUREA,2022/11/15,Antimetabolite,1967,E R SQUIBB AND SONS L L C,completed:2009/06/01-2025/03/31; completed:2009/06/01-2025/05/31,0003-6335; 0003-6336; 0003-6337,X6Q56QN5QC,hydroxyurea,hydroxyurea,X6Q56QN5QC,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/740e054b-faac-7c27-f06d-a56efb699355/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=740e054b-faac-7c27-f06d-a56efb699355,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=740e054b-faac-7c27-f06d-a56efb699355,740e054b-faac-7c27-f06d-a56efb699355,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,NDA,011459,Vistaril,HYDROXYZINE PAMOATE,2024/04/29,Antihistamine,,PFIZER LABORATORIES DIV PFIZER INC,1994/11/28-; completed:1968/11/15-2023/12/31,0069-5410; 0069-5420,M20215MUFR,HYDROXYZINE PAMOATE,HYDROXYZINE,30S50YM8OG,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/c271f97f-040e-492b-9194-2c8b74675a95/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c271f97f-040e-492b-9194-2c8b74675a95,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=c271f97f-040e-492b-9194-2c8b74675a95,c271f97f-040e-492b-9194-2c8b74675a95,,,
HUMAN PRESCRIPTION DRUG LABEL,EMULSION,INTRAVENOUS,NDA,019942,Intralipid,I. V. FAT EMULSION,2022/07/21,Lipid Emulsion,,BAXTER HEALTHCARE CORPORATION,2004/04/01-,0338-0520,241ATL177A,SOYBEAN OIL,SOYBEAN OIL,241ATL177A,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/dd269651-30e8-43f0-880f-484346eaafeb/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=dd269651-30e8-43f0-880f-484346eaafeb,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=dd269651-30e8-43f0-880f-484346eaafeb,dd269651-30e8-43f0-880f-484346eaafeb,,,
HUMAN PRESCRIPTION DRUG LABEL,EMULSION,INTRAVENOUS,NDA,019942,Intralipid,I.V. FAT EMULSION,2024/04/18,Lipid Emulsion,1993,FRESENIUS KABI USA LLC,2004/04/01-,65219-537,241ATL177A,SOYBEAN OIL,SOYBEAN OIL,241ATL177A,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/98460eae-5195-48d2-ab73-00d276879ef6/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=98460eae-5195-48d2-ab73-00d276879ef6,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=98460eae-5195-48d2-ab73-00d276879ef6,98460eae-5195-48d2-ab73-00d276879ef6,,,
HUMAN PRESCRIPTION DRUG LABEL,EMULSION,INTRAVENOUS,NDA,020248,Intralipid,I.V. FAT EMULSION,2023/10/13,Lipid Emulsion,1975,FRESENIUS KABI USA LLC,2004/04/01-,65219-539,241ATL177A,SOYBEAN OIL,SOYBEAN OIL,241ATL177A,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/bdcc364b-77b2-4939-8add-03e5396d46c2/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=bdcc364b-77b2-4939-8add-03e5396d46c2,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=bdcc364b-77b2-4939-8add-03e5396d46c2,bdcc364b-77b2-4939-8add-03e5396d46c2,,,
HUMAN PRESCRIPTION DRUG LABEL,EMULSION,INTRAVENOUS,NDA,018449,Intralipid,I.V. FAT EMULSION,2023/10/13,Lipid Emulsion,1975,FRESENIUS KABI USA LLC,2004/04/01-,65219-531; 65219-533; 65219-535,241ATL177A,SOYBEAN OIL,SOYBEAN OIL,241ATL177A,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/61e025f1-a38e-4af2-9e18-13ea12977cf5/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=61e025f1-a38e-4af2-9e18-13ea12977cf5,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=61e025f1-a38e-4af2-9e18-13ea12977cf5,61e025f1-a38e-4af2-9e18-13ea12977cf5,,,
HUMAN PRESCRIPTION DRUG LABEL,EMULSION,INTRAVENOUS,NDA,017643,Intralipid,I.V. FAT EMULSION,2022/07/25,Lipid Emulsion,,BAXTER HEALTHCARE CORP,2014/12/12-,0338-0518,241ATL177A,SOYBEAN OIL,SOYBEAN OIL,241ATL177A,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/069460a5-3e9a-428f-b2dc-3405690f4fd7/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=069460a5-3e9a-428f-b2dc-3405690f4fd7,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=069460a5-3e9a-428f-b2dc-3405690f4fd7,069460a5-3e9a-428f-b2dc-3405690f4fd7,,,
HUMAN PRESCRIPTION DRUG LABEL,EMULSION,INTRAVENOUS,NDA,018449,Intralipid,I.V. FAT EMULSION,2022/07/21,Lipid Emulsion,,BAXTER HEALTHCARE CORPORATION,2004/04/01-,0338-0519,241ATL177A,SOYBEAN OIL,SOYBEAN OIL,241ATL177A,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/a69c82da-15ba-4d4d-8d7f-871dc3981eb8/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a69c82da-15ba-4d4d-8d7f-871dc3981eb8,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=a69c82da-15ba-4d4d-8d7f-871dc3981eb8,a69c82da-15ba-4d4d-8d7f-871dc3981eb8,,,
HUMAN PRESCRIPTION DRUG LABEL,EMULSION,INTRAVENOUS,NDA,020248,Intralipid,I.V. FAT EMULSION,2022/07/21,Lipid Emulsion,,BAXTER HEALTHCARE CORPORATION,2004/04/01-,0338-0519,241ATL177A,SOYBEAN OIL,SOYBEAN OIL,241ATL177A,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/55609586-f0b4-42e6-8dd9-cd090afb5dca/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=55609586-f0b4-42e6-8dd9-cd090afb5dca,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=55609586-f0b4-42e6-8dd9-cd090afb5dca,55609586-f0b4-42e6-8dd9-cd090afb5dca,,,
HUMAN PRESCRIPTION DRUG LABEL,EMULSION,INTRAVENOUS,NDA,020248,Intralipid,I.V. FAT EMULSION,2019/01/09,Lipid Emulsion,,BAXTER HEALTHCARE CORPORATION,2004/04/01-,0338-0519,241ATL177A,SOYBEAN OIL,SOYBEAN OIL,241ATL177A,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/cbd3396e-6b85-41bf-82d2-940beba86686/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=cbd3396e-6b85-41bf-82d2-940beba86686,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=cbd3396e-6b85-41bf-82d2-940beba86686,cbd3396e-6b85-41bf-82d2-940beba86686,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,214900,BREXAFEMME,IBREXAFUNGERP,2023/12/01,Triterpenoid Antifungal,2021,SCYNEXIS INC,2021/07/01-,75788-115,M4NU2SDX3E,IBREXAFUNGERP CITRATE,IBREXAFUNGERP,A92JFM5XNU,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/c33be3a1-c4fd-512c-e053-2995a90a63eb/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c33be3a1-c4fd-512c-e053-2995a90a63eb,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=c33be3a1-c4fd-512c-e053-2995a90a63eb,c33be3a1-c4fd-512c-e053-2995a90a63eb,,,
HUMAN PRESCRIPTION DRUG LABEL,"CAPSULE; SUSPENSION; TABLET, FILM COATED",ORAL,NDA,205552;210563;217003,Imbruvica,IBRUTINIB,2024/05/09,Kinase Inhibitor,2013,PHARMACYCLICS LLC,2013/11/13-; 2017/12/20-; 2018/02/16-; 2022/08/24-,57962-007; 57962-014; 57962-070; 57962-140; 57962-280; 57962-420; 57962-560,1X70OSD4VX,IBRUTINIB,IBRUTINIB,1X70OSD4VX,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/0dfd0279-ff17-4ea9-89be-9803c71bab44/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0dfd0279-ff17-4ea9-89be-9803c71bab44,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=0dfd0279-ff17-4ea9-89be-9803c71bab44,0dfd0279-ff17-4ea9-89be-9803c71bab44,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRAVENOUS,NDA,022348,Caldolor,IBUPROFEN,2023/05/17,Nonsteroidal Anti-inflammatory Drug,1974,CUMBERLAND PHARMACEUTICALS INC,2009/06/11-; 2020/01/01-,66220-284; 66220-287,WK2XYI10QM,ibuprofen,ibuprofen,WK2XYI10QM,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/1eaa7790-f1a1-4f51-b10a-cbbaf033f684/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1eaa7790-f1a1-4f51-b10a-cbbaf033f684,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=1eaa7790-f1a1-4f51-b10a-cbbaf033f684,1eaa7790-f1a1-4f51-b10a-cbbaf033f684,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, COATED",ORAL,NDA,022519,DUEXIS,IBUPROFEN AND FAMOTIDINE,2023/08/31,Histamine-2 Receptor Antagonist; Nonsteroidal Anti-inflammatory Drug,2011,HORIZON THERAPEUTICS USA INC,completed:2011/12/05-2025/08/31,75987-010,5QZO15J2Z8; WK2XYI10QM,FAMOTIDINE; IBUPROFEN,FAMOTIDINE; IBUPROFEN,5QZO15J2Z8; WK2XYI10QM,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/558b9f26-37b2-423b-932d-25a37afe57ec/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=558b9f26-37b2-423b-932d-25a37afe57ec,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=558b9f26-37b2-423b-932d-25a37afe57ec,558b9f26-37b2-423b-932d-25a37afe57ec,,,
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION,INTRAVENOUS,NDA,021903,NEOPROFEN,IBUPROFEN LYSINE,2023/11/02,Nonsteroidal Anti-inflammatory Drug,1974,RECORDATI RARE DISEASES INC,2006/04/13-,55292-122,N01ORX9D6S,ibuprofen lysine,ibuprofen,WK2XYI10QM,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/6f5ede6f-b0b7-4fc8-969e-652f60ead047/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6f5ede6f-b0b7-4fc8-969e-652f60ead047,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=6f5ede6f-b0b7-4fc8-969e-652f60ead047,6f5ede6f-b0b7-4fc8-969e-652f60ead047,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,020491,Corvert,IBUTILIDE FUMARATE,2024/01/25,Antiarrhythmic,,PHARMACIA AND UPJOHN COMPANY LLC,1995/12/28-,0009-3794,9L5X4M5L6I,IBUTILIDE FUMARATE,IBUTILIDE,2436VX1U9B,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/2428969a-7431-4e94-9503-ad5c680e2ea4/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2428969a-7431-4e94-9503-ad5c680e2ea4,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=2428969a-7431-4e94-9503-ad5c680e2ea4,2428969a-7431-4e94-9503-ad5c680e2ea4,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,020491,Corvert,IBUTILIDE FUMARATE,2024/01/25,Antiarrhythmic,,PHARMACIA AND UPJOHN COMPANY LLC,1995/12/28-,0009-3794,9L5X4M5L6I,IBUTILIDE FUMARATE,IBUTILIDE,2436VX1U9B,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/b7d717ed-022d-4459-b5e6-098c2a8b7427/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b7d717ed-022d-4459-b5e6-098c2a8b7427,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=b7d717ed-022d-4459-b5e6-098c2a8b7427,b7d717ed-022d-4459-b5e6-098c2a8b7427,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",SUBCUTANEOUS,NDA,022150,Firazyr,ICATIBANT ACETATE,2024/01/19,Bradykinin B2 Receptor Antagonist,2011,TAKEDA PHARMACEUTICALS AMERICA INC,2011/08/25-,54092-702,325O8467XK,icatibant acetate,icatibant,7PG89G35Q7,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/ed6657ca-ab68-477a-9968-e12dc928b540/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ed6657ca-ab68-477a-9968-e12dc928b540,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=ed6657ca-ab68-477a-9968-e12dc928b540,ed6657ca-ab68-477a-9968-e12dc928b540,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAPERITONEAL,NDA,021321,EXTRANEAL,"ICODEXTRIN, SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE",2024/04/22,,2002,BAXTER HEALTHCARE CORPORATION,2002/12/20-,0941-0679,02F3473H9O; 2NX48Z0A9G; 451W47IQ8X; M4I0D6VV5M; TU7HW0W0QT,CALCIUM CHLORIDE; ICODEXTRIN; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE,CALCIUM CATION; CHLORIDE ION; ICODEXTRIN; LACTIC ACID; MAGNESIUM CATION; SODIUM CATION,2M83C4R6ZB; 2NX48Z0A9G; 33X04XA5AT; LYR4M0NH37; Q32ZN48698; T6V3LHY838,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/d5b85158-b0d6-4855-9d07-8d1b3ad9ab71/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d5b85158-b0d6-4855-9d07-8d1b3ad9ab71,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=d5b85158-b0d6-4855-9d07-8d1b3ad9ab71,d5b85158-b0d6-4855-9d07-8d1b3ad9ab71,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,NDA,202057,Vascepa,ICOSAPENT ETHYL,2023/04/24,,2012,AMARIN PHARMA INC,2012/10/01-; 2016/09/16-,52937-001; 52937-003; 52937-101,6GC8A4PAYH,icosapent ethyl,icosapent,AAN7QOV9EA,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/9c1a2828-1583-4414-ab22-a60480e8e508/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9c1a2828-1583-4414-ab22-a60480e8e508,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=9c1a2828-1583-4414-ab22-a60480e8e508,9c1a2828-1583-4414-ab22-a60480e8e508,,,
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION,INTRAVENOUS,NDA,050734,Idamycin PFS,IDARUBICIN HYDROCHLORIDE,2024/03/11,Anthracycline Topoisomerase Inhibitor,,PFIZER LABORATORIES DIV PFIZER INC,1997/02/17-,0013-2576; 0013-2586; 0013-2596,5VV3MDU5IE,IDARUBICIN HYDROCHLORIDE,IDARUBICIN,ZRP63D75JW,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/0a5a6d93-cc1e-4d7f-8da1-446c134503b3/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0a5a6d93-cc1e-4d7f-8da1-446c134503b3,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=0a5a6d93-cc1e-4d7f-8da1-446c134503b3,0a5a6d93-cc1e-4d7f-8da1-446c134503b3,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,205858,Zydelig,IDELALISIB,2022/03/01,Kinase Inhibitor,2014,GILEAD SCIENCES INC,2014/07/23-,61958-1701; 61958-1702,YG57I8T5M0,IDELALISIB,IDELALISIB,YG57I8T5M0,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/efbdafa9-d18c-4e85-b4a2-1e620fc74e50/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=efbdafa9-d18c-4e85-b4a2-1e620fc74e50,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=efbdafa9-d18c-4e85-b4a2-1e620fc74e50,efbdafa9-d18c-4e85-b4a2-1e620fc74e50,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, POWDER, FOR SOLUTION",INTRAVENOUS,NDA,019763,IFOSFAMIDE,IFOSFAMIDE,2019/10/30,Alkylating Drug,1988,BAXTER HEALTHCARE CORPORATION,1988/12/30-,10019-927; 10019-929,UM20QQM95Y,IFOSFAMIDE,IFOSFAMIDE,UM20QQM95Y,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/efb1d03b-2d91-406e-8110-d3a58b8fa7cc/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=efb1d03b-2d91-406e-8110-d3a58b8fa7cc,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=efb1d03b-2d91-406e-8110-d3a58b8fa7cc,efb1d03b-2d91-406e-8110-d3a58b8fa7cc,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, POWDER, FOR SOLUTION",INTRAVENOUS,NDA,019763,IFOSFAMIDE,IFOSFAMIDE,2018/07/30,Alkylating Drug,1988,BAXTER HEALTHCARE CORPORATION,1988/12/30-,10019-925; 10019-926,UM20QQM95Y,IFOSFAMIDE,IFOSFAMIDE,UM20QQM95Y,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/91e433a9-6800-43a6-ac13-a49a04a5aecd/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=91e433a9-6800-43a6-ac13-a49a04a5aecd,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=91e433a9-6800-43a6-ac13-a49a04a5aecd,91e433a9-6800-43a6-ac13-a49a04a5aecd,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, POWDER, FOR SOLUTION",INTRAVENOUS,NDA,019763,IFEX,IFOSFAMIDE,2018/07/26,Alkylating Drug,1988,BAXTER HEALTHCARE CORPORATION,1988/12/30-,0338-3991; 0338-3993,UM20QQM95Y,IFOSFAMIDE,IFOSFAMIDE,UM20QQM95Y,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/b7241707-7538-4d1a-91e7-3a25a91e0b9a/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b7241707-7538-4d1a-91e7-3a25a91e0b9a,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=b7241707-7538-4d1a-91e7-3a25a91e0b9a,b7241707-7538-4d1a-91e7-3a25a91e0b9a,,,
HUMAN PRESCRIPTION DRUG LABEL,KIT; TABLET,ORAL,NDA,022192,Fanapt,ILOPERIDONE,2024/04/08,Atypical Antipsychotic,2009,VANDA PHARMACEUTICALS INC,2015/09/15-; 2015/12/01-; 2015/12/15-; 2016/01/15-; 2016/05/01-,43068-101; 43068-102; 43068-104; 43068-106; 43068-108; 43068-110; 43068-112; 43068-113; 43068-901; 43068-902; 43068-903,VPO7KJ050N,ILOPERIDONE,ILOPERIDONE,VPO7KJ050N,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/33f60b40-3fca-11de-8f56-0002a5d5c51b/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=33f60b40-3fca-11de-8f56-0002a5d5c51b,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=33f60b40-3fca-11de-8f56-0002a5d5c51b,33f60b40-3fca-11de-8f56-0002a5d5c51b,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,217933,AURLUMYN,ILOPROST,2024/03/11,Prostacycline,2004,EICOS SCIENCES INC,2024/05/01-,83226-2001,JED5K35YGL,ILOPROST,ILOPROST,JED5K35YGL,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/f3306add-2edd-8494-e053-2a95a90a7a78/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f3306add-2edd-8494-e053-2a95a90a7a78,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=f3306add-2edd-8494-e053-2a95a90a7a78,f3306add-2edd-8494-e053-2a95a90a7a78,,,
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION,INHALATION,NDA,021779,VENTAVIS,ILOPROST,2022/07/26,Prostacycline,2004,ACTELION PHARMACEUTICALS US INC,2005/05/07-; 2009/08/24-,66215-302; 66215-303,JED5K35YGL,iloprost,iloprost,JED5K35YGL,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/d3bebc1c-f032-402a-bbc9-aff024276ed1/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d3bebc1c-f032-402a-bbc9-aff024276ed1,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=d3bebc1c-f032-402a-bbc9-aff024276ed1,d3bebc1c-f032-402a-bbc9-aff024276ed1,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,021588,Gleevec,IMATINIB MESYLATE,2024/03/01,Kinase Inhibitor,2001,NOVARTIS PHARMACEUTICALS CORPORATION,2001/05/15-; 2014/12/23-,0078-0401; 0078-0649,8A1O1M485B,IMATINIB MESYLATE,IMATINIB,BKJ8M8G5HI,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/211ef2da-2868-4a77-8055-1cb2cd78e24b/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=211ef2da-2868-4a77-8055-1cb2cd78e24b,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=211ef2da-2868-4a77-8055-1cb2cd78e24b,211ef2da-2868-4a77-8055-1cb2cd78e24b,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, POWDER, FOR SOLUTION",INTRAVENOUS,ANDA; NDA,050587;062756,PRIMAXIN IV,IMIPENEM AND CILASTATIN SODIUM,2023/12/01,Penem Antibacterial; Renal Dehydropeptidase Inhibitor,1985,MERCK SHARP AND DOHME LLC,1985/11/26-; completed:1985/11/26-2017/05/01; completed:1987/01/08-2016/05/31,0006-3514; 0006-3516; 0006-3551; 0006-3552,5428WXZ74M; 71OTZ9ZE0A,CILASTATIN SODIUM; IMIPENEM,CILASTATIN; IMIPENEM ANHYDROUS,141A6AMN38; Q20IM7HE75,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/f41d8abd-7792-4918-1b93-bd83ea01955e/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f41d8abd-7792-4918-1b93-bd83ea01955e,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=f41d8abd-7792-4918-1b93-bd83ea01955e,f41d8abd-7792-4918-1b93-bd83ea01955e,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, POWDER, FOR SOLUTION",INTRAVENOUS,NDA,212819,RECARBRIO,"IMIPENEM ANHYDROUS, CILASTATIN, AND RELEBACTAM ANHYDROUS",2023/07/26,Penem Antibacterial; Renal Dehydropeptidase Inhibitor; beta Lactamase Inhibitor,2019,MERCK SHARP AND DOHME LLC,2020/01/06-,0006-3856,141A6AMN38; 1OQF7TT3PF; Q20IM7HE75,CILASTATIN; IMIPENEM ANHYDROUS; RELEBACTAM ANHYDROUS,CILASTATIN; IMIPENEM ANHYDROUS; RELEBACTAM ANHYDROUS,141A6AMN38; 1OQF7TT3PF; Q20IM7HE75,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/be32f468-738b-40df-a425-591e12f65159/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=be32f468-738b-40df-a425-591e12f65159,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=be32f468-738b-40df-a425-591e12f65159,be32f468-738b-40df-a425-591e12f65159,,,
HUMAN PRESCRIPTION DRUG LABEL,CREAM,TOPICAL,NDA,022483,Zyclara,IMIQUIMOD,2024/01/08,,1997,BAUSCH HEALTH US LLC,2011/11/28-; 2012/01/01-; 2012/02/29-,99207-270; 99207-271; 99207-276,P1QW714R7M,IMIQUIMOD,IMIQUIMOD,P1QW714R7M,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/28cd9b5b-680b-480f-b33d-9c5b52bbf03d/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=28cd9b5b-680b-480f-b33d-9c5b52bbf03d,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=28cd9b5b-680b-480f-b33d-9c5b52bbf03d,28cd9b5b-680b-480f-b33d-9c5b52bbf03d,,,
HUMAN PRESCRIPTION DRUG LABEL,CREAM,TOPICAL,NDA,020723,Aldara,IMIQUIMOD,2023/10/05,,1997,BAUSCH HEALTH US LLC,1997/02/27-,99207-260,P1QW714R7M,IMIQUIMOD,IMIQUIMOD,P1QW714R7M,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/0c3aed27-7b3f-442e-9f60-f2f5c672c85d/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0c3aed27-7b3f-442e-9f60-f2f5c672c85d,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=0c3aed27-7b3f-442e-9f60-f2f5c672c85d,0c3aed27-7b3f-442e-9f60-f2f5c672c85d,,,
HUMAN PRESCRIPTION DRUG LABEL,CREAM,TOPICAL,NDA,022483,Imiquimod,IMIQUIMOD,2020/06/30,,1997,OCEANSIDE PHARMACUETICALS,2018/06/27-,68682-272,P1QW714R7M,imiquimod,imiquimod,P1QW714R7M,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/d86eeb0e-70e0-4c72-aaa3-37daa1d8611e/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d86eeb0e-70e0-4c72-aaa3-37daa1d8611e,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=d86eeb0e-70e0-4c72-aaa3-37daa1d8611e,d86eeb0e-70e0-4c72-aaa3-37daa1d8611e,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",SUBCUTANEOUS,NDA,214012,LEQVIO,INCLISIRAN,2024/03/01,,2021,NOVARTIS PHARMACEUTICALS CORPORATION,2021/12/22-,0078-1000,UPC6BTX7PY,INCLISIRAN SODIUM,INCLISIRAN,UOW2C71PG5,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/6fc0afca-4513-4c35-b594-6544aee29a44/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6fc0afca-4513-4c35-b594-6544aee29a44,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=6fc0afca-4513-4c35-b594-6544aee29a44,6fc0afca-4513-4c35-b594-6544aee29a44,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRAVENOUS,NDA,216264,BLUDIGO,INDIGOTINDISULFONATE SODIUM,2022/11/16,Diagnostic Dye,2022,PROVEPHARM INC,2022/09/06-,81284-315,D3741U8K7L,INDIGOTINDISULFONATE SODIUM,INDIGOTINDISULFONIC ACID,X7OI7JF73P,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/73f246c4-b127-452e-856f-134b56cb8870/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=73f246c4-b127-452e-856f-134b56cb8870,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=73f246c4-b127-452e-856f-134b56cb8870,73f246c4-b127-452e-856f-134b56cb8870,,,
HUMAN PRESCRIPTION DRUG LABEL,KIT,INTRAVENOUS,NDA,020314,OCTREOSCAN,INDIUM IN -111 PENTETREOTIDE,2022/02/21,Radioactive Diagnostic Agent,,CURIUM US LLC,2015/10/14-,69945-050,58TD96H03I; M312JJ6Z32,INDIUM CHLORIDE IN-111; INDIUM IN-111 PENTETREOTIDE,INDIUM CATION IN-111; INDIUM IN-111 PENTETREOTIDE,M312JJ6Z32; WJZ06C0H8L,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/93d8f3b2-1216-41dc-a63d-0e812b33891d/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=93d8f3b2-1216-41dc-a63d-0e812b33891d,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=93d8f3b2-1216-41dc-a63d-0e812b33891d,93d8f3b2-1216-41dc-a63d-0e812b33891d,,,
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION,INTRAVENOUS,NDA,019841,INDIUM IN 111 CHLORIDE,INDIUM IN 111 CHLORIDE,2019/12/19,,,CURIUM US LLC,2007/12/07-,69945-132,58TD96H03I,INDIUM CHLORIDE IN-111,INDIUM CATION IN-111,WJZ06C0H8L,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/e07e66ef-fb9e-4f9f-b63f-ab28f622cb2e/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e07e66ef-fb9e-4f9f-b63f-ab28f622cb2e,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=e07e66ef-fb9e-4f9f-b63f-ab28f622cb2e,e07e66ef-fb9e-4f9f-b63f-ab28f622cb2e,,,
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION,INTRAVENOUS,NDA,019044,Indium in 111 Oxyquinoline,INDIUM IN-111 OXYQUINOLINE,2024/01/10,,,MEDI PHYSICS INC DBA GE HEALTHCARE,1985/12/01-,17156-021,LGX9OL562T,Indium In-111 Oxyquinoline,Indium Cation In-111,WJZ06C0H8L,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/4c52c904-8137-4b10-8a85-d9b96c2d8a00/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4c52c904-8137-4b10-8a85-d9b96c2d8a00,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=4c52c904-8137-4b10-8a85-d9b96c2d8a00,4c52c904-8137-4b10-8a85-d9b96c2d8a00,,,
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION,INTRATHECAL,NDA,017707,Indium DTPA In 111,INDIUM IN-111 PENTETATE DISODIUM,2024/01/10,,,MEDI PHYSICS INC DBA GE HEALTHCARE,1982/02/18-,17156-251,7UIT3ZGC8E,Indium In-111 Pentetate Disodium,Indium Cation In-111,WJZ06C0H8L,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/4fea5871-b515-4f69-a297-11507ddd7817/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4fea5871-b515-4f69-a297-11507ddd7817,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=4fea5871-b515-4f69-a297-11507ddd7817,4fea5871-b515-4f69-a297-11507ddd7817,,,
HUMAN PRESCRIPTION DRUG LABEL,KIT,INTERSTITIAL; INTRADERMAL; INTRAVASCULAR; INTRAVENOUS,NDA,211580,PINPOINT Lymphatics Kit; SPY Elite Kit; SPY Lymphatics Kit; SPY-MIS Kit; SPY-PHI Kit,INDOCYANINE GREEN,2023/06/15,,1959,NOVADAQ TECHNOLOGIES INC,2018/11/21-; 2019/09/10-,66259-037; 66259-306; 66259-903; 66259-936; 66259-937,059QF0KO0R; IX6J1063HV,INDOCYANINE GREEN; WATER,INDOCYANINE GREEN ACID FORM; WATER,059QF0KO0R; C4V974V932,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/95d11200-1cca-4044-b652-82dac72103b9/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=95d11200-1cca-4044-b652-82dac72103b9,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=95d11200-1cca-4044-b652-82dac72103b9,95d11200-1cca-4044-b652-82dac72103b9,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAVENOUS,NDA,011525,IC-GREEN,INDOCYANINE GREEN,2015/03/02,,,NOVADAQ TECHNOLOGIES INC,2015/03/06-,69450-701,IX6J1063HV,Indocyanine green,Indocyanine Green Acid Form,C4V974V932,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/65ca3d6d-5186-4e84-9949-92c6ee7df296/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=65ca3d6d-5186-4e84-9949-92c6ee7df296,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=65ca3d6d-5186-4e84-9949-92c6ee7df296,65ca3d6d-5186-4e84-9949-92c6ee7df296,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAVENOUS,NDA,011525,IC-Green,INDOCYANINE GREEN,2013/09/17,,,NOVADAQ TECHNOLOGIES INC,2013/09/25-,66259-701,IX6J1063HV,Indocyanine green,Indocyanine Green Acid Form,C4V974V932,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/dcfbec6c-6f44-4eb8-92c1-460ee76e63ab/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=dcfbec6c-6f44-4eb8-92c1-460ee76e63ab,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=dcfbec6c-6f44-4eb8-92c1-460ee76e63ab,dcfbec6c-6f44-4eb8-92c1-460ee76e63ab,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAVENOUS,NDA,011525,IC-Green,INDOCYANINE GREEN,2013/08/30,,,NOVADAQ TECHNOLOGIES INC,2013/09/15-,75874-701,IX6J1063HV,Indocyanine green,Indocyanine Green Acid Form,C4V974V932,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/3a3e5487-52e9-47cd-8d2b-d5378d6feed4/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3a3e5487-52e9-47cd-8d2b-d5378d6feed4,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=3a3e5487-52e9-47cd-8d2b-d5378d6feed4,3a3e5487-52e9-47cd-8d2b-d5378d6feed4,,,
HUMAN PRESCRIPTION DRUG LABEL,SUSPENSION,ORAL,NDA,018332,Indocin,INDOMETHACIN,2023/07/27,Nonsteroidal Anti-inflammatory Drug,1965,ZYLA LIFE SCIENCES US LLC,2019/02/04-,69344-101,XXE1CET956,INDOMETHACIN,INDOMETHACIN,XXE1CET956,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/73878376-1d24-423b-9f37-3666e83c95da/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=73878376-1d24-423b-9f37-3666e83c95da,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=73878376-1d24-423b-9f37-3666e83c95da,73878376-1d24-423b-9f37-3666e83c95da,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAVENOUS,NDA,022536,Indomethacin,INDOMETHACIN,2023/06/16,Nonsteroidal Anti-inflammatory Drug,1965,FRESENIUS KABI USA LLC,2010/03/19-,63323-659,XXE1CET956,INDOMETHACIN,INDOMETHACIN,XXE1CET956,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/30e38747-c553-4e2d-bc23-634e1dd90b8d/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=30e38747-c553-4e2d-bc23-634e1dd90b8d,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=30e38747-c553-4e2d-bc23-634e1dd90b8d,30e38747-c553-4e2d-bc23-634e1dd90b8d,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAVENOUS,NDA,022536,Indomethacin,INDOMETHACIN,2023/06/01,Nonsteroidal Anti-inflammatory Drug,1965,FRESENIUS KABI USA LLC,2010/03/19-,63323-659,XXE1CET956,INDOMETHACIN,INDOMETHACIN,XXE1CET956,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/dd5caa3f-3c09-4034-bf43-2df80c61c07b/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=dd5caa3f-3c09-4034-bf43-2df80c61c07b,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=dd5caa3f-3c09-4034-bf43-2df80c61c07b,dd5caa3f-3c09-4034-bf43-2df80c61c07b,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAVENOUS,NDA,022536,Indomethacin,INDOMETHACIN,2023/04/12,Nonsteroidal Anti-inflammatory Drug,1965,FRESENIUS KABI USA LLC,2010/03/19-,63323-659,XXE1CET956,INDOMETHACIN,INDOMETHACIN,XXE1CET956,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/ec482425-358c-4500-8f5d-79c1379c1fa8/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ec482425-358c-4500-8f5d-79c1379c1fa8,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=ec482425-358c-4500-8f5d-79c1379c1fa8,ec482425-358c-4500-8f5d-79c1379c1fa8,,,
HUMAN PRESCRIPTION DRUG LABEL,SUSPENSION,ORAL,NDA,018332,INDOCIN,INDOMETHACIN,2018/05/28,Nonsteroidal Anti-inflammatory Drug,1965,IROKO PHARMACEUTICALS LLC,1985/10/10-,42211-101,XXE1CET956,INDOMETHACIN,INDOMETHACIN,XXE1CET956,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/06de3c9d-63bf-47c1-f78c-4fbdd482928a/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=06de3c9d-63bf-47c1-f78c-4fbdd482928a,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=06de3c9d-63bf-47c1-f78c-4fbdd482928a,06de3c9d-63bf-47c1-f78c-4fbdd482928a,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,NDA,204768,Tivorbex,INDOMETHACIN,2018/01/31,Nonsteroidal Anti-inflammatory Drug,1965,IROKO PHARMACEUTICALS LLC,2015/07/06-,42211-201; 42211-202,XXE1CET956,INDOMETHACIN,INDOMETHACIN,XXE1CET956,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/04ca474c-798e-43dd-be7a-1b36720e6a3d/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=04ca474c-798e-43dd-be7a-1b36720e6a3d,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=04ca474c-798e-43dd-be7a-1b36720e6a3d,04ca474c-798e-43dd-be7a-1b36720e6a3d,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,NDA,214622,TRUSELTIQ,INFIGRATINIB,2022/02/07,,2021,QED THERAPEUTICS INC,2021/05/28-,72730-101; 72730-111; 72730-202; 72730-506,A4055ME1VK,INFIGRATINIB,INFIGRATINIB,A4055ME1VK,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/af9a96cf-1cd7-8ace-e053-2a95a90a18cc/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=af9a96cf-1cd7-8ace-e053-2a95a90a18cc,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=af9a96cf-1cd7-8ace-e053-2a95a90a18cc,af9a96cf-1cd7-8ace-e053-2a95a90a18cc,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",SUBCUTANEOUS,NDA,211172,Tegsedi,INOTERSEN,2024/01/25,Antisense Oligonucleotide; Transthyretin-directed RNA Interaction,2018,AKCEA THERAPEUTICS INC,2018/10/05-,72126-007,950736UC77,INOTERSEN SODIUM,INOTERSEN,0IEO0F56LV,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/8513207e-b55f-417b-9473-af785146a543/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8513207e-b55f-417b-9473-af785146a543,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=8513207e-b55f-417b-9473-af785146a543,8513207e-b55f-417b-9473-af785146a543,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRAVENOUS,NDA,022290,AdreView,IOBENGUANE I-123,2024/01/10,,2008,MEDI PHYSICS INC,2008/09/19-,17156-235,P2TH1XYZ84,IOBENGUANE I-123,IOBENGUANE I-123,P2TH1XYZ84,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/c89d3ecc-4f4c-4566-8808-79152344194d/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c89d3ecc-4f4c-4566-8808-79152344194d,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=c89d3ecc-4f4c-4566-8808-79152344194d,c89d3ecc-4f4c-4566-8808-79152344194d,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVASCULAR,NDA,020351,Visipaque,IODIXANOL,2023/05/05,Radiographic Contrast Agent,1996,GE HEALTHCARE INC,2002/12/13-; 2003/09/09-,0407-2222; 0407-2223,HW8W27HTXX,Iodixanol,Iodixanol,HW8W27HTXX,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/e9d87b8c-7695-4c0f-8e81-000dedb5f66d/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e9d87b8c-7695-4c0f-8e81-000dedb5f66d,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=e9d87b8c-7695-4c0f-8e81-000dedb5f66d,e9d87b8c-7695-4c0f-8e81-000dedb5f66d,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,022454,DaTscan,IOFLUPANE I-123,2024/01/10,Radioactive Diagnostic Agent,2011,MEDI PHYSICS INC DBA GE HEALTHCARE,2011/03/01-,17156-210,3MM99T8R5Q,ioflupane I-123,ioflupane I-123,3MM99T8R5Q,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/ef7804d7-c691-495b-8aaf-5bc54fd5d9f6/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ef7804d7-c691-495b-8aaf-5bc54fd5d9f6,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=ef7804d7-c691-495b-8aaf-5bc54fd5d9f6,ef7804d7-c691-495b-8aaf-5bc54fd5d9f6,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRATHECAL; INTRAVASCULAR; INTRAVENOUS; ORAL,NDA,018956;020608,OMNIPAQUE,IOHEXOL,2024/02/01,Radiographic Contrast Agent,1985,GE HEALTHCARE INC,2005/08/11-; 2006/07/21-; 2006/09/21-,0407-1412; 0407-1413; 0407-1414,4419T9MX03,IOHEXOL,IOHEXOL,4419T9MX03,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/f9e9d558-064c-4b86-8d96-2f8a678c89f9/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f9e9d558-064c-4b86-8d96-2f8a678c89f9,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=f9e9d558-064c-4b86-8d96-2f8a678c89f9,f9e9d558-064c-4b86-8d96-2f8a678c89f9,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION; SOLUTION",INTRA-ARTICULAR; INTRATHECAL; INTRAVASCULAR; INTRAVENOUS; ORAL; RECTAL,NDA,018956,OMNIPAQUE,IOHEXOL,2023/05/05,Radiographic Contrast Agent,1985,GE HEALTHCARE INC,1985/12/26-; 2004/05/25-; 2004/07/15-; 2018/04/27-,0407-1401; 0407-1411; 0407-1412; 0407-1413; 0407-1414; 0407-1415; 0407-1416,4419T9MX03,Iohexol,Iohexol,4419T9MX03,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/eee15ebe-d349-4497-acef-6abe7a8247fb/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=eee15ebe-d349-4497-acef-6abe7a8247fb,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=eee15ebe-d349-4497-acef-6abe7a8247fb,eee15ebe-d349-4497-acef-6abe7a8247fb,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVASCULAR,NDA,018735,ISOVUE 200; ISOVUE 250; ISOVUE 300; ISOVUE 370,IOPAMIDOL,2023/04/01,Radiographic Contrast Agent,,BRACCO DIAGNOSTICS INC,1985/12/31-,0270-1314; 0270-1315; 0270-1316; 0270-1317,JR13W81H44,IOPAMIDOL,IOPAMIDOL,JR13W81H44,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/ae8c18c9-3e7d-4515-b980-120025a88fc1/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ae8c18c9-3e7d-4515-b980-120025a88fc1,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=ae8c18c9-3e7d-4515-b980-120025a88fc1,ae8c18c9-3e7d-4515-b980-120025a88fc1,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,020327,ISOVUE 300; ISOVUE 370,IOPAMIDOL,2023/04/01,Radiographic Contrast Agent,,BRACCO DIAGNOSTICS INC,2014/06/20-,0270-1315; 0270-1316,JR13W81H44,IOPAMIDOL,IOPAMIDOL,JR13W81H44,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/797a11d7-dcd4-43ff-311b-3b48a10da2f2/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=797a11d7-dcd4-43ff-311b-3b48a10da2f2,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=797a11d7-dcd4-43ff-311b-3b48a10da2f2,797a11d7-dcd4-43ff-311b-3b48a10da2f2,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRATHECAL,NDA,018735,ISOVUE-M,IOPAMIDOL,2022/11/03,Radiographic Contrast Agent,,BRACCO DIAGNOSTICS INC,1985/12/31-,0270-1411; 0270-1412,JR13W81H44,IOPAMIDOL,IOPAMIDOL,JR13W81H44,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/11e893d2-0183-4581-b908-c8b7302c7edb/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=11e893d2-0183-4581-b908-c8b7302c7edb,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=11e893d2-0183-4581-b908-c8b7302c7edb,11e893d2-0183-4581-b908-c8b7302c7edb,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRA-ARTERIAL; INTRAVENOUS,NDA,020220,Ultravist,IOPROMIDE,2023/05/21,Radiographic Contrast Agent,1995,BAYER HEALTHCARE PHARMACEUTICALS INC,2009/12/30-; 2022/06/08-; completed:2009/12/30-2021/01/03,50419-342; 50419-344; 50419-346; 50419-347; 50419-348,712BAC33MZ,IOPROMIDE,IOPROMIDE,712BAC33MZ,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/df917c3a-59a2-4ed1-8470-8a5394c73325/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=df917c3a-59a2-4ed1-8470-8a5394c73325,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=df917c3a-59a2-4ed1-8470-8a5394c73325,df917c3a-59a2-4ed1-8470-8a5394c73325,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRA-ARTERIAL,NDA,021425,Ultravist,IOPROMIDE,2023/04/25,Radiographic Contrast Agent,1995,BAYER HEALTHCARE PHARMACEUTICALS INC,2018/05/04-,50419-344; 50419-346,712BAC33MZ,IOPROMIDE,IOPROMIDE,712BAC33MZ,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/65647318-27e4-4f37-bd68-50eea52d6c5b/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=65647318-27e4-4f37-bd68-50eea52d6c5b,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=65647318-27e4-4f37-bd68-50eea52d6c5b,65647318-27e4-4f37-bd68-50eea52d6c5b,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRA-ARTERIAL,NDA,021425,Ultravist,IOPROMIDE,2023/04/25,Radiographic Contrast Agent,1995,BAYER HEALTHCARE PHARMACEUTICALS INC,2009/12/30-; completed:2009/12/30-2020/04/30,50419-342; 50419-344; 50419-346,712BAC33MZ,IOPROMIDE,IOPROMIDE,712BAC33MZ,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/d96a7883-d160-40a1-bdbd-2e8d7877cd18/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d96a7883-d160-40a1-bdbd-2e8d7877cd18,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=d96a7883-d160-40a1-bdbd-2e8d7877cd18,d96a7883-d160-40a1-bdbd-2e8d7877cd18,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRAVASCULAR,NDA,013295,Conray,IOTHALAMATE MEGLUMINE,2023/05/11,Radiographic Contrast Agent,,LIEBEL FLARSHEIM COMPANY LLC,2003/10/14-,0019-0953,XUW72GOP7W,IOTHALAMATE MEGLUMINE,IOTHALAMIC ACID,16CHD79MIX,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/1292abfc-496f-4df7-9a08-72072953e1f1/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1292abfc-496f-4df7-9a08-72072953e1f1,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=1292abfc-496f-4df7-9a08-72072953e1f1,1292abfc-496f-4df7-9a08-72072953e1f1,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRA-ARTERIAL; INTRAVENOUS,NDA,020923,Optiray 300; Optiray 320; Optiray 350,IOVERSOL,2023/02/17,Radiographic Contrast Agent,1988,LIEBEL FLARSHEIM COMPANY LLC,2011/10/17-,0019-1323; 0019-1332; 0019-1333,N3RIB7X24K,IOVERSOL,IOVERSOL,N3RIB7X24K,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/6cb6ca5f-b249-49b0-a9eb-8aa583da7c74/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6cb6ca5f-b249-49b0-a9eb-8aa583da7c74,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=6cb6ca5f-b249-49b0-a9eb-8aa583da7c74,6cb6ca5f-b249-49b0-a9eb-8aa583da7c74,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRA-ARTERIAL; INTRAVENOUS,NDA,020923,Optiray 300; Optiray 320; Optiray 350,IOVERSOL,2023/02/17,Radiographic Contrast Agent,1988,LIEBEL FLARSHEIM COMPANY LLC,2020/11/18-,0019-1323; 0019-1332; 0019-1333,N3RIB7X24K,IOVERSOL,IOVERSOL,N3RIB7X24K,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/cd718d1c-f813-4114-a50d-c744ff7eb1bf/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=cd718d1c-f813-4114-a50d-c744ff7eb1bf,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=cd718d1c-f813-4114-a50d-c744ff7eb1bf,cd718d1c-f813-4114-a50d-c744ff7eb1bf,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRA-ARTERIAL; INTRAVENOUS,NDA,019710,Optiray 300; Optiray 320; Optiray 350,IOVERSOL,2023/02/17,Radiographic Contrast Agent,1988,LIEBEL FLARSHEIM COMPANY LLC,2012/03/04-,0019-1323; 0019-1332; 0019-1333,N3RIB7X24K,IOVERSOL,IOVERSOL,N3RIB7X24K,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/549d38db-d4ed-4708-8f76-7cdaa157063f/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=549d38db-d4ed-4708-8f76-7cdaa157063f,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=549d38db-d4ed-4708-8f76-7cdaa157063f,549d38db-d4ed-4708-8f76-7cdaa157063f,,,
HUMAN PRESCRIPTION DRUG LABEL,"AEROSOL, METERED",INHALATION,NDA,021527,Atrovent HFA,IPRATROPIUM BROMIDE,2023/10/05,Anticholinergic,2004,BOEHRINGER INGELHEIM PHARMACEUTICALS INC,2005/05/01-,0597-0087,J697UZ2A9J,IPRATROPIUM BROMIDE,IPRATROPIUM,GR88G0I6UL,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/170e98ef-5560-4068-be7d-e649068eb884/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=170e98ef-5560-4068-be7d-e649068eb884,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=170e98ef-5560-4068-be7d-e649068eb884,170e98ef-5560-4068-be7d-e649068eb884,,,
HUMAN PRESCRIPTION DRUG LABEL,"SPRAY, METERED",INHALATION,NDA,021747,Combivent Respimat,IPRATROPIUM BROMIDE AND ALBUTEROL,2024/04/15,Anticholinergic; beta2-Adrenergic Agonist,1996,BOEHRINGER INGELHEIM PHARMACEUTICALS INC,2012/07/01-,0597-0024,021SEF3731; J697UZ2A9J,ALBUTEROL SULFATE; IPRATROPIUM BROMIDE,ALBUTEROL; IPRATROPIUM,GR88G0I6UL; QF8SVZ843E,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/9832312e-0310-4ab6-8501-afa976fc7eb2/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9832312e-0310-4ab6-8501-afa976fc7eb2,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=9832312e-0310-4ab6-8501-afa976fc7eb2,9832312e-0310-4ab6-8501-afa976fc7eb2,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,NDA,218276,FABHALTA,IPTACOPAN,2024/03/13,,2023,NOVARTIS PHARMACEUTICALS CORPORATION,2023/12/05-,0078-1189,XW5CK7C6YH,IPTACOPAN HYDROCHLORIDE,IPTACOPAN,8E05T07Z6W,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/a76b5845-6e21-4d3b-ad07-cd8df1b60bee/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a76b5845-6e21-4d3b-ad07-cd8df1b60bee,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=a76b5845-6e21-4d3b-ad07-cd8df1b60bee,a76b5845-6e21-4d3b-ad07-cd8df1b60bee,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,020757,Avapro,IRBESARTAN,2021/11/16,Angiotensin 2 Receptor Blocker,1997,SANOFI AVENTIS U S LLC,2013/01/01-,0024-5850; 0024-5851; 0024-5852,J0E2756Z7N,IRBESARTAN,IRBESARTAN,J0E2756Z7N,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/7885b2a8-be4e-48ab-8113-4e6ab791eb98/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7885b2a8-be4e-48ab-8113-4e6ab791eb98,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=7885b2a8-be4e-48ab-8113-4e6ab791eb98,7885b2a8-be4e-48ab-8113-4e6ab791eb98,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,020758,Avalide,IRBESARTAN AND HYDROCHLOROTHIAZIDE,2023/07/24,Angiotensin 2 Receptor Blocker; Thiazide Diuretic,1997,SANOFI AVENTIS U S LLC,2013/01/01-,0024-5855; 0024-5856,0J48LPH2TH; J0E2756Z7N,HYDROCHLOROTHIAZIDE; IRBESARTAN,HYDROCHLOROTHIAZIDE; IRBESARTAN,0J48LPH2TH; J0E2756Z7N,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/0d91895e-c869-4b33-9b83-d55c1ad6317e/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0d91895e-c869-4b33-9b83-d55c1ad6317e,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=0d91895e-c869-4b33-9b83-d55c1ad6317e,0d91895e-c869-4b33-9b83-d55c1ad6317e,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, POWDER, FOR SOLUTION",INTRAVENOUS,NDA,207793,Onivyde,IRINOTECAN HYDROCHLORIDE,2024/02/16,Topoisomerase Inhibitor,1996,IPSEN BIOPHARMACEUTICALS INC,2015/10/22-,15054-0043,042LAQ1IIS,IRINOTECAN HYDROCHLORIDE,IRINOTECAN,7673326042,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/c8b58efa-1820-48a4-b70d-62918fc4abfc/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c8b58efa-1820-48a4-b70d-62918fc4abfc,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=c8b58efa-1820-48a4-b70d-62918fc4abfc,c8b58efa-1820-48a4-b70d-62918fc4abfc,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,020571,Camptosar,IRINOTECAN HYDROCHLORIDE,2023/05/16,Topoisomerase Inhibitor,1996,PHARMACIA AND UPJOHN COMPANY LLC,1996/06/14-,0009-7529,042LAQ1IIS,IRINOTECAN HYDROCHLORIDE,IRINOTECAN,7673326042,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/e518dfc6-7e93-4fee-a66c-51e1ab71c056/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e518dfc6-7e93-4fee-a66c-51e1ab71c056,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=e518dfc6-7e93-4fee-a66c-51e1ab71c056,e518dfc6-7e93-4fee-a66c-51e1ab71c056,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRAMUSCULAR; INTRAVENOUS,NDA,017441,INFeD,IRON DEXTRAN,2021/09/20,Parenteral Iron Replacement; Phosphate Binder,1974,ALLERGAN INC,1974/04/29-,0023-6082,95HR524N2M,IRON DEXTRAN,FERRIC CATION,91O4LML611,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/94b01b1e-794b-4bea-8e24-2e54683fc023/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=94b01b1e-794b-4bea-8e24-2e54683fc023,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=94b01b1e-794b-4bea-8e24-2e54683fc023,94b01b1e-794b-4bea-8e24-2e54683fc023,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,021135,Venofer,IRON SUCROSE,2022/06/01,Parenteral Iron Replacement; Phosphate Binder,2000,FRESENIUS MEDICAL CARE HOLDINGS INC,2008/11/04-; 2011/01/27-,49230-530; 49230-534,FZ7NYF5N8L,IRON SUCROSE,FERRIC CATION,91O4LML611,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/f1ab1a22-2b99-4d27-8b5a-9c3bcd5e3040/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f1ab1a22-2b99-4d27-8b5a-9c3bcd5e3040,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=f1ab1a22-2b99-4d27-8b5a-9c3bcd5e3040,f1ab1a22-2b99-4d27-8b5a-9c3bcd5e3040,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,021135,Venofer,IRON SUCROSE,2022/06/01,Parenteral Iron Replacement; Phosphate Binder,2000,AMERICAN REGENT INC,2014/07/14-,0517-2340,FZ7NYF5N8L,IRON SUCROSE,FERRIC CATION,91O4LML611,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/b998ef36-81fa-40a1-9cd1-6d6156f91564/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b998ef36-81fa-40a1-9cd1-6d6156f91564,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=b998ef36-81fa-40a1-9cd1-6d6156f91564,b998ef36-81fa-40a1-9cd1-6d6156f91564,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,021135,Venofer,IRON SUCROSE,2022/06/01,Parenteral Iron Replacement; Phosphate Binder,2000,AMERICAN REGENT INC,2000/11/10-; 2007/06/12-; 2011/01/27-,0517-2310; 0517-2325; 0517-2340,FZ7NYF5N8L,IRON SUCROSE,FERRIC CATION,91O4LML611,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/626dc9e5-c6b4-4f9c-9bf4-774fd3ae619a/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=626dc9e5-c6b4-4f9c-9bf4-774fd3ae619a,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=626dc9e5-c6b4-4f9c-9bf4-774fd3ae619a,626dc9e5-c6b4-4f9c-9bf4-774fd3ae619a,,,
HUMAN PRESCRIPTION DRUG LABEL,"CAPSULE; INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAVENOUS; ORAL,NDA,207500;207501,CRESEMBA,ISAVUCONAZONIUM SULFATE,2023/12/08,Azole Antifungal,2015,ASTELLAS PHARMA US INC,2015/03/06-; 2015/11/04-; 2022/11/22-,0469-0420; 0469-0520; 0469-2860,31Q44514JV,ISAVUCONAZONIUM SULFATE,ISAVUCONAZOLE,60UTO373KE,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/8f7f73b8-586a-4df0-935f-fecd4696c16c/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8f7f73b8-586a-4df0-935f-fecd4696c16c,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=8f7f73b8-586a-4df0-935f-fecd4696c16c,8f7f73b8-586a-4df0-935f-fecd4696c16c,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,011961,Marplan,ISOCARBOXAZID,2023/07/17,Monoamine Oxidase Inhibitor,,VALIDUS PHARMACEUTICALS LLC,1959/07/01-,30698-032,34237V843T,ISOCARBOXAZID,ISOCARBOXAZID,34237V843T,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/ac387aa0-3f04-4865-a913-db6ed6f4fdc5/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ac387aa0-3f04-4865-a913-db6ed6f4fdc5,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=ac387aa0-3f04-4865-a913-db6ed6f4fdc5,ac387aa0-3f04-4865-a913-db6ed6f4fdc5,,,
HUMAN PRESCRIPTION DRUG LABEL,INHALANT,INHALATION,NDA,017624,FORANE,ISOFLURANE,2022/11/01,General Anesthetic,,BAXTER HEALTHCARE CORPORATION,1979/12/18-,10019-360,CYS9AKD70P,ISOFLURANE,ISOFLURANE,CYS9AKD70P,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/3d30eb8d-a62e-475f-926b-78ba63bee9c8/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3d30eb8d-a62e-475f-926b-78ba63bee9c8,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=3d30eb8d-a62e-475f-926b-78ba63bee9c8,3d30eb8d-a62e-475f-926b-78ba63bee9c8,,,
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION,INTRAVENOUS,NDA,019018,TrophAmine,"ISOLEUCINE, LEUCINE, LYSINE ACETATE, METHIONINE, PHENYLALANINE, THREONINE, TRYPTOPHAN, VALINE, CYSTEINE HYDROCHLORIDE, HISTIDINE, TYROSINE, N-ACETYL-TYROSINE, ALANINE, ARGININE, PROLINE, SERINE, GLYCI",2022/08/22,Amino Acid,,B BRAUN MEDICAL INC,2020/10/27-,0264-1933,04Y7590D77; 1EQV5MLY3D; 2ZD004190S; 30KYC7MIAI; 3KX376GY7L; 42HK56048U; 452VLY9402; 47E5O17Y3R; 4QD397987E; 8DUH1N11BX; 94ZLA3W45F; 9DLQ4CIU6V; AE28F7PNPL; DA8G610ZO5; GMW67QNF9C; HG18B9YRS7; OF5P57N2ZX; TE7660XO1C; TTL6G7LIWZ; ZT934N0X4W,ACETYL L-TYROSINE; ALANINE; ARGININE; ASPARTIC ACID; CYSTEINE HYDROCHLORIDE; GLUTAMIC ACID; GLYCINE; HISTIDINE; ISOLEUCINE; LEUCINE,ACETYL L-TYROSINE; ALANINE; ARGININE; ASPARTIC ACID; CYSTEINE; GLUTAMIC ACID; GLYCINE; HISTIDINE; ISOLEUCINE; LEUCINE,04Y7590D77; 1EQV5MLY3D; 2ZD004190S; 30KYC7MIAI; 3KX376GY7L; 42HK56048U; 452VLY9402; 47E5O17Y3R; 4QD397987E; 8DUH1N11BX; 94ZLA3W45F; 9DLQ4CIU6V; AE28F7PNPL; DA8G610ZO5; GMW67QNF9C; HG18B9YRS7; K3Z4F929H6; K848JZ4886; OF5P57N2ZX; TE7660XO1C,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/cb6d23ff-3ec5-445a-acbe-f88fd57949bf/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=cb6d23ff-3ec5-445a-acbe-f88fd57949bf,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=cb6d23ff-3ec5-445a-acbe-f88fd57949bf,cb6d23ff-3ec5-445a-acbe-f88fd57949bf,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,012093,Isosorbide Dinitrate,ISOSORBIDE DINITRATE,2020/03/02,Nitrate Vasodilator,,OCEANSIDE PHARMACEUTICALS,2020/03/02-,68682-192; 68682-193,IA7306519N,ISOSORBIDE DINITRATE,ISOSORBIDE DINITRATE,IA7306519N,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/723d9f78-9d77-4575-af27-1aa117e6b8d7/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=723d9f78-9d77-4575-af27-1aa117e6b8d7,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=723d9f78-9d77-4575-af27-1aa117e6b8d7,723d9f78-9d77-4575-af27-1aa117e6b8d7,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,012093,Isordil Titradose,ISOSORBIDE DINITRATE,2019/08/08,Nitrate Vasodilator,,BAUSCH HEALTH US LLC,2013/04/01-,0187-0152; 0187-0192,IA7306519N,ISOSORBIDE DINITRATE,ISOSORBIDE DINITRATE,IA7306519N,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/8ddd2577-311a-4967-bb67-ad72e2b76f83/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8ddd2577-311a-4967-bb67-ad72e2b76f83,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=8ddd2577-311a-4967-bb67-ad72e2b76f83,8ddd2577-311a-4967-bb67-ad72e2b76f83,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",SUBCUTANEOUS,NDA,018310,LYMPHAZURIN,ISOSULFAN BLUE,2012/01/31,,1981,UNITED STATES SURGICAL CORPORATION,2012/01/12-,63261-250,39N9K8S2A4,ISOSULFAN BLUE,ISOSULFAN BLUE,39N9K8S2A4,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/cbee4532-238b-4f91-86ae-f8c0c1b6d7da/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=cbee4532-238b-4f91-86ae-f8c0c1b6d7da,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=cbee4532-238b-4f91-86ae-f8c0c1b6d7da,cbee4532-238b-4f91-86ae-f8c0c1b6d7da,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,NDA,021951;211913,Absorica; Absorica LD,ISOTRETINOIN,2023/06/12,Retinoid,1982,SUN PHARMACEUTICAL INDUSTRIES INC,2012/06/08-; 2015/02/17-; 2019/11/20-; completed:2019/11/20-2019/11/20,10631-002; 10631-003; 10631-004; 10631-005; 10631-006; 10631-007; 10631-115; 10631-116; 10631-117; 10631-118; 10631-133; 10631-134,EH28UP18IF,ISOTRETINOIN,ISOTRETINOIN,EH28UP18IF,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/3ef0cff8-19c1-4441-b780-fca6c7ee1615/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3ef0cff8-19c1-4441-b780-fca6c7ee1615,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=3ef0cff8-19c1-4441-b780-fca6c7ee1615,3ef0cff8-19c1-4441-b780-fca6c7ee1615,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,022075,NOURIANZ,ISTRADEFYLLINE,2023/09/13,,2019,KYOWA KIRIN INC,2019/08/27-,42747-602; 42747-604,2GZ0LIK7T4,istradefylline,istradefylline,2GZ0LIK7T4,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/a7d008cb-b273-4049-a5d2-9c6902910d58/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a7d008cb-b273-4049-a5d2-9c6902910d58,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=a7d008cb-b273-4049-a5d2-9c6902910d58,a7d008cb-b273-4049-a5d2-9c6902910d58,,,
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION,ORAL,NDA,020657,itraconazole,ITRACONAZOLE,2024/04/18,Azole Antifungal,,PATRIOT PHARMACEUTICALS LLC,completed:1997/02/21-2025/05/31,10147-0150,304NUG5GF4,ITRACONAZOLE,ITRACONAZOLE,304NUG5GF4,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/8e41e42c-3ae0-4091-970b-bc0086755f1d/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8e41e42c-3ae0-4091-970b-bc0086755f1d,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=8e41e42c-3ae0-4091-970b-bc0086755f1d,8e41e42c-3ae0-4091-970b-bc0086755f1d,,,
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION,ORAL,NDA,020657,SPORANOX,ITRACONAZOLE,2024/03/29,Azole Antifungal,,JANSSEN PHARMACEUTICALS INC,completed:1997/02/21-2025/05/31,50458-295,304NUG5GF4,ITRACONAZOLE,ITRACONAZOLE,304NUG5GF4,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/ae50721d-ee15-4ee7-9fe7-afd98c56461b/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ae50721d-ee15-4ee7-9fe7-afd98c56461b,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=ae50721d-ee15-4ee7-9fe7-afd98c56461b,ae50721d-ee15-4ee7-9fe7-afd98c56461b,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,NDA,020083,itraconazole,ITRACONAZOLE,2024/03/25,Azole Antifungal,,PATRIOT PHARMACEUTICALS,2005/02/01-,10147-1700,304NUG5GF4,ITRACONAZOLE,ITRACONAZOLE,304NUG5GF4,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/6242b7ad-eaa0-a524-b6e0-ec33e63407db/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6242b7ad-eaa0-a524-b6e0-ec33e63407db,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=6242b7ad-eaa0-a524-b6e0-ec33e63407db,6242b7ad-eaa0-a524-b6e0-ec33e63407db,,,
HUMAN PRESCRIPTION DRUG LABEL,"CAPSULE, GELATIN COATED",ORAL,NDA,208901,Tolsura,ITRACONAZOLE,2024/03/01,Azole Antifungal,1992,MAYNE PHARMA COMMERCIAL LLC,2018/12/11-,51862-462,304NUG5GF4,ITRACONAZOLE,ITRACONAZOLE,304NUG5GF4,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/306352d1-9d5a-49ad-b72d-893b99546861/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=306352d1-9d5a-49ad-b72d-893b99546861,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=306352d1-9d5a-49ad-b72d-893b99546861,306352d1-9d5a-49ad-b72d-893b99546861,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,NDA,020083,SPORANOX,ITRACONAZOLE,2024/02/14,Azole Antifungal,,JANSSEN PHARMACEUTICALS INC,1992/09/11-,50458-290,304NUG5GF4,ITRACONAZOLE,ITRACONAZOLE,304NUG5GF4,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/a4d555fa-787c-40fb-bb7d-b0d4f7318fd0/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a4d555fa-787c-40fb-bb7d-b0d4f7318fd0,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=a4d555fa-787c-40fb-bb7d-b0d4f7318fd0,a4d555fa-787c-40fb-bb7d-b0d4f7318fd0,,,
HUMAN PRESCRIPTION DRUG LABEL,"SOLUTION; TABLET, FILM COATED",ORAL,NDA,206143;209964,Corlanor,IVABRADINE,2022/02/14,Hyperpolarization-activated Cyclic Nucleotide-gated Channel Blocker,2015,AMGEN INC,2015/04/20-; 2019/04/19-,55513-800; 55513-810; 55513-813,TP19837BZK,IVABRADINE HYDROCHLORIDE,IVABRADINE,3H48L0LPZQ,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/92018a65-38f6-45f7-91d4-a34921b81d0d/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=92018a65-38f6-45f7-91d4-a34921b81d0d,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=92018a65-38f6-45f7-91d4-a34921b81d0d,92018a65-38f6-45f7-91d4-a34921b81d0d,,,
HUMAN PRESCRIPTION DRUG LABEL,"GRANULE; TABLET, FILM COATED",ORAL,NDA,203188;207925,Kalydeco,IVACAFTOR,2023/10/16,Cystic Fibrosis Transmembrane Conductance Regulator Potentiator,2012,VERTEX PHARMACEUTICALS INCORPORATED,2012/01/31-; 2015/03/23-; 2019/04/29-; 2023/05/03-,51167-200; 51167-300; 51167-400; 51167-600; 51167-770; 51167-785,1Y740ILL1Z,ivacaftor,ivacaftor,1Y740ILL1Z,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/0ab0c9f8-3eee-4e0f-9f3f-c1e16aaffe25/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0ab0c9f8-3eee-4e0f-9f3f-c1e16aaffe25,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=0ab0c9f8-3eee-4e0f-9f3f-c1e16aaffe25,0ab0c9f8-3eee-4e0f-9f3f-c1e16aaffe25,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,050742,STROMECTOL,IVERMECTIN,2023/12/10,Antiparasitic; Pediculicide,,MERCK SHARP AND DOHME LLC,1996/11/22-,0006-0032,8883YP2R6D,IVERMECTIN,IVERMECTIN,8883YP2R6D,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/681888c9-af79-4b7d-ae80-c3f4f6f1effd/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=681888c9-af79-4b7d-ae80-c3f4f6f1effd,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=681888c9-af79-4b7d-ae80-c3f4f6f1effd,681888c9-af79-4b7d-ae80-c3f4f6f1effd,,,
HUMAN PRESCRIPTION DRUG LABEL,CREAM,TOPICAL,NDA,206255,SOOLANTRA,IVERMECTIN,2022/10/14,Antiparasitic; Pediculicide,1996,GALDERMA LABORATORIES L P,2015/01/01-,0299-3823,8883YP2R6D,IVERMECTIN,IVERMECTIN,8883YP2R6D,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/b1d5b166-ab06-4ab5-b0c6-31126238118a/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b1d5b166-ab06-4ab5-b0c6-31126238118a,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=b1d5b166-ab06-4ab5-b0c6-31126238118a,b1d5b166-ab06-4ab5-b0c6-31126238118a,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,211192,TIBSOVO,IVOSIDENIB,2023/10/30,Isocitrate Dehydrogenase 1 Inhibitor,2018,SERVIER PHARMACEUTICAL LLC,2021/10/19-,72694-617,Q2PCN8MAM6,ivosidenib,ivosidenib,Q2PCN8MAM6,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/65d254c0-67ad-42c4-b972-ad463b755b2d/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=65d254c0-67ad-42c4-b972-ad463b755b2d,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=65d254c0-67ad-42c4-b972-ad463b755b2d,65d254c0-67ad-42c4-b972-ad463b755b2d,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,211192,Tibsovo,IVOSIDENIB,2022/05/12,Isocitrate Dehydrogenase 1 Inhibitor,2018,AGIOS PHARMACEUTICALS INC,completed:2018/07/20-2024/11/30,71334-100,Q2PCN8MAM6,IVOSIDENIB,IVOSIDENIB,Q2PCN8MAM6,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/5b6d8ae8-bac8-4e1b-b1b4-7f9665e62de5/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5b6d8ae8-bac8-4e1b-b1b4-7f9665e62de5,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=5b6d8ae8-bac8-4e1b-b1b4-7f9665e62de5,5b6d8ae8-bac8-4e1b-b1b4-7f9665e62de5,,,
HUMAN PRESCRIPTION DRUG LABEL,KIT,INTRAVENOUS,NDA,022065,IXEMPRA,IXABEPILONE,2023/01/25,Microtubule Inhibitor,2007,R PHARM US OPERATING LLC,2007/10/16-,70020-1910; 70020-1911,K27005NP0A,IXABEPILONE,IXABEPILONE,K27005NP0A,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/241f0b1e-8b95-470d-876f-bf1804daaf18/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=241f0b1e-8b95-470d-876f-bf1804daaf18,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=241f0b1e-8b95-470d-876f-bf1804daaf18,241f0b1e-8b95-470d-876f-bf1804daaf18,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,NDA,208462,NINLARO,IXAZOMIB,2024/03/01,Proteasome Inhibitor,2015,TAKEDA PHARMACEUTICALS AMERICA INC,2015/11/20-,63020-230; 63020-390; 63020-400,46CWK97Z3K,ixazomib citrate,ixazomib,71050168A2,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/038f2461-834b-4488-9ebd-863c83eef5a7/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=038f2461-834b-4488-9ebd-863c83eef5a7,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=038f2461-834b-4488-9ebd-863c83eef5a7,038f2461-834b-4488-9ebd-863c83eef5a7,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRAMUSCULAR; INTRAVENOUS,NDA,016812,Ketalar,KETAMINE HYDROCHLORIDE,2023/06/23,General Anesthetic,1970,PAR PHARMACEUTICAL INC,2007/10/01-,42023-113; 42023-114; 42023-115,O18YUO0I83,KETAMINE HYDROCHLORIDE,KETAMINE,690G0D6V8H,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/14e8f864-8b8a-4e7e-8439-e510d3107063/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=14e8f864-8b8a-4e7e-8439-e510d3107063,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=14e8f864-8b8a-4e7e-8439-e510d3107063,14e8f864-8b8a-4e7e-8439-e510d3107063,,,
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION/ DROPS,OPHTHALMIC,NDA,021528,ACULAR LS,KETOROLAC TROMETHAMINE,2024/04/19,Cyclooxygenase Inhibitor; Nonsteroidal Anti-inflammatory Drug,1991,ALLERGAN INC,2003/08/19-,0023-9277,4EVE5946BQ,KETOROLAC TROMETHAMINE,KETOROLAC,YZI5105V0L,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/4fad0873-f79c-4f07-9fac-5060be6b38fe/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4fad0873-f79c-4f07-9fac-5060be6b38fe,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=4fad0873-f79c-4f07-9fac-5060be6b38fe,4fad0873-f79c-4f07-9fac-5060be6b38fe,,,
HUMAN PRESCRIPTION DRUG LABEL,"SPRAY, METERED",NASAL,NDA,022382,Sprix,KETOROLAC TROMETHAMINE,2023/07/28,Cyclooxygenase Inhibitor; Nonsteroidal Anti-inflammatory Drug,1989,ZYLA LIFE SCIENCES US LLC,2011/04/26-,69344-144,4EVE5946BQ,KETOROLAC TROMETHAMINE,KETOROLAC,YZI5105V0L,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/97005a1c-167e-4676-bae7-e49b38c36f9e/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=97005a1c-167e-4676-bae7-e49b38c36f9e,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=97005a1c-167e-4676-bae7-e49b38c36f9e,97005a1c-167e-4676-bae7-e49b38c36f9e,,,
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION/ DROPS,OPHTHALMIC,NDA,022427,ACUVAIL,KETOROLAC TROMETHAMINE,2019/02/01,Cyclooxygenase Inhibitor; Nonsteroidal Anti-inflammatory Drug,1991,ALLERGAN INC,2009/08/01-,0023-3507,4EVE5946BQ,KETOROLAC TROMETHAMINE,KETOROLAC,YZI5105V0L,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/3cea5803-a446-4d2c-9747-f3fb034332c8/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3cea5803-a446-4d2c-9747-f3fb034332c8,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=3cea5803-a446-4d2c-9747-f3fb034332c8,3cea5803-a446-4d2c-9747-f3fb034332c8,,,
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION/ DROPS,OPHTHALMIC,NDA,019700,Acular,KETOROLAC TROMETHAMINE,2012/06/01,Cyclooxygenase Inhibitor; Nonsteroidal Anti-inflammatory Drug,1991,ALLERGAN INC,1992/12/01-,0023-2181,4EVE5946BQ,KETOROLAC TROMETHAMINE,KETOROLAC,YZI5105V0L,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/c94644d3-7b64-4f3d-a0c7-12c77466a0fc/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c94644d3-7b64-4f3d-a0c7-12c77466a0fc,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=c94644d3-7b64-4f3d-a0c7-12c77466a0fc,c94644d3-7b64-4f3d-a0c7-12c77466a0fc,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAVENOUS,NDA,215841,LOCAMETZ,KIT FOR THE PREPARATION OF GALLIUM GA 68 GOZETOTIDE,2023/11/08,,2020,ADVANCED ACCELERATOR APPLICATIONS USA INC,2022/03/23-,69488-017,9AG41L3AOQ,GOZETOTIDE,GOZETOTIDE,9AG41L3AOQ,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/1ea62b65-8138-4a88-8a33-4060ececa42f/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1ea62b65-8138-4a88-8a33-4060ececa42f,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=1ea62b65-8138-4a88-8a33-4060ececa42f,1ea62b65-8138-4a88-8a33-4060ececa42f,,,
HUMAN PRESCRIPTION DRUG LABEL,KIT,INTRAVENOUS,NDA,214032,ILLUCCIX,KIT FOR THE PREPARATION OF GALLIUM GA 68 GOZETOTIDE INJECTION,2023/10/13,,2020,TELIX PHARMACEUTICALS US INC,2021/12/17-,74725-100,9AG41L3AOQ,GOZETOTIDE,GOZETOTIDE,9AG41L3AOQ,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/d4643b31-9b4f-673f-e053-2a95a90a559d/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d4643b31-9b4f-673f-e053-2a95a90a559d,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=d4643b31-9b4f-673f-e053-2a95a90a559d,d4643b31-9b4f-673f-e053-2a95a90a559d,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INHALATION; INTRAVENOUS,NDA,018511,DRAXIMAGE DTPA,KIT FOR THE PREPARATION OF TECHNETIUM TC 99M PENTETATE,2023/05/08,Lead Chelator,1974,JUBILANT DRAXIMAGE INC DBA JUBILANT RADIOPHARMA,1989/12/29-,65174-288,7A314HQM0I,Pentetic Acid,Pentetic Acid,7A314HQM0I,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/becdab53-f7a7-7280-6930-21f3a61b99e7/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=becdab53-f7a7-7280-6930-21f3a61b99e7,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=becdab53-f7a7-7280-6930-21f3a61b99e7,becdab53-f7a7-7280-6930-21f3a61b99e7,,,
HUMAN PRESCRIPTION DRUG LABEL,KIT,INHALATION,NDA,022335,TECHNEGAS,KIT FOR THE PREPARATION OF TECHNETIUM TC 99M-LABELED CARBON INHALATION AEROSOL,2024/02/05,,2023,CYCLOMEDICA AUSTRALIA PTY LIMITED,2023/09/29-,73814-989,4QQN74LH4O,GRAPHITE,GRAPHITE,4QQN74LH4O,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/10ab1c14-3e01-e12b-e063-6394a90aea2f/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=10ab1c14-3e01-e12b-e063-6394a90aea2f,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=10ab1c14-3e01-e12b-e063-6394a90aea2f,10ab1c14-3e01-e12b-e063-6394a90aea2f,,,
HUMAN PRESCRIPTION DRUG LABEL,KIT,INHALATION,NDA,022335,TECHNEGAS,KIT FOR THE PREPARATION OF TECHNETIUM TC 99M-LABELED CARBON INHALATION AEROSOL,2024/01/24,,2023,CYCLOMEDICA AUSTRALIA PTY LIMITED,2023/09/29-,73814-987,4QQN74LH4O,GRAPHITE,GRAPHITE,4QQN74LH4O,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/10320da4-0c64-4d03-e063-6394a90a1923/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=10320da4-0c64-4d03-e063-6394a90a1923,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=10320da4-0c64-4d03-e063-6394a90a1923,10320da4-0c64-4d03-e063-6394a90a1923,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRAVENOUS,NDA,213330,Labetalol Hydrochloride,LABETALOL HYDROCHLORIDE,2024/04/09,beta-Adrenergic Blocker,1984,HIKMA PHARMACEUTICALS USA INC,2022/03/18-,0641-6252,1GEV3BAW9J,LABETALOL HYDROCHLORIDE,LABETALOL,R5H8897N95,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/1c9d496d-cace-4283-82bb-6dcd3828b73e/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1c9d496d-cace-4283-82bb-6dcd3828b73e,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=1c9d496d-cace-4283-82bb-6dcd3828b73e,1c9d496d-cace-4283-82bb-6dcd3828b73e,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRAVENOUS,NDA,213330,Labetalol HCl in Dextrose; Labetalol HCl in Sodium Chloride,LABETALOL HYDROCHLORIDE,2022/03/01,beta-Adrenergic Blocker,1984,HIKMA PHARMACEUTICALS USA INC,2020/11/09-,0143-9363; 0143-9364; 0143-9365; 0143-9366,1GEV3BAW9J,LABETALOL HYDROCHLORIDE,LABETALOL,R5H8897N95,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/99a715a0-4579-410c-b102-7ef6fab8db55/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=99a715a0-4579-410c-b102-7ef6fab8db55,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=99a715a0-4579-410c-b102-7ef6fab8db55,99a715a0-4579-410c-b102-7ef6fab8db55,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,018716,Trandate,LABETALOL HYDROCHLORIDE,2009/12/14,beta-Adrenergic Blocker,,PROMETHEUS LABORATORIES INC,1984/05/31-,65483-391; 65483-392; 65483-393,1GEV3BAW9J,labetalol hydrochloride,labetalol,R5H8897N95,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/a4195473-51a9-40f1-8678-1478ebca2d84/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a4195473-51a9-40f1-8678-1478ebca2d84,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=a4195473-51a9-40f1-8678-1478ebca2d84,a4195473-51a9-40f1-8678-1478ebca2d84,,,
HUMAN PRESCRIPTION DRUG LABEL,"CAPSULE, EXTENDED RELEASE",ORAL,NDA,216185,MOTPOLY XR,LACOSAMIDE,2023/12/21,,2008,AUCTA PHARMACEUTICALS INC,2023/05/05-,73289-0063; 73289-0064; 73289-0065,563KS2PQY5,LACOSAMIDE,LACOSAMIDE,563KS2PQY5,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/fb8235b4-4cd3-6f22-e053-6294a90a545c/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=fb8235b4-4cd3-6f22-e053-6294a90a545c,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=fb8235b4-4cd3-6f22-e053-6294a90a545c,fb8235b4-4cd3-6f22-e053-6294a90a545c,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION; SOLUTION; TABLET, FILM COATED",INTRAVENOUS; ORAL,NDA,022253;022254;022255,Vimpat,LACOSAMIDE,2023/10/06,,2008,UCB INC,2009/05/26-; 2010/04/20-,0131-1810; 0131-2477; 0131-2478; 0131-2479; 0131-2480; 0131-5410,563KS2PQY5,LACOSAMIDE,LACOSAMIDE,563KS2PQY5,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/9e79b42c-38a3-4b2c-a196-a5a1948250e2/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9e79b42c-38a3-4b2c-a196-a5a1948250e2,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=9e79b42c-38a3-4b2c-a196-a5a1948250e2,9e79b42c-38a3-4b2c-a196-a5a1948250e2,,,
HUMAN PRESCRIPTION DRUG LABEL,GEL,VAGINAL,NDA,208352,Phexxi,"LACTIC ACID, L-, CITRIC ACID MONOHYDRATE, AND POTASSIUM BITARTRATE",2023/11/21,Anti-coagulant; Calculi Dissolution Agent,2020,EVOFEM INC,2020/08/01-,69751-100,2968PHW8QP; F9S9FFU82N; NPT6P8P3UU,"CITRIC ACID MONOHYDRATE; LACTIC ACID, L-; POTASSIUM BITARTRATE","ANHYDROUS CITRIC ACID; LACTIC ACID, L-; TARTARIC ACID",F9S9FFU82N; W4888I119H; XF417D3PSL,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/173ff411-7227-47b0-94dc-844e1ebaf14e/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=173ff411-7227-47b0-94dc-844e1ebaf14e,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=173ff411-7227-47b0-94dc-844e1ebaf14e,173ff411-7227-47b0-94dc-844e1ebaf14e,,,
HUMAN PRESCRIPTION DRUG LABEL,"SOLUTION; TABLET, FILM COATED",ORAL,NDA,021003;021004,EPIVIR HBV,LAMIVUDINE,2021/12/22,Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor,1995,GLAXOSMITHKLINE LLC,1998/12/17-; 1998/12/23-,0173-0662; 0173-0663,2T8Q726O95,LAMIVUDINE,LAMIVUDINE,2T8Q726O95,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/2df7349c-f5d7-47b5-d29b-1b6b31985591/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2df7349c-f5d7-47b5-d29b-1b6b31985591,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=2df7349c-f5d7-47b5-d29b-1b6b31985591,2df7349c-f5d7-47b5-d29b-1b6b31985591,,,
HUMAN PRESCRIPTION DRUG LABEL,"SOLUTION; TABLET, FILM COATED",ORAL,NDA,020564;020596,EPIVIR,LAMIVUDINE,2020/09/01,Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor,1995,VIIV HEALTHCARE COMPANY,2010/10/04-,49702-203; 49702-204; 49702-205,2T8Q726O95,LAMIVUDINE,LAMIVUDINE,2T8Q726O95,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/89226149-47fa-4f7d-bb1f-1aa7034486b8/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=89226149-47fa-4f7d-bb1f-1aa7034486b8,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=89226149-47fa-4f7d-bb1f-1aa7034486b8,89226149-47fa-4f7d-bb1f-1aa7034486b8,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,022141,CIMDUO,LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE,2021/02/15,Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor,2018,MYLAN SPECIALTY L P,2018/06/25-,49502-450,2T8Q726O95; OTT9J7900I,LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE,LAMIVUDINE; TENOFOVIR ANHYDROUS,2T8Q726O95; W4HFE001U5,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/a300f04d-118f-4136-aaf3-ddfd00197f86/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a300f04d-118f-4136-aaf3-ddfd00197f86,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=a300f04d-118f-4136-aaf3-ddfd00197f86,a300f04d-118f-4136-aaf3-ddfd00197f86,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,020857,COMBIVIR,LAMIVUDINE AND ZIDOVUDINE,2023/08/22,Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor,1997,VIIV HEALTHCARE COMPANY,2010/10/19-,49702-202,2T8Q726O95; 4B9XT59T7S,LAMIVUDINE; ZIDOVUDINE,LAMIVUDINE; ZIDOVUDINE,2T8Q726O95; 4B9XT59T7S,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/16da660b-9981-4d24-a14a-94c7744fce4f/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=16da660b-9981-4d24-a14a-94c7744fce4f,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=16da660b-9981-4d24-a14a-94c7744fce4f,16da660b-9981-4d24-a14a-94c7744fce4f,,,
HUMAN PRESCRIPTION DRUG LABEL,"KIT; TABLET; TABLET, FOR SUSPENSION; TABLET, ORALLY DISINTEGRATING",ORAL,NDA,020241;020764;022251,LAMICTAL; LAMICTAL ODT,LAMOTRIGINE,2023/02/09,Anti-epileptic Agent; Mood Stabilizer,1994,GLAXOSMITHKLINE LLC,1995/01/17-; 1995/01/18-; 1996/08/15-; 1998/09/03-; 1998/09/04-,0173-0526; 0173-0527; 0173-0594; 0173-0633; 0173-0642; 0173-0643; 0173-0644; 0173-0699; 0173-0772; 0173-0774; 0173-0776; 0173-0777; 0173-0778; 0173-0779; 0173-0780; 0173-0817,U3H27498KS,LAMOTRIGINE,LAMOTRIGINE,U3H27498KS,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/d7e3572d-56fe-4727-2bb4-013ccca22678/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d7e3572d-56fe-4727-2bb4-013ccca22678,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=d7e3572d-56fe-4727-2bb4-013ccca22678,d7e3572d-56fe-4727-2bb4-013ccca22678,,,
HUMAN PRESCRIPTION DRUG LABEL,"KIT; TABLET, FILM COATED, EXTENDED RELEASE",ORAL,NDA,022115,LAMICTAL XR,LAMOTRIGINE,2023/01/31,Anti-epileptic Agent; Mood Stabilizer,1994,GLAXOSMITHKLINE LLC,2009/07/06-; 2011/03/31-; 2011/08/15-,0173-0754; 0173-0755; 0173-0756; 0173-0757; 0173-0758; 0173-0759; 0173-0760; 0173-0761; 0173-0781,U3H27498KS,LAMOTRIGINE,LAMOTRIGINE,U3H27498KS,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/3e2c9a35-6a39-41d7-ad84-3c0bb8894b09/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3e2c9a35-6a39-41d7-ad84-3c0bb8894b09,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=3e2c9a35-6a39-41d7-ad84-3c0bb8894b09,3e2c9a35-6a39-41d7-ad84-3c0bb8894b09,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,SUBCUTANEOUS,NDA,022074,SOMATULINE DEPOT,LANREOTIDE ACETATE,2023/11/02,Somatostatin Analog,2007,IPSEN BIOPHARMACEUTICALS INC,2007/11/14-,15054-1060; 15054-1090; 15054-1120,IEU56G3J9C,lanreotide acetate,lanreotide,0G3DE8943Y,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/6e4a41fd-a753-4362-87ee-8cc56ed3660d/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6e4a41fd-a753-4362-87ee-8cc56ed3660d,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=6e4a41fd-a753-4362-87ee-8cc56ed3660d,6e4a41fd-a753-4362-87ee-8cc56ed3660d,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,SUBCUTANEOUS,NDA,215395,Lanreotide Acetate,LANREOTIDE ACETATE,2023/09/01,Somatostatin Analog,2007,CIPLA USA INC,2021/12/24-,69097-870; 69097-880; 69097-890,IEU56G3J9C,LANREOTIDE ACETATE,LANREOTIDE,0G3DE8943Y,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/11da176a-99bc-4ada-8b3f-6bd2b37a6313/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=11da176a-99bc-4ada-8b3f-6bd2b37a6313,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=11da176a-99bc-4ada-8b3f-6bd2b37a6313,11da176a-99bc-4ada-8b3f-6bd2b37a6313,,,
HUMAN PRESCRIPTION DRUG LABEL,"CAPSULE, DELAYED RELEASE; TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE",ORAL,NDA,020406;021428,Prevacid; Prevacid SoluTab,LANSOPRAZOLE,2023/09/11,Proton Pump Inhibitor,1995,TAKEDA PHARMACEUTICALS AMERICA INC,1995/05/10-; 2002/08/30-,64764-046; 64764-543; 64764-544,0K5C5T2QPG,lansoprazole,lansoprazole,0K5C5T2QPG,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/71ba78cb-7e46-43eb-9425-fa130f537f84/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=71ba78cb-7e46-43eb-9425-fa130f537f84,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=71ba78cb-7e46-43eb-9425-fa130f537f84,71ba78cb-7e46-43eb-9425-fa130f537f84,,,
HUMAN PRESCRIPTION DRUG LABEL,"POWDER; TABLET, CHEWABLE",ORAL,NDA,021468;204734,Fosrenol,LANTHANUM CARBONATE,2023/12/20,Phosphate Binder,2004,TAKEDA PHARMACEUTICALS AMERICA INC,2004/10/26-; 2005/11/23-; 2014/09/24-,54092-252; 54092-253; 54092-254; 54092-256; 54092-257,490D9F069T,LANTHANUM CARBONATE,LANTHANUM CATION (3+),O7FU5X12W5,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/f10776b2-2c25-4343-aabe-68f302e5cb54/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f10776b2-2c25-4343-aabe-68f302e5cb54,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=f10776b2-2c25-4343-aabe-68f302e5cb54,f10776b2-2c25-4343-aabe-68f302e5cb54,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,022059,TYKERB,LAPATINIB,2024/03/20,Kinase Inhibitor,2007,NOVARTIS PHARMACEUTICALS CORPORATION,2016/08/03-,0078-0671,G873GX646R,LAPATINIB DITOSYLATE,LAPATINIB,0VUA21238F,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/eee37f88-ec6a-4c30-b8aa-e2c71f93088c/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=eee37f88-ec6a-4c30-b8aa-e2c71f93088c,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=eee37f88-ec6a-4c30-b8aa-e2c71f93088c,eee37f88-ec6a-4c30-b8aa-e2c71f93088c,,,
HUMAN PRESCRIPTION DRUG LABEL,"CAPSULE; SOLUTION, CONCENTRATE",ORAL; OROPHARYNGEAL,NDA,210861;211710,VITRAKVI,LAROTRECTINIB,2023/11/03,Kinase Inhibitor,2018,BAYER HEALTHCARE PHARMACEUTICALS INC,2019/07/26-; 2022/12/06-,50419-390; 50419-391; 50419-392; 50419-393,PF9462I9HX,LAROTRECTINIB,LAROTRECTINIB,PF9462I9HX,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/0c8ca614-58b2-4aa4-83d3-0387a8f782fd/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0c8ca614-58b2-4aa4-83d3-0387a8f782fd,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=0c8ca614-58b2-4aa4-83d3-0387a8f782fd,0c8ca614-58b2-4aa4-83d3-0387a8f782fd,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE; SOLUTION,ORAL,NDA,210861;211710,VITRAKVI,LAROTRECTINIB,2018/12/05,Kinase Inhibitor,2018,LOXO ONCOLOGY INC,2018/11/26-,71777-390; 71777-391; 71777-392,PF9462I9HX,LAROTRECTINIB,LAROTRECTINIB,PF9462I9HX,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/9525f887-a055-4e33-8e92-898d42828cd1/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9525f887-a055-4e33-8e92-898d42828cd1,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=9525f887-a055-4e33-8e92-898d42828cd1,9525f887-a055-4e33-8e92-898d42828cd1,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,211280,Reyvow,LASMIDITAN,2022/09/15,,2020,ELI LILLY AND COMPANY,2019/10/11-,0002-4312; 0002-4491,760I9WM792,lasmiditan,lasmiditan,760I9WM792,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/aea3358c-ff41-4490-9e6d-c7bf7b3de13f/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=aea3358c-ff41-4490-9e6d-c7bf7b3de13f,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=aea3358c-ff41-4490-9e6d-c7bf7b3de13f,aea3358c-ff41-4490-9e6d-c7bf7b3de13f,,,
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION/ DROPS,OPHTHALMIC; TOPICAL,NDA,206185,XELPROS,LATANOPROST,2023/06/28,Prostaglandin Analog,1996,SUN PHARMACEUTICAL INDUSTRIES INC,2018/09/12-,47335-317,6Z5B6HVF6O,LATANOPROST,LATANOPROST,6Z5B6HVF6O,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/34ad5cf6-4df0-4104-bddd-4c7631133ded/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=34ad5cf6-4df0-4104-bddd-4c7631133ded,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=34ad5cf6-4df0-4104-bddd-4c7631133ded,34ad5cf6-4df0-4104-bddd-4c7631133ded,,,
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION/ DROPS,OPHTHALMIC,NDA,020597,XALATAN,LATANOPROST,2023/05/15,,1996,VIATRIS SPECIALTY LLC,2024/05/15-,58151-419,6Z5B6HVF6O,LATANOPROST,LATANOPROST ACID,EJ85341990,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/a98595b3-9f47-48e0-b18d-550a2095f264/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a98595b3-9f47-48e0-b18d-550a2095f264,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=a98595b3-9f47-48e0-b18d-550a2095f264,a98595b3-9f47-48e0-b18d-550a2095f264,,,
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION,OPHTHALMIC,NDA,020597,Xalatan,LATANOPROST,2022/12/27,Prostaglandin Analog,1996,PFIZER LABORATORIES DIV PFIZER INC,1995/03/20-,0013-8303,6Z5B6HVF6O,LATANOPROST,LATANOPROST,6Z5B6HVF6O,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/f4e73059-5ba0-4d73-9ea1-09d8d654e844/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f4e73059-5ba0-4d73-9ea1-09d8d654e844,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=f4e73059-5ba0-4d73-9ea1-09d8d654e844,f4e73059-5ba0-4d73-9ea1-09d8d654e844,,,
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION/ DROPS,OPHTHALMIC,NDA,216472,IYUZEH,LATANOPROST OPHTHALMIC SOLUTION 0.005%,2023/10/26,Prostaglandin Analog,1996,THEA PHARMA INC,2023/07/14-,82584-003,6Z5B6HVF6O,LATANOPROST,LATANOPROST,6Z5B6HVF6O,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/192fc081-cc38-4e83-b779-9592e060b915/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=192fc081-cc38-4e83-b779-9592e060b915,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=192fc081-cc38-4e83-b779-9592e060b915,192fc081-cc38-4e83-b779-9592e060b915,,,
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION/ DROPS,OPHTHALMIC,NDA,207795,Vyzulta,LATANOPROSTENE BUNOD,2024/02/27,,2017,BAUSCH AND LOMB INCORPORATED,2017/11/02-,24208-504,I6393O0922,LATANOPROSTENE BUNOD,LATANOPROST ACID,EJ85341990,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/60ce7900-a677-4fc2-88d0-1603baa9dbd4/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=60ce7900-a677-4fc2-88d0-1603baa9dbd4,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=60ce7900-a677-4fc2-88d0-1603baa9dbd4,60ce7900-a677-4fc2-88d0-1603baa9dbd4,,,
HUMAN PRESCRIPTION DRUG LABEL,"PELLET; TABLET, FILM COATED",ORAL,NDA,205834;212477,Harvoni,LEDIPASVIR AND SOFOSBUVIR,2021/06/28,Hepatitis C Virus NS5A Inhibitor; Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor,2014,GILEAD SCIENCES INC,2014/10/10-; 2019/08/28-,61958-1801; 61958-1803; 61958-1804; 61958-1805,013TE6E4WV; WJ6CA3ZU8B,LEDIPASVIR; SOFOSBUVIR,LEDIPASVIR; SOFOSBUVIR,013TE6E4WV; WJ6CA3ZU8B,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f4ec77e4-bae8-4db0-b3d5-bde09c5fa075,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=f4ec77e4-bae8-4db0-b3d5-bde09c5fa075,f4ec77e4-bae8-4db0-b3d5-bde09c5fa075,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,020905,Arava,LEFLUNOMIDE,2022/10/04,Antirheumatic Agent,1998,SANOFI AVENTIS U S LLC,1998/09/10-,0088-2160; 0088-2161; 0088-2162,G162GK9U4W,LEFLUNOMIDE,LEFLUNOMIDE,G162GK9U4W,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/320f63f2-fac3-4aee-aff8-85724e00ef52/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=320f63f2-fac3-4aee-aff8-85724e00ef52,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=320f63f2-fac3-4aee-aff8-85724e00ef52,320f63f2-fac3-4aee-aff8-85724e00ef52,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,212028,DAYVIGO,LEMBOREXANT,2023/12/18,Orexin Receptor Antagonist,2019,EISAI INC,2020/04/07-; completed:2020/04/07-2023/02/28,62856-405; 62856-410; 62856-455,0K5743G68X,LEMBOREXANT,LEMBOREXANT,0K5743G68X,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/7074cb65-77b3-45d2-8e8d-da8dc0f70bfd/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7074cb65-77b3-45d2-8e8d-da8dc0f70bfd,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=7074cb65-77b3-45d2-8e8d-da8dc0f70bfd,7074cb65-77b3-45d2-8e8d-da8dc0f70bfd,,,
HUMAN PRESCRIPTION DRUG LABEL,"KIT; TABLET, FILM COATED",ORAL; SUBCUTANEOUS,NDA,215973;215974,Sunlenca,LENACAPAVIR SODIUM,2023/10/02,Human Immunodeficiency Virus 1 Capsid Inhibitor,2022,GILEAD SCIENCES,2022/12/22-,61958-3001; 61958-3002,BDT58WJ9WE,LENACAPAVIR SODIUM,LENACAPAVIR,A9A0O6FB4H,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/e5652804-29c4-40d7-aeb2-0142ed2a7b5b/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e5652804-29c4-40d7-aeb2-0142ed2a7b5b,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=e5652804-29c4-40d7-aeb2-0142ed2a7b5b,e5652804-29c4-40d7-aeb2-0142ed2a7b5b,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,NDA,021880,Revlimid,LENALIDOMIDE,2023/03/24,Thalidomide Analog,2005,CELGENE CORPORATION,2005/12/27-; 2006/06/29-; 2012/04/16-; 2013/06/06-,59572-402; 59572-405; 59572-410; 59572-415; 59572-420; 59572-425,F0P408N6V4,LENALIDOMIDE,LENALIDOMIDE,F0P408N6V4,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/5fa97bf5-28a2-48f1-8955-f56012d296be/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5fa97bf5-28a2-48f1-8955-f56012d296be,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=5fa97bf5-28a2-48f1-8955-f56012d296be,5fa97bf5-28a2-48f1-8955-f56012d296be,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,217759,Joenja,LENIOLISIB,2023/03/29,Kinase Inhibitor,2023,PHARMING HEALTHCARE INC,2023/03/29-,71274-170,3700M1H39Q,Leniolisib phosphate,Leniolisib,L22772Z9CP,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/eefbcef8-2130-4654-8f29-b58077e08212/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=eefbcef8-2130-4654-8f29-b58077e08212,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=eefbcef8-2130-4654-8f29-b58077e08212,eefbcef8-2130-4654-8f29-b58077e08212,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE; KIT,ORAL,NDA,206947,Lenvima,LENVATINIB,2024/04/10,Kinase Inhibitor,2015,EISAI INC,2015/02/13-; 2016/05/13-; 2018/08/15-,62856-704; 62856-708; 62856-710; 62856-712; 62856-714; 62856-718; 62856-720; 62856-724,EE083865G2,LENVATINIB,LENVATINIB,EE083865G2,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/f4bedd21-efde-44c6-9d9c-b48b78d7ed1e/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f4bedd21-efde-44c6-9d9c-b48b78d7ed1e,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=f4bedd21-efde-44c6-9d9c-b48b78d7ed1e,f4bedd21-efde-44c6-9d9c-b48b78d7ed1e,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION; TABLET, FILM COATED",INTRAVENOUS; ORAL,NDA,209939;209940,PREVYMIS,LETERMOVIR,2023/08/02,Cytomegalovirus DNA Terminase Complex Inhibitor,2017,MERCK SHARP AND DOHME LLC,2017/11/08-,0006-3075; 0006-3076; 0006-5003; 0006-5004,1H09Y5WO1F,LETERMOVIR,LETERMOVIR,1H09Y5WO1F,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/1b49df80-be4f-47e0-a0b7-123f3e69395b/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1b49df80-be4f-47e0-a0b7-123f3e69395b,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=1b49df80-be4f-47e0-a0b7-123f3e69395b,1b49df80-be4f-47e0-a0b7-123f3e69395b,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,020726,Femara,LETROZOLE,2024/01/11,Aromatase Inhibitor,1997,NOVARTIS PHARMACEUTICALS CORPORATION,1997/07/31-,0078-0249,7LKK855W8I,LETROZOLE,LETROZOLE,7LKK855W8I,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/82b77d74-085f-45ac-a7dd-1f5c038bf406/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=82b77d74-085f-45ac-a7dd-1f5c038bf406,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=82b77d74-085f-45ac-a7dd-1f5c038bf406,82b77d74-085f-45ac-a7dd-1f5c038bf406,,,
HUMAN PRESCRIPTION DRUG LABEL,KIT,ORAL,NDA,209935,KISQALI FEMARA CO-PACK,LETROZOLE AND RIBOCICLIB,2023/08/24,Aromatase Inhibitor; Kinase Inhibitor,2017,NOVARTIS PHARMACEUTICALS CORPORATION,2017/05/04-,0078-0909; 0078-0916; 0078-0923,7LKK855W8I; BG7HLX2919,LETROZOLE; RIBOCICLIB SUCCINATE,LETROZOLE; RIBOCICLIB,7LKK855W8I; TK8ERE8P56,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/aa5e4446-19cd-4235-a382-5b48bf6c3b2f/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=aa5e4446-19cd-4235-a382-5b48bf6c3b2f,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=aa5e4446-19cd-4235-a382-5b48bf6c3b2f,aa5e4446-19cd-4235-a382-5b48bf6c3b2f,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRAVENOUS,NDA,020678,CLINIMIX E,"LEUCINE, PHENYLALANINE, LYSINE, METHIONINE, ISOLEUCINE, VALINE, HISTIDINE, THREONINE, TRYPTOPHAN, ALANINE, GLYCINE, ARGININE, PROLINE, SERINE, TYROSINE, SODIUM ACETATE, DIBASIC POTASSIUM PHOSPHATE, MA",2021/04/13,Amino Acid; Osmotic Laxative; Potassium Salt,1997,BAXTER HEALTHCARE CORPORATION,1997/03/26-; 2020/09/21-,0338-0202; 0338-0206; 0338-0210; 0338-0214; 0338-1113; 0338-1115; 0338-1123; 0338-1125; 0338-1142; 0338-1144; 0338-1145; 0338-1147; 0338-1148,02F3473H9O; 04Y7590D77; 2ZD004190S; 42HK56048U; 451W47IQ8X; 452VLY9402; 4550K0SC9B; 47E5O17Y3R; 4QD397987E; 8DUH1N11BX; 94ZLA3W45F; 9DLQ4CIU6V; AE28F7PNPL; CI71S98N1Z; GMW67QNF9C; HG18B9YRS7; IY9XDZ35W2; K3Z4F929H6; M4I0D6VV5M; OF5P57N2ZX,ALANINE; ARGININE; Alanine; CALCIUM CHLORIDE; DEXTROSE; GLYCINE; Glycine; HISTIDINE; ISOLEUCINE; LEUCINE,ACETATE ION; ALANINE; ARGININE; CALCIUM CATION; CHLORIDE ION; DEXTROSE; GLYCINE; HISTIDINE; ISOLEUCINE; LEUCINE,04Y7590D77; 295O53K152; 2M83C4R6ZB; 2ZD004190S; 42HK56048U; 452VLY9402; 47E5O17Y3R; 4QD397987E; 569DQM74SC; 8DUH1N11BX; 94ZLA3W45F; 9DLQ4CIU6V; AE28F7PNPL; GMW67QNF9C; HG18B9YRS7; IY9XDZ35W2; K3Z4F929H6; LYR4M0NH37; NK08V8K8HR; OF5P57N2ZX,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/8469d6fb-d6ef-476f-8cc3-0905192de0a8/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8469d6fb-d6ef-476f-8cc3-0905192de0a8,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=8469d6fb-d6ef-476f-8cc3-0905192de0a8,8469d6fb-d6ef-476f-8cc3-0905192de0a8,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, EMULSION",SUBCUTANEOUS,NDA,211488,CAMCEVI,LEUPROLIDE,2023/04/03,Gonadotropin Releasing Hormone Receptor Agonist,2021,ACCORD BIOPHARMA INC,2022/04/05-,69448-014,8E3C3C493W,LEUPROLIDE MESYLATE,LEUPROLIDE,EFY6W0M8TG,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/d7a8761a-d953-413a-e053-2a95a90a60ee/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d7a8761a-d953-413a-e053-2a95a90a60ee,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=d7a8761a-d953-413a-e053-2a95a90a60ee,d7a8761a-d953-413a-e053-2a95a90a60ee,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, EMULSION",SUBCUTANEOUS,NDA,211488,CAMCEVI,LEUPROLIDE,2021/11/15,Gonadotropin Releasing Hormone Receptor Agonist,2021,FORESEE PHARMACEUTICALS CO LTD,2022/12/30-,72851-042,8E3C3C493W,LEUPROLIDE MESYLATE,LEUPROLIDE,EFY6W0M8TG,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/768af325-a1bb-4692-97ce-4853feb356a8/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=768af325-a1bb-4692-97ce-4853feb356a8,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=768af325-a1bb-4692-97ce-4853feb356a8,768af325-a1bb-4692-97ce-4853feb356a8,,,
HUMAN PRESCRIPTION DRUG LABEL,KIT,INTRAMUSCULAR; TOPICAL,NDA,019732;020517,Lupron Depot,LEUPROLIDE ACETATE,2024/03/12,Gonadotropin Releasing Hormone Receptor Agonist,1989,ABBVIE INC,1989/01/26-; 1995/12/22-,0074-3346; 0074-3473; 0074-3642; 0074-3683,37JNS02E7V,LEUPROLIDE ACETATE,LEUPROLIDE,EFY6W0M8TG,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/cbc8f94e-7330-4465-05ad-16d64493a5dd/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=cbc8f94e-7330-4465-05ad-16d64493a5dd,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=cbc8f94e-7330-4465-05ad-16d64493a5dd,cbc8f94e-7330-4465-05ad-16d64493a5dd,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SUSPENSION, EXTENDED RELEASE",SUBCUTANEOUS,NDA,021343;021379;021488;021731,Eligard,LEUPROLIDE ACETATE,2024/01/23,Gonadotropin Releasing Hormone Receptor Agonist,2002,TOLMAR INC,2023/03/06-; 2023/11/01-; 2023/11/27-; 2024/01/11-,62935-227; 62935-306; 62935-461; 62935-756,37JNS02E7V,LEUPROLIDE ACETATE,LEUPROLIDE,EFY6W0M8TG,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/b7b679a9-6823-4ef8-8d31-3ab5058ffcfc/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b7b679a9-6823-4ef8-8d31-3ab5058ffcfc,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=b7b679a9-6823-4ef8-8d31-3ab5058ffcfc,b7b679a9-6823-4ef8-8d31-3ab5058ffcfc,,,
HUMAN PRESCRIPTION DRUG LABEL,KIT,INTRAMUSCULAR,NDA,205054,LEUPROLIDE ACETATE DEPOT,LEUPROLIDE ACETATE,2023/11/01,Gonadotropin Releasing Hormone Receptor Agonist,2018,CIPLA USA INC,2022/07/15-,69097-909,37JNS02E7V,LEUPROLIDE ACETATE,LEUPROLIDE,EFY6W0M8TG,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/1563a30b-66e0-445d-ba3e-1ccd5218133f/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1563a30b-66e0-445d-ba3e-1ccd5218133f,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=1563a30b-66e0-445d-ba3e-1ccd5218133f,1563a30b-66e0-445d-ba3e-1ccd5218133f,,,
HUMAN PRESCRIPTION DRUG LABEL,KIT,INTRAMUSCULAR; TOPICAL,NDA,020011,Lupron Depot,LEUPROLIDE ACETATE,2023/10/27,Gonadotropin Releasing Hormone Receptor Agonist,1985,ABBVIE INC,1990/10/22-,0074-3641,37JNS02E7V; ND2M416302,ISOPROPYL ALCOHOL; LEUPROLIDE ACETATE,ISOPROPYL ALCOHOL; LEUPROLIDE,EFY6W0M8TG; ND2M416302,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/00c486b0-bd7b-4898-834d-8c656e5e73cb/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=00c486b0-bd7b-4898-834d-8c656e5e73cb,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=00c486b0-bd7b-4898-834d-8c656e5e73cb,00c486b0-bd7b-4898-834d-8c656e5e73cb,,,
HUMAN PRESCRIPTION DRUG LABEL,KIT,INTRAMUSCULAR; TOPICAL,NDA,020708,Lupron Depot,LEUPROLIDE ACETATE,2023/10/27,Gonadotropin Releasing Hormone Receptor Agonist,1985,ABBVIE INC,2010/11/08-,0074-3663,37JNS02E7V,LEUPROLIDE ACETATE,LEUPROLIDE,EFY6W0M8TG,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/60aad237-e1da-4705-cbbb-b3ca79e89ad8/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=60aad237-e1da-4705-cbbb-b3ca79e89ad8,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=60aad237-e1da-4705-cbbb-b3ca79e89ad8,60aad237-e1da-4705-cbbb-b3ca79e89ad8,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SUSPENSION, EXTENDED RELEASE",SUBCUTANEOUS,NDA,213150,Fensolvi,LEUPROLIDE ACETATE,2023/04/29,Gonadotropin Releasing Hormone Receptor Agonist,1985,TOLMAR INC,2023/03/06-,62935-163,37JNS02E7V,LEUPROLIDE ACETATE,LEUPROLIDE,EFY6W0M8TG,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/2c311700-edf4-4f2a-a468-9875489a6cc7/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2c311700-edf4-4f2a-a468-9875489a6cc7,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=2c311700-edf4-4f2a-a468-9875489a6cc7,2c311700-edf4-4f2a-a468-9875489a6cc7,,,
HUMAN PRESCRIPTION DRUG LABEL,KIT,INTRAMUSCULAR; TOPICAL,NDA,020263,Lupron Depot-PED,LEUPROLIDE ACETATE,2023/04/14,Gonadotropin Releasing Hormone Receptor Agonist,1985,ABBVIE INC,1993/04/16-; 2023/04/14-,0074-2108; 0074-2282; 0074-2440; 0074-3575; 0074-3779; 0074-9694,37JNS02E7V,LEUPROLIDE ACETATE,LEUPROLIDE,EFY6W0M8TG,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/e99f47d2-da10-3127-ecb3-e5d942ae6e81/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e99f47d2-da10-3127-ecb3-e5d942ae6e81,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=e99f47d2-da10-3127-ecb3-e5d942ae6e81,e99f47d2-da10-3127-ecb3-e5d942ae6e81,,,
HUMAN PRESCRIPTION DRUG LABEL,KIT,SUBCUTANEOUS,NDA,213150,Fensolvi,LEUPROLIDE ACETATE,2022/04/28,Gonadotropin Releasing Hormone Receptor Agonist,1985,TOLMAR INC,2020/06/03-,62935-153,37JNS02E7V,LEUPROLIDE ACETATE,LEUPROLIDE,EFY6W0M8TG,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/dfb6e01c-f138-471d-bf5b-2be38247e3f0/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=dfb6e01c-f138-471d-bf5b-2be38247e3f0,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=dfb6e01c-f138-471d-bf5b-2be38247e3f0,dfb6e01c-f138-471d-bf5b-2be38247e3f0,,,
HUMAN PRESCRIPTION DRUG LABEL,KIT,SUBCUTANEOUS,NDA,021343;021379;021488;021731,ELIGARD,LEUPROLIDE ACETATE,2019/04/29,Gonadotropin Releasing Hormone Receptor Agonist,2002,TOLMAR INC,2002/05/15-; 2002/08/26-; 2003/02/26-; 2005/01/07-,62935-223; 62935-303; 62935-453; 62935-753,37JNS02E7V,LEUPROLIDE ACETATE,LEUPROLIDE,EFY6W0M8TG,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/b78d1919-9dee-44fa-90f9-e0a26d32481d/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b78d1919-9dee-44fa-90f9-e0a26d32481d,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=b78d1919-9dee-44fa-90f9-e0a26d32481d,b78d1919-9dee-44fa-90f9-e0a26d32481d,,,
HUMAN PRESCRIPTION DRUG LABEL,"SOLUTION, CONCENTRATE",INHALATION,NDA,020837,Xopenex,LEVALBUTEROL HYDROCHLORIDE,2022/09/14,beta2-Adrenergic Agonist,1999,AKORN,2015/02/26-,17478-171,WDQ1526QJM,Levalbuterol Hydrochloride,Levalbuterol,EDN2NBH5SS,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/0c47c47d-45f7-4eb4-b1f8-7d6c633a1f69/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0c47c47d-45f7-4eb4-b1f8-7d6c633a1f69,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=0c47c47d-45f7-4eb4-b1f8-7d6c633a1f69,0c47c47d-45f7-4eb4-b1f8-7d6c633a1f69,,,
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION,INHALATION,NDA,020837,Xopenex,LEVALBUTEROL HYDROCHLORIDE,2022/09/14,beta2-Adrenergic Agonist,1999,AKORN,2015/02/27-,17478-172; 17478-173; 17478-174,WDQ1526QJM,Levalbuterol Hydrochloride,Levalbuterol,EDN2NBH5SS,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/7e2644e6-36c5-4988-8e52-bec90e2cd2f0/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7e2644e6-36c5-4988-8e52-bec90e2cd2f0,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=7e2644e6-36c5-4988-8e52-bec90e2cd2f0,7e2644e6-36c5-4988-8e52-bec90e2cd2f0,,,
HUMAN PRESCRIPTION DRUG LABEL,"AEROSOL, METERED",ORAL,NDA,021730,XOPENEX HFA,LEVALBUTEROL TARTRATE,2024/01/01,beta2-Adrenergic Agonist,1999,LUPIN PHARMACEUTICALS INC,2023/11/10-,27437-056,ADS4I3E22M,LEVALBUTEROL TARTRATE,LEVALBUTEROL,EDN2NBH5SS,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/70a35706-d7a8-4a48-98c6-1cab1c42fe8d/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=70a35706-d7a8-4a48-98c6-1cab1c42fe8d,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=70a35706-d7a8-4a48-98c6-1cab1c42fe8d,70a35706-d7a8-4a48-98c6-1cab1c42fe8d,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,212895,Conjupri,LEVAMLODIPINE,2023/11/14,,2019,CSPC OUYI PHARMACEUTICAL CO LTD,2021/10/08-,24075-0411; 24075-0413,12WW9T2ITA,LEVAMLODIPINE MALEATE,LEVAMLODIPINE,0P6NLP6806,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/c3cca66e-348a-43e8-8f96-e995104dae3d/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c3cca66e-348a-43e8-8f96-e995104dae3d,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=c3cca66e-348a-43e8-8f96-e995104dae3d,c3cca66e-348a-43e8-8f96-e995104dae3d,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,212895,Conjupri,LEVAMLODIPINE,2022/05/03,,2019,WRASER LLC,2021/08/15-,66992-425; 66992-430,12WW9T2ITA,LEVAMLODIPINE MALEATE,LEVAMLODIPINE,0P6NLP6806,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/f389d4dd-82fd-43a3-8fc4-d8d7a3706fd4/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f389d4dd-82fd-43a3-8fc4-d8d7a3706fd4,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=f389d4dd-82fd-43a3-8fc4-d8d7a3706fd4,f389d4dd-82fd-43a3-8fc4-d8d7a3706fd4,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,NDA,022285,Keppra XR,LEVETIRACETAM,2024/04/22,,1999,UCB INC,2008/09/24-; 2009/04/01-,50474-598; 50474-599,44YRR34555,LEVETIRACETAM,LEVETIRACETAM,44YRR34555,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/2919e43b-69a8-434c-a2d2-1f3ecd7554c0/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2919e43b-69a8-434c-a2d2-1f3ecd7554c0,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=2919e43b-69a8-434c-a2d2-1f3ecd7554c0,2919e43b-69a8-434c-a2d2-1f3ecd7554c0,,,
HUMAN PRESCRIPTION DRUG LABEL,"SOLUTION; TABLET, FILM COATED",ORAL,NDA,021035;021505,Keppra,LEVETIRACETAM,2024/04/22,,1999,UCB INC,2000/04/24-; 2003/10/20-,50474-001; 50474-594; 50474-595; 50474-596; 50474-597,44YRR34555,LEVETIRACETAM,LEVETIRACETAM,44YRR34555,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/3ca9df05-a506-4ec8-a4fe-320f1219ab21/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3ca9df05-a506-4ec8-a4fe-320f1219ab21,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=3ca9df05-a506-4ec8-a4fe-320f1219ab21,3ca9df05-a506-4ec8-a4fe-320f1219ab21,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, EXTENDED RELEASE",ORAL,NDA,204417,ELEPSIA XR 1000 MG; ELEPSIA XR 1500 MG,LEVETIRACETAM,2024/03/25,,1999,TRIPOINT THERAPEUTICS LLC,2021/02/12-,80705-100; 80705-101,44YRR34555,LEVETIRACETAM,LEVETIRACETAM,44YRR34555,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/cac83d47-88a2-4447-a0c0-90b44ffda0ac/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=cac83d47-88a2-4447-a0c0-90b44ffda0ac,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=cac83d47-88a2-4447-a0c0-90b44ffda0ac,cac83d47-88a2-4447-a0c0-90b44ffda0ac,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FOR SUSPENSION",ORAL,NDA,207958,Spritam,LEVETIRACETAM,2024/03/22,,1999,APRECIA PHARMACEUTICALS LLC,2016/02/05-,43485-101; 43485-102; 43485-103; 43485-104,44YRR34555,LEVETIRACETAM,LEVETIRACETAM,44YRR34555,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/be651c31-383f-11e4-916c-0800200c9a66/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=be651c31-383f-11e4-916c-0800200c9a66,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=be651c31-383f-11e4-916c-0800200c9a66,be651c31-383f-11e4-916c-0800200c9a66,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION, CONCENTRATE",INTRAVENOUS,NDA,021872,Keppra,LEVETIRACETAM,2024/03/14,,1999,UCB INC,2006/08/23-,50474-002,44YRR34555,LEVETIRACETAM,LEVETIRACETAM,44YRR34555,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/c6d5784d-abf9-45fe-ac5a-d5c53bd50f7e/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c6d5784d-abf9-45fe-ac5a-d5c53bd50f7e,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=c6d5784d-abf9-45fe-ac5a-d5c53bd50f7e,c6d5784d-abf9-45fe-ac5a-d5c53bd50f7e,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRAVENOUS,NDA,202543,Levetiracetam,LEVETIRACETAM,2023/10/30,,1999,WG CRITICAL CARE LLC,2020/08/24-,44567-501; 44567-502,44YRR34555,LEVETIRACETAM,LEVETIRACETAM,44YRR34555,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/5e5b0ed3-b104-45a7-bb3e-ee56febb46e8/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5e5b0ed3-b104-45a7-bb3e-ee56febb46e8,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=5e5b0ed3-b104-45a7-bb3e-ee56febb46e8,5e5b0ed3-b104-45a7-bb3e-ee56febb46e8,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRAVENOUS,NDA,202543,Levetiracetam,LEVETIRACETAM,2023/10/15,,1999,MYLAN INSTITUTIONAL LLC,2012/01/16-,67457-255; 67457-265; 67457-266,44YRR34555,LEVETIRACETAM,LEVETIRACETAM,44YRR34555,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/70e52e89-3844-4cd9-a406-b29e9520a12c/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=70e52e89-3844-4cd9-a406-b29e9520a12c,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=70e52e89-3844-4cd9-a406-b29e9520a12c,70e52e89-3844-4cd9-a406-b29e9520a12c,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRAVENOUS,NDA,202543,Levetiracetam,LEVETIRACETAM,2023/09/29,,1999,WG CRITICAL CARE LLC,2020/08/24-,44567-500; 44567-501; 44567-502; 44567-503,44YRR34555,LEVETIRACETAM,LEVETIRACETAM,44YRR34555,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/62f3d1c8-ca5b-4760-9fc9-41e4fb4cc926/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=62f3d1c8-ca5b-4760-9fc9-41e4fb4cc926,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=62f3d1c8-ca5b-4760-9fc9-41e4fb4cc926,62f3d1c8-ca5b-4760-9fc9-41e4fb4cc926,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, EXTENDED RELEASE",ORAL,NDA,204417,Elepsia XR,LEVETIRACETAM,2021/01/06,,1999,SUN PHARMA ADVANCED RESEARCH COMPANY LIMITED,2019/05/17-,47133-574; 47133-575,44YRR34555,LEVETIRACETAM,LEVETIRACETAM,44YRR34555,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/12e147dc-4f5b-4117-8a8e-a8c429ad0217/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=12e147dc-4f5b-4117-8a8e-a8c429ad0217,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=12e147dc-4f5b-4117-8a8e-a8c429ad0217,12e147dc-4f5b-4117-8a8e-a8c429ad0217,,,
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION,ORAL,NDA,019257,Carnitor,LEVOCARNITINE,2024/01/23,Carnitine Analog,,LEADIANT BIOSCIENCES INC,1986/04/10-,54482-145,0G389FZZ9M,LEVOCARNITINE,LEVOCARNITINE,0G389FZZ9M,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/b2cbc620-59fd-47b6-9e4b-7e3e31533a1c/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b2cbc620-59fd-47b6-9e4b-7e3e31533a1c,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=b2cbc620-59fd-47b6-9e4b-7e3e31533a1c,b2cbc620-59fd-47b6-9e4b-7e3e31533a1c,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,018948,CARNITOR,LEVOCARNITINE,2023/11/21,Carnitine Analog,,LEADIANT BIOSCIENCES INC,1985/12/27-,54482-144,0G389FZZ9M,LEVOCARNITINE,LEVOCARNITINE,0G389FZZ9M,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/d2133bc3-9c15-48bd-8b16-b8995a6a14cd/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d2133bc3-9c15-48bd-8b16-b8995a6a14cd,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=d2133bc3-9c15-48bd-8b16-b8995a6a14cd,d2133bc3-9c15-48bd-8b16-b8995a6a14cd,,,
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION,ORAL,NDA,019257,Carnitor SF,LEVOCARNITINE,2023/11/21,Carnitine Analog,,LEADIANT BIOSCIENCES INC,1986/04/10-,54482-148,0G389FZZ9M,LEVOCARNITINE,LEVOCARNITINE,0G389FZZ9M,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/dd904490-83f3-4cd3-bb6f-68e28509b4b6/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=dd904490-83f3-4cd3-bb6f-68e28509b4b6,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=dd904490-83f3-4cd3-bb6f-68e28509b4b6,dd904490-83f3-4cd3-bb6f-68e28509b4b6,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,020182,Carnitor,LEVOCARNITINE,2023/11/20,Carnitine Analog,,LEADIANT BIOSCIENCES INC,1992/12/16-,54482-147,0G389FZZ9M,LEVOCARNITINE,LEVOCARNITINE,0G389FZZ9M,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/cf801cc4-775e-433d-9d32-e5d9a98981d3/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=cf801cc4-775e-433d-9d32-e5d9a98981d3,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=cf801cc4-775e-433d-9d32-e5d9a98981d3,cf801cc4-775e-433d-9d32-e5d9a98981d3,,,
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION,ORAL,NDA,019257,Levocarnitine,LEVOCARNITINE,2022/11/15,Carnitine Analog,,AKORN,1986/04/10-,50383-171,0G389FZZ9M,LEVOCARNITINE,LEVOCARNITINE,0G389FZZ9M,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/3563c2f5-9814-4d55-8d90-bd7d6dcff36b/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3563c2f5-9814-4d55-8d90-bd7d6dcff36b,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=3563c2f5-9814-4d55-8d90-bd7d6dcff36b,3563c2f5-9814-4d55-8d90-bd7d6dcff36b,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,018948,Levocarnitine,LEVOCARNITINE,2022/11/10,Carnitine Analog,,AKORN,2005/11/01-,50383-172,0G389FZZ9M,LEVOCARNITINE,LEVOCARNITINE,0G389FZZ9M,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/c8a590a7-628b-45c5-ac2c-24214a69eaa6/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c8a590a7-628b-45c5-ac2c-24214a69eaa6,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=c8a590a7-628b-45c5-ac2c-24214a69eaa6,c8a590a7-628b-45c5-ac2c-24214a69eaa6,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,INHALATION,NDA,209184,Inbrija,LEVODOPA,2023/01/19,Aromatic Amino Acid,1970,ACORDA THERAPEUTICS INC,2018/12/22-,10144-342,46627O600J,LEVODOPA,LEVODOPA,46627O600J,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/a906f8e1-6e1c-480a-8276-c01bc65dd3be/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a906f8e1-6e1c-480a-8276-c01bc65dd3be,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=a906f8e1-6e1c-480a-8276-c01bc65dd3be,a906f8e1-6e1c-480a-8276-c01bc65dd3be,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,214133,Recorlev,LEVOKETOCONAZOLE,2023/06/16,Cortisol Synthesis Inhibitor,1981,XERIS PHARMACEUTICALS INC,2021/12/30-,72065-003,2DJ8R0NT7K,LEVOKETOCONAZOLE,LEVOKETOCONAZOLE,2DJ8R0NT7K,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/d4c5fead-bc4a-fb02-e053-2a95a90ae4fc/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d4c5fead-bc4a-fb02-e053-2a95a90ae4fc,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=d4c5fead-bc4a-fb02-e053-2a95a90ae4fc,d4c5fead-bc4a-fb02-e053-2a95a90ae4fc,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAVENOUS,NDA,020140,Fusilev,LEVOLEUCOVORIN,2024/05/17,Folate Analog,1952,ACROTECH BIOPHARMA INC,completed:2008/08/15-2024/05/24,72893-009,778XL6VBS8,LEVOLEUCOVORIN CALCIUM,LEVOLEUCOVORIN,990S25980Y,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/2255268c-b703-42e5-a81a-0fb223a77fd6/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2255268c-b703-42e5-a81a-0fb223a77fd6,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=2255268c-b703-42e5-a81a-0fb223a77fd6,2255268c-b703-42e5-a81a-0fb223a77fd6,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAVENOUS,NDA,211226,KHAPZORY,LEVOLEUCOVORIN,2024/03/18,Folate Analog,1952,ACROTECH BIOPHARMA INC,2019/01/02-,72893-004,5TXQ76K65T,LEVOLEUCOVORIN DISODIUM,LEVOLEUCOVORIN,990S25980Y,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/344f65ac-9f04-49d7-b7c3-4ba19bd7b429/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=344f65ac-9f04-49d7-b7c3-4ba19bd7b429,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=344f65ac-9f04-49d7-b7c3-4ba19bd7b429,344f65ac-9f04-49d7-b7c3-4ba19bd7b429,,,
HUMAN PRESCRIPTION DRUG LABEL,"CAPSULE, EXTENDED RELEASE; KIT",ORAL,NDA,204168,Fetzima,LEVOMILNACIPRAN HYDROCHLORIDE,2024/04/19,Serotonin and Norepinephrine Reuptake Inhibitor,2009,ALLERGAN INC,2013/07/25-; 2023/03/24-,0456-2200; 0456-2202; 0456-2212; 0456-2220; 0456-2240; 0456-2280,371U2ZK31U,LEVOMILNACIPRAN HYDROCHLORIDE; levomilnacipran hydrochloride,levomilnacipran,UGM0326TXX,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/f371258d-91b3-4b6a-ac99-434a1964c3af/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f371258d-91b3-4b6a-ac99-434a1964c3af,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=f371258d-91b3-4b6a-ac99-434a1964c3af,f371258d-91b3-4b6a-ac99-434a1964c3af,,,
HUMAN PRESCRIPTION DRUG LABEL,INTRAUTERINE DEVICE,INTRAUTERINE,NDA,206229,LILETTA,LEVONORGESTREL,2023/06/29,Progestin; Progestin-containing Intrauterine System,1968,ALLERGAN INC,2016/05/31-,0023-5858,5W7SIA7YZW,LEVONORGESTREL,LEVONORGESTREL,5W7SIA7YZW,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/aaf0eb2a-f88a-4f26-a445-0fd30176c326/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=aaf0eb2a-f88a-4f26-a445-0fd30176c326,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=aaf0eb2a-f88a-4f26-a445-0fd30176c326,aaf0eb2a-f88a-4f26-a445-0fd30176c326,,,
HUMAN PRESCRIPTION DRUG LABEL,INTRAUTERINE DEVICE,INTRAUTERINE,NDA,208224,Kyleena,LEVONORGESTREL,2023/03/13,Progestin; Progestin-containing Intrauterine System,2000,BAYER HEALTHCARE PHARMACEUTICALS INC,2016/09/19-,50419-424,5W7SIA7YZW,LEVONORGESTREL,LEVONORGESTREL,5W7SIA7YZW,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/2e07c155-21e1-4781-9633-ce8bddd47080/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2e07c155-21e1-4781-9633-ce8bddd47080,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=2e07c155-21e1-4781-9633-ce8bddd47080,2e07c155-21e1-4781-9633-ce8bddd47080,,,
HUMAN PRESCRIPTION DRUG LABEL,INTRAUTERINE DEVICE,INTRAUTERINE,NDA,203159,Skyla,LEVONORGESTREL,2023/01/31,Progestin; Progestin-containing Intrauterine System,2000,BAYER HEALTHCARE PHARMACEUTICALS INC,2013/01/11-,50419-422,5W7SIA7YZW,LEVONORGESTREL,LEVONORGESTREL,5W7SIA7YZW,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/9f44ff35-e052-49cd-a1c2-0bfd87d49309/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9f44ff35-e052-49cd-a1c2-0bfd87d49309,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=9f44ff35-e052-49cd-a1c2-0bfd87d49309,9f44ff35-e052-49cd-a1c2-0bfd87d49309,,,
HUMAN PRESCRIPTION DRUG LABEL,INTRAUTERINE DEVICE,INTRAUTERINE,NDA,021225,Mirena,LEVONORGESTREL,2022/08/12,Progestin; Progestin-containing Intrauterine System,2000,BAYER HEALTHCARE PHARMACEUTICALS INC,2009/10/01-,50419-423,5W7SIA7YZW,LEVONORGESTREL,LEVONORGESTREL,5W7SIA7YZW,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/dcbd6aa2-b3fa-479a-a676-56ea742962fc/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=dcbd6aa2-b3fa-479a-a676-56ea742962fc,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=dcbd6aa2-b3fa-479a-a676-56ea742962fc,dcbd6aa2-b3fa-479a-a676-56ea742962fc,,,
HUMAN PRESCRIPTION DRUG LABEL,KIT,ORAL,NDA,021840,Seasonique,LEVONORGESTREL / ETHINYL ESTRADIOL AND ETHINYL ESTRADIOL,2023/06/16,Estrogen; Progestin; Progestin-containing Intrauterine System,1982,TEVA WOMEN S HEALTH LLC,completed:2006/07/10-2024/06/30,51285-087,423D2T571U; 5W7SIA7YZW,ETHINYL ESTRADIOL; LEVONORGESTREL,ETHINYL ESTRADIOL; LEVONORGESTREL,423D2T571U; 5W7SIA7YZW,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/95e06935-8788-420c-b4a4-dc6ea339c7d0/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=95e06935-8788-420c-b4a4-dc6ea339c7d0,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=95e06935-8788-420c-b4a4-dc6ea339c7d0,95e06935-8788-420c-b4a4-dc6ea339c7d0,,,
HUMAN PRESCRIPTION DRUG LABEL,KIT,ORAL,NDA,208612,levonorgestrel and ethinyl estradiol,LEVONORGESTREL AND ETHINYL ESTRADIOL,2023/11/22,Estrogen; Progestin; Progestin-containing Intrauterine System,1997,ACELLA PHARMACEUTICALS,2023/08/21-,42192-623,423D2T571U; 5W7SIA7YZW,ETHINYL ESTRADIOL; LEVONORGESTREL,ETHINYL ESTRADIOL; LEVONORGESTREL,423D2T571U; 5W7SIA7YZW,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/167b12a0-cdff-4081-a0a4-164482c239fa/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=167b12a0-cdff-4081-a0a4-164482c239fa,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=167b12a0-cdff-4081-a0a4-164482c239fa,167b12a0-cdff-4081-a0a4-164482c239fa,,,
HUMAN PRESCRIPTION DRUG LABEL,KIT,ORAL,NDA,208612,Balcoltra,LEVONORGESTREL AND ETHINYL ESTRADIOL,2023/11/21,Estrogen; Progestin; Progestin-containing Intrauterine System,1997,AVION PHARMACEUTICALS,2018/04/10-,75854-602,423D2T571U; 5W7SIA7YZW,ETHINYL ESTRADIOL; LEVONORGESTREL,ETHINYL ESTRADIOL; LEVONORGESTREL,423D2T571U; 5W7SIA7YZW,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/752ab698-4b48-4614-8016-d1d33ee7c007/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=752ab698-4b48-4614-8016-d1d33ee7c007,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=752ab698-4b48-4614-8016-d1d33ee7c007,752ab698-4b48-4614-8016-d1d33ee7c007,,,
HUMAN PRESCRIPTION DRUG LABEL,KIT,ORAL,NDA,209405,Tyblume,LEVONORGESTREL AND ETHINYL ESTRADIOL,2023/02/12,Estrogen; Progestin; Progestin-containing Intrauterine System,1968,EXELTIS USA INC,2020/10/26-,0642-7471,423D2T571U; 5W7SIA7YZW,ETHINYL ESTRADIOL; LEVONORGESTREL,ETHINYL ESTRADIOL; LEVONORGESTREL,423D2T571U; 5W7SIA7YZW,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/b2482d51-d606-4aaa-8af4-19e4fe2f8872/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b2482d51-d606-4aaa-8af4-19e4fe2f8872,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=b2482d51-d606-4aaa-8af4-19e4fe2f8872,b2482d51-d606-4aaa-8af4-19e4fe2f8872,,,
HUMAN PRESCRIPTION DRUG LABEL,PATCH,TRANSDERMAL,NDA,204017,Twirla,LEVONORGESTREL/ETHINYL ESTRADIOL,2023/11/13,Estrogen; Progestin; Progestin-containing Intrauterine System,1968,AGILE THERAPEUTICS INC,2020/09/11-,71671-100,423D2T571U; 5W7SIA7YZW,ETHINYL ESTRADIOL; LEVONORGESTREL,ETHINYL ESTRADIOL; LEVONORGESTREL,423D2T571U; 5W7SIA7YZW,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/bcaf8db0-1750-425d-b008-255b5e7a9cc6/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=bcaf8db0-1750-425d-b008-255b5e7a9cc6,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=bcaf8db0-1750-425d-b008-255b5e7a9cc6,bcaf8db0-1750-425d-b008-255b5e7a9cc6,,,
HUMAN PRESCRIPTION DRUG LABEL,KIT,ORAL,NDA,204061,QUARTETTE,LEVONORGESTREL/ETHINYL ESTRADIOL AND ETHINYL ESTRADIOL,2023/06/16,Estrogen; Progestin; Progestin-containing Intrauterine System,1982,TEVA WOMEN S HEALTH LLC,completed:2013/07/25-2025/01/31,51285-431,423D2T571U; 5W7SIA7YZW,ETHINYL ESTRADIOL; LEVONORGESTREL,ETHINYL ESTRADIOL; LEVONORGESTREL,423D2T571U; 5W7SIA7YZW,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/99c669d8-12ef-4d3a-8761-02d5acb0c8b0/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=99c669d8-12ef-4d3a-8761-02d5acb0c8b0,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=99c669d8-12ef-4d3a-8761-02d5acb0c8b0,99c669d8-12ef-4d3a-8761-02d5acb0c8b0,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,021402,Synthroid,LEVOTHYROXINE SODIUM,2024/02/20,l-Thyroxine,2002,ABBVIE INC,2002/02/24-; 2002/07/24-,0074-3727; 0074-4341; 0074-4552; 0074-5182; 0074-6594; 0074-6624; 0074-7068; 0074-7069; 0074-7070; 0074-7148; 0074-7149; 0074-9296,9J765S329G,LEVOTHYROXINE SODIUM,LEVOTHYROXINE,Q51BO43MG4,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/1e11ad30-1041-4520-10b0-8f9d30d30fcc/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1e11ad30-1041-4520-10b0-8f9d30d30fcc,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=1e11ad30-1041-4520-10b0-8f9d30d30fcc,1e11ad30-1041-4520-10b0-8f9d30d30fcc,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,021210,Levothyroxine Sodium,LEVOTHYROXINE SODIUM,2024/02/07,l-Thyroxine,,AMNEAL PHARMACEUTICALS NY LLC,2003/12/01-; 2007/10/01-,69238-1830; 69238-1831; 69238-1832; 69238-1833; 69238-1834; 69238-1835; 69238-1836; 69238-1837; 69238-1838; 69238-1839; 69238-1840; 69238-1841,9J765S329G,LEVOTHYROXINE SODIUM,LEVOTHYROXINE,Q51BO43MG4,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/fca88c97-5cd4-4834-ba87-deb5bd637788/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=fca88c97-5cd4-4834-ba87-deb5bd637788,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=fca88c97-5cd4-4834-ba87-deb5bd637788,fca88c97-5cd4-4834-ba87-deb5bd637788,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,021116,levothyroxine sodium,LEVOTHYROXINE SODIUM,2024/01/31,l-Thyroxine,2002,ALVOGEN INC,2019/05/07-,47781-640; 47781-643; 47781-646; 47781-649; 47781-651; 47781-654; 47781-657; 47781-659; 47781-662; 47781-665; 47781-668; 47781-671,9J765S329G,LEVOTHYROXINE SODIUM,LEVOTHYROXINE,Q51BO43MG4,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/4ddcaec1-a58f-340b-9bc1-bbe048b8c885/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4ddcaec1-a58f-340b-9bc1-bbe048b8c885,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=4ddcaec1-a58f-340b-9bc1-bbe048b8c885,4ddcaec1-a58f-340b-9bc1-bbe048b8c885,,,
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION,ORAL,NDA,206977,Tirosint SOL,LEVOTHYROXINE SODIUM,2023/11/30,l-Thyroxine,2000,IBSA PHARMA INC,2019/03/01-; 2021/07/01-,71858-0105; 71858-0110; 71858-0112; 71858-0113; 71858-0115; 71858-0117; 71858-0120; 71858-0125; 71858-0130; 71858-0135; 71858-0140; 71858-0145; 71858-0150; 71858-0155; 71858-0160,9J765S329G,LEVOTHYROXINE SODIUM,LEVOTHYROXINE,Q51BO43MG4,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/5d378add-f13d-40f2-99dc-0f2340ab44b7/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5d378add-f13d-40f2-99dc-0f2340ab44b7,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=5d378add-f13d-40f2-99dc-0f2340ab44b7,5d378add-f13d-40f2-99dc-0f2340ab44b7,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,NDA,021924,Tirosint,LEVOTHYROXINE SODIUM,2023/11/27,l-Thyroxine,2000,IBSA PHARMA INC,2018/12/01-; 2023/03/01-,71858-0005; 71858-0010; 71858-0012; 71858-0013; 71858-0015; 71858-0017; 71858-0020; 71858-0025; 71858-0030; 71858-0035; 71858-0040; 71858-0045; 71858-0050; 71858-0055; 71858-0060,9J765S329G,LEVOTHYROXINE SODIUM,LEVOTHYROXINE,Q51BO43MG4,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/7a7ade79-0165-4e31-b84e-667416c00c7e/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7a7ade79-0165-4e31-b84e-667416c00c7e,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=7a7ade79-0165-4e31-b84e-667416c00c7e,7a7ade79-0165-4e31-b84e-667416c00c7e,,,
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION,ORAL,NDA,214047,THYQUIDITY,LEVOTHYROXINE SODIUM,2023/03/30,l-Thyroxine,2000,AZURITY PHARMACEUTICALS INC,2023/04/05-,52652-1950,9J765S329G,LEVOTHYROXINE SODIUM,LEVOTHYROXINE,Q51BO43MG4,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/c17ec992-a122-4cd9-8469-d91255c32440/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c17ec992-a122-4cd9-8469-d91255c32440,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=c17ec992-a122-4cd9-8469-d91255c32440,c17ec992-a122-4cd9-8469-d91255c32440,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,214253,Levothyroxine Sodium,LEVOTHYROXINE SODIUM,2022/11/01,l-Thyroxine,1969,HIKMA PHARMACEUTICALS USA INC,2022/11/15-,24201-002,9J765S329G,LEVOTHYROXINE SODIUM,LEVOTHYROXINE,Q51BO43MG4,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/6279390b-ee61-4ef9-ac15-25537ca783c1/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6279390b-ee61-4ef9-ac15-25537ca783c1,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=6279390b-ee61-4ef9-ac15-25537ca783c1,6279390b-ee61-4ef9-ac15-25537ca783c1,,,
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION,ORAL,NDA,214047,THYQUIDITY,LEVOTHYROXINE SODIUM,2022/09/14,l-Thyroxine,2000,VISTAPHARM INC,completed:2021/02/15-2024/07/31,66689-105,9J765S329G,LEVOTHYROXINE SODIUM,LEVOTHYROXINE,Q51BO43MG4,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/67dbca4d-1aea-48f8-a013-c14d5dc75f50/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=67dbca4d-1aea-48f8-a013-c14d5dc75f50,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=67dbca4d-1aea-48f8-a013-c14d5dc75f50,67dbca4d-1aea-48f8-a013-c14d5dc75f50,,,
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION,ORAL,NDA,215809,ERMEZA,LEVOTHYROXINE SODIUM,2022/04/15,l-Thyroxine,2000,MYLAN SPECIALTY L P,2022/12/14-,49502-378,9J765S329G,LEVOTHYROXINE SODIUM,LEVOTHYROXINE,Q51BO43MG4,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/8ceeadb4-18be-46c7-9204-68b4edfbb96b/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8ceeadb4-18be-46c7-9204-68b4edfbb96b,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=8ceeadb4-18be-46c7-9204-68b4edfbb96b,8ceeadb4-18be-46c7-9204-68b4edfbb96b,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,021301,LEVOXYL,LEVOTHYROXINE SODIUM,2020/12/15,l-Thyroxine,2001,PFIZER LABORATORIES DIV PFIZER INC,2001/05/25-,60793-850; 60793-851; 60793-852; 60793-853; 60793-854; 60793-855; 60793-856; 60793-857; 60793-858; 60793-859; 60793-860,9J765S329G,LEVOTHYROXINE SODIUM,LEVOTHYROXINE,Q51BO43MG4,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/758588c3-c63e-491b-0aa2-4f50d80cb174/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=758588c3-c63e-491b-0aa2-4f50d80cb174,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=758588c3-c63e-491b-0aa2-4f50d80cb174,758588c3-c63e-491b-0aa2-4f50d80cb174,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,210632,Levothyroxine Sodium,LEVOTHYROXINE SODIUM,2020/12/04,l-Thyroxine,2002,FRESENIUS KABI USA LLC,2018/05/29-,63323-885,9J765S329G,Levothyroxine sodium,Levothyroxine,Q51BO43MG4,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/50b1c8a4-75b6-49c8-80fc-3841ee80b183/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=50b1c8a4-75b6-49c8-80fc-3841ee80b183,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=50b1c8a4-75b6-49c8-80fc-3841ee80b183,50b1c8a4-75b6-49c8-80fc-3841ee80b183,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,210632,Levothyroxine Sodium,LEVOTHYROXINE SODIUM,2020/12/04,l-Thyroxine,2002,FRESENIUS KABI USA LLC,2018/05/29-,63323-885,9J765S329G,Levothyroxine sodium,Levothyroxine,Q51BO43MG4,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/388a1f15-8c1c-46a5-997f-7f326f696b59/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=388a1f15-8c1c-46a5-997f-7f326f696b59,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=388a1f15-8c1c-46a5-997f-7f326f696b59,388a1f15-8c1c-46a5-997f-7f326f696b59,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,021210,Unithroid,LEVOTHYROXINE SODIUM,2019/06/19,l-Thyroxine,2001,AMNEAL PHARMACEUTICALS LLC,2014/07/03-,60846-801; 60846-802; 60846-803; 60846-804; 60846-805; 60846-806; 60846-807; 60846-808; 60846-809; 60846-810; 60846-811; 60846-812,9J765S329G,levothyroxine sodium,levothyroxine,Q51BO43MG4,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/07562e72-7eaa-4ce6-94f0-e08814787e50/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=07562e72-7eaa-4ce6-94f0-e08814787e50,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=07562e72-7eaa-4ce6-94f0-e08814787e50,07562e72-7eaa-4ce6-94f0-e08814787e50,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,210632,Levothyroxine Sodium,LEVOTHYROXINE SODIUM,2019/04/05,l-Thyroxine,2002,FRESENIUS KABI USA LLC,2018/05/29-,63323-885; 63323-890; 63323-895,9J765S329G,Levothyroxine sodium,Levothyroxine,Q51BO43MG4,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/08f4b1f8-6807-47e7-bef8-8d1972aa0557/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=08f4b1f8-6807-47e7-bef8-8d1972aa0557,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=08f4b1f8-6807-47e7-bef8-8d1972aa0557,08f4b1f8-6807-47e7-bef8-8d1972aa0557,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAVENOUS,NDA,202231,Levothyroxine Sodium,LEVOTHYROXINE SODIUM ANHYDROUS,2022/10/26,l-Thyroxine,1969,PAR PHARMACEUTICAL INC,2011/06/24-,42023-201; 42023-202; 42023-203,054I36CPMN,LEVOTHYROXINE SODIUM ANHYDROUS,LEVOTHYROXINE,Q51BO43MG4,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/9d815416-11c9-470e-a82f-89b0bf232e12/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9d815416-11c9-470e-a82f-89b0bf232e12,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=9d815416-11c9-470e-a82f-89b0bf232e12,9d815416-11c9-470e-a82f-89b0bf232e12,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAVENOUS,NDA,202231,Levothyroxine Sodium,LEVOTHYROXINE SODIUM ANHYDROUS,2019/12/31,l-Thyroxine,1969,FRESENIUS KABI USA LLC,2011/06/24-,63323-649,054I36CPMN,LEVOTHYROXINE SODIUM ANHYDROUS,LEVOTHYROXINE,Q51BO43MG4,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/f88f44d8-2f18-4155-9d78-6323d19fbafe/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f88f44d8-2f18-4155-9d78-6323d19fbafe,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=f88f44d8-2f18-4155-9d78-6323d19fbafe,f88f44d8-2f18-4155-9d78-6323d19fbafe,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAVENOUS,NDA,202231,Levothyroxine Sodium,LEVOTHYROXINE SODIUM ANHYDROUS,2019/12/31,l-Thyroxine,1969,FRESENIUS KABI USA LLC,2011/06/24-,63323-647; 63323-648; 63323-649,054I36CPMN,LEVOTHYROXINE SODIUM ANHYDROUS,LEVOTHYROXINE,Q51BO43MG4,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/ce990712-49c1-4f66-9ee4-c770e8ec394c/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ce990712-49c1-4f66-9ee4-c770e8ec394c,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=ce990712-49c1-4f66-9ee4-c770e8ec394c,ce990712-49c1-4f66-9ee4-c770e8ec394c,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAVENOUS,NDA,202231,Levothyroxine Sodium,LEVOTHYROXINE SODIUM ANHYDROUS,2019/12/31,l-Thyroxine,1969,FRESENIUS KABI USA LLC,2011/06/24-,63323-648; 63323-649,054I36CPMN,LEVOTHYROXINE SODIUM ANHYDROUS,LEVOTHYROXINE,Q51BO43MG4,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/152d071f-d4aa-46d2-b397-61c1cabdd86d/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=152d071f-d4aa-46d2-b397-61c1cabdd86d,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=152d071f-d4aa-46d2-b397-61c1cabdd86d,152d071f-d4aa-46d2-b397-61c1cabdd86d,,,
HUMAN PRESCRIPTION DRUG LABEL,PATCH,CUTANEOUS,NDA,020612,LIDODERM,LIDOCAINE,2022/11/27,Amide Local Anesthetic; Antiarrhythmic,,ENDO PHARMACEUTICALS INC,completed:1999/03/20-2025/03/31,63481-687,98PI200987,LIDOCAINE,LIDOCAINE,98PI200987,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/f1c40164-4626-4290-9012-c00e33420a33/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f1c40164-4626-4290-9012-c00e33420a33,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=f1c40164-4626-4290-9012-c00e33420a33,f1c40164-4626-4290-9012-c00e33420a33,,,
HUMAN PRESCRIPTION DRUG LABEL,PATCH,TOPICAL,NDA,207962,Ztlido,LIDOCAINE,2021/04/21,Amide Local Anesthetic; Antiarrhythmic,1953,SCILEX PHARMACEUTICALS INC,2018/04/26-,69557-111,98PI200987,LIDOCAINE,LIDOCAINE,98PI200987,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/a1b17507-4560-490d-a388-74e7fd7eaa5e/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a1b17507-4560-490d-a388-74e7fd7eaa5e,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=a1b17507-4560-490d-a388-74e7fd7eaa5e,a1b17507-4560-490d-a388-74e7fd7eaa5e,,,
HUMAN PRESCRIPTION DRUG LABEL,CREAM,TOPICAL,NDA,019941,PRILOLID,LIDOCAINE 2.5% AND PRILOCAINE 2.5%,2016/10/20,Amide Local Anesthetic; Antiarrhythmic,,STERLING KNIGHT PHARMACEUTICALS LLC,2016/10/05-,69336-828,046O35D44R; 98PI200987,LIDOCAINE; PRILOCAINE,LIDOCAINE; PRILOCAINE,046O35D44R; 98PI200987,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/96977d02-55a0-4fd1-90c6-0e375826536e/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=96977d02-55a0-4fd1-90c6-0e375826536e,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=96977d02-55a0-4fd1-90c6-0e375826536e,96977d02-55a0-4fd1-90c6-0e375826536e,,,
HUMAN PRESCRIPTION DRUG LABEL,CREAM,TOPICAL,NDA,019941,LIDOPRIL XR,LIDOCAINE 2.5% AND PRILOCAINE 2.5%,2016/10/04,Amide Local Anesthetic; Antiarrhythmic,,STERLING KNIGHT PHARMACEUTICALS LLC,2016/08/16-,69336-826,046O35D44R; 98PI200987,LIDOCAINE; PRILOCAINE,LIDOCAINE; PRILOCAINE,046O35D44R; 98PI200987,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/77d8a9c1-b168-4f02-b92b-2ce5abc5be55/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=77d8a9c1-b168-4f02-b92b-2ce5abc5be55,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=77d8a9c1-b168-4f02-b92b-2ce5abc5be55,77d8a9c1-b168-4f02-b92b-2ce5abc5be55,,,
HUMAN PRESCRIPTION DRUG LABEL,CREAM,TOPICAL,NDA,019941,LIDOPRIL,LIDOCAINE 2.5% AND PRILOCAINE 2.5%,2016/08/17,Amide Local Anesthetic; Antiarrhythmic,,STERLING KNIGHT PHARMACEUTICALS LLC,2016/07/07-,69336-825,046O35D44R; 98PI200987,LIDOCAINE; PRILOCAINE,LIDOCAINE; PRILOCAINE,046O35D44R; 98PI200987,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/1edfa2e0-8a9a-4c15-8688-61193d75178a/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1edfa2e0-8a9a-4c15-8688-61193d75178a,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=1edfa2e0-8a9a-4c15-8688-61193d75178a,1edfa2e0-8a9a-4c15-8688-61193d75178a,,,
HUMAN PRESCRIPTION DRUG LABEL,GEL,PERIODONTAL,NDA,021451,Oraqix,LIDOCAINE AND PRILOCAINE,2024/01/26,Amide Local Anesthetic; Antiarrhythmic,2003,DENTSPLY PHARMACEUTICAL,2004/01/02-,66312-110,046O35D44R; 98PI200987,LIDOCAINE; PRILOCAINE,LIDOCAINE; PRILOCAINE,046O35D44R; 98PI200987,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/b501d239-923b-48b2-82ed-6c5c253a67e2/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b501d239-923b-48b2-82ed-6c5c253a67e2,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=b501d239-923b-48b2-82ed-6c5c253a67e2,b501d239-923b-48b2-82ed-6c5c253a67e2,,,
HUMAN PRESCRIPTION DRUG LABEL,CREAM,TOPICAL,NDA,021717,PLIAGLIS,LIDOCAINE AND TETRACAINE,2021/01/12,Amide Local Anesthetic; Antiarrhythmic; Ester Local Anesthetic,2006,TARO PHARMACEUTICALS U S A INC,2018/12/11-,51672-5305,0619F35CGV; 98PI200987,lidocaine; tetracaine,lidocaine; tetracaine,0619F35CGV; 98PI200987,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/9838a8a2-dd5a-4eb2-beee-2fb45d35f6de/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9838a8a2-dd5a-4eb2-beee-2fb45d35f6de,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=9838a8a2-dd5a-4eb2-beee-2fb45d35f6de,9838a8a2-dd5a-4eb2-beee-2fb45d35f6de,,,
HUMAN PRESCRIPTION DRUG LABEL,CREAM,TOPICAL,NDA,021717,Pliaglis,LIDOCAINE AND TETRACAINE,2020/10/06,Amide Local Anesthetic; Antiarrhythmic; Ester Local Anesthetic,2006,OBA PHARMACEUTICALS INC,2020/01/24-,73575-010,0619F35CGV; 98PI200987,lidocaine; tetracaine,lidocaine; tetracaine,0619F35CGV; 98PI200987,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/4ccdf61b-3128-4a97-a89c-a11e40823938/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4ccdf61b-3128-4a97-a89c-a11e40823938,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=4ccdf61b-3128-4a97-a89c-a11e40823938,4ccdf61b-3128-4a97-a89c-a11e40823938,,,
HUMAN PRESCRIPTION DRUG LABEL,CREAM,TOPICAL,NDA,021717,Pliaglis,LIDOCAINE AND TETRACAINE,2020/08/19,Amide Local Anesthetic; Antiarrhythmic; Ester Local Anesthetic,2006,OBA PHARMACEUTICALS INC,2020/01/24-,73575-009,0619F35CGV; 98PI200987,lidocaine; tetracaine,lidocaine; tetracaine,0619F35CGV; 98PI200987,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/8a1b2553-ce65-4557-b33d-cb3dd2a307fa/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8a1b2553-ce65-4557-b33d-cb3dd2a307fa,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=8a1b2553-ce65-4557-b33d-cb3dd2a307fa,8a1b2553-ce65-4557-b33d-cb3dd2a307fa,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",EPIDURAL; INFILTRATION; INTRACAUDAL; PERINEURAL,NDA,006488,Xylocaine MPF,LIDOCAINE HYDROCHLORIDE,2024/05/13,Amide Local Anesthetic; Antiarrhythmic,,FRESENIUS KABI USA LLC,2011/07/18-,63323-492; 63323-493; 63323-496,EC2CNF7XFP,LIDOCAINE HYDROCHLORIDE ANHYDROUS,LIDOCAINE,98PI200987,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/d5e0d06f-ba1e-44d4-aa89-39d6c146dc23/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d5e0d06f-ba1e-44d4-aa89-39d6c146dc23,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=d5e0d06f-ba1e-44d4-aa89-39d6c146dc23,d5e0d06f-ba1e-44d4-aa89-39d6c146dc23,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",EPIDURAL; INFILTRATION; INTRACAUDAL; PERINEURAL,NDA,006488,Xylocaine MPF,LIDOCAINE HYDROCHLORIDE,2024/03/15,Amide Local Anesthetic; Antiarrhythmic,,FRESENIUS KABI USA LLC,2020/10/30-,65219-810; 65219-812; 65219-814,EC2CNF7XFP,LIDOCAINE HYDROCHLORIDE ANHYDROUS,LIDOCAINE,98PI200987,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/fe265eb5-eaeb-4f47-82dd-238c1d53fec4/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=fe265eb5-eaeb-4f47-82dd-238c1d53fec4,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=fe265eb5-eaeb-4f47-82dd-238c1d53fec4,fe265eb5-eaeb-4f47-82dd-238c1d53fec4,,,
HUMAN PRESCRIPTION DRUG LABEL,GEL,OPHTHALMIC,NDA,022221,Akten,LIDOCAINE HYDROCHLORIDE,2021/11/15,Amide Local Anesthetic; Antiarrhythmic,1972,AKORN,2008/10/08-,17478-792,EC2CNF7XFP,Lidocaine Hydrochloride Anhydrous,Lidocaine,98PI200987,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/c1f638dc-c386-45e8-9adc-d0f295794679/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c1f638dc-c386-45e8-9adc-d0f295794679,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=c1f638dc-c386-45e8-9adc-d0f295794679,c1f638dc-c386-45e8-9adc-d0f295794679,,,
HUMAN PRESCRIPTION DRUG LABEL,KIT,EPIDURAL; INFILTRATION,NDA,016964,ReadySharp-A,LIDOCAINE HYDROCHLORIDE AND BUPIVACAINE HYDROCHLORIDE,2017/12/19,Amide Local Anesthetic; Antiarrhythmic,,TERRAIN PHARMACEUTICALS,2015/12/29-,53225-3125,7TQO7W3VT8; V13007Z41A,BUPIVACAINE HYDROCHLORIDE; LIDOCAINE HYDROCHLORIDE,BUPIVACAINE; LIDOCAINE,98PI200987; Y8335394RO,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/28115cb6-118b-612a-e054-00144ff88e88/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=28115cb6-118b-612a-e054-00144ff88e88,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=28115cb6-118b-612a-e054-00144ff88e88,28115cb6-118b-612a-e054-00144ff88e88,,,
HUMAN PRESCRIPTION DRUG LABEL,GEL,OPHTHALMIC,NDA,022221,AKTEN,LIDOCAINE HYDROCHLORIDE ANHYDROUS,2024/04/19,Amide Local Anesthetic; Antiarrhythmic,1972,THEA PHARMA INC,2022/12/01-,82584-792,EC2CNF7XFP,LIDOCAINE HYDROCHLORIDE ANHYDROUS,LIDOCAINE,98PI200987,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/70ff9fb7-d323-4fe6-b1b1-6033e05f0749/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=70ff9fb7-d323-4fe6-b1b1-6033e05f0749,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=70ff9fb7-d323-4fe6-b1b1-6033e05f0749,70ff9fb7-d323-4fe6-b1b1-6033e05f0749,,,
HUMAN PRESCRIPTION DRUG LABEL,KIT,EPIDURAL; INFILTRATION; INTRA-ARTICULAR; INTRALESIONAL; INTRAMUSCULAR,NDA,016964,ReadySharp Anesthetics plus Betamethasone,"LIDOCAINE HYDROCHLORIDE, BUPIVACAINE HYDROCHLORIDE, AND BETAMETHASONE SODIUM PHOSPHATE AND BETAMETHASONE ACETATE",2016/12/08,Amide Local Anesthetic; Antiarrhythmic; Corticosteroid,,TERRAIN PHARMACEUTICALS,2015/12/29-,53225-4105,7BK02SCL3W; 7TQO7W3VT8; TI05AO53L7; V13007Z41A,BETAMETHASONE ACETATE; BETAMETHASONE SODIUM PHOSPHATE; BUPIVACAINE HYDROCHLORIDE; LIDOCAINE HYDROCHLORIDE,BETAMETHASONE; BUPIVACAINE; LIDOCAINE,9842X06Q6M; 98PI200987; Y8335394RO,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/432c2026-99ec-49e0-e054-00144ff8d46c/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=432c2026-99ec-49e0-e054-00144ff8d46c,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=432c2026-99ec-49e0-e054-00144ff8d46c,432c2026-99ec-49e0-e054-00144ff8d46c,,,
HUMAN PRESCRIPTION DRUG LABEL,KIT,EPIDURAL; INFILTRATION; INTRAMUSCULAR; INTRAVENOUS,NDA,016964,ReadySharp Anesthetics plus Dexamethasone,"LIDOCAINE HYDROCHLORIDE, BUPIVACAINE HYDROCHLORIDE, AND DEXAMETHASONE SODIUM PHOSPHATE",2017/12/19,Amide Local Anesthetic; Antiarrhythmic; Corticosteroid,,TERRAIN PHARMACEUTICALS,2015/12/29-,53225-4210,7TQO7W3VT8; AI9376Y64P; V13007Z41A,BUPIVACAINE HYDROCHLORIDE; DEXAMETHASONE SODIUM PHOSPHATE; LIDOCAINE HYDROCHLORIDE,BUPIVACAINE; DEXAMETHASONE; LIDOCAINE,7S5I7G3JQL; 98PI200987; Y8335394RO,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/433c1e4f-b7b7-4eda-e054-00144ff88e88/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=433c1e4f-b7b7-4eda-e054-00144ff88e88,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=433c1e4f-b7b7-4eda-e054-00144ff88e88,433c1e4f-b7b7-4eda-e054-00144ff88e88,,,
HUMAN PRESCRIPTION DRUG LABEL,KIT,EPIDURAL; INFILTRATION; INTRAMUSCULAR; INTRAVENOUS,NDA,016964,ReadySharp Anesthetics plus Ketorolac,"LIDOCAINE HYDROCHLORIDE, BUPIVACAINE HYDROCHLORIDE, AND KETOROLAC TROMETHAMINE",2017/12/19,Amide Local Anesthetic; Antiarrhythmic; Cyclooxygenase Inhibitor; Nonsteroidal Anti-inflammatory Drug,,TERRAIN PHARMACEUTICALS,2015/12/29-,53225-4000,4EVE5946BQ; 7TQO7W3VT8; V13007Z41A,BUPIVACAINE HYDROCHLORIDE; KETOROLAC TROMETHAMINE; LIDOCAINE HYDROCHLORIDE,BUPIVACAINE; KETOROLAC; LIDOCAINE,98PI200987; Y8335394RO; YZI5105V0L,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/43402281-92b1-61aa-e054-00144ff88e88/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=43402281-92b1-61aa-e054-00144ff88e88,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=43402281-92b1-61aa-e054-00144ff88e88,43402281-92b1-61aa-e054-00144ff88e88,,,
HUMAN PRESCRIPTION DRUG LABEL,KIT,EPIDURAL; INFILTRATION; INTRA-ARTICULAR; INTRALESIONAL; INTRAMUSCULAR; SOFT TISSUE,NDA,016964,ReadySharp-P40,"LIDOCAINE HYDROCHLORIDE, BUPIVACAINE HYDROCHLORIDE, AND METHYLPREDNISOLONE ACETATE",2016/12/13,Amide Local Anesthetic; Antiarrhythmic; Corticosteroid,,TERRAIN PHARMACEUTICALS,2015/12/29-,53225-3335,43502P7F0P; 7TQO7W3VT8; V13007Z41A,BUPIVACAINE HYDROCHLORIDE; LIDOCAINE HYDROCHLORIDE; METHYLPREDNISOLONE ACETATE,BUPIVACAINE; LIDOCAINE; METHYLPREDNISOLONE,98PI200987; X4W7ZR7023; Y8335394RO,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/28247e4a-0a18-0365-e054-00144ff88e88/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=28247e4a-0a18-0365-e054-00144ff88e88,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=28247e4a-0a18-0365-e054-00144ff88e88,28247e4a-0a18-0365-e054-00144ff88e88,,,
HUMAN PRESCRIPTION DRUG LABEL,KIT,EPIDURAL; INFILTRATION; INTRA-ARTICULAR; INTRALESIONAL; INTRAMUSCULAR; SOFT TISSUE,NDA,016964,ReadySharp-P80,"LIDOCAINE HYDROCHLORIDE, BUPIVACAINE HYDROCHLORIDE, AND METHYLPREDNISOLONE ACETATE",2016/12/13,Amide Local Anesthetic; Antiarrhythmic; Corticosteroid,,TERRAIN PHARMACEUTICALS,2015/12/29-,53225-3440,43502P7F0P; 7TQO7W3VT8; V13007Z41A,BUPIVACAINE HYDROCHLORIDE; LIDOCAINE HYDROCHLORIDE; METHYLPREDNISOLONE ACETATE,BUPIVACAINE; LIDOCAINE; METHYLPREDNISOLONE,98PI200987; X4W7ZR7023; Y8335394RO,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/2823a219-0466-5dda-e054-00144ff88e88/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2823a219-0466-5dda-e054-00144ff88e88,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=2823a219-0466-5dda-e054-00144ff88e88,2823a219-0466-5dda-e054-00144ff88e88,,,
HUMAN PRESCRIPTION DRUG LABEL,KIT,EPIDURAL; INFILTRATION; INTRA-ARTICULAR; INTRALESIONAL; INTRAMUSCULAR; SOFT TISSUE,NDA,016964,ReadySharp Anesthetics plus MethylPrednisolone 80,"LIDOCAINE HYDROCHLORIDE, BUPIVACAINE HYDROCHLORIDE, AND METHYLPREDNISOLONE ACETATE",2016/12/09,Amide Local Anesthetic; Antiarrhythmic; Corticosteroid,,TERRAIN PHARMACEUTICALS,2015/12/29-,53225-4315,43502P7F0P; 7TQO7W3VT8; V13007Z41A,BUPIVACAINE HYDROCHLORIDE; LIDOCAINE HYDROCHLORIDE; METHYLPREDNISOLONE ACETATE,BUPIVACAINE; LIDOCAINE; METHYLPREDNISOLONE,98PI200987; X4W7ZR7023; Y8335394RO,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/43775cf1-4477-449a-e054-00144ff88e88/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=43775cf1-4477-449a-e054-00144ff88e88,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=43775cf1-4477-449a-e054-00144ff88e88,43775cf1-4477-449a-e054-00144ff88e88,,,
HUMAN PRESCRIPTION DRUG LABEL,KIT,EPIDURAL; INFILTRATION; INTRA-ARTICULAR; INTRAMUSCULAR; TOPICAL,NDA,014901,LT,"LIDOCAINE HYDROCHLORIDE, TRIAMCINOLONE ACETONIDE, POVIDONE-IODINE AND ISOPROPYL ALCOHOL",2015/08/26,Amide Local Anesthetic; Antiarrhythmic; Corticosteroid,,SA LLC,2015/07/01-,69420-4002,85H0HZU99M; F446C597KA; ND2M416302; V13007Z41A,ISOPROPYL ALCOHOL; LIDOCAINE HYDROCHLORIDE; POVIDONE-IODINE; TRIAMCINOLONE ACETONIDE,IODINE; ISOPROPYL ALCOHOL; LIDOCAINE; TRIAMCINOLONE ACETONIDE,9679TC07X4; 98PI200987; F446C597KA; ND2M416302,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/6ac1a90b-cbff-49b5-bc7d-5839d332cb85/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6ac1a90b-cbff-49b5-bc7d-5839d332cb85,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=6ac1a90b-cbff-49b5-bc7d-5839d332cb85,6ac1a90b-cbff-49b5-bc7d-5839d332cb85,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",EPIDURAL; INFILTRATION; INTRACAUDAL; PERINEURAL,NDA,006488,Xylocaine; Xylocaine MPF,"LIDOCAINE HYDROCHLORIDE; LIDOCAINE HYDROCHLORIDE,EPINEPHRINE BITARTRATE",2022/09/15,Amide Local Anesthetic; Antiarrhythmic; Catecholamine; alpha-Adrenergic Agonist; beta-Adrenergic Agonist,,FRESENIUS KABI USA LLC,2010/08/12-,63323-482; 63323-485; 63323-486; 63323-492; 63323-495,30Q7KI53AK; EC2CNF7XFP,EPINEPHRINE BITARTRATE; LIDOCAINE HYDROCHLORIDE ANHYDROUS,EPINEPHRINE; LIDOCAINE,98PI200987; YKH834O4BH,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/4dd52202-8eef-4136-92dd-ada573b7cf74/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4dd52202-8eef-4136-92dd-ada573b7cf74,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=4dd52202-8eef-4136-92dd-ada573b7cf74,4dd52202-8eef-4136-92dd-ada573b7cf74,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",EPIDURAL; INFILTRATION; INTRACAUDAL; PERINEURAL,NDA,006488,Xylocaine; Xylocaine MPF,"LIDOCAINE HYDROCHLORIDE; LIDOCAINE HYDROCHLORIDE,EPINEPHRINE BITARTRATE",2021/08/25,Amide Local Anesthetic; Antiarrhythmic; Catecholamine; alpha-Adrenergic Agonist; beta-Adrenergic Agonist,,FRESENIUS KABI USA LLC,2010/08/12-,63323-481; 63323-482; 63323-483; 63323-484; 63323-485; 63323-486; 63323-487; 63323-488; 63323-489; 63323-491; 63323-492; 63323-495,30Q7KI53AK; EC2CNF7XFP,EPINEPHRINE BITARTRATE; LIDOCAINE HYDROCHLORIDE ANHYDROUS,EPINEPHRINE; LIDOCAINE,98PI200987; YKH834O4BH,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/ba082c2f-64f4-419d-9c88-74f203316e17/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ba082c2f-64f4-419d-9c88-74f203316e17,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=ba082c2f-64f4-419d-9c88-74f203316e17,ba082c2f-64f4-419d-9c88-74f203316e17,,,
HUMAN PRESCRIPTION DRUG LABEL,PATCH,TOPICAL,NDA,020612,LIDODERM,LIDOCAINE PATCH 5%,2022/12/02,Amide Local Anesthetic; Antiarrhythmic,,TPU PHARMA INC,2023/03/01-,61959-001,98PI200987,LIDOCAINE,LIDOCAINE,98PI200987,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/db0092f5-02a0-4076-ac32-969f075a6ab1/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=db0092f5-02a0-4076-ac32-969f075a6ab1,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=db0092f5-02a0-4076-ac32-969f075a6ab1,db0092f5-02a0-4076-ac32-969f075a6ab1,,,
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION/ DROPS,OPHTHALMIC,NDA,208073,Xiidra,LIFITEGRAST,2024/04/24,Lymphocyte Function-Associated Antigen-1 Antagonist,2016,BAUSCH AND LOMB INCORPORATED,2024/01/02-,24208-911,038E5L962W,LIFITEGRAST,LIFITEGRAST,038E5L962W,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/1a914080-a3c0-44be-b601-0ae3160e77eb/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1a914080-a3c0-44be-b601-0ae3160e77eb,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=1a914080-a3c0-44be-b601-0ae3160e77eb,1a914080-a3c0-44be-b601-0ae3160e77eb,,,
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION/ DROPS,OPHTHALMIC,NDA,208073,Xiidra,LIFITEGRAST,2023/08/02,Lymphocyte Function-Associated Antigen-1 Antagonist,2016,NOVARTIS PHARMACEUTICALS CORPORATION,2016/07/11-,0078-0911,038E5L962W,LIFITEGRAST,LIFITEGRAST,038E5L962W,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/8589d376-ac10-4ddb-9c53-2e0c8d5675c4/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8589d376-ac10-4ddb-9c53-2e0c8d5675c4,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=8589d376-ac10-4ddb-9c53-2e0c8d5675c4,8589d376-ac10-4ddb-9c53-2e0c8d5675c4,,,
HUMAN PRESCRIPTION DRUG LABEL,"CAPSULE, GELATIN COATED",ORAL,NDA,202811,Linzess,LINACLOTIDE,2023/06/12,Guanylate Cyclase-C Agonist,2012,ALLERGAN INC,2012/09/08-; 2017/01/30-,0456-1201; 0456-1202; 0456-1203,N0TXR0XR5X,LINACLOTIDE,LINACLOTIDE,N0TXR0XR5X,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/09beda19-56d6-4a56-afdc-9a77b70b2ef3/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=09beda19-56d6-4a56-afdc-9a77b70b2ef3,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=09beda19-56d6-4a56-afdc-9a77b70b2ef3,09beda19-56d6-4a56-afdc-9a77b70b2ef3,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,201280,Tradjenta,LINAGLIPTIN,2023/06/26,Dipeptidyl Peptidase 4 Inhibitor,2011,BOEHRINGER INGELHEIM PHARMACEUTICALS INC,2011/05/09-,0597-0140,3X29ZEJ4R2,LINAGLIPTIN,LINAGLIPTIN,3X29ZEJ4R2,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/c797ea5c-cab7-494b-9044-27eba0cfe40f/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c797ea5c-cab7-494b-9044-27eba0cfe40f,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=c797ea5c-cab7-494b-9044-27eba0cfe40f,c797ea5c-cab7-494b-9044-27eba0cfe40f,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,NDA,208026,Jentadueto XR,LINAGLIPTIN AND METFORMIN HYDROCHLORIDE,2023/06/26,Biguanide; Dipeptidyl Peptidase 4 Inhibitor,2012,BOEHRINGER INGELHEIM PHARMACEUTICALS INC,2016/05/27-,0597-0270; 0597-0275,3X29ZEJ4R2; 786Z46389E,LINAGLIPTIN; METFORMIN HYDROCHLORIDE,LINAGLIPTIN; METFORMIN,3X29ZEJ4R2; 9100L32L2N,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/3d02a4d4-d312-80b4-05c4-691b8f0aa7aa/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3d02a4d4-d312-80b4-05c4-691b8f0aa7aa,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=3d02a4d4-d312-80b4-05c4-691b8f0aa7aa,3d02a4d4-d312-80b4-05c4-691b8f0aa7aa,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,201281,Jentadueto,LINAGLIPTIN AND METFORMIN HYDROCHLORIDE,2022/04/27,Biguanide; Dipeptidyl Peptidase 4 Inhibitor,2012,BOEHRINGER INGELHEIM PHARMACEUTICALS INC,2012/02/13-,0597-0146; 0597-0147; 0597-0148,3X29ZEJ4R2; 786Z46389E,LINAGLIPTIN; METFORMIN HYDROCHLORIDE,LINAGLIPTIN; METFORMIN,3X29ZEJ4R2; 9100L32L2N,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/f6dd9b86-0d18-95d4-2bc7-05591bfdd597/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f6dd9b86-0d18-95d4-2bc7-05591bfdd597,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=f6dd9b86-0d18-95d4-2bc7-05591bfdd597,f6dd9b86-0d18-95d4-2bc7-05591bfdd597,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAMUSCULAR; INTRAVENOUS; SUBCONJUNCTIVAL,NDA,050317,Lincocin,LINCOMYCIN HYDROCHLORIDE,2024/03/14,,,PHARMACIA AND UPJOHN COMPANY LLC,1964/12/29-; 2023/04/18-; 2023/08/18-,0009-0104; 0009-0107; 0009-0555,M6T05Z2B68,LINCOMYCIN HYDROCHLORIDE,LINCOMYCIN,BOD072YW0F,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/c01906fa-2c73-4c13-9765-2fd06628d263/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c01906fa-2c73-4c13-9765-2fd06628d263,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=c01906fa-2c73-4c13-9765-2fd06628d263,c01906fa-2c73-4c13-9765-2fd06628d263,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,021131,Zyvox,LINEZOLID,2024/05/20,Oxazolidinone Antibacterial,2000,PHARMACIA AND UPJOHN COMPANY LLC,2015/02/18-,0009-7807,ISQ9I6J12J,LINEZOLID,LINEZOLID,ISQ9I6J12J,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/3e5e9975-6f36-42e4-ab46-0e75dda83592/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3e5e9975-6f36-42e4-ab46-0e75dda83592,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=3e5e9975-6f36-42e4-ab46-0e75dda83592,3e5e9975-6f36-42e4-ab46-0e75dda83592,,,
HUMAN PRESCRIPTION DRUG LABEL,"GRANULE, FOR SUSPENSION; INJECTION, SOLUTION; TABLET, FILM COATED",INTRAVENOUS; ORAL,NDA,021130;021131;021132,Zyvox,LINEZOLID,2024/05/20,Oxazolidinone Antibacterial,2000,PHARMACIA AND UPJOHN COMPANY LLC,2000/04/18-; 2015/10/12-,0009-5136; 0009-5137; 0009-5138; 0009-5140,ISQ9I6J12J,LINEZOLID,LINEZOLID,ISQ9I6J12J,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/6e70e63b-bfd5-478d-a8ee-8ba22c9efabd/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6e70e63b-bfd5-478d-a8ee-8ba22c9efabd,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=6e70e63b-bfd5-478d-a8ee-8ba22c9efabd,6e70e63b-bfd5-478d-a8ee-8ba22c9efabd,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,206473,Linezolid,LINEZOLID,2023/09/01,Oxazolidinone Antibacterial,2000,HOSPIRA INC,2015/06/18-,0409-4883,ISQ9I6J12J,LINEZOLID,LINEZOLID,ISQ9I6J12J,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/c401f1a8-cc37-461b-bfef-f2e156629bf8/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c401f1a8-cc37-461b-bfef-f2e156629bf8,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=c401f1a8-cc37-461b-bfef-f2e156629bf8,c401f1a8-cc37-461b-bfef-f2e156629bf8,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,021131,Zyvox,LINEZOLID,2023/08/31,Oxazolidinone Antibacterial,2000,PHARMACIA AND UPJOHN COMPANY LLC,2015/07/06-,0009-4992,ISQ9I6J12J,LINEZOLID,LINEZOLID,ISQ9I6J12J,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/122faa9e-c71a-4597-9552-5fb330b7d8b9/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=122faa9e-c71a-4597-9552-5fb330b7d8b9,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=122faa9e-c71a-4597-9552-5fb330b7d8b9,122faa9e-c71a-4597-9552-5fb330b7d8b9,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,021131,Zyvox,LINEZOLID,2018/09/03,Oxazolidinone Antibacterial,2000,FRESENIUS KABI NORGE AS,2018/06/05-,66298-5140,ISQ9I6J12J,LINEZOLID,LINEZOLID,ISQ9I6J12J,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/efe6818c-b798-4d1d-8196-6447a305ad71/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=efe6818c-b798-4d1d-8196-6447a305ad71,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=efe6818c-b798-4d1d-8196-6447a305ad71,efe6818c-b798-4d1d-8196-6447a305ad71,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,021131,Zyvox,LINEZOLID,2018/09/03,Oxazolidinone Antibacterial,2000,FRESENIUS KABI NORGE AS,2018/06/04-,66298-5137,ISQ9I6J12J,LINEZOLID,LINEZOLID,ISQ9I6J12J,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/ce57225b-4580-442b-8c48-8045297cbb50/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ce57225b-4580-442b-8c48-8045297cbb50,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=ce57225b-4580-442b-8c48-8045297cbb50,ce57225b-4580-442b-8c48-8045297cbb50,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRAVENOUS,NDA,021131,Zyvox,LINEZOLID,2018/09/03,Oxazolidinone Antibacterial,2000,FRESENIUS KABI NORGE AS,2018/06/05-,66298-7807,ISQ9I6J12J,LINEZOLID,LINEZOLID,ISQ9I6J12J,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/b0c75e79-bf29-4f1d-a45d-ae28398a52d9/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b0c75e79-bf29-4f1d-a45d-ae28398a52d9,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=b0c75e79-bf29-4f1d-a45d-ae28398a52d9,b0c75e79-bf29-4f1d-a45d-ae28398a52d9,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,010379,Cytomel,LIOTHYRONINE SODIUM,2019/07/24,l-Triiodothyronine,1956,PFIZER LABORATORIES DIV PFIZER INC,1956/05/08-,60793-115; 60793-116; 60793-117,GCA9VV7D2N,LIOTHYRONINE SODIUM,LIOTHYRONINE,06LU7C9H1V,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/51452b31-ff68-4e0c-b982-c15502ebf1d3/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=51452b31-ff68-4e0c-b982-c15502ebf1d3,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=51452b31-ff68-4e0c-b982-c15502ebf1d3,51452b31-ff68-4e0c-b982-c15502ebf1d3,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,SUBCUTANEOUS,NDA,022341,Victoza,LIRAGLUTIDE,2023/07/05,GLP-1 Receptor Agonist,2010,NOVO NORDISK,2010/01/25-,0169-4060,839I73S42A,LIRAGLUTIDE,LIRAGLUTIDE,839I73S42A,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/5a9ef4ea-c76a-4d34-a604-27c5b505f5a4/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5a9ef4ea-c76a-4d34-a604-27c5b505f5a4,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=5a9ef4ea-c76a-4d34-a604-27c5b505f5a4,5a9ef4ea-c76a-4d34-a604-27c5b505f5a4,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",SUBCUTANEOUS,NDA,206321,Saxenda,LIRAGLUTIDE,2023/04/20,GLP-1 Receptor Agonist,2010,NOVO NORDISK,2014/12/31-,0169-2800,839I73S42A,LIRAGLUTIDE,LIRAGLUTIDE,839I73S42A,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/3946d389-0926-4f77-a708-0acb8153b143/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3946d389-0926-4f77-a708-0acb8153b143,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=3946d389-0926-4f77-a708-0acb8153b143,3946d389-0926-4f77-a708-0acb8153b143,,,
HUMAN PRESCRIPTION DRUG LABEL,"CAPSULE; TABLET, CHEWABLE",ORAL,NDA,021977;208510,Vyvanse,LISDEXAMFETAMINE DIMESYLATE,2023/10/13,Central Nervous System Stimulant,2007,TAKEDA PHARMACEUTICALS AMERICA INC,2007/02/23-; 2007/12/10-; 2014/08/30-; 2017/01/28-,59417-101; 59417-102; 59417-103; 59417-104; 59417-105; 59417-106; 59417-107; 59417-115; 59417-116; 59417-117; 59417-118; 59417-119; 59417-120,SJT761GEGS,LISDEXAMFETAMINE DIMESYLATE,LISDEXAMFETAMINE,H645GUL8KJ,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/704e4378-ca83-445c-8b45-3cfa51c1ecad/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=704e4378-ca83-445c-8b45-3cfa51c1ecad,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=704e4378-ca83-445c-8b45-3cfa51c1ecad,704e4378-ca83-445c-8b45-3cfa51c1ecad,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,019777,Zestril,LISINOPRIL,2024/01/29,Angiotensin Converting Enzyme Inhibitor,1988,TWI PHARMACEUTICALS INC,2024/04/25-,24979-238; 24979-239; 24979-240; 24979-241; 24979-242; 24979-243,E7199S1YWR,LISINOPRIL,LISINOPRIL ANHYDROUS,7Q3P4BS2FD,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/838c2d78-d2d8-4981-9ec9-e50ef9e1a5d8/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=838c2d78-d2d8-4981-9ec9-e50ef9e1a5d8,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=838c2d78-d2d8-4981-9ec9-e50ef9e1a5d8,838c2d78-d2d8-4981-9ec9-e50ef9e1a5d8,,,
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION,ORAL,NDA,208401,Qbrelis,LISINOPRIL,2023/04/30,Angiotensin Converting Enzyme Inhibitor,1988,AZURITY PHARMACEUTICALS INC,2016/08/29-,52652-3001,E7199S1YWR,LISINOPRIL,LISINOPRIL ANHYDROUS,7Q3P4BS2FD,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/9f6e4e57-a489-4b36-b093-b93865d3717c/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9f6e4e57-a489-4b36-b093-b93865d3717c,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=9f6e4e57-a489-4b36-b093-b93865d3717c,9f6e4e57-a489-4b36-b093-b93865d3717c,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,019777,Zestril,LISINOPRIL,2020/06/22,Angiotensin Converting Enzyme Inhibitor,1988,ALMATICA PHARMA LLC,2015/04/07-,52427-438; 52427-439; 52427-440; 52427-441; 52427-442; 52427-443,E7199S1YWR,LISINOPRIL,LISINOPRIL ANHYDROUS,7Q3P4BS2FD,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/a95727ae-2bf1-e675-4a36-71043a8af3b8/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a95727ae-2bf1-e675-4a36-71043a8af3b8,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=a95727ae-2bf1-e675-4a36-71043a8af3b8,a95727ae-2bf1-e675-4a36-71043a8af3b8,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,019888,Zestoretic,LISINOPRIL AND HYDROCHLOROTHIAZIDE,2021/07/01,Angiotensin Converting Enzyme Inhibitor; Thiazide Diuretic,,ALMATICA PHARMA INC,2015/04/15-,52427-435; 52427-436; 52427-437,0J48LPH2TH; E7199S1YWR,HYDROCHLOROTHIAZIDE; LISINOPRIL,HYDROCHLOROTHIAZIDE; LISINOPRIL ANHYDROUS,0J48LPH2TH; 7Q3P4BS2FD,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/0d3a966f-f937-05a8-a90f-5aa52ebbd613/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0d3a966f-f937-05a8-a90f-5aa52ebbd613,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=0d3a966f-f937-05a8-a90f-5aa52ebbd613,0d3a966f-f937-05a8-a90f-5aa52ebbd613,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,NDA,018027,LITHOBID,LITHIUM CARBONATE,2022/10/28,Mood Stabilizer,,ANI PHARMACEUTICALS INC,2014/07/01-,62559-280,2BMD2GNA4V,LITHIUM CARBONATE,LITHIUM CATION,8H8Z5UER66,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/f7f5b69a-c2a1-4586-a189-1475d41387c0/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f7f5b69a-c2a1-4586-a189-1475d41387c0,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=f7f5b69a-c2a1-4586-a189-1475d41387c0,f7f5b69a-c2a1-4586-a189-1475d41387c0,,,
HUMAN PRESCRIPTION DRUG LABEL,"CAPSULE, GELATIN COATED; SOLUTION; TABLET",ORAL,NDA,017812;018421;018558,Lithium; Lithium Carbonate,LITHIUM; LITHIUM CARBONATE,2022/11/22,Mood Stabilizer,1970,HIKMA PHARMACEUTICALS USA INC,1980/11/26-; 1982/01/29-; 1982/06/14-; 1987/01/28-; completed:1980/12/23-2022/08/31,0054-2526; 0054-2527; 0054-2531; 0054-3527; 0054-4527; 0054-8526; 0054-8527; 0054-8528; 0054-8531,2BMD2GNA4V; 5Z6E9K79YV,LITHIUM CARBONATE; LITHIUM CITRATE,LITHIUM CATION,8H8Z5UER66,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/7dc9c6d2-6d9a-49e4-a8ab-437b0ed5f84e/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7dc9c6d2-6d9a-49e4-a8ab-437b0ed5f84e,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=7dc9c6d2-6d9a-49e4-a8ab-437b0ed5f84e,7dc9c6d2-6d9a-49e4-a8ab-437b0ed5f84e,,,
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION/ DROPS,OPHTHALMIC,NDA,020191,ALOMIDE,LODOXAMIDE TROMETHAMINE,2023/05/10,Mast Cell Stabilizer,,NOVARTIS PHARMACEUTICALS CORPORATION,1993/09/30-,0078-0736,50LV9A548L,LODOXAMIDE TROMETHAMINE,LODOXAMIDE,SPU695OD73,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/74317375-53a5-44f7-91ea-aa5f5cfe1851/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=74317375-53a5-44f7-91ea-aa5f5cfe1851,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=74317375-53a5-44f7-91ea-aa5f5cfe1851,74317375-53a5-44f7-91ea-aa5f5cfe1851,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,209229,Lucemyra,LOFEXIDINE HYDROCHLORIDE,2023/10/05,,2018,USWM LLC,2021/02/09-,78670-050,V47G1SDI1B,LOFEXIDINE HYDROCHLORIDE,LOFEXIDINE,UI82K0T627,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/b748f308-ba71-4fd9-84ec-ec7e0f210885/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b748f308-ba71-4fd9-84ec-ec7e0f210885,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=b748f308-ba71-4fd9-84ec-ec7e0f210885,b748f308-ba71-4fd9-84ec-ec7e0f210885,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,NDA,203858,Juxtapid,LOMITAPIDE MESYLATE,2024/01/25,Microsomal Triglyceride Transfer Protein Inhibitor,2012,CHIESI USA INC,2013/01/03-,10122-405; 10122-410; 10122-420; 10122-430,X4S83CP54E,LOMITAPIDE MESYLATE,LOMITAPIDE,82KUB0583F,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/61a0be9d-ee58-43e0-b5cb-141011835081/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=61a0be9d-ee58-43e0-b5cb-141011835081,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=61a0be9d-ee58-43e0-b5cb-141011835081,61a0be9d-ee58-43e0-b5cb-141011835081,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,NDA,203858,Juxtapid,LOMITAPIDE MESYLATE,2022/04/28,Microsomal Triglyceride Transfer Protein Inhibitor,2012,AMRYT PHARMACEUTICALS DAC,2013/01/03-,76431-105; 76431-110; 76431-120; 76431-130,X4S83CP54E,LOMITAPIDE MESYLATE,LOMITAPIDE,82KUB0583F,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/e4c45bb5-15f4-437e-ab98-a649b3676d14/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e4c45bb5-15f4-437e-ab98-a649b3676d14,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=e4c45bb5-15f4-437e-ab98-a649b3676d14,e4c45bb5-15f4-437e-ab98-a649b3676d14,,,
HUMAN PRESCRIPTION DRUG LABEL,"CAPSULE, GELATIN COATED",ORAL,NDA,017588,Gleostine,LOMUSTINE,2024/01/23,Alkylating Drug,1976,NEXTSOURCE BIOTECHNOLOGY LLC,2014/08/18-,58181-3040; 58181-3041; 58181-3042,7BRF0Z81KG,LOMUSTINE,LOMUSTINE,7BRF0Z81KG,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/7f77526b-4c40-409c-82ea-d0f934d89cc2/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7f77526b-4c40-409c-82ea-d0f934d89cc2,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=7f77526b-4c40-409c-82ea-d0f934d89cc2,7f77526b-4c40-409c-82ea-d0f934d89cc2,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,NDA,213969,Zokinvy,LONAFARNIB,2024/04/04,Farnesyltransferase Inhibitor,2020,EIGER BIOPHARMACEUTICALS INC,2020/11/20-,73079-050; 73079-075,IOW153004F,LONAFARNIB,LONAFARNIB,IOW153004F,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/956a142f-35d6-4fe3-8aef-7e4878d275ed/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=956a142f-35d6-4fe3-8aef-7e4878d275ed,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=956a142f-35d6-4fe3-8aef-7e4878d275ed,956a142f-35d6-4fe3-8aef-7e4878d275ed,,,
HUMAN PRESCRIPTION DRUG LABEL,"SOLUTION; TABLET, FILM COATED",ORAL,NDA,021251;021906,Kaletra,LOPINAVIR AND RITONAVIR,2023/04/06,Cytochrome P450 3A Inhibitor; Protease Inhibitor,2000,ABBVIE INC,2010/06/18-; 2020/04/08-; completed:2020/04/08-2020/04/30; completed:2020/04/08-2023/03/05,0074-0522; 0074-1575; 0074-2605; 0074-3008; 0074-3956; 0074-4014; 0074-6799,2494G1JF75; O3J8G9O825,LOPINAVIR; RITONAVIR,LOPINAVIR; RITONAVIR,2494G1JF75; O3J8G9O825,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/8290add3-4449-4e58-6c97-8fe1eec972e3/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8290add3-4449-4e58-6c97-8fe1eec972e3,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=8290add3-4449-4e58-6c97-8fe1eec972e3,8290add3-4449-4e58-6c97-8fe1eec972e3,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRAMUSCULAR; INTRAVENOUS,NDA,018140,Lorazepam,LORAZEPAM,2024/04/10,Benzodiazepine,,HIKMA PHARMACEUTICALS USA INC,1980/07/25-,0641-6048; 0641-6049; 0641-6050; 0641-6051,O26FZP769L,LORAZEPAM,LORAZEPAM,O26FZP769L,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/4084fa74-9fd2-45ef-9d56-27bfa31d4e46/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4084fa74-9fd2-45ef-9d56-27bfa31d4e46,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=4084fa74-9fd2-45ef-9d56-27bfa31d4e46,4084fa74-9fd2-45ef-9d56-27bfa31d4e46,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRAMUSCULAR; INTRAVENOUS,NDA,018140,Lorazepam,LORAZEPAM,2024/04/09,Benzodiazepine,,HIKMA PHARMACEUTICALS USA INC,1980/07/25-,0641-6044; 0641-6045; 0641-6046; 0641-6047,O26FZP769L,LORAZEPAM,LORAZEPAM,O26FZP769L,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/e9b54e42-04cf-4c62-90e1-36f7b31a4e81/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e9b54e42-04cf-4c62-90e1-36f7b31a4e81,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=e9b54e42-04cf-4c62-90e1-36f7b31a4e81,e9b54e42-04cf-4c62-90e1-36f7b31a4e81,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRAMUSCULAR; INTRAVENOUS,NDA,018140,Ativan,LORAZEPAM,2023/04/07,Benzodiazepine,,HIKMA PHARMACEUTICALS USA INC,1980/07/25-,0641-6000; 0641-6001; 0641-6002; 0641-6003,O26FZP769L,LORAZEPAM,LORAZEPAM,O26FZP769L,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/5fc0e987-61c9-40c4-b0d5-fcea07c8733e/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5fc0e987-61c9-40c4-b0d5-fcea07c8733e,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=5fc0e987-61c9-40c4-b0d5-fcea07c8733e,5fc0e987-61c9-40c4-b0d5-fcea07c8733e,,,
HUMAN PRESCRIPTION DRUG LABEL,"CAPSULE, EXTENDED RELEASE",ORAL,NDA,214826,LOREEV XR,LORAZEPAM,2023/01/20,Benzodiazepine,1977,ALMATICA PHARMA LLC,2021/08/31-; 2022/03/01-,52427-658; 52427-661; 52427-663; 52427-667,O26FZP769L,LORAZEPAM,LORAZEPAM,O26FZP769L,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/227734c1-bf01-9607-73ea-5a1f38a89bd9/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=227734c1-bf01-9607-73ea-5a1f38a89bd9,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=227734c1-bf01-9607-73ea-5a1f38a89bd9,227734c1-bf01-9607-73ea-5a1f38a89bd9,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,017794,Ativan,LORAZEPAM,2023/01/13,Benzodiazepine,,BAUSCH HEALTH US LLC,2013/05/01-,0187-0063; 0187-0064; 0187-0065,O26FZP769L,lorazepam,lorazepam,O26FZP769L,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/89057c93-8155-4040-acec-64e877bd2b4c/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=89057c93-8155-4040-acec-64e877bd2b4c,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=89057c93-8155-4040-acec-64e877bd2b4c,89057c93-8155-4040-acec-64e877bd2b4c,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRAMUSCULAR; INTRAVENOUS,NDA,018140,Lorazepam,LORAZEPAM,2022/04/26,Benzodiazepine,,HIKMA PHARMACEUTICALS USA INC,1980/07/25-,0641-6207,O26FZP769L,LORAZEPAM,LORAZEPAM,O26FZP769L,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/b79b38ee-c29d-4099-964f-000031f47f5a/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b79b38ee-c29d-4099-964f-000031f47f5a,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=b79b38ee-c29d-4099-964f-000031f47f5a,b79b38ee-c29d-4099-964f-000031f47f5a,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRAMUSCULAR; INTRAVENOUS,NDA,018140,Lorazepam,LORAZEPAM,2021/04/27,Benzodiazepine,,CIVICA INC,2020/12/07-,72572-380,O26FZP769L,LORAZEPAM,LORAZEPAM,O26FZP769L,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/5140798d-8571-41fb-84a4-e182aac3f64c/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5140798d-8571-41fb-84a4-e182aac3f64c,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=5140798d-8571-41fb-84a4-e182aac3f64c,5140798d-8571-41fb-84a4-e182aac3f64c,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,210868,Lorbrena,LORLATINIB,2023/09/07,Kinase Inhibitor,2018,PFIZER LABORATORIES DIV PFIZER INC,2018/11/19-,0069-0227; 0069-0231,OSP71S83EU,LORLATINIB,LORLATINIB,OSP71S83EU,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/2b34d62d-e02a-4af3-bc0d-1571dd4ee76d/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2b34d62d-e02a-4af3-bc0d-1571dd4ee76d,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=2b34d62d-e02a-4af3-bc0d-1571dd4ee76d,2b34d62d-e02a-4af3-bc0d-1571dd4ee76d,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,210868,Lorbrena,LORLATINIB,2023/03/22,Kinase Inhibitor,2018,U S PHARMACEUTICALS,2023/01/03-,63539-927,OSP71S83EU,LORLATINIB,LORLATINIB,OSP71S83EU,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/004f93d7-a1cd-4b67-9207-31cdcb5c5976/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=004f93d7-a1cd-4b67-9207-31cdcb5c5976,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=004f93d7-a1cd-4b67-9207-31cdcb5c5976,004f93d7-a1cd-4b67-9207-31cdcb5c5976,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,020386,COZAAR,LOSARTAN POTASSIUM,2022/06/01,Angiotensin 2 Receptor Blocker,1995,ORGANON LLC,2021/06/01-,78206-121; 78206-122; 78206-123,3ST302B24A,losartan potassium,losartan,JMS50MPO89,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/9949448f-c3b9-44ee-94ed-c1aca8c90f39/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9949448f-c3b9-44ee-94ed-c1aca8c90f39,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=9949448f-c3b9-44ee-94ed-c1aca8c90f39,9949448f-c3b9-44ee-94ed-c1aca8c90f39,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,020387,HYZAAR,LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE,2023/03/17,Angiotensin 2 Receptor Blocker; Thiazide Diuretic,1995,ORGANON LLC,2021/06/01-,78206-139; 78206-140; 78206-141,0J48LPH2TH; 3ST302B24A,hydrochlorothiazide; losartan potassium,hydrochlorothiazide; losartan,0J48LPH2TH; JMS50MPO89,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/4116ccde-2e23-45f4-b12f-6337df877744/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4116ccde-2e23-45f4-b12f-6337df877744,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=4116ccde-2e23-45f4-b12f-6337df877744,4116ccde-2e23-45f4-b12f-6337df877744,,,
HUMAN PRESCRIPTION DRUG LABEL,SUSPENSION,TOPICAL,NDA,210565,Inveltys,LOTEPREDNOL ETABONATE,2024/03/27,Corticosteroid,1998,ALCON LABORATORIES INC,2018/08/22-,71571-121,YEH1EZ96K6,LOTEPREDNOL ETABONATE,LOTEPREDNOL,Z8CBU6KR16,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/2ec16df8-2e5c-4e06-8d28-21df76f27d72/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2ec16df8-2e5c-4e06-8d28-21df76f27d72,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=2ec16df8-2e5c-4e06-8d28-21df76f27d72,2ec16df8-2e5c-4e06-8d28-21df76f27d72,,,
HUMAN PRESCRIPTION DRUG LABEL,SUSPENSION/ DROPS,OPHTHALMIC,NDA,210933,Eysuvis,LOTEPREDNOL ETABONATE,2024/03/26,Corticosteroid,1998,ALCON LABORATORIES INC,2020/11/18-,71571-333,YEH1EZ96K6,LOTEPREDNOL ETABONATE,LOTEPREDNOL,Z8CBU6KR16,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/a2169d82-4275-4ab6-a1c3-c274080b815c/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a2169d82-4275-4ab6-a1c3-c274080b815c,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=a2169d82-4275-4ab6-a1c3-c274080b815c,a2169d82-4275-4ab6-a1c3-c274080b815c,,,
HUMAN PRESCRIPTION DRUG LABEL,SUSPENSION/ DROPS,OPHTHALMIC,NDA,020803,loteprednol etabonate,LOTEPREDNOL ETABONATE,2024/02/09,Corticosteroid,,BAUSCH AND LOMB AMERICAS INC,2024/02/09-,82260-361,YEH1EZ96K6,LOTEPREDNOL ETABONATE,LOTEPREDNOL,Z8CBU6KR16,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/7714824b-29ed-442a-ad2d-13ee2fc6bc42/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7714824b-29ed-442a-ad2d-13ee2fc6bc42,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=7714824b-29ed-442a-ad2d-13ee2fc6bc42,7714824b-29ed-442a-ad2d-13ee2fc6bc42,,,
HUMAN PRESCRIPTION DRUG LABEL,SUSPENSION/ DROPS,OPHTHALMIC,NDA,020583,LOTEMAX,LOTEPREDNOL ETABONATE,2023/04/17,Corticosteroid,,BAUSCH AND LOMB INCORPORATED,1998/03/09-,24208-299,YEH1EZ96K6,LOTEPREDNOL ETABONATE,LOTEPREDNOL,Z8CBU6KR16,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/f37d74ac-5f9c-40a8-b43b-35148fc66bbe/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f37d74ac-5f9c-40a8-b43b-35148fc66bbe,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=f37d74ac-5f9c-40a8-b43b-35148fc66bbe,f37d74ac-5f9c-40a8-b43b-35148fc66bbe,,,
HUMAN PRESCRIPTION DRUG LABEL,GEL,OPHTHALMIC,NDA,208219,Lotemax SM,LOTEPREDNOL ETABONATE,2023/03/17,Corticosteroid,1998,BAUSCH AND LOMB INCORPORATED,2019/02/25-,24208-507,YEH1EZ96K6,LOTEPREDNOL ETABONATE,LOTEPREDNOL,Z8CBU6KR16,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/6f9477b5-699f-4d3b-b9a6-0cc238266237/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6f9477b5-699f-4d3b-b9a6-0cc238266237,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=6f9477b5-699f-4d3b-b9a6-0cc238266237,6f9477b5-699f-4d3b-b9a6-0cc238266237,,,
HUMAN PRESCRIPTION DRUG LABEL,GEL,OPHTHALMIC,NDA,202872,LOTEMAX,LOTEPREDNOL ETABONATE,2023/02/28,Corticosteroid,1998,BAUSCH AND LOMB INCORPORATED,2012/10/12-,24208-503,YEH1EZ96K6,LOTEPREDNOL ETABONATE,LOTEPREDNOL,Z8CBU6KR16,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/9a666065-d467-42b8-8ecd-0ec1de9986d5/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9a666065-d467-42b8-8ecd-0ec1de9986d5,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=9a666065-d467-42b8-8ecd-0ec1de9986d5,9a666065-d467-42b8-8ecd-0ec1de9986d5,,,
HUMAN PRESCRIPTION DRUG LABEL,OINTMENT,OPHTHALMIC,NDA,200738,Lotemax,LOTEPREDNOL ETABONATE,2022/11/30,Corticosteroid,1998,BAUSCH AND LOMB INCORPORATED,2011/04/15-,24208-443,YEH1EZ96K6,LOTEPREDNOL ETABONATE,LOTEPREDNOL,Z8CBU6KR16,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/902a3c6b-2625-44ec-a077-926e012b3176/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=902a3c6b-2625-44ec-a077-926e012b3176,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=902a3c6b-2625-44ec-a077-926e012b3176,902a3c6b-2625-44ec-a077-926e012b3176,,,
HUMAN PRESCRIPTION DRUG LABEL,SUSPENSION/ DROPS,OPHTHALMIC,NDA,020803,Alrex,LOTEPREDNOL ETABONATE,2022/03/31,Corticosteroid,,BAUSCH AND LOMB INCORPORATED,1998/03/09-,24208-353,YEH1EZ96K6,LOTEPREDNOL ETABONATE,LOTEPREDNOL,Z8CBU6KR16,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/21c76da0-50a1-41c0-91b8-8cc4dcc27f60/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=21c76da0-50a1-41c0-91b8-8cc4dcc27f60,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=21c76da0-50a1-41c0-91b8-8cc4dcc27f60,21c76da0-50a1-41c0-91b8-8cc4dcc27f60,,,
HUMAN PRESCRIPTION DRUG LABEL,SUSPENSION/ DROPS,OPHTHALMIC,NDA,050804,Zylet,LOTEPREDNOL ETABONATE AND TOBRAMYCIN,2022/04/30,Aminoglycoside Antibacterial; Corticosteroid,2004,BAUSCH AND LOMB INCORPORATED,2004/12/14-,24208-358,VZ8RRZ51VK; YEH1EZ96K6,LOTEPREDNOL ETABONATE; TOBRAMYCIN,LOTEPREDNOL; TOBRAMYCIN,VZ8RRZ51VK; Z8CBU6KR16,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/3dd9b060-5355-404d-bdf1-09ee8b52a9f5/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3dd9b060-5355-404d-bdf1-09ee8b52a9f5,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=3dd9b060-5355-404d-bdf1-09ee8b52a9f5,3dd9b060-5355-404d-bdf1-09ee8b52a9f5,,,
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION/ DROPS,OPHTHALMIC,NDA,217603,XDEMVY,LOTILANER OPHTHALMIC SOLUTION,2023/07/26,Ectoparasiticide,2023,TARSUS PHARMACEUTICALS INC,2023/08/14-,81942-125,HEH4938D7K,Lotilaner,Lotilaner,HEH4938D7K,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/ccd9e37c-654e-4e84-8c85-6523457df979/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ccd9e37c-654e-4e84-8c85-6523457df979,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=ccd9e37c-654e-4e84-8c85-6523457df979,ccd9e37c-654e-4e84-8c85-6523457df979,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, EXTENDED RELEASE",ORAL,NDA,021316,Altoprev,LOVASTATIN,2024/03/14,HMG-CoA Reductase Inhibitor,2002,COVIS PHARMA US INC,2016/05/01-,70515-628; 70515-629; 70515-630,9LHU78OQFD,LOVASTATIN,LOVASTATIN,9LHU78OQFD,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/8c0db100-5df9-49c3-8af9-1bc03ae609b9/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8c0db100-5df9-49c3-8af9-1bc03ae609b9,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=8c0db100-5df9-49c3-8af9-1bc03ae609b9,8c0db100-5df9-49c3-8af9-1bc03ae609b9,,,
HUMAN PRESCRIPTION DRUG LABEL,"AEROSOL, POWDER",INHALATION,NDA,022549,Adasuve,LOXAPINE,2024/01/09,,1975,ALEXZA PHARMACEUTICALS INC,2022/05/31-,51097-001,LER583670J,LOXAPINE,LOXAPINE,LER583670J,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/50e11732-7387-452d-b3e6-db3a431d5c4a/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=50e11732-7387-452d-b3e6-db3a431d5c4a,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=50e11732-7387-452d-b3e6-db3a431d5c4a,50e11732-7387-452d-b3e6-db3a431d5c4a,,,
HUMAN PRESCRIPTION DRUG LABEL,"CAPSULE, GELATIN COATED",ORAL,NDA,021908,Amitiza,LUBIPROSTONE,2024/03/25,Chloride Channel Activator,2006,SPECGX LLC,2024/04/01-,23635-508; 23635-524,7662KG2R6K,lubiprostone,lubiprostone,7662KG2R6K,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/164a2b47-0a52-4bb4-9e71-5342c2e951f4/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=164a2b47-0a52-4bb4-9e71-5342c2e951f4,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=164a2b47-0a52-4bb4-9e71-5342c2e951f4,164a2b47-0a52-4bb4-9e71-5342c2e951f4,,,
HUMAN PRESCRIPTION DRUG LABEL,"CAPSULE, GELATIN COATED",ORAL,NDA,021908,Amitiza,LUBIPROSTONE,2024/01/18,Chloride Channel Activator,2006,TAKEDA PHARMACEUTICALS AMERICA INC,completed:2006/01/31-2027/03/31,64764-080; 64764-240,7662KG2R6K,lubiprostone,lubiprostone,7662KG2R6K,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/d474ac6a-444d-4aa6-9986-24be6fcf811d/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d474ac6a-444d-4aa6-9986-24be6fcf811d,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=d474ac6a-444d-4aa6-9986-24be6fcf811d,d474ac6a-444d-4aa6-9986-24be6fcf811d,,,
HUMAN PRESCRIPTION DRUG LABEL,CREAM,TOPICAL,NDA,204153,LULICONAZOLE,LULICONAZOLE,2020/04/30,Azole Antifungal,2013,OCEANSIDE PHARMACEUTICALS,2018/06/15-,68682-850,RE91AN4S8G,LULICONAZOLE,LULICONAZOLE,RE91AN4S8G,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/7ccda3ba-9c98-468d-83c6-7f0cc7c88c33/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7ccda3ba-9c98-468d-83c6-7f0cc7c88c33,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=7ccda3ba-9c98-468d-83c6-7f0cc7c88c33,7ccda3ba-9c98-468d-83c6-7f0cc7c88c33,,,
HUMAN PRESCRIPTION DRUG LABEL,CREAM,TOPICAL,NDA,204153,Luzu,LULICONAZOLE,2020/04/01,Azole Antifungal,2013,BAUSCH HEALTH US LLC,2013/11/14-,99207-850,RE91AN4S8G,LULICONAZOLE,LULICONAZOLE,RE91AN4S8G,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/a7016010-ce43-4c09-8d21-aeb697ffed31/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a7016010-ce43-4c09-8d21-aeb697ffed31,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=a7016010-ce43-4c09-8d21-aeb697ffed31,a7016010-ce43-4c09-8d21-aeb697ffed31,,,
HUMAN PRESCRIPTION DRUG LABEL,"GRANULE; TABLET, FILM COATED",ORAL,NDA,206038;211358,ORKAMBI,LUMACAFTOR AND IVACAFTOR,2023/08/10,Cystic Fibrosis Transmembrane Conductance Regulator Potentiator,2015,VERTEX PHARMACEUTICALS INCORPORATED,2015/07/02-; 2016/09/28-; 2018/08/07-; 2022/09/02-,51167-122; 51167-500; 51167-700; 51167-809; 51167-900,1Y740ILL1Z; EGP8L81APK,ivacaftor; lumacaftor,ivacaftor; lumacaftor,1Y740ILL1Z; EGP8L81APK,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/3fc1c40e-cfac-47a1-9e1a-61ead3570600/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3fc1c40e-cfac-47a1-9e1a-61ead3570600,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=3fc1c40e-cfac-47a1-9e1a-61ead3570600,3fc1c40e-cfac-47a1-9e1a-61ead3570600,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",SUBCUTANEOUS,NDA,214103,OXLUMO,LUMASIRAN,2023/10/06,,2020,ALNYLAM PHARMACEUTICALS INC,2020/11/23-,71336-1002,RZT8C352O1,lumasiran,lumasiran,RZT8C352O1,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/16985a31-f5e4-4557-9266-fc78d4bc5055/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=16985a31-f5e4-4557-9266-fc78d4bc5055,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=16985a31-f5e4-4557-9266-fc78d4bc5055,16985a31-f5e4-4557-9266-fc78d4bc5055,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,NDA,209500,CAPLYTA,LUMATEPERONE,2023/06/29,Atypical Antipsychotic,2019,INTRA CELLULAR THERAPIES INC,2020/02/01-; 2022/08/09-,72060-110; 72060-121; 72060-142,70BSQ12069,LUMATEPERONE,LUMATEPERONE,70BSQ12069,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/db730b06-6351-47fd-8183-e61e61bbead5/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=db730b06-6351-47fd-8183-e61e61bbead5,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=db730b06-6351-47fd-8183-e61e61bbead5,db730b06-6351-47fd-8183-e61e61bbead5,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,200603,Latuda,LURASIDONE HYDROCHLORIDE,2023/07/21,Atypical Antipsychotic,2010,SUMITOMO PHARMA AMERICA INC,2010/10/28-; 2011/12/07-; 2012/04/26-; 2013/07/12-,63402-302; 63402-304; 63402-306; 63402-308; 63402-312,O0P4I5851I,lurasidone hydrochloride,lurasidone,22IC88528T,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/afad3051-9df2-4c54-9684-e8262a133af8/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=afad3051-9df2-4c54-9684-e8262a133af8,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=afad3051-9df2-4c54-9684-e8262a133af8,afad3051-9df2-4c54-9684-e8262a133af8,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAVENOUS,NDA,213702,ZEPZELCA,LURBINECTEDIN,2023/07/28,Alkylating Drug,2020,JAZZ PHARMACEUTICALS INC,2020/06/15-,68727-712,2CN60TN6ZS,LURBINECTEDIN,LURBINECTEDIN,2CN60TN6ZS,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/632bb50c-3bcb-4c85-9056-fc33410550ae/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=632bb50c-3bcb-4c85-9056-fc33410550ae,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=632bb50c-3bcb-4c85-9056-fc33410550ae,632bb50c-3bcb-4c85-9056-fc33410550ae,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,210923,Mulpleta,LUSUTROMBOPAG,2020/10/29,,2018,SHIONOGI INC,2018/08/27-,59630-551,6LL5JFU42F,LUSUTROMBOPAG,LUSUTROMBOPAG,6LL5JFU42F,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/f9fd0cfd-717d-4a87-99bc-de7b38807e55/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f9fd0cfd-717d-4a87-99bc-de7b38807e55,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=f9fd0cfd-717d-4a87-99bc-de7b38807e55,f9fd0cfd-717d-4a87-99bc-de7b38807e55,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRAVENOUS,NDA,208700,Lutathera,LUTETIUM LU 177 DOTATATE,2024/04/23,,2018,ADVANCED ACCELERATOR APPLICATIONS USA INC,2018/01/26-,69488-003,AE221IM3BB,LUTETIUM OXODOTREOTIDE LU-177,LUTETIUM OXODOTREOTIDE LU-177,AE221IM3BB,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/72d1a024-00b7-418a-b36e-b2cb48f2ab55/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=72d1a024-00b7-418a-b36e-b2cb48f2ab55,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=72d1a024-00b7-418a-b36e-b2cb48f2ab55,72d1a024-00b7-418a-b36e-b2cb48f2ab55,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,215833,PLUVICTO,LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN,2024/01/18,Radioligand Therapeutic Agent,2022,ADVANCED ACCELERATOR APPLICATIONS USA INC,2022/03/23-,69488-010,G6UF363ECX,LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN,LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN,G6UF363ECX,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/fb973a8d-7fea-4a7a-963f-2a8e67a46e55/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=fb973a8d-7fea-4a7a-963f-2a8e67a46e55,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=fb973a8d-7fea-4a7a-963f-2a8e67a46e55,fb973a8d-7fea-4a7a-963f-2a8e67a46e55,,,
HUMAN PRESCRIPTION DRUG LABEL,"GRANULE, FOR SOLUTION",ORAL,NDA,205598,Macrilen,MACIMORELIN ACETATE,2021/01/30,Growth Hormone Secretagogue Receptor Agonist,2017,NOVO NORDISK,completed:2022/01/31-2027/02/28,0169-1401,8680B21W73,MACIMORELIN,MACIMORELIN,8680B21W73,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/6034c9b8-5a36-4961-a5dd-11ebf7bdab78/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6034c9b8-5a36-4961-a5dd-11ebf7bdab78,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=6034c9b8-5a36-4961-a5dd-11ebf7bdab78,6034c9b8-5a36-4961-a5dd-11ebf7bdab78,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,204410,OPSUMIT,MACITENTAN,2024/04/02,Endothelin Receptor Antagonist,2013,ACTELION PHARMACEUTICALS US INC,2013/11/04-,66215-501,Z9K9Y9WMVL,MACITENTAN,MACITENTAN,Z9K9Y9WMVL,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/1e484a50-55db-4b85-8c57-6cd1b0353abd/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1e484a50-55db-4b85-8c57-6cd1b0353abd,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=1e484a50-55db-4b85-8c57-6cd1b0353abd,1e484a50-55db-4b85-8c57-6cd1b0353abd,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,218490,OPSYNVI,MACITENTAN AND TADALAFIL,2024/04/02,Endothelin Receptor Antagonist; Phosphodiesterase 5 Inhibitor,2024,ACTELION PHARMACEUTICALS US INC,2024/03/22-,66215-812; 66215-814,742SXX0ICT; Z9K9Y9WMVL,MACITENTAN; TADALAFIL,MACITENTAN; TADALAFIL,742SXX0ICT; Z9K9Y9WMVL,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/6945b183-18d3-40de-afd1-c88e33cc1a63/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6945b183-18d3-40de-afd1-c88e33cc1a63,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=6945b183-18d3-40de-afd1-c88e33cc1a63,6945b183-18d3-40de-afd1-c88e33cc1a63,,,
HUMAN PRESCRIPTION DRUG LABEL,CREAM,TOPICAL,NDA,016763,SULFAMYLON,MAFENIDE ACETATE,2023/07/03,Methylated Sulfonamide Antibacterial,,RISING PHARMA HOLDINGS INC,2020/05/18-,16571-723,RQ6LP6Z0WY,MAFENIDE ACETATE,MAFENIDE,58447S8P4L,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/008eaa23-8f19-4e39-85ff-540c1c834a9e/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=008eaa23-8f19-4e39-85ff-540c1c834a9e,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=008eaa23-8f19-4e39-85ff-540c1c834a9e,008eaa23-8f19-4e39-85ff-540c1c834a9e,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAMUSCULAR; INTRAVENOUS,NDA,019316,Magnesium Sulfate,MAGNESIUM SULFATE HEPTAHYDRATE,2023/11/06,Calculi Dissolution Agent; Osmotic Laxative,,FRESENIUS KABI USA LLC,2000/08/08-,63323-064,SK47B8698T,MAGNESIUM SULFATE HEPTAHYDRATE,MAGNESIUM CATION,T6V3LHY838,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/e9c10579-29f3-4889-8881-0626f63968d4/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e9c10579-29f3-4889-8881-0626f63968d4,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=e9c10579-29f3-4889-8881-0626f63968d4,e9c10579-29f3-4889-8881-0626f63968d4,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAMUSCULAR; INTRAVENOUS,NDA,019316,Magnesium Sulfate,MAGNESIUM SULFATE HEPTAHYDRATE,2021/12/13,Calculi Dissolution Agent; Osmotic Laxative,,FRESENIUS KABI USA LLC,2016/01/29-,63323-642,SK47B8698T,MAGNESIUM SULFATE HEPTAHYDRATE,MAGNESIUM CATION,T6V3LHY838,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/77f70e00-3934-4fd9-a581-4cf3df8c42d2/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=77f70e00-3934-4fd9-a581-4cf3df8c42d2,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=77f70e00-3934-4fd9-a581-4cf3df8c42d2,77f70e00-3934-4fd9-a581-4cf3df8c42d2,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAMUSCULAR; INTRAVENOUS,NDA,019316,Magnesium Sulfate,MAGNESIUM SULFATE HEPTAHYDRATE,2021/02/24,Calculi Dissolution Agent; Osmotic Laxative,,FRESENIUS KABI USA LLC,2000/08/08-,63323-064,SK47B8698T,MAGNESIUM SULFATE HEPTAHYDRATE,MAGNESIUM CATION,T6V3LHY838,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/e921a46b-9a5b-4163-9c88-224247541f14/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e921a46b-9a5b-4163-9c88-224247541f14,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=e921a46b-9a5b-4163-9c88-224247541f14,e921a46b-9a5b-4163-9c88-224247541f14,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAMUSCULAR; INTRAVENOUS,NDA,019316,Magnesium Sulfate,MAGNESIUM SULFATE HEPTAHYDRATE,2021/02/23,Calculi Dissolution Agent; Osmotic Laxative,,FRESENIUS KABI USA LLC,2000/08/08-,63323-064,SK47B8698T,MAGNESIUM SULFATE HEPTAHYDRATE,MAGNESIUM CATION,T6V3LHY838,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/6a5d362b-7aa7-40d3-898d-09407cce0713/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6a5d362b-7aa7-40d3-898d-09407cce0713,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=6a5d362b-7aa7-40d3-898d-09407cce0713,6a5d362b-7aa7-40d3-898d-09407cce0713,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,020488,Magnesium Sulfate in Dextrose,MAGNESIUM SULFATE IN DEXTROSE,2023/07/17,Calculi Dissolution Agent; Osmotic Laxative,1941,HOSPIRA INC,2005/09/27-,0409-6727,SK47B8698T,MAGNESIUM SULFATE HEPTAHYDRATE,MAGNESIUM CATION,T6V3LHY838,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/03ebeabb-8386-4af4-3086-bdf3c3fc4a5a/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=03ebeabb-8386-4af4-3086-bdf3c3fc4a5a,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=03ebeabb-8386-4af4-3086-bdf3c3fc4a5a,03ebeabb-8386-4af4-3086-bdf3c3fc4a5a,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,020309,Magnesium Sulfate in Water,MAGNESIUM SULFATE IN WATER,2023/10/23,Calculi Dissolution Agent; Osmotic Laxative,,HOSPIRA INC,2005/08/22-; 2006/03/31-; 2022/11/14-; 2022/12/27-; 2023/06/19-,0409-2050; 0409-3164; 0409-4121; 0409-5239; 0409-6729; 0409-6730,SK47B8698T,MAGNESIUM SULFATE HEPTAHYDRATE,MAGNESIUM CATION,T6V3LHY838,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/22ca78b4-f5a3-4144-cf89-5f633acf1e6d/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=22ca78b4-f5a3-4144-cf89-5f633acf1e6d,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=22ca78b4-f5a3-4144-cf89-5f633acf1e6d,22ca78b4-f5a3-4144-cf89-5f633acf1e6d,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,018962,MANGANESE,MANGANESE CHLORIDE,2023/12/06,Paramagnetic Contrast Agent,,HOSPIRA INC,2005/01/31-,0409-4091,QQE170PANO,MANGANESE CHLORIDE,MANGANESE CATION (2+),H6EP7W5457,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/6e979070-5035-4076-e09c-b52466be3c68/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6e979070-5035-4076-e09c-b52466be3c68,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=6e979070-5035-4076-e09c-b52466be3c68,6e979070-5035-4076-e09c-b52466be3c68,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,INHALATION,NDA,202049,Bronchitol,MANNITOL,2024/01/01,Osmotic Diuretic,1964,CHIESI USA INC,completed:2021/02/01-2025/09/30,10122-212,3OWL53L36A,mannitol,mannitol,3OWL53L36A,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/454f092e-dcd0-47bd-a521-b07400403dad/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=454f092e-dcd0-47bd-a521-b07400403dad,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=454f092e-dcd0-47bd-a521-b07400403dad,454f092e-dcd0-47bd-a521-b07400403dad,,,
HUMAN PRESCRIPTION DRUG LABEL,KIT,INHALATION,NDA,022368,Aridol Bronchial Challenge Test Kit,MANNITOL,2023/02/13,Osmotic Diuretic,1964,METHAPHARM INC,2010/10/05-,67850-552,3OWL53L36A,MANNITOL,MANNITOL,3OWL53L36A,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/5387a4fb-b894-4cba-88a3-a947217d34da/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5387a4fb-b894-4cba-88a3-a947217d34da,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=5387a4fb-b894-4cba-88a3-a947217d34da,5387a4fb-b894-4cba-88a3-a947217d34da,,,
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION,ORAL,NDA,214662,Livmarli,MARALIXIBAT CHLORIDE,2024/04/01,Ileal Bile Acid Transporter Inhibitor,2021,MIRUM PHARMACEUTICALS INC,2021/09/29-,79378-110,V78M04F0XC,maralixibat chloride,maralixibat,UYB6UOF69L,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/64000394-1ef6-4e76-8ba8-11f25ba1b167/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=64000394-1ef6-4e76-8ba8-11f25ba1b167,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=64000394-1ef6-4e76-8ba8-11f25ba1b167,64000394-1ef6-4e76-8ba8-11f25ba1b167,,,
HUMAN PRESCRIPTION DRUG LABEL,"KIT; SOLUTION; TABLET, FILM COATED",ORAL,NDA,022128;208984,SELZENTRY,MARAVIROC,2022/09/26,CCR5 Co-receptor Antagonist,2007,VIIV HEALTHCARE COMPANY,2011/05/16-; 2016/11/04-; 2020/10/30-; completed:2016/11/04-2024/10/31,49702-223; 49702-224; 49702-233; 49702-235; 49702-237; 49702-260,MD6P741W8A,MARAVIROC,MARAVIROC,MD6P741W8A,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/46f30ac5-c96b-429e-976d-8c5ee1c0761b/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=46f30ac5-c96b-429e-976d-8c5ee1c0761b,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=46f30ac5-c96b-429e-976d-8c5ee1c0761b,46f30ac5-c96b-429e-976d-8c5ee1c0761b,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, COATED",ORAL,NDA,215596,Livtencity,MARIBAVIR,2024/03/28,Cytomegalovirus pUL97 Kinase Inhibitor,2021,TAKEDA PHARMACEUTICALS AMERICA INC,2021/11/23-,64764-800,PTB4X93HE1,MARIBAVIR,MARIBAVIR,PTB4X93HE1,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/c94fc2c5-e840-4f18-b7d8-d5eacb26d3a0/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c94fc2c5-e840-4f18-b7d8-d5eacb26d3a0,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=c94fc2c5-e840-4f18-b7d8-d5eacb26d3a0,c94fc2c5-e840-4f18-b7d8-d5eacb26d3a0,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, CHEWABLE",ORAL,NDA,208398,VERMOX,MEBENDAZOLE,2021/10/05,Anthelmintic,1974,JANSSEN PHARMACEUTICALS INC,2016/10/20-,50458-675,81G6I5V05I,mebendazole,mebendazole,81G6I5V05I,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/a720c424-517a-461b-8e13-6c37caf8aa3f/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a720c424-517a-461b-8e13-6c37caf8aa3f,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=a720c424-517a-461b-8e13-6c37caf8aa3f,a720c424-517a-461b-8e13-6c37caf8aa3f,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAVENOUS,NDA,018963,Choletec,MEBROFENIN,2020/10/18,,,BRACCO DIAGNOSTICS INC,1987/01/21-,0270-0083,7PV0B6ED98,MEBROFENIN,MEBROFENIN,7PV0B6ED98,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/fd085485-998d-42a3-879a-b2d96cb8aed7/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=fd085485-998d-42a3-879a-b2d96cb8aed7,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=fd085485-998d-42a3-879a-b2d96cb8aed7,fd085485-998d-42a3-879a-b2d96cb8aed7,,,
HUMAN PRESCRIPTION DRUG LABEL,GEL,TOPICAL,NDA,202317,VALCHLOR,MECHLORETHAMINE HYDROCHLORIDE,2023/12/29,Alkylating Drug,1949,HELSINN THERAPEUTICS U S INC,2018/11/08-,69639-120,50D9XSG0VR,MECHLORETHAMINE,MECHLORETHAMINE,50D9XSG0VR,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/6a52e4c2-6a9f-4ebb-bc77-046b4f8bcd57/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6a52e4c2-6a9f-4ebb-bc77-046b4f8bcd57,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=6a52e4c2-6a9f-4ebb-bc77-046b4f8bcd57,6a52e4c2-6a9f-4ebb-bc77-046b4f8bcd57,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET; TABLET, CHEWABLE",ORAL,NDA,010721,Antivert,MECLIZINE HCL,2022/10/18,Antiemetic,1957,CASPER PHARMA LLC,2020/01/15-,70199-002; 70199-003; 70199-004; 70199-018,HDP7W44CIO,MECLIZINE HYDROCHLORIDE,MECLIZINE,3L5TQ84570,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/4a5d81fc-ad25-4c3f-a91c-93fe334c02e5/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4a5d81fc-ad25-4c3f-a91c-93fe334c02e5,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=4a5d81fc-ad25-4c3f-a91c-93fe334c02e5,4a5d81fc-ad25-4c3f-a91c-93fe334c02e5,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,011839,Provera,MEDROXYPROGESTERONE ACETATE,2024/03/11,Progestin,,PHARMACIA AND UPJOHN COMPANY LLC,2018/11/11-; 2019/09/03-; 2020/07/20-,0009-0051; 0009-0065; 0009-0287,C2QI4IOI2G,MEDROXYPROGESTERONE ACETATE,MEDROXYPROGESTERONE,HSU1C9YRES,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/a586be28-96af-4fed-a13f-9b94fd4c7405/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a586be28-96af-4fed-a13f-9b94fd4c7405,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=a586be28-96af-4fed-a13f-9b94fd4c7405,a586be28-96af-4fed-a13f-9b94fd4c7405,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SUSPENSION",INTRAMUSCULAR,NDA,020246,Depo-Provera,MEDROXYPROGESTERONE ACETATE,2020/12/31,Progestin,1959,PHARMACIA AND UPJOHN COMPANY LLC,1992/10/29-,0009-0746; 0009-7376,C2QI4IOI2G,MEDROXYPROGESTERONE ACETATE,MEDROXYPROGESTERONE,HSU1C9YRES,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/199cf13e-0859-4a73-9b45-e700d0cd1049/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=199cf13e-0859-4a73-9b45-e700d0cd1049,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=199cf13e-0859-4a73-9b45-e700d0cd1049,199cf13e-0859-4a73-9b45-e700d0cd1049,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SUSPENSION",SUBCUTANEOUS,NDA,021583,Depo-SubQ Provera,MEDROXYPROGESTERONE ACETATE,2020/12/14,Progestin,1959,PHARMACIA AND UPJOHN COMPANY LLC,2005/05/02-,0009-4709,C2QI4IOI2G,MEDROXYPROGESTERONE ACETATE,MEDROXYPROGESTERONE,HSU1C9YRES,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/390087a6-f3c3-4f0b-a930-79acf412f153/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=390087a6-f3c3-4f0b-a930-79acf412f153,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=390087a6-f3c3-4f0b-a930-79acf412f153,390087a6-f3c3-4f0b-a930-79acf412f153,,,
HUMAN PRESCRIPTION DRUG LABEL,SUSPENSION,ORAL,NDA,021530,Meloxicam,MELOXICAM,2024/01/24,Nonsteroidal Anti-inflammatory Drug,2004,AVONDALE PHARMACEUTICALS LLC,2005/11/01-,71740-339,VG2QF83CGL,Meloxicam,Meloxicam,VG2QF83CGL,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/4ddf5a4d-8e84-419d-8e3a-c91b85501885/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4ddf5a4d-8e84-419d-8e3a-c91b85501885,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=4ddf5a4d-8e84-419d-8e3a-c91b85501885,4ddf5a4d-8e84-419d-8e3a-c91b85501885,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,NDA,207233,Vivlodex,MELOXICAM,2021/04/30,Nonsteroidal Anti-inflammatory Drug,2000,EGALET US INC,2019/02/04-,69344-205; 69344-206,VG2QF83CGL,MELOXICAM,MELOXICAM,VG2QF83CGL,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/11771dcf-0803-4de9-a2fe-73edec256209/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=11771dcf-0803-4de9-a2fe-73edec256209,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=11771dcf-0803-4de9-a2fe-73edec256209,11771dcf-0803-4de9-a2fe-73edec256209,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,NDA,207233,Vivlodex,MELOXICAM,2019/04/08,Nonsteroidal Anti-inflammatory Drug,2000,IROKO PHARMACEUTICALS LLC,2015/10/31-,42211-205; 42211-206,VG2QF83CGL,meloxicam,meloxicam,VG2QF83CGL,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/fcfd6c24-98d0-4b7b-8336-936899ef61de/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=fcfd6c24-98d0-4b7b-8336-936899ef61de,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=fcfd6c24-98d0-4b7b-8336-936899ef61de,fcfd6c24-98d0-4b7b-8336-936899ef61de,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAVENOUS,NDA,207155,EVOMELA,MELPHALAN,2023/06/13,Alkylating Drug,1964,ACROTECH BIOPHARMA INC,2016/03/31-,72893-001,1VXP4V453T,MELPHALAN HYDROCHLORIDE,MELPHALAN,Q41OR9510P,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/69f55869-dc11-408e-8fc7-47634269a52c/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=69f55869-dc11-408e-8fc7-47634269a52c,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=69f55869-dc11-408e-8fc7-47634269a52c,69f55869-dc11-408e-8fc7-47634269a52c,,,
HUMAN PRESCRIPTION DRUG LABEL,KIT,INTRA-ARTERIAL,NDA,201848,Hepzato Kit,"MELPHALAN HYDROCHLORIDE INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",2023/12/05,Alkylating Drug; Osmotic Laxative,1964,DELCATH SYSTEMS INC,2023/12/04-,75833-601,1VXP4V453T; 451W47IQ8X,Melphalan Hydrochloride; Sodium Chloride,Sodium Cation; melphalan,LYR4M0NH37; Q41OR9510P,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/4f83c8f7-4cc0-4219-88d5-7cfddce91198/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4f83c8f7-4cc0-4219-88d5-7cfddce91198,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=4f83c8f7-4cc0-4219-88d5-7cfddce91198,4f83c8f7-4cc0-4219-88d5-7cfddce91198,,,
HUMAN PRESCRIPTION DRUG LABEL,"CAPSULE, EXTENDED RELEASE; KIT",ORAL,NDA,022525,Namenda XR,MEMANTINE HYDROCHLORIDE,2019/11/15,N-methyl-D-aspartate Receptor Antagonist,2003,ALLERGAN INC,2011/10/31-; completed:2011/09/15-2018/12/31; completed:2011/10/31-2022/07/31,0456-3400; 0456-3407; 0456-3414; 0456-3421; 0456-3428,JY0WD0UA60,MEMANTINE HYDROCHLORIDE; memantine hydrochloride,memantine,W8O17SJF3T,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/710f523f-0158-4639-8ce7-57598247d48c/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=710f523f-0158-4639-8ce7-57598247d48c,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=710f523f-0158-4639-8ce7-57598247d48c,710f523f-0158-4639-8ce7-57598247d48c,,,
HUMAN PRESCRIPTION DRUG LABEL,KIT; TABLET,ORAL,NDA,021487,Namenda,MEMANTINE HYDROCHLORIDE,2018/11/01,N-methyl-D-aspartate Receptor Antagonist,2003,ALLERGAN INC,2003/10/16-,0456-3200; 0456-3205; 0456-3210,JY0WD0UA60,MEMANTINE HYDROCHLORIDE,memantine,W8O17SJF3T,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/b9f27baf-aa2a-443a-9ef5-e002d23407ba/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b9f27baf-aa2a-443a-9ef5-e002d23407ba,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=b9f27baf-aa2a-443a-9ef5-e002d23407ba,b9f27baf-aa2a-443a-9ef5-e002d23407ba,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE; KIT,ORAL,NDA,206439,Namzaric,MEMANTINE HYDROCHLORIDE AND DONEPEZIL HYDROCHLORIDE,2024/05/13,Cholinesterase Inhibitor; N-methyl-D-aspartate Receptor Antagonist,2014,ALLERGAN INC,2014/12/24-; 2016/07/18-; 2016/11/28-,0456-1207; 0456-1214; 0456-1221; 0456-1228; 0456-1229,3O2T2PJ89D; JY0WD0UA60,donepezil hydrochloride; memantine hydrochloride,donepezil; memantine,8SSC91326P; W8O17SJF3T,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/90fedc32-19e5-480c-afc6-f35a5cf4b9aa/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=90fedc32-19e5-480c-afc6-f35a5cf4b9aa,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=90fedc32-19e5-480c-afc6-f35a5cf4b9aa,90fedc32-19e5-480c-afc6-f35a5cf4b9aa,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS,NDA,021171,DEMEROL,MEPERIDINE HYDROCHLORIDE,2024/04/05,Opioid Agonist,1942,HOSPIRA INC,2005/08/25-; 2005/09/13-; 2005/09/15-; 2005/10/12-; 2006/02/24-,0409-1176; 0409-1178; 0409-1179; 0409-1180; 0409-1181; 0409-1362; 0409-1418,N8E7F7Q170,MEPERIDINE HYDROCHLORIDE,MEPERIDINE,9E338QE28F,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/b31d1308-28c3-43f4-e0a6-2f3ed76b8975/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b31d1308-28c3-43f4-e0a6-2f3ed76b8975,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=b31d1308-28c3-43f4-e0a6-2f3ed76b8975,b31d1308-28c3-43f4-e0a6-2f3ed76b8975,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,005010,Demerol,MEPERIDINE HYDROCHLORIDE,2023/12/25,Opioid Agonist,1942,VALIDUS PHARMACEUTICALS LLC,1942/11/10-,30698-335; 30698-337,N8E7F7Q170,MEPERIDINE HYDROCHLORIDE,MEPERIDINE,9E338QE28F,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/5cb2674c-a70d-4022-9188-3f711cccff5e/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5cb2674c-a70d-4022-9188-3f711cccff5e,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=5cb2674c-a70d-4022-9188-3f711cccff5e,5cb2674c-a70d-4022-9188-3f711cccff5e,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,009053,PURINETHOL,MERCAPTOPURINE,2024/01/03,Nucleoside Metabolic Inhibitor,1953,STASON PHARMACEUTICALS INC,2022/01/15-,60763-601,E7WED276I5,MERCAPTOPURINE,MERCAPTOPURINE ANHYDROUS,PKK6MUZ20G,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/bfb03539-907f-4424-9c88-6a03ed9467e6/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=bfb03539-907f-4424-9c88-6a03ed9467e6,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=bfb03539-907f-4424-9c88-6a03ed9467e6,bfb03539-907f-4424-9c88-6a03ed9467e6,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, POWDER, FOR SOLUTION",INTRAVENOUS,NDA,215212,Meropenem,MEROPENEM,2023/07/31,Penem Antibacterial,1996,WG CRITICAL CARE LLC,2023/09/08-,44567-402,FV9J3JU8B1,MEROPENEM,MEROPENEM ANHYDROUS,YOP6PX0BAO,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/240325ba-47a8-4ad1-bcab-6772069ee790/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=240325ba-47a8-4ad1-bcab-6772069ee790,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=240325ba-47a8-4ad1-bcab-6772069ee790,240325ba-47a8-4ad1-bcab-6772069ee790,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, POWDER, FOR SOLUTION",INTRAVENOUS,NDA,209776,VABOMERE,MEROPENEM-VABORBACTAM,2023/10/19,Penem Antibacterial; beta Lactamase Inhibitor,2017,MELINTA THERAPEUTICS LLC,2017/10/02-,70842-120,1C75676F8V; FV9J3JU8B1,MEROPENEM; VABORBACTAM,MEROPENEM ANHYDROUS; VABORBACTAM,1C75676F8V; YOP6PX0BAO,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/e237fd0f-3050-42a3-b43e-b6fb4824e93d/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e237fd0f-3050-42a3-b43e-b6fb4824e93d,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=e237fd0f-3050-42a3-b43e-b6fb4824e93d,e237fd0f-3050-42a3-b43e-b6fb4824e93d,,,
HUMAN PRESCRIPTION DRUG LABEL,"CAPSULE, EXTENDED RELEASE",ORAL,NDA,022301,APRISO,MESALAMINE,2024/01/09,Aminosalicylate,1987,SALIX PHARMACEUTICALS INC,2008/10/31-,65649-103,4Q81I59GXC,MESALAMINE,MESALAMINE,4Q81I59GXC,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/7951139c-b271-45a4-b523-34b23800917b/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7951139c-b271-45a4-b523-34b23800917b,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=7951139c-b271-45a4-b523-34b23800917b,7951139c-b271-45a4-b523-34b23800917b,,,
HUMAN PRESCRIPTION DRUG LABEL,SUSPENSION,RECTAL,NDA,019618,Rowasa,MESALAMINE,2023/10/31,Aminosalicylate,,MEDA PHARMACEUTICALS INC,2016/03/24-,0037-0066,4Q81I59GXC,MESALAMINE,MESALAMINE,4Q81I59GXC,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/e505ab99-1943-4216-a178-4d5dbe64e3b2/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e505ab99-1943-4216-a178-4d5dbe64e3b2,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=e505ab99-1943-4216-a178-4d5dbe64e3b2,e505ab99-1943-4216-a178-4d5dbe64e3b2,,,
HUMAN PRESCRIPTION DRUG LABEL,SUPPOSITORY,RECTAL,NDA,021252,Canasa,MESALAMINE,2023/10/24,Aminosalicylate,1987,ALLERGAN INC,2001/01/05-,58914-501,4Q81I59GXC,MESALAMINE,Mesalamine,4Q81I59GXC,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/89d91601-152b-4398-bebe-af1c023e9935/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=89d91601-152b-4398-bebe-af1c023e9935,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=89d91601-152b-4398-bebe-af1c023e9935,89d91601-152b-4398-bebe-af1c023e9935,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, DELAYED RELEASE",ORAL,NDA,022000,Lialda,MESALAMINE,2023/10/24,Aminosalicylate,1987,TAKEDA PHARMACEUTICALS AMERICA INC,2007/01/16-,54092-476,4Q81I59GXC,MESALAMINE,MESALAMINE,4Q81I59GXC,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/3098a080-be86-4265-9818-7fc4beab77b7/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3098a080-be86-4265-9818-7fc4beab77b7,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=3098a080-be86-4265-9818-7fc4beab77b7,3098a080-be86-4265-9818-7fc4beab77b7,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,NDA,020049,Pentasa,MESALAMINE,2023/10/24,Aminosalicylate,,TAKEDA PHARMACEUTICALS AMERICA INC,1993/05/10-; 2004/07/08-,54092-189; 54092-191,4Q81I59GXC,MESALAMINE,MESALAMINE,4Q81I59GXC,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/e39d9a3d-5d3a-4bb6-aab1-fdbb2a598606/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e39d9a3d-5d3a-4bb6-aab1-fdbb2a598606,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=e39d9a3d-5d3a-4bb6-aab1-fdbb2a598606,e39d9a3d-5d3a-4bb6-aab1-fdbb2a598606,,,
HUMAN PRESCRIPTION DRUG LABEL,"CAPSULE, DELAYED RELEASE",ORAL,NDA,204412,Delzicol,MESALAMINE,2023/10/24,Aminosalicylate,1987,ALLERGAN INC,2016/05/16-,0023-5853,4Q81I59GXC,MESALAMINE,MESALAMINE,4Q81I59GXC,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/71b02324-9430-4269-825f-8fcac5eeaefb/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=71b02324-9430-4269-825f-8fcac5eeaefb,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=71b02324-9430-4269-825f-8fcac5eeaefb,71b02324-9430-4269-825f-8fcac5eeaefb,,,
HUMAN PRESCRIPTION DRUG LABEL,SUSPENSION,RECTAL,NDA,019618,sfRowasa Sulfite-Free Formulation,MESALAMINE,2023/10/15,Aminosalicylate,,MEDA PHARMACEUTICALS INC,2016/03/24-,0037-0022,4Q81I59GXC,MESALAMINE,MESALAMINE,4Q81I59GXC,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/aa273fdc-f7c4-4901-8f71-59ae03b8cdb1/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=aa273fdc-f7c4-4901-8f71-59ae03b8cdb1,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=aa273fdc-f7c4-4901-8f71-59ae03b8cdb1,aa273fdc-f7c4-4901-8f71-59ae03b8cdb1,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,020855,MESNEX,MESNA,2019/12/21,Cytoprotective Agent,1988,BAXTER HEALTHCARE CORPORATION,2002/03/21-,67108-3565,NR7O1405Q9,MESNA,2-MERCAPTOETHANESULFONIC ACID,VHD28S0H7F,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/4a51ffdb-f59f-4e02-b3c4-f3457ab7b514/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4a51ffdb-f59f-4e02-b3c4-f3457ab7b514,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=4a51ffdb-f59f-4e02-b3c4-f3457ab7b514,4a51ffdb-f59f-4e02-b3c4-f3457ab7b514,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,019884,MESNA,MESNA,2018/12/17,Cytoprotective Agent,1988,BAXTER HEALTHCARE CORPORATION,1988/12/30-,10019-951,NR7O1405Q9,MESNA,2-MERCAPTOETHANESULFONIC ACID,VHD28S0H7F,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/a880160b-fa82-453a-a971-29ab897876a7/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a880160b-fa82-453a-a971-29ab897876a7,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=a880160b-fa82-453a-a971-29ab897876a7,a880160b-fa82-453a-a971-29ab897876a7,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,019884,MESNA,MESNA,2018/12/17,Cytoprotective Agent,1988,BAXTER HEALTHCARE CORPORATION,1988/12/30-,10019-953,NR7O1405Q9,MESNA,2-MERCAPTOETHANESULFONIC ACID,VHD28S0H7F,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/fe1683ef-0569-411e-8188-0499884632ad/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=fe1683ef-0569-411e-8188-0499884632ad,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=fe1683ef-0569-411e-8188-0499884632ad,fe1683ef-0569-411e-8188-0499884632ad,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,019884,MESNEX,MESNA,2018/12/17,Cytoprotective Agent,1988,BAXTER HEALTHCARE CORPORATION,1988/12/30-,0338-1305,NR7O1405Q9,MESNA,2-MERCAPTOETHANESULFONIC ACID,VHD28S0H7F,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/49fdfbc3-69f8-4706-9d11-bf60e4e7811b/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=49fdfbc3-69f8-4706-9d11-bf60e4e7811b,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=49fdfbc3-69f8-4706-9d11-bf60e4e7811b,49fdfbc3-69f8-4706-9d11-bf60e4e7811b,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,019884,MESNEX,MESNA,2018/07/24,Cytoprotective Agent,1988,BAXTER HEALTHCARE CORPORATION,1988/12/30-,0338-1307,NR7O1405Q9,MESNA,2-MERCAPTOETHANESULFONIC ACID,VHD28S0H7F,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/2e8eebc3-ea75-4c57-bfe1-2c5dc2c37806/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2e8eebc3-ea75-4c57-bfe1-2c5dc2c37806,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=2e8eebc3-ea75-4c57-bfe1-2c5dc2c37806,2e8eebc3-ea75-4c57-bfe1-2c5dc2c37806,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,022503,Metaxalone,METAXALONE,2023/07/13,Muscle Relaxant,1962,PRIMUS PHARMACEUTICALS,2023/02/01-,68040-712,1NMA9J598Y,METAXALONE,METAXALONE,1NMA9J598Y,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/f27ca677-f0cc-4710-bd94-ff1bf0d916cb/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f27ca677-f0cc-4710-bd94-ff1bf0d916cb,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=f27ca677-f0cc-4710-bd94-ff1bf0d916cb,f27ca677-f0cc-4710-bd94-ff1bf0d916cb,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,013217,Metaxalone,METAXALONE,2019/05/23,Muscle Relaxant,,AMNEAL PHARMACEUTICALS OF NEW YORK LLC,2007/11/01-,0115-1748,1NMA9J598Y,METAXALONE,METAXALONE,1NMA9J598Y,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/d6fc4788-2a34-4411-b143-ad636298eec3/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d6fc4788-2a34-4411-b143-ad636298eec3,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=d6fc4788-2a34-4411-b143-ad636298eec3,d6fc4788-2a34-4411-b143-ad636298eec3,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,NDA,021748,Glumetza,METFORMIN HYDROCHLORIDE,2024/03/27,Biguanide,1995,SANTARUS INC,2006/08/01-; 2008/06/17-; 2018/03/20-,68012-002; 68012-003; 68012-004,786Z46389E,METFORMIN HYDROCHLORIDE,METFORMIN,9100L32L2N,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/fb832474-88d9-4e29-95cd-fbc446944cc4/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=fb832474-88d9-4e29-95cd-fbc446944cc4,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=fb832474-88d9-4e29-95cd-fbc446944cc4,fb832474-88d9-4e29-95cd-fbc446944cc4,,,
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION,ORAL,NDA,021591,Riomet,METFORMIN HYDROCHLORIDE,2018/12/06,Biguanide,1995,SUN PHARMACEUTICAL INDUSTRIES INC,2004/01/04-,10631-206; 10631-238,786Z46389E,METFORMIN HYDROCHLORIDE,METFORMIN,9100L32L2N,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/05d4df4b-dfe8-4828-b423-a3d4f2c4114a/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=05d4df4b-dfe8-4828-b423-a3d4f2c4114a,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=05d4df4b-dfe8-4828-b423-a3d4f2c4114a,05d4df4b-dfe8-4828-b423-a3d4f2c4114a,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,NDA,021574,FORTAMET,METFORMIN HYDROCHLORIDE,2018/11/30,Biguanide,1995,SHIONOGI INC,2004/04/27-,59630-574; 59630-575,786Z46389E,METFORMIN HYDROCHLORIDE,METFORMIN,9100L32L2N,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/ed71d7ea-f5af-4406-8b0d-68e17cb1e61e/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ed71d7ea-f5af-4406-8b0d-68e17cb1e61e,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=ed71d7ea-f5af-4406-8b0d-68e17cb1e61e,ed71d7ea-f5af-4406-8b0d-68e17cb1e61e,,,
HUMAN PRESCRIPTION DRUG LABEL,"KIT; POWDER, FOR SOLUTION",INHALATION,NDA,019193,Provocholine; Provocholine Inhalation Solution,METHACHOLINE CHLORIDE; METHACHOLINE CHLORIDE INHALATION SOLUTION,2023/02/14,Cholinergic Receptor Agonist,1986,METHAPHARM INC,2013/03/27-; 2022/03/03-,64281-100; 64281-110,0W5ETF9M2K,METHACHOLINE CHLORIDE,METHACHOLINE,03V657ZD3V,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/e8983096-65e6-41f2-8b6f-bbf0a7227307/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e8983096-65e6-41f2-8b6f-bbf0a7227307,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=e8983096-65e6-41f2-8b6f-bbf0a7227307,e8983096-65e6-41f2-8b6f-bbf0a7227307,,,
HUMAN PRESCRIPTION DRUG LABEL,CONCENTRATE,ORAL,NDA,017116,METHADOSE; METHADOSE SUGAR-FREE,METHADONE HYDROCHLORIDE,2023/12/21,Opioid Agonist,1947,SPECGX LLC,1973/03/14-,0406-0527; 0406-8725,229809935B,METHADONE HYDROCHLORIDE,METHADONE,UC6VBE7V1Z,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/808a9d0b-720b-4034-a862-5122ff514608/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=808a9d0b-720b-4034-a862-5122ff514608,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=808a9d0b-720b-4034-a862-5122ff514608,808a9d0b-720b-4034-a862-5122ff514608,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS,NDA,021624,Methadone Hydrochloride,METHADONE HYDROCHLORIDE,2023/12/01,Opioid Agonist,,MYLAN INSTITUTIONAL LLC,2012/12/20-,67457-217,229809935B,Methadone Hydrochloride,Methadone,UC6VBE7V1Z,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/092d78eb-6423-495c-bf0d-e6532bea7138/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=092d78eb-6423-495c-bf0d-e6532bea7138,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=092d78eb-6423-495c-bf0d-e6532bea7138,092d78eb-6423-495c-bf0d-e6532bea7138,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,017058,DISKETS,METHADONE HYDROCHLORIDE,2023/12/01,Opioid Agonist,1947,HIKMA PHARMACEUTICALS USA INC,1973/03/14-,0054-4538,229809935B,METHADONE HYDROCHLORIDE,METHADONE,UC6VBE7V1Z,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/e6af84de-cbfc-4a3b-bd73-6bcf77337168/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e6af84de-cbfc-4a3b-bd73-6bcf77337168,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=e6af84de-cbfc-4a3b-bd73-6bcf77337168,e6af84de-cbfc-4a3b-bd73-6bcf77337168,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,005378,Desoxyn,METHAMPHETAMINE HYDROCHLORIDE,2022/09/08,Amphetamine Anorectic; Central Nervous System Stimulant,,KEY THERAPEUTICS,2022/09/01-,70868-820,997F43Z9CV,METHAMPHETAMINE HYDROCHLORIDE,METHAMPHETAMINE,44RAL3456C,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/81bfc45f-c345-47d0-9fc9-77abe553b541/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=81bfc45f-c345-47d0-9fc9-77abe553b541,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=81bfc45f-c345-47d0-9fc9-77abe553b541,81bfc45f-c345-47d0-9fc9-77abe553b541,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,017681,HIPREX,METHENAMINE HIPPURATE,2022/02/02,,,VALIDUS PHARMACEUTICALS LLC,1976/09/09-,30698-477,M329791L57,METHENAMINE HIPPURATE,METHENAMINE,J50OIX95QV,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/c8ddaa11-5753-46eb-8bd4-8f1d874a3ec4/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c8ddaa11-5753-46eb-8bd4-8f1d874a3ec4,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=c8ddaa11-5753-46eb-8bd4-8f1d874a3ec4,c8ddaa11-5753-46eb-8bd4-8f1d874a3ec4,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRAMUSCULAR; INTRAVENOUS,NDA,011790,ROBAXIN,METHOCARBAMOL,2024/04/10,Muscle Relaxant,,HIKMA PHARMACEUTICALS USA INC,2017/10/17-,0641-6217,125OD7737X,METHOCARBAMOL,METHOCARBAMOL,125OD7737X,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/a418c43a-afe8-4a19-a57a-95c8dbe3d3d8/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a418c43a-afe8-4a19-a57a-95c8dbe3d3d8,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=a418c43a-afe8-4a19-a57a-95c8dbe3d3d8,a418c43a-afe8-4a19-a57a-95c8dbe3d3d8,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRAMUSCULAR; INTRAVENOUS,NDA,011790,ROBAXIN,METHOCARBAMOL,2024/04/10,Muscle Relaxant,,HIKMA PHARMACEUTICALS USA INC,1959/06/16-,0641-6103,125OD7737X,METHOCARBAMOL,METHOCARBAMOL,125OD7737X,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/090a3d3d-92c3-4c30-a648-436461f81702/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=090a3d3d-92c3-4c30-a648-436461f81702,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=090a3d3d-92c3-4c30-a648-436461f81702,090a3d3d-92c3-4c30-a648-436461f81702,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAMUSCULAR; INTRAVENOUS; RECTAL,NDA,011559,Brevital Sodium,METHOHEXITAL SODIUM,2021/02/01,Barbiturate,,PAR PHARMACEUTICAL INC,2007/11/01-,42023-105,60200PNZ7Q,METHOHEXITAL SODIUM,METHOHEXITAL,E5B8ND5IPE,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/eccd8340-ead3-4363-8902-0c19d33aa2ac/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=eccd8340-ead3-4363-8902-0c19d33aa2ac,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=eccd8340-ead3-4363-8902-0c19d33aa2ac,eccd8340-ead3-4363-8902-0c19d33aa2ac,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAMUSCULAR; INTRATHECAL; INTRAVENOUS; SUBCUTANEOUS,NDA,011719,Methotrexate,METHOTREXATE,2024/01/01,Folate Analog Metabolic Inhibitor,1953,HOSPIRA INC,2013/11/11-; 2014/09/25-,61703-350; 61703-408,3IG1E710ZN,METHOTREXATE SODIUM,METHOTREXATE,YL5FZ2Y5U1,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/0e30eaef-5a09-4104-8a11-c32933eadeab/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0e30eaef-5a09-4104-8a11-c32933eadeab,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=0e30eaef-5a09-4104-8a11-c32933eadeab,0e30eaef-5a09-4104-8a11-c32933eadeab,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAMUSCULAR; INTRATHECAL; INTRAVENOUS; SUBCUTANEOUS,NDA,011719,Methotrexate,METHOTREXATE,2023/12/31,Folate Analog Metabolic Inhibitor,1953,HOSPIRA INC,2022/10/17-,61703-124,3IG1E710ZN,METHOTREXATE SODIUM,METHOTREXATE,YL5FZ2Y5U1,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/bd287e89-32f9-4396-95fa-4b562869f476/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=bd287e89-32f9-4396-95fa-4b562869f476,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=bd287e89-32f9-4396-95fa-4b562869f476,bd287e89-32f9-4396-95fa-4b562869f476,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAMUSCULAR; INTRATHECAL; INTRAVENOUS; SUBCUTANEOUS,NDA,011719,Methotrexate,METHOTREXATE,2023/12/14,Folate Analog Metabolic Inhibitor,1953,HOSPIRA INC,2001/02/26-; 2005/07/27-,61703-350; 61703-408,3IG1E710ZN,METHOTREXATE SODIUM,METHOTREXATE,YL5FZ2Y5U1,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/0d63ba29-b692-41b4-87e8-351265c8273f/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0d63ba29-b692-41b4-87e8-351265c8273f,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=0d63ba29-b692-41b4-87e8-351265c8273f,0d63ba29-b692-41b4-87e8-351265c8273f,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",SUBCUTANEOUS,NDA,204824,Otrexup,METHOTREXATE,2023/12/14,Folate Analog Metabolic Inhibitor,1953,ANTARES PHARMA INC,2013/10/11-; completed:2013/10/11-2016/09/30,54436-010; 54436-012; 54436-015; 54436-017; 54436-020; 54436-022; 54436-025; 54436-075,YL5FZ2Y5U1,METHOTREXATE,METHOTREXATE,YL5FZ2Y5U1,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/9ab8ce16-f7de-41d4-a4c8-1c742621b6d5/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9ab8ce16-f7de-41d4-a4c8-1c742621b6d5,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=9ab8ce16-f7de-41d4-a4c8-1c742621b6d5,9ab8ce16-f7de-41d4-a4c8-1c742621b6d5,,,
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION,ORAL,NDA,212479,JYLAMVO,METHOTREXATE,2023/12/01,Folate Analog Metabolic Inhibitor,1953,SHORLA ONCOLOGY INC,2023/12/15-,81927-204,YL5FZ2Y5U1,METHOTREXATE,METHOTREXATE,YL5FZ2Y5U1,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/96e931f5-51ae-4bdf-a441-bb0dd26d4c0e/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=96e931f5-51ae-4bdf-a441-bb0dd26d4c0e,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=96e931f5-51ae-4bdf-a441-bb0dd26d4c0e,96e931f5-51ae-4bdf-a441-bb0dd26d4c0e,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",SUBCUTANEOUS,NDA,205776,Rasuvo,METHOTREXATE,2023/09/01,Folate Analog Metabolic Inhibitor,1953,MEDEXUS PHARMA INC,2014/07/10-,59137-505; 59137-510; 59137-515; 59137-520; 59137-525; 59137-530; 59137-535; 59137-540; 59137-550,3IG1E710ZN,methotrexate sodium,methotrexate,YL5FZ2Y5U1,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/d0075461-0e7e-4967-9c9b-d6440e912c0e/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d0075461-0e7e-4967-9c9b-d6440e912c0e,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=d0075461-0e7e-4967-9c9b-d6440e912c0e,d0075461-0e7e-4967-9c9b-d6440e912c0e,,,
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION,ORAL,NDA,208400,Xatmep,METHOTREXATE,2022/06/28,Folate Analog Metabolic Inhibitor,1953,AZURITY PHARMACEUTICALS INC,2017/05/01-,52652-2001,YL5FZ2Y5U1,METHOTREXATE,METHOTREXATE,YL5FZ2Y5U1,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/aec9984e-34c5-481b-b6bf-9bb5caf1daf8/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=aec9984e-34c5-481b-b6bf-9bb5caf1daf8,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=aec9984e-34c5-481b-b6bf-9bb5caf1daf8,aec9984e-34c5-481b-b6bf-9bb5caf1daf8,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",EXTRACORPOREAL,NDA,020969,UVADEX,METHOXSALEN,2023/11/10,Photoactivated Radical Generator; Psoralen,,THERAKOS INC,1999/02/25-,64067-216,U4VJ29L7BQ,Methoxsalen,Methoxsalen,U4VJ29L7BQ,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/5ad333bd-845f-43f8-9ecf-43491f26c7c7/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5ad333bd-845f-43f8-9ecf-43491f26c7c7,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=5ad333bd-845f-43f8-9ecf-43491f26c7c7,5ad333bd-845f-43f8-9ecf-43491f26c7c7,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,NDA,010596,Celontin,METHSUXIMIDE,2023/08/08,Anti-epileptic Agent,,PARKE DAVIS DIV OF PFIZER INC,1957/02/08-,0071-0525,0G76K8X6C0,METHSUXIMIDE,METHSUXIMIDE,0G76K8X6C0,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/64a6ee88-c6b1-4e13-8208-b6772ef65a74/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=64a6ee88-c6b1-4e13-8208-b6772ef65a74,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=64a6ee88-c6b1-4e13-8208-b6772ef65a74,64a6ee88-c6b1-4e13-8208-b6772ef65a74,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRAVENOUS,NDA,204630,PROVAYBLUE,METHYLENE BLUE,2024/02/12,Oxidation-Reduction Agent,2016,AMERICAN REGENT INC,2016/04/08-; 2020/04/08-,0517-0125; 0517-0371; 0517-0374; 0517-0381,T42P99266K,METHYLENE BLUE,METHYLENE BLUE CATION,ZMZ79891ZH,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/4f6848e5-35ed-4046-b13c-3032b5ba3232/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4f6848e5-35ed-4046-b13c-3032b5ba3232,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=4f6848e5-35ed-4046-b13c-3032b5ba3232,4f6848e5-35ed-4046-b13c-3032b5ba3232,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION; TABLET",ORAL; SUBCUTANEOUS,NDA,021964;208271,Relistor,METHYLNALTREXONE BROMIDE,2024/05/14,Opioid Antagonist,2008,SALIX PHARMACEUTICALS INC,2008/04/24-; 2008/08/01-,65649-150; 65649-551; 65649-552,RFO6IL3D3M,METHYLNALTREXONE BROMIDE,METHYLNALTREXONE,0RK7M7IABE,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/c488fb7c-0a5b-487c-b452-996809d1cb99/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c488fb7c-0a5b-487c-b452-996809d1cb99,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=c488fb7c-0a5b-487c-b452-996809d1cb99,c488fb7c-0a5b-487c-b452-996809d1cb99,,,
HUMAN PRESCRIPTION DRUG LABEL,PATCH,TRANSDERMAL,NDA,021514,Daytrana,METHYLPHENIDATE,2024/04/12,Central Nervous System Stimulant,2006,NOVEN THERAPEUTICS LLC,2006/04/06-,68968-5552; 68968-5553; 68968-5554; 68968-5555,207ZZ9QZ49,METHYLPHENIDATE,METHYLPHENIDATE,207ZZ9QZ49,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/2c312c31-3198-4775-91ab-294e0b4b9e7f/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2c312c31-3198-4775-91ab-294e0b4b9e7f,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=2c312c31-3198-4775-91ab-294e0b4b9e7f,2c312c31-3198-4775-91ab-294e0b4b9e7f,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, ORALLY DISINTEGRATING",ORAL,NDA,205489,Cotempla XR-ODT,METHYLPHENIDATE,2024/03/27,Central Nervous System Stimulant,1955,NEOS THERAPEUTICS BRANDS LLC,2017/06/20-,70165-100; 70165-200; 70165-300,207ZZ9QZ49,METHYLPHENIDATE,METHYLPHENIDATE,207ZZ9QZ49,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/33f70f58-c871-42c8-8adb-345caeafefcd/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=33f70f58-c871-42c8-8adb-345caeafefcd,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=33f70f58-c871-42c8-8adb-345caeafefcd,33f70f58-c871-42c8-8adb-345caeafefcd,,,
HUMAN PRESCRIPTION DRUG LABEL,"CAPSULE, EXTENDED RELEASE",ORAL,NDA,205831,APTENSIO XR,METHYLPHENIDATE HYDROCHLORIDE,2024/04/08,Central Nervous System Stimulant,1955,RHODES PHARMACEUTICALS L P,2015/04/17-,42858-401; 42858-402; 42858-403; 42858-404; 42858-405; 42858-406; 42858-407,4B3SC438HI,METHYLPHENIDATE HYDROCHLORIDE,METHYLPHENIDATE,207ZZ9QZ49,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/5adedc01-ebf0-11e3-ac10-0800200c9a66/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5adedc01-ebf0-11e3-ac10-0800200c9a66,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=5adedc01-ebf0-11e3-ac10-0800200c9a66,5adedc01-ebf0-11e3-ac10-0800200c9a66,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA; NDA Authorized Generic,021121;021121,methylphenidate Hydrochloride,METHYLPHENIDATE HYDROCHLORIDE,2023/11/29,Central Nervous System Stimulant,2000,PATRIOT PHARMACEUTICALS LLC,completed:2000/08/01-2025/04/30; completed:2000/08/01-2025/05/31; completed:2000/08/01-2025/08/31,10147-0685; 10147-0686; 10147-0687; 10147-0688,4B3SC438HI,METHYLPHENIDATE HYDROCHLORIDE,METHYLPHENIDATE,207ZZ9QZ49,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/dad446b7-b26c-44f2-9e30-4cbd10d8b23c/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=dad446b7-b26c-44f2-9e30-4cbd10d8b23c,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=dad446b7-b26c-44f2-9e30-4cbd10d8b23c,dad446b7-b26c-44f2-9e30-4cbd10d8b23c,,,
HUMAN PRESCRIPTION DRUG LABEL,"CAPSULE, EXTENDED RELEASE",ORAL,NDA,021259,METADATE CD,METHYLPHENIDATE HYDROCHLORIDE,2023/10/31,Central Nervous System Stimulant,1955,AYTU BIOPHARMA INC,2024/02/22-,69654-579; 69654-580; 69654-581; 69654-582; 69654-583; 69654-584,4B3SC438HI,methylphenidate hydrochloride,methylphenidate,207ZZ9QZ49,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/be59f8b4-7842-42cc-9559-bfa747f0baa5/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=be59f8b4-7842-42cc-9559-bfa747f0baa5,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=be59f8b4-7842-42cc-9559-bfa747f0baa5,be59f8b4-7842-42cc-9559-bfa747f0baa5,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, EXTENDED RELEASE",ORAL,NDA,021121,CONCERTA,METHYLPHENIDATE HYDROCHLORIDE,2023/10/27,Central Nervous System Stimulant,2000,JANSSEN PHARMACEUTICALS INC,2000/08/01-,50458-585; 50458-586; 50458-587; 50458-588,4B3SC438HI,METHYLPHENIDATE HYDROCHLORIDE,METHYLPHENIDATE,207ZZ9QZ49,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/1a88218c-5b18-4220-8f56-526de1a276cd/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1a88218c-5b18-4220-8f56-526de1a276cd,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=1a88218c-5b18-4220-8f56-526de1a276cd,1a88218c-5b18-4220-8f56-526de1a276cd,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, EXTENDED RELEASE",ORAL,NDA,216117,Methylphenidate Hydrochloride,METHYLPHENIDATE HYDROCHLORIDE,2023/10/26,Central Nervous System Stimulant,2000,TRIGEN LABORATORIES LLC,2022/06/23-,13811-700; 13811-711,4B3SC438HI,METHYLPHENIDATE HYDROCHLORIDE,METHYLPHENIDATE,207ZZ9QZ49,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/dd8d7b6e-c23d-4e16-bb53-959e9127ebc6/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=dd8d7b6e-c23d-4e16-bb53-959e9127ebc6,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=dd8d7b6e-c23d-4e16-bb53-959e9127ebc6,dd8d7b6e-c23d-4e16-bb53-959e9127ebc6,,,
HUMAN PRESCRIPTION DRUG LABEL,"SUSPENSION, EXTENDED RELEASE",ORAL,NDA,202100,Quillivant XR,METHYLPHENIDATE HYDROCHLORIDE,2023/10/26,Central Nervous System Stimulant,1955,NEXTWAVE PHARMACEUTICALS INC,2012/10/01-; 2013/01/04-,24478-321; 24478-322; 24478-323; 24478-324,4B3SC438HI,METHYLPHENIDATE HYDROCHLORIDE,METHYLPHENIDATE,207ZZ9QZ49,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/c2dc2109-44a6-4797-b04e-18761dd9d45a/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c2dc2109-44a6-4797-b04e-18761dd9d45a,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=c2dc2109-44a6-4797-b04e-18761dd9d45a,c2dc2109-44a6-4797-b04e-18761dd9d45a,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,NDA,209311,JORNAY PM Extended-Release,METHYLPHENIDATE HYDROCHLORIDE,2023/10/19,Central Nervous System Stimulant,1955,IRONSHORE PHARMACEUTICALS INC,2019/06/01-,71376-201; 71376-202; 71376-203; 71376-204; 71376-205,4B3SC438HI,Methylphenidate Hydrochloride,Methylphenidate,207ZZ9QZ49,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/d95dede0-b1ff-4489-8f91-3bbe122852bf/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d95dede0-b1ff-4489-8f91-3bbe122852bf,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=d95dede0-b1ff-4489-8f91-3bbe122852bf,d95dede0-b1ff-4489-8f91-3bbe122852bf,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, EXTENDED RELEASE",ORAL,NDA,216117,RELEXXII,METHYLPHENIDATE HYDROCHLORIDE,2023/10/17,Central Nervous System Stimulant,2000,VERTICAL PHARMACEUTICALS LLC,2022/06/23-,68025-084; 68025-088; 68025-089; 68025-095; 68025-096; 68025-097; 68025-098,4B3SC438HI,METHYLPHENIDATE HYDROCHLORIDE,METHYLPHENIDATE,207ZZ9QZ49,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/22d5fa47-b5b9-4fd9-980c-4eb88e95ae5d/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=22d5fa47-b5b9-4fd9-980c-4eb88e95ae5d,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=22d5fa47-b5b9-4fd9-980c-4eb88e95ae5d,22d5fa47-b5b9-4fd9-980c-4eb88e95ae5d,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,010187,Ritalin,METHYLPHENIDATE HYDROCHLORIDE,2023/10/13,Central Nervous System Stimulant,1955,NOVARTIS PHARMACEUTICALS CORPORATION,completed:1955/12/31-2026/08/31,0078-0439; 0078-0440; 0078-0441,4B3SC438HI,METHYLPHENIDATE HYDROCHLORIDE,METHYLPHENIDATE,207ZZ9QZ49,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/c0bf0835-6a2f-4067-a158-8b86c4b0668a/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c0bf0835-6a2f-4067-a158-8b86c4b0668a,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=c0bf0835-6a2f-4067-a158-8b86c4b0668a,c0bf0835-6a2f-4067-a158-8b86c4b0668a,,,
HUMAN PRESCRIPTION DRUG LABEL,"CAPSULE, EXTENDED RELEASE",ORAL,NDA,021284,Ritalin LA,METHYLPHENIDATE HYDROCHLORIDE,2023/10/13,Central Nervous System Stimulant,1955,NOVARTIS PHARMACEUTICALS CORPORATION,2002/06/05-,0078-0370; 0078-0371; 0078-0372; 0078-0424,4B3SC438HI,METHYLPHENIDATE HYDROCHLORIDE,METHYLPHENIDATE,207ZZ9QZ49,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/effd952d-ac94-47bb-b107-589a4934dcca/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=effd952d-ac94-47bb-b107-589a4934dcca,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=effd952d-ac94-47bb-b107-589a4934dcca,effd952d-ac94-47bb-b107-589a4934dcca,,,
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION,ORAL,NDA,021419,Methylin,METHYLPHENIDATE HYDROCHLORIDE,2023/06/15,Central Nervous System Stimulant,1955,SHIONOGI INC,2002/12/19-,59630-750; 59630-755,4B3SC438HI,METHYLPHENIDATE HYDROCHLORIDE,METHYLPHENIDATE,207ZZ9QZ49,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/9e3c22d9-71d9-46a7-b315-8021c94c4bec/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9e3c22d9-71d9-46a7-b315-8021c94c4bec,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=9e3c22d9-71d9-46a7-b315-8021c94c4bec,9e3c22d9-71d9-46a7-b315-8021c94c4bec,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,011153,Medrol,METHYLPREDNISOLONE,2024/01/04,Corticosteroid,,PHARMACIA AND UPJOHN COMPANY LLC,1957/10/24-; 2013/09/20-; completed:1957/10/24-2015/05/24; completed:1957/10/24-2022/09/30,0009-0020; 0009-0022; 0009-0049; 0009-0056; 0009-0073; 0009-0176,X4W7ZR7023,METHYLPREDNISOLONE,METHYLPREDNISOLONE,X4W7ZR7023,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/39d5270b-d957-4821-93d6-501b7b9f02d4/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=39d5270b-d957-4821-93d6-501b7b9f02d4,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=39d5270b-d957-4821-93d6-501b7b9f02d4,39d5270b-d957-4821-93d6-501b7b9f02d4,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SUSPENSION",INTRALESIONAL; INTRAMUSCULAR; INTRASYNOVIAL; SOFT TISSUE,NDA,011757,Depo-Medrol,METHYLPREDNISOLONE ACETATE,2024/01/23,Corticosteroid,,PHARMACIA AND UPJOHN COMPANY LLC,1959/05/28-; completed:1959/05/28-2022/10/31,0009-3073; 0009-3475,43502P7F0P,METHYLPREDNISOLONE ACETATE,METHYLPREDNISOLONE,X4W7ZR7023,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/bf1b104d-85cb-414d-a366-78068c82c883/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=bf1b104d-85cb-414d-a366-78068c82c883,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=bf1b104d-85cb-414d-a366-78068c82c883,bf1b104d-85cb-414d-a366-78068c82c883,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SUSPENSION",INTRALESIONAL; INTRAMUSCULAR; INTRASYNOVIAL; SOFT TISSUE,NDA,011757,Depo-Medrol,METHYLPREDNISOLONE ACETATE,2024/01/04,Corticosteroid,,PHARMACIA AND UPJOHN COMPANY LLC,1959/05/28-,0009-0274; 0009-0280; 0009-0306,43502P7F0P,METHYLPREDNISOLONE ACETATE,METHYLPREDNISOLONE,X4W7ZR7023,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/823b0010-2b57-4e76-b5ac-4a8c2963438f/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=823b0010-2b57-4e76-b5ac-4a8c2963438f,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=823b0010-2b57-4e76-b5ac-4a8c2963438f,823b0010-2b57-4e76-b5ac-4a8c2963438f,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SUSPENSION",INTRA-ARTICULAR; INTRALESIONAL; INTRAMUSCULAR; SOFT TISSUE,NDA,011757,Depo-Medrol,METHYLPREDNISOLONE ACETATE,2024/01/04,Corticosteroid,,PHARMACIA AND UPJOHN COMPANY LLC,1959/05/28-,0009-3073; 0009-3475,43502P7F0P,METHYLPREDNISOLONE ACETATE,METHYLPREDNISOLONE,X4W7ZR7023,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/9a7b3837-e038-48bf-97e9-78ad463760dc/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9a7b3837-e038-48bf-97e9-78ad463760dc,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=9a7b3837-e038-48bf-97e9-78ad463760dc,9a7b3837-e038-48bf-97e9-78ad463760dc,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, POWDER, FOR SOLUTION",INTRAMUSCULAR; INTRAVENOUS,NDA,011856,SOLU-MEDROL,METHYLPREDNISOLONE SODIUM SUCCINATE,2024/01/23,Corticosteroid,,PHARMACIA AND UPJOHN COMPANY LLC,1959/04/02-,0009-0039; 0009-0047; 0009-0698,LEC9GKY20K,METHYLPREDNISOLONE SODIUM SUCCINATE,METHYLPREDNISOLONE,X4W7ZR7023,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/7271310c-7764-4812-aa30-a5e90987c7a9/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7271310c-7764-4812-aa30-a5e90987c7a9,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=7271310c-7764-4812-aa30-a5e90987c7a9,7271310c-7764-4812-aa30-a5e90987c7a9,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, POWDER, FOR SOLUTION; KIT",INTRAMUSCULAR; INTRAVENOUS,NDA,011856,SOLU-MEDROL; Solu-Medrol,METHYLPREDNISOLONE SODIUM SUCCINATE,2024/01/04,Corticosteroid,,PHARMACIA AND UPJOHN COMPANY LLC,1959/04/02-; completed:1959/04/02-2021/01/31,0009-0003; 0009-0018; 0009-0039; 0009-0047; 0009-0698; 0009-0758; 0009-0796; 0009-0850,LEC9GKY20K,METHYLPREDNISOLONE SODIUM SUCCINATE,METHYLPREDNISOLONE,X4W7ZR7023,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/cd99be87-c8d9-48d6-a8e5-e081052e3f19/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=cd99be87-c8d9-48d6-a8e5-e081052e3f19,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=cd99be87-c8d9-48d6-a8e5-e081052e3f19,cd99be87-c8d9-48d6-a8e5-e081052e3f19,,,
HUMAN PRESCRIPTION DRUG LABEL,SPRAY,NASAL,NDA,209388,GIMOTI,METOCLOPRAMIDE HYDROCHLORIDE,2021/01/07,Dopamine-2 Receptor Antagonist,1979,EVOKE PHARMA INC,2020/06/19-,72089-307,W1792A2RVD,METOCLOPRAMIDE HYDROCHLORIDE,METOCLOPRAMIDE,L4YEB44I46,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/95269b1f-779c-4ca0-9f86-e74e677f9900/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=95269b1f-779c-4ca0-9f86-e74e677f9900,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=95269b1f-779c-4ca0-9f86-e74e677f9900,95269b1f-779c-4ca0-9f86-e74e677f9900,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,017854,Reglan,METOCLOPRAMIDE HYDROCHLORIDE,2020/06/19,Dopamine-2 Receptor Antagonist,1979,ANI PHARMACEUTICALS INC,2011/07/05-,62559-165; 62559-166,W1792A2RVD,METOCLOPRAMIDE HYDROCHLORIDE,METOCLOPRAMIDE,L4YEB44I46,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/de55c133-eb08-4a35-91a2-5dc093027397/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=de55c133-eb08-4a35-91a2-5dc093027397,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=de55c133-eb08-4a35-91a2-5dc093027397,de55c133-eb08-4a35-91a2-5dc093027397,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,017386,METOLAZONE,METOLAZONE,2018/03/26,Thiazide-like Diuretic,,H J HARKINS CO INC,2017/12/08-,76519-1166,TZ7V40X7VX,METOLAZONE,METOLAZONE,TZ7V40X7VX,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/6856a354-e84f-10cc-e053-2a91aa0a5e70/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6856a354-e84f-10cc-e053-2a91aa0a5e70,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=6856a354-e84f-10cc-e053-2a91aa0a5e70,6856a354-e84f-10cc-e053-2a91aa0a5e70,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, EXTENDED RELEASE",ORAL,NDA,019962,TOPROL XL,METOPROLOL SUCCINATE,2023/04/24,beta-Adrenergic Blocker,1992,ARALEZ PHARMACEUTICALS US INC,2018/01/01-,70347-025; 70347-050; 70347-100; 70347-200,TH25PD4CCB,METOPROLOL SUCCINATE,METOPROLOL,GEB06NHM23,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/991fe00b-498b-400e-9e5b-921cb07d9b2c/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=991fe00b-498b-400e-9e5b-921cb07d9b2c,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=991fe00b-498b-400e-9e5b-921cb07d9b2c,991fe00b-498b-400e-9e5b-921cb07d9b2c,,,
HUMAN PRESCRIPTION DRUG LABEL,"CAPSULE, EXTENDED RELEASE",ORAL,NDA,210428,KAPSPARGO,METOPROLOL SUCCINATE,2023/04/12,beta-Adrenergic Blocker,1992,SUN PHARMACEUTICAL INDUSTRIES INC,2018/03/15-,10631-008; 10631-009; 10631-010; 10631-011,TH25PD4CCB,METOPROLOL SUCCINATE,METOPROLOL,GEB06NHM23,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/9cfa55b4-15c6-40f7-b6e5-41096ee51bfc/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9cfa55b4-15c6-40f7-b6e5-41096ee51bfc,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=9cfa55b4-15c6-40f7-b6e5-41096ee51bfc,9cfa55b4-15c6-40f7-b6e5-41096ee51bfc,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, EXTENDED RELEASE",ORAL,NDA,019962,TOPROL XL,METOPROLOL SUCCINATE,2022/11/28,beta-Adrenergic Blocker,1992,MELINTA THERAPEUTICS LLC,2023/07/03-,70842-110; 70842-111; 70842-112; 70842-113,TH25PD4CCB,METOPROLOL SUCCINATE,METOPROLOL,GEB06NHM23,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/496ddfaa-7c9c-4888-b747-a210249b367a/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=496ddfaa-7c9c-4888-b747-a210249b367a,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=496ddfaa-7c9c-4888-b747-a210249b367a,496ddfaa-7c9c-4888-b747-a210249b367a,,,
HUMAN PRESCRIPTION DRUG LABEL,"CAPSULE, EXTENDED RELEASE",ORAL,NDA,210428,Metoprolol Succinate,METOPROLOL SUCCINATE,2018/02/07,beta-Adrenergic Blocker,1992,SUN PHARMACEUTICAL INDUSTRIES INC,2018/02/07-,63304-008; 63304-009; 63304-010; 63304-011,TH25PD4CCB,METOPROLOL SUCCINATE,METOPROLOL,GEB06NHM23,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/90aa06a3-100f-4466-b950-506303707b01/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=90aa06a3-100f-4466-b950-506303707b01,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=90aa06a3-100f-4466-b950-506303707b01,90aa06a3-100f-4466-b950-506303707b01,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,017963,Lopressor,METOPROLOL TARTRATE,2023/09/14,beta-Adrenergic Blocker,1992,VALIDUS PHARMACEUTICALS LLC,2014/05/05-,30698-458; 30698-459,W5S57Y3A5L,METOPROLOL TARTRATE,METOPROLOL,GEB06NHM23,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/0283bc9d-6998-493a-824a-d4c85f704111/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0283bc9d-6998-493a-824a-d4c85f704111,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=0283bc9d-6998-493a-824a-d4c85f704111,0283bc9d-6998-493a-824a-d4c85f704111,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,018303,Lopressor HCT,METOPROLOL TARTRATE AND HYDROCHLOROTHIAZIDE,2023/09/13,Thiazide Diuretic; beta-Adrenergic Blocker,1984,VALIDUS PHARMACEUTICALS LLC,2014/06/30-,30698-461; 30698-462; 30698-463,0J48LPH2TH; W5S57Y3A5L,HYDROCHLOROTHIAZIDE; METOPROLOL TARTRATE,HYDROCHLOROTHIAZIDE; METOPROLOL,0J48LPH2TH; GEB06NHM23,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/d8964894-3cd8-41c1-a844-148d2ef38a88/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d8964894-3cd8-41c1-a844-148d2ef38a88,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=d8964894-3cd8-41c1-a844-148d2ef38a88,d8964894-3cd8-41c1-a844-148d2ef38a88,,,
HUMAN PRESCRIPTION DRUG LABEL,GEL,TOPICAL,NDA,021789,METROGEL,METRONIDAZOLE,2023/11/27,Nitroimidazole Antimicrobial,1963,GALDERMA LABORATORIES L P,completed:2005/06/30-2026/05/31,0299-3820,140QMO216E,METRONIDAZOLE,Metronidazole,140QMO216E,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/ab3a8a2d-714a-4beb-af8a-99bc3ac3ebbe/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ab3a8a2d-714a-4beb-af8a-99bc3ac3ebbe,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=ab3a8a2d-714a-4beb-af8a-99bc3ac3ebbe,ab3a8a2d-714a-4beb-af8a-99bc3ac3ebbe,,,
HUMAN PRESCRIPTION DRUG LABEL,GEL,TOPICAL,NDA,205223,Nuvessa,METRONIDAZOLE,2023/11/10,Nitroimidazole Antimicrobial,1963,EXELTIS USA INC,2018/03/10-,0642-7466,140QMO216E,METRONIDAZOLE,METRONIDAZOLE,140QMO216E,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/3b6ff39d-f84b-43b3-9b07-c0521c6d7968/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3b6ff39d-f84b-43b3-9b07-c0521c6d7968,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=3b6ff39d-f84b-43b3-9b07-c0521c6d7968,3b6ff39d-f84b-43b3-9b07-c0521c6d7968,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,NDA,020334,Flagyl,METRONIDAZOLE,2023/10/20,Nitroimidazole Antimicrobial,,PFIZER LABORATORIES DIV PFIZER INC,1995/05/03-,0025-1942,140QMO216E,METRONIDAZOLE,METRONIDAZOLE,140QMO216E,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/a2883ca1-5a9a-4259-9d80-46ab67274384/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a2883ca1-5a9a-4259-9d80-46ab67274384,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=a2883ca1-5a9a-4259-9d80-46ab67274384,a2883ca1-5a9a-4259-9d80-46ab67274384,,,
HUMAN PRESCRIPTION DRUG LABEL,CREAM,TOPICAL,NDA,020743,Metronidazole,METRONIDAZOLE,2022/06/21,Nitroimidazole Antimicrobial,,OCEANSIDE PHARMACEUTICALS,2023/08/01-,68682-202,140QMO216E,metronidazole,metronidazole,140QMO216E,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/cdf2e251-4bbc-4434-9b00-bef6284491e4/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=cdf2e251-4bbc-4434-9b00-bef6284491e4,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=cdf2e251-4bbc-4434-9b00-bef6284491e4,cdf2e251-4bbc-4434-9b00-bef6284491e4,,,
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION,INTRAVENOUS,NDA,018900,METRONIDAZOLE,METRONIDAZOLE,2021/12/15,Nitroimidazole Antimicrobial,,B BRAUN MEDICAL INC,1983/09/29-,0264-5535,140QMO216E,METRONIDAZOLE,METRONIDAZOLE,140QMO216E,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/fd191c06-9d3b-4e46-9f79-90f6af614947/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=fd191c06-9d3b-4e46-9f79-90f6af614947,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=fd191c06-9d3b-4e46-9f79-90f6af614947,fd191c06-9d3b-4e46-9f79-90f6af614947,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,018657,Metronidazole,METRONIDAZOLE,2021/12/15,Nitroimidazole Antimicrobial,,BAXTER HEALTHCARE CORPORATION,1981/12/24-,0338-9541,140QMO216E,METRONIDAZOLE,METRONIDAZOLE,140QMO216E,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/9d762edb-12ac-429d-b1f0-7af5d3b909d4/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9d762edb-12ac-429d-b1f0-7af5d3b909d4,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=9d762edb-12ac-429d-b1f0-7af5d3b909d4,9d762edb-12ac-429d-b1f0-7af5d3b909d4,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,018657,Metronidazole,METRONIDAZOLE,2021/12/15,Nitroimidazole Antimicrobial,,BAXTER HEALTHCARE CORPORATION,1981/12/24-,0338-1055,140QMO216E,METRONIDAZOLE,METRONIDAZOLE,140QMO216E,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/d2112f37-5080-4a19-bcc3-6386b49abe1d/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d2112f37-5080-4a19-bcc3-6386b49abe1d,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=d2112f37-5080-4a19-bcc3-6386b49abe1d,d2112f37-5080-4a19-bcc3-6386b49abe1d,,,
HUMAN PRESCRIPTION DRUG LABEL,CREAM,TOPICAL,NDA,020743,Noritate,METRONIDAZOLE,2020/06/01,Nitroimidazole Antimicrobial,,BAUSCH HEALTH US LLC,2013/08/09-,0187-5202,140QMO216E,metronidazole,metronidazole,140QMO216E,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/706b09da-6cf9-421d-8e91-f3999474d322/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=706b09da-6cf9-421d-8e91-f3999474d322,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=706b09da-6cf9-421d-8e91-f3999474d322,706b09da-6cf9-421d-8e91-f3999474d322,,,
HUMAN PRESCRIPTION DRUG LABEL,LOTION,TOPICAL,NDA,020901,MetroLotion,METRONIDAZOLE,2018/06/27,Nitroimidazole Antimicrobial,,GALDERMA LABORATORIES L P,1998/11/24-,0299-3838,140QMO216E,METRONIDAZOLE,METRONIDAZOLE,140QMO216E,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/c4e07c26-245d-3e51-6a47-fccde22334d2/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c4e07c26-245d-3e51-6a47-fccde22334d2,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=c4e07c26-245d-3e51-6a47-fccde22334d2,c4e07c26-245d-3e51-6a47-fccde22334d2,,,
HUMAN PRESCRIPTION DRUG LABEL,CREAM,TOPICAL,NDA,020531,MetroCream,METRONIDAZOLE,2018/06/26,Nitroimidazole Antimicrobial,,GALDERMA LABORATORIES L P,1995/09/20-,0299-3836,140QMO216E,Metronidazole,Metronidazole,140QMO216E,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/43d5e570-f359-564d-9bb4-51784ad97b6f/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=43d5e570-f359-564d-9bb4-51784ad97b6f,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=43d5e570-f359-564d-9bb4-51784ad97b6f,43d5e570-f359-564d-9bb4-51784ad97b6f,,,
HUMAN PRESCRIPTION DRUG LABEL,SUSPENSION,ORAL,NDA,216755,LIKMEZ,METRONIDAZOLE ORAL,2024/03/06,Nitroimidazole Antimicrobial,1963,KESIN PHARMA CORPORATION,2023/10/13-,81033-066,140QMO216E,METRONIDAZOLE,METRONIDAZOLE,140QMO216E,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/23927a8b-1641-4104-aa85-d7b7bf4ebb9d/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=23927a8b-1641-4104-aa85-d7b7bf4ebb9d,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=23927a8b-1641-4104-aa85-d7b7bf4ebb9d,23927a8b-1641-4104-aa85-d7b7bf4ebb9d,,,
HUMAN PRESCRIPTION DRUG LABEL,"CAPSULE, GELATIN COATED",ORAL,NDA,012911,Metopirone,METYRAPONE,2023/11/13,Adrenal Steroid Synthesis Inhibitor,1961,HRA PHARMA RARE DISEASES,1962/01/25-,76336-455,ZS9KD92H6V,METYRAPONE,METYRAPONE,ZS9KD92H6V,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/3a27d0ef-83a7-4e1c-9430-46a3326ee8d8/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3a27d0ef-83a7-4e1c-9430-46a3326ee8d8,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=3a27d0ef-83a7-4e1c-9430-46a3326ee8d8,3a27d0ef-83a7-4e1c-9430-46a3326ee8d8,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,NDA,017871,Demser,METYROSINE,2021/07/01,Catecholamine Synthesis Inhibitor,,BAUSCH HEALTH US LLC,1979/10/03-,25010-305,DOQ0J0TPF7,metyrosine,metyrosine,DOQ0J0TPF7,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/32fb2f2f-34b5-4cd5-9145-c3ab37c5ca92/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=32fb2f2f-34b5-4cd5-9145-c3ab37c5ca92,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=32fb2f2f-34b5-4cd5-9145-c3ab37c5ca92,32fb2f2f-34b5-4cd5-9145-c3ab37c5ca92,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAVENOUS,NDA,212156,Micafungin,MICAFUNGIN,2021/06/30,Echinocandin Antifungal,2005,PAR PHARMACEUTICAL INC,2021/08/01-,42023-229; 42023-230,IS1UP79R56,MICAFUNGIN SODIUM,MICAFUNGIN,R10H71BSWG,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/70b3f044-95ca-4503-b669-ed39972592b6/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=70b3f044-95ca-4503-b669-ed39972592b6,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=70b3f044-95ca-4503-b669-ed39972592b6,70b3f044-95ca-4503-b669-ed39972592b6,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRAVENOUS,NDA,216142,Micafungin in Sodium Chloride,MICAFUNGIN IN SODIUM CHLORIDE,2023/09/29,Echinocandin Antifungal,2005,BAXTER HEALTHCARE CORPORATION,2023/09/29-,0338-9051; 0338-9053; 0338-9055,IS1UP79R56,MICAFUNGIN SODIUM,MICAFUNGIN,R10H71BSWG,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/a95f901e-0ac4-4ec0-9720-9c6a066cd06c/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a95f901e-0ac4-4ec0-9720-9c6a066cd06c,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=a95f901e-0ac4-4ec0-9720-9c6a066cd06c,a95f901e-0ac4-4ec0-9720-9c6a066cd06c,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAVENOUS,NDA,021506,Mycamine,MICAFUNGIN SODIUM,2022/08/04,Echinocandin Antifungal,2005,ASTELLAS PHARMA US INC,2005/03/16-; 2006/06/27-,0469-3211; 0469-3250,IS1UP79R56,MICAFUNGIN SODIUM,MICAFUNGIN,R10H71BSWG,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/a064c4a7-25ec-4a2c-afc2-703491a4a38b/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a064c4a7-25ec-4a2c-afc2-703491a4a38b,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=a064c4a7-25ec-4a2c-afc2-703491a4a38b,a064c4a7-25ec-4a2c-afc2-703491a4a38b,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,BUCCAL,NDA,022404,Oravig,MICONAZOLE,2024/01/08,Azole Antifungal,1974,GALT PHARMACEUTICALS LLC,2021/12/31-,61825-303,7NNO0D7S5M,MICONAZOLE,MICONAZOLE,7NNO0D7S5M,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/dc2427ff-e566-4b48-b289-9e51c011250a/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=dc2427ff-e566-4b48-b289-9e51c011250a,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=dc2427ff-e566-4b48-b289-9e51c011250a,dc2427ff-e566-4b48-b289-9e51c011250a,,,
HUMAN PRESCRIPTION DRUG LABEL,OINTMENT,TOPICAL,NDA,021026,VUSION,"MICONAZOLE NITRATE, ZINC OXIDE, WHITE PETROLATUM",2018/08/15,Azole Antifungal,2006,MYLAN PHARMACEUTICALS INC,2020/02/06-,0378-9730,4T6H12BN9U; SOI2LOH54Z; VW4H1CYW1K,MICONAZOLE NITRATE; PETROLATUM; ZINC OXIDE,MICONAZOLE; PETROLATUM; ZINC OXIDE,4T6H12BN9U; 7NNO0D7S5M; SOI2LOH54Z,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/b44b452d-3630-4cb5-8ed1-1f8edac4690c/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b44b452d-3630-4cb5-8ed1-1f8edac4690c,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=b44b452d-3630-4cb5-8ed1-1f8edac4690c,b44b452d-3630-4cb5-8ed1-1f8edac4690c,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,211844,Midazolam in Sodium Chloride,MIDAZOLAM,2023/01/31,Benzodiazepine,1985,WG CRITICAL CARE LLC,2020/12/31-,44567-610; 44567-611,R60L0SM5BC,MIDAZOLAM,MIDAZOLAM,R60L0SM5BC,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/f051776f-94c5-4e34-80ed-f45b9c36881e/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f051776f-94c5-4e34-80ed-f45b9c36881e,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=f051776f-94c5-4e34-80ed-f45b9c36881e,f051776f-94c5-4e34-80ed-f45b9c36881e,,,
HUMAN PRESCRIPTION DRUG LABEL,SPRAY,NASAL,NDA,211321,Nayzilam,MIDAZOLAM,2023/01/19,Benzodiazepine,1985,UCB INC,2019/05/17-,50474-500,R60L0SM5BC,midazolam,midazolam,R60L0SM5BC,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/2b29422e-54d5-4a49-8522-e9cf752368c3/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2b29422e-54d5-4a49-8522-e9cf752368c3,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=2b29422e-54d5-4a49-8522-e9cf752368c3,2b29422e-54d5-4a49-8522-e9cf752368c3,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAMUSCULAR,NDA,209566,Seizalam,MIDAZOLAM HYDROCHLORIDE,2023/01/26,Benzodiazepine,1985,MERIDIAN MEDICAL TECHNOLOGIES LLC,2018/09/14-,11704-650,W7TTW573JJ,midazolam hydrochloride,midazolam,R60L0SM5BC,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/cb2381bf-984a-48a8-95c0-3017c34cc170/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=cb2381bf-984a-48a8-95c0-3017c34cc170,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=cb2381bf-984a-48a8-95c0-3017c34cc170,cb2381bf-984a-48a8-95c0-3017c34cc170,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,215868,MIDAZOLAM HYDROCHLORIDE,MIDAZOLAM HYDROCHLORIDE,2022/12/01,Benzodiazepine,1985,EXELA PHARMA SCIENCES LLC,2022/12/01-,51754-2130; 51754-2131,W7TTW573JJ,MIDAZOLAM HYDROCHLORIDE,MIDAZOLAM,R60L0SM5BC,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/7b42059c-16ad-4826-829b-83b42a39435b/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7b42059c-16ad-4826-829b-83b42a39435b,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=7b42059c-16ad-4826-829b-83b42a39435b,7b42059c-16ad-4826-829b-83b42a39435b,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAMUSCULAR,NDA,216359,N/A,"MIDAZOLAM INJECTION, 10 MG",2024/05/09,Benzodiazepine,1985,RAFA LABORATORIES LTD,2022/08/08-,71053-595,R60L0SM5BC,MIDAZOLAM,MIDAZOLAM,R60L0SM5BC,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/d7362b4d-68a3-99a0-e053-2995a90a4f60/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d7362b4d-68a3-99a0-e053-2995a90a4f60,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=d7362b4d-68a3-99a0-e053-2995a90a4f60,d7362b4d-68a3-99a0-e053-2995a90a4f60,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,202107,Korlym,MIFEPRISTONE,2024/04/12,Progestin Antagonist,2000,CORCEPT THERAPEUTICS INCORPORATED,2012/02/17-,76346-073,320T6RNW1F,MIFEPRISTONE,MIFEPRISTONE,320T6RNW1F,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/542f3fae-8bc8-4f00-9228-e4b66c9ad6a9/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=542f3fae-8bc8-4f00-9228-e4b66c9ad6a9,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=542f3fae-8bc8-4f00-9228-e4b66c9ad6a9,542f3fae-8bc8-4f00-9228-e4b66c9ad6a9,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,NDA,208623,Galafold,MIGALASTAT HYDROCHLORIDE,2023/06/27,,2018,AMICUS THERAPEUTICS US LLC,2018/08/10-,71904-100,CLY7M0XD20,MIGALASTAT HYDROCHLORIDE,MIGALASTAT,C4XNY919FW,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/66dbd928-0f1c-48b1-a832-54e4abd9f1db/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=66dbd928-0f1c-48b1-a832-54e4abd9f1db,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=66dbd928-0f1c-48b1-a832-54e4abd9f1db,66dbd928-0f1c-48b1-a832-54e4abd9f1db,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,NDA,215211,OPFOLDA,MIGLUSTAT,2023/10/06,Enzyme Stabilizer; Glucosylceramide Synthase Inhibitor,2003,AMICUS THERAPEUTICS US LLC,2023/10/11-,71904-300,ADN3S497AZ,MIGLUSTAT,MIGLUSTAT,ADN3S497AZ,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/d7c38298-37db-5a80-e053-2995a90aee40/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d7c38298-37db-5a80-e053-2995a90aee40,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=d7c38298-37db-5a80-e053-2995a90aee40,d7c38298-37db-5a80-e053-2995a90aee40,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,NDA,021348,Zavesca,MIGLUSTAT,2023/04/20,Enzyme Stabilizer; Glucosylceramide Synthase Inhibitor,2003,ACTELION PHARMACEUTICALS US INC,2003/07/31-,66215-201,ADN3S497AZ,MIGLUSTAT,MIGLUSTAT,ADN3S497AZ,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/817892d1-ee12-4632-85fc-57ccdf16d7b8/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=817892d1-ee12-4632-85fc-57ccdf16d7b8,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=817892d1-ee12-4632-85fc-57ccdf16d7b8,817892d1-ee12-4632-85fc-57ccdf16d7b8,,,
HUMAN PRESCRIPTION DRUG LABEL,"KIT; TABLET, FILM COATED",ORAL,NDA,022256,Savella,MILNACIPRAN HYDROCHLORIDE,2023/12/12,Serotonin and Norepinephrine Reuptake Inhibitor,2009,ALLERGAN INC,2009/04/17-,0456-1500; 0456-1510; 0456-1512; 0456-1525; 0456-1550,RNZ43O5WW5,MILNACIPRAN HYDROCHLORIDE; milnacipran hydrochloride,milnacipran,G56VK1HF36,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/16a4a314-f97e-4e91-95e9-576a3773d284/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=16a4a314-f97e-4e91-95e9-576a3773d284,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=16a4a314-f97e-4e91-95e9-576a3773d284,16a4a314-f97e-4e91-95e9-576a3773d284,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,NDA,204684,IMPAVIDO,MILTEFOSINE,2023/10/11,Antileishmanial,2014,PROFOUNDA INC,2015/10/29-,69051-300,53EY29W7EC,MILTEFOSINE,MILTEFOSINE,53EY29W7EC,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/bcb387ac-2e90-4f5e-94b2-d3635190678e/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=bcb387ac-2e90-4f5e-94b2-d3635190678e,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=bcb387ac-2e90-4f5e-94b2-d3635190678e,bcb387ac-2e90-4f5e-94b2-d3635190678e,,,
HUMAN PRESCRIPTION DRUG LABEL,"AEROSOL, FOAM",TOPICAL,NDA,213690,ZILXI,MINOCYCLINE,2024/02/09,Tetracycline-class Drug,1971,JOURNEY MEDICAL CORPORATION,2022/10/01-,69489-212,0020414E5U,MINOCYCLINE HYDROCHLORIDE,MINOCYCLINE,FYY3R43WGO,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/cbffa96e-2446-43cf-ba5e-38c645302afd/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=cbffa96e-2446-43cf-ba5e-38c645302afd,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=cbffa96e-2446-43cf-ba5e-38c645302afd,cbffa96e-2446-43cf-ba5e-38c645302afd,,,
HUMAN PRESCRIPTION DRUG LABEL,"AEROSOL, FOAM",TOPICAL,NDA,212379,AMZEEQ,MINOCYCLINE,2023/01/25,Tetracycline-class Drug,1971,JOURNEY MEDICAL CORPORATION,2022/03/25-,69489-201,0020414E5U,MINOCYCLINE HYDROCHLORIDE,MINOCYCLINE,FYY3R43WGO,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/cc251492-977b-4eb1-a088-a90831324bad/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=cc251492-977b-4eb1-a088-a90831324bad,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=cc251492-977b-4eb1-a088-a90831324bad,cc251492-977b-4eb1-a088-a90831324bad,,,
HUMAN PRESCRIPTION DRUG LABEL,"AEROSOL, FOAM",TOPICAL,NDA,213690,ZILXI,MINOCYCLINE,2022/09/13,Tetracycline-class Drug,1971,JOURNEY MEDICAL CORPORATION,2020/10/01-,72356-103,0020414E5U,MINOCYCLINE HYDROCHLORIDE,MINOCYCLINE,FYY3R43WGO,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/116f9ade-1bdc-4162-98d8-d3a0c592f419/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=116f9ade-1bdc-4162-98d8-d3a0c592f419,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=116f9ade-1bdc-4162-98d8-d3a0c592f419,116f9ade-1bdc-4162-98d8-d3a0c592f419,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRAVENOUS,NDA,050444,Minocin,MINOCYCLINE HYDROCHLORIDE,2021/07/28,Tetracycline-class Drug,,MELINTA THERAPEUTICS LLC,2013/04/19-,70842-160,0020414E5U,MINOCYCLINE HYDROCHLORIDE,MINOCYCLINE,FYY3R43WGO,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/e415c323-8219-464b-9e3e-72c5a796cdaa/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e415c323-8219-464b-9e3e-72c5a796cdaa,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=e415c323-8219-464b-9e3e-72c5a796cdaa,e415c323-8219-464b-9e3e-72c5a796cdaa,,,
HUMAN PRESCRIPTION DRUG LABEL,POWDER,ORAL,NDA,050781,Arestin,MINOCYCLINE HYDROCHLORIDE,2020/06/01,Tetracycline-class Drug,,ORAPHARMA INC,2011/03/21-,65976-100,0020414E5U,Minocycline Hydrochloride,Minocycline,FYY3R43WGO,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/8515df41-1936-4f3b-86ba-d2bb2a8441fb/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8515df41-1936-4f3b-86ba-d2bb2a8441fb,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=8515df41-1936-4f3b-86ba-d2bb2a8441fb,8515df41-1936-4f3b-86ba-d2bb2a8441fb,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,NDA,050808,Solodyn,MINOCYCLINE HYDROCHLORIDE,2017/09/12,Tetracycline-class Drug,1971,BAUSCH HEALTH US LLC,2009/07/23-; 2010/09/27-; completed:2006/05/08-2013/05/31; completed:2006/05/08-2014/02/28,99207-460; 99207-461; 99207-462; 99207-463; 99207-464; 99207-465; 99207-466; 99207-467,0020414E5U,minocycline hydrochloride,minocycline,FYY3R43WGO,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/1b9dfa57-f295-4038-8aec-8efc54817d07/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1b9dfa57-f295-4038-8aec-8efc54817d07,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=1b9dfa57-f295-4038-8aec-8efc54817d07,1b9dfa57-f295-4038-8aec-8efc54817d07,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",SUBCUTANEOUS,NDA,203568,Kynamro,MIPOMERSEN SODIUM,2017/01/17,Antisense Oligonucleotide; Apolipoprotein B-100 Synthesis Inhibitor,,KASTLE THERAPEUTICS LLC,2016/05/02-,70688-0502,18EAY4870E,MIPOMERSEN SODIUM,MIPOMERSEN,9GJ8S4GU0M,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/774c7847-490b-41d5-9e0e-2baedbc94f62/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=774c7847-490b-41d5-9e0e-2baedbc94f62,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=774c7847-490b-41d5-9e0e-2baedbc94f62,774c7847-490b-41d5-9e0e-2baedbc94f62,,,
HUMAN PRESCRIPTION DRUG LABEL,"GRANULE, FOR SUSPENSION, EXTENDED RELEASE; TABLET, FILM COATED, EXTENDED RELEASE",ORAL,NDA,202611;213801,Myrbetriq,MIRABEGRON,2022/07/13,beta3-Adrenergic Agonist,2012,ASTELLAS PHARMA US INC,2012/06/28-; 2021/03/25-,0469-2601; 0469-2602; 0469-5020,MVR3JL3B2V,MIRABEGRON,MIRABEGRON,MVR3JL3B2V,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/ba9e9e15-e666-4c56-9271-2e24739cfa2d/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ba9e9e15-e666-4c56-9271-2e24739cfa2d,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=ba9e9e15-e666-4c56-9271-2e24739cfa2d,ba9e9e15-e666-4c56-9271-2e24739cfa2d,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED; TABLET, ORALLY DISINTEGRATING",ORAL,NDA,020415;021208,REMERON; REMERONSOLTAB,MIRTAZAPINE,2024/03/04,,1996,ORGANON LLC,2021/06/01-,78206-156; 78206-158; 78206-159; 78206-160; 78206-161,A051Q2099Q,MIRTAZAPINE,MIRTAZAPINE,A051Q2099Q,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/98ad1917-a094-44f5-a28f-a64a8cfcd887/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=98ad1917-a094-44f5-a28f-a64a8cfcd887,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=98ad1917-a094-44f5-a28f-a64a8cfcd887,98ad1917-a094-44f5-a28f-a64a8cfcd887,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,019268,Cytotec,MISOPROSTOL,2021/07/09,Prostaglandin E1 Analog,,PFIZER LABORATORIES DIV PFIZER INC,1986/12/27-,0025-1451; 0025-1461,0E43V0BB57,MISOPROSTOL,MISOPROSTOL,0E43V0BB57,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/4ab12da7-5731-4e06-bf1c-bc3f2e711f12/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4ab12da7-5731-4e06-bf1c-bc3f2e711f12,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=4ab12da7-5731-4e06-bf1c-bc3f2e711f12,4ab12da7-5731-4e06-bf1c-bc3f2e711f12,,,
HUMAN PRESCRIPTION DRUG LABEL,"KIT; TABLET, FILM COATED",ORAL,NDA,216196,Pyrukynd,MITAPIVAT,2023/12/20,Pyruvate Kinase Activator,2022,AGIOS PHARMACEUTICALS INC,2022/02/18-,71334-205; 71334-210; 71334-215; 71334-220; 71334-225; 71334-230,2WTV10SIKH,MITAPIVAT,MITAPIVAT,2WTV10SIKH,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/4ccee896-e313-4c6c-9674-b4746ada0a90/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4ccee896-e313-4c6c-9674-b4746ada0a90,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=4ccee896-e313-4c6c-9674-b4746ada0a90,4ccee896-e313-4c6c-9674-b4746ada0a90,,,
HUMAN PRESCRIPTION DRUG LABEL,KIT,OPHTHALMIC,NDA,022572,Mitosol,MITOMYCIN,2022/12/15,Alkylating Drug,1974,MOBIUS THERAPEUTICS LLC,2012/02/08-,49771-002,50SG953SK6,Mitomycin,Mitomycin,50SG953SK6,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/244002c6-c61d-43fe-9326-072797113979/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=244002c6-c61d-43fe-9326-072797113979,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=244002c6-c61d-43fe-9326-072797113979,244002c6-c61d-43fe-9326-072797113979,,,
HUMAN PRESCRIPTION DRUG LABEL,KIT,URETERAL,NDA,211728,JELMYTO,MITOMYCIN,2022/10/05,Alkylating Drug,1974,UROGEN PHARMA INC,2020/05/01-,72493-103,50SG953SK6,Mitomycin,Mitomycin,50SG953SK6,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/3d3d5053-5427-4a68-a40b-edb60699521e/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3d3d5053-5427-4a68-a40b-edb60699521e,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=3d3d5053-5427-4a68-a40b-edb60699521e,3d3d5053-5427-4a68-a40b-edb60699521e,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,016885,Lysodren,MITOTANE,2024/02/23,,1970,HRA PHARMA RARE DISEASES,1978/10/15-,76336-080,78E4J5IB5J,mitotane,mitotane,78E4J5IB5J,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/f0cd76e9-460c-450e-b094-172e636f340a/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f0cd76e9-460c-450e-b094-172e636f340a,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=f0cd76e9-460c-450e-b094-172e636f340a,f0cd76e9-460c-450e-b094-172e636f340a,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,NDA,215310,EXKIVITY,MOBOCERTINIB,2023/09/15,Kinase Inhibitor,2021,TAKEDA PHARMACEUTICALS AMERICA INC,2021/09/15-,63020-040,39HBQ4A67L,Mobocertinib,Mobocertinib,39HBQ4A67L,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/f1a91500-a944-4cb8-b4a8-ae278bcf728d/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f1a91500-a944-4cb8-b4a8-ae278bcf728d,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=f1a91500-a944-4cb8-b4a8-ae278bcf728d,f1a91500-a944-4cb8-b4a8-ae278bcf728d,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,020717,Provigil,MODAFINIL,2022/12/31,Sympathomimetic-like Agent,1998,CEPHALON LLC,1999/02/15-,63459-101; 63459-201,R3UK8X3U3D,MODAFINIL,MODAFINIL,R3UK8X3U3D,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/e16c26ad-7bc2-d155-3a5d-da83ad6492c8/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e16c26ad-7bc2-d155-3a5d-da83ad6492c8,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=e16c26ad-7bc2-d155-3a5d-da83ad6492c8,e16c26ad-7bc2-d155-3a5d-da83ad6492c8,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,216873,Ojjaara,MOMELOTINIB,2023/09/15,,2023,GLAXOSMITHKLINE LLC,2023/09/15-,81864-101; 81864-102; 81864-103,LDX8893L5D,MOMELOTINIB DIHYDROCHLORIDE MONOHYDRATE,MOMELOTINIB,6O01GMS00P,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/4a672fd1-eb7b-4aa9-9b23-845e4b5dc400/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4a672fd1-eb7b-4aa9-9b23-845e4b5dc400,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=4a672fd1-eb7b-4aa9-9b23-845e4b5dc400,4a672fd1-eb7b-4aa9-9b23-845e4b5dc400,,,
HUMAN PRESCRIPTION DRUG LABEL,AEROSOL,INHALATION,NDA,205641,ASMANEX HFA,MOMETASONE FUROATE,2023/03/24,Corticosteroid,1987,ORGANON LLC,2021/06/01-,78206-111; 78206-112; 78206-113,04201GDN4R,MOMETASONE FUROATE,MOMETASONE,8HR4QJ6DW8,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/0c6d63da-41bc-4894-bead-198e66c848ac/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0c6d63da-41bc-4894-bead-198e66c848ac,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=0c6d63da-41bc-4894-bead-198e66c848ac,0c6d63da-41bc-4894-bead-198e66c848ac,,,
HUMAN PRESCRIPTION DRUG LABEL,IMPLANT,INTRASINAL,NDA,209310,Sinuva,MOMETASONE FUROATE,2023/01/26,Corticosteroid,1987,INTERSECT ENT INC,2018/02/01-,10599-003,04201GDN4R,MOMETASONE FUROATE,MOMETASONE,8HR4QJ6DW8,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/e33c1b23-cdc6-4f64-94ba-24b0b42c09bf/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e33c1b23-cdc6-4f64-94ba-24b0b42c09bf,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=e33c1b23-cdc6-4f64-94ba-24b0b42c09bf,e33c1b23-cdc6-4f64-94ba-24b0b42c09bf,,,
HUMAN PRESCRIPTION DRUG LABEL,INHALANT,INHALATION,NDA,021067,ASMANEX,MOMETASONE FUROATE,2022/11/14,Corticosteroid,1987,ORGANON LLC,2021/06/01-,78206-114; 78206-115,04201GDN4R,Mometasone Furoate,Mometasone,8HR4QJ6DW8,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/10b36fb2-6b0d-4f20-b197-3564d6f594b9/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=10b36fb2-6b0d-4f20-b197-3564d6f594b9,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=10b36fb2-6b0d-4f20-b197-3564d6f594b9,10b36fb2-6b0d-4f20-b197-3564d6f594b9,,,
HUMAN PRESCRIPTION DRUG LABEL,AEROSOL,INHALATION,NDA,022518,Dulera,MOMETASONE FUROATE AND FORMOTEROL FUMARATE DIHYDRATE,2023/03/24,Corticosteroid; beta2-Adrenergic Agonist,2010,ORGANON LLC,2021/06/01-,78206-125; 78206-126; 78206-127,04201GDN4R; W34SHF8J2K,formoterol fumarate; mometasone furoate,formoterol; mometasone,5ZZ84GCW8B; 8HR4QJ6DW8,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/8f399784-f257-4f31-b3dc-368bf2a1864d/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8f399784-f257-4f31-b3dc-368bf2a1864d,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=8f399784-f257-4f31-b3dc-368bf2a1864d,8f399784-f257-4f31-b3dc-368bf2a1864d,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRAVENOUS,NDA,212121,POTASSIUM PHOSPHATES,MONOBASIC POTASSIUM PHOSPHATE AND DIBASIC POTASSIUM PHOSPHATE,2019/12/27,,1983,CMP PHARMA INC,2019/09/19-,46287-024,4J9FJ0HL51; CI71S98N1Z,"POTASSIUM PHOSPHATE, DIBASIC; POTASSIUM PHOSPHATE, MONOBASIC",PHOSPHATE ION,NK08V8K8HR,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/2c2078d1-9edc-4d0c-a72a-5491c28a5aac/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2c2078d1-9edc-4d0c-a72a-5491c28a5aac,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=2c2078d1-9edc-4d0c-a72a-5491c28a5aac,2c2078d1-9edc-4d0c-a72a-5491c28a5aac,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,NDA,210296,BAFIERTAM,MONOMETHYL FUMARATE,2024/03/31,,2013,BANNER LIFE SCIENCES LLC,2020/04/28-,69387-001,45IUB1PX8R,monomethyl fumarate,monomethyl fumarate,45IUB1PX8R,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/a161f9d4-70f1-4097-957a-eafb35d3274f/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a161f9d4-70f1-4097-957a-eafb35d3274f,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=a161f9d4-70f1-4097-957a-eafb35d3274f,a161f9d4-70f1-4097-957a-eafb35d3274f,,,
HUMAN PRESCRIPTION DRUG LABEL,"GRANULE; TABLET, CHEWABLE; TABLET, FILM COATED",ORAL,NDA,020829;020830;021409,SINGULAIR,MONTELUKAST SODIUM,2023/11/20,Leukotriene Receptor Antagonist,1998,ORGANON LLC,2021/06/01-,78206-170; 78206-171; 78206-172; 78206-173,U1O3J18SFL,MONTELUKAST SODIUM,MONTELUKAST,MHM278SD3E,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/482dcc92-b47f-4ea6-854a-f5ac2aea7842/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=482dcc92-b47f-4ea6-854a-f5ac2aea7842,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=482dcc92-b47f-4ea6-854a-f5ac2aea7842,482dcc92-b47f-4ea6-854a-f5ac2aea7842,,,
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION,ORAL,NDA,022195,Morphine Sulfate,MORPHINE SULFATE,2024/11/15,Opioid Agonist,1941,HIKMA PHARMACEUTICALS USA INC,2008/03/17-; completed:2008/03/17-2021/10/31,0054-0237; 0054-0238; 0054-0404; 0054-0517,X3P646A2J0,MORPHINE SULFATE,MORPHINE,76I7G6D29C,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/ca359246-4674-4b32-b8b2-673d32b7112f/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ca359246-4674-4b32-b8b2-673d32b7112f,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=ca359246-4674-4b32-b8b2-673d32b7112f,ca359246-4674-4b32-b8b2-673d32b7112f,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",EPIDURAL; INTRATHECAL,NDA,018565,INFUMORPH 200; INFUMORPH 500,MORPHINE SULFATE,2024/04/10,Opioid Agonist,1941,HIKMA PHARMACEUTICALS USA INC,1984/09/18-,0641-6039; 0641-6040,X3P646A2J0,MORPHINE SULFATE,MORPHINE,76I7G6D29C,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/db9ac9e3-d761-4a99-9f34-4946ebe8f255/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=db9ac9e3-d761-4a99-9f34-4946ebe8f255,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=db9ac9e3-d761-4a99-9f34-4946ebe8f255,db9ac9e3-d761-4a99-9f34-4946ebe8f255,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,EPIDURAL; INTRATHECAL; INTRAVENOUS,NDA,018565,Duramorph,MORPHINE SULFATE,2024/04/09,Opioid Agonist,1941,HIKMA PHARMACEUTICALS USA INC,1984/09/18-,0641-6019; 0641-6020,X3P646A2J0,MORPHINE SULFATE,MORPHINE,76I7G6D29C,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/ebb18761-e5c4-4238-bb84-f9549f500210/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ebb18761-e5c4-4238-bb84-f9549f500210,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=ebb18761-e5c4-4238-bb84-f9549f500210,ebb18761-e5c4-4238-bb84-f9549f500210,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAMUSCULAR; INTRAVENOUS,NDA,204223,Morphine Sulfate,MORPHINE SULFATE,2024/01/01,Opioid Agonist,1941,FRESENIUS KABI USA LLC,2013/10/30-,76045-004; 76045-005; 76045-006; 76045-007; 76045-008,X3P646A2J0,Morphine Sulfate,Morphine,76I7G6D29C,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/1f53de80-efc8-4930-b3e3-fba0d026af05/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1f53de80-efc8-4930-b3e3-fba0d026af05,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=1f53de80-efc8-4930-b3e3-fba0d026af05,1f53de80-efc8-4930-b3e3-fba0d026af05,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,019516,MS Contin,MORPHINE SULFATE,2023/12/27,Opioid Agonist,1941,RHODES PHARMACEUTICALS L P,2017/05/15-,42858-515; 42858-631; 42858-760; 42858-799; 42858-900,X3P646A2J0,morphine sulfate,morphine,76I7G6D29C,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/c354b3bf-86c0-4bb8-8b1f-be2164942698/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c354b3bf-86c0-4bb8-8b1f-be2164942698,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=c354b3bf-86c0-4bb8-8b1f-be2164942698,c354b3bf-86c0-4bb8-8b1f-be2164942698,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,202515,Morphine Sulfate; Morphine sulfate,MORPHINE SULFATE,2023/12/26,Opioid Agonist,1941,HOSPIRA INC,2023/11/20-; completed:2023/11/20-2023/11/20,0409-1896; 0409-2022,X3P646A2J0,MORPHINE SULFATE,MORPHINE,76I7G6D29C,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/ee8057d1-ed12-4e18-9efa-d83504abf612/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ee8057d1-ed12-4e18-9efa-d83504abf612,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=ee8057d1-ed12-4e18-9efa-d83504abf612,ee8057d1-ed12-4e18-9efa-d83504abf612,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,202515,Morphine Sulfate,MORPHINE SULFATE,2023/12/26,Opioid Agonist,1941,HOSPIRA INC,2012/08/07-; 2012/08/20-; 2012/08/23-; 2012/09/24-; completed:2012/08/20-2015/09/01,0409-1890; 0409-1891; 0409-1892; 0409-1893; 0409-1894,X3P646A2J0,MORPHINE SULFATE,MORPHINE,76I7G6D29C,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/be420e8b-bcb0-49b5-bb4d-1df8b9959809/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=be420e8b-bcb0-49b5-bb4d-1df8b9959809,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=be420e8b-bcb0-49b5-bb4d-1df8b9959809,be420e8b-bcb0-49b5-bb4d-1df8b9959809,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,022207,Morphine Sulfate,MORPHINE SULFATE,2023/09/06,Opioid Agonist,1941,HIKMA PHARMACEUTICALS USA INC,2008/03/17-,0054-0235; 0054-0236,X3P646A2J0,MORPHINE SULFATE,MORPHINE,76I7G6D29C,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/3c847554-3b4b-4d24-a145-2ef7e9b83699/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3c847554-3b4b-4d24-a145-2ef7e9b83699,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=3c847554-3b4b-4d24-a145-2ef7e9b83699,3c847554-3b4b-4d24-a145-2ef7e9b83699,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAMUSCULAR; INTRAVENOUS,NDA,204223,Morphine Sulfate,MORPHINE SULFATE,2021/02/25,Opioid Agonist,1941,FRESENIUS KABI USA LLC,2013/10/30-,76045-004; 76045-005; 76045-006; 76045-007; 76045-008,X3P646A2J0,MORPHINE SULFATE,MORPHINE,76I7G6D29C,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/b62ee1ef-db55-417a-a02e-b103890f9c4b/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b62ee1ef-db55-417a-a02e-b103890f9c4b,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=b62ee1ef-db55-417a-a02e-b103890f9c4b,b62ee1ef-db55-417a-a02e-b103890f9c4b,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAMUSCULAR; INTRAVENOUS,NDA,204223,Morphine Sulfate,MORPHINE SULFATE,2020/01/29,Opioid Agonist,1941,FRESENIUS KABI USA LLC,2018/04/10-,63323-451; 63323-452; 63323-454; 63323-455; 63323-458,X3P646A2J0,MORPHINE SULFATE,MORPHINE,76I7G6D29C,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/582f42e5-444e-4246-af8c-e7e28097c69a/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=582f42e5-444e-4246-af8c-e7e28097c69a,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=582f42e5-444e-4246-af8c-e7e28097c69a,582f42e5-444e-4246-af8c-e7e28097c69a,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,NDA,019516,MS Contin,MORPHINE SULFATE,2017/03/23,Opioid Agonist,1941,PURDUE PHARMA LP,1987/07/01-,59011-260; 59011-261; 59011-262; 59011-263; 59011-264,X3P646A2J0,morphine sulfate,morphine,76I7G6D29C,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/e0472c35-3f44-42e2-9b75-37b2e9ff65f6/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e0472c35-3f44-42e2-9b75-37b2e9ff65f6,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=e0472c35-3f44-42e2-9b75-37b2e9ff65f6,e0472c35-3f44-42e2-9b75-37b2e9ff65f6,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",SUBCUTANEOUS,NDA,217159,Aphexda,MOTIXAFORTIDE,2023/09/04,,2023,BIOLINERX USA INC,2023/09/08-,82737-073,3ZPX60DV8A,MOTIXAFORTIDE ACETATE,MOTIXAFORTIDE,DA9G065962,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/f7cdc584-ebf0-a68e-e053-6294a90a9ea9/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f7cdc584-ebf0-a68e-e053-6294a90a9ea9,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=f7cdc584-ebf0-a68e-e053-6294a90a9ea9,f7cdc584-ebf0-a68e-e053-6294a90a9ea9,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,210867,Moxidectin,MOXIDECTIN,2024/05/02,,2018,MEDICINES DEVELOPMENT FOR GLOBAL HEALTH,2019/12/02-,71705-050,NGU5H31YO9,MOXIDECTIN,MOXIDECTIN,NGU5H31YO9,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/6eb02ae9-9065-176f-e053-2991aa0ac891/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6eb02ae9-9065-176f-e053-2991aa0ac891,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=6eb02ae9-9065-176f-e053-2991aa0ac891,6eb02ae9-9065-176f-e053-2991aa0ac891,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,205572,Moxifloxacin,MOXIFLOXACIN HYDROCHLORIDE,2024/05/06,Fluoroquinolone Antibacterial,1999,FRESENIUS KABI USA LLC,2015/03/18-,63323-850,C53598599T,MOXIFLOXACIN HYDROCHLORIDE,MOXIFLOXACIN,U188XYD42P,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/a4e28b09-714b-46e7-b4e6-0163cad78fc5/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a4e28b09-714b-46e7-b4e6-0163cad78fc5,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=a4e28b09-714b-46e7-b4e6-0163cad78fc5,a4e28b09-714b-46e7-b4e6-0163cad78fc5,,,
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION/ DROPS,OPHTHALMIC,NDA,021598,VIGAMOX,MOXIFLOXACIN HYDROCHLORIDE,2023/04/20,Fluoroquinolone Antibacterial,1999,NOVARTIS PHARMACEUTICALS CORPORATION,2003/05/07-,0078-0939,C53598599T,MOXIFLOXACIN HYDROCHLORIDE,MOXIFLOXACIN,U188XYD42P,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/ad783689-2b59-448c-b0d6-e8b70cf8b062/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ad783689-2b59-448c-b0d6-e8b70cf8b062,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=ad783689-2b59-448c-b0d6-e8b70cf8b062,ad783689-2b59-448c-b0d6-e8b70cf8b062,,,
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION,OPHTHALMIC,NDA,022428,MOXEZA,MOXIFLOXACIN HYDROCHLORIDE,2021/08/11,Fluoroquinolone Antibacterial,1999,ALCON LABORATORIES INC,2011/01/18-,0065-0006,C53598599T,MOXIFLOXACIN HYDROCHLORIDE,MOXIFLOXACIN,U188XYD42P,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/05248b68-16a9-488d-a39f-5137d2410471/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=05248b68-16a9-488d-a39f-5137d2410471,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=05248b68-16a9-488d-a39f-5137d2410471,05248b68-16a9-488d-a39f-5137d2410471,,,
HUMAN PRESCRIPTION DRUG LABEL,"CAPSULE; INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION; POWDER, FOR SUSPENSION; TABLET, FILM COATED",INTRAVENOUS; ORAL,NDA,050722;050723;050758;050759,CellCept,MYCOPHENOLATE MOFETIL; MYCOPHENOLATE MOFETIL HYDROCHLORIDE,2024/02/21,Antimetabolite Immunosuppressant,1995,GENENTECH INC,1995/05/03-; 1997/06/19-; 1998/08/12-; 1998/10/01-,0004-0259; 0004-0260; 0004-0261; 0004-0298,9242ECW6R0; UXH81S8ZVB,MYCOPHENOLATE MOFETIL; MYCOPHENOLATE MOFETIL HYDROCHLORIDE,MYCOPHENOLIC ACID,HU9DX48N0T,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/37241e87-4af4-4dc3-a1aa-ea6f20d8dc40/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=37241e87-4af4-4dc3-a1aa-ea6f20d8dc40,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=37241e87-4af4-4dc3-a1aa-ea6f20d8dc40,37241e87-4af4-4dc3-a1aa-ea6f20d8dc40,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, DELAYED RELEASE",ORAL,NDA,050791,Myfortic,MYCOPHENOLIC ACID,2023/08/08,Antimetabolite Immunosuppressant,2004,NOVARTIS PHARMACEUTICALS CORPORATION,2004/02/27-,0078-0385; 0078-0386,WX877SQI1G,MYCOPHENOLATE SODIUM,MYCOPHENOLIC ACID,HU9DX48N0T,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/eed26501-890d-4ff6-88e7-6dbea4726e53/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=eed26501-890d-4ff6-88e7-6dbea4726e53,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=eed26501-890d-4ff6-88e7-6dbea4726e53,eed26501-890d-4ff6-88e7-6dbea4726e53,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,NDA,018677,Cesamet,NABILONE,2021/01/19,Cannabinoid,,BAUSCH HEALTH US LLC,2020/03/09-,0187-1231,2N4O9L084N,NABILONE,NABILONE,2N4O9L084N,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/83c7ac15-ece9-47de-b83c-d575544fa449/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=83c7ac15-ece9-47de-b83c-d575544fa449,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=83c7ac15-ece9-47de-b83c-d575544fa449,83c7ac15-ece9-47de-b83c-d575544fa449,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,018063,Corgard,NADOLOL,2023/07/21,beta-Adrenergic Blocker,,USWM LLC,completed:2022/02/01-2024/09/30; completed:2022/02/01-2024/10/31,78670-100; 78670-101,FEN504330V,nadolol,nadolol,FEN504330V,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/c3c0fc03-7cca-4ac9-94b1-e3666470fe16/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c3c0fc03-7cca-4ac9-94b1-e3666470fe16,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=c3c0fc03-7cca-4ac9-94b1-e3666470fe16,c3c0fc03-7cca-4ac9-94b1-e3666470fe16,,,
HUMAN PRESCRIPTION DRUG LABEL,"SPRAY, METERED",NASAL,NDA,019886,Synarel,NAFARELIN ACETATE,2023/02/22,Gonadotropin Releasing Hormone Receptor Agonist,,PFIZER LABORATORIES DIV PFIZER INC,1990/02/13-,0025-0166,8ENZ0QJW4H,NAFARELIN ACETATE,NAFARELIN,1X0094V6JV,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/d0aa57cb-d2f4-46d7-af43-7c8b06aa81a6/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d0aa57cb-d2f4-46d7-af43-7c8b06aa81a6,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=d0aa57cb-d2f4-46d7-af43-7c8b06aa81a6,d0aa57cb-d2f4-46d7-af43-7c8b06aa81a6,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,050655,NAFCILLIN,NAFCILLIN,2018/09/21,Penicillin-class Antibacterial,,BAXTER HEALTHCARE CORPORATION,1989/10/31-,0338-1017; 0338-1019,49G3001BCK,NAFCILLIN SODIUM,NAFCILLIN,4CNZ27M7RV,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/cd2d18c5-95a2-4fb4-bd8b-b5d39e2da416/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=cd2d18c5-95a2-4fb4-bd8b-b5d39e2da416,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=cd2d18c5-95a2-4fb4-bd8b-b5d39e2da416,cd2d18c5-95a2-4fb4-bd8b-b5d39e2da416,,,
HUMAN PRESCRIPTION DRUG LABEL,GEL,TOPICAL,NDA,204286,Naftin,NAFTIFINE HYDROCHLORIDE,2023/12/12,Allylamine Antifungal,1988,SEBELA PHARMACEUTICALS INC,2018/03/01-,54766-772,25UR9N9041,NAFTIFINE HYDROCHLORIDE,NAFTIFINE,4FB1TON47A,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/6645994a-ecb3-277b-e053-2a91aa0a81e5/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6645994a-ecb3-277b-e053-2a91aa0a81e5,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=6645994a-ecb3-277b-e053-2a91aa0a81e5,6645994a-ecb3-277b-e053-2a91aa0a81e5,,,
HUMAN PRESCRIPTION DRUG LABEL,GEL,TOPICAL,NDA,019356,Naftin,NAFTIFINE HYDROCHLORIDE,2018/12/21,Allylamine Antifungal,,SEBELA PHARMACEUTICALS INC,2018/01/22-,54766-770,25UR9N9041,NAFTIFINE HYDROCHLORIDE,NAFTIFINE,4FB1TON47A,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/6371fceb-b98e-86a5-e053-2a91aa0a3d9e/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6371fceb-b98e-86a5-e053-2a91aa0a3d9e,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=6371fceb-b98e-86a5-e053-2a91aa0a3d9e,6371fceb-b98e-86a5-e053-2a91aa0a3d9e,,,
HUMAN PRESCRIPTION DRUG LABEL,CREAM,TOPICAL,NDA,019599,Naftin,NAFTIFINE HYDROCHLORIDE,2013/04/25,Allylamine Antifungal,,MERZ PHARMACEUTICALS LLC,1998/06/01-,0259-4126,25UR9N9041,NAFTIFINE HYDROCHLORIDE,NAFTIFINE,4FB1TON47A,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/f4b6c5d8-615c-47d6-8ad9-523c7ab146af/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f4b6c5d8-615c-47d6-8ad9-523c7ab146af,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=f4b6c5d8-615c-47d6-8ad9-523c7ab146af,f4b6c5d8-615c-47d6-8ad9-523c7ab146af,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,208854,SYMPROIC,NALDEMEDINE,2022/12/23,Opioid Antagonist,2017,BIODELIVERY SCIENCES INTERNATIONAL INC,2019/06/14-,59385-041,V1N8F1RVVO,naldemedine tosylate,naldemedine,03KSI6WLXH,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/b1a1256c-a1eb-4abe-ab1e-30e4711afd16/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b1a1256c-a1eb-4abe-ab1e-30e4711afd16,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=b1a1256c-a1eb-4abe-ab1e-30e4711afd16,b1a1256c-a1eb-4abe-ab1e-30e4711afd16,,,
HUMAN PRESCRIPTION DRUG LABEL,SPRAY,NASAL,NDA,217470,OPVEE,NALMEFENE HYDROCHLORIDE,2023/11/20,Opioid Antagonist,1995,INDIVIOR INC,2023/10/02-,12496-0003,K7K69QC05X,nalmefene hydrochloride,nalmefene,TOV02TDP9I,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/999a4269-9e54-4801-b2ac-2a7276f0b94f/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=999a4269-9e54-4801-b2ac-2a7276f0b94f,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=999a4269-9e54-4801-b2ac-2a7276f0b94f,999a4269-9e54-4801-b2ac-2a7276f0b94f,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,204760,MOVANTIK,NALOXEGOL OXALATE,2023/12/28,Opioid Antagonist,2014,REDHILL BIOPHARMA LTD,2020/10/01-,57841-1300; 57841-1301,65I14TNM33,NALOXEGOL OXALATE,NALOXEGOL,44T7335BKE,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/300a6474-ebcd-4404-8040-48fdcfcc1635/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=300a6474-ebcd-4404-8040-48fdcfcc1635,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=300a6474-ebcd-4404-8040-48fdcfcc1635,300a6474-ebcd-4404-8040-48fdcfcc1635,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,204760,MOVANTIK,NALOXEGOL OXALATE,2023/03/28,Opioid Antagonist,2014,VALINOR PHARMA LLC,2023/03/28-,82625-8801; 82625-8802,65I14TNM33,NALOXEGOL OXALATE,NALOXEGOL,44T7335BKE,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/28596788-b73f-4247-85fc-3105f51fff5a/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=28596788-b73f-4247-85fc-3105f51fff5a,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=28596788-b73f-4247-85fc-3105f51fff5a,28596788-b73f-4247-85fc-3105f51fff5a,,,
HUMAN PRESCRIPTION DRUG LABEL,SPRAY,NASAL,NDA,212045,KLOXXADO,NALOXONE HCL,2022/05/10,Opioid Antagonist,1971,HIKMA SPECIALTY USA INC,2021/08/03-,59467-679,F850569PQR,NALOXONE HYDROCHLORIDE,NALOXONE,36B82AMQ7N,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/ebf0f833-c1c0-487c-8f29-01fa8c61b6cb/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ebf0f833-c1c0-487c-8f29-01fa8c61b6cb,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=ebf0f833-c1c0-487c-8f29-01fa8c61b6cb,ebf0f833-c1c0-487c-8f29-01fa8c61b6cb,,,
HUMAN PRESCRIPTION DRUG LABEL,SPRAY,NASAL,NDA,208969,REXTOVY,NALOXONE HYDROCHLORIDE,2024/05/02,Opioid Antagonist,1971,INTERNATIONAL MEDICATION SYSTEMS LTD,2024/05/02-,76329-3669,F850569PQR,NALOXONE HYDROCHLORIDE,NALOXONE,36B82AMQ7N,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/fe9735db-c57e-44a8-bffb-b87a84c2a6f3/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=fe9735db-c57e-44a8-bffb-b87a84c2a6f3,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=fe9735db-c57e-44a8-bffb-b87a84c2a6f3,fe9735db-c57e-44a8-bffb-b87a84c2a6f3,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAMUSCULAR; SUBCUTANEOUS,NDA,212854,Zimhi,NALOXONE HYDROCHLORIDE,2022/09/29,Opioid Antagonist,1971,USWM LLC,2022/03/31-,78670-140,F850569PQR,NALOXONE HYDROCHLORIDE,NALOXONE,36B82AMQ7N,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/52e49022-9172-4da3-ba83-5995cacca9fb/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=52e49022-9172-4da3-ba83-5995cacca9fb,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=52e49022-9172-4da3-ba83-5995cacca9fb,52e49022-9172-4da3-ba83-5995cacca9fb,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAMUSCULAR; SUBCUTANEOUS,NDA,215457,"Naloxone Hydrochloride Injection, USP, Auto-Injector",NALOXONE HYDROCHLORIDE,2022/03/11,Opioid Antagonist,1971,KALEO INC,2022/02/28-,60842-002,F850569PQR,NALOXONE HYDROCHLORIDE,NALOXONE,36B82AMQ7N,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/b5463553-b775-47a3-8d10-31e01ca1ec72/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b5463553-b775-47a3-8d10-31e01ca1ec72,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=b5463553-b775-47a3-8d10-31e01ca1ec72,b5463553-b775-47a3-8d10-31e01ca1ec72,,,
HUMAN PRESCRIPTION DRUG LABEL,SPRAY,NASAL,NDA,208411,Narcan,NALOXONE HYDROCHLORIDE,2020/11/01,Opioid Antagonist,1971,EMERGENT DEVICES INC,2017/01/24-,69547-212; 69547-353,F850569PQR,NALOXONE HYDROCHLORIDE,NALOXONE,36B82AMQ7N,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/724df050-5332-4d0a-9a5f-17bf08a547e1/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=724df050-5332-4d0a-9a5f-17bf08a547e1,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=724df050-5332-4d0a-9a5f-17bf08a547e1,724df050-5332-4d0a-9a5f-17bf08a547e1,,,
HUMAN PRESCRIPTION DRUG LABEL,KIT,INTRAMUSCULAR,NDA,021897,VIVITROL,NALTREXONE,2022/09/30,Opioid Antagonist,1984,ALKERMES INC,2006/06/13-,65757-300; 65757-301,5S6W795CQM,naltrexone,naltrexone,5S6W795CQM,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/cd11c435-b0f0-4bb9-ae78-60f101f3703f/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=cd11c435-b0f0-4bb9-ae78-60f101f3703f,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=cd11c435-b0f0-4bb9-ae78-60f101f3703f,cd11c435-b0f0-4bb9-ae78-60f101f3703f,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, EXTENDED RELEASE",ORAL,NDA,200063,Contrave Extended-Release,NALTREXONE HYDROCHLORIDE AND BUPROPION HYDROCHLORIDE,2023/11/30,Aminoketone; Opioid Antagonist,2014,NALPROPION PHARMACEUTICALS LLC,2014/10/22-,51267-890,Z6375YW9SF; ZG7E5POY8O,BUPROPION HYDROCHLORIDE; NALTREXONE HYDROCHLORIDE,BUPROPION; NALTREXONE,01ZG3TPX31; 5S6W795CQM,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/485ff360-32c8-11df-928b-0002a5d5c51b/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=485ff360-32c8-11df-928b-0002a5d5c51b,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=485ff360-32c8-11df-928b-0002a5d5c51b,485ff360-32c8-11df-928b-0002a5d5c51b,,,
HUMAN PRESCRIPTION DRUG LABEL,SUSPENSION,ORAL,NDA,018965,Naprosyn,NAPROXEN,2021/04/30,Nonsteroidal Anti-inflammatory Drug,1976,ATHENA BIOSCIENCE LLC,2018/01/01-,71511-701,57Y76R9ATQ,NAPROXEN,NAPROXEN,57Y76R9ATQ,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/f9b4173d-7836-4d7d-b149-1d96f9377ad0/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f9b4173d-7836-4d7d-b149-1d96f9377ad0,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=f9b4173d-7836-4d7d-b149-1d96f9377ad0,f9b4173d-7836-4d7d-b149-1d96f9377ad0,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, DELAYED RELEASE",ORAL,NDA,022511,Vimovo,NAPROXEN AND ESOMEPRAZOLE MAGNESIUM,2023/07/25,Nonsteroidal Anti-inflammatory Drug; Proton Pump Inhibitor,2010,HORIZON THERAPEUTICS USA INC,2010/07/06-,75987-030; 75987-031,57Y76R9ATQ; R6DXU4WAY9,Esomeprazole Magnesium; Naproxen,Esomeprazole; Naproxen,57Y76R9ATQ; N3PA6559FT,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/baa47781-7151-4c75-a9a2-d2eac0a7d55e/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=baa47781-7151-4c75-a9a2-d2eac0a7d55e,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=baa47781-7151-4c75-a9a2-d2eac0a7d55e,baa47781-7151-4c75-a9a2-d2eac0a7d55e,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,NDA,020353,Naprelan,NAPROXEN SODIUM,2023/04/01,Nonsteroidal Anti-inflammatory Drug,1976,ALMATICA PHARMA INC,2014/01/17-,52427-272; 52427-273; 52427-274,9TN87S3A3C,NAPROXEN SODIUM,NAPROXEN,57Y76R9ATQ,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/e633ff0b-eab7-f167-8d08-e9236e54042b/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e633ff0b-eab7-f167-8d08-e9236e54042b,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=e633ff0b-eab7-f167-8d08-e9236e54042b,e633ff0b-eab7-f167-8d08-e9236e54042b,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,NDA,020353,Naprelan,NAPROXEN SODIUM,2013/08/22,Nonsteroidal Anti-inflammatory Drug,,SHIONOGI INC,1996/04/01-,59630-375; 59630-777; 59630-850,9TN87S3A3C,NAPROXEN SODIUM,NAPROXEN,57Y76R9ATQ,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/15ab6690-53bf-4669-950f-35db4dba8fac/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=15ab6690-53bf-4669-950f-35db4dba8fac,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=15ab6690-53bf-4669-950f-35db4dba8fac,15ab6690-53bf-4669-950f-35db4dba8fac,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET; TABLET, DELAYED RELEASE",ORAL,NDA,017581;018164;020067,EC-NAPROXEN; NAPROXEN; NAPROXEN SODIUM DS,NAPROXEN; NAPROXEN SODIUM,2024/04/13,Nonsteroidal Anti-inflammatory Drug,1976,WOODWARD PHARMA SERVICES LLC,2018/10/15-,69784-500; 69784-501; 69784-505; 69784-550,57Y76R9ATQ; 9TN87S3A3C,NAPROXEN; NAPROXEN SODIUM,NAPROXEN,57Y76R9ATQ,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/0728935b-19fc-4a10-aeba-29c42ce7f472/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0728935b-19fc-4a10-aeba-29c42ce7f472,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=0728935b-19fc-4a10-aeba-29c42ce7f472,0728935b-19fc-4a10-aeba-29c42ce7f472,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET; TABLET, DELAYED RELEASE",ORAL,NDA,017581;018164;020067,Anaprox DS; EC-Naprosyn; Naprosyn,NAPROXEN; NAPROXEN SODIUM,2021/04/30,Nonsteroidal Anti-inflammatory Drug,1976,CANTON LABORATORIES,2016/06/01-,69437-203; 69437-316; 69437-415; 69437-416,57Y76R9ATQ; 9TN87S3A3C,NAPROXEN; NAPROXEN SODIUM,NAPROXEN,57Y76R9ATQ,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/8bff5df5-d856-4237-b6a8-ae445b454844/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8bff5df5-d856-4237-b6a8-ae445b454844,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=8bff5df5-d856-4237-b6a8-ae445b454844,8bff5df5-d856-4237-b6a8-ae445b454844,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET; TABLET, DELAYED RELEASE",ORAL,NDA,017581;018164;020067,EC-NAPROXEN; NAPROXEN; NAPROXEN SODIUM; NAPROXEN SODIUM DS,NAPROXEN; NAPROXEN SODIUM,2016/08/11,Nonsteroidal Anti-inflammatory Drug,,CAMERON PHARMACEUTICALS LLC,2016/07/10-,42494-400; 42494-402; 42494-403; 42494-404; 42494-405; 42494-407; 42494-408,57Y76R9ATQ; 9TN87S3A3C,NAPROXEN; NAPROXEN SODIUM; naproxen,NAPROXEN; naproxen,57Y76R9ATQ,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/b86b31e9-1726-414a-877e-50079c017339/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b86b31e9-1726-414a-877e-50079c017339,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=b86b31e9-1726-414a-877e-50079c017339,b86b31e9-1726-414a-877e-50079c017339,,,
HUMAN PRESCRIPTION DRUG LABEL,SUSPENSION/ DROPS,OPHTHALMIC,NDA,050514,NATACYN,NATAMYCIN,2023/10/09,Polyene Antimicrobial,,EYEVANCE PHARMACEUTICALS LLC,2021/06/12-,71776-005,8O0C852CPO,NATAMYCIN,NATAMYCIN,8O0C852CPO,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/2818fcb8-5bac-41fb-864e-3b598308a428/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2818fcb8-5bac-41fb-864e-3b598308a428,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=2818fcb8-5bac-41fb-864e-3b598308a428,2818fcb8-5bac-41fb-864e-3b598308a428,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,021742,Bystolic,NEBIVOLOL HYDROCHLORIDE,2023/06/16,beta-Adrenergic Blocker,2007,ALLERGAN INC,2008/01/22-,0456-1402; 0456-1405; 0456-1410; 0456-1420,JGS34J7L9I,nebivolol hydrochloride,nebivolol,030Y90569U,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/8b8ad213-1dc8-454e-a524-075685c0e1a8/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8b8ad213-1dc8-454e-a524-075685c0e1a8,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=8b8ad213-1dc8-454e-a524-075685c0e1a8,8b8ad213-1dc8-454e-a524-075685c0e1a8,,,
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION/ DROPS,OPHTHALMIC,NDA,021009,ALOCRIL,NEDOCROMIL SODIUM,2018/06/01,Mast Cell Stabilizer,,ALLERGAN INC,2000/02/03-,0023-8842,ET8IF4KS1T,NEDOCROMIL SODIUM,NEDOCROMIL,0B535E0BN0,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/2fe8d7ad-2158-4169-94b0-719ad20242b7/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2fe8d7ad-2158-4169-94b0-719ad20242b7,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=2fe8d7ad-2158-4169-94b0-719ad20242b7,2fe8d7ad-2158-4169-94b0-719ad20242b7,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",SUBCUTANEOUS,NDA,215842,RIVFLOZA,NEDOSIRAN,2023/09/29,,2023,NOVO NORDISK,2024/02/19-,0169-5306; 0169-5307; 0169-5308,EGR9KYM536,NEDOSIRAN SODIUM,NEDOSIRAN,13U9R5J3WL,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/ace9d4bc-4d20-4beb-9e9d-888690424833/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ace9d4bc-4d20-4beb-9e9d-888690424833,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=ace9d4bc-4d20-4beb-9e9d-888690424833,ace9d4bc-4d20-4beb-9e9d-888690424833,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRAVENOUS,NDA,021877,Arranon,NELARABINE,2022/09/08,Nucleoside Metabolic Inhibitor,2005,NOVARTIS PHARMACEUTICALS CORPORATION,2016/10/05-,0078-0683,60158CV180,NELARABINE,NELARABINE,60158CV180,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/fffa5d75-0dba-4ad7-a252-5f60fa28489a/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=fffa5d75-0dba-4ad7-a252-5f60fa28489a,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=fffa5d75-0dba-4ad7-a252-5f60fa28489a,fffa5d75-0dba-4ad7-a252-5f60fa28489a,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,020779;021503,VIRACEPT,NELFINAVIR MESYLATE,2024/03/22,Protease Inhibitor,1997,AGOURON,1997/03/14-; 2003/04/30-,63010-010; 63010-027,98D603VP8V,NELFINAVIR MESYLATE,NELFINAVIR,HO3OGH5D7I,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/e72c2bc6-9462-4a2e-8e1d-b97592376cbd/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e72c2bc6-9462-4a2e-8e1d-b97592376cbd,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=e72c2bc6-9462-4a2e-8e1d-b97592376cbd,e72c2bc6-9462-4a2e-8e1d-b97592376cbd,,,
HUMAN PRESCRIPTION DRUG LABEL,SUSPENSION,AURICULAR (OTIC),NDA,060613,CASPORYN HC,NEOMYCIN AND POLYMYXIN B SULFATES AND HYDROCORTISONE OTIC,2022/10/13,Aminoglycoside Antibacterial; Corticosteroid; Polymyxin-class Antibacterial,,CASPER PHARMA LLC,2019/03/15-,70199-011,057Y626693; 19371312D4; WI4X0X7BPJ,HYDROCORTISONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE,HYDROCORTISONE; NEOMYCIN; POLYMYXIN B,I16QD7X297; J2VZ07J96K; WI4X0X7BPJ,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/14bb3363-1b52-4596-afcc-47457b064217/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=14bb3363-1b52-4596-afcc-47457b064217,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=14bb3363-1b52-4596-afcc-47457b064217,14bb3363-1b52-4596-afcc-47457b064217,,,
HUMAN PRESCRIPTION DRUG LABEL,OINTMENT,OPHTHALMIC,NDA,050417,"Neomycin and Polymyxin B sulfates, Bacitracin zinc","NEOMYCIN AND POLYMYXIN B SULFATES, BACITRACIN ZINC",2017/04/05,Aminoglycoside Antibacterial; Polymyxin-class Antibacterial,,CASPER PHARMA LLC,2017/04/07-,70199-010,057Y626693; 19371312D4; 89Y4M234ES,BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE,BACITRACIN; NEOMYCIN; POLYMYXIN B,58H6RWO52I; I16QD7X297; J2VZ07J96K,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/27b51a77-a690-42ca-ad60-6f657202a198/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=27b51a77-a690-42ca-ad60-6f657202a198,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=27b51a77-a690-42ca-ad60-6f657202a198,27b51a77-a690-42ca-ad60-6f657202a198,,,
HUMAN PRESCRIPTION DRUG LABEL,SUSPENSION,OPHTHALMIC,NDA,050023,Maxitrol,"NEOMYCIN SULFATE, POLYMYXIN B SULFATE AND DEXAMETHASONE",2023/12/13,Aminoglycoside Antibacterial; Corticosteroid; Polymyxin-class Antibacterial,,HARROW EYE LLC,1964/11/15-,82667-100,057Y626693; 19371312D4; 7S5I7G3JQL,DEXAMETHASONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE,DEXAMETHASONE; NEOMYCIN; POLYMYXIN B,7S5I7G3JQL; I16QD7X297; J2VZ07J96K,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/ecfb954f-5554-0ad2-e053-2995a90a7516/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ecfb954f-5554-0ad2-e053-2995a90a7516,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=ecfb954f-5554-0ad2-e053-2995a90a7516,ecfb954f-5554-0ad2-e053-2995a90a7516,,,
HUMAN PRESCRIPTION DRUG LABEL,SUSPENSION,OPHTHALMIC,NDA,050023,Maxitrol,"NEOMYCIN SULFATE, POLYMYXIN B SULFATE AND DEXAMETHASONE",2023/11/21,Aminoglycoside Antibacterial; Corticosteroid; Polymyxin-class Antibacterial,,NOVARTIS PHARMACEUTICALS CORPORATION,completed:1964/11/15-2024/10/31,0078-0792,057Y626693; 19371312D4; 7S5I7G3JQL,DEXAMETHASONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE,DEXAMETHASONE; NEOMYCIN; POLYMYXIN B,7S5I7G3JQL; I16QD7X297; J2VZ07J96K,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/ed267dad-a3d5-f4e9-e053-2a95a90a6143/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ed267dad-a3d5-f4e9-e053-2a95a90a6143,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=ed267dad-a3d5-f4e9-e053-2a95a90a6143,ed267dad-a3d5-f4e9-e053-2a95a90a6143,,,
HUMAN PRESCRIPTION DRUG LABEL,OINTMENT,OPHTHALMIC,NDA,050065,MAXITROL,"NEOMYCIN SULFATE, POLYMYXIN B SULFATE AND DEXAMETHASONE",2023/06/27,Aminoglycoside Antibacterial; Corticosteroid; Polymyxin-class Antibacterial,,NOVARTIS PHARMACEUTICALS CORPORATION,1972/01/17-,0078-0771,057Y626693; 19371312D4; 7S5I7G3JQL,DEXAMETHASONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE,DEXAMETHASONE; NEOMYCIN; POLYMYXIN B,7S5I7G3JQL; I16QD7X297; J2VZ07J96K,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/22c6d2db-85af-4a3b-a014-80d901a86717/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=22c6d2db-85af-4a3b-a014-80d901a86717,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=22c6d2db-85af-4a3b-a014-80d901a86717,22c6d2db-85af-4a3b-a014-80d901a86717,,,
HUMAN PRESCRIPTION DRUG LABEL,OINTMENT,OPHTHALMIC,NDA,050065,MAXITROL,"NEOMYCIN SULFATE, POLYMYXIN B SULFATE AND DEXAMETHASONE",2020/10/28,Aminoglycoside Antibacterial; Corticosteroid; Polymyxin-class Antibacterial,,ALCON LABORATORIES INC,completed:1972/01/17-2024/05/31,0065-0631,057Y626693; 19371312D4; 7S5I7G3JQL,DEXAMETHASONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE,DEXAMETHASONE; NEOMYCIN; POLYMYXIN B,7S5I7G3JQL; I16QD7X297; J2VZ07J96K,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/d17cecdb-c7cb-41cc-a11e-00c6ed0dcc11/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d17cecdb-c7cb-41cc-a11e-00c6ed0dcc11,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=d17cecdb-c7cb-41cc-a11e-00c6ed0dcc11,d17cecdb-c7cb-41cc-a11e-00c6ed0dcc11,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,203629,Neostigmine Methylsulfate,NEOSTIGMINE METHYLSULFATE,2024/01/22,Cholinesterase Inhibitor,1939,FRESENIUS KABI USA LLC,2015/01/08-,65219-811,98IMH7M386,NEOSTIGMINE METHYLSULFATE,NEOSTIGMINE,3982TWQ96G,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/088f96eb-20b8-48f8-ac83-329f75a44ce1/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=088f96eb-20b8-48f8-ac83-329f75a44ce1,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=088f96eb-20b8-48f8-ac83-329f75a44ce1,088f96eb-20b8-48f8-ac83-329f75a44ce1,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,203629,Neostigmine Methylsulfate,NEOSTIGMINE METHYLSULFATE,2024/01/01,Cholinesterase Inhibitor,1939,FRESENIUS KABI USA LLC,2018/09/18-,76045-214; 76045-383,98IMH7M386,NEOSTIGMINE METHYLSULFATE,NEOSTIGMINE,3982TWQ96G,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/b0b509c3-8dc8-48cc-b7a8-16b93ad706c6/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b0b509c3-8dc8-48cc-b7a8-16b93ad706c6,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=b0b509c3-8dc8-48cc-b7a8-16b93ad706c6,b0b509c3-8dc8-48cc-b7a8-16b93ad706c6,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRAVENOUS,NDA,204078,Bloxiverz,NEOSTIGMINE METHYLSULFATE,2023/12/31,Cholinesterase Inhibitor,1939,EXELA PHARMA SCIENCES LLC,2013/07/24-; 2023/11/06-,51754-1200; 51754-1210; 51754-1220,98IMH7M386,NEOSTIGMINE METHYLSULFATE,NEOSTIGMINE,3982TWQ96G,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/d2f55643-2b0d-4ef9-a9d8-b7138b314372/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d2f55643-2b0d-4ef9-a9d8-b7138b314372,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=d2f55643-2b0d-4ef9-a9d8-b7138b314372,d2f55643-2b0d-4ef9-a9d8-b7138b314372,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,203629,Neostigmine Methylsulfate,NEOSTIGMINE METHYLSULFATE,2022/12/13,Cholinesterase Inhibitor,1939,FRESENIUS KABI USA LLC,2015/01/08-,63323-413; 63323-415,98IMH7M386,NEOSTIGMINE METHYLSULFATE,NEOSTIGMINE,3982TWQ96G,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/6448229c-e650-47ba-bb00-cba3604502c5/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6448229c-e650-47ba-bb00-cba3604502c5,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=6448229c-e650-47ba-bb00-cba3604502c5,6448229c-e650-47ba-bb00-cba3604502c5,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRAVENOUS,NDA,204078,Bloxiverz,NEOSTIGMINE METHYLSULFATE,2021/03/03,Cholinesterase Inhibitor,1939,EXELA PHARMA SCIENCES LLC,2021/03/03-,51754-1240,98IMH7M386,NEOSTIGMINE METHYLSULFATE,NEOSTIGMINE,3982TWQ96G,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/761d8917-27da-4a0c-9acc-98688cbc1d46/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=761d8917-27da-4a0c-9acc-98688cbc1d46,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=761d8917-27da-4a0c-9acc-98688cbc1d46,761d8917-27da-4a0c-9acc-98688cbc1d46,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRAVENOUS,NDA,204078,Bloxiverz,NEOSTIGMINE METHYLSULFATE,2021/03/03,Cholinesterase Inhibitor,1939,EXELA PHARMA SCIENCES LLC,2021/03/03-,51754-1240,98IMH7M386,NEOSTIGMINE METHYLSULFATE,NEOSTIGMINE,3982TWQ96G,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/1fb5c812-1e63-4bd9-a68e-7f9dc5e7a33a/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1fb5c812-1e63-4bd9-a68e-7f9dc5e7a33a,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=1fb5c812-1e63-4bd9-a68e-7f9dc5e7a33a,1fb5c812-1e63-4bd9-a68e-7f9dc5e7a33a,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,203629,Neostigmine Methylsulfate,NEOSTIGMINE METHYLSULFATE,2019/10/11,Cholinesterase Inhibitor,1939,FRESENIUS KABI USA LLC,2015/01/08-,63323-413; 63323-415,98IMH7M386,NEOSTIGMINE METHYLSULFATE,NEOSTIGMINE,3982TWQ96G,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/d0e11e4c-41c3-4874-b567-579db655fba3/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d0e11e4c-41c3-4874-b567-579db655fba3,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=d0e11e4c-41c3-4874-b567-579db655fba3,d0e11e4c-41c3-4874-b567-579db655fba3,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRAVENOUS,NDA,216903,PREVDUO,NEOSTIGMINE METHYLSULFATE AND GLYCOPYRROLATE,2023/02/23,Anticholinergic; Cholinergic Muscarinic Antagonist; Cholinesterase Inhibitor,2023,PAR PHARMACEUTICAL INC,2023/05/15-,42023-269,98IMH7M386; V92SO9WP2I,GLYCOPYRROLATE; NEOSTIGMINE METHYLSULFATE,GLYCOPYRRONIUM; NEOSTIGMINE,3982TWQ96G; A14FB57V1D,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/dd8ad38f-247b-4948-a13c-8f3a4921b4f1/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=dd8ad38f-247b-4948-a13c-8f3a4921b4f1,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=dd8ad38f-247b-4948-a13c-8f3a4921b4f1,dd8ad38f-247b-4948-a13c-8f3a4921b4f1,,,
HUMAN PRESCRIPTION DRUG LABEL,SUSPENSION/ DROPS,OPHTHALMIC,NDA,203491,ILEVRO,NEPAFENAC,2024/02/23,Nonsteroidal Anti-inflammatory Drug,2005,HARROW EYE LLC,2024/05/01-,82667-400,0J9L7J6V8C,NEPAFENAC,NEPAFENAC,0J9L7J6V8C,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/10f411d3-a81e-074a-e063-6294a90ab547/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=10f411d3-a81e-074a-e063-6294a90ab547,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=10f411d3-a81e-074a-e063-6294a90ab547,10f411d3-a81e-074a-e063-6294a90ab547,,,
HUMAN PRESCRIPTION DRUG LABEL,SUSPENSION/ DROPS,OPHTHALMIC,NDA,203491,ILEVRO,NEPAFENAC,2023/04/20,Nonsteroidal Anti-inflammatory Drug,2005,NOVARTIS PHARMACEUTICALS CORPORATION,2012/12/20-,0078-0743,0J9L7J6V8C,Nepafenac,Nepafenac,0J9L7J6V8C,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/f089b583-0310-4ca8-8d41-52b06b08d1ed/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f089b583-0310-4ca8-8d41-52b06b08d1ed,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=f089b583-0310-4ca8-8d41-52b06b08d1ed,f089b583-0310-4ca8-8d41-52b06b08d1ed,,,
HUMAN PRESCRIPTION DRUG LABEL,SUSPENSION/ DROPS,OPHTHALMIC,NDA,021862,NEVANAC,NEPAFENAC,2023/04/19,Nonsteroidal Anti-inflammatory Drug,2005,NOVARTIS PHARMACEUTICALS CORPORATION,2005/09/06-,0078-0778,0J9L7J6V8C,NEPAFENAC,NEPAFENAC,0J9L7J6V8C,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/a2909252-c5f1-421f-9073-b7be90b45b51/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a2909252-c5f1-421f-9073-b7be90b45b51,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=a2909252-c5f1-421f-9073-b7be90b45b51,a2909252-c5f1-421f-9073-b7be90b45b51,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,208051,Nerlynx,NERATINIB,2024/03/25,Kinase Inhibitor,2017,PUMA BIOTECHNOLOGY INC,2017/07/17-,70437-240,9RM7XY23ZS,NERATINIB MALEATE ANHYDROUS,NERATINIB,JJH94R3PWB,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/d1e41dcf-e82a-47c2-a0ad-6c6eef621834/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d1e41dcf-e82a-47c2-a0ad-6c6eef621834,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=d1e41dcf-e82a-47c2-a0ad-6c6eef621834,d1e41dcf-e82a-47c2-a0ad-6c6eef621834,,,
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION/ DROPS,OPHTHALMIC; TOPICAL,NDA,208254,Rhopressa,NETARSUDIL,2023/02/21,Rho Kinase Inhibitor,2017,ALCON LABORATORIES INC,2017/12/18-,70727-497,VL756B1K0U,NETARSUDIL MESYLATE,NETARSUDIL,W6I5QDT7QI,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/7d4f0e3a-5b86-4c43-982a-813b22ae7e22/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7d4f0e3a-5b86-4c43-982a-813b22ae7e22,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=7d4f0e3a-5b86-4c43-982a-813b22ae7e22,7d4f0e3a-5b86-4c43-982a-813b22ae7e22,,,
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION/ DROPS,OPHTHALMIC; TOPICAL,NDA,208259,Rocklatan,"NETARSUDIL AND LATANOPROST OPHTHALMIC SOLUTION, 0.02%/0.005%",2023/02/21,Prostaglandin Analog; Rho Kinase Inhibitor,2019,ALCON LABORATORIES INC,2019/03/12-,70727-529,6Z5B6HVF6O; VL756B1K0U,LATANOPROST; NETARSUDIL MESYLATE,LATANOPROST; NETARSUDIL,6Z5B6HVF6O; W6I5QDT7QI,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/b1d71f41-be06-4a08-94d4-e352198f09c2/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b1d71f41-be06-4a08-94d4-e352198f09c2,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=b1d71f41-be06-4a08-94d4-e352198f09c2,b1d71f41-be06-4a08-94d4-e352198f09c2,,,
HUMAN PRESCRIPTION DRUG LABEL,SUSPENSION; TABLET,ORAL,NDA,020636;020933,Viramune,NEVIRAPINE,2022/06/19,Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor,1996,BOEHRINGER INGELHEIM PHARMACEUTICALS INC,2001/10/01-; completed:2001/08/01-2021/06/30,0597-0046; 0597-0047,99DK7FVK1H,NEVIRAPINE,NEVIRAPINE,99DK7FVK1H,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/5ec05500-6333-4bd0-ac83-464fad0d5162/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5ec05500-6333-4bd0-ac83-464fad0d5162,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=5ec05500-6333-4bd0-ac83-464fad0d5162,5ec05500-6333-4bd0-ac83-464fad0d5162,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRAVENOUS,NDA,022119,Ammonia N 13,NH3N13,2019/10/30,Radioactive Diagnostic Agent,2007,THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH,2007/08/23-,13267-456,9OQO0E343Z,AMMONIA N-13,AMMONIA N-13,9OQO0E343Z,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/c857724f-b172-4844-ad42-6fa4c42b0405/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c857724f-b172-4844-ad42-6fa4c42b0405,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=c857724f-b172-4844-ad42-6fa4c42b0405,c857724f-b172-4844-ad42-6fa4c42b0405,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,019734,CARDENE IV,NICARDIPINE HYDROCHLORIDE,2024/03/27,Dihydropyridine Calcium Channel Blocker,1988,BAXTER HEALTHCARE CORPORATION,1992/01/30-,43066-026; 43066-028,K5BC5011K3,NICARDIPINE HYDROCHLORIDE,NICARDIPINE,CZ5312222S,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/a3e33add-0d09-423a-9109-42e5ba7148d5/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a3e33add-0d09-423a-9109-42e5ba7148d5,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=a3e33add-0d09-423a-9109-42e5ba7148d5,a3e33add-0d09-423a-9109-42e5ba7148d5,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,019734,CARDENE IV,NICARDIPINE HYDROCHLORIDE,2024/03/27,Dihydropyridine Calcium Channel Blocker,1988,BAXTER HEALTHCARE CORPORATION,1992/01/30-,43066-009; 43066-016,K5BC5011K3,NICARDIPINE HYDROCHLORIDE,NICARDIPINE,CZ5312222S,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/f12cea0d-b7cd-41d8-b551-2c74cc7f5f4e/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f12cea0d-b7cd-41d8-b551-2c74cc7f5f4e,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=f12cea0d-b7cd-41d8-b551-2c74cc7f5f4e,f12cea0d-b7cd-41d8-b551-2c74cc7f5f4e,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,019734,Cardene IV,NICARDIPINE HYDROCHLORIDE,2024/03/27,Dihydropyridine Calcium Channel Blocker,1988,BAXTER HEALTHCARE CORPORATION,1992/01/30-,43066-021; 43066-024,K5BC5011K3,NICARDIPINE HYDROCHLORIDE,NICARDIPINE,CZ5312222S,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/5499cfac-9147-4d5d-a8cb-f8d64f1481af/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5499cfac-9147-4d5d-a8cb-f8d64f1481af,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=5499cfac-9147-4d5d-a8cb-f8d64f1481af,5499cfac-9147-4d5d-a8cb-f8d64f1481af,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRAVENOUS,NDA,022276,Nicardipine Hydrochloride,NICARDIPINE HYDROCHLORIDE,2024/02/12,Dihydropyridine Calcium Channel Blocker,1988,HIKMA PHARMACEUTICALS USA INC,2012/03/02-; 2016/04/07-,0143-9633; 0143-9634; 0143-9689,K5BC5011K3,NICARDIPINE HYDROCHLORIDE,NICARDIPINE,CZ5312222S,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/18fb1c2b-0c1e-436c-a5b6-d4840b5da228/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=18fb1c2b-0c1e-436c-a5b6-d4840b5da228,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=18fb1c2b-0c1e-436c-a5b6-d4840b5da228,18fb1c2b-0c1e-436c-a5b6-d4840b5da228,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRAVENOUS,NDA,022276,Nicardipine Hydrochloride,NICARDIPINE HYDROCHLORIDE,2021/07/21,Dihydropyridine Calcium Channel Blocker,1988,HIKMA PHARMACEUTICALS USA INC,2012/03/02-,0143-9542,K5BC5011K3,NICARDIPINE HYDROCHLORIDE,NICARDIPINE,CZ5312222S,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/55bd6dcc-1f12-4378-8e9e-1ceed26818f5/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=55bd6dcc-1f12-4378-8e9e-1ceed26818f5,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=55bd6dcc-1f12-4378-8e9e-1ceed26818f5,55bd6dcc-1f12-4378-8e9e-1ceed26818f5,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRAVENOUS,NDA,022276,Nicardipine Hydrochloride,NICARDIPINE HYDROCHLORIDE,2018/12/12,Dihydropyridine Calcium Channel Blocker,1988,WEST WARD PHARMACEUTICALS CORP,2012/03/02-,0143-9593,K5BC5011K3,NICARDIPINE HYDROCHLORIDE,NICARDIPINE,CZ5312222S,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/0eb7d839-63d9-4b51-bf7b-4a8fde6339b5/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0eb7d839-63d9-4b51-bf7b-4a8fde6339b5,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=0eb7d839-63d9-4b51-bf7b-4a8fde6339b5,0eb7d839-63d9-4b51-bf7b-4a8fde6339b5,,,
HUMAN PRESCRIPTION DRUG LABEL,"SPRAY, METERED",NASAL,NDA,020385,Nicotrol,NICOTINE,2022/05/31,Cholinergic Nicotinic Agonist,,PHARMACIA AND UPJOHN COMPANY LLC,1996/05/22-,0009-5401,6M3C89ZY6R,NICOTINE,NICOTINE,6M3C89ZY6R,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/acb7d02d-249b-4645-ac1b-8ff9a56dd244/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=acb7d02d-249b-4645-ac1b-8ff9a56dd244,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=acb7d02d-249b-4645-ac1b-8ff9a56dd244,acb7d02d-249b-4645-ac1b-8ff9a56dd244,,,
HUMAN PRESCRIPTION DRUG LABEL,INHALANT,INHALATION,NDA,020714,Nicotrol,NICOTINE,2021/07/13,Cholinergic Nicotinic Agonist,,PHARMACIA AND UPJOHN COMPANY LLC,1997/05/02-,0009-5400,6M3C89ZY6R,NICOTINE,NICOTINE,6M3C89ZY6R,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/62245d7d-b50d-48d9-9f03-071c61620ccf/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=62245d7d-b50d-48d9-9f03-071c61620ccf,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=62245d7d-b50d-48d9-9f03-071c61620ccf,62245d7d-b50d-48d9-9f03-071c61620ccf,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,NDA,019684,Procardia XL,NIFEDIPINE,2023/11/27,Dihydropyridine Calcium Channel Blocker,,PFIZER LABORATORIES DIV PFIZER INC,1989/09/06-,0069-2650; 0069-2660; 0069-2670,I9ZF7L6G2L,NIFEDIPINE,NIFEDIPINE,I9ZF7L6G2L,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/8ebcb33c-f43b-4b36-9f94-9774b2a59e06/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8ebcb33c-f43b-4b36-9f94-9774b2a59e06,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=8ebcb33c-f43b-4b36-9f94-9774b2a59e06,8ebcb33c-f43b-4b36-9f94-9774b2a59e06,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,213464,LAMPIT,NIFURTIMOX,2023/06/02,,2020,BAYER HEALTHCARE PHARMACEUTICALS INC,2020/10/01-,50419-750; 50419-751,M84I3K7C2O,NIFURTIMOX,NIFURTIMOX,M84I3K7C2O,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/90d09714-a8b1-4696-8ada-f99dc54d0721/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=90d09714-a8b1-4696-8ada-f99dc54d0721,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=90d09714-a8b1-4696-8ada-f99dc54d0721,90d09714-a8b1-4696-8ada-f99dc54d0721,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,NDA,022068,Tasigna,NILOTINIB,2024/02/29,Kinase Inhibitor,2007,NOVARTIS PHARMACEUTICALS CORPORATION,2007/10/29-,0078-0526; 0078-0592; 0078-0951,F41401512X,NILOTINIB,NILOTINIB,F41401512X,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/6093952a-5248-45cb-ad17-33716a411146/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6093952a-5248-45cb-ad17-33716a411146,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=6093952a-5248-45cb-ad17-33716a411146,6093952a-5248-45cb-ad17-33716a411146,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,020169,Nilandron,NILUTAMIDE,2022/07/08,Androgen Receptor Inhibitor,,CONCORDIA PHARMACEUTICALS INC,2013/07/15-,59212-111,51G6I8B902,Nilutamide,Nilutamide,51G6I8B902,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/5ccf0e9a-8935-4c8c-b883-b4967281eb4a/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5ccf0e9a-8935-4c8c-b883-b4967281eb4a,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=5ccf0e9a-8935-4c8c-b883-b4967281eb4a,5ccf0e9a-8935-4c8c-b883-b4967281eb4a,,,
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION,ORAL,NDA,203340,Nymalize,NIMODIPINE,2023/03/31,Dihydropyridine Calcium Channel Blocker,1988,AZURITY PHARMACEUTICALS INC,2020/05/04-,24338-230; 24338-260,57WA9QZ5WH,nimodipine,nimodipine,57WA9QZ5WH,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/e660fa26-b5c4-4d6d-8887-9e22b6666a10/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e660fa26-b5c4-4d6d-8887-9e22b6666a10,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=e660fa26-b5c4-4d6d-8887-9e22b6666a10,e660fa26-b5c4-4d6d-8887-9e22b6666a10,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,NDA,205832,Ofev,NINTEDANIB,2022/11/01,Kinase Inhibitor,2014,BOEHRINGER INGELHEIM PHARMACEUTICALS INC,2014/10/15-,0597-0143; 0597-0145,42F62RTZ4G,NINTEDANIB ESYLATE,NINTEDANIB,G6HRD2P839,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/da1c9f37-779e-4682-816f-93d0faa4cfc9/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=da1c9f37-779e-4682-816f-93d0faa4cfc9,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=da1c9f37-779e-4682-816f-93d0faa4cfc9,da1c9f37-779e-4682-816f-93d0faa4cfc9,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,214876,ZEJULA,NIRAPARIB,2024/05/02,Poly(ADP-Ribose) Polymerase Inhibitor,2017,GLAXOSMITHKLINE LLC,2023/06/27-,0173-0909; 0173-0912; 0173-0915,195Q483UZD,NIRAPARIB TOSYLATE MONOHYDRATE,niraparib,HMC2H89N35,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/b7f675e2-159c-490c-b6f4-3f16d9492b7d/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b7f675e2-159c-490c-b6f4-3f16d9492b7d,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=b7f675e2-159c-490c-b6f4-3f16d9492b7d,b7f675e2-159c-490c-b6f4-3f16d9492b7d,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,NDA,208447,ZEJULA,NIRAPARIB,2023/04/26,Poly(ADP-Ribose) Polymerase Inhibitor,2017,GLAXOSMITHKLINE LLC,completed:2017/03/27-2024/08/31,69656-103,HMC2H89N35,niraparib,niraparib,HMC2H89N35,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/c15c7b7e-4b7f-4489-bbbc-884caeee0669/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c15c7b7e-4b7f-4489-bbbc-884caeee0669,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=c15c7b7e-4b7f-4489-bbbc-884caeee0669,c15c7b7e-4b7f-4489-bbbc-884caeee0669,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,216793,AKEEGA,NIRAPARIB TOSYLATE MONOHYDRATE AND ABIRATERONE ACETATE,2023/08/22,Cytochrome P450 17A1 Inhibitor; Poly(ADP-Ribose) Polymerase Inhibitor,2023,JANSSEN BIOTECH INC,2023/08/11-,57894-050; 57894-100,195Q483UZD; EM5OCB9YJ6,ABIRATERONE ACETATE; NIRAPARIB TOSYLATE MONOHYDRATE,ABIRATERONE; NIRAPARIB,G819A456D0; HMC2H89N35,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/8245a990-3268-4613-b5c5-9537858a1eb9/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8245a990-3268-4613-b5c5-9537858a1eb9,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=8245a990-3268-4613-b5c5-9537858a1eb9,8245a990-3268-4613-b5c5-9537858a1eb9,,,
HUMAN PRESCRIPTION DRUG LABEL,KIT,ORAL,NDA,217188,Paxlovid,NIRMATRELVIR AND RITONAVIR,2023/10/18,Cytochrome P450 3A Inhibitor; Protease Inhibitor,2023,PFIZER LABORATORIES DIV PFIZER INC,2023/10/18-; completed:2023/05/25-2023/05/25,0069-5001; 0069-5017; 0069-5045; 0069-5317; 0069-5321,7R9A5P7H32; O3J8G9O825,NIRMATRELVIR; RITONAVIR,NIRMATRELVIR; RITONAVIR,7R9A5P7H32; O3J8G9O825,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/8a99d6d6-fd9e-45bb-b1bf-48c7f761232a/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8a99d6d6-fd9e-45bb-b1bf-48c7f761232a,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=8a99d6d6-fd9e-45bb-b1bf-48c7f761232a,8a99d6d6-fd9e-45bb-b1bf-48c7f761232a,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,217677,OGSIVEO,NIROGACESTAT,2023/04/01,,2023,SPRINGWORKS THERAPEUTICS INC,2023/11/27-,82448-050; 82448-100; 82448-150,QZ62892OFJ,NIROGACESTAT,NIROGACESTAT,QZ62892OFJ,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/f172e6ff-3190-41b0-b95a-58a7ef9e9e1e/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f172e6ff-3190-41b0-b95a-58a7ef9e9e1e,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=f172e6ff-3190-41b0-b95a-58a7ef9e9e1e,f172e6ff-3190-41b0-b95a-58a7ef9e9e1e,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,NDA,020356,Sular,NISOLDIPINE,2023/01/24,Dihydropyridine Calcium Channel Blocker,,COVIS PHARMA US INC,2017/02/03-,70515-500; 70515-501; 70515-503,4I8HAB65SZ,NISOLDIPINE,NISOLDIPINE,4I8HAB65SZ,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/589157fa-d129-4de3-be3d-e0e1c22c5873/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=589157fa-d129-4de3-be3d-e0e1c22c5873,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=589157fa-d129-4de3-be3d-e0e1c22c5873,589157fa-d129-4de3-be3d-e0e1c22c5873,,,
HUMAN PRESCRIPTION DRUG LABEL,"POWDER, FOR SUSPENSION",ORAL,NDA,021498,Alinia,NITAZOXANIDE,2024/03/20,Antiprotozoal,2002,LUPIN PHARMACEUTICALS INC,2013/10/09-,27437-106,SOA12P041N,NITAZOXANIDE,NITAZOXANIDE,SOA12P041N,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/e90f98d9-3c9b-4e75-ba18-5517283eadf0/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e90f98d9-3c9b-4e75-ba18-5517283eadf0,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=e90f98d9-3c9b-4e75-ba18-5517283eadf0,e90f98d9-3c9b-4e75-ba18-5517283eadf0,,,
HUMAN PRESCRIPTION DRUG LABEL,"POWDER, FOR SUSPENSION; TABLET",ORAL,NDA,021497;021498,Alinia,NITAZOXANIDE,2023/12/05,Antiprotozoal,2002,ROMARK LABORATORIES L C,2002/11/22-; 2004/07/21-,67546-111; 67546-212,SOA12P041N,NITAZOXANIDE,NITAZOXANIDE,SOA12P041N,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/56b1575a-dff4-4c5a-a159-2f858e7a0cb8/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=56b1575a-dff4-4c5a-a159-2f858e7a0cb8,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=56b1575a-dff4-4c5a-a159-2f858e7a0cb8,56b1575a-dff4-4c5a-a159-2f858e7a0cb8,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,209449,NITYR,NITISINONE,2024/01/23,4-Hydroxyphenyl-Pyruvate Dioxygenase Inhibitor,2002,CYCLE PHARMACEUTICALS LTD,2017/07/26-,70709-000; 70709-002; 70709-005,K5BN214699,nitisinone,nitisinone,K5BN214699,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/00fd1905-27e4-420e-8dc5-a69e4ddc1526/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=00fd1905-27e4-420e-8dc5-a69e4ddc1526,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=00fd1905-27e4-420e-8dc5-a69e4ddc1526,00fd1905-27e4-420e-8dc5-a69e4ddc1526,,,
HUMAN PRESCRIPTION DRUG LABEL,SUSPENSION,ORAL,NDA,206356,ORFADIN,NITISINONE,2022/06/20,4-Hydroxyphenyl-Pyruvate Dioxygenase Inhibitor,2002,SWEDISH ORPHAN BIOVITRUM AB PUBL,2016/06/01-,66658-204,K5BN214699,NITISINONE,NITISINONE,K5BN214699,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/00307f42-748d-4227-8c6f-ed5f0a89ae0a/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=00307f42-748d-4227-8c6f-ed5f0a89ae0a,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=00307f42-748d-4227-8c6f-ed5f0a89ae0a,00307f42-748d-4227-8c6f-ed5f0a89ae0a,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,NDA,021232,Orfadin,NITISINONE,2021/11/30,4-Hydroxyphenyl-Pyruvate Dioxygenase Inhibitor,2002,SWEDISH ORPHAN BIOVITRUM AB PUBL,2016/07/01-,66658-102; 66658-105; 66658-110; 66658-120,K5BN214699,nitisinone,nitisinone,K5BN214699,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/5d449b73-d503-4132-b978-d890491975df/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5d449b73-d503-4132-b978-d890491975df,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=5d449b73-d503-4132-b978-d890491975df,5d449b73-d503-4132-b978-d890491975df,,,
HUMAN PRESCRIPTION DRUG LABEL,GAS,INHALATION,NDA,202860,GENOSYL,NITRIC OXIDE,2023/12/19,Vasodilator,1999,VERO BIOTECH INC,2019/12/20-,72385-001,31C4KY9ESH,NITRIC OXIDE,NITRIC OXIDE,31C4KY9ESH,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/c9560c54-9e28-4039-a4e5-5000c41c6c85/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c9560c54-9e28-4039-a4e5-5000c41c6c85,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=c9560c54-9e28-4039-a4e5-5000c41c6c85,c9560c54-9e28-4039-a4e5-5000c41c6c85,,,
HUMAN PRESCRIPTION DRUG LABEL,GAS,INHALATION,NDA,020845,INOMAX,NITRIC OXIDE,2023/04/12,Vasodilator,1999,INO THERAPEUTICS LLC,1999/12/23-,64693-002; 64693-003,31C4KY9ESH,nitric oxide,nitric oxide,31C4KY9ESH,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/762b51be-1893-4cd1-9511-e645fc420d3a/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=762b51be-1893-4cd1-9511-e645fc420d3a,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=762b51be-1893-4cd1-9511-e645fc420d3a,762b51be-1893-4cd1-9511-e645fc420d3a,,,
HUMAN PRESCRIPTION DRUG LABEL,GAS,INHALATION,NDA,202860,GENOSYL,NITRIC OXIDE,2023/01/20,Vasodilator,1999,VERO BIOTECH INC,2022/12/28-,72385-002,31C4KY9ESH,NITRIC OXIDE,NITRIC OXIDE,31C4KY9ESH,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/8e6b2a92-7915-4709-9076-3a591bf195eb/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8e6b2a92-7915-4709-9076-3a591bf195eb,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=8e6b2a92-7915-4709-9076-3a591bf195eb,8e6b2a92-7915-4709-9076-3a591bf195eb,,,
HUMAN PRESCRIPTION DRUG LABEL,SUSPENSION,ORAL,NDA,009175,Furadantin,NITROFURANTOIN,2024/03/28,Nitrofuran Antibacterial,1953,CASPER PHARMA LLC,2020/12/23-; 2024/02/01-,70199-006; 70199-036,927AH8112L,NITROFURANTOIN,NITROFURANTOIN,927AH8112L,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/00af0dea-ac7b-43f2-9f51-2a9f9e7f7d21/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=00af0dea-ac7b-43f2-9f51-2a9f9e7f7d21,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=00af0dea-ac7b-43f2-9f51-2a9f9e7f7d21,00af0dea-ac7b-43f2-9f51-2a9f9e7f7d21,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,NDA,016620,Macrodantin,NITROFURANTOIN MACROCRYSTALS,2020/06/01,Nitrofuran Antibacterial,,ALMATICA PHARMA LLC,2010/09/27-,52427-286; 52427-287; 52427-288,927AH8112L,NITROFURANTOIN,NITROFURANTOIN,927AH8112L,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/89d8696b-f9ce-9691-6222-8416ca143bba/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=89d8696b-f9ce-9691-6222-8416ca143bba,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=89d8696b-f9ce-9691-6222-8416ca143bba,89d8696b-f9ce-9691-6222-8416ca143bba,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,NDA,016620,nitrofurantoin macrocrystals,NITROFURANTOIN MACROCRYSTALS,2019/11/20,Nitrofuran Antibacterial,,ALVOGEN INC,2010/09/27-,47781-306; 47781-307; 47781-308,927AH8112L,NITROFURANTOIN,NITROFURANTOIN,927AH8112L,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/62c1bb9c-79a2-41e3-9dfa-352f92253881/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=62c1bb9c-79a2-41e3-9dfa-352f92253881,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=62c1bb9c-79a2-41e3-9dfa-352f92253881,62c1bb9c-79a2-41e3-9dfa-352f92253881,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,NDA,020064,NITROFURANTOIN MONOHYDRATE MACROCRYSTALLINE,NITROFURANTOIN MONOHYDRATE,2018/08/29,Nitrofuran Antibacterial,,H J HARKINS COMPANY INC,2009/11/17-,52959-783,927AH8112L; E1QI2CQQ1I,NITROFURANTOIN; NITROFURANTOIN MONOHYDRATE,NITROFURANTOIN,927AH8112L,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/749b9a79-becc-5850-e053-2a91aa0a8e8f/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=749b9a79-becc-5850-e053-2a91aa0a8e8f,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=749b9a79-becc-5850-e053-2a91aa0a8e8f,749b9a79-becc-5850-e053-2a91aa0a8e8f,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,NDA,020064,Macrobid,NITROFURANTOIN MONOHYDRATE/MACROCRYSTALLINE,2023/06/30,Nitrofuran Antibacterial,,ALMATICA PHARMA LLC,2011/05/31-,52427-285,927AH8112L; E1QI2CQQ1I,NITROFURANTOIN; NITROFURANTOIN MONOHYDRATE,NITROFURANTOIN,927AH8112L,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/8f270a9f-12a1-44d4-bc7e-873613555801/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8f270a9f-12a1-44d4-bc7e-873613555801,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=8f270a9f-12a1-44d4-bc7e-873613555801,8f270a9f-12a1-44d4-bc7e-873613555801,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,NDA,020064,Nitrofurantoin Monohydrate/ Macrocrystalline,NITROFURANTOIN MONOHYDRATE/MACROCRYSTALLINE,2023/06/30,Nitrofuran Antibacterial,,ALVOGEN INC,2011/05/25-,47781-303,927AH8112L; E1QI2CQQ1I,NITROFURANTOIN; NITROFURANTOIN MONOHYDRATE,NITROFURANTOIN,927AH8112L,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/1a86deef-0887-43b1-bb96-dbc222b15931/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1a86deef-0887-43b1-bb96-dbc222b15931,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=1a86deef-0887-43b1-bb96-dbc222b15931,1a86deef-0887-43b1-bb96-dbc222b15931,,,
HUMAN PRESCRIPTION DRUG LABEL,OINTMENT,RECTAL,NDA,021359,Rectiv,NITROGLYCERIN,2024/04/26,Nitrate Vasodilator,1955,ALLERGAN INC,2011/06/21-,58914-301,G59M7S0WS3,NITROGLYCERIN,NITROGLYCERIN,G59M7S0WS3,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/603aa9ed-54c4-4a35-ade4-690fa44850e4/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=603aa9ed-54c4-4a35-ade4-690fa44850e4,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=603aa9ed-54c4-4a35-ade4-690fa44850e4,603aa9ed-54c4-4a35-ade4-690fa44850e4,,,
HUMAN PRESCRIPTION DRUG LABEL,SPRAY,ORAL,NDA,018705,NITROLINGUAL,NITROGLYCERIN,2024/01/08,Nitrate Vasodilator,1997,ALLEGIS PHARMACEUTICALS LLC,2019/07/01-,28595-550,G59M7S0WS3,NITROGLYCERIN,NITROGLYCERIN,G59M7S0WS3,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/d8765f0e-1fe9-4e2a-9138-186c093edceb/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d8765f0e-1fe9-4e2a-9138-186c093edceb,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=d8765f0e-1fe9-4e2a-9138-186c093edceb,d8765f0e-1fe9-4e2a-9138-186c093edceb,,,
HUMAN PRESCRIPTION DRUG LABEL,PATCH,TRANSDERMAL,NDA,020145,NITRO-DUR,NITROGLYCERIN,2023/05/30,Nitrate Vasodilator,,INGENUS PHARMACEUTICALS LLC,2017/12/06-,50742-513; 50742-514; 50742-515; 50742-516; 50742-517; 50742-518,G59M7S0WS3,NITROGLYCERIN,NITROGLYCERIN,G59M7S0WS3,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/5e15296c-5acd-4bcc-80a8-b49cb1ef3eb0/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5e15296c-5acd-4bcc-80a8-b49cb1ef3eb0,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=5e15296c-5acd-4bcc-80a8-b49cb1ef3eb0,5e15296c-5acd-4bcc-80a8-b49cb1ef3eb0,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,SUBLINGUAL,NDA,021134,Nitrostat,NITROGLYCERIN,2023/02/15,Nitrate Vasodilator,1981,VIATRIS SPECIALTY LLC,2024/02/02-; 2024/02/09-,58151-309; 58151-310; 58151-311,G59M7S0WS3,NITROGLYCERIN,NITROGLYCERIN,G59M7S0WS3,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/9a52da75-d0af-4237-96c0-0b12adfa8636/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9a52da75-d0af-4237-96c0-0b12adfa8636,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=9a52da75-d0af-4237-96c0-0b12adfa8636,9a52da75-d0af-4237-96c0-0b12adfa8636,,,
HUMAN PRESCRIPTION DRUG LABEL,"AEROSOL, METERED",SUBLINGUAL,NDA,021780,NitroMist,NITROGLYCERIN,2020/06/08,Nitrate Vasodilator,2006,EVUS PHARMACEUTICALS LLC,2016/01/25-,73262-430,G59M7S0WS3,NITROGLYCERIN,NITROGLYCERIN,G59M7S0WS3,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/db97f3b9-6608-482f-a0ef-ad1cf610e520/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=db97f3b9-6608-482f-a0ef-ad1cf610e520,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=db97f3b9-6608-482f-a0ef-ad1cf610e520,db97f3b9-6608-482f-a0ef-ad1cf610e520,,,
HUMAN PRESCRIPTION DRUG LABEL,SPRAY,ORAL,NDA,018705,NITROLINGUAL,NITROGLYCERIN,2018/08/07,Nitrate Vasodilator,1997,ESPERO PHARMACEUTICALS INC,2016/03/01-,70007-300,G59M7S0WS3,NITROGLYCERIN,NITROGLYCERIN,G59M7S0WS3,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/2b7c772a-adef-4eef-bb83-aaa798e1b712/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2b7c772a-adef-4eef-bb83-aaa798e1b712,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=2b7c772a-adef-4eef-bb83-aaa798e1b712,2b7c772a-adef-4eef-bb83-aaa798e1b712,,,
HUMAN PRESCRIPTION DRUG LABEL,POWDER,SUBLINGUAL,NDA,208424,GONITRO,NITROGLYCERIN,2018/06/20,Nitrate Vasodilator,1981,ESPERO PHARMACEUTICALS INC,2016/07/01-,70007-400,G59M7S0WS3,NITROGLYCERIN,NITROGLYCERIN,G59M7S0WS3,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/1418d832-4a6a-45ab-8414-25e23f393abb/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1418d832-4a6a-45ab-8414-25e23f393abb,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=1418d832-4a6a-45ab-8414-25e23f393abb,1418d832-4a6a-45ab-8414-25e23f393abb,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,SUBLINGUAL,NDA,021134,Nitrostat,NITROGLYCERIN,2018/02/28,Nitrate Vasodilator,1981,PARKE DAVIS DIV OF PFIZER INC,2000/05/01-; completed:2000/05/01-2025/02/28; completed:2000/05/01-2025/04/30,0071-0417; 0071-0418; 0071-0419,G59M7S0WS3,NITROGLYCERIN,NITROGLYCERIN,G59M7S0WS3,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/79ba021e-183c-4b4d-822e-4ff5ef54ca61/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=79ba021e-183c-4b4d-822e-4ff5ef54ca61,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=79ba021e-183c-4b4d-822e-4ff5ef54ca61,79ba021e-183c-4b4d-822e-4ff5ef54ca61,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRAVENOUS,NDA,019970,Nitroglycerin In Dextrose,NITROGLYCERIN,2016/08/22,Nitrate Vasodilator,,BAXTER HEALTHCARE COMPANY,1989/12/29-,0338-1047; 0338-1049; 0338-1051,G59M7S0WS3,NITROGLYCERIN,NITROGLYCERIN,G59M7S0WS3,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/457a026c-ebce-4701-9deb-2d7652759a99/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=457a026c-ebce-4701-9deb-2d7652759a99,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=457a026c-ebce-4701-9deb-2d7652759a99,457a026c-ebce-4701-9deb-2d7652759a99,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION, CONCENTRATE",INTRAVENOUS,NDA,007513,LEVOPHED,NOREPINEPHRINE BITARTRATE,2024/03/11,Catecholamine,1950,HOSPIRA INC,2024/03/11-,0409-0161,IFY5PE3ZRW,NOREPINEPHRINE BITARTRATE,NOREPINEPHRINE,X4W3ENH1CV,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/2c7dd2b0-cc10-4db6-bf56-6eb154ebeb10/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2c7dd2b0-cc10-4db6-bf56-6eb154ebeb10,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=2c7dd2b0-cc10-4db6-bf56-6eb154ebeb10,2c7dd2b0-cc10-4db6-bf56-6eb154ebeb10,,,
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION,INTRAVENOUS,NDA,214628,Norepinephrine,NOREPINEPHRINE BITARTRATE,2024/02/12,Catecholamine,1950,LONG GROVE PHARMACEUTICALS LLC,2024/02/02-,81298-9655; 81298-9658; 81298-9659,IFY5PE3ZRW,NOREPINEPHRINE BITARTRATE,NOREPINEPHRINE,X4W3ENH1CV,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/759807dd-61a8-4f6f-8bf5-f6ee773c81bc/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=759807dd-61a8-4f6f-8bf5-f6ee773c81bc,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=759807dd-61a8-4f6f-8bf5-f6ee773c81bc,759807dd-61a8-4f6f-8bf5-f6ee773c81bc,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,214313,NOREPINEPHRINE BITARTRATE,NOREPINEPHRINE BITARTRATE,2023/11/21,Catecholamine,1950,BAXTER HEALTHCARE CORPORATION,2021/01/15-; 2023/11/21-,0338-0108; 0338-0112; 0338-0116,IFY5PE3ZRW,NOREPINEPHRINE BITARTRATE,NOREPINEPHRINE,X4W3ENH1CV,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/6363e9b4-29df-4553-904d-a563e5adda6e/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6363e9b4-29df-4553-904d-a563e5adda6e,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=6363e9b4-29df-4553-904d-a563e5adda6e,6363e9b4-29df-4553-904d-a563e5adda6e,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,215700,NOREPINEPHRINE BITARTRATE IN SODIUM CHLORIDE,NOREPINEPHRINE BITARTRATE,2023/07/31,Catecholamine,1950,WG CRITICAL CARE LLC,2022/09/15-,44567-640; 44567-641; 44567-642,IFY5PE3ZRW,NOREPINEPHRINE BITARTRATE,NOREPINEPHRINE,X4W3ENH1CV,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/ddbef60d-c20a-4ada-928f-e87074c08a54/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ddbef60d-c20a-4ada-928f-e87074c08a54,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=ddbef60d-c20a-4ada-928f-e87074c08a54,ddbef60d-c20a-4ada-928f-e87074c08a54,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION, CONCENTRATE",INTRAVENOUS,NDA,007513,LEVOPHED,NOREPINEPHRINE BITARTRATE,2020/11/02,Catecholamine,1950,HOSPIRA INC,2009/04/27-; completed:2005/04/30-2019/05/01,0409-1443; 0409-3375,IFY5PE3ZRW,NOREPINEPHRINE BITARTRATE,NOREPINEPHRINE,X4W3ENH1CV,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/c4de72a8-2a75-4984-ce90-e4870226dc12/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c4de72a8-2a75-4984-ce90-e4870226dc12,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=c4de72a8-2a75-4984-ce90-e4870226dc12,c4de72a8-2a75-4984-ce90-e4870226dc12,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,214628,NOREPINEPHRINE BITARTRATE,NOREPINEPHRINE IN SODIUM CHLORIDE,2022/10/20,Catecholamine,1950,PAR PHARMACEUTICAL INC,2023/01/04-,42023-245; 42023-246; 42023-247,IFY5PE3ZRW,NOREPINEPHRINE BITARTRATE,NOREPINEPHRINE,X4W3ENH1CV,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/1f112215-cef7-46a0-b838-ba0542a99d2c/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1f112215-cef7-46a0-b838-ba0542a99d2c,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=1f112215-cef7-46a0-b838-ba0542a99d2c,1f112215-cef7-46a0-b838-ba0542a99d2c,,,
HUMAN PRESCRIPTION DRUG LABEL,KIT,ORAL,NDA,204426,Taytulla,"NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL, AND FERROUS FUMARATE",2023/06/26,Estrogen; Progestin,1968,ALLERGAN INC,2016/05/01-,0023-5862,423D2T571U; 9S44LIC7OJ,ETHINYL ESTRADIOL; NORETHINDRONE ACETATE,ETHINYL ESTRADIOL; NORETHINDRONE,423D2T571U; T18F433X4S,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/2fa8e8dc-f7b0-429a-b554-0e3c4291c92c/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2fa8e8dc-f7b0-429a-b554-0e3c4291c92c,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=2fa8e8dc-f7b0-429a-b554-0e3c4291c92c,2fa8e8dc-f7b0-429a-b554-0e3c4291c92c,,,
HUMAN PRESCRIPTION DRUG LABEL,KIT,ORAL,NDA,022501,Lo Loestrin Fe,"NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL, ETHINYL ESTRADIOL AND FERROUS FUMARATE",2022/11/04,Estrogen; Progestin,1968,ALLERGAN INC,2010/12/01-,0430-0420,423D2T571U; 9S44LIC7OJ,ETHINYL ESTRADIOL; NORETHINDRONE ACETATE,ETHINYL ESTRADIOL; NORETHINDRONE,423D2T571U; T18F433X4S,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/c33072cf-625d-4b4a-981e-ec049c5d78aa/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c33072cf-625d-4b4a-981e-ec049c5d78aa,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=c33072cf-625d-4b4a-981e-ec049c5d78aa,c33072cf-625d-4b4a-981e-ec049c5d78aa,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,NDA,018013,PAMELOR,NORTRIPTYLINE HYDROCHLORIDE,2020/02/17,Tricyclic Antidepressant,,SPECGX LLC,1977/08/01-,0406-9910; 0406-9911; 0406-9912; 0406-9913,00FN6IH15D,NORTRIPTYLINE HYDROCHLORIDE,NORTRIPTYLINE,BL03SY4LXB,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/e17dc299-f52d-414d-ab6e-e809bd6f8acb/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e17dc299-f52d-414d-ab6e-e809bd6f8acb,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=e17dc299-f52d-414d-ab6e-e809bd6f8acb,e17dc299-f52d-414d-ab6e-e809bd6f8acb,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRATHECAL,NDA,209531,Spinraza,NUSINERSEN,2024/04/24,Antisense Oligonucleotide; Survival Motor Neuron-2-directed RNA Interaction,2016,BIOGEN,2016/12/23-,64406-058,5Z9SP3X666,Nusinersen,Nusinersen,5Z9SP3X666,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/dd70cd5f-b0fc-4ba4-a5ea-89a34778bd94/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=dd70cd5f-b0fc-4ba4-a5ea-89a34778bd94,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=dd70cd5f-b0fc-4ba4-a5ea-89a34778bd94,dd70cd5f-b0fc-4ba4-a5ea-89a34778bd94,,,
HUMAN PRESCRIPTION DRUG LABEL,SUSPENSION,ORAL,NDA,050299,Nystatin,NYSTATIN,2024/04/11,Polyene Antifungal,,CHARTWELL RX LLC,1971/04/14-,62135-813,BDF1O1C72E,NYSTATIN,NYSTATIN,BDF1O1C72E,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/9954118e-abe6-4388-98c9-4473d39b2e28/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9954118e-abe6-4388-98c9-4473d39b2e28,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=9954118e-abe6-4388-98c9-4473d39b2e28,9954118e-abe6-4388-98c9-4473d39b2e28,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,207999,Ocaliva,OBETICHOLIC ACID,2022/10/18,Farnesoid X Receptor Agonist,2016,INTERCEPT PHARMACEUTICALS INC,2016/05/27-,69516-005; 69516-010,0462Z4S4OZ,OBETICHOLIC ACID,OBETICHOLIC ACID,0462Z4S4OZ,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/cdfbe0cd-eb15-45a1-ac17-531bcda21aec/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=cdfbe0cd-eb15-45a1-ac17-531bcda21aec,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=cdfbe0cd-eb15-45a1-ac17-531bcda21aec,cdfbe0cd-eb15-45a1-ac17-531bcda21aec,,,
HUMAN PRESCRIPTION DRUG LABEL,"CAPSULE, DELAYED RELEASE",ORAL,NDA,208232,Mycapssa,OCTREOTIDE,2024/01/10,Somatostatin Analog,1988,CHIESI USA INC,2020/07/06-,10122-550,RWM8CCW8GP,Octreotide,Octreotide,RWM8CCW8GP,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/58d80bc6-bdfb-4908-93e7-aace447c8d1a/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=58d80bc6-bdfb-4908-93e7-aace447c8d1a,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=58d80bc6-bdfb-4908-93e7-aace447c8d1a,58d80bc6-bdfb-4908-93e7-aace447c8d1a,,,
HUMAN PRESCRIPTION DRUG LABEL,"CAPSULE, DELAYED RELEASE",ORAL,NDA,208232,Mycapssa,OCTREOTIDE,2023/09/15,Somatostatin Analog,1988,AMRYT PHARMACEUTICALS DESIGNATED ACTIVITY COMPANY,2020/07/06-,69880-120,RWM8CCW8GP,Octreotide,Octreotide,RWM8CCW8GP,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/62a5e1eb-b48e-4ea6-8781-f75e490b17e4/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=62a5e1eb-b48e-4ea6-8781-f75e490b17e4,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=62a5e1eb-b48e-4ea6-8781-f75e490b17e4,62a5e1eb-b48e-4ea6-8781-f75e490b17e4,,,
HUMAN PRESCRIPTION DRUG LABEL,KIT,INTRAMUSCULAR,NDA,021008,Sandostatin LAR Depot,OCTREOTIDE ACETATE,2024/03/01,Somatostatin Analog,1988,NOVARTIS PHARMACEUTICALS CORPORATION,2016/07/22-,0078-0811; 0078-0818; 0078-0825,75R0U2568I,OCTREOTIDE ACETATE,OCTREOTIDE,RWM8CCW8GP,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/d0b7fe9e-7000-4b79-ba3b-291ce92c14f9/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d0b7fe9e-7000-4b79-ba3b-291ce92c14f9,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=d0b7fe9e-7000-4b79-ba3b-291ce92c14f9,d0b7fe9e-7000-4b79-ba3b-291ce92c14f9,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS; SUBCUTANEOUS,NDA,019667,Sandostatin,OCTREOTIDE ACETATE,2023/11/03,Somatostatin Analog,1988,NOVARTIS PHARMACEUTICALS CORPORATION,1988/10/21-,0078-0180; 0078-0181; 0078-0182,75R0U2568I,OCTREOTIDE ACETATE,OCTREOTIDE,RWM8CCW8GP,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/4e2c9856-1836-49f0-9472-4dbeeb408f39/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4e2c9856-1836-49f0-9472-4dbeeb408f39,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=4e2c9856-1836-49f0-9472-4dbeeb408f39,4e2c9856-1836-49f0-9472-4dbeeb408f39,,,
HUMAN PRESCRIPTION DRUG LABEL,"CAPSULE; CAPSULE, COATED PELLETS",ORAL,NDA,215498,Bylvay,ODEVIXIBAT,2024/02/12,Ileal Bile Acid Transporter Inhibitor,2021,IPSEN BIOPHARMACEUTICALS INC,2024/01/10-,15054-3301; 15054-3302; 15054-3303; 15054-3304,2W150K0UUC,odevixibat,odevixibat,2W150K0UUC,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/0935cd31-3251-4a0a-ac23-25ca4be12be9/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0935cd31-3251-4a0a-ac23-25ca4be12be9,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=0935cd31-3251-4a0a-ac23-25ca4be12be9,0935cd31-3251-4a0a-ac23-25ca4be12be9,,,
HUMAN PRESCRIPTION DRUG LABEL,"CAPSULE, COATED PELLETS",ORAL,NDA,215498,BYLVAY,ODEVIXIBAT,2023/06/15,Ileal Bile Acid Transporter Inhibitor,2021,ALBIREO PHARMA INC,2021/07/20-,74528-020; 74528-040; 74528-060; 74528-120,2W150K0UUC,odevixibat,odevixibat,2W150K0UUC,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/151f1d3e-2bf4-47ce-b1be-a892de3258fa/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=151f1d3e-2bf4-47ce-b1be-a892de3258fa,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=151f1d3e-2bf4-47ce-b1be-a892de3258fa,151f1d3e-2bf4-47ce-b1be-a892de3258fa,,,
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION/ DROPS,OPHTHALMIC,NDA,019921,OCUFLOX,OFLOXACIN,2017/04/23,Quinolone Antimicrobial,,ALLERGAN INC,1993/08/01-,11980-779,A4P49JAZ9H,ofloxacin,ofloxacin,A4P49JAZ9H,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/7aab4449-3dda-4e2c-8e40-b3244a548bf5/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7aab4449-3dda-4e2c-8e40-b3244a548bf5,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=7aab4449-3dda-4e2c-8e40-b3244a548bf5,7aab4449-3dda-4e2c-8e40-b3244a548bf5,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, POWDER, FOR SOLUTION; TABLET; TABLET, ORALLY DISINTEGRATING",INTRAMUSCULAR; ORAL,NDA,020592;021086;021253,ZYPREXA Intramuscular; ZYPREXA Zydis; Zyprexa,OLANZAPINE,2023/12/13,Atypical Antipsychotic,1996,ELI LILLY AND COMPANY,1996/10/01-; 1997/06/23-; 2000/01/10-; 2000/06/01-; 2001/03/01-,0002-4112; 0002-4115; 0002-4116; 0002-4117; 0002-4415; 0002-4420; 0002-4453; 0002-4454; 0002-4455; 0002-4456; 0002-7597,N7U69T4SZR,Olanzapine,Olanzapine,N7U69T4SZR,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/d5051fbc-846b-4946-82df-341fb1216341/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d5051fbc-846b-4946-82df-341fb1216341,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=d5051fbc-846b-4946-82df-341fb1216341,d5051fbc-846b-4946-82df-341fb1216341,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, POWDER, FOR SOLUTION; TABLET; TABLET, ORALLY DISINTEGRATING",INTRAMUSCULAR; ORAL,NDA,020592;021086;021253,ZYPREXA Intramuscular; ZYPREXA Zydis; Zyprexa,OLANZAPINE,2023/10/09,Atypical Antipsychotic,1996,H PHARMA LLC,1996/10/01-; 1997/06/23-; 2000/01/10-; 2000/06/01-; 2001/03/01-,61269-630; 61269-631; 61269-632; 61269-633; 61269-634; 61269-635; 61269-640; 61269-650; 61269-651; 61269-652; 61269-653,N7U69T4SZR,Olanzapine,Olanzapine,N7U69T4SZR,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/b418946a-1ab4-4d89-a012-d94fc361a3c4/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b418946a-1ab4-4d89-a012-d94fc361a3c4,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=b418946a-1ab4-4d89-a012-d94fc361a3c4,b418946a-1ab4-4d89-a012-d94fc361a3c4,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,NDA,021520,Symbyax,OLANZAPINE AND FLUOXETINE HYDROCHLORIDE,2023/08/18,Atypical Antipsychotic; Serotonin Reuptake Inhibitor,2003,ELI LILLY AND COMPANY,2003/12/24-; 2007/04/09-,0002-3230; 0002-3231,I9W7N6B1KJ; N7U69T4SZR,Fluoxetine hydrochloride; Olanzapine,Fluoxetine; Olanzapine; fluoxetine,01K63SUP8D; N7U69T4SZR,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/6b28c424-0b7e-4b75-b090-f116b113554e/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6b28c424-0b7e-4b75-b090-f116b113554e,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=6b28c424-0b7e-4b75-b090-f116b113554e,6b28c424-0b7e-4b75-b090-f116b113554e,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,213378,LYBALVI,OLANZAPINE AND SAMIDORPHAN L-MALATE,2024/01/31,Atypical Antipsychotic; Opioid Antagonist,2021,ALKERMES INC,2021/09/20-,65757-651; 65757-652; 65757-653; 65757-654,0AJQ5N56E0; N7U69T4SZR,olanzapine; samidorphan L-malate,olanzapine; samidorphan,7W2581Z5L8; N7U69T4SZR,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/32ffddd1-4e2b-45d9-9b36-bb730167ec80/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=32ffddd1-4e2b-45d9-9b36-bb730167ec80,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=32ffddd1-4e2b-45d9-9b36-bb730167ec80,32ffddd1-4e2b-45d9-9b36-bb730167ec80,,,
HUMAN PRESCRIPTION DRUG LABEL,KIT,INTRAMUSCULAR,NDA,022173,ZYPREXA Relprevv,OLANZAPINE PAMOATE,2023/12/15,Atypical Antipsychotic,1996,ELI LILLY AND COMPANY,2009/12/11-,0002-7635; 0002-7636; 0002-7637,X7S6Q4MHCB,Olanzapine pamoate,Olanzapine,N7U69T4SZR,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/f9a73185-88de-4d7b-b3c0-bbf231483241/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f9a73185-88de-4d7b-b3c0-bbf231483241,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=f9a73185-88de-4d7b-b3c0-bbf231483241,f9a73185-88de-4d7b-b3c0-bbf231483241,,,
HUMAN PRESCRIPTION DRUG LABEL,KIT,INTRAMUSCULAR,NDA,022173,ZYPREXA Relprevv,OLANZAPINE PAMOATE,2023/10/12,Atypical Antipsychotic,1996,H PHARMA LLC,2009/12/11-,61269-660; 61269-661; 61269-662,X7S6Q4MHCB,Olanzapine pamoate,Olanzapine,N7U69T4SZR,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/11544cba-64a9-49cb-8d74-da228053b252/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=11544cba-64a9-49cb-8d74-da228053b252,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=11544cba-64a9-49cb-8d74-da228053b252,11544cba-64a9-49cb-8d74-da228053b252,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,208558,Lynparza,OLAPARIB,2023/11/06,Poly(ADP-Ribose) Polymerase Inhibitor,2014,ASTRAZENECA PHARMACEUTICALS LP,2017/08/17-,0310-0668; 0310-0679,WOH1JD9AR8,OLAPARIB,OLAPARIB,WOH1JD9AR8,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/741ff3e3-dc1a-45a6-84e5-2481b27131aa/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=741ff3e3-dc1a-45a6-84e5-2481b27131aa,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=741ff3e3-dc1a-45a6-84e5-2481b27131aa,741ff3e3-dc1a-45a6-84e5-2481b27131aa,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,210730,OLINVYK,OLICERIDINE,2023/12/20,,2020,TREVENA INC,2020/08/07-,71308-011; 71308-021; 71308-301,MCN858TCP0,OLICERIDINE,OLICERIDINE,MCN858TCP0,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/ce167984-8b9d-40b7-84ce-d0f33fff1eaa/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ce167984-8b9d-40b7-84ce-d0f33fff1eaa,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=ce167984-8b9d-40b7-84ce-d0f33fff1eaa,ce167984-8b9d-40b7-84ce-d0f33fff1eaa,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, EMULSION",INTRAVENOUS,NDA,204508,Clinolipid,OLIVE OIL AND SOYBEAN OIL,2024/04/24,Lipid Emulsion,1975,BAXTER HEALTHCARE CORPORATION,2016/01/01-,0338-9540,241ATL177A; 6UYK2W1W1E,OLIVE OIL; SOYBEAN OIL,OLIVE OIL; SOYBEAN OIL,241ATL177A; 6UYK2W1W1E,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/ae98eb03-c0e7-49d1-b024-77968e3d9d6e/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ae98eb03-c0e7-49d1-b024-77968e3d9d6e,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=ae98eb03-c0e7-49d1-b024-77968e3d9d6e,ae98eb03-c0e7-49d1-b024-77968e3d9d6e,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,021286,Benicar,OLMESARTAN MEDOXOMIL,2023/07/12,Angiotensin 2 Receptor Blocker,2002,COSETTE PHARMACEUTICALS INC,2022/09/01-,0713-0860; 0713-0861; 0713-0862,6M97XTV3HD,OLMESARTAN MEDOXOMIL,OLMESARTAN,8W1IQP3U10,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/5b6f8a18-8f8a-4521-81c3-3a39c73c6646/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5b6f8a18-8f8a-4521-81c3-3a39c73c6646,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=5b6f8a18-8f8a-4521-81c3-3a39c73c6646,5b6f8a18-8f8a-4521-81c3-3a39c73c6646,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,200175,Tribenzor,OLMESARTAN MEDOXOMIL / AMLODIPINE BESYLATE / HYDROCHLOROTHIAZIDE,2023/07/12,Angiotensin 2 Receptor Blocker; Calcium Channel Blocker; Dihydropyridine Calcium Channel Blocker; Thiazide Diuretic,2010,COSETTE PHARMACEUTICALS INC,2022/09/01-,0713-0874; 0713-0875; 0713-0876; 0713-0877; 0713-0878,0J48LPH2TH; 6M97XTV3HD; 864V2Q084H,AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL,AMLODIPINE; HYDROCHLOROTHIAZIDE; OLMESARTAN,0J48LPH2TH; 1J444QC288; 8W1IQP3U10,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/2f56d0bc-236b-41a0-9fc0-21cdfea8d890/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2f56d0bc-236b-41a0-9fc0-21cdfea8d890,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=2f56d0bc-236b-41a0-9fc0-21cdfea8d890,2f56d0bc-236b-41a0-9fc0-21cdfea8d890,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,200175,Tribenzor,OLMESARTAN MEDOXOMIL / AMLODIPINE BESYLATE / HYDROCHLOROTHIAZIDE,2022/06/07,Angiotensin 2 Receptor Blocker; Calcium Channel Blocker; Dihydropyridine Calcium Channel Blocker; Thiazide Diuretic,2010,DAIICHI SANKYO INC,completed:2010/07/31-2023/07/31; completed:2010/07/31-2024/02/29; completed:2010/07/31-2024/05/31; completed:2010/07/31-2024/06/30; completed:2010/07/31-2024/08/31,65597-114; 65597-115; 65597-116; 65597-117; 65597-118,0J48LPH2TH; 6M97XTV3HD; 864V2Q084H,AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL,AMLODIPINE; HYDROCHLOROTHIAZIDE; OLMESARTAN,0J48LPH2TH; 1J444QC288; 8W1IQP3U10,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/5562b3f5-8757-11de-8a39-0800200c9a66/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5562b3f5-8757-11de-8a39-0800200c9a66,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=5562b3f5-8757-11de-8a39-0800200c9a66,5562b3f5-8757-11de-8a39-0800200c9a66,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,021532,Benicar HCT,OLMESARTAN MEDOXOMIL-HYDROCHLOROTHIAZIDE,2023/07/12,Angiotensin 2 Receptor Blocker; Thiazide Diuretic,2003,COSETTE PHARMACEUTICALS INC,2022/09/01-,0713-0863; 0713-0864; 0713-0865,0J48LPH2TH; 6M97XTV3HD,HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL,HYDROCHLOROTHIAZIDE; OLMESARTAN,0J48LPH2TH; 8W1IQP3U10,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/881a1c32-c209-4038-9c5e-c5e46c6e0546/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=881a1c32-c209-4038-9c5e-c5e46c6e0546,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=881a1c32-c209-4038-9c5e-c5e46c6e0546,881a1c32-c209-4038-9c5e-c5e46c6e0546,,,
HUMAN PRESCRIPTION DRUG LABEL,"SPRAY, METERED",INHALATION,NDA,203108,Striverdi Respimat,OLODATEROL RESPIMAT INHALATION SPRAY,2023/05/23,beta2-Adrenergic Agonist,2014,BOEHRINGER INGELHEIM PHARMACEUTICALS INC,2014/08/01-,0597-0192,65R445W3V9,OLODATEROL HYDROCHLORIDE,OLODATEROL,VD2YSN1AFD,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/5d9a5433-857e-44ea-b3d6-2a400ca0cef5/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5d9a5433-857e-44ea-b3d6-2a400ca0cef5,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=5d9a5433-857e-44ea-b3d6-2a400ca0cef5,5d9a5433-857e-44ea-b3d6-2a400ca0cef5,,,
HUMAN PRESCRIPTION DRUG LABEL,"SPRAY, METERED",NASAL,NDA,211746,Ryaltris,OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE,2024/05/15,Corticosteroid; Histamine-1 Receptor Antagonist; Histamine-1 Receptor Inhibitor; Mast Cell Stabilizer,2022,HIKMA SPECIALTY USA INC,2022/08/15-,59467-700,2XG66W44KF; MTW0WEG809,MOMETASONE FUROATE MONOHYDRATE; OLOPATADINE HYDROCHLORIDE,MOMETASONE; OLOPATADINE,8HR4QJ6DW8; D27V6190PM,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/382eac74-a7ce-4f42-ac0a-b253308f335f/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=382eac74-a7ce-4f42-ac0a-b253308f335f,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=382eac74-a7ce-4f42-ac0a-b253308f335f,382eac74-a7ce-4f42-ac0a-b253308f335f,,,
HUMAN PRESCRIPTION DRUG LABEL,"CAPSULE, GELATIN COATED",ORAL,NDA,019715,Dipentum,OLSALAZINE SODIUM,2023/10/15,Aminosalicylate,,MEDA PHARMACEUTICALS INC,2015/05/15-,0037-6860,Y7JEW0XG7I,OLSALAZINE SODIUM,OLSALAZINE,ULS5I8J03O,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/8512d0c6-db4e-4673-b3b4-28975c18413f/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8512d0c6-db4e-4673-b3b4-28975c18413f,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=8512d0c6-db4e-4673-b3b4-28975c18413f,8512d0c6-db4e-4673-b3b4-28975c18413f,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,NDA,215814,REZLIDHIA,OLUTASIDENIB,2023/03/29,,2022,RIGEL PHARMACEUTICALS INC,2022/12/01-,71332-005,0T4IMT8S5Z,OLUTASIDENIB,OLUTASIDENIB,0T4IMT8S5Z,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/4a0c7c8b-b95f-455d-9600-b7351e4397fe/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4a0c7c8b-b95f-455d-9600-b7351e4397fe,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=4a0c7c8b-b95f-455d-9600-b7351e4397fe,4a0c7c8b-b95f-455d-9600-b7351e4397fe,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION; TABLET, FILM COATED",INTRAVENOUS; ORAL,NDA,209816;209817,NUZYRA,OMADACYCLINE,2021/06/03,Tetracycline-class Antibacterial,2018,PARATEK PHARMACEUTICALS INC,2019/02/01-,71715-001; 71715-002,090IP5RV8F,omadacycline,omadacycline,090IP5RV8F,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/51591524-4703-44c6-8bde-dce3e6a463d1/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=51591524-4703-44c6-8bde-dce3e6a463d1,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=51591524-4703-44c6-8bde-dce3e6a463d1,51591524-4703-44c6-8bde-dce3e6a463d1,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,NDA,216718,SKYCLARYS,OMAVELOXOLONE,2024/01/30,,2023,REATA PHARMACEUTICALS INC,2023/02/28-,73179-250,G69Z98951Q,omaveloxolone,omaveloxolone,G69Z98951Q,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/f1a1100e-8318-1596-e053-2995a90a533e/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f1a1100e-8318-1596-e053-2995a90a533e,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=f1a1100e-8318-1596-e053-2995a90a533e,f1a1100e-8318-1596-e053-2995a90a533e,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,NDA,204977,Omtryg,OMEGA-3-ACID ETHYL ESTERS,2016/03/31,Omega-3 Fatty Acid,2004,TRYGG PHARMA INC,2016/07/01-,61112-001,D87YGH4Z0Q,OMEGA-3-ACID ETHYL ESTERS,OMEGA-3 FATTY ACIDS,71M78END5S,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/5fe15bdb-f59f-4b87-8e5d-8a3d5683eb3d/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5fe15bdb-f59f-4b87-8e5d-8a3d5683eb3d,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=5fe15bdb-f59f-4b87-8e5d-8a3d5683eb3d,5fe15bdb-f59f-4b87-8e5d-8a3d5683eb3d,,,
HUMAN PRESCRIPTION DRUG LABEL,"CAPSULE, DELAYED RELEASE",ORAL,NDA,019810,Omeprazole Delayed-Release,OMEPRAZOLE,2009/08/25,Proton Pump Inhibitor,1989,RANBAXY LABORATORIES INC,2008/07/25-,63304-445,KG60484QX9,OMEPRAZOLE,OMEPRAZOLE,KG60484QX9,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/b43f6b44-9de3-4efb-a467-487aee28f6a0/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b43f6b44-9de3-4efb-a467-487aee28f6a0,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=b43f6b44-9de3-4efb-a467-487aee28f6a0,b43f6b44-9de3-4efb-a467-487aee28f6a0,,,
HUMAN PRESCRIPTION DRUG LABEL,KIT,ORAL,NDA,213593,Konvomep,OMEPRAZOLE AND SODIUM BICARBONATE,2023/08/30,Proton Pump Inhibitor,2004,AZURITY PHARMACEUTICALS INC,2023/02/15-,65628-272,8MDF5V39QO; KG60484QX9,OMEPRAZOLE; SODIUM BICARBONATE,BICARBONATE ION; OMEPRAZOLE,HN1ZRA3Q20; KG60484QX9,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/688ed6f1-d78a-4006-a682-57021cb38a3e/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=688ed6f1-d78a-4006-a682-57021cb38a3e,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=688ed6f1-d78a-4006-a682-57021cb38a3e,688ed6f1-d78a-4006-a682-57021cb38a3e,,,
HUMAN PRESCRIPTION DRUG LABEL,"CAPSULE; POWDER, FOR SUSPENSION",ORAL,NDA,021636;021849,ZEGERID,OMEPRAZOLE AND SODIUM BICARBONATE,2023/07/19,Proton Pump Inhibitor,2004,SANTARUS INC,2004/06/15-; 2006/02/27-; 2014/06/15-,68012-052; 68012-054; 68012-102; 68012-104,8MDF5V39QO; KG60484QX9,OMEPRAZOLE; SODIUM BICARBONATE,BICARBONATE ION; OMEPRAZOLE,HN1ZRA3Q20; KG60484QX9,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/cd6868b9-5824-442b-8d65-4db29ecb70a4/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=cd6868b9-5824-442b-8d65-4db29ecb70a4,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=cd6868b9-5824-442b-8d65-4db29ecb70a4,cd6868b9-5824-442b-8d65-4db29ecb70a4,,,
HUMAN PRESCRIPTION DRUG LABEL,"GRANULE, DELAYED RELEASE",ORAL,NDA,022056,Prilosec,OMEPRAZOLE MAGNESIUM,2024/03/19,Proton Pump Inhibitor,1989,COVIS PHARMA US INC,2017/08/25-,70515-610; 70515-625,426QFE7XLK,OMEPRAZOLE MAGNESIUM,OMEPRAZOLE,KG60484QX9,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/b6761f84-53ac-4745-a8c8-1e5427d7e179/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b6761f84-53ac-4745-a8c8-1e5427d7e179,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=b6761f84-53ac-4745-a8c8-1e5427d7e179,b6761f84-53ac-4745-a8c8-1e5427d7e179,,,
HUMAN PRESCRIPTION DRUG LABEL,"CAPSULE, DELAYED RELEASE",ORAL,NDA,213004,Talicia,"OMEPRAZOLE MAGNESIUM, AMOXICILLIN AND RIFABUTIN",2024/05/01,Penicillin-class Antibacterial; Proton Pump Inhibitor; Rifamycin Antimycobacterial,2019,REDHILL BIOPHARMA LTD,2020/03/09-,57841-1150,1W306TDA6S; 426QFE7XLK; 804826J2HU,AMOXICILLIN; OMEPRAZOLE MAGNESIUM; RIFABUTIN,AMOXICILLIN ANHYDROUS; OMEPRAZOLE; RIFABUTIN,1W306TDA6S; 9EM05410Q9; KG60484QX9,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/68c4e9dc-dbcf-4151-b6f7-5e4b9922b76f/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=68c4e9dc-dbcf-4151-b6f7-5e4b9922b76f,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=68c4e9dc-dbcf-4151-b6f7-5e4b9922b76f,68c4e9dc-dbcf-4151-b6f7-5e4b9922b76f,,,
HUMAN PRESCRIPTION DRUG LABEL,KIT,ORAL,NDA,050824,Omeclamox-Pak,"OMEPRAZOLE, CLARITHROMYCIN, AMOXICILLIN",2023/08/17,Macrolide Antimicrobial; Penicillin-class Antibacterial; Proton Pump Inhibitor,2011,CUMBERLAND PHARMACEUTICALS INC,2012/04/27-,66220-422,804826J2HU; H1250JIK0A; KG60484QX9,AMOXICILLIN; CLARITHROMYCIN; OMEPRAZOLE,AMOXICILLIN ANHYDROUS; CLARITHROMYCIN; OMEPRAZOLE,9EM05410Q9; H1250JIK0A; KG60484QX9,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/9e52c29a-fdbe-4a4d-b280-d700eba5b94f/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9e52c29a-fdbe-4a4d-b280-d700eba5b94f,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=9e52c29a-fdbe-4a4d-b280-d700eba5b94f,9e52c29a-fdbe-4a4d-b280-d700eba5b94f,,,
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION/ DROPS,OPHTHALMIC,NDA,215092,Omlonti,OMIDENEPAG ISOPROPYL,2023/10/09,Prostaglandin E2 Receptor Agonist,2022,SANTEN INCORPORATED,2022/09/23-,65086-002,G0G0H52U6K,OMIDENEPAG ISOPROPYL,OMIDENEPAG,Z95F9F9LU4,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/8e440b2c-fbe5-4c86-b7f3-3da00a5b2924/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8e440b2c-fbe5-4c86-b7f3-3da00a5b2924,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=8e440b2c-fbe5-4c86-b7f3-3da00a5b2924,8e440b2c-fbe5-4c86-b7f3-3da00a5b2924,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,NDA,212489,ONGENTYS,OPICAPONE,2023/12/12,Catechol-O-Methyltransferase Inhibitor,2020,AMNEAL PHARMACEUTICALS LLC,2024/04/05-,64896-402; 64896-403,Y5929UIJ5N,OPICAPONE,OPICAPONE,Y5929UIJ5N,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/a511a531-112e-43f8-a43f-5334b0efe979/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a511a531-112e-43f8-a43f-5334b0efe979,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=a511a531-112e-43f8-a43f-5334b0efe979,a511a531-112e-43f8-a43f-5334b0efe979,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,NDA,212489,ONGENTYS,OPICAPONE,2020/04/26,Catechol-O-Methyltransferase Inhibitor,2020,NEUROCRINE BIOSCIENCES INC,2020/04/24-,70370-3025; 70370-3050,Y5929UIJ5N,OPICAPONE,OPICAPONE,Y5929UIJ5N,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/278a60c4-2353-4657-b486-f392b93181b7/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=278a60c4-2353-4657-b486-f392b93181b7,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=278a60c4-2353-4657-b486-f392b93181b7,278a60c4-2353-4657-b486-f392b93181b7,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,213051,RYBELSUS,ORAL SEMAGLUTIDE,2024/01/24,GLP-1 Receptor Agonist,2017,NOVO NORDISK,2019/09/20-,0169-4303; 0169-4307; 0169-4314,53AXN4NNHX,SEMAGLUTIDE,SEMAGLUTIDE,53AXN4NNHX,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/27f15fac-7d98-4114-a2ec-92494a91da98/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=27f15fac-7d98-4114-a2ec-92494a91da98,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=27f15fac-7d98-4114-a2ec-92494a91da98,27f15fac-7d98-4114-a2ec-92494a91da98,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAVENOUS,NDA,206334,Orbactiv,ORITAVANCIN,2022/02/25,Lipoglycopeptide Antibacterial,2014,MELINTA THERAPEUTICS LLC,2014/09/01-,70842-140,PUG62FRZ2E,ORITAVANCIN,ORITAVANCIN,PUG62FRZ2E,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/ff09a726-9f9b-4e30-b509-396781293220/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ff09a726-9f9b-4e30-b509-396781293220,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=ff09a726-9f9b-4e30-b509-396781293220,ff09a726-9f9b-4e30-b509-396781293220,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAVENOUS,NDA,214155,Kimyrsa,ORITAVANCIN DIPHOSPHATE,2021/07/30,Lipoglycopeptide Antibacterial,2014,MELINTA THERAPEUTICS LLC,2021/03/23-,70842-225,VL1P93MKZN,ORITAVANCIN DIPHOSPHATE,ORITAVANCIN,PUG62FRZ2E,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/5e755c40-6e73-4572-b474-4d8a131693d1/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5e755c40-6e73-4572-b474-4d8a131693d1,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=5e755c40-6e73-4572-b474-4d8a131693d1,5e755c40-6e73-4572-b474-4d8a131693d1,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,NDA,020766,Xenical,ORLISTAT,2023/12/15,Intestinal Lipase Inhibitor,1999,H PHARMA LLC,2010/12/17-,61269-460,95M8R751W8,ORLISTAT,ORLISTAT,95M8R751W8,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/6240792b-9224-2d10-e053-2a91aa0a2c3e/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6240792b-9224-2d10-e053-2a91aa0a2c3e,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=6240792b-9224-2d10-e053-2a91aa0a2c3e,6240792b-9224-2d10-e053-2a91aa0a2c3e,,,
HUMAN PRESCRIPTION DRUG LABEL,"CAPSULE; POWDER, FOR SUSPENSION",ORAL,NDA,021087;021246,Tamiflu,OSELTAMIVIR PHOSPHATE,2023/12/14,Neuraminidase Inhibitor,1999,GENENTECH INC,1999/10/27-; 2011/03/21-,0004-0800; 0004-0801; 0004-0802; 0004-0822,4A3O49NGEZ,OSELTAMIVIR PHOSPHATE,OSELTAMIVIR ACID,K6106LV5Q8,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/ee3c9555-60f2-4f82-a760-11983c86e97b/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ee3c9555-60f2-4f82-a760-11983c86e97b,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=ee3c9555-60f2-4f82-a760-11983c86e97b,ee3c9555-60f2-4f82-a760-11983c86e97b,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, COATED",ORAL,NDA,212801,Isturisa,OSILODROSTAT,2023/11/03,Cortisol Synthesis Inhibitor,2020,RECORDATI RARE DISEASES INC,2020/03/31-; completed:2020/03/31-2023/04/03,55292-320; 55292-321; 55292-322,Y6581YAW9V,OSILODROSTAT PHOSPHATE,OSILODROSTAT,5YL4IQ1078,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/f3a5ec24-63c3-4d83-b1c0-6c550fbe7ae2/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f3a5ec24-63c3-4d83-b1c0-6c550fbe7ae2,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=f3a5ec24-63c3-4d83-b1c0-6c550fbe7ae2,f3a5ec24-63c3-4d83-b1c0-6c550fbe7ae2,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,208065,TAGRISSO,OSIMERTINIB,2024/04/29,Kinase Inhibitor,2015,ASTRAZENECA PHARMACEUTICALS LP,2015/11/13-,0310-1349; 0310-1350,3C06JJ0Z2O,OSIMERTINIB,OSIMERTINIB,3C06JJ0Z2O,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/5e81b4a7-b971-45e1-9c31-29cea8c87ce7/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5e81b4a7-b971-45e1-9c31-29cea8c87ce7,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=5e81b4a7-b971-45e1-9c31-29cea8c87ce7,5e81b4a7-b971-45e1-9c31-29cea8c87ce7,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,203505,Osphena,OSPEMIFENE,2024/02/16,Estrogen Agonist/Antagonist,2013,DUCHESNAY USA INC,2023/04/01-,55494-580,B0P231ILBK,OSPEMIFENE,OSPEMIFENE,B0P231ILBK,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/9accbcc9-78ee-4f84-9b7e-704f2ab1c413/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9accbcc9-78ee-4f84-9b7e-704f2ab1c413,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=9accbcc9-78ee-4f84-9b7e-704f2ab1c413,9accbcc9-78ee-4f84-9b7e-704f2ab1c413,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,203505,Osphena,OSPEMIFENE,2023/03/16,Estrogen Agonist/Antagonist,2013,SHIONOGI INC,completed:2013/02/26-2025/07/31,59630-580,B0P231ILBK,OSPEMIFENE,OSPEMIFENE,B0P231ILBK,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/8462d6ab-e3cd-4efa-a360-75bf8f917287/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8462d6ab-e3cd-4efa-a360-75bf8f917287,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=8462d6ab-e3cd-4efa-a360-75bf8f917287,8462d6ab-e3cd-4efa-a360-75bf8f917287,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,NDA,215888,VIVJOA,OTESECONAZOLE,2022/07/12,Azole Antifungal,2022,MYCOVIA PHARMACEUTICALS INC,2022/07/11-,74695-823,VHH774W97N,OTESECONAZOLE,OTESECONAZOLE,VHH774W97N,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/e21d5008-800e-4417-927f-14340341865f/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e21d5008-800e-4417-927f-14340341865f,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=e21d5008-800e-4417-927f-14340341865f,e21d5008-800e-4417-927f-14340341865f,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,050640,OXACILLIN,OXACILLIN,2018/09/21,Penicillin-class Antibacterial,,BAXTER HEALTHCARE CORPORATION,1989/10/26-,0338-1013; 0338-1015,G0V6C994Q5,OXACILLIN SODIUM,OXACILLIN,UH95VD7V76,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/d893e45b-7f18-4c67-b10c-1e2e52a6b3ef/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d893e45b-7f18-4c67-b10c-1e2e52a6b3ef,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=d893e45b-7f18-4c67-b10c-1e2e52a6b3ef,d893e45b-7f18-4c67-b10c-1e2e52a6b3ef,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION, CONCENTRATE",INTRAVENOUS,NDA,022160,Oxaliplatin,OXALIPLATIN,2022/07/31,Platinum-based Drug,2002,TEVA PARENTERAL MEDICINES INC,2009/08/11-,0703-3985; 0703-3986,04ZR38536J,OXALIPLATIN,OXALIPLATIN,04ZR38536J,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/9e51cc79-620c-48d7-b267-78e43c1ef6e4/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9e51cc79-620c-48d7-b267-78e43c1ef6e4,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=9e51cc79-620c-48d7-b267-78e43c1ef6e4,9e51cc79-620c-48d7-b267-78e43c1ef6e4,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,NDA,217927,Coxanto,OXAPROZIN,2023/09/06,Nonsteroidal Anti-inflammatory Drug,1992,SOLUBIOMIX LLC,2023/10/24-,69499-403,MHJ80W9LRB,OXAPROZIN,OXAPROZIN,MHJ80W9LRB,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/1c54398b-0f57-42b7-9067-0f8012c7813e/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1c54398b-0f57-42b7-9067-0f8012c7813e,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=1c54398b-0f57-42b7-9067-0f8012c7813e,1c54398b-0f57-42b7-9067-0f8012c7813e,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,NDA,217927,Oxaprozin,OXAPROZIN,2023/09/06,Nonsteroidal Anti-inflammatory Drug,1992,AYURAX LLC,2023/11/14-,73308-403,MHJ80W9LRB,OXAPROZIN,OXAPROZIN,MHJ80W9LRB,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/75482b79-38b0-4765-af3e-726b7ad38b90/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=75482b79-38b0-4765-af3e-726b7ad38b90,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=75482b79-38b0-4765-af3e-726b7ad38b90,75482b79-38b0-4765-af3e-726b7ad38b90,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,018841,Daypro,OXAPROZIN,2022/11/17,Nonsteroidal Anti-inflammatory Drug,1992,PFIZER LABORATORIES DIV PFIZER INC,1992/10/29-,0025-1381,MHJ80W9LRB,OXAPROZIN,OXAPROZIN,MHJ80W9LRB,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/ea1de47e-3101-4414-817c-0a098af8988c/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ea1de47e-3101-4414-817c-0a098af8988c,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=ea1de47e-3101-4414-817c-0a098af8988c,ea1de47e-3101-4414-817c-0a098af8988c,,,
HUMAN PRESCRIPTION DRUG LABEL,"SUSPENSION; TABLET, FILM COATED",ORAL,NDA,021014;021285,Trileptal,OXCARBAZEPINE,2024/03/07,Anti-epileptic Agent,2000,NOVARTIS PHARMACEUTICALS CORPORATION,2000/01/30-; 2001/05/30-,0078-0337; 0078-0357; 0078-0456; 0078-0457,VZI5B1W380,OXCARBAZEPINE,OXCARBAZEPINE,VZI5B1W380,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/4c5c86c8-ab7f-4fcf-bc1b-5a0b1fd0691b/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4c5c86c8-ab7f-4fcf-bc1b-5a0b1fd0691b,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=4c5c86c8-ab7f-4fcf-bc1b-5a0b1fd0691b,4c5c86c8-ab7f-4fcf-bc1b-5a0b1fd0691b,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,202810,OXTELLAR XR,OXCARBAZEPINE,2023/12/20,Anti-epileptic Agent,2000,SUPERNUS PHARMACEUTICALS INC,2013/01/17-,17772-121; 17772-122; 17772-123,VZI5B1W380,OXCARBAZEPINE,OXCARBAZEPINE,VZI5B1W380,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/aa610e56-1d1d-11e1-8bc2-0800200c9a66/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=aa610e56-1d1d-11e1-8bc2-0800200c9a66,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=aa610e56-1d1d-11e1-8bc2-0800200c9a66,aa610e56-1d1d-11e1-8bc2-0800200c9a66,,,
HUMAN PRESCRIPTION DRUG LABEL,LOTION,TOPICAL,NDA,020209,Oxistat,OXICONAZOLE NITRATE,2022/08/23,Azole Antifungal,,ANI PHARMACEUTICALS INC,2022/09/12-,62559-285,RQ8UL4C17S,oxiconazole nitrate,oxiconazole,C668Q9I33J,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/64ef2286-0f56-4a8a-b07b-4a597f078ae0/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=64ef2286-0f56-4a8a-b07b-4a597f078ae0,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=64ef2286-0f56-4a8a-b07b-4a597f078ae0,64ef2286-0f56-4a8a-b07b-4a597f078ae0,,,
HUMAN PRESCRIPTION DRUG LABEL,CREAM; LOTION,TOPICAL,NDA,019828;020209,Oxistat,OXICONAZOLE NITRATE,2020/09/10,Azole Antifungal,,PHARMADERM A DIVISION OF FOUGERA PHARMACEUTICALS INC,1988/12/30-; 1992/09/30-,10337-358; 10337-359,RQ8UL4C17S,oxiconazole nitrate,oxiconazole,C668Q9I33J,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/b87a89d2-6e45-4eb8-be2c-7f55f34d61e5/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b87a89d2-6e45-4eb8-be2c-7f55f34d61e5,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=b87a89d2-6e45-4eb8-be2c-7f55f34d61e5,b87a89d2-6e45-4eb8-be2c-7f55f34d61e5,,,
HUMAN PRESCRIPTION DRUG LABEL,PATCH,TRANSDERMAL,NDA,021351,OXYTROL,OXYBUTYNIN,2023/11/02,Cholinergic Muscarinic Antagonist,1975,ALLERGAN INC,2003/02/26-,0023-6153,K9P6MC7092,OXYBUTYNIN,OXYBUTYNIN,K9P6MC7092,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/20dee37f-1412-44ed-9e8b-f4379ce23eb0/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=20dee37f-1412-44ed-9e8b-f4379ce23eb0,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=20dee37f-1412-44ed-9e8b-f4379ce23eb0,20dee37f-1412-44ed-9e8b-f4379ce23eb0,,,
HUMAN PRESCRIPTION DRUG LABEL,GEL,TRANSDERMAL,NDA,022204,GELNIQUE,OXYBUTYNIN CHLORIDE,2019/03/01,Cholinergic Muscarinic Antagonist,1975,ALLERGAN INC,2017/04/01-; completed:2017/04/01-2020/10/31,0023-5812; 0023-5861,L9F3D9RENQ,OXYBUTYNIN CHLORIDE,OXYBUTYNIN,K9P6MC7092,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/57616d79-9e68-4ec7-a25f-ebee07576351/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=57616d79-9e68-4ec7-a25f-ebee07576351,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=57616d79-9e68-4ec7-a25f-ebee07576351,57616d79-9e68-4ec7-a25f-ebee07576351,,,
HUMAN PRESCRIPTION DRUG LABEL,"CAPSULE, EXTENDED RELEASE",ORAL,NDA,208090,XTAMPZA ER,OXYCODONE,2023/12/20,Opioid Agonist,1950,COLLEGIUM PHARMACEUTICAL INC,2016/05/10-,24510-110; 24510-115; 24510-120; 24510-130; 24510-140,CD35PMG570,OXYCODONE,OXYCODONE,CD35PMG570,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/b0a5ded2-8ee2-49ca-a86c-2b28ae40f60c/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b0a5ded2-8ee2-49ca-a86c-2b28ae40f60c,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=b0a5ded2-8ee2-49ca-a86c-2b28ae40f60c,b0a5ded2-8ee2-49ca-a86c-2b28ae40f60c,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,NDA,022272,OxyContin,OXYCODONE HYDROCHLORIDE,2024/05/03,Opioid Agonist,1950,PURDUE PHARMA LP,2010/08/08-,59011-410; 59011-415; 59011-420; 59011-430; 59011-440; 59011-460; 59011-480,C1ENJ2TE6C,OXYCODONE HYDROCHLORIDE,OXYCODONE,CD35PMG570,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/bfdfe235-d717-4855-a3c8-a13d26dadede/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=bfdfe235-d717-4855-a3c8-a13d26dadede,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=bfdfe235-d717-4855-a3c8-a13d26dadede,bfdfe235-d717-4855-a3c8-a13d26dadede,,,
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION,ORAL,NDA,201194,Oxycodone Hydrochloride,OXYCODONE HYDROCHLORIDE,2024/04/26,Opioid Agonist,1950,VISTAPHARM LLC,completed:2012/03/15-2024/12/31; completed:2012/03/15-2025/05/31,66689-401; 66689-403,C1ENJ2TE6C,OXYCODONE HYDROCHLORIDE,OXYCODONE,CD35PMG570,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/d7dceba3-96dc-4593-bc8f-318052bdb520/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d7dceba3-96dc-4593-bc8f-318052bdb520,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=d7dceba3-96dc-4593-bc8f-318052bdb520,d7dceba3-96dc-4593-bc8f-318052bdb520,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,202080,OXAYDO,OXYCODONE HYDROCHLORIDE,2024/04/24,Opioid Agonist,1950,ZYLA LIFE SCIENCES US LLC,2015/09/01-,69344-113; 69344-213,C1ENJ2TE6C,OXYCODONE HYDROCHLORIDE,OXYCODONE,CD35PMG570,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/cff0c64a-63f5-4b3c-909a-cdecf6755cbe/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=cff0c64a-63f5-4b3c-909a-cdecf6755cbe,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=cff0c64a-63f5-4b3c-909a-cdecf6755cbe,cff0c64a-63f5-4b3c-909a-cdecf6755cbe,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,021011,Roxicodone,OXYCODONE HYDROCHLORIDE,2024/04/22,Opioid Agonist,1950,SPECGX LLC,2000/08/31-,23635-581; 23635-582,C1ENJ2TE6C,OXYCODONE HYDROCHLORIDE,OXYCODONE,CD35PMG570,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/5a8157d3-ba20-4abf-b0d4-6ad141b31d63/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5a8157d3-ba20-4abf-b0d4-6ad141b31d63,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=5a8157d3-ba20-4abf-b0d4-6ad141b31d63,5a8157d3-ba20-4abf-b0d4-6ad141b31d63,,,
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION,ORAL,NDA,200535,Oxycodone Hydrochloride,OXYCODONE HYDROCHLORIDE,2024/01/12,Opioid Agonist,1950,GENUS LIFESCIENCES INC,2010/10/20-; 2013/09/09-,64950-353; 64950-354,C1ENJ2TE6C,Oxycodone Hydrochloride,Oxycodone,CD35PMG570,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/6869fec9-1837-4221-afd8-5cc6fadd025d/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6869fec9-1837-4221-afd8-5cc6fadd025d,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=6869fec9-1837-4221-afd8-5cc6fadd025d,6869fec9-1837-4221-afd8-5cc6fadd025d,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,NDA,200534,Oxycodone Hydrochloride,OXYCODONE HYDROCHLORIDE,2024/01/12,Opioid Agonist,1950,GENUS LIFESCIENCES INC,2010/10/20-,64950-901,C1ENJ2TE6C,Oxycodone Hydrochloride,Oxycodone,CD35PMG570,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/061cf52b-4432-422d-a97b-c3e1f8c4bab6/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=061cf52b-4432-422d-a97b-c3e1f8c4bab6,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=061cf52b-4432-422d-a97b-c3e1f8c4bab6,061cf52b-4432-422d-a97b-c3e1f8c4bab6,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, EXTENDED RELEASE",ORAL,NDA,022272,Oxycodone Hydrochloride,OXYCODONE HYDROCHLORIDE,2021/03/24,Opioid Agonist,1950,CAMBER PHARMACEUTICALS INC,2020/12/23-,31722-109; 31722-110; 31722-111,C1ENJ2TE6C,OXYCODONE HYDROCHLORIDE,OXYCODONE,CD35PMG570,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/e8990bfc-e16c-46b2-a3b6-9c9c883aa72a/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e8990bfc-e16c-46b2-a3b6-9c9c883aa72a,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=e8990bfc-e16c-46b2-a3b6-9c9c883aa72a,e8990bfc-e16c-46b2-a3b6-9c9c883aa72a,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,NDA,205777,TARGINIQ ER,OXYCODONE HYDROCHLORIDE/NALOXONE HYDROCHLORIDE,2016/12/22,Opioid Agonist; Opioid Antagonist,2014,PURDUE PHARMA LP,2020/01/01-,59011-520; 59011-521; 59011-522,C1ENJ2TE6C; F850569PQR,NALOXONE HYDROCHLORIDE; OXYCODONE HYDROCHLORIDE,NALOXONE; OXYCODONE,36B82AMQ7N; CD35PMG570,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/98e70c9c-fa3c-e63f-41d4-dac3c6fec51d/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=98e70c9c-fa3c-e63f-41d4-dac3c6fec51d,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=98e70c9c-fa3c-e63f-41d4-dac3c6fec51d,98e70c9c-fa3c-e63f-41d4-dac3c6fec51d,,,
HUMAN PRESCRIPTION DRUG LABEL,CREAM,TOPICAL,NDA,208552,Rhofade,OXYMETAZOLINE HYDROCHLORIDE,2023/05/09,Vasoconstrictor,1964,EPI HEALTH LLC,2021/01/18-,71403-003,K89MJ0S5VY,OXYMETAZOLINE HYDROCHLORIDE,oxymetazoline,8VLN5B44ZY,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/e82b5788-a855-4165-a81f-7f15cb874612/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e82b5788-a855-4165-a81f-7f15cb874612,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=e82b5788-a855-4165-a81f-7f15cb874612,e82b5788-a855-4165-a81f-7f15cb874612,,,
HUMAN PRESCRIPTION DRUG LABEL,CREAM,TOPICAL,NDA,208552,Rhofade,OXYMETAZOLINE HYDROCHLORIDE,2019/10/31,Vasoconstrictor,1964,ACLARIS THERAPEUTICS INC,2017/01/18-,71180-003,K89MJ0S5VY,oxymetazoline Hydrochloride,oxymetazoline,8VLN5B44ZY,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/8968299e-2a4f-41a8-9088-6343ea6c91f4/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8968299e-2a4f-41a8-9088-6343ea6c91f4,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=8968299e-2a4f-41a8-9088-6343ea6c91f4,8968299e-2a4f-41a8-9088-6343ea6c91f4,,,
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION/ DROPS,OPHTHALMIC,NDA,212520,UPNEEQ,OXYMETAZOLINE HYDROCHLORIDE OPHTHALMIC,2023/05/09,Vasoconstrictor,1964,RVL PHARMACEUTICALS INC,2020/08/21-,73687-062,K89MJ0S5VY,OXYMETAZOLINE HYDROCHLORIDE,OXYMETAZOLINE,8VLN5B44ZY,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/cf6c9a1f-2367-46d2-99c3-c7d67ec6f519/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=cf6c9a1f-2367-46d2-99c3-c7d67ec6f519,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=cf6c9a1f-2367-46d2-99c3-c7d67ec6f519,cf6c9a1f-2367-46d2-99c3-c7d67ec6f519,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAMUSCULAR; INTRAVENOUS,NDA,018248,Oxytocin,OXYTOCIN,2023/10/16,Oxytocic,,FRESENIUS KABI USA LLC,2000/08/10-,63323-012,1JQS135EYN,OXYTOCIN,OXYTOCIN,1JQS135EYN,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/c7fd585a-99b7-4309-b003-a6cbef05372c/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c7fd585a-99b7-4309-b003-a6cbef05372c,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=c7fd585a-99b7-4309-b003-a6cbef05372c,c7fd585a-99b7-4309-b003-a6cbef05372c,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRAVENOUS,NDA,018261,Pitocin,OXYTOCIN,2023/06/27,Oxytocic,,ENDO USA INC,2024/05/06-,42023-116,1JQS135EYN,OXYTOCIN,OXYTOCIN,1JQS135EYN,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/6e5a66fc-e507-497c-b5ce-44a8c95898ad/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6e5a66fc-e507-497c-b5ce-44a8c95898ad,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=6e5a66fc-e507-497c-b5ce-44a8c95898ad,6e5a66fc-e507-497c-b5ce-44a8c95898ad,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRAVENOUS,NDA,018261,Pitocin,OXYTOCIN,2023/06/05,Oxytocic,,PAR PHARMACEUTICAL INC,2023/12/22-,42023-116,1JQS135EYN,OXYTOCIN,OXYTOCIN,1JQS135EYN,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/dddcdcc3-cd4d-4573-98ac-9468bea23a8b/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=dddcdcc3-cd4d-4573-98ac-9468bea23a8b,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=dddcdcc3-cd4d-4573-98ac-9468bea23a8b,dddcdcc3-cd4d-4573-98ac-9468bea23a8b,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAMUSCULAR; INTRAVENOUS,NDA,018248,Oxytocin,OXYTOCIN,2021/09/01,Oxytocic,,FRESENIUS KABI USA LLC,2000/08/10-,63323-012,1JQS135EYN,OXYTOCIN,OXYTOCIN,1JQS135EYN,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/6d7d1280-f286-4f39-89f3-2b96571810e6/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6d7d1280-f286-4f39-89f3-2b96571810e6,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=6d7d1280-f286-4f39-89f3-2b96571810e6,6d7d1280-f286-4f39-89f3-2b96571810e6,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRAVENOUS,NDA,018261,Pitocin,OXYTOCIN,2021/06/15,Oxytocic,,PAR PHARMACEUTICAL INC,2008/02/01-,42023-116,1JQS135EYN,OXYTOCIN,OXYTOCIN,1JQS135EYN,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/969d5b35-0add-4c23-9605-6a5b6ab65c95/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=969d5b35-0add-4c23-9605-6a5b6ab65c95,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=969d5b35-0add-4c23-9605-6a5b6ab65c95,969d5b35-0add-4c23-9605-6a5b6ab65c95,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRAVENOUS,NDA,018261,Pitocin,OXYTOCIN,2020/11/12,Oxytocic,,PAR PHARMACEUTICAL INC,2018/05/01-,42023-130,1JQS135EYN,OXYTOCIN,OXYTOCIN,1JQS135EYN,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/6d4b2c25-2e5d-49b5-93bc-2ae8a20916d1/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6d4b2c25-2e5d-49b5-93bc-2ae8a20916d1,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=6d4b2c25-2e5d-49b5-93bc-2ae8a20916d1,6d4b2c25-2e5d-49b5-93bc-2ae8a20916d1,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRAMUSCULAR; INTRAVENOUS,NDA,018243,Oxytocin,OXYTOCIN,2019/12/30,Oxytocic,,HIKMA PHARMACEUTICALS USA INC,1980/04/29-,0641-6114; 0641-6115,1JQS135EYN,OXYTOCIN,OXYTOCIN,1JQS135EYN,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/a9b62187-4141-487c-a9da-f42ad7f9b408/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a9b62187-4141-487c-a9da-f42ad7f9b408,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=a9b62187-4141-487c-a9da-f42ad7f9b408,a9b62187-4141-487c-a9da-f42ad7f9b408,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE; KIT,ORAL,NDA,209899,ZEPOSIA; ZEPOSIA 7-Day Starter Pack; ZEPOSIA Starter Kit,OZANIMOD HYDROCHLORIDE,2023/08/10,Sphingosine 1-phosphate Receptor Modulator,2020,CELGENE CORPORATION,2020/03/27-,59572-810; 59572-820; 59572-890,3UPR33JAAM,OZANIMOD HYDROCHLORIDE,OZANIMOD,Z80293URPV,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/93ce2fab-edfb-4804-8074-963071de51e4/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=93ce2fab-edfb-4804-8074-963071de51e4,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=93ce2fab-edfb-4804-8074-963071de51e4,93ce2fab-edfb-4804-8074-963071de51e4,,,
HUMAN PRESCRIPTION DRUG LABEL,CREAM,TOPICAL,NDA,208945,Xepi,OZENOXACIN,2023/09/25,Quinolone Antimicrobial,2017,BIOFRONTERA INC,completed:2019/12/19-2024/07/31,70621-103,V0LH498RFO,OZENOXACIN,OZENOXACIN,V0LH498RFO,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/2765b37b-4862-473f-b4cd-8da908088e8b/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2765b37b-4862-473f-b4cd-8da908088e8b,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=2765b37b-4862-473f-b4cd-8da908088e8b,2765b37b-4862-473f-b4cd-8da908088e8b,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION",INTRAVENOUS,NDA,211875,PACLITAXEL PROTEIN BOUND PARTICLES ALBUMIN BOUND,PACLITAXEL,2023/05/31,Microtubule Inhibitor,2005,AMERICAN REGENT INC,2023/05/02-,0517-4300,P88XT4IS4D,PACLITAXEL,PACLITAXEL,P88XT4IS4D,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/f06d1bb3-83f1-4d84-8004-4c6681ad8a5a/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f06d1bb3-83f1-4d84-8004-4c6681ad8a5a,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=f06d1bb3-83f1-4d84-8004-4c6681ad8a5a,f06d1bb3-83f1-4d84-8004-4c6681ad8a5a,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION",INTRAVENOUS,NDA,021660,ABRAXANE,PACLITAXEL,2022/10/31,Microtubule Inhibitor,2005,ABRAXIS BIOSCIENCE LLC,2005/02/10-,68817-134,P88XT4IS4D,PACLITAXEL,PACLITAXEL,P88XT4IS4D,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/24d10449-2936-4cd3-b7db-a7683db721e4/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=24d10449-2936-4cd3-b7db-a7683db721e4,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=24d10449-2936-4cd3-b7db-a7683db721e4,24d10449-2936-4cd3-b7db-a7683db721e4,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,NDA,208712,Vonjo,PACRITINIB,2022/03/07,Kinase Inhibitor,2022,CTI BIOPHARMA CORP,2022/02/28-,72482-100,G22N65IL3O,Pacritinib,Pacritinib,G22N65IL3O,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/4b5ab444-0e1a-4984-99db-76ad11a298ee/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4b5ab444-0e1a-4984-99db-76ad11a298ee,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=4b5ab444-0e1a-4984-99db-76ad11a298ee,4b5ab444-0e1a-4984-99db-76ad11a298ee,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRAVENOUS,NDA,214907,Cytalux,PAFOLACIANINE INJECTION,2023/07/12,Optical Imaging Agent,2021,ON TARGET LABORATORIES INC,2021/11/29-,81052-138,4HUF3V875C,PAFOLACIANINE SODIUM,PAFOLACIANINE,F7BD3Z4X8L,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/d21952b9-7c4e-3a56-e053-2a95a90a0ab0/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d21952b9-7c4e-3a56-e053-2a95a90a0ab0,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=d21952b9-7c4e-3a56-e053-2a95a90a0ab0,d21952b9-7c4e-3a56-e053-2a95a90a0ab0,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,212436,Ibrance,PALBOCICLIB,2024/03/05,Kinase Inhibitor,2015,PFIZER LABORATORIES DIV PFIZER INC,2020/03/30-,0069-0284; 0069-0486; 0069-0688,G9ZF61LE7G,PALBOCICLIB,PALBOCICLIB,G9ZF61LE7G,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/fecbdd7d-b729-41b5-9872-231b8fe104ce/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=fecbdd7d-b729-41b5-9872-231b8fe104ce,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=fecbdd7d-b729-41b5-9872-231b8fe104ce,fecbdd7d-b729-41b5-9872-231b8fe104ce,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,NDA,207103,Ibrance,PALBOCICLIB,2024/03/04,Kinase Inhibitor,2015,PFIZER LABORATORIES DIV PFIZER INC,2015/02/03-,0069-0187; 0069-0188; 0069-0189,G9ZF61LE7G,PALBOCICLIB,PALBOCICLIB,G9ZF61LE7G,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/e0e6412f-50b4-4fd4-9364-62818d121a07/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e0e6412f-50b4-4fd4-9364-62818d121a07,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=e0e6412f-50b4-4fd4-9364-62818d121a07,e0e6412f-50b4-4fd4-9364-62818d121a07,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,212436,Ibrance,PALBOCICLIB,2024/03/04,Kinase Inhibitor,2015,U S PHARMACEUTICALS,2020/03/30-,63539-284; 63539-486; 63539-688,G9ZF61LE7G,PALBOCICLIB,PALBOCICLIB,G9ZF61LE7G,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/89a142d5-7e61-48bf-9e77-e2cd124c4792/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=89a142d5-7e61-48bf-9e77-e2cd124c4792,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=89a142d5-7e61-48bf-9e77-e2cd124c4792,89a142d5-7e61-48bf-9e77-e2cd124c4792,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,NDA,207103,Ibrance,PALBOCICLIB,2024/03/04,Kinase Inhibitor,2015,U S PHARMACEUTICALS,2015/02/03-; 2017/05/08-,63539-187; 63539-188; 63539-189,G9ZF61LE7G,PALBOCICLIB,PALBOCICLIB,G9ZF61LE7G,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/86718885-da44-4d3d-b3ca-06cbcedcffd8/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=86718885-da44-4d3d-b3ca-06cbcedcffd8,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=86718885-da44-4d3d-b3ca-06cbcedcffd8,86718885-da44-4d3d-b3ca-06cbcedcffd8,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, EXTENDED RELEASE",ORAL,NDA,021999,INVEGA,PALIPERIDONE,2023/08/23,Atypical Antipsychotic,2006,JANSSEN PHARMACEUTICALS INC,2006/12/19-; 2009/09/10-,50458-550; 50458-551; 50458-552; 50458-554,838F01T721,PALIPERIDONE,PALIPERIDONE,838F01T721,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/7b8e5b26-b9e4-4704-921b-3c3c0d159916/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7b8e5b26-b9e4-4704-921b-3c3c0d159916,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=7b8e5b26-b9e4-4704-921b-3c3c0d159916,7b8e5b26-b9e4-4704-921b-3c3c0d159916,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRAMUSCULAR,NDA,022264,INVEGA SUSTENNA,PALIPERIDONE PALMITATE,2022/08/15,Atypical Antipsychotic,2006,JANSSEN PHARMACEUTICALS INC,2009/07/31-,50458-560; 50458-561; 50458-562; 50458-563; 50458-564,R8P8USM8FR,paliperidone palmitate,paliperidone,838F01T721,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/1af14e42-951d-414d-8564-5d5fce138554/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1af14e42-951d-414d-8564-5d5fce138554,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=1af14e42-951d-414d-8564-5d5fce138554,1af14e42-951d-414d-8564-5d5fce138554,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SUSPENSION, EXTENDED RELEASE",INTRAMUSCULAR,NDA,207946,INVEGA TRINZA,PALIPERIDONE PALMITATE,2022/03/23,Atypical Antipsychotic,2006,JANSSEN PHARMACEUTICALS INC,2015/05/19-,50458-606; 50458-607; 50458-608; 50458-609,R8P8USM8FR,paliperidone palmitate,paliperidone,838F01T721,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/c39e65d7-fa44-4e4c-8b12-a654d3ed0eae/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c39e65d7-fa44-4e4c-8b12-a654d3ed0eae,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=c39e65d7-fa44-4e4c-8b12-a654d3ed0eae,c39e65d7-fa44-4e4c-8b12-a654d3ed0eae,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SUSPENSION, EXTENDED RELEASE",INTRAMUSCULAR,NDA,207946,INVEGA HAFYERA,PALIPERIDONE PALMITATE,2021/10/27,Atypical Antipsychotic,2006,JANSSEN PHARMACEUTICALS INC,2021/08/30-,50458-611; 50458-612,R8P8USM8FR,paliperidone palmitate,paliperidone,838F01T721,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/6cd61892-d2cb-434d-83ed-5c1b2c4e7a0b/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6cd61892-d2cb-434d-83ed-5c1b2c4e7a0b,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=6cd61892-d2cb-434d-83ed-5c1b2c4e7a0b,6cd61892-d2cb-434d-83ed-5c1b2c4e7a0b,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,NDA,022233,ALOXI,PALONOSETRON HYDROCHLORIDE,2020/04/09,Serotonin-3 Receptor Antagonist,2003,HELSINN THERAPEUTICS U S INC,2014/05/28-,69639-104,23310D4I19,PALONOSETRON HYDROCHLORIDE,PALONOSETRON,5D06587D6R,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/ab89d423-4275-4651-9ae7-9002f17ab0a1/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ab89d423-4275-4651-9ae7-9002f17ab0a1,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=ab89d423-4275-4651-9ae7-9002f17ab0a1,ab89d423-4275-4651-9ae7-9002f17ab0a1,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,NDA,215559,SOHONOS,PALOVAROTENE,2023/08/24,Retinoid,2023,IPSEN BIOPHARMACEUTICALS INC,2023/08/16-,15054-0010; 15054-0015; 15054-0025; 15054-0050; 15054-0100,28K6I5M16G,palovarotene,palovarotene,28K6I5M16G,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/67dce406-7cc4-4d66-92de-ad18b6df0625/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=67dce406-7cc4-4d66-92de-ad18b6df0625,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=67dce406-7cc4-4d66-92de-ad18b6df0625,67dce406-7cc4-4d66-92de-ad18b6df0625,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,NDA,205353,FARYDAK,PANOBINOSTAT,2021/07/27,Histone Deacetylase Inhibitor,2015,SECURA BIO INC,2015/02/23-,73116-100; 73116-101; 73116-102,HN0T99OO4V,PANOBINOSTAT LACTATE,PANOBINOSTAT,9647FM7Y3Z,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/1b97bd3a-1040-4511-b0e6-4758e8083ae5/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1b97bd3a-1040-4511-b0e6-4758e8083ae5,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=1b97bd3a-1040-4511-b0e6-4758e8083ae5,1b97bd3a-1040-4511-b0e6-4758e8083ae5,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAVENOUS,NDA,209463,Pantoprazole Sodium,PANTOPRAZOLE SODIUM,2023/07/19,Proton Pump Inhibitor,2000,HIKMA PHARMACEUTICALS USA INC,2017/09/22-,0143-9300,6871619Q5X,PANTOPRAZOLE SODIUM,PANTOPRAZOLE,D8TST4O562,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/1e102c44-232b-4aaf-b457-2a740c47193a/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1e102c44-232b-4aaf-b457-2a740c47193a,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=1e102c44-232b-4aaf-b457-2a740c47193a,1e102c44-232b-4aaf-b457-2a740c47193a,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, POWDER, FOR SOLUTION",INTRAVENOUS,NDA,020988,Protonix I.V.,PANTOPRAZOLE SODIUM,2023/07/19,Proton Pump Inhibitor,2000,WYETH PHARMACEUTICALS LLC A SUBSIDIARY OF PFIZER INC,2013/05/01-,0008-4001,6871619Q5X,PANTOPRAZOLE SODIUM,PANTOPRAZOLE,D8TST4O562,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/f39b3e7d-39d2-4c8a-9974-4ab885241880/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f39b3e7d-39d2-4c8a-9974-4ab885241880,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=f39b3e7d-39d2-4c8a-9974-4ab885241880,f39b3e7d-39d2-4c8a-9974-4ab885241880,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAVENOUS,NDA,209463,Pantoprazole Sodium,PANTOPRAZOLE SODIUM,2023/07/10,Proton Pump Inhibitor,2000,HIKMA PHARMACEUTICALS USA INC,2017/09/22-,0143-9284,6871619Q5X,PANTOPRAZOLE SODIUM,PANTOPRAZOLE,D8TST4O562,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/b02f3f85-8f9b-4d06-8eae-73e592626f3e/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b02f3f85-8f9b-4d06-8eae-73e592626f3e,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=b02f3f85-8f9b-4d06-8eae-73e592626f3e,b02f3f85-8f9b-4d06-8eae-73e592626f3e,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, POWDER, FOR SOLUTION",INTRAVENOUS,NDA,020988,Protonix I.V.,PANTOPRAZOLE SODIUM,2023/06/30,Proton Pump Inhibitor,2000,WYETH PHARMACEUTICALS LLC A SUBSIDIARY OF PFIZER INC,2001/05/01-,0008-0923,6871619Q5X,PANTOPRAZOLE SODIUM,PANTOPRAZOLE,D8TST4O562,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/51e4144a-489e-436c-609a-39305f8f56ba/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=51e4144a-489e-436c-609a-39305f8f56ba,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=51e4144a-489e-436c-609a-39305f8f56ba,51e4144a-489e-436c-609a-39305f8f56ba,,,
HUMAN PRESCRIPTION DRUG LABEL,"GRANULE, DELAYED RELEASE; TABLET, DELAYED RELEASE",ORAL,NDA,020987;022020,Protonix Delayed-Release,PANTOPRAZOLE SODIUM,2023/06/30,Proton Pump Inhibitor,2000,WYETH PHARMACEUTICALS LLC A SUBSIDIARY OF PFIZER INC,2000/05/01-; 2008/02/29-,0008-0841; 0008-0843; 0008-0844,6871619Q5X,PANTOPRAZOLE SODIUM,PANTOPRAZOLE,D8TST4O562,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/08098cb2-c048-4640-f387-6beec4a38936/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=08098cb2-c048-4640-f387-6beec4a38936,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=08098cb2-c048-4640-f387-6beec4a38936,08098cb2-c048-4640-f387-6beec4a38936,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,217512,PANTOPRAZOLE SODIUM,PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE,2024/02/14,Proton Pump Inhibitor,2000,BAXTER HEALTHCARE CORPORATION,2024/02/14-,0338-9644; 0338-9646; 0338-9648,6871619Q5X,PANTOPRAZOLE SODIUM,PANTOPRAZOLE,D8TST4O562,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/a476e063-9450-4793-9a22-16b0a0a61cd0/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a476e063-9450-4793-9a22-16b0a0a61cd0,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=a476e063-9450-4793-9a22-16b0a0a61cd0,a476e063-9450-4793-9a22-16b0a0a61cd0,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,020819,Zemplar,PARICALCITOL,2021/05/01,Vitamin D Analog; Vitamin D2 Analog,1998,ABBVIE INC,1998/04/17-,0074-1658; 0074-4637,6702D36OG5,PARICALCITOL,PARICALCITOL,6702D36OG5,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/7259652f-81bc-4ad1-bba5-d01f9fac1b80/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7259652f-81bc-4ad1-bba5-d01f9fac1b80,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=7259652f-81bc-4ad1-bba5-d01f9fac1b80,7259652f-81bc-4ad1-bba5-d01f9fac1b80,,,
HUMAN PRESCRIPTION DRUG LABEL,"CAPSULE, LIQUID FILLED",ORAL,NDA,021606,Zemplar,PARICALCITOL,2021/04/01,Vitamin D Analog; Vitamin D2 Analog,1998,ABBVIE INC,2018/04/20-; completed:2010/06/14-2014/09/03; completed:2010/06/14-2019/12/30,0074-4314; 0074-4317; 0074-9036; 0074-9037,6702D36OG5,PARICALCITOL,PARICALCITOL,6702D36OG5,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/1b27c026-2d60-47b4-2a9c-ded1818f21b5/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1b27c026-2d60-47b4-2a9c-ded1818f21b5,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=1b27c026-2d60-47b4-2a9c-ded1818f21b5,1b27c026-2d60-47b4-2a9c-ded1818f21b5,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,NDA,020936,PAXIL CR,PAROXETINE HYDROCHLORIDE,2024/01/10,Serotonin Reuptake Inhibitor,1992,APOTEX CORP,2011/01/01-; completed:2011/01/01-2021/09/30; completed:2011/01/01-2022/04/20; completed:2011/01/01-2022/11/30,60505-3668; 60505-3669; 60505-3670; 60505-4377; 60505-4378; 60505-4379,X2ELS050D8,PAROXETINE HYDROCHLORIDE,PAROXETINE,41VRH5220H,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/483bd97f-c4d0-4e23-aaa8-6334f4471e0c/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=483bd97f-c4d0-4e23-aaa8-6334f4471e0c,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=483bd97f-c4d0-4e23-aaa8-6334f4471e0c,483bd97f-c4d0-4e23-aaa8-6334f4471e0c,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,020031,PAXIL,PAROXETINE HYDROCHLORIDE,2023/12/25,Serotonin Reuptake Inhibitor,1992,APOTEX CORP,2019/03/11-,60505-4517; 60505-4518; 60505-4519; 60505-4520,X2ELS050D8,PAROXETINE HYDROCHLORIDE,PAROXETINE,41VRH5220H,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/ef3b5cbe-f9e1-c1ac-79da-cfe14e3a7e7e/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ef3b5cbe-f9e1-c1ac-79da-cfe14e3a7e7e,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=ef3b5cbe-f9e1-c1ac-79da-cfe14e3a7e7e,ef3b5cbe-f9e1-c1ac-79da-cfe14e3a7e7e,,,
HUMAN PRESCRIPTION DRUG LABEL,"SUSPENSION; TABLET, FILM COATED",ORAL,NDA,020031;020710,PAXIL,PAROXETINE HYDROCHLORIDE,2023/01/18,Serotonin Reuptake Inhibitor,1992,APOTEX CORP,completed:2011/01/01-2021/05/31; completed:2011/01/01-2025/11/30,60505-0402; 60505-3666,X2ELS050D8,PAROXETINE HYDROCHLORIDE,PAROXETINE,41VRH5220H,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/584ace29-6e40-432f-950f-ab7e98653d32/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=584ace29-6e40-432f-950f-ab7e98653d32,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=584ace29-6e40-432f-950f-ab7e98653d32,584ace29-6e40-432f-950f-ab7e98653d32,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,021299,PEXEVA,PAROXETINE MESYLATE,2023/08/31,Serotonin Reuptake Inhibitor,1992,SEBELA PHARMACEUTICALS INC,completed:2017/06/02-2024/05/31,54766-201; 54766-202; 54766-203; 54766-204,M711N184JE,PAROXETINE MESYLATE,PAROXETINE,41VRH5220H,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/50fe88bd-f0dd-5fad-e054-00144ff8d46c/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=50fe88bd-f0dd-5fad-e054-00144ff8d46c,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=50fe88bd-f0dd-5fad-e054-00144ff8d46c,50fe88bd-f0dd-5fad-e054-00144ff8d46c,,,
HUMAN PRESCRIPTION DRUG LABEL,KIT,INTRAMUSCULAR,NDA,203255,Signifor LAR,PASIREOTIDE,2024/01/24,Somatostatin Analog,2012,RECORDATI RARE DISEASES INC,2014/12/15-,55292-139; 55292-140; 55292-141; 55292-142; 55292-143,98H1T17066,PASIREOTIDE,PASIREOTIDE,98H1T17066,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/a0aad470-3f38-af97-e053-2995a90a383a/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a0aad470-3f38-af97-e053-2995a90a383a,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=a0aad470-3f38-af97-e053-2995a90a383a,a0aad470-3f38-af97-e053-2995a90a383a,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,SUBCUTANEOUS,NDA,200677,Signifor,PASIREOTIDE,2023/08/03,Somatostatin Analog,2012,RECORDATI RARE DISEASES INC,2012/12/14-,55292-131; 55292-132; 55292-133,98H1T17066,PASIREOTIDE,PASIREOTIDE,98H1T17066,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/a09a25fc-a5a3-0c82-e053-2995a90a5d74/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a09a25fc-a5a3-0c82-e053-2995a90a5d74,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=a09a25fc-a5a3-0c82-e053-2995a90a5d74,a09a25fc-a5a3-0c82-e053-2995a90a5d74,,,
HUMAN PRESCRIPTION DRUG LABEL,"POWDER, FOR SUSPENSION",ORAL,NDA,205739,VELTASSA,PATIROMER,2023/11/16,Potassium Binder,2015,VIFOR PHARMA INC,2015/10/23-,53436-084; 53436-168; 53436-252,1FQ2RY5YHH,patiromer,patiromer,1FQ2RY5YHH,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/bf002984-d6c9-46df-aecb-a07733f763c1/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=bf002984-d6c9-46df-aecb-a07733f763c1,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=bf002984-d6c9-46df-aecb-a07733f763c1,bf002984-d6c9-46df-aecb-a07733f763c1,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, LIPID COMPLEX",INTRAVENOUS,NDA,210922,Onpattro,PATISIRAN,2023/01/19,Small Interfering RNA; Transthyretin-directed RNA Interaction,2018,ALNYLAM PHARMACEUTICALS INC,2018/08/13-,71336-1000,WO0YM16LKG,patisiran sodium,patisiran,50FKX8CB2Y,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/e87ec36f-b4b4-49d4-aea4-d4ffb09b0970/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e87ec36f-b4b4-49d4-aea4-d4ffb09b0970,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=e87ec36f-b4b4-49d4-aea4-d4ffb09b0970,e87ec36f-b4b4-49d4-aea4-d4ffb09b0970,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,022465,VOTRIENT,PAZOPANIB HYDROCHLORIDE,2024/01/25,Kinase Inhibitor,2009,NOVARTIS PHARMACEUTICALS CORPORATION,2016/07/12-; completed:2016/07/12-2024/10/31,0078-0670; 0078-1077,33Y9ANM545,PAZOPANIB HYDROCHLORIDE,PAZOPANIB,7RN5DR86CK,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/eeaaaf38-fb86-4d9f-a19d-0f61daac2fd7/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=eeaaaf38-fb86-4d9f-a19d-0f61daac2fd7,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=eeaaaf38-fb86-4d9f-a19d-0f61daac2fd7,eeaaaf38-fb86-4d9f-a19d-0f61daac2fd7,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVITREAL,NDA,217171,Syfovre,PEGCETACOPLAN,2024/03/22,Complement Inhibitor,2021,APELLIS PHARMACEUTICALS INC,2023/02/17-,73606-020,TO3JYR3BOU,Pegcetacoplan,Pegcetacoplan,TO3JYR3BOU,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/b4434e61-9ec9-4e0e-bd60-45aaa0a87e64/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b4434e61-9ec9-4e0e-bd60-45aaa0a87e64,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=b4434e61-9ec9-4e0e-bd60-45aaa0a87e64,b4434e61-9ec9-4e0e-bd60-45aaa0a87e64,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",SUBCUTANEOUS,NDA,215014,Empaveli,PEGCETACOPLAN,2024/02/14,Complement Inhibitor,2021,APELLIS PHARMACEUTICALS INC,2021/05/14-,73606-010,TO3JYR3BOU,Pegcetacoplan,Pegcetacoplan,TO3JYR3BOU,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/c23d89e9-b00b-4520-e053-2995a90a95af/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c23d89e9-b00b-4520-e053-2995a90a95af,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=c23d89e9-b00b-4520-e053-2995a90a95af,c23d89e9-b00b-4520-e053-2995a90a95af,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAVENOUS,NDA,214511,LUMISIGHT,PEGULICIANINE,2024/04/17,,2024,LUMICELL INC,2024/04/17-,82292-040,T6HE85WN0Q,PEGULICIANINE,Pegulicianine,T6HE85WN0Q,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/7160e774-663a-43e4-ba4a-06cc57830e66/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7160e774-663a-43e4-ba4a-06cc57830e66,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=7160e774-663a-43e4-ba4a-06cc57830e66,7160e774-663a-43e4-ba4a-06cc57830e66,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRAVENOUS,NDA,209472,Pemfexy,PEMETREXED,2023/05/15,Folate Analog Metabolic Inhibitor,2004,EAGLE PHARMACEUTICALS INC,2022/02/01-,42367-531,236Y2F7D9J,PEMETREXED MONOHYDRATE,PEMETREXED,04Q9AIZ7NO,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/2308f4e8-21c8-49c1-a5b8-deb8610bac6a/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2308f4e8-21c8-49c1-a5b8-deb8610bac6a,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=2308f4e8-21c8-49c1-a5b8-deb8610bac6a,2308f4e8-21c8-49c1-a5b8-deb8610bac6a,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION, CONCENTRATE",INTRAVENOUS,NDA,214218,PEMETREXED,PEMETREXED,2023/02/01,Folate Analog Metabolic Inhibitor,2004,HOSPIRA INC,2023/02/01-,0409-0004; 0409-0020; 0409-0021,2PKU919BA9,PEMETREXED DISODIUM,PEMETREXED,04Q9AIZ7NO,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/3e087418-69ff-47fa-93c2-f28699309433/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3e087418-69ff-47fa-93c2-f28699309433,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=3e087418-69ff-47fa-93c2-f28699309433,3e087418-69ff-47fa-93c2-f28699309433,,,
HUMAN PRESCRIPTION DRUG LABEL,"SOLUTION, CONCENTRATE",INTRAVENOUS,NDA,208419,Pemetrexed,PEMETREXED,2022/12/01,Folate Analog Metabolic Inhibitor,2004,TEVA PHARMACEUTICALS INC,2022/05/31-; 2022/06/01-,0480-4514; 0480-4515; 0480-4516,236Y2F7D9J,PEMETREXED MONOHYDRATE,PEMETREXED,04Q9AIZ7NO,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/8b660f68-b770-4e0a-b2f9-25e663deecc3/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8b660f68-b770-4e0a-b2f9-25e663deecc3,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=8b660f68-b770-4e0a-b2f9-25e663deecc3,8b660f68-b770-4e0a-b2f9-25e663deecc3,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAVENOUS,NDA,208746,Pemetrexed,PEMETREXED,2022/07/22,Folate Analog Metabolic Inhibitor,2004,HOSPIRA INC,2022/06/20-; completed:2022/06/20-2022/06/20,0409-1060; 0409-1061; 0409-1062,HU11J9IK8F,PEMETREXED TROMETHAMINE ANHYDROUS,PEMETREXED,04Q9AIZ7NO,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/8cdb5b46-c003-4bf6-95c2-c7af169b3f47/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8cdb5b46-c003-4bf6-95c2-c7af169b3f47,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=8cdb5b46-c003-4bf6-95c2-c7af169b3f47,8cdb5b46-c003-4bf6-95c2-c7af169b3f47,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION, CONCENTRATE",INTRAVENOUS,NDA,214218,PEMETREXED,PEMETREXED,2022/07/19,Folate Analog Metabolic Inhibitor,2004,HOSPIRA INC,2022/06/27-,0409-1045; 0409-2188; 0409-3532,2PKU919BA9,PEMETREXED DISODIUM,PEMETREXED,04Q9AIZ7NO,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/3ae68628-7ab0-4491-b3ae-6a8330b719c8/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3ae68628-7ab0-4491-b3ae-6a8330b719c8,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=3ae68628-7ab0-4491-b3ae-6a8330b719c8,3ae68628-7ab0-4491-b3ae-6a8330b719c8,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,214408,Pemetrexed,PEMETREXED DISODIUM,2023/10/25,Folate Analog Metabolic Inhibitor,2004,ACCORD HEALTHCARE INC,2022/09/08-,16729-522,F4GSH45R4C,PEMETREXED DISODIUM HEMIPENTAHYDRATE,PEMETREXED,04Q9AIZ7NO,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/7b19dfbb-88c3-4328-9036-3b104015c06b/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7b19dfbb-88c3-4328-9036-3b104015c06b,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=7b19dfbb-88c3-4328-9036-3b104015c06b,7b19dfbb-88c3-4328-9036-3b104015c06b,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRAVENOUS,NDA,215179,PEMRYDI RTU,PEMETREXED DISODIUM,2023/06/09,Folate Analog Metabolic Inhibitor,2004,AMNEAL PHARMACEUTICALS LLC,2023/06/06-,70121-2453; 70121-2461; 70121-2462,F4GSH45R4C,PEMETREXED DISODIUM HEMIPENTAHYDRATE,PEMETREXED,04Q9AIZ7NO,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/0f006b06-ab85-423d-ba0c-dfc3fc25844e/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0f006b06-ab85-423d-ba0c-dfc3fc25844e,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=0f006b06-ab85-423d-ba0c-dfc3fc25844e,0f006b06-ab85-423d-ba0c-dfc3fc25844e,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRAVENOUS,NDA,215179,Pemetrexed,PEMETREXED DISODIUM,2023/06/03,Folate Analog Metabolic Inhibitor,2004,SHILPA MEDICARE LIMITED,2023/06/03-,63759-3048; 63759-3049; 63759-3050,F4GSH45R4C,PEMETREXED DISODIUM HEMIPENTAHYDRATE,PEMETREXED,04Q9AIZ7NO,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/fe432994-e61b-4a87-8c98-cc20b847d0fe/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=fe432994-e61b-4a87-8c98-cc20b847d0fe,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=fe432994-e61b-4a87-8c98-cc20b847d0fe,fe432994-e61b-4a87-8c98-cc20b847d0fe,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAVENOUS,NDA,021462,Alimta,PEMETREXED DISODIUM,2023/05/19,Folate Analog Metabolic Inhibitor,2004,ELI LILLY AND COMPANY,2004/02/04-; 2007/09/07-,0002-7623; 0002-7640,9T47E4OM16,Pemetrexed disodium heptahydrate,Pemetrexed,04Q9AIZ7NO,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/f5a860f3-37ec-429c-ae04-9c88d7c55c08/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f5a860f3-37ec-429c-ae04-9c88d7c55c08,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=f5a860f3-37ec-429c-ae04-9c88d7c55c08,f5a860f3-37ec-429c-ae04-9c88d7c55c08,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,214657,Pemetrexed,PEMETREXED DISODIUM,2023/04/26,Folate Analog Metabolic Inhibitor,2004,SANDOZ INC,2022/06/08-,0781-3518; 0781-3519; 0781-3520,2PKU919BA9,PEMETREXED DISODIUM,PEMETREXED,04Q9AIZ7NO,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/7ac04ab7-7f8c-46ce-ab56-a7a08cd02ab3/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7ac04ab7-7f8c-46ce-ab56-a7a08cd02ab3,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=7ac04ab7-7f8c-46ce-ab56-a7a08cd02ab3,7ac04ab7-7f8c-46ce-ab56-a7a08cd02ab3,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,213736,PEMAZYRE,PEMIGATINIB,2023/06/01,Kinase Inhibitor,2020,INCYTE CORPORATION,2020/04/17-,50881-026; 50881-027; 50881-028,Y6BX7BL23K,PEMIGATINIB,PEMIGATINIB,Y6BX7BL23K,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/9e1f2222-1d89-4e63-989c-ccebe2ab1eb4/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9e1f2222-1d89-4e63-989c-ccebe2ab1eb4,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=9e1f2222-1d89-4e63-989c-ccebe2ab1eb4,9e1f2222-1d89-4e63-989c-ccebe2ab1eb4,,,
HUMAN PRESCRIPTION DRUG LABEL,CREAM,TOPICAL,NDA,020629,Denavir,PENCICLOVIR,2018/11/26,Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor,1996,MYLAN PHARMACEUTICALS INC,2018/09/24-,0378-9720,359HUE8FJC,PENCICLOVIR,PENCICLOVIR,359HUE8FJC,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/61229829-55a0-4d6f-a423-4b48a2b4d8e5/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=61229829-55a0-4d6f-a423-4b48a2b4d8e5,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=61229829-55a0-4d6f-a423-4b48a2b4d8e5,61229829-55a0-4d6f-a423-4b48a2b4d8e5,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,019854,Depen,PENICILLAMINE,2023/07/19,Antirheumatic Agent,,MEDA PHARMACEUTICALS INC,1978/11/30-,0037-4401,GNN1DV99GX,PENICILLAMINE,PENICILLAMINE,GNN1DV99GX,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/38f8ae60-b354-11de-8a39-0800200c9a66/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=38f8ae60-b354-11de-8a39-0800200c9a66,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=38f8ae60-b354-11de-8a39-0800200c9a66,38f8ae60-b354-11de-8a39-0800200c9a66,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,NDA,019853,Cuprimine,PENICILLAMINE,2020/10/01,Antirheumatic Agent,,BAUSCH HEALTH US LLC,1970/12/04-,25010-705,GNN1DV99GX,Penicillamine,Penicillamine,GNN1DV99GX,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/80e736d3-2017-4d68-94b4-38255c3c59c6/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=80e736d3-2017-4d68-94b4-38255c3c59c6,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=80e736d3-2017-4d68-94b4-38255c3c59c6,80e736d3-2017-4d68-94b4-38255c3c59c6,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,050638,PENICILLIN G POTASSIUM,PENICILLIN G,2021/05/13,Penicillin-class Antibacterial,,BAXTER HEALTHCARE CORPORATION,1990/06/25-,0338-1021; 0338-1023; 0338-1025,VL775ZTH4C,PENICILLIN G POTASSIUM,PENICILLIN G,Q42T66VG0C,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/9e58122f-5c75-4905-a774-d3a4dae4ff8c/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9e58122f-5c75-4905-a774-d3a4dae4ff8c,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=9e58122f-5c75-4905-a774-d3a4dae4ff8c,9e58122f-5c75-4905-a774-d3a4dae4ff8c,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SUSPENSION",INTRAMUSCULAR,NDA,050141,BICILLIN L-A,PENICILLIN G BENZATHINE,2023/10/13,Penicillin-class Antibacterial,,PFIZER LABORATORIES DIV PFIZER INC,1952/06/27-,60793-700; 60793-701; 60793-702,RIT82F58GK,PENICILLIN G BENZATHINE,PENICILLIN G,Q42T66VG0C,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/012d46f1-d0a0-4676-a879-cd320297ab16/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=012d46f1-d0a0-4676-a879-cd320297ab16,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=012d46f1-d0a0-4676-a879-cd320297ab16,012d46f1-d0a0-4676-a879-cd320297ab16,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SUSPENSION",INTRAMUSCULAR,NDA,050138,BICILLIN CR,PENICILLIN G BENZATHINE AND PENICILLIN G PROCAINE,2023/10/13,Penicillin-class Antibacterial,,PFIZER LABORATORIES DIV PFIZER INC,1953/05/18-,60793-600; 60793-601,17R794ESYN; RIT82F58GK,PENICILLIN G BENZATHINE; PENICILLIN G PROCAINE,PENICILLIN G,Q42T66VG0C,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/b5640fc6-76d8-428d-80e6-760d769af8bb/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b5640fc6-76d8-428d-80e6-760d769af8bb,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=b5640fc6-76d8-428d-80e6-760d769af8bb,b5640fc6-76d8-428d-80e6-760d769af8bb,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SUSPENSION",INTRAMUSCULAR,NDA,050138,BICILLIN C-R 900/300,PENICILLIN G BENZATHINE AND PENICILLIN G PROCAINE,2023/10/13,Penicillin-class Antibacterial,,PFIZER LABORATORIES DIV PFIZER INC,1953/05/18-,60793-602,17R794ESYN; RIT82F58GK,PENICILLIN G BENZATHINE; PENICILLIN G PROCAINE,PENICILLIN G,Q42T66VG0C,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/ba7b9199-4710-4189-a85d-77ed75befe4d/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ba7b9199-4710-4189-a85d-77ed75befe4d,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=ba7b9199-4710-4189-a85d-77ed75befe4d,ba7b9199-4710-4189-a85d-77ed75befe4d,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAMUSCULAR; INTRAVENOUS,NDA,019264,Pentam 300,PENTAMIDINE ISETHIONATE,2022/09/13,Antiprotozoal,,FRESENIUS KABI USA LLC,2001/01/16-,63323-113,V2P3K60DA2,PENTAMIDINE ISETHIONATE,PENTAMIDINE,673LC5J4LQ,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/cc2b635e-4840-4dc3-a177-5484371680e8/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=cc2b635e-4840-4dc3-a177-5484371680e8,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=cc2b635e-4840-4dc3-a177-5484371680e8,cc2b635e-4840-4dc3-a177-5484371680e8,,,
HUMAN PRESCRIPTION DRUG LABEL,INHALANT,INHALATION,NDA,019887,NebuPent,PENTAMIDINE ISETHIONATE,2020/01/23,Antiprotozoal,,FRESENIUS KABI USA LLC,2011/02/15-,63323-877,V2P3K60DA2,PENTAMIDINE ISETHIONATE,PENTAMIDINE,673LC5J4LQ,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/e2ad9d3c-b6c3-4f70-87e0-722a8ff94ccb/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e2ad9d3c-b6c3-4f70-87e0-722a8ff94ccb,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=e2ad9d3c-b6c3-4f70-87e0-722a8ff94ccb,e2ad9d3c-b6c3-4f70-87e0-722a8ff94ccb,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION, CONCENTRATE",INHALATION; INTRAVENOUS,NDA,021749,Pentetate calcium trisodium,PENTETATE CALCIUM TRISODIUM,2021/01/06,Lead Chelator,2004,HAMELN PHARMA GMBH,completed:2004/08/11-2026/05/31,70651-001,G79YN26H5B,pentetate calcium trisodium,pentetic acid,7A314HQM0I,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/bc563e90-10e5-475d-aa84-b0e3d582ae95/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=bc563e90-10e5-475d-aa84-b0e3d582ae95,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=bc563e90-10e5-475d-aa84-b0e3d582ae95,bc563e90-10e5-475d-aa84-b0e3d582ae95,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION, CONCENTRATE",INHALATION; INTRAVENOUS,NDA,021751,Pentetate zinc trisodium,PENTETATE ZINC TRISODIUM,2021/01/06,Lead Chelator,2004,HAMELN PHARMA GMBH,completed:2004/08/11-2026/05/31,70651-002,NXU65IC8PG,Pentetate zinc trisodium,pentetic acid,7A314HQM0I,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/366e7ca9-4fd3-4688-bd83-1f369885e0fc/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=366e7ca9-4fd3-4688-bd83-1f369885e0fc,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=366e7ca9-4fd3-4688-bd83-1f369885e0fc,366e7ca9-4fd3-4688-bd83-1f369885e0fc,,,
HUMAN PRESCRIPTION DRUG LABEL,"CAPSULE, GELATIN COATED",ORAL,NDA,020193,ELMIRON,PENTOSAN POLYSULFATE SODIUM,2022/11/10,Glycosaminoglycan,,JANSSEN PHARMACEUTICALS INC,1996/09/26-,50458-098,914032762Y,PENTOSAN POLYSULFATE SODIUM,PENTOSAN POLYSULFATE,F59P8B75R4,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/f0ba651e-3d8a-11df-8fbe-119855d89593/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f0ba651e-3d8a-11df-8fbe-119855d89593,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=f0ba651e-3d8a-11df-8fbe-119855d89593,f0ba651e-3d8a-11df-8fbe-119855d89593,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAVENOUS,NDA,020122,Nipent,PENTOSTATIN,2023/12/21,Nucleoside Metabolic Inhibitor,,HOSPIRA INC,2007/08/15-,0409-0801,395575MZO7,PENTOSTATIN,PENTOSTATIN,395575MZO7,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/674e0e6d-46ed-4868-9196-04019d667716/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=674e0e6d-46ed-4868-9196-04019d667716,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=674e0e6d-46ed-4868-9196-04019d667716,674e0e6d-46ed-4868-9196-04019d667716,,,
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION,INTRAVENOUS,NDA,206426,Rapivab,PERAMIVIR,2022/11/14,,2014,BIOCRYST PHARMACEUTICALS INC,2014/12/20-,72769-181,QW7Y7ZR15U,peramivir,peramivir anhydrous,9ZS94HQO3B,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/fe04f6cd-e71c-4bd4-abac-97720bba2a0d/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=fe04f6cd-e71c-4bd4-abac-97720bba2a0d,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=fe04f6cd-e71c-4bd4-abac-97720bba2a0d,fe04f6cd-e71c-4bd4-abac-97720bba2a0d,,,
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION,INTRAVENOUS,NDA,206426,Rapivab,PERAMIVIR,2020/06/17,,2014,SEQIRUS USA INC,2014/12/20-,61364-181,QW7Y7ZR15U,peramivir,peramivir anhydrous,9ZS94HQO3B,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/7fdedaec-9e53-4a37-a4e4-a301c8a251b8/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7fdedaec-9e53-4a37-a4e4-a301c8a251b8,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=7fdedaec-9e53-4a37-a4e4-a301c8a251b8,7fdedaec-9e53-4a37-a4e4-a301c8a251b8,,,
HUMAN PRESCRIPTION DRUG LABEL,SUSPENSION; TABLET,ORAL,NDA,202834;208277,Fycompa,PERAMPANEL,2024/01/05,Noncompetitive AMPA Glutamate Receptor Antagonist,2012,CATALYST PHARMACEUTICALS INC,2024/01/02-,69616-272; 69616-274; 69616-276; 69616-278; 69616-280; 69616-282; 69616-290,H821664NPK,PERAMPANEL,PERAMPANEL,H821664NPK,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/ec812ea3-de3a-4271-957c-db8f692d1ae3/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ec812ea3-de3a-4271-957c-db8f692d1ae3,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=ec812ea3-de3a-4271-957c-db8f692d1ae3,ec812ea3-de3a-4271-957c-db8f692d1ae3,,,
HUMAN PRESCRIPTION DRUG LABEL,SUSPENSION; TABLET,ORAL,NDA,202834;208277,Fycompa,PERAMPANEL,2023/11/16,Noncompetitive AMPA Glutamate Receptor Antagonist,2012,EISAI INC,2012/10/22-; 2016/04/30-,62856-272; 62856-274; 62856-276; 62856-278; 62856-280; 62856-282; 62856-290,H821664NPK,PERAMPANEL,PERAMPANEL,H821664NPK,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/71cf3309-e182-473c-8b0b-280cabd0e122/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=71cf3309-e182-473c-8b0b-280cabd0e122,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=71cf3309-e182-473c-8b0b-280cabd0e122,71cf3309-e182-473c-8b0b-280cabd0e122,,,
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION,OPHTHALMIC,NDA,216675,MIEBO,PERFLUOROHEXYLOCTANE,2024/01/01,,2023,BAUSCH AND LOMB INCORPORATED,2023/05/18-,24208-377,7VYX4ELWQM,Perfluorohexyloctane,PERFLUOROHEXYLOCTANE,7VYX4ELWQM,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/6b283c02-7df4-4c00-951b-555cddffe77c/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6b283c02-7df4-4c00-951b-555cddffe77c,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=6b283c02-7df4-4c00-951b-555cddffe77c,6b283c02-7df4-4c00-951b-555cddffe77c,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SUSPENSION",INTRAVENOUS,NDA,021064,DEFINITY RT,PERFLUTREN,2024/03/13,Contrast Agent for Ultrasound Imaging,2001,LANTHEUS MEDICAL IMAGING INC,2020/10/01-,11994-017,CK0N3WH0SR,PERFLUTREN,PERFLUTREN,CK0N3WH0SR,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/7b9de6ab-a3ac-40c9-8103-139dc7a464a2/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7b9de6ab-a3ac-40c9-8103-139dc7a464a2,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=7b9de6ab-a3ac-40c9-8103-139dc7a464a2,7b9de6ab-a3ac-40c9-8103-139dc7a464a2,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SUSPENSION",INTRAVENOUS,NDA,021064,Definity,PERFLUTREN,2024/03/13,Contrast Agent for Ultrasound Imaging,2001,LANTHEUS MEDICAL IMAGING INC,2001/07/31-,11994-011,CK0N3WH0SR,PERFLUTREN,PERFLUTREN,CK0N3WH0SR,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/8ab9c79c-1b5c-4e86-899c-cc74686f070a/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8ab9c79c-1b5c-4e86-899c-cc74686f070a,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=8ab9c79c-1b5c-4e86-899c-cc74686f070a,8ab9c79c-1b5c-4e86-899c-cc74686f070a,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,205003,Prestalia,PERINDOPRIL ARGININE AND AMLODIPINE BESYLATE,2019/10/25,Angiotensin Converting Enzyme Inhibitor; Calcium Channel Blocker; Dihydropyridine Calcium Channel Blocker,2015,ADHERA THERAPEUTICS INC,2015/01/26-,72931-010; 72931-011; 72931-012,864V2Q084H; TFT5IM1KGB,amlodipine besylate; perindopril arginine,amlodipine; perindoprilat,1J444QC288; 2UV6ZNQ92K,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/eaa2bbbc-5fcc-4f15-a51c-c4e1bf320c90/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=eaa2bbbc-5fcc-4f15-a51c-c4e1bf320c90,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=eaa2bbbc-5fcc-4f15-a51c-c4e1bf320c90,eaa2bbbc-5fcc-4f15-a51c-c4e1bf320c90,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,020184,Perindopril Erbumine,PERINDOPRIL ERBUMINE,2015/05/28,Angiotensin Converting Enzyme Inhibitor,1993,MARLEX PHARMACEUTICALS INC,2015/05/01-,10135-599; 10135-600,1964X464OJ,PERINDOPRIL ERBUMINE,PERINDOPRILAT,2UV6ZNQ92K,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/fcaefca9-e6ca-4c97-9eb8-7f1c619ce4d0/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=fcaefca9-e6ca-4c97-9eb8-7f1c619ce4d0,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=fcaefca9-e6ca-4c97-9eb8-7f1c619ce4d0,fcaefca9-e6ca-4c97-9eb8-7f1c619ce4d0,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,020184,Aceon,PERINDOPRIL ERBUMINE,2013/03/11,Angiotensin Converting Enzyme Inhibitor,1993,XOMA US LLC,1993/12/30-,76234-000; 76234-001; 76234-002,1964X464OJ,PERINDOPRIL ERBUMINE,PERINDOPRILAT,2UV6ZNQ92K,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/97a9e8bf-91ed-4256-97d4-f9504bb01373/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=97a9e8bf-91ed-4256-97d4-f9504bb01373,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=97a9e8bf-91ed-4256-97d4-f9504bb01373,97a9e8bf-91ed-4256-97d4-f9504bb01373,,,
HUMAN PRESCRIPTION DRUG LABEL,CREAM,TOPICAL,NDA,019855,ELIMITE,PERMETHRIN,2024/01/24,Pyrethroid,,AUROBINDO PHARMA LIMITED,2024/01/22-,59651-834,509F88P9SZ,PERMETHRIN,PERMETHRIN,509F88P9SZ,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/443c0446-ccba-4f52-83ed-4c3163f35807/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=443c0446-ccba-4f52-83ed-4c3163f35807,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=443c0446-ccba-4f52-83ed-4c3163f35807,443c0446-ccba-4f52-83ed-4c3163f35807,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,NDA,211810,Turalio,PEXIDARTINIB HYDROCHLORIDE,2023/11/21,Kinase Inhibitor,2019,DAIICHI SANKYO INC,2023/02/01-,65597-407,YS6WAI3XN7,PEXIDARTINIB HYDROCHLORIDE,PEXIDARTINIB,6783M2LV5X,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/7b0ec4bf-b2ac-49ee-96af-7740ad3f2e16/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7b0ec4bf-b2ac-49ee-96af-7740ad3f2e16,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=7b0ec4bf-b2ac-49ee-96af-7740ad3f2e16,7b0ec4bf-b2ac-49ee-96af-7740ad3f2e16,,,
HUMAN PRESCRIPTION DRUG LABEL,"CAPSULE, EXTENDED RELEASE",ORAL,NDA,018074,PHENDIMETRAZINE TARTRATE,PHENDIMETRAZINE TARTRATE,2023/08/24,Sympathomimetic Amine Anorectic,,ACERTIS PHARMACEUTICALS LLC,2022/11/01-,72989-409,6985IP0T80,PHENDIMETRAZINE TARTRATE,PHENDIMETRAZINE,AB2794W8KV,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/162140d3-b833-4633-9759-95821a46a690/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=162140d3-b833-4633-9759-95821a46a690,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=162140d3-b833-4633-9759-95821a46a690,162140d3-b833-4633-9759-95821a46a690,,,
HUMAN PRESCRIPTION DRUG LABEL,"CAPSULE, EXTENDED RELEASE",ORAL,NDA,018074,PHENDIMETRAZINE TARTRATE,PHENDIMETRAZINE TARTRATE,2022/10/10,Sympathomimetic Amine Anorectic,,VIRTUS PHARMACEUTICALS LLC,2018/07/01-,69543-409,6985IP0T80,PHENDIMETRAZINE TARTRATE,PHENDIMETRAZINE,AB2794W8KV,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/669fafd4-ac03-4bbc-ba86-28d1efbaf8c6/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=669fafd4-ac03-4bbc-ba86-28d1efbaf8c6,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=669fafd4-ac03-4bbc-ba86-28d1efbaf8c6,669fafd4-ac03-4bbc-ba86-28d1efbaf8c6,,,
HUMAN PRESCRIPTION DRUG LABEL,"CAPSULE, EXTENDED RELEASE; TABLET",ORAL,ANDA; NDA,018074;091042,PHENDIMETRAZINE TARTRATE ER; Phendimetrazine Tartrate,PHENDIMETRAZINE TARTRATE,2018/09/21,Sympathomimetic Amine Anorectic,,H J HARKINS COMPANY INC,2007/06/19-; 2010/09/15-,52959-282; 52959-886,6985IP0T80,PHENDIMETRAZINE TARTRATE,PHENDIMETRAZINE,AB2794W8KV,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/49b13acc-c7a9-4f7c-bcc2-2c73fcedab52/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=49b13acc-c7a9-4f7c-bcc2-2c73fcedab52,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=49b13acc-c7a9-4f7c-bcc2-2c73fcedab52,49b13acc-c7a9-4f7c-bcc2-2c73fcedab52,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,011909,Nardil,PHENELZINE SULFATE,2020/12/09,Monoamine Oxidase Inhibitor,,PARKE DAVIS DIV OF PFIZER INC,1961/06/09-,0071-0350,2681D7P965,PHENELZINE SULFATE,PHENELZINE,O408N561GF,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/513a41d0-37d4-4355-8a6d-a2c643bce6fa/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=513a41d0-37d4-4355-8a6d-a2c643bce6fa,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=513a41d0-37d4-4355-8a6d-a2c643bce6fa,513a41d0-37d4-4355-8a6d-a2c643bce6fa,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRAVENOUS,NDA,215910,SEZABY,PHENOBARBITAL SODIUM,2023/01/06,,2022,SUN PHARMACEUTICAL INDUSTRIES INC,2022/12/25-,62756-301,SW9M9BB5K3,PHENOBARBITAL SODIUM,PHENOBARBITAL,YQE403BP4D,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/8c7d0402-4977-4c25-bc4b-11db91339e9a/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8c7d0402-4977-4c25-bc4b-11db91339e9a,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=8c7d0402-4977-4c25-bc4b-11db91339e9a,8c7d0402-4977-4c25-bc4b-11db91339e9a,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,NDA,008708,Dibenzyline,PHENOXYBENZAMINE HYDROCHLORIDE,2023/07/03,alpha-Adrenergic Blocker,,CONCORDIA PHARMACEUTICALS INC,1953/01/26-,59212-001,X1IEG24OHL,PHENOXYBENZAMINE HYDROCHLORIDE,PHENOXYBENZAMINE,0TTZ664R7Z,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/8852dd44-098c-4d99-88e0-a092a8e08e11/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8852dd44-098c-4d99-88e0-a092a8e08e11,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=8852dd44-098c-4d99-88e0-a092a8e08e11,8852dd44-098c-4d99-88e0-a092a8e08e11,,,
HUMAN PRESCRIPTION DRUG LABEL,"CAPSULE, EXTENDED RELEASE",ORAL,NDA,022580,Qsymia,PHENTERMINE AND TOPIRAMATE,2023/12/11,Sympathomimetic Amine Anorectic,2012,VIVUS LLC,2012/09/17-,62541-201; 62541-202; 62541-203; 62541-204,0H73WJJ391; 0K2I505OTV,PHENTERMINE HYDROCHLORIDE; TOPIRAMATE,PHENTERMINE; TOPIRAMATE,0H73WJJ391; C045TQL4WP,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/40dd5602-53da-45ac-bb4b-15789aba40f9/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=40dd5602-53da-45ac-bb4b-15789aba40f9,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=40dd5602-53da-45ac-bb4b-15789aba40f9,40dd5602-53da-45ac-bb4b-15789aba40f9,,,
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION/ DROPS,OPHTHALMIC,NDA,217064,Ryzumvi,PHENTOLAMINE MESYLATE,2023/11/15,alpha-Adrenergic Blocker,1952,OYSTER POINT PHARMA INC,2024/03/25-,83368-075,Y7543E5K9T,PHENTOLAMINE MESYLATE,PHENTOLAMINE,Z468598HBV,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/96bb1e53-c2cc-4e60-a21a-db0269c371bf/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=96bb1e53-c2cc-4e60-a21a-db0269c371bf,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=96bb1e53-c2cc-4e60-a21a-db0269c371bf,96bb1e53-c2cc-4e60-a21a-db0269c371bf,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",SUBMUCOSAL,NDA,022159,Oraverse,PHENTOLAMINE MESYLATE,2018/12/05,alpha-Adrenergic Blocker,1952,SEPTODONT INC,2011/06/01-,0362-0101,Y7543E5K9T,Phentolamine Mesylate,Phentolamine,Z468598HBV,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/4025cf98-ea87-4531-b0fc-6283c84f63f3/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4025cf98-ea87-4531-b0fc-6283c84f63f3,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=4025cf98-ea87-4531-b0fc-6283c84f63f3,4025cf98-ea87-4531-b0fc-6283c84f63f3,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION, CONCENTRATE",INTRAOCULAR,NDA,205388,Omidria,PHENYLEPHRINE AND KETOROLAC,2023/07/07,Cyclooxygenase Inhibitor; Nonsteroidal Anti-inflammatory Drug; alpha-1 Adrenergic Agonist,2014,RAYNER SURGICAL INC,2023/07/01-,82604-600,1WS297W6MV; YZI5105V0L,KETOROLAC; PHENYLEPHRINE,KETOROLAC; PHENYLEPHRINE,1WS297W6MV; YZI5105V0L,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/f25d7a42-da2a-7310-e053-2995a90a590f/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f25d7a42-da2a-7310-e053-2995a90a590f,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=f25d7a42-da2a-7310-e053-2995a90a590f,f25d7a42-da2a-7310-e053-2995a90a590f,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION, CONCENTRATE",INTRAOCULAR,NDA,205388,Omidria,PHENYLEPHRINE AND KETOROLAC,2022/12/14,Cyclooxygenase Inhibitor; Nonsteroidal Anti-inflammatory Drug; alpha-1 Adrenergic Agonist,2014,OMEROS CORPORATION,2014/06/13-,62225-600,1WS297W6MV; YZI5105V0L,KETOROLAC; PHENYLEPHRINE,KETOROLAC; PHENYLEPHRINE,1WS297W6MV; YZI5105V0L,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/21470688-4e81-4ea5-ac38-f72e10552e7e/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=21470688-4e81-4ea5-ac38-f72e10552e7e,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=21470688-4e81-4ea5-ac38-f72e10552e7e,21470688-4e81-4ea5-ac38-f72e10552e7e,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,212909,Biorphen,PHENYLEPHRINE HYDROCHLORIDE,2024/04/25,alpha-1 Adrenergic Agonist,1954,DR REDDY S LABORATORIES INC,2022/11/25-,43598-172; 43598-199,04JA59TNSJ,PHENYLEPHRINE HYDROCHLORIDE,PHENYLEPHRINE,1WS297W6MV,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/2f715e4e-b269-b935-d2c9-003cb29770be/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2f715e4e-b269-b935-d2c9-003cb29770be,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=2f715e4e-b269-b935-d2c9-003cb29770be,2f715e4e-b269-b935-d2c9-003cb29770be,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRAVENOUS,NDA,203826,Phenylephrine Hydrochloride,PHENYLEPHRINE HYDROCHLORIDE,2024/04/10,alpha-1 Adrenergic Agonist,2012,HIKMA PHARMACEUTICALS USA INC,2012/12/18-,0641-6229,04JA59TNSJ,PHENYLEPHRINE HYDROCHLORIDE,PHENYLEPHRINE,1WS297W6MV,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/c3f358dd-4a36-4808-9943-e01f88604be5/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c3f358dd-4a36-4808-9943-e01f88604be5,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=c3f358dd-4a36-4808-9943-e01f88604be5,c3f358dd-4a36-4808-9943-e01f88604be5,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTABLE, LIPOSOMAL; INJECTION",INTRAVENOUS,NDA,203826,IMMPHENTIV; Phenylephrine Hydrochloride,PHENYLEPHRINE HYDROCHLORIDE,2024/04/09,alpha-1 Adrenergic Agonist,2012,HIKMA PHARMACEUTICALS USA INC,2012/12/18-; 2019/06/19-; 2023/03/09-,0641-6142; 0641-6188; 0641-6189; 0641-6245; 0641-6246,04JA59TNSJ,PHENYLEPHRINE HYDROCHLORIDE,PHENYLEPHRINE,1WS297W6MV,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/e1a7ab4b-0afe-4463-a039-5be0323cf2f7/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e1a7ab4b-0afe-4463-a039-5be0323cf2f7,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=e1a7ab4b-0afe-4463-a039-5be0323cf2f7,e1a7ab4b-0afe-4463-a039-5be0323cf2f7,,,
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION/ DROPS,OPHTHALMIC,NDA,207926,Phenylephrine Hydrochloride,PHENYLEPHRINE HYDROCHLORIDE,2023/12/18,alpha-1 Adrenergic Agonist,1939,AKORN,completed:2015/01/15-2024/07/31; completed:2015/01/15-2024/11/30,17478-201; 17478-206,04JA59TNSJ,Phenylephrine Hydrochloride,Phenylephrine,1WS297W6MV,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/49558551-cbed-4518-a6d4-16cfd893eab0/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=49558551-cbed-4518-a6d4-16cfd893eab0,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=49558551-cbed-4518-a6d4-16cfd893eab0,49558551-cbed-4518-a6d4-16cfd893eab0,,,
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION/ DROPS,OPHTHALMIC,NDA,203510,Phenylephrine Hydrochloride,PHENYLEPHRINE HYDROCHLORIDE,2023/06/29,alpha-1 Adrenergic Agonist,1939,PARAGON BIOTECK INC,2013/04/15-,42702-102; 42702-103,04JA59TNSJ,PHENYLEPHRINE HYDROCHLORIDE,PHENYLEPHRINE,1WS297W6MV,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/a4d3fe20-f063-11e0-ac29-0002a5d5c51b/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a4d3fe20-f063-11e0-ac29-0002a5d5c51b,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=a4d3fe20-f063-11e0-ac29-0002a5d5c51b,a4d3fe20-f063-11e0-ac29-0002a5d5c51b,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRAVENOUS,NDA,203826,Phenylephrine Hydrochloride,PHENYLEPHRINE HYDROCHLORIDE,2023/04/07,alpha-1 Adrenergic Agonist,2012,CIVICA INC,2020/12/02-,72572-570; 72572-571,04JA59TNSJ,PHENYLEPHRINE HYDROCHLORIDE,PHENYLEPHRINE,1WS297W6MV,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/7a23ed28-3912-4398-b660-bf9ec3ee3926/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7a23ed28-3912-4398-b660-bf9ec3ee3926,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=7a23ed28-3912-4398-b660-bf9ec3ee3926,7a23ed28-3912-4398-b660-bf9ec3ee3926,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,212909,Biorphen,PHENYLEPHRINE HYDROCHLORIDE,2022/08/29,alpha-1 Adrenergic Agonist,1954,ETON PHARMACEUTICALS INC,2019/11/15-; completed:2021/03/11-2021/04/01,71863-202; 71863-203; 71863-208,04JA59TNSJ,PHENYLEPHRINE HYDROCHLORIDE,PHENYLEPHRINE,1WS297W6MV,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/bf7daa65-2a6c-4d59-a6f3-3af70edcc7e2/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=bf7daa65-2a6c-4d59-a6f3-3af70edcc7e2,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=bf7daa65-2a6c-4d59-a6f3-3af70edcc7e2,bf7daa65-2a6c-4d59-a6f3-3af70edcc7e2,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRAVENOUS,NDA,204300,Vazculep,PHENYLEPHRINE HYDROCHLORIDE,2021/03/26,alpha-1 Adrenergic Agonist,1954,EXELA PHRAMA SCIENCES LLC,2021/03/26-,51754-4000; 51754-4010; 51754-4020,04JA59TNSJ,PHENYLEPHRINE HYDROCHLORIDE,PHENYLEPHRINE,1WS297W6MV,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/c73fc68d-6a3d-4d99-8869-cc64d7c6bf94/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c73fc68d-6a3d-4d99-8869-cc64d7c6bf94,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=c73fc68d-6a3d-4d99-8869-cc64d7c6bf94,c73fc68d-6a3d-4d99-8869-cc64d7c6bf94,,,
HUMAN PRESCRIPTION DRUG LABEL,SUSPENSION,ORAL,NDA,008762,Dilantin-125,PHENYTOIN,2023/02/02,Anti-epileptic Agent,1953,VIATRIS SPECIALTY LLC,2024/04/19-,58151-115,6158TKW0C5,PHENYTOIN,PHENYTOIN,6158TKW0C5,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/f339f9e4-b289-4efe-82b9-46c57d1dc277/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f339f9e4-b289-4efe-82b9-46c57d1dc277,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=f339f9e4-b289-4efe-82b9-46c57d1dc277,f339f9e4-b289-4efe-82b9-46c57d1dc277,,,
HUMAN PRESCRIPTION DRUG LABEL,SUSPENSION,ORAL,NDA,008762,Dilantin-125,PHENYTOIN,2022/03/11,Anti-epileptic Agent,1953,PARKE DAVIS DIV OF PFIZER INC,completed:1953/01/06-2025/03/31,0071-2214,6158TKW0C5,PHENYTOIN,PHENYTOIN,6158TKW0C5,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/051742b5-b0f0-44a5-8d31-3288527b0638/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=051742b5-b0f0-44a5-8d31-3288527b0638,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=051742b5-b0f0-44a5-8d31-3288527b0638,051742b5-b0f0-44a5-8d31-3288527b0638,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRAVENOUS,NDA,214793,PYLARIFY,PIFLUFOLASTAT F-18,2023/11/20,Radioactive Diagnostic Agent,2021,PROGENICS PHARMACEUTICALS INC,2021/05/26-,71258-022,3934EF02T7,PIFLUFOLASTAT F-18,PIFLUFOLASTAT F-18,3934EF02T7,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/a00e5cbc-4fd5-4280-82ec-cd3498df4553/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a00e5cbc-4fd5-4280-82ec-cd3498df4553,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=a00e5cbc-4fd5-4280-82ec-cd3498df4553,a00e5cbc-4fd5-4280-82ec-cd3498df4553,,,
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION/ DROPS,OPHTHALMIC,NDA,214028,VUITY,PILOCARPINE HYDROCHLORIDE,2023/03/28,Cholinergic Receptor Agonist,1974,ABBVIE INC,2021/10/28-,0074-7098,0WW6D218XJ,Pilocarpine Hydrochloride,Pilocarpine,01MI4Q9DI3,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/8d806897-8a2a-4518-8c68-0ec3b778de50/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8d806897-8a2a-4518-8c68-0ec3b778de50,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=8d806897-8a2a-4518-8c68-0ec3b778de50,8d806897-8a2a-4518-8c68-0ec3b778de50,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,020237,Salagen,PILOCARPINE HYDROCHLORIDE,2022/02/11,Cholinergic Receptor Agonist,,CONCORDIA PHARMACEUTICALS INC,2019/09/01-,59212-705; 59212-775,0WW6D218XJ,PILOCARPINE HYDROCHLORIDE,PILOCARPINE,01MI4Q9DI3,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/62eda83d-d043-4c7e-8fcf-75d05efbf35b/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=62eda83d-d043-4c7e-8fcf-75d05efbf35b,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=62eda83d-d043-4c7e-8fcf-75d05efbf35b,62eda83d-d043-4c7e-8fcf-75d05efbf35b,,,
HUMAN PRESCRIPTION DRUG LABEL,"CAPSULE; TABLET, COATED",ORAL,NDA,207318;210793,NUPLAZID,PIMAVANSERIN TARTRATE,2023/09/19,Atypical Antipsychotic,2016,ACADIA PHARMACEUTICALS INC,2018/06/28-,63090-100; 63090-340,NA83F1SJSR,pimavanserin tartrate,pimavanserin,JZ963P0DIK,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/1e6bea44-57d6-4bac-9328-46e1ee59f83b/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1e6bea44-57d6-4bac-9328-46e1ee59f83b,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=1e6bea44-57d6-4bac-9328-46e1ee59f83b,1e6bea44-57d6-4bac-9328-46e1ee59f83b,,,
HUMAN PRESCRIPTION DRUG LABEL,CREAM,TOPICAL,NDA,021302,ELIDEL,PIMECROLIMUS,2020/09/30,Calcineurin Inhibitor Immunosuppressant,2001,BAUSCH HEALTH US LLC,2001/12/02-,0187-5100; 0187-5101; 0187-5102; 0187-5103,7KYV510875,Pimecrolimus,Pimecrolimus,7KYV510875,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/e4027e5a-0f9b-4070-b196-f60172f45c4c/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e4027e5a-0f9b-4070-b196-f60172f45c4c,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=e4027e5a-0f9b-4070-b196-f60172f45c4c,e4027e5a-0f9b-4070-b196-f60172f45c4c,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,021073,Actos,PIOGLITAZONE,2022/10/25,Peroxisome Proliferator Receptor alpha Agonist; Peroxisome Proliferator Receptor gamma Agonist; Thiazolidinedione,1999,TAKEDA PHARMACEUTICALS AMERICA INC,1999/07/15-,64764-151; 64764-301; 64764-451,JQT35NPK6C,PIOGLITAZONE HYDROCHLORIDE,pioglitazone,X4OV71U42S,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/d2ddc491-88a9-4063-9150-443b4fa4330c/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d2ddc491-88a9-4063-9150-443b4fa4330c,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=d2ddc491-88a9-4063-9150-443b4fa4330c,d2ddc491-88a9-4063-9150-443b4fa4330c,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,021925,Duetact,PIOGLITAZONE AND GLIMEPIRIDE,2022/10/24,Peroxisome Proliferator Receptor alpha Agonist; Peroxisome Proliferator Receptor gamma Agonist; Sulfonylurea; Thiazolidinedione,2006,TAKEDA PHARMACEUTICALS AMERICA INC,2006/07/28-,64764-302; 64764-304,6KY687524K; JQT35NPK6C,glimepiride; pioglitazone hydrochloride,glimepiride; pioglitazone,6KY687524K; X4OV71U42S,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/f8b0c917-3fdd-4a28-a47d-6225b8195458/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f8b0c917-3fdd-4a28-a47d-6225b8195458,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=f8b0c917-3fdd-4a28-a47d-6225b8195458,f8b0c917-3fdd-4a28-a47d-6225b8195458,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,021842,Actoplus Met,PIOGLITAZONE AND METFORMIN HYDROCHLORIDE,2023/12/05,Biguanide; Peroxisome Proliferator Receptor alpha Agonist; Peroxisome Proliferator Receptor gamma Agonist; Thiazolidinedione,2005,TAKEDA PHARMACEUTICALS AMERICA INC,2005/08/29-,64764-158,786Z46389E; JQT35NPK6C,PIOGLITAZONE HYDROCHLORIDE; metformin hydrochloride,metformin; pioglitazone,9100L32L2N; X4OV71U42S,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/42e49120-6f3f-11db-9fe1-0800200c9a66/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=42e49120-6f3f-11db-9fe1-0800200c9a66,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=42e49120-6f3f-11db-9fe1-0800200c9a66,42e49120-6f3f-11db-9fe1-0800200c9a66,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,050750,Zosyn,PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM,2024/05/01,Penicillin-class Antibacterial; beta Lactamase Inhibitor,1993,BAXTER HEALTHCARE CORPORATION,2023/04/01-,0338-9632; 0338-9636; 0338-9638,M98T69Q7HP; UXA545ABTT,PIPERACILLIN SODIUM; TAZOBACTAM SODIUM,PIPERACILLIN ANHYDROUS; TAZOBACTAM,9I628532GX; SE10G96M8W,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/8db6bd91-2106-4bfd-8cc8-38aaf1e18d17/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8db6bd91-2106-4bfd-8cc8-38aaf1e18d17,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=8db6bd91-2106-4bfd-8cc8-38aaf1e18d17,8db6bd91-2106-4bfd-8cc8-38aaf1e18d17,,,
HUMAN PRESCRIPTION DRUG LABEL,"CAPSULE; TABLET, COATED",ORAL,NDA,022535;208780,ESBRIET,PIRFENIDONE,2023/03/08,Pyridone,2014,GENENTECH INC,2014/10/15-; 2017/01/11-,50242-121; 50242-122; 50242-123,D7NLD2JX7U,PIRFENIDONE,PIRFENIDONE,D7NLD2JX7U,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/2e8c3537-36d7-4de5-9b5c-7a624b9a9e6e/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2e8c3537-36d7-4de5-9b5c-7a624b9a9e6e,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=2e8c3537-36d7-4de5-9b5c-7a624b9a9e6e,2e8c3537-36d7-4de5-9b5c-7a624b9a9e6e,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,NDA,022535,Esbriet,PIRFENIDONE,2014/10/28,Pyridone,2014,INTERMUNE INC,2014/10/16-,64116-121,D7NLD2JX7U,PIRFENIDONE,PIRFENIDONE,D7NLD2JX7U,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/0ab861c2-d5ca-4f92-854c-6477971a1b38/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0ab861c2-d5ca-4f92-854c-6477971a1b38,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=0ab861c2-d5ca-4f92-854c-6477971a1b38,0ab861c2-d5ca-4f92-854c-6477971a1b38,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,NDA,018147,Feldene,PIROXICAM,2024/05/16,Nonsteroidal Anti-inflammatory Drug,1982,PFIZER LABORATORIES DIV PFIZER INC,completed:1994/05/25-2024/01/31; completed:1994/05/25-2024/06/30,0069-3220; 0069-3230,13T4O6VMAM,PIROXICAM,PIROXICAM,13T4O6VMAM,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/dedef9e5-23de-49ff-895a-30906b5c7da3/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=dedef9e5-23de-49ff-895a-30906b5c7da3,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=dedef9e5-23de-49ff-895a-30906b5c7da3,dedef9e5-23de-49ff-895a-30906b5c7da3,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, COATED",ORAL,NDA,216059,JAYPIRCA,PIRTOBRUTINIB,2023/12/20,Kinase Inhibitor,2023,ELI LILLY AND COMPANY,2023/01/27-,0002-6902; 0002-7026,JNA39I7ZVB,pirtobrutinib,pirtobrutinib,JNA39I7ZVB,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/bd551845-0878-49a4-860f-839b83f6b801/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=bd551845-0878-49a4-860f-839b83f6b801,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=bd551845-0878-49a4-860f-839b83f6b801,bd551845-0878-49a4-860f-839b83f6b801,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,022363,Livalo,PITAVASTATIN CALCIUM,2024/02/02,HMG-CoA Reductase Inhibitor,2009,KOWA PHARMACEUTICALS AMERICA INC,2019/05/16-,66869-104; 66869-204; 66869-404,IYD54XEG3W,pitavastatin calcium,pitavastatin,M5681Q5F9P,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/44dcbf97-99ec-427c-ba50-207e0069d6d2/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=44dcbf97-99ec-427c-ba50-207e0069d6d2,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=44dcbf97-99ec-427c-ba50-207e0069d6d2,44dcbf97-99ec-427c-ba50-207e0069d6d2,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,208379,ZYPITAMAG,PITAVASTATIN MAGNESIUM,2024/01/15,HMG-CoA Reductase Inhibitor,2009,MEDICURE INTERNATIONAL INC,2018/03/09-,25208-201; 25208-202,M5681Q5F9P,PITAVASTATIN,PITAVASTATIN,M5681Q5F9P,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/c8c50e03-5cb8-43f4-bdef-8edd12f1945f/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c8c50e03-5cb8-43f4-bdef-8edd12f1945f,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=c8c50e03-5cb8-43f4-bdef-8edd12f1945f,c8c50e03-5cb8-43f4-bdef-8edd12f1945f,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,208379,ZYPITAMAG,PITAVASTATIN MAGNESIUM,2022/10/17,HMG-CoA Reductase Inhibitor,,ZYDUS LIFESCIENCES LIMITED,2018/03/09-,70771-1117; 70771-1118,M5681Q5F9P,PITAVASTATIN,PITAVASTATIN,M5681Q5F9P,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/e9f0fe3a-0462-4c24-8f22-3c89afe8fcea/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e9f0fe3a-0462-4c24-8f22-3c89afe8fcea,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=e9f0fe3a-0462-4c24-8f22-3c89afe8fcea,e9f0fe3a-0462-4c24-8f22-3c89afe8fcea,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,211150,Wakix,PITOLISANT HYDROCHLORIDE,2022/12/22,Histamine-3 Receptor Antagonist/Inverse Agonist,2019,HARMONY BIOSCIENCES LLC,2019/08/14-,72028-045; 72028-178,YV33CH63HI,PITOLISANT HYDROCHLORIDE,PITOLISANT,4BC83L4PIY,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/8daa5562-824e-476c-9652-26ceef3d4b0e/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8daa5562-824e-476c-9652-26ceef3d4b0e,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=8daa5562-824e-476c-9652-26ceef3d4b0e,8daa5562-824e-476c-9652-26ceef3d4b0e,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRAVENOUS,NDA,210303,Zemdri (plazomicin),PLAZOMICIN,2023/02/27,,2018,CIPLA USA INC,2018/07/16-,69097-820,LYO9XZ250J,plazomicin,plazomicin,LYO9XZ250J,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/eccf9fd9-53ac-4252-a106-5567b3a82a70/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=eccf9fd9-53ac-4252-a106-5567b3a82a70,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=eccf9fd9-53ac-4252-a106-5567b3a82a70,eccf9fd9-53ac-4252-a106-5567b3a82a70,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRAVENOUS,NDA,210303,Zemdri (plazomicin),PLAZOMICIN,2023/02/27,,2018,CIPLA THERAPEUTICS INC,2018/07/16-,80735-820,LYO9XZ250J,PLAZOMICIN,PLAZOMICIN,LYO9XZ250J,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/1243fcd3-de84-428b-901e-d83d65e4d98c/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1243fcd3-de84-428b-901e-d83d65e4d98c,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=1243fcd3-de84-428b-901e-d83d65e4d98c,1243fcd3-de84-428b-901e-d83d65e4d98c,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRAVENOUS,NDA,210303,Zemdri (plazomicin),PLAZOMICIN,2018/06/29,,2018,ACHAOGEN INC,2018/07/16-,71045-010,LYO9XZ250J,plazomicin,plazomicin,LYO9XZ250J,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/0b82ffed-27f4-4f5c-8135-670c148f0e12/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0b82ffed-27f4-4f5c-8135-670c148f0e12,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=0b82ffed-27f4-4f5c-8135-670c148f0e12,0b82ffed-27f4-4f5c-8135-670c148f0e12,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,208745,Trulance Immediate release,PLECANATIDE,2024/04/04,Guanylate Cyclase-C Agonist,2017,SALIX PHARMACEUTICALS INC,2017/02/21-,65649-003,7IK8Z952OK,PLECANATIDE,PLECANATIDE,7IK8Z952OK,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/fe2895bf-71a6-493a-b0ca-e06b2dfefc82/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=fe2895bf-71a6-493a-b0ca-e06b2dfefc82,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=fe2895bf-71a6-493a-b0ca-e06b2dfefc82,fe2895bf-71a6-493a-b0ca-e06b2dfefc82,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",SUBCUTANEOUS,NDA,022311,Mozobil,PLERIXAFOR,2023/10/05,Hematopoietic Stem Cell Mobilizer,2008,SANOFI AVENTIS U S LLC,2013/09/01-,0024-5862,S915P5499N,PLERIXAFOR,PLERIXAFOR,S915P5499N,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/0ed08d2b-5051-46b2-aa37-1d6275bf9003/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0ed08d2b-5051-46b2-aa37-1d6275bf9003,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=0ed08d2b-5051-46b2-aa37-1d6275bf9003,0ed08d2b-5051-46b2-aa37-1d6275bf9003,,,
HUMAN PRESCRIPTION DRUG LABEL,GEL,TOPICAL,NDA,020529,Condylox,PODOFILOX,2024/01/29,,,ALLERGAN INC,1997/03/13-,0023-6118,L36H50F353,PODOFILOX,PODOFILOX,L36H50F353,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/032e4bcb-b1ed-4029-b2a6-e92f3bf5cc37/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=032e4bcb-b1ed-4029-b2a6-e92f3bf5cc37,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=032e4bcb-b1ed-4029-b2a6-e92f3bf5cc37,032e4bcb-b1ed-4029-b2a6-e92f3bf5cc37,,,
HUMAN PRESCRIPTION DRUG LABEL,KIT,INTRAVENOUS,NDA,205098,Varithena,POLIDOCANOL,2023/10/02,Sclerosing Agent,2013,BIOCOMPATIBLES INC,2013/11/25-; 2014/07/10-; completed:2014/07/10-2017/01/09; completed:2017/12/22-2023/04/30,60635-107; 60635-111; 60635-118; 60635-123; 60635-133,0AWH8BFG9A,POLIDOCANOL,POLIDOCANOL,0AWH8BFG9A,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/dfd6b4a0-b0dc-11e2-9e96-0800200c9a66/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=dfd6b4a0-b0dc-11e2-9e96-0800200c9a66,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=dfd6b4a0-b0dc-11e2-9e96-0800200c9a66,dfd6b4a0-b0dc-11e2-9e96-0800200c9a66,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,021201,Asclera,POLIDOCANOL,2023/02/09,Sclerosing Agent,2010,METHAPHARM INC,2010/06/01-,67850-140; 67850-141,0AWH8BFG9A,POLIDOCANOL,POLIDOCANOL,0AWH8BFG9A,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/bb1f342b-5352-4059-a0b2-e60fd652fd28/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=bb1f342b-5352-4059-a0b2-e60fd652fd28,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=bb1f342b-5352-4059-a0b2-e60fd652fd28,bb1f342b-5352-4059-a0b2-e60fd652fd28,,,
HUMAN PRESCRIPTION DRUG LABEL,"POWDER, FOR SOLUTION",ORAL,NDA,019797,NuLYTELY,"POLYETHYLENE GLYCOL 3350, SODIUM CHLORIDE, SODIUM BICARBONATE AND POTASSIUM CHLORIDE",2022/06/16,Osmotic Laxative; Potassium Salt,1991,BRAINTREE LABORATORIES INC,completed:1991/04/22-2024/08/31,52268-302,451W47IQ8X; 660YQ98I10; 8MDF5V39QO; G2M7P15E5P,POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE,CHLORIDE ION; POLYETHYLENE GLYCOL 3350; POTASSIUM CATION; SODIUM CATION,295O53K152; G2M7P15E5P; LYR4M0NH37; Q32ZN48698,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/e7cf708c-937e-4aae-ab0a-0361c144a256/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e7cf708c-937e-4aae-ab0a-0361c144a256,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=e7cf708c-937e-4aae-ab0a-0361c144a256,e7cf708c-937e-4aae-ab0a-0361c144a256,,,
HUMAN PRESCRIPTION DRUG LABEL,"POWDER, FOR SOLUTION",ORAL,NDA,019011,GoLYTELY,"POLYETHYLENE GLYCOL 3350, SODIUM SULFATE ANHYDROUS, SODIUM BICARBONATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE",2021/05/28,Osmotic Laxative,1984,BRAINTREE LABORATORIES INC,1984/07/13-; completed:1984/07/13-2022/05/31; completed:1984/07/13-2022/10/31,52268-100; 52268-101; 52268-700,36KCS0R750; 451W47IQ8X; 660YQ98I10; 8MDF5V39QO; G2M7P15E5P,POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE; SODIUM SULFATE ANHYDROUS,BICARBONATE ION; CHLORIDE ION; POLYETHYLENE GLYCOL 3350; POTASSIUM CATION; SODIUM CATION; SULFATE ION,295O53K152; 7IS9N8KPMG; G2M7P15E5P; HN1ZRA3Q20; LYR4M0NH37; Q32ZN48698,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/57d22b0b-1ae0-4203-babc-f3bac17bd1c9/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=57d22b0b-1ae0-4203-babc-f3bac17bd1c9,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=57d22b0b-1ae0-4203-babc-f3bac17bd1c9,57d22b0b-1ae0-4203-babc-f3bac17bd1c9,,,
HUMAN PRESCRIPTION DRUG LABEL,KIT,ORAL,NDA,215344,SUFLAVE,"POLYETHYLENE GLYCOL 3350, SODIUM SULFATE, POTASSIUM CHLORIDE, MAGNESIUM SULFATE, AND SODIUM CHLORIDE FOR ORAL SOLUTION",2023/06/15,Calculi Dissolution Agent; Osmotic Laxative; Potassium Salt,2023,BRAINTREE LABORATORIES INC,2023/06/15-,52268-550,0YPR65R21J; 451W47IQ8X; 660YQ98I10; G2M7P15E5P; ML30MJ2U7I,MAGNESIUM SULFATE ANHYDROUS; POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM CHLORIDE; SODIUM SULFATE,CHLORIDE ION; MAGNESIUM CATION; POLYETHYLENE GLYCOL 3350; POTASSIUM CATION; SODIUM SULFATE ANHYDROUS,295O53K152; 36KCS0R750; G2M7P15E5P; Q32ZN48698; T6V3LHY838,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/546cfc44-791c-4524-99a9-6a0af96c4ec8/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=546cfc44-791c-4524-99a9-6a0af96c4ec8,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=546cfc44-791c-4524-99a9-6a0af96c4ec8,546cfc44-791c-4524-99a9-6a0af96c4ec8,,,
HUMAN PRESCRIPTION DRUG LABEL,KIT,ORAL,NDA,209381,Plenvu,"POLYETHYLENE GLYCOL 3350, SODIUM SULFATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE, ASCORBIC ACID, SODIUM ASCORBATE",2023/09/01,Osmotic Laxative; Potassium Salt; Vitamin C,2006,SALIX PHARMACEUTICALS INC,2018/05/04-,65649-400,0YPR65R21J; 451W47IQ8X; 660YQ98I10; G2M7P15E5P; PQ6CK8PD0R; S033EH8359,ASCORBIC ACID; POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM ASCORBATE; SODIUM CHLORIDE; SODIUM SULFATE,ASCORBIC ACID; CHLORIDE ION; POLYETHYLENE GLYCOL 3350; POTASSIUM CATION; SODIUM SULFATE ANHYDROUS,295O53K152; 36KCS0R750; G2M7P15E5P; PQ6CK8PD0R; Q32ZN48698,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/79f930fa-5674-4f30-8ae8-9448d6243797/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=79f930fa-5674-4f30-8ae8-9448d6243797,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=79f930fa-5674-4f30-8ae8-9448d6243797,79f930fa-5674-4f30-8ae8-9448d6243797,,,
HUMAN PRESCRIPTION DRUG LABEL,KIT,ORAL,NDA,021881,MoviPrep,"POLYETHYLENE GLYCOL 3350, SODIUM SULFATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE, ASCORBIC ACID, SODIUM ASCORBATE",2023/06/01,Osmotic Laxative; Potassium Salt; Vitamin C,2006,SALIX PHARMACEUTICALS INC,2006/10/01-,65649-201,0YPR65R21J; 451W47IQ8X; 660YQ98I10; G2M7P15E5P; PQ6CK8PD0R; S033EH8359,ASCORBIC ACID; POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM ASCORBATE; SODIUM CHLORIDE; SODIUM SULFATE,ASCORBIC ACID; CHLORIDE ION; POLYETHYLENE GLYCOL 3350; POTASSIUM CATION; SODIUM SULFATE ANHYDROUS,295O53K152; 36KCS0R750; G2M7P15E5P; PQ6CK8PD0R; Q32ZN48698,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/8ff46193-2a3b-4de0-9572-775dda8cd8b2/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8ff46193-2a3b-4de0-9572-775dda8cd8b2,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=8ff46193-2a3b-4de0-9572-775dda8cd8b2,8ff46193-2a3b-4de0-9572-775dda8cd8b2,,,
HUMAN PRESCRIPTION DRUG LABEL,KIT,ORAL,NDA,021881,"PEG-3350, Electrolytes, and Ascorbate","POLYETHYLENE GLYCOL 3350, SODIUM SULFATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE, SODIUM ASCORBATE, AND ASCORBIC ACID",2023/06/01,Osmotic Laxative; Potassium Salt; Vitamin C,2006,OCEANSIDE PHARMACEUTICALS,2006/10/01-,68682-201,0YPR65R21J; 451W47IQ8X; 660YQ98I10; G2M7P15E5P; PQ6CK8PD0R; S033EH8359,ASCORBIC ACID; POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM ASCORBATE; SODIUM CHLORIDE; SODIUM SULFATE,ASCORBIC ACID; CHLORIDE ION; POLYETHYLENE GLYCOL 3350; POTASSIUM CATION; SODIUM SULFATE ANHYDROUS,295O53K152; 36KCS0R750; G2M7P15E5P; PQ6CK8PD0R; Q32ZN48698,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/cd9c0751-10fa-4f5f-bf29-742823541d22/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=cd9c0751-10fa-4f5f-bf29-742823541d22,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=cd9c0751-10fa-4f5f-bf29-742823541d22,cd9c0751-10fa-4f5f-bf29-742823541d22,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,NDA,204026,Pomalyst,POMALIDOMIDE,2023/03/24,Thalidomide Analog,2013,CELGENE CORPORATION,2013/02/18-,59572-501; 59572-502; 59572-503; 59572-504,D2UX06XLB5,POMALIDOMIDE,POMALIDOMIDE,D2UX06XLB5,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/2b25ef01-5c9e-11e1-b86c-0800200c9a66/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2b25ef01-5c9e-11e1-b86c-0800200c9a66,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=2b25ef01-5c9e-11e1-b86c-0800200c9a66,2b25ef01-5c9e-11e1-b86c-0800200c9a66,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,203469,Iclusig,PONATINIB HYDROCHLORIDE,2024/03/26,Kinase Inhibitor,2012,TAKEDA PHARMACEUTICALS AMERICA INC,2012/12/14-; 2015/04/22-; 2021/01/11-,63020-533; 63020-534; 63020-535; 63020-536,96R6PU3D8J,ponatinib hydrochloride,ponatinib,4340891KFS,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/16d804b6-4957-43ee-b18c-3b36ec37c5ac/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=16d804b6-4957-43ee-b18c-3b36ec37c5ac,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=16d804b6-4957-43ee-b18c-3b36ec37c5ac,16d804b6-4957-43ee-b18c-3b36ec37c5ac,,,
HUMAN PRESCRIPTION DRUG LABEL,"KIT; TABLET, FILM COATED",ORAL,NDA,213498,PONVORY,PONESIMOD,2023/08/16,Sphingosine 1-phosphate Receptor Modulator,2021,JANSSEN PHARMACEUTICALS INC,2021/03/18-,50458-707; 50458-720,5G7AKV2MKP,PONESIMOD,PONESIMOD,5G7AKV2MKP,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/5be69660-738c-4db7-b0d4-517aa873dc41/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5be69660-738c-4db7-b0d4-517aa873dc41,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=5be69660-738c-4db7-b0d4-517aa873dc41,5be69660-738c-4db7-b0d4-517aa873dc41,,,
HUMAN PRESCRIPTION DRUG LABEL,"POWDER, FOR SUSPENSION; SOLUTION; SUSPENSION; TABLET, COATED",INTRAVENOUS; ORAL,NDA,022003;205053;205596;214770,NOXAFIL,POSACONAZOLE,2023/10/20,Azole Antifungal,2006,MERCK SHARP AND DOHME LLC,2006/09/15-; 2013/11/25-; 2014/03/13-; 2021/06/08-,0085-1328; 0085-2224; 0085-4324; 0085-4331,6TK1G07BHZ,POSACONAZOLE; posaconazole,POSACONAZOLE; posaconazole,6TK1G07BHZ,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/b073b082-7b57-4423-8c06-4fd4263d6f84/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b073b082-7b57-4423-8c06-4fd4263d6f84,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=b073b082-7b57-4423-8c06-4fd4263d6f84,b073b082-7b57-4423-8c06-4fd4263d6f84,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION, CONCENTRATE",INTRAVENOUS,NDA,018896,Potassium Acetate,POTASSIUM ACETATE,2021/07/20,Osmotic Laxative; Potassium Salt,,HOSPIRA INC,2013/12/23-,0409-3294,M911911U02,POTASSIUM ACETATE,POTASSIUM CATION,295O53K152,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/c58f8112-d587-493a-91b7-2b48c80bb7bf/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c58f8112-d587-493a-91b7-2b48c80bb7bf,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=c58f8112-d587-493a-91b7-2b48c80bb7bf,c58f8112-d587-493a-91b7-2b48c80bb7bf,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION, CONCENTRATE",INTRAVENOUS,NDA,018896,Potassium Acetate,POTASSIUM ACETATE,2021/07/20,Osmotic Laxative; Potassium Salt,,HOSPIRA INC,2014/03/27-,0409-8183,M911911U02,POTASSIUM ACETATE,POTASSIUM CATION,295O53K152,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/c7eabefd-2781-439b-b8f4-cb3ea25a4720/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c7eabefd-2781-439b-b8f4-cb3ea25a4720,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=c7eabefd-2781-439b-b8f4-cb3ea25a4720,c7eabefd-2781-439b-b8f4-cb3ea25a4720,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION, CONCENTRATE",INTRAVENOUS,NDA,018896,Potassium Acetate,POTASSIUM ACETATE,2019/12/04,Osmotic Laxative; Potassium Salt,,HOSPIRA INC,2005/07/07-,0409-8183,M911911U02,POTASSIUM ACETATE,POTASSIUM CATION,295O53K152,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/8123cce8-42e3-49e4-a488-3bb836ecccd0/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8123cce8-42e3-49e4-a488-3bb836ecccd0,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=8123cce8-42e3-49e4-a488-3bb836ecccd0,8123cce8-42e3-49e4-a488-3bb836ecccd0,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION, CONCENTRATE",INTRAVENOUS,NDA,018896,Potassium Acetate,POTASSIUM ACETATE,2019/12/04,Osmotic Laxative; Potassium Salt,,HOSPIRA INC,2005/07/05-,0409-3294,M911911U02,POTASSIUM ACETATE,POTASSIUM CATION,295O53K152,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/e9772b82-1e2b-4c4b-aa47-677491dbf73c/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e9772b82-1e2b-4c4b-aa47-677491dbf73c,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=e9772b82-1e2b-4c4b-aa47-677491dbf73c,e9772b82-1e2b-4c4b-aa47-677491dbf73c,,,
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION,ORAL,NDA,206814,Potassium Chloride,POTASSIUM CHLORIDE,2024/05/09,,1948,VISTAPHARM LLC,completed:2015/02/15-2025/05/31,66689-047; 66689-048,660YQ98I10,POTASSIUM CHLORIDE,CHLORIDE ION; POTASSIUM CATION,295O53K152; Q32ZN48698,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/142c30ff-a839-4616-8167-ad4b07d8456f/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=142c30ff-a839-4616-8167-ad4b07d8456f,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=142c30ff-a839-4616-8167-ad4b07d8456f,142c30ff-a839-4616-8167-ad4b07d8456f,,,
HUMAN PRESCRIPTION DRUG LABEL,"POWDER, FOR SOLUTION",ORAL,NDA,208019,POKONZA,POTASSIUM CHLORIDE,2024/03/22,Osmotic Laxative; Potassium Salt,1948,CARWIN PHARMACEUTICAL ASSOCIATES LLC,2023/09/19-,15370-305,660YQ98I10,Potassium Chloride,POTASSIUM CATION,295O53K152,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/7c5cc705-e5da-4487-86c9-9d545a95afb4/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7c5cc705-e5da-4487-86c9-9d545a95afb4,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=7c5cc705-e5da-4487-86c9-9d545a95afb4,7c5cc705-e5da-4487-86c9-9d545a95afb4,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,NDA,019123,Potassium Chloride,POTASSIUM CHLORIDE,2023/05/22,Osmotic Laxative; Potassium Salt,1948,UPSHER SMITH LABORATORIES LLC,1986/04/17-,0832-5322; 0832-5323,660YQ98I10,potassium chloride,Potassium cation,295O53K152,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/616f0de7-8843-44a1-8fa6-274d889286aa/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=616f0de7-8843-44a1-8fa6-274d889286aa,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=616f0de7-8843-44a1-8fa6-274d889286aa,616f0de7-8843-44a1-8fa6-274d889286aa,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,019904,Potassium Chloride,POTASSIUM CHLORIDE,2022/06/13,,,BAXTER HEALTHCARE CORPORATION,1989/12/26-,0338-0703; 0338-0705; 0338-0709,660YQ98I10,POTASSIUM CHLORIDE,CHLORIDE ION; POTASSIUM CATION,295O53K152; Q32ZN48698,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/092ddee4-572d-4771-8d95-880cea01097e/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=092ddee4-572d-4771-8d95-880cea01097e,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=092ddee4-572d-4771-8d95-880cea01097e,092ddee4-572d-4771-8d95-880cea01097e,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,NDA,019123,KLOR-CON,POTASSIUM CHLORIDE,2020/09/23,Osmotic Laxative; Potassium Salt,1948,UPSHER SMITH LABORATORIES LLC,1986/04/17-,0245-5315; 0245-5316,660YQ98I10,potassium chloride,Potassium cation,295O53K152,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/1ff53330-065c-4213-9c0c-ac498621d09d/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1ff53330-065c-4213-9c0c-ac498621d09d,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=1ff53330-065c-4213-9c0c-ac498621d09d,1ff53330-065c-4213-9c0c-ac498621d09d,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,020161,Potassium Chloride,POTASSIUM CHLORIDE,2020/06/18,,,ICU MEDICAL INC,2019/04/01-,0990-7074; 0990-7075; 0990-7077,660YQ98I10,POTASSIUM CHLORIDE,CHLORIDE ION; POTASSIUM CATION,295O53K152; Q32ZN48698,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/eb56a807-ea94-4edb-9811-a04b19568468/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=eb56a807-ea94-4edb-9811-a04b19568468,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=eb56a807-ea94-4edb-9811-a04b19568468,eb56a807-ea94-4edb-9811-a04b19568468,,,
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION,ORAL,NDA,206814,Potassium Chloride,POTASSIUM CHLORIDE,2020/06/01,,1948,PAR PHARMACEUTICAL,2015/05/04-,0603-1542; 0603-1543,660YQ98I10,Potassium Chloride,Chloride Ion; Potassium Cation,295O53K152; Q32ZN48698,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/e5214432-3517-4a90-9412-036752bd1139/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e5214432-3517-4a90-9412-036752bd1139,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=e5214432-3517-4a90-9412-036752bd1139,e5214432-3517-4a90-9412-036752bd1139,,,
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION,ORAL,NDA,206814,Potassium Chloride,POTASSIUM CHLORIDE,2020/06/01,Osmotic Laxative; Potassium Salt,1948,GENUS LIFESCIENCES INC,2015/02/15-; completed:2015/02/15-2015/09/07,64950-320; 64950-322,660YQ98I10,Potassium Chloride,POTASSIUM CATION,295O53K152,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/14cd12ee-a4a3-465a-9550-58c9ef0e4f21/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=14cd12ee-a4a3-465a-9550-58c9ef0e4f21,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=14cd12ee-a4a3-465a-9550-58c9ef0e4f21,14cd12ee-a4a3-465a-9550-58c9ef0e4f21,,,
HUMAN PRESCRIPTION DRUG LABEL,"POWDER, FOR SOLUTION",ORAL,NDA,208019,Potassium Chloride,POTASSIUM CHLORIDE,2020/04/28,,1948,PAR PHARMACEUTICAL,2015/09/18-,0603-1554,660YQ98I10,Potassium Chloride,Chloride Ion; Potassium Cation,295O53K152; Q32ZN48698,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/a64d7151-09a6-474c-83fc-36c7cf582d32/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a64d7151-09a6-474c-83fc-36c7cf582d32,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=a64d7151-09a6-474c-83fc-36c7cf582d32,a64d7151-09a6-474c-83fc-36c7cf582d32,,,
HUMAN PRESCRIPTION DRUG LABEL,"POWDER, FOR SOLUTION",ORAL,NDA,208019,Potassium Chloride,POTASSIUM CHLORIDE,2020/04/28,,1948,GENUS LIFESCIENCES INC,2015/09/07-,64950-321,660YQ98I10,Potassium Chloride,Chloride Ion; Potassium Cation,295O53K152; Q32ZN48698,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/23d818e7-c076-40de-8dc1-0b51ba4be96a/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=23d818e7-c076-40de-8dc1-0b51ba4be96a,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=23d818e7-c076-40de-8dc1-0b51ba4be96a,23d818e7-c076-40de-8dc1-0b51ba4be96a,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,NDA,018279,K-Tab,POTASSIUM CHLORIDE,2018/04/01,Osmotic Laxative; Potassium Salt,1948,ABBVIE INC,completed:1980/06/09-2021/07/27; completed:1980/06/09-2022/08/09; completed:1980/06/09-2025/02/15; completed:2017/06/01-2023/11/04,0074-3023; 0074-3058; 0074-3278; 0074-7804,660YQ98I10,POTASSIUM CHLORIDE,POTASSIUM CATION,295O53K152,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/6594df99-d8ce-49b9-3fbe-9ec7cdc9199b/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6594df99-d8ce-49b9-3fbe-9ec7cdc9199b,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=6594df99-d8ce-49b9-3fbe-9ec7cdc9199b,6594df99-d8ce-49b9-3fbe-9ec7cdc9199b,,,
HUMAN PRESCRIPTION DRUG LABEL,"CAPSULE, EXTENDED RELEASE",ORAL,NDA,018238,Micro-K 10 Extencaps; Micro-K Extencaps,POTASSIUM CHLORIDE,2009/12/21,Osmotic Laxative; Potassium Salt,,THER RX CORPORATION,2009/08/01-,64011-009; 64011-010,660YQ98I10,POTASSIUM CHLORIDE,POTASSIUM CATION,295O53K152,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/cb128705-d8c7-4341-a976-d8fd7371df6d/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=cb128705-d8c7-4341-a976-d8fd7371df6d,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=cb128705-d8c7-4341-a976-d8fd7371df6d,cb128705-d8c7-4341-a976-d8fd7371df6d,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,017634,Potassium Chloride in Dextrose,POTASSIUM CHLORIDE AND DEXTROSE MONOHYDRATE,2019/07/15,,1979,BAXTER HEALTHCARE CORPORATION,1979/02/01-,0338-0683,660YQ98I10; LX22YL083G,DEXTROSE MONOHYDRATE; POTASSIUM CHLORIDE,ANHYDROUS DEXTROSE; CHLORIDE ION; POTASSIUM CATION,295O53K152; 5SL0G7R0OK; Q32ZN48698,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/45de5402-5e61-4bbd-8bbc-5e3392c9920e/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=45de5402-5e61-4bbd-8bbc-5e3392c9920e,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=45de5402-5e61-4bbd-8bbc-5e3392c9920e,45de5402-5e61-4bbd-8bbc-5e3392c9920e,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,017648,Potassium Chloride in Sodium Chloride,POTASSIUM CHLORIDE AND SODIUM CHLORIDE,2019/01/11,,,BAXTER HEALTHCARE CORPORATION,1979/02/02-,0338-0691; 0338-0695; 0338-0704,451W47IQ8X; 660YQ98I10,POTASSIUM CHLORIDE; SODIUM CHLORIDE,CHLORIDE ION; POTASSIUM CATION; SODIUM CATION,295O53K152; LYR4M0NH37; Q32ZN48698,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/becc7410-0a25-49f5-b0c3-240078479dc8/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=becc7410-0a25-49f5-b0c3-240078479dc8,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=becc7410-0a25-49f5-b0c3-240078479dc8,becc7410-0a25-49f5-b0c3-240078479dc8,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRA-ARTERIAL,NDA,018608,Plegisol,"POTASSIUM CHLORIDE, SODIUM CHLORIDE, CALCIUM CHLORIDE, AND MAGNESIUM CHLORIDE",2024/03/18,,,HOSPIRA INC,2005/07/28-,0409-7969,02F3473H9O; 451W47IQ8X; 660YQ98I10; M4I0D6VV5M,CALCIUM CHLORIDE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM CHLORIDE,CALCIUM CATION; CHLORIDE ION; MAGNESIUM CATION; POTASSIUM CATION; SODIUM CATION,295O53K152; 2M83C4R6ZB; LYR4M0NH37; Q32ZN48698; T6V3LHY838,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/35a174f0-f0d7-4ec7-3f81-d3d572c059cf/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=35a174f0-f0d7-4ec7-3f81-d3d572c059cf,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=35a174f0-f0d7-4ec7-3f81-d3d572c059cf,35a174f0-f0d7-4ec7-3f81-d3d572c059cf,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,019685,Potassium Chloride in Lactated Ringers and Dextrose,"POTASSIUM CHLORIDE, SODIUM CHLORIDE, CALCIUM CHLORIDE, SODIUM LACTATE, AND DEXTROSE MONOHYDRATE",2021/06/24,,,ICU MEDICAL INC,2019/11/25-,0990-7111,451W47IQ8X; 660YQ98I10; LX22YL083G; M4I0D6VV5M; TU7HW0W0QT,CALCIUM CHLORIDE; DEXTROSE MONOHYDRATE; POTASSIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE,"ANHYDROUS DEXTROSE; CALCIUM CATION; CHLORIDE ION; LACTIC ACID, UNSPECIFIED FORM; POTASSIUM CATION; SODIUM CATION",295O53K152; 2M83C4R6ZB; 33X04XA5AT; 5SL0G7R0OK; LYR4M0NH37; Q32ZN48698,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/237b39fa-916e-4a54-99c8-4ae9ad54f056/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=237b39fa-916e-4a54-99c8-4ae9ad54f056,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=237b39fa-916e-4a54-99c8-4ae9ad54f056,237b39fa-916e-4a54-99c8-4ae9ad54f056,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, EXTENDED RELEASE",ORAL,NDA,019071,UROCIT-K,POTASSIUM CITRATE,2024/05/23,Anti-coagulant; Calculi Dissolution Agent,1985,MISSION PHARMACAL COMPANY,1985/09/01-; 1992/09/01-; 2010/01/27-,0178-0600; 0178-0610; 0178-0615,EE90ONI6FF,POTASSIUM CITRATE,ANHYDROUS CITRIC ACID,XF417D3PSL,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/72cdea1b-2240-41db-987d-86d5c6aaa978/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=72cdea1b-2240-41db-987d-86d5c6aaa978,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=72cdea1b-2240-41db-987d-86d5c6aaa978,72cdea1b-2240-41db-987d-86d5c6aaa978,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,019071,Potassium Citrate,POTASSIUM CITRATE,2022/08/11,Anti-coagulant; Calculi Dissolution Agent,1985,UPSHER SMITH LABORATORIES LLC,2006/09/01-,0245-0070; 0245-0071,EE90ONI6FF,POTASSIUM CITRATE,ANHYDROUS CITRIC ACID,XF417D3PSL,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/2215dc1d-0b5a-469e-9b51-4d7480a51078/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2215dc1d-0b5a-469e-9b51-4d7480a51078,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=2215dc1d-0b5a-469e-9b51-4d7480a51078,2215dc1d-0b5a-469e-9b51-4d7480a51078,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION, CONCENTRATE",INTRAVENOUS,NDA,212832,Potassium Phosphates,"POTASSIUM PHOSPHATE, MONOBASIC POTASSIUM PHOSPHATE, DIBASIC",2022/04/12,,1983,FRESENIUS KABI USA LLC,2020/02/10-,65219-052; 65219-054; 65219-056,4J9FJ0HL51; CI71S98N1Z,"Potassium Phosphate, Dibasic; Potassium Phosphate, Monobasic",Phosphate Ion; Potassium Cation,295O53K152; NK08V8K8HR,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/475f5cd7-45bd-412a-b419-9962585d6cda/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=475f5cd7-45bd-412a-b419-9962585d6cda,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=475f5cd7-45bd-412a-b419-9962585d6cda,475f5cd7-45bd-412a-b419-9962585d6cda,,,
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION,OPHTHALMIC,NDA,018634,Betadine,POVIDONE-IODINE,2022/06/29,,,ALCON LABORATORIES INC,2000/04/01-,0065-0411,85H0HZU99M,POVIDONE-IODINE,IODINE,9679TC07X4,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/b026de1b-9949-4557-ac49-c7b0038c24cd/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b026de1b-9949-4557-ac49-c7b0038c24cd,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=b026de1b-9949-4557-ac49-c7b0038c24cd,b026de1b-9949-4557-ac49-c7b0038c24cd,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRAVENOUS,NDA,022468,Folotyn,PRALATREXATE,2023/06/01,Folate Analog Metabolic Inhibitor,2009,ACROTECH BIOPHARMA INC,2009/09/24-,72893-003; 72893-005,A8Q8I19Q20,PRALATREXATE,PRALATREXATE,A8Q8I19Q20,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/9f3d9c4d-9386-4451-b712-0fbdc5478d8f/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9f3d9c4d-9386-4451-b712-0fbdc5478d8f,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=9f3d9c4d-9386-4451-b712-0fbdc5478d8f,9f3d9c4d-9386-4451-b712-0fbdc5478d8f,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS,NDA,014134,Protopam Chloride,PRALIDOXIME CHLORIDE,2024/05/06,Cholinesterase Reactivator,,BAMBOO US BIDCO LLC,1965/03/10-,83703-036,38X7XS076H,PRALIDOXIME CHLORIDE,PRALIDOXIME,P7MU9UTP52,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/17407365-3681-5a43-e063-6394a90a0391/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=17407365-3681-5a43-e063-6394a90a0391,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=17407365-3681-5a43-e063-6394a90a0391,17407365-3681-5a43-e063-6394a90a0391,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS,NDA,014134,Protopam Chloride,PRALIDOXIME CHLORIDE,2018/01/01,Cholinesterase Reactivator,,BAXTER HEALTHCARE CORPORATION,1965/03/10-,60977-141,38X7XS076H,PRALIDOXIME CHLORIDE,PRALIDOXIME,P7MU9UTP52,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/2741d8fd-51c2-46be-880b-99f2b20a6137/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2741d8fd-51c2-46be-880b-99f2b20a6137,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=2741d8fd-51c2-46be-880b-99f2b20a6137,2741d8fd-51c2-46be-880b-99f2b20a6137,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,NDA,213721,Gavreto,PRALSETINIB,2024/04/25,Kinase Inhibitor,2020,RIGEL PHARMACEUTICALS INC,2024/05/01-,71332-006,1WPE73O1WV,PRALSETINIB,PRALSETINIB,1WPE73O1WV,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/16edd46e-28b8-f06d-e063-6394a90ae31b/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=16edd46e-28b8-f06d-e063-6394a90ae31b,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=16edd46e-28b8-f06d-e063-6394a90ae31b,16edd46e-28b8-f06d-e063-6394a90ae31b,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,NDA,213721,Gavreto,PRALSETINIB,2024/03/31,Kinase Inhibitor,2020,GENENTECH INC,2021/07/01-,50242-210,1WPE73O1WV,PRALSETINIB,PRALSETINIB,1WPE73O1WV,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/59984249-e3ff-4f97-8d7a-c1a905d604a8/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=59984249-e3ff-4f97-8d7a-c1a905d604a8,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=59984249-e3ff-4f97-8d7a-c1a905d604a8,59984249-e3ff-4f97-8d7a-c1a905d604a8,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, EXTENDED RELEASE",ORAL,NDA,022421,Mirapex ER,PRAMIPEXOLE DIHYDROCHLORIDE,2023/11/08,Nonergot Dopamine Agonist,1997,BOEHRINGER INGELHEIM PHARMACEUTICALS INC,completed:2010/02/22-2023/11/30; completed:2010/02/22-2024/06/30; completed:2010/02/22-2024/07/31; completed:2010/02/22-2024/08/31; completed:2011/06/18-2024/08/31,0597-0109; 0597-0113; 0597-0115; 0597-0116; 0597-0285; 0597-0286; 0597-0287,3D867NP06J,PRAMIPEXOLE DIHYDROCHLORIDE,PRAMIPEXOLE,83619PEU5T,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/e2902ed1-cfeb-4815-adc3-129c577917a1/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e2902ed1-cfeb-4815-adc3-129c577917a1,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=e2902ed1-cfeb-4815-adc3-129c577917a1,e2902ed1-cfeb-4815-adc3-129c577917a1,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,SUBCUTANEOUS,NDA,021332,SymlinPen,PRAMLINTIDE ACETATE,2019/12/18,Amylin Analog,2005,ASTRAZENECA PHARMACEUTICALS LP,2015/01/08-,0310-6615; 0310-6627,726I6TE06G,pramlintide acetate,pramlintide,D3FM8FA78T,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/4aea30ff-eb0d-45c1-b114-3127966328ff/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4aea30ff-eb0d-45c1-b114-3127966328ff,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=4aea30ff-eb0d-45c1-b114-3127966328ff,4aea30ff-eb0d-45c1-b114-3127966328ff,,,
HUMAN PRESCRIPTION DRUG LABEL,INSERT,VAGINAL,NDA,208470,Intrarosa,PRASTERONE,2023/01/17,,2016,MILLICENT US INC,2020/11/01-,72495-401; 72495-501,459AG36T1B,PRASTERONE,PRASTERONE,459AG36T1B,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/ada639d4-bac0-2ad0-e053-2a95a90afce7/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ada639d4-bac0-2ad0-e053-2a95a90afce7,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=ada639d4-bac0-2ad0-e053-2a95a90afce7,ada639d4-bac0-2ad0-e053-2a95a90afce7,,,
HUMAN PRESCRIPTION DRUG LABEL,INSERT,VAGINAL,NDA,208470,Intrarosa,PRASTERONE,2020/11/11,,2016,AMAG PHARMACEUTICALS INC,2017/07/24-,64011-601,459AG36T1B,PRASTERONE,PRASTERONE,459AG36T1B,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/df731acd-7276-4fef-b037-bc7f30c112cb/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=df731acd-7276-4fef-b037-bc7f30c112cb,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=df731acd-7276-4fef-b037-bc7f30c112cb,df731acd-7276-4fef-b037-bc7f30c112cb,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, COATED",ORAL,NDA,022307,Effient,PRASUGREL HYDROCHLORIDE,2022/09/07,P2Y12 Platelet Inhibitor,2009,COSETTE PHARMACEUTICALS INC,2022/09/01-,0713-0881; 0713-0882,G89JQ59I13,PRASUGREL HYDROCHLORIDE,PRASUGREL,34K66TBT99,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/69ea2d58-5353-4222-b61f-cab976fa7e5e/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=69ea2d58-5353-4222-b61f-cab976fa7e5e,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=69ea2d58-5353-4222-b61f-cab976fa7e5e,69ea2d58-5353-4222-b61f-cab976fa7e5e,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,018714,Biltricide,PRAZIQUANTEL,2023/12/06,Anthelmintic,1982,BAYER HEALTHCARE PHARMACEUTICALS INC,2011/04/21-,50419-747,6490C9U457,PRAZIQUANTEL,PRAZIQUANTEL,6490C9U457,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/34ce1cdd-648e-4f1e-8512-bf3d4cc22eb9/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=34ce1cdd-648e-4f1e-8512-bf3d4cc22eb9,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=34ce1cdd-648e-4f1e-8512-bf3d4cc22eb9,34ce1cdd-648e-4f1e-8512-bf3d4cc22eb9,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,NDA,017442,Minipress,PRAZOSIN HYDROCHLORIDE,2024/05/07,alpha-Adrenergic Blocker,,PFIZER LABORATORIES DIV PFIZER INC,completed:1994/05/10-2024/04/30; completed:1994/05/10-2024/05/31,0069-4310; 0069-4370; 0069-4380,X0Z7454B90,PRAZOSIN HYDROCHLORIDE,PRAZOSIN,XM03YJ541D,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/36c4da56-502e-4da1-acf7-8e81ee453dcc/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=36c4da56-502e-4da1-acf7-8e81ee453dcc,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=36c4da56-502e-4da1-acf7-8e81ee453dcc,36c4da56-502e-4da1-acf7-8e81ee453dcc,,,
HUMAN PRESCRIPTION DRUG LABEL,SUSPENSION/ DROPS,OPHTHALMIC,NDA,017100,PRED MILD,PREDNISOLONE ACETATE,2024/02/29,Corticosteroid,,ALLERGAN INC,1972/12/01-,11980-174,8B2807733D,PREDNISOLONE ACETATE,PREDNISOLONE,9PHQ9Y1OLM,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/4fcce64a-94ea-4031-ad5a-c4eddc73a910/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4fcce64a-94ea-4031-ad5a-c4eddc73a910,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=4fcce64a-94ea-4031-ad5a-c4eddc73a910,4fcce64a-94ea-4031-ad5a-c4eddc73a910,,,
HUMAN PRESCRIPTION DRUG LABEL,SUSPENSION/ DROPS,OPHTHALMIC,NDA,017011,PRED FORTE,PREDNISOLONE ACETATE,2024/02/29,Corticosteroid,,ALLERGAN INC,1973/06/01-,11980-180,8B2807733D,PREDNISOLONE ACETATE,PREDNISOLONE,9PHQ9Y1OLM,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/00a5aa88-e361-4ea7-8922-530c738b726e/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=00a5aa88-e361-4ea7-8922-530c738b726e,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=00a5aa88-e361-4ea7-8922-530c738b726e,00a5aa88-e361-4ea7-8922-530c738b726e,,,
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION,ORAL,NDA,019157,PEDIAPRED,PREDNISOLONE SODIUM PHOSPHATE,2024/02/01,Corticosteroid,,ROYAL PHARMACEUTICALS,2018/02/07-,68791-104,IV021NXA9J,Prednisolone Sodium Phosphate,PREDNISOLONE,9PHQ9Y1OLM,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/1b996564-a777-4d37-ae00-b6a5ffc5e596/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1b996564-a777-4d37-ae00-b6a5ffc5e596,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=1b996564-a777-4d37-ae00-b6a5ffc5e596,1b996564-a777-4d37-ae00-b6a5ffc5e596,,,
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION,ORAL,NDA,019157,Prednisolone Sodium Phosphate,PREDNISOLONE SODIUM PHOSPHATE,2023/03/28,Corticosteroid,,SETON PHARMACEUTICALS LLC,2013/10/18-,13925-166,IV021NXA9J,PREDNISOLONE SODIUM PHOSPHATE,PREDNISOLONE,9PHQ9Y1OLM,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/833ba492-8823-43b4-9a91-8b28d94a740b/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=833ba492-8823-43b4-9a91-8b28d94a740b,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=833ba492-8823-43b4-9a91-8b28d94a740b,833ba492-8823-43b4-9a91-8b28d94a740b,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, ORALLY DISINTEGRATING",ORAL,NDA,021959,Orapred ODT,PREDNISOLONE SODIUM PHOSPHATE,2022/02/16,Corticosteroid,1955,CONCORDIA PHARMACEUTICALS INC,2006/06/01-,59212-700; 59212-701; 59212-702,IV021NXA9J,PREDNISOLONE SODIUM PHOSPHATE,PREDNISOLONE,9PHQ9Y1OLM,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/1e379543-c4cf-4e72-953b-db15b7f0c2a1/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1e379543-c4cf-4e72-953b-db15b7f0c2a1,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=1e379543-c4cf-4e72-953b-db15b7f0c2a1,1e379543-c4cf-4e72-953b-db15b7f0c2a1,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, DELAYED RELEASE",ORAL,NDA,202020,RAYOS,PREDNISONE,2021/05/24,Corticosteroid,1955,HORIZON THERAPEUTICS USA INC,2012/07/27-,75987-020; 75987-021; 75987-022,VB0R961HZT,PREDNISONE,PREDNISONE,VB0R961HZT,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/281ab967-7565-4bef-9c0c-a646589c671e/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=281ab967-7565-4bef-9c0c-a646589c671e,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=281ab967-7565-4bef-9c0c-a646589c671e,281ab967-7565-4bef-9c0c-a646589c671e,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,NDA,209501,Lyrica CR,PREGABALIN,2023/12/27,,2004,VIATRIS SPECIALTY LLC,2023/12/27-,58151-245; 58151-246; 58151-247,55JG375S6M,PREGABALIN,PREGABALIN,55JG375S6M,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/f280bbd8-2af2-444a-bd96-e409337ca6dd/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f280bbd8-2af2-444a-bd96-e409337ca6dd,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=f280bbd8-2af2-444a-bd96-e409337ca6dd,f280bbd8-2af2-444a-bd96-e409337ca6dd,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE; SOLUTION,ORAL,NDA,021446;022488,Lyrica,PREGABALIN,2023/12/20,,2004,VIATRIS SPECIALTY LLC,2024/02/07-,58151-236; 58151-237; 58151-238; 58151-239; 58151-240; 58151-241; 58151-242; 58151-243; 58151-244,55JG375S6M,PREGABALIN,PREGABALIN,55JG375S6M,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/d4734e7d-5079-455e-8ff5-8f4539c998a9/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d4734e7d-5079-455e-8ff5-8f4539c998a9,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=d4734e7d-5079-455e-8ff5-8f4539c998a9,d4734e7d-5079-455e-8ff5-8f4539c998a9,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE; SOLUTION,ORAL,NDA,021446;022488,Lyrica,PREGABALIN,2020/06/15,,2004,PARKE DAVIS DIV OF PFIZER INC,2004/12/30-; 2010/01/04-,0071-1012; 0071-1013; 0071-1014; 0071-1015; 0071-1016; 0071-1017; 0071-1018; 0071-1019; 0071-1020,55JG375S6M,PREGABALIN,PREGABALIN,55JG375S6M,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/60185c88-ecfd-46f9-adb9-b97c6b00a553/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=60185c88-ecfd-46f9-adb9-b97c6b00a553,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=60185c88-ecfd-46f9-adb9-b97c6b00a553,60185c88-ecfd-46f9-adb9-b97c6b00a553,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,NDA,209501,Lyrica CR,PREGABALIN,2020/06/15,,2004,PARKE DAVIS DIV OF PFIZER INC,2018/01/01-,0071-1026; 0071-1027; 0071-1029,55JG375S6M,PREGABALIN,PREGABALIN,55JG375S6M,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/2d832165-3d98-497c-84b0-2d9ae3f838f9/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2d832165-3d98-497c-84b0-2d9ae3f838f9,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=2d832165-3d98-497c-84b0-2d9ae3f838f9,2d832165-3d98-497c-84b0-2d9ae3f838f9,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,212862,Pretomanid,PRETOMANID,2022/12/28,Antimycobacterial,2019,MYLAN SPECIALTY L P,2019/11/07-,49502-476,2XOI31YC4N,Pretomanid,Pretomanid,2XOI31YC4N,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/f1906fc9-cb3c-4e13-8a4a-da76100c1bf3/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f1906fc9-cb3c-4e13-8a4a-da76100c1bf3,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=f1906fc9-cb3c-4e13-8a4a-da76100c1bf3,f1906fc9-cb3c-4e13-8a4a-da76100c1bf3,,,
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION,ORAL,NDA,209139,PREXXARTAN,PREXXARTAN,2018/01/02,Angiotensin 2 Receptor Blocker,1996,MEDICURE INTERNATIONAL INC,2018/01/02-,25208-100,80M03YXJ7I,VALSARTAN,VALSARTAN,80M03YXJ7I,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/df73d781-65d8-4aaa-9b0f-de4341f639ec/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=df73d781-65d8-4aaa-9b0f-de4341f639ec,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=df73d781-65d8-4aaa-9b0f-de4341f639ec,df73d781-65d8-4aaa-9b0f-de4341f639ec,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",SUBMUCOSAL,NDA,021383,Citanest Forte,PRILOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE,2017/10/17,Amide Local Anesthetic; Catecholamine; alpha-Adrenergic Agonist; beta-Adrenergic Agonist,,DENTSPLY PHARMACEUTICAL INC,1965/11/18-,66312-540,30Q7KI53AK; MJW015BAPH,EPINEPHRINE BITARTRATE; PRILOCAINE HYDROCHLORIDE,EPINEPHRINE; PRILOCAINE,046O35D44R; YKH834O4BH,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/a654df2a-68bc-43c5-bd97-ad43f8679dc0/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a654df2a-68bc-43c5-bd97-ad43f8679dc0,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=a654df2a-68bc-43c5-bd97-ad43f8679dc0,a654df2a-68bc-43c5-bd97-ad43f8679dc0,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,008316,Primaquine Phosphate,PRIMAQUINE PHOSPHATE,2024/05/03,Antimalarial,,SANOFI AVENTIS U S LLC,2011/04/15-,0024-1596,H0982HF78B,PRIMAQUINE PHOSPHATE,PRIMAQUINE,MVR3634GX1,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/1bfbf4ae-81b8-4160-a00d-6322aadd4b59/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1bfbf4ae-81b8-4160-a00d-6322aadd4b59,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=1bfbf4ae-81b8-4160-a00d-6322aadd4b59,1bfbf4ae-81b8-4160-a00d-6322aadd4b59,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,009170,Mysoline,PRIMIDONE,2020/07/06,Anti-epileptic Agent,,BAUSCH HEALTH US LLC,2009/06/24-,66490-690; 66490-691,13AFD7670Q,Primidone,Primidone,13AFD7670Q,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/af593171-dabb-4ea3-b44c-89ed457b2c46/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=af593171-dabb-4ea3-b44c-89ed457b2c46,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=af593171-dabb-4ea3-b44c-89ed457b2c46,af593171-dabb-4ea3-b44c-89ed457b2c46,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,NDA,016785,Matulane,PROCARBAZINE HYDROCHLORIDE,2023/11/20,Alkylating Drug,,LEADIANT BIOSCIENCES INC,1985/12/27-,54482-054,XH0NPH5ZX8,PROCARBAZINE HYDROCHLORIDE,PROCARBAZINE,35S93Y190K,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/1aa75a3a-18c9-49e1-91a6-293d0b7da756/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1aa75a3a-18c9-49e1-91a6-293d0b7da756,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=1aa75a3a-18c9-49e1-91a6-293d0b7da756,1aa75a3a-18c9-49e1-91a6-293d0b7da756,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,NDA,019781,Prometrium,PROGESTERONE,2024/03/07,Progesterone,,ACERTIS PHARMACEUTICALS LLC,2022/11/01-,72989-372; 72989-373,4G7DS2Q64Y,PROGESTERONE,PROGESTERONE,4G7DS2Q64Y,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/1cf237ff-c4f8-4faa-a7aa-77599c856889/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1cf237ff-c4f8-4faa-a7aa-77599c856889,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=1cf237ff-c4f8-4faa-a7aa-77599c856889,1cf237ff-c4f8-4faa-a7aa-77599c856889,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,NDA,019781,Prometrium,PROGESTERONE,2022/10/10,Progesterone,,VIRTUS PHARMACEUTICALS,2016/07/15-,69543-372; 69543-373,4G7DS2Q64Y,PROGESTERONE,PROGESTERONE,4G7DS2Q64Y,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/a451784e-f6a0-414a-8409-3407f1d1d086/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a451784e-f6a0-414a-8409-3407f1d1d086,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=a451784e-f6a0-414a-8409-3407f1d1d086,a451784e-f6a0-414a-8409-3407f1d1d086,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAMUSCULAR,NDA,017362,PROGESTERONE,PROGESTERONE,2022/10/05,Progesterone,,ACTAVIS PHARMA INC,1978/05/11-,0591-3128,4G7DS2Q64Y,PROGESTERONE,PROGESTERONE,4G7DS2Q64Y,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/a09a3b76-36f1-4d20-930e-7e3da97e7ebd/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a09a3b76-36f1-4d20-930e-7e3da97e7ebd,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=a09a3b76-36f1-4d20-930e-7e3da97e7ebd,a09a3b76-36f1-4d20-930e-7e3da97e7ebd,,,
HUMAN PRESCRIPTION DRUG LABEL,INSERT,VAGINAL,NDA,022057,ENDOMETRIN,PROGESTERONE,2022/08/16,Progesterone,2007,FERRING PHARMACEUTICALS INC,2007/06/21-,55566-6500,4G7DS2Q64Y,PROGESTERONE,PROGESTERONE,4G7DS2Q64Y,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/2ba50fa9-b349-40cb-9a4b-1af8faa4ec09/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2ba50fa9-b349-40cb-9a4b-1af8faa4ec09,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=2ba50fa9-b349-40cb-9a4b-1af8faa4ec09,2ba50fa9-b349-40cb-9a4b-1af8faa4ec09,,,
HUMAN PRESCRIPTION DRUG LABEL,RING,VAGINAL,NDA,201110,Ferring Pharmaceuticals Inc.,PROGESTERONE,2021/07/15,Progesterone,1974,FERRING PHARMACEUTICALS INC,2022/05/01-,55566-9400,4G7DS2Q64Y,progesterone,progesterone,4G7DS2Q64Y,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/de063435-6aa7-4711-8732-1c5d0358e98b/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=de063435-6aa7-4711-8732-1c5d0358e98b,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=de063435-6aa7-4711-8732-1c5d0358e98b,de063435-6aa7-4711-8732-1c5d0358e98b,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,NDA,019781,Progesterone,PROGESTERONE,2020/06/19,Progesterone,,VIRTUS PHARMACEUTICALS,2016/07/13-,69543-374; 69543-375,4G7DS2Q64Y,PROGESTERONE,PROGESTERONE,4G7DS2Q64Y,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/2fac2189-5d9d-4408-a1cf-b6bbdf643adc/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2fac2189-5d9d-4408-a1cf-b6bbdf643adc,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=2fac2189-5d9d-4408-a1cf-b6bbdf643adc,2fac2189-5d9d-4408-a1cf-b6bbdf643adc,,,
HUMAN PRESCRIPTION DRUG LABEL,GEL,VAGINAL,NDA,020701,Crinone,PROGESTERONE,2019/01/16,Progesterone,,ALLERGAN INC,1997/05/13-,0023-6150; 0023-6151,4G7DS2Q64Y,PROGESTERONE,PROGESTERONE,4G7DS2Q64Y,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/75e97aa1-daa4-45f9-b2e2-1a371302914e/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=75e97aa1-daa4-45f9-b2e2-1a371302914e,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=75e97aa1-daa4-45f9-b2e2-1a371302914e,75e97aa1-daa4-45f9-b2e2-1a371302914e,,,
HUMAN PRESCRIPTION DRUG LABEL,GEL,VAGINAL,NDA,020701,Prochieve,PROGESTERONE,2009/11/19,Progesterone,,COLUMBIA LABORATORIES,1997/05/13-,55056-0406; 55056-1601,4G7DS2Q64Y,progesterone,progesterone,4G7DS2Q64Y,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/9f8dc923-65d7-42ff-b718-97e7a7e87822/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9f8dc923-65d7-42ff-b718-97e7a7e87822,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=9f8dc923-65d7-42ff-b718-97e7a7e87822,9f8dc923-65d7-42ff-b718-97e7a7e87822,,,
HUMAN PRESCRIPTION DRUG LABEL,GEL,VAGINAL,NDA,020701,Crinone,PROGESTERONE,2009/11/19,Progesterone,,COLUMBIA LABORATORIES INC,1997/05/13-,55056-0806; 55056-0808; 55056-0818,4G7DS2Q64Y,progesterone,progesterone,4G7DS2Q64Y,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/2c8ffbd2-6b7a-42c7-b29e-e4de69dad9e6/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2c8ffbd2-6b7a-42c7-b29e-e4de69dad9e6,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=2c8ffbd2-6b7a-42c7-b29e-e4de69dad9e6,2c8ffbd2-6b7a-42c7-b29e-e4de69dad9e6,,,
HUMAN PRESCRIPTION DRUG LABEL,"CAPSULE, EXTENDED RELEASE",ORAL,NDA,021416,RYTHMOL SR,PROPAFENONE HYDROCHLORIDE,2018/11/02,Antiarrhythmic,1989,GLAXOSMITHKLINE LLC,2011/03/17-,0173-0823; 0173-0824; 0173-0826,33XCH0HOCD,PROPAFENONE HYDROCHLORIDE,PROPAFENONE,68IQX3T69U,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/8bb1bc4a-a019-49c8-af81-be899822428f/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8bb1bc4a-a019-49c8-af81-be899822428f,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=8bb1bc4a-a019-49c8-af81-be899822428f,8bb1bc4a-a019-49c8-af81-be899822428f,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, EMULSION",INTRAVENOUS,NDA,019627,Diprivan,PROPOFOL,2024/04/18,General Anesthetic,,FRESENIUS KABI USA LLC,2020/01/13-,65219-800,YI7VU623SF,PROPOFOL,PROPOFOL,YI7VU623SF,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/5cec3b97-5183-4a9d-accd-21e76c99d3dd/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5cec3b97-5183-4a9d-accd-21e76c99d3dd,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=5cec3b97-5183-4a9d-accd-21e76c99d3dd,5cec3b97-5183-4a9d-accd-21e76c99d3dd,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, EMULSION",INTRAVENOUS,NDA,019627,Diprivan,PROPOFOL,2023/11/28,General Anesthetic,,FRESENIUS KABI USA LLC,2009/11/13-,63323-269,YI7VU623SF,PROPOFOL,PROPOFOL,YI7VU623SF,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/fee3bd4a-ade3-41fa-839a-48e9af69bcf4/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=fee3bd4a-ade3-41fa-839a-48e9af69bcf4,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=fee3bd4a-ade3-41fa-839a-48e9af69bcf4,fee3bd4a-ade3-41fa-839a-48e9af69bcf4,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, EMULSION",INTRAVENOUS,NDA,019627,Diprivan,PROPOFOL,2023/11/13,General Anesthetic,,FRESENIUS KABI USA LLC,2009/11/17-,63323-269,YI7VU623SF,PROPOFOL,PROPOFOL,YI7VU623SF,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/e3105799-a4b6-f3f4-e6e2-b2b29bbdb538/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e3105799-a4b6-f3f4-e6e2-b2b29bbdb538,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=e3105799-a4b6-f3f4-e6e2-b2b29bbdb538,e3105799-a4b6-f3f4-e6e2-b2b29bbdb538,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, EMULSION",INTRAVENOUS,NDA,019627,Diprivan,PROPOFOL,2023/09/15,General Anesthetic,,FRESENIUS KABI USA LLC,2009/11/13-,63323-269,YI7VU623SF,PROPOFOL,PROPOFOL,YI7VU623SF,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/d1ae9e26-ffd6-43df-bbd6-869cdede6afe/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d1ae9e26-ffd6-43df-bbd6-869cdede6afe,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=d1ae9e26-ffd6-43df-bbd6-869cdede6afe,d1ae9e26-ffd6-43df-bbd6-869cdede6afe,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, EMULSION",INTRAVENOUS,NDA,019627,Diprivan,PROPOFOL,2023/04/28,General Anesthetic,,FRESENIUS KABI USA LLC,2009/11/13-,63323-269,YI7VU623SF,PROPOFOL,PROPOFOL,YI7VU623SF,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/ee0c3437-614d-4631-a061-257f5f60c70b/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ee0c3437-614d-4631-a061-257f5f60c70b,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=ee0c3437-614d-4631-a061-257f5f60c70b,ee0c3437-614d-4631-a061-257f5f60c70b,,,
HUMAN PRESCRIPTION DRUG LABEL,"CAPSULE, EXTENDED RELEASE",ORAL,NDA,021438,InnoPran XL,PROPRANOLOL HYDROCHLORIDE,2024/03/20,beta-Adrenergic Blocker,2003,ANI PHARMACEUTICALS INC,2018/02/22-,62559-590; 62559-591,F8A3652H1V,PROPRANOLOL HYDROCHLORIDE,PROPRANOLOL,9Y8NXQ24VQ,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/cd5601b3-4d87-4c3b-acac-b476e787609d/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=cd5601b3-4d87-4c3b-acac-b476e787609d,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=cd5601b3-4d87-4c3b-acac-b476e787609d,cd5601b3-4d87-4c3b-acac-b476e787609d,,,
HUMAN PRESCRIPTION DRUG LABEL,"CAPSULE, EXTENDED RELEASE",ORAL,NDA,021438,Inderal XL,PROPRANOLOL HYDROCHLORIDE,2024/03/20,beta-Adrenergic Blocker,2003,ANI PHARMACEUTICALS INC,2018/02/22-,62559-600; 62559-601,F8A3652H1V,PROPRANOLOL HYDROCHLORIDE,PROPRANOLOL,9Y8NXQ24VQ,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/ac196ff5-9215-402b-bc57-69aa87f8bade/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ac196ff5-9215-402b-bc57-69aa87f8bade,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=ac196ff5-9215-402b-bc57-69aa87f8bade,ac196ff5-9215-402b-bc57-69aa87f8bade,,,
HUMAN PRESCRIPTION DRUG LABEL,"CAPSULE, EXTENDED RELEASE",ORAL,NDA,018553,INDERAL LA,PROPRANOLOL HYDROCHLORIDE,2023/11/20,beta-Adrenergic Blocker,,ANI PHARMACEUTICALS INC,2017/04/28-,62559-520; 62559-521; 62559-522; 62559-523,F8A3652H1V,PROPRANOLOL HYDROCHLORIDE,PROPRANOLOL,9Y8NXQ24VQ,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/35d28979-36b1-4630-b85e-a44e0a443734/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=35d28979-36b1-4630-b85e-a44e0a443734,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=35d28979-36b1-4630-b85e-a44e0a443734,35d28979-36b1-4630-b85e-a44e0a443734,,,
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION,ORAL,NDA,205410,HEMANGEOL,PROPRANOLOL HYDROCHLORIDE,2023/01/02,beta-Adrenergic Blocker,1967,PIERRE FABRE PHARMACEUTICALS INC,2014/04/14-,64370-375,F8A3652H1V,PROPRANOLOL HYDROCHLORIDE,PROPRANOLOL,9Y8NXQ24VQ,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/b6f9dd2a-632b-87eb-70f0-b2064d7ed48a/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b6f9dd2a-632b-87eb-70f0-b2064d7ed48a,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=b6f9dd2a-632b-87eb-70f0-b2064d7ed48a,b6f9dd2a-632b-87eb-70f0-b2064d7ed48a,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,006188,Propylthiouracil,PROPYLTHIOURACIL,2023/10/20,Thyroid Hormone Synthesis Inhibitor,,PAR PHARMACEUTICAL INC,1947/07/28-,67253-651,721M9407IY,PROPYLTHIOURACIL,PROPYLTHIOURACIL,721M9407IY,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/b0c23a2c-b250-4c0d-9b2a-c1483faa2ca0/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b0c23a2c-b250-4c0d-9b2a-c1483faa2ca0,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=b0c23a2c-b250-4c0d-9b2a-c1483faa2ca0,b0c23a2c-b250-4c0d-9b2a-c1483faa2ca0,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,210166,MOTEGRITY,PRUCALOPRIDE,2022/10/28,Serotonin-4 Receptor Agonist,2018,TAKEDA PHARMACEUTICALS AMERICA INC,2018/12/14-,54092-546; 54092-547,4V2G75E1CK,PRUCALOPRIDE SUCCINATE,PRUCALOPRIDE,0A09IUW5TP,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/bca1e4c6-4b2b-4876-8ab3-654629c4ff1b/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=bca1e4c6-4b2b-4876-8ab3-654629c4ff1b,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=bca1e4c6-4b2b-4876-8ab3-654629c4ff1b,bca1e4c6-4b2b-4876-8ab3-654629c4ff1b,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,NDA,021626,Radiogardase,PRUSSIAN BLUE INSOLUBLE CAPSULES,2021/10/07,Decorporation Agent,2003,HEYL CHEM PHARM FABRIK GMBH AND CO KG,2010/03/24-,58060-002,TLE294X33A,FERRIC FERROCYANIDE,FERRIC FERROCYANIDE,TLE294X33A,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/baa68c79-5f3d-468a-a510-58b9e978cd50/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=baa68c79-5f3d-468a-a510-58b9e978cd50,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=baa68c79-5f3d-468a-a510-58b9e978cd50,baa68c79-5f3d-468a-a510-58b9e978cd50,,,
HUMAN PRESCRIPTION DRUG LABEL,SUSPENSION,ORAL,NDA,205919,PURIXAN,PURIXAN,2024/05/01,Nucleoside Metabolic Inhibitor,1953,NOVA LABORATORIES LTD,2014/04/28-,62484-0020,E7WED276I5,Mercaptopurine,MERCAPTOPURINE ANHYDROUS,PKK6MUZ20G,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/9fd27952-7787-47d9-b6cf-7af2dc38217b/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9fd27952-7787-47d9-b6cf-7af2dc38217b,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=9fd27952-7787-47d9-b6cf-7af2dc38217b,9fd27952-7787-47d9-b6cf-7af2dc38217b,,,
HUMAN PRESCRIPTION DRUG LABEL,"SOLUTION; TABLET; TABLET, EXTENDED RELEASE",ORAL,NDA,009829;011665;015193,Mestinon,PYRIDOSTIGMINE BROMIDE,2020/12/02,Cholinesterase Inhibitor,,BAUSCH HEALTH US LLC,1955/04/06-; 1959/01/12-; 1965/01/25-,0187-3010; 0187-3012; 0187-3013,KVI301NA53,pyridostigmine bromide,pyridostigmine,19QM69HH21,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/a851795e-b7a8-40c3-9922-5e79d3eb4d92/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a851795e-b7a8-40c3-9922-5e79d3eb4d92,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=a851795e-b7a8-40c3-9922-5e79d3eb4d92,a851795e-b7a8-40c3-9922-5e79d3eb4d92,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,008578,Daraprim,PYRIMETHAMINE,2021/11/11,Dihydrofolate Reductase Inhibitor Antimalarial,,VYERA PHARMACEUTICALS LLC,1953/01/23-,69413-330,Z3614QOX8W,PYRIMETHAMINE,PYRIMETHAMINE,Z3614QOX8W,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/5368616d-6520-6f6e-2053-686b72656c69/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5368616d-6520-6f6e-2053-686b72656c69,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=5368616d-6520-6f6e-2053-686b72656c69,5368616d-6520-6f6e-2053-686b72656c69,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,018708,DORAL,QUAZEPAM,2023/01/31,Benzodiazepine,1985,GALT PHARMACEUTICALS LLC,2017/07/19-,61825-165,JF8V0828ZI,QUAZEPAM,QUAZEPAM,JF8V0828ZI,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/9727e8b4-14f1-451d-9630-84eabc772e42/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9727e8b4-14f1-451d-9630-84eabc772e42,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=9727e8b4-14f1-451d-9630-84eabc772e42,9727e8b4-14f1-451d-9630-84eabc772e42,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, EXTENDED RELEASE",ORAL,NDA,022047,SEROQUEL XR,QUETIAPINE,2022/01/27,Atypical Antipsychotic,1997,ASTRAZENECA PHARMACEUTICALS LP,2007/07/16-; 2009/02/01-,0310-0280; 0310-0281; 0310-0282; 0310-0283; 0310-0284,2S3PL1B6UJ,QUETIAPINE FUMARATE,QUETIAPINE,BGL0JSY5SI,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/473a3ac4-67f4-4782-baa9-7f9bdd8761f4/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=473a3ac4-67f4-4782-baa9-7f9bdd8761f4,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=473a3ac4-67f4-4782-baa9-7f9bdd8761f4,473a3ac4-67f4-4782-baa9-7f9bdd8761f4,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,020639,SEROQUEL,QUETIAPINE,2022/01/27,Atypical Antipsychotic,1997,ASTRAZENECA PHARMACEUTICALS LP,1997/10/01-; 2000/11/13-; 2006/02/13-,0310-0271; 0310-0272; 0310-0274; 0310-0275; 0310-0278; 0310-0279,2S3PL1B6UJ,QUETIAPINE FUMARATE,QUETIAPINE,BGL0JSY5SI,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/0584dda8-bc3c-48fe-1a90-79608f78e8a0/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0584dda8-bc3c-48fe-1a90-79608f78e8a0,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=0584dda8-bc3c-48fe-1a90-79608f78e8a0,0584dda8-bc3c-48fe-1a90-79608f78e8a0,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,020125,ACCURETIC,QUINAPRIL AND HYDROCHLOROTHIAZIDE; QUINAPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE,2023/09/18,Angiotensin Converting Enzyme Inhibitor; Thiazide Diuretic,,PARKE DAVIS DIV OF PFIZER INC,2021/11/29-; 2021/12/06-; completed:1999/12/28-2023/02/28; completed:2019/11/18-2019/11/18,0071-0223; 0071-3112; 0071-5212; 0071-7225,0J48LPH2TH; 33067B3N2M,HYDROCHLOROTHIAZIDE; QUINAPRIL HYDROCHLORIDE,HYDROCHLOROTHIAZIDE; QUINAPRILAT,0J48LPH2TH; 34SSX5LDE5,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/80e9d61d-9674-4ac4-b84c-79a875d408dd/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=80e9d61d-9674-4ac4-b84c-79a875d408dd,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=80e9d61d-9674-4ac4-b84c-79a875d408dd,80e9d61d-9674-4ac4-b84c-79a875d408dd,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,019885,Accupril,QUINAPRIL; QUINAPRIL HYDROCHLORIDE,2023/09/15,Angiotensin Converting Enzyme Inhibitor,,PARKE DAVIS DIV OF PFIZER INC,1991/11/19-; completed:2019/11/19-2019/11/19,0071-0527; 0071-0530; 0071-0532; 0071-0535; 0071-1205; 0071-1410; 0071-1620; 0071-1840,33067B3N2M,QUINAPRIL HYDROCHLORIDE,QUINAPRILAT,34SSX5LDE5,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/63cf5651-d52c-4d27-9fd4-ed9cd9724dff/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=63cf5651-d52c-4d27-9fd4-ed9cd9724dff,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=63cf5651-d52c-4d27-9fd4-ed9cd9724dff,63cf5651-d52c-4d27-9fd4-ed9cd9724dff,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,NDA,021799,Qualaquin,QUININE SULFATE,2019/08/29,Antimalarial,2005,SUN PHARMACEUTICAL INDUSTRIES INC,2005/08/12-,49708-153,KF7Z0E0Q2B,Quinine Sulfate,Quinine,A7V27PHC7A,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/1c44c8b7-8b38-4487-a8ba-a94f708d1f50/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1c44c8b7-8b38-4487-a8ba-a94f708d1f50,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=1c44c8b7-8b38-4487-a8ba-a94f708d1f50,1c44c8b7-8b38-4487-a8ba-a94f708d1f50,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,NDA,021799,Qualaquin,QUININE SULFATE,2013/04/23,Antimalarial,2005,AR SCIENTIFIC INC,2005/08/12-,13310-153,KF7Z0E0Q2B,Quinine Sulfate,Quinine,A7V27PHC7A,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/1f66fba7-4026-4504-918d-4c88f2835cc0/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1f66fba7-4026-4504-918d-4c88f2835cc0,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=1f66fba7-4026-4504-918d-4c88f2835cc0,1f66fba7-4026-4504-918d-4c88f2835cc0,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,216993,VANFLYTA,QUIZARTINIB,2024/02/05,Kinase Inhibitor,2023,DAIICHI SANKYO INC,2023/07/20-,65597-504; 65597-511,WK7Q6ZIZ10,QUIZARTINIB DIHYDROCHLORIDE,QUIZARTINIB,7LA4O6Q0D3,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/29cdbcfe-497d-4e78-bb7b-2d4acafe8e86/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=29cdbcfe-497d-4e78-bb7b-2d4acafe8e86,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=29cdbcfe-497d-4e78-bb7b-2d4acafe8e86,29cdbcfe-497d-4e78-bb7b-2d4acafe8e86,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, DELAYED RELEASE",ORAL,NDA,020973,Aciphex,RABEPRAZOLE SODIUM,2023/11/22,Proton Pump Inhibitor,1999,WAYLIS THERAPEUTICS LLC,2022/05/15-,80725-243,3L36P16U4R,rabeprazole sodium,rabeprazole,32828355LL,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/1eb38279-0237-4967-be7a-c53a826c1138/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1eb38279-0237-4967-be7a-c53a826c1138,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=1eb38279-0237-4967-be7a-c53a826c1138,1eb38279-0237-4967-be7a-c53a826c1138,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, DELAYED RELEASE",ORAL,NDA,020973,Aciphex,RABEPRAZOLE SODIUM,2022/05/18,Proton Pump Inhibitor,1999,WOODWARD PHARMA SERVICES LLC,2022/05/15-,69784-243,3L36P16U4R,rabeprazole sodium,rabeprazole,32828355LL,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/42282e11-3179-420e-b979-e53dd5bd4b12/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=42282e11-3179-420e-b979-e53dd5bd4b12,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=42282e11-3179-420e-b979-e53dd5bd4b12,42282e11-3179-420e-b979-e53dd5bd4b12,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, DELAYED RELEASE",ORAL,NDA,020973,AcipHex,RABEPRAZOLE SODIUM,2020/11/04,Proton Pump Inhibitor,1999,EISAI INC,1999/08/19-,62856-243,3L36P16U4R,RABEPRAZOLE SODIUM,RABEPRAZOLE,32828355LL,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/5d103551-978f-472a-9c62-51e6e4dea068/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5d103551-978f-472a-9c62-51e6e4dea068,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=5d103551-978f-472a-9c62-51e6e4dea068,5d103551-978f-472a-9c62-51e6e4dea068,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRAVENOUS,NDA,203971,Xofigo,RADIUM RA 223 DICHLORIDE,2019/12/10,Radioactive alpha-Particle Emitting Therapeutic Agent,2013,BAYER HEALTHCARE PHARMACEUTICALS INC,2013/05/20-,50419-208,RJ00KV3VTG,RADIUM RA-223 DICHLORIDE,RADIUM RA-223 CATION,9H414A99MD,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/a398400e-bd31-41a9-9696-4f7c06569ede/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a398400e-bd31-41a9-9696-4f7c06569ede,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=a398400e-bd31-41a9-9696-4f7c06569ede,a398400e-bd31-41a9-9696-4f7c06569ede,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,020815,Evista,RALOXIFENE HYDROCHLORIDE,2023/05/19,Estrogen Agonist/Antagonist,1997,ELI LILLY AND COMPANY,1998/01/06-,0002-4184,4F86W47BR6,Raloxifene hydrochloride,Raloxifene,YX9162EO3I,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/fcaaa6dc-74e8-4fb8-800c-5574bf0f8de9/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=fcaaa6dc-74e8-4fb8-800c-5574bf0f8de9,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=fcaaa6dc-74e8-4fb8-800c-5574bf0f8de9,fcaaa6dc-74e8-4fb8-800c-5574bf0f8de9,,,
HUMAN PRESCRIPTION DRUG LABEL,"GRANULE, FOR SUSPENSION; TABLET, CHEWABLE; TABLET, FILM COATED",ORAL,NDA,022145;203045;205786,ISENTRESS,RALTEGRAVIR,2023/11/15,Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor,2007,MERCK SHARP AND DOHME LLC,2007/10/12-; 2011/12/21-; 2013/12/20-; 2017/05/26-,0006-0227; 0006-0473; 0006-0477; 0006-3080; 0006-3603,43Y000U234,RALTEGRAVIR POTASSIUM,RALTEGRAVIR,22VKV8053U,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/89a5ec53-d956-4329-8004-0f40f51c88a3/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=89a5ec53-d956-4329-8004-0f40f51c88a3,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=89a5ec53-d956-4329-8004-0f40f51c88a3,89a5ec53-d956-4329-8004-0f40f51c88a3,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,022145,ISENTRESS,RALTEGRAVIR,2017/07/27,Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor,,H J HARKINS COMPANY INC,2017/07/31-,76519-1130,43Y000U234,RALTEGRAVIR POTASSIUM,RALTEGRAVIR,22VKV8053U,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/5554d179-32dd-531e-e054-00144ff8d46c/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5554d179-32dd-531e-e054-00144ff8d46c,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=5554d179-32dd-531e-e054-00144ff8d46c,5554d179-32dd-531e-e054-00144ff8d46c,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,021782,Rozerem,RAMELTEON,2023/01/04,Melatonin Receptor Agonist,2005,TAKEDA PHARMACEUTICALS AMERICA INC,2005/07/22-,64764-805,901AS54I69,ramelteon,ramelteon,901AS54I69,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/9de82310-70e8-47b9-b1fc-6c6848b99455/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9de82310-70e8-47b9-b1fc-6c6848b99455,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=9de82310-70e8-47b9-b1fc-6c6848b99455,9de82310-70e8-47b9-b1fc-6c6848b99455,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,NDA,019901,ALTACE,RAMIPRIL,2023/11/28,Angiotensin Converting Enzyme Inhibitor,1991,PFIZER LABORATORIES DIV PFIZER INC,1991/01/28-,61570-110; 61570-111; 61570-112; 61570-120,L35JN3I7SJ,RAMIPRIL,RAMIPRILAT,6N5U4QFC3G,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/0fc34cd8-86e6-4034-73bd-4263a68ba046/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0fc34cd8-86e6-4034-73bd-4263a68ba046,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=0fc34cd8-86e6-4034-73bd-4263a68ba046,0fc34cd8-86e6-4034-73bd-4263a68ba046,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAMUSCULAR; INTRAVENOUS,NDA,019090,ZANTAC,RANITIDINE HYDROCHLORIDE,2020/05/21,Histamine-2 Receptor Antagonist,,TELIGENT INC,2017/01/18-,52565-096,BK76465IHM,RANITIDINE HYDROCHLORIDE,RANITIDINE,884KT10YB7,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/95dc4515-7690-4881-ae14-9f8655a68dfe/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=95dc4515-7690-4881-ae14-9f8655a68dfe,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=95dc4515-7690-4881-ae14-9f8655a68dfe,95dc4515-7690-4881-ae14-9f8655a68dfe,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAMUSCULAR; INTRAVENOUS,NDA,019090,ZANTAC,RANITIDINE HYDROCHLORIDE,2020/05/21,Histamine-2 Receptor Antagonist,,TELIGENT PHARMA INC,2017/08/23-,52565-101; 52565-102,BK76465IHM,RANITIDINE HYDROCHLORIDE,RANITIDINE,884KT10YB7,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/c1b12354-9409-4e76-bcdc-024c190d6583/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c1b12354-9409-4e76-bcdc-024c190d6583,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=c1b12354-9409-4e76-bcdc-024c190d6583,c1b12354-9409-4e76-bcdc-024c190d6583,,,
HUMAN PRESCRIPTION DRUG LABEL,GRANULE,ORAL,NDA,216018,ASPRUZYO SPRINKLE,RANOLAZINE,2022/03/02,Anti-anginal,2006,SUN PHARMACEUTICAL INDUSTRIES INC,2022/02/28-,47335-624; 47335-625,A6IEZ5M406,RANOLAZINE,RANOLAZINE,A6IEZ5M406,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/dd9f81e4-50da-4551-aed5-559d304df42e/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=dd9f81e4-50da-4551-aed5-559d304df42e,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=dd9f81e4-50da-4551-aed5-559d304df42e,dd9f81e4-50da-4551-aed5-559d304df42e,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,NDA,021526,Ranexa,RANOLAZINE,2010/04/26,Anti-anginal,2006,GILEAD SCIENCES INC,2006/01/27-; 2007/02/12-,61958-1001; 61958-1002,A6IEZ5M406,ranolazine,ranolazine,A6IEZ5M406,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/8d442b8c-97a8-40a9-8603-f9cd0542cedc/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8d442b8c-97a8-40a9-8603-f9cd0542cedc,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=8d442b8c-97a8-40a9-8603-f9cd0542cedc,8d442b8c-97a8-40a9-8603-f9cd0542cedc,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,021641,Azilect,RASAGILINE MESYLATE,2020/06/30,Monoamine Oxidase Inhibitor,2006,TEVA NEUROSCIENCE INC,2006/07/10-,68546-142; 68546-229,LH8C2JI290,RASAGILINE MESYLATE,RASAGILINE,003N66TS6T,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/a40d0e73-3f9f-4b01-979d-402c9cdaeb60/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a40d0e73-3f9f-4b01-979d-402c9cdaeb60,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=a40d0e73-3f9f-4b01-979d-402c9cdaeb60,a40d0e73-3f9f-4b01-979d-402c9cdaeb60,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,022161,LEXISCAN,REGADENOSON,2018/12/21,Pharmacologic Cardiac Stress Test Agent,2008,ASTELLAS PHARMA US INC,2008/04/10-,0469-6501,2XLN4Y044H,regadenoson,REGADENOSON ANHYDROUS,7AXV542LZ4,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/057289f4-2e18-4c1e-bed4-6c1858e2ef16/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=057289f4-2e18-4c1e-bed4-6c1858e2ef16,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=057289f4-2e18-4c1e-bed4-6c1858e2ef16,057289f4-2e18-4c1e-bed4-6c1858e2ef16,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,203085,Stivarga,REGORAFENIB,2020/12/09,Kinase Inhibitor,2012,BAYER HEALTHCARE PHARMACEUTICALS INC,2012/09/27-,50419-171,MGN125FS9D,REGORAFENIB,REGORAFENIB ANHYDROUS,24T2A1DOYB,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/824f19c9-0546-4a8a-8d8f-c4055c04f7c7/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=824f19c9-0546-4a8a-8d8f-c4055c04f7c7,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=824f19c9-0546-4a8a-8d8f-c4055c04f7c7,824f19c9-0546-4a8a-8d8f-c4055c04f7c7,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,214621,Orgovyx,RELUGOLIX,2024/01/18,Gonadotropin Releasing Hormone Receptor Antagonist,2020,SUMITOMO PHARMA AMERICA INC,2020/12/18-,72974-120,P76B05O5V6,RELUGOLIX,RELUGOLIX,P76B05O5V6,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/077a92f6-9f1b-479a-87c7-c92b5db6aa9c/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=077a92f6-9f1b-479a-87c7-c92b5db6aa9c,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=077a92f6-9f1b-479a-87c7-c92b5db6aa9c,077a92f6-9f1b-479a-87c7-c92b5db6aa9c,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,214846,Myfembree,"RELUGOLIX, ESTRADIOL HEMIHYDRATE, AND NORETHINDRONE ACETATE",2024/05/10,Estrogen; Gonadotropin Releasing Hormone Receptor Antagonist; Progestin,2021,SUMITOMO PHARMA AMERICA INC,2021/05/26-,72974-415,9S44LIC7OJ; CXY7B3Q98Z; P76B05O5V6,ESTRADIOL HEMIHYDRATE; NORETHINDRONE ACETATE; RELUGOLIX,ESTRADIOL; NORETHINDRONE; RELUGOLIX,4TI98Z838E; P76B05O5V6; T18F433X4S,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/fc3feb73-cc84-43a8-aa32-b262460495e8/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=fc3feb73-cc84-43a8-aa32-b262460495e8,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=fc3feb73-cc84-43a8-aa32-b262460495e8,fc3feb73-cc84-43a8-aa32-b262460495e8,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION; INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAVENOUS,NDA,214787,Veklury,REMDESIVIR,2024/03/06,SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor,2020,GILEAD SCIENCES INC,2020/11/01-; 2022/03/25-,61958-2901; 61958-2902,3QKI37EEHE,REMDESIVIR,REMDESIVIR,3QKI37EEHE,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/c0978fa8-53ff-4ca2-82a7-567fd3e958ca/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c0978fa8-53ff-4ca2-82a7-567fd3e958ca,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=c0978fa8-53ff-4ca2-82a7-567fd3e958ca,c0978fa8-53ff-4ca2-82a7-567fd3e958ca,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAVENOUS,NDA,020630,Ultiva,REMIFENTANIL HYDROCHLORIDE,2023/12/20,Opioid Agonist,1996,MYLAN INSTITUTIONAL LLC,2023/06/21-; 2023/09/18-,72078-034; 72078-035; 72078-036,5V444H5WIC,Remifentanil Hydrochloride,Remifentanil,P10582JYYK,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/8b4c8696-e23e-4c51-a4d2-babab5bd945a/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8b4c8696-e23e-4c51-a4d2-babab5bd945a,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=8b4c8696-e23e-4c51-a4d2-babab5bd945a,8b4c8696-e23e-4c51-a4d2-babab5bd945a,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAVENOUS,NDA,020630,Ultiva,REMIFENTANIL HYDROCHLORIDE,2022/04/15,Opioid Agonist,1996,MYLAN INSTITUTIONAL LLC,2020/04/15-,67457-912; 67457-913; 67457-914,5V444H5WIC,Remifentanil Hydrochloride,Remifentanil,P10582JYYK,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/4dbcb8f9-1987-4b66-bd2f-d251fda0be10/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4dbcb8f9-1987-4b66-bd2f-d251fda0be10,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=4dbcb8f9-1987-4b66-bd2f-d251fda0be10,4dbcb8f9-1987-4b66-bd2f-d251fda0be10,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAVENOUS,NDA,020630,Ultiva,REMIFENTANIL HYDROCHLORIDE,2021/06/15,Opioid Agonist,1996,MYLAN INSTITUTIONAL LLC,1996/11/06-,67457-198,5V444H5WIC,Remifentanil Hydrochloride,Remifentanil,P10582JYYK,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/dbc63b6e-f8c5-4fd0-8ec3-4f5e19125313/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=dbc63b6e-f8c5-4fd0-8ec3-4f5e19125313,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=dbc63b6e-f8c5-4fd0-8ec3-4f5e19125313,dbc63b6e-f8c5-4fd0-8ec3-4f5e19125313,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAVENOUS,NDA,212295,BYFAVO,REMIMAZOLAM BESYLATE,2023/10/16,,2020,ACACIA PHARMA LTD,2020/10/06-,71390-011,280XQ6482H,remimazolam besylate,Remimazolam,7V4A8U16MB,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/4e1838f2-b999-41a7-a761-d94f09aa531f/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4e1838f2-b999-41a7-a761-d94f09aa531f,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=4e1838f2-b999-41a7-a761-d94f09aa531f,4e1838f2-b999-41a7-a761-d94f09aa531f,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRAMUSCULAR; SUBCUTANEOUS,NDA,008975,Purified Cortrophin Gel,REPOSITORY CORTICOTROPIN,2023/10/25,Adrenocorticotropic Hormone,,ANI PHARMACEUTICALS INC,2021/10/29-,62559-860,K0U68Q2TXA,CORTICOTROPIN,CORTICOTROPIN,K0U68Q2TXA,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/f27544ee-a0e2-4d84-b193-1c9efdf9e34c/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f27544ee-a0e2-4d84-b193-1c9efdf9e34c,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=f27544ee-a0e2-4d84-b193-1c9efdf9e34c,f27544ee-a0e2-4d84-b193-1c9efdf9e34c,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRAMUSCULAR; SUBCUTANEOUS,NDA,008372,Acthar,REPOSITORY CORTICOTROPIN,2023/10/11,Adrenocorticotropic Hormone,1952,MALLINCKRODT ARD LLC,2013/01/07-,63004-8710,K0U68Q2TXA,CORTICOTROPIN,CORTICOTROPIN,K0U68Q2TXA,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/7b48ddec-e815-45f4-9ca0-5c0daaf56f30/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7b48ddec-e815-45f4-9ca0-5c0daaf56f30,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=7b48ddec-e815-45f4-9ca0-5c0daaf56f30,7b48ddec-e815-45f4-9ca0-5c0daaf56f30,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,NDA,218213,Augtyro,REPOTRECTINIB,2023/11/15,Kinase Inhibitor,2023,E R SQUIBB AND SONS L L C,2023/12/05-,0003-4040,08O3FQ4UNP,REPOTRECTINIB,REPOTRECTINIB,08O3FQ4UNP,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/fb526827-40ba-4462-94cf-179ae3b0cb8a/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=fb526827-40ba-4462-94cf-179ae3b0cb8a,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=fb526827-40ba-4462-94cf-179ae3b0cb8a,fb526827-40ba-4462-94cf-179ae3b0cb8a,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, COATED",ORAL,NDA,217785,REZDIFFRA,RESMETIROM,2024/03/14,,2024,MADRIGAL PHARMACEUTICALS INC,2024/03/14-,82576-060; 82576-080; 82576-100,RE0V0T1ES0,RESMETIROM,RESMETIROM,RE0V0T1ES0,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/e67ea09f-a840-439c-86c8-f98585f978b2/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e67ea09f-a840-439c-86c8-f98585f978b2,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=e67ea09f-a840-439c-86c8-f98585f978b2,e67ea09f-a840-439c-86c8-f98585f978b2,,,
HUMAN PRESCRIPTION DRUG LABEL,OINTMENT,TOPICAL,NDA,022055,Altabax,RETAPAMULIN,2023/06/05,Pleuromutilin Antibacterial,2007,ALMIRALL LLC,2016/05/01-,16110-518,4MG6O8991R,RETAPAMULIN,RETAPAMULIN,4MG6O8991R,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/7c91eee4-242b-4af2-a39b-7842a9d95143/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7c91eee4-242b-4af2-a39b-7842a9d95143,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=7c91eee4-242b-4af2-a39b-7842a9d95143,7c91eee4-242b-4af2-a39b-7842a9d95143,,,
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION,INHALATION,NDA,210598,YUPELRI,REVEFENACIN,2022/05/03,Anticholinergic,2018,MYLAN SPECIALTY L P,2018/12/03-,49502-806,G2AE2VE07O,REVEFENACIN,REVEFENACIN,G2AE2VE07O,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/6dfebf04-7c90-436a-9b16-750d3c1ee0a6/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6dfebf04-7c90-436a-9b16-750d3c1ee0a6,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=6dfebf04-7c90-436a-9b16-750d3c1ee0a6,6dfebf04-7c90-436a-9b16-750d3c1ee0a6,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAVENOUS,NDA,217417,REZZAYO,REZAFUNGIN,2023/06/08,Echinocandin Antifungal,2023,MELINTA THERAPEUTICS LLC,2023/06/09-,70842-240,G013B5478J,REZAFUNGIN,REZAFUNGIN,G013B5478J,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/90073508-6dca-4d27-aa5a-ed837737c35b/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=90073508-6dca-4d27-aa5a-ed837737c35b,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=90073508-6dca-4d27-aa5a-ed837737c35b,90073508-6dca-4d27-aa5a-ed837737c35b,,,
HUMAN PRESCRIPTION DRUG LABEL,"POWDER, FOR SOLUTION",INHALATION,NDA,018859,Ribavirin,RIBAVIRIN,2020/04/23,Nucleoside Analog Antiviral,,CAMERON PHARMACEUTICALS,2020/04/15-,42494-423,49717AWG6K,Ribavirin,Ribavirin,49717AWG6K,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/7ea8dafa-d3d8-493e-a0db-e783d92fb13f/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7ea8dafa-d3d8-493e-a0db-e783d92fb13f,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=7ea8dafa-d3d8-493e-a0db-e783d92fb13f,7ea8dafa-d3d8-493e-a0db-e783d92fb13f,,,
HUMAN PRESCRIPTION DRUG LABEL,"POWDER, FOR SOLUTION",INHALATION,NDA,018859,Ribavirin,RIBAVIRIN,2019/05/01,Nucleoside Analog Antiviral,,OCEANSIDE PHARMACEUTICALS,2017/04/14-,68682-019,49717AWG6K,Ribavirin,Ribavirin,49717AWG6K,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/d74aa4f3-0b7d-480d-b5bf-41ddf808b260/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d74aa4f3-0b7d-480d-b5bf-41ddf808b260,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=d74aa4f3-0b7d-480d-b5bf-41ddf808b260,d74aa4f3-0b7d-480d-b5bf-41ddf808b260,,,
HUMAN PRESCRIPTION DRUG LABEL,"POWDER, FOR SOLUTION",INHALATION,NDA,018859,Virazole,RIBAVIRIN,2019/05/01,Nucleoside Analog Antiviral,,BAUSCH HEALTH US LLC,1986/01/01-,0187-0007,49717AWG6K,Ribavirin,Ribavirin,49717AWG6K,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/adf16e64-345f-469a-b987-3fbdd17e0ac2/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=adf16e64-345f-469a-b987-3fbdd17e0ac2,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=adf16e64-345f-469a-b987-3fbdd17e0ac2,adf16e64-345f-469a-b987-3fbdd17e0ac2,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,209092,KISQALI,RIBOCICLIB,2023/08/24,Kinase Inhibitor,2017,NOVARTIS PHARMACEUTICALS CORPORATION,2017/03/13-,0078-0860; 0078-0867; 0078-0874,BG7HLX2919,RIBOCICLIB SUCCINATE,RIBOCICLIB,TK8ERE8P56,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/aaeaef94-f3f5-4367-8ea2-b181d7be2da8/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=aaeaef94-f3f5-4367-8ea2-b181d7be2da8,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=aaeaef94-f3f5-4367-8ea2-b181d7be2da8,aaeaef94-f3f5-4367-8ea2-b181d7be2da8,,,
HUMAN PRESCRIPTION DRUG LABEL,KIT; SOLUTION/ DROPS,OPHTHALMIC,NDA,203324,Photrexa; Photrexa Cross-linking Kit; Photrexa Viscous,RIBOFLAVIN 5-PHOSPHATE IN 20% DEXTRAN OPHTHALMIC; RIBOFLAVIN 5-PHOSPHATE OPHTHALMIC,2023/11/16,Photoenhancer,2016,GLAUKOS CORPORATION,2017/09/25-; completed:2016/04/15-2022/10/01,25357-022; 25357-023; 25357-025,957E53WV42,RIBOFLAVIN 5'-PHOSPHATE SODIUM ANHYDROUS,RIBOFLAVIN 5'-PHOSPHATE,7N464URE7E,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/f82cfe92-1a24-11e3-8ffd-0800200c9a66/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f82cfe92-1a24-11e3-8ffd-0800200c9a66,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=f82cfe92-1a24-11e3-8ffd-0800200c9a66,f82cfe92-1a24-11e3-8ffd-0800200c9a66,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,NDA,050689,Mycobutin,RIFABUTIN,2021/11/01,Rifamycin Antimycobacterial,,PFIZER LABORATORIES DIV PFIZER INC,1992/12/23-,0013-5301,1W306TDA6S,RIFABUTIN,RIFABUTIN,1W306TDA6S,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/3e1a6613-bdd3-4261-93b3-d7f5cc09064b/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3e1a6613-bdd3-4261-93b3-d7f5cc09064b,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=3e1a6613-bdd3-4261-93b3-d7f5cc09064b,3e1a6613-bdd3-4261-93b3-d7f5cc09064b,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAVENOUS,NDA,050627,Rifadin IV NOVAPLUS,RIFAMPIN,2024/04/25,Rifamycin Antibacterial,,SANOFI AVENTIS U S LLC,completed:2017/02/01-2025/10/31,0068-0599,VJT6J7R4TR,RIFAMPIN,RIFAMPIN,VJT6J7R4TR,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/87839f65-cb33-412e-929e-564136501a84/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=87839f65-cb33-412e-929e-564136501a84,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=87839f65-cb33-412e-929e-564136501a84,87839f65-cb33-412e-929e-564136501a84,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAVENOUS,NDA,050627,Rifadin IV,RIFAMPIN,2024/04/25,Rifamycin Antibacterial,,SANOFI AVENTIS U S LLC,completed:1989/05/25-2026/09/30,0068-0597,VJT6J7R4TR,RIFAMPIN,RIFAMPIN,VJT6J7R4TR,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/036ab68e-5085-4edc-bd83-784b43d64eab/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=036ab68e-5085-4edc-bd83-784b43d64eab,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=036ab68e-5085-4edc-bd83-784b43d64eab,036ab68e-5085-4edc-bd83-784b43d64eab,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, DELAYED RELEASE",ORAL,NDA,210910,Aemcolo,RIFAMYCIN,2023/12/15,Rifamycin Antibacterial,2018,REDHILL BIOPHARMA LTD,2021/07/01-,57841-1200; 57841-1201,DU69T8ZZPA,Rifamycin,Rifamycin,DU69T8ZZPA,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/b31ff668-ee1f-4d89-8b69-68df2a0d2243/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b31ff668-ee1f-4d89-8b69-68df2a0d2243,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=b31ff668-ee1f-4d89-8b69-68df2a0d2243,b31ff668-ee1f-4d89-8b69-68df2a0d2243,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,021024,Priftin,RIFAPENTINE,2018/07/06,Rifamycin Antimycobacterial,1998,SANOFI AVENTIS U S LLC,2017/02/08-,0088-2102,XJM390A33U,RIFAPENTINE,RIFAPENTINE,XJM390A33U,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/3a64fb70-b85e-43d9-8bcd-7e893f568ae1/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3a64fb70-b85e-43d9-8bcd-7e893f568ae1,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=3a64fb70-b85e-43d9-8bcd-7e893f568ae1,3a64fb70-b85e-43d9-8bcd-7e893f568ae1,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,021361,XIFAXAN,RIFAXIMIN,2023/11/15,Rifamycin Antibacterial,2004,SALIX PHARMACEUTICALS INC,2004/07/25-; 2010/05/01-,65649-301; 65649-303,L36O5T016N,RIFAXIMIN,RIFAXIMIN,L36O5T016N,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/c5e8e2fd-7087-4b78-9181-cc259c0be2f1/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c5e8e2fd-7087-4b78-9181-cc259c0be2f1,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=c5e8e2fd-7087-4b78-9181-cc259c0be2f1,c5e8e2fd-7087-4b78-9181-cc259c0be2f1,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED; TABLET, FOR SUSPENSION",ORAL,NDA,202022;219016,EDURANT; EDURANT PED,RILPIVIRINE HYDROCHLORIDE,2024/05/02,Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor,2011,JANSSEN PRODUCTS LP,2011/05/20-; 2024/03/15-,59676-278; 59676-280,212WAX8KDD,RILPIVIRINE HYDROCHLORIDE,RILPIVIRINE,FI96A8X663,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/03880372-2c68-45c6-a53a-f420c49541d6/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=03880372-2c68-45c6-a53a-f420c49541d6,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=03880372-2c68-45c6-a53a-f420c49541d6,03880372-2c68-45c6-a53a-f420c49541d6,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,020599,Rilutek,RILUZOLE,2024/05/31,Benzothiazole,1995,COVIS PHARMA US INC,completed:2016/08/01-2024/05/31,70515-700,7LJ087RS6F,riluzole,riluzole,7LJ087RS6F,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/6ddc26d7-a6fe-46dd-8b49-c55aa111f83e/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6ddc26d7-a6fe-46dd-8b49-c55aa111f83e,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=6ddc26d7-a6fe-46dd-8b49-c55aa111f83e,6ddc26d7-a6fe-46dd-8b49-c55aa111f83e,,,
HUMAN PRESCRIPTION DRUG LABEL,LIQUID,ORAL,NDA,209080,TIGLUTIK,RILUZOLE,2024/02/08,Benzothiazole,1995,EDW PHARMA INC,2018/09/21-,70726-0303,7LJ087RS6F,RILUZOLE,RILUZOLE,7LJ087RS6F,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/75d68f19-4208-109e-e053-2991aa0ac857/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=75d68f19-4208-109e-e053-2991aa0ac857,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=75d68f19-4208-109e-e053-2991aa0ac857,75d68f19-4208-109e-e053-2991aa0ac857,,,
HUMAN PRESCRIPTION DRUG LABEL,FILM,ORAL,NDA,212640,Exservan,RILUZOLE,2022/12/21,Benzothiazole,1995,MITSUBISHI TANABE PHARMA AMERICA INC,2021/05/01-,70510-2201,7LJ087RS6F,RILUZOLE,RILUZOLE,7LJ087RS6F,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/f981ebe9-f931-4b4e-b7d1-2133f7aa6d66/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f981ebe9-f931-4b4e-b7d1-2133f7aa6d66,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=f981ebe9-f931-4b4e-b7d1-2133f7aa6d66,f981ebe9-f931-4b4e-b7d1-2133f7aa6d66,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, ORALLY DISINTEGRATING",ORAL,NDA,212728,NURTEC ODT,RIMEGEPANT SULFATE,2024/04/12,Calcitonin Gene-related Peptide Receptor Antagonist,2020,PFIZER LABORATORIES DIV PFIZER INC,2020/03/05-,72618-3000; 72618-3001,1383NM3Q0H,RIMEGEPANT SULFATE,RIMEGEPANT,997WVV895X,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/9ef08e09-1098-35cc-e053-2a95a90a3e1d/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9ef08e09-1098-35cc-e053-2a95a90a3e1d,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=9ef08e09-1098-35cc-e053-2a95a90a3e1d,9ef08e09-1098-35cc-e053-2a95a90a3e1d,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,204819,Adempas,RIOCIGUAT,2023/01/31,Soluble Guanylate Cyclase Stimulator,2013,BAYER HEALTHCARE PHARMACEUTICALS INC,2013/10/08-,50419-250; 50419-251; 50419-252; 50419-253; 50419-254,RU3FE2Y4XI,RIOCIGUAT,RIOCIGUAT,RU3FE2Y4XI,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/7b57509a-3d5d-41d4-8fed-1471e26372a3/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7b57509a-3d5d-41d4-8fed-1471e26372a3,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=7b57509a-3d5d-41d4-8fed-1471e26372a3,7b57509a-3d5d-41d4-8fed-1471e26372a3,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,213973,QINLOCK,RIPRETINIB,2023/10/31,Kinase Inhibitor,2020,DECIPHERA PHARMACEUTICALS LLC,2020/05/15-,73207-101,9XW757O13D,Ripretinib,Ripretinib,9XW757O13D,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/9f18e462-03dd-4296-a02a-a0577e3ee78d/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9f18e462-03dd-4296-a02a-a0577e3ee78d,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=9f18e462-03dd-4296-a02a-a0577e3ee78d,9f18e462-03dd-4296-a02a-a0577e3ee78d,,,
HUMAN PRESCRIPTION DRUG LABEL,"POWDER, FOR SOLUTION",ORAL,NDA,213535,EVRYSDI,RISDIPLAM,2024/03/08,Survival of Motor Neuron 2 Splicing Modifier,2020,GENENTECH INC,2020/08/07-,50242-175,76RS4S2ET1,RISDIPLAM,RISDIPLAM,76RS4S2ET1,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/eceb9a99-7191-4be5-87c3-0102707cf98e/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=eceb9a99-7191-4be5-87c3-0102707cf98e,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=eceb9a99-7191-4be5-87c3-0102707cf98e,eceb9a99-7191-4be5-87c3-0102707cf98e,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,020835,Actonel,RISEDRONATE SODIUM,2023/10/01,Bisphosphonate,1998,ALLERGAN INC,2002/05/17-; 2008/04/22-; completed:1998/03/27-2020/02/28; completed:2000/04/14-2020/07/28; completed:2007/04/16-2010/03/31,0430-0470; 0430-0471; 0430-0472; 0430-0477; 0430-0478,F67L43UT5C; HU2YAQ274O,RISEDRONATE SODIUM HEMI-PENTAHYDRATE; RISEDRONATE SODIUM MONOHYDRATE,RISEDRONIC ACID,KM2Z91756Z,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/24ed00e0-25e2-49a8-97fc-66c1b417dc0b/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=24ed00e0-25e2-49a8-97fc-66c1b417dc0b,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=24ed00e0-25e2-49a8-97fc-66c1b417dc0b,24ed00e0-25e2-49a8-97fc-66c1b417dc0b,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, DELAYED RELEASE",ORAL,NDA,022560,Atelvia,RISEDRONATE SODIUM,2023/10/01,Bisphosphonate,1998,ALLERGAN INC,2010/12/01-,0430-0979,F67L43UT5C; HU2YAQ274O,RISEDRONATE SODIUM HEMI-PENTAHYDRATE; RISEDRONATE SODIUM MONOHYDRATE,RISEDRONIC ACID,KM2Z91756Z,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/c8b9ab88-1a26-46c3-80ec-4eaa45202021/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c8b9ab88-1a26-46c3-80ec-4eaa45202021,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=c8b9ab88-1a26-46c3-80ec-4eaa45202021,c8b9ab88-1a26-46c3-80ec-4eaa45202021,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SUSPENSION, EXTENDED RELEASE",SUBCUTANEOUS,NDA,213586,UZEDY,RISPERIDONE,2024/04/30,Atypical Antipsychotic,1993,TEVA PHARMACEUTICALS USA INC,2023/05/01-,51759-305; 51759-410; 51759-520; 51759-630; 51759-740; 51759-850; 51759-960,L6UH7ZF8HC,RISPERIDONE,RISPERIDONE,L6UH7ZF8HC,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/734eb776-4be0-4808-834b-0d8b0f9e021e/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=734eb776-4be0-4808-834b-0d8b0f9e021e,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=734eb776-4be0-4808-834b-0d8b0f9e021e,734eb776-4be0-4808-834b-0d8b0f9e021e,,,
HUMAN PRESCRIPTION DRUG LABEL,KIT,INTRAMUSCULAR,NDA,021346,RISPERDAL CONSTA,RISPERIDONE,2024/02/08,Atypical Antipsychotic,2003,JANSSEN PHARMACEUTICALS INC,2003/10/29-,50458-306; 50458-307; 50458-308; 50458-309,L6UH7ZF8HC,RISPERIDONE,RISPERIDONE,L6UH7ZF8HC,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/bb34ee82-d2c2-43b8-ba21-2825c0954691/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=bb34ee82-d2c2-43b8-ba21-2825c0954691,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=bb34ee82-d2c2-43b8-ba21-2825c0954691,bb34ee82-d2c2-43b8-ba21-2825c0954691,,,
HUMAN PRESCRIPTION DRUG LABEL,KIT,SUBCUTANEOUS,NDA,210655,PERSERIS,RISPERIDONE,2023/08/15,Atypical Antipsychotic,1993,INDIVIOR INC,2018/11/09-,12496-0090; 12496-0120,L6UH7ZF8HC,Risperidone,Risperidone,L6UH7ZF8HC,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/a4f21b1a-5691-4b14-a56d-651962d06f39/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a4f21b1a-5691-4b14-a56d-651962d06f39,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=a4f21b1a-5691-4b14-a56d-651962d06f39,a4f21b1a-5691-4b14-a56d-651962d06f39,,,
HUMAN PRESCRIPTION DRUG LABEL,KIT,INTRAMUSCULAR,NDA,212849,Rykindo extended-release microspheres,RISPERIDONE,2023/06/09,Atypical Antipsychotic,1993,SHANDONG LUYE PHARMACEUTICAL CO LTD,2023/06/20-,72526-101; 72526-102; 72526-103; 72526-104,L6UH7ZF8HC,Risperidone,Risperidone,L6UH7ZF8HC,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/58534c96-96f5-4c2e-a061-92d4506aee91/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=58534c96-96f5-4c2e-a061-92d4506aee91,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=58534c96-96f5-4c2e-a061-92d4506aee91,58534c96-96f5-4c2e-a061-92d4506aee91,,,
HUMAN PRESCRIPTION DRUG LABEL,"SOLUTION; TABLET; TABLET, ORALLY DISINTEGRATING",ORAL,NDA,020272;020588;021444,Risperidone; Risperidone M-TAB,RISPERIDONE,2022/09/14,Atypical Antipsychotic,1993,JANSSEN PHARMACEUTICAL INC,1996/06/10-; completed:1993/12/29-2020/08/31; completed:2003/04/02-2018/03/31,50458-591; 50458-592; 50458-593; 50458-594; 50458-595; 50458-596; 50458-601; 50458-602; 50458-603; 50458-604; 50458-605,L6UH7ZF8HC,risperidone,risperidone,L6UH7ZF8HC,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/701e1cd8-2868-4d29-85a9-a2212c88165f/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=701e1cd8-2868-4d29-85a9-a2212c88165f,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=701e1cd8-2868-4d29-85a9-a2212c88165f,701e1cd8-2868-4d29-85a9-a2212c88165f,,,
HUMAN PRESCRIPTION DRUG LABEL,"SOLUTION; TABLET; TABLET, ORALLY DISINTEGRATING",ORAL,NDA,020272;020588;021444,RISPERDAL; RISPERDAL M-TAB,RISPERIDONE,2022/08/31,Atypical Antipsychotic,1993,JANSSEN PHARMACEUTICALS INC,1993/12/29-; 1996/06/10-; 2003/04/02-,50458-300; 50458-302; 50458-305; 50458-315; 50458-320; 50458-325; 50458-330; 50458-335; 50458-350; 50458-355; 50458-395,L6UH7ZF8HC,risperidone,risperidone,L6UH7ZF8HC,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/7e117c7e-02fc-4343-92a1-230061dfc5e0/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7e117c7e-02fc-4343-92a1-230061dfc5e0,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=7e117c7e-02fc-4343-92a1-230061dfc5e0,7e117c7e-02fc-4343-92a1-230061dfc5e0,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,NDA,215830,Litfulo,RITLECITINIB,2023/12/04,,2023,PFIZER LABORATORIES DIV PFIZER INC,2023/07/06-,0069-0334,EAG4T1459K,RITLECITINIB TOSYLATE,RITLECITINIB,2OYE00PC25,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/6b2f9446-fb23-4741-b73a-5a2f993733c3/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6b2f9446-fb23-4741-b73a-5a2f993733c3,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=6b2f9446-fb23-4741-b73a-5a2f993733c3,6b2f9446-fb23-4741-b73a-5a2f993733c3,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,NDA,215830,Litfulo,RITLECITINIB,2023/06/23,,2023,U S PHARMACEUTICALS,2023/07/06-,63539-334,EAG4T1459K,RITLECITINIB TOSYLATE,RITLECITINIB,2OYE00PC25,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/1882f799-61b0-4813-965a-4910c4ae419c/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1882f799-61b0-4813-965a-4910c4ae419c,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=1882f799-61b0-4813-965a-4910c4ae419c,1882f799-61b0-4813-965a-4910c4ae419c,,,
HUMAN PRESCRIPTION DRUG LABEL,"POWDER; SOLUTION; TABLET, FILM COATED",ORAL,NDA,020659;022417;209512,Norvir,RITONAVIR,2022/12/15,Cytochrome P450 3A Inhibitor; Protease Inhibitor,1996,ABBVIE INC,2017/06/07-; 2022/08/16-; completed:2010/05/06-2023/02/09; completed:2010/05/06-2024/02/14,0074-1940; 0074-2340; 0074-3333; 0074-3399,O3J8G9O825,RITONAVIR,RITONAVIR,O3J8G9O825,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/2849298e-de6e-47bb-8194-56e075b33fc3/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2849298e-de6e-47bb-8194-56e075b33fc3,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=2849298e-de6e-47bb-8194-56e075b33fc3,2849298e-de6e-47bb-8194-56e075b33fc3,,,
HUMAN PRESCRIPTION DRUG LABEL,"GRANULE, FOR SUSPENSION; KIT; TABLET, FILM COATED",ORAL,NDA,022406;215859,XARELTO; Xarelto,RIVAROXABAN,2023/11/21,Factor Xa Inhibitor,2011,JANSSEN PHARMACEUTICALS INC,2011/07/01-; 2011/11/04-; 2011/11/05-; 2014/09/16-; 2018/10/09-,50458-575; 50458-577; 50458-578; 50458-579; 50458-580; 50458-584,9NDF7JZ4M3,RIVAROXABAN,RIVAROXABAN,9NDF7JZ4M3,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/10db92f9-2300-4a80-836b-673e1ae91610/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=10db92f9-2300-4a80-836b-673e1ae91610,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=10db92f9-2300-4a80-836b-673e1ae91610,10db92f9-2300-4a80-836b-673e1ae91610,,,
HUMAN PRESCRIPTION DRUG LABEL,"PATCH, EXTENDED RELEASE",TRANSDERMAL,NDA,022083,Exelon,RIVASTIGMINE,2024/05/08,Cholinesterase Inhibitor,2000,NOVARTIS PHARMACEUTICALS CORPORATION,2007/07/06-,0078-0501; 0078-0502; 0078-0503,PKI06M3IW0,RIVASTIGMINE,RIVASTIGMINE,PKI06M3IW0,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/07c12e14-bbd5-4ec8-84e4-fbe7b5ba10e0/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=07c12e14-bbd5-4ec8-84e4-fbe7b5ba10e0,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=07c12e14-bbd5-4ec8-84e4-fbe7b5ba10e0,07c12e14-bbd5-4ec8-84e4-fbe7b5ba10e0,,,
HUMAN PRESCRIPTION DRUG LABEL,FILM,ORAL,NDA,205394,RIZAFILM,RIZATRIPTAN BENZOATE,2024/01/10,Serotonin-1b and Serotonin-1d Receptor Agonist,1998,GENSCO LABORATORIES LLC,2024/01/10-,35781-0600,WR978S7QHH,RIZATRIPTAN BENZOATE,RIZATRIPTAN,51086HBW8G,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/fa32794e-d26d-e0bf-e053-6294a90abb0e/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=fa32794e-d26d-e0bf-e053-6294a90abb0e,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=fa32794e-d26d-e0bf-e053-6294a90abb0e,fa32794e-d26d-e0bf-e053-6294a90abb0e,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET; TABLET, ORALLY DISINTEGRATING",ORAL,NDA,020864;020865,MAXALT; MAXALT-MLT,RIZATRIPTAN BENZOATE,2022/06/01,Serotonin-1b and Serotonin-1d Receptor Agonist,1998,ORGANON LLC,2021/06/01-,78206-142; 78206-143,WR978S7QHH,rizatriptan benzoate,rizatriptan,51086HBW8G,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/007b4644-e0e7-4863-9ae3-fe09676b3f5f/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=007b4644-e0e7-4863-9ae3-fe09676b3f5f,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=007b4644-e0e7-4863-9ae3-fe09676b3f5f,007b4644-e0e7-4863-9ae3-fe09676b3f5f,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRAMUSCULAR; INTRAVENOUS,NDA,017558,Robinul,ROBINUL,2017/06/29,Anticholinergic; Cholinergic Muscarinic Antagonist,,WEST WARD PHARMACEUTICALS CORP,1975/02/06-,0641-6104; 0641-6105; 0641-6106; 0641-6107,V92SO9WP2I,GLYCOPYRROLATE,GLYCOPYRRONIUM,A14FB57V1D,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/38f88829-a226-4810-866c-1b62c47e8aee/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=38f88829-a226-4810-866c-1b62c47e8aee,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=38f88829-a226-4810-866c-1b62c47e8aee,38f88829-a226-4810-866c-1b62c47e8aee,,,
HUMAN PRESCRIPTION DRUG LABEL,CREAM,TOPICAL,NDA,215985,ZORYVE,ROFLUMILAST,2024/02/08,Phosphodiesterase 4 Inhibitor,2011,ARCUTIS BIOTHERAPEUTICS INC,2022/07/29-,80610-130,0P6C6ZOP5U,ROFLUMILAST,roflumilast,0P6C6ZOP5U,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/ec1bb0d1-f38a-4080-831a-68791d1d1fdb/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ec1bb0d1-f38a-4080-831a-68791d1d1fdb,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=ec1bb0d1-f38a-4080-831a-68791d1d1fdb,ec1bb0d1-f38a-4080-831a-68791d1d1fdb,,,
HUMAN PRESCRIPTION DRUG LABEL,"AEROSOL, FOAM",TOPICAL,NDA,217242,ZORYVE,ROFLUMILAST,2023/12/20,Phosphodiesterase 4 Inhibitor,2011,ARCUTIS BIOTHERAPEUTICS INC,2023/12/15-,80610-430,0P6C6ZOP5U,roflumilast,roflumilast,0P6C6ZOP5U,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/f9e0b4a9-a227-4947-b00c-41fb18d16589/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f9e0b4a9-a227-4947-b00c-41fb18d16589,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=f9e0b4a9-a227-4947-b00c-41fb18d16589,f9e0b4a9-a227-4947-b00c-41fb18d16589,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,022522,Daliresp,ROFLUMILAST,2020/03/12,Phosphodiesterase 4 Inhibitor,2011,ASTRAZENECA PHARMACEUTICALS LP,2015/07/01-,0310-0088; 0310-0095,0P6C6ZOP5U,roflumilast,roflumilast,0P6C6ZOP5U,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/c9a1d0a8-581f-4f91-a2b8-f419192d0ebf/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c9a1d0a8-581f-4f91-a2b8-f419192d0ebf,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=c9a1d0a8-581f-4f91-a2b8-f419192d0ebf,c9a1d0a8-581f-4f91-a2b8-f419192d0ebf,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,206500,Varubi,ROLAPITANT,2020/08/19,Substance P/Neurokinin-1 Receptor Antagonist,2015,TERSERA THERAPEUTICS LLC,2015/10/07-,70720-101,57O5S1QSAQ,ROLAPITANT HYDROCHLORIDE,rolapitant,NLE429IZUC,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/a52896cd-4a98-49b8-82db-bf1985a64d97/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a52896cd-4a98-49b8-82db-bf1985a64d97,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=a52896cd-4a98-49b8-82db-bf1985a64d97,a52896cd-4a98-49b8-82db-bf1985a64d97,,,
HUMAN PRESCRIPTION DRUG LABEL,KIT,INTRAVENOUS,NDA,022393,ISTODAX,ROMIDEPSIN,2023/01/31,Histone Deacetylase Inhibitor,2009,CELGENE CORPORATION,2010/01/04-; completed:2010/01/04-2016/07/27,59572-983; 59572-984,CX3T89XQBK,ROMIDEPSIN,ROMIDEPSIN,CX3T89XQBK,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/03b39d40-90fe-11df-9de6-0002a5d5c51b/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=03b39d40-90fe-11df-9de6-0002a5d5c51b,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=03b39d40-90fe-11df-9de6-0002a5d5c51b,03b39d40-90fe-11df-9de6-0002a5d5c51b,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION, CONCENTRATE",INTRAVENOUS,NDA,208574,Romidepsin,ROMIDEPSIN,2021/12/31,Histone Deacetylase Inhibitor,2009,TEVA PARENTERAL MEDICINES INC,2020/04/14-,0703-4004,CX3T89XQBK,ROMIDEPSIN,ROMIDEPSIN,CX3T89XQBK,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/a0478684-e477-4b52-97a9-04a76e794c87/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a0478684-e477-4b52-97a9-04a76e794c87,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=a0478684-e477-4b52-97a9-04a76e794c87,a0478684-e477-4b52-97a9-04a76e794c87,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",EPIDURAL,NDA,020533,Naropin,ROPIVACAINE HYDROCHLORIDE,2024/05/22,Amide Local Anesthetic,,FRESENIUS KABI USA LLC,1996/09/24-,63323-288,V910P86109,ROPIVACAINE HYDROCHLORIDE,ROPIVACAINE,7IO5LYA57N,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/56dfabf7-f7a8-4601-b17a-cb16fb995b0f/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=56dfabf7-f7a8-4601-b17a-cb16fb995b0f,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=56dfabf7-f7a8-4601-b17a-cb16fb995b0f,56dfabf7-f7a8-4601-b17a-cb16fb995b0f,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",EPIDURAL; INFILTRATION; PERINEURAL,NDA,020533,Naropin,ROPIVACAINE HYDROCHLORIDE,2024/05/14,Amide Local Anesthetic,1996,FRESENIUS KABI USA LLC,1996/09/24-,63323-285; 63323-286; 63323-287; 63323-288,V910P86109,ROPIVACAINE HYDROCHLORIDE,ROPIVACAINE,7IO5LYA57N,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/23d2d448-a744-4877-9f2d-7e57c198da89/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=23d2d448-a744-4877-9f2d-7e57c198da89,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=23d2d448-a744-4877-9f2d-7e57c198da89,23d2d448-a744-4877-9f2d-7e57c198da89,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",EPIDURAL; INFILTRATION; PERINEURAL,NDA,020533,Naropin,ROPIVACAINE HYDROCHLORIDE,2022/09/23,Amide Local Anesthetic,,FRESENIUS KABI USA LLC,2009/08/04-,63323-285; 63323-286; 63323-288,V910P86109,ROPIVACAINE HYDROCHLORIDE,ROPIVACAINE,7IO5LYA57N,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/c6613708-c1f7-4f5c-91a3-ebbc1d7905c6/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c6613708-c1f7-4f5c-91a3-ebbc1d7905c6,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=c6613708-c1f7-4f5c-91a3-ebbc1d7905c6,c6613708-c1f7-4f5c-91a3-ebbc1d7905c6,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",EPIDURAL; INFILTRATION; PERINEURAL,NDA,020533,Naropin,ROPIVACAINE HYDROCHLORIDE,2022/02/11,Amide Local Anesthetic,,FRESENIUS KABI USA LLC,2009/08/04-,63323-285; 63323-286,V910P86109,ROPIVACAINE HYDROCHLORIDE,ROPIVACAINE,7IO5LYA57N,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/dff4a1e4-4b2a-4a64-b6d8-ea470dee88f7/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=dff4a1e4-4b2a-4a64-b6d8-ea470dee88f7,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=dff4a1e4-4b2a-4a64-b6d8-ea470dee88f7,dff4a1e4-4b2a-4a64-b6d8-ea470dee88f7,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,NDA,208647,EZALLOR SPRINKLE,ROSUVASTATIN,2023/08/16,HMG-CoA Reductase Inhibitor,2003,SUN PHARMACEUTICAL INDUSTRIES INC,2019/05/04-,47335-984; 47335-985; 47335-986; 47335-987,83MVU38M7Q,ROSUVASTATIN CALCIUM,ROSUVASTATIN,413KH5ZJ73,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/619add8c-3e39-4bb7-8828-450bd82c0404/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=619add8c-3e39-4bb7-8828-450bd82c0404,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=619add8c-3e39-4bb7-8828-450bd82c0404,619add8c-3e39-4bb7-8828-450bd82c0404,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,021366,Crestor,ROSUVASTATIN,2023/07/27,HMG-CoA Reductase Inhibitor,2003,ASTRAZENECA PHARMACEUTICALS LP,2022/01/24-; 2022/05/09-,0310-7560; 0310-7570; 0310-7580; 0310-7590,83MVU38M7Q,ROSUVASTATIN CALCIUM,ROSUVASTATIN,413KH5ZJ73,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/325a5d0e-9a72-4015-9fcd-1655fb504cee/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=325a5d0e-9a72-4015-9fcd-1655fb504cee,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=325a5d0e-9a72-4015-9fcd-1655fb504cee,325a5d0e-9a72-4015-9fcd-1655fb504cee,,,
HUMAN PRESCRIPTION DRUG LABEL,"KIT; PATCH, EXTENDED RELEASE",TRANSDERMAL,NDA,021829,Neupro,ROTIGOTINE,2022/07/27,Nonergot Dopamine Agonist,2007,UCB INC,2012/04/02-,50474-801; 50474-802; 50474-803; 50474-804; 50474-805; 50474-806; 50474-808,87T4T8BO2E,rotigotine,rotigotine,87T4T8BO2E,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/939e28c5-f3a9-42c0-9a2d-8d471d82a6e0/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=939e28c5-f3a9-42c0-9a2d-8d471d82a6e0,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=939e28c5-f3a9-42c0-9a2d-8d471d82a6e0,939e28c5-f3a9-42c0-9a2d-8d471d82a6e0,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,209115,Rubraca,RUCAPARIB,2024/02/21,Poly(ADP-Ribose) Polymerase Inhibitor,2016,CLOVIS ONCOLOGY INC,completed:2016/12/19-2025/07/31; completed:2016/12/19-2025/12/31; completed:2017/05/01-2025/07/31,69660-201; 69660-202; 69660-203,41AX9SJ8KO,RUCAPARIB CAMSYLATE,RUCAPARIB,8237F3U7EH,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/a6d46c03-bb1d-417b-b8e5-3bffe352fe29/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a6d46c03-bb1d-417b-b8e5-3bffe352fe29,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=a6d46c03-bb1d-417b-b8e5-3bffe352fe29,a6d46c03-bb1d-417b-b8e5-3bffe352fe29,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,209115,Rubraca,RUCAPARIB,2023/09/30,Poly(ADP-Ribose) Polymerase Inhibitor,2016,PHARMAAND GMBH,2016/12/19-; 2017/05/01-,82154-0783; 82154-0784; 82154-0785,41AX9SJ8KO,RUCAPARIB CAMSYLATE,RUCAPARIB,8237F3U7EH,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/0295d202-1cfe-7659-e063-6294a90a476e/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0295d202-1cfe-7659-e063-6294a90a476e,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=0295d202-1cfe-7659-e063-6294a90a476e,0295d202-1cfe-7659-e063-6294a90a476e,,,
HUMAN PRESCRIPTION DRUG LABEL,"SUSPENSION; TABLET, FILM COATED",ORAL,NDA,021911;201367,Banzel,RUFINAMIDE,2022/12/17,,2008,EISAI INC,2008/11/14-; 2011/03/03-,62856-582; 62856-583; 62856-584,WFW942PR79,RUFINAMIDE,RUFINAMIDE,WFW942PR79,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/0a3fa925-1abd-458a-bd57-4ae780a1ef2d/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0a3fa925-1abd-458a-bd57-4ae780a1ef2d,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=0a3fa925-1abd-458a-bd57-4ae780a1ef2d,0a3fa925-1abd-458a-bd57-4ae780a1ef2d,,,
HUMAN PRESCRIPTION DRUG LABEL,CREAM,TOPICAL,NDA,215309,OPZELURA,RUXOLITINIB,2023/09/20,Janus Kinase Inhibitor; Kinase Inhibitor,2011,INCYTE CORPORATION,2021/09/21-,50881-007,436LRU32H5,RUXOLITINIB PHOSPHATE,RUXOLITINIB,82S8X8XX8H,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/24da5509-6631-4795-9d42-273faecd08e7/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=24da5509-6631-4795-9d42-273faecd08e7,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=24da5509-6631-4795-9d42-273faecd08e7,24da5509-6631-4795-9d42-273faecd08e7,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,202192,JAKAFI,RUXOLITINIB,2023/01/31,Janus Kinase Inhibitor; Kinase Inhibitor,2011,INCYTE CORPORATION,2011/11/16-,50881-005; 50881-010; 50881-015; 50881-020; 50881-025,82S8X8XX8H,RUXOLITINIB,RUXOLITINIB,82S8X8XX8H,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/f1c82580-87ae-11e0-bc84-0002a5d5c51b/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f1c82580-87ae-11e0-bc84-0002a5d5c51b,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=f1c82580-87ae-11e0-bc84-0002a5d5c51b,f1c82580-87ae-11e0-bc84-0002a5d5c51b,,,
HUMAN PRESCRIPTION DRUG LABEL,"CAPSULE, LIQUID FILLED",ORAL,NDA,207997,RYDAPT,RYDAPT,2023/05/22,Kinase Inhibitor,2017,NOVARTIS PHARMACEUTICALS CORPORATION,2017/04/28-,0078-0698,ID912S5VON,MIDOSTAURIN,MIDOSTAURIN,ID912S5VON,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/11fa3fc9-6776-49a6-b1c1-653f627c3e58/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=11fa3fc9-6776-49a6-b1c1-653f627c3e58,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=11fa3fc9-6776-49a6-b1c1-653f627c3e58,11fa3fc9-6776-49a6-b1c1-653f627c3e58,,,
HUMAN PRESCRIPTION DRUG LABEL,"PELLET; TABLET, FILM COATED",ORAL,NDA,207620;218591,ENTRESTO,SACUBITRIL AND VALSARTAN,2024/04/12,Angiotensin 2 Receptor Blocker; Neprilysin Inhibitor,2015,NOVARTIS PHARMACEUTICALS CORPORATION,2015/07/07-; 2024/04/12-,0078-0659; 0078-0696; 0078-0777; 0078-1231; 0078-1238; 0078-9659; 0078-9777,17ERJ0MKGI; 80M03YXJ7I,SACUBITRIL; VALSARTAN,SACUBITRILAT; VALSARTAN,80M03YXJ7I; SPI5PBF81S,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/000dc81d-ab91-450c-8eae-8eb74e72296f/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=000dc81d-ab91-450c-8eae-8eb74e72296f,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=000dc81d-ab91-450c-8eae-8eb74e72296f,000dc81d-ab91-450c-8eae-8eb74e72296f,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,207145,Xadago,SAFINAMIDE MESYLATE,2023/12/20,Monoamine Oxidase Type B Inhibitor,2017,MDD US OPERATIONS LLC A SUBSIDIARY OF SUPERNUS PHARMACEUTICALS INC,2017/05/08-,27505-110; 27505-111,YS90V3DTX0,SAFINAMIDE MESYLATE,SAFINAMIDE,90ENL74SIG,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/c4d65f28-983f-42b4-bb23-023ae0fe81b2/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c4d65f28-983f-42b4-bb23-023ae0fe81b2,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=c4d65f28-983f-42b4-bb23-023ae0fe81b2,c4d65f28-983f-42b4-bb23-023ae0fe81b2,,,
HUMAN PRESCRIPTION DRUG LABEL,"POWDER, METERED",INHALATION; ORAL,NDA,020692,SEREVENT DISKUS,SALMETEROL XINAFOATE,2022/10/10,beta2-Adrenergic Agonist,1994,GLAXOSMITHKLINE LLC,1997/11/25-,0173-0521,6EW8Q962A5,SALMETEROL XINAFOATE,SALMETEROL,2I4BC502BT,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/12d9728e-6b5c-4aee-bfb0-745e542ed2e4/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=12d9728e-6b5c-4aee-bfb0-745e542ed2e4,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=12d9728e-6b5c-4aee-bfb0-745e542ed2e4,12d9728e-6b5c-4aee-bfb0-745e542ed2e4,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,022181,Sapropterin Dihydrochloride,SAPROPTERIN DIHYDROCHLORIDE,2021/12/20,Phenylalanine Hydroxylase Activator,2007,DR REDDYS LABORATORIES INC,2020/10/01-,43598-749,RG277LF5B3,SAPROPTERIN DIHYDROCHLORIDE,SAPROPTERIN,EGX657432I,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/83bf50fd-f70c-037a-5c8f-b32f69208d20/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=83bf50fd-f70c-037a-5c8f-b32f69208d20,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=83bf50fd-f70c-037a-5c8f-b32f69208d20,83bf50fd-f70c-037a-5c8f-b32f69208d20,,,
HUMAN PRESCRIPTION DRUG LABEL,"POWDER, FOR SOLUTION; TABLET",ORAL,NDA,022181;205065,Kuvan,SAPROPTERIN DIHYDROCHLORIDE,2021/02/08,Phenylalanine Hydroxylase Activator,2007,BIOMARIN PHARMACEUTICAL INC,2007/12/14-; 2014/02/21-; 2015/05/27-,68135-300; 68135-301; 68135-482,RG277LF5B3,SAPROPTERIN DIHYDROCHLORIDE,SAPROPTERIN,EGX657432I,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/af38711e-8873-4790-a92d-4d583e23fb89/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=af38711e-8873-4790-a92d-4d583e23fb89,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=af38711e-8873-4790-a92d-4d583e23fb89,af38711e-8873-4790-a92d-4d583e23fb89,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, COATED",ORAL,NDA,209521,Seysara,SARECYCLINE HYDROCHLORIDE,2023/11/09,Tetracycline-class Drug,2018,ALMIRALL LLC,2019/01/04-,16110-245; 16110-246; 16110-247,36718856JR,SARECYCLINE HYDROCHLORIDE,SARECYCLINE,94O110CX2E,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/b200957c-3004-4988-be97-9fd619a83649/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b200957c-3004-4988-be97-9fd619a83649,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=b200957c-3004-4988-be97-9fd619a83649,b200957c-3004-4988-be97-9fd619a83649,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,022350,ONGLYZA,SAXAGLIPTIN,2019/10/24,Dipeptidyl Peptidase 4 Inhibitor,2009,ASTRAZENECA PHARMACEUTICALS LP,2014/11/20-,0310-6100; 0310-6105,Z8J84YIX6L,saxagliptin hydrochloride,saxagliptin anhydrous,8I7IO46IVQ,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/c5116390-e0fe-4969-94cb-e9de5165fbab/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c5116390-e0fe-4969-94cb-e9de5165fbab,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=c5116390-e0fe-4969-94cb-e9de5165fbab,c5116390-e0fe-4969-94cb-e9de5165fbab,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,NDA,200678,KOMBIGLYZE XR,SAXAGLIPTIN AND METFORMIN HYDROCHLORIDE,2019/10/24,Biguanide; Dipeptidyl Peptidase 4 Inhibitor,2010,ASTRAZENECA PHARMACEUTICALS LP,2014/12/04-,0310-6125; 0310-6135; 0310-6145,786Z46389E; Z8J84YIX6L,metformin hydrochloride; saxagliptin hydrochloride,metformin; saxagliptin anhydrous,8I7IO46IVQ; 9100L32L2N,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/fbd25da4-ebe6-45c9-beb8-93523d11a0b4/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=fbd25da4-ebe6-45c9-beb8-93523d11a0b4,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=fbd25da4-ebe6-45c9-beb8-93523d11a0b4,fbd25da4-ebe6-45c9-beb8-93523d11a0b4,,,
HUMAN PRESCRIPTION DRUG LABEL,"PATCH, EXTENDED RELEASE",TRANSDERMAL,NDA,017874,Transderm Scop,SCOPOLAMINE,2024/03/14,Anticholinergic,1979,BAXTER HEALTHCARE CORPORATION,completed:2016/12/01-2025/02/28,10019-553,DL48G20X8X,SCOPOLAMINE,SCOPOLAMINE,DL48G20X8X,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/b877a694-a1d0-4280-937a-a06820b12a88/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b877a694-a1d0-4280-937a-a06820b12a88,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=b877a694-a1d0-4280-937a-a06820b12a88,b877a694-a1d0-4280-937a-a06820b12a88,,,
HUMAN PRESCRIPTION DRUG LABEL,GRANULE,ORAL,NDA,209363,SOLOSEC,SECNIDAZOLE,2022/07/01,Nitroimidazole Antimicrobial,2017,LUPIN PHARMACEUTICALS INC,2017/10/30-,27437-051,R3459K699K,SECNIDAZOLE,SECNIDAZOLE,R3459K699K,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/551e43d5-f700-4d6e-8029-026f8a8932ff/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=551e43d5-f700-4d6e-8029-026f8a8932ff,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=551e43d5-f700-4d6e-8029-026f8a8932ff,551e43d5-f700-4d6e-8029-026f8a8932ff,,,
HUMAN PRESCRIPTION DRUG LABEL,RING,VAGINAL,NDA,209627,ANNOVERA,SEGESTERONE ACETATE AND ETHINYL ESTRADIOL,2022/08/23,Estrogen; Progestin,2018,THERAPEUTICSMD INC,2019/08/12-,50261-313,423D2T571U; 9AMX4Q13CC,ethinyl estradiol; segesterone acetate,ethinyl estradiol; segesterone,09Q5UV3747; 423D2T571U,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/37bb9ebd-2e99-4453-bbe6-9dd4a2897193/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=37bb9ebd-2e99-4453-bbe6-9dd4a2897193,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=37bb9ebd-2e99-4453-bbe6-9dd4a2897193,37bb9ebd-2e99-4453-bbe6-9dd4a2897193,,,
HUMAN PRESCRIPTION DRUG LABEL,PATCH,TRANSDERMAL,NDA,021336,EMSAM,SELEGILINE,2020/05/15,Monoamine Oxidase Inhibitor; Monoamine Oxidase Type B Inhibitor,2006,MYLAN SPECIALTY L P,2006/02/27-,49502-900; 49502-901; 49502-902,2K1V7GP655,SELEGILINE,SELEGILINE,2K1V7GP655,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/b891bd9f-fdb8-4862-89c5-ecdd700398a3/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b891bd9f-fdb8-4862-89c5-ecdd700398a3,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=b891bd9f-fdb8-4862-89c5-ecdd700398a3,b891bd9f-fdb8-4862-89c5-ecdd700398a3,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, ORALLY DISINTEGRATING",ORAL,NDA,021479,ZELAPAR,SELEGILINE HYDROCHLORIDE,2021/06/01,Monoamine Oxidase Inhibitor; Monoamine Oxidase Type B Inhibitor,2006,BAUSCH HEALTH US LLC,2006/06/14-,0187-0453,6W731X367Q,SELEGILINE HYDROCHLORIDE,SELEGILINE,2K1V7GP655,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/380d7717-2a79-42f3-a712-efe5e7696ba0/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=380d7717-2a79-42f3-a712-efe5e7696ba0,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=380d7717-2a79-42f3-a712-efe5e7696ba0,380d7717-2a79-42f3-a712-efe5e7696ba0,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,209379,Selenious Acid,SELENIOUS ACID,2021/08/01,,2019,AMERICAN REGENT INC,2019/07/01-; 2022/03/28-,0517-6502; 0517-6560,H6241UJ22B,SELENIUM,SELENIUM,H6241UJ22B,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/49324999-50e3-43ed-a8dd-156d6dbedd9f/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=49324999-50e3-43ed-a8dd-156d6dbedd9f,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=49324999-50e3-43ed-a8dd-156d6dbedd9f,49324999-50e3-43ed-a8dd-156d6dbedd9f,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, POWDER, FOR SOLUTION; KIT; TABLET, COATED",INTRAVENOUS; ORAL,NDA,207947;214275,UPTRAVI; UPTRAVI Titration Pack,SELEXIPAG,2023/04/19,Prostacyclin Receptor Agonist,2015,ACTELION PHARMACEUTICALS US INC,2015/12/21-; 2021/07/29-,66215-602; 66215-604; 66215-606; 66215-608; 66215-610; 66215-612; 66215-614; 66215-616; 66215-628; 66215-718,5EXC0E384L,SELEXIPAG,SELEXIPAG,5EXC0E384L,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/a7a23b87-f892-4e2c-8e2e-ebf841220f90/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a7a23b87-f892-4e2c-8e2e-ebf841220f90,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=a7a23b87-f892-4e2c-8e2e-ebf841220f90,a7a23b87-f892-4e2c-8e2e-ebf841220f90,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,212306,XPOVIO,SELINEXOR,2022/07/25,Nuclear Export Inhibitor,2019,KARYOPHARM THERAPEUTICS INC,2019/07/10-; 2021/05/19-,72237-101; 72237-102; 72237-103; 72237-104,31TZ62FO8F,selinexor,selinexor,31TZ62FO8F,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/f6dd2682-75a6-4863-90a8-a3197f6f78a8/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f6dd2682-75a6-4863-90a8-a3197f6f78a8,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=f6dd2682-75a6-4863-90a8-a3197f6f78a8,f6dd2682-75a6-4863-90a8-a3197f6f78a8,,,
HUMAN PRESCRIPTION DRUG LABEL,"CAPSULE; TABLET, COATED",ORAL,NDA,213246;218160,RETEVMO,SELPERCATINIB,2024/04/10,Kinase Inhibitor,2020,ELI LILLY AND COMPANY,2020/05/08-; 2024/04/10-,0002-2980; 0002-3977; 0002-5340; 0002-5562; 0002-6082; 0002-6120,CEGM9YBNGD,selpercatinib,selpercatinib,CEGM9YBNGD,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/7fa848ba-a59c-4144-9f52-64d090f4d828/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7fa848ba-a59c-4144-9f52-64d090f4d828,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=7fa848ba-a59c-4144-9f52-64d090f4d828,7fa848ba-a59c-4144-9f52-64d090f4d828,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,NDA,213756,KOSELUGO,SELUMETINIB,2024/01/24,Kinase Inhibitor,2020,ASTRAZENECA PHARMACEUTICALS LP,2020/04/16-,0310-0610; 0310-0625,6UH91I579U,SELUMETINIB,SELUMETINIB,6UH91I579U,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/7d042c61-f28f-4ab5-ab10-d7558c0d49ff/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7d042c61-f28f-4ab5-ab10-d7558c0d49ff,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=7d042c61-f28f-4ab5-ab10-d7558c0d49ff,7d042c61-f28f-4ab5-ab10-d7558c0d49ff,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",SUBCUTANEOUS,NDA,215256,WEGOVY,SEMAGLUTIDE,2024/03/01,GLP-1 Receptor Agonist,2017,NOVO NORDISK,2021/06/05-,0169-4501; 0169-4505; 0169-4517; 0169-4524; 0169-4525,53AXN4NNHX,SEMAGLUTIDE,SEMAGLUTIDE,53AXN4NNHX,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/ee06186f-2aa3-4990-a760-757579d8f77b/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ee06186f-2aa3-4990-a760-757579d8f77b,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=ee06186f-2aa3-4990-a760-757579d8f77b,ee06186f-2aa3-4990-a760-757579d8f77b,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",SUBCUTANEOUS,NDA,209637,Ozempic,SEMAGLUTIDE,2023/09/22,GLP-1 Receptor Agonist,2017,NOVO NORDISK,2020/09/30-; 2022/04/25-; 2022/10/07-; completed:2017/12/06-2023/10/31; completed:2017/12/06-2025/09/30,0169-4130; 0169-4132; 0169-4136; 0169-4181; 0169-4772,53AXN4NNHX,SEMAGLUTIDE,SEMAGLUTIDE,53AXN4NNHX,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/adec4fd2-6858-4c99-91d4-531f5f2a2d79/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=adec4fd2-6858-4c99-91d4-531f5f2a2d79,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=adec4fd2-6858-4c99-91d4-531f5f2a2d79,adec4fd2-6858-4c99-91d4-531f5f2a2d79,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,NDA,212994,AZSTARYS,SERDEXMETHYLPHENIDATE AND DEXMETHYLPHENIDATE,2023/10/18,Central Nervous System Stimulant,2021,CORIUM LLC,2021/07/16-,65038-286; 65038-429; 65038-561,1678OK0E08; FN54BT298Y,DEXMETHYLPHENIDATE HYDROCHLORIDE; SERDEXMETHYLPHENIDATE CHLORIDE,DEXMETHYLPHENIDATE,M32RH9MFGP,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/00b5e716-5564-4bbd-acaf-df2bc45a5663/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=00b5e716-5564-4bbd-acaf-df2bc45a5663,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=00b5e716-5564-4bbd-acaf-df2bc45a5663,00b5e716-5564-4bbd-acaf-df2bc45a5663,,,
HUMAN PRESCRIPTION DRUG LABEL,CREAM,TOPICAL,NDA,021385,Ertaczo,SERTACONAZOLE NITRATE,2020/12/18,Azole Antifungal,2003,BAUSCH HEALTH US LLC,2003/12/10-,0187-5115,1DV05410M5,Sertaconazole Nitrate,Sertaconazole,72W71I16EG,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/821073f7-33f6-464d-baed-f66d97987d6d/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=821073f7-33f6-464d-baed-f66d97987d6d,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=821073f7-33f6-464d-baed-f66d97987d6d,821073f7-33f6-464d-baed-f66d97987d6d,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,NDA,215133,sertraline HCl,SERTRALINE HYDROCHLORIDE,2023/08/24,Serotonin Reuptake Inhibitor,1991,ALMATICA PHARMA LLC,2021/10/04-,52427-664; 52427-672,UTI8907Y6X,SERTRALINE HYDROCHLORIDE,SERTRALINE,QUC7NX6WMB,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/8c8bcba9-eaeb-aa44-f9ea-b580de55a439/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8c8bcba9-eaeb-aa44-f9ea-b580de55a439,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=8c8bcba9-eaeb-aa44-f9ea-b580de55a439,8c8bcba9-eaeb-aa44-f9ea-b580de55a439,,,
HUMAN PRESCRIPTION DRUG LABEL,"SOLUTION, CONCENTRATE; TABLET, FILM COATED",ORAL,NDA,019839;020990,Zoloft,SERTRALINE HYDROCHLORIDE,2023/08/15,Serotonin Reuptake Inhibitor,1991,VIATRIS SPECIALTY LLC,2023/09/25-,58151-574; 58151-575; 58151-576; 58151-601,UTI8907Y6X,SERTRALINE HYDROCHLORIDE,SERTRALINE,QUC7NX6WMB,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/fda754f6-d0f3-4dce-a17a-927d64f912f7/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=fda754f6-d0f3-4dce-a17a-927d64f912f7,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=fda754f6-d0f3-4dce-a17a-927d64f912f7,fda754f6-d0f3-4dce-a17a-927d64f912f7,,,
HUMAN PRESCRIPTION DRUG LABEL,"SOLUTION, CONCENTRATE; TABLET, FILM COATED",ORAL,NDA,019839;020990,Zoloft,SERTRALINE HYDROCHLORIDE,2023/01/15,Serotonin Reuptake Inhibitor,1991,ROERIG,1992/02/11-; 2017/01/06-,0049-0050; 0049-4900; 0049-4910; 0049-4960,UTI8907Y6X,SERTRALINE HYDROCHLORIDE,SERTRALINE,QUC7NX6WMB,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/fe9e8b7d-61ea-409d-84aa-3ebd79a046b5/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=fe9e8b7d-61ea-409d-84aa-3ebd79a046b5,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=fe9e8b7d-61ea-409d-84aa-3ebd79a046b5,fe9e8b7d-61ea-409d-84aa-3ebd79a046b5,,,
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION,SUBCUTANEOUS,NDA,213793,Imcivree,SETMELANOTIDE,2023/11/21,Melanocortin 4 Receptor Agonist,2020,RHYTHM PHARMACEUTICALS INC,2020/12/14-,72829-010,N7T15V1FUY,SETMELANOTIDE,SETMELANOTIDE,N7T15V1FUY,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/70c3ccf7-4df0-4c75-ba07-fede9970c8d9/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=70c3ccf7-4df0-4c75-ba07-fede9970c8d9,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=70c3ccf7-4df0-4c75-ba07-fede9970c8d9,70c3ccf7-4df0-4c75-ba07-fede9970c8d9,,,
HUMAN PRESCRIPTION DRUG LABEL,"POWDER, FOR SUSPENSION; TABLET, FILM COATED",ORAL,NDA,022127;022318,Renvela,SEVELAMER CARBONATE,2023/09/25,Phosphate Binder,2000,GENZYME CORPORATION,2009/08/12-,58468-0130; 58468-0131; 58468-0132; 58468-0133,9YCX42I8IU,SEVELAMER CARBONATE,SEVELAMER,941N5DUU5C,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/e6328460-a57b-450b-a48c-6dcd4b476360/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e6328460-a57b-450b-a48c-6dcd4b476360,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=e6328460-a57b-450b-a48c-6dcd4b476360,e6328460-a57b-450b-a48c-6dcd4b476360,,,
HUMAN PRESCRIPTION DRUG LABEL,LIQUID,INHALATION,NDA,020478,Ultane,SEVOFLURANE,2022/08/18,General Anesthetic,,ABBVIE INC,1995/06/07-,0074-4456,38LVP0K73A,SEVOFLURANE,SEVOFLURANE,38LVP0K73A,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/c9aa6489-5a36-44ed-9512-b996833d82f7/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c9aa6489-5a36-44ed-9512-b996833d82f7,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=c9aa6489-5a36-44ed-9512-b996833d82f7,c9aa6489-5a36-44ed-9512-b996833d82f7,,,
HUMAN PRESCRIPTION DRUG LABEL,LIQUID,INHALATION,NDA,020478,Ultane,SEVOFLURANE,2022/08/18,General Anesthetic,,ABBVIE INC,1995/06/07-,0074-4456,38LVP0K73A,SEVOFLURANE,SEVOFLURANE,38LVP0K73A,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/4c6e76bc-c964-4955-e0a3-511d3386a9cc/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4c6e76bc-c964-4955-e0a3-511d3386a9cc,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=4c6e76bc-c964-4955-e0a3-511d3386a9cc,4c6e76bc-c964-4955-e0a3-511d3386a9cc,,,
HUMAN PRESCRIPTION DRUG LABEL,SUSPENSION,ORAL,NDA,214952,Liqrev,SILDENAFIL,2023/04/30,Phosphodiesterase 5 Inhibitor,1998,CMP PHARMA INC,2023/04/30-,46287-055,BW9B0ZE037,SILDENAFIL CITRATE,SILDENAFIL,3M7OB98Y7H,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/13fb930a-fc46-4e0d-8d05-39162c156714/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=13fb930a-fc46-4e0d-8d05-39162c156714,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=13fb930a-fc46-4e0d-8d05-39162c156714,13fb930a-fc46-4e0d-8d05-39162c156714,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION; POWDER, FOR SUSPENSION; TABLET, FILM COATED",INTRAVENOUS; ORAL,NDA,021845;022473;203109,Revatio,SILDENAFIL CITRATE,2023/01/27,Phosphodiesterase 5 Inhibitor,1998,PFIZER LABORATORIES DIV PFIZER INC,2005/06/03-; 2009/11/18-; 2014/06/02-,0069-0336; 0069-0338; 0069-4190,BW9B0ZE037,SILDENAFIL CITRATE,SILDENAFIL,3M7OB98Y7H,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/f158fe10-d5dc-4432-b2c9-fc665401291b/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f158fe10-d5dc-4432-b2c9-fc665401291b,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=f158fe10-d5dc-4432-b2c9-fc665401291b,f158fe10-d5dc-4432-b2c9-fc665401291b,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,020895,Viagra,SILDENAFIL CITRATE,2017/12/15,Phosphodiesterase 5 Inhibitor,1998,PFIZER LABORATORIES DIV PFIZER INC,1998/03/27-,0069-4200; 0069-4210; 0069-4220,BW9B0ZE037,SILDENAFIL CITRATE,SILDENAFIL,3M7OB98Y7H,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/0b0be196-0c62-461c-94f4-9a35339b4501/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0b0be196-0c62-461c-94f4-9a35339b4501,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=0b0be196-0c62-461c-94f4-9a35339b4501,0b0be196-0c62-461c-94f4-9a35339b4501,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,NDA,022206,RAPAFLO,SILODOSIN,2020/12/01,alpha-Adrenergic Blocker,2008,ALLERGAN INC,2009/03/23-,0023-6142; 0023-6147,CUZ39LUY82,SILODOSIN,SILODOSIN,CUZ39LUY82,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/da0314f6-b1d6-44ee-8b1e-f763dbb8613f/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=da0314f6-b1d6-44ee-8b1e-f763dbb8613f,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=da0314f6-b1d6-44ee-8b1e-f763dbb8613f,da0314f6-b1d6-44ee-8b1e-f763dbb8613f,,,
HUMAN PRESCRIPTION DRUG LABEL,CREAM,TOPICAL,NDA,017381,SILVADENE,SILVER SULFADIAZINE,2021/07/16,Sulfonamide Antibacterial,,PFIZER LABORATORIES DIV PFIZER INC,1973/11/26-,61570-131,W46JY43EJR,SILVER SULFADIAZINE,SULFADIAZINE,0N7609K889,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/c437213a-1cd4-445e-a39f-bbcacb9f746f/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c437213a-1cd4-445e-a39f-bbcacb9f746f,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=c437213a-1cd4-445e-a39f-bbcacb9f746f,c437213a-1cd4-445e-a39f-bbcacb9f746f,,,
HUMAN PRESCRIPTION DRUG LABEL,CREAM,TOPICAL,NDA,018578,SSD Cream,SILVER SULFADIAZINE,2019/04/24,Sulfonamide Antibacterial,,DR REDDYS LABORATORIES INC,2011/05/04-,43598-210,W46JY43EJR,Silver Sulfadiazine,Sulfadiazine,0N7609K889,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/30d6dc33-e457-466b-9159-d8e7cd791820/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=30d6dc33-e457-466b-9159-d8e7cd791820,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=30d6dc33-e457-466b-9159-d8e7cd791820,30d6dc33-e457-466b-9159-d8e7cd791820,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,019766,ZOCOR,SIMVASTATIN,2023/08/09,HMG-CoA Reductase Inhibitor,1991,ORGANON LLC,2021/06/01-; completed:2021/06/01-2021/06/02,78206-179; 78206-180; 78206-181; 78206-182,AGG2FN16EV,SIMVASTATIN,SIMVASTATIN,AGG2FN16EV,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/8f55d5de-5a4f-4a39-8c84-c53976dd6af9/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8f55d5de-5a4f-4a39-8c84-c53976dd6af9,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=8f55d5de-5a4f-4a39-8c84-c53976dd6af9,8f55d5de-5a4f-4a39-8c84-c53976dd6af9,,,
HUMAN PRESCRIPTION DRUG LABEL,SUSPENSION,ORAL,NDA,206679,FloLipid,SIMVASTATIN,2023/02/09,HMG-CoA Reductase Inhibitor,1991,SALERNO PHARMACEUTICALS CO,2017/11/01-,29273-401; 29273-402,AGG2FN16EV,SIMVASTATIN,SIMVASTATIN,AGG2FN16EV,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/6ee17d10-6eb1-452a-99e8-02381368b3fe/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6ee17d10-6eb1-452a-99e8-02381368b3fe,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=6ee17d10-6eb1-452a-99e8-02381368b3fe,6ee17d10-6eb1-452a-99e8-02381368b3fe,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAVENOUS,NDA,210850,Sincalide,SINCALIDE,2024/05/14,Cholecystokinin Analog,1976,FOSUN PHARMA USA INC,2023/01/09-,72266-248,M03GIQ7Z6P,SINCALIDE,SINCALIDE,M03GIQ7Z6P,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/efbc189e-f5f8-0ac7-e053-2995a90a68a9/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=efbc189e-f5f8-0ac7-e053-2995a90a68a9,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=efbc189e-f5f8-0ac7-e053-2995a90a68a9,efbc189e-f5f8-0ac7-e053-2995a90a68a9,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAVENOUS,NDA,017697,SINCALIDE,SINCALIDE,2024/01/26,Cholecystokinin Analog,1976,FRESENIUS KABI USA LLC,2023/04/01-,63323-579,M03GIQ7Z6P,Sincalide,Sincalide,M03GIQ7Z6P,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/bb5057da-8568-49b9-947d-fab7d8d8f257/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=bb5057da-8568-49b9-947d-fab7d8d8f257,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=bb5057da-8568-49b9-947d-fab7d8d8f257,bb5057da-8568-49b9-947d-fab7d8d8f257,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAVENOUS,NDA,210850,Sincalide,SINCALIDE,2023/11/01,Cholecystokinin Analog,1976,MAIA PHARMACEUTICALS INC,2022/11/25-,70511-131,M03GIQ7Z6P,SINCALIDE,SINCALIDE,M03GIQ7Z6P,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/4149af34-7b3d-4200-9609-ea856b1d6aab/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4149af34-7b3d-4200-9609-ea856b1d6aab,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=4149af34-7b3d-4200-9609-ea856b1d6aab,4149af34-7b3d-4200-9609-ea856b1d6aab,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAVENOUS,NDA,017697,KINEVAC,SINCALIDE,2023/10/18,Cholecystokinin Analog,1976,BRACCO DIAGNOSTICS INC,1976/07/21-,0270-0556,M03GIQ7Z6P,Sincalide,Sincalide,M03GIQ7Z6P,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/1408aabb-6982-48e5-ae9f-504ec43b0003/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1408aabb-6982-48e5-ae9f-504ec43b0003,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=1408aabb-6982-48e5-ae9f-504ec43b0003,1408aabb-6982-48e5-ae9f-504ec43b0003,,,
HUMAN PRESCRIPTION DRUG LABEL,OINTMENT,TOPICAL,NDA,021902,Veregen,SINECATECHINS,2022/11/10,,2006,ANI PHARMACEUTICALS INC,2022/11/10-,62559-385,T432289GYZ,SINECATECHINS,SINECATECHINS,T432289GYZ,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/f0fc1e21-e3cf-4bce-860c-307f670b192e/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f0fc1e21-e3cf-4bce-860c-307f670b192e,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=f0fc1e21-e3cf-4bce-860c-307f670b192e,f0fc1e21-e3cf-4bce-860c-307f670b192e,,,
HUMAN PRESCRIPTION DRUG LABEL,OINTMENT,TOPICAL,NDA,021902,Veregen,SINECATECHINS,2021/08/12,,2006,PHARMADERM A DIVISION OF FOUGERA PHARMACEUTICALS INC,completed:2007/12/14-2024/11/29,10337-450,T432289GYZ,SINECATECHINS,SINECATECHINS,T432289GYZ,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/2c1cd745-79ab-487d-b759-995794cedb92/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2c1cd745-79ab-487d-b759-995794cedb92,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=2c1cd745-79ab-487d-b759-995794cedb92,2c1cd745-79ab-487d-b759-995794cedb92,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,209884,MAYZENT,SIPONIMOD,2023/08/10,Sphingosine 1-phosphate Receptor Modulator,2019,NOVARTIS PHARMACEUTICALS CORPORATION,2019/03/26-,0078-0979; 0078-0986; 0078-1014,RR6P8L282I,SIPONIMOD,SIPONIMOD,RR6P8L282I,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/44492772-5aed-4627-bd85-e8e89f308bb3/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=44492772-5aed-4627-bd85-e8e89f308bb3,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=44492772-5aed-4627-bd85-e8e89f308bb3,44492772-5aed-4627-bd85-e8e89f308bb3,,,
HUMAN PRESCRIPTION DRUG LABEL,"SOLUTION; TABLET, SUGAR COATED",ORAL,NDA,021083;021110,Rapamune,SIROLIMUS,2024/01/22,Kinase Inhibitor; mTOR Inhibitor Immunosuppressant,1999,WYETH PHARMACEUTICALS LLC A SUBSIDIARY OF PFIZER INC,completed:1999/09/01-2025/01/31; completed:2001/07/01-2025/10/31; completed:2001/07/01-2025/12/31; completed:2010/03/01-2025/02/28,0008-1030; 0008-1040; 0008-1041; 0008-1042,W36ZG6FT64,SIROLIMUS,SIROLIMUS,W36ZG6FT64,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/3275b824-3f82-4151-2ab2-0036a9ba0acc/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3275b824-3f82-4151-2ab2-0036a9ba0acc,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=3275b824-3f82-4151-2ab2-0036a9ba0acc,3275b824-3f82-4151-2ab2-0036a9ba0acc,,,
HUMAN PRESCRIPTION DRUG LABEL,GEL,TOPICAL,NDA,213478,HYFTOR,SIROLIMUS,2024/01/11,Kinase Inhibitor; mTOR Inhibitor Immunosuppressant,1999,NOBELPHARMA AMERICA LLC,2022/03/23-,73683-101,W36ZG6FT64,SIROLIMUS,SIROLIMUS,W36ZG6FT64,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/edb3ea90-5adc-48ec-99f5-ab963e302f18/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=edb3ea90-5adc-48ec-99f5-ab963e302f18,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=edb3ea90-5adc-48ec-99f5-ab963e302f18,edb3ea90-5adc-48ec-99f5-ab963e302f18,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION",INTRAVENOUS,NDA,213312,FYARRO,SIROLIMUS,2021/12/06,Kinase Inhibitor; mTOR Inhibitor Immunosuppressant,2021,AADI BIOSCIENCE,2021/12/06-,80803-153,W36ZG6FT64,SIROLIMUS,SIROLIMUS,W36ZG6FT64,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/0f9bb784-53e2-46f9-a65d-1c6c2a230eaf/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0f9bb784-53e2-46f9-a65d-1c6c2a230eaf,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=0f9bb784-53e2-46f9-a65d-1c6c2a230eaf,0f9bb784-53e2-46f9-a65d-1c6c2a230eaf,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,211566,ZITUVIO,SITAGLIPTIN,2024/03/22,Dipeptidyl Peptidase 4 Inhibitor,2006,ZYDUS PHARMACEUTICALS USA INC,2023/11/30-,70710-1240; 70710-1241; 70710-1242,QFP0P1DV7Z,SITAGLIPTIN,SITAGLIPTIN,QFP0P1DV7Z,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/abfdea45-c0ca-41e3-a510-e89810bc9cfe/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=abfdea45-c0ca-41e3-a510-e89810bc9cfe,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=abfdea45-c0ca-41e3-a510-e89810bc9cfe,abfdea45-c0ca-41e3-a510-e89810bc9cfe,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,211566,ZITUVIO,SITAGLIPTIN,2024/03/22,Dipeptidyl Peptidase 4 Inhibitor,2006,ZYDUS LIFESCIENCES LIMITED,2023/11/30-,70771-1770; 70771-1771; 70771-1772,QFP0P1DV7Z,SITAGLIPTIN,SITAGLIPTIN,QFP0P1DV7Z,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/b2da9d77-154b-48f7-8793-3f4a24dfafc6/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b2da9d77-154b-48f7-8793-3f4a24dfafc6,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=b2da9d77-154b-48f7-8793-3f4a24dfafc6,b2da9d77-154b-48f7-8793-3f4a24dfafc6,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,211566,Sitagliptin,SITAGLIPTIN,2024/03/22,Dipeptidyl Peptidase 4 Inhibitor,2006,ZYDUS LIFESCIENCES LIMITED,2023/11/30-,70771-1790; 70771-1791; 70771-1792,QFP0P1DV7Z,SITAGLIPTIN,SITAGLIPTIN,QFP0P1DV7Z,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/e5ac97e8-3a0b-4750-8e3f-337412570746/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e5ac97e8-3a0b-4750-8e3f-337412570746,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=e5ac97e8-3a0b-4750-8e3f-337412570746,e5ac97e8-3a0b-4750-8e3f-337412570746,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,211566,Sitagliptin,SITAGLIPTIN,2024/03/22,Dipeptidyl Peptidase 4 Inhibitor,2006,ZYDUS PHARMACEUTICALS USA INC,2023/11/30-,70710-1899; 70710-1900; 70710-1901,QFP0P1DV7Z,SITAGLIPTIN,SITAGLIPTIN,QFP0P1DV7Z,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/6a970e80-b753-48fa-9fff-87e7a5044982/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6a970e80-b753-48fa-9fff-87e7a5044982,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=6a970e80-b753-48fa-9fff-87e7a5044982,6a970e80-b753-48fa-9fff-87e7a5044982,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,021995,JANUVIA,SITAGLIPTIN,2023/07/31,Dipeptidyl Peptidase 4 Inhibitor,2006,MERCK SHARP AND DOHME LLC,2006/10/16-,0006-0112; 0006-0221; 0006-0277,TS63EW8X6F,SITAGLIPTIN PHOSPHATE,SITAGLIPTIN,QFP0P1DV7Z,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/f85a48d0-0407-4c50-b0fa-7673a160bf01/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f85a48d0-0407-4c50-b0fa-7673a160bf01,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=f85a48d0-0407-4c50-b0fa-7673a160bf01,f85a48d0-0407-4c50-b0fa-7673a160bf01,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,216743,Sitagliptin and metformin hydrochloride,SITAGLIPTIN AND METFORMIN HYDROCHLORIDE,2024/03/23,Biguanide; Dipeptidyl Peptidase 4 Inhibitor,2007,ZYDUS LIFESCIENCES LIMITED,2024/03/14-,70771-1869; 70771-1870,786Z46389E; QFP0P1DV7Z,METFORMIN HYDROCHLORIDE; SITAGLIPTIN,METFORMIN; SITAGLIPTIN,9100L32L2N; QFP0P1DV7Z,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/e07abcb1-1f0c-4cad-8405-8eedba4b8ff8/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e07abcb1-1f0c-4cad-8405-8eedba4b8ff8,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=e07abcb1-1f0c-4cad-8405-8eedba4b8ff8,e07abcb1-1f0c-4cad-8405-8eedba4b8ff8,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,216743,Sitagliptin and metformin hydrochloride,SITAGLIPTIN AND METFORMIN HYDROCHLORIDE,2024/03/22,Biguanide; Dipeptidyl Peptidase 4 Inhibitor,2007,ZYDUS PHARMACEUTICALS USA INC,2024/03/14-,70710-1986; 70710-1987,786Z46389E; QFP0P1DV7Z,METFORMIN HYDROCHLORIDE; SITAGLIPTIN,METFORMIN; SITAGLIPTIN,9100L32L2N; QFP0P1DV7Z,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/4d812277-21a8-4de3-b728-e3fdd01305b5/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4d812277-21a8-4de3-b728-e3fdd01305b5,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=4d812277-21a8-4de3-b728-e3fdd01305b5,4d812277-21a8-4de3-b728-e3fdd01305b5,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,216743,ZITUVIMET,SITAGLIPTIN AND METFORMIN HYDROCHLORIDE,2024/03/22,Biguanide; Dipeptidyl Peptidase 4 Inhibitor,2007,ZYDUS LIFESCIENCES LIMITED,2024/03/14-,70771-1859; 70771-1860,786Z46389E; QFP0P1DV7Z,METFORMIN HYDROCHLORIDE; SITAGLIPTIN,METFORMIN; SITAGLIPTIN,9100L32L2N; QFP0P1DV7Z,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/0098dec4-f0e5-45d5-8aa4-5d0faf9ab142/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0098dec4-f0e5-45d5-8aa4-5d0faf9ab142,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=0098dec4-f0e5-45d5-8aa4-5d0faf9ab142,0098dec4-f0e5-45d5-8aa4-5d0faf9ab142,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,216743,ZITUVIMET,SITAGLIPTIN AND METFORMIN HYDROCHLORIDE,2024/03/22,Biguanide; Dipeptidyl Peptidase 4 Inhibitor,2007,ZYDUS PHARMACEUTICALS USA INC,2024/03/14-,70710-1786; 70710-1787,786Z46389E; QFP0P1DV7Z,METFORMIN HYDROCHLORIDE; SITAGLIPTIN,METFORMIN; SITAGLIPTIN,9100L32L2N; QFP0P1DV7Z,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/eeda90a0-4941-4716-8684-f9f12cbdf3af/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=eeda90a0-4941-4716-8684-f9f12cbdf3af,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=eeda90a0-4941-4716-8684-f9f12cbdf3af,eeda90a0-4941-4716-8684-f9f12cbdf3af,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,022044,JANUMET,SITAGLIPTIN AND METFORMIN HYDROCHLORIDE,2024/01/09,Biguanide; Dipeptidyl Peptidase 4 Inhibitor,2007,MERCK SHARP AND DOHME LLC,2007/03/30-,0006-0575; 0006-0577,786Z46389E; TS63EW8X6F,METFORMIN HYDROCHLORIDE; SITAGLIPTIN PHOSPHATE,METFORMIN; SITAGLIPTIN,9100L32L2N; QFP0P1DV7Z,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/d19c7ed0-ad5c-426e-b2df-722508f97d67/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d19c7ed0-ad5c-426e-b2df-722508f97d67,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=d19c7ed0-ad5c-426e-b2df-722508f97d67,d19c7ed0-ad5c-426e-b2df-722508f97d67,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,NDA,202270,JANUMET XR,SITAGLIPTIN AND METFORMIN HYDROCHLORIDE,2023/08/07,Biguanide; Dipeptidyl Peptidase 4 Inhibitor,2012,MERCK SHARP AND DOHME LLC,2012/02/02-,0006-0078; 0006-0080; 0006-0081,786Z46389E; TS63EW8X6F,METFORMIN HYDROCHLORIDE; SITAGLIPTIN PHOSPHATE,METFORMIN; SITAGLIPTIN,9100L32L2N; QFP0P1DV7Z,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/64beb3d2-3aeb-4cd5-ba11-dacf6c9a5b50/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=64beb3d2-3aeb-4cd5-ba11-dacf6c9a5b50,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=64beb3d2-3aeb-4cd5-ba11-dacf6c9a5b50,64beb3d2-3aeb-4cd5-ba11-dacf6c9a5b50,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, EMULSION",INTRAVENOUS,NDA,207648,Smoflipid,SMOFLIPID,2023/07/14,Lipid Emulsion,2016,FRESENIUS KABI USA LLC,2016/07/13-,63323-820,241ATL177A; 6UYK2W1W1E; C9H2L21V7U; XGF7L72M0F,FISH OIL; MEDIUM-CHAIN TRIGLYCERIDES; OLIVE OIL; SOYBEAN OIL,FISH OIL; MEDIUM-CHAIN TRIGLYCERIDES; OLIVE OIL; SOYBEAN OIL,241ATL177A; 6UYK2W1W1E; C9H2L21V7U; XGF7L72M0F,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/e0e9d917-ff6f-488e-a6a8-0ad59dd17d80/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e0e9d917-ff6f-488e-a6a8-0ad59dd17d80,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=e0e9d917-ff6f-488e-a6a8-0ad59dd17d80,e0e9d917-ff6f-488e-a6a8-0ad59dd17d80,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION, CONCENTRATE",INTRAVENOUS,NDA,018893,Sodium Acetate,SODIUM ACETATE,2021/05/07,Osmotic Laxative,,HOSPIRA INC,2013/11/19-,0409-3299,NVG71ZZ7P0,SODIUM ACETATE ANHYDROUS,ACETATE ION; SODIUM CATION,569DQM74SC; LYR4M0NH37,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/c3be2468-45e8-4ecc-a30b-e966743a563f/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c3be2468-45e8-4ecc-a30b-e966743a563f,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=c3be2468-45e8-4ecc-a30b-e966743a563f,c3be2468-45e8-4ecc-a30b-e966743a563f,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION, CONCENTRATE",INTRAVENOUS,NDA,018893,Sodium Acetate,SODIUM ACETATE,2021/05/07,,,HOSPIRA INC,2014/03/05-,0409-7299,NVG71ZZ7P0,SODIUM ACETATE ANHYDROUS,ACETATE ION; SODIUM CATION,569DQM74SC; LYR4M0NH37,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/ce9a7469-c4ba-4f60-8f7a-47ef0974316e/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ce9a7469-c4ba-4f60-8f7a-47ef0974316e,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=ce9a7469-c4ba-4f60-8f7a-47ef0974316e,ce9a7469-c4ba-4f60-8f7a-47ef0974316e,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION, CONCENTRATE",INTRAVENOUS,NDA,018893,Sodium Acetate,SODIUM ACETATE,2019/11/27,,,HOSPIRA INC,2005/03/31-,0409-7299,NVG71ZZ7P0,SODIUM ACETATE ANHYDROUS,ACETATE ION; SODIUM CATION,569DQM74SC; LYR4M0NH37,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/c91ede49-c7cc-47b7-0f93-e6841dd5916a/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c91ede49-c7cc-47b7-0f93-e6841dd5916a,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=c91ede49-c7cc-47b7-0f93-e6841dd5916a,c91ede49-c7cc-47b7-0f93-e6841dd5916a,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION, CONCENTRATE",INTRAVENOUS,NDA,018893,Sodium Acetate,SODIUM ACETATE,2018/10/24,Osmotic Laxative,,HOSPIRA INC,2005/04/30-,0409-3299,NVG71ZZ7P0,SODIUM ACETATE ANHYDROUS,ACETATE ION; SODIUM CATION,569DQM74SC; LYR4M0NH37,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/abc41ed1-9512-4bea-9295-1a9ca134b6c2/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=abc41ed1-9512-4bea-9295-1a9ca134b6c2,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=abc41ed1-9512-4bea-9295-1a9ca134b6c2,abc41ed1-9512-4bea-9295-1a9ca134b6c2,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRATHECAL,NDA,020577,Elliotts B,"SODIUM CATION, SODIUM BICARBONATE, ANHYDROUS DEXTROSE, MAGNESIUM SULFATE, POTASSIUM CHLORIDE, CALCIUM CHLORIDE, SODIUM PHOSPHATE",2018/11/16,Blood Coagulation Factor; Calculi Dissolution Agent; Osmotic Laxative; Phosphate Binder; Potassium Salt,,LUKARE MEDICAL LLC,2013/06/04-,55792-007,451W47IQ8X; 5SL0G7R0OK; 660YQ98I10; 8MDF5V39QO; DE08037SAB; M4I0D6VV5M; SE337SVY37,"MAGNESIUM SULFATE, UNSPECIFIED; anhydrous dextrose; calcium chloride; potassium chloride; sodium bicarbonate; sodium chloride; sodium phosphate",MAGNESIUM CATION; anhydrous dextrose; bicarbonate ion; calcium cation; chloride ion; phosphate ion; potassium cation; sodium cation,295O53K152; 2M83C4R6ZB; 5SL0G7R0OK; HN1ZRA3Q20; LYR4M0NH37; NK08V8K8HR; Q32ZN48698; T6V3LHY838,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/08036dbd-55b3-47b9-9890-000f253544f3/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=08036dbd-55b3-47b9-9890-000f253544f3,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=08036dbd-55b3-47b9-9890-000f253544f3,08036dbd-55b3-47b9-9890-000f253544f3,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRATHECAL,NDA,020577,Elliotts B,"SODIUM CATION, SODIUM BICARBONATE, ANHYDROUS DEXTROSE, MAGNESIUM SULFATE, POTASSIUM CHLORIDE, CALCIUM CHLORIDE, SODIUM PHOSPHATE",2012/08/22,Blood Coagulation Factor; Calculi Dissolution Agent; Osmotic Laxative; Phosphate Binder; Potassium Salt,,QOL MEDICAL LLC,2006/09/27-,67871-007,451W47IQ8X; 5SL0G7R0OK; 660YQ98I10; 8MDF5V39QO; DE08037SAB; M4I0D6VV5M; SE337SVY37,anhydrous dextrose; calcium chloride; magnesium sulfate; potassium chloride; sodium bicarbonate; sodium chloride; sodium phosphate,anhydrous dextrose; bicarbonate ion; calcium cation; chloride ion; magnesium cation; phosphate ion; potassium cation; sodium cation,295O53K152; 2M83C4R6ZB; 5SL0G7R0OK; HN1ZRA3Q20; LYR4M0NH37; NK08V8K8HR; Q32ZN48698; T6V3LHY838,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/b1e83fb1-7f51-41b7-a1eb-495414bbf1f2/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b1e83fb1-7f51-41b7-a1eb-495414bbf1f2,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=b1e83fb1-7f51-41b7-a1eb-495414bbf1f2,b1e83fb1-7f51-41b7-a1eb-495414bbf1f2,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,019635,Sodium Chloride,SODIUM CHLORIDE,2024/05/07,,,B BRAUN MEDICAL INC,1988/03/09-,0264-7800; 0264-7802,451W47IQ8X,SODIUM CHLORIDE,CHLORIDE ION; SODIUM CATION,LYR4M0NH37; Q32ZN48698,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/7f22c06b-6b4d-4b49-a4b2-d2169f2bd653/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7f22c06b-6b4d-4b49-a4b2-d2169f2bd653,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=7f22c06b-6b4d-4b49-a4b2-d2169f2bd653,7f22c06b-6b4d-4b49-a4b2-d2169f2bd653,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,019635,Sodium Chloride,SODIUM CHLORIDE,2024/05/06,,,B BRAUN MEDICAL INC,1988/03/09-; 1988/03/19-,0264-7805; 0264-7806,451W47IQ8X,SODIUM CHLORIDE,CHLORIDE ION; SODIUM CATION,LYR4M0NH37; Q32ZN48698,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/f2475fa3-ab1d-4b81-8127-b58cd0790a54/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f2475fa3-ab1d-4b81-8127-b58cd0790a54,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=f2475fa3-ab1d-4b81-8127-b58cd0790a54,f2475fa3-ab1d-4b81-8127-b58cd0790a54,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS,NDA,202832,sodium chloride,SODIUM CHLORIDE,2024/03/04,Osmotic Laxative,2012,MEDEFIL INC,2012/01/13-,64253-202,451W47IQ8X,SODIUM CHLORIDE,SODIUM CATION,LYR4M0NH37,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/d1468c0f-dd4f-4d38-a84c-c1d110303965/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d1468c0f-dd4f-4d38-a84c-c1d110303965,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=d1468c0f-dd4f-4d38-a84c-c1d110303965,d1468c0f-dd4f-4d38-a84c-c1d110303965,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,019465;019759,Sodium Chloride,SODIUM CHLORIDE,2024/01/11,,,HOSPIRA INC,2005/06/30-; completed:2005/09/13-2020/03/01,0409-7101; 0409-7132,451W47IQ8X,SODIUM CHLORIDE,CHLORIDE ION; SODIUM CATION,LYR4M0NH37; Q32ZN48698,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/a2a964f7-c3ec-4dfb-e3a0-6d8136a80397/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a2a964f7-c3ec-4dfb-e3a0-6d8136a80397,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=a2a964f7-c3ec-4dfb-e3a0-6d8136a80397,a2a964f7-c3ec-4dfb-e3a0-6d8136a80397,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION, CONCENTRATE",INTRAVENOUS,NDA,018897,Sodium Chloride,SODIUM CHLORIDE,2024/01/11,,,HOSPIRA INC,2005/07/29-; completed:2005/10/18-2018/05/01,0409-6657; 0409-6660,451W47IQ8X,SODIUM CHLORIDE,CHLORIDE ION; SODIUM CATION,LYR4M0NH37; Q32ZN48698,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/018a8807-1331-41c3-4889-c7ec502a9043/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=018a8807-1331-41c3-4889-c7ec502a9043,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=018a8807-1331-41c3-4889-c7ec502a9043,018a8807-1331-41c3-4889-c7ec502a9043,,,
HUMAN PRESCRIPTION DRUG LABEL,IRRIGANT,IRRIGATION,NDA,016733,Sodium Chloride,SODIUM CHLORIDE,2023/09/07,,,B BRAUN MEDICAL INC,2009/09/14-,0264-2201,451W47IQ8X,SODIUM CHLORIDE,CHLORIDE ION; SODIUM CATION,LYR4M0NH37; Q32ZN48698,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/0d59a04a-32e6-485b-b638-a1e6c09e9642/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0d59a04a-32e6-485b-b638-a1e6c09e9642,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=0d59a04a-32e6-485b-b638-a1e6c09e9642,0d59a04a-32e6-485b-b638-a1e6c09e9642,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRAVASCULAR,NDA,021569,SODIUM CHLORIDE,SODIUM CHLORIDE,2022/12/20,Osmotic Laxative,2006,LIEBEL FLARSHEIM COMPANY LLC,2012/09/01-,0019-1188,451W47IQ8X,SODIUM CHLORIDE,SODIUM CATION,LYR4M0NH37,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/e4540d03-06b4-4b4d-b859-75c13e5c20dd/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e4540d03-06b4-4b4d-b859-75c13e5c20dd,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=e4540d03-06b4-4b4d-b859-75c13e5c20dd,e4540d03-06b4-4b4d-b859-75c13e5c20dd,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRAVENOUS,NDA,020178,Sodium Chloride,SODIUM CHLORIDE,2022/12/07,,,BAXTER HEALTHCARE CORPORATION,1992/12/07-,0338-0182; 0338-0186; 0338-0192; 0338-0196,451W47IQ8X,SODIUM CHLORIDE,CHLORIDE ION; SODIUM CATION,LYR4M0NH37; Q32ZN48698,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/2fae04e3-20b1-4b8c-b1fb-646b384836f1/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2fae04e3-20b1-4b8c-b1fb-646b384836f1,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=2fae04e3-20b1-4b8c-b1fb-646b384836f1,2fae04e3-20b1-4b8c-b1fb-646b384836f1,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS,NDA,018803,Sodium Chloride,SODIUM CHLORIDE,2022/11/21,Osmotic Laxative,,HOSPIRA INC,2005/02/28-; completed:2005/02/28-2018/05/01,0409-1918; 0409-4888,451W47IQ8X,SODIUM CHLORIDE,CHLORIDE ION; SODIUM CATION,LYR4M0NH37; Q32ZN48698,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/8eb172da-dcd4-4660-4a8f-ad44a14b4af7/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8eb172da-dcd4-4660-4a8f-ad44a14b4af7,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=8eb172da-dcd4-4660-4a8f-ad44a14b4af7,8eb172da-dcd4-4660-4a8f-ad44a14b4af7,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRAVENOUS,NDA,020178,SODIUM CHLORIDE,SODIUM CHLORIDE,2022/07/29,,,BAXTER HEALTHCARE CORPORATION,1992/12/07-,0338-0160; 0338-0162; 0338-0164; 0338-0166,451W47IQ8X,SODIUM CHLORIDE,CHLORIDE ION; SODIUM CATION,LYR4M0NH37; Q32ZN48698,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/123bd10a-90c7-499e-97f6-acf7e0f0fb4e/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=123bd10a-90c7-499e-97f6-acf7e0f0fb4e,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=123bd10a-90c7-499e-97f6-acf7e0f0fb4e,123bd10a-90c7-499e-97f6-acf7e0f0fb4e,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRAVENOUS,NDA,019635,Sodium Chloride,SODIUM CHLORIDE,2022/03/14,,,B BRAUN MEDICAL INC,2016/08/09-,0264-9375,451W47IQ8X,SODIUM CHLORIDE,CHLORIDE ION; SODIUM CATION,LYR4M0NH37; Q32ZN48698,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/24a08a93-df23-474b-873e-c59ec8855f9f/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=24a08a93-df23-474b-873e-c59ec8855f9f,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=24a08a93-df23-474b-873e-c59ec8855f9f,24a08a93-df23-474b-873e-c59ec8855f9f,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,019635,Sodium Chloride,SODIUM CHLORIDE,2022/02/28,,,B BRAUN MEDICAL INC,2013/12/31-,0264-7800,451W47IQ8X,SODIUM CHLORIDE,CHLORIDE ION; SODIUM CATION,LYR4M0NH37; Q32ZN48698,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/47a0313f-36df-4fa6-a828-c9e1946ba9b0/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=47a0313f-36df-4fa6-a828-c9e1946ba9b0,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=47a0313f-36df-4fa6-a828-c9e1946ba9b0,47a0313f-36df-4fa6-a828-c9e1946ba9b0,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,017464,Sodium Chloride,SODIUM CHLORIDE,2022/02/23,,,B BRAUN MEDICAL INC,1978/02/08-,0264-1800,451W47IQ8X,SODIUM CHLORIDE,CHLORIDE ION; SODIUM CATION,LYR4M0NH37; Q32ZN48698,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/cc14fafd-3dcd-4fc8-bdbd-6f355c375768/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=cc14fafd-3dcd-4fc8-bdbd-6f355c375768,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=cc14fafd-3dcd-4fc8-bdbd-6f355c375768,cc14fafd-3dcd-4fc8-bdbd-6f355c375768,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,016677,Nacellate Solution 0.9% - 250mL,SODIUM CHLORIDE,2022/02/23,,,IT MEDICAL LLC,2017/03/01-,70529-022,451W47IQ8X,SODIUM CHLORIDE,CHLORIDE ION,Q32ZN48698,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/17413769-c552-4efa-97dd-ce0bf68be5a7/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=17413769-c552-4efa-97dd-ce0bf68be5a7,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=17413769-c552-4efa-97dd-ce0bf68be5a7,17413769-c552-4efa-97dd-ce0bf68be5a7,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,016677,Nacellate Solution 0.9% - 1000mL,SODIUM CHLORIDE,2022/02/23,,,IT MEDICAL LLC,2017/03/01-,70529-024,451W47IQ8X,SODIUM CHLORIDE,CHLORIDE ION,Q32ZN48698,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/14d1173d-d43c-4e7e-a945-35a5d612da19/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=14d1173d-d43c-4e7e-a945-35a5d612da19,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=14d1173d-d43c-4e7e-a945-35a5d612da19,14d1173d-d43c-4e7e-a945-35a5d612da19,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,017464,Nacellate Solution 0.9% - 100mL,SODIUM CHLORIDE,2022/02/23,,,IT MEDICAL LLC,2017/03/01-,70529-021,451W47IQ8X,SODIUM CHLORIDE,CHLORIDE ION,Q32ZN48698,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/5664d350-2ab2-4e50-9c57-fd42f987c5dd/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5664d350-2ab2-4e50-9c57-fd42f987c5dd,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=5664d350-2ab2-4e50-9c57-fd42f987c5dd,5664d350-2ab2-4e50-9c57-fd42f987c5dd,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,016677,Nacellate Solution 0.9% - 500mL,SODIUM CHLORIDE,2022/02/23,,,IT MEDICAL LLC,2017/03/01-,70529-023,451W47IQ8X,SODIUM CHLORIDE,CHLORIDE ION,Q32ZN48698,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/f648434a-c642-4677-9a54-eb49058f8362/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f648434a-c642-4677-9a54-eb49058f8362,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=f648434a-c642-4677-9a54-eb49058f8362,f648434a-c642-4677-9a54-eb49058f8362,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,019635,Sodium Chloride,SODIUM CHLORIDE,2022/01/31,,,B BRAUN MEDICAL INC,1988/03/09-; 1998/03/09-,0264-5802; 0264-5804,451W47IQ8X,SODIUM CHLORIDE,CHLORIDE ION; SODIUM CATION,LYR4M0NH37; Q32ZN48698,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/e44c41ae-c9c8-4dd8-ba6c-cebb585378aa/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e44c41ae-c9c8-4dd8-ba6c-cebb585378aa,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=e44c41ae-c9c8-4dd8-ba6c-cebb585378aa,e44c41ae-c9c8-4dd8-ba6c-cebb585378aa,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION, CONCENTRATE",INTRAVENOUS,NDA,018897,SODIUM CHLORIDE,SODIUM CHLORIDE,2021/07/21,,,HOSPIRA INC,2005/04/30-,0409-1141,451W47IQ8X,SODIUM CHLORIDE,CHLORIDE ION; SODIUM CATION,LYR4M0NH37; Q32ZN48698,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/af6aebad-ef03-4d19-9a40-18e5a278b812/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=af6aebad-ef03-4d19-9a40-18e5a278b812,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=af6aebad-ef03-4d19-9a40-18e5a278b812,af6aebad-ef03-4d19-9a40-18e5a278b812,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,016366;018090,Sodium Chloride,SODIUM CHLORIDE,2021/03/08,,,ICU MEDICAL INC,2019/04/01-,0990-7730; 0990-7983; 0990-7984; 0990-7985,451W47IQ8X,SODIUM CHLORIDE,CHLORIDE ION; SODIUM CATION,LYR4M0NH37; Q32ZN48698,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/5f372b75-d7a4-471e-8ac6-290040fc84b0/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5f372b75-d7a4-471e-8ac6-290040fc84b0,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=5f372b75-d7a4-471e-8ac6-290040fc84b0,5f372b75-d7a4-471e-8ac6-290040fc84b0,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRAVENOUS,NDA,020178,SODIUM CHLORIDE,SODIUM CHLORIDE,2021/02/19,,,BAXTER HEALTHCARE CORPORATION,1992/12/07-,0338-9151; 0338-9159,451W47IQ8X,SODIUM CHLORIDE,CHLORIDE ION; SODIUM CATION,LYR4M0NH37; Q32ZN48698,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/aeaed9cb-b629-4019-88d2-a916179427de/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=aeaed9cb-b629-4019-88d2-a916179427de,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=aeaed9cb-b629-4019-88d2-a916179427de,aeaed9cb-b629-4019-88d2-a916179427de,,,
HUMAN PRESCRIPTION DRUG LABEL,IRRIGANT,IRRIGATION,NDA,017514;018314,Sodium Chloride,SODIUM CHLORIDE,2020/10/29,,,ICU MEDICAL INC,2019/08/01-,0990-6138; 0990-7138; 0990-7972,451W47IQ8X,SODIUM CHLORIDE,CHLORIDE ION; SODIUM CATION,LYR4M0NH37; Q32ZN48698,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/3cfdeee0-ff14-4341-8396-b11c2a037c60/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3cfdeee0-ff14-4341-8396-b11c2a037c60,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=3cfdeee0-ff14-4341-8396-b11c2a037c60,3cfdeee0-ff14-4341-8396-b11c2a037c60,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS,NDA,018800,BACTERIOSTATIC SODIUM CHLORIDE,SODIUM CHLORIDE,2020/10/29,Osmotic Laxative,,HOSPIRA INC,2005/04/30-,0409-1966,451W47IQ8X,SODIUM CHLORIDE,CHLORIDE ION; SODIUM CATION,LYR4M0NH37; Q32ZN48698,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/376093e7-e09e-4a57-3199-195e45251866/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=376093e7-e09e-4a57-3199-195e45251866,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=376093e7-e09e-4a57-3199-195e45251866,376093e7-e09e-4a57-3199-195e45251866,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRAVENOUS,NDA,020178,Sodium Chloride,SODIUM CHLORIDE,2020/01/27,,,BAXTER HEALTHCARE CORPORATION,1992/12/07-,0338-0553,451W47IQ8X,SODIUM CHLORIDE,CHLORIDE ION; SODIUM CATION,LYR4M0NH37; Q32ZN48698,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/fbc01464-8885-4075-af41-911ffec5ae92/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=fbc01464-8885-4075-af41-911ffec5ae92,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=fbc01464-8885-4075-af41-911ffec5ae92,fbc01464-8885-4075-af41-911ffec5ae92,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,016677,SODIUM CHLORIDE,SODIUM CHLORIDE,2019/05/29,,,BAXTER HEALTHCARE CORPORATION,1970/12/09-,0338-9543,451W47IQ8X,SODIUM CHLORIDE,CHLORIDE ION; SODIUM CATION,LYR4M0NH37; Q32ZN48698,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/958d35f0-6834-43be-a700-fa58f38b4c19/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=958d35f0-6834-43be-a700-fa58f38b4c19,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=958d35f0-6834-43be-a700-fa58f38b4c19,958d35f0-6834-43be-a700-fa58f38b4c19,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,016677;018016,Sodium Chloride,SODIUM CHLORIDE,2019/05/29,,,BAXTER HEALTHCARE CORPORATION,1970/12/09-; 1979/02/02-,0338-0043; 0338-0049,451W47IQ8X,SODIUM CHLORIDE,CHLORIDE ION; SODIUM CATION,LYR4M0NH37; Q32ZN48698,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/f55bd888-5e01-474d-871b-24654c070178/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f55bd888-5e01-474d-871b-24654c070178,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=f55bd888-5e01-474d-871b-24654c070178,f55bd888-5e01-474d-871b-24654c070178,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,019022,Sodium Chloride,SODIUM CHLORIDE,2018/05/23,,,BAXTER HEALTHCARE CORPORATION,1983/11/01-,0338-0054; 0338-0056,451W47IQ8X,SODIUM CHLORIDE,CHLORIDE ION; SODIUM CATION,LYR4M0NH37; Q32ZN48698,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/181705c7-40e4-4d7d-b9ea-ada99380e7a9/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=181705c7-40e4-4d7d-b9ea-ada99380e7a9,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=181705c7-40e4-4d7d-b9ea-ada99380e7a9,181705c7-40e4-4d7d-b9ea-ada99380e7a9,,,
HUMAN PRESCRIPTION DRUG LABEL,IRRIGANT,IRRIGATION,NDA,019319,Sodium Chloride,SODIUM CHLORIDE,2018/04/02,,,BAXTER HEALTHCARE CORPORATION,1985/05/17-,0338-0051,451W47IQ8X,SODIUM CHLORIDE,CHLORIDE ION; SODIUM CATION,LYR4M0NH37; Q32ZN48698,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/7c72520e-de3c-493d-8aea-11933376d968/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7c72520e-de3c-493d-8aea-11933376d968,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=7c72520e-de3c-493d-8aea-11933376d968,7c72520e-de3c-493d-8aea-11933376d968,,,
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION,IRRIGATION,NDA,016733,Sodium Chloride for Irrigation,SODIUM CHLORIDE FOR IRRIGATION,2021/08/06,,,B BRAUN MEDICAL INC,2013/04/19-,0264-7388,451W47IQ8X,SODIUM CHLORIDE,CHLORIDE ION; SODIUM CATION,LYR4M0NH37; Q32ZN48698,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/5bd9b176-0402-4a3f-a6b4-c3f393fc092a/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5bd9b176-0402-4a3f-a6b4-c3f393fc092a,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=5bd9b176-0402-4a3f-a6b4-c3f393fc092a,5bd9b176-0402-4a3f-a6b4-c3f393fc092a,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION, CONCENTRATE",INTRAVENOUS,NDA,018895,TPN Electrolytes,"SODIUM CHLORIDE, CALCIUM CHLORIDE, POTASSIUM CHLORIDE, MAGNESIUM CHLORIDE, AND SODIUM ACETATE ANHYDROUS",2024/01/16,,,HOSPIRA INC,2005/02/28-,0409-5779,02F3473H9O; 451W47IQ8X; 660YQ98I10; M4I0D6VV5M; NVG71ZZ7P0,CALCIUM CHLORIDE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE ANHYDROUS; SODIUM CHLORIDE,ACETATE ION; CALCIUM CATION; CHLORIDE ION; MAGNESIUM CATION; POTASSIUM CATION; SODIUM CATION,295O53K152; 2M83C4R6ZB; 569DQM74SC; LYR4M0NH37; Q32ZN48698; T6V3LHY838,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/c00817bc-7b62-4abe-0280-e7930eda3f94/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c00817bc-7b62-4abe-0280-e7930eda3f94,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=c00817bc-7b62-4abe-0280-e7930eda3f94,c00817bc-7b62-4abe-0280-e7930eda3f94,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,016682,Lacellate Solution - 250,"SODIUM CHLORIDE, POTASSIUM CHLORIDE, SODIUM LACTATE AND CALCIUM CHLORIDE",2022/02/23,Blood Coagulation Factor; Osmotic Laxative; Phosphate Binder; Potassium Salt,,IT MEDICAL LLC,2017/03/01-,70529-025,451W47IQ8X; 660YQ98I10; M4I0D6VV5M; TU7HW0W0QT,CALCIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE,CALCIUM CATION; CHLORIDE ION; LACTIC ACID; POTASSIUM CATION,295O53K152; 2M83C4R6ZB; 33X04XA5AT; Q32ZN48698,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/6fbfe1f7-3db1-4c9f-aafb-d336a563c9c2/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6fbfe1f7-3db1-4c9f-aafb-d336a563c9c2,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=6fbfe1f7-3db1-4c9f-aafb-d336a563c9c2,6fbfe1f7-3db1-4c9f-aafb-d336a563c9c2,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,016682,Lacellate Solution - 500,"SODIUM CHLORIDE, POTASSIUM CHLORIDE, SODIUM LACTATE AND CALCIUM CHLORIDE",2022/02/23,Blood Coagulation Factor; Osmotic Laxative; Phosphate Binder; Potassium Salt,,IT MEDICAL LLC,2017/03/01-,70529-026,451W47IQ8X; 660YQ98I10; M4I0D6VV5M; TU7HW0W0QT,CALCIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE,CALCIUM CATION; CHLORIDE ION; LACTIC ACID; POTASSIUM CATION,295O53K152; 2M83C4R6ZB; 33X04XA5AT; Q32ZN48698,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/cd731bff-1a61-462e-8366-c7131174ee31/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=cd731bff-1a61-462e-8366-c7131174ee31,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=cd731bff-1a61-462e-8366-c7131174ee31,cd731bff-1a61-462e-8366-c7131174ee31,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,016682,Lacellate Solution - 1000,"SODIUM CHLORIDE, POTASSIUM CHLORIDE, SODIUM LACTATE AND CALCIUM CHLORIDE",2022/02/23,Blood Coagulation Factor; Osmotic Laxative; Phosphate Binder; Potassium Salt,,IT MEDICAL LLC,2017/03/01-,70529-027,451W47IQ8X; 660YQ98I10; M4I0D6VV5M; TU7HW0W0QT,CALCIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE,CALCIUM CATION; CHLORIDE ION; LACTIC ACID; POTASSIUM CATION,295O53K152; 2M83C4R6ZB; 33X04XA5AT; Q32ZN48698,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/91ae5b40-9b59-4231-8ab3-69502245d918/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=91ae5b40-9b59-4231-8ab3-69502245d918,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=91ae5b40-9b59-4231-8ab3-69502245d918,91ae5b40-9b59-4231-8ab3-69502245d918,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,016682,Lactated Ringers,"SODIUM CHLORIDE, POTASSIUM CHLORIDE, SODIUM LACTATE AND CALCIUM CHLORIDE",2019/10/09,,,BAXTER HEALTHCARE CORPORATION,1971/03/22-,0338-0117,451W47IQ8X; 660YQ98I10; M4I0D6VV5M; TU7HW0W0QT,CALCIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE,CALCIUM CATION; CHLORIDE ION; LACTIC ACID; POTASSIUM CATION; SODIUM CATION,295O53K152; 2M83C4R6ZB; 33X04XA5AT; LYR4M0NH37; Q32ZN48698,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/dad7735c-709b-40ea-ab7a-15577e24a966/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=dad7735c-709b-40ea-ab7a-15577e24a966,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=dad7735c-709b-40ea-ab7a-15577e24a966,dad7735c-709b-40ea-ab7a-15577e24a966,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,017378,Plasma-Lyte A,"SODIUM CHLORIDE, SODIUM GLUCONATE, SODIUM ACETATE, POTASSIUM CHLORIDE AND MAGNESIUM CHLORIDE",2019/08/05,Osmotic Laxative,,BAXTER HEALTHCARE CORPORATION,1979/02/02-,0338-0221,02F3473H9O; 451W47IQ8X; 4550K0SC9B; 660YQ98I10; R6Q3791S76,MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE; SODIUM GLUCONATE,ACETATE ION; CHLORIDE ION; GLUCONIC ACID; MAGNESIUM CATION; POTASSIUM CATION; SODIUM CATION,295O53K152; 569DQM74SC; LYR4M0NH37; Q32ZN48698; R4R8J0Q44B; T6V3LHY838,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/6ec9e61c-2c26-402f-8604-f446b2e34058/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6ec9e61c-2c26-402f-8604-f446b2e34058,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=6ec9e61c-2c26-402f-8604-f446b2e34058,6ec9e61c-2c26-402f-8604-f446b2e34058,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,017378,Plasma-Lyte 148,"SODIUM CHLORIDE, SODIUM GLUCONATE, SODIUM ACETATE, POTASSIUM CHLORIDE, AND MAGNESIUM CHLORIDE",2019/08/05,Osmotic Laxative,,BAXTER HEALTHCARE CORPORATION,1979/02/02-,0338-0179,02F3473H9O; 451W47IQ8X; 4550K0SC9B; 660YQ98I10; R6Q3791S76,MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE; SODIUM GLUCONATE,ACETATE ION; CHLORIDE ION; GLUCONIC ACID; MAGNESIUM CATION; POTASSIUM CATION; SODIUM CATION,295O53K152; 569DQM74SC; LYR4M0NH37; Q32ZN48698; R4R8J0Q44B; T6V3LHY838,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/7eee0bda-06d8-4cc4-85e9-7c6e4801f09c/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7eee0bda-06d8-4cc4-85e9-7c6e4801f09c,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=7eee0bda-06d8-4cc4-85e9-7c6e4801f09c,7eee0bda-06d8-4cc4-85e9-7c6e4801f09c,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,019696,Isolyte S pH 7.4,"SODIUM CHLORIDE, SODIUM GLUCONATE, SODIUM ACETATE, POTASSIUM CHLORIDE, MAGNESIUM CHLORIDE, SODIUM PHOSPHATE, DIBASIC, AND POTASSIUM PHOSPHATE",2023/10/06,Osmotic Laxative; Potassium Salt,,B BRAUN MEDICAL INC,1989/09/29-,0264-7707,02F3473H9O; 451W47IQ8X; 4550K0SC9B; 4J9FJ0HL51; 660YQ98I10; GR686LBA74; R6Q3791S76,"MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; POTASSIUM PHOSPHATE, MONOBASIC; SODIUM ACETATE; SODIUM CHLORIDE; SODIUM GLUCONATE; SODIUM PHOSPHATE, DIBASIC",ACETATE ION; CHLORIDE ION; GLUCONIC ACID; MAGNESIUM CATION; PHOSPHATE ION; POTASSIUM CATION; SODIUM CATION,295O53K152; 569DQM74SC; LYR4M0NH37; NK08V8K8HR; Q32ZN48698; R4R8J0Q44B; T6V3LHY838,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/150437b6-320e-4c69-a434-2a26a1f0b2e4/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=150437b6-320e-4c69-a434-2a26a1f0b2e4,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=150437b6-320e-4c69-a434-2a26a1f0b2e4,150437b6-320e-4c69-a434-2a26a1f0b2e4,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAPERITONEAL,NDA,017512;020163;020183,DIANEAL Low Calcium with Dextrose; DIANEAL PD-2 with Dextrose,"SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE AND DEXTROSE",2019/11/21,Blood Coagulation Factor; Osmotic Laxative; Phosphate Binder,1981,BAXTER HEALTHCARE CORPORATION,1978/09/27-; 1992/12/04-,0941-0409; 0941-0411; 0941-0413; 0941-0415; 0941-0424; 0941-0426; 0941-0427; 0941-0429; 0941-0430; 0941-0433; 0941-0457; 0941-0459; 0941-0484; 0941-0487; 0941-0490,02F3473H9O; 451W47IQ8X; LX22YL083G; M4I0D6VV5M; TU7HW0W0QT,CALCIUM CHLORIDE; DEXTROSE MONOHYDRATE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE,ANHYDROUS DEXTROSE; CALCIUM CATION; CHLORIDE ION; LACTIC ACID; MAGNESIUM CATION; SODIUM CATION,2M83C4R6ZB; 33X04XA5AT; 5SL0G7R0OK; LYR4M0NH37; Q32ZN48698; T6V3LHY838,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/aa268d3f-7389-4f25-801f-5d4825495f08/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=aa268d3f-7389-4f25-801f-5d4825495f08,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=aa268d3f-7389-4f25-801f-5d4825495f08,aa268d3f-7389-4f25-801f-5d4825495f08,,,
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION,IRRIGATION,NDA,018681,Lactated Ringers Irrigation,"SODIUM CHLORIDE, SODIUM LACTATE, POTASSIUM CHLORIDE AND CALCIUM CHLORIDE",2021/08/06,Osmotic Laxative,,B BRAUN MEDICAL INC,2014/09/02-,0264-7389,451W47IQ8X; 660YQ98I10; M4I0D6VV5M; TU7HW0W0QT,CALCIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE,CALCIUM CATION; CHLORIDE ION; LACTIC ACID; POTASSIUM CATION; SODIUM CATION,295O53K152; 2M83C4R6ZB; 33X04XA5AT; LYR4M0NH37; Q32ZN48698,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/0db56c7a-2b8f-4593-8591-2c481c92b2cf/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0db56c7a-2b8f-4593-8591-2c481c92b2cf,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=0db56c7a-2b8f-4593-8591-2c481c92b2cf,0db56c7a-2b8f-4593-8591-2c481c92b2cf,,,
HUMAN PRESCRIPTION DRUG LABEL,IRRIGANT,IRRIGATION,NDA,018681,Lactated Ringers,"SODIUM CHLORIDE, SODIUM LACTATE, POTASSIUM CHLORIDE, AND CALCIUM CHLORIDE",2023/09/07,,,B BRAUN MEDICAL INC,1982/12/27-,0264-2203,451W47IQ8X; 660YQ98I10; M4I0D6VV5M; TU7HW0W0QT,CALCIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE,CALCIUM CATION; CHLORIDE ION; LACTIC ACID; POTASSIUM CATION; SODIUM CATION,295O53K152; 2M83C4R6ZB; 33X04XA5AT; LYR4M0NH37; Q32ZN48698,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/a9910e09-5aea-4ee1-a35e-ae4abf8b80b4/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a9910e09-5aea-4ee1-a35e-ae4abf8b80b4,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=a9910e09-5aea-4ee1-a35e-ae4abf8b80b4,a9910e09-5aea-4ee1-a35e-ae4abf8b80b4,,,
HUMAN PRESCRIPTION DRUG LABEL,IRRIGANT,IRRIGATION,NDA,019416,Lactated Ringers,"SODIUM CHLORIDE, SODIUM LACTATE, POTASSIUM CHLORIDE, AND CALCIUM CHLORIDE",2020/10/29,,,ICU MEDICAL INC,2019/07/01-,0990-7828,451W47IQ8X; 660YQ98I10; M4I0D6VV5M; TU7HW0W0QT,CALCIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE,"CALCIUM CATION; CHLORIDE ION; LACTIC ACID, UNSPECIFIED FORM; POTASSIUM CATION; SODIUM CATION",295O53K152; 2M83C4R6ZB; 33X04XA5AT; LYR4M0NH37; Q32ZN48698,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/b96eb740-749a-4d3a-ae63-b8e3947cad30/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b96eb740-749a-4d3a-ae63-b8e3947cad30,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=b96eb740-749a-4d3a-ae63-b8e3947cad30,b96eb740-749a-4d3a-ae63-b8e3947cad30,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,017608;017641,Lactated Ringers; Lactated Ringers and Dextrose,"SODIUM CHLORIDE, SODIUM LACTATE, POTASSIUM CHLORIDE, AND CALCIUM CHLORIDE; SODIUM CHLORIDE, SODIUM LACTATE, POTASSIUM CHLORIDE, CALCIUM CHLORIDE, AND DEXTROSE MONOHYDRATE",2021/09/16,,,ICU MEDICAL INC,2019/06/24-,0990-7929; 0990-7953,451W47IQ8X; 660YQ98I10; LX22YL083G; M4I0D6VV5M; TU7HW0W0QT,CALCIUM CHLORIDE; DEXTROSE MONOHYDRATE; POTASSIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE,"ANHYDROUS DEXTROSE; CALCIUM CATION; CHLORIDE ION; LACTIC ACID, UNSPECIFIED FORM; POTASSIUM CATION; SODIUM CATION",295O53K152; 2M83C4R6ZB; 33X04XA5AT; 5SL0G7R0OK; LYR4M0NH37; Q32ZN48698,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/d310d170-5eeb-471b-af1a-0e845001d21d/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d310d170-5eeb-471b-af1a-0e845001d21d,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=d310d170-5eeb-471b-af1a-0e845001d21d,d310d170-5eeb-471b-af1a-0e845001d21d,,,
HUMAN PRESCRIPTION DRUG LABEL,IRRIGANT,IRRIGATION,NDA,018921,Lactated Ringers,"SODIUM CHLORIDE, SOLDIUM LACTATE, POTASSIUM CHLORIDE AND CALCIUM CHLORIDE",2018/01/02,,,BAXTER HEALTHCARE CORPORATION,1984/04/03-,0338-0137,451W47IQ8X; 660YQ98I10; M4I0D6VV5M; TU7HW0W0QT,CALCIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE,CALCIUM CATION; CHLORIDE ION; LACTIC ACID; POTASSIUM CATION; SODIUM CATION,295O53K152; 2M83C4R6ZB; 33X04XA5AT; LYR4M0NH37; Q32ZN48698,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/5215ec33-8cfe-4885-ae92-e6a12100bd27/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5215ec33-8cfe-4885-ae92-e6a12100bd27,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=5215ec33-8cfe-4885-ae92-e6a12100bd27,5215ec33-8cfe-4885-ae92-e6a12100bd27,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRAVENOUS,NDA,020955,Ferrlecit,SODIUM FERRIC GLUCONATE COMPLEX,2022/03/29,Parenteral Iron Replacement; Phosphate Binder,1999,SANOFI AVENTIS U S LLC,2011/03/01-,0024-2792,CC9149U2QX,SODIUM FERRIC GLUCONATE COMPLEX,FERRIC CATION,91O4LML611,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/1fe028ff-42ac-4329-b1a5-a9dadfcb79f6/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1fe028ff-42ac-4329-b1a5-a9dadfcb79f6,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=1fe028ff-42ac-4329-b1a5-a9dadfcb79f6,1fe028ff-42ac-4329-b1a5-a9dadfcb79f6,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRAVENOUS,NDA,020955,Ferrlecit,SODIUM FERRIC GLUCONATE COMPLEX,2022/03/28,Parenteral Iron Replacement; Phosphate Binder,1999,SANOFI AVENTIS U S LLC,2014/07/07-,0024-2794,CC9149U2QX,SODIUM FERRIC GLUCONATE COMPLEX,FERRIC CATION,91O4LML611,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/b25b34ab-9cf1-4a2b-bdf2-5eaf66625999/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b25b34ab-9cf1-4a2b-bdf2-5eaf66625999,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=b25b34ab-9cf1-4a2b-bdf2-5eaf66625999,b25b34ab-9cf1-4a2b-bdf2-5eaf66625999,,,
HUMAN PRESCRIPTION DRUG LABEL,"CAPSULE, GELATIN COATED",ORAL,NDA,018671,Sodium Iodide I 123,SODIUM IODIDE I 123,2018/04/17,,,CARDINAL HEALTH INC,2003/01/02-,48815-1001; 48815-1002,29UKX3A616,SODIUM IODIDE I-123,IODIDE ION I-123,98QPV8670C,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/50415c27-1928-4307-b1dc-648f47edf65d/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=50415c27-1928-4307-b1dc-648f47edf65d,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=50415c27-1928-4307-b1dc-648f47edf65d,50415c27-1928-4307-b1dc-648f47edf65d,,,
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION,ORAL,NDA,021305,HICON,SODIUM IODIDE I 131,2022/05/17,Radioactive Therapeutic Agent,1971,JUBILANT DRAXIMAGE INC DBA JUBILANT RADIOPHARMA,2003/04/07-,65174-880,29VCO8ACHH,SODIUM IODIDE I-131,IODIDE ION I-131,4GC1FOQ22U,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/524a0dac-6e2b-2c0c-04b4-76d85dba63c5/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=524a0dac-6e2b-2c0c-04b4-76d85dba63c5,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=524a0dac-6e2b-2c0c-04b4-76d85dba63c5,524a0dac-6e2b-2c0c-04b4-76d85dba63c5,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,NDA,021305,Sodium Iodide I 131 Diagnostic,SODIUM IODIDE I 131,2020/08/25,Radioactive Therapeutic Agent,1971,JUBILANT DRAXIMAGE INC DBA JUBILANT RADIOPHARMA,2006/05/01-,65174-461,29VCO8ACHH,Sodium Iodide I-131,IODIDE ION I-131,4GC1FOQ22U,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/46b8d7ba-432d-d610-84f2-550bf9d0bae3/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=46b8d7ba-432d-d610-84f2-550bf9d0bae3,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=46b8d7ba-432d-d610-84f2-550bf9d0bae3,46b8d7ba-432d-d610-84f2-550bf9d0bae3,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,203922,Sodium Nitrite,SODIUM NITRITE,2022/02/14,,2011,HOPE PHARMACEUTICALS,2012/02/14-,60267-311,M0KG633D4F,Sodium Nitrite,Nitrite Ion,J39976L608,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/52f01c6e-172a-47a9-98a6-9eab7651a032/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=52f01c6e-172a-47a9-98a6-9eab7651a032,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=52f01c6e-172a-47a9-98a6-9eab7651a032,52f01c6e-172a-47a9-98a6-9eab7651a032,,,
HUMAN PRESCRIPTION DRUG LABEL,KIT,INTRAVENOUS,NDA,201444,NITHIODOTE,SODIUM NITRITE AND SODIUM THIOSULFATE,2023/06/07,,1992,HOPE PHARMACEUTICALS,2011/01/14-,60267-812,HX1032V43M; M0KG633D4F,Sodium Nitrite; Sodium Thiosulfate,NITRITE ION; THIOSULFATE ION,J39976L608; LLT6XV39PY,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/ff4941b3-9901-4aab-adcf-c5327bede34e/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ff4941b3-9901-4aab-adcf-c5327bede34e,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=ff4941b3-9901-4aab-adcf-c5327bede34e,ff4941b3-9901-4aab-adcf-c5327bede34e,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,209387,NIPRIDE RTU,SODIUM NITROPRUSSIDE,2018/07/20,Vasodilator,1988,EXELA PHARMA SCIENCES LLC,2017/03/20-; 2018/07/20-; completed:2018/02/09-2019/08/30,51754-1006; 51754-1018; 51754-1029,EAO03PE1TC,SODIUM NITROPRUSSIDE,NITROPRUSSIDE,169D1260KM,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/5acf0836-93ff-4064-b888-3f560e8a558d/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5acf0836-93ff-4064-b888-3f560e8a558d,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=5acf0836-93ff-4064-b888-3f560e8a558d,5acf0836-93ff-4064-b888-3f560e8a558d,,,
HUMAN PRESCRIPTION DRUG LABEL,"FOR SUSPENSION, EXTENDED RELEASE",ORAL,NDA,214755,Lumryz,SODIUM OXYBATE,2023/06/07,Central Nervous System Depressant,2002,AVADEL CNS PHARMACEUTICALS LLC,2023/05/01-,13551-001; 13551-002; 13551-003; 13551-004,7G33012534,SODIUM OXYBATE,4-HYDROXYBUTANOIC ACID,30IW36W5B2,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/10e5e40c-52f3-4c73-8a34-2c29c690a934/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=10e5e40c-52f3-4c73-8a34-2c29c690a934,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=10e5e40c-52f3-4c73-8a34-2c29c690a934,10e5e40c-52f3-4c73-8a34-2c29c690a934,,,
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION,ORAL,NDA,021196,Xyrem,SODIUM OXYBATE,2023/04/25,Central Nervous System Depressant,2002,JAZZ PHARMACEUTICALS INC,2002/07/17-,68727-100,7G33012534,SODIUM OXYBATE,4-HYDROXYBUTANOIC ACID,30IW36W5B2,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/926eb076-a4a8-45e4-91ef-411f0aa4f3ca/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=926eb076-a4a8-45e4-91ef-411f0aa4f3ca,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=926eb076-a4a8-45e4-91ef-411f0aa4f3ca,926eb076-a4a8-45e4-91ef-411f0aa4f3ca,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRAVENOUS,NDA,215025,Sodium Phenylacetate and Sodium Benzoate,SODIUM PHENYLACETATE AND SODIUM BENZOATE,2024/05/09,Nitrogen Binding Agent,1987,FOSUN PHARMA USA INC,2021/11/14-,72266-236,48N6U1781G; OJ245FE5EU,SODIUM BENZOATE; SODIUM PHENYLACETATE,BENZOIC ACID; PHENYLACETIC ACID,8SKN0B0MIM; ER5I1W795A,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/cee1e9a2-bbe5-2419-e053-2a95a90ac3ef/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=cee1e9a2-bbe5-2419-e053-2a95a90ac3ef,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=cee1e9a2-bbe5-2419-e053-2a95a90ac3ef,cee1e9a2-bbe5-2419-e053-2a95a90ac3ef,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRAVENOUS,NDA,215025,Sodium Phenylacetate and Sodium Benzoate,SODIUM PHENYLACETATE AND SODIUM BENZOATE,2023/01/16,Nitrogen Binding Agent,1987,MAIA PHARMACEUTICALS,2021/07/01-,70511-102,48N6U1781G; OJ245FE5EU,SODIUM BENZOATE; SODIUM PHENYLACETATE,BENZOIC ACID; PHENYLACETIC ACID,8SKN0B0MIM; ER5I1W795A,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/ab40b62b-9f8d-4394-92d5-09d9f1941eaa/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ab40b62b-9f8d-4394-92d5-09d9f1941eaa,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=ab40b62b-9f8d-4394-92d5-09d9f1941eaa,ab40b62b-9f8d-4394-92d5-09d9f1941eaa,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION, CONCENTRATE",INTRAVENOUS,NDA,020645,Ammonul,SODIUM PHENYLACETATE AND SODIUM BENZOATE,2020/12/01,Nitrogen Binding Agent,1987,BAUSCH HEALTH US LLC,2005/02/17-,0187-0010,48N6U1781G; OJ245FE5EU,sodium benzoate; sodium phenylacetate,benzoic acid; phenylacetic acid,8SKN0B0MIM; ER5I1W795A,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/e00521d3-84f1-4586-b4a8-9dc17ffffcb1/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e00521d3-84f1-4586-b4a8-9dc17ffffcb1,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=e00521d3-84f1-4586-b4a8-9dc17ffffcb1,e00521d3-84f1-4586-b4a8-9dc17ffffcb1,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION, CONCENTRATE",INTRAVENOUS,NDA,020645,Ammonul,SODIUM PHENYLACETATE AND SODIUM BENZOATE,2018/01/12,Nitrogen Binding Agent,1987,UCYCLYD PHARMA INC,2005/02/17-,62592-720,48N6U1781G; OJ245FE5EU,SODIUM BENZOATE; SODIUM PHENYLACETATE,BENZOIC ACID; PHENYLACETIC ACID,8SKN0B0MIM; ER5I1W795A,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/d564f2b1-9fc7-4201-8066-d745ac3a671f/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d564f2b1-9fc7-4201-8066-d745ac3a671f,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=d564f2b1-9fc7-4201-8066-d745ac3a671f,d564f2b1-9fc7-4201-8066-d745ac3a671f,,,
HUMAN PRESCRIPTION DRUG LABEL,KIT; PELLET,ORAL,NDA,216513,PHEBURANE,SODIUM PHENYLBUTYRATE,2023/08/17,Nitrogen Binding Agent,1996,MEDUNIK USA,2022/08/26-; 2022/09/14-,71770-200; 71770-210,NT6K61736T,SODIUM PHENYLBUTYRATE,PHENYLBUTYRIC ACID,7WY7YBI87E,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/d15f2cbf-4d22-40b5-8ef9-16b9d323a7f9/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d15f2cbf-4d22-40b5-8ef9-16b9d323a7f9,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=d15f2cbf-4d22-40b5-8ef9-16b9d323a7f9,d15f2cbf-4d22-40b5-8ef9-16b9d323a7f9,,,
HUMAN PRESCRIPTION DRUG LABEL,POWDER; TABLET,ORAL,NDA,020572;020573,BUPHENYL; Buphenyl,SODIUM PHENYLBUTYRATE,2023/04/11,Nitrogen Binding Agent,,HORIZON THERAPEUTICS USA INC,1996/04/30-; 1996/05/13-,75987-060; 75987-070,NT6K61736T,SODIUM PHENYLBUTYRATE,PHENYLBUTYRIC ACID,7WY7YBI87E,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/463a36fa-3eb2-4326-8bd0-c8c7a11bca3a/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=463a36fa-3eb2-4326-8bd0-c8c7a11bca3a,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=463a36fa-3eb2-4326-8bd0-c8c7a11bca3a,463a36fa-3eb2-4326-8bd0-c8c7a11bca3a,,,
HUMAN PRESCRIPTION DRUG LABEL,KIT,ORAL,NDA,214860,OLPRUVA,SODIUM PHENYLBUTYRATE,2022/12/22,Nitrogen Binding Agent,1996,ACER THERAPEUTICS INC,2022/12/22-,72542-200; 72542-300; 72542-400; 72542-500; 72542-600; 72542-667,NT6K61736T,sodium phenylbutyrate,phenylbutyric acid,7WY7YBI87E,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/89abc31c-43e8-4809-9eb7-172cb31a86f1/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=89abc31c-43e8-4809-9eb7-172cb31a86f1,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=89abc31c-43e8-4809-9eb7-172cb31a86f1,89abc31c-43e8-4809-9eb7-172cb31a86f1,,,
HUMAN PRESCRIPTION DRUG LABEL,"POWDER, FOR SUSPENSION",ORAL,NDA,216660,RELYVRIO,SODIUM PHENYLBUTYRATE/TAURURSODIOL,2024/01/02,Nitrogen Binding Agent,2022,AMYLYX PHARMACEUTICALS INC,2022/09/29-,73063-035,NT6K61736T; U7XRV7RZ1I,SODIUM PHENYLBUTYRATE; TAURURSODIOL DIHYDRATE,PHENYLBUTYRIC ACID; TAURURSODIOL,60EUX8MN5X; 7WY7YBI87E,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/126747c4-39f3-4e20-8f3c-7b8596d8ba7d/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=126747c4-39f3-4e20-8f3c-7b8596d8ba7d,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=126747c4-39f3-4e20-8f3c-7b8596d8ba7d,126747c4-39f3-4e20-8f3c-7b8596d8ba7d,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,018892,Sodium Phosphates,"SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE AND SODIUM PHOSPHATE, DIBASIC, ANHYDROUS",2020/09/14,Osmotic Laxative,,HOSPIRA INC,2005/06/02-,0409-7391,22ADO53M6F; 593YOG76RN,"SODIUM PHOSPHATE, DIBASIC, ANHYDROUS; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE",PHOSPHATE ION; SODIUM CATION,LYR4M0NH37; NK08V8K8HR,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/6f044d16-295e-43ff-72a3-b045c387bc5c/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6f044d16-295e-43ff-72a3-b045c387bc5c,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=6f044d16-295e-43ff-72a3-b045c387bc5c,6f044d16-295e-43ff-72a3-b045c387bc5c,,,
HUMAN PRESCRIPTION DRUG LABEL,LIQUID,ORAL,NDA,209589,CLENPIQ,"SODIUM PICOSULFATE, MAGNESIUM OXIDE, AND ANHYDROUS CITRIC ACID",2023/09/05,Anti-coagulant; Calculi Dissolution Agent; Osmotic Laxative; Stimulant Laxative,2012,FERRING PHARMACEUTICALS INC,2023/03/29-,55566-6800,3A3U0GI71G; LR57574HN8; XF417D3PSL,ANHYDROUS CITRIC ACID; MAGNESIUM OXIDE; SODIUM PICOSULFATE,ANHYDROUS CITRIC ACID; DEACETYLBISACODYL; MAGNESIUM CATION,R09078E41Y; T6V3LHY838; XF417D3PSL,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/e95fff66-4ec0-4001-a727-33e66a5ec7d5/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e95fff66-4ec0-4001-a727-33e66a5ec7d5,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=e95fff66-4ec0-4001-a727-33e66a5ec7d5,e95fff66-4ec0-4001-a727-33e66a5ec7d5,,,
HUMAN PRESCRIPTION DRUG LABEL,LIQUID,ORAL,NDA,209589,CLENPIQ,"SODIUM PICOSULFATE, MAGNESIUM OXIDE, AND ANHYDROUS CITRIC ACID",2020/10/26,Anti-coagulant; Calculi Dissolution Agent; Osmotic Laxative; Stimulant Laxative,2012,FERRING PHARMACEUTICALS INC,2018/06/29-,55566-6700,3A3U0GI71G; LR57574HN8; XF417D3PSL,ANHYDROUS CITRIC ACID; MAGNESIUM OXIDE; SODIUM PICOSULFATE,ANHYDROUS CITRIC ACID; DEACETYLBISACODYL; MAGNESIUM CATION,R09078E41Y; T6V3LHY838; XF417D3PSL,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/ea24a07b-34ca-4da4-ba69-73bbf44de20d/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ea24a07b-34ca-4da4-ba69-73bbf44de20d,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=ea24a07b-34ca-4da4-ba69-73bbf44de20d,ea24a07b-34ca-4da4-ba69-73bbf44de20d,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,213135,SUTAB,"SODIUM SULFATE, MAGNESIUM SULFATE, AND POTASSIUM CHLORIDE",2023/11/03,Calculi Dissolution Agent; Osmotic Laxative; Potassium Salt,2020,BRAINTREE LABORATORIES INC,2020/11/10-,52268-201,0YPR65R21J; 660YQ98I10; ML30MJ2U7I,MAGNESIUM SULFATE ANHYDROUS; POTASSIUM CHLORIDE; SODIUM SULFATE,MAGNESIUM CATION; POTASSIUM CATION; SODIUM SULFATE ANHYDROUS,295O53K152; 36KCS0R750; T6V3LHY838,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/dddd2701-4d46-44de-a9f8-303d4dcceef7/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=dddd2701-4d46-44de-a9f8-303d4dcceef7,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=dddd2701-4d46-44de-a9f8-303d4dcceef7,dddd2701-4d46-44de-a9f8-303d4dcceef7,,,
HUMAN PRESCRIPTION DRUG LABEL,"SOLUTION, CONCENTRATE",ORAL,NDA,022372,"SODIUM SULFATE, POTASSIUM SULFATE AND MAGNESIUM SULFATE","SODIUM SULFATE, POTASSIUM SULFATE, MAGNESIUM SULFATE",2022/07/05,Calculi Dissolution Agent; Osmotic Laxative; Potassium Salt,2010,AFFORDABLE PHARMACEUTICALS LLC,2010/08/05-,10572-012; 10572-112,0YPR65R21J; 1K573LC5TV; DE08037SAB,"MAGNESIUM SULFATE, UNSPECIFIED FORM; POTASSIUM SULFATE; SODIUM SULFATE",MAGNESIUM CATION; POTASSIUM CATION; SODIUM CATION,295O53K152; LYR4M0NH37; T6V3LHY838,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/f86bdcc8-e643-4160-89ae-01c89bee842d/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f86bdcc8-e643-4160-89ae-01c89bee842d,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=f86bdcc8-e643-4160-89ae-01c89bee842d,f86bdcc8-e643-4160-89ae-01c89bee842d,,,
HUMAN PRESCRIPTION DRUG LABEL,"SOLUTION, CONCENTRATE",ORAL,NDA,022372,SUPREP Bowel Prep,"SODIUM SULFATE, POTASSIUM SULFATE, MAGNESIUM SULFATE",2020/08/18,Calculi Dissolution Agent; Osmotic Laxative; Potassium Salt,2010,BRAINTREE LABORATORIES INC,2010/08/05-,52268-012; 52268-112,0YPR65R21J; 1K573LC5TV; DE08037SAB,"MAGNESIUM SULFATE, UNSPECIFIED FORM; POTASSIUM SULFATE; SODIUM SULFATE",MAGNESIUM CATION; POTASSIUM CATION; SODIUM CATION,295O53K152; LYR4M0NH37; T6V3LHY838,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/2f5f06de-ee98-44c0-be7e-9a998d1e5c16/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2f5f06de-ee98-44c0-be7e-9a998d1e5c16,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=2f5f06de-ee98-44c0-be7e-9a998d1e5c16,2f5f06de-ee98-44c0-be7e-9a998d1e5c16,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,203923,Sodium Thiosulfate,SODIUM THIOSULFATE,2023/11/16,,1992,HOPE PHARMACEUTICALS,2012/02/14-,60267-705,HX1032V43M,Sodium Thiosulfate,THIOSULFATE ION,LLT6XV39PY,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/82f55408-2de9-463d-85e8-b39c3b259f0b/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=82f55408-2de9-463d-85e8-b39c3b259f0b,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=82f55408-2de9-463d-85e8-b39c3b259f0b,82f55408-2de9-463d-85e8-b39c3b259f0b,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,212937,PEDMARK,SODIUM THIOSULFATE,2022/09/30,,1992,FENNEC PHARMACEUTICALS INC,2022/10/03-,73077-010,HX1032V43M,SODIUM THIOSULFATE,THIOSULFATE ION,LLT6XV39PY,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/f98c7076-2a7b-4fd7-ab90-eed5e9137bae/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f98c7076-2a7b-4fd7-ab90-eed5e9137bae,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=f98c7076-2a7b-4fd7-ab90-eed5e9137bae,f98c7076-2a7b-4fd7-ab90-eed5e9137bae,,,
HUMAN PRESCRIPTION DRUG LABEL,"POWDER, FOR SUSPENSION",ORAL,NDA,207078,LOKELMA,SODIUM ZIRCONIUM CYCLOSILICATE,2024/02/08,,2018,ASTRAZENECA PHARMACEUTICALS LP,2018/09/04-,0310-1105; 0310-1110,D652ZWF066,SODIUM ZIRCONIUM CYCLOSILICATE,ZIRCONIUM CYCLOSILICATE ION,536D9C8ST5,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/90bf8e28-748d-4e4b-a19f-9cf483370eff/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=90bf8e28-748d-4e4b-a19f-9cf483370eff,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=90bf8e28-748d-4e4b-a19f-9cf483370eff,90bf8e28-748d-4e4b-a19f-9cf483370eff,,,
HUMAN PRESCRIPTION DRUG LABEL,"PELLET; TABLET, FILM COATED",ORAL,NDA,204671;212480,Sovaldi,SOFOSBUVIR,2023/02/06,Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor,2013,GILEAD SCIENCES INC,2013/12/06-; 2019/08/28-,61958-1501; 61958-1503; 61958-1504; 61958-1505,WJ6CA3ZU8B,SOFOSBUVIR,SOFOSBUVIR,WJ6CA3ZU8B,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/80beab2c-396e-4a37-a4dc-40fdb62859cf/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=80beab2c-396e-4a37-a4dc-40fdb62859cf,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=80beab2c-396e-4a37-a4dc-40fdb62859cf,80beab2c-396e-4a37-a4dc-40fdb62859cf,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,209195,Vosevi,"SOFOSBUVIR, VELPATASVIR, AND VOXILAPREVIR",2024/03/14,Hepatitis C Virus NS3/4A Protease Inhibitor; Hepatitis C Virus NS5A Inhibitor; Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor,2017,GILEAD SCIENCES INC,2017/07/18-,61958-2401,0570F37359; KCU0C7RS7Z; WJ6CA3ZU8B,SOFOSBUVIR; VELPATASVIR; VOXILAPREVIR,SOFOSBUVIR; VELPATASVIR; VOXILAPREVIR,0570F37359; KCU0C7RS7Z; WJ6CA3ZU8B,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/17ffc094-8ca7-45d2-80d8-fd043bc9a221/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=17ffc094-8ca7-45d2-80d8-fd043bc9a221,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=17ffc094-8ca7-45d2-80d8-fd043bc9a221,17ffc094-8ca7-45d2-80d8-fd043bc9a221,,,
HUMAN PRESCRIPTION DRUG LABEL,SUSPENSION,ORAL,NDA,209529,VESIcare LS,SOLIFENACIN SUCCINATE,2022/10/31,Cholinergic Muscarinic Antagonist,2004,ASTELLAS PHARMA US INC,2020/05/26-,51248-250,KKA5DLD701,SOLIFENACIN SUCCINATE,SOLIFENACIN,A8910SQJ1U,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/e0300384-e980-45d5-8ed4-48a2618671ae/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e0300384-e980-45d5-8ed4-48a2618671ae,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=e0300384-e980-45d5-8ed4-48a2618671ae,e0300384-e980-45d5-8ed4-48a2618671ae,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,021518,VESIcare,SOLIFENACIN SUCCINATE,2022/10/31,Cholinergic Muscarinic Antagonist,2004,ASTELLAS PHARMA US INC,2005/01/05-,51248-150; 51248-151,KKA5DLD701,SOLIFENACIN SUCCINATE,SOLIFENACIN,A8910SQJ1U,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/9acee910-cdb2-4052-b8b3-c26aff1c8716/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9acee910-cdb2-4052-b8b3-c26aff1c8716,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=9acee910-cdb2-4052-b8b3-c26aff1c8716,9acee910-cdb2-4052-b8b3-c26aff1c8716,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,211230,SUNOSI,SOLRIAMFETOL,2023/07/06,Dopamine and Norepinephrine Reuptake Inhibitor,2019,AXSOME THERAPEUTICS INC,2019/06/18-,81968-350; 81968-351,939U7C91AI,SOLRIAMFETOL,SOLRIAMFETOL,939U7C91AI,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/362f206b-73e7-4009-8c34-5a9df55679ab/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=362f206b-73e7-4009-8c34-5a9df55679ab,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=362f206b-73e7-4009-8c34-5a9df55679ab,362f206b-73e7-4009-8c34-5a9df55679ab,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,NDA,205266,Odomzo,SONIDEGIB,2023/08/29,Hedgehog Pathway Inhibitor,2015,SUN PHARMACEUTICAL INDUSTRIES INC,2017/09/21-,47335-303,W421AI34UW,SONIDEGIB PHOSPHATE,SONIDEGIB,0RLU3VTK5M,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/028312dc-d155-4fd5-8abd-6bb9f011d3cc/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=028312dc-d155-4fd5-8abd-6bb9f011d3cc,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=028312dc-d155-4fd5-8abd-6bb9f011d3cc,028312dc-d155-4fd5-8abd-6bb9f011d3cc,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,021923,Nexavar,SORAFENIB,2023/08/28,Kinase Inhibitor,2005,BAYER HEALTHCARE PHARMACEUTICALS INC,2005/12/20-; 2023/10/02-,50419-488; 50419-489,9ZOQ3TZI87,SORAFENIB,SORAFENIB,9ZOQ3TZI87,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/b50667e4-5ebc-4968-a646-d605058dbef0/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b50667e4-5ebc-4968-a646-d605058dbef0,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=b50667e4-5ebc-4968-a646-d605058dbef0,b50667e4-5ebc-4968-a646-d605058dbef0,,,
HUMAN PRESCRIPTION DRUG LABEL,IRRIGANT,URETHRAL,NDA,018316,Sorbitol-Mannitol,SORBITOL AND MANNITOL,2021/04/07,Osmotic Diuretic,,ICU MEDICAL INC,2019/10/01-,0990-7981,3OWL53L36A; 506T60A25R,MANNITOL; SORBITOL,MANNITOL; SORBITOL,3OWL53L36A; 506T60A25R,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/5b44e248-4b7b-4777-954a-921c7b309944/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5b44e248-4b7b-4777-954a-921c7b309944,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=5b44e248-4b7b-4777-954a-921c7b309944,5b44e248-4b7b-4777-954a-921c7b309944,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,216203,INPEFA,SOTAGLIFLOZIN,2024/01/15,Sodium-Glucose Cotransporter 2 Inhibitor,2023,LEXICON PHARMACEUTICALS INC,2023/05/26-; completed:2023/05/26-2023/05/26,70183-220; 70183-221; 70183-240; 70183-241,6B4ZBS263Y,sotagliflozin,sotagliflozin,6B4ZBS263Y,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/1a46614e-05f6-421a-b6f4-d6f8760d643a/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1a46614e-05f6-421a-b6f4-d6f8760d643a,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=1a46614e-05f6-421a-b6f4-d6f8760d643a,1a46614e-05f6-421a-b6f4-d6f8760d643a,,,
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION,ORAL,NDA,205108,SOTYLIZE,SOTALOL HYDROCHLORIDE,2024/01/24,Antiarrhythmic,1992,AZURITY PHARMACEUTICALS INC,2015/03/01-,24338-530,HEC37C70XX,SOTALOL HYDROCHLORIDE,SOTALOL,A6D97U294I,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/1f33f900-0777-4a92-a7f7-00cf3d57d95c/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1f33f900-0777-4a92-a7f7-00cf3d57d95c,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=1f33f900-0777-4a92-a7f7-00cf3d57d95c,1f33f900-0777-4a92-a7f7-00cf3d57d95c,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRAVENOUS,NDA,022306,Sotalol hydrochloride,SOTALOL HYDROCHLORIDE,2023/10/05,Antiarrhythmic,1992,ALTATHERA PHARMACEUTICALS LLC,2015/10/15-,69724-112,HEC37C70XX,SOTALOL HYDROCHLORIDE,SOTALOL,A6D97U294I,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/ff3061ab-d930-4318-a5be-684e38be229e/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ff3061ab-d930-4318-a5be-684e38be229e,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=ff3061ab-d930-4318-a5be-684e38be229e,ff3061ab-d930-4318-a5be-684e38be229e,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,019865;021151,BETAPACE; BETAPACE AF,SOTALOL HYDROCHLORIDE,2023/06/15,Antiarrhythmic,1992,COVIS PHARMA US INC,2016/09/01-,70515-105; 70515-106; 70515-109; 70515-115; 70515-116; 70515-119,HEC37C70XX,SOTALOL HYDROCHLORIDE,SOTALOL,A6D97U294I,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/afce2787-8899-4098-87c8-f1e8dd19e6dd/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=afce2787-8899-4098-87c8-f1e8dd19e6dd,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=afce2787-8899-4098-87c8-f1e8dd19e6dd,afce2787-8899-4098-87c8-f1e8dd19e6dd,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,019865,BETAPACE; BETAPACE AF,SOTALOL HYDROCHLORIDE,2023/06/15,Antiarrhythmic,1992,LEGACY PHARMA USA INC,2016/09/01-,83107-005; 83107-006; 83107-007; 83107-008; 83107-009; 83107-010,HEC37C70XX,SOTALOL HYDROCHLORIDE,SOTALOL,A6D97U294I,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/a6a7702f-36c9-45db-b640-453dc324baee/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a6a7702f-36c9-45db-b640-453dc324baee,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=a6a7702f-36c9-45db-b640-453dc324baee,a6a7702f-36c9-45db-b640-453dc324baee,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, COATED",ORAL,NDA,214665,LUMAKRAS,SOTORASIB,2023/10/12,,2021,AMGEN INC,2021/05/28-; 2023/02/02-,55513-488; 55513-504,2B2VM6UC8G,SOTORASIB,SOTORASIB,2B2VM6UC8G,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/c80a362c-7ac3-4894-a076-0691e68ef8c1/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c80a362c-7ac3-4894-a076-0691e68ef8c1,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=c80a362c-7ac3-4894-a076-0691e68ef8c1,c80a362c-7ac3-4894-a076-0691e68ef8c1,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,019531,NutriLipid I.V. Fat Emulsion,SOYBEAN OIL,2023/05/17,Lipid Emulsion,1975,B BRAUN MEDICAL INC,2014/06/30-,0264-4460,241ATL177A,SOYBEAN OIL,SOYBEAN OIL,241ATL177A,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/193290b1-a0a1-4054-a22a-de5c9e7a8b73/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=193290b1-a0a1-4054-a22a-de5c9e7a8b73,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=193290b1-a0a1-4054-a22a-de5c9e7a8b73,193290b1-a0a1-4054-a22a-de5c9e7a8b73,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,216403,FILSPARI,SPARSENTAN,2023/02/17,Angiotensin 2 Receptor Blocker; Endothelin Receptor Antagonist,2023,TRAVERE THERAPEUTICS INC,2023/02/17-,68974-200; 68974-400,9242RO5URM,SPARSENTAN,SPARSENTAN,9242RO5URM,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/d7354af1-f304-f4d9-e053-2995a90ab219/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d7354af1-f304-f4d9-e053-2995a90ab219,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=d7354af1-f304-f4d9-e053-2995a90ab219,d7354af1-f304-f4d9-e053-2995a90ab219,,,
HUMAN PRESCRIPTION DRUG LABEL,SUSPENSION,TOPICAL,NDA,022408,Natroba,SPINOSAD,2021/04/28,Pediculicide,2011,PARAPRO LLC,2011/01/25-,52246-929,XPA88EAP6V,SPINOSAD,spinosad,XPA88EAP6V,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/fa90ccc8-2df0-49f7-8878-2b33e34cd272/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=fa90ccc8-2df0-49f7-8878-2b33e34cd272,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=fa90ccc8-2df0-49f7-8878-2b33e34cd272,fa90ccc8-2df0-49f7-8878-2b33e34cd272,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,012151,Aldactone,SPIRONOLACTONE,2023/12/11,Aldosterone Antagonist,1960,PFIZER LABORATORIES DIV PFIZER INC,1960/01/21-,0025-1001; 0025-1031; 0025-1041,27O7W4T232,SPIRONOLACTONE,SPIRONOLACTONE,27O7W4T232,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/0fed2822-3a03-4b64-9857-c682fcd462bc/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0fed2822-3a03-4b64-9857-c682fcd462bc,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=0fed2822-3a03-4b64-9857-c682fcd462bc,0fed2822-3a03-4b64-9857-c682fcd462bc,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,012616,ALDACTAZIDE,SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE,2024/04/02,Aldosterone Antagonist; Thiazide Diuretic,,PFIZER LABORATORIES DIV PFIZER INC,completed:1978/01/01-2023/08/31; completed:1978/01/01-2025/01/31,0025-1011; 0025-1021,0J48LPH2TH; 27O7W4T232,HYDROCHLOROTHIAZIDE; SPIRONOLACTONE,HYDROCHLOROTHIAZIDE; SPIRONOLACTONE,0J48LPH2TH; 27O7W4T232,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/d44637a7-b980-4bb1-832c-f5a0f73f8259/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d44637a7-b980-4bb1-832c-f5a0f73f8259,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=d44637a7-b980-4bb1-832c-f5a0f73f8259,d44637a7-b980-4bb1-832c-f5a0f73f8259,,,
HUMAN PRESCRIPTION DRUG LABEL,IRRIGANT,IRRIGATION,NDA,016734,Sterile Water,STERILE WATER,2021/08/09,,,B BRAUN MEDICAL INC,2013/09/13-,0264-7386,059QF0KO0R,WATER,WATER,059QF0KO0R,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/d99f9133-e4d0-4dee-b611-dbc3f918b547/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d99f9133-e4d0-4dee-b611-dbc3f918b547,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=d99f9133-e4d0-4dee-b611-dbc3f918b547,d99f9133-e4d0-4dee-b611-dbc3f918b547,,,
HUMAN PRESCRIPTION DRUG LABEL,"CAPSULE; POWDER, FOR SUSPENSION",ORAL,NDA,206709;207223,Diacomit,STIRIPENTOL,2022/07/24,,2018,BIOCODEX INC,2018/08/21-,68418-7939; 68418-7940; 68418-7941; 68418-7942,R02XOT8V8I,Stiripentol,Stiripentol,R02XOT8V8I,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/58304ba8-9779-4658-811e-94ffe08c3f16/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=58304ba8-9779-4658-811e-94ffe08c3f16,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=58304ba8-9779-4658-811e-94ffe08c3f16,58304ba8-9779-4658-811e-94ffe08c3f16,,,
HUMAN PRESCRIPTION DRUG LABEL,"POWDER, FOR SOLUTION",INTRAVENOUS,NDA,050577,Zanosar,STREPTOZOCIN,2023/04/24,Alkylating Drug,,TEVA PARENTERAL MEDICINES INC,2003/12/03-,0703-4636,5W494URQ81,STREPTOZOCIN,STREPTOZOCIN,5W494URQ81,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/15d161ed-9e7b-4c92-ba45-0556d2423e67/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=15d161ed-9e7b-4c92-ba45-0556d2423e67,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=15d161ed-9e7b-4c92-ba45-0556d2423e67,15d161ed-9e7b-4c92-ba45-0556d2423e67,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAVENOUS,NDA,214993,NephroScan,SUCCIMER,2024/01/31,Lead Chelator,1982,THERAGNOSTICS INC,2022/02/18-,71083-0020,DX1U2629QE,SUCCIMER,SUCCIMER,DX1U2629QE,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/ddd90c4a-5792-49c9-837f-710d1a604742/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ddd90c4a-5792-49c9-837f-710d1a604742,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=ddd90c4a-5792-49c9-837f-710d1a604742,ddd90c4a-5792-49c9-837f-710d1a604742,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,NDA,019998,Chemet,SUCCIMER,2023/01/11,Lead Chelator,,RECORDATI RARE DISEASES INC,2013/08/21-,55292-201,DX1U2629QE,SUCCIMER,SUCCIMER,DX1U2629QE,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/62035612-9505-3a3f-1ac8-e2dbd711d24e/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=62035612-9505-3a3f-1ac8-e2dbd711d24e,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=62035612-9505-3a3f-1ac8-e2dbd711d24e,62035612-9505-3a3f-1ac8-e2dbd711d24e,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAMUSCULAR; INTRAVENOUS,NDA,215143,Succinylcholine Chloride,SUCCINYLCHOLINE CHLORIDE,2024/04/10,Depolarizing Neuromuscular Blocker,1952,HIKMA PHARMACEUTICALS USA INC,2022/03/17-,0641-6234,8L0S1G435E,SUCCINYLCHOLINE CHLORIDE DIHYDRATE,SUCCINYLCHOLINE,J2R869A8YF,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/cb5b3361-9099-4a12-b545-f1e50b0781dd/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=cb5b3361-9099-4a12-b545-f1e50b0781dd,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=cb5b3361-9099-4a12-b545-f1e50b0781dd,cb5b3361-9099-4a12-b545-f1e50b0781dd,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAMUSCULAR; INTRAVENOUS; PARENTERAL,NDA,008453,ANECTINE NOV,SUCCINYLCHOLINE CHLORIDE,2024/03/13,Depolarizing Neuromuscular Blocker,1952,DELPHARM BOUCHERVILLE CANADA INC,2017/06/22-,82650-139,I9L0DDD30I,SUCCINYLCHOLINE CHLORIDE,SUCCINYLCHOLINE,J2R869A8YF,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/138f1329-11c2-51ed-e063-6294a90a0702/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=138f1329-11c2-51ed-e063-6294a90a0702,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=138f1329-11c2-51ed-e063-6294a90a0702,138f1329-11c2-51ed-e063-6294a90a0702,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAMUSCULAR; INTRAVENOUS; PARENTERAL,NDA,008453,ANECTINE CIV,SUCCINYLCHOLINE CHLORIDE,2024/03/13,Depolarizing Neuromuscular Blocker,1952,DELPHARM BOUCHERVILLE CANADA INC,2017/06/22-,82650-138,I9L0DDD30I,SUCCINYLCHOLINE CHLORIDE,SUCCINYLCHOLINE,J2R869A8YF,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/138f172a-4b99-537e-e063-6394a90a6997/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=138f172a-4b99-537e-e063-6394a90a6997,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=138f172a-4b99-537e-e063-6394a90a6997,138f172a-4b99-537e-e063-6394a90a6997,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAMUSCULAR; INTRAVENOUS; PARENTERAL,NDA,008453,Anectine,SUCCINYLCHOLINE CHLORIDE,2023/11/29,Depolarizing Neuromuscular Blocker,1952,CIVICA INC,2020/12/11-,72572-750,I9L0DDD30I,SUCCINYLCHOLINE CHLORIDE,SUCCINYLCHOLINE,J2R869A8YF,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/0b990f84-9515-44bd-a97d-a97bbead065c/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0b990f84-9515-44bd-a97d-a97bbead065c,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=0b990f84-9515-44bd-a97d-a97bbead065c,0b990f84-9515-44bd-a97d-a97bbead065c,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAMUSCULAR; INTRAVENOUS; PARENTERAL,NDA,008453,Anectine,SUCCINYLCHOLINE CHLORIDE,2023/11/29,Depolarizing Neuromuscular Blocker,1952,SANDOZ INC,2019/06/12-,0781-9053,I9L0DDD30I,SUCCINYLCHOLINE CHLORIDE,SUCCINYLCHOLINE,J2R869A8YF,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/04a4e6f5-6fa1-42e1-a3f9-21fca7786b15/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=04a4e6f5-6fa1-42e1-a3f9-21fca7786b15,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=04a4e6f5-6fa1-42e1-a3f9-21fca7786b15,04a4e6f5-6fa1-42e1-a3f9-21fca7786b15,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAMUSCULAR; INTRAVENOUS; PARENTERAL,NDA,008453,Anectine,SUCCINYLCHOLINE CHLORIDE,2023/11/29,Depolarizing Neuromuscular Blocker,1952,SANDOZ INC,2017/06/22-,0781-3411,I9L0DDD30I,SUCCINYLCHOLINE CHLORIDE,SUCCINYLCHOLINE,J2R869A8YF,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/a1e5d29f-111e-4a44-addf-beeb6ea81711/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a1e5d29f-111e-4a44-addf-beeb6ea81711,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=a1e5d29f-111e-4a44-addf-beeb6ea81711,a1e5d29f-111e-4a44-addf-beeb6ea81711,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAMUSCULAR; INTRAVENOUS,NDA,008845,QUELICIN,SUCCINYLCHOLINE CHLORIDE,2023/05/05,Depolarizing Neuromuscular Blocker,1952,HOSPIRA INC,2005/04/30-; completed:2005/06/23-2013/08/01,0409-6629; 0409-6970,I9L0DDD30I,SUCCINYLCHOLINE CHLORIDE,SUCCINYLCHOLINE,J2R869A8YF,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/fb08161e-7711-406d-e7b3-ea4515c07983/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=fb08161e-7711-406d-e7b3-ea4515c07983,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=fb08161e-7711-406d-e7b3-ea4515c07983,fb08161e-7711-406d-e7b3-ea4515c07983,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,018333,Carafate,SUCRALFATE,2023/06/23,Aluminum Complex,,ALLERGAN INC,1981/10/30-,58914-171,XX73205DH5,SUCRALFATE,SUCRALFATE,XX73205DH5,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/c87c6b50-6977-4fa7-ae98-40c0753f7aee/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c87c6b50-6977-4fa7-ae98-40c0753f7aee,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=c87c6b50-6977-4fa7-ae98-40c0753f7aee,c87c6b50-6977-4fa7-ae98-40c0753f7aee,,,
HUMAN PRESCRIPTION DRUG LABEL,SUSPENSION,ORAL,NDA,019183,Carafate,SUCRALFATE,2023/06/08,Aluminum Complex,,ALLERGAN INC,1993/12/16-,58914-170,XX73205DH5,SUCRALFATE,SUCRALFATE,XX73205DH5,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/0fb67b1c-b4c0-46f2-8a81-df1510e006aa/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0fb67b1c-b4c0-46f2-8a81-df1510e006aa,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=0fb67b1c-b4c0-46f2-8a81-df1510e006aa,0fb67b1c-b4c0-46f2-8a81-df1510e006aa,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, CHEWABLE",ORAL,NDA,205109,Velphoro,SUCROFERRIC OXYHYDROXIDE,2023/10/18,Phosphate Binder,2013,FRESENIUS MEDICAL CARE NORTH AMERICA,2013/11/27-,49230-645,87PZU03K0K,FERRIC OXYHYDROXIDE,FERRIC OXYHYDROXIDE,87PZU03K0K,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/237da26c-f38c-4faa-93ad-735e71c9d0c1/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=237da26c-f38c-4faa-93ad-735e71c9d0c1,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=237da26c-f38c-4faa-93ad-735e71c9d0c1,237da26c-f38c-4faa-93ad-735e71c9d0c1,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,SUBLINGUAL,NDA,209128,Dsuvia,SUFENTANIL,2023/12/18,Opioid Agonist,1984,ACELRX PHARMACEUTICALS INC,2018/11/02-,61621-430,AFE2YW0IIZ,SUFENTANIL,SUFENTANIL,AFE2YW0IIZ,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/8b580f3d-e3b5-4086-b093-87a980631147/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8b580f3d-e3b5-4086-b093-87a980631147,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=8b580f3d-e3b5-4086-b093-87a980631147,8b580f3d-e3b5-4086-b093-87a980631147,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,EPIDURAL; INTRAVENOUS,NDA,019050,Sufentanil Citrate,SUFENTANIL CITRATE,2022/09/14,Opioid Agonist,1984,AKORN,2010/12/01-,17478-050,S9ZFX8403R,Sufentanil Citrate,Sufentanil,AFE2YW0IIZ,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/95e639db-1ca3-4328-b347-7ea348f6cc72/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=95e639db-1ca3-4328-b347-7ea348f6cc72,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=95e639db-1ca3-4328-b347-7ea348f6cc72,95e639db-1ca3-4328-b347-7ea348f6cc72,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,022225,BRIDION,SUGAMMADEX,2023/12/01,,2015,MERCK SHARP AND DOHME LLC,2015/12/15-,0006-5423; 0006-5425,ERJ6X2MXV7,SUGAMMADEX SODIUM,SUGAMMADEX,361LPM2T56,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/5171d883-fe8f-482c-97ab-40b00975b64a/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5171d883-fe8f-482c-97ab-40b00975b64a,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=5171d883-fe8f-482c-97ab-40b00975b64a,5171d883-fe8f-482c-97ab-40b00975b64a,,,
HUMAN PRESCRIPTION DRUG LABEL,KIT,INTRAVENOUS,NDA,216974,Xacduro,SULBACTAM AND DURLOBACTAM,2023/09/12,beta Lactamase Inhibitor,2023,LAJOLLA PHARMACEUTICAL COMPANY,2023/06/06-,68547-111,DKQ4T82YE6; F78MDZ9CW9,durlobactam sodium; sulbactam sodium,durlobactam; sulbactam,PSA33KO9WA; S4TF6I2330,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/c0167aec-a89d-4e96-afe5-2ccf3e89fe72/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c0167aec-a89d-4e96-afe5-2ccf3e89fe72,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=c0167aec-a89d-4e96-afe5-2ccf3e89fe72,c0167aec-a89d-4e96-afe5-2ccf3e89fe72,,,
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION,TOPICAL,NDA,018738,Exelderm,SULCONAZOLE NITRATE,2022/11/08,Azole Antifungal,,JOURNEY MEDICAL CORPORATION,2019/06/07-,69489-721,1T89100D5U,Sulconazole Nitrate,SULCONAZOLE,5D9HAA5Q5S,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/5b73e83e-8d3c-4d96-b4f6-9f854430add8/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5b73e83e-8d3c-4d96-b4f6-9f854430add8,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=5b73e83e-8d3c-4d96-b4f6-9f854430add8,5b73e83e-8d3c-4d96-b4f6-9f854430add8,,,
HUMAN PRESCRIPTION DRUG LABEL,CREAM,TOPICAL,NDA,018737,Exelderm,SULCONAZOLE NITRATE,2022/07/19,Azole Antifungal,,JOURNEY MEDICAL CORPORATION,2019/06/07-,69489-711,1T89100D5U,Sulconazole Nitrate,SULCONAZOLE,5D9HAA5Q5S,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/1d822e06-f37e-4984-8365-efd4c4451478/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1d822e06-f37e-4984-8365-efd4c4451478,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=1d822e06-f37e-4984-8365-efd4c4451478,1d822e06-f37e-4984-8365-efd4c4451478,,,
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION,TOPICAL,NDA,018738,Sulconazole Nitrate,SULCONAZOLE NITRATE,2021/01/17,Azole Antifungal,,JG PHARMA INC,2020/02/24-,72143-321,1T89100D5U,Sulconazole Nitrate,SULCONAZOLE,5D9HAA5Q5S,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/cf6f4340-940c-4a61-b675-456e3297d810/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=cf6f4340-940c-4a61-b675-456e3297d810,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=cf6f4340-940c-4a61-b675-456e3297d810,cf6f4340-940c-4a61-b675-456e3297d810,,,
HUMAN PRESCRIPTION DRUG LABEL,CREAM,TOPICAL,NDA,018737,Sulconazole Nitrate,SULCONAZOLE NITRATE,2020/02/04,Azole Antifungal,,JG PHARMA,2020/02/04-,72143-311,1T89100D5U,Sulconazole Nitrate,SULCONAZOLE,5D9HAA5Q5S,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/5b731aa0-fb3f-4a96-9034-636138cbca03/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5b731aa0-fb3f-4a96-9034-636138cbca03,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=5b731aa0-fb3f-4a96-9034-636138cbca03,5b731aa0-fb3f-4a96-9034-636138cbca03,,,
HUMAN PRESCRIPTION DRUG LABEL,LOTION,TOPICAL,NDA,019931,Klaron,SULFACETAMIDE SODIUM,2020/08/31,Sulfonamide Antibacterial,,BAUSCH HEALTH US LLC,1996/12/23-,0187-5198,4NRT660KJQ,sulfacetamide sodium,sulfacetamide,4965G3J0F5,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/66ab38ea-5cea-47be-97f2-486517999fb0/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=66ab38ea-5cea-47be-97f2-486517999fb0,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=66ab38ea-5cea-47be-97f2-486517999fb0,66ab38ea-5cea-47be-97f2-486517999fb0,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,017377,Bactrim; Bactrim DS,SULFAMETHOXAZOLE AND TRIMETHOPRIM,2024/04/09,Dihydrofolate Reductase Inhibitor Antibacterial; Sulfonamide Antimicrobial,,SUN PHARMACEUTICAL INDUSTRIES INC,2004/11/01-,49708-145; 49708-146,AN164J8Y0X; JE42381TNV,SULFAMETHOXAZOLE; TRIMETHOPRIM,SULFAMETHOXAZOLE; TRIMETHOPRIM,AN164J8Y0X; JE42381TNV,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/f59d0c04-9c66-4d53-a0e1-cb55570deb62/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f59d0c04-9c66-4d53-a0e1-cb55570deb62,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=f59d0c04-9c66-4d53-a0e1-cb55570deb62,f59d0c04-9c66-4d53-a0e1-cb55570deb62,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, DELAYED RELEASE",ORAL,NDA,007073,Azulfidine EN-tabs,SULFASALAZINE,2022/10/27,Aminosalicylate,,PFIZER LABORATORIES DIV PFIZER INC,1950/06/20-,0013-0102,3XC8GUZ6CB,SULFASALAZINE,SULFASALAZINE,3XC8GUZ6CB,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/b9ef541a-93c8-4428-ba45-398aa0b327d1/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b9ef541a-93c8-4428-ba45-398aa0b327d1,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=b9ef541a-93c8-4428-ba45-398aa0b327d1,b9ef541a-93c8-4428-ba45-398aa0b327d1,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,007073,Azulfidine,SULFASALAZINE,2022/10/26,Aminosalicylate,,PFIZER LABORATORIES DIV PFIZER INC,1950/06/20-,0013-0101,3XC8GUZ6CB,SULFASALAZINE,SULFASALAZINE,3XC8GUZ6CB,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/ddbe69f3-bd55-45f3-a64f-f60226c744c4/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ddbe69f3-bd55-45f3-a64f-f60226c744c4,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=ddbe69f3-bd55-45f3-a64f-f60226c744c4,ddbe69f3-bd55-45f3-a64f-f60226c744c4,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION; KIT",INTRAVENOUS; INTRAVESICAL,NDA,203684,LumaSon; Lumason,SULFUR HEXAFLUORIDE,2023/11/21,Contrast Agent for Ultrasound Imaging,2014,BRACCO DIAGNOSTICS INC,2020/01/15-; 2021/04/01-,0270-7097; 0270-7099,841B886EJ7; EAG959U971; WS7LR3I1D6,"DISTEAROYLPHOSPHATIDYLCHOLINE, DL-; SODIUM 1,2-DIPALMITOYL-SN-GLYCERO-3-PHOSPHO-(1'-RAC-GLYCEROL); SULFUR HEXAFLUORIDE","DISTEAROYLPHOSPHATIDYLCHOLINE, DL-; SODIUM 1,2-DIPALMITOYL-SN-GLYCERO-3-PHOSPHO-(1'-RAC-GLYCEROL); SULFUR HEXAFLUORIDE",841B886EJ7; EAG959U971; WS7LR3I1D6,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/69822a55-226c-f133-e3b8-2b5826667c5b/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=69822a55-226c-f133-e3b8-2b5826667c5b,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=69822a55-226c-f133-e3b8-2b5826667c5b,69822a55-226c-f133-e3b8-2b5826667c5b,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION; KIT",INTRAVENOUS; INTRAVESICAL,NDA,203684,LumaSon,SULFUR HEXAFLUORIDE,2023/08/10,Contrast Agent for Ultrasound Imaging,2014,BRACCO DIAGNOSTICS INC,2015/01/15-; 2021/04/01-,0270-7097; 0270-7099,841B886EJ7; EAG959U971; WS7LR3I1D6,"DISTEAROYLPHOSPHATIDYLCHOLINE, DL-; SODIUM 1,2-DIPALMITOYL-SN-GLYCERO-3-PHOSPHO-(1'-RAC-GLYCEROL); SULFUR HEXAFLUORIDE","DISTEAROYLPHOSPHATIDYLCHOLINE, DL-; SODIUM 1,2-DIPALMITOYL-SN-GLYCERO-3-PHOSPHO-(1'-RAC-GLYCEROL); SULFUR HEXAFLUORIDE",841B886EJ7; EAG959U971; WS7LR3I1D6,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/7c679424-c3f7-ed02-892f-20ca0d775089/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7c679424-c3f7-ed02-892f-20ca0d775089,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=7c679424-c3f7-ed02-892f-20ca0d775089,7c679424-c3f7-ed02-892f-20ca0d775089,,,
HUMAN PRESCRIPTION DRUG LABEL,SPRAY,NASAL,NDA,020626,IMITREX,SUMATRIPTAN,2024/03/22,Serotonin-1b and Serotonin-1d Receptor Agonist,1992,GLAXOSMITHKLINE LLC,completed:1997/09/18-2024/09/30; completed:1997/10/10-2025/07/31,0173-0523; 0173-0524,8R78F6L9VO,SUMATRIPTAN,SUMATRIPTAN,8R78F6L9VO,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/cc11b09d-e6cc-4cf8-1495-5ac64d5aae5f/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=cc11b09d-e6cc-4cf8-1495-5ac64d5aae5f,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=cc11b09d-e6cc-4cf8-1495-5ac64d5aae5f,cc11b09d-e6cc-4cf8-1495-5ac64d5aae5f,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,020132,IMITREX,SUMATRIPTAN,2024/02/21,Serotonin-1b and Serotonin-1d Receptor Agonist,1992,GLAXOSMITHKLINE LLC,2003/12/17-; 2003/12/19-,0173-0735; 0173-0736; 0173-0737,J8BDZ68989,SUMATRIPTAN SUCCINATE,SUMATRIPTAN,8R78F6L9VO,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/584abe73-8290-4484-ff8e-5890831c095e/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=584abe73-8290-4484-ff8e-5890831c095e,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=584abe73-8290-4484-ff8e-5890831c095e,584abe73-8290-4484-ff8e-5890831c095e,,,
HUMAN PRESCRIPTION DRUG LABEL,SPRAY,NASAL,NDA,210884,TOSYMRA,SUMATRIPTAN,2023/12/18,Serotonin-1b and Serotonin-1d Receptor Agonist,1992,UPSHER SMITH LABORATORIES LLC,2019/07/08-,0245-0812,8R78F6L9VO,Sumatriptan,Sumatriptan,8R78F6L9VO,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/015a5cf9-f246-48bc-b91e-cd730a53d8aa/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=015a5cf9-f246-48bc-b91e-cd730a53d8aa,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=015a5cf9-f246-48bc-b91e-cd730a53d8aa,015a5cf9-f246-48bc-b91e-cd730a53d8aa,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,SUBCUTANEOUS,NDA,020080,IMITREX,SUMATRIPTAN,2023/02/08,Serotonin-1b and Serotonin-1d Receptor Agonist,1992,GLAXOSMITHKLINE LLC,1997/01/23-; 1997/01/27-; 2006/04/06-,0173-0478; 0173-0479; 0173-0739,J8BDZ68989,SUMATRIPTAN SUCCINATE,SUMATRIPTAN,8R78F6L9VO,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/fee7d073-0b99-48f2-7985-0d8cf970894b/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=fee7d073-0b99-48f2-7985-0d8cf970894b,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=fee7d073-0b99-48f2-7985-0d8cf970894b,fee7d073-0b99-48f2-7985-0d8cf970894b,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",SUBCUTANEOUS,NDA,208223,ZEMBRACE SymTouch,SUMATRIPTAN,2019/06/10,Serotonin-1b and Serotonin-1d Receptor Agonist,1992,PROMIUS PHARMA LLC,2016/02/22-,67857-809,J8BDZ68989,SUMATRIPTAN SUCCINATE,SUMATRIPTAN,8R78F6L9VO,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/d565763d-b740-411d-bbb4-13536017d634/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d565763d-b740-411d-bbb4-13536017d634,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=d565763d-b740-411d-bbb4-13536017d634,d565763d-b740-411d-bbb4-13536017d634,,,
HUMAN PRESCRIPTION DRUG LABEL,SPRAY,NASAL,NDA,210884,TOSYMRA,SUMATRIPTAN,2019/01/25,Serotonin-1b and Serotonin-1d Receptor Agonist,1992,PROMIUS PHARMA LLC,2019/07/08-,67857-812,8R78F6L9VO,Sumatriptan,Sumatriptan,8R78F6L9VO,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/7260d567-3824-230d-836d-8065302baaec/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7260d567-3824-230d-836d-8065302baaec,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=7260d567-3824-230d-836d-8065302baaec,7260d567-3824-230d-836d-8065302baaec,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,SUBCUTANEOUS,NDA,022239,Sumavel DosePro,SUMATRIPTAN,2014/02/07,Serotonin-1b and Serotonin-1d Receptor Agonist,1992,ZOGENIX INC,2009/07/15-; 2013/12/04-,43376-104; 43376-106,J8BDZ68989,SUMATRIPTAN SUCCINATE,SUMATRIPTAN,8R78F6L9VO,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/6a4c0c2f-497d-4c5c-84c4-9ab42780cbde/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6a4c0c2f-497d-4c5c-84c4-9ab42780cbde,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=6a4c0c2f-497d-4c5c-84c4-9ab42780cbde,6a4c0c2f-497d-4c5c-84c4-9ab42780cbde,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,NASAL,NDA,206099,Onzetra Xsail,SUMATRIPTAN SUCCINATE,2024/04/18,Serotonin-1b and Serotonin-1d Receptor Agonist,1992,CURRAX PHARMACEUTICALS LLC,2015/10/01-,42847-311,J8BDZ68989,SUMATRIPTAN SUCCINATE,Sumatriptan,8R78F6L9VO,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/a8a9889e-69b9-4a57-b8c0-d40b1025c559/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a8a9889e-69b9-4a57-b8c0-d40b1025c559,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=a8a9889e-69b9-4a57-b8c0-d40b1025c559,a8a9889e-69b9-4a57-b8c0-d40b1025c559,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",SUBCUTANEOUS,NDA,208223,ZEMBRACE SYMTOUCH,SUMATRIPTAN SUCCINATE,2023/01/27,Serotonin-1b and Serotonin-1d Receptor Agonist,1992,UPSHER SMITH LABORATORIES LLC,2016/02/22-,0245-0809,J8BDZ68989,Sumatriptan Succinate,Sumatriptan,8R78F6L9VO,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/6e5b104f-2b9e-416e-92fb-ef1bdaea867d/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6e5b104f-2b9e-416e-92fb-ef1bdaea867d,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=6e5b104f-2b9e-416e-92fb-ef1bdaea867d,6e5b104f-2b9e-416e-92fb-ef1bdaea867d,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,021926,Treximet,SUMATRIPTAN SUCCINATE AND NAPROXEN SODIUM,2024/02/16,Nonsteroidal Anti-inflammatory Drug; Serotonin-1b and Serotonin-1d Receptor Agonist,2008,CURRAX PHARMACEUTICALS LLC,2008/04/25-,42847-850,9TN87S3A3C; J8BDZ68989,Naproxen Sodium; Sumatriptan Succinate,NAPROXEN; SUMATRIPTAN,57Y76R9ATQ; 8R78F6L9VO,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/42ddf376-8dc0-4236-be2a-0c6ae92ece04/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=42ddf376-8dc0-4236-be2a-0c6ae92ece04,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=42ddf376-8dc0-4236-be2a-0c6ae92ece04,42ddf376-8dc0-4236-be2a-0c6ae92ece04,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,NDA,021938,SUTENT,SUNITINIB MALATE,2022/12/08,Kinase Inhibitor,2006,U S PHARMACEUTICALS,2006/01/26-,63539-017; 63539-019,LVX8N1UT73,SUNITINIB MALATE,SUNITINIB,V99T50803M,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/a5d555f5-d66a-4f94-abcf-96fa6d71a32f/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a5d555f5-d66a-4f94-abcf-96fa6d71a32f,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=a5d555f5-d66a-4f94-abcf-96fa6d71a32f,a5d555f5-d66a-4f94-abcf-96fa6d71a32f,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,NDA,021938,SUTENT,SUNITINIB MALATE,2021/09/08,Kinase Inhibitor,2006,PFIZER LABORATORIES DIV PFIZER INC,2006/01/26-; 2014/07/12-,0069-0550; 0069-0770; 0069-0830; 0069-0980,LVX8N1UT73,SUNITINIB MALATE,SUNITINIB,V99T50803M,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/43a4d7f8-48ae-4a63-9108-2fa8e3ea9d9c/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=43a4d7f8-48ae-4a63-9108-2fa8e3ea9d9c,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=43a4d7f8-48ae-4a63-9108-2fa8e3ea9d9c,43a4d7f8-48ae-4a63-9108-2fa8e3ea9d9c,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,204569,BELSOMRA,SUVOREXANT,2023/02/28,Orexin Receptor Antagonist,2014,MERCK SHARP AND DOHME LLC,2014/08/29-,0006-0005; 0006-0033; 0006-0325; 0006-0335,081L192FO9,suvorexant,suvorexant,081L192FO9,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/e5b72731-1acb-45b7-9c13-290ad12d3951/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e5b72731-1acb-45b7-9c13-290ad12d3951,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=e5b72731-1acb-45b7-9c13-290ad12d3951,e5b72731-1acb-45b7-9c13-290ad12d3951,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, EXTENDED RELEASE",ORAL,NDA,206406,Envarsus XR,TACROLIMUS,2024/04/16,Calcineurin Inhibitor Immunosuppressant,1994,VELOXIS PHARMACEUTICALS INC,2015/09/01-,68992-3010; 68992-3040; 68992-3075,WM0HAQ4WNM,TACROLIMUS,TACROLIMUS ANHYDROUS,Y5L2157C4J,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/de2315b0-6344-43ac-9aea-3e3b68d828e7/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=de2315b0-6344-43ac-9aea-3e3b68d828e7,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=de2315b0-6344-43ac-9aea-3e3b68d828e7,de2315b0-6344-43ac-9aea-3e3b68d828e7,,,
HUMAN PRESCRIPTION DRUG LABEL,"CAPSULE, GELATIN COATED; GRANULE, FOR SUSPENSION; INJECTION, SOLUTION",INTRAVENOUS; ORAL,NDA,050708;050709;210115,Prograf,TACROLIMUS,2023/08/25,Calcineurin Inhibitor Immunosuppressant,1994,ASTELLAS PHARMA US INC,1994/04/08-; 1998/08/24-; 2018/05/24-,0469-0607; 0469-0617; 0469-0657; 0469-1230; 0469-1330; 0469-3016,WM0HAQ4WNM,TACROLIMUS,TACROLIMUS ANHYDROUS,Y5L2157C4J,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/7f667de1-9dfa-4bd6-8ba0-15ee2d78873b/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7f667de1-9dfa-4bd6-8ba0-15ee2d78873b,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=7f667de1-9dfa-4bd6-8ba0-15ee2d78873b,7f667de1-9dfa-4bd6-8ba0-15ee2d78873b,,,
HUMAN PRESCRIPTION DRUG LABEL,OINTMENT,TOPICAL,NDA,050777,Protopic,TACROLIMUS,2022/06/07,Calcineurin Inhibitor Immunosuppressant,,LEO PHARMA INC,completed:2000/12/08-2024/12/31,50222-203; 50222-211,WM0HAQ4WNM,TACROLIMUS,TACROLIMUS ANHYDROUS,Y5L2157C4J,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/51218de3-dabc-4972-9c5b-750c8b1d8083/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=51218de3-dabc-4972-9c5b-750c8b1d8083,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=51218de3-dabc-4972-9c5b-750c8b1d8083,51218de3-dabc-4972-9c5b-750c8b1d8083,,,
HUMAN PRESCRIPTION DRUG LABEL,OINTMENT,TOPICAL,NDA,050777,Tacrolimus,TACROLIMUS,2021/11/15,Calcineurin Inhibitor Immunosuppressant,,PADAGIS ISRAEL PHARMACEUTICALS LTD,2014/11/20-,45802-390; 45802-700,WM0HAQ4WNM,TACROLIMUS,TACROLIMUS ANHYDROUS,Y5L2157C4J,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/6b601eaf-4f3a-4a8b-8cd8-1000defa9822/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6b601eaf-4f3a-4a8b-8cd8-1000defa9822,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=6b601eaf-4f3a-4a8b-8cd8-1000defa9822,6b601eaf-4f3a-4a8b-8cd8-1000defa9822,,,
HUMAN PRESCRIPTION DRUG LABEL,"CAPSULE, COATED, EXTENDED RELEASE",ORAL,NDA,204096,ASTAGRAF XL,TACROLIMUS EXTENDED-RELEASE CAPSULES,2023/08/25,Calcineurin Inhibitor Immunosuppressant,1994,ASTELLAS PHARMA US INC,2013/07/19-,0469-0647; 0469-0677; 0469-0687,WM0HAQ4WNM,TACROLIMUS,TACROLIMUS ANHYDROUS,Y5L2157C4J,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/550a5cd4-fbf2-4c09-b577-6bde8fcbdf6e/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=550a5cd4-fbf2-4c09-b577-6bde8fcbdf6e,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=550a5cd4-fbf2-4c09-b577-6bde8fcbdf6e,550a5cd4-fbf2-4c09-b577-6bde8fcbdf6e,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,022332,ADCIRCA,TADALAFIL,2023/06/26,Phosphodiesterase 5 Inhibitor,2003,UNITED THERAPEUTICS CORPORATION,2009/05/22-,66302-467,742SXX0ICT,Tadalafil,tadalafil,742SXX0ICT,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/ff61b237-be8e-461b-8114-78c52a8ad0ae/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ff61b237-be8e-461b-8114-78c52a8ad0ae,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=ff61b237-be8e-461b-8114-78c52a8ad0ae,ff61b237-be8e-461b-8114-78c52a8ad0ae,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,021368,Cialis,TADALAFIL,2023/06/26,Phosphodiesterase 5 Inhibitor,2003,ELI LILLY AND COMPANY,2003/11/26-; 2008/01/07-,0002-4462; 0002-4463; 0002-4464; 0002-4465,742SXX0ICT,Tadalafil,Tadalafil,742SXX0ICT,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/bcd8f8ab-81a2-4891-83db-24a0b0e25895/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=bcd8f8ab-81a2-4891-83db-24a0b0e25895,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=bcd8f8ab-81a2-4891-83db-24a0b0e25895,bcd8f8ab-81a2-4891-83db-24a0b0e25895,,,
HUMAN PRESCRIPTION DRUG LABEL,SUSPENSION,ORAL,NDA,214522,TADLIQ,TADALAFIL,2022/10/15,Phosphodiesterase 5 Inhibitor,2003,CMP PHARMA INC,2022/08/30-,46287-045,742SXX0ICT,Tadalafil,tadalafil,742SXX0ICT,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/7a909b25-3772-403e-a5fe-e4a040293fb7/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7a909b25-3772-403e-a5fe-e4a040293fb7,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=7a909b25-3772-403e-a5fe-e4a040293fb7,7a909b25-3772-403e-a5fe-e4a040293fb7,,,
HUMAN PRESCRIPTION DRUG LABEL,"CAPSULE, LIQUID FILLED",ORAL,NDA,211996;212161,Vyndamax; Vyndaqel,TAFAMIDIS; TAFAMIDIS MEGLUMINE,2024/01/10,,2019,PFIZER LABORATORIES DIV PFIZER INC,2019/05/16-; 2019/08/27-,0069-1975; 0069-8730,8FG9H9D31J; ZU7CF08A1A,TAFAMIDIS; TAFAMIDIS MEGLUMINE,TAFAMIDIS,8FG9H9D31J,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/1b4121ee-a733-4456-a917-be2603477839/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1b4121ee-a733-4456-a917-be2603477839,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=1b4121ee-a733-4456-a917-be2603477839,1b4121ee-a733-4456-a917-be2603477839,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,210607,Arakoda,TAFENOQUINE,2023/01/11,,2018,DEGREES PHARMACEUTICALS LLC,2018/08/20-,71475-257,262P8GS9L9,TAFENOQUINE,TAFENOQUINE,262P8GS9L9,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/299e49d8-470f-4779-a010-4a1ee0e0c6cd/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=299e49d8-470f-4779-a010-4a1ee0e0c6cd,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=299e49d8-470f-4779-a010-4a1ee0e0c6cd,299e49d8-470f-4779-a010-4a1ee0e0c6cd,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,210795,Krintafel,TAFENOQUINE SUCCINATE,2023/08/02,,2018,GLAXOSMITHKLINE LLC,2019/01/22-,0173-0889,DL5J0B8VSS,TAFENOQUINE SUCCINATE,TAFENOQUINE,262P8GS9L9,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/5cf989d5-36f5-4561-a30b-9fcb9deb6b6a/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5cf989d5-36f5-4561-a30b-9fcb9deb6b6a,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=5cf989d5-36f5-4561-a30b-9fcb9deb6b6a,5cf989d5-36f5-4561-a30b-9fcb9deb6b6a,,,
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION/ DROPS,OPHTHALMIC,NDA,202514,ZIOPTAN,TAFLUPROST,2024/04/17,Prostaglandin Analog,2012,THEA PHARMA INC,2022/10/28-,82584-609,1O6WQ6T7G3,TAFLUPROST,TAFLUPROST,1O6WQ6T7G3,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/db529b54-2ac7-4020-9791-7333bbe6c90f/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=db529b54-2ac7-4020-9791-7333bbe6c90f,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=db529b54-2ac7-4020-9791-7333bbe6c90f,db529b54-2ac7-4020-9791-7333bbe6c90f,,,
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION/ DROPS,OPHTHALMIC,NDA,202514,ZIOPTAN,TAFLUPROST,2022/10/04,Prostaglandin Analog,2012,AKORN,2014/11/26-,17478-609,1O6WQ6T7G3,Tafluprost,Tafluprost,1O6WQ6T7G3,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/a3173c26-0e19-47af-a01c-3fc06b2700d1/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a3173c26-0e19-47af-a01c-3fc06b2700d1,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=a3173c26-0e19-47af-a01c-3fc06b2700d1,a3173c26-0e19-47af-a01c-3fc06b2700d1,,,
HUMAN PRESCRIPTION DRUG LABEL,"CAPSULE, LIQUID FILLED",ORAL,NDA,217439,Talzenna,TALAZOPARIB,2024/04/17,Poly(ADP-Ribose) Polymerase Inhibitor,2018,PFIZER LABORATORIES DIV PFIZER INC,2024/04/17-,0069-0252; 0069-0353; 0069-0454; 0069-0546; 0069-0655; 0069-0757,02WK9U5NZC,TALAZOPARIB TOSYLATE,TALAZOPARIB,9QHX048FRV,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/c6fd147f-a77e-4a0b-9280-e82ecc41b4be/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c6fd147f-a77e-4a0b-9280-e82ecc41b4be,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=c6fd147f-a77e-4a0b-9280-e82ecc41b4be,c6fd147f-a77e-4a0b-9280-e82ecc41b4be,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,NDA,211651,Talzenna,TALAZOPARIB,2024/02/21,Poly(ADP-Ribose) Polymerase Inhibitor,2018,U S PHARMACEUTICALS,2018/12/10-; 2023/06/21-,63539-051; 63539-295,02WK9U5NZC,TALAZOPARIB TOSYLATE,TALAZOPARIB,9QHX048FRV,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/13839d4f-6acf-4ffb-a128-79df59319273/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=13839d4f-6acf-4ffb-a128-79df59319273,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=13839d4f-6acf-4ffb-a128-79df59319273,13839d4f-6acf-4ffb-a128-79df59319273,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,NDA,211651,Talzenna,TALAZOPARIB,2024/02/14,Poly(ADP-Ribose) Polymerase Inhibitor,2018,PFIZER LABORATORIES DIV PFIZER INC,2018/10/26-; 2022/01/31-; 2023/06/21-,0069-0296; 0069-1031; 0069-1195; 0069-1235; 0069-1501; 0069-1751,02WK9U5NZC,TALAZOPARIB TOSYLATE,TALAZOPARIB,9QHX048FRV,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/f2423edd-6d24-495c-aec1-c2f457f08d9a/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f2423edd-6d24-495c-aec1-c2f457f08d9a,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=f2423edd-6d24-495c-aec1-c2f457f08d9a,f2423edd-6d24-495c-aec1-c2f457f08d9a,,,
HUMAN PRESCRIPTION DRUG LABEL,POWDER,INTRAPLEURAL,NDA,205555,Steritalc 2g; Steritalc 3g; Steritalc 4g,TALC,2023/01/12,,,NOVATECH SA,2017/08/01-; 2017/11/01-,62327-222; 62327-333; 62327-444,7SEV7J4R1U,TALC,TALC,7SEV7J4R1U,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/c94e51d9-beef-4b06-e053-2a95a90a754a/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c94e51d9-beef-4b06-e053-2a95a90a754a,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=c94e51d9-beef-4b06-e053-2a95a90a754a,c94e51d9-beef-4b06-e053-2a95a90a754a,,,
HUMAN PRESCRIPTION DRUG LABEL,POWDER,INTRAPLEURAL,NDA,021388,Sterile Talc,TALC,2014/06/05,,2003,BRYAN CORPORATION,2003/12/15-,63256-200,7SEV7J4R1U,Talc,Talc,7SEV7J4R1U,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/72b10d15-8337-49ab-ad8d-0e990192598e/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=72b10d15-8337-49ab-ad8d-0e990192598e,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=72b10d15-8337-49ab-ad8d-0e990192598e,72b10d15-8337-49ab-ad8d-0e990192598e,,,
HUMAN PRESCRIPTION DRUG LABEL,"AEROSOL, POWDER",INTRAPLEURAL,NDA,020587,Sclerosol,TALC,2012/10/18,,,BRYAN CORP,2013/06/30-,63256-100,7SEV7J4R1U,Talc,Talc,7SEV7J4R1U,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/c89eb8fd-6c31-4f8b-8103-1f559424eda1/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c89eb8fd-6c31-4f8b-8103-1f559424eda1,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=c89eb8fd-6c31-4f8b-8103-1f559424eda1,c89eb8fd-6c31-4f8b-8103-1f559424eda1,,,
HUMAN PRESCRIPTION DRUG LABEL,LIQUID,ORAL,NDA,021807,SOLTAMOX,TAMOXIFEN CITRATE,2021/11/29,Estrogen Agonist/Antagonist,1977,MAYNE PHARMA,2021/06/18-,51862-682,7FRV7310N6,TAMOXIFEN CITRATE,Tamoxifen,094ZI81Y45,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/1e6ff055-590c-41e6-9530-1fdf04cdbd02/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1e6ff055-590c-41e6-9530-1fdf04cdbd02,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=1e6ff055-590c-41e6-9530-1fdf04cdbd02,1e6ff055-590c-41e6-9530-1fdf04cdbd02,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,NDA,020579,FLOMAX,TAMSULOSIN HYDROCHLORIDE,2023/11/07,alpha-Adrenergic Blocker,1997,SANOFI AVENTIS U S LLC,2019/04/16-,0024-5837,11SV1951MR,TAMSULOSIN HYDROCHLORIDE,TAMSULOSIN,G3P28OML5I,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/6771ad8e-ac92-4aec-b484-5d8350a353f8/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6771ad8e-ac92-4aec-b484-5d8350a353f8,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=6771ad8e-ac92-4aec-b484-5d8350a353f8,6771ad8e-ac92-4aec-b484-5d8350a353f8,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,022304,Nucynta,TAPENTADOL HYDROCHLORIDE,2023/12/21,Opioid Agonist,2008,COLLEGIUM PHARMACEUTICAL INC,2019/04/01-,24510-050; 24510-075; 24510-100,71204KII53,TAPENTADOL HYDROCHLORIDE,TAPENTADOL,H8A007M585,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/80938c30-9fe3-4c7d-9d9c-5476638cfb2d/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=80938c30-9fe3-4c7d-9d9c-5476638cfb2d,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=80938c30-9fe3-4c7d-9d9c-5476638cfb2d,80938c30-9fe3-4c7d-9d9c-5476638cfb2d,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,NDA,200533,Nucynta ER,TAPENTADOL HYDROCHLORIDE,2023/12/20,Opioid Agonist,2008,COLLEGIUM PHARMACEUTICAL INC,2019/04/19-,24510-058; 24510-116; 24510-174; 24510-232; 24510-291,71204KII53,TAPENTADOL HYDROCHLORIDE,TAPENTADOL,H8A007M585,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/c3d04d70-0155-4147-9ce4-a3b1fad4b373/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c3d04d70-0155-4147-9ce4-a3b1fad4b373,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=c3d04d70-0155-4147-9ce4-a3b1fad4b373,c3d04d70-0155-4147-9ce4-a3b1fad4b373,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,022304,Nucynta,TAPENTADOL HYDROCHLORIDE,2018/12/07,Opioid Agonist,2008,DEPO NF SUB LLC,2017/06/16-,69865-210; 69865-220; 69865-230,71204KII53,TAPENTADOL HYDROCHLORIDE,TAPENTADOL,H8A007M585,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/ad05d6a0-addc-46e9-a5bd-7892b262b090/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ad05d6a0-addc-46e9-a5bd-7892b262b090,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=ad05d6a0-addc-46e9-a5bd-7892b262b090,ad05d6a0-addc-46e9-a5bd-7892b262b090,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED, EXTENDED RELEASE",ORAL,NDA,200533,Nucynta ER,TAPENTADOL HYDROCHLORIDE,2018/10/22,Opioid Agonist,2008,DEPO NF SUB LLC,2017/06/16-,69865-240; 69865-245; 69865-250; 69865-260; 69865-265,71204KII53,TAPENTADOL HYDROCHLORIDE,TAPENTADOL,H8A007M585,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/40671852-846e-4bc1-8e15-1f71add24414/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=40671852-846e-4bc1-8e15-1f71add24414,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=40671852-846e-4bc1-8e15-1f71add24414,40671852-846e-4bc1-8e15-1f71add24414,,,
HUMAN PRESCRIPTION DRUG LABEL,CREAM,TOPICAL,NDA,215272,VTAMA,TAPINAROF,2023/12/22,Aryl Hydrocarbon Receptor Agonist,2022,DERMAVANT SCIENCES INC,2022/05/26-,81672-5051,84HW7D0V04,TAPINAROF,TAPINAROF,84HW7D0V04,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/9309d20f-8cd4-4c96-93fa-7f730e83c7ab/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9309d20f-8cd4-4c96-93fa-7f730e83c7ab,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=9309d20f-8cd4-4c96-93fa-7f730e83c7ab,9309d20f-8cd4-4c96-93fa-7f730e83c7ab,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE; SUSPENSION,ORAL,NDA,205677;214517,Hetlioz; Hetlioz LQ,TASIMELTEON,2022/12/21,Melatonin Receptor Agonist,2014,VANDA PHARMACEUTICALS INC,2014/04/04-; 2020/12/10-,43068-220; 43068-304,SHS4PU80D9,TASIMELTEON,TASIMELTEON,SHS4PU80D9,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/ca4a9b63-708e-49e9-8f9b-010625443b90/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ca4a9b63-708e-49e9-8f9b-010625443b90,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=ca4a9b63-708e-49e9-8f9b-010625443b90,ca4a9b63-708e-49e9-8f9b-010625443b90,,,
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION,INTRALUMINAL,NDA,214520,DEFENCATH,TAUROLIDINE AND HEPARIN,2024/04/11,Anti-coagulant; Unfractionated Heparin,2023,CORMEDIX INC,2024/04/09-; completed:2024/04/09-2024/04/09,72990-103; 72990-105,8OBZ1M4V3V; T2410KM04A,HEPARIN; TAUROLIDINE,HEPARIN; TAUROLIDINE,8OBZ1M4V3V; T2410KM04A,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/13b3a61e-5a4b-4afb-8fa1-d76ebdb344d6/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=13b3a61e-5a4b-4afb-8fa1-d76ebdb344d6,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=13b3a61e-5a4b-4afb-8fa1-d76ebdb344d6,13b3a61e-5a4b-4afb-8fa1-d76ebdb344d6,,,
HUMAN PRESCRIPTION DRUG LABEL,"AEROSOL, FOAM",TOPICAL,NDA,202428,FABIOR,TAZAROTENE,2024/05/09,Retinoid,1997,MAYNE PHARMA,2017/03/10-,51862-295,81BDR9Y8PS,tazarotene,tazarotene,81BDR9Y8PS,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/ae0afed7-1d60-45fd-a08b-8db094618521/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ae0afed7-1d60-45fd-a08b-8db094618521,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=ae0afed7-1d60-45fd-a08b-8db094618521,ae0afed7-1d60-45fd-a08b-8db094618521,,,
HUMAN PRESCRIPTION DRUG LABEL,LOTION,TOPICAL,NDA,211882,Arazlo,TAZAROTENE,2023/09/26,Retinoid,1997,BAUSCH HEALTH US LLC,2019/12/19-,0187-2098,81BDR9Y8PS,TAZAROTENE,TAZAROTENE,81BDR9Y8PS,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/d941ff25-c221-4a55-8012-0dcf3bbcbbd1/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d941ff25-c221-4a55-8012-0dcf3bbcbbd1,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=d941ff25-c221-4a55-8012-0dcf3bbcbbd1,d941ff25-c221-4a55-8012-0dcf3bbcbbd1,,,
HUMAN PRESCRIPTION DRUG LABEL,CREAM,CUTANEOUS,NDA,021184,TAZORAC,TAZAROTENE,2022/12/15,Retinoid,1997,ALMIRALL LLC,2020/02/03-,16110-915; 16110-916,81BDR9Y8PS,tazarotene,tazarotene,81BDR9Y8PS,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/021744d1-a6d7-4ad6-99c2-7187c24e64c6/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=021744d1-a6d7-4ad6-99c2-7187c24e64c6,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=021744d1-a6d7-4ad6-99c2-7187c24e64c6,021744d1-a6d7-4ad6-99c2-7187c24e64c6,,,
HUMAN PRESCRIPTION DRUG LABEL,GEL,CUTANEOUS,NDA,020600,Tazorac,TAZAROTENE,2020/02/26,Retinoid,1997,ALMIRALL LLC,2020/02/21-,16110-042; 16110-833,81BDR9Y8PS,TAZAROTENE,TAZAROTENE,81BDR9Y8PS,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/4e4e4b81-420e-4492-8a74-80b692a80057/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4e4e4b81-420e-4492-8a74-80b692a80057,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=4e4e4b81-420e-4492-8a74-80b692a80057,4e4e4b81-420e-4492-8a74-80b692a80057,,,
HUMAN PRESCRIPTION DRUG LABEL,GEL,CUTANEOUS,NDA,020600,TAZORAC,TAZAROTENE,2018/04/16,Retinoid,1997,ALLERGAN INC,1997/08/01-,0023-0042; 0023-8335,81BDR9Y8PS,TAZAROTENE,TAZAROTENE,81BDR9Y8PS,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/75145c21-6ef2-455a-8a67-d48ddd4181a4/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=75145c21-6ef2-455a-8a67-d48ddd4181a4,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=75145c21-6ef2-455a-8a67-d48ddd4181a4,75145c21-6ef2-455a-8a67-d48ddd4181a4,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,211723,TAZVERIK,TAZEMETOSTAT,2023/12/21,Methyltransferase Inhibitor,2020,EPIZYME INC,2020/01/23-,72607-100,6P89T5M073,tazemetostat hydrobromide,tazemetostat,Q40W93WPE1,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/7db07b5f-4e22-467c-9c0a-f830b08dbb1d/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7db07b5f-4e22-467c-9c0a-f830b08dbb1d,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=7db07b5f-4e22-467c-9c0a-f830b08dbb1d,7db07b5f-4e22-467c-9c0a-f830b08dbb1d,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,050750,Zosyn in Galaxy Containers,TAZOBACTAM SODIUM AND PIPERACILLIN SODIUM,2023/03/15,Penicillin-class Antibacterial; beta Lactamase Inhibitor,1993,WYETH PHARMACEUTICALS LLC A SUBSIDIARY OF PFIZER INC,1998/03/01-,0206-8860; 0206-8861; 0206-8862,M98T69Q7HP; UXA545ABTT,PIPERACILLIN SODIUM; TAZOBACTAM SODIUM,PIPERACILLIN ANHYDROUS; TAZOBACTAM,9I628532GX; SE10G96M8W,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/8ab9d90d-2f7f-4599-a44f-3d0a8f8ab623/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8ab9d90d-2f7f-4599-a44f-3d0a8f8ab623,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=8ab9d90d-2f7f-4599-a44f-3d0a8f8ab623,8ab9d90d-2f7f-4599-a44f-3d0a8f8ab623,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAVENOUS,NDA,019882,Technescan MAG3,TECHNESCAN TC 99M MERTIATIDE,2022/12/13,,,CURIUM US LLC,1990/06/15-,69945-096,9NV2SR34P8,BETIATIDE,BETIATIDE,9NV2SR34P8,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/0571c18b-1d5e-47bd-bddf-54d74ce1b442/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0571c18b-1d5e-47bd-bddf-54d74ce1b442,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=0571c18b-1d5e-47bd-bddf-54d74ce1b442,0571c18b-1d5e-47bd-bddf-54d74ce1b442,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, POWDER, FOR SOLUTION",INTRAVENOUS,NDA,018035,Technetium Tc 99m Medronate,TECHNETIUM TC 99M MEDRONATE,2020/08/25,,,JUBILANT DRAXIMAGE INC DBA JUBILANT RADIOPHARMA,2004/02/27-,65174-660,73OS0QIN3O,MEDRONIC ACID,MEDRONIC ACID,73OS0QIN3O,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/3c91d0d8-6cc5-834c-bda0-aa83a873b9fb/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3c91d0d8-6cc5-834c-bda0-aa83a873b9fb,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=3c91d0d8-6cc5-834c-bda0-aa83a873b9fb,3c91d0d8-6cc5-834c-bda0-aa83a873b9fb,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAVENOUS,NDA,216820,TECHNETIUM Tc 99m MERTIATIDE,TECHNETIUM TC 99M MERTIATIDE,2023/01/22,,1990,JUBILANT DRAXIMAGE INC DBA JUBILANT RADIOPHARMA,2023/03/31-,65174-261,9NV2SR34P8,BETIATIDE,BETIATIDE,9NV2SR34P8,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/d497f2a2-8e8d-4372-ba09-f8e6b22d2cf8/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d497f2a2-8e8d-4372-ba09-f8e6b22d2cf8,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=d497f2a2-8e8d-4372-ba09-f8e6b22d2cf8,d497f2a2-8e8d-4372-ba09-f8e6b22d2cf8,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAVENOUS,NDA,018321,Technescan HDP,TECHNETIUM TC 99M OXIDRONATE,2022/12/20,,,CURIUM US LLC,2015/10/13-,69945-091,H852YK87WP,OXIDRONATE DISODIUM,OXIDRONIC ACID,71MR4V32TI,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/6fc2e41e-a1bf-4e0f-924a-88be0372d4af/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6fc2e41e-a1bf-4e0f-924a-88be0372d4af,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=6fc2e41e-a1bf-4e0f-924a-88be0372d4af,6fc2e41e-a1bf-4e0f-924a-88be0372d4af,,,
HUMAN PRESCRIPTION DRUG LABEL,KIT,INTRAVENOUS; ORAL; SUBCUTANEOUS,NDA,017858,Kit for the Prepartion of Technetium Tc99m Sulfur Colloid,TECHNETIUM TC 99M SULFUR COLLOID,2020/03/31,Radioactive Diagnostic Agent,1978,SUN PHARMACEUTICAL INDUSTRIES INC,1978/04/19-,45567-0030,556Q0P6PB1,TECHNETIUM TC-99M SULFUR COLLOID,TECHNETIUM TC-99M SULFUR COLLOID,556Q0P6PB1,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/eeaf70fd-46bd-4fec-ba9d-2366fdf07888/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=eeaf70fd-46bd-4fec-ba9d-2366fdf07888,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=eeaf70fd-46bd-4fec-ba9d-2366fdf07888,eeaf70fd-46bd-4fec-ba9d-2366fdf07888,,,
HUMAN PRESCRIPTION DRUG LABEL,KIT,INTRAVENOUS,NDA,019981,Ultratag RBC,TECHNETIUM TC 99M-LABELED RED BLOOD CELLS,2024/05/16,,,CURIUM US LLC,1991/06/10-,69945-068,1BQV3749L5,STANNOUS CHLORIDE,STANNOUS CATION,QI30938BMS,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/9f999b75-8a66-40bf-9352-478850b41225/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9f999b75-8a66-40bf-9352-478850b41225,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=9f999b75-8a66-40bf-9352-478850b41225,9f999b75-8a66-40bf-9352-478850b41225,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,017243,Ultra-Technekow V4,TECHNETIUM TC-99M,2022/06/09,,,CURIUM US LLC,2014/06/10-,69945-010; 69945-015; 69945-020; 69945-025; 69945-030; 69945-035; 69945-051; 69945-060; 69945-075; 69945-110; 69945-140; 69945-160; 69945-190,A0730CX801,TECHNETIUM TC-99M SODIUM PERTECHNETATE,TECHNETIUM TC-99M PERTECHNETATE,PPP8783IQ1,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/98947d99-5be5-461e-ad36-7425d3646389/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=98947d99-5be5-461e-ad36-7425d3646389,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=98947d99-5be5-461e-ad36-7425d3646389,98947d99-5be5-461e-ad36-7425d3646389,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAVENOUS,NDA,019829,CERETEC,TECHNETIUM TC-99M EXAMETAZIME,2024/01/10,Radioactive Diagnostic Agent,,MEDI PHYSICS INC DBA GE HEALTHCARE,1988/12/30-,17156-022,3B744AG22N,TECHNETIUM TC-99M EXAMETAZIME,TECHNETIUM TC-99M EXAMETAZIME,3B744AG22N,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/3c1eca7e-57a0-4876-8ed6-cd655ef5e296/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3c1eca7e-57a0-4876-8ed6-cd655ef5e296,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=3c1eca7e-57a0-4876-8ed6-cd655ef5e296,3c1eca7e-57a0-4876-8ed6-cd655ef5e296,,,
HUMAN PRESCRIPTION DRUG LABEL,KIT,INTRAVENOUS,NDA,019829,Ceretec,TECHNETIUM TC-99M EXAMETAZIME AND COBALTOUS CHLORIDE,2024/01/10,Radioactive Diagnostic Agent,1988,MEDI PHYSICS INC DBA GE HEALTHCARE,2018/09/25-,17156-025,3B744AG22N; EVS87XF13W,Cobaltous Chloride; Technetium Tc-99m Exametazime,COBALTOUS CATION; Technetium Tc-99m Exametazime,3B744AG22N; AI1MR454XG,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/d9c291e0-cd0d-43d2-87b4-defefd531942/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d9c291e0-cd0d-43d2-87b4-defefd531942,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=d9c291e0-cd0d-43d2-87b4-defefd531942,d9c291e0-cd0d-43d2-87b4-defefd531942,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,017771,TechneLite,TECHNETIUM TC99M GENERATOR,2023/01/31,,,LANTHEUS MEDICAL IMAGING INC,1975/11/01-,11994-090; 11994-091,A0730CX801,TECHNETIUM TC-99M SODIUM PERTECHNETATE,TECHNETIUM TC-99M PERTECHNETATE,PPP8783IQ1,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/3ae14c6b-3daf-4dd1-bbdb-e990fe8100e4/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3ae14c6b-3daf-4dd1-bbdb-e990fe8100e4,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=3ae14c6b-3daf-4dd1-bbdb-e990fe8100e4,3ae14c6b-3daf-4dd1-bbdb-e990fe8100e4,,,
HUMAN PRESCRIPTION DRUG LABEL,"CAPSULE; INJECTION, SOLUTION, CONCENTRATE",INTRAVENOUS; ORAL,NDA,208627;214518,TPOXX,TECOVIRIMAT MONOHYDRATE,2023/07/12,Orthopoxvirus VP37 Envelope Wrapping Protein Inhibitor,2018,SIGA TECHNOLOGIES INC,2018/08/31-; 2022/05/31-,50072-010; 50072-200,F925RR824R; SB96YO2BR8,TECOVIRIMAT; TECOVIRIMAT MONOHYDRATE,TECOVIRIMAT,F925RR824R,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/fce826ab-4d6a-4139-a2ee-a304a913a253/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=fce826ab-4d6a-4139-a2ee-a304a913a253,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=fce826ab-4d6a-4139-a2ee-a304a913a253,fce826ab-4d6a-4139-a2ee-a304a913a253,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION; TABLET, FILM COATED",INTRAVENOUS; ORAL,NDA,205435;205436,SIVEXTRO,TEDIZOLID PHOSPHATE,2023/03/10,Oxazolidinone Antibacterial,2014,MERCK SHARP AND DOHME LLC,2014/06/20-,67919-040; 67919-041,O7DRJ6R4DW,tedizolid phosphate,tedizolid,97HLQ82NGL,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/75672079-589f-451a-bdbf-eaebcfcc80a9/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=75672079-589f-451a-bdbf-eaebcfcc80a9,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=75672079-589f-451a-bdbf-eaebcfcc80a9,75672079-589f-451a-bdbf-eaebcfcc80a9,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION; TABLET, FILM COATED",INTRAVENOUS; ORAL,NDA,205435;205436,SIVEXTRO,TEDIZOLID PHOSPHATE,2022/07/25,Oxazolidinone Antibacterial,2014,NABRIVA THERAPEUTICS US INC,2014/06/20-,72000-310; 72000-320,O7DRJ6R4DW,TEDIZOLID PHOSPHATE,TEDIZOLID,97HLQ82NGL,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/11d5c110-c48c-438f-9c7d-5adf99938534/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=11d5c110-c48c-438f-9c7d-5adf99938534,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=11d5c110-c48c-438f-9c7d-5adf99938534,11d5c110-c48c-438f-9c7d-5adf99938534,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION; KIT",SUBCUTANEOUS; TOPICAL,NDA,203441,Gattex,TEDUGLUTIDE,2024/02/28,GLP-2 Analog,2012,TAKEDA PHARMACEUTICALS AMERICA INC,2012/12/21-,68875-0101; 68875-0102; 68875-0103,3K9958V90M; 7M19191IKG,alcohol; teduglutide,alcohol; teduglutide,3K9958V90M; 7M19191IKG,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/66b69c1e-b25c-44d3-b5ff-1c1de9a516fa/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=66b69c1e-b25c-44d3-b5ff-1c1de9a516fa,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=66b69c1e-b25c-44d3-b5ff-1c1de9a516fa,66b69c1e-b25c-44d3-b5ff-1c1de9a516fa,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,021200,ZELNORM,TEGASEROD,2020/06/09,Serotonin-4 Receptor Agonist,2002,ALFASIGMA USA INC,2019/08/01-,0525-0971,458VC51857,TEGASEROD,TEGASEROD,458VC51857,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/6a44eefe-fbe8-431c-a418-2571b26aa42e/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6a44eefe-fbe8-431c-a418-2571b26aa42e,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=6a44eefe-fbe8-431c-a418-2571b26aa42e,6a44eefe-fbe8-431c-a418-2571b26aa42e,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAVENOUS,NDA,022110,VIBATIV,TELAVANCIN HYDROCHLORIDE,2023/11/10,Lipoglycopeptide Antibacterial,2009,CUMBERLAND PHARMACEUTICALS INC,2021/01/01-,66220-315,0701472ZG0,telavancin hydrochloride,telavancin,XK134822Z0,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/5359b759-db7c-4672-9e8a-59c93869bd91/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5359b759-db7c-4672-9e8a-59c93869bd91,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=5359b759-db7c-4672-9e8a-59c93869bd91,5359b759-db7c-4672-9e8a-59c93869bd91,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAVENOUS,NDA,022110,Vibativ,TELAVANCIN HYDROCHLORIDE,2014/03/31,Lipoglycopeptide Antibacterial,2009,THERAVANCE INC,2009/11/05-,52118-001; 52118-002,0701472ZG0,telavancin hydrochloride,telavancin,XK134822Z0,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/9fc67b76-9ba1-45ec-9749-ca3f3a6477d9/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9fc67b76-9ba1-45ec-9749-ca3f3a6477d9,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=9fc67b76-9ba1-45ec-9749-ca3f3a6477d9,9fc67b76-9ba1-45ec-9749-ca3f3a6477d9,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,020850,Micardis,TELMISARTAN,2022/12/19,Angiotensin 2 Receptor Blocker,1998,BOEHRINGER INGELHEIM PHARMACEUTICALS INC,completed:2000/12/01-2025/04/30; completed:2000/12/01-2025/06/30,0597-0039; 0597-0040; 0597-0041,U5SYW473RQ,TELMISARTAN,TELMISARTAN,U5SYW473RQ,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/cfb9309f-e0df-4a55-9542-0e869fce05fb/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=cfb9309f-e0df-4a55-9542-0e869fce05fb,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=cfb9309f-e0df-4a55-9542-0e869fce05fb,cfb9309f-e0df-4a55-9542-0e869fce05fb,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,021162,Micardis HCT,TELMISARTAN AND HYDROCHLOROTHIAZIDE,2023/06/29,Angiotensin 2 Receptor Blocker; Thiazide Diuretic,2000,BOEHRINGER INGELHEIM PHARMACEUTICALS INC,2000/12/01-,0597-0042; 0597-0043; 0597-0044,0J48LPH2TH; U5SYW473RQ,HYDROCHLOROTHIAZIDE; TELMISARTAN,HYDROCHLOROTHIAZIDE; TELMISARTAN,0J48LPH2TH; U5SYW473RQ,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/b078dae2-664d-4144-847a-3b9d9b557402/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b078dae2-664d-4144-847a-3b9d9b557402,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=b078dae2-664d-4144-847a-3b9d9b557402,b078dae2-664d-4144-847a-3b9d9b557402,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,208794,Xermelo,TELOTRISTAT ETHYL,2022/10/25,Tryptophan Hydroxylase Inhibitor,2017,LEXICON PHARMACEUTICALS INC,2017/03/01-,70183-125,8G388563M7,telotristat ethyl,telotristat,381V4FCV2Z,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/f9108ac3-ca6e-4faf-9d04-953abb64d072/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f9108ac3-ca6e-4faf-9d04-953abb64d072,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=f9108ac3-ca6e-4faf-9d04-953abb64d072,f9108ac3-ca6e-4faf-9d04-953abb64d072,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,208794,Xermelo,TELOTRISTAT ETHYL,2022/10/25,Tryptophan Hydroxylase Inhibitor,2017,LEXICON PHARMACEUTICALS INC,2017/03/01-,70183-125,8G388563M7,telotristat ethyl,telotristat,381V4FCV2Z,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/f11c21f8-f725-445e-b38e-1e4c5b05bcc6/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f11c21f8-f725-445e-b38e-1e4c5b05bcc6,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=f11c21f8-f725-445e-b38e-1e4c5b05bcc6,f11c21f8-f725-445e-b38e-1e4c5b05bcc6,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,208794,Xermelo,TELOTRISTAT ETHYL,2022/10/04,Tryptophan Hydroxylase Inhibitor,2017,TERSERA THERAPEUTICS LLC,2020/10/05-,70720-125,8G388563M7,telotristat ethyl,telotristat,381V4FCV2Z,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/a4ac9d62-887c-4c8f-b04d-a5f31cec7c86/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a4ac9d62-887c-4c8f-b04d-a5f31cec7c86,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=a4ac9d62-887c-4c8f-b04d-a5f31cec7c86,a4ac9d62-887c-4c8f-b04d-a5f31cec7c86,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,NDA,018163,TEMAZEPAM,TEMAZEPAM,2024/05/14,Benzodiazepine,,SPECGX LLC,2010/02/23-,0406-9959; 0406-9960; 0406-9961; 0406-9962,CHB1QD2QSS,TEMAZEPAM,TEMAZEPAM,CHB1QD2QSS,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/c9bc61b4-a579-4003-98da-b6f6e381c150/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c9bc61b4-a579-4003-98da-b6f6e381c150,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=c9bc61b4-a579-4003-98da-b6f6e381c150,c9bc61b4-a579-4003-98da-b6f6e381c150,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,NDA,018163,RESTORIL,TEMAZEPAM,2024/05/09,Benzodiazepine,,SPECGX LLC,1981/02/27-,0406-9914; 0406-9915; 0406-9916; 0406-9917,CHB1QD2QSS,TEMAZEPAM,TEMAZEPAM,CHB1QD2QSS,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/bc56f7fd-1aaf-48ff-8aa7-d467e59e1015/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=bc56f7fd-1aaf-48ff-8aa7-d467e59e1015,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=bc56f7fd-1aaf-48ff-8aa7-d467e59e1015,bc56f7fd-1aaf-48ff-8aa7-d467e59e1015,,,
HUMAN PRESCRIPTION DRUG LABEL,"CAPSULE; INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAVENOUS; ORAL,NDA,021029;022277,TEMODAR,TEMOZOLOMIDE,2023/09/14,Alkylating Drug,1999,MERCK SHARP AND DOHME LLC,1999/08/11-; 2009/02/27-,0085-1366; 0085-1381; 0085-1417; 0085-1425; 0085-1430; 0085-1519; 0085-3004,YF1K15M17Y,Temozolomide,Temozolomide,YF1K15M17Y,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/046a9011-3911-4d3f-a15f-fbb56d5aad56/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=046a9011-3911-4d3f-a15f-fbb56d5aad56,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=046a9011-3911-4d3f-a15f-fbb56d5aad56,046a9011-3911-4d3f-a15f-fbb56d5aad56,,,
HUMAN PRESCRIPTION DRUG LABEL,KIT,INTRAVENOUS,NDA,022088,Torisel,TEMSIROLIMUS,2023/04/28,Kinase Inhibitor,2007,WYETH PHARMACEUTICALS LLC A SUBSIDIARY OF PFIZER INC,2007/07/01-,0008-1179,624KN6GM2T,TEMSIROLIMUS,TEMSIROLIMUS,624KN6GM2T,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/95b7dc92-2180-42f1-8699-3c28f609e674/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=95b7dc92-2180-42f1-8699-3c28f609e674,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=95b7dc92-2180-42f1-8699-3c28f609e674,95b7dc92-2180-42f1-8699-3c28f609e674,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,213931,XPHOZAH 10 mg; XPHOZAH 20 mg; XPHOZAH 30 mg,TENAPANOR,2023/10/17,Sodium-Hydrogen Exchanger 3 Inhibitor,2019,ARDELYX INC,2023/10/17-,73154-110; 73154-120; 73154-130,WYD79216A6,TENAPANOR,TENAPANOR,WYD79216A6,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/c57e279c-0f1b-4238-81b7-4e0dc0cc60c5/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c57e279c-0f1b-4238-81b7-4e0dc0cc60c5,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=c57e279c-0f1b-4238-81b7-4e0dc0cc60c5,c57e279c-0f1b-4238-81b7-4e0dc0cc60c5,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,211801,IBSRELA,TENAPANOR HYDROCHLORIDE,2022/04/14,Sodium-Hydrogen Exchanger 3 Inhibitor,2019,ARDELYX INC,2019/09/12-,73154-050,50605O2ZNS,TENAPANOR HYDROCHLORIDE,TENAPANOR,WYD79216A6,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/2102da5f-a1a0-4ac7-a1f6-38698cf7273a/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2102da5f-a1a0-4ac7-a1f6-38698cf7273a,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=2102da5f-a1a0-4ac7-a1f6-38698cf7273a,2102da5f-a1a0-4ac7-a1f6-38698cf7273a,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,208464,VEMLIDY,TENOFOVIR ALAFENAMIDE,2024/04/04,Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor,2015,GILEAD SCIENCES INC,2016/11/10-,61958-2301,FWF6Q91TZO,TENOFOVIR ALAFENAMIDE FUMARATE,TENOFOVIR ANHYDROUS,W4HFE001U5,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/72e6b33c-0351-4070-9172-eeaa186c01d2/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=72e6b33c-0351-4070-9172-eeaa186c01d2,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=72e6b33c-0351-4070-9172-eeaa186c01d2,72e6b33c-0351-4070-9172-eeaa186c01d2,,,
HUMAN PRESCRIPTION DRUG LABEL,"POWDER; TABLET, COATED",ORAL,NDA,021356;022577,Viread,TENOFOVIR DISOPROXIL FUMARATE,2021/03/11,Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor,2001,GILEAD SCIENCES INC,2001/10/26-; 2012/01/18-,61958-0401; 61958-0403; 61958-0404; 61958-0405; 61958-0406,OTT9J7900I,TENOFOVIR DISOPROXIL FUMARATE,TENOFOVIR ANHYDROUS,W4HFE001U5,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/33fd6418-fbdc-42ca-a50d-ce2a476a5418/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=33fd6418-fbdc-42ca-a50d-ce2a476a5418,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=33fd6418-fbdc-42ca-a50d-ce2a476a5418,33fd6418-fbdc-42ca-a50d-ce2a476a5418,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,214096,TEPMETKO,TEPOTINIB HYDROCHLORIDE,2024/02/23,Kinase Inhibitor,2021,EMD SERONO INC,2021/02/03-,44087-5000,VY5YX2TQ1F,Tepotinib Hydrochloride,Tepotinib,1IJV77EI07,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/80a0f1b9-071a-47f5-9e67-32d638a669dc/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=80a0f1b9-071a-47f5-9e67-32d638a669dc,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=80a0f1b9-071a-47f5-9e67-32d638a669dc,80a0f1b9-071a-47f5-9e67-32d638a669dc,,,
HUMAN PRESCRIPTION DRUG LABEL,CREAM,VAGINAL,NDA,021735,Terconazole Vaginal Cream 0.8%,TERCONAZOLE,2021/02/16,Azole Antifungal,,E FOUGERA AND CO A DIVISION OF FOUGERA PHARMACEUTICALS INC,2005/02/01-,0168-0347,0KJ2VE664U,terconazole,terconazole,0KJ2VE664U,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/f59448bd-f730-46d2-a785-c2d6205579ff/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f59448bd-f730-46d2-a785-c2d6205579ff,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=f59448bd-f730-46d2-a785-c2d6205579ff,f59448bd-f730-46d2-a785-c2d6205579ff,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,202992,Aubagio,TERIFLUNOMIDE,2023/11/21,Pyrimidine Synthesis Inhibitor,2012,GENZYME CORPORATION,2013/05/01-,58468-0210; 58468-0211,1C058IKG3B,TERIFLUNOMIDE,TERIFLUNOMIDE,1C058IKG3B,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/4650d12c-b9c8-4525-b07f-a2d773eca155/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4650d12c-b9c8-4525-b07f-a2d773eca155,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=4650d12c-b9c8-4525-b07f-a2d773eca155,4650d12c-b9c8-4525-b07f-a2d773eca155,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",SUBCUTANEOUS,NDA,021318,Forteo,TERIPARATIDE,2023/12/11,Parathyroid Hormone Analog,1987,ELI LILLY AND COMPANY,2002/11/26-,0002-8400,10T9CSU89I,Teriparatide,Teriparatide,10T9CSU89I,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/aae667c5-381f-4f92-93df-2ed6158d07b0/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=aae667c5-381f-4f92-93df-2ed6158d07b0,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=aae667c5-381f-4f92-93df-2ed6158d07b0,aae667c5-381f-4f92-93df-2ed6158d07b0,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAVENOUS,NDA,022231,Terlivaz,TERLIPRESSIN,2024/04/15,Vasopressin Receptor Agonist,2022,MALLINCKRODT HOSPITAL PRODUCTS INC,2022/09/14-,43825-200,7Z5X49W53P,Terlipressin,Terlipressin,7Z5X49W53P,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/3a35b86c-f451-4fac-8499-43019e4da354/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3a35b86c-f451-4fac-8499-43019e4da354,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=3a35b86c-f451-4fac-8499-43019e4da354,3a35b86c-f451-4fac-8499-43019e4da354,,,
HUMAN PRESCRIPTION DRUG LABEL,GEL,TRANSDERMAL,NDA,022309,AndroGel,TESTOSTERONE,2023/12/20,Androgen,1953,ASCEND THERAPEUTICS U S LLC,2023/02/17-,17139-562,3XMK78S47O,TESTOSTERONE,TESTOSTERONE,3XMK78S47O,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/f4e8d29b-8707-4d47-e053-2a95a90aecee/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f4e8d29b-8707-4d47-e053-2a95a90aecee,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=f4e8d29b-8707-4d47-e053-2a95a90aecee,f4e8d29b-8707-4d47-e053-2a95a90aecee,,,
HUMAN PRESCRIPTION DRUG LABEL,"GEL, METERED",NASAL,NDA,205488,Natesto nasal gel,TESTOSTERONE,2022/12/19,Androgen,1953,ACERUS PHARMACEUTICALS CORPORATION,2020/05/08-,42667-5511,3XMK78S47O,TESTOSTERONE,TESTOSTERONE,3XMK78S47O,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/dea6bed1-eaca-11e3-ac10-0800200c9a66/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=dea6bed1-eaca-11e3-ac10-0800200c9a66,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=dea6bed1-eaca-11e3-ac10-0800200c9a66,dea6bed1-eaca-11e3-ac10-0800200c9a66,,,
HUMAN PRESCRIPTION DRUG LABEL,"GEL, METERED",TOPICAL,NDA,021463,FORTESTA,TESTOSTERONE,2022/01/31,Androgen,1953,ENDO PHARMACEUTICALS INC,2010/12/29-,63481-183,3XMK78S47O,TESTOSTERONE,TESTOSTERONE,3XMK78S47O,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/053a7300-0bce-11e0-9d16-0002a5d5c51b/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=053a7300-0bce-11e0-9d16-0002a5d5c51b,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=053a7300-0bce-11e0-9d16-0002a5d5c51b,053a7300-0bce-11e0-9d16-0002a5d5c51b,,,
HUMAN PRESCRIPTION DRUG LABEL,GEL,TRANSDERMAL,NDA,021454,Testim,TESTOSTERONE,2021/08/25,Androgen,1953,ENDO PHARMACEUTICALS INC,2002/10/31-,66887-001,3XMK78S47O,TESTOSTERONE,TESTOSTERONE,3XMK78S47O,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/9f2aae1f-898d-4955-be31-678e0cf85395/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9f2aae1f-898d-4955-be31-678e0cf85395,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=9f2aae1f-898d-4955-be31-678e0cf85395,9f2aae1f-898d-4955-be31-678e0cf85395,,,
HUMAN PRESCRIPTION DRUG LABEL,GEL,TRANSDERMAL,NDA,022309,Androgel,TESTOSTERONE,2020/11/01,Androgen,1953,ABBVIE INC,completed:2011/04/29-2025/05/01,0051-8462,3XMK78S47O,testosterone,testosterone,3XMK78S47O,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/8677ba5b-8374-46cb-854c-403972e9ddf3/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8677ba5b-8374-46cb-854c-403972e9ddf3,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=8677ba5b-8374-46cb-854c-403972e9ddf3,8677ba5b-8374-46cb-854c-403972e9ddf3,,,
HUMAN PRESCRIPTION DRUG LABEL,PATCH,TRANSDERMAL,NDA,020489,Androderm,TESTOSTERONE,2020/05/18,Androgen,1953,ALLERGAN INC,completed:1995/09/29-2024/09/30,0023-5990; 0023-5992,3XMK78S47O,TESTOSTERONE,TESTOSTERONE,3XMK78S47O,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/e58a5328-fdd9-40cb-a19f-8ed798989b9c/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e58a5328-fdd9-40cb-a19f-8ed798989b9c,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=e58a5328-fdd9-40cb-a19f-8ed798989b9c,e58a5328-fdd9-40cb-a19f-8ed798989b9c,,,
HUMAN PRESCRIPTION DRUG LABEL,GEL,NASAL,NDA,205488,Natesto,TESTOSTERONE,2019/12/19,Androgen,1953,AYTU BIOSCIENCE INC,2017/09/01-,69654-239,3XMK78S47O,testosterone,testosterone,3XMK78S47O,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/68d0447b-f75a-4fb2-96ba-de822b74aebb/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=68d0447b-f75a-4fb2-96ba-de822b74aebb,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=68d0447b-f75a-4fb2-96ba-de822b74aebb,68d0447b-f75a-4fb2-96ba-de822b74aebb,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,BUCCAL,NDA,021543,Striant,TESTOSTERONE,2009/11/19,Androgen,,COLUMBIA LABORATORIES INC,2003/06/19-,55056-3060,3XMK78S47O,testosterone,testosterone,3XMK78S47O,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/ac47efbe-025b-4688-bcd3-a10a0b012b34/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ac47efbe-025b-4688-bcd3-a10a0b012b34,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=ac47efbe-025b-4688-bcd3-a10a0b012b34,ac47efbe-025b-4688-bcd3-a10a0b012b34,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAMUSCULAR,NDA,216318,TESTOSTERONE,TESTOSTERONE CYPIONATE,2022/06/12,Androgen,,SLAYBACK PHARMA LLC,2022/06/13-,71225-127,M0XW1UBI14,TESTOSTERONE CYPIONATE,TESTOSTERONE,3XMK78S47O,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/cb411b78-0072-42b0-b75d-85ee96cfbf3c/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=cb411b78-0072-42b0-b75d-85ee96cfbf3c,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=cb411b78-0072-42b0-b75d-85ee96cfbf3c,cb411b78-0072-42b0-b75d-85ee96cfbf3c,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,SUBCUTANEOUS,NDA,209863,XYOSTED,TESTOSTERONE ENANTHATE,2024/01/04,Androgen,1953,ANTARES PHARMA INC,2018/11/15-,54436-200; 54436-250; 54436-275,7Z6522T8N9,TESTOSTERONE ENANTHATE,TESTOSTERONE,3XMK78S47O,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/8a3d204c-be26-49e0-8599-0ac12a272e81/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8a3d204c-be26-49e0-8599-0ac12a272e81,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=8a3d204c-be26-49e0-8599-0ac12a272e81,8a3d204c-be26-49e0-8599-0ac12a272e81,,,
HUMAN PRESCRIPTION DRUG LABEL,"CAPSULE, LIQUID FILLED",ORAL,NDA,208088,Tlando Tee-lan-doh,TESTOSTERONE UNDECANOATE,2024/02/01,Androgen,1953,VERITY PHARMACEUTICALS INC,2022/04/15-,74676-0112,H16A5VCT9C,TESTOSTERONE UNDECANOATE,TESTOSTERONE,3XMK78S47O,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/4b0b92e9-6d3c-a0e5-e1c7-342999f72580/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4b0b92e9-6d3c-a0e5-e1c7-342999f72580,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=4b0b92e9-6d3c-a0e5-e1c7-342999f72580,4b0b92e9-6d3c-a0e5-e1c7-342999f72580,,,
HUMAN PRESCRIPTION DRUG LABEL,"CAPSULE, LIQUID FILLED",ORAL,NDA,208088,Tlando,TESTOSTERONE UNDECANOATE,2023/12/14,Androgen,1953,ANTARES PHARMA INC,2022/04/15-,54436-112,H16A5VCT9C,TESTOSTERONE UNDECANOATE,TESTOSTERONE,3XMK78S47O,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/479b55bd-2023-486a-8922-3b1de48b935c/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=479b55bd-2023-486a-8922-3b1de48b935c,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=479b55bd-2023-486a-8922-3b1de48b935c,479b55bd-2023-486a-8922-3b1de48b935c,,,
HUMAN PRESCRIPTION DRUG LABEL,"CAPSULE, LIQUID FILLED",ORAL,NDA,213953,Kyzatrex,TESTOSTERONE UNDECANOATE,2023/10/26,Androgen,1953,MARIUS PHARMACEUTICALS,2022/07/27-,80603-101; 80603-103; 80603-105,H16A5VCT9C,TESTOSTERONE UNDECANOATE,TESTOSTERONE,3XMK78S47O,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/7f7167a7-2a25-47e2-acf5-33f499fce971/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7f7167a7-2a25-47e2-acf5-33f499fce971,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=7f7167a7-2a25-47e2-acf5-33f499fce971,7f7167a7-2a25-47e2-acf5-33f499fce971,,,
HUMAN PRESCRIPTION DRUG LABEL,"CAPSULE, LIQUID FILLED",ORAL,NDA,206089,Jatenzo,TESTOSTERONE UNDECANOATE,2023/08/15,Androgen,1953,TOLMAR INC,2019/08/01-,69087-158; 69087-198; 69087-237,H16A5VCT9C,TESTOSTERONE UNDECANOATE,TESTOSTERONE,3XMK78S47O,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/ed7b5d41-7475-4c10-99b9-b62b3434ae60/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ed7b5d41-7475-4c10-99b9-b62b3434ae60,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=ed7b5d41-7475-4c10-99b9-b62b3434ae60,ed7b5d41-7475-4c10-99b9-b62b3434ae60,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRAMUSCULAR,NDA,022219,Aveed,TESTOSTERONE UNDECANOATE,2021/08/28,Androgen,1953,ENDO USA INC,2014/03/05-,67979-511,H16A5VCT9C,TESTOSTERONE UNDECANOATE,TESTOSTERONE,3XMK78S47O,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/f80f025b-17d8-40af-8739-20ce07902045/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f80f025b-17d8-40af-8739-20ce07902045,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=f80f025b-17d8-40af-8739-20ce07902045,f80f025b-17d8-40af-8739-20ce07902045,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,021894,Xenazine,TETRABENAZINE,2019/11/01,Vesicular Monoamine Transporter 2 Inhibitor,2008,LUNDBECK PHARMACEUTICALS LLC,2008/11/24-,67386-421; 67386-422,Z9O08YRN8O,TETRABENAZINE,TETRABENAZINE,Z9O08YRN8O,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/ac768bab-8afa-4446-bc7f-caeeffec0cda/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ac768bab-8afa-4446-bc7f-caeeffec0cda,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=ac768bab-8afa-4446-bc7f-caeeffec0cda,ac768bab-8afa-4446-bc7f-caeeffec0cda,,,
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION,OPHTHALMIC,NDA,208135,Tetracaine Hydrochloride,TETRACAINE HYDROCHLORIDE,2024/01/19,Ester Local Anesthetic,1965,ALCON LABORATORIES INC,2016/11/02-,0065-0741,5NF5D4OPCI,Tetracaine Hydrochloride,Tetracaine,0619F35CGV,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/5c7b1de4-9f55-1d0e-ef6d-b0ba2cbaba79/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5c7b1de4-9f55-1d0e-ef6d-b0ba2cbaba79,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=5c7b1de4-9f55-1d0e-ef6d-b0ba2cbaba79,5c7b1de4-9f55-1d0e-ef6d-b0ba2cbaba79,,,
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION/ DROPS,OPHTHALMIC,NDA,210821,Tetracaine Hydrochloride,TETRACAINE HYDROCHLORIDE,2022/05/31,Ester Local Anesthetic,1965,BAUSCH AND LOMB INCORPORATED,2022/09/23-,24208-092,5NF5D4OPCI,TETRACAINE HYDROCHLORIDE,TETRACAINE,0619F35CGV,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/8352a2c8-15e7-4719-ac06-df10ff6b0568/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8352a2c8-15e7-4719-ac06-df10ff6b0568,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=8352a2c8-15e7-4719-ac06-df10ff6b0568,8352a2c8-15e7-4719-ac06-df10ff6b0568,,,
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION/ DROPS,OPHTHALMIC,NDA,210821,Tetracaine Hydrochloride,TETRACAINE HYDROCHLORIDE,2022/05/01,Ester Local Anesthetic,1965,BAUSCH AND LOMB AMERICAS INC,2022/09/21-,82260-920,5NF5D4OPCI,TETRACAINE HYDROCHLORIDE,TETRACAINE,0619F35CGV,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/f12d5944-0d6c-43ff-89fd-e0b5669e9b4a/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f12d5944-0d6c-43ff-89fd-e0b5669e9b4a,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=f12d5944-0d6c-43ff-89fd-e0b5669e9b4a,f12d5944-0d6c-43ff-89fd-e0b5669e9b4a,,,
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION/ DROPS,OPHTHALMIC,NDA,210821,Tetracaine Hydrochloride,TETRACAINE HYDROCHLORIDE,2022/02/28,Ester Local Anesthetic,1965,OCEANSIDE PHARMACEUTICALS,2019/06/27-,68682-920,5NF5D4OPCI,TETRACAINE HYDROCHLORIDE,TETRACAINE,0619F35CGV,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/807dae5d-f34a-4f3d-9f54-dd350b056a92/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=807dae5d-f34a-4f3d-9f54-dd350b056a92,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=807dae5d-f34a-4f3d-9f54-dd350b056a92,807dae5d-f34a-4f3d-9f54-dd350b056a92,,,
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION/ DROPS,OPHTHALMIC,NDA,210821,Tetracaine Hydrochloride,TETRACAINE HYDROCHLORIDE,2020/04/06,Ester Local Anesthetic,1965,BAUSCH HEALTH US LLC,2019/06/27-,0187-0920,5NF5D4OPCI,TETRACAINE HYDROCHLORIDE,TETRACAINE,0619F35CGV,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/78404c9e-9c31-4b0a-90f4-04182e82e183/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=78404c9e-9c31-4b0a-90f4-04182e82e183,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=78404c9e-9c31-4b0a-90f4-04182e82e183,78404c9e-9c31-4b0a-90f4-04182e82e183,,,
HUMAN PRESCRIPTION DRUG LABEL,SPRAY,NASAL,NDA,208032,Kovanaze,TETRACAINE HYDROCHLORIDE AND OXYMETAZOLINE HYDROCHLORIDE,2018/11/16,Ester Local Anesthetic; Vasoconstrictor,2016,ST RENATUS,2016/09/01-,69803-100,5NF5D4OPCI; K89MJ0S5VY,OXYMETAZOLINE HYDROCHLORIDE; TETRACAINE HYDROCHLORIDE,OXYMETAZOLINE; TETRACAINE,0619F35CGV; 8VLN5B44ZY,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/d2af5404-3cfe-445d-8328-19e667ecdc43/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d2af5404-3cfe-445d-8328-19e667ecdc43,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=d2af5404-3cfe-445d-8328-19e667ecdc43,d2af5404-3cfe-445d-8328-19e667ecdc43,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAVENOUS,NDA,019785,Cardiolite,TETRAKIS(2-METHOXYISOBUTYLISOCYANIDE)COPPER(I) TETRAFLUOROBORATE,2022/12/06,,1990,LANTHEUS MEDICAL IMAGING INC,1990/12/20-,11994-001,N6OU7HJ70P,TETRAKIS(2-METHOXYISOBUTYLISOCYANIDE)COPPER(I) TETRAFLUOROBORATE,TETRAKIS(2-METHOXYISOBUTYLISOCYANIDE)COPPER(I) TETRAFLUOROBORATE,N6OU7HJ70P,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/49662def-2fb9-47b2-8467-ca56f6006167/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=49662def-2fb9-47b2-8467-ca56f6006167,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=49662def-2fb9-47b2-8467-ca56f6006167,49662def-2fb9-47b2-8467-ca56f6006167,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAVENOUS,NDA,019785,Kit for the Preparation of Technetium Tc99m Sestamibi,TETRAKIS(2-METHOXYISOBUTYLISOCYANIDE)COPPER(I) TETRAFLUOROBORATE,2022/11/18,,1990,LANTHEUS MEDICAL IMAGING INC,1990/12/20-,11994-003,N6OU7HJ70P,TETRAKIS(2-METHOXYISOBUTYLISOCYANIDE)COPPER(I) TETRAFLUOROBORATE,TETRAKIS(2-METHOXYISOBUTYLISOCYANIDE)COPPER(I) TETRAFLUOROBORATE,N6OU7HJ70P,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/8c03a854-185a-45d7-883f-9f87e4750181/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8c03a854-185a-45d7-883f-9f87e4750181,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=8c03a854-185a-45d7-883f-9f87e4750181,8c03a854-185a-45d7-883f-9f87e4750181,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAVENOUS,NDA,020372,Myoview,TETROFOSMIN,2024/01/10,,1996,MEDI PHYSICS INC DBA GE HEALTHCARE,2009/02/26-,17156-026,3J0KPB596Q,Tetrofosmin,Tetrofosmin,3J0KPB596Q,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/98c85037-a907-4a3a-8864-c3a5298b4759/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=98c85037-a907-4a3a-8864-c3a5298b4759,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=98c85037-a907-4a3a-8864-c3a5298b4759,98c85037-a907-4a3a-8864-c3a5298b4759,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAVENOUS,NDA,020372,Myoview,TETROFOSMIN,2024/01/10,,1996,MEDI PHYSICS INC DBA GE HEALTHCARE,1996/02/09-,17156-024,3J0KPB596Q,Tetrofosmin,Tetrofosmin,3J0KPB596Q,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/4a8e5ed7-57f4-4d48-93cd-5f307207a3a0/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4a8e5ed7-57f4-4d48-93cd-5f307207a3a0,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=4a8e5ed7-57f4-4d48-93cd-5f307207a3a0,4a8e5ed7-57f4-4d48-93cd-5f307207a3a0,,,
HUMAN PRESCRIPTION DRUG LABEL,KIT,ORAL,NDA,210491,SYMDEKO,TEZACAFTOR AND IVACAFTOR,2023/10/16,Cystic Fibrosis Transmembrane Conductance Regulator Potentiator,2018,VERTEX PHARMACEUTICALS INCORPORATED,2018/02/12-; 2019/06/21-,51167-113; 51167-661,1Y740ILL1Z; 8RW88Y506K,Ivacaftor; Tezacaftor,Ivacaftor; Tezacaftor,1Y740ILL1Z; 8RW88Y506K,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/302ae804-37db-44fd-ac2f-3dbdeda9aa4b/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=302ae804-37db-44fd-ac2f-3dbdeda9aa4b,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=302ae804-37db-44fd-ac2f-3dbdeda9aa4b,302ae804-37db-44fd-ac2f-3dbdeda9aa4b,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,NDA,020785,Thalomid,THALIDOMIDE,2023/03/24,,1998,CELGENE CORPORATION,2003/06/20-; 2007/03/20-,59572-205; 59572-210; 59572-215; 59572-220,4Z8R6ORS6L,THALIDOMIDE,THALIDOMIDE,4Z8R6ORS6L,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/2eda833b-1357-4ed4-a093-194524fcb061/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2eda833b-1357-4ed4-a093-194524fcb061,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=2eda833b-1357-4ed4-a093-194524fcb061,2eda833b-1357-4ed4-a093-194524fcb061,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,018150,THALLOUS CHLORIDE Tl 201,"THALLOUS CHLORIDE, TL 201",2019/12/19,Radioactive Diagnostic Agent,1979,CURIUM US LLC,2015/11/04-,69945-120,3I8Y076A0E,THALLOUS CHLORIDE TL-201,THALLOUS CATION TL-201,4877X14G4C,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/0da81fc0-a137-46d3-9378-d8053a82e61a/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0da81fc0-a137-46d3-9378-d8053a82e61a,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=0da81fc0-a137-46d3-9378-d8053a82e61a,0da81fc0-a137-46d3-9378-d8053a82e61a,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,019826,Theophylline in Dextrose,THEOPHYLLINE ANHYDROUS AND DEXTROSE,2017/08/11,Methylxanthine,,B BRAUN MEDICAL INC,1992/08/14-,0264-9554,0I55128JYK; LX22YL083G,DEXTROSE MONOHYDRATE; THEOPHYLLINE ANHYDROUS,ANHYDROUS DEXTROSE; THEOPHYLLINE ANHYDROUS,0I55128JYK; 5SL0G7R0OK,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/c3bb34c1-89b2-48c3-9ad2-16b4b2bce5f9/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c3bb34c1-89b2-48c3-9ad2-16b4b2bce5f9,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=c3bb34c1-89b2-48c3-9ad2-16b4b2bce5f9,c3bb34c1-89b2-48c3-9ad2-16b4b2bce5f9,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,012429,TABLOID,THIOGUANINE,2023/05/16,Antimetabolite,,WAYLIS THERAPEUTICS LLC,2023/05/15-,80725-630,FTK8U1GZNX,THIOGUANINE,THIOGUANINE ANHYDROUS,WIX31ZPX66,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/44b0c461-47fb-4106-ba11-6ed85530235c/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=44b0c461-47fb-4106-ba11-6ed85530235c,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=44b0c461-47fb-4106-ba11-6ed85530235c,44b0c461-47fb-4106-ba11-6ed85530235c,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,012429,TABLOID,THIOGUANINE,2022/12/29,Antimetabolite,,WOODWARD PHARMA SERVICES LLC,2022/06/30-,69784-630,FTK8U1GZNX,THIOGUANINE,THIOGUANINE ANHYDROUS,WIX31ZPX66,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/344df8bc-b16d-4b75-b4c8-40de7d465849/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=344df8bc-b16d-4b75-b4c8-40de7d465849,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=344df8bc-b16d-4b75-b4c8-40de7d465849,344df8bc-b16d-4b75-b4c8-40de7d465849,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,012429,TABLOID,THIOGUANINE,2022/08/03,Antimetabolite,,ASPEN GLOBAL INC,completed:2013/03/12-2025/03/31,76388-880,FTK8U1GZNX,THIOGUANINE,THIOGUANINE ANHYDROUS,WIX31ZPX66,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/4490128b-e73f-4849-9d6e-e8591639d771/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4490128b-e73f-4849-9d6e-e8591639d771,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=4490128b-e73f-4849-9d6e-e8591639d771,4490128b-e73f-4849-9d6e-e8591639d771,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, POWDER, FOR SOLUTION",INTRACAVITARY; INTRAVENOUS; INTRAVESICAL,NDA,208264,TEPADINA,THIOTEPA,2020/03/27,Alkylating Drug,1959,AMNEAL PHARMACEUTICALS LLC,2017/08/15-,70121-1630; 70121-1631,905Z5W3GKH,THIOTEPA,THIOTEPA,905Z5W3GKH,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/559e353c-2dc0-16ba-e054-00144ff8d46c/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=559e353c-2dc0-16ba-e054-00144ff8d46c,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=559e353c-2dc0-16ba-e054-00144ff8d46c,559e353c-2dc0-16ba-e054-00144ff8d46c,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,022433,BRILINTA,TICAGRELOR,2024/03/22,P2Y12 Platelet Inhibitor,2011,ASTRAZENECA PHARMACEUTICALS LP,2011/08/05-; 2015/09/04-,0186-0776; 0186-0777,GLH0314RVC,TICAGRELOR,TICAGRELOR,GLH0314RVC,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/f7b3f443-e83d-4bf2-0e96-023448fed9a8/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f7b3f443-e83d-4bf2-0e96-023448fed9a8,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=f7b3f443-e83d-4bf2-0e96-023448fed9a8,f7b3f443-e83d-4bf2-0e96-023448fed9a8,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAVENOUS,NDA,205645,Tigecycline,TIGECYCLINE,2024/02/20,Tetracycline-class Antibacterial,2005,FRESENIUS KABI USA LLC,2016/12/01-,63323-960,70JE2N95KR,TIGECYCLINE,TIGECYCLINE,70JE2N95KR,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/acf5dbe5-ca75-4300-816f-b3f4625f6e7d/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=acf5dbe5-ca75-4300-816f-b3f4625f6e7d,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=acf5dbe5-ca75-4300-816f-b3f4625f6e7d,acf5dbe5-ca75-4300-816f-b3f4625f6e7d,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAVENOUS,NDA,021821,Tygacil,TIGECYCLINE,2023/04/20,Tetracycline-class Antibacterial,2005,WYETH PHARMACEUTICALS LLC A SUBSIDIARY OF PFIZER INC,2008/06/15-,0008-4990,70JE2N95KR,TIGECYCLINE,TIGECYCLINE,70JE2N95KR,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/2ccdb48e-c14a-4eeb-348c-4920ccfd7465/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2ccdb48e-c14a-4eeb-348c-4920ccfd7465,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=2ccdb48e-c14a-4eeb-348c-4920ccfd7465,2ccdb48e-c14a-4eeb-348c-4920ccfd7465,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAVENOUS,NDA,021821,Tygacil,TIGECYCLINE,2022/07/21,Tetracycline-class Antibacterial,2005,WYETH PHARMACEUTICALS LLC A SUBSIDIARY OF PFIZER INC,2017/02/08-,0008-4994,70JE2N95KR,TIGECYCLINE,TIGECYCLINE,70JE2N95KR,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/fd826e47-1b77-4ffd-bb22-fda3379903b0/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=fd826e47-1b77-4ffd-bb22-fda3379903b0,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=fd826e47-1b77-4ffd-bb22-fda3379903b0,fd826e47-1b77-4ffd-bb22-fda3379903b0,,,
HUMAN PRESCRIPTION DRUG LABEL,KIT,INTRADERMAL; SUBCUTANEOUS,NDA,202207,Kit for the preparation of Lymphoseek (technetium Tc 99m tilmanocept),TILMANOCEPT,2023/09/25,Radioactive Diagnostic Agent,2013,CARDINAL HEALTH LLC,2017/09/20-,65857-425; 65857-450,8IHI69PQTC,TECHNETIUM TC-99M TILMANOCEPT,TECHNETIUM TC-99M TILMANOCEPT,8IHI69PQTC,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/72f31b09-4d7b-475c-b37a-9daf2ad80240/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=72f31b09-4d7b-475c-b37a-9daf2ad80240,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=72f31b09-4d7b-475c-b37a-9daf2ad80240,72f31b09-4d7b-475c-b37a-9daf2ad80240,,,
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION/ DROPS,OPHTHALMIC,NDA,020439,BETIMOL,TIMOLOL,2024/04/17,beta-Adrenergic Blocker,,THEA PHARMA INC,2022/11/15-; 2022/12/01-,82584-001; 82584-002,817W3C6175,TIMOLOL,TIMOLOL ANHYDROUS,5JKY92S7BR,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/3ae775f4-340c-4bf4-aa49-8a31daba0f8b/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3ae775f4-340c-4bf4-aa49-8a31daba0f8b,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=3ae775f4-340c-4bf4-aa49-8a31daba0f8b,3ae775f4-340c-4bf4-aa49-8a31daba0f8b,,,
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION/ DROPS,OPHTHALMIC,NDA,020439,Betimol,TIMOLOL,2020/10/08,beta-Adrenergic Blocker,,AKORN,2014/01/02-,76478-001; 76478-002,817W3C6175,Timolol,Timolol Anhydrous,5JKY92S7BR,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/3d7acd55-33b1-4a24-99ae-01f87b0dca1f/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3d7acd55-33b1-4a24-99ae-01f87b0dca1f,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=3d7acd55-33b1-4a24-99ae-01f87b0dca1f,3d7acd55-33b1-4a24-99ae-01f87b0dca1f,,,
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION,OPHTHALMIC,NDA,020439,Betimol,TIMOLOL,2010/03/18,,,VISTAKON PHARMACEUTICALS LLC,2000/10/01-,68669-522; 68669-525,817W3C6175,timolol,timolol,817W3C6175,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/00f62dd1-dad2-4892-8a5d-21e5e54509ce/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=00f62dd1-dad2-4892-8a5d-21e5e54509ce,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=00f62dd1-dad2-4892-8a5d-21e5e54509ce,00f62dd1-dad2-4892-8a5d-21e5e54509ce,,,
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION,OPHTHALMIC,NDA,018086,Timoptic,TIMOLOL MALEATE,2022/04/30,beta-Adrenergic Blocker,,BAUSCH AND LOMB INCORPORATED,2016/12/30-,24208-812; 24208-813,P8Y54F701R,Timolol Maleate,Timolol Anhydrous,5JKY92S7BR,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/45ac65b3-19f7-4f33-aebf-cadd3daa4bf1/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=45ac65b3-19f7-4f33-aebf-cadd3daa4bf1,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=45ac65b3-19f7-4f33-aebf-cadd3daa4bf1,45ac65b3-19f7-4f33-aebf-cadd3daa4bf1,,,
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION,OPHTHALMIC,NDA,020330,Timoptic-XE,TIMOLOL MALEATE,2022/03/31,beta-Adrenergic Blocker,,BAUSCH AND LOMB INCORPORATED,2016/05/31-,24208-814; 24208-816,P8Y54F701R,Timolol Maleate,TIMOLOL ANHYDROUS,5JKY92S7BR,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/a4d03de7-06b7-4cfc-9d1b-616969df209c/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a4d03de7-06b7-4cfc-9d1b-616969df209c,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=a4d03de7-06b7-4cfc-9d1b-616969df209c,a4d03de7-06b7-4cfc-9d1b-616969df209c,,,
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION/ DROPS,OPHTHALMIC,NDA,021516,Istalol,TIMOLOL MALEATE,2022/03/31,beta-Adrenergic Blocker,1978,BAUSCH AND LOMB INCORPORATED,2004/08/02-,24208-004,P8Y54F701R,TIMOLOL MALEATE,TIMOLOL ANHYDROUS,5JKY92S7BR,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/258bbc8d-00ee-45b0-ac35-6f16c4e8d45f/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=258bbc8d-00ee-45b0-ac35-6f16c4e8d45f,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=258bbc8d-00ee-45b0-ac35-6f16c4e8d45f,258bbc8d-00ee-45b0-ac35-6f16c4e8d45f,,,
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION,OPHTHALMIC,NDA,019463,Timoptic in Ocudose,TIMOLOL MALEATE,2022/01/31,beta-Adrenergic Blocker,,BAUSCH AND LOMB INCORPORATED,2022/02/17-,24208-498; 24208-499,P8Y54F701R,TIMOLOL MALEATE; Timolol Maleate,TIMOLOL ANHYDROUS,5JKY92S7BR,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/d130f0ec-c3b5-4bc3-8f4a-68fd6c3ec0cf/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d130f0ec-c3b5-4bc3-8f4a-68fd6c3ec0cf,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=d130f0ec-c3b5-4bc3-8f4a-68fd6c3ec0cf,d130f0ec-c3b5-4bc3-8f4a-68fd6c3ec0cf,,,
HUMAN PRESCRIPTION DRUG LABEL,"SOLUTION, GEL FORMING / DROPS",OPHTHALMIC,NDA,020963,Timolol GFS,TIMOLOL MALEATE,2021/05/31,beta-Adrenergic Blocker,1978,SANDOZ INC,1998/12/24-,61314-224; 61314-225,P8Y54F701R,TIMOLOL MALEATE,TIMOLOL ANHYDROUS,5JKY92S7BR,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/72b0d0ec-832a-4c25-b845-2537ab506354/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=72b0d0ec-832a-4c25-b845-2537ab506354,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=72b0d0ec-832a-4c25-b845-2537ab506354,72b0d0ec-832a-4c25-b845-2537ab506354,,,
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION,OPHTHALMIC,NDA,019463,Timoptic in Ocudose,TIMOLOL MALEATE,2020/01/06,beta-Adrenergic Blocker,,BAUSCH HEALTH US LLC,1986/11/05-,0187-1496; 0187-1498,P8Y54F701R,TIMOLOL MALEATE; Timolol Maleate,TIMOLOL ANHYDROUS,5JKY92S7BR,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/c1293d51-b633-486c-8e13-fcf60063faeb/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c1293d51-b633-486c-8e13-fcf60063faeb,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=c1293d51-b633-486c-8e13-fcf60063faeb,c1293d51-b633-486c-8e13-fcf60063faeb,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,021618,Tindamax,TINIDAZOLE,2021/12/27,Nitroimidazole Antimicrobial,2004,MISSION PHARMACAL COMPANY,2004/05/17-,0178-8250; 0178-8500,033KF7V46H,TINIDAZOLE,TINIDAZOLE,033KF7V46H,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/a0d01539-8413-4703-94cc-d221918630a1/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a0d01539-8413-4703-94cc-d221918630a1,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=a0d01539-8413-4703-94cc-d221918630a1,a0d01539-8413-4703-94cc-d221918630a1,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, SUGAR COATED",ORAL,NDA,019569,Thiola,TIOPRONIN,2024/01/08,Reducing and Complexing Thiol,,MISSION PHARMACAL COMPANY,1988/08/11-,0178-0900,C5W04GO61S,TIOPRONIN,TIOPRONIN,C5W04GO61S,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/494a714e-923c-cd57-df6c-12886afb265a/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=494a714e-923c-cd57-df6c-12886afb265a,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=494a714e-923c-cd57-df6c-12886afb265a,494a714e-923c-cd57-df6c-12886afb265a,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, DELAYED RELEASE",ORAL,NDA,211843,Thiola EC,TIOPRONIN,2024/01/08,Reducing and Complexing Thiol,1988,MISSION PHARMACAL COMPANY,2019/06/28-,0178-0901; 0178-0902,C5W04GO61S,TIOPRONIN,TIOPRONIN,C5W04GO61S,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/20298a52-a194-a161-8632-d84b6f26e23c/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=20298a52-a194-a161-8632-d84b6f26e23c,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=20298a52-a194-a161-8632-d84b6f26e23c,20298a52-a194-a161-8632-d84b6f26e23c,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,INHALATION; ORAL,NDA,021395,Spiriva HandiHaler,TIOTROPIUM BROMIDE,2022/01/19,Anticholinergic,2004,BOEHRINGER INGELHEIM PHARMACEUTICALS INC,2005/10/11-,0597-0075,L64SXO195N,TIOTROPIUM BROMIDE MONOHYDRATE,TIOTROPIUM,0EB439235F,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/820839ef-e53d-47e8-a3b9-d911ff92e6a9/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=820839ef-e53d-47e8-a3b9-d911ff92e6a9,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=820839ef-e53d-47e8-a3b9-d911ff92e6a9,820839ef-e53d-47e8-a3b9-d911ff92e6a9,,,
HUMAN PRESCRIPTION DRUG LABEL,"SPRAY, METERED",INHALATION,NDA,206756,Stiolto Respimat,TIOTROPIUM BROMIDE AND OLODATEROL,2023/05/23,Anticholinergic; beta2-Adrenergic Agonist,2015,BOEHRINGER INGELHEIM PHARMACEUTICALS INC,2015/05/21-,0597-0155,65R445W3V9; L64SXO195N,OLODATEROL HYDROCHLORIDE; TIOTROPIUM BROMIDE MONOHYDRATE,OLODATEROL; TIOTROPIUM,0EB439235F; VD2YSN1AFD,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/01e15aee-40e0-23f3-537f-c96dd63e2cb1/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=01e15aee-40e0-23f3-537f-c96dd63e2cb1,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=01e15aee-40e0-23f3-537f-c96dd63e2cb1,01e15aee-40e0-23f3-537f-c96dd63e2cb1,,,
HUMAN PRESCRIPTION DRUG LABEL,"SPRAY, METERED",INHALATION,NDA,021936;207070,Spiriva Respimat,TIOTROPIUM BROMIDE INHALATION SPRAY,2023/10/02,Anticholinergic,2004,BOEHRINGER INGELHEIM PHARMACEUTICALS INC,2014/09/30-; 2015/09/15-,0597-0100; 0597-0160,XX112XZP0J,TIOTROPIUM BROMIDE ANHYDROUS,TIOTROPIUM,0EB439235F,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/7b656b14-fcaa-2741-f6f0-e0be48971c02/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7b656b14-fcaa-2741-f6f0-e0be48971c02,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=7b656b14-fcaa-2741-f6f0-e0be48971c02,7b656b14-fcaa-2741-f6f0-e0be48971c02,,,
HUMAN PRESCRIPTION DRUG LABEL,"CAPSULE, LIQUID FILLED",ORAL,NDA,021814,Aptivus,TIPRANAVIR,2024/05/17,Protease Inhibitor,2005,BOEHRINGER INGELHEIM PHARMACEUTICALS INC,2005/07/01-,0597-0003,ZZT404XD09,TIPRANAVIR,TIPRANAVIR,ZZT404XD09,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/08982e49-d2eb-4b25-b01a-1be52fd669ef/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=08982e49-d2eb-4b25-b01a-1be52fd669ef,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=08982e49-d2eb-4b25-b01a-1be52fd669ef,08982e49-d2eb-4b25-b01a-1be52fd669ef,,,
HUMAN PRESCRIPTION DRUG LABEL,OINTMENT,TOPICAL,NDA,213189,Klisyri,TIRBANIBULIN,2024/04/18,Microtubule Inhibitor,2020,ALMIRALL LLC,2020/12/14-,16110-391,4V9848RS5G,TIRBANIBULIN,TIRBANIBULIN,4V9848RS5G,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/589c8de8-b773-4d47-b60c-48471806cccc/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=589c8de8-b773-4d47-b60c-48471806cccc,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=589c8de8-b773-4d47-b60c-48471806cccc,589c8de8-b773-4d47-b60c-48471806cccc,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,020912;020913,AGGRASTAT,TIROFIBAN,2023/11/17,Platelet Aggregation Inhibitor,1998,MEDICURE INTERNATIONAL INC,1998/05/14-; 2016/10/15-,25208-001; 25208-002,6H925F8O5J,TIROFIBAN HYDROCHLORIDE,TIROFIBAN,GGX234SI5H,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/fe0ced75-ccbf-4d2e-bd0d-b57e60ab913f/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=fe0ced75-ccbf-4d2e-bd0d-b57e60ab913f,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=fe0ced75-ccbf-4d2e-bd0d-b57e60ab913f,fe0ced75-ccbf-4d2e-bd0d-b57e60ab913f,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,020912;020913,AGGRASTAT,TIROFIBAN,2023/01/03,Platelet Aggregation Inhibitor,1998,MEDICURE INTERNATIONAL INC,1998/05/14-; 2016/10/15-,25208-901; 25208-902,6H925F8O5J,TIROFIBAN HYDROCHLORIDE,TIROFIBAN,GGX234SI5H,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/e850111f-e713-41a2-9c65-21c517cf5511/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e850111f-e713-41a2-9c65-21c517cf5511,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=e850111f-e713-41a2-9c65-21c517cf5511,e850111f-e713-41a2-9c65-21c517cf5511,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",SUBCUTANEOUS,NDA,217806,ZEPBOUND; Zepbound,TIRZEPATIDE,2024/03/28,GLP-1 Receptor Agonist; Glucose-dependent Insulinotropic Polypeptide Receptor Agonist,2022,ELI LILLY AND COMPANY,2023/11/08-,0002-0152; 0002-0243; 0002-1214; 0002-1340; 0002-1423; 0002-2002; 0002-2457; 0002-2460; 0002-2471; 0002-2484; 0002-2495; 0002-2506,OYN3CCI6QE,tirzepatide,tirzepatide,OYN3CCI6QE,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/487cd7e7-434c-4925-99fa-aa80b1cc776b/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=487cd7e7-434c-4925-99fa-aa80b1cc776b,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=487cd7e7-434c-4925-99fa-aa80b1cc776b,487cd7e7-434c-4925-99fa-aa80b1cc776b,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",SUBCUTANEOUS,NDA,215866,MOUNJARO,TIRZEPATIDE,2023/09/22,GLP-1 Receptor Agonist; Glucose-dependent Insulinotropic Polypeptide Receptor Agonist,2022,ELI LILLY AND COMPANY,2022/05/13-; 2023/07/28-,0002-1152; 0002-1243; 0002-1457; 0002-1460; 0002-1471; 0002-1484; 0002-1495; 0002-1506; 0002-2214; 0002-2340; 0002-2423; 0002-3002,OYN3CCI6QE,tirzepatide,tirzepatide,OYN3CCI6QE,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/d2d7da5d-ad07-4228-955f-cf7e355c8cc0/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d2d7da5d-ad07-4228-955f-cf7e355c8cc0,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=d2d7da5d-ad07-4228-955f-cf7e355c8cc0,d2d7da5d-ad07-4228-955f-cf7e355c8cc0,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,NDA,212904,FOTIVDA,TIVOZANIB,2022/08/18,Kinase Inhibitor,2021,AVEO PHARMACEUTICALS INC,2021/03/10-,45629-089; 45629-134,8A9H4VK35Z,tivozanib hydrochloride,tivozanib,172030934T,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/de77155c-ecf2-4f15-9758-21d271449d83/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=de77155c-ecf2-4f15-9758-21d271449d83,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=de77155c-ecf2-4f15-9758-21d271449d83,de77155c-ecf2-4f15-9758-21d271449d83,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE; TABLET,ORAL,NDA,020397;021447,Zanaflex,TIZANIDINE HYDROCHLORIDE,2021/11/01,Central alpha-2 Adrenergic Agonist,1996,COVIS PHARMA US INC,2018/08/01-,70515-594; 70515-602; 70515-604; 70515-606,B53E3NMY5C,TIZANIDINE HYDROCHLORIDE,TIZANIDINE,6AI06C00GW,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/043d9e51-bfa2-4add-9058-5ece332f7e99/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=043d9e51-bfa2-4add-9058-5ece332f7e99,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=043d9e51-bfa2-4add-9058-5ece332f7e99,043d9e51-bfa2-4add-9058-5ece332f7e99,,,
HUMAN PRESCRIPTION DRUG LABEL,OINTMENT,OPHTHALMIC,NDA,050555,TOBREX,TOBRAMYCIN,2023/04/19,Aminoglycoside Antibacterial,,NOVARTIS PHARMACEUTICALS CORPORATION,1981/06/28-,0078-0813,VZ8RRZ51VK,TOBRAMYCIN,TOBRAMYCIN,VZ8RRZ51VK,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/5b66bba3-cf97-4a9c-b618-ba5f277f20f6/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5b66bba3-cf97-4a9c-b618-ba5f277f20f6,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=5b66bba3-cf97-4a9c-b618-ba5f277f20f6,5b66bba3-cf97-4a9c-b618-ba5f277f20f6,,,
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION,INHALATION,NDA,201820,BETHKIS,TOBRAMYCIN,2023/02/24,Aminoglycoside Antibacterial,1980,CHIESI USA INC,2013/04/15-,10122-820,VZ8RRZ51VK,TOBRAMYCIN,TOBRAMYCIN,VZ8RRZ51VK,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/1cd3d47b-025f-4705-9daf-cf07725ec223/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1cd3d47b-025f-4705-9daf-cf07725ec223,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=1cd3d47b-025f-4705-9daf-cf07725ec223,1cd3d47b-025f-4705-9daf-cf07725ec223,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,INHALATION; ORAL,NDA,201688,TOBI Podhaler,TOBRAMYCIN,2023/02/15,Aminoglycoside Antibacterial,1975,MYLAN SPECIALTY L P,completed:2021/09/01-2026/12/31,49502-401,VZ8RRZ51VK,TOBRAMYCIN,TOBRAMYCIN,VZ8RRZ51VK,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/c4b5bb1f-e158-4ac1-9c35-e98a416c743a/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c4b5bb1f-e158-4ac1-9c35-e98a416c743a,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=c4b5bb1f-e158-4ac1-9c35-e98a416c743a,c4b5bb1f-e158-4ac1-9c35-e98a416c743a,,,
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION,INHALATION; ORAL,NDA,050753,TOBI,TOBRAMYCIN,2023/02/15,Aminoglycoside Antibacterial,1975,MYLAN SPECIALTY L P,2022/06/23-,49502-345,VZ8RRZ51VK,TOBRAMYCIN,TOBRAMYCIN,VZ8RRZ51VK,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/6a3c3871-1d3a-44d6-8be3-526b30123ef7/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6a3c3871-1d3a-44d6-8be3-526b30123ef7,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=6a3c3871-1d3a-44d6-8be3-526b30123ef7,6a3c3871-1d3a-44d6-8be3-526b30123ef7,,,
HUMAN PRESCRIPTION DRUG LABEL,SUSPENSION/ DROPS,OPHTHALMIC,NDA,050818,Tobradex ST,TOBRAMYCIN / DEXAMETHASONE,2023/10/09,Aminoglycoside Antibacterial; Corticosteroid,1988,EYEVANCE PHARMACEUTICALS LLC,2021/05/19-,71776-035,7S5I7G3JQL; VZ8RRZ51VK,DEXAMETHASONE; TOBRAMYCIN,DEXAMETHASONE; TOBRAMYCIN,7S5I7G3JQL; VZ8RRZ51VK,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/c2d7325e-4f58-5590-e053-2a95a90ace1b/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c2d7325e-4f58-5590-e053-2a95a90ace1b,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=c2d7325e-4f58-5590-e053-2a95a90ace1b,c2d7325e-4f58-5590-e053-2a95a90ace1b,,,
HUMAN PRESCRIPTION DRUG LABEL,OINTMENT,OPHTHALMIC,NDA,050616,TobraDex,TOBRAMYCIN AND DEXAMETHASONE,2023/08/02,Aminoglycoside Antibacterial; Corticosteroid,,NOVARTIS PHARMACEUTICALS CORPORATION,1988/10/15-,0078-0876,7S5I7G3JQL; VZ8RRZ51VK,DEXAMETHASONE; TOBRAMYCIN,DEXAMETHASONE; TOBRAMYCIN,7S5I7G3JQL; VZ8RRZ51VK,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/7f310e0e-0d3b-493d-b6c4-238493a2a9b9/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7f310e0e-0d3b-493d-b6c4-238493a2a9b9,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=7f310e0e-0d3b-493d-b6c4-238493a2a9b9,7f310e0e-0d3b-493d-b6c4-238493a2a9b9,,,
HUMAN PRESCRIPTION DRUG LABEL,SUSPENSION/ DROPS,OPHTHALMIC,NDA,050592,TobraDex,TOBRAMYCIN AND DEXAMETHASONE,2023/04/19,Aminoglycoside Antibacterial; Corticosteroid,,NOVARTIS PHARMACEUTICALS CORPORATION,1988/09/15-,0078-0953,7S5I7G3JQL; VZ8RRZ51VK,DEXAMETHASONE; TOBRAMYCIN,DEXAMETHASONE; TOBRAMYCIN,7S5I7G3JQL; VZ8RRZ51VK,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/c662bb23-f30c-451d-aa6c-f3f26fb72377/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c662bb23-f30c-451d-aa6c-f3f26fb72377,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=c662bb23-f30c-451d-aa6c-f3f26fb72377,c662bb23-f30c-451d-aa6c-f3f26fb72377,,,
HUMAN PRESCRIPTION DRUG LABEL,"SOLUTION; TABLET, FILM COATED; TABLET, FILM COATED, EXTENDED RELEASE",ORAL,NDA,203214;208246;213082,XELJANZ; XELJANZ XR,TOFACITINIB,2024/05/21,Janus Kinase Inhibitor,2012,PFIZER LABORATORIES DIV PFIZER INC,2012/11/09-; 2016/03/07-; 2018/07/02-; 2020/01/21-; 2021/02/08-,0069-0501; 0069-0502; 0069-1001; 0069-1002; 0069-1029,O1FF4DIV0D,TOFACITINIB CITRATE,TOFACITINIB,87LA6FU830,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/cf74ba2f-afc5-4baa-8594-979c889a5831/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=cf74ba2f-afc5-4baa-8594-979c889a5831,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=cf74ba2f-afc5-4baa-8594-979c889a5831,cf74ba2f-afc5-4baa-8594-979c889a5831,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, EXTENDED RELEASE; TABLET, FILM COATED",ORAL,NDA,203214;208246,XELJANZ; XELJANZ XR,TOFACITINIB,2024/05/10,Janus Kinase Inhibitor,2012,U S PHARMACEUTICALS,2012/11/08-; 2016/03/07-; 2018/07/02-; 2020/01/21-,63539-012; 63539-016; 63539-501; 63539-502,O1FF4DIV0D,TOFACITINIB CITRATE,TOFACITINIB,87LA6FU830,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/68e3d6b2-7838-4d2d-a417-09d919b43e13/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=68e3d6b2-7838-4d2d-a417-09d919b43e13,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=68e3d6b2-7838-4d2d-a417-09d919b43e13,68e3d6b2-7838-4d2d-a417-09d919b43e13,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRATHECAL,NDA,215887,QALSODY,TOFERSEN,2023/04/25,Antisense Oligonucleotide,2023,BIOGEN INC,2023/04/25-,64406-109,2NU6F9601K,tofersen,tofersen,2NU6F9601K,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/81356b45-1cb7-4eef-88ea-e44cc18b47c5/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=81356b45-1cb7-4eef-88ea-e44cc18b47c5,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=81356b45-1cb7-4eef-88ea-e44cc18b47c5,81356b45-1cb7-4eef-88ea-e44cc18b47c5,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,020697,Tasmar,TOLCAPONE,2020/10/02,Catechol-O-Methyltransferase Inhibitor,,BAUSCH HEALTH US LLC,2004/07/27-,0187-0938,CIF6334OLY,Tolcapone,Tolcapone,CIF6334OLY,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/a0e47a9d-78e7-4523-983a-aa259f221736/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a0e47a9d-78e7-4523-983a-aa259f221736,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=a0e47a9d-78e7-4523-983a-aa259f221736,a0e47a9d-78e7-4523-983a-aa259f221736,,,
HUMAN PRESCRIPTION DRUG LABEL,"CAPSULE, EXTENDED RELEASE",ORAL,NDA,021228,Detrol LA,TOLTERODINE TARTRATE,2023/03/15,Cholinergic Muscarinic Antagonist,2000,VIATRIS SPECIALTY LLC,2024/01/10-; 2024/03/20-,58151-103; 58151-104,5T619TQR3R,TOLTERODINE TARTRATE,TOLTERODINE,WHE7A56U7K,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/d7274947-4f88-47ee-a39f-bd5ac46fcf8d/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d7274947-4f88-47ee-a39f-bd5ac46fcf8d,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=d7274947-4f88-47ee-a39f-bd5ac46fcf8d,d7274947-4f88-47ee-a39f-bd5ac46fcf8d,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,020771,Detrol,TOLTERODINE TARTRATE,2023/02/15,Cholinergic Muscarinic Antagonist,,VIATRIS SPECIALTY LLC,2024/05/10-; 2024/05/21-,58151-098; 58151-099,5T619TQR3R,TOLTERODINE TARTRATE,TOLTERODINE,WHE7A56U7K,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/41eb00d2-64e3-4ec9-8732-4bfc81b04180/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=41eb00d2-64e3-4ec9-8732-4bfc81b04180,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=41eb00d2-64e3-4ec9-8732-4bfc81b04180,41eb00d2-64e3-4ec9-8732-4bfc81b04180,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,020771,Detrol,TOLTERODINE TARTRATE,2021/09/29,Cholinergic Muscarinic Antagonist,,PHARMACIA AND UPJOHN COMPANY LLC,1998/03/25-; completed:1998/03/25-2024/12/31,0009-4541; 0009-4544,5T619TQR3R,TOLTERODINE TARTRATE,TOLTERODINE,WHE7A56U7K,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/42f819c9-4108-4ca7-92c5-a213037dd4db/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=42f819c9-4108-4ca7-92c5-a213037dd4db,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=42f819c9-4108-4ca7-92c5-a213037dd4db,42f819c9-4108-4ca7-92c5-a213037dd4db,,,
HUMAN PRESCRIPTION DRUG LABEL,"CAPSULE, EXTENDED RELEASE",ORAL,NDA,021228,Detrol LA,TOLTERODINE TARTRATE,2018/07/15,Cholinergic Muscarinic Antagonist,2000,PHARMACIA AND UPJOHN COMPANY LLC,completed:2000/02/22-2024/12/31,0009-5190; 0009-5191,5T619TQR3R,TOLTERODINE TARTRATE,TOLTERODINE,WHE7A56U7K,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/c98eb213-9c80-4698-9710-a9855059b8bb/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c98eb213-9c80-4698-9710-a9855059b8bb,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=c98eb213-9c80-4698-9710-a9855059b8bb,c98eb213-9c80-4698-9710-a9855059b8bb,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,022275,SAMSCA,TOLVAPTAN,2022/11/09,Vasopressin V2 Receptor Antagonist,2009,OTSUKA AMERICA PHARMACEUTICAL INC,2009/05/19-,59148-020; 59148-021,21G72T1950,TOLVAPTAN,TOLVAPTAN,21G72T1950,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/5526617c-c7b9-4556-886d-729bbabbc566/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5526617c-c7b9-4556-886d-729bbabbc566,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=5526617c-c7b9-4556-886d-729bbabbc566,5526617c-c7b9-4556-886d-729bbabbc566,,,
HUMAN PRESCRIPTION DRUG LABEL,KIT; TABLET,ORAL,NDA,204441,JYNARQUE; Jynarque,TOLVAPTAN,2022/11/08,Vasopressin V2 Receptor Antagonist,2009,OTSUKA AMERICA PHARMACEUTICAL INC,2018/04/23-; 2020/01/13-,59148-079; 59148-080; 59148-082; 59148-083; 59148-087; 59148-088; 59148-089,21G72T1950,TOLVAPTAN,TOLVAPTAN,21G72T1950,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/3febc0a1-9e5a-4ce0-843d-210f21d862c4/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3febc0a1-9e5a-4ce0-843d-210f21d862c4,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=3febc0a1-9e5a-4ce0-843d-210f21d862c4,3febc0a1-9e5a-4ce0-843d-210f21d862c4,,,
HUMAN PRESCRIPTION DRUG LABEL,"CAPSULE, EXTENDED RELEASE",ORAL,NDA,205122,QUDEXY XR,TOPIRAMATE,2024/01/24,,1996,UPSHER SMITH LABORATORIES LLC,2014/04/11-,0245-1071; 0245-1072; 0245-1073; 0245-1074; 0245-1075,0H73WJJ391,Topiramate,Topiramate,0H73WJJ391,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/46f54677-3a22-4c38-9b92-923020164e15/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=46f54677-3a22-4c38-9b92-923020164e15,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=46f54677-3a22-4c38-9b92-923020164e15,46f54677-3a22-4c38-9b92-923020164e15,,,
HUMAN PRESCRIPTION DRUG LABEL,"CAPSULE, EXTENDED RELEASE",ORAL,NDA,201635,Trokendi XR,TOPIRAMATE,2023/12/20,,1996,SUPERNUS PHARMACEUTICALS,2013/08/16-,17772-101; 17772-102; 17772-103; 17772-104,0H73WJJ391,TOPIRAMATE,TOPIRAMATE,0H73WJJ391,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/2dc7957e-a3e5-46bb-aa66-f3250f872f5e/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2dc7957e-a3e5-46bb-aa66-f3250f872f5e,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=2dc7957e-a3e5-46bb-aa66-f3250f872f5e,2dc7957e-a3e5-46bb-aa66-f3250f872f5e,,,
HUMAN PRESCRIPTION DRUG LABEL,"CAPSULE, COATED PELLETS; TABLET, COATED",ORAL,NDA,020505;020844,Topamax,TOPIRAMATE,2023/05/12,,1996,JANSSEN PHARMACEUTICALS INC,1997/01/01-; 1998/11/01-,50458-639; 50458-640; 50458-641; 50458-642; 50458-645; 50458-647,0H73WJJ391,TOPIRAMATE,TOPIRAMATE,0H73WJJ391,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/21628112-0c47-11df-95b3-498d55d89593/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=21628112-0c47-11df-95b3-498d55d89593,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=21628112-0c47-11df-95b3-498d55d89593,21628112-0c47-11df-95b3-498d55d89593,,,
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION,ORAL,NDA,214679,Eprontia,TOPIRAMATE,2023/05/11,,1996,AZURITY PHARMACEUTICALS INC,2021/12/06-,52652-9001,0H73WJJ391,TOPIRAMATE,TOPIRAMATE,0H73WJJ391,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/e2a4df59-fead-4a01-9021-9eda02c48010/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e2a4df59-fead-4a01-9021-9eda02c48010,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=e2a4df59-fead-4a01-9021-9eda02c48010,e2a4df59-fead-4a01-9021-9eda02c48010,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,NDA,020981,HYCAMTIN,TOPOTECAN,2022/07/07,Topoisomerase Inhibitor,1996,NOVARTIS PHARMACEUTICALS CORPORATION,2017/02/24-; 2017/07/07-,0078-0672; 0078-0673,956S425ZCY,TOPOTECAN HYDROCHLORIDE,TOPOTECAN,7M7YKX2N15,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/aa0815bb-8916-4c2c-9201-b04eb78e91fa/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=aa0815bb-8916-4c2c-9201-b04eb78e91fa,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=aa0815bb-8916-4c2c-9201-b04eb78e91fa,aa0815bb-8916-4c2c-9201-b04eb78e91fa,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION, CONCENTRATE",INTRAVENOUS,NDA,200582,Topotecan,TOPOTECAN,2021/02/01,Topoisomerase Inhibitor,1996,HOSPIRA INC,2011/02/21-,0409-0302,956S425ZCY,TOPOTECAN HYDROCHLORIDE,TOPOTECAN,7M7YKX2N15,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/1d4e1cce-c57e-4a8b-be96-f95a2778e221/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1d4e1cce-c57e-4a8b-be96-f95a2778e221,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=1d4e1cce-c57e-4a8b-be96-f95a2778e221,1d4e1cce-c57e-4a8b-be96-f95a2778e221,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAVENOUS,NDA,020671,HYCAMTIN,TOPOTECAN HYDROCHLORIDE,2022/07/07,Topoisomerase Inhibitor,1996,NOVARTIS PHARMACEUTICALS CORPORATION,2016/12/21-,0078-0674,956S425ZCY,TOPOTECAN HYDROCHLORIDE,TOPOTECAN,7M7YKX2N15,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/eeee060c-a9ec-423e-a374-8484009f8524/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=eeee060c-a9ec-423e-a374-8484009f8524,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=eeee060c-a9ec-423e-a374-8484009f8524,eeee060c-a9ec-423e-a374-8484009f8524,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,020497,Fareston,TOREMIFENE CITRATE,2023/09/15,Estrogen Agonist/Antagonist,1997,KYOWA KIRIN INC,1997/06/30-,42747-327,2498Y783QT,TOREMIFENE CITRATE,TOREMIFENE,7NFE54O27T,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/2cab8dd1-3a10-48e6-86ce-0e5275ed49e5/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2cab8dd1-3a10-48e6-86ce-0e5275ed49e5,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=2cab8dd1-3a10-48e6-86ce-0e5275ed49e5,2cab8dd1-3a10-48e6-86ce-0e5275ed49e5,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,213218,SOAANZ,TORSEMIDE,2024/01/16,Loop Diuretic,1993,SARFEZ PHARMACEUTICALS INC,2021/10/01-; 2022/01/24-; completed:2022/01/24-2024/11/30; completed:2022/01/24-2024/12/31,73502-286; 73502-287; 73502-288; 73502-586; 73502-687; 73502-786,W31X2H97FB,Torsemide,Torsemide,W31X2H97FB,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/05eaa163-b6e9-438a-85f8-6a60e743d460/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=05eaa163-b6e9-438a-85f8-6a60e743d460,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=05eaa163-b6e9-438a-85f8-6a60e743d460,05eaa163-b6e9-438a-85f8-6a60e743d460,,,
HUMAN PRESCRIPTION DRUG LABEL,"KIT; TABLET, FILM COATED",ORAL,NDA,217700;218033,OJEMDA,TOVORAFENIB,2024/04/26,,2024,DAY ONE BIOPHARMACEUTICALS INC,2024/04/30-,82950-001; 82950-012,ZN90E4027M,TOVORAFENIB,TOVORAFENIB,ZN90E4027M,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/ea3a9631-3a66-6a7c-e053-2995a90ae2ad/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ea3a9631-3a66-6a7c-e053-2995a90ae2ad,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=ea3a9631-3a66-6a7c-e053-2995a90ae2ad,ea3a9631-3a66-6a7c-e053-2995a90ae2ad,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAVENOUS,NDA,207953,YONDELIS,TRABECTEDIN,2020/09/22,Alkylating Drug,2015,JANSSEN PRODUCTS LP,2015/10/23-,59676-610,ID0YZQ2TCP,Trabectedin,Trabectedin,ID0YZQ2TCP,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/472bd78e-be17-4b9d-90f4-9482c3aec9ff/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=472bd78e-be17-4b9d-90f4-9482c3aec9ff,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=472bd78e-be17-4b9d-90f4-9482c3aec9ff,472bd78e-be17-4b9d-90f4-9482c3aec9ff,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,209376,Multrys,TRACE ELEMENTS INJECTION 4,2021/06/01,Copper Absorption Inhibitor; Paramagnetic Contrast Agent,2020,AMERICAN REGENT INC,2021/09/01-,0517-9302,89DS0H96TB; F6A27P4Q4R; LRX7AJ16DT; W00LYS4T26,CUPRIC SULFATE; MANGANESE SULFATE; SELENIOUS ACID; ZINC SULFATE,CUPRIC CATION; MANGANESE CATION (2+); SELENIOUS ACID; ZINC CATION,13S1S8SF37; 8CBV67279L; F6A27P4Q4R; H6EP7W5457,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/995f1efa-aca0-4b6c-9099-f8e757c2133a/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=995f1efa-aca0-4b6c-9099-f8e757c2133a,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=995f1efa-aca0-4b6c-9099-f8e757c2133a,995f1efa-aca0-4b6c-9099-f8e757c2133a,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,209376,Tralement,TRACE ELEMENTS INJECTION 4,2020/07/07,Copper Absorption Inhibitor; Paramagnetic Contrast Agent,2020,AMERICAN REGENT INC,2020/09/29-,0517-9305,89DS0H96TB; F6A27P4Q4R; LRX7AJ16DT; W00LYS4T26,CUPRIC SULFATE; MANGANESE SULFATE; SELENIOUS ACID; ZINC SULFATE,CUPRIC CATION; MANGANESE CATION (2+); SELENIOUS ACID; ZINC CATION,13S1S8SF37; 8CBV67279L; F6A27P4Q4R; H6EP7W5457,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/a49ffb90-f307-433e-a86e-aaea6d6a9982/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a49ffb90-f307-433e-a86e-aaea6d6a9982,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=a49ffb90-f307-433e-a86e-aaea6d6a9982,a49ffb90-f307-433e-a86e-aaea6d6a9982,,,
HUMAN PRESCRIPTION DRUG LABEL,"CAPSULE, EXTENDED RELEASE",ORAL,NDA,022370,ConZip,TRAMADOL HYDROCHLORIDE,2023/12/22,Opioid Agonist,1995,VERTICAL PHARMACEUTICALS LLC,2011/09/20-,68025-071; 68025-072; 68025-073,9N7R477WCK,TRAMADOL HYDROCHLORIDE,TRAMADOL,39J1LGJ30J,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/a65b4d05-3a1c-4aa1-848a-d20ac9aaf62f/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a65b4d05-3a1c-4aa1-848a-d20ac9aaf62f,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=a65b4d05-3a1c-4aa1-848a-d20ac9aaf62f,a65b4d05-3a1c-4aa1-848a-d20ac9aaf62f,,,
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION,ORAL,NDA,214044,QDOLO,TRAMADOL HYDROCHLORIDE,2023/12/21,Opioid Agonist,1995,ATHENA BIOSCIENCE LLC,2020/09/11-,71511-301,9N7R477WCK,TRAMADOL HYDROCHLORIDE,TRAMADOL,39J1LGJ30J,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/949661c5-2b98-46f9-a002-7e73f1e00952/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=949661c5-2b98-46f9-a002-7e73f1e00952,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=949661c5-2b98-46f9-a002-7e73f1e00952,949661c5-2b98-46f9-a002-7e73f1e00952,,,
HUMAN PRESCRIPTION DRUG LABEL,"CAPSULE, EXTENDED RELEASE",ORAL,NDA,022370,TRAMADOL HYDROCHLORIDE EXTENDED RELEASE,TRAMADOL HYDROCHLORIDE,2010/05/21,Opioid Agonist,1995,GALEPHAR PHARMACEUTICAL RESEARCH INC,2030/01/15-,66277-252; 66277-253; 66277-254,9N7R477WCK,TRAMADOL HYDROCHLORIDE,TRAMADOL,39J1LGJ30J,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/23466565-6c73-2047-6f6f-64204d616e23/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=23466565-6c73-2047-6f6f-64204d616e23,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=23466565-6c73-2047-6f6f-64204d616e23,23466565-6c73-2047-6f6f-64204d616e23,,,
HUMAN PRESCRIPTION DRUG LABEL,"POWDER, FOR SOLUTION; TABLET, FILM COATED",ORAL,NDA,204114;217513,Mekinist,TRAMETINIB,2024/03/29,Kinase Inhibitor,2013,NOVARTIS PHARMACEUTICALS CORPORATION,2016/03/17-; 2023/03/16-; completed:2016/03/17-2023/10/31; completed:2016/03/17-2024/04/30,0078-0666; 0078-0668; 0078-1105; 0078-1112; 0078-1161,BSB9VJ5TUT,TRAMETINIB DIMETHYL SULFOXIDE,TRAMETINIB,33E86K87QN,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/0002ad27-779d-42ab-83b5-bc65453412a1/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0002ad27-779d-42ab-83b5-bc65453412a1,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=0002ad27-779d-42ab-83b5-bc65453412a1,0002ad27-779d-42ab-83b5-bc65453412a1,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,019281,Cyklokapron,TRANEXAMIC ACID,2024/04/03,Antifibrinolytic Agent,1986,PFIZER LABORATORIES DIV PFIZER INC,1986/12/30-,0013-1114,6T84R30KC1,TRANEXAMIC ACID,TRANEXAMIC ACID,6T84R30KC1,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/6e89a7d9-4da4-42aa-b7f8-c602c24eefe5/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6e89a7d9-4da4-42aa-b7f8-c602c24eefe5,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=6e89a7d9-4da4-42aa-b7f8-c602c24eefe5,6e89a7d9-4da4-42aa-b7f8-c602c24eefe5,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,022430,Lysteda,TRANEXAMIC ACID,2021/12/02,Antifibrinolytic Agent,1986,AMRING PHARMACEUTICALS INC,2010/05/17-,69918-300,6T84R30KC1,TRANEXAMIC ACID,TRANEXAMIC ACID,6T84R30KC1,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/a7e3180d-cf5b-4c2c-a31f-68bf6181f19a/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a7e3180d-cf5b-4c2c-a31f-68bf6181f19a,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=a7e3180d-cf5b-4c2c-a31f-68bf6181f19a,a7e3180d-cf5b-4c2c-a31f-68bf6181f19a,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,212020,TRANEXAMIC ACID IN SODIUM CHLORIDE,TRANEXAMIC ACID,2019/04/22,Antifibrinolytic Agent,1986,EXELA PHARMA SCIENCES LLC,2019/06/01-,51754-0108,6T84R30KC1,TRANEXAMIC ACID,TRANEXAMIC ACID,6T84R30KC1,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/db36ddf2-4ac5-47ac-bdce-e3fa6983073e/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=db36ddf2-4ac5-47ac-bdce-e3fa6983073e,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=db36ddf2-4ac5-47ac-bdce-e3fa6983073e,db36ddf2-4ac5-47ac-bdce-e3fa6983073e,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,012342,PARNATE,TRANYLCYPROMINE SULFATE,2021/08/27,Monoamine Oxidase Inhibitor,1961,CONCORDIA PHARMACEUTICALS INC,2013/01/14-,59212-447,7ZAT6ES870,TRANYLCYPROMINE SULFATE,TRANYLCYPROMINE,3E3V44J4Z9,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/b72d8187-dfcc-4ea0-b5e9-c0be95b69a27/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b72d8187-dfcc-4ea0-b5e9-c0be95b69a27,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=b72d8187-dfcc-4ea0-b5e9-c0be95b69a27,b72d8187-dfcc-4ea0-b5e9-c0be95b69a27,,,
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION/ DROPS,OPHTHALMIC,NDA,021994,Travatan Z,TRAVOPROST,2023/06/27,Prostaglandin Analog,2001,NOVARTIS PHARMACEUTICALS CORPORATION,2006/10/20-,0078-0946,WJ68R08KX9,TRAVOPROST,TRAVOPROST,WJ68R08KX9,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/028455e0-ae77-4213-8819-3b58ef7d6a14/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=028455e0-ae77-4213-8819-3b58ef7d6a14,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=028455e0-ae77-4213-8819-3b58ef7d6a14,028455e0-ae77-4213-8819-3b58ef7d6a14,,,
HUMAN PRESCRIPTION DRUG LABEL,IMPLANT,INTRACAMERAL,NDA,218010,iDose TR,TRAVOPROST INTRACAMERAL,2023/12/20,Prostaglandin Analog,2001,GLAUKOS CORPORATION,2023/12/13-,25357-100,WJ68R08KX9,TRAVOPROST,TRAVOPROST,WJ68R08KX9,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/92f6d3e2-8328-47df-972c-23008f4a1c1c/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=92f6d3e2-8328-47df-972c-23008f4a1c1c,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=92f6d3e2-8328-47df-972c-23008f4a1c1c,92f6d3e2-8328-47df-972c-23008f4a1c1c,,,
HUMAN PRESCRIPTION DRUG LABEL,INHALANT; KIT,ORAL,NDA,214324,Tyvaso DPI,TREPROSTINIL,2024/01/26,Prostacycline Vasodilator,2002,UNITED THERAPEUTICS CORPORATION,2022/05/23-; 2023/06/27-; completed:2022/05/23-2024/03/31,66302-600; 66302-610; 66302-616; 66302-620; 66302-630; 66302-632; 66302-640; 66302-648; 66302-650; 66302-664; 66302-716; 66302-720; 66302-732; 66302-748; 66302-764,RUM6K67ESG,treprostinil,treprostinil,RUM6K67ESG,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/ddc3d400-bcb3-4b09-aae2-0768b10a5b0f/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ddc3d400-bcb3-4b09-aae2-0768b10a5b0f,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=ddc3d400-bcb3-4b09-aae2-0768b10a5b0f,ddc3d400-bcb3-4b09-aae2-0768b10a5b0f,,,
HUMAN PRESCRIPTION DRUG LABEL,INHALANT,ORAL,NDA,022387,TYVASO,TREPROSTINIL,2023/12/08,Prostacycline Vasodilator,2002,UNITED THERAPEUTICS CORPORATION,2009/08/14-,66302-206,RUM6K67ESG,treprostinil,treprostinil,RUM6K67ESG,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/cbc31ab1-a80f-4b50-a3b1-39910b0fb609/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=cbc31ab1-a80f-4b50-a3b1-39910b0fb609,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=cbc31ab1-a80f-4b50-a3b1-39910b0fb609,cbc31ab1-a80f-4b50-a3b1-39910b0fb609,,,
HUMAN PRESCRIPTION DRUG LABEL,"KIT; TABLET, EXTENDED RELEASE",ORAL,NDA,203496,Orenitram,TREPROSTINIL,2023/11/07,Prostacycline Vasodilator,2002,UNITED THERAPEUTICS CORPORATION,2013/12/20-; 2023/02/14-,66302-300; 66302-302; 66302-310; 66302-325; 66302-350; 66302-361; 66302-362; 66302-363,RUM6K67ESG,treprostinil,treprostinil,RUM6K67ESG,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/8ed2003a-c801-411e-831e-d06079bb0d7c/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8ed2003a-c801-411e-831e-d06079bb0d7c,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=8ed2003a-c801-411e-831e-d06079bb0d7c,8ed2003a-c801-411e-831e-d06079bb0d7c,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS; SUBCUTANEOUS,NDA,021272,Remodulin; Sterile Diluent for Remodulin,TREPROSTINIL; WATER,2023/10/09,Prostacycline Vasodilator,2002,UNITED THERAPEUTICS CORPORATION,2002/05/22-; 2022/01/25-; 2023/09/28-,66302-101; 66302-102; 66302-105; 66302-110; 66302-111; 66302-112; 66302-114; 66302-120; 66302-150,059QF0KO0R; RUM6K67ESG,treprostinil; water,treprostinil; water,059QF0KO0R; RUM6K67ESG,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/6c80bb38-e8db-4138-9f0d-dbbf9c673185/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6c80bb38-e8db-4138-9f0d-dbbf9c673185,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=6c80bb38-e8db-4138-9f0d-dbbf9c673185,6c80bb38-e8db-4138-9f0d-dbbf9c673185,,,
HUMAN PRESCRIPTION DRUG LABEL,CREAM; GEL,TOPICAL,NDA,017340;017522;017579;017955;019049,Retin-A,TRETINOIN,2024/05/17,Retinoid,,BAUSCH HEALTH US LLC,1973/04/30-; 1974/07/30-; 1975/07/30-; 1979/07/30-; 1988/10/30-,0187-5160; 0187-5162; 0187-5164; 0187-5170; 0187-5172,5688UTC01R,TRETINOIN,TRETINOIN,5688UTC01R,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/9556d73d-c573-4e0a-9feb-764ce2d1107b/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9556d73d-c573-4e0a-9feb-764ce2d1107b,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=9556d73d-c573-4e0a-9feb-764ce2d1107b,9556d73d-c573-4e0a-9feb-764ce2d1107b,,,
HUMAN PRESCRIPTION DRUG LABEL,GEL,TOPICAL,NDA,020475,Retin-A MICRO,TRETINOIN,2024/04/09,Retinoid,1971,BAUSCH HEALTH US LLC,1997/02/07-; 2002/05/10-; 2014/01/28-; 2017/10/23-,0187-5140; 0187-5144; 0187-5146; 0187-5148,5688UTC01R,TRETINOIN,TRETINOIN,5688UTC01R,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/08ab7e0c-1437-455f-815c-98904d96a289/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=08ab7e0c-1437-455f-815c-98904d96a289,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=08ab7e0c-1437-455f-815c-98904d96a289,08ab7e0c-1437-455f-815c-98904d96a289,,,
HUMAN PRESCRIPTION DRUG LABEL,GEL,TOPICAL,NDA,022070,Atralin,TRETINOIN,2024/02/01,Retinoid,1973,BAUSCH HEALTH US LLC,2007/07/26-,13548-070,5688UTC01R,Tretinoin,Tretinoin,5688UTC01R,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/b6b45969-a64a-4ce3-b3b6-157d2568a301/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b6b45969-a64a-4ce3-b3b6-157d2568a301,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=b6b45969-a64a-4ce3-b3b6-157d2568a301,b6b45969-a64a-4ce3-b3b6-157d2568a301,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,NDA,020438,Vesanoid,TRETINOIN,2023/11/22,Retinoid,1995,H PHARMA LLC,2024/02/01-,61269-750,5688UTC01R,TRETINOIN,TRETINOIN,5688UTC01R,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/7fed0b42-2098-4418-9977-c373c3ffd24a/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7fed0b42-2098-4418-9977-c373c3ffd24a,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=7fed0b42-2098-4418-9977-c373c3ffd24a,7fed0b42-2098-4418-9977-c373c3ffd24a,,,
HUMAN PRESCRIPTION DRUG LABEL,LOTION,TOPICAL,NDA,209353,Altreno,TRETINOIN,2020/03/02,Retinoid,1973,BAUSCH HEALTH US LLC,2018/08/24-,0187-0005,5688UTC01R,TRETINOIN,TRETINOIN,5688UTC01R,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/1412aba5-71aa-4cce-8db4-c189bed1852c/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1412aba5-71aa-4cce-8db4-c189bed1852c,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=1412aba5-71aa-4cce-8db4-c189bed1852c,1412aba5-71aa-4cce-8db4-c189bed1852c,,,
HUMAN PRESCRIPTION DRUG LABEL,CREAM,TOPICAL,NDA,021108,Renova,TRETINOIN,2019/09/30,Retinoid,,BAUSCH HEALTH US LLC,2000/08/31-,0187-5150,5688UTC01R,Tretinoin,Tretinoin,5688UTC01R,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/9f0a0e8d-1051-48a4-80c5-1bd260dd9c36/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9f0a0e8d-1051-48a4-80c5-1bd260dd9c36,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=9f0a0e8d-1051-48a4-80c5-1bd260dd9c36,9f0a0e8d-1051-48a4-80c5-1bd260dd9c36,,,
HUMAN PRESCRIPTION DRUG LABEL,CREAM,TOPICAL,NDA,017340;017522;019049,Tretinoin Cream,TRETINOIN,2019/01/01,Retinoid,,OBAGI COSMECEUTICALS LLC,1973/01/26-; 1974/07/19-; 1988/09/16-,62032-412; 62032-414; 62032-417,5688UTC01R,TRETINOIN,TRETINOIN,5688UTC01R,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/745cc3ce-60b4-4479-a055-316817567949/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=745cc3ce-60b4-4479-a055-316817567949,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=745cc3ce-60b4-4479-a055-316817567949,745cc3ce-60b4-4479-a055-316817567949,,,
HUMAN PRESCRIPTION DRUG LABEL,CREAM,TOPICAL,NDA,214902,TWYNEO,TRETINOIN AND BENZOYL PEROXIDE,2023/07/11,Retinoid,2021,GALDERMA LABORATORIES L P,2022/03/15-,0299-5945,5688UTC01R; W9WZN9A0GM,Benzoyl Peroxide; Tretinoin,Benzoyl Peroxide; Tretinoin,5688UTC01R; W9WZN9A0GM,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/27208dff-e376-4c18-b56e-0a260f685a39/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=27208dff-e376-4c18-b56e-0a260f685a39,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=27208dff-e376-4c18-b56e-0a260f685a39,27208dff-e376-4c18-b56e-0a260f685a39,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SUSPENSION",INTRA-ARTICULAR; INTRAMUSCULAR,NDA,014901,KENALOG-40; KENALOG-80,TRIAMCINOLONE ACETONIDE,2023/10/31,Corticosteroid,,E R SQUIBB AND SONS L L C,2009/06/01-; 2019/04/12-,0003-0293; 0003-0315,F446C597KA,triamcinolone acetonide,TRIAMCINOLONE ACETONIDE,F446C597KA,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/cf970688-cd77-b95c-4bd9-c541590e9722/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=cf970688-cd77-b95c-4bd9-c541590e9722,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=cf970688-cd77-b95c-4bd9-c541590e9722,cf970688-cd77-b95c-4bd9-c541590e9722,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SUSPENSION",INTRA-ARTICULAR; INTRALESIONAL,NDA,012041,KENALOG-10,TRIAMCINOLONE ACETONIDE,2023/10/27,Corticosteroid,,E R SQUIBB AND SONS L L C,2009/06/01-,0003-0494,F446C597KA,triamcinolone acetonide,TRIAMCINOLONE ACETONIDE,F446C597KA,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/ec04ecbb-2896-3feb-85fd-a64aba93b289/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ec04ecbb-2896-3feb-85fd-a64aba93b289,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=ec04ecbb-2896-3feb-85fd-a64aba93b289,ec04ecbb-2896-3feb-85fd-a64aba93b289,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SUSPENSION",OPHTHALMIC,NDA,022048,TRIESENCE,TRIAMCINOLONE ACETONIDE,2023/08/04,Corticosteroid,1957,ALCON LABORATORIES INC,2007/11/15-,0065-0543,F446C597KA,TRIAMCINOLONE ACETONIDE,TRIAMCINOLONE ACETONIDE,F446C597KA,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/3f045347-3e5e-4bbd-90f8-6c3100985ca5/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3f045347-3e5e-4bbd-90f8-6c3100985ca5,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=3f045347-3e5e-4bbd-90f8-6c3100985ca5,3f045347-3e5e-4bbd-90f8-6c3100985ca5,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SUSPENSION",OPHTHALMIC,NDA,211950,Xipere,TRIAMCINOLONE ACETONIDE,2022/09/30,Corticosteroid,1957,BAUSCH AND LOMB INCORPORATED,2021/12/17-,24208-040,F446C597KA,TRIAMCINOLONE ACETONIDE,TRIAMCINOLONE ACETONIDE,F446C597KA,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/ea6ad429-967f-4f75-a33d-e06f849bee80/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ea6ad429-967f-4f75-a33d-e06f849bee80,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=ea6ad429-967f-4f75-a33d-e06f849bee80,ea6ad429-967f-4f75-a33d-e06f849bee80,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SUSPENSION",OPHTHALMIC,NDA,211950,Xipere,TRIAMCINOLONE ACETONIDE,2021/12/21,Corticosteroid,1957,CLEARSIDE BIOMEDICAL INC,2021/11/12-,71565-040,F446C597KA,TRIAMCINOLONE ACETONIDE,TRIAMCINOLONE ACETONIDE,F446C597KA,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/c55c3521-a033-4683-9a57-3207f59a4029/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c55c3521-a033-4683-9a57-3207f59a4029,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=c55c3521-a033-4683-9a57-3207f59a4029,c55c3521-a033-4683-9a57-3207f59a4029,,,
HUMAN PRESCRIPTION DRUG LABEL,"AEROSOL, SPRAY",TOPICAL,NDA,012104,Kenalog,TRIAMCINOLONE ACETONIDE,2018/11/09,Corticosteroid,,SUN PHARMACEUTICAL INDUSTRIES INC,2009/05/19-,10631-093,F446C597KA,TRIAMCINOLONE ACETONIDE,TRIAMCINOLONE ACETONIDE,F446C597KA,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/cdf6c80c-ddbd-498f-8897-3c0feebafe31/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=cdf6c80c-ddbd-498f-8897-3c0feebafe31,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=cdf6c80c-ddbd-498f-8897-3c0feebafe31,cdf6c80c-ddbd-498f-8897-3c0feebafe31,,,
HUMAN PRESCRIPTION DRUG LABEL,KIT,INTRA-ARTICULAR,NDA,208845,Zilretta,TRIAMCINOLONE ACETONIDE EXTENDED-RELEASE INJECTABLE SUSPENSION,2023/12/08,Corticosteroid,1957,PACIRA PHARMACEUTICALS INC,2017/10/06-,65250-003,F446C597KA,TRIAMCINOLONE ACETONIDE,TRIAMCINOLONE ACETONIDE,F446C597KA,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/cd5c4673-21f2-4126-9556-da847b3a228b/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=cd5c4673-21f2-4126-9556-da847b3a228b,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=cd5c4673-21f2-4126-9556-da847b3a228b,cd5c4673-21f2-4126-9556-da847b3a228b,,,
HUMAN PRESCRIPTION DRUG LABEL,KIT,EPIDURAL; INFILTRATION; INTRA-ARTICULAR; INTRACAUDAL; INTRAMUSCULAR; INTRAVENOUS; PERINEURAL; TOPICAL,NDA,014901,P-Care K80MX,"TRIAMCINOLONE ACETONIDE, BUPIVACAINE HCL, LIDOCAINE HCL, SODIUM CHLORIDE, POVIDONE IODINE, ISOPROPYL ALCOHOL",2020/02/03,Amide Local Anesthetic; Antiarrhythmic; Corticosteroid,,RX PHARMA PACK INC,2017/06/16-,49836-007,451W47IQ8X; 7TQO7W3VT8; 85H0HZU99M; EC2CNF7XFP; F446C597KA; ND2M416302,BUPIVACAINE HYDROCHLORIDE; ISOPROPYL ALCOHOL; LIDOCAINE HYDROCHLORIDE ANHYDROUS; POVIDONE-IODINE; SODIUM CHLORIDE; TRIAMCINOLONE ACETONIDE,BUPIVACAINE; CHLORIDE ION; IODINE; ISOPROPYL ALCOHOL; LIDOCAINE; SODIUM CATION; TRIAMCINOLONE ACETONIDE,9679TC07X4; 98PI200987; F446C597KA; LYR4M0NH37; ND2M416302; Q32ZN48698; Y8335394RO,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/56b90729-de15-4df9-9590-4da216fa9cd9/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=56b90729-de15-4df9-9590-4da216fa9cd9,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=56b90729-de15-4df9-9590-4da216fa9cd9,56b90729-de15-4df9-9590-4da216fa9cd9,,,
HUMAN PRESCRIPTION DRUG LABEL,KIT,EPIDURAL; INFILTRATION; INTRA-ARTICULAR; INTRACAUDAL; INTRAMUSCULAR; INTRAVENOUS; PERINEURAL; TOPICAL,NDA,014901,P-Care K40MX,"TRIAMCINOLONE ACETONIDE, BUPIVACAINE HCL, LIDOCAINE HCL, SODIUM CHLORIDE, POVIDONE IODINE, ISOPROPYL ALCOHOL",2020/02/03,Amide Local Anesthetic; Antiarrhythmic; Corticosteroid,,RX PHARMA PACK INC,2017/06/16-,49836-004,451W47IQ8X; 7TQO7W3VT8; 85H0HZU99M; EC2CNF7XFP; F446C597KA; ND2M416302,BUPIVACAINE HYDROCHLORIDE; ISOPROPYL ALCOHOL; LIDOCAINE HYDROCHLORIDE ANHYDROUS; POVIDONE-IODINE; SODIUM CHLORIDE; TRIAMCINOLONE ACETONIDE,BUPIVACAINE; CHLORIDE ION; IODINE; ISOPROPYL ALCOHOL; LIDOCAINE; SODIUM CATION; TRIAMCINOLONE ACETONIDE,9679TC07X4; 98PI200987; F446C597KA; LYR4M0NH37; ND2M416302; Q32ZN48698; Y8335394RO,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/a7bceca8-7dda-4fff-80de-01858b90c928/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a7bceca8-7dda-4fff-80de-01858b90c928,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=a7bceca8-7dda-4fff-80de-01858b90c928,a7bceca8-7dda-4fff-80de-01858b90c928,,,
HUMAN PRESCRIPTION DRUG LABEL,KIT,INTRA-ARTICULAR; INTRAMUSCULAR; TOPICAL,NDA,014901,P-Care K80,"TRIAMCINOLONE ACETONIDE, POVIDONE IODINE, ISOPROPYL ALCOHOL",2020/02/03,Corticosteroid,,RX PHARMA PACK INC,2017/06/16-,49836-008,85H0HZU99M; F446C597KA; ND2M416302,ISOPROPYL ALCOHOL; POVIDONE-IODINE; TRIAMCINOLONE ACETONIDE,IODINE; ISOPROPYL ALCOHOL; TRIAMCINOLONE ACETONIDE,9679TC07X4; F446C597KA; ND2M416302,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/b0ffed4f-350e-4d0d-93cc-f56ca5101d9b/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b0ffed4f-350e-4d0d-93cc-f56ca5101d9b,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=b0ffed4f-350e-4d0d-93cc-f56ca5101d9b,b0ffed4f-350e-4d0d-93cc-f56ca5101d9b,,,
HUMAN PRESCRIPTION DRUG LABEL,KIT,INTRA-ARTICULAR; INTRAMUSCULAR; TOPICAL,NDA,014901,P-Care K40G,"TRIAMCINOLONE ACETONIDE, POVIDONE-IODINE, ISOPROPYL ALCOHOL",2020/02/03,Corticosteroid,,RX PHARMA PACK INC,2017/06/16-,49836-005,85H0HZU99M; F446C597KA; ND2M416302,ISOPROPYL ALCOHOL; POVIDONE-IODINE; TRIAMCINOLONE ACETONIDE,IODINE; ISOPROPYL ALCOHOL; TRIAMCINOLONE ACETONIDE,9679TC07X4; F446C597KA; ND2M416302,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/2b68a677-3e60-4dbf-9976-1822ceb036fd/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2b68a677-3e60-4dbf-9976-1822ceb036fd,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=2b68a677-3e60-4dbf-9976-1822ceb036fd,2b68a677-3e60-4dbf-9976-1822ceb036fd,,,
HUMAN PRESCRIPTION DRUG LABEL,KIT,INTRA-ARTICULAR; INTRAMUSCULAR; TOPICAL,NDA,014901,P-Care K80G,"TRIAMCINOLONE ACETONIDE, POVIDONE-IODINE, ISOPROPYL ALCOHOL",2020/02/03,Corticosteroid,,RX PHARMA PACK INC,2017/06/16-,49836-009,85H0HZU99M; F446C597KA; ND2M416302,ISOPROPYL ALCOHOL; POVIDONE-IODINE; TRIAMCINOLONE ACETONIDE,IODINE; ISOPROPYL ALCOHOL; TRIAMCINOLONE ACETONIDE,9679TC07X4; F446C597KA; ND2M416302,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/5b57ba83-eed9-437b-b632-6b8ebf51cd29/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5b57ba83-eed9-437b-b632-6b8ebf51cd29,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=5b57ba83-eed9-437b-b632-6b8ebf51cd29,5b57ba83-eed9-437b-b632-6b8ebf51cd29,,,
HUMAN PRESCRIPTION DRUG LABEL,KIT,INTRA-ARTICULAR; INTRAMUSCULAR; TOPICAL,NDA,014901,P-Care K40,"TRIAMCINOLONE ACETONIDE, POVIDONE-IODINE, ISOPROPYL ALCOHOL",2020/01/31,Corticosteroid,,RX PHARMA PACK INC,2017/06/16-,49836-006,85H0HZU99M; F446C597KA; ND2M416302,ISOPROPYL ALCOHOL; POVIDONE-IODINE; TRIAMCINOLONE ACETONIDE,IODINE; ISOPROPYL ALCOHOL; TRIAMCINOLONE ACETONIDE,9679TC07X4; F446C597KA; ND2M416302,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/89e97f59-9329-4943-a00a-2b8685fc5993/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=89e97f59-9329-4943-a00a-2b8685fc5993,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=89e97f59-9329-4943-a00a-2b8685fc5993,89e97f59-9329-4943-a00a-2b8685fc5993,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,NDA,013174,Dyrenium,TRIAMTERENE,2023/07/03,Potassium-sparing Diuretic,,CONCORDIA PHARMACEUTICALS INC,1999/01/01-; 1999/10/01-,59212-002; 59212-003,WS821Z52LQ,TRIAMTERENE,TRIAMTERENE,WS821Z52LQ,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/ebb177c0-d45d-4443-a85a-e76bd9931a42/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ebb177c0-d45d-4443-a85a-e76bd9931a42,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=ebb177c0-d45d-4443-a85a-e76bd9931a42,ebb177c0-d45d-4443-a85a-e76bd9931a42,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,017892,Halcion,TRIAZOLAM,2024/03/22,Benzodiazepine,1982,PHARMACIA AND UPJOHN COMPANY LLC,1982/11/15-,0009-0017,1HM943223R,TRIAZOLAM,TRIAZOLAM,1HM943223R,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/a0da0dba-a56d-486b-a45b-e8a7cdfbeac6/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a0da0dba-a56d-486b-a45b-e8a7cdfbeac6,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=a0da0dba-a56d-486b-a45b-e8a7cdfbeac6,a0da0dba-a56d-486b-a45b-e8a7cdfbeac6,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,208711,EGATEN,TRICLABENDAZOLE,2024/01/22,Anthelmintic,2019,NOVARTIS PHARMACEUTICALS CORPORATION,2019/02/13-,0078-0937,4784C8E03O,TRICLABENDAZOLE,TRICLABENDAZOLE,4784C8E03O,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/5552884e-10ea-450c-9658-d3d4f33c946e/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5552884e-10ea-450c-9658-d3d4f33c946e,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=5552884e-10ea-450c-9658-d3d4f33c946e,5552884e-10ea-450c-9658-d3d4f33c946e,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,NDA,019194,Syprine,TRIENTINE HYDROCHLORIDE,2020/09/01,Copper Chelator,,BAUSCH HEALTH US LLC,1985/11/08-,0187-2120,HC3NX54582,trientine hydrochloride,trientine,SJ76Y07H5F,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/c34f77a7-996b-4470-b5df-d946a7fe5dbe/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c34f77a7-996b-4470-b5df-d946a7fe5dbe,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=c34f77a7-996b-4470-b5df-d946a7fe5dbe,c34f77a7-996b-4470-b5df-d946a7fe5dbe,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,215760,CUVRIOR,TRIENTINE TETRAHYDROCHLORIDE,2024/01/31,Copper Chelator,1985,ORPHALAN SA,2022/09/14-,81802-001,7360URE56Q,TRIENTINE TETRAHYDROCHLORIDE,TRIENTINE,SJ76Y07H5F,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/f73feeae-62ad-401e-b9f7-5cb269127750/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f73feeae-62ad-401e-b9f7-5cb269127750,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=f73feeae-62ad-401e-b9f7-5cb269127750,f73feeae-62ad-401e-b9f7-5cb269127750,,,
HUMAN PRESCRIPTION DRUG LABEL,CREAM,TOPICAL,NDA,211527,AKLIEF,TRIFAROTENE,2023/10/31,Retinoid,2019,GALDERMA LABORATORIES L P,2019/10/04-,0299-5935,0J8RN2W0HK,Trifarotene,Trifarotene,0J8RN2W0HK,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/62d910db-85a6-4696-b69b-4bd2f3080cfc/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=62d910db-85a6-4696-b69b-4bd2f3080cfc,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=62d910db-85a6-4696-b69b-4bd2f3080cfc,62d910db-85a6-4696-b69b-4bd2f3080cfc,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,207981,LONSURF,TRIFLURIDINE AND TIPIRACIL,2023/08/08,Nucleoside Analog Antiviral; Nucleoside Metabolic Inhibitor; Thymidine Phosphorylase Inhibitor,2015,TAIHO PHARMACEUTICAL CO LTD,2015/09/22-,64842-1020; 64842-1025,4H59KLQ0A4; RMW9V5RW38,TIPIRACIL HYDROCHLORIDE; TRIFLURIDINE,TIPIRACIL; TRIFLURIDINE,NGO10K751P; RMW9V5RW38,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/f5beed22-d71d-4c0d-8dca-2c7317d65d85/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f5beed22-d71d-4c0d-8dca-2c7317d65d85,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=f5beed22-d71d-4c0d-8dca-2c7317d65d85,f5beed22-d71d-4c0d-8dca-2c7317d65d85,,,
HUMAN PRESCRIPTION DRUG LABEL,LIQUID,ORAL,NDA,213687,DOJOLVI,TRIHEPTANOIN,2023/06/19,Medium-chain Triglyceride,2020,ULTRAGENYX PHARMACEUTICAL INC,2020/07/01-,69794-050,2P6O7CFW5K,TRIHEPTANOIN,TRIHEPTANOIN,2P6O7CFW5K,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/4cfeb8bd-143e-4dd7-bc34-b0bcda02460d/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4cfeb8bd-143e-4dd7-bc34-b0bcda02460d,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=4cfeb8bd-143e-4dd7-bc34-b0bcda02460d,4cfeb8bd-143e-4dd7-bc34-b0bcda02460d,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAVENOUS,NDA,214200,COSELA,TRILACICLIB,2023/08/03,Kinase Inhibitor,2021,G THERAPEUTICS INC,2021/02/12-,73462-101,4BX07W725T,trilaciclib dihydrochloride,trilaciclib,U6072DO9XG,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/4b06922c-498d-4871-a037-84a44e6a6b6c/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4b06922c-498d-4871-a037-84a44e6a6b6c,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=4b06922c-498d-4871-a037-84a44e6a6b6c,4b06922c-498d-4871-a037-84a44e6a6b6c,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRAMUSCULAR,NDA,017530,Tigan,TRIMETHOBENZAMIDE HYDROCHLORIDE,2023/03/06,Antiemetic,,PAR PHARMACEUTICAL INC,2008/08/01-,42023-119,WDQ5P1SX7Q,TRIMETHOBENZAMIDE HYDROCHLORIDE,TRIMETHOBENZAMIDE,W2X096QY97,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/7da90678-b229-4ad6-9193-2b8a3e9ba695/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7da90678-b229-4ad6-9193-2b8a3e9ba695,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=7da90678-b229-4ad6-9193-2b8a3e9ba695,7da90678-b229-4ad6-9193-2b8a3e9ba695,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,018679,Trimethoprim,TRIMETHOPRIM,2024/01/26,Dihydrofolate Reductase Inhibitor Antibacterial,,DR REDDY S LABRATORIES INC,2024/01/30-,75907-043,AN164J8Y0X,TRIMETHOPRIM,TRIMETHOPRIM,AN164J8Y0X,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/73ccebc1-7412-2424-d62c-a5180ec52d81/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=73ccebc1-7412-2424-d62c-a5180ec52d81,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=73ccebc1-7412-2424-d62c-a5180ec52d81,73ccebc1-7412-2424-d62c-a5180ec52d81,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,018679,Trimethoprim,TRIMETHOPRIM,2021/02/16,Dihydrofolate Reductase Inhibitor Antibacterial,,MAYNE PHARMA,2016/07/18-,51862-486,AN164J8Y0X,TRIMETHOPRIM,TRIMETHOPRIM,AN164J8Y0X,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/8a0098dd-c316-4591-8e58-10531ff2048f/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8a0098dd-c316-4591-8e58-10531ff2048f,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=8a0098dd-c316-4591-8e58-10531ff2048f,8a0098dd-c316-4591-8e58-10531ff2048f,,,
HUMAN PRESCRIPTION DRUG LABEL,KIT,INTRAMUSCULAR,NDA,208956,TRIPTODUR,TRIPTORELIN,2024/05/10,Gonadotropin Releasing Hormone Receptor Agonist,2000,AZURITY PHARMACEUTICALS INC,2017/09/08-,24338-150,9081Y98W2V,TRIPTORELIN,TRIPTORELIN,9081Y98W2V,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/f41380e7-b830-432d-a5f5-a872932f107e/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f41380e7-b830-432d-a5f5-a872932f107e,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=f41380e7-b830-432d-a5f5-a872932f107e,f41380e7-b830-432d-a5f5-a872932f107e,,,
HUMAN PRESCRIPTION DRUG LABEL,KIT,INTRAMUSCULAR,NDA,020715;021288;022437,Trelstar,TRIPTORELIN PAMOATE,2024/04/15,Gonadotropin Releasing Hormone Receptor Agonist,2000,VERITY PHARMACEUTICALS INC,2000/06/15-; 2001/06/29-; 2010/03/11-,74676-5902; 74676-5904; 74676-5906,08AN7WA2G0,TRIPTORELIN PAMOATE,TRIPTORELIN,9081Y98W2V,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/b1b84d62-a369-a4b7-5c41-dd1f553a18f3/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b1b84d62-a369-a4b7-5c41-dd1f553a18f3,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=b1b84d62-a369-a4b7-5c41-dd1f553a18f3,b1b84d62-a369-a4b7-5c41-dd1f553a18f3,,,
HUMAN PRESCRIPTION DRUG LABEL,SOLUTION,ORAL,NDA,217026,Daybue,TROFINETIDE,2023/03/29,,2023,ACADIA PHARMACEUTICALS INC,2022/12/31-,63090-660,Z2ME8F52QL,trofinetide,trofinetide,Z2ME8F52QL,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/67e6f2d9-21f6-466f-9def-826c6a4b8257/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=67e6f2d9-21f6-466f-9def-826c6a4b8257,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=67e6f2d9-21f6-466f-9def-826c6a4b8257,67e6f2d9-21f6-466f-9def-826c6a4b8257,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,013025,THAM,TROMETHAMINE,2023/12/18,,,HOSPIRA INC,2020/06/24-,0409-1593,023C2WHX2V,TROMETHAMINE,TROMETHAMINE,023C2WHX2V,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/4af52118-c12b-4ad5-30bb-959848357e8a/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4af52118-c12b-4ad5-30bb-959848357e8a,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=4af52118-c12b-4ad5-30bb-959848357e8a,4af52118-c12b-4ad5-30bb-959848357e8a,,,
HUMAN PRESCRIPTION DRUG LABEL,"SPRAY, METERED",OPHTHALMIC,NDA,215352,MYDCOMBI,TROPICAMIDE AND PHENYLEPHRINE HYDROCHLORIDE,2023/05/09,Anticholinergic; alpha-1 Adrenergic Agonist,2023,EYENOVIA INC,2023/05/09-,81046-0111,04JA59TNSJ; N0A3Z5XTC6,Phenylephrine Hydrochloride; Tropicamide,Phenylephrine; Tropicamide,1WS297W6MV; N0A3Z5XTC6,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/dbff7eeb-a16a-4106-ae5e-4effdd33cc45/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=dbff7eeb-a16a-4106-ae5e-4effdd33cc45,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=dbff7eeb-a16a-4106-ae5e-4effdd33cc45,dbff7eeb-a16a-4106-ae5e-4effdd33cc45,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAOCULAR; OPHTHALMIC,NDA,021670,VISIONBLUE,TRYPAN BLUE,2023/10/05,Diagnostic Dye,2004,D O R C DUTCH OPHTHALMIC RESEARCH CENTER INTERNATIONAL B V,2004/12/16-,68803-612,I2ZWO3LS3M,TRYPAN BLUE,TRYPAN BLUE FREE ACID,768N7QO4KH,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/a44bc2ef-3d7f-4125-a7f7-c5969b1b4142/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a44bc2ef-3d7f-4125-a7f7-c5969b1b4142,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=a44bc2ef-3d7f-4125-a7f7-c5969b1b4142,a44bc2ef-3d7f-4125-a7f7-c5969b1b4142,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAOCULAR; OPHTHALMIC,NDA,022278,MEMBRANEBLUE,TRYPAN BLUE,2021/11/15,Diagnostic Dye,2004,DUTCH OPHTHALMIC RESEARCH CENTER INTERNATIONAL B V,2009/02/20-,68803-672,I2ZWO3LS3M,TRYPAN BLUE,TRYPAN BLUE FREE ACID,768N7QO4KH,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/0364aceb-dd3f-4bac-b468-25379a07ccfc/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0364aceb-dd3f-4bac-b468-25379a07ccfc,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=0364aceb-dd3f-4bac-b468-25379a07ccfc,0364aceb-dd3f-4bac-b468-25379a07ccfc,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,213411,TUKYSA,TUCATINIB,2023/01/23,Kinase Inhibitor,2020,SEAGEN INC,2020/04/17-,51144-001; 51144-002,234248D0HH,Tucatinib,Tucatinib,234248D0HH,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/f27eb1b9-b7fc-424e-988f-84dd7bb195a3/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f27eb1b9-b7fc-424e-988f-84dd7bb195a3,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=f27eb1b9-b7fc-424e-988f-84dd7bb195a3,f27eb1b9-b7fc-424e-988f-84dd7bb195a3,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,211765,UBRELVY,UBROGEPANT,2023/06/01,Calcitonin Gene-related Peptide Receptor Antagonist,2019,ALLERGAN INC,2019/12/23-,0023-6498; 0023-6501,AD0O8X2QJR,UBROGEPANT,UBROGEPANT,AD0O8X2QJR,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/fd9f9458-fd96-4688-be3f-f77b3d1af6ab/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=fd9f9458-fd96-4688-be3f-f77b3d1af6ab,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=fd9f9458-fd96-4688-be3f-f77b3d1af6ab,fd9f9458-fd96-4688-be3f-f77b3d1af6ab,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,022474,Ella,ULIPRISTAL ACETATE,2023/11/01,Progesterone Agonist/Antagonist,2010,HRA PHARMA AMERICA INC,2020/05/11-,73302-456,YF7V70N02B,ULIPRISTAL ACETATE,ULIPRISTAL,6J5J15Q2X8,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/2bf93d23-cddd-4613-9066-5b5fa090404b/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2bf93d23-cddd-4613-9066-5b5fa090404b,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=2bf93d23-cddd-4613-9066-5b5fa090404b,2bf93d23-cddd-4613-9066-5b5fa090404b,,,
HUMAN PRESCRIPTION DRUG LABEL,"AEROSOL, POWDER",ORAL,NDA,205382,Incruse Ellipta,UMECLIDINIUM,2023/12/13,Anticholinergic,2013,GLAXOSMITHKLINE LLC,2014/04/30-,0173-0873,7AN603V4JV,UMECLIDINIUM BROMIDE,UMECLIDINIUM,GE2T1418SV,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/dbb64747-1505-49d7-9a33-99dd402e96d3/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=dbb64747-1505-49d7-9a33-99dd402e96d3,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=dbb64747-1505-49d7-9a33-99dd402e96d3,dbb64747-1505-49d7-9a33-99dd402e96d3,,,
HUMAN PRESCRIPTION DRUG LABEL,POWDER,INHALATION,NDA,203975,Anoro Ellipta,UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE,2023/06/02,Anticholinergic; beta2-Adrenergic Agonist,2013,GLAXOSMITHKLINE LLC,2014/01/31-,0173-0869,40AHO2C6DG; 7AN603V4JV,UMECLIDINIUM BROMIDE; VILANTEROL TRIFENATATE,UMECLIDINIUM; VILANTEROL,028LZY775B; GE2T1418SV,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/2dbd0671-c565-40c5-bf0f-e324db26799c/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2dbd0671-c565-40c5-bf0f-e324db26799c,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=2dbd0671-c565-40c5-bf0f-e324db26799c,2dbd0671-c565-40c5-bf0f-e324db26799c,,,
HUMAN PRESCRIPTION DRUG LABEL,"SOLUTION; TABLET, EXTENDED RELEASE",ORAL,NDA,211675;218347,Rinvoq,UPADACITINIB,2024/04/26,Janus Kinase Inhibitor,2019,ABBVIE INC,2019/08/16-; 2024/04/26-,0074-1043; 0074-2306; 0074-2310; 0074-2320,4RA0KN46E0,UPADACITINIB; upadacitinib,UPADACITINIB; upadacitinib,4RA0KN46E0,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/2966aec7-2ef0-923c-d8ff-fe1a957bf095/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2966aec7-2ef0-923c-d8ff-fe1a957bf095,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=2966aec7-2ef0-923c-d8ff-fe1a957bf095,2966aec7-2ef0-923c-d8ff-fe1a957bf095,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,NDA,020617,PYtest,"UREA, C-14",2022/06/07,,,AVENT INC,1997/05/09-,42536-6044,WBZ6M63TEE,Urea C-14,Urea C-14,WBZ6M63TEE,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/13148b04-9295-41bb-bd8b-76dbd4ce7c00/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=13148b04-9295-41bb-bd8b-76dbd4ce7c00,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=13148b04-9295-41bb-bd8b-76dbd4ce7c00,13148b04-9295-41bb-bd8b-76dbd4ce7c00,,,
HUMAN PRESCRIPTION DRUG LABEL,GRANULE,ORAL,NDA,208169,XURIDEN,URIDINE TRIACETATE,2022/11/11,Pyrimidine Analog,2015,WELLSTAT THERAPEUTICS CORPORATION,2015/09/08-,69468-152,2WP61F175M,uridine triacetate,uridine,WHI7HQ7H85,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/40606ca9-4f14-45b7-8632-fc2d17d11a2e/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=40606ca9-4f14-45b7-8632-fc2d17d11a2e,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=40606ca9-4f14-45b7-8632-fc2d17d11a2e,40606ca9-4f14-45b7-8632-fc2d17d11a2e,,,
HUMAN PRESCRIPTION DRUG LABEL,GRANULE,ORAL,NDA,208159,VISTOGARD,URIDINE TRIACETATE,2018/11/15,Pyrimidine Analog,2015,WELLSTAT THERAPEUTICS CORPORATION,2016/03/01-,69468-151,2WP61F175M,uridine triacetate,uridine,WHI7HQ7H85,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/5a0ba417-8a4a-4d7f-b85a-1839ee8bd3f1/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5a0ba417-8a4a-4d7f-b85a-1839ee8bd3f1,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=5a0ba417-8a4a-4d7f-b85a-1839ee8bd3f1,5a0ba417-8a4a-4d7f-b85a-1839ee8bd3f1,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,020675,Urso 250; Urso Forte,URSODIOL,2023/01/12,Bile Acid,1997,ALLERGAN INC,1997/12/10-,58914-785; 58914-790,724L30Y2QR,Ursodiol,Ursodiol; ursodiol,724L30Y2QR,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/e8fc4fc2-fe5c-4cba-b6e0-5ceaf2157a61/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e8fc4fc2-fe5c-4cba-b6e0-5ceaf2157a61,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=e8fc4fc2-fe5c-4cba-b6e0-5ceaf2157a61,e8fc4fc2-fe5c-4cba-b6e0-5ceaf2157a61,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,215192,VAFSEO,VADADUSTAT,2024/03/27,,2024,AKEBIA THERAPEUTICS INC,2024/03/28-,59922-641; 59922-642; 59922-643,I60W9520VV,VADADUSTAT,VADADUSTAT,I60W9520VV,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/ac9da724-5a62-4ab6-a89c-376a25f6195b/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ac9da724-5a62-4ab6-a89c-376a25f6195b,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=ac9da724-5a62-4ab6-a89c-376a25f6195b,ac9da724-5a62-4ab6-a89c-376a25f6195b,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,020487,VALTREX,VALACYCLOVIR HYDROCHLORIDE,2022/11/14,Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor; Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor; Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor,1995,GLAXOSMITHKLINE LLC,1995/08/01-; 2002/08/12-,0173-0565; 0173-0933,G447S0T1VC,VALACYCLOVIR HYDROCHLORIDE,ACYCLOVIR,X4HES1O11F,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/f8e0d8f8-cb73-4206-a484-88f5c4fbd719/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f8e0d8f8-cb73-4206-a484-88f5c4fbd719,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=f8e0d8f8-cb73-4206-a484-88f5c4fbd719,f8e0d8f8-cb73-4206-a484-88f5c4fbd719,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE; KIT,ORAL,NDA,209241;218390,INGREZZA; INGREZZA Sprinkle,VALBENAZINE,2024/04/30,Vesicular Monoamine Transporter 2 Inhibitor,2017,NEUROCRINE BIOSCIENCES INC,2017/10/04-; 2018/12/14-; 2021/04/23-; 2023/08/18-; 2024/04/30-,70370-1060; 70370-1080; 70370-2040; 70370-2046; 70370-2048; 70370-4040; 70370-4060; 70370-4080,5SML1T733B,VALBENAZINE TOSYLATE,VALBENAZINE,54K37P50KH,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/4c970164-cafb-421f-9eb5-c226ef0a3417/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4c970164-cafb-421f-9eb5-c226ef0a3417,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=4c970164-cafb-421f-9eb5-c226ef0a3417,4c970164-cafb-421f-9eb5-c226ef0a3417,,,
HUMAN PRESCRIPTION DRUG LABEL,"POWDER, FOR SOLUTION; TABLET, FILM COATED",ORAL,NDA,021304;022257,Valcyte,VALGANCICLOVIR; VALGANCICLOVIR HYDROCHLORIDE,2024/01/11,Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor; Nucleoside Analog Antiviral,2001,GENENTECH INC,2001/03/29-; 2009/08/28-,0004-0038; 0004-0039,4P3T9QF9NZ,VALGANCICLOVIR HYDROCHLORIDE,GANCICLOVIR,P9G3CKZ4P5,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/dc548ff9-e8ea-4d6e-b9b4-e31f53ac4078/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=dc548ff9-e8ea-4d6e-b9b4-e31f53ac4078,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=dc548ff9-e8ea-4d6e-b9b4-e31f53ac4078,dc548ff9-e8ea-4d6e-b9b4-e31f53ac4078,,,
HUMAN PRESCRIPTION DRUG LABEL,"POWDER, FOR SOLUTION; TABLET, FILM COATED",ORAL,NDA,021304;022257,Valcyte,VALGANCICLOVIR; VALGANCICLOVIR HYDROCHLORIDE,2023/12/01,Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor; Nucleoside Analog Antiviral,2001,H PHARMA LLC,2001/03/29-; 2009/08/28-,61269-480; 61269-485,4P3T9QF9NZ,VALGANCICLOVIR HYDROCHLORIDE,GANCICLOVIR,P9G3CKZ4P5,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/4c517a39-2ded-4c5a-8d56-276853414b31/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4c517a39-2ded-4c5a-8d56-276853414b31,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=4c517a39-2ded-4c5a-8d56-276853414b31,4c517a39-2ded-4c5a-8d56-276853414b31,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,020849,ProSol,"VALINE, LYSINE, HISTIDINE, ISOLEUCINE, LEUCINE, PHENYLALANINE, THREONINE, METHIONINE, TRYPTOPHAN, ALANINE, GLYCINE, ARGININE, PROLINE, GLUTAMIC ACID, SERINE, ASPARTIC ACID AND TYROSINE",2020/10/07,Amino Acid,1998,BAXTER HEALTHCARE CORPORATION,1998/08/26-,0338-0499,04Y7590D77; 2ZD004190S; 30KYC7MIAI; 3KX376GY7L; 42HK56048U; 452VLY9402; 47E5O17Y3R; 4QD397987E; 8DUH1N11BX; 94ZLA3W45F; 9DLQ4CIU6V; AE28F7PNPL; GMW67QNF9C; HG18B9YRS7; OF5P57N2ZX; TE7660XO1C; TTL6G7LIWZ,ALANINE; ARGININE; ASPARTIC ACID; GLUTAMIC ACID; GLYCINE; HISTIDINE; ISOLEUCINE; LEUCINE; LYSINE ACETATE; METHIONINE,ALANINE; ARGININE; ASPARTIC ACID; GLUTAMIC ACID; GLYCINE; HISTIDINE; ISOLEUCINE; LEUCINE; LYSINE; METHIONINE,04Y7590D77; 2ZD004190S; 30KYC7MIAI; 3KX376GY7L; 42HK56048U; 452VLY9402; 47E5O17Y3R; 4QD397987E; 8DUH1N11BX; 94ZLA3W45F; 9DLQ4CIU6V; AE28F7PNPL; GMW67QNF9C; HG18B9YRS7; K3Z4F929H6; OF5P57N2ZX; TE7660XO1C,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/cc2ace81-5881-43f1-ba94-41b674adc2fc/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=cc2ace81-5881-43f1-ba94-41b674adc2fc,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=cc2ace81-5881-43f1-ba94-41b674adc2fc,cc2ace81-5881-43f1-ba94-41b674adc2fc,,,
HUMAN PRESCRIPTION DRUG LABEL,"SOLUTION, CONCENTRATE",INTRAVESICAL,NDA,020892,Valstar,VALRUBICIN,2023/10/25,,1981,ENDO PHARMACEUTICALS SOLUTIONS INC,1998/10/01-,67979-001,2C6NUM6878,VALRUBICIN,VALRUBICIN,2C6NUM6878,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/e96f30a0-6662-11de-8f80-0002a5d5c51b/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e96f30a0-6662-11de-8f80-0002a5d5c51b,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=e96f30a0-6662-11de-8f80-0002a5d5c51b,e96f30a0-6662-11de-8f80-0002a5d5c51b,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,021283,Diovan,VALSARTAN,2023/07/11,Angiotensin 2 Receptor Blocker,1996,NOVARTIS PHARMACEUTICALS CORPORATION,2001/07/01-,0078-0358; 0078-0359; 0078-0360; 0078-0423,80M03YXJ7I,VALSARTAN,VALSARTAN,80M03YXJ7I,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/5ddba454-f3e6-43c2-a7a6-58365d297213/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5ddba454-f3e6-43c2-a7a6-58365d297213,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=5ddba454-f3e6-43c2-a7a6-58365d297213,5ddba454-f3e6-43c2-a7a6-58365d297213,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,020818,Diovan HCT,VALSARTAN AND HYDROCHLOROTHIAZIDE,2023/07/11,Angiotensin 2 Receptor Blocker; Thiazide Diuretic,1998,NOVARTIS PHARMACEUTICALS CORPORATION,1998/03/06-; 2006/04/28-,0078-0314; 0078-0315; 0078-0383; 0078-0471; 0078-0472,0J48LPH2TH; 80M03YXJ7I,HYDROCHLOROTHIAZIDE; VALSARTAN,HYDROCHLOROTHIAZIDE; VALSARTAN,0J48LPH2TH; 80M03YXJ7I,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/d76a0419-05ee-437e-884c-65807aea9569/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d76a0419-05ee-437e-884c-65807aea9569,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=d76a0419-05ee-437e-884c-65807aea9569,d76a0419-05ee-437e-884c-65807aea9569,,,
HUMAN PRESCRIPTION DRUG LABEL,KIT,ORAL,NDA,215239,AGAMREE,VAMOROLONE,2024/01/05,Corticosteroid,2023,CATALYST PHARMACEUTICALS INC,2024/02/01-,69616-264,8XP29XMB43,VAMOROLONE,VAMOROLONE,8XP29XMB43,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/fb376f09-cf9c-42b5-b4dd-02d5bcd73211/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=fb376f09-cf9c-42b5-b4dd-02d5bcd73211,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=fb376f09-cf9c-42b5-b4dd-02d5bcd73211,fb376f09-cf9c-42b5-b4dd-02d5bcd73211,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,211962,Vancomycin,VANCOMYCIN,2023/03/23,Glycopeptide Antibacterial,1958,XELLIA PHARMACEUTICALS USA LLC,2019/02/15-; 2019/02/23-; 2020/05/13-,70594-041; 70594-042; 70594-043; 70594-044; 70594-056; 70594-057; 70594-058,6Q205EH1VU,VANCOMYCIN,VANCOMYCIN,6Q205EH1VU,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/60bee69b-be70-412c-9e83-a24a0a8a5e7b/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=60bee69b-be70-412c-9e83-a24a0a8a5e7b,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=60bee69b-be70-412c-9e83-a24a0a8a5e7b,60bee69b-be70-412c-9e83-a24a0a8a5e7b,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,213895,Vancomycin,VANCOMYCIN,2021/09/10,Glycopeptide Antibacterial,1958,XELLIA PHARMACEUTICALS USA LLC,2021/08/26-,70594-040,6Q205EH1VU,VANCOMYCIN,VANCOMYCIN,6Q205EH1VU,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/5105259a-c16e-4875-a920-50fefc92b822/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5105259a-c16e-4875-a920-50fefc92b822,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=5105259a-c16e-4875-a920-50fefc92b822,5105259a-c16e-4875-a920-50fefc92b822,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS; INTRAVITREAL,NDA,050671,VANCOMYCIN HYDROCHLORIDE,VANCOMYCIN HYDROCHLORIDE,2024/01/25,Glycopeptide Antibacterial,,BAXTER HEALTHCARE CORPORATION,1958/11/14-,0338-0122; 0338-0124; 0338-3551; 0338-3552; 0338-3580; 0338-3581; 0338-3582; 0338-3583,71WO621TJD,VANCOMYCIN HYDROCHLORIDE,VANCOMYCIN,6Q205EH1VU,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/99e523d8-9bde-43cb-8434-497015e5dcbd/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=99e523d8-9bde-43cb-8434-497015e5dcbd,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=99e523d8-9bde-43cb-8434-497015e5dcbd,99e523d8-9bde-43cb-8434-497015e5dcbd,,,
HUMAN PRESCRIPTION DRUG LABEL,KIT,ORAL,NDA,208910,FIRVANQ,VANCOMYCIN HYDROCHLORIDE,2023/12/08,Glycopeptide Antibacterial,1964,AZURITY PHARMACEUTICALS INC,2018/01/26-,65628-204; 65628-205; 65628-206; 65628-208,71WO621TJD,VANCOMYCIN HYDROCHLORIDE,VANCOMYCIN,6Q205EH1VU,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/5aca5508-b577-446c-9980-ab4c7582b4b9/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5aca5508-b577-446c-9980-ab4c7582b4b9,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=5aca5508-b577-446c-9980-ab4c7582b4b9,5aca5508-b577-446c-9980-ab4c7582b4b9,,,
HUMAN PRESCRIPTION DRUG LABEL,KIT,ORAL,NDA,208910,FIRVANQ,VANCOMYCIN HYDROCHLORIDE,2023/12/08,Glycopeptide Antibacterial,1964,AZURITY PHARMACEUTICALS INC,2020/02/14-,65628-015; 65628-016,71WO621TJD,VANCOMYCIN HYDROCHLORIDE,VANCOMYCIN,6Q205EH1VU,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/984208d5-395b-0c59-e053-2995a90a4f42/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=984208d5-395b-0c59-e053-2995a90a4f42,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=984208d5-395b-0c59-e053-2995a90a4f42,984208d5-395b-0c59-e053-2995a90a4f42,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, POWDER, FOR SOLUTION",INTRAVENOUS; ORAL,NDA,210274,VANCOMYCIN HYDROCHLORIDE,VANCOMYCIN HYDROCHLORIDE,2023/04/19,Glycopeptide Antibacterial,1958,HIKMA PHARMACEUTICALS USA INC,2023/02/02-,0143-9161; 0143-9162,71WO621TJD,VANCOMYCIN HYDROCHLORIDE,VANCOMYCIN,6Q205EH1VU,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/8eccafe8-40c9-495a-872d-7f45a98ee759/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8eccafe8-40c9-495a-872d-7f45a98ee759,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=8eccafe8-40c9-495a-872d-7f45a98ee759,8eccafe8-40c9-495a-872d-7f45a98ee759,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, POWDER, FOR SOLUTION",INTRAVENOUS; ORAL,NDA,210274,VANCOMYCIN HYDROCHLORIDE,VANCOMYCIN HYDROCHLORIDE,2023/04/12,Glycopeptide Antibacterial,1958,HIKMA PHARMACEUTICALS USA INC,2023/02/02-; 2023/02/03-,0143-9163; 0143-9164,71WO621TJD,VANCOMYCIN HYDROCHLORIDE,VANCOMYCIN,6Q205EH1VU,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/e4ce7b87-fab4-4b7a-b121-eba136c464ce/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e4ce7b87-fab4-4b7a-b121-eba136c464ce,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=e4ce7b87-fab4-4b7a-b121-eba136c464ce,e4ce7b87-fab4-4b7a-b121-eba136c464ce,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAVENOUS,NDA,209481,Vancomycin Hydrochloride,VANCOMYCIN HYDROCHLORIDE,2022/03/02,Glycopeptide Antibacterial,1958,MYLAN INSTITUTIONAL LLC,2018/08/31-; 2018/12/06-; completed:2018/08/31-2022/02/28,67457-705; 67457-822; 67457-823; 67457-824,71WO621TJD,VANCOMYCIN HYDROCHLORIDE,VANCOMYCIN,6Q205EH1VU,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/caf22ccb-df75-45ea-a1d0-ccb2d37272fb/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=caf22ccb-df75-45ea-a1d0-ccb2d37272fb,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=caf22ccb-df75-45ea-a1d0-ccb2d37272fb,caf22ccb-df75-45ea-a1d0-ccb2d37272fb,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,NDA,050606,Vancocin,VANCOMYCIN HYDROCHLORIDE,2022/01/04,Glycopeptide Antibacterial,1986,ANI PHARMACEUTICALS INC,2014/11/17-,62559-310; 62559-311,71WO621TJD,VANCOMYCIN HYDROCHLORIDE,VANCOMYCIN,6Q205EH1VU,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/a078d9c2-f89c-4f9f-8ded-60ffb2983c3f/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a078d9c2-f89c-4f9f-8ded-60ffb2983c3f,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=a078d9c2-f89c-4f9f-8ded-60ffb2983c3f,a078d9c2-f89c-4f9f-8ded-60ffb2983c3f,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,022405,CAPRELSA,VANDETANIB,2024/04/19,Kinase Inhibitor,2011,GENZYME CORPORATION,2011/07/25-,58468-7820; 58468-7840,YO460OQ37K,VANDETANIB,VANDETANIB,YO460OQ37K,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/e5721cb8-4185-47b9-bbb3-1c587e558a03/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e5721cb8-4185-47b9-bbb3-1c587e558a03,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=e5721cb8-4185-47b9-bbb3-1c587e558a03,e5721cb8-4185-47b9-bbb3-1c587e558a03,,,
HUMAN PRESCRIPTION DRUG LABEL,SPRAY,NASAL,NDA,213978,Tyrvaya,VARENICLINE,2024/02/08,Cholinergic Receptor Agonist; Partial Cholinergic Nicotinic Agonist,2006,OYSTER POINT PHARMA,2021/10/20-,73521-030,82269ASB48,VARENICLINE TARTRATE,VARENICLINE,W6HS99O8ZO,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/014c93dc-5737-479c-a9f0-aaadac1ac298/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=014c93dc-5737-479c-a9f0-aaadac1ac298,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=014c93dc-5737-479c-a9f0-aaadac1ac298,014c93dc-5737-479c-a9f0-aaadac1ac298,,,
HUMAN PRESCRIPTION DRUG LABEL,"KIT; TABLET, FILM COATED",ORAL,NDA,021928,CHANTIX,VARENICLINE TARTRATE,2024/04/23,Cholinergic Receptor Agonist; Partial Cholinergic Nicotinic Agonist,2006,PFIZER LABORATORIES DIV PFIZER INC,2006/05/10-,0069-0468; 0069-0469; 0069-0471,82269ASB48,VARENICLINE TARTRATE,VARENICLINE,W6HS99O8ZO,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/f0ff4f27-5185-4881-a749-c6b7a0ca5696/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f0ff4f27-5185-4881-a749-c6b7a0ca5696,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=f0ff4f27-5185-4881-a749-c6b7a0ca5696,f0ff4f27-5185-4881-a749-c6b7a0ca5696,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRAVENOUS,NDA,204485,Vasostrict,VASOPRESSIN,2023/02/27,,2014,ENDO USA INC,2014/11/12-; 2017/02/27-; 2021/12/15-; completed:2021/12/15-2021/12/15; completed:2023/12/01-2023/12/01,42023-164; 42023-190; 42023-219; 42023-220; 42023-237; 42023-268,Y87Y826H08,"VASOPRESSIN, UNSPECIFIED","VASOPRESSIN, UNSPECIFIED",Y87Y826H08,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/b1147beb-743e-4c62-8927-91192447f8b8/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b1147beb-743e-4c62-8927-91192447f8b8,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=b1147beb-743e-4c62-8927-91192447f8b8,b1147beb-743e-4c62-8927-91192447f8b8,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,212593,Vasopressin,VASOPRESSIN,2023/01/01,,2014,AMERICAN REGENT INC,2022/02/03-; 2023/06/21-,0517-1020; 0517-1030,Y4907O6MFD,VASOPRESSIN,VASOPRESSIN,Y4907O6MFD,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/0ab267f4-9ec9-44fd-8521-f975074667d9/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0ab267f4-9ec9-44fd-8521-f975074667d9,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=0ab267f4-9ec9-44fd-8521-f975074667d9,0ab267f4-9ec9-44fd-8521-f975074667d9,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRAVENOUS,NDA,204485,Vasopressin,VASOPRESSIN,2022/02/08,,2014,DR REDDYS LABORATORIES INC,2014/11/12-,43598-085,Y87Y826H08,"VASOPRESSIN, UNSPECIFIED","VASOPRESSIN, UNSPECIFIED",Y87Y826H08,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/3cecafe6-94b8-452d-8f4c-d2559d79fe98/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3cecafe6-94b8-452d-8f4c-d2559d79fe98,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=3cecafe6-94b8-452d-8f4c-d2559d79fe98,3cecafe6-94b8-452d-8f4c-d2559d79fe98,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRAVENOUS,NDA,204485,Vasostrict,VASOPRESSIN,2021/11/30,,2014,PAR PHARMACEUTICAL INC,2022/12/05-,42023-164,Y87Y826H08,"VASOPRESSIN, UNSPECIFIED","VASOPRESSIN, UNSPECIFIED",Y87Y826H08,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/b97e5c3e-ca28-4ffa-80af-6c5bdbadaf10/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b97e5c3e-ca28-4ffa-80af-6c5bdbadaf10,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=b97e5c3e-ca28-4ffa-80af-6c5bdbadaf10,b97e5c3e-ca28-4ffa-80af-6c5bdbadaf10,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRAVENOUS,NDA,217569,Vasopressin in 0.9% Sodium Chloride,VASOPRESSIN IN 0.9% SODIUM CHLORIDE,2024/02/05,,2014,BAXTER HEALTHCARE CORPORATION,2023/09/29-,0338-9640; 0338-9647,Y4907O6MFD,VASOPRESSIN,VASOPRESSIN,Y4907O6MFD,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/b5b2c367-6b7e-40be-a296-c4632f3e783f/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b5b2c367-6b7e-40be-a296-c4632f3e783f,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=b5b2c367-6b7e-40be-a296-c4632f3e783f,b5b2c367-6b7e-40be-a296-c4632f3e783f,,,
HUMAN PRESCRIPTION DRUG LABEL,"PELLET; TABLET, FILM COATED",ORAL,NDA,208341;214187,Epclusa,VELPATASVIR AND SOFOSBUVIR,2022/05/02,Hepatitis C Virus NS5A Inhibitor; Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor,2016,GILEAD SCIENCES INC,2016/06/28-; 2020/03/19-; 2021/06/10-,61958-2201; 61958-2203; 61958-2204; 61958-2205,KCU0C7RS7Z; WJ6CA3ZU8B,SOFOSBUVIR; VELPATASVIR,SOFOSBUVIR; VELPATASVIR,KCU0C7RS7Z; WJ6CA3ZU8B,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/7f30631a-ee3b-4cfe-866b-964df3f0a44f/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7f30631a-ee3b-4cfe-866b-964df3f0a44f,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=7f30631a-ee3b-4cfe-866b-964df3f0a44f,7f30631a-ee3b-4cfe-866b-964df3f0a44f,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,202429,ZELBORAF,VEMURAFENIB,2023/11/27,Kinase Inhibitor,2011,GENENTECH INC,2011/08/17-,50242-090,207SMY3FQT,VEMURAFENIB,VEMURAFENIB,207SMY3FQT,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/38eea320-7e0c-485a-bc30-98c3c45e2763/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=38eea320-7e0c-485a-bc30-98c3c45e2763,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=38eea320-7e0c-485a-bc30-98c3c45e2763,38eea320-7e0c-485a-bc30-98c3c45e2763,,,
HUMAN PRESCRIPTION DRUG LABEL,"KIT; TABLET, FILM COATED",ORAL,NDA,208573,Venclexta,VENETOCLAX,2022/06/15,BCL-2 Inhibitor,2016,ABBVIE INC,2016/04/11-,0074-0561; 0074-0566; 0074-0576; 0074-0579,N54AIC43PW,Venetoclax,Venetoclax,N54AIC43PW,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/b118a40d-6b56-cee3-10f6-ded821a97018/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b118a40d-6b56-cee3-10f6-ded821a97018,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=b118a40d-6b56-cee3-10f6-ded821a97018,b118a40d-6b56-cee3-10f6-ded821a97018,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, EXTENDED RELEASE",ORAL,NDA,215429,venlafaxine,VENLAFAXINE,2023/08/24,Serotonin and Norepinephrine Reuptake Inhibitor,1993,ALMATICA PHARMA LLC,2022/06/30-,52427-632,18XP3YT5NH,VENLAFAXINE BESYLATE MONOHYDRATE,VENLAFAXINE,GRZ5RCB1QG,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/e81a2daf-b8b2-7c05-b532-bc775700b100/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e81a2daf-b8b2-7c05-b532-bc775700b100,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=e81a2daf-b8b2-7c05-b532-bc775700b100,e81a2daf-b8b2-7c05-b532-bc775700b100,,,
HUMAN PRESCRIPTION DRUG LABEL,"CAPSULE, EXTENDED RELEASE",ORAL,NDA,020699,Effexor XR,VENLAFAXINE HYDROCHLORIDE,2023/08/15,Serotonin and Norepinephrine Reuptake Inhibitor,1997,VIATRIS SPECIALTY LLC,2023/10/10-,58151-125; 58151-126; 58151-127,7D7RX5A8MO,VENLAFAXINE HYDROCHLORIDE,VENLAFAXINE,GRZ5RCB1QG,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/c848a5d8-ba94-4c84-80e3-0bf35fb8e32e/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c848a5d8-ba94-4c84-80e3-0bf35fb8e32e,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=c848a5d8-ba94-4c84-80e3-0bf35fb8e32e,c848a5d8-ba94-4c84-80e3-0bf35fb8e32e,,,
HUMAN PRESCRIPTION DRUG LABEL,"CAPSULE, EXTENDED RELEASE",ORAL,NDA,020699,Effexor XR,VENLAFAXINE HYDROCHLORIDE,2022/08/29,Serotonin and Norepinephrine Reuptake Inhibitor,1997,WYETH PHARMACEUTICALS LLC A SUBSIDIARY OF PFIZER INC,1997/11/01-,0008-0833; 0008-0836; 0008-0837,7D7RX5A8MO,VENLAFAXINE HYDROCHLORIDE,VENLAFAXINE,GRZ5RCB1QG,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/53c3e7ac-1852-4d70-d2b6-4fca819acf26/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=53c3e7ac-1852-4d70-d2b6-4fca819acf26,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=53c3e7ac-1852-4d70-d2b6-4fca819acf26,53c3e7ac-1852-4d70-d2b6-4fca819acf26,,,
HUMAN PRESCRIPTION DRUG LABEL,"CAPSULE, EXTENDED RELEASE",ORAL,NDA,020943,Verapamil Hydrochloride,VERAPAMIL HYDROCHLORIDE,2023/03/31,Calcium Channel Blocker,1998,CHARTWELL RX LLC,1998/11/25-,62135-532,V3888OEY5R,VERAPAMIL HYDROCHLORIDE,VERAPAMIL,CJ0O37KU29,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/18f6d349-8c5c-4443-ac65-16bf6619ecdc/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=18f6d349-8c5c-4443-ac65-16bf6619ecdc,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=18f6d349-8c5c-4443-ac65-16bf6619ecdc,18f6d349-8c5c-4443-ac65-16bf6619ecdc,,,
HUMAN PRESCRIPTION DRUG LABEL,"CAPSULE, DELAYED RELEASE PELLETS",ORAL,NDA,019614,VERELAN,VERAPAMIL HYDROCHLORIDE,2023/02/22,Calcium Channel Blocker,,LANNETT COMPANY INC,1990/05/29-,62175-580; 62175-581; 62175-582; 62175-583,V3888OEY5R,VERAPAMIL HYDROCHLORIDE,VERAPAMIL,CJ0O37KU29,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/92f7adf1-cb8c-4c6e-95d1-9afd28fe5116/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=92f7adf1-cb8c-4c6e-95d1-9afd28fe5116,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=92f7adf1-cb8c-4c6e-95d1-9afd28fe5116,92f7adf1-cb8c-4c6e-95d1-9afd28fe5116,,,
HUMAN PRESCRIPTION DRUG LABEL,"CAPSULE, EXTENDED RELEASE",ORAL,NDA,020943,Verapamil Hydrochloride,VERAPAMIL HYDROCHLORIDE,2022/12/27,Calcium Channel Blocker,1998,LANNETT COMPANY INC,1998/11/25-,62175-485; 62175-486; 62175-487,V3888OEY5R,VERAPAMIL HYDROCHLORIDE,VERAPAMIL,CJ0O37KU29,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/f3b3580a-4e6b-402f-bf88-f3157d9139b1/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f3b3580a-4e6b-402f-bf88-f3157d9139b1,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=f3b3580a-4e6b-402f-bf88-f3157d9139b1,f3b3580a-4e6b-402f-bf88-f3157d9139b1,,,
HUMAN PRESCRIPTION DRUG LABEL,"CAPSULE, DELAYED RELEASE PELLETS",ORAL,NDA,019614,Verapamil Hydrochloride,VERAPAMIL HYDROCHLORIDE,2022/10/17,Calcium Channel Blocker,,TEVA PHARMACEUTICALS INC,1990/05/29-,0591-2880; 0591-2882; 0591-2884; 0591-2886,V3888OEY5R,VERAPAMIL HYDROCHLORIDE,VERAPAMIL,CJ0O37KU29,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/0742cf97-601b-4c13-a6c3-1a6a616ed292/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0742cf97-601b-4c13-a6c3-1a6a616ed292,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=0742cf97-601b-4c13-a6c3-1a6a616ed292,0742cf97-601b-4c13-a6c3-1a6a616ed292,,,
HUMAN PRESCRIPTION DRUG LABEL,"CAPSULE, EXTENDED RELEASE",ORAL,NDA,020943,VERELAN PM,VERAPAMIL HYDROCHLORIDE,2022/07/01,Calcium Channel Blocker,1998,LANNETT COMPANY INC,1998/11/25-,62175-570; 62175-571; 62175-572,V3888OEY5R,VERAPAMIL HYDROCHLORIDE,VERAPAMIL,CJ0O37KU29,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/fd1b433f-1895-4af0-9d1f-3901c6d34c20/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=fd1b433f-1895-4af0-9d1f-3901c6d34c20,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=fd1b433f-1895-4af0-9d1f-3901c6d34c20,fd1b433f-1895-4af0-9d1f-3901c6d34c20,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,214377,VERQUVO,VERICIGUAT,2023/10/26,Soluble Guanylate Cyclase Stimulator,2021,MERCK SHARP AND DOHME LLC,2021/02/01-,0006-5028; 0006-5029; 0006-5030,LV66ADM269,VERICIGUAT,VERICIGUAT,LV66ADM269,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/17056d73-1b1b-4bf2-9c07-b7a9367f0d6d/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=17056d73-1b1b-4bf2-9c07-b7a9367f0d6d,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=17056d73-1b1b-4bf2-9c07-b7a9367f0d6d,17056d73-1b1b-4bf2-9c07-b7a9367f0d6d,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAVENOUS,NDA,021119,Visudyne,VERTEPORFIN FOR INJECTION,2023/02/24,Photoenhancer,2000,BAUSCH AND LOMB INCORPORATED,2000/04/12-,24208-560,0X9PA28K43,VERTEPORFIN,VERTEPORFIN,0X9PA28K43,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/2f0a34ce-3c57-4ac8-b28e-512be807272f/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2f0a34ce-3c57-4ac8-b28e-512be807272f,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=2f0a34ce-3c57-4ac8-b28e-512be807272f,2f0a34ce-3c57-4ac8-b28e-512be807272f,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAVENOUS,NDA,021119,Visudyne,VERTEPORFIN FOR INJECTION,2021/07/21,Photoenhancer,2000,BAUSCH HEALTH US LLC,2000/04/12-,0187-5600,0X9PA28K43,VERTEPORFIN,VERTEPORFIN,0X9PA28K43,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/952f4c80-50b1-4308-9ee6-311ffefb13df/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=952f4c80-50b1-4308-9ee6-311ffefb13df,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=952f4c80-50b1-4308-9ee6-311ffefb13df,952f4c80-50b1-4308-9ee6-311ffefb13df,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAVENOUS,NDA,021119,Visudyne,VERTEPORFIN FOR INJECTION,2010/04/07,Photoenhancer,,QLT OPHTHALMICS INC,2000/04/12-,50236-001,0X9PA28K43,VERTEPORFIN,VERTEPORFIN,0X9PA28K43,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/31512723-9ff0-4e18-aa3a-55ab833038c6/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=31512723-9ff0-4e18-aa3a-55ab833038c6,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=31512723-9ff0-4e18-aa3a-55ab833038c6,31512723-9ff0-4e18-aa3a-55ab833038c6,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,213006,GEMTESA,VIBEGRON,2024/02/08,beta3-Adrenergic Agonist,2020,SUMITOMO PHARMA AMERICA INC,2020/12/29-,73336-075,M5TSE03W5U,vibegron,vibegron,M5TSE03W5U,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/25f21d25-14f8-4fda-91f6-7aa8b68aa1c8/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=25f21d25-14f8-4fda-91f6-7aa8b68aa1c8,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=25f21d25-14f8-4fda-91f6-7aa8b68aa1c8,25f21d25-14f8-4fda-91f6-7aa8b68aa1c8,,,
HUMAN PRESCRIPTION DRUG LABEL,"POWDER, FOR SOLUTION",ORAL,NDA,022006,SABRIL,VIGABATRIN,2021/10/20,Anti-epileptic Agent,2009,LUNDBECK PHARMACEUTICALS LLC,2009/08/21-,67386-211,GR120KRT6K,VIGABATRIN,VIGABATRIN,GR120KRT6K,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/a88ac1b4-e2c9-45c0-b321-4785902172e3/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a88ac1b4-e2c9-45c0-b321-4785902172e3,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=a88ac1b4-e2c9-45c0-b321-4785902172e3,a88ac1b4-e2c9-45c0-b321-4785902172e3,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,020427,SABRIL,VIGABATRIN,2021/10/20,Anti-epileptic Agent,2009,LUNDBECK PHARMACEUTICALS LLC,2009/08/21-,67386-111,GR120KRT6K,VIGABATRIN,VIGABATRIN,GR120KRT6K,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/a5d389d2-d0e1-4395-a2a2-b552808e7f98/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a5d389d2-d0e1-4395-a2a2-b552808e7f98,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=a5d389d2-d0e1-4395-a2a2-b552808e7f98,a5d389d2-d0e1-4395-a2a2-b552808e7f98,,,
HUMAN PRESCRIPTION DRUG LABEL,KIT; TABLET,ORAL,NDA,022567,VIIBRYD,VILAZODONE HYDROCHLORIDE,2023/10/01,,2011,ALLERGAN INC,2011/04/29-; completed:2011/04/29-2016/08/31; completed:2011/04/29-2023/10/31,0456-1100; 0456-1101; 0456-1110; 0456-1120; 0456-1140,U8HTX2GK8J,VILAZODONE HYDROCHLORIDE,VILAZODONE,S239O2OOV3,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/4c55ccfb-c4cf-11df-851a-0800200c9a66/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4c55ccfb-c4cf-11df-851a-0800200c9a66,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=4c55ccfb-c4cf-11df-851a-0800200c9a66,4c55ccfb-c4cf-11df-851a-0800200c9a66,,,
HUMAN PRESCRIPTION DRUG LABEL,"CAPSULE, EXTENDED RELEASE",ORAL,NDA,211964,QELBREE,VILOXAZINE HYDROCHLORIDE,2023/12/20,Norepinephrine Reuptake Inhibitor,2021,SUPERNUS PHARMACEUTICALS INC,2021/04/02-,17772-131; 17772-132; 17772-133,OQW30I1332,VILOXAZINE HYDROCHLORIDE,VILOXAZINE,5I5Y2789ZF,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/aedf408d-0f84-418d-9416-7c39ddb0d29a/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=aedf408d-0f84-418d-9416-7c39ddb0d29a,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=aedf408d-0f84-418d-9416-7c39ddb0d29a,aedf408d-0f84-418d-9416-7c39ddb0d29a,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,212154,Viltepso,VILTOLARSEN,2023/08/01,,2020,NS PHARMA INC,2020/08/13-,73292-011,SXA7YP6EKX,viltolarsen,viltolarsen,SXA7YP6EKX,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/1ffff9a8-6d6a-4dcb-8493-1b6cc3a5d123/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1ffff9a8-6d6a-4dcb-8493-1b6cc3a5d123,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=1ffff9a8-6d6a-4dcb-8493-1b6cc3a5d123,1ffff9a8-6d6a-4dcb-8493-1b6cc3a5d123,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,NDA,203388,ERIVEDGE,VISMODEGIB,2023/03/27,Hedgehog Pathway Inhibitor,2012,GENENTECH INC,2012/01/30-,50242-140,25X868M3DS,VISMODEGIB,VISMODEGIB,25X868M3DS,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/eb368bb6-80e3-4df9-8a85-91df0a2ada6a/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=eb368bb6-80e3-4df9-8a85-91df0a2ada6a,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=eb368bb6-80e3-4df9-8a85-91df0a2ada6a,eb368bb6-80e3-4df9-8a85-91df0a2ada6a,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAMUSCULAR,NDA,006823,AQUASOL A,VITAMIN A PALMITATE,2020/08/14,,,CASPER PHARMA LLC,2020/10/01-,70199-026,1D1K0N0VVC,VITAMIN A PALMITATE,RETINOL,G2SH0XKK91,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/ec825f1c-c15f-44de-ad46-8ab9c49ec21c/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ec825f1c-c15f-44de-ad46-8ab9c49ec21c,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=ec825f1c-c15f-44de-ad46-8ab9c49ec21c,ec825f1c-c15f-44de-ad46-8ab9c49ec21c,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,NDA,213716,LUPKYNIS,VOCLOSPORIN,2024/05/09,Calcineurin Inhibitor Immunosuppressant,2021,AURINIA PHARMA U S INC,2021/01/22-,75626-001,2PN063X6B1,VOCLOSPORIN,VOCLOSPORIN,2PN063X6B1,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/9f489295-1156-52c7-5fd0-5c4c52f9b813/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9f489295-1156-52c7-5fd0-5c4c52f9b813,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=9f489295-1156-52c7-5fd0-5c4c52f9b813,9f489295-1156-52c7-5fd0-5c4c52f9b813,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,215151,VOQUEZNA,VONOPRAZAN FUMARATE,2023/11/08,,2022,PHATHOM PHARMACEUTICALS INC,2023/11/10-,81520-100; 81520-200,4QW3X4AMLB,vonoprazan fumarate,vonoprazan,1R5L3J156G,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/0cc52ac5-77ec-4d66-a770-762a1a960914/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0cc52ac5-77ec-4d66-a770-762a1a960914,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=0cc52ac5-77ec-4d66-a770-762a1a960914,0cc52ac5-77ec-4d66-a770-762a1a960914,,,
HUMAN PRESCRIPTION DRUG LABEL,KIT,ORAL,NDA,215152;215153,VOQUEZNA DUAL PAK; VOQUEZNA TRIPLE PAK,"VONOPRAZAN FUMARATE AND AMOXICILLIN; VONOPRAZAN FUMARATE, AMOXICILLIN AND CLARITHROMYCIN",2024/05/07,Macrolide Antimicrobial; Penicillin-class Antibacterial,2022,PHATHOM PHARMACEUTICALS INC,2023/11/08-,81520-250; 81520-255,4QW3X4AMLB; 804826J2HU; H1250JIK0A,amoxicillin; clarithromycin; vonoprazan fumarate,amoxicillin anhydrous; clarithromycin; vonoprazan,1R5L3J156G; 9EM05410Q9; H1250JIK0A,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/0cb2ee04-8581-46c8-a781-7be170ab5c86/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0cb2ee04-8581-46c8-a781-7be170ab5c86,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=0cb2ee04-8581-46c8-a781-7be170ab5c86,0cb2ee04-8581-46c8-a781-7be170ab5c86,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,204886,ZONTIVITY,VORAPAXAR,2022/10/18,Protease-activated Receptor-1 Antagonist,2014,WRASER PHARMACEUTICALS LLC,2022/09/21-,66992-208,IN66038E6C,VORAPAXAR SULFATE,VORAPAXAR,ZCE93644N2,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/f2abe3ed-ed3d-4215-a489-b18341ce85bc/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f2abe3ed-ed3d-4215-a489-b18341ce85bc,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=f2abe3ed-ed3d-4215-a489-b18341ce85bc,f2abe3ed-ed3d-4215-a489-b18341ce85bc,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,204886,ZONTIVITY,VORAPAXAR,2021/04/08,Protease-activated Receptor-1 Antagonist,2014,ARALEZ PHARMACEUTICALS US INC,2014/05/08-,70347-208,IN66038E6C,VORAPAXAR SULFATE,VORAPAXAR,ZCE93644N2,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/f001f406-8cf1-40a4-bbf5-1775fe020122/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f001f406-8cf1-40a4-bbf5-1775fe020122,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=f001f406-8cf1-40a4-bbf5-1775fe020122,f001f406-8cf1-40a4-bbf5-1775fe020122,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAVENOUS,NDA,021267,VFEND,VORICONAZOLE,2022/12/22,Azole Antifungal,2002,ROERIG,2002/05/24-,0049-3190,JFU09I87TR,VORICONAZOLE,VORICONAZOLE,JFU09I87TR,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/dac26bcd-7a59-401f-9f66-a0649767cece/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=dac26bcd-7a59-401f-9f66-a0649767cece,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=dac26bcd-7a59-401f-9f66-a0649767cece,dac26bcd-7a59-401f-9f66-a0649767cece,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAVENOUS,NDA,021267,VFEND,VORICONAZOLE,2022/12/22,Azole Antifungal,2002,ROERIG,2012/10/24-,0049-4190,JFU09I87TR,VORICONAZOLE,VORICONAZOLE,JFU09I87TR,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/08d08721-1f4c-478a-8abf-d9c402d50553/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=08d08721-1f4c-478a-8abf-d9c402d50553,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=08d08721-1f4c-478a-8abf-d9c402d50553,08d08721-1f4c-478a-8abf-d9c402d50553,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION; POWDER, FOR SUSPENSION; TABLET, FILM COATED",INTRAVENOUS; ORAL,NDA,021266;021267;021630,VFEND,VORICONAZOLE,2022/11/01,Azole Antifungal,2002,ROERIG,2003/03/28-,0049-3160; 0049-3170; 0049-3180; 0049-3190,JFU09I87TR,VORICONAZOLE,VORICONAZOLE,JFU09I87TR,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/ce3ef5cf-3087-4d92-9d94-9eb8287228db/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ce3ef5cf-3087-4d92-9d94-9eb8287228db,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=ce3ef5cf-3087-4d92-9d94-9eb8287228db,ce3ef5cf-3087-4d92-9d94-9eb8287228db,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,NDA,021991,ZOLINZA,VORINOSTAT,2023/11/21,Histone Deacetylase Inhibitor,2006,MERCK SHARP AND DOHME LLC,2006/10/06-,0006-0568,58IFB293JI,VORINOSTAT,VORINOSTAT,58IFB293JI,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/cd86ee78-2781-468b-930c-3c4677bcc092/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=cd86ee78-2781-468b-930c-3c4677bcc092,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=cd86ee78-2781-468b-930c-3c4677bcc092,cd86ee78-2781-468b-930c-3c4677bcc092,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,204447,Trintellix,VORTIOXETINE,2023/08/30,,2013,TAKEDA PHARMACEUTICALS AMERICA INC,2013/10/02-,64764-720; 64764-730; 64764-750,TKS641KOAY,VORTIOXETINE HYDROBROMIDE,VORTIOXETINE,3O2K1S3WQV,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/1a5b68e2-14d0-419d-9ec6-1ca97145e838/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1a5b68e2-14d0-419d-9ec6-1ca97145e838,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=1a5b68e2-14d0-419d-9ec6-1ca97145e838,1a5b68e2-14d0-419d-9ec6-1ca97145e838,,,
HUMAN PRESCRIPTION DRUG LABEL,KIT,SUBCUTANEOUS,NDA,214938,VOXZOGO 0.4mg; VOXZOGO 0.56mg; VOXZOGO 1.2mg,VOSORITIDE,2024/04/11,C-type Natriuretic Peptide Analog,2021,BIOMARIN PHARMACEUTICAL INC,2021/11/19-,68135-082; 68135-119; 68135-181,7SE5582Q2P,VOSORITIDE,VOSORITIDE,7SE5582Q2P,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/228e8560-04a4-4bb1-a81f-29531a9e4d27/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=228e8560-04a4-4bb1-a81f-29531a9e4d27,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=228e8560-04a4-4bb1-a81f-29531a9e4d27,228e8560-04a4-4bb1-a81f-29531a9e4d27,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED; TABLET, FOR SUSPENSION",ORAL,NDA,213137;216157,OXBRYTA,VOXELOTOR,2023/12/26,Hemoglobin S Polymerization Inhibitor,2019,GLOBAL BLOOD THERAPEUTICS INC A SUBSIDIARY OF PFIZER INC,2019/11/25-; 2021/12/17-,72786-101; 72786-102; 72786-111,3ZO554A4Q8,Voxelotor,Voxelotor,3ZO554A4Q8,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/3c557fac-29ec-483f-b691-8a935d4decc3/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3c557fac-29ec-483f-b691-8a935d4decc3,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=3c557fac-29ec-483f-b691-8a935d4decc3,3c557fac-29ec-483f-b691-8a935d4decc3,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,SUBCUTANEOUS,NDA,215515,AMVUTTRA,VUTRISIRAN,2023/01/27,Small Interfering RNA; Transthyretin-directed RNA Interaction,2022,ALNYLAM PHARMACEUTICALS INC,2022/06/13-,71336-1003,GB4I2JI8UI,VUTRISIRAN,VUTRISIRAN,GB4I2JI8UI,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/8db0facb-81b6-4006-9239-27dc6409c5d3/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8db0facb-81b6-4006-9239-27dc6409c5d3,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=8db0facb-81b6-4006-9239-27dc6409c5d3,8db0facb-81b6-4006-9239-27dc6409c5d3,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRAVENOUS,NDA,019633,Sterile Water,WATER,2024/04/10,,,B BRAUN MEDICAL INC,1988/02/24-,0264-7850,059QF0KO0R,WATER,WATER,059QF0KO0R,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/8fc8d87a-3951-4ac5-97df-c161ffc90475/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8fc8d87a-3951-4ac5-97df-c161ffc90475,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=8fc8d87a-3951-4ac5-97df-c161ffc90475,8fc8d87a-3951-4ac5-97df-c161ffc90475,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS,NDA,018801,Sterile Water,WATER,2024/01/11,,,HOSPIRA INC,2005/06/16-,0409-4887,059QF0KO0R,WATER,WATER,059QF0KO0R,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/2b9ea23a-f9e9-48a8-25b7-519e3bbd6828/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2b9ea23a-f9e9-48a8-25b7-519e3bbd6828,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=2b9ea23a-f9e9-48a8-25b7-519e3bbd6828,2b9ea23a-f9e9-48a8-25b7-519e3bbd6828,,,
HUMAN PRESCRIPTION DRUG LABEL,IRRIGANT,IRRIGATION,NDA,016734,Sterile Water,WATER,2023/09/06,,,B BRAUN MEDICAL INC,1970/09/10-,0264-2101,059QF0KO0R,WATER,WATER,059QF0KO0R,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/f4284eb6-e553-46d4-90d8-efc80a90a480/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f4284eb6-e553-46d4-90d8-efc80a90a480,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=f4284eb6-e553-46d4-90d8-efc80a90a480,f4284eb6-e553-46d4-90d8-efc80a90a480,,,
HUMAN PRESCRIPTION DRUG LABEL,INJECTION,INTRAVENOUS,NDA,019633,Sterile Water,WATER,2021/08/06,,,B BRAUN MEDICAL INC,2014/09/04-,0264-7385,059QF0KO0R,WATER,WATER,059QF0KO0R,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/8924e52e-8622-4ed6-a061-1908183e0a18/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8924e52e-8622-4ed6-a061-1908183e0a18,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=8924e52e-8622-4ed6-a061-1908183e0a18,8924e52e-8622-4ed6-a061-1908183e0a18,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,019869,Sterile Water,WATER,2020/06/19,,,ICU MEDICAL INC,2019/06/01-,0990-7118,059QF0KO0R,WATER,WATER,059QF0KO0R,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/1c0bbcb7-5ed6-4ee7-b297-080d3359474e/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1c0bbcb7-5ed6-4ee7-b297-080d3359474e,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=1c0bbcb7-5ed6-4ee7-b297-080d3359474e,1c0bbcb7-5ed6-4ee7-b297-080d3359474e,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,018632,Sterile Water,WATER,2019/12/29,,,BAXTER HEALTHCARE COMPANY,1982/06/30-,0338-0013,059QF0KO0R,WATER,WATER,059QF0KO0R,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/8bcf5572-49e1-4302-9522-56f57904cb4a/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8bcf5572-49e1-4302-9522-56f57904cb4a,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=8bcf5572-49e1-4302-9522-56f57904cb4a,8bcf5572-49e1-4302-9522-56f57904cb4a,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,018233,Sterile Water,WATER,2019/07/22,,,ICU MEDICAL INC,2019/10/01-,0990-7990,059QF0KO0R,WATER,WATER,059QF0KO0R,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/aab10f03-26ae-4dbc-a481-ef025e48b405/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=aab10f03-26ae-4dbc-a481-ef025e48b405,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=aab10f03-26ae-4dbc-a481-ef025e48b405,aab10f03-26ae-4dbc-a481-ef025e48b405,,,
HUMAN PRESCRIPTION DRUG LABEL,IRRIGANT,IRRIGATION,NDA,017428;017866,Sterile Water,WATER,2017/10/17,,1974,BAXTER HEALTHCARE CORPORATION,1974/12/31-; 1980/05/30-,0338-0003; 0338-0004,059QF0KO0R,WATER,WATER,059QF0KO0R,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/ef3e79c5-3f58-4b36-a296-64b7d9a651c1/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ef3e79c5-3f58-4b36-a296-64b7d9a651c1,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=ef3e79c5-3f58-4b36-a296-64b7d9a651c1,ef3e79c5-3f58-4b36-a296-64b7d9a651c1,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,018632,Sterile Water,WATER,2016/05/31,,,BAXTER HEALTHCARE COMPANY,1982/06/30-,0338-0013,059QF0KO0R,WATER,WATER,059QF0KO0R,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/210dc9ab-d6ca-4552-ac19-1be17792d290/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=210dc9ab-d6ca-4552-ac19-1be17792d290,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=210dc9ab-d6ca-4552-ac19-1be17792d290,210dc9ab-d6ca-4552-ac19-1be17792d290,,,
HUMAN PRESCRIPTION DRUG LABEL,GAS,INHALATION,NDA,214375,XENOVIEW,XENON XE 129 HYPERPOLARIZED,2022/12/30,Hyperpolarized Contrast Agent,2022,POLAREAN INC,2022/12/23-,80534-1000; 80534-6350,206GF3GB41; 726Q6M95ZA; 9C7571UDT5; N762921K75,"HELIUM; NITROGEN; XENON XE-129; XENON XE-129, HYPERPOLARIZED","HELIUM; NITROGEN; XENON XE-129; XENON XE-129, HYPERPOLARIZED",206GF3GB41; 726Q6M95ZA; 9C7571UDT5; N762921K75,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/70e33fe3-c722-439b-b3db-c2a22f229c8a/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=70e33fe3-c722-439b-b3db-c2a22f229c8a,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=70e33fe3-c722-439b-b3db-c2a22f229c8a,70e33fe3-c722-439b-b3db-c2a22f229c8a,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,020547,ACCOLATE,ZAFIRLUKAST,2024/05/23,Leukotriene Receptor Antagonist,,STRIDES PHARMA SCIENCE LIMITED,2023/01/02-,64380-177; 64380-178,XZ629S5L50,ZAFIRLUKAST,ZAFIRLUKAST,XZ629S5L50,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/3bbd0e85-6014-46cd-a363-60102c4bc5a2/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3bbd0e85-6014-46cd-a363-60102c4bc5a2,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=3bbd0e85-6014-46cd-a363-60102c4bc5a2,3bbd0e85-6014-46cd-a363-60102c4bc5a2,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, COATED",ORAL,NDA,020547,Zafirlukast,ZAFIRLUKAST,2023/04/28,Leukotriene Receptor Antagonist,,STRIDES PHARMA SCIENCE LIMITED,2022/08/01-; 2022/09/15-,64380-187; 64380-188,XZ629S5L50,ZAFIRLUKAST,ZAFIRLUKAST,XZ629S5L50,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/baba507f-6557-4551-815c-9ab6606e4ee1/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=baba507f-6557-4551-815c-9ab6606e4ee1,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=baba507f-6557-4551-815c-9ab6606e4ee1,baba507f-6557-4551-815c-9ab6606e4ee1,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, COATED",ORAL,NDA,020547,Zafirlukast,ZAFIRLUKAST,2018/11/25,Leukotriene Receptor Antagonist,,PAR PHARMACEUTICAL INC,completed:2010/11/19-2024/04/30; completed:2010/11/19-2024/09/30,49884-549; 49884-554,XZ629S5L50,ZAFIRLUKAST,ZAFIRLUKAST,XZ629S5L50,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/0262e192-94f4-423d-a58e-bb374dc106fe/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0262e192-94f4-423d-a58e-bb374dc106fe,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=0262e192-94f4-423d-a58e-bb374dc106fe,0262e192-94f4-423d-a58e-bb374dc106fe,,,
HUMAN PRESCRIPTION DRUG LABEL,POWDER,INHALATION,NDA,021036,RELENZA,ZANAMIVIR,2023/10/24,Neuraminidase Inhibitor,1999,GLAXOSMITHKLINE LLC,1999/09/22-,0173-0681,L6O3XI777I,ZANAMIVIR,ZANAMIVIR,L6O3XI777I,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/d7c3bcc3-0c0d-4068-fd80-88cf54a376ef/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d7c3bcc3-0c0d-4068-fd80-88cf54a376ef,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=d7c3bcc3-0c0d-4068-fd80-88cf54a376ef,d7c3bcc3-0c0d-4068-fd80-88cf54a376ef,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,NDA,213217,BRUKINSA,ZANUBRUTINIB,2024/04/29,Kinase Inhibitor,2019,BEIGENE USA INC,2019/11/14-,72579-011,AG9MHG098Z,ZANUBRUTINIB,ZANUBRUTINIB,AG9MHG098Z,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/3e08fe23-d70e-424c-bc51-1222e320f902/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3e08fe23-d70e-424c-bc51-1222e320f902,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=3e08fe23-d70e-424c-bc51-1222e320f902,3e08fe23-d70e-424c-bc51-1222e320f902,,,
HUMAN PRESCRIPTION DRUG LABEL,SPRAY,NASAL,NDA,216386,ZAVZPRET,ZAVEGEPANT,2023/03/09,Calcitonin Gene-related Peptide Receptor Antagonist,2023,U S PHARMACEUTICALS,2023/06/01-,63539-135,000QCM6HAL,ZAVEGEPANT HYDROCHLORIDE,ZAVEGEPANT,ODU3ZAZ94J,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/1191475f-e999-49f4-a805-93ad08596b1b/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1191475f-e999-49f4-a805-93ad08596b1b,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=1191475f-e999-49f4-a805-93ad08596b1b,1191475f-e999-49f4-a805-93ad08596b1b,,,
HUMAN PRESCRIPTION DRUG LABEL,SPRAY,NASAL,NDA,216386,ZAVZPRET,ZAVEGEPANT,2023/03/09,Calcitonin Gene-related Peptide Receptor Antagonist,2023,PFIZER LABORATORIES DIV PFIZER INC,2023/06/01-,0069-3500,000QCM6HAL,ZAVEGEPANT HYDROCHLORIDE,ZAVEGEPANT,ODU3ZAZ94J,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/9c4a7aec-daef-4961-ba77-92f4b58be780/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9c4a7aec-daef-4961-ba77-92f4b58be780,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=9c4a7aec-daef-4961-ba77-92f4b58be780,9c4a7aec-daef-4961-ba77-92f4b58be780,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRATHECAL,NDA,021060,PRIALT,ZICONOTIDE ACETATE,2023/10/30,N-type Calcium Channel Antagonist,2004,TERSERA THERAPEUTICS LLC,2018/10/15-,70720-720; 70720-722; 70720-723,T2I226K69M,ziconotide acetate,ZICONOTIDE,7I64C51O16,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/b025d8ed-937d-4597-9ad1-0b2f6e0ee5b1/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b025d8ed-937d-4597-9ad1-0b2f6e0ee5b1,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=b025d8ed-937d-4597-9ad1-0b2f6e0ee5b1,b025d8ed-937d-4597-9ad1-0b2f6e0ee5b1,,,
HUMAN PRESCRIPTION DRUG LABEL,"CAPSULE; INJECTION, SOLUTION; SOLUTION",INTRAVENOUS; ORAL,NDA,019655;019910;019951,RETROVIR,ZIDOVUDINE,2023/06/15,Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor,1987,VIIV HEALTHCARE COMPANY,2010/10/28-; 2010/11/04-,49702-211; 49702-212; 49702-213,4B9XT59T7S,ZIDOVUDINE,ZIDOVUDINE,4B9XT59T7S,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/6df09f15-b102-431c-adde-d7aeef6f5d84/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6df09f15-b102-431c-adde-d7aeef6f5d84,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=6df09f15-b102-431c-adde-d7aeef6f5d84,6df09f15-b102-431c-adde-d7aeef6f5d84,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,020471,ZYFLO,ZILEUTON,2022/01/13,5-Lipoxygenase Inhibitor,,CHIESI USA INC,1996/12/06-,10122-901,V1L22WVE2S,ZILEUTON,ZILEUTON,V1L22WVE2S,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/aee65202-fddb-497f-9f11-17cc727cb157/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=aee65202-fddb-497f-9f11-17cc727cb157,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=aee65202-fddb-497f-9f11-17cc727cb157,aee65202-fddb-497f-9f11-17cc727cb157,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",SUBCUTANEOUS,NDA,216834,ZILBRYSQ,ZILUCOPLAN,2024/05/09,Complement Inhibitor,2023,UCB INC,2024/01/03-,50474-990; 50474-991; 50474-992,YG391PK0CC,zilucoplan,zilucoplan,YG391PK0CC,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/9f1d53d6-e495-4a3a-8bb9-680a15d25034/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9f1d53d6-e495-4a3a-8bb9-680a15d25034,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=9f1d53d6-e495-4a3a-8bb9-680a15d25034,9f1d53d6-e495-4a3a-8bb9-680a15d25034,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,NDA,020458,GALZIN,ZINC ACETATE,2024/04/29,Copper Absorption Inhibitor,,TEVA PHARMACEUTICALS USA INC,1997/03/03-,57844-208; 57844-215,FM5526K07A,ZINC ACETATE,ZINC CATION,13S1S8SF37,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/a0c72bff-20f3-4241-b966-34a95178d1a3/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a0c72bff-20f3-4241-b966-34a95178d1a3,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=a0c72bff-20f3-4241-b966-34a95178d1a3,a0c72bff-20f3-4241-b966-34a95178d1a3,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,018959,ZINC,ZINC CHLORIDE,2024/04/05,Copper Absorption Inhibitor,,HOSPIRA INC,1990/09/30-,0409-4090,86Q357L16B,ZINC CHLORIDE,ZINC CATION,13S1S8SF37,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/9a1914a0-e195-4233-c1be-bc2075580eb8/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9a1914a0-e195-4233-c1be-bc2075580eb8,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=9a1914a0-e195-4233-c1be-bc2075580eb8,9a1914a0-e195-4233-c1be-bc2075580eb8,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,209377,Zinc Sulfate,ZINC SULFATE,2020/10/01,Copper Absorption Inhibitor,1957,AMERICAN REGENT INC,2019/10/01-; 2020/05/18-,0517-6101; 0517-6103; 0517-8005,89DS0H96TB,ZINC SULFATE,ZINC CATION,13S1S8SF37,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/4b528c88-07a0-4dce-84c6-ccd32555bbff/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4b528c88-07a0-4dce-84c6-ccd32555bbff,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=4b528c88-07a0-4dce-84c6-ccd32555bbff,4b528c88-07a0-4dce-84c6-ccd32555bbff,,,
HUMAN PRESCRIPTION DRUG LABEL,"CAPSULE; INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INTRAMUSCULAR; ORAL,NDA,020825;020919,Geodon,ZIPRASIDONE; ZIPRASIDONE HYDROCHLORIDE; ZIPRASIDONE MESYLATE,2022/02/23,Atypical Antipsychotic,2001,ROERIG,2003/12/23-; 2019/08/01-; 2021/11/08-; 2023/07/14-; completed:2001/02/05-2020/04/30,0049-0052; 0049-0054; 0049-0056; 0049-0058; 0049-0352; 0049-0354; 0049-0356; 0049-0358; 0049-3920; 0049-3960; 0049-3980; 0049-3990,216X081ORU; 3X6SAX83JZ; 6UKA5VEJ6X,ZIPRASIDONE; ZIPRASIDONE HYDROCHLORIDE; ZIPRASIDONE MESYLATE,ZIPRASIDONE,6UKA5VEJ6X,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/8326928a-2cb6-4f7f-9712-03a425a14c37/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8326928a-2cb6-4f7f-9712-03a425a14c37,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=8326928a-2cb6-4f7f-9712-03a425a14c37,8326928a-2cb6-4f7f-9712-03a425a14c37,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,021817,Reclast,ZOLEDRONIC ACID,2022/07/07,Bisphosphonate,2001,NOVARTIS PHARMACEUTICALS CORPORATION,2007/04/01-,0078-0435,6XC1PAD3KF,ZOLEDRONIC ACID,ZOLEDRONIC ACID ANHYDROUS,70HZ18PH24,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/3c79ff9c-a6f4-405d-b19c-7e473a61dedc/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3c79ff9c-a6f4-405d-b19c-7e473a61dedc,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=3c79ff9c-a6f4-405d-b19c-7e473a61dedc,3c79ff9c-a6f4-405d-b19c-7e473a61dedc,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,203231,zoledronic acid,ZOLEDRONIC ACID,2021/09/20,Bisphosphonate,2001,SAGENT PHARMACEUTICALS,2015/09/01-,25021-826,6XC1PAD3KF,zoledronic acid,zoledronic acid anhydrous,70HZ18PH24,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/deb89be7-f40e-4fd4-a2cb-96634b45da84/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=deb89be7-f40e-4fd4-a2cb-96634b45da84,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=deb89be7-f40e-4fd4-a2cb-96634b45da84,deb89be7-f40e-4fd4-a2cb-96634b45da84,,,
HUMAN PRESCRIPTION DRUG LABEL,"INJECTION, SOLUTION",INTRAVENOUS,NDA,203231,zoledronic acid,ZOLEDRONIC ACID,2021/09/16,Bisphosphonate,2001,SAGENT PHARMACEUTICALS,2013/03/02-,25021-826,6XC1PAD3KF,zoledronic acid,zoledronic acid anhydrous,70HZ18PH24,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/567578e6-cd2d-4339-b0f6-7a15444c0639/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=567578e6-cd2d-4339-b0f6-7a15444c0639,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=567578e6-cd2d-4339-b0f6-7a15444c0639,567578e6-cd2d-4339-b0f6-7a15444c0639,,,
HUMAN PRESCRIPTION DRUG LABEL,"SPRAY, METERED",NASAL,NDA,021450,ZOMIG,ZOLMITRIPTAN,2019/05/31,Serotonin-1b and Serotonin-1d Receptor Agonist,1997,AMNEAL PHARMACEUTICALS,completed:2012/07/02-2025/01/31; completed:2013/12/06-2024/04/30,64896-681; 64896-682,2FS66TH3YW,ZOLMITRIPTAN,ZOLMITRIPTAN,2FS66TH3YW,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/84b51cb9-83f3-4a49-7fa3-1adc0f963658/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=84b51cb9-83f3-4a49-7fa3-1adc0f963658,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=84b51cb9-83f3-4a49-7fa3-1adc0f963658,84b51cb9-83f3-4a49-7fa3-1adc0f963658,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,NDA,215721,zolpidem tartrate,ZOLPIDEM TARTRATE,2023/05/10,gamma-Aminobutyric Acid A Receptor Positive Modulator; gamma-Aminobutyric Acid-ergic Agonist,1992,ALMATICA PHARMA LLC,2023/05/09-,52427-775,WY6W63843K,ZOLPIDEM TARTRATE,ZOLPIDEM,7K383OQI23,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/2f1a3600-9bd6-3651-3ab5-1e4e0b0a3916/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2f1a3600-9bd6-3651-3ab5-1e4e0b0a3916,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=2f1a3600-9bd6-3651-3ab5-1e4e0b0a3916,2f1a3600-9bd6-3651-3ab5-1e4e0b0a3916,,,
HUMAN PRESCRIPTION DRUG LABEL,TABLET,ORAL,NDA,021997,Edluar,ZOLPIDEM TARTRATE,2022/08/15,gamma-Aminobutyric Acid A Receptor Positive Modulator; gamma-Aminobutyric Acid-ergic Agonist,1992,MEDA PHARMACEUTICALS INC,2009/07/24-,0037-6010; 0037-6050,WY6W63843K,ZOLPIDEM TARTRATE,ZOLPIDEM,7K383OQI23,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/a32884d0-85b5-11de-8a39-0800200c9a66/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a32884d0-85b5-11de-8a39-0800200c9a66,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=a32884d0-85b5-11de-8a39-0800200c9a66,a32884d0-85b5-11de-8a39-0800200c9a66,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, COATED",ORAL,NDA,021774,Ambien CR,ZOLPIDEM TARTRATE,2019/02/12,gamma-Aminobutyric Acid A Receptor Positive Modulator; gamma-Aminobutyric Acid-ergic Agonist,1992,SANOFI AVENTIS U S LLC,2005/09/19-,0024-5501; 0024-5521,WY6W63843K,ZOLPIDEM TARTRATE,ZOLPIDEM,7K383OQI23,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/404c858c-89ac-4c9d-8a96-8702a28e6e76/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=404c858c-89ac-4c9d-8a96-8702a28e6e76,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=404c858c-89ac-4c9d-8a96-8702a28e6e76,404c858c-89ac-4c9d-8a96-8702a28e6e76,,,
HUMAN PRESCRIPTION DRUG LABEL,"TABLET, FILM COATED",ORAL,NDA,019908,Ambien,ZOLPIDEM TARTRATE,2019/02/12,gamma-Aminobutyric Acid A Receptor Positive Modulator; gamma-Aminobutyric Acid-ergic Agonist,1992,SANOFI AVENTIS U S LLC,1993/04/01-,0024-5401; 0024-5421,WY6W63843K,ZOLPIDEM TARTRATE,ZOLPIDEM,7K383OQI23,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/c36cadf4-65a4-4466-b409-c82020b42452/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c36cadf4-65a4-4466-b409-c82020b42452,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=c36cadf4-65a4-4466-b409-c82020b42452,c36cadf4-65a4-4466-b409-c82020b42452,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,NDA,020789,Zonegran,ZONISAMIDE,2023/11/17,Anti-epileptic Agent,,CONCORDIA PHARMACEUTICALS INC,2000/03/27-,59212-680; 59212-681,459384H98V,ZONISAMIDE,ZONISAMIDE,459384H98V,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/d12de43e-3ac3-4335-bc85-70d7366a91eb/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d12de43e-3ac3-4335-bc85-70d7366a91eb,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=d12de43e-3ac3-4335-bc85-70d7366a91eb,d12de43e-3ac3-4335-bc85-70d7366a91eb,,,
HUMAN PRESCRIPTION DRUG LABEL,SUSPENSION,ORAL,NDA,214273,ZONISADE,ZONISAMIDE,2023/03/30,Anti-epileptic Agent,2000,AZURITY PHRAMACEUTICALS INC,2022/07/15-,52652-8001,459384H98V,ZONISAMIDE,ZONISAMIDE,459384H98V,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/ac16fa15-32e9-4f92-8bc6-d8d41ae002c6/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ac16fa15-32e9-4f92-8bc6-d8d41ae002c6,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=ac16fa15-32e9-4f92-8bc6-d8d41ae002c6,ac16fa15-32e9-4f92-8bc6-d8d41ae002c6,,,
HUMAN PRESCRIPTION DRUG LABEL,CAPSULE,ORAL,NDA,217369,ZURZUVAE,ZURANOLONE,2023/11/01,Neuroactive Steroid Gamma-Aminobutyric Acid A Receptor Positive Modulator,2023,BIOGEN MA INC,2023/10/31-,64406-029; 64406-030; 64406-031,7ZW49N180B,ZURANOLONE,ZURANOLONE,7ZW49N180B,https://fdalabel.fda.gov:8443/fdalabel/services/spl/set-ids/f18e53b0-d0bb-422d-8de7-ab64b7292b29/spl-doc,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f18e53b0-d0bb-422d-8de7-ab64b7292b29,https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=f18e53b0-d0bb-422d-8de7-ab64b7292b29,f18e53b0-d0bb-422d-8de7-ab64b7292b29,,,